PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hashimoto, Y; Akiyama, Y; Yuasa, Y				Hashimoto, Yutaka; Akiyama, Yoshimitsu; Yuasa, Yasuhito			Multiple-to-Multiple Relationships between MicroRNAs and Target Genes in Gastric Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; SCIRRHOUS CARCINOMA; CELLS; PROLIFERATION; DIFFERENTIATION; CARCINOGENESIS; ESTABLISHMENT; METHYLATION; EXPRESSION; INHIBITORS	MicroRNAs (miRNAs) act as transcriptional regulators and play pivotal roles in carcinogenesis. According to miRNA target databases, one miRNA may regulate many genes as its targets, while one gene may be targeted by many miRNAs. These findings indicate that relationships between miRNAs and their targets may not be one-to-one. However, many reports have described only a one-to-one, one-to-multiple or multiple-to-one relationship between miRNA and its target gene in human cancers. Thus, it is necessary to determine whether or not a combination of some miRNAs would regulate multiple targets and be involved in carcinogenesis. To find some groups of miRNAs that may synergistically regulate their targets in human gastric cancer (GC), we re-analyzed our previous miRNA expression array data and found that 50 miRNAs were up-regulated on treatment with 5-aza-2'-deoxycytidine in a GC cell line. The "TargetScan'' miRNA target database predicted that some of these miRNAs have common target genes. We also referred to the GEO database for expression of these common target genes in human GCs, which might be related to gastric carcinogenesis. In this study, we analyzed two miRNA combinations, miR-224 and -452, and miR-181c and -340. Over-expression of both miRNA combinations dramatically down-regulated their target genes, DPYSL2 and KRAS, and KRAS and MECP2, respectively. These miRNA combinations synergistically decreased cell proliferation upon transfection. Furthermore, we revealed that these miRNAs were down-regulated through promoter hypermethylation in GC cells. Thus, it is likely that the relationships between miRNAs and their targets are not one-to-one but multiple-to-multiple in GCs, and that these complex relationships may be related to gastric carcinogenesis.	[Hashimoto, Yutaka; Akiyama, Yoshimitsu; Yuasa, Yasuhito] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Yuasa, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan.	yuasa.monc@tmd.ac.jp	Hashimoto, Yutaka/B-9821-2017	Hashimoto, Yutaka/0000-0003-2188-2957	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants from the A3 Foresight Program of the Japan Society for the Promotion of Science (JSPS) (YY), and Research Fellowships of the JSPS for Young Scientists (YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cheung HH, 2011, ONCOGENE, V30, P3404, DOI 10.1038/onc.2011.60; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Hashimoto Y, 2010, CARCINOGENESIS, V31, P777, DOI 10.1093/carcin/bgq013; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jimeno A, 2009, J CLIN ONCOL, V27, P1130, DOI 10.1200/JCO.2008.19.8168; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Mencia N, 2011, BIOCHEM PHARMACOL, V82, P1572, DOI 10.1016/j.bcp.2011.08.009; Merritt WM, 2010, CANCER RES, V70, P2571, DOI 10.1158/0008-5472.CAN-09-2536; Ooi CH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002415; Shimada S, 2012, GUT, V61, P344, DOI 10.1136/gutjnl-2011-300050; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wen XZ, 2004, BIOCHEM BIOPH RES CO, V316, P100, DOI 10.1016/j.bbrc.2004.02.016; White NMA, 2010, BRIT J CANCER, V102, P1244, DOI 10.1038/sj.bjc.6605634; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; YANAGIHARA K, 1993, INT J CANCER, V54, P200, DOI 10.1002/ijc.2910540207; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141	26	166	170	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62589	10.1371/journal.pone.0062589	http://dx.doi.org/10.1371/journal.pone.0062589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667495	gold, Green Submitted, Green Published			2022-12-27	WOS:000319055600030
J	El Bakkali, A; Haouane, H; Moukhli, A; Costes, E; Van Damme, P; Khadari, B				El Bakkali, Ahmed; Haouane, Hicham; Moukhli, Abdelmajid; Costes, Evelyne; Van Damme, Patrick; Khadari, Bouchaib			Construction of Core Collections Suitable for Association Mapping to Optimize Use of Mediterranean Olive (Olea europaea L.) Genetic Resources	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEAT; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; SAMPLING STRATEGIES; GENOMIC SELECTION; CANDIDATE GENES; DIVERSITY; MARKERS; CULTIVARS; ALGORITHM	Phenotypic characterisation of germplasm collections is a decisive step towards association mapping analyses, but it is particularly expensive and tedious for woody perennial plant species. Characterisation could be more efficient if focused on a reasonably sized subset of accessions, or so-called core collection (CC), reflecting the geographic origin and variability of the germplasm. The questions that arise concern the sample size to use and genetic parameters that should be optimized in a core collection to make it suitable for association mapping. Here we investigated these questions in olive (Olea europaea L.), a perennial fruit species. By testing different sampling methods and sizes in a worldwide olive germplasm bank (OWGB Marrakech, Morocco) containing 502 unique genotypes characterized by nuclear and plastid loci, a two-step sampling method was proposed. The Shannon- Weaver diversity index was found to be the best criterion to be maximized in the first step using the CORE HUNTER program. A primary core collection of 50 entries (CC50)was defined that captured more than 80% of the diversity. This latter was subsequently used as a kernel with the MSTRAT program to capture the remaining diversity. 200 core collections of 94 entries (CC94) were thus built for flexibility in the choice of varieties to be studied. Most entries of both core collections (CC50 and CC94) were revealed to be unrelated due to the low kinship coefficient, whereas a genetic structure spanning the eastern and western/central Mediterranean regions was noted. Linkage disequilibrium was observed in CC94 which was mainly explained by a genetic structure effect as noted for OWGB Marrakech. Since they reflect the geographic origin and diversity of olive germplasm and are of reasonable size, both core collections will be of major interest to develop long-term association studies and thus enhance genomic selection in olive species.	[El Bakkali, Ahmed; Haouane, Hicham; Costes, Evelyne; Khadari, Bouchaib] INRA, UMR Ameliorat Genet & Adaptat Plantes AGAP, F-34060 Montpellier, France; [El Bakkali, Ahmed; Haouane, Hicham] Montpellier SupAgro, UMR AGAP, Montpellier, France; [El Bakkali, Ahmed] INRA Meknes, UR Ameliorat Plantes & Conservat Ressources Phyto, Meknes, Morocco; [El Bakkali, Ahmed; Van Damme, Patrick] Univ Ghent, Dept Plant Prod, B-9000 Ghent, Belgium; [Moukhli, Abdelmajid] INRA Marrakech, UR Ameliorat Plantes, Marrakech, Morocco; [Van Damme, Patrick] Czech Univ Life Sci Prague, Inst Trop & Subtrop, Prague, Czech Republic; [Khadari, Bouchaib] Conservatoire Bot Natl Mediterraneen, UMR AGAP, Montpellier, France	INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Moulay Ismail University of Meknes; Ghent University; Czech University of Life Sciences Prague; Universite de Montpellier	Khadari, B (corresponding author), INRA, UMR Ameliorat Genet & Adaptat Plantes AGAP, F-34060 Montpellier, France.	khadari@supagro.inra.fr	, Patrick/AAI-8779-2020; Van Damme, Patrick/H-6693-2018; Khadari, Bouchaib/K-7965-2015	Van Damme, Patrick/0000-0002-2548-633X; Moukhli, Abdelmajid/0000-0001-5933-7167; Ahmed, El Bakkali/0000-0002-2936-8197	Merit Scholarship Program for High Technology of the Islamic Development Bank (IDB) [1430H/2009]; Agropolis Foundation FruitMed [0901-007]	Merit Scholarship Program for High Technology of the Islamic Development Bank (IDB); Agropolis Foundation FruitMed	This study was supported by the Merit Scholarship Program for High Technology 1430H/2009 of the Islamic Development Bank (IDB) and by Agropolis Foundation FruitMed No 0901-007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Angiolillo A, 1999, THEOR APPL GENET, V98, P411, DOI 10.1007/s001220051087; Antunes AFS, 1999, ACTA HORTIC, P103, DOI 10.17660/ActaHortic.1999.474.17; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Arunyawat U, 2012, TREE GENET GENOMES, V8, P737, DOI 10.1007/s11295-011-0460-9; Baldoni L, 2009, MOL BREEDING, V24, P213, DOI 10.1007/s11032-009-9285-8; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Barnaud A, 2006, THEOR APPL GENET, V112, P708, DOI 10.1007/s00122-005-0174-1; Bartolini G, 1999, ACTA HORTIC, P159, DOI 10.17660/ActaHortic.1999.474.30; Bartolini G, 2002, CLASSIFICATION ORIGI, P85; Bartolini G., 1998, OLIVE GERMPLASM CULT; Bartolini G, 2005, OLIVE GERMPLASM CULT; Bartolini G, 2008, OLIVE GERMPLASM OLEA; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Bellini E., 2008, Advances in Horticultural Science, V22, P73; Ben Sadok I, 2013, TREE GENET GENOMES, V9, P205, DOI 10.1007/s11295-012-0548-x; Besnard G, 2001, GENET SEL EVOL, V33, pS251, DOI 10.1186/BF03500883; Besnard G, 2001, J AM SOC HORTIC SCI, V126, P668, DOI 10.21273/JASHS.126.6.668; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Cao K, 2012, TREE GENET GENOMES, V8, P975, DOI 10.1007/s11295-012-0477-8; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Borba TCD, 2010, GENET MOL BIOL, V33, P515, DOI 10.1590/S1415-47572010005000065; Del Carpio DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019624; Diez CM, 2012, CROP SCI, V52, P211, DOI 10.2135/cropsci2011.02.0110; Ehrenreich IM, 2007, GENETICS, V176, P1223, DOI 10.1534/genetics.107.071928; El Aabidine AZ, 2010, CROP SCI, V50, P2291, DOI 10.2135/cropsci2009.10.0632; Escribano P, 2008, ANN APPL BIOL, V153, P25, DOI 10.1111/j.1744-7348.2008.00232.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feng JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006121; Franco J, 2006, CROP SCI, V46, P854, DOI 10.2135/cropsci2005.07-0201; Franco J, 2005, CROP SCI, V45, P1035, DOI 10.2135/cropsci2004.0292; Frankel O.H., 1984, CROP GENETIC RESOURC, P249; Gonzalez-Martinez SC, 2006, GENETICS, V172, P1915, DOI 10.1534/genetics.105.047126; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Grenier C, 2000, THEOR APPL GENET, V101, P190, DOI 10.1007/s001220051468; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haouane H, 2011, GENETICA, V139, P1083, DOI 10.1007/s10709-011-9608-7; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Hu J, 2000, THEOR APPL GENET, V101, P264, DOI 10.1007/s001220051478; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jestin C, 2011, MOL BREEDING, V27, P271, DOI 10.1007/s11032-010-9429-x; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Khadari B, 2003, THEOR APPL GENET, V106, P521, DOI 10.1007/s00122-002-1079-x; Khadari B, 2010, J AM SOC HORTIC SCI, V135, P548, DOI 10.21273/JASHS.135.6.548; Laucou V, 2011, THEOR APPL GENET, V122, P1233, DOI 10.1007/s00122-010-1527-y; Le Cunff L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-31; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Marita JM, 2000, GENET RESOUR CROP EV, V47, P515, DOI 10.1023/A:1008784610962; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Mendil M., 2006, CATALOGUE VARIETES A; Mezmouk S, 2011, THEOR APPL GENET, V122, P1149, DOI 10.1007/s00122-010-1519-y; Miranda C, 2010, J AM SOC HORTIC SCI, V135, P428, DOI 10.21273/JASHS.135.5.428; Moutier N, 2004, IDENTIFICATION CARAC, V1; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nei M., 1987, MOL EVOLUTIONARY GEN; Padula G., 2008, Advances in Horticultural Science, V22, P87; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Pessoa-Filho M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-127; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Pritsa T, 1999, ACTA HORTIC, P117, DOI 10.17660/ActaHortic.1999.474.20; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Reale S, 2006, GENOME, V49, P1193, DOI 10.1139/G06-068; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Richards CM, 2009, J AM SOC HORTIC SCI, V134, P228, DOI 10.21273/JASHS.134.2.228; Ripa V., 2008, Advances in Horticultural Science, V22, P95; Rosati A, 2010, SCI HORTIC-AMSTERDAM, V126, P200, DOI 10.1016/j.scienta.2010.07.010; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarri V, 2006, GENOME, V49, P1606, DOI 10.1139/G06-126; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Shannon C. E., 1949, MATH THEORY COMMUNIC; Skot L, 2007, GENETICS, V177, P535, DOI 10.1534/genetics.107.071522; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Thachuk C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-243; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Trigui A, 2002, OLIVIERS TUNISIE CAT, V1; Van Hintum T. J. L., 2000, IPGRI TECHNICAL B; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang YZ, 2011, SCI HORTIC-AMSTERDAM, V128, P311, DOI 10.1016/j.scienta.2011.01.025; Wei XM, 2006, THEOR APPL GENET, V114, P155, DOI 10.1007/s00122-006-0418-8; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao WG, 2010, MOL BREEDING, V26, P639, DOI 10.1007/s11032-010-9400-x; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	98	58	59	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61265	10.1371/journal.pone.0061265	http://dx.doi.org/10.1371/journal.pone.0061265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667437	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700011
J	Roperto, S; Russo, V; Ozkul, A; Corteggio, A; Sepici-Dincel, A; Catoi, C; Esposito, I; Riccardi, MG; Urraro, C; Luca, R; Ceccarelli, DM; Longo, M; Roperto, F				Roperto, Sante; Russo, Valeria; Ozkul, Ayhan; Corteggio, Annunziata; Sepici-Dincel, Aylin; Catoi, Cornel; Esposito, Iolanda; Riccardi, Marita G.; Urraro, Chiara; Luca, Roberta; Ceccarelli, Dora M.; Longo, Michele; Roperto, Franco			Productive Infection of Bovine Papillomavirus Type 2 in the Urothelial Cells of Naturally Occurring Urinary Bladder Tumors in Cattle and Water Buffaloes	PLOS ONE			English	Article							L1 CAPSID PROTEIN; ORGANIZATION; PROGRESSION; LESIONS; CANCER; CYCLE	Background: Papillomaviruses (PVs) are highly epitheliotropic as they usually establish productive infections within squamous epithelia of the skin, the anogenital tract and the oral cavity. In this study, early (E) and late (L) protein expression of bovine papillomavirus type 2 (BPV-2) in the urothelium of the urinary bladder is described in cows and water buffaloes suffering from naturally occurring papillomavirus-associated urothelial bladder tumors. Methods and Findings: E5 protein, the major oncoprotein of the BPV-2, was detected in all tumors. L1 DNA was amplified by PCR, cloned and sequenced and confirmed to be L1 DNA. The major capsid protein, L1, believed to be only expressed in productive papillomavirus infection was detected by Western blot analysis. Immunohistochemical investigations confirmed the presence of L1 protein both in the cytoplasm and nuclei of cells of the neoplastic urothelium. Finally, the early protein E2, required for viral DNA replication and known to be a pivotal factor for both productive and persistent infection, was detected by Western blot and immunohistochemically. Electron microscopic investigations detected electron dense particles, the shape and size of which are consistent with submicroscopic features of viral particles, in nuclei of neoplastic urothelium. Conclusion: This study shows that both active and productive infections by BPV-2 in the urothelium of the bovine and bubaline urinary bladder can occur in vivo.	[Roperto, Sante] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Sez Malattie Infett, Naples, Italy; [Russo, Valeria; Corteggio, Annunziata; Esposito, Iolanda; Riccardi, Marita G.; Urraro, Chiara; Luca, Roberta; Ceccarelli, Dora M.] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Sez Patol Gen, Naples, Italy; [Ozkul, Ayhan] Ankara Univ, Fac Vet Med, Dept Pathol, TR-06100 Ankara, Turkey; [Sepici-Dincel, Aylin] Gazi Univ, Fac Med, Hlth Res & Practice Ctr, Ankara, Turkey; [Catoi, Cornel] Univ Agr Sci & Vet Med, Fac Vet Med, Dept Pathol, Cluj Napoca, Romania; [Longo, Michele] CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, I-80125 Naples, Italy; [Roperto, Franco] Univ Naples Federico II, Dipartimento Biol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Ankara University; Gazi University; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Roperto, S (corresponding author), Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Sez Malattie Infett, Naples, Italy.	sante.roperto@unina.it	riccardi, marita georgia/AAD-3454-2020; Corteggio, Annunziata/AAL-5277-2021; Longo, Michele/AAB-5972-2020; Vecchio, Domenico/I-4102-2013; LONGO, Michele/AAB-9188-2019	riccardi, marita georgia/0000-0002-9097-8939; Vecchio, Domenico/0000-0002-8766-7224; LONGO, Michele/0000-0003-4798-0504; Corteggio, Annunziata/0000-0002-9017-317X; roperto, sante/0000-0001-6210-5519	Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR); Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF); Assessorato alla Sanita della Regione Basilicata; Assessorato alla Sanita della Regione Campania	Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF); Assessorato alla Sanita della Regione Basilicata; Assessorato alla Sanita della Regione Campania	This work was sponsored by grants from the Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR), Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF), and Assessorato alla Sanita della Regione Basilicata and della Regione Campania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2010, AIDS, V24, P2355, DOI 10.1097/QAD.0b013e32833db9ea; [Anonymous], 2007, IARC MON EV CARC RIS; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Borzacchiello G, 2006, ONCOGENE, V25, P1251, DOI 10.1038/sj.onc.1209152; Campo M. S., 1992, CANCER RES, V53, P1; Campo MS, 2006, PAPILLOMAVIRUS RESEARCH: FROM NATURAL HISTORY TO VACCINES AND BEYOND, P1; Campo MS, 2002, VIRUS RES, V89, P249, DOI 10.1016/S0168-1702(02)00193-4; Das Ghosh D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044678; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Doorbar J, 2007, DIS MARKERS, V23, P297, DOI 10.1155/2007/613150; dos Santos RCS, 1998, J GEN VIROL, V79, P2127, DOI 10.1099/0022-1317-79-9-2127; Graham SV, 2006, PAPILLOMAVIRUS RESEARCH: FROM NATURAL HISTORY TO VACCINES AND BEYOND, P193; Griesser H, 2009, AM J CLIN PATHOL, V132, P840, DOI 10.1309/AJCPCU0HBFFFGDTV; Hernandez J, 2011, AM J CLIN PATHOL, V135, P436, DOI 10.1309/AJCPR5VD6NSQRWBN; Johansson C, 2012, EMBO J, V31, P3212, DOI 10.1038/emboj.2012.147; Lunardi M, 2013, VET MICROBIOL, V162, P207, DOI 10.1016/j.vetmic.2012.08.030; Melsheimer P, 2003, ACTA CYTOL, V47, P124, DOI 10.1159/000326491; Middleton K, 2003, J VIROL, V77, P10186, DOI 10.1128/JVI.77.19.10186-10201.2003; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Morgan IM, 2006, PAPILLOMAVIRUS RESEARCH: FROM NATURAL HISTORY TO VACCINES AND BEYOND, P73; Muller M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002761; Pathania S, 2012, TRANSBOUND EMERG DIS, V59, P79, DOI 10.1111/j.1865-1682.2011.01248.x; Peek RM, 2005, CANCER RES, V65, P8583, DOI 10.1158/0008-5472.CAN-05-1777; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Roperto S, 2010, J COMP PATHOL, V142, P95, DOI 10.1016/j.jcpa.2009.08.156; Roperto S, 2008, J GEN VIROL, V89, P3027, DOI 10.1099/vir.0.2008/004457-0; Roperto S, 2013, J GEN VIROL, V94, P403, DOI 10.1099/vir.0.047662-0; Roperto S, 2012, RES VET SCI, V93, P1361, DOI 10.1016/j.rvsc.2012.06.009; Roperto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033569; Roperto S, 2011, J GEN VIROL, V92, P1787, DOI 10.1099/vir.0.031740-0; Roperto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010299; Sarmadi S, 2012, ARCH GYNECOL OBSTET, V285, P779, DOI 10.1007/s00404-011-2010-y; Shafti-Keramat S, 2009, VIROLOGY, V393, P1, DOI 10.1016/j.virol.2009.07.036; Shigehara K, 2011, J MED VIROL, V83, P277, DOI 10.1002/jmv.21966; Shigehara K, 2011, CANCER-AM CANCER SOC, V117, P2067, DOI 10.1002/cncr.25777; Somvanshi R, 2011, TRANSBOUND EMERG DIS, V58, P327, DOI 10.1111/j.1865-1682.2011.01211.x; Somvanshi R, 2012, TROP ANIM HEALTH PRO, V44, P855, DOI 10.1007/s11250-011-9978-y; Wosiaki SR, 2005, MEM I O CRUZ, V101, P635; Xiao W, 2010, ACTA CYTOL, V54, P661, DOI 10.1159/000325229; Yemelyanova A, 2013, MODERN PATHOL, V26, P268, DOI 10.1038/modpathol.2012.156; Zhu W, 2012, ARCH VIROL, V157, P85, DOI 10.1007/s00705-011-1140-7; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	43	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62227	10.1371/journal.pone.0062227	http://dx.doi.org/10.1371/journal.pone.0062227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667460	gold, Green Submitted, Green Published			2022-12-27	WOS:000319654700027
J	Wang, F; Sun, GP; Zou, YF; Zhong, F; Ma, T; Li, XQ				Wang, Fang; Sun, Guoping; Zou, Yanfeng; Zhong, Fei; Ma, Tai; Li, Xiaoqiu			Protective Role of Helicobacter pylori Infection in Prognosis of Gastric Cancer: Evidence from 2454 Patients with Gastric Cancer	PLOS ONE			English	Article							CLINICOPATHOLOGICAL FEATURES; ADJUVANT CHEMOTHERAPY; NO INFLUENCE; SURVIVAL; METAANALYSIS; CARCINOMA; MUCOSA	Background: A number of studies have investigated the association between Helicobacter pylori (H. pylori) infection and the prognosis of gastric cancer (GC), with inconsistent and inconclusive results. We performed a meta-analysis to derive a more precise estimation of the association. Methodology/Principal Findings: A systematic search of PubMed, EMBASE, Cochrane and Chinese wanfang databases was performed with the last search updated on February 19, 2013. The hazard ratio (HR) and its 95% confidence interval (95% CI) were used to assess the strength of association. A total of 12 studies including 2454 patients with GC were involved in this meta-analysis. The pooled HR was 0.71 (95% CI: 0.57-0.87; P = 0.001) for OS and 0.60 (95% CI: 0.30-1.18; P = 0.139) for DFS in GC patients, respectively. The protective role of H. pylori infection in the prognosis of GC was also observed among different subgroups stratified by ethnicity, statistical methodology, H. pylori evaluation method and quality assessment. There was no evidence of publication bias. Conclusions/Significance: This meta-analysis suggests a protective role for H. pylori infection in the prognosis of GC. The underlying mechanisms need to be further elucidated, which could provide new therapeutic approaches for GC.	[Wang, Fang; Sun, Guoping; Zhong, Fei; Ma, Tai; Li, Xiaoqiu] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Anhui, Peoples R China; [Zou, Yanfeng] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Sun, GP (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Anhui, Peoples R China.	sunguoping@ahmu.edu.cn			National Natural Science Foundation of China [81071986, 81272739, 81001283]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81071986, 81272739, 81001283). The funders had no role in study design, data collection and analysis, decision to pubish, or preparation of the manuscript.	Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blaser MJ, 1999, J INFECT DIS, V179, P1523, DOI 10.1086/314785; Chen HY, 2012, CANCER SCI, V103, P73, DOI 10.1111/j.1349-7006.2011.02129.x; Choi IK, 2012, CANCER CHEMOTH PHARM, V70, P555, DOI 10.1007/s00280-012-1944-5; Choi J, 2009, EJC SUPPL, V7, P374, DOI 10.1016/S1359-6349(09)71267-4; Correa Pelayo, 2011, US Gastroenterol Hepatol Rev, V7, P59; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan J, 2008, LUNG CANCER, V61, P91, DOI 10.1016/j.lungcan.2007.11.011; FORMAN D, 1991, BRIT MED J, V302, P1302, DOI 10.1136/bmj.302.6788.1302; Gan Lu, 2011, Academic Journal of Second Military Medical University, V32, P1300; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hur H, 2012, J KOREAN SURG SOC, V83, P203, DOI 10.4174/jkss.2012.83.4.203; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang S, 2009, J CLIN ONCOL, V27; Kang SY, 2010, ANN ONCOL, V21, P229; Kang SY, 2012, INT J CANCER, V130, P948, DOI 10.1002/ijc.26081; Kurtenkov O, 2003, IMMUNOL INVEST, V32, P83, DOI 10.1081/IMM-120019210; Lee HS, 2002, MODERN PATHOL, V15, P632, DOI 10.1038/modpathol.3880578; LEE WJ, 1995, J CLIN GASTROENTEROL, V21, P203, DOI 10.1097/00004836-199510000-00007; LEE WJ, 1995, BRIT J SURG, V82, P802, DOI 10.1002/bjs.1800820627; Marrelli D, 2009, HELICOBACTER, V14, P379; Marrelli D, 2009, CANCER, V115, P2071, DOI 10.1002/cncr.24253; Mattsson A, 1998, J CLIN INVEST, V102, P51, DOI 10.1172/JCI22; Meimarakis G, 2006, LANCET ONCOL, V7, P211, DOI 10.1016/S1470-2045(06)70586-1; Meyer HJ, 2011, DTSCH ARZTEBL INT, V108, P698, DOI 10.3238/arztebl.2011.0698; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Popat S, 2004, J CLIN ONCOL, V22, P529, DOI 10.1200/JCO.2004.05.064; Qiu HB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-374; Rad R, 2006, LANCET ONCOL, V7, P364, DOI 10.1016/S1470-2045(06)70672-6; Safaee Ardekani Gholamreza, 2012, PLoS One, V7, pe47054, DOI 10.1371/journal.pone.0047054; Santos RS, 2010, GASTROENTEROLOGY, V138, pS891; Santos Renata S., 2011, Arq. Gastroenterol., V48, P109, DOI 10.1590/S0004-28032011000200005; Syrios J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-264; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Van Ness M, 2012, J GASTROINTEST ONCOL, V3, P243, DOI 10.3978/j.issn.2078-6891.2012.017; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wu MS, 2002, HEPATO-GASTROENTEROL, V49, P285; Zhang YF, 2012, WORLD J GASTROENTERO, V18, P3602, DOI 10.3748/wjg.v18.i27.3602	41	7	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62440	10.1371/journal.pone.0062440	http://dx.doi.org/10.1371/journal.pone.0062440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667477	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700036
J	Ginsburg, I; Kohen, R; Shalish, M; Varon, D; Shai, E; Koren, E				Ginsburg, Isaac; Kohen, Ron; Shalish, Miri; Varon, David; Shai, Ella; Koren, Erez			The Oxidant-Scavenging Abilities in the Oral Cavity May Be Regulated by a Collaboration among Antioxidants in Saliva, Microorganisms, Blood Cells and Polyphenols: A Chemiluminescence-Based Study	PLOS ONE			English	Article							MICROBIAL HEMOLYSINS; TEA POLYPHENOLS; OXIDATION; SYSTEM; DAMAGE; ERYTHROCYTES; PROTEINASES; CYTOKINES; PEROXIDE; ALBUMIN	Saliva has become a central research issue in oral physiology and pathology. Over the evolution, the oral cavity has evolved the antioxidants uric acid, ascorbate reduced glutathione, plasma-derived albumin and antioxidants polyphenols from nutrients that are delivered to the oral cavity. However, blood cells extravasated from injured capillaries in gingival pathologies, or following tooth brushing and use of tooth picks, may attenuate the toxic activities of H2O2 generated by oral streptococci and by oxidants generated by activated phagocytes. Employing a highly sensitive luminol-dependent chemiluminescence, the DPPH radical and XTT assays to quantify oxidant-scavenging abilities (OSA), we show that saliva can strongly decompose both oxygen and nitrogen species. However, lipophilic antioxidant polyphenols in plants, which are poorly soluble in water and therefore not fully available as effective antioxidants, can nevertheless be solubilized either by small amounts of ethanol, whole saliva or also by salivary albumin and mucin. Plant-derived polyphenols can also act in collaboration with whole saliva, human red blood cells, platelets, and also with catalase-positive microorganisms to decompose reactive oxygen species (ROS). Furthermore, polyphenols from nutrient can avidly adhere to mucosal surfaces, are retained there for long periods and may function as a "slow-release devises'' capable of affecting the redox status in the oral cavity. The OSA of saliva is due to the sum result of low molecular weight antioxidants, albumin, polyphenols from nutrients, blood elements and microbial antioxidants. Taken together, saliva and its antioxidants are considered regulators of the redox status in the oral cavity under physiological and pathological conditions.	[Ginsburg, Isaac; Koren, Erez] Hebrew Univ Jerusalem, Fac Med Dent, Hadassah Med Ctr, Inst Dent Sci, Jerusalem, Israel; [Kohen, Ron; Koren, Erez] Hebrew Univ Jerusalem, Sch Pharm, Hadassah Fac Med, Inst Drug Res,Richard & Jean Zarbin Chair Med Stu, IL-91120 Jerusalem, Israel; [Shalish, Miri] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Orthodont, Jerusalem, Israel; [Varon, David; Shai, Ella] Hadassah Med Ctr, Coagulat Unit, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Ginsburg, I (corresponding author), Hebrew Univ Jerusalem, Fac Med Dent, Hadassah Med Ctr, Inst Dent Sci, Jerusalem, Israel.	ginsburg@mail.huji.ac.il	Kohen, Ron/ABC-2281-2021	Kohen, Ron/0000-0001-7268-9845	Israel Science Foundation [241/04]; Yedidut Foundation (Mexico)	Israel Science Foundation(Israel Science Foundation); Yedidut Foundation (Mexico)	This work was supported by an endowment fund by the late Dr. S. M. Robbins of Cleveland, Ohio, United States, by the Israel Science Foundation (grant number 241/04) and by the Yedidut Foundation (Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Atsumi T, 1999, ANTIOXID REDOX SIGN, V1, P537, DOI 10.1089/ars.1999.1.4-537; Baxter NJ, 1997, BIOCHEMISTRY-US, V36, P5566, DOI 10.1021/bi9700328; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chapple ILC, 2002, J CLIN PATHOL-MOL PA, V55, P367; Fabian TK, 2008, CHEM BIOL SALIVA HLT; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; GINSBURG I, 1995, FREE RADICAL RES, V22, P489, DOI 10.3109/10715769509150323; Ginsburg I, 1998, MED HYPOTHESES, V51, P337, DOI 10.1016/S0306-9877(98)90059-7; Ginsburg I, 2012, ORAL DIS, DOI [10.1111/odi.12038, DOI 10.1111/0DI.12038]; Ginsburg Isaac, 2004, Inflammopharmacology, V12, P305, DOI 10.1163/1568560043696218; Ginsburg Isaac, 1999, Inflammopharmacology, V7, P47, DOI 10.1007/s10787-999-0025-9; Ginsburg I, 2012, ARCH ORAL BIOL, V57, P1327, DOI 10.1016/j.archoralbio.2012.04.019; Ginsburg I, 2011, ARCH BIOCHEM BIOPHYS, V506, P12, DOI 10.1016/j.abb.2010.11.009; Gorelik S, 2008, FASEB J, V22, P41, DOI 10.1096/fj.07-9041com; Gorelik S, 2012, ARCH INTERN MED, V172, P1424, DOI 10.1001/archinternmed.2012.3638; GRISHAM MB, 1990, AM J PHYSIOL, V258, pC115, DOI 10.1152/ajpcell.1990.258.1.C115; Grossman S., 2011, Trends in Cancer Research, Volume 7, P57; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Halliwell B., 2007, FREE RADICALS BIOL M; HAMILTONMILLER JMT, 1995, ANTIMICROB AGENTS CH, V39, P2375, DOI 10.1128/AAC.39.11.2375; Hua Y, 2006, J NEUROSURG, V104, P305, DOI 10.3171/jns.2006.104.2.305; Koren E, 2010, EXP BIOL MED, V235, P689, DOI 10.1258/ebm.2010.009370; Koren E, 2009, J AGR FOOD CHEM, V57, P7644, DOI 10.1021/jf9006449; Koren E, 2009, EXP BIOL MED, V234, P940, DOI 10.3181/0901-RM-22; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kusuda M, 2006, BIOSCI BIOTECH BIOCH, V70, P152, DOI 10.1271/bbb.70.152; Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013; Lee MJ, 2004, CANCER EPIDEM BIOMAR, V13, P132, DOI 10.1158/1055-9965.EPI-03-0040; Liskmann S, 2007, CLIN ORAL IMPLAN RES, V18, P27, DOI 10.1111/j.1600-0501.2006.01296.x; Lotito SB, 2000, BIOL RES, V33, P151; Mathes SH, 2010, BIOTECHNOL BIOENG, V107, P1029, DOI 10.1002/bit.22893; MEHANSHO H, 1987, ANNU REV NUTR, V7, P423, DOI 10.1146/annurev.nu.07.070187.002231; Mueller S, 1997, BLOOD, V90, P4973, DOI 10.1182/blood.V90.12.4973.4973_4973_4978; Nagler RM, 2002, FREE RADICAL BIO MED, V32, P268, DOI 10.1016/S0891-5849(01)00806-1; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Ofek I, 2003, FEMS IMMUNOL MED MIC, V38, P181, DOI 10.1016/S0928-8244(03)00228-1; Richards RS, 1998, MED HYPOTHESES, V50, P363, DOI 10.1016/S0306-9877(98)90206-7; Sakanaka S, 1996, BIOSCI BIOTECH BIOCH, V60, P745, DOI 10.1271/bbb.60.745; Santangelo Carmela, 2007, Ann Ist Super Sanita, V43, P394; Sculley DV, 2002, P NUTR SOC, V61, P137, DOI 10.1079/PNS2001141; Sies H, 2007, CELL MOL LIFE SCI, V64, P2181, DOI 10.1007/s00018-007-7230-8; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; THOMAS EL, 1978, INFECT IMMUN, V20, P456, DOI 10.1128/IAI.20.2.456-463.1978; TOTH KM, 1984, J CLIN INVEST, V74, P292, DOI 10.1172/JCI111414	46	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63062	10.1371/journal.pone.0063062	http://dx.doi.org/10.1371/journal.pone.0063062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658797	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500053
J	Nichols, EK; Talley, LE; Birungi, N; McClelland, A; Madraa, E; Chandia, AB; Nivet, J; Flores-Ayala, R; Serdula, MK				Nichols, Erin K.; Talley, Leisel E.; Birungi, Nelly; McClelland, Amanda; Madraa, Elizabeth; Chandia, Agnes B.; Nivet, Jacqueline; Flores-Ayala, Rafael; Serdula, Mary K.			Suspected Outbreak of Riboflavin Deficiency among Populations Reliant on Food Assistance: A Case Study of Drought-Stricken Karamoja, Uganda, 2009-2010	PLOS ONE			English	Article							MICRONUTRIENT DEFICIENCIES; IRON	Background: In 2009, a humanitarian response was launched to address a food security and livelihoods crisis in Karamoja, Uganda. During a polio immunization campaign in mid-August 2009, health workers in Nakapiripit District reported a concern about an increase in mouth sores, or angular stomatitis (AS) and gum ulcerations, among children in one village, and an investigation was launched. Objective: This article describes the investigation, lessons learned, and provides guidance for monitoring micronutrient deficiencies among populations receiving food assistance. Design: An investigation into a suspected outbreak of riboflavin (vitamin B2) deficiency was initiated, including a rapid assessment, mass screening, a convenience sample collection of blood specimens (n = 58 symptomatic cases and n = 18 asymptomatic individuals), and analysis of the general food ration (70% ration). Results: Findings showed signs of AS in only 399 (0.2%) of 179,172 screened individuals, including adults and children. Biochemical analysis confirmed riboflavin deficiency in 84.5% of specimens from symptomatic individuals and 94.4% of specimens from asymptomatic individuals. Ration distribution data showed that 55% of distributions provided less than half the riboflavin RDA. Conclusion: Evidence was insufficient to confirm an actual outbreak of riboflavin deficiency, though the present investigation adds further documentation that micronutrient deficiencies continue to persist among populations in emergency settings. This article describes challenges, lessons learned, and guidance for monitoring micronutrient deficiencies among food assistance recipients, including: ongoing nutrition monitoring and surveillance; training and sensitization about micronutrient deficiencies, sensitization of the population about locally-available food, and identifying ways to improve micronutrient interventions.	[Nichols, Erin K.] US PHS, Epidem Intelligence Serv Assigned, Div Nutr Phys Act & Obes, Ctr Dis Control & Prevent,Commissioned Corps, Atlanta, GA USA; [Talley, Leisel E.] Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth, Atlanta, GA USA; [Birungi, Nelly] UNICEF Uganda Country Off, Kampala, Uganda; [McClelland, Amanda] Concern Worldwide Emergency Response Team, Kampala, Uganda; [Madraa, Elizabeth; Chandia, Agnes B.] Minist Hlth Uganda, Nutr Unit, Kampala, Uganda; [Nivet, Jacqueline] United Nations World Food Programme, Off Country Director, Kampala, Uganda; [Flores-Ayala, Rafael; Serdula, Mary K.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Int Micronutrient Malnutr Prevent & Control Tea, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; United States Public Health Service; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Nichols, EK (corresponding author), US PHS, Epidem Intelligence Serv Assigned, Div Nutr Phys Act & Obes, Ctr Dis Control & Prevent,Commissioned Corps, Atlanta, GA USA.	EKNichols@cdc.gov			Concern Worldwide, UNICEF; U.S. Centers for Disease Control and Prevention (CDC); World Food Programme (WFP); World Health Organization (WHO)	Concern Worldwide, UNICEF; U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); World Food Programme (WFP); World Health Organization (WHO)(World Health Organization)	Funding and technical assistance for this investigation were provided by Concern Worldwide, UNICEF, the U.S. Centers for Disease Control and Prevention (CDC), World Food Programme (WFP), and World Health Organization (WHO). The funders had a role in design, data collection, data review, data analysis, and biological testing.	BATES CJ, 1994, BRIT J NUTR, V72, P601, DOI 10.1079/BJN19940062; Bickley LS, 2007, BATES GUIDE PHYS EXA, P230; Blanck HM, 2002, AM J CLIN NUTR, V76, P430, DOI 10.1093/ajcn/76.2.430; Branca F, 2002, ANN NUTR METAB, V46, P8, DOI 10.1159/000066397; de Pee S, 2008, FOOD NUTR BULL, V29, P232, DOI 10.1177/156482650802900309; Orient JM, 2005, SAPIRAS ART SCI BEDS, P260; POWERS HJ, 1995, P NUTR SOC, V54, P509, DOI 10.1079/PNS19950019; Prinzo ZW, 2002, P NUTR SOC, V61, P251, DOI 10.1079/PNS2002151; Ramakrishnan U, 2002, NUTR REV, V60, pS46, DOI 10.1301/00296640260130731; The Sphere Project, 2010, HUM CHART MIN STAND, P103; Uganda Ministry of Health, 2008, SUMM NUTR HLTH ASS K; UNHCR UNICEF WFP WHO, 2002, FOOD NUTR NEEDS EM; WFP, 2009, VULN AN MAPP WFP; ZeptoMetrix Corporation, 2006, GLUT RED ASS KIT	14	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62976	10.1371/journal.pone.0062976	http://dx.doi.org/10.1371/journal.pone.0062976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658790	gold, Green Published, Green Submitted			2022-12-27	WOS:000321200500047
J	de Souza, WR; Morais, ER; Krohn, NG; Savoldi, M; Goldman, MHS; Rodrigues, F; Caldana, C; Semelka, CT; Tikunov, AP; Macdonald, JM; Goldman, GH				de Souza, Wagner R.; Morais, Enyara Rezende; Krohn, Nadia Graciele; Savoldi, Marcela; Goldman, Maria Helena S.; Rodrigues, Fernando; Caldana, Camila; Semelka, Charles T.; Tikunov, Andrey P.; Macdonald, Jeffrey M.; Goldman, Gustavo Henrique			Identification of Metabolic Pathways Influenced by the G-Protein Coupled in Aspergillus nidulans	PLOS ONE			English	Article							AMINO-ACID PERMEASES; MAJOR FACILITATOR SUPERFAMILY; NUCLEAR-MAGNETIC-RESONANCE; SACCHAROMYCES-CEREVISIAE; SEXUAL DEVELOPMENT; KINASE-A; SECONDARY METABOLISM; FUNGAL DEVELOPMENT; MASS-SPECTROMETRY; GENE	Heterotrimeric G-protein-mediated signaling pathways play a pivotal role in transmembrane signaling in eukaryotes. Our main aim was to identify signaling pathways regulated by A. nidulans GprB and GprD G-protein coupled receptors (GPCRs). When these two null mutant strains were compared to the wild-type strain, the Delta gprB mutant showed an increased protein kinase A (PKA) activity while growing in glucose 1% and during starvation. In contrast, the Delta gprD has a much lower PKA activity upon starvation. Transcriptomics and 1(H) NMR-based metabolomics were performed on two single null mutants grown on glucose. We noted modulation in the expression of 11 secondary metabolism gene clusters when the Delta gprB and Delta gprD mutant strains were grown in 1% glucose. Several members of the sterigmatocystin-aflatoxin gene cluster presented down-regulation in both mutant strains. The genes of the NR-PKS monodictyphenone biosynthesis cluster had overall increased mRNA accumulation in Delta gprB, while in the Delta gprD mutant strain the genes had decreased mRNA accumulation. Principal component analysis of the metabolomic data demonstrated that there was a significant metabolite shift in the Delta gprD strain. The 1(H) NMR analysis revealed significant expression of essential amino acids with elevated levels in the Delta gprD strain, compared to the wild-type and Delta gprB strains. With the results, we demonstrated the differential expression of a variety of genes related mainly to secondary metabolism, sexual development, stress signaling, and amino acid metabolism. We propose that the absence of GPCRs triggered stress responses at the genetic level. The data suggested an intimate relationship among different G-protein coupled receptors, fine-tune regulation of secondary and amino acid metabolisms, and fungal development.	[Caldana, Camila] CTBE, Lab Nacl Ciencia & Tecnol Bioetanol, Campinas, SP, Brazil; [de Souza, Wagner R.; Morais, Enyara Rezende; Krohn, Nadia Graciele; Tikunov, Andrey P.; Goldman, Gustavo Henrique] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-05508 Ribeirao Preto, SP, Brazil; [Goldman, Maria Helena S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Rodrigues, Fernando] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Semelka, Charles T.; Tikunov, Andrey P.; Macdonald, Jeffrey M.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [Semelka, Charles T.; Tikunov, Andrey P.; Macdonald, Jeffrey M.] Univ N Carolina, UNC Metab Facil, Chapel Hill, NC USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade do Minho; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Goldman, GH (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-05508 Ribeirao Preto, SP, Brazil.	ggoldman@usp.br	de Souza, Wagner R/D-8907-2019; Rodrigues, Fernando/T-5299-2018; Rodrigues, Fernando/A-3123-2011; Goldman, Maria Helena S./D-1424-2012; Goldman, Gustavo Henrique/F-1848-2013	de Souza, Wagner R/0000-0002-6287-0074; Rodrigues, Fernando/0000-0001-8436-9398; Goldman, Maria Helena S./0000-0002-6786-9320; Goldman, Gustavo Henrique/0000-0002-2986-350X; Krohn, Nadia Graciele/0000-0001-9933-4163	FAPESP (Fundacao para Amparo a Pesquisa do Estado de Sao Paulo); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); NIH [P30ES10126]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	FAPESP (Fundacao para Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors would like to thank FAPESP (Fundacao para Amparo a Pesquisa do Estado de Sao Paulo) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) for financial support. Funding for the metabolomic studies was provided by NIH grants P30ES10126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affeldt KJ, 2012, TOXINS, V4, P695, DOI 10.3390/toxins4090695; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Bajmoczi M, 1998, BIOCHEM BIOPH RES CO, V243, P205, DOI 10.1006/bbrc.1998.8082; Barker BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-62; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Boernsen KO, 2005, ANAL CHEM, V77, P7255, DOI 10.1021/ac0508604; BRIZA P, 1994, P NATL ACAD SCI USA, V91, P4524, DOI 10.1073/pnas.91.10.4524; Cahova M, 2012, EXP BIOL MED, V237, P211, DOI 10.1258/ebm.2011.011189; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; CHANG YC, 1993, GENETICS, V133, P29; Dechant R, 2008, CURR OPIN CELL BIOL, V20, P678, DOI 10.1016/j.ceb.2008.09.009; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; Eigentler A, 2012, ARCH MICROBIOL, V194, P427, DOI 10.1007/s00203-011-0773-y; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gehrke A, 2010, APPL ENVIRON MICROB, V76, P3989, DOI 10.1128/AEM.00052-10; Gerke J, 2012, APPL ENVIRON MICROB, V78, P8234, DOI 10.1128/AEM.01808-12; Haas H, 2003, BIOCHEM J, V371, P505, DOI 10.1042/BJ20021685; Han KH, 2004, MOL MICROBIOL, V51, P1333, DOI 10.1111/j.1365-2958.2003.03940.x; Hicks J, 2001, MOL MICROBIOL, V39, P1482, DOI 10.1046/j.1365-2958.2001.02332.x; Hoffmann B, 2001, MOL BIOL CELL, V12, P2846, DOI 10.1091/mbc.12.9.2846; Hoffmann B, 2000, MOL MICROBIOL, V37, P28, DOI 10.1046/j.1365-2958.2000.01954.x; Hynes MJ, 2010, EUKARYOT CELL, V9, P1039, DOI 10.1128/EC.00080-10; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; Kim JD, 2011, EUKARYOT CELL, V10, P820, DOI 10.1128/EC.00231-10; Kosugi A, 2001, BIOSCI BIOTECH BIOCH, V65, P728, DOI 10.1271/bbb.65.728; Krysan DJ, 2005, EUKARYOT CELL, V4, P1364, DOI 10.1128/EC.4.8.1364-1374.2005; Kunze M, 2006, BBA-MOL CELL RES, V1763, P1441, DOI 10.1016/j.bbamcr.2006.09.009; Lafon A, 2006, FUNGAL GENET BIOL, V43, P490, DOI 10.1016/j.fgb.2006.02.001; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lowe RGT, 2010, MOL PLANT MICROBE IN, V23, P1605, DOI 10.1094/MPMI-04-10-0092; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; MARKHAM P, 1993, FEMS MICROBIOL REV, V10, P287; NAKAFUKU M, 1988, P NATL ACAD SCI USA, V85, P1374, DOI 10.1073/pnas.85.5.1374; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x; PALL ML, 1981, MICROBIOL REV, V45, P462, DOI 10.1128/MMBR.45.3.462-480.1981; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PEOPLES OP, 1989, J BIOL CHEM, V264, P15298; Perez-Sanchez L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-317; Regenberg B, 2000, YEAST, V16, P1111, DOI 10.1002/1097-0061(20000915)16:12<1111::AID-YEA611>3.0.CO;2-3; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Rolland F, 2000, MOL MICROBIOL, V38, P348, DOI 10.1046/j.1365-2958.2000.02125.x; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Roze LV, 2004, MYCOPATHOLOGIA, V158, P219, DOI 10.1023/B:MYCO.0000041841.71648.6e; Sa-Correia I, 2002, J BIOTECHNOL, V98, P215, DOI 10.1016/S0168-1656(02)00133-5; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; SCHIMIDT A, 1994, MOL CELL BIOL, V14, P6597; Seo JA, 2004, MOL MICROBIOL, V53, P1611, DOI 10.1111/j.1365-2958.2004.04232.x; Shimizu K, 2003, GENETICS, V165, P1095; Shimizu K, 2001, GENETICS, V157, P591; Soid-Raggi G, 2006, MOL MICROBIOL, V59, P854, DOI 10.1111/j.1365-2958.2005.04996.x; Son H, 2011, FUNGAL GENET BIOL, V48, P408, DOI 10.1016/j.fgb.2011.01.002; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; STANBROUGH M, 1995, J BACTERIOL, V177, P94, DOI 10.1128/jb.177.1.94-102.1995; STRINGER MA, 1991, GENE DEV, V5, P1161, DOI 10.1101/gad.5.7.1161; Thevelein JM, 2005, BIOCHEM SOC T, V33, P253, DOI 10.1042/BST0330253; TIKUNOV AP, 2013, CURRENT METABOLOMICS, V1, P1; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1028, DOI 10.1016/j.bbrc.2005.01.064; Valerio A, 2011, AGING-US, V3, P464, DOI 10.18632/aging.100322; Vandamme J, 2012, CELL SIGNAL, V24, P1610, DOI 10.1016/j.cellsig.2012.04.001; Veech RL, 2001, IUBMB LIFE, V51, P241; von Dohren H, 2009, FUNGAL GENET BIOL, V46, pS45, DOI 10.1016/j.fgb.2008.08.008; Yoshizawa F, 2012, J PHARMACOL SCI, V118, P149, DOI 10.1254/jphs.11R05FM; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	70	15	16	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62088	10.1371/journal.pone.0062088	http://dx.doi.org/10.1371/journal.pone.0062088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658706	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000029
J	Li, PC; Green, MD; Forsburg, SL				Li, Pao-Chen; Green, Marc D.; Forsburg, Susan L.			Mutations Disrupting Histone Methylation Have Different Effects on Replication Timing in S. pombe Centromere	PLOS ONE			English	Article							FISSION YEAST CENTROMERES; RNA INTERFERENCE; DNA-REPLICATION; CHROMODOMAIN PROTEIN; EPIGENETIC CONTROL; CHP1 CHROMODOMAIN; SILENCING FACTORS; HETEROCHROMATIN; HP1; COMPLEX	The fission yeast pericentromere comprises repetitive sequence elements packaged into heterchromatin marked by histone H3K9 methylation and Swi6 binding. Transient disruption of Swi6 during S phase allows a period of RNA synthesis which programs the RNAi machinery to maintain histone methylation. However, Swi6 is also required for early replication timing. We show that not only Swi6 but also the chromodomain protein Chp1 are delocalized during S phase. Different from loss of swi6, mutations that disrupt histone methylation in the centromere, chp1 Delta and clr4 Delta, undergo early DNA replication. However, timing is modestly delayed in RNAi mutants dcr1 Delta or rdp1 Delta, while hrr1 Delta mutants resemble swi6 Delta in their replication delay. Finally, we show that recruitment of RNA polymerase II in the centromere occurs independently of replication. These different effects indicate that replication timing is not simply linked to histone methylation.	[Li, Pao-Chen; Green, Marc D.; Forsburg, Susan L.] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA USA	University of Southern California	Forsburg, SL (corresponding author), Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA.	forsburg@usc.edu		Forsburg, Susan L/0000-0002-4895-8598	National Science Foundation [MCB 0640103]; National Institutes of Health [R01 GM059321]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059321] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation MCB 0640103 and by National Institutes of Health R01 GM059321 to SLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Alper BJ, 2012, CHROMOSOME RES, V20, P521, DOI 10.1007/s10577-012-9288-x; Asakawa H, 2005, MOL BIOL CELL, V16, P2325, DOI 10.1091/mbc.e04-11-0996; Auth T, 2006, EXP CELL RES, V312, P3349, DOI 10.1016/j.yexcr.2006.07.014; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Carmichael JB, 2004, MOL BIOL CELL, V15, P1425, DOI 10.1091/mbc.E03-06-0433; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; DeBeauchamp JL, 2008, MOL CELL BIOL, V28, P2154, DOI 10.1128/MCB.01637-07; Dohke K, 2008, GENES CELLS, V13, P1027, DOI 10.1111/j.1365-2443.2008.01225.x; Dorn ES, 2011, EPIGENETICS-US, V6, P552, DOI 10.4161/epi.6.5.15082; Douglas ME, 2012, CURR BIOL, V22, pR81, DOI 10.1016/j.cub.2011.12.028; Ekwall K, 1996, J CELL SCI, V109, P2637; Ekwall K, 2007, ANNU REV GENET, V41, P63, DOI 10.1146/annurev.genet.41.110306.130127; Gilbert DM, 2010, COLD SH Q B, V75, P143, DOI 10.1101/sqb.2010.75.011; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hayashi A, 2012, P NATL ACAD SCI USA, V109, P6159, DOI 10.1073/pnas.1116972109; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Hayashi MT, 2009, NAT CELL BIOL, V11, P357, DOI 10.1038/ncb1845; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Hodson JA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng134; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kim SM, 2003, GENE DEV, V17, P330, DOI 10.1101/gad.1046203; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Knott SRV, 2009, EPIGENETICS-US, V4, P262; Lejeune E, 2010, COLD SH Q B, V75, P275, DOI 10.1101/sqb.2010.75.024; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Li PC, 2013, CELL REP, V3, P638, DOI 10.1016/j.celrep.2013.02.007; Li PC, 2011, CELL CYCLE, V10, P323, DOI 10.4161/cc.10.2.14552; LIMADEFARIA A, 1968, NATURE, V217, P138, DOI 10.1038/217138a0; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Partridge JF, 2000, GENE DEV, V14, P783; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Patel PK, 2008, MOL BIOL CELL, V19, P5550, DOI 10.1091/mbc.E08-06-0645; Petrie VJ, 2005, MOL CELL BIOL, V25, P2331, DOI 10.1128/MCB.25.6.2331-2346.2005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pidoux AL, 2000, J CELL SCI, V113, P4177; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Rougemaille M, 2008, J BIOL CHEM, V283, P25770, DOI 10.1074/jbc.C800140200; Rougemaille M, 2012, P NATL ACAD SCI USA, V109, P11258, DOI 10.1073/pnas.1204947109; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schalch T, 2009, MOL CELL, V34, P36, DOI 10.1016/j.molcel.2009.02.024; Schwaiger M, 2010, GENOME RES, V20, P771, DOI 10.1101/gr.101790.109; Shareef MM, 2003, GENETICA, V117, P127; SINGH J, 1993, NATURE, V361, P271, DOI 10.1038/361271a0; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017; Trembecka-Lucas DO, 2012, CELL CYCLE, V11, P2170, DOI 10.4161/cc.20673; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501	62	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61464	10.1371/journal.pone.0061464	http://dx.doi.org/10.1371/journal.pone.0061464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658693	gold, Green Published, Green Submitted			2022-12-27	WOS:000319167000014
J	Auray, G; Facci, MR; van Kessel, J; Buchanan, R; Babiuk, LA; Gerdts, V				Auray, Gael; Facci, Marina R.; van Kessel, Jill; Buchanan, Rachelle; Babiuk, Lorne A.; Gerdts, Volker			Porcine Neonatal Blood Dendritic Cells, but Not Monocytes, Are More Responsive to TLRs Stimulation than Their Adult Counterparts	PLOS ONE			English	Article							LYMPH-NODE CELLS; T-CELLS; INNATE IMMUNITY; CORD BLOOD; CHEMOKINE PRODUCTION; ADAPTIVE IMMUNITY; HUMAN ROTAVIRUS; HUMAN NEWBORNS; SUBSETS; TH2	The neonatal immune system is often considered as immature or impaired compared to the adult immune system. This higher susceptibility to infections is partly due to the skewing of the neonatal immune response towards a Th2 response. Activation and maturation of dendritic cells (DCs) play an important role in shaping the immune response, therefore, DCs are a target of choice for the development of efficient and protective vaccine formulations able to redirect the neonatal immune response to a protective Th1 response. As pigs are becoming more important for vaccine development studies due to their similarity to the human immune system, we decided to compare the activation and maturation of a subpopulation of porcine DCs in adult and neonatal pigs following stimulation with different TLR ligands, which are promising candidates for adjuvants in vaccine formulations. Porcine blood derived DCs (BDCs) were directly isolated from blood and consisted of a mix of conventional and plasmacytoid DCs. Following CpG ODN (TLR9 ligand) and imiquimod (TLR7 ligand) stimulation, neonatal BDCs showed higher levels of expression of costimulatory molecules and similar (CpG ODN) or higher (imiquimod) levels of IL-12 compared to adult BDCs. Another interesting feature was that only neonatal BDCs produced IFN-alpha after TLR7 or TLR9 ligand stimulation. Stimulation with CpG ODN and imiquimod also induced enhanced expression of several chemokines. Moreover, in a mixed leukocyte reaction assay, neonatal BDCs displayed a greater ability to induce lymphoproliferation. These findings suggest that when stimulated via TLR7 or TLR9 porcine DCs display similar if not better response than adult porcine DCs.	[Auray, Gael; Facci, Marina R.; van Kessel, Jill; Buchanan, Rachelle; Gerdts, Volker] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Auray, Gael] Univ Montreal, Fac Med Vet, St Hyacinthe, PQ J2S 7C6, Canada; [Gerdts, Volker] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Babiuk, Lorne A.] Univ Alberta, Edmonton, AB, Canada	University of Saskatchewan; Universite de Montreal; University of Saskatchewan; University of Alberta	Gerdts, V (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada.	volker.gerdts@usask.ca		Gerdts, Volker/0000-0001-8229-1611	Natural Science and Engineering Research Council; Alberta Agriculture Funding Consortium; CIHR; Bill and Melinda Gates Foundation Grand Challenges in Global Health Initiative grant	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Agriculture Funding Consortium; CIHR(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates Foundation Grand Challenges in Global Health Initiative grant	This work was supported by the Natural Science and Engineering Research Council, the Alberta Agriculture Funding Consortium, CIHR and the Bill and Melinda Gates Foundation Grand Challenges in Global Health Initiative grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Adkins B, 2000, J IMMUNOL, V164, P2347, DOI 10.4049/jimmunol.164.5.2347; Adkins Becky, 2007, Current Immunology Reviews, V3, P151; Auray G, 2010, MOL IMMUNOL, V47, P2103, DOI 10.1016/j.molimm.2010.03.016; Bachmann MF, 2006, NAT REV IMMUNOL, V6, P159, DOI 10.1038/nri1776; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Borras FE, 2001, BRIT J HAEMATOL, V113, P925, DOI 10.1046/j.1365-2141.2001.02840.x; Bracci L, 2008, EXPERT REV VACCINES, V7, P373, DOI 10.1586/14760584.7.3.373; Chaung HC, 2010, COMP IMMUNOL MICROB, V33, P197, DOI 10.1016/j.cimid.2008.10.001; Dadaglio G, 2002, J IMMUNOL, V168, P2219, DOI 10.4049/jimmunol.168.5.2219; Dakic A, 2004, J IMMUNOL, V172, P1018, DOI 10.4049/jimmunol.172.2.1018; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; Dar A, 2008, VET IMMUNOL IMMUNOP, V123, P324, DOI 10.1016/j.vetimm.2008.02.007; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; De Wit D, 2004, BLOOD, V103, P1030, DOI 10.1182/blood-2003-04-1216; De Wit D, 2003, J AUTOIMMUN, V21, P277, DOI 10.1016/j.jaut.2003.08.003; DERBYSHIRE JB, 1990, VET IMMUNOL IMMUNOP, V24, P227, DOI 10.1016/0165-2427(90)90038-T; Facci MR, 2011, VET IMMUNOL IMMUNOP, V141, P11, DOI 10.1016/j.vetimm.2011.01.005; Facci MR, 2010, IMMUNOLOGY, V129, P396, DOI 10.1111/j.1365-2567.2009.03192.x; Ferret-Bernard S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-19; Ferret-Bernard S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013705; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Glezen WP, 2003, VACCINE, V21, P3389, DOI 10.1016/S0264-410X(03)00339-6; Gold MC, 2006, PEDIATR RES, V60, P34, DOI 10.1203/01.pdr.0000220352.13547.f4; Gonzalez AM, 2010, IMMUNOLOGY, V131, P242, DOI 10.1111/j.1365-2567.2010.03298.x; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Jamin A, 2006, VET IMMUNOL IMMUNOP, V114, P224, DOI 10.1016/j.vetimm.2006.08.009; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Lee HH, 2008, J EXP MED, V205, P2269, DOI 10.1084/jem.20071371; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Li LQ, 2004, IMMUNITY, V20, P429, DOI 10.1016/S1074-7613(04)00072-X; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Makhseed M, 2001, HUM REPROD, V16, P2219, DOI 10.1093/humrep/16.10.2219; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; O'Keeffe M, 2005, BLOOD, V106, P3457, DOI 10.1182/blood-2004-12-4965; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Penna G, 2002, J IMMUNOL, V169, P6673, DOI 10.4049/jimmunol.169.12.6673; Piqueras B, 2006, BLOOD, V107, P2613, DOI 10.1182/blood-2005-07-2965; Proietto AI, 2004, IMMUNOBIOLOGY, V209, P163, DOI 10.1016/j.imbio.2004.03.002; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Summerfield A, 2003, IMMUNOLOGY, V110, P440, DOI 10.1111/j.1365-2567.2003.01755.x; Summerfield A, 2009, DEV COMP IMMUNOL, V33, P299, DOI 10.1016/j.dci.2008.05.005; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Tourais-Esteves I, 2008, DEV COMP IMMUNOL, V32, P1231, DOI 10.1016/j.dci.2008.03.011; Velilla PA, 2006, CLIN IMMUNOL, V121, P251, DOI 10.1016/j.clim.2006.08.010; Wang GH, 2010, J IMMUNOL, V185, P71, DOI 10.4049/jimmunol.0903806; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zelnickova P, 2008, VET IMMUNOL IMMUNOP, V124, P367, DOI 10.1016/j.vetimm.2008.04.016; Zhang LH, 2006, DEV COMP IMMUNOL, V30, P589, DOI 10.1016/j.dci.2005.07.005; Zhang LH, 2007, MOL IMMUNOL, V44, P1141, DOI 10.1016/j.molimm.2006.07.001; Zhang LH, 2007, VACCINE, V25, P1735, DOI 10.1016/j.vaccine.2006.11.033; Zhang W, 2008, VET IMMUNOL IMMUNOP, V121, P222, DOI 10.1016/j.vetimm.2007.10.001	60	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e59629	10.1371/journal.pone.0059629	http://dx.doi.org/10.1371/journal.pone.0059629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667422	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600002
J	Mackay, DF; Haw, S; Newby, DE; Langhorne, P; Lloyd, SM; McConnachie, A; Pell, JP				Mackay, Daniel F.; Haw, Sally; Newby, David E.; Langhorne, Peter; Lloyd, Suzanne M.; McConnachie, Alex; Pell, Jill P.			Impact of Scotland's Comprehensive, Smoke-Free Legislation on Stroke	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; SECONDHAND SMOKE; PASSIVE SMOKING; ISCHEMIC-STROKE; RISK-FACTOR; HOSPITAL ADMISSIONS; CHINESE WOMEN; HEART-DISEASE; IMPLEMENTATION	Background: Previous studies have reported a reduction in acute coronary events following smoke-free legislation. Evidence is lacking on whether stroke is also reduced. The aim was to determine whether the incidence of stroke, overall and by sub-type, fell following introduction of smoke-free legislation across Scotland on 26 March 2006. Methods and Findings: A negative binomial regression model was used to determine whether the introduction of smoke-free legislation resulted in a step and/or slope change in stroke incidence. The model was adjusted for age-group, sex, socioeconomic deprivation quintile, urban/rural residence and month. Interaction tests were also performed. Routine hospital administrative data and death certificates were used to identify all hospital admissions and pre-hospital deaths due to stroke (ICD10 codes I61, I63 and I64) in Scotland between 2000 and 2010 inclusive. Prior to the legislation, rates of all stroke, intracerebral haemorrhage and unspecified stroke were decreasing, whilst cerebral infarction was increasing at 0.97% per annum. Following the legislation, there was a dramatic fall in cerebral infarctions that persisted for around 20 months. No visible effect was observed for other types of stroke. The model confirmed an 8.90% (95% CI 4.85, 12.77, p < 0.001) stepwise reduction in cerebral infarction at the time the legislation was implemented, after adjustment for potential confounders. Conclusions: Following introduction of national, comprehensive smoke-free legislation there was a selective reduction in cerebral infarction that was not apparent in other types of stroke.	[Mackay, Daniel F.; Lloyd, Suzanne M.; McConnachie, Alex; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Haw, Sally] Univ Stirling, Sch Nursing Midwifery & Hlth, Stirling FK9 4LA, Scotland; [Newby, David E.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Langhorne, Peter] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Stirling; University of Edinburgh; University of Glasgow	Pell, JP (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	jill.pell@glasgow.ac.uk	Newby, David Ernest/AAB-1364-2019; Lloyd, Suzanne/H-7424-2013	Pell, Jill/0000-0002-8898-7035	NHS Health Scotland; British Heart Foundation [RG/10/9/28286] Funding Source: researchfish	NHS Health Scotland; British Heart Foundation(British Heart Foundation)	This study was funded by a project grant from NHS Health Scotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CS, 2004, STROKE, V35, P633, DOI 10.1161/01.STR.0000115751.45473.48; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; DINTENFASS L, 1975, MED J AUSTRALIA, V1, P617, DOI 10.5694/j.1326-5377.1975.tb111612.x; DONNAN GA, 1989, LANCET, V2, P643; Edwards R, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.020347; GILL JS, 1989, ARCH INTERN MED, V149, P2053, DOI 10.1001/archinte.149.9.2053; Glantz S, 1995, JAMA-J AM MED ASSOC, V272, P1047; Haw SJ, 2007, BRIT MED J, V335, P549, DOI 10.1136/bmj.39315.670208.47; He Y, 2008, CIRCULATION, V118, P1535, DOI 10.1161/CIRCULATIONAHA.108.784801; Herman PM, 2011, AM J PUBLIC HEALTH, V101, P491, DOI 10.2105/AJPH.2009.179572; Juster HR, 2007, AM J PUBLIC HEALTH, V97, P2035, DOI 10.2105/AJPH.2006.099994; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Law MR, 2003, PROG CARDIOVASC DIS, V46, P31, DOI 10.1016/S0033-0620(03)00078-1; Mackay DF, 2010, HEART, V96, P1525, DOI 10.1136/hrt.2010.199026; Mackay DF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026188; MCGILL HC, 1979, PREV MED, V8, P390, DOI 10.1016/0091-7435(79)90016-1; MEHTA P, 1982, PROSTA LEUKOTR MED, V9, P141, DOI 10.1016/0262-1746(82)90002-6; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Ovbiagele B, 2006, CEREBROVASC DIS, V21, P260, DOI 10.1159/000091224; Panagiotakos DB, 2004, AM J MED, V116, P145, DOI 10.1016/j.amjmed.2003.07.019; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Puranik R, 2003, PROG CARDIOVASC DIS, V45, P443, DOI 10.1053/pcad.2003.YPCAD13; Qureshi AI, 2005, STROKE, V36, pE74, DOI 10.1161/01.STR.0000177475.30281.7f; Raupach T, 2006, EUR HEART J, V27, P386, DOI 10.1093/eurheartj/ehi601; ROGERS RL, 1983, JAMA-J AM MED ASSOC, V250, P2796, DOI 10.1001/jama.250.20.2796; SANDLER DP, 1989, AM J PUBLIC HEALTH, V79, P163, DOI 10.2105/AJPH.79.2.163; Scottish Stroke Care Audit, 2011, NAT REP STROK SERV S; Semple S, 2007, TOB CONTROL, V16, P127, DOI 10.1136/tc.2006.018119; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Whincup PH, 2004, BRIT MED J, V329, P200, DOI 10.1136/bmj.38146.427188.55; You RX, 1999, AM J PUBLIC HEALTH, V89, P572, DOI 10.2105/AJPH.89.4.572; Zhang XL, 2005, AM J EPIDEMIOL, V161, P213, DOI 10.1093/aje/kwi028	34	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62597	10.1371/journal.pone.0062597	http://dx.doi.org/10.1371/journal.pone.0062597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667497	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600032
J	Miosic, S; Knop, K; Hoslscher, D; Greiner, J; Gosch, C; Thill, J; Kai, M; Shrestha, BK; Schneider, B; Crecelius, AC; Schubert, US; Svatos, A; Stich, K; Halbwirth, H				Miosic, Silvija; Knop, Katrin; Hoeslscher, Dirk; Greiner, Juergen; Gosch, Christian; Thill, Jana; Kai, Marco; Shrestha, Binita Kumari; Schneider, Bernd; Crecelius, Anna C.; Schubert, Ulrich S.; Svatos, Ales; Stich, Karl; Halbwirth, Heidi			4-Deoxyaurone Formation in Bidens ferulifolia (Jacq.) DC	PLOS ONE			English	Article							POLYPHENOL OXIDASE; AUREUSIDIN SYNTHASE; HONEY GUIDES; COLOR-VISION; BIOSYNTHESIS; ULTRAVIOLET; FLAVONOIDS; ABSORPTION; EXPRESSION; MECHANISM	The formation of 4-deoxyaurones, which serve as UV nectar guides in Bidens ferulifolia (Jacq.) DC., was established by combination of UV photography, mass spectrometry, and biochemical assays and the key step in aurone formation was studied. The yellow flowering ornamental plant accumulates deoxy type anthochlor pigments (69-deoxychalcones and the corresponding 4-deoxyaurones) in the basal part of the flower surface whilst the apex contains only yellow carotenoids. For UV sensitive pollinating insects, this appears as a bicoloured floral pattern which can be visualized in situ by specific ammonia staining of the anthochlor pigments. The petal back side, in contrast, shows a faintly UV absorbing centre and UV absorbing rays along the otherwise UV reflecting petal apex. Matrix-free UV laser desorption/ionisation mass spectrometric imaging (LDI-MSI) indicated the presence of 9 anthochlors in the UV absorbing areas. The prevalent pigments were derivatives of okanin and maritimetin. Enzyme preparations from flowers, leaves, stems and roots of B. ferulifolia and from plants, which do not accumulate aurones e.g. Arabidopsis thaliana, were able to convert chalcones to aurones. Thus, aurone formation could be catalyzed by a widespread enzyme and seems to depend mainly on a specific biochemical background, which favours the formation of aurones at the expense of flavonoids. In contrast to 4-hydroxyaurone formation, hydroxylation and oxidative cyclization to the 4-deoxyaurones does not occur in one single step but is catalyzed by two separate enzymes, chalcone 3-hydroxylase and aurone synthase (catechol oxidase reaction). Aurone formation shows an optimum at pH 7.5 or above, which is another striking contrast to 4-hydroxyaurone formation in Antirrhinum majus L. This is the first example of a plant catechol oxidase type enzyme being involved in the flavonoid pathway and in an anabolic reaction in general.	[Miosic, Silvija; Greiner, Juergen; Gosch, Christian; Thill, Jana; Shrestha, Binita Kumari; Stich, Karl; Halbwirth, Heidi] Vienna Univ Technol, Inst Verfahrenstech Umwelttech & Tech Biowissensc, A-1060 Vienna, Austria; [Knop, Katrin; Crecelius, Anna C.; Schubert, Ulrich S.] Univ Jena, Lehrstuhl Schubert 2, IOMC, Inst Organ Chem & Makromol Chem, Jena, Germany; [Hoeslscher, Dirk; Kai, Marco; Schneider, Bernd; Svatos, Ales] Max Planck Inst Chem Okol, Jena, Germany	Technische Universitat Wien; Friedrich Schiller University of Jena; Max Planck Society	Halbwirth, H (corresponding author), Vienna Univ Technol, Inst Verfahrenstech Umwelttech & Tech Biowissensc, A-1060 Vienna, Austria.	hhalb@mail.zserv.tuwien.ac.at	Crecelius-Vitz, Anna C./G-5836-2012; Schubert, Ulrich S/B-5777-2009; Schubert, Ulrich/M-8136-2019; Schneider, Bernd/A-3287-2014; Svatos, Ales/A-3305-2014	Crecelius-Vitz, Anna C./0000-0001-5215-6101; Schubert, Ulrich S/0000-0003-4978-4670; Schubert, Ulrich/0000-0003-4978-4670; Schneider, Bernd/0000-0003-4788-1565; Svatos, Ales/0000-0003-1032-7288; Haselmair-Gosch, Christian/0000-0003-3231-0962; Halbwirth, Heidi/0000-0001-9059-5850	Austrian Science Fund (FWF) [V18-B03, P24331-B16]; EU [MRTN_CT-2006-03580 5]; TU Innovatives Projekt 'KILIT-MS'; Austrian Science Fund (FWF) [P 24331] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EU(European Commission); TU Innovatives Projekt 'KILIT-MS'; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	These investigations were supported by grants from the Austrian Science Fund (FWF, www.fwf.ac.at): [Projects V18-B03 and P24331-B16]. J. Thill acknowledges her Marie Curie scholarship from EU [MRTN_CT-2006-03580 5]. H. Halbwirth and K. Stich acknowledge support by TU Innovatives Projekt 'KILIT-MS'. This work was performed in the frame of Cost Action FA1006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias E, 2007, J FOOD SCI, V72, pC464, DOI 10.1111/j.1750-3841.2007.00514.x; Bomati EK, 2005, J BIOL CHEM, V280, P30496, DOI 10.1074/jbc.M502239200; Bradley J, 2000, GENETIC ENG YELLOW F, P39; Braune W, 1967, PFLANZENANATOMISCHES, P23; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Chandra A, 2001, J AGR FOOD CHEM, V49, P3515, DOI 10.1021/jf010389p; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Clark C, 1979, MADRONO, V26, P22; DAUMER K, 1958, Z VERGL PHYSIOL, V41, P49; Davies K. M., 1997, Biotechnology of ornamental plants., P259; Davies KM, 2006, PHYSIOL PLANTARUM, V128, P593, DOI 10.1111/j.1399-3054.2006.00774.x; Farag MA, 2009, PLANT PHYSIOL, V151, P1096, DOI 10.1104/pp.109.141481; FORKMANN G, 1980, BIOCHEM GENET, V18, P519, DOI 10.1007/BF00484399; GULDBERG LD, 1975, AM MIDL NAT, V93, P35, DOI 10.2307/2424103; Halbwirth H, 2006, PLANT SCI, V170, P587, DOI 10.1016/j.plantsci.2005.10.013; Halbwirth H, 1997, PLANT SCI, V122, P125, DOI 10.1016/S0168-9452(96)04553-0; Halbwirth H, 2008, NAT PROD COMMUN, V3, P1259; Halbwirth H, 2009, J AGR FOOD CHEM, V57, P4983, DOI 10.1021/jf900121z; Harborne J. B., 1993, INTRO ECOLOGICAL BIO, V4th; Harborne J.B., 1967, COMP BIOCH FLAVONOID; HARBORNE JB, 1978, BIOCHEM SYST ECOL, V6, P287, DOI 10.1016/0305-1978(78)90047-9; Holscher D, 2009, PLANT J, V60, P907, DOI 10.1111/j.1365-313X.2009.04012.x; Leonard AS, 2011, FUNCT ECOL, V25, P1293, DOI 10.1111/j.1365-2435.2011.01885.x; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; MCCREA KD, 1983, AM J BOT, V70, P369, DOI 10.2307/2443245; MENZEL R, 1993, BIOL REV, V68, P81, DOI 10.1111/j.1469-185X.1993.tb00732.x; Nakanishi K., 1999, COMPREHENSIVE NATURA, V1, P713; Nakayama T, 2002, J BIOSCI BIOENG, V94, P487, DOI 10.1016/S1389-1723(02)80184-0; Nakayama T, 2000, SCIENCE, V290, P1163, DOI 10.1126/science.290.5494.1163; Nakayama T, 2001, FEBS LETT, V499, P107, DOI 10.1016/S0014-5793(01)02529-7; Ono E, 2006, PLANT J, V45, P133, DOI 10.1111/j.1365-313X.2005.02625.x; Ono E, 2006, P NATL ACAD SCI USA, V103, P11075, DOI 10.1073/pnas.0604246103; RIESEBERG LH, 1985, AM J BOT, V72, P999, DOI 10.2307/2443442; Sanchez-Gonzalez M, 2006, J AGR FOOD CHEM, V54, P4646, DOI 10.1021/jf060900k; SANDERMANN H, 1972, J BIOL CHEM, V247, P5123; Sato T, 2001, PLANT SCI, V160, P229, DOI 10.1016/S0168-9452(00)00385-X; Schlangen K, 2010, J EXP BOT, V61, P3451, DOI 10.1093/jxb/erq169; Schlangen K, 2009, PHYTOCHEMISTRY, V70, P889, DOI 10.1016/j.phytochem.2009.04.017; Schlangen K, 2009, PLANT SCI, V177, P97, DOI 10.1016/j.plantsci.2009.04.002; Scogin R., 1976, BIOCHEM SYST ECOL, P165; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Shimada N, 2003, PLANT PHYSIOL, V131, P941, DOI 10.1104/pp.004820; Strack D, 2001, ANGEW CHEM INT EDIT, V40, P3791, DOI 10.1002/1521-3773(20011015)40:20<3791::AID-ANIE3791>3.0.CO;2-T; THOMPSON WR, 1972, SCIENCE, V177, P528, DOI 10.1126/science.177.4048.528; VADECASTEELE K, 1982, J CHROMATOGR, V240, P81; WELLE R, 1988, FEBS LETT, V236, P221, DOI 10.1016/0014-5793(88)80318-1; WILSON JM, 1976, PHYTOCHEMISTRY, V15, P1333, DOI 10.1016/S0031-9422(00)97113-9; Wimmer G, 1998, PHYTOCHEMISTRY, V47, P1013, DOI 10.1016/S0031-9422(97)00646-8	48	19	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61766	10.1371/journal.pone.0061766	http://dx.doi.org/10.1371/journal.pone.0061766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667445	gold, Green Published			2022-12-27	WOS:000319055600014
J	Bendorf, A; Kelly, PJ; Kerridge, IH; McCaughan, GW; Myerson, B; Stewart, C; Pussell, BA				Bendorf, Aric; Kelly, Patrick J.; Kerridge, Ian H.; McCaughan, Geoffrey W.; Myerson, Brian; Stewart, Cameron; Pussell, Bruce A.			An International Comparison of the Effect of Policy Shifts to Organ Donation following Cardiocirculatory Death (DCD) on Donation Rates after Brain Death (DBD) and Transplantation Rates	PLOS ONE			English	Article							CARDIAC DEATH; SINGLE-CENTER; DONORS	During the past decade an increasing number of countries have adopted policies that emphasize donation after cardiocirculatory death (DCD) in an attempt to address the widening gap between the demand for transplantable organs and the availability of organs from donation after brain death (DBD) donors. In order to examine how these policy shifts have affected overall deceased organ donor (DD) and DBD rates, we analyzed deceased donation rates from 82 countries from 2000-2010. On average, overall DD, DBD and DCD rates have increased over time, with the proportion of DCD increasing 0.3% per year (p = 0.01). Countries with higher DCD rates have, on average, lower DBD rates. For every one-per million population (pmp) increase in the DCD rate, the average DBD rate decreased by 1.02 pmp (95% CI: 0.73, 1.32; p<0.0001). We also found that the number of organs transplanted per donor was significantly lower in DCD when compared to DBD donors with 1.51 less transplants per DCD compared to DBD (95% CI: 1.23, 1.79; p<0.001). Whilst the results do not infer a causal relationship between increased DCD and decreased DBD rates, the significant correlation between higher DCD and lower DBD rates coupled with the reduced number of organs transplanted per DCD donor suggests that a national policy focus on DCD may lead to an overall reduction in the number of transplants performed.	[Bendorf, Aric; Kerridge, Ian H.; Myerson, Brian; Stewart, Cameron] Univ Sydney, Ctr Values Eth & Law Med, Sch Publ Hlth, Sydney Med Sch, Sydney, NSW 2006, Australia; [Kelly, Patrick J.; Kerridge, Ian H.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Kerridge, Ian H.] Royal N Shore Hosp, Dept Haematol, Sydney, NSW, Australia; [McCaughan, Geoffrey W.] Univ Sydney, Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia; [McCaughan, Geoffrey W.] Univ Sydney, Centenary Res Inst, Sydney, NSW 2006, Australia; [Stewart, Cameron] Univ Sydney, Sydney Law Sch, Ctr Hlth Governance Law & Eth, Sydney, NSW 2006, Australia; [Pussell, Bruce A.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Pussell, Bruce A.] Prince Wales Hosp, Dept Nephrol, Sydney, NSW, Australia	University of Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney; University of Sydney; University of Sydney; Centenary Institute; University of Sydney; University of New South Wales Sydney	Bendorf, A (corresponding author), Univ Sydney, Ctr Values Eth & Law Med, Sch Publ Hlth, Sydney Med Sch, Sydney, NSW 2006, Australia.	aric.bendorf@sydney.edu.au		MCCAUGHAN, GEOFFREY/0000-0002-1483-1636; Kerridge, Ian/0000-0001-7445-4660; Kelly, Patrick/0000-0002-5015-0977; Stewart, Cameron/0000-0003-3625-0899				Abt PL, 2006, J AM COLL SURGEONS, V203, P208, DOI 10.1016/j.jamcollsurg.2006.03.014; Alessandro AM, 2007, TRANSPLANT REV, V21, P230, DOI DOI 10.1016/J.TRRE.2007.07.001; [Anonymous], 1979, BMJ-BRIT MED J, V1, P332; [Anonymous], 1968, JAMA, V205, P337; [Anonymous], 2008, 136 4 MILL NAT PLAN; [Anonymous], 2008, CONTR DET DEATH; [Anonymous], 1980, NAT C COMM US LAWS C; Bellingham JM, 2011, SURGERY, V150, P692, DOI 10.1016/j.surg.2011.07.057; Bendorf A, 2012, INTERN MED J, V42, P866, DOI 10.1111/j.1445-5994.2012.02792.x; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dominguez-Gil B, 2011, TRANSPL INT, V24, P676, DOI 10.1111/j.1432-2277.2011.01257.x; Harrison JH, 1956, T AM CLIN CLIM ASS, V67, P166; Hernadez-Alejandro R, 2011, CAN J ANESTH, V58, P599, DOI 10.1007/s12630-011-9511-9; International Figures on Donation and Transplantation-2011-Council of Europe, 2012, NEWSLETTER TRANSPLAN, V17, P3; Joffe Ari R, 2011, Philos Ethics Humanit Med, V6, P17, DOI 10.1186/1747-5341-6-17; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Leoni Excell, 2011, ANZOD REG REP 2011; Mason DP, 2012, ANN THORAC SURG, V94, P406, DOI 10.1016/j.athoracsur.2012.03.059; Matesanz R, 2012, AM J TRANSPLANT, V12, P2498, DOI 10.1111/j.1600-6143.2012.04128.x; Mollaret P, 1959, REV NEUROL-FRANCE, V101, P3; Nath J, 2011, LANCET, V377, P203, DOI 10.1016/S0140-6736(11)60038-X; Orman ES, 2013, LIVER TRANSPLANT, V19, P59, DOI 10.1002/lt.23547; Saidi RF, 2010, AM J TRANSPLANT, V10, P2536, DOI 10.1111/j.1600-6143.2010.03215.x; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Smith R G, 1983, Melb Univ Law Rev, V14, P199; Summers DM, 2010, TRANSPLANTATION, V90, P1506, DOI 10.1097/TP.0b013e3182007b33; Twisk JWR, 2003, APPL LONGITUDINAL DA; Veatch RM, 2008, NEW ENGL J MED, V359, P672, DOI 10.1056/NEJMp0805451	28	49	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62010	10.1371/journal.pone.0062010	http://dx.doi.org/10.1371/journal.pone.0062010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667452	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700021
J	Li, X; Wang, H; Gan, SH; Jiang, DQ; Tian, GM; Zhang, ZJ				Li, Xia; Wang, Hang; Gan, ShaoHua; Jiang, DaQian; Tian, GuangMing; Zhang, ZhiJian			Eco-Stoichiometric Alterations in Paddy Soil Ecosystem Driven by Phosphorus Application	PLOS ONE			English	Article							ECOENZYMATIC STOICHIOMETRY; ENZYME-ACTIVITY; ORGANIC-CARBON; CROP ROTATIONS; NUTRIENT; NITROGEN; FERTILIZER; FIELD; MANURE; LIMITATION	Agricultural fertilization may change processes of elemental biogeochemical cycles and alter the ecological function. Ecoenzymatic stoichiometric feature plays a critical role in global soil carbon (C) metabolism, driving element cycles, and mediating atmospheric composition in response to agricultural nutrient management. Despite the importance on crop growth, the role of phosphorous (P) in compliance with eco-stoichiometry on soil C and nitrogen (N) sequestration in the paddy field remains poorly understood in the context of climate change. Here, we collected soil samples from a field experiment after 6 years of chemical P application at a gradient of 0 (P-0), 30 (P-30), 60 (P-60), and 90 (P-90) kg ha(-1) in order to evaluate the role of P on stoichiometric properties in terms of soil chemical, microbial biomass, and eco-enzyme activities as well as greenhouse gas (GHG: CO2, N2O and CH4) emissions. Continuous P input increased soil total organic C and N by 1.3-9.2% and 3%-13%, respectively. P input induced C and N limitations as indicated by the decreased ratio of C:P and N:P in the soil and microbial biomass. A synergistic mechanism among the ecoenzymatic stoichiometry, which regulated the ecological function of microbial C and N acquisition and were stoichiometrically related to P input, stimulated soil C and N sequestration in the paddy field. The lower emissions of N2O and CH4 under the higher P application (P-60 and P-90) in July and the insignificant difference in N2O emission in August compared to P-30; however, continuous P input enhanced CO2 fluxes for both samplings. There is a technical conflict for simultaneously regulating three types of GHGs in terms of the eco-stoichiometry mechanism under P fertilization. Thus, it is recommended that the P input in paddy fields not exceed 60 kg ha(-1) may maximize soil C sequestration, minimize P export, and guarantee grain yields.	[Li, Xia; Wang, Hang; Gan, ShaoHua; Tian, GuangMing; Zhang, ZhiJian] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, DaQian; Zhang, ZhiJian] Columbia Univ, Dept Earth & Environm Engn, New York, NY USA; [Zhang, ZhiJian] Zhejiang Univ, China Acad West Reg Dev, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Columbia University; Zhejiang University	Zhang, ZJ (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zhangzhijian@zju.edu.cn			Natural Science Foundation of China [40701162]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of China (40701162)(http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adviento-Borbe MAA, 2007, GLOBAL CHANGE BIOL, V13, P1972, DOI 10.1111/j.1365-2486.2007.01421.x; Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Bao S.D., 2000, AGROCHEMICAL ANAL SO, P78; Bell LW, 2012, AGR ECOSYST ENVIRON, V158, P156, DOI 10.1016/j.agee.2012.06.006; Bradford MA, 2008, FUNCT ECOL, V22, P964, DOI 10.1111/j.1365-2435.2008.01404.x; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; Cai ZC, 2012, SCI CHINA EARTH SCI, V55, P173, DOI 10.1007/s11430-011-4309-8; Cherif M, 2009, P ROY SOC B-BIOL SCI, V276, P487, DOI 10.1098/rspb.2008.0560; Ciampitti IA, 2011, SOIL SCI SOC AM J, V75, P616, DOI 10.2136/sssaj2010.0168; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; German DP, 2011, SOIL BIOL BIOCHEM, V43, P1387, DOI 10.1016/j.soilbio.2011.03.017; Hall EK, 2011, ECOSYSTEMS, V14, P261, DOI 10.1007/s10021-010-9408-4; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hill BH, 2012, ECOL INDIC, V18, P540, DOI 10.1016/j.ecolind.2012.01.007; Hobbie SE, 2002, PLANT SOIL, V242, P163, DOI 10.1023/A:1019670731128; Huang QR, 2009, PEDOSPHERE, V19, P727, DOI 10.1016/S1002-0160(09)60168-5; IRRI, 2009, WORLD RIC STAT ROUGH; Lee CH, 2010, AGR ECOSYST ENVIRON, V138, P343, DOI 10.1016/j.agee.2010.05.011; Liu DY, 2011, BIORESOURCE TECHNOL, V102, P9040, DOI 10.1016/j.biortech.2011.07.052; Ma K, 2011, FEMS MICROBIOL ECOL, V75, P446, DOI 10.1111/j.1574-6941.2010.01018.x; Marichal R, 2011, SOIL BIOL BIOCHEM, V43, P1528, DOI 10.1016/j.soilbio.2011.04.001; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; OECD, 2000, ENV IND AGR METH RES; Peng PQ, 2005, CHIN J APPL ECOL, V16, P1872; Reganold JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012346; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Sander T, 2008, GEODERMA, V145, P303, DOI 10.1016/j.geoderma.2008.03.024; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Shange RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040338; Shrestha M, 2010, ISME J, V4, P1545, DOI 10.1038/ismej.2010.89; Sims JT, 1998, J ENVIRON QUAL, V27, P277, DOI 10.2134/jeq1998.00472425002700020006x; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sinsabaugh RL, 2012, ANNU REV ECOL EVOL S, V43, P313, DOI 10.1146/annurev-ecolsys-071112-124414; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wang DanYing, 2010, Acta Agriculturae Zhejiangensis, V22, P330; Wang K, 2001, CHEMOSPHERE, V42, P209, DOI 10.1016/S0045-6535(00)00127-2; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Zhang Y., 2012, PLOS ONE, V7; Zhang ZJ, 2011, ENVIRON TECHNOL, V32, P197, DOI 10.1080/09593330.2010.494689; Zhang ZJ, 2007, ENVIRON POLLUT, V145, P425, DOI 10.1016/j.envpol.2006.05.031	50	22	27	9	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61141	10.1371/journal.pone.0061141	http://dx.doi.org/10.1371/journal.pone.0061141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667435	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700010
J	Vasireddy, V; Mills, JA; Gaddameedi, R; Basner-Tschakarjan, E; Kohnke, M; Black, AD; Alexandrov, K; Zhou, SZ; Maguire, AM; Chung, DC; Mac, H; Sullivan, L; Gadue, P; Bennicelli, JL; French, DL; Bennett, J				Vasireddy, Vidyullatha; Mills, Jason A.; Gaddameedi, Rajashekhar; Basner-Tschakarjan, Etiena; Kohnke, Monika; Black, Aaron D.; Alexandrov, Krill; Zhou, Shangzhen; Maguire, Albert M.; Chung, Daniel C.; Mac, Helen; Sullivan, Lisa; Gadue, Paul; Bennicelli, Jeannette L.; French, Deborah L.; Bennett, Jean			AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models	PLOS ONE			English	Article							RAB ESCORT PROTEIN-1; PLURIPOTENT STEM-CELLS; LEBERS CONGENITAL AMAUROSIS; RETINAL-PIGMENT EPITHELIUM; CHM GENE; GERANYLGERANYL TRANSFERASE; EXPRESSION; TRANSGENE; MUTATIONS; DEGENERATION	Choroideremia (CHM) is an X- linked retinal degeneration that is symptomatic in the 1st or 2nd decade of life causing nyctalopia and loss of peripheral vision. The disease progresses through mid-life, when most patients become blind. CHM is a favorable target for gene augmentation therapy, as the disease is due to loss of function of a protein necessary for retinal cell health, Rab Escort Protein 1 (REP1). The CHM cDNA can be packaged in recombinant adeno-associated virus (rAAV), which has an established track record in human gene therapy studies, and, in addition, there are sensitive and quantitative assays to document REP1 activity. An animal model that accurately reflects the human condition is not available. In this study, we tested the ability to restore REP1 function in personalized in vitro models of CHM: lymphoblasts and induced pluripotent stems cells (iPSCs) from human patients. The initial step of evaluating safety of the treatment was carried out by evaluating for acute retinal histopathologic effects in normal-sighted mice and no obvious toxicity was identified. Delivery of the CHM cDNA to affected cells restores REP1 enzymatic activity and also restores proper protein trafficking. The gene transfer is efficient and the preliminary safety data are encouraging. These studies pave the way for a human clinical trial of gene therapy for CHM.	[Vasireddy, Vidyullatha; Gaddameedi, Rajashekhar; Black, Aaron D.; Maguire, Albert M.; Chung, Daniel C.; Bennicelli, Jeannette L.; Bennett, Jean] Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Mills, Jason A.; Basner-Tschakarjan, Etiena; Zhou, Shangzhen; Maguire, Albert M.; Chung, Daniel C.; Mac, Helen; Gadue, Paul; French, Deborah L.; Bennett, Jean] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Kohnke, Monika; Alexandrov, Krill] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Sullivan, Lisa] Childrens Hosp Philadelphia, Dept Anat Pathol, Philadelphia, PA 19104 USA; [Gadue, Paul; French, Deborah L.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Queensland; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bennett, J (corresponding author), Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA.	jebennet@mail.med.upenn.edu			Choroideremia Research Foundation; Foundation Fighting Blindness Wynne-Gund TRAP Therapy [TA-GT-1211-05640UPA-WG]; Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia; Paul and Evanina Mackall Foundation Trust; F.M. Kirby Center for Molecular Ophthalmology; Treatrush; Knights Templar Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R24EY019861] Funding Source: NIH RePORTER	Choroideremia Research Foundation; Foundation Fighting Blindness Wynne-Gund TRAP Therapy; Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia; Paul and Evanina Mackall Foundation Trust; F.M. Kirby Center for Molecular Ophthalmology; Treatrush; Knights Templar Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors are grateful for support from The Choroideremia Research Foundation, Foundation Fighting Blindness Wynne-Gund TRAP Therapy grant TA-GT-1211-05640UPA-WG, the Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia, Treatrush, Knights Templar Foundation, Research to Prevent Blindness, the Paul and Evanina Mackall Foundation Trust, and the F.M. Kirby Center for Molecular Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; Amado D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000659; Arland V, 2003, VISION RES, V43, P919, DOI 10.1016/S0042-6989(02)00389-9; Basiji DA, 2007, CLIN LAB MED, V27, P653, DOI 10.1016/j.cll.2007.05.008; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Coussa RG, 2012, OPHTHALMIC GENET, V33, P57, DOI 10.3109/13816810.2011.620056; Coussa RG, 2012, OPHTHALMIC GENET, V33, P66, DOI 10.3109/13816810.2011.623261; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; CREMERS FPM, 1990, AM J HUM GENET, V47, P622; Cremers Frans P. M., 1992, Human Molecular Genetics, V1, P71, DOI 10.1093/hmg/1.2.71; FLANNERY JG, 1990, INVEST OPHTH VIS SCI, V31, P229; Forsythe P, 1997, EXP EYE RES, V64, P487, DOI 10.1006/exer.1996.0200; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495; Herzog RW, 1999, THROMB HAEMOSTASIS, V82, P540, DOI 10.1055/s-0037-1615877; Hoffman LM, 1997, INVEST OPHTH VIS SCI, V38, P2224; Keiser NW, 2005, MOL VIS, V11, P1052; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lerou PH, 2008, NAT PROTOC, V3, P923, DOI 10.1038/nprot.2008.60; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Lipinski D.M., 2012, PROG RETIN EYE RES; MacDonald IM, 2009, SURV OPHTHALMOL, V54, P401, DOI 10.1016/j.survophthal.2009.02.008; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; McGrath KE, 2008, J IMMUNOL METHODS, V336, P91, DOI 10.1016/j.jim.2008.04.012; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Perez-Cano HJ, 2009, AM J MED GENET A, V149A, P2134, DOI 10.1002/ajmg.a.32727; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Phillips MJ, 2012, INVEST OPHTH VIS SCI, V53, P2007, DOI 10.1167/iovs.11-9313; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Polo JM, 2010, CELL STEM CELL, V7, P5, DOI 10.1016/j.stem.2010.05.018; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Rafuse E V, 1968, Can J Ophthalmol, V3, P347; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; SANKILA EM, 1992, NAT GENET, V1, P109, DOI 10.1038/ng0592-109; Seabra M. C., 2005, INVEST OPHTH VIS SCI, V46, P3556; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Seabra MC, 1996, OPHTHALMIC GENET, V17, P43, DOI 10.3109/13816819609057869; Sergeev YV, 2009, MUTAT RES-FUND MOL M, V665, P44, DOI 10.1016/j.mrfmmm.2009.02.015; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Strunnikova NV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008402; Tolmachova T, 2006, J CLIN INVEST, V116, P386, DOI 10.1172/JCI26617; Tolmachova T, 2012, J GENE MED, V14, P158, DOI 10.1002/jgm.1652; VANBOKHOVEN H, 1994, HUM MOL GENET, V3, P1047, DOI 10.1093/hmg/3.7.1047; vandenHurk JAJM, 1997, HUM MUTAT, V9, P110, DOI 10.1002/(SICI)1098-1004(1997)9:2<110::AID-HUMU2>3.3.CO;2-9; Vasireddy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021193; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	52	58	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61396	10.1371/journal.pone.0061396	http://dx.doi.org/10.1371/journal.pone.0061396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667438	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700012
J	Ryu, SW; Yoon, J; Yim, N; Choi, K; Choi, C				Ryu, Seung-Wook; Yoon, Jonghee; Yim, Nambin; Choi, Kyungsun; Choi, Chulhee			Downregulation of OPA3 Is Responsible for Transforming Growth Factor-beta-Induced Mitochondrial Elongation and F-Actin Rearrangement in Retinal Pigment Epithelial ARPE-19 Cells	PLOS ONE			English	Article							TGF-BETA; DYNAMICS; BIOGENESIS; FUSION; LIGASE; CANCER	Transforming growth factor-beta signaling is known to be a key signaling pathway in the induction of epithelial-mesenchymal transition. However, the mechanism of TGF-beta signaling in the modulation of EMT remains unclear. In this study, we found that TGF-beta treatment resulted in elongation of mitochondria accompanied by induction of N-cadherin, vimentin, and F-actin in retinal pigment epithelial cells. Moreover, OPA3, which plays a crucial role in mitochondrial dynamics, was downregulated following TGF-beta treatment. Suppression of TGF-beta signaling using Smad2 siRNA prevented loss of OPA3 induced by TGF-beta. Knockdown of OPA3 by siRNA and inducible shRNA significantly increased stress fiber levels, cell length, cell migration and mitochondrial elongation. In contrast, forced expression of OPA3 in ARPE-19 cells inhibited F-actin rearrangement and induced mitochondrial fragmentation. We also showed that Drp1 depletion increased cell length and induced rearrangement of F-actin. Depletion of Mfn1 blocked the increase in cell length during TGF-beta-mediated EMT. These results collectively substantiate the involvement of mitochondrial dynamics in TGF-beta-induced EMT.	[Ryu, Seung-Wook; Yoon, Jonghee; Yim, Nambin; Choi, Kyungsun; Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Ryu, Seung-Wook; Choi, Chulhee] Korea Adv Inst Sci & Technol, KI Biocentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Ryu, SW (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	ryus@kaist.ac.kr; cchoi@kaist.ac.kr	Choi, Chulhee/C-1642-2011	Choi, Chulhee/0000-0001-5542-9136; Yoon, Jonghee/0000-0003-3886-2792	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012007370]; Korean Health Technology R & D project, the Ministry of Health & Welfare, Republic of Korea [A111025]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Health Technology R & D project, the Ministry of Health & Welfare, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2012007370), and by the Korean Health Technology R & D project, the Ministry of Health & Welfare, Republic of Korea (A111025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Chang CR, 2007, EMBO REP, V8, P1088, DOI 10.1038/sj.embor.7401118; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Choi K, 2012, MOL VIS, V18, P1010; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Favre C, 2010, ONCOGENE, V29, P3964, DOI 10.1038/onc.2010.146; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Kar R, 2010, BIOCHEM BIOPH RES CO, V399, P548, DOI 10.1016/j.bbrc.2010.07.108; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481; Ryu SW, 2010, CELL MOL LIFE SCI, V67, P2839, DOI 10.1007/s00018-010-0365-z; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Wang XY, 2008, BBA-MOL BASIS DIS, V1782, P51, DOI 10.1016/j.bbadis.2007.11.002; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002	25	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63495	10.1371/journal.pone.0063495	http://dx.doi.org/10.1371/journal.pone.0063495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658835	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100068
J	Xu, HD; Wu, D; Gu, JH; Ge, JB; Wu, JC; Han, R; Liang, ZQ; Qin, ZH				Xu, Hai-Dong; Wu, Dan; Gu, Jin-Hua; Ge, Jian-Bin; Wu, Jun-Chao; Han, Rong; Liang, Zhong-Qin; Qin, Zheng-Hong			The Pro-Survival Role of Autophagy Depends on Bcl-2 Under Nutrition Stress Conditions	PLOS ONE			English	Article							CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; APOPTOSIS; ACTIVATION; PROTEIN; PHOSPHORYLATION; INHIBITION; CLEARANCE; INDUCTION; NEURONS	Autophagy can be induced under nutrition stress conditions. Bcl-2 is a pro-survival protein which inhibits apoptosis and autophagy. However, the role of Bcl-2 in autophagy regulation and cell survival under nutrition deprivation has not been fully understood. This study sought to investigate if Bcl-2 upregulation is essential in limiting autophagic activity and prevent cell death under nutrition deprivation conditions. Autophagic activity was monitored by the changes in GFP-LC3 localization and protein levels of Beclin1, LC3-II, cathepsin D and p62 in neuroblastoma SH-SY5Y cells underwent serum deprivation. Manipulation of Bcl-2 function was achieved with siRNAs and small molecular inhibitors. The cell viability and apoptosis were assessed with MTT assay and Annexin V/PI staining. The results showed that serum starvation increased protein levels of LC3-II and Beclin1 but decreased autophagy substrate p62. Autophagy activation induced by serum deprivation and rapamycin was accompanied by an upregulation of Bcl-2 protein levels. When Bcl-2 was knocked down with siRNA or inhibited with HA 14-1 or ABT-737, serum starvation induced profound cell death and enhanced autophagic flux under nutrition deprivation conditions, while knockdown of autophagic gene Beclin1 or autophagy inhibitors (bafilomycin A1 and E64D), rescued cell death. In contrast, overexpression of Bcl-2 inhibited autophagy and blocked cell death in response to serum deprivation. These data suggest that Bcl-2 plays an essential role in limiting autophagy activation and preventing initiation of programmed cell death. Thus Bcl-2 may be an important mechanism for balancing beneficial and detrimental impacts of autophagy on cell survival.	[Liang, Zhong-Qin] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China; Soochow Univ, Sch Pharmaceut Sci, Lab Aging & Nervous Dis, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Liang, ZQ (corresponding author), Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China.	lzq2003cn@yahoo.com.cn; qinzhenhong@suda.edu.cn	Xu, Haidong/Q-1095-2019		Natural Science Foundation of China [30930035]; National Basic Research Key Program (973 program) [CB510003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Key Program (973 program)(National Basic Research Program of China)	This work was supported by the grant from the Natural Science Foundation of China (No.30930035), http://159.226.244.22/portal/proj_search.asp; the National Basic Research Key Program (973 program, CB510003), http://www.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; MANN SS, 1994, J BIOL CHEM, V269, P11492; McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mohan N, 2011, NEUROSCI LETT, V502, P24, DOI 10.1016/j.neulet.2011.07.016; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qin ZH, 1999, J NEUROSCI, V19, P4023; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Robert G, 2012, AUTOPHAGY, V8, P637, DOI 10.4161/auto.19084; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu SW, 2008, STEM CELLS, V26, P2602, DOI 10.1634/stemcells.2008-0153; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang XD, 2009, J NEUROSCI RES, V87, P3600, DOI 10.1002/jnr.22152	42	40	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63232	10.1371/journal.pone.0063232	http://dx.doi.org/10.1371/journal.pone.0063232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658815	gold, Green Published, Green Submitted			2022-12-27	WOS:000321202100058
J	Baleeiro, RB; Wiesmuller, KH; Dahne, L; Lademann, J; Barbuto, JA; Walden, P				Baleeiro, Renato B.; Wiesmueller, Karl-Heinz; Daehne, Lars; Lademann, Juergen; Barbuto, Jose A.; Walden, Peter			Direct Activation of Human Dendritic Cells by Particle-Bound but Not Soluble MHC Class II Ligand	PLOS ONE			English	Article							COLORECTAL-CANCER PATIENTS; ANTIGEN PRESENTATION; SIGNAL-TRANSDUCTION; IN-VITRO; T-CELLS; VACCINATION; PEPTIDE; BLOOD; LYMPHOCYTES; MATURATION	Dendritic cells (DCs) are key activators of cellular immune responses through their capacity to induce naive T cells and sustained effector T cell responses. This capacity is a function of their superior efficiency of antigen presentation via MHC class I and class II molecules, and the expression of co-stimulatory cell surface molecules and cytokines. Maturation of DCs is induced by microbial factors via pattern recognition receptors such as Toll-like receptors, pro-inflammatory cytokines or cognate interaction with CD4(+) T cells. Here we show that, unexpectedly, the PanDR helper T cell epitope PADRE, a generic T helper cell antigen presented by a large fraction of HLA-DR alleles, when delivered in particle-bound form induced maturation of human DCs. The DCs that received the particle-bound PADRE displayed all features of fully mature DCs, such as high expression of the co-stimulatory molecules CD80, CD86, CD83, the MHC-II molecule HLA-DR, secretion of high levels of the biologically active IL-12 (IL-12p70) and induction of vigorous proliferation of naive CD4(+) T cells. Furthermore, the maturation of DCs induced by particle-bound PADRE was shown to involve sphingosine kinase, calcium signaling from internal sources and downstream signaling through the MAP kinase and the p72syk pathways, and finally activation of the transcription factor NF-kappa B. Based on our findings, we propose that particle-bound PADRE may be used as a DC activator in DC-based vaccines.	[Baleeiro, Renato B.; Lademann, Juergen; Walden, Peter] Humboldt Univ, Charite Univ Med, D-10099 Berlin, Germany; [Baleeiro, Renato B.; Lademann, Juergen; Walden, Peter] Free Univ Berlin, Dept Dermatol Venerol & Allergol, Berlin, Germany; [Baleeiro, Renato B.; Barbuto, Jose A.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Wiesmueller, Karl-Heinz] Univ Tubingen, Tubingen, Germany; [Wiesmueller, Karl-Heinz] EMC Microcollect GmbH, Tubingen, Germany; [Daehne, Lars] Surflay Nanotec GmbH, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Universidade de Sao Paulo; Eberhard Karls University of Tubingen; EMC Microcollections GmbH	Walden, P (corresponding author), Humboldt Univ, Charite Univ Med, D-10099 Berlin, Germany.	peter.walden@charite.de	Barbuto, Jose A. M./H-5299-2011	Barbuto, Jose A. M./0000-0001-9526-6781; Jurgen, Lademann/0000-0003-1828-7460	Bundesministerium fur Bildung und Forschung (BMBF, German Ministry for Education and Research) WING Programme for Nanobiotechnology [13N9196, 13N9197]; Coordenacao de aprimoramento de pessoal de nivel superior (Capes); Deutscher Akademischer Austausch Dienst (DAAD); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Bundesministerium fur Bildung und Forschung (BMBF, German Ministry for Education and Research) WING Programme for Nanobiotechnology; Coordenacao de aprimoramento de pessoal de nivel superior (Capes); Deutscher Akademischer Austausch Dienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grants from the Bundesministerium fur Bildung und Forschung (BMBF, German Ministry for Education and Research) WING Programme for Nanobiotechnology Grants 13N9196 and 13N9197, Coordenacao de aprimoramento de pessoal de nivel superior (Capes), Deutscher Akademischer Austausch Dienst (DAAD), and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daccak R, 2004, CURR OPIN IMMUNOL, V16, P108, DOI 10.1016/j.coi.2003.11.006; Alexander J, 2004, VACCINE, V22, P2362, DOI 10.1016/j.vaccine.2003.11.061; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; ALTOMONTE M, 1993, J IMMUNOL, V151, P5115; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Andreae S, 2003, BLOOD, V102, P2130, DOI 10.1182/blood-2003-01-0273; Andrews DA, 2002, BLOOD, V100, P3392, DOI 10.1182/blood.V100.9.3392; Bagley KC, 2004, CLIN DIAGN LAB IMMUN, V11, P77, DOI 10.1128/CDLI.11.1.77-82.2004; Bobbitt KR, 2000, J IMMUNOL, V165, P5588, DOI 10.4049/jimmunol.165.10.5588; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Connolly SF, 2007, IMMUNOL RES, V39, P115, DOI 10.1007/s12026-007-0076-1; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Draber P, 2011, MOL CELL BIOL, V31, P4550, DOI 10.1128/MCB.05817-11; EGNER W, 1995, IMMUNOLOGY, V85, P611; Herrmann TL, 2005, J LEUKOCYTE BIOL, V78, P1397, DOI 10.1189/jlb.0205105; Jang MJ, 2011, VACCINE, V29, P2400, DOI 10.1016/j.vaccine.2011.01.036; Kavanagh B, 2007, J IMMUNOTHER, V30, P762, DOI 10.1097/CJI.0b013e318133451c; Kirit MA, 2000, BLOOD, V96, P1039; Lang P, 2001, SCIENCE, V291, P1537, DOI 10.1126/science.291.5508.1537; Lesterhuis WJ, 2010, ANTICANCER RES, V30, P5091; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Nguyen A, 2004, FEBS LETT, V572, P307, DOI 10.1016/j.febslet.2004.06.061; O'Sullivan B, 2003, CRIT REV IMMUNOL, V23, P83, DOI 10.1615/CritRevImmunol.v23.i12.50; Ocadlikova D, 2010, NEOPLASMA, V57, P455, DOI 10.4149/neo_2010_05_455; Peyratout CS, 2004, ANGEW CHEM INT EDIT, V43, P3762, DOI 10.1002/anie.200300568; QIN SF, 1995, BIOCHEM J, V308, P347, DOI 10.1042/bj3080347; Ressing ME, 2000, J IMMUNOTHER, V23, P255, DOI 10.1097/00002371-200003000-00010; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Schuler G, 1995, ADV EXP MED BIOL, V378, P43; Shumilina E, 2011, AM J PHYSIOL-CELL PH, V300, pC1205, DOI 10.1152/ajpcell.00039.2011; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Sun C, 2012, MOL BIOL REP, V39, P3179, DOI 10.1007/s11033-011-1084-8; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wierecky J, 2006, CANCER RES, V66, P5910, DOI 10.1158/0008-5472.CAN-05-3905; ZHOU LJ, 1992, J IMMUNOL, V149, P735	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63039	10.1371/journal.pone.0063039	http://dx.doi.org/10.1371/journal.pone.0063039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658796	Green Submitted, Green Published, gold			2022-12-27	WOS:000321200500052
J	Boehm, D; Mazurier, C; Giarratana, MC; Darghouth, D; Faussat, AM; Harmand, L; Douay, L				Boehm, Daniela; Mazurier, Christelle; Giarratana, Marie-Catherine; Darghouth, Dhouha; Faussat, Anne-Marie; Harmand, Laurence; Douay, Luc			Caspase-3 Is Involved in the Signalling in Erythroid Differentiation by Targeting Late Progenitors	PLOS ONE			English	Article							SELECTIVE NONPEPTIDE INHIBITORS; NONAPOPTOTIC FUNCTION; CELL-DIFFERENTIATION; ACTIVATION; APOPTOSIS; ERYTHROPOIESIS; DEGRADATION; AUTOPHAGY; CLEAVAGE; POTENT	A role for caspase activation in erythroid differentiation has been established, yet its precise mode of action remains elusive. A drawback of all previous investigations on caspase activation in ex vivo erythroid differentiation is the lack of an in vitro model producing full enucleation of erythroid cells. Using a culture system which renders nearly 100% enucleated red cells from human CD34(+) cells, we investigated the role of active caspase-3 in erythropoiesis. Profound effects of caspase-3 inhibition were found on erythroid cell growth and differentiation when inhibitors were added to CD34(+) cells at the start of the culture and showed dose-response to the concentration of inhibitor employed. Enucleation was only reduced as a function of the reduced maturity of the culture and the increased cell death of mature cells while the majority of cells retained their ability to extrude their nuclei. Cell cycle analysis after caspase-3 inhibition showed caspase-3 to play a critical role in cell proliferation and highlighted a novel function of this protease in erythroid differentiation, i.e. its contribution to cell cycle regulation at the mitotic phase. While the effect of caspase-3 inhibitor treatment on CD34(+) derived cells was not specific to the erythroid lineage, showing a similar reduction of cell expansion in myeloid cultures, the mechanism of action in both lineages appeared to be distinct with a strong induction of apoptosis causing the decreased yield of myeloid cells. Using a series of colony-forming assays we were able to pinpoint the stage at which cells were most sensitive to caspase-3 inhibition and found activated caspase-3 to play a signalling role in erythroid differentiation by targeting mature BFU-E and CFU-E but not early BFU-E.	[Boehm, Daniela; Mazurier, Christelle; Giarratana, Marie-Catherine; Darghouth, Dhouha; Faussat, Anne-Marie; Harmand, Laurence; Douay, Luc] Univ Paris 06, CDR St Antoine Proliferat & Differentiat Cellules, Paris, France; [Boehm, Daniela; Mazurier, Christelle; Giarratana, Marie-Catherine; Darghouth, Dhouha; Harmand, Laurence; Douay, Luc] INSERM, UMR S938, Paris, France; [Mazurier, Christelle; Harmand, Laurence; Douay, Luc] Etab Francais Sang Ile France, Unite Ingn & Rapie Cellulaire, Creteil, France; [Faussat, Anne-Marie; Douay, Luc] Univ Paris 06, IFR St Antoine 65, Paris, France; [Douay, Luc] Hop St Antoine, AP HP, F-75571 Paris, France; [Douay, Luc] Hop Trousseau, Serv Hematol Biol, F-75571 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Douay, L (corresponding author), Univ Paris 06, CDR St Antoine Proliferat & Differentiat Cellules, Paris, France.	luc.douay@sat.aphp.fr	Boehm, Daniela/AAD-7605-2020; Boehm, Daniela/J-9366-2013; ITEMAN, Isabelle/F-8764-2018	Boehm, Daniela/0000-0003-3188-5115; Boehm, Daniela/0000-0003-3188-5115; , Laurence/0000-0001-7265-9726	DIM Stem Pole; Etablissement Francais du Sang; association "Combattre la leucemie"	DIM Stem Pole; Etablissement Francais du Sang; association "Combattre la leucemie"	This work was supported by funding from the DIM Stem Pole, the Etablissement Francais du Sang and the association "Combattre la leucemie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratosin D, 2005, CYTOM PART A, V66A, P78, DOI 10.1002/cyto.a.20152; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Carlile GW, 2009, FEBS LETT, V583, P848, DOI 10.1016/j.febslet.2009.01.047; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Fadeel B, 1998, BLOOD, V92, P4808, DOI 10.1182/blood.V92.12.4808.424k01_4808_4818; Feinstein-Rotkopf Y, 2009, APOPTOSIS, V14, P980, DOI 10.1007/s10495-009-0346-6; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Garderet L, 2010, HAEMATOL-HEMATOL J, V95, P398, DOI 10.3324/haematol.2009.012773; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Hashimoto T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018449; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Kolbus A, 2002, J EXP MED, V196, P1347, DOI 10.1084/jem.20020562; Krauss SW, 2005, BLOOD, V106, P2200, DOI 10.1182/blood-2005-04-1357; Kuranaga E, 2006, CELL, V126, P583, DOI 10.1016/j.cell.2006.05.048; Larsen BD, 2010, CELL CYCLE, V9, P2940, DOI 10.4161/cc.9.15.12335; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Lee D, 2001, J MED CHEM, V44, P2015, DOI 10.1021/jm0100537; Lee D, 2000, J BIOL CHEM, V275, P16007, DOI 10.1074/jbc.275.21.16007; Lindberg EH, 2001, BRIT J HAEMATOL, V112, P714, DOI 10.1046/j.1365-2141.2001.02581.x; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Mortensen M, 2010, CELL CYCLE, V9, P1901, DOI 10.4161/cc.9.10.11603; Negrotto S, 2006, EXP HEMATOL, V34, P1420, DOI 10.1016/j.exphem.2006.05.017; Newton K, 2003, GENE DEV, V17, P819, DOI 10.1101/gad.1077403; Nhan TQ, 2006, AM J PATHOL, V169, P729, DOI 10.2353/ajpath.2006.060105; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Rubiolo C, 2006, BLOOD, V108, P152, DOI 10.1182/blood-2005-09-3866; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Svingen PA, 2004, CLIN CANCER RES, V10, P6807, DOI 10.1158/1078-0432.CCR-0778-02; Sztiller-Sikorska M, 2009, BRIT J PHARMACOL, V157, P1451, DOI 10.1111/j.1476-5381.2009.00333.x; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Wang J, 2000, J CELL SCI, V113, P753; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247	38	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62303	10.1371/journal.pone.0062303	http://dx.doi.org/10.1371/journal.pone.0062303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658722	gold, Green Published, Green Submitted			2022-12-27	WOS:000321200500023
J	Han, J; Wang, L				Han, Jing; Wang, Lin			Nondestructive Intervention to Multi-Agent Systems through an Intelligent Agent	PLOS ONE			English	Article							DYNAMICALLY CHANGING ENVIRONMENT; CONSENSUS; CONVERGENCE; BEHAVIOR; MOTION	For a given multi-agent system where the local interaction rule of the existing agents can not be re-designed, one way to intervene the collective behavior of the system is to add one or a few special agents into the group which are still treated as normal agents by the existing ones. We study how to lead a Vicsek-like flocking model to reach synchronization by adding special agents. A popular method is to add some simple leaders (fixed-headings agents). However, we add one intelligent agent, called 'shill', which uses online feedback information of the group to decide the shill's moving direction at each step. A novel strategy for the shill to coordinate the group is proposed. It is strictly proved that a shill with this strategy and a limited speed can synchronize every agent in the group. The computer simulations show the effectiveness of this strategy in different scenarios, including different group sizes, shill speed, and with or without noise. Compared to the method of adding some fixed-heading leaders, our method can guarantee synchronization for any initial configuration in the deterministic scenario and improve the synchronization level significantly in low density groups, or model with noise. This suggests the advantage and power of feedback information in intervention of collective behavior.	[Han, Jing] Chinese Acad Sci, Acad Math & Syst Sci, Key Lab Syst & Control, Beijing, Peoples R China; [Wang, Lin] Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Shanghai Jiao Tong University	Han, J (corresponding author), Chinese Acad Sci, Acad Math & Syst Sci, Key Lab Syst & Control, Beijing, Peoples R China.	hanjing@amss.ac.cn			National Natural Science Foundation of China [60574068, 61104137]; Knowledge Innovation Program of the Chinese Academy of Sciences [KJCX3-SYW-S01]; Research Fund for the Doctoral Program of Higher Education of China; National Key Basic Research Program of China [2010CB731403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Key Basic Research Program of China(National Basic Research Program of China)	This work is supported by the National Natural Science Foundation of China (No. 60574068, No. 61104137), the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KJCX3-SYW-S01), the Research Fund for the Doctoral Program of Higher Education of China, and the National Key Basic Research Program of China (No. 2010CB731403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Cao M, 2008, SIAM J CONTROL OPTIM, V47, P575, DOI 10.1137/060657005; Cao M, 2008, SIAM J CONTROL OPTIM, V47, P601, DOI 10.1137/060657029; Cao YC, 2012, IEEE T AUTOMAT CONTR, V57, P33, DOI 10.1109/TAC.2011.2146830; Ceccarelli N, 2008, AUTOMATICA, V44, P3025, DOI 10.1016/j.automatica.2008.04.024; COLORNI A, 1992, FROM ANIM ANIMAT, P134; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Cucker F, 2007, IEEE T AUTOMAT CONTR, V52, P852, DOI 10.1109/TAC.2007.895842; Gomez-Gardenes J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012313; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Hong YG, 2008, AUTOMATICA, V44, P846, DOI 10.1016/j.automatica.2007.07.004; Jadbabaie A, 2003, IEEE T AUTOMAT CONTR, V48, P988, DOI 10.1109/TAC.2003.812781; Jing Han, 2006, Journal of Systems Science and Complexity, V19, P54, DOI 10.1007/s11424-006-0054-z; Han J, 2005, PROCEEDINGS OF THE 24TH CHINESE CONTROL CONFERENCE, VOLS 1 AND 2, P184; Kunz H, 2003, ARTIF LIFE, V9, P237, DOI 10.1162/106454603322392451; Liu JM, 2002, ARTIF INTELL, V136, P101, DOI 10.1016/S0004-3702(01)00174-6; Liu ZX, 2011, AUTOMATICA, V47, P2697, DOI 10.1016/j.automatica.2011.08.047; Liu ZX, 2009, AUTOMATICA, V45, P2744, DOI 10.1016/j.automatica.2009.09.015; Monderer D, 2009, ARTIF INTELL, V173, P180, DOI 10.1016/j.artint.2008.10.005; Ren W, 2008, COMMUN CONTROL ENG, P3; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Stone P, 2010, P 9 INT C AUT AG MUL, V8; Su HS, 2009, IEEE T AUTOMAT CONTR, V54, P293, DOI 10.1109/TAC.2008.2010897; Tang GG, 2006, P 25 CHIN CONTR C, P379; Tang G, 2007, J SYST SCI COMPLEX, V20, P173, DOI 10.1007/s11424-007-9016-3; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Wang L, 2008, J SYST SCI COMPLEX, V21, P406, DOI 10.1007/s11424-008-9122-x; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029182; Yu H, 2008, J INTELL ROBOT SYST, V53, P87, DOI 10.1007/s10846-008-9230-9	34	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61542	10.1371/journal.pone.0061542	http://dx.doi.org/10.1371/journal.pone.0061542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658695	Green Submitted, Green Published, gold			2022-12-27	WOS:000321200500008
J	Mohammed, MA; Marshall, T; Nirantharakumar, K; Stevens, A; Fitzmaurice, D				Mohammed, Mohammed A.; Marshall, Tom; Nirantharakumar, Krishnarajah; Stevens, Andrew; Fitzmaurice, David			Patterns of Warfarin Use in Subgroups of Patients with Atrial Fibrillation: A Cross-Sectional Analysis of 430 General Practices in the United Kingdom	PLOS ONE			English	Article							ORAL ANTICOAGULANTS; STROKE; RISK; MANAGEMENT; POPULATION; PREVALENCE; GUIDELINES; MORTALITY; HISTORY	Background: Despite the proven efficacy of warfarin, its use in patients with Atrial Fibrillation (AF) is reportedly low. We investigated the underuse and overuse of warfarin in the management of AF in general practices in the United Kingdom (UK) against the National Institute of Clinical Excellence (NICE, UK) guidelines whilst seeking to identify subgroups of AF patients to inform efforts to optimise warfarin use. Methodology: A retrospective database analysis to determine warfarin prescribing using tree models based on 50361 patients with AF (classified as low, moderate and high risk of stroke using CHADS2) from 430 general practices in the UK. Results: Over one-third (37.0%, 4573/12351) of low risk AF patients were on warfarin, compared with 47.1% (8349/17709) moderate risk AF patients and 54.9% (11142/20301) high risk AF patients. Clinical subgroups (n = 15 low risk subgroups, n = 15 medium risk subgroups, n = 22 high risk subgroups) were identified. Several factors not supported by current guidelines (age, BMI, dementia, gender) were associated with the use of warfarin. Gender and BMI were associated with warfarin use in low and medium risk AF patients but not in high risk AF patients. Conclusion: Whilst NICE guidelines suggest that all high risk AF patients should be on warfarin, half of those at moderate risk should be on warfarin and none of those at low risk should be on warfarin, we found evidence of over and under use of warfarin. Interventions to optimise warfarin therapy tailored to and targeting specific subgroups of AF patients identified by the tree models are required.	[Mohammed, Mohammed A.; Marshall, Tom; Nirantharakumar, Krishnarajah; Stevens, Andrew; Fitzmaurice, David] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England	University of Birmingham	Marshall, T (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England.	t.p.marshall@bham.ac.uk		Marshall, Tom/0000-0001-9277-5214; Stevens, Andrew/0000-0003-2079-3397	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. The views expressed in this publication are not necessarily those of the NIHR, the Department of Health, University of Birmingham or the CLAHRC-BBC Theme Management/ Steering Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MI, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006186.pub2; Aguilar MI, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001927.pub2; [Anonymous], 2006, NICE CLIN GUID, V36; Atrial Fibrillation, 2006, NAT CLIN GUID MAN PR; Baczek VL, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-5; Baczek VL, 2012, BMC FAMILY PRACTICE, V3, P13; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; DeWilde S, 2006, HEART, V92, P1064, DOI 10.1136/hrt.2005.069492; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gattellari, 2010, STROKE, V41, pE398, DOI 10.1161/STR.0b013e3181da4950; Harper Paul R, 2005, Health Policy, V71, P315, DOI 10.1016/j.healthpol.2004.05.002; Havard J, 2009, BRIT J CARDIOLOGY, V16, P237; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Kammersgaard LP, 2006, CEREBROVASC DIS, V21, P187, DOI 10.1159/000090531; KANNEL WB, 1982, N ENGL J MED, V0306; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Meiltz A, 2008, EUROPACE, V10, P674, DOI 10.1093/europace/eun086; Meinertz T, 2011, CLIN RES CARDIOL, V100, P897, DOI 10.1007/s00392-011-0320-5; National Collaborating Centre for Chronic Conditions, 2006, ATR FIBR NAT CLIN GU; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Stein PD, 2009, CLIN CHEST MED, V30, P489, DOI 10.1016/j.ccm.2009.05.006; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Steyerberg EW, 2019, CLIN PREDICTION MODE, V2nd, DOI 10.1007/978-0-387-77244-8; The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), 2010, EUR HEART J, V31, P2369, DOI DOI 10.1093/EURHEARTJ/EHQ278; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	38	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61979	10.1371/journal.pone.0061979	http://dx.doi.org/10.1371/journal.pone.0061979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658703	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500014
J	Wappler, EA; Institoris, A; Dutta, S; Katakam, PVG; Busija, DW				Wappler, Edina A.; Institoris, Adam; Dutta, Somhrita; Katakam, Prasad V. G.; Busija, David W.			Mitochondrial Dynamics Associated with Oxygen-Glucose Deprivation in Rat Primary Neuronal Cultures	PLOS ONE			English	Article							INDUCED CELL-DEATH; CORTICAL-NEURONS; PHYSIOLOGICAL FUNCTIONS; PROTEIN DRP1; FISSION; APOPTOSIS; FUSION; MITOFUSIN-2; INJURY; OPA1	Our objective was to investigate the mitochondrial dynamics following oxygen-glucose deprivation (OGD) in cultured rat cortical neurons. We documented changes in morphology, protein expression, and DNA levels in mitochondria following OGD and examined the roles of mitochondrial fission [dynamin-related protein 1 (Drp1), fission protein-1 (Fis1)] and fusion [mitofusin-1 (Mfn1), mitofusin-2 (Mfn2), and optic atrophy-1 protein (OPA1)] proteins on mitochondrial biogenesis and morphogenesis. We tested the effects of two Drp1 blockers [15-deoxy-Delta 12,14-Prostaglandin J(2) (PGJ(2)) and Mitochondrial Division Inhibitor (Mdivi-1)] on mitochondrial dynamics and cell survival. One hour of OGD had minimal effects on neuronal viability but mitochondria appeared condensed. Three hours of OGD caused a 60% decrease in neuronal viability accompanied by a transition from primarily normal/tubular and lesser number of rounded mitochondria during normoxia to either poorly labeled or small and large rounded mitochondria. The percentage of rounded mitochondria remained the same. The mitochondrial voltage-dependent anion channel, Complex V, and mitoDNA levels increased after OGD associated with a dramatic reduction in Drp1 expression, less reduction in Mfn2 expression, an increase in Mfn1 expression, with no changes in either OPA1 or Fis1. Although PGJ(2) increased polymerization of Drp1, it did not reduce cell death or alter mitochondrial morphology following OGD and Mdivi-1 did not protect neurons against OGD. In summary, mitochondrial biogenesis and maintained fusion occurred in neurons along with mitochondrial fission following OGD; thus Mfn1 but not Drp1 may be a major regulator of these processes.	[Wappler, Edina A.; Dutta, Somhrita; Katakam, Prasad V. G.; Busija, David W.] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; [Institoris, Adam] Univ Szeged, Sch Med, Dept Physiol, Szeged, Hungary	Tulane University; Szeged University	Wappler, EA (corresponding author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.	eawappler@gmail.com	K, P/AAL-6310-2021	Wappler-Guzzetta, Edina/0000-0002-2195-5960; Katakam, Prasad/0000-0002-4708-9140	State of Louisiana; National Institutes of Health [HL-030260, HL-065380, HL-077731, HL-093554]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065380, R01HL077731, R01HL030260, R01HL093554] Funding Source: NIH RePORTER	State of Louisiana; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Regents Professorship from the State of Louisiana, and National Institutes of Health grants HL-030260, HL-065380,HL-077731 and HL-093554 (Dr. David Busija). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bertoni-Freddari C, 2003, NATURWISSENSCHAFTEN, V90, P68, DOI 10.1007/s00114-002-0398-8; Blackstone C, 2011, NAT CELL BIOL, V13, P521, DOI 10.1038/ncb0511-521; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chbicheb S, 2011, BIOCHEM PHARMACOL, V81, P1087, DOI 10.1016/j.bcp.2011.02.006; Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cho MH, 2012, BRAIN RES, V1454, P100, DOI 10.1016/j.brainres.2012.03.010; Cho SG, 2010, AM J PHYSIOL-RENAL, V299, pF199, DOI 10.1152/ajprenal.00716.2009; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gaspar T, 2006, J NEUROCHEM, V98, P555, DOI 10.1111/j.1471-4159.2006.03899.x; Giedt RJ, 2012, FREE RADICAL BIO MED, V52, P348, DOI [10.1016/j.freeradbiomed.2011.10.491, 10.1007/s10439-012-0568-6]; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Grohm J, 2012, CELL DEATH DIFFER; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kageyama Y, 2011, CURR OPIN CELL BIOL, V23, P427, DOI 10.1016/j.ceb.2011.04.009; Kane CJM, 2011, BRAIN BEHAV IMMUN, V25, pS137, DOI 10.1016/j.bbi.2011.02.016; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Karbowski M, 2010, ADV EXP MED BIOL, V687, P131; Katura T, 2010, MOL PHARMACOL, V77, P601, DOI 10.1124/mol.109.061010; Kis B, 2003, J NEUROCHEM, V87, P969, DOI 10.1046/j.1471-4159.2003.02072.x; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lin TN, 2006, ARTERIOSCL THROM VAS, V26, P481, DOI 10.1161/01.ATV.0000201933.53964.5b; Liu WT, 2012, J NEUROSCI RES, V90, P1183, DOI 10.1002/jnr.23016; Martinez Alma E., 2012, Inflammation & Allergy Drug Targets, V11, P58; Mishra N, 2010, BIOCHEM BIOPH RES CO, V395, P17, DOI 10.1016/j.bbrc.2010.03.093; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Ong SB, 2012, CARDIOVASC RES, V94, P190, DOI 10.1093/cvr/cvr312; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Otera Hidenori, 2011, Small GTPases, V2, P167; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Qi X, 2011, MOL BIOL CELL, V22, P256, DOI 10.1091/mbc.E10-06-0551; Rambold Angelika S, 2011, Commun Integr Biol, V4, P752; Rival T, 2011, EMBO REP, V12, P223, DOI 10.1038/embor.2010.214; Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Uo T, 2009, EXP NEUROL, V218, P274, DOI 10.1016/j.expneurol.2009.05.010; Wang WL, 2010, BIOCHEM BIOPH RES CO, V400, P587, DOI 10.1016/j.bbrc.2010.08.108; Westermann B, 2010, SEMIN CELL DEV BIOL, V21, P542, DOI 10.1016/j.semcdb.2009.12.003; Xiang ZM, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-18; Yeh CH, 2006, SHOCK, V26, P262, DOI 10.1097/01.shk.0000225863.56714.96; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Zhang WB, 2010, BIOCHEM BIOPH RES CO, V397, P270, DOI 10.1016/j.bbrc.2010.05.099; Zhao J, 2009, BRAIN RES, V1302, P240, DOI 10.1016/j.brainres.2009.09.034	57	52	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63206	10.1371/journal.pone.0063206	http://dx.doi.org/10.1371/journal.pone.0063206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658809	Green Submitted, Green Published, gold			2022-12-27	WOS:000321200500060
J	Beare, D; McQuatters-Gollop, A; van der Hammen, T; Machiels, M; Teoh, SJ; Hall-Spencer, JM				Beare, Doug; McQuatters-Gollop, Abigail; van der Hammen, Tessa; Machiels, Marcel; Teoh, Shwu Jiau; Hall-Spencer, Jason M.			Long-Term Trends in Calcifying Plankton and pH in the North Sea	PLOS ONE			English	Article							OCEAN; ATLANTIC; IMPACTS; CONSISTENCY	Relationships between six calcifying plankton groups and pH are explored in a highly biologically productive and data-rich area of the central North Sea using time-series datasets. The long-term trends show that abundances of foraminiferans, coccolithophores, and echinoderm larvae have risen over the last few decades while the abundances of bivalves and pteropods have declined. Despite good coverage of pH data for the study area there is uncertainty over the quality of this historical dataset; pH appears to have been declining since the mid 1990s but there was no statistical connection between the abundance of the calcifying plankton and the pH trends. If there are any effects of pH on calcifying plankton in the North Sea they appear to be masked by the combined effects of other climatic (e.g. temperature), chemical (nutrient concentrations) and biotic (predation) drivers. Certain calcified plankton have proliferated in the central North Sea, and are tolerant of changes in pH that have occurred since the 1950s but bivalve larvae and pteropods have declined. An improved monitoring programme is required as ocean acidification may be occurring at a rate that will exceed the environmental niches of numerous planktonic taxa, testing their capacities for acclimation and genetic adaptation.	[Beare, Doug; Teoh, Shwu Jiau] Nat Resources Management, Batu Maung, Penang, Malaysia; [McQuatters-Gollop, Abigail] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England; [van der Hammen, Tessa; Machiels, Marcel] Inst Marine Resources & Ecosyst Studies, Dept Fisheries, Ijmuiden, North Holland, Netherlands; [Hall-Spencer, Jason M.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	Wageningen University & Research; University of Plymouth	Beare, D (corresponding author), Nat Resources Management, Batu Maung, Penang, Malaysia.	dbeare@cgiar.org	Hall-Spencer, Jason/F-9179-2013; Hall-Spencer, Jason/AFN-7866-2022	Hall-Spencer, Jason/0000-0002-6915-2518; McQuatters-Gollop, Abigail/0000-0002-6043-9563	European Union; European Project on Ocean Acidification; Mediterranean Sea Acidification under a changing climate [265103]; NERC [NE/H01702X/1] Funding Source: UKRI; Natural Environment Research Council [NE/H01702X/1] Funding Source: researchfish; Division Of Ocean Sciences [1154661] Funding Source: National Science Foundation	European Union(European Commission); European Project on Ocean Acidification; Mediterranean Sea Acidification under a changing climate; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The Seventh Framework Programme of the European Union partially funded the current work as part of the projects 'Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors', 'EPOCA: The European Project on Ocean Acidification' and MedSeA: Mediterranean Sea Acidification under a changing climate' (grant agreement 265103). The Consultative Group on International Agricultural Research (CGIAR) Program on Climate Change, Agriculture and Food Security, which is a strategic partnership of CGIAR and Future Earth are also owed a debt of thanks. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artioli Y, 2012, J MARINE SYST, V102, P1, DOI 10.1016/j.jmarsys.2012.04.006; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Batten SD, 2003, PROG OCEANOGR, V58, P193, DOI 10.1016/j.pocean.2003.08.004; Beare DJ, 2002, ICES J MAR SCI, V59, P711, DOI 10.1006/jmsc.2002.1207; Beare DJ, 2002, J SEA RES, V48, P29, DOI 10.1016/S1385-1101(02)00131-4; Beaugrand G, 2013, NAT CLIM CHANGE, V3, P263, DOI 10.1038/NCLIMATE1753; Bijma J, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000388; BRESLOW NE, 1984, J R STAT SOC C-APPL, V33, P38; Briggs RP, 2002, ICES J MAR SCI, V59, P109, DOI 10.1006/jmsc.2001.1144; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; COLEBROOK J M, 1975, Bulletins of Marine Ecology, V8, P123; Comeau S, 2012, P ROY SOC B-BIOL SCI, V279, P732, DOI 10.1098/rspb.2011.0910; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; de Boer MN, 2010, MAR ECOL PROG SER, V408, P265, DOI 10.3354/meps08598; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Friedman J. H., 1984, VARIABLE SPAN SMOOTH; Granger C.W., 2000, Q REV ECON FINANC, V40, P337, DOI DOI 10.1016/S1062-9769(00)00042-9; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; HAYS GC, 1993, J MAR BIOL ASSOC UK, V73, P967, DOI 10.1017/S0025315400034846; Head EJH, 2010, J PLANKTON RES, V32, P1633, DOI 10.1093/plankt/fbq090; Heath MR, 2008, MAR ECOL PROG SER, V363, P183, DOI 10.3354/meps07460; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; HYDES DJ, 2013, 2012ACOM83 ICES CM; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Kirby RR, 2007, MAR ECOL PROG SER, V330, P31, DOI 10.3354/meps330031; Kirby RR, 2009, P ROY SOC B-BIOL SCI, V276, P4095, DOI 10.1098/rspb.2009.1320; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; Mackas DL, 2012, ICES J MAR SCI, V69, P448, DOI 10.1093/icesjms/fsr163; McQuatters-Gollop A, 2011, NATURE, V472, pE6, DOI 10.1038/nature09950; MONAGHAN P, 1992, BIODIVERS CONSERV, V1, P98, DOI 10.1007/BF00731037; Nielsen LT, 2010, MAR BIOL RES, V6, P542, DOI 10.1080/17451000903476941; Ohman MD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039901; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; Raitsos DE, 2006, LIMNOL OCEANOGR, V51, P2122, DOI 10.4319/lo.2006.51.5.2122; REID CP, 2002, FISH RES, V50, P163; Reid PC, 2009, ADV MAR BIOL, V56, P1, DOI 10.1016/S0065-2881(09)56001-4; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Stumpp M, 2012, P NATL ACAD SCI USA, V109, P18192, DOI 10.1073/pnas.1209174109; Teal LR, 2008, MAR ECOL PROG SER, V358, P219, DOI 10.3354/meps07367; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Weijerman M, 2005, MAR ECOL PROG SER, V298, P21, DOI 10.3354/meps298021; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105	48	22	22	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61175	10.1371/journal.pone.0061175	http://dx.doi.org/10.1371/journal.pone.0061175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658686	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000007
J	Domingo, MS; Alberdi, MT; Azanza, B; Silva, PG; Morales, J				Domingo, M. Soledad; Alberdi, M. Teresa; Azanza, Beatriz; Silva, Pablo G.; Morales, Jorge			Origin of an Assemblage Massively Dominated by Carnivorans from the Miocene of Spain	PLOS ONE			English	Article							MADRID BASIN; FELIDAE; TAPHONOMY; MACHAIRODONTINAE; BATALLONES-1; SYSTEMATICS; MORTALITY; SIMOCYON; SKELETON; EUROPE	Carnivoran-dominated fossil sites provide precious insights into the diversity and ecology of species rarely recovered in the fossil record. The lower level assemblage of Batallones-1 fossil site (Late Miocene; Madrid Basin, Spain) has yielded one of the most abundant and diversified carnivoran assemblage ever known from the Cenozoic record of mammals. A comprehensive taphonomic study is carried out here in order to constrain the concentration mode of this remarkable assemblage. Another distinctive feature of Batallones-1 is that the accumulation of carnivoran remains took place in the context of a geomorphological landform (cavity formation through a piping process) practically unknown in the generation of fossil sites. Two characteristics of the assemblage highly restrict the probable causes for the accumulation of the remains: (1) the overwhelming number of carnivorans individuals; and (2) the mortality profiles estimated for the four most abundant taxa do not correspond to the classic mortality types but rather were the consequence of the behavior of the taxa. This evidence together with other taphonomic data supports the hypothesis that carnivoran individuals actively entered the cavity searching for resources (food or water) and were unable to exit. The scarcity of herbivores implies that the shaft was well visible and avoided by these taxa. Fossil bones exhibit a very good preservation state as a consequence of their deposition in the restricted and protective environment of the chamber. Batallones-1 had another assemblage (upper level assemblage) that was dominated by herbivore remains and that potentially corresponded to the final stages of the cavity filling.	[Domingo, M. Soledad] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Alberdi, M. Teresa; Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Madrid, Spain; [Azanza, Beatriz] Univ Zaragoza, Inst Univ Invest Ciencias Ambientales Aragon, Dept Ciencias Tierra, Fac Ciencias, Zaragoza, Spain; [Silva, Pablo G.] Univ Salamanca, Dept Geol, Escuela Politecn Super Avila, Avila, Spain	University of Michigan System; University of Michigan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Zaragoza; University of Salamanca	Domingo, MS (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	soldomingo@gmail.com	Morales, Jorge/L-1476-2014; Silva, Pablo G./ABG-7664-2020; Alberdi, Maria Teresa/ABG-8623-2020; Azanza, Beatriz/B-5206-2008; Domingo, M. Soledad/I-1614-2014; Silva, Pablo G/G-8950-2015	Morales, Jorge/0000-0001-5170-5754; Silva, Pablo G./0000-0003-1470-292X; Alberdi, Maria Teresa/0000-0002-7071-360X; Azanza, Beatriz/0000-0003-2487-547X; Silva, Pablo G/0000-0003-1470-292X; Domingo, M. Soledad/0000-0002-4755-8867	Spanish Ministry of Economy Competitiveness [CGL2008-05813-C02-01/BTE, CGL2011-25754, CGL2010-19116/BOS]; Fundacion Espanola para la Ciencia y la Tecnologia (FECYT)	Spanish Ministry of Economy Competitiveness(Spanish Government); Fundacion Espanola para la Ciencia y la Tecnologia (FECYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was funded by the Spanish Ministry of Economy and Competitiveness research projects CGL2008-05813-C02-01/BTE, CGL2011-25754 and CGL2010-19116/BOS and is included in the BSCH-UCM 910607 Research Group. MSD was supported by a postdoctoral fellowship from the Fundacion Espanola para la Ciencia y la Tecnologia (FECYT) and the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCALA L, 1994, MACROMAMIFEROS NEOGE; Andrews P, 1990, OWLS CAVES FOSSILS; Anton M, 2004, J VERTEBR PALEONTOL, V24, P957, DOI 10.1671/0272-4634(2004)024[0957:FKCSOT]2.0.CO;2; AntuEn, 2000, ARQUEOLOGIA PALEONTO, V6, P190; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Behrensmeyer AK, 1975, B MUS COMP ZOOL HARV, V146, P473; BRAIN C. K, 1981, HUNTERS HUNTED INTRO; CALVO JP, 1989, PALAEOGEOGR PALAEOCL, V70, P199, DOI 10.1016/0031-0182(89)90090-4; Domingo MS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2138; Domingo MS, 2012, NEUES JAHRB GEOL P-A, V265, P131, DOI 10.1127/0077-7749/2012/0251; Domingo MS, 2012, LETHAIA, V45, P386, DOI 10.1111/j.1502-3931.2011.00294.x; Eberth David A., 2007, P265; Eisenberg J.F., 1981, MAMMALIAN RAD; Cano ARG, 2011, PALAEOGEOGR PALAEOCL, V307, P193, DOI 10.1016/j.palaeo.2011.05.014; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Klein R.G., 1984, ANAL ANIMAL BONES AR; Kos AM, 2003, J ARCHAEOL SCI, V30, P769, DOI 10.1016/S0305-4403(02)00251-0; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Marean CW, 1995, J HUM EVOL, V29, P515, DOI 10.1006/jhev.1995.1074; Martin Escorza C, 2005, 16 REUNION BIENAL RE, P109; Mein P., 1975, P 6 C REG COMM MED N, P77; Merino L., 2006, ESTUD GEOL-MADRID, V62, P53; Morales J., 2008, Publicaciones del Seminario de Paleontologia de Zaragoza, V8, P41; Peigne S, 2005, ACTA PALAEONTOL POL, V50, P219; Peigne S, 2008, PALAEONTOLOGY, V51, P943, DOI 10.1111/j.1475-4983.2008.00788.x; Pokines JT, 2007, J ARCHAEOL SCI, V34, P1914, DOI 10.1016/j.jas.2007.01.012; Pozo M., 2004, Geogaceta, V35, P143; Salesa MJ, 2008, ZOOL J LINN SOC-LOND, V152, P593, DOI 10.1111/j.1096-3642.2007.00370.x; Salesa MJ, 2012, J SYST PALAEONTOL, V10, P87, DOI 10.1080/14772019.2011.566584; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Salesa MJ, 2006, J ZOOL, V268, P243, DOI 10.1111/j.1469-7998.2005.00032.x; Salesa MJ, 2006, P NATL ACAD SCI USA, V103, P379, DOI 10.1073/pnas.0504899102; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; Domingo MS, 2007, PALAEOGEOGR PALAEOCL, V255, P361, DOI 10.1016/j.palaeo.2007.08.004; Domingo MS, 2011, PALAIOS, V26, P55, DOI 10.2110/palo.2010.p10-047r; Spencer LM, 2003, PALEOBIOLOGY, V29, P561, DOI 10.1666/0094-8373(2003)029<0561:TAOLMR>2.0.CO;2; Stock C., 1992, SCI SERIES, V37, P1; VOORHIES M R, 1969, Contributions to Geology Special Paper, P1; Wang X., 1993, NATL GEOGRAPHIC RES, V9, P422; Wolverton S, 2006, J HUM EVOL, V50, P540, DOI 10.1016/j.jhevol.2005.12.009	40	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63046	10.1371/journal.pone.0063046	http://dx.doi.org/10.1371/journal.pone.0063046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650542	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000087
J	Kuo, RL; Kao, LT; Lin, SJ; Wang, RYL; Shih, SR				Kuo, Rei-Lin; Kao, Li-Ting; Lin, Sue-Jane; Wang, Robert Yung-Liang; Shih, Shin-Ru			MDA5 Plays a Crucial Role in Enterovirus 71 RNA-Mediated IRF3 Activation	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; INTERFERON REGULATORY FACTOR-3; HEPATITIS-C VIRUS; RIG-I; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; INNATE IMMUNITY; POLIOVIRUS INFECTION; 5'-TRIPHOSPHATE RNA	Induction of type-I interferons (IFNs), IFN-alpha/beta, is crucial to innate immunity against RNA virus infection. Cytoplasmic retinoic acid-inducible gene I (RIG-I)-like receptors, including RIG-I and melanoma differentiation-associated gene 5 (MDA5), are critical pathogen sensors for activation of type-I IFN expression in response to RNA virus infection. MDA5 is required for type-I IFN expression in mouse models in response to infection by picornaviruses, such as encephalomyocarditis virus (EMCV) and coxsackievirus B3. Enterovirus 71 (EV71) belongs to picornaviridae and contains positive-stranded RNA genome that is linked with VPg protein at the 5' end. Although a recent study showed that EV71 3C protease could suppress RIG-I-mediated IFN-beta response, the cytoplasmic RIG-I-like receptor that is directly involved in the recognition of EV71 RNA remains unclear. Using EV71-derived RNA as an agonist, we demonstrate that MDA5 is involved in EV71 RNA-mediated IRF3 activation and IFN-beta transcription. Our data also show that overexpression of the MDA5 protein reverses the suppression of IRF3 activation caused by EV71 infection. These results indicate that MDA5 is an important factor for EV71 RNA-activated type-I IFN expression. Furthermore, we also show that EV71 infection enhances MDA5 degradation and that the degradation could be inhibited by a broad spectrum caspase inhibitor.	[Kuo, Rei-Lin; Kao, Li-Ting; Lin, Sue-Jane; Wang, Robert Yung-Liang; Shih, Shin-Ru] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan; [Kuo, Rei-Lin; Kao, Li-Ting; Lin, Sue-Jane; Shih, Shin-Ru] Chang Gung Univ, Coll Med, Dept Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Wang, Robert Yung-Liang] Chang Gung Univ, Coll Med, Dept Biomed Sci, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University	Kuo, RL (corresponding author), Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan.	rlkuo@mail.cgu.edu.tw	Shih, Shin-Ru/M-9711-2016; Wang, Robert YL/AAI-8416-2020	Wang, Robert YL/0000-0002-1322-3890; Shih, Shin-Ru/0000-0003-4874-401X	Chang Gung Memorial Hospital [CMRPD 1A0571]; National Science Council, Taiwan [NSC100-2320-B-182-019-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Memorial Hospital (grant no. CMRPD 1A0571) and the National Science Council (grant no. NSC100-2320-B-182-019-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, J VIROL, V86, P185, DOI 10.1128/JVI.05245-11; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Drahos J, 2009, J VIROL, V83, P11581, DOI 10.1128/JVI.01490-09; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jin YH, 2012, J VIROL, V86, P1531, DOI 10.1128/JVI.06457-11; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Kuo RL, 2002, J GEN VIROL, V83, P1367, DOI 10.1099/0022-1317-83-6-1367; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; RACANIELLO VR, 2007, FIELDS VIROLOGY, P796; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rodriguez-Pulido M, 2011, J VIROL, V85, P6492, DOI 10.1128/JVI.00599-11; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Weng KF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000593; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	49	69	79	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63431	10.1371/journal.pone.0063431	http://dx.doi.org/10.1371/journal.pone.0063431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650567	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000112
J	Ruano, C; Henriquez, P; Martinez-Gonzalez, MA; Bes-Rastrollo, M; Ruiz-Canela, M; Sanchez-Villegas, A				Ruano, Cristina; Henriquez, Patricia; Angel Martinez-Gonzalez, Miguel; Bes-Rastrollo, Maira; Ruiz-Canela, Miguel; Sanchez-Villegas, Almudena			Empirically Derived Dietary Patterns and Health-Related Quality of Life in the SUN Project	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MEDITERRANEAN DIET; FATTY-ACIDS; DEPRESSIVE SYMPTOMS; NEUROTROPHIC FACTOR; INSULIN-RESISTANCE; METABOLIC SYNDROME; GLYCEMIC INDEX; FAST-FOOD; RISK	Objective: The analysis of dietary patterns has become a valuable tool to examine diet-disease relationships but little is known about their effects on quality of life. Our aim was to ascertain the association between major dietary patterns and mental and physical quality of life after 4 years of follow-up. Materials and Methods: This analysis included 11,128 participants from the "Seguimiento Universidad de Navarra'' (SUN) cohort. Dietary habits were assessed using a validated food-frequency questionnaire. Factor analysis was used to derive dietary patterns. Quality of life was measured with the validated Spanish version of the SF-36 Health Survey. Results: Two major dietary patterns were identified, the 'Western' dietary pattern (rich in red meats, processed pastries and fast-food) and the "Mediterranean'' dietary pattern (high in fruits, vegetables and olive oil). After controlling for confounders, the Western dietary pattern was associated with quality of life in all domains. The magnitude of these differences between the subjects in the highest (quintile 5) and the lowest quintile of adherence to the Western pattern ranged from 20.8 (for mental health) to 23.5 (for vitality). On the contrary, the Mediterranean dietary pattern was associated with better quality of life domains: differences ranged from + 1.3 (for physical functioning) to + 3.4 (for vitality) when comparing extreme quintiles of adherence. Additional sensitivity analyses did not change the reported differences. Conclusions: Whereas baseline adherence to a Western dietary pattern was inversely associated with self-perceived quality of life after 4 years of follow-up, baseline adherence to a Mediterranean dietary pattern was directly associated with better scores in quality of life four years later in the SUN Project.	[Ruano, Cristina; Henriquez, Patricia; Sanchez-Villegas, Almudena] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Angel Martinez-Gonzalez, Miguel; Bes-Rastrollo, Maira; Ruiz-Canela, Miguel; Sanchez-Villegas, Almudena] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Ruano, Cristina; Henriquez, Patricia; Angel Martinez-Gonzalez, Miguel; Sanchez-Villegas, Almudena] Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr, CIBEROBN, CB06 03, Madrid, Spain	Universidad de Las Palmas de Gran Canaria; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Ruano, C (corresponding author), Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain.	cruano@proyinves.ulpgc.es	Bes-Rastrollo, Maira/A-1329-2009; Ruiz-Canela, Miguel/I-7738-2016; Sanchez-Villegas, Almudena/T-6733-2019; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Stefanadis, Christodoulos/ABH-2232-2020	Bes-Rastrollo, Maira/0000-0002-9139-4206; Ruiz-Canela, Miguel/0000-0002-7684-2787; Sanchez-Villegas, Almudena/0000-0001-7733-9238; Stefanadis, Christodoulos/0000-0001-5974-6454; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Instituto de Salud Carlos III, Official Agency of the Spanish Government for biomedical research [PI01/0619, PI030678, PI040233, PI042241, PI050976, PI070240, PI070312, PI081943, PI080819, PI1002293, PI1002658, RD06/0045, G03/140]; Navarra Regional Government [36/2001, 43/2002, 41/2005, 36/2008]	Instituto de Salud Carlos III, Official Agency of the Spanish Government for biomedical research; Navarra Regional Government	The SUN Project has received funding from Instituto de Salud Carlos III, Official Agency of the Spanish Government for biomedical research (Grants PI01/0619, PI030678, PI040233, PI042241, PI050976, PI070240, PI070312, PI081943, PI080819, PI1002293, PI1002658, RD06/0045, and G03/140), the Navarra Regional Government (36/2001, 43/2002, 41/2005 and 36/2008) and the University of Navarra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; ALONSO J, 1999, MED CLIN-BARCELONA, V12, P113; Ascherio A, 1999, NEW ENGL J MED, V340, P1994, DOI 10.1056/NEJM199906243402511; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Bes-Rastrollo M, 2005, REV ESP OBESIDAD, V3, P352; Bottiglieri T, 1996, NUTR REV, V54, P382, DOI 10.1111/j.1753-4887.1996.tb03851.x; Castren E, 1998, PROG BRAIN RES, V117, P57; Chrysohoou C, 2004, J AM COLL CARDIOL, V44, P152, DOI 10.1016/j.jacc.2004.03.039; Corica F, 2008, INT J OBESITY, V32, P185, DOI 10.1038/sj.ijo.0803687; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Juan PMFS, 2009, NUTR HOSP, V24, P515, DOI 10.3305/nh.2009.24.5.4461; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Galland L, 2010, NUTR CLIN PRACT, V25, P634, DOI 10.1177/0884533610385703; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Guiterrez-Bedmar M, 2009, INT J ENV RES PUB HE, V6, P310, DOI 10.3390/ijerph6010310; Sanchez PH, 2012, EUR J CLIN NUTR, V66, P360, DOI 10.1038/ejcn.2011.146; Hislop TG, 2006, J CLIN ONCOL, V24, P2311, DOI 10.1200/JCO.2005.04.3042; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Isganaitis E, 2005, ARTERIOSCL THROM VAS, V25, P2451, DOI 10.1161/01.ATV.0000186208.06964.91; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Kim J, 1978, FACTOR ANAL STAT MET; Levitan EB, 2008, METABOLISM, V57, P437, DOI 10.1016/j.metabol.2007.11.002; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Martinez-Gonzalez MA, 2002, NUTR NEUROSCI, V5, P65, DOI 10.1080/10284150290007047; MARTINEZGONZALE.MA, 2006, BMJ-BRIT MED J, V336, P1348; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Mataix Verdu J., 2009, TABLA COMPOSICION AL, V5th; McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Munoz MA, 2009, BRIT J NUTR, V101, P1821, DOI 10.1017/S0007114508143598; Murakami K, 2008, NUTRITION, V24, P140, DOI 10.1016/j.nut.2007.10.013; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Plaisted CS, 1999, J AM DIET ASSOC, V99, pS84, DOI 10.1016/S0002-8223(99)00421-6; Pucci G, 2012, QUAL LIFE RES, V21, P1537, DOI 10.1007/s11136-011-0083-5; Raczek AE, 1998, J CLIN EPIDEMIOL, V51, P1203, DOI 10.1016/S0895-4356(98)00112-7; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Serra-Majem L, 2009, BRIT J NUTR, V101, pS21, DOI 10.1017/S0007114509990559; Serrano-Aguilar P, 2009, QUAL LIFE RES, V18, P171, DOI 10.1007/s11136-008-9427-1; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Terry P, 2001, CANCER EPIDEM BIOMAR, V10, P1281; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Trichopoulos D, 2001, BRIT J NUTR, V85, P133, DOI 10.1079/BJN2000282; TRICHOPOULOU A, 2009, BMJ-BRIT MED J, V23, P338; UTTS J, 1996, SEEING STAT; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; Verberne L, 2010, NUTR CANCER, V62, P860, DOI 10.1080/01635581.2010.509834; Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076; Vogl M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-203; WANNAMETHEE G, 1991, INT J EPIDEMIOL, V20, P239, DOI 10.1093/ije/20.1.239; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Willet W, 1998, NUTR EPIDEMIOLOGY	64	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61490	10.1371/journal.pone.0061490	http://dx.doi.org/10.1371/journal.pone.0061490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23658694	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000015
J	Sanganahalli, BG; Herman, P; Hyder, F; Kannurpatti, SS				Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed; Kannurpatti, Sridhar S.			Mitochondrial Functional State Impacts Spontaneous Neocortical Activity and Resting State fMRI	PLOS ONE			English	Article							RAT SOMATOSENSORY CORTEX; BOLD SIGNAL FLUCTUATIONS; NEURONAL-ACTIVITY; DEFAULT NETWORK; IN-VIVO; INTERHEMISPHERIC SYNCHRONY; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; SLOW OSCILLATIONS; CALCIUM-UPTAKE	Mitochondrial Ca2+ uptake, central to neural metabolism and function, is diminished in aging whereas enhanced after acute/sub-acute traumatic brain injury. To develop relevant translational models for these neuropathologies, we determined the impact of perturbed mitochondrial Ca2+ uptake capacities on intrinsic brain activity using clinically relevant markers. From a multi-compartment estimate of probable baseline Ca2+ ranges in the brain, we hypothesized that reduced or enhanced mitochondrial Ca2+ uptake capacity would decrease or increase spontaneous neuronal activity respectively. As resting state fMRI-BOLD fluctuations and stimulus-evoked BOLD responses have similar physiological origins [ 1] and stimulus-evoked neuronal and hemodynamic responses are modulated by mitochondrial Ca2+ uptake capacity [2,3] respectively, we tested our hypothesis by measuring hemodynamic fluctuations and spontaneous neuronal activities during normal and altered mitochondrial functional states. Mitochondrial Ca2+ uptake capacity was perturbed by pharmacologically inhibiting or enhancing the mitochondrial Ca2+ uniporter (mCU) activity. Neuronal electrical activity and cerebral blood flow (CBF) fluctuations were measured simultaneously and integrated with fMRI-BOLD fluctuations at 11.7T. mCU inhibition reduced spontaneous neuronal activity and the resting state functional connectivity (RSFC), whereas mCU enhancement increased spontaneous neuronal activity but reduced RSFC. We conclude that increased or decreased mitochondrial Ca2+ uptake capacities lead to diminished resting state modes of brain functional connectivity.	[Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Hyder, Fahmeed] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Magnet Resonance Res Ctr, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Core Ctr Quantitat Neurosci Magnet Resonance, New Haven, CT USA; [Kannurpatti, Sridhar S.] UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA	Yale University; Yale University; Yale University; Yale University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kannurpatti, SS (corresponding author), UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA.	kannursr@umdnj.edu	Sanganahalli, Basavaraju G/C-3296-2008; Herman, Peter/E-7028-2010; Hyder, Fahmeed/A-2644-2015	Sanganahalli, Basavaraju G/0000-0002-0851-6621; Hyder, Fahmeed/0000-0001-7822-4002; Herman, Peter/0000-0003-2218-9652	American Heart Association [0930132N]; National Institute of Health [P30NS052519]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067528] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the American Heart Association 0930132N (SK) and National Institute of Health P30NS052519 (FH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bardutzky J, 2005, J CEREBR BLOOD F MET, V25, P968, DOI 10.1038/sj.jcbfm.9600095; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Busche MA, 2012, P NATL ACAD SCI US; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Fluegge D, 2012, NAT NEUROSCI, V15, P754, DOI 10.1038/nn.3074; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Huttunen JK, 2008, NEUROIMAGE, V39, P775, DOI 10.1016/j.neuroimage.2007.06.042; Hyder F, 2010, P NATL ACAD SCI USA, V107, P10773, DOI 10.1073/pnas.1005135107; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; Kannurpatti SS, 2008, J CEREBR BLOOD F MET, V28, P772, DOI 10.1038/sj.jcbfm.9600574; Kannurpatti SS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00007; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Kannurpatti SS, 2000, NEUROCHEM RES, V25, P1527, DOI 10.1023/A:1026602100160; Kannurpatti SS BB, 2003, MAP REVERSIBLE MODUL, P1856; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kreiner L, 2006, J BIOL CHEM, V281, P4691, DOI 10.1074/jbc.M511971200; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESLIE SW, 1985, BRAIN RES, V329, P177, DOI 10.1016/0006-8993(85)90523-2; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Luu P, 2001, J CLIN NEUROPHYSIOL, V18, P302, DOI 10.1097/00004691-200107000-00002; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Moreira PI, 2006, J ALZHEIMERS DIS, V9, P101; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nagayama S, 2007, NEURON, V53, P789, DOI 10.1016/j.neuron.2007.02.018; Nemoto EM, 2005, ADV EXP MED BIOL, V566, P83; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Sanganahalli BG, 2009, J NEUROSCI, V29, P1707, DOI 10.1523/JNEUROSCI.5549-08.2009; Sanganahalli BG, 2013, J CEREBRAL IN PRESS; Sarnat HB, 2011, CAN J NEUROL SCI, V38, P909, DOI 10.1017/S0317167100012518; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schulz K, 2012, NAT METHODS, V9, P597, DOI [10.1038/NMETH.2013, 10.1038/nmeth.2013]; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Simpson PB, 2000, J BIOENERG BIOMEMBR, V32, P5, DOI 10.1023/A:1005552126516; Simpson PB, 1998, BRAIN RES REV, V26, P72, DOI 10.1016/S0165-0173(97)00056-8; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Tsytsarev V, 2012, J NEUROSCI METH, V203, P136, DOI 10.1016/j.jneumeth.2011.09.005; Ueki M, 1992, ACTA ANAESTH SCAND, V36, P5; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; Vern BA, 1997, BRAIN RES, V775, P233, DOI 10.1016/S0006-8993(97)01028-7; Vern BA, 1998, ADV EXP MED BIOL, V454, P561; VITORICA J, 1986, BRAIN RES, V378, P36, DOI 10.1016/0006-8993(86)90284-2; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	72	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63317	10.1371/journal.pone.0063317	http://dx.doi.org/10.1371/journal.pone.0063317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650561	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000106
J	Mello, A; Ding, GC; Piceno, YM; Napoli, C; Tom, LM; DeSantis, TZ; Andersen, GL; Smalla, K; Bonfante, P				Mello, Antonietta; Ding, Guo-Chun; Piceno, Yvette M.; Napoli, Chiara; Tom, Lauren M.; DeSantis, Todd Z.; Andersen, Gary L.; Smalla, Kornelia; Bonfante, Paola			Truffle Brules Have an Impact on the Diversity of Soil Bacterial Communities	PLOS ONE			English	Article							MYCORRHIZA HELPER BACTERIA; BLACK TRUFFLE; MICROBIAL COMMUNITIES; TUBER-MAGNATUM; RHIZOSPHERE; AMPLIFICATION; POPULATIONS; VOLATILES; PLANTS; DGGE	Background: The development of Tuber melanosporum mycorrhizal symbiosis is associated with the production of an area devoid of vegetation (commonly referred to by the French word 'brule') around the symbiotic plants and where the fruiting bodies of T. melanosporum are usually collected. The extent of the ecological impact of such an area is still being discovered. While the relationship between T. melanosporum and the other fungi present in the brule has been assessed, no data are available on the relationship between this fungus and the bacteria inhabiting the brule. Methodology/Principal Findings: We used DGGE and DNA microarrays of 16S rRNA gene fragments to compare the bacterial and archaeal communities inside and outside of truffle brules. Soil samples were collected in 2008 from four productive T. melanosporum/Quercus pubescens truffle-grounds located in Cahors, France, showing characteristic truffle brule. All the samples were analyzed by DGGE and one truffle-ground was analyzed also using phylogenetic microarrays. DGGE profiles showed differences in the bacterial community composition, and the microarrays revealed a few differences in relative richness between the brule interior and exterior zones, as well as differences in the relative abundance of several taxa. Conclusions/Significance: The different signal intensities we have measured for members of bacteria and archaea inside versus outside the brule are the first demonstration, to our knowledge, that not only fungal communities, but also other microorganisms are affected by T. melanosporum. Firmicutes (e.g., Bacillus), several genera of Actinobacteria, and a few Cyanobacteria had greater representation inside the brule compared with outside, whereas Pseudomonas and several genera within the class Flavobacteriaceae had higher relative abundances outside the brule. The findings from this study may contribute to future searches for microbial bio-indicators of brules.	[Mello, Antonietta] CNR, Turin UOS, Inst Plant Protect, I-00185 Rome, Italy; [Ding, Guo-Chun; Smalla, Kornelia] Julius Kuhn Inst, Braunschweig, Germany; [Piceno, Yvette M.; Tom, Lauren M.; DeSantis, Todd Z.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Napoli, Chiara; Bonfante, Paola] Dept Life Sci & Syst Biol, Turin, Italy; [DeSantis, Todd Z.] Second Genome Inc, San Bruno, CA USA	Consiglio Nazionale delle Ricerche (CNR); Julius Kuhn-Institut; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mello, A (corresponding author), CNR, Turin UOS, Inst Plant Protect, I-00185 Rome, Italy.	a.mello@ipp.cnr.it	Smalla, Kornelia/H-4002-2011; Bonfante, Paola/ABE-6733-2020; Mello, Antonietta/B-9101-2015; Mello, Antonietta/AFX-6601-2022; Andersen, Gary/G-2792-2015; ding, guo-chun/A-6821-2012; Tom, Lauren/E-9739-2015; Piceno, Yvette/I-6738-2016	Mello, Antonietta/0000-0002-6311-377X; Mello, Antonietta/0000-0002-6311-377X; Andersen, Gary/0000-0002-1618-9827; ding, guo-chun/0000-0001-6702-3782; Piceno, Yvette/0000-0002-7915-4699; Bonfante, Paola/0000-0003-3576-8530; ding, guo-chun/0000-0002-5468-5979	Regione Piemonte for the project "Carta del suolo del Tuber melanosporum''	Regione Piemonte for the project "Carta del suolo del Tuber melanosporum''	The source of funding is Regione Piemonte for the project "Carta del suolo del Tuber melanosporum.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli A, 2004, SOIL BIOL BIOCHEM, V36, P859, DOI 10.1016/j.soilbio.2004.02.004; Barbieri E, 2000, APPL ENVIRON MICROB, V66, P5035, DOI 10.1128/AEM.66.11.5035-5042.2000; Barbieri E, 2005, FEMS MICROBIOL LETT, V247, P23, DOI 10.1016/j.femsle.2005.04.027; Barbieri E, 2007, ENVIRON MICROBIOL, V9, P2234, DOI 10.1111/j.1462-2920.2007.01338.x; Barbieri E, 2010, FUNGAL BIOL-UK, V114, P936, DOI 10.1016/j.funbio.2010.09.001; Bonet JA, 2006, AGRON SUSTAIN DEV, V26, P69, DOI 10.1051/agro:2005059; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Buzzini P, 2005, ARCH MICROBIOL, V184, P187, DOI 10.1007/s00203-005-0043-y; Ceruti A., 2003, SPECIE EUROPEE GENER; Chevalier G, 2010, METHODE RAISONNEE TR, P55; Delmas J., 1983, TRUFFE SA CULTURE; Delmont TO, 2011, J MICROBIOL METH, V86, P397, DOI 10.1016/j.mimet.2011.06.013; Ding GC, 2012, BIOMETRICAL J, V54, P94, DOI 10.1002/bimj.201000164; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Frey-Klett P, 2005, NEW PHYTOL, V168, P4, DOI 10.1111/j.1469-8137.2005.01553.x; Garbeva P, 2003, MICROB ECOL, V45, P302, DOI 10.1007/s00248-002-2034-8; Giri BS, 2012, APPL BIOCHEM BIOTECH, V167, P1744, DOI 10.1007/s12010-012-9647-2; Gomes NCM, 2005, FEMS MICROBIOL ECOL, V54, P21, DOI 10.1016/j.femsec.2005.02.005; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Heuer H., 1997, Modern soil microbiology., P353; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Lloyd-Jones G, 2005, J MICROBIOL METH, V60, P217, DOI 10.1016/j.mimet.2004.09.011; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Milling A, 2004, PLANT SOIL, V266, P23; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Napoli C, 2010, NEW PHYTOL, V185, P237, DOI 10.1111/j.1469-8137.2009.03053.x; Nubel U, 1996, J BACTERIOL, V178, P5636; Pacioni G, 2007, MYCOL RES, V111, P1450, DOI 10.1016/j.mycres.2007.08.016; PLATTNER I, 1995, MYCOL RES, V99, P1367, DOI 10.1016/S0953-7562(09)81223-9; Sbrana C, 2002, FEMS MICROBIOL LETT, V211, P195, DOI 10.1111/j.1574-6968.2002.tb11224.x; Schafer H, 2010, J EXP BOT, V61, P315, DOI 10.1093/jxb/erp355; Sourzat P, 2010, PRINCIPE PRECAUTION, P32; Splivallo R, 2007, NEW PHYTOL, V175, P417, DOI 10.1111/j.1469-8137.2007.02141.x; Splivallo R, 2011, NEW PHYTOL, V189, P688, DOI 10.1111/j.1469-8137.2010.03523.x; Streiblova E, 2012, FEMS MICROBIOL ECOL, V80, P1, DOI 10.1111/j.1574-6941.2011.01283.x; TALOU T, 1987, J AGR FOOD CHEM, V35, P774, DOI 10.1021/jf00077a031; Tarkka MT, 2009, CURR GENET, V55, P233, DOI 10.1007/s00294-009-0241-2; Trivedi P, 2012, ISME J, V6, P363, DOI 10.1038/ismej.2011.100; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Weinert N, 2011, FEMS MICROBIOL ECOL, V75, P497, DOI 10.1111/j.1574-6941.2010.01025.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wilson KH, 2002, APPL ENVIRON MICROB, V68, P2535, DOI 10.1128/AEM.68.5.2535-2541.2002	51	43	46	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61945	10.1371/journal.pone.0061945	http://dx.doi.org/10.1371/journal.pone.0061945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23667413	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300020
J	Nielsen, SS; Toft, N; Okura, H				Nielsen, Soren Saxmose; Toft, Nils; Okura, Hisako			Dynamics of Specific Anti-Mycobacterium avium Subsp paratuberculosis Antibody Response through Age	PLOS ONE			English	Article							BOVINE-PARATUBERCULOSIS; DAIRY-COWS; IMMUNE-RESPONSES; DIAGNOSTIC-TESTS; MILK-PRODUCTION; CATTLE; ELISA; INFECTIONS; SIMULATION; MODEL	Mycobacterium avium subsp. paratuberculosis (MAP) causes a chronic infection in cattle. MAP infected cattle with humoral immune (HI) reactions with IgG antibodies are usually those where latency of infection has ceased and their infection is progressing towards reduced milk yield, weight loss and significant bacterial excretion in feces. The proportion of detectable infections among all infected animals that will develop disease is often referred to as 'the tip of the iceberg'. The purpose of this study was to estimate this proportion. Test-records from 18,972 Danish dairy cows with MAP specific IgG antibodies on their final test-record were used to estimate age-specific sensitivities (Se). These cows were the infected ones considered to develop disease in a population with a representative age-distribution and were defined as cases. The specificity (Sp) of the test was estimated based on test-results from 166,905 cows, which had no MAP IgG antibodies in their final four test-records. The Sp, age-specific Se and maximum Se were used to estimate the probability of having HI at a given age resulting in the proportion of infected cows with HI at a given age. For cows 2 years of age, the proportion of detectable cases was 0.33, while it was 0.94 for cows 5 years of age. Thus, there was a significant shift in the tip of the iceberg with aging. This study provided a model for estimating the proportion of latent chronic infections that would progress to disease, and the results can be used to model infection dynamics.	[Nielsen, Soren Saxmose; Toft, Nils; Okura, Hisako] Univ Copenhagen, Dept Large Anim Sci, Frederiksberg C, Denmark	University of Copenhagen	Nielsen, SS (corresponding author), Univ Copenhagen, Dept Large Anim Sci, Frederiksberg C, Denmark.	saxmose@sund.ku.dk		Nielsen, Soren/0000-0003-2417-0787; Toft, Nils/0000-0002-0265-3764	University of Copenhagen; Danish Government	University of Copenhagen; Danish Government	Salaries for the authors were paid by University of Copenhagen based on basic funding from the Danish Government. The Danish Cattle Federation made available the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begg DJ, 2011, IMMUNOBIOLOGY, V216, P840, DOI 10.1016/j.imbio.2010.12.004; Collins MT, 2005, CLIN DIAGN LAB IMMUN, V12, P685, DOI 10.1128/CDLI.12.6.685-692.2005; Collins MT, 2002, CLIN DIAGN LAB IMMUN, V9, P1367, DOI 10.1128/CDLI.9.6.1367-1371.2002; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; Coussens PM, 2004, INFECT IMMUN, V72, P3089, DOI 10.1128/IAI.72.6.3089-3096.2004; Groenendaal H, 2002, PREV VET MED, V54, P225, DOI 10.1016/S0167-5877(02)00027-2; Hastie TJT RJ, 1997, GEN ADDITIVE MODELS; Koets AP, 2001, INFECT IMMUN, V69, P1492, DOI 10.1128/IAI.69.3.1492-1498.2001; Kudahl AB, 2009, J DAIRY SCI, V92, P4340, DOI 10.3168/jds.2009-2039; Kudahl AB, 2007, PREV VET MED, V78, P97, DOI 10.1016/j.prevetmed.2006.05.015; Marce C, 2010, J DAIRY SCI, V93, P4455, DOI 10.3168/jds.2010-3139; Mitchell RM, 2008, PREV VET MED, V83, P360, DOI 10.1016/j.prevetmed.2007.09.006; Nielsen SS, 2007, CATTLE PRACT, V15, P161; Nielsen SS, 2006, J DAIRY SCI, V89, P4557, DOI 10.3168/jds.S0022-0302(06)72505-X; Nielsen SS, 2009, J DAIRY SCI, V92, P149, DOI 10.3168/jds.2008-1488; Nielsen SS, 2008, VET MICROBIOL, V132, P274, DOI 10.1016/j.vetmic.2008.05.018; Nielsen SS, 2012, VET IMMUNOL IMMUNOP, V149, P6, DOI 10.1016/j.vetimm.2012.05.013; Nielsen SS, 2006, J DAIRY SCI, V89, P569, DOI 10.3168/jds.S0022-0302(06)72120-8; OIE, 2009, VAL CERT DIAGN ASS; Parikka M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002944; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Sorge US, 2011, J DAIRY SCI, V94, P754, DOI 10.3168/jds.2010-3404; Stabel JR, 2009, VET MICROBIOL, V136, P306, DOI 10.1016/j.vetmic.2008.11.025; Stabel JR, 2001, VET IMMUNOL IMMUNOP, V79, P69, DOI 10.1016/S0165-2427(01)00253-7; Subharat S, 2012, VET IMMUNOL IMMUNOP, V149, P225, DOI 10.1016/j.vetimm.2012.07.005; Sweeney RW, 2011, VET CLIN N AM-FOOD A, V27, P537, DOI 10.1016/j.cvfa.2011.07.001; van Hulzen KJE, 2012, J DAIRY SCI, V95, P2740, DOI 10.3168/jds.2011-5005; Wells SJKN, 2010, EFFECT DELAYING EXPO, P19; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Windsor PA, 2010, VET J, V184, P37, DOI 10.1016/j.tvjl.2009.01.007	30	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e63009	10.1371/journal.pone.0063009	http://dx.doi.org/10.1371/journal.pone.0063009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658660	Green Published, Green Submitted, gold			2022-12-27	WOS:000321662800073
J	Chen, L; Phillips, AL; Condon, AG; Parry, MAJ; Hu, YG				Chen, Liang; Phillips, Andrew L.; Condon, Anthony G.; Parry, Martin A. J.; Hu, Yin-Gang			GA-Responsive Dwarfing Gene Rht12 Affects the Developmental and Agronomic Traits in Common Bread Wheat	PLOS ONE			English	Article							SPRING-WHEAT; COLEOPTILE LENGTH; GRAIN-YIELD; PHOTOPERIOD SENSITIVITY; FLORET DEVELOPMENT; STEM ELONGATION; ISOGENIC LINES; KERNEL NUMBER; EARLY GROWTH; HEIGHT	Opportunities exist for replacing reduced height (Rht) genes Rht-B1b and Rht-D1b with alternative dwarfing genes, such as the gibberellin-responsive gene Rht12, for bread wheat improvement. However, a comprehensive understanding of the effects and mode of action of Rht12 is lacking. In the present study, the effects of Rht12 were characterized by analyzing its effects on seeding vigour, seedling roots, leaf and stem morphology, spike development and carbohydrate assimilation and distribution. This was carried out in the four genotypes of F-2:3 lines derived from a cross between Ningchun45 and Karcagi (12) in two experiments of autumn sowing and spring sowing. Rht12 significantly decreased stem length (43%similar to 48% for peduncle) and leaf length (25%similar to 30% for flag leaf) while the thickness of the internode walls and width of the leaves were increased. Though the final plant stature was shortened (40%) by Rht12, the seedling vigour, especially coleoptile length and root traits at the seedling stage, were not affected adversely. Rht12 elongated the duration of the spike development phase, improved the proportion of spike dry weight at anthesis and significantly increased floret fertility (14%) in the autumn sowing experiment. However, Rht12 delayed anthesis date by around 5 days and even the dominant Vrn-B1 allele could not compensate this negative effect. Additionally, grain size was reduced with the ability to support spike development after anthesis decreased in Rht12 lines. Finally, grain yield was similar between the dwarf and tall lines in the autumn sowing experiment. Thus, Rht12 could substantially reduce plant height without altering seeding vigour and significantly increase spikelet fertility in the favourable autumn sowing environment. The successful utilization of Rht12 in breeding programs will require careful selection since it might delay ear emergence. Nonetheless, the potential exists for wheat improvement by using Rht12.	[Chen, Liang; Hu, Yin-Gang] NW A& F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Phillips, Andrew L.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England; [Condon, Anthony G.] CSIRO Plant Ind, Canberra, ACT, Australia; [Hu, Yin-Gang] NW A& F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Northwest A&F University - China	Hu, YG (corresponding author), NW A& F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn	Condon, Anthony G/F-3255-2011	Parry, Martin/0000-0002-4477-672X	Ministry of Science and Technology [2011AA100504, 2013AA102902]; Northwest AF University [ZD2012002]; China 111 Project P. R. China [B12007]; ACIAR Project of Australia [CIM/2005/111]; Biotechnology and Biological Sciences Research Council (BBSRC) of the UK under the 20:20 Wheat(R) Institute Strategic Programme; BBSRC [BBS/E/C/00005202, BB/E006922/1, BB/I000607/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005202, BB/E006922/1, BB/I000607/1] Funding Source: researchfish	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Northwest AF University; China 111 Project P. R. China; ACIAR Project of Australia(Australian Ctr Intl Agr Res); Biotechnology and Biological Sciences Research Council (BBSRC) of the UK under the 20:20 Wheat(R) Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2011AA100504, 2013AA102902) of the Ministry of Science and Technology, the key project of Chinese Universities Scientific Fund, Northwest A&F University (ZD2012002) and the China 111 Project (B12007), P. R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. ALP and MAJP are supported by the Biotechnology and Biological Sciences Research Council (BBSRC) of the UK under the 20:20 Wheat (R) Institute Strategic Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addisu M, 2009, EUPHYTICA, V166, P249, DOI 10.1007/s10681-008-9838-7; Aldrich J., 1993, Plant Molecular Biology Reporter, V11, P128, DOI 10.1007/BF02670471; ALLAN RE, 1989, CROP SCI, V29, P1103, DOI 10.2135/cropsci1989.0011183X002900050001x; Bancal MO, 2007, ANN BOT-LONDON, V100, P777, DOI 10.1093/aob/mcm163; Berry PM, 2007, EUPHYTICA, V154, P165, DOI 10.1007/s10681-006-9284-3; Berry PM, 2000, FIELD CROP RES, V67, P59, DOI 10.1016/S0378-4290(00)00084-8; Botwright TL, 2005, ANN BOT-LONDON, V95, P631, DOI 10.1093/aob/mci069; Botwright TL, 2001, EUPHYTICA, V119, P349, DOI 10.1023/A:1017527911084; Butler JD, 2005, CROP SCI, V45, P939, DOI 10.2135/cropsci2004.0323; Calderini DF, 1996, ANN BOT-LONDON, V77, P583, DOI 10.1006/anbo.1996.0073; Chapman SC, 2007, EUPHYTICA, V157, P391, DOI 10.1007/s10681-006-9304-3; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Chen LA, 2011, AUST J CROP SCI, V5, P318; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Ellis MH, 2005, THEOR APPL GENET, V111, P423, DOI 10.1007/s00122-005-2008-6; Ellis MH, 2004, FUNCT PLANT BIOL, V31, P583, DOI 10.1071/FP03207; FISCHER RA, 1980, AUST J PLANT PHYSIOL, V7, P169, DOI 10.1071/PP9800169; FISCHER RA, 1975, CROP SCI, V15, P607, DOI 10.2135/cropsci1975.0011183X001500050002x; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; FLINTHAM JE, 1983, THEOR APPL GENET, V66, P249, DOI 10.1007/BF00251155; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; GARDNER JS, 1985, AM J BOT, V72, P548, DOI 10.2307/2443587; Gasperini D, 2012, J EXP BOT, V63, P4419, DOI 10.1093/jxb/ers138; Gonzalez FG, 2005, EUPHYTICA, V146, P253, DOI 10.1007/s10681-005-9021-3; Gonzalez FG, 2003, FIELD CROP RES, V81, P29, DOI 10.1016/S0378-4290(02)00196-X; GRIFFITHS FEW, 1985, ANN BOT-LONDON, V56, P501, DOI 10.1093/oxfordjournals.aob.a087035; Hansen H, 2000, PLANT PHYSIOL, V124, P1437, DOI 10.1104/pp.124.3.1437; HAUN JR, 1973, AGRON J, V65, P116, DOI 10.2134/agronj1973.00021962006500010035x; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Iwaki K, 2002, THEOR APPL GENET, V104, P571, DOI 10.1007/s00122-001-0769-0; KEYES GJ, 1989, ANN BOT-LONDON, V64, P683, DOI 10.1093/oxfordjournals.aob.a087894; KIRBY EJM, 1988, FIELD CROP RES, V18, P127, DOI 10.1016/0378-4290(88)90004-4; Korzun V, 1997, PLANT BREEDING, V116, P227, DOI 10.1111/j.1439-0523.1997.tb00987.x; LAW CN, 1976, HEREDITY, V36, P49, DOI 10.1038/hdy.1976.5; Mahdi L, 1998, FIELD CROP RES, V58, P187, DOI 10.1016/S0378-4290(98)00094-X; Miralles DJ, 1995, PLANT BREEDING, V114, P392, DOI 10.1111/j.1439-0523.1995.tb00818.x; Miralles DJ, 1998, FIELD CROP RES, V59, P21, DOI 10.1016/S0378-4290(98)00103-8; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Prasil IT, 2004, ANN BOT-LONDON, V94, P413, DOI 10.1093/aob/mch158; PUGSLEY AT, 1971, AUST J AGR RES, V22, P21, DOI 10.1071/AR9710021; Rebetzke GJ, 2007, FIELD CROP RES, V100, P10, DOI 10.1016/j.fcr.2006.05.001; Rebetzke GJ, 2012, FIELD CROP RES, V126, P87, DOI 10.1016/j.fcr.2011.09.022; Rebetzke GJ, 2004, AUST J AGR RES, V55, P733, DOI 10.1071/AR04037; Rebetzke GJ, 1999, EUPHYTICA, V106, P159, DOI 10.1023/A:1003518920119; Rebetzke GJ, 2000, AUST J AGR RES, V51, P235, DOI 10.1071/AR99043; RICHARDS RA, 1992, AUST J AGR RES, V43, P529, DOI 10.1071/AR9920529; SHACKLEY BJ, 1995, AUST J EXP AGR, V35, P579, DOI 10.1071/EA9950579; Slafer GA, 1996, FIELD CROP RES, V46, P1, DOI 10.1016/0378-4290(95)00081-X; SLAFER GA, 1994, AUST J PLANT PHYSIOL, V21, P393, DOI 10.1071/PP9940393; SLAFER GA, 1990, FIELD CROP RES, V23, P255, DOI 10.1016/0378-4290(90)90058-J; Slafer GA, 2001, EUPHYTICA, V119, P191, DOI 10.1023/A:1017535632171; STAPPER M, 1990, AUST J AGR RES, V41, P1021, DOI 10.1071/AR9901043; SUTKA J, 1987, EUPHYTICA, V36, P521, DOI 10.1007/BF00041496; Thomas SG, 2004, PLANT PHYSIOL, V135, P668, DOI 10.1104/pp.104.040279; VIGLASI P, 1968, ACTA AGRON HUNG, V17, P205; WADDINGTON SR, 1983, ANN BOT-LONDON, V51, P119, DOI 10.1093/oxfordjournals.aob.a086434; Wojciechowski T, 2009, J EXP BOT, V60, P2565, DOI 10.1093/jxb/erp107; Worland AJ, 1998, THEOR APPL GENET, V96, P1110, DOI 10.1007/s001220050846; WORLAND AJ, 1988, PLANT BREEDING, V100, P247, DOI 10.1111/j.1439-0523.1988.tb00250.x; WORLAND AJ, 1994, PLANT BREEDING, V113, P187, DOI 10.1111/j.1439-0523.1994.tb00722.x; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; YOUSSEFIAN S, 1992, FIELD CROP RES, V28, P191, DOI 10.1016/0378-4290(92)90040-G; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang XK, 2006, EUPHYTICA, V152, P109, DOI 10.1007/s10681-006-9184-6	66	52	58	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62285	10.1371/journal.pone.0062285	http://dx.doi.org/10.1371/journal.pone.0062285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658622	Green Submitted, Green Published, gold			2022-12-27	WOS:000318343700046
J	Argyros, R; Nelson, S; Kull, A; Chen, MT; Stadheim, TA; Jiang, B				Argyros, Rebecca; Nelson, Stephanie; Kull, Angela; Chen, Ming-Tang; Stadheim, Terrance A.; Jiang, Bo			A Phenylalanine to Serine Substitution within an O-Protein Mannosyltransferase Led to Strong Resistance to PMT-Inhibitors in Pichia pastoris	PLOS ONE			English	Article							CANDIDA-ALBICANS; YEAST; GLYCOSYLATION; MANNOSYLATION; FAMILY; MANNOSE	Protein O-mannosyltransferases (PMTs) catalyze the initial reaction of protein O-mannosylation by transferring the first mannose unit onto serine and threonine residues of a nascent polypeptide being synthesized in the endoplasmic reticulum (ER). The PMTs are well conserved in eukaryotic organisms, and in vivo defects of these enzymes result in cell death in yeast and congenital diseases in humans. A group of rhodanine-3-acetic acid derivatives (PMTi) specifically inhibits PMT activity both in vitro and in vivo. As such, these chemical compounds have been effectively used to minimize the extent of O-mannosylation on heterologously produced proteins from different yeast expression hosts. However, very little is known about how these PMT-inhibitors interact with the PMT enzyme, or what structural features of the PMTs are required for inhibitor-protein interactions. To better understand the inhibitor-enzyme interactions, and to gain potential insights for developing more effective PMT-inhibitors, we isolated PMTi-resistant mutants in Pichia pastoris. In this study, we report the identification and characterization of a point mutation within the PpPMT2 gene. We demonstrate that this F664S point mutation resulted in a near complete loss of PMTi sensitivity, both in terms of growth-inhibition and reduction in O-mannosylglycan site occupancy. Our results provide genetic evidence demonstrating that the F664 residue plays a critical role in mediating the inhibitory effects of these PMTi compounds. Our data also indicate that the main target of these PMT-inhibitors in P. pastoris is Pmt2p, and that the F664 residue most likely interacts directly with the PMTi-compounds.	[Argyros, Rebecca; Nelson, Stephanie; Kull, Angela; Chen, Ming-Tang; Stadheim, Terrance A.; Jiang, Bo] GlycoFi Inc, Lebanon, NH USA		Jiang, B (corresponding author), GlycoFi Inc, Lebanon, NH USA.	bo_jiang@merck.com			Merck	Merck(Merck & Company)	All authors are employees of Merck. The research was fully funded by Merck. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo J, 2011, MOL MICROBIOL, V79, P1529, DOI 10.1111/j.1365-2958.2011.07537.x; Balashov SV, 2006, ANTIMICROB AGENTS CH, V50, P2058, DOI 10.1128/AAC.01653-05; Barnard GC, 2010, J IND MICROBIOL BIOT, V37, P961, DOI 10.1007/s10295-010-0746-1; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Cantero PD, 2007, MOL MICROBIOL, V64, P1115, DOI 10.1111/j.1365-2958.2007.05723.x; Chen MT, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-91; Choi BK, 2012, APPL MICROBIOL BIOT, V95, P671, DOI 10.1007/s00253-012-4067-3; Cregg JM, 2009, METHOD ENZYMOL, V463, P169, DOI 10.1016/S0076-6879(09)63013-5; Desai R, 2009, Patent No. [WO 2009/143041 A1, 2009143041]; Ernst JF, 2001, MED MYCOL, V39, P67, DOI 10.1080/714031008; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Hopkins D, 2011, GLYCOBIOLOGY, V21, P1616, DOI 10.1093/glycob/cwr108; Kuroda K, 2008, APPL ENVIRON MICROB, V74, P446, DOI 10.1128/AEM.02106-07; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Li HJ, 2009, CURR OPIN BIOTECH, V20, P678, DOI 10.1016/j.copbio.2009.10.009; Lommel M, 2011, J BIOL CHEM, V286, P39768, DOI 10.1074/jbc.M111.281196; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Nett JH, 2013, PLOS ONE UNPUB; Orchard MG, 2004, BIOORG MED CHEM LETT, V14, P3975, DOI 10.1016/j.bmcl.2004.05.050; Peman J, 2009, EXPERT REV ANTI-INFE, V7, P453, DOI [10.1586/eri.09.18, 10.1586/ERI.09.18]; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Potgieter TI, 2009, J BIOTECHNOL, V139, P318, DOI 10.1016/j.jbiotec.2008.12.015; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Stadheim TA, 2008, NAT PROTOC, V3, P1026, DOI 10.1038/nprot.2008.76; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; Willer T, 2005, MOL MICROBIOL, V57, P156, DOI 10.1111/j.1365-2958.2005.04692.x; Winston F., 2008, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB1303BS82	33	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62229	10.1371/journal.pone.0062229	http://dx.doi.org/10.1371/journal.pone.0062229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667461	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600018
J	Martens, KAE; Pieruccini-Faria, F; Almeida, QJ				Martens, Kaylena A. Ehgoetz; Pieruccini-Faria, Frederico; Almeida, Quincy J.			Could Sensory Mechanisms Be a Core Factor That Underlies Freezing of Gait in Parkinson's Disease?	PLOS ONE			English	Article							BILATERAL COORDINATION; INFORMATION; LOCOMOTION; DEFICITS	The main objective of this study was to determine how manipulating the amount of sensory information available about the body and surrounding environment influenced freezing of gait (FOG), while walking through a doorway. It was hypothesized that the more limited the sensory information, the greater the occurrence of freezing of gait. Nineteen patients with Parkinson's disease who experience freezing of gait (PD-FOG) walked through a doorway or into open space in complete darkness. The three doorway conditions included: (i) FRAME (DARK) - walking through the remembered door frame; (ii) FRAME - walking through the door with the door frame illuminated; (iii) FRAME+BODY - walking through the door (both the door and the limbs illuminated). Additionally, two conditions of walking away from the doorway included: (iv) NO FRAME (DARK) - walking into open space; (v) NO FRAME+BODY - walking into open space with the limbs illuminated, to evaluate whether perception (or fear) of the doorway might account for FOG behaviour. Key outcome measures included: the number of freezing of gait episodes recorded, total duration of freezing of gait, and the percentage of time spent frozen. Significantly more freezing of gait episodes occurred when participants walked toward the doorway in complete darkness compared to walking into open space (p < 0.05). Similar to previous studies, velocity (p < 0.001) and step length (p < 0.0001) significantly decreased when walking through the door in complete darkness, compared to all other conditions. Significant increases in step width variability were also identified but only when walking into open space (p < 0.005). These results support the notion that sensory deficits may have a profound impact on freezing of gait that need to be carefully considered.	[Martens, Kaylena A. Ehgoetz] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada; [Martens, Kaylena A. Ehgoetz; Pieruccini-Faria, Frederico; Almeida, Quincy J.] Wilfrid Laurier Univ, Sun Life Financial Movement Disorders Res & Rehab, Waterloo, ON N2L 3C5, Canada	University of Waterloo; Wilfrid Laurier University	Almeida, QJ (corresponding author), Wilfrid Laurier Univ, Sun Life Financial Movement Disorders Res & Rehab, Waterloo, ON N2L 3C5, Canada.	qalmeida@wlu.ca	Pieruccini-Faria, Frederico/ABD-8020-2020; Faria, Frederico P/C-4020-2015; Ehgoetz Martens, Kaylena/G-9997-2016	Faria, Frederico P/0000-0002-7659-4285; Ehgoetz Martens, Kaylena/0000-0002-8488-2295	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI); Canadian Institutes of Health	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work has been funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Foundation for Innovation (CFI), and Canadian Institutes of Health.	Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; Almeida QJ, 2005, NEUROSCIENCE, V134, P283, DOI 10.1016/j.neuroscience.2005.02.050; Bartels AL, 2003, J CLIN NEUROSCI, V10, P584, DOI 10.1016/S0967-5868(03)00192-9; Bhatt H, 2012, PARKINSONISM RELAT D; Cowie D, 2012, MOVEMENT DISORD, V27, P492, DOI 10.1002/mds.23990; Cowie D, 2010, NEUROPSYCHOLOGIA, V48, P2750, DOI 10.1016/j.neuropsychologia.2010.05.022; Darmon A, 1999, REV NEUROL-FRANCE, V155, P1047; FAHN S, 1995, ADV NEUROL, V67, P53; Franklin S, 2012, J NEUROPHYSIOL, V108, P467, DOI 10.1152/jn.01123.2011; Giladi N, 2001, ADV NEUROL, V86, P273; GILADI N, 1992, NEUROLOGY, V42, P333, DOI 10.1212/WNL.42.2.333; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Henderson JM, 2003, BEHAV BRAIN RES, V139, P105, DOI 10.1016/S0166-4328(02)00087-6; Iansek R, 2006, MOVEMENT DISORD, V21, P1419, DOI 10.1002/mds.20998; Jiang Y, 2006, CLIN REHABIL, V20, P36, DOI 10.1191/0269215506cr925oa; Keijsers NLW, 2005, EUR J NEUROSCI, V21, P239, DOI 10.1111/j.1460-9568.2004.03840.x; Knobl P, 2012, J NEUROL NEUROSUR PS, V83, P98, DOI 10.1136/jnnp-2011-300869; Lajoie Y, 1996, NEUROLOGY, V47, P109, DOI 10.1212/WNL.47.1.109; Lewis SJG, 2009, PARKINSONISM RELAT D, V15, P333, DOI 10.1016/j.parkreldis.2008.08.006; Martens DJ, 1996, BRAIN RES, V733, P253, DOI 10.1016/0006-8993(96)00547-1; Martens KAE, 2012, MOVEMENT DISORD, V27, P387, DOI 10.1002/mds.24042; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Morris TR, 2012, PARKINSONISM RELAT D, V18, P572, DOI 10.1016/j.parkreldis.2012.03.001; Naismith SL, 2010, MOVEMENT DISORD, V25, P1000, DOI 10.1002/mds.23005; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Schrader C, 2008, CLIN NEUROPHYSIOL, V119, P1139, DOI 10.1016/j.clinph.2008.01.005; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Voss M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002866; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3	31	48	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62602	10.1371/journal.pone.0062602	http://dx.doi.org/10.1371/journal.pone.0062602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667499	gold, Green Published, Green Submitted			2022-12-27	WOS:000319055600034
J	Pawlik, JR; Loh, TL; McMurray, SE; Finelli, CM				Pawlik, Joseph R.; Loh, Tse-Lynn; McMurray, Steven E.; Finelli, Christopher M.			Sponge Communities on Caribbean Coral Reefs Are Structured by Factors That Are Top-Down, Not Bottom-Up	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; RESOURCE TRADE-OFF; FLORIDA-KEYS; XESTOSPONGIA-MUTA; CHEMICAL DEFENSES; PREDATORY FISHES; MYCALE-LAEVIS; GROWTH; DIVERSITY; ECOLOGY	Caribbean coral reefs have been transformed in the past few decades with the demise of reef-building corals, and sponges are now the dominant habitat-forming organisms on most reefs. Competing hypotheses propose that sponge communities are controlled primarily by predatory fishes (top-down) or by the availability of picoplankton to suspension-feeding sponges (bottom-up). We tested these hypotheses on Conch Reef, off Key Largo, Florida, by placing sponges inside and outside predator-excluding cages at sites with less and more planktonic food availability (15 m vs. 30 m depth). There was no evidence of a bottom-up effect on the growth of any of 5 sponge species, and 2 of 5 species grew more when caged at the shallow site with lower food abundance. There was, however, a strong effect of predation by fishes on sponge species that lacked chemical defenses. Sponges with chemical defenses grew slower than undefended species, demonstrating a resource trade-off between growth and the production of secondary metabolites. Surveys of the benthic community on Conch Reef similarly did not support a bottom-up effect, with higher sponge cover at the shallower depth. We conclude that the structure of sponge communities on Caribbean coral reefs is primarily top-down, and predict that removal of sponge predators by overfishing will shift communities toward faster-growing, undefended species that better compete for space with threatened reef-building corals.	[Pawlik, Joseph R.; Loh, Tse-Lynn; McMurray, Steven E.; Finelli, Christopher M.] Univ N Carolina, Ctr Marine Sci, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	University of North Carolina; University of North Carolina Wilmington	Pawlik, JR (corresponding author), Univ N Carolina, Ctr Marine Sci, Dept Biol & Marine Biol, Wilmington, NC 28401 USA.	pawlikj@uncw.edu	Pawlik, Joseph R/I-5718-2012	Pawlik, Joseph/0000-0002-8559-8456; Loh, Tse-Lynn/0000-0003-1360-1991; McMurray, Steven/0000-0002-1187-5916	National Science Foundation's Biological Oceanography Program [1029515]; National Oceanic and Atmospheric Administration	National Science Foundation's Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by a grant from the National Science Foundation's Biological Oceanography Program (1029515) and funding from the National Oceanic and Atmospheric Administration's Aquarius Reef Base and Coral Reef Conservation Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2010, PROG OCEANOGR, V84, P242, DOI 10.1016/j.pocean.2009.10.001; ALBRIZIO S, 1995, J NAT PRODUCTS, V58, P647, DOI 10.1021/np50119a002; Assmann M, 2000, MAR ECOL PROG SER, V207, P255, DOI 10.3354/meps207255; CHANAS B, 1995, MAR ECOL PROG SER, V127, P195, DOI 10.3354/meps127195; Chanas B, 1996, OECOLOGIA, V107, P225, DOI 10.1007/BF00327906; CHIAPPONE M, 1994, B MAR SCI, V54, P747; Colella MA, 2012, CORAL REEFS, V31, P621, DOI 10.1007/s00338-012-0880-5; Denyer JL, 2010, J ECOL, V98, P498, DOI 10.1111/j.1365-2745.2009.01633.x; Duckworth AR, 2012, MAR ECOL PROG SER, V462, P67, DOI 10.3354/meps09853; Dunlap M, 1996, MAR BIOL, V126, P117, DOI 10.1007/BF00571383; Erwin PM, 2008, MAR ECOL PROG SER, V362, P139, DOI 10.3354/meps07464; Freeman CJ, 2011, LIMNOL OCEANOGR, V56, P1577, DOI 10.4319/lo.2011.56.5.1577; Freidenburg TL, 2007, J EXP MAR BIOL ECOL, V347, P8, DOI 10.1016/j.jembe.2007.02.012; FRETWELL SD, 1987, OIKOS, V50, P291, DOI 10.2307/3565489; HALL SJ, 1990, AM NAT, V136, P657, DOI 10.1086/285121; Huang DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034459; HUNTER MD, 1992, ECOLOGY, V73, P724; Kaandorp JA, 1999, MAR BIOL, V134, P295, DOI 10.1007/s002270050547; Kubanek J, 2000, MAR ECOL PROG SER, V207, P69, DOI 10.3354/meps207069; Leichter JJ, 2005, J PHYS OCEANOGR, V35, P1945, DOI 10.1175/JPO2808.1; Leichter JJ, 1998, MAR ECOL PROG SER, V166, P83, DOI 10.3354/meps166083; Leong W, 2010, OIKOS, V119, P1417, DOI 10.1111/j.1600-0706.2010.18092.x; Leong W, 2010, MAR ECOL PROG SER, V406, P71, DOI 10.3354/meps08541; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; Levin SA, 2008, BIOSCIENCE, V58, P27, DOI 10.1641/B580107; Loh TL, 2012, MAR ECOL PROG SER, V465, P111, DOI 10.3354/meps09904; Loh TL, 2009, J EXP MAR BIOL ECOL, V374, P45, DOI 10.1016/j.jembe.2009.04.007; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; Madrigal J, 2011, ECOLOGY, V92, P282, DOI 10.1890/10-0643.1; Maliao RJ, 2008, MAR BIOL, V154, P841, DOI 10.1007/s00227-008-0977-0; Marasco RJ, 2007, CAN J FISH AQUAT SCI, V64, P928, DOI 10.1139/F07-062; McLean EL, 2012, MAR ECOL IN PRESS; McMurray SE, 2008, MAR BIOL, V155, P159, DOI 10.1007/s00227-008-1014-z; McMurray SE, 2011, LIMNOL OCEANOGR, V56, P2243, DOI 10.4319/lo.2011.56.6.2243; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Miller SL, 2000, MAR TECHNOL SOC J, V34, P69, DOI 10.4031/MTSJ.34.4.9; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pawlik, 1997, P 8 INT COR REEF S, V2, P1255; Pawlik JR, 2008, MAR ECOL PROG SER, V368, P137, DOI 10.3354/meps07615; Pawlik JR, 2007, MAR ECOL PROG SER, V339, P93, DOI 10.3354/meps339093; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Pawlik JR, 2002, J CHEM ECOL, V28, P1103, DOI 10.1023/A:1016221415028; Pawlik JR, 1998, LIMNOL OCEANOGR, V43, P1396, DOI 10.4319/lo.1998.43.6.1396; PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183; Puyana M, 2001, THESIS UCSD LA JOLLA; RANDALL JE, 1968, MAR BIOL, V1, P216, DOI 10.1007/BF00347115; Ruckelshaus M, 2008, BIOSCIENCE, V58, P53, DOI 10.1641/B580110; Stokes MD, 2011, MAR ECOL-EVOL PERSP, V32, P364, DOI 10.1111/j.1439-0485.2011.00469.x; Trussell GC, 2006, MAR ECOL PROG SER, V323, P149, DOI 10.3354/meps323149; Walters KD, 2005, INTEGR COMP BIOL, V45, P352, DOI 10.1093/icb/45.2.352; Wilson DM, 1999, J CHEM ECOL, V25, P2811, DOI 10.1023/A:1020811810223	58	54	56	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62573	10.1371/journal.pone.0062573	http://dx.doi.org/10.1371/journal.pone.0062573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667492	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600029
J	Johansson, KSL; Vrede, T; Lebret, K; Johnson, RK				Johansson, Karin S. L.; Vrede, Tobias; Lebret, Karen; Johnson, Richard K.			Zooplankton Feeding on the Nuisance Flagellate Gonyostomum semen	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; ALGAL SIZE; LAKES; PHYTOPLANKTON; DYNAMICS; DAPHNIA; RAPHIDOPHYCEAE; RESPONSES; RESERVOIR; INVASION	The large bloom-forming flagellate Gonyostomum semen has been hypothesized to be inedible to naturally occurring zooplankton due to its large cell size and ejection of long slimy threads (trichocysts) induced by physical stimulation. In a grazing experiment using radiolabelled algae and zooplankton collected from lakes with recurring blooms of G. semen and lakes that rarely experience blooms, we found that Eudiaptomus gracilis and Holopedium gibberum fed on G. semen at high rates, whereas Daphnia cristata and Ceriodaphnia spp. did not. Grazing rates of E. gracilis were similar between bloom-lakes and lakes with low biomass of G. semen, indicating that the ability to feed on G. semen was not a result of local adaptation. The high grazing rates of two of the taxa in our experiment imply that some of the nutrients and energy taken up by G. semen can be transferred directly to higher trophic levels, although the predominance of small cladocerans during blooms may limit the importance of G. semen as a food resource. Based on grazing rates and previous observations on abundances of E. gracilis and H. gibberum, we conclude that there is a potential for grazer control of G. semen and discuss why blooms of G. semen still occur.	[Johansson, Karin S. L.; Vrede, Tobias; Johnson, Richard K.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Lebret, Karen] Lund Univ, Dept Biol, Lund, Sweden	Swedish University of Agricultural Sciences; Lund University	Johansson, KSL (corresponding author), Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden.	karin.johansson@slu.se	Lebret, Karen/G-8822-2013; Vrede, Tobias/C-1956-2015; Johnson, Richard K./P-4991-2014; Vrede, Tobias/AAC-6469-2019	Lebret, Karen/0000-0002-5262-8954; Vrede, Tobias/0000-0001-8235-9890; Johnson, Richard K./0000-0001-7979-6563; Vrede, Tobias/0000-0001-8235-9890; Lebret, Karen/0000-0002-3853-1662				Brohan P., 2006, J GEOPHYS RES-ATMOS, V111; BURNS CW, 1968, LIMNOL OCEANOGR, V13, P675, DOI 10.4319/lo.1968.13.4.0675; CRONBERG G, 1988, HYDROBIOLOGIA, V161, P217, DOI 10.1007/BF00044113; DEMOTT WR, 1991, J PLANKTON RES, V13, P1203, DOI 10.1093/plankt/13.6.1203; Figueroa RI, 2006, J PHYCOL, V42, P859, DOI 10.1111/j.1529-8817.2006.00240.x; GLIWICZ ZM, 1990, ECOLOGY, V71, P691, DOI 10.2307/1940323; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Gutseit K, 2007, FRESHWATER BIOL, V52, P28, DOI 10.1111/j.1365-2427.2006.01668.x; Hansson LA, 2000, ECOLOGY, V81, P842, DOI 10.2307/177381; HONGVE D, 1988, PROC INT ASSOC THE 1, V23, P430; HORN W, 1981, INT REV GES HYDROBIO, V66, P787, DOI 10.1002/iroh.19810660603; Johansson KSL, 2013, AQUAT SCI, V75, P447, DOI 10.1007/s00027-013-0291-x; Lampert W., 1985, Advances in Limnology, V21, P311; LAMPERT W, 1988, B MAR SCI, V43, P620; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lebret K, 2012, LIMNOL OCEANOGR, V57, P727, DOI 10.4319/lo.2012.57.3.0727; LECOHU R, 1989, ARCH HYDROBIOL, V117, P225; LEPISTO L, 1994, HYDROBIOLOGIA, V273, P1, DOI 10.1007/BF00126764; Lundgren A, 1978, VERH INT VER LIMNOL, V20, P863; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; MURTAUGH PA, 1985, J PLANKTON RES, V7, P415, DOI 10.1093/plankt/7.3.415; Negro AI, 2000, HYDROBIOLOGIA, V424, P25, DOI 10.1023/A:1003940625437; Olin M, 2006, HYDROBIOLOGIA, V553, P67, DOI 10.1007/s10750-005-0786-0; Pithart David, 1997, Archiv fuer Hydrobiologie Supplement, V119, P119; Poniewozik M, 2011, OCEANOL HYDROBIOL ST, V40, P22, DOI 10.2478/s13545-011-0013-8; Rengefors K, 2012, HARMFUL ALGAE, V18, P65, DOI 10.1016/j.hal.2012.04.005; Salonen K, 2000, J PLANKTON RES, V22, P1841, DOI 10.1093/plankt/22.10.1841; Tessier A.J., 1986, ECOLOGY, V67, P286; Trigal C, 2013, HARMFUL ALG IN PRESS; Trigal C, 2011, FRESHWATER BIOL, V56, P1937, DOI 10.1111/j.1365-2427.2011.02615.x; VANDERPLOEG HA, 1988, B MAR SCI, V43, P377; WALTERS CJ, 1990, CAN J FISH AQUAT SCI, V47, P401, DOI 10.1139/f90-042; WEBSTER KE, 1978, LIMNOL OCEANOGR, V23, P1238, DOI 10.4319/lo.1978.23.6.1238; Williamson CE, 1996, LIMNOL OCEANOGR, V41, P224, DOI 10.4319/lo.1996.41.2.0224	34	20	20	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62557	10.1371/journal.pone.0062557	http://dx.doi.org/10.1371/journal.pone.0062557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667489	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700047
J	Jones, EF; Sinha, SP; Newitt, DC; Klifa, C; Kornak, J; Park, CC; Hylton, NM				Jones, Ella F.; Sinha, Sumedha P.; Newitt, David C.; Klifa, Catherine; Kornak, John; Park, Catherine C.; Hylton, Nola M.			MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant Chemotherapy	PLOS ONE			English	Article							CANCER; EXPRESSION; ANGIOGENESIS; CELLS; RISK; VIVO	Rationale and Objectives: Normal-appearing stromal tissues surrounding breast tumors can harbor abnormalities that lead to increased risk of local recurrence. The objective of this study was to develop a new imaging methodology to characterize the signal patterns of stromal tissue and to investigate their association with recurrence-free survival following neoadjuvant chemotherapy. Materials and Methods: Fifty patients with locally-advanced breast cancer were imaged with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) before (V1) and after one cycle (V2) of adriamycin-cytoxan therapy. Contrast enhancement in normal-appearing stroma around the tumor was characterized by the mean percent enhancement (PE) and mean signal enhancement ratio (SER) in distance bands of 5 mm from the tumor edge. Global PE and SER were calculated by averaging all stromal bands 5 to 40 mm from tumor. Proximity-dependent PE and SER were analyzed using a linear mixed effects model and Cox proportional hazards model for recurrence-free survival. Results: The mixed effects model displayed a decreasing radial trend in PE at both V1 and V2. An increasing trend was less pronounced in SER. Survival analysis showed that the hazard ratio estimates for each unit decrease in global SER was statistically significant at V1 [estimated hazard ratio = 0.058, 95% Wald CI (0.003, 1.01), likelihood ratio p = 0.03]; but was not so for V2. Conclusions: These findings show that stromal tissue outside the tumor can be quantitatively characterized by DCE-MRI, and suggest that stromal enhancement measurements may be further developed for use as a potential predictor of recurrence/disease-free survival following therapy.	[Jones, Ella F.; Sinha, Sumedha P.; Newitt, David C.; Klifa, Catherine; Kornak, John; Park, Catherine C.; Hylton, Nola M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Jones, EF (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	ella.jones@ucsf.edu	Hylton, Nola/AAF-7861-2019; Jones, Ella/AAZ-6292-2020; Jones, Ella F./W-2725-2019	Jones, Ella/0000-0001-8700-2129; 	Komen Grant [SAC110017]; NIH [R01 CA69587, R01 116182, R21 CA 152499]; American Cancer Society [RSG-07-1110-01]; NATIONAL CANCER INSTITUTE [R01CA069587, R21CA152499] Funding Source: NIH RePORTER	Komen Grant(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Komen Grant SAC110017, NIH R01 CA69587, NIH R01 116182, NIH R21 CA 152499 and the American Cancer Society: RSG-07-1110-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ACR PRACT GUID PERF; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Graham SJ, 1997, MAGNET RESON MED, V38, P669, DOI 10.1002/mrm.1910380422; GRAY RJ, 1992, J AM STAT ASSOC, V87, P942, DOI 10.2307/2290630; Griffiths L, 1997, CANCER RES, V57, P570; Guidi AJ, 1997, CANCER, V80, P1945, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y; Hattangadi J, 2008, AM J ROENTGENOL, V190, P1630, DOI 10.2214/AJR.07.2533; Hylton N M, 1999, Magn Reson Imaging Clin N Am, V7, P411; Hylton NM, 1999, MAGN RESON IMAGING C, V7, px; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Klifa C, 2004, P ANN INT IEEE EMBS, V26, P1667; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Li KL, 2008, RADIOLOGY, V248, P79, DOI 10.1148/radiol.2481070846; Li SP, 2011, RADIOLOGY, V260, P68, DOI 10.1148/radiol.11102493; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Nabavizadeh N, 2011, INTEGR BIOL-UK, V3, P490, DOI 10.1039/c0ib00089b; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P339, DOI 10.1002/jmri.22045; Partridge SC, 2005, AM J ROENTGENOL, V184, P1774, DOI 10.2214/ajr.184.6.01841774; Partridge SC, 2002, AM J ROENTGENOL, V179, P1193, DOI 10.2214/ajr.179.5.1791193; Partridge SC, 1999, ST HEAL T, V62, P259; Roskelley CD, 2001, CANCER RES, V61, P6788; Singer L, 2012, ACAD RADIOL, V19, P526, DOI 10.1016/j.acra.2011.11.003; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8	26	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61969	10.1371/journal.pone.0061969	http://dx.doi.org/10.1371/journal.pone.0061969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667451	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700020
J	Mitchell, JG; Seuront, L; Doubell, MJ; Losic, D; Voelcker, NH; Seymour, J; Lal, R				Mitchell, James G.; Seuront, Laurent; Doubell, Mark J.; Losic, Dusan; Voelcker, Nicolas H.; Seymour, Justin; Lal, Ratnesh			The Role of Diatom Nanostructures in Biasing Diffusion to Improve Uptake in a Patchy Nutrient Environment	PLOS ONE			English	Article							PHAEOCYSTIS-GLOBOSA; PHYTOPLANKTON; SIZE; PATCHINESS; PHOSPHORUS; TURBULENCE; PATTERNS; SEAWATER; PLANKTON; NITRATE	Background: Diatoms are important single-celled autotrophs that dominate most lit aquatic environments and are distinguished by surficial frustules with intricate designs of unknown function. Principal Findings: We show that some frustule designs constrain diffusion to positively alter nutrient uptake. In nutrient gradients of 4 to 160 times over <5 cm, the screened-chambered morphology of Coscincodiscus sp. biases the nutrient diffusion towards the cell by at least 3.8 times the diffusion to the seawater. In contrast, the open-chambers of Thalassiosira eccentrica produce at least a 1.3 times diffusion advantage to the membrane over Coscincodiscus sp. when nutrients are homogeneous. Significance: Diffusion constraint explains the success of particular diatom species at given times and the overall success of diatoms. The results help answer the unresolved question of how adjacent microplankton compete. Furthermore, diffusion constraint by supramembrane nanostructures to alter molecular diffusion suggests that microbes compete via supramembrane topology, a competitive mechanism not considered by the standard smooth-surface equations used for nutrient uptake nor in microbial ecology and cell physiology.	[Mitchell, James G.; Seuront, Laurent] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Seuront, Laurent; Doubell, Mark J.] South Australian Res & Dev Inst, West Beach, SA, Australia; [Seuront, Laurent] Univ Sci & Technol Lille, CNRS, Lab Oceanol & Geosci, Stn Marine, Wimereux, France; [Losic, Dusan] Univ Adelaide, Sch Chem Engn, Adelaide, SA, Australia; [Voelcker, Nicolas H.] Univ S Australia, Mawson Inst, Adelaide, SA 5001, Australia; [Seymour, Justin] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Lal, Ratnesh] Univ Calif San Diego, Dept Mech & Aerosp Engn & Bioengn, La Jolla, CA 92093 USA	Flinders University South Australia; South Australian Research & Development Institute (SARDI); Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; University of Adelaide; University of South Australia; University of Technology Sydney; University of California System; University of California San Diego	Mitchell, JG (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	jim.mitchell@flinders.edu.au	Voelcker, Nicolas H/D-6199-2012; Losic, Dusan/B-2436-2009; Lal, Ratnesh/AAG-5424-2019; Doubell, Mark/F-2884-2016	Voelcker, Nicolas H/0000-0002-1536-7804; Losic, Dusan/0000-0002-1930-072X; Seymour, Justin/0000-0002-3745-6541; Seuront, Laurent/0000-0002-0051-5202; Mitchell, Jim/0000-0002-8445-0935; Doubell, Mark/0000-0003-3272-9659	Australian Research Council (ARC); Flinders University; Australian Antarctic Division; ARC; US National Institutes of Health	Australian Research Council (ARC)(Australian Research Council); Flinders University; Australian Antarctic Division; ARC(Australian Research Council); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.G.M., L.S., N.H.V., J.S. and D.L. were supported by the Australian Research Council (ARC) and Flinders University. J.G.M. and L.S. were supported by the Australian Antarctic Division. R.L. was supported by the ARC and the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bach LT, 2012, MAR BIOL, V159, P1853, DOI 10.1007/s00227-012-1945-2; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BIENFANG PK, 1982, MAR BIOL, V67, P295, DOI 10.1007/BF00397670; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Cardenas MB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035343; Chatterjee S, 2012, VIRUSES-BASEL, V4, P3162, DOI 10.3390/v4113162; Doubell MJ, 2006, APPL ENVIRON MICROB, V72, P4475, DOI 10.1128/AEM.02959-05; Durham WM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238102; Franck VM, 2006, MARINE ECOLOGY PROGR, V252, P15; FUHRMAN JA, 1986, MAR ECOL PROG SER, V33, P237, DOI 10.3354/meps033237; Gradmann D, 1999, EUR BIOPHYS J BIOPHY, V28, P591, DOI 10.1007/s002490050241; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HASLE GR, 1970, T AM MICROSC SOC, V89, P469, DOI 10.2307/3224555; Hood RR, 2006, HARMFUL ALGAE, V5, P459, DOI 10.1016/j.hal.2006.04.014; KarpBoss L, 1996, OCEANOGR MAR BIOL, V34, P71; LEHMAN JT, 1982, SCIENCE, V216, P729, DOI 10.1126/science.216.4547.729; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Miklasz KA, 2010, LIMNOL OCEANOGR, V55, P2513, DOI 10.4319/lo.2010.55.6.2513; MITCHELL JG, 1985, NATURE, V316, P58, DOI 10.1038/316058a0; Musielak MM, 2009, J FLUID MECH, V638, P401, DOI 10.1017/S0022112009991108; Peters F, 2006, J MARINE SYST, V61, P134, DOI 10.1016/j.jmarsys.2005.11.012; Pomeroy LR, 2007, OCEANOGRAPHY, V20, P28, DOI 10.5670/oceanog.2007.45; Sanudo-Wilhelmy SA, 2004, NATURE, V432, P897, DOI 10.1038/nature03125; Schapira M, 2008, J MAR BIOL ASSOC UK, V88, P649, DOI 10.1017/S0025315408001306; Schlimpert S, 2012, CELL, V151, P1270, DOI 10.1016/j.cell.2012.10.046; Schneider IC, 2005, BIOPHYS J, V89, P1420, DOI 10.1529/biophysj.105.061218; Seuront L, 2007, BIOGEOCHEMISTRY, V83, P173, DOI 10.1007/s10533-007-9097-z; Seuront L, 2005, MAR ECOL PROG SER, V302, P93, DOI 10.3354/meps302093; Seuront L, 2002, MAR ECOL PROG SER, V232, P29, DOI 10.3354/meps232029; Seuront L, 2001, DEEP-SEA RES PT I, V48, P1199, DOI 10.1016/S0967-0637(00)00089-3; Seuront L, 2006, LIMNOL OCEANOGR-METH, V4, P260, DOI 10.4319/lom.2006.4.260; Seymour JR, 2008, ESTUAR COAST SHELF S, V80, P589, DOI 10.1016/j.ecss.2008.09.011; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Taylor JR, 2012, SCIENCE, V338, P675, DOI 10.1126/science.1219417; Thorpe SA, 2007, INTRO OCEAN TURBULEN, P240; Villareal TA, 1999, NATURE, V397, P423, DOI 10.1038/17103; Yamashita H, 2012, J MOL BIOL, V422, P300, DOI 10.1016/j.jmb.2012.05.018	39	34	34	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e59548	10.1371/journal.pone.0059548	http://dx.doi.org/10.1371/journal.pone.0059548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667421	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000319654700004
J	Auffret, AG; Cousins, SAO				Auffret, Alistair G.; Cousins, Sara A. O.			Humans as Long-Distance Dispersers of Rural Plant Communities	PLOS ONE			English	Article							HUMAN-MEDIATED DISPERSAL; SEED DISPERSAL; LANDSCAPE; HISTORY; TRAITS; SHEEP	Humans are known for their capacity to disperse organisms long distances. Long-distance dispersal can be important for species threatened by habitat destruction, but research into human-mediated dispersal is often focused upon few and/or invasive species. Here we use citizen science to identify the capacity for humans to disperse seeds on their clothes and footwear from a known species pool in a valuable habitat, allowing for an assessment of the fraction and types of species dispersed by humans in an alternative context. We collected material from volunteers cutting 48 species-rich meadows throughout Sweden. We counted 24 354 seeds of 197 species, representing 34% of the available species pool, including several rare and protected species. However, 71 species (36%) are considered invasive elsewhere in the world. Trait analysis showed that seeds with hooks or other appendages were more likely to be dispersed by humans, as well as those with a persistent seed bank. More activity in a meadow resulted in more dispersal, both in terms of species and representation of the source communities. Average potential dispersal distances were measured at 13 km. We consider humans capable seed dispersers, transporting a significant proportion of the plant communities in which they are active, just like more traditional vectors such as livestock. When rural populations were larger, people might have been regular and effective seed dispersers, and the net rural-urban migration resulting in a reduction in humans in the landscape may have exacerbated the dispersal failure evident in declining plant populations today. With the fragmentation of habitat and changes in land use resulting from agricultural change, and the increased mobility of humans worldwide, the dispersal role of humans may have shifted from providers of regular local and landscape dispersal to providers of much rarer long-distance and regional dispersal, and international invasion.	[Auffret, Alistair G.; Cousins, Sara A. O.] Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden	Stockholm University	Auffret, AG (corresponding author), Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden.	alistair.auffret@natgeo.su.se	Cousins, Sara/A-2437-2012; Auffret, Alistair/AGB-4949-2022; Auffret, Alistair/AAJ-7335-2020	Cousins, Sara/0000-0003-2656-2645; Auffret, Alistair/0000-0002-4190-4423	Stockholm University; cross-disciplinary project EkoKlim at Stockholm University	Stockholm University; cross-disciplinary project EkoKlim at Stockholm University	Funding was provided by AEW Smitt's scholarship from Stockholm University 2009/10 and and the cross-disciplinary project EkoKlim at Stockholm University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggemyr E, 2012, J BIOGEOGR, V39, P1645, DOI 10.1111/j.1365-2699.2012.02733.x; Aronsson M., 2010, 2010 RED LIST SWEDIS, P201; Auffret AG, 2012, J VEG SCI, V23, P970, DOI 10.1111/j.1654-1103.2012.01413.x; Auffret AG, 2011, APPL VEG SCI, V14, P291, DOI 10.1111/j.1654-109X.2011.01124.x; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bruun HH, 2002, AMBIO, V31, P425, DOI 10.1639/0044-7447(2002)031[0425:TPIOLH]2.0.CO;2; Bullock JM, 2011, OIKOS, V120, P1201, DOI 10.1111/j.1600-0706.2010.19092.x; Chown SL, 2012, P NATL ACAD SCI USA, V109, P4938, DOI 10.1073/pnas.1119787109; CLIFFORD H. T., 1956, Proceedings of the Botanical Society of the British Isles, V2, P129; Cortes MC, 2013, BIOL REV, V88, P255, DOI 10.1111/j.1469-185X.2012.00250.x; Cousins SAO, 2001, LANDSCAPE ECOL, V16, P41, DOI 10.1023/A:1008108704358; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; FALINSKI J B, 1972, Acta Societatis Botanicorum Poloniae, V41, P357, DOI 10.5586/asbp.1972.028; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Holl S, 2009, GEOINFORMATICS; Hovstad KA, 2009, J VEG SCI, V20, P455, DOI 10.1111/j.1654-1103.2009.01049.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Keitt TH, 2012, RDBIPGSQL POSTGRESQL; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Mount A, 2009, J ENVIRON MANAGE, V91, P168, DOI 10.1016/j.jenvman.2009.08.002; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Ozinga WA, 2009, ECOL LETT, V12, P66, DOI 10.1111/j.1461-0248.2008.01261.x; Partel M, 1999, LANDSCAPE ECOL, V14, P187, DOI 10.1023/A:1008040114832; Pickering C, 2010, J SUSTAIN TOUR, V18, P239, DOI 10.1080/09669580903406613; Pickering CM, 2011, BIOL INVASIONS, V13, P1869, DOI 10.1007/s10530-011-0006-y; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; Romermann C, 2005, OIKOS, V110, P219, DOI 10.1111/j.0030-1299.2005.13911.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Satterthwaite D, 2010, PHILOS T R SOC B, V365, P2809, DOI 10.1098/rstb.2010.0136; Solymos P, 2009, J STAT SOFTW, V29, P1; Soons MB, 2005, DIVERS DISTRIB, V11, P165, DOI 10.1111/j.1366-9516.2005.00148.x; Stein C, 2008, OIKOS, V117, P1469, DOI 10.1111/j.0030-1299.2008.16766.x; Taylor K, 2012, DIVERS DISTRIB, V18, P942, DOI 10.1111/j.1472-4642.2012.00926.x; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Vargas P, 2012, ECOGRAPHY, V35, P33, DOI 10.1111/j.1600-0587.2011.06980.x; von der Lippe M, 2012, PERSPECT PLANT ECOL, V14, P123, DOI 10.1016/j.ppees.2011.09.006; Wagner HH, 2013, ECOGRAPHY, V36, P374, DOI 10.1111/j.1600-0587.2012.07463.x; Ware C, 2012, BIOL INVASIONS, V14, P567, DOI 10.1007/s10530-011-0098-4; Wichmann MC, 2009, P ROY SOC B-BIOL SCI, V276, P523, DOI 10.1098/rspb.2008.1131; Wilson JB, 2012, J VEG SCI, V23, P796, DOI 10.1111/j.1654-1103.2012.01400.x; Woodruffe-Peacock EA, 1918, J ECOL, V6, P110, DOI 10.2307/2255362	43	33	34	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62763	10.1371/journal.pone.0062763	http://dx.doi.org/10.1371/journal.pone.0062763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658770	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500037
J	Preuschoff, I; Muller, HH; Sperling, W; Biermann, T; Bergner, M; Kornhuber, J; Groemer, TW				Preuschoff, Irene; Mueller, Helge H.; Sperling, Wolfgang; Biermann, Teresa; Bergner, Matthias; Kornhuber, Johannes; Groemer, Teja W.			iPad-Assisted Measurements of Duration Estimation in Psychiatric Patients and Healthy Control Subjects	PLOS ONE			English	Article							HAND-HELD COMPUTERS; TIME PERCEPTION; MEMORY; DEPRESSION; EXPERIENCE; CANNABIS; DISORDER; DEFICITS	Handheld devices with touchscreen controls have become widespread in the general population. In this study, we examined the duration estimates (explicit timing) made by patients in a major general hospital and healthy control subjects using a custom iPad application. We methodically assessed duration estimates using this novel device. We found that both psychiatric and non-psychiatric patients significantly overestimated time periods compared with healthy control subjects, who estimated elapsed time very precisely. The use of touchscreen-based methodologies can provide valuable information about patients.	[Preuschoff, Irene; Mueller, Helge H.; Sperling, Wolfgang; Biermann, Teresa; Bergner, Matthias; Kornhuber, Johannes; Groemer, Teja W.] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Groemer, TW (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany.	teja.groemer@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014; Müller, Helge H.O./P-9524-2018	Kornhuber, Johannes/0000-0002-8096-3987; Biermann, Teresa/0000-0003-4876-3915; Groemer, Teja/0000-0003-3854-716X				Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Arning K, 2009, BEHAV INFORM TECHNOL, V28, P251, DOI 10.1080/01449290701679395; Atakan Z, 2012, CURR PHARM DESIGN, V18, P4915, DOI 10.2174/138161212802884852; Balci Fuat, 2009, P161, DOI 10.1007/978-1-59745-422-3_8; Bauer LO, 2001, DRUG ALCOHOL DEPEN, V63, P87, DOI 10.1016/S0376-8716(00)00195-2; Biermann T, 2011, PHARMACOPSYCHIATRY, V44, P179, DOI 10.1055/s-0031-1280815; Block RA, 2000, MEM COGNITION, V28, P1333, DOI 10.3758/BF03211834; Bschor T, 2004, ACTA PSYCHIAT SCAND, V109, P222, DOI 10.1046/j.0001-690X.2003.00244.x; Carrasco MC, 2000, EXP AGING RES, V26, P139, DOI 10.1080/036107300243605; Coelho M, 2004, J INT NEUROPSYCH SOC, V10, P332, DOI 10.1017/S1355617704103019; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; FARRUGIA N, 2012, P 12 INT C MUS PERC, P292; Freudenmann RW, 2001, NERVENARZT, V72, P40, DOI 10.1007/s001150050710; Haller G, 2009, J AM MED INFORM ASSN, V16, P651, DOI 10.1197/jamia.M3041; Hancock PA, 2010, ACTA PSYCHOL, V133, P170, DOI 10.1016/j.actpsy.2009.11.005; HANCOCK PA, 1992, CURR PSYCHOL RES REV, V11, P203, DOI 10.1007/BF02686841; Lustig C, 2005, BRAIN COGNITION, V58, P9, DOI 10.1016/j.bandc.2004.09.005; Lustig C, 2011, BRAIN COGNITION, V77, P298, DOI 10.1016/j.bandc.2011.07.007; Mahlber R, 2008, EUR PSYCHIAT, V23, P430, DOI 10.1016/j.eurpsy.2007.07.001; Mundt C, 1998, NERVENARZT, V69, P38, DOI 10.1007/s001150050236; Petry NM, 1998, ADDICTION, V93, P729, DOI 10.1046/j.1360-0443.1998.9357298.x; Pleil KE, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00063; RAMMSAYER T, 1990, INT J NEUROSCI, V53, P111, DOI 10.3109/00207459008986593; Rueda AD, 2009, NEUROPSYCHOLOGY, V23, P178, DOI 10.1037/a0014289; Schroeders U, 2010, EUR J PSYCHOL ASSESS, V26, P284, DOI 10.1027/1015-5759/a000038; Sevigny MC, 2003, BRAIN COGNITION, V53, P351, DOI 10.1016/S0278-2626(03)00141-6; Sewell RA, 2013, PSYCHOPHARMACOLOGY, V226, P401, DOI 10.1007/s00213-012-2915-6; Sysoeva OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012650; TYSK L, 1984, PERCEPT MOTOR SKILL, V58, P455, DOI 10.2466/pms.1984.58.2.455; TYSK L, 1983, PERCEPT MOTOR SKILL, V56, P983, DOI 10.2466/pms.1983.56.3.983; Vispoel WPRTR, 1994, APPL MEAN EDUC, V7, P53, DOI DOI 10.1207/S15324818AME0701_5; Volz HP, 2001, NEUROREPORT, V12, P313, DOI 10.1097/00001756-200102120-00026; Wright P, 2000, ERGONOMICS, V43, P702, DOI 10.1080/001401300404689	33	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61295	10.1371/journal.pone.0061295	http://dx.doi.org/10.1371/journal.pone.0061295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AF	23658689	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500006
J	Qian, YF; Dai, JH; Liu, R; Chen, MJ; Zhou, XT; Chu, RY				Qian, Yi-Feng; Dai, Jin-Hui; Liu, Rui; Chen, Min-Jie; Zhou, Xing-Tao; Chu, Ren-Yuan			Effects of the Chromatic Defocus Caused by Interchange of Two Monochromatic Lights on Refraction and Ocular Dimension in Guinea Pigs	PLOS ONE			English	Article							FORM-DEPRIVATION MYOPIA; EYE GROWTH; SPECTACLE LENSES; ACCOMMODATION; ABERRATION; COMPENSATION; SIMULATIONS; SIGNALS; EMMETROPIZATION; RESPONSES	To investigate refractive and axial responses to the shift of focal plane resulting from the interchange of two monochromatic lights separately corresponding to the peak wavelengths of the cones absorption spectrum in retina, fifty 2-week-old pigmented guinea pigs were randomly assigned to five groups based on the mode of illumination: short-wavelength light (SL), middle-wavelength light (ML) and broad-band white light (BL) for 20 weeks, SL for 10 weeks followed by ML for 10 weeks (STM), as well as ML for 10 weeks followed by SL for 10 weeks (MTS). Biometric and refractive measurements were then performed every 2 weeks. After 10 weeks, SL and STM groups became more hyperopic and had less vitreous elongation than BL group. However, ML and MTS groups became more myopic and had more vitreous elongation. After interchange of the monochromatic light, the refractive error decreased rapidly by about 1.93D and the vitreous length increased by 0.14 mm in STM group from 10 to 12 weeks. After that, there were no significant intergroup differences between STM and BL groups. The interchange from ML to SL quickly increased the refractive error by about 1.53D and decreased the vitreous length by about 0.13 mm in MTS group after two weeks. At this time, there were also no significant intergroup differences between MTS and BL groups. The guinea pig eye can accurately detect the shift in focal plane caused by interchange of two monochromatic lights and rapidly generate refractive and axial responses. However, an excessive compensation was induced. Some properties of photoreceptors or retina may be changed by the monochromatic light to influence the following refractive development.	[Qian, Yi-Feng; Dai, Jin-Hui; Liu, Rui; Chen, Min-Jie; Zhou, Xing-Tao; Chu, Ren-Yuan] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Qian, Yi-Feng; Dai, Jin-Hui; Liu, Rui; Chen, Min-Jie; Zhou, Xing-Tao; Chu, Ren-Yuan] Minist Hlth PR China, Key Lab Myopia, Shanghai, Peoples R China	Fudan University	Dai, JH (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China.	daijinhui8@126.com	zhou, xt/GWZ-9212-2022		National Natural Science Foundation of China [81070750, 81271040, 81100689]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants from the National Natural Science Foundation of China (No. 81070750 and 81271040 to JHD, No. 81100689 to RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FINCHAM EF, 1951, BRIT J OPHTHALMOL, V35, P381, DOI 10.1136/bjo.35.7.381; FLITCROFT DI, 1990, VISUAL NEUROSCI, V5, P547, DOI 10.1017/S0952523800000705; Graham B, 1999, VISION RES, V39, P189, DOI 10.1016/S0042-6989(98)00189-8; Howlett MHC, 2009, VISION RES, V49, P219, DOI 10.1016/j.visres.2008.10.008; Howlett MC, 2002, INVEST OPHTHALMOL VI, V43; Howlett MHC, 2006, VISION RES, V46, P267, DOI 10.1016/j.visres.2005.06.036; HUNG LF, 1995, NAT MED, V1, P761, DOI 10.1038/nm0895-761; JACOBS GH, 1994, BEHAV NEUROSCI, V108, P993, DOI 10.1037/0735-7044.108.5.993; Kroger RHH, 1996, J COMP PHYSIOL A, V179, P837; KROGER RHH, 1994, VISION RES, V34, P1807, DOI 10.1016/0042-6989(94)90305-0; Kruger PB, 2005, VISION RES, V45, P1265, DOI 10.1016/j.visres.2004.11.017; KRUGER PB, 1993, VISION RES, V33, P1397, DOI 10.1016/0042-6989(93)90046-Y; KRUGER PB, 1995, VISION RES, V35, P2415, DOI 10.1016/0042-6989(94)00316-5; Kruger PB, 1997, VISION RES, V37, P2511, DOI 10.1016/S0042-6989(97)00056-4; Lee JH, 1999, OPHTHAL PHYSL OPT, V19, P223, DOI 10.1046/j.1475-1313.1999.00440.x; Liu R, 2011, EXP EYE RES, V92, P447, DOI 10.1016/j.exer.2011.03.003; Lu F, 2009, EXP EYE RES, V89, P101, DOI 10.1016/j.exer.2009.02.019; MCBRIEN NA, 1992, VISION RES, V32, P843, DOI 10.1016/0042-6989(92)90027-G; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; ROHRER B, 1992, J PHYSIOL-LONDON, V449, P363, DOI 10.1113/jphysiol.1992.sp019090; Rucker FJ, 2008, VISION RES, V48, P1929, DOI 10.1016/j.visres.2008.06.021; Rucker FJ, 2004, VISION RES, V44, P2931, DOI 10.1016/j.visres.2004.07.005; Rucker FJ, 2008, VISION RES, V48, P1980, DOI 10.1016/j.visres.2008.06.003; Rucker FJ, 2009, VISION RES, V49, P1775, DOI 10.1016/j.visres.2009.04.014; SCHAEFFEL F, 1991, VISION RES, V31, P717, DOI 10.1016/0042-6989(91)90011-S; Seidemann A, 2002, VISION RES, V42, P2409, DOI 10.1016/S0042-6989(02)00262-6; Shaikh AW, 1999, OPTOMETRY VISION SCI, V76, P308, DOI 10.1097/00006324-199905000-00019; Siegwart JT, 1998, VISION RES, V38, P3505, DOI 10.1016/S0042-6989(98)00053-4; Smith EL, 1999, OPTOMETRY VISION SCI, V76, P428, DOI 10.1097/00006324-199906000-00023; SMITH EL, 1987, INVEST OPHTH VIS SCI, V28, P1236; Smith EL, 1999, VISION RES, V39, P1415, DOI 10.1016/S0042-6989(98)00229-6; SMITH EL, 1994, VISION RES, V34, P293, DOI 10.1016/0042-6989(94)90088-4; Smith EL, 2000, VISION RES, V40, P371, DOI 10.1016/S0042-6989(99)00184-4; Stark LR, 2002, VISION RES, V42, P1485, DOI 10.1016/S0042-6989(02)00074-3; TROILO D, 1993, VISION RES, V33, P1311, DOI 10.1016/0042-6989(93)90039-Y; WALLMAN J, 1987, VISION RES, V27, P1139, DOI 10.1016/0042-6989(87)90027-7; WIESEL TN, 1977, NATURE, V266, P66, DOI 10.1038/266066a0; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; WILDSOET CF, 1993, VISION RES, V33, P1593, DOI 10.1016/0042-6989(93)90026-S; Zhou XT, 2007, VISION RES, V47, P1103, DOI 10.1016/j.visres.2007.01.002	40	18	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63229	10.1371/journal.pone.0063229	http://dx.doi.org/10.1371/journal.pone.0063229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658814	gold, Green Published, Green Submitted			2022-12-27	WOS:000321200500063
J	Di Domizio, J; Dorta-Estremera, S; Cao, W				Di Domizio, Jeremy; Dorta-Estremera, Stephanie; Cao, Wei			Methylated BSA Mimics Amyloid-Related Proteins and Triggers Inflammation	PLOS ONE			English	Article							BACTERIAL-DNA; P-COMPONENT; MISFOLDING DISEASES; NALP3 INFLAMMASOME; IMMUNE-RESPONSE; NUCLEIC-ACIDS; STRANDED-DNA; NORMAL MICE; ARTHRITIS; OLIGOMERS	The mechanistic study of inflammatory or autoimmune diseases requires the generation of mouse models that reproduce the alterations in immune responses observed in patients. Methylated bovine serum albumin (mBSA) has been widely used to induce antigen-specific inflammation in targeted organs or in combination with single stranded DNA (ssDNA) to generate anti-nucleic acids antibodies in vivo. However, the mechanism by which this modified protein triggers inflammation is poorly understood. By analyzing the biochemical properties of mBSA, we found that mBSA exhibits features of an intermediate of protein misfolding pathway. mBSA readily interact with a list of dyes that have binding specificity towards amyloid fibrils. Intriguingly, mBSA displayed cytotoxic activity and its binding to ssDNA further enhanced formation of beta-sheet rich amyloid fibrils. Moreover, mBSA is recognized by the serum amyloid P, a protein unanimously associated with amyloid plaques in vivo. In macrophages, we observed that mBSA disrupted the lysosomal compartment, signaled along the NLRP3 inflammasome pathway, and activated caspase 1, which led to the production of IL-1 beta. In vivo, mBSA triggered rapid and prominent immune cell infiltration that is dependent on IL-1 beta induction. Taken together, these data demonstrate that by mimicking amyloidogenic proteins mBSA exhibits strong innate immune functions and serves as a potent adjuvant. These findings advance our understanding on the underlying mechanism of how aberrant immune responses lead to autoimmune reactions.	[Di Domizio, Jeremy; Dorta-Estremera, Stephanie; Cao, Wei] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Cao, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	wcao@mdanderson.org	Di Domizio, Jeremy/L-1777-2019	Cao, Wei/0000-0002-8952-9159; Dorta-Estremera, Stephanie/0000-0003-4440-6806	National Institutes of Health [AI074809]; University of Texas M. D. Anderson Cancer Center Institutional Research Grant Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas M. D. Anderson Cancer Center Institutional Research Grant Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants from National Institutes of Health Grant AI074809 and The University of Texas M. D. Anderson Cancer Center Institutional Research Grant Program (to WC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith DL, 2009, EUR J IMMUNOL, V39, P2040, DOI 10.1002/eji.200939578; BALTZ ML, 1986, CLIN EXP IMMUNOL, V66, P691; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Di Domizio J, 2012, P NATL ACAD SCI USA, V109, P14550, DOI 10.1073/pnas.1206923109; Di Domizio J, 2012, J BIOL CHEM, V287, P736, DOI 10.1074/jbc.M111.238477; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; EDGINGTON SM, 1992, MOL IMMUNOL, V29, P609, DOI 10.1016/0161-5890(92)90197-6; FLANDERS KC, 1988, BIOCHEMISTRY-US, V27, P739, DOI 10.1021/bi00402a037; FUCHS S, 1975, J IMMUNOL, V114, P1287; Gilkeson GS, 1996, J EXP MED, V183, P1389, DOI 10.1084/jem.183.4.1389; GILKESON GS, 1989, J IMMUNOL, V142, P1482; GILKESON GS, 1989, CLIN IMMUNOL IMMUNOP, V51, P362, DOI 10.1016/0090-1229(89)90034-2; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257; HENEKA MT, 2012, NATURE, V493, P674, DOI DOI 10.1038/NATURE11729; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lindgren M, 2010, FEBS J, V277, P1380, DOI 10.1111/j.1742-4658.2010.07571.x; Masters SL, 2011, TRENDS MOL MED, V17, P276, DOI 10.1016/j.molmed.2011.01.005; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Meroni PL, 2011, J AUTOIMMUN, V36, P1, DOI 10.1016/j.jaut.2010.10.004; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Pisetsky DS, 1996, IMMUNITY, V5, P303, DOI 10.1016/S1074-7613(00)80256-3; PLESCIA OJ, 1964, P NATL ACAD SCI USA, V52, P279, DOI 10.1073/pnas.52.2.279; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Salminen A, 2008, J CELL MOL MED, V12, P2255, DOI 10.1111/j.1582-4934.2008.00496.x; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sideras K, 2009, ADV CLIN CHEM, V47, P1, DOI 10.1016/S0065-2423(09)47001-X; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; VANDENBERG WB, 1984, J CLIN INVEST, V74, P1850, DOI 10.1172/JCI111604; VANLENT PLEM, 1989, IMMUNOLOGY, V67, P447; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Whitehouse M, 2012, LUPUS, V21, P217, DOI 10.1177/0961203311429818; WILCOX BJ, 1982, NEUROSCI LETT, V29, P105, DOI 10.1016/0304-3940(82)90337-8	43	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63214	10.1371/journal.pone.0063214	http://dx.doi.org/10.1371/journal.pone.0063214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650555	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000100
J	Kuster, CJ; Von Elert, E				Kuster, Christian J.; Von Elert, Eric			Interspecific Differences between D. pulex and D. magna in Tolerance to Cyanobacteria with Protease Inhibitors	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DAPHNIA-MAGNA; MICROCYSTIS-AERUGINOSA; TOXIC CYANOBACTERIA; GROWTH-RATE; GALEATA; LAKE; IDENTIFICATION; POPULATION; DYNAMICS	It is known that cyanobacteria negatively affect herbivores due to their production of toxins such as protease inhibitors. In the present study we investigated potential interspecific differences between two major herbivores, Daphnia magna and Daphnia pulex, in terms of their tolerance to cyanobacteria with protease inhibitors. Seven clones each of D. magna and of D. pulex were isolated from different habitats in Europe and North America. To test for interspecific differences in the daphnids' tolerance to cyanobacteria, their somatic and population growth rates were determined for each D. magna and D. pulex clone after exposure to varying concentrations of two Microcystis aeruginosa strains. The M. aeruginosa strains NIVA and PCC- contained either chymotrypsin or trypsin inhibitors, but no microcystins. Mean somatic and population growth rates on a diet with 20% NIVA were significantly more reduced in D. pulex than in D. magna. On a diet with 10% PCC-, the population growth of D. pulex was significantly more reduced than that of D. magna. This indicates that D. magna is more tolerant to cyanobacteria with protease inhibitors than D. pulex. The reduction of growth rates was possibly caused by an interference of cyanobacterial inhibitors with proteases in the gut of Daphnia, as many other conceivable factors, which might have been able to explain the reduced growth, could be excluded as causal factors. Protease assays revealed that the sensitivities of chymotrypsins and trypsins to cyanobacterial protease inhibitors did not differ between D. magna and D. pulex. However, D. magna exhibited a 2.3-fold higher specific chymotrypsin activity than D. pulex, which explains the observed higher tolerance to cyanobacterial protease inhibitors of D. magna. The present study suggests that D. magna may control the development of cyanobacterial blooms more efficiently than D. pulex due to differences in their tolerance to cyanobacteria with protease inhibitors.	[Kuster, Christian J.; Von Elert, Eric] Univ Cologne, Inst Zool, Cologne, Germany	University of Cologne	Kuster, CJ (corresponding author), Univ Cologne, Inst Zool, Weyertal 119, Cologne, Germany.	meroder@gmx.de	von Elert, Eric/S-1666-2018	von Elert, Eric/0000-0001-7758-716X	German Research Foundation (DFG) [El 179/6-1]; Collaborative Research Centre Molecular Basis of Evolutionary Innovations [680]	German Research Foundation (DFG)(German Research Foundation (DFG)); Collaborative Research Centre Molecular Basis of Evolutionary Innovations	This study was supported by two grants to EvE from the German Research Foundation (DFG): grant number El 179/6-1 and by a grant within the Collaborative Research Centre 680 Molecular Basis of Evolutionary Innovations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal MK, 2005, ENVIRON TOXICOL, V20, P314, DOI 10.1002/tox.20123; Agrawal MK, 2001, HYDROBIOLOGIA, V464, P37, DOI 10.1023/A:1013946514556; Blom JF, 2006, ARCH HYDROBIOL, V167, P547, DOI 10.1127/0003-9136/2006/0167-0547; Brzezinski T, 2007, LIMNOL OCEANOGR, V52, P2350, DOI 10.4319/lo.2007.52.6.2350; CARMICHAEL WW, 1994, SCI AM, V270, P78, DOI 10.1038/scientificamerican0194-78; Codd GA, 2005, TOXICOL APPL PHARM, V203, P264, DOI 10.1016/j.taap.2004.02.016; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Czarnecki O, 2006, ENVIRON MICROBIOL, V8, P77, DOI 10.1111/j.1462-2920.2005.00870.x; DEMEESTER L, 1994, OECOLOGIA, V97, P333, DOI 10.1007/BF00317323; DeMott WR, 1997, FRESHWATER BIOL, V38, P649, DOI 10.1046/j.1365-2427.1997.00222.x; DeMott WR, 2005, OECOLOGIA, V142, P20, DOI 10.1007/s00442-004-1716-y; DeMott WR, 2002, ECOLOGY, V83, P3426, DOI 10.1890/0012-9658(2002)083[3426:SCVADT]2.0.CO;2; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Dokulil MT, 2000, HYDROBIOLOGIA, V438, P1, DOI 10.1023/A:1004155810302; Gademann K, 2008, CURR ORG CHEM, V12, P326, DOI 10.2174/138527208783743750; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; Haag CR, 2009, GENETICS, V182, P313, DOI 10.1534/genetics.109.101147; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; Hansson LA, 2007, FRESHWATER BIOL, V52, P1290, DOI 10.1111/j.1365-2427.2007.01765.x; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; Koch U, 2009, OECOLOGIA, V159, P317, DOI 10.1007/s00442-008-1216-6; Kuster C, 2012, HYDROBIOLOGIA, P1; Kuster CJ, 2012, MOL ECOL RESOUR, V12, P1048, DOI 10.1111/j.1755-0998.2012.03177.x; LAMPERT W, 1991, ARCH HYDROBIOL, V120, P447; Lampert W, 1996, FUNCT ECOL, V10, P631, DOI 10.2307/2390173; Lurling M, 2003, LIMNOL OCEANOGR, V48, P2214; Lurling M, 2003, ENVIRON TOXICOL CHEM, V22, P1281, DOI [10.1002/etc.5620220614, 10.1897/1551-5028(2003)022&lt;1281:LHCODE&gt;2.0.CO;2]; Martin-Creuzburg D, 2004, J CHEM ECOL, V30, P483, DOI 10.1023/B:JOEC.0000018624.94689.95; Martin-Creuzburg D, 2008, LIMNOL OCEANOGR, V53, P456, DOI 10.4319/lo.2008.53.2.0456; Matthes M, 2004, HYDROBIOLOGIA, V526, P33, DOI 10.1023/B:HYDR.0000041616.86446.01; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pflugmacher S, 1998, BBA-GEN SUBJECTS, V1425, P527, DOI 10.1016/S0304-4165(98)00107-X; PIJANOWSKA J, 1993, OECOLOGIA, V96, P40, DOI 10.1007/BF00318028; Pires LMD, 2011, AQUAT TOXICOL, V104, P230, DOI 10.1016/j.aquatox.2011.05.001; PORTER KG, 1984, LIMNOL OCEANOGR, V29, P365, DOI 10.4319/lo.1984.29.2.0365; Rohrlack T, 1999, APPL ENVIRON MICROB, V65, P737; Rohrlack T, 2001, APPL ENVIRON MICROB, V67, P3523, DOI 10.1128/AEM.67.8.3523-3529.2001; Sarnelle O, 2005, LIMNOL OCEANOGR, V50, P1565, DOI 10.4319/lo.2005.50.5.1565; Sarnelle O, 2007, LIMNOL OCEANOGR, V52, P2120, DOI 10.4319/lo.2007.52.5.2120; Schaack S, 2010, P ROY SOC B-BIOL SCI, V277, P2381, DOI 10.1098/rspb.2009.2253; Schwarzenberger A, 2013, OECOLOGIA, V172, P11, DOI 10.1007/s00442-012-2479-5; Schwarzenberger A, 2012, MOL ECOL, V21, P4898, DOI 10.1111/j.1365-294X.2012.05753.x; Schwarzenberger Anke, 2010, BMC Physiology, V10, P6, DOI 10.1186/1472-6793-10-6; Sigee DC, 1999, HYDROBIOLOGIA, V395, P161, DOI 10.1023/A:1017097502124; Sivonen K, 1999, MONITORING MANAGEMEN, P41; THRELKELD ST, 1979, ECOLOGY, V60, P165, DOI 10.2307/1936478; Tucker S, 2005, APPL ENVIRON MICROB, V71, P629, DOI 10.1128/AEM.71.2.629-635.2005; von Elert E, 2005, J NAT PROD, V68, P1324, DOI 10.1021/np050079r; von Elert E, 2004, COMP BIOCHEM PHYS B, V137, P287, DOI 10.1016/j.cbpc.2003.11.008; von Elert E, 2003, P ROY SOC B-BIOL SCI, V270, P1209, DOI 10.1098/rspb.2003.2357; von Elert E, 2002, LIMNOL OCEANOGR, V47, P1764, DOI 10.4319/lo.2002.47.6.1764; von Elert E, 1997, LIMNOL OCEANOGR, V42, P1796, DOI 10.4319/lo.1997.42.8.1796; von Elert E, 2012, J EXP BIOL, V215, P2051, DOI 10.1242/jeb.068742; Wacker A, 2001, ECOLOGY, V82, P2507, DOI 10.2307/2679932; Wang DM, 2011, SCI TOTAL ENVIRON, V409, P1351, DOI 10.1016/j.scitotenv.2010.12.024; Watanabe H, 2005, GENOME, V48, P606, DOI 10.1139/G05-038; Weckesser J, 1996, SYST APPL MICROBIOL, V19, P133, DOI 10.1016/S0723-2020(96)80038-5	58	12	12	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62658	10.1371/journal.pone.0062658	http://dx.doi.org/10.1371/journal.pone.0062658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650523	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000067
J	Singh-Blom, UM; Natarajan, N; Tewari, A; Woods, JO; Dhillon, IS; Marcotte, EM				Singh-Blom, U. Martin; Natarajan, Nagarajan; Tewari, Ambuj; Woods, John O.; Dhillon, Inderjit S.; Marcotte, Edward M.			Prediction and Validation of Gene-Disease Associations Using Methods Inspired by Social Network Analyses	PLOS ONE			English	Article							GENOME; DATABASE; PRIORITIZATION; IDENTIFICATION; INTEGRATION; PHENOTYPE; RESOURCE; BIOLOGY; WALKING; MODELS	Correctly identifying associations of genes with diseases has long been a goal in biology. With the emergence of large-scale gene-phenotype association datasets in biology, we can leverage statistical and machine learning methods to help us achieve this goal. In this paper, we present two methods for predicting gene-disease associations based on functional gene associations and gene-phenotype associations in model organisms. The first method, the Katz measure, is motivated from its success in social network link prediction, and is very closely related to some of the recent methods proposed for gene-disease association inference. The second method, called CATAPULT (Combining dATa Across species using Positive-Unlabeled Learning Techniques), is a supervised machine learning method that uses a biased support vector machine where the features are derived from walks in a heterogeneous gene-trait network. We study the performance of the proposed methods and related state-of-the-art methods using two different evaluation strategies, on two distinct data sets, namely OMIM phenotypes and drug-target interactions. Finally, by measuring the performance of the methods using two different evaluation strategies, we show that even though both methods perform very well, the Katz measure is better at identifying associations between traits and poorly studied genes, whereas CATAPULT is better suited to correctly identifying gene-trait associations overall. The authors want to thank Jon Laurent and Kris McGary for some of the data used, and Li and Patra for making their code available. Most of Ambuj Tewari's contribution to this work happened while he was a postdoctoral fellow at the University of Texas at Austin.	[Singh-Blom, U. Martin; Woods, John O.; Marcotte, Edward M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Singh-Blom, U. Martin] Karolinska Inst, Dept Med, Stockholm, Sweden; [Natarajan, Nagarajan; Dhillon, Inderjit S.] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Tewari, Ambuj] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Karolinska Institutet; University of Texas System; University of Texas Austin; University of Michigan System; University of Michigan; University of Texas System; University of Texas Austin	Dhillon, IS (corresponding author), Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA.	marcotte@mail.utexas.edu; inderjit@cs.utexas.edu			U.S. Army Research [58343-MA]; Cancer Prevention AMP; Research Institute of Texas (CPRIT); U.S. National Science Foundation; United States National Institutes of Health; Welch Foundation [F1515]; Packard Foundation; DOD Army [W911NF-10-1-0529]; U.S. National Science Foundation [CCF-0916309]; Moncrief Grand Challenge Award	U.S. Army Research(United States Department of DefenseUS Army Research Laboratory (ARL)); Cancer Prevention AMP; Research Institute of Texas (CPRIT); U.S. National Science Foundation(National Science Foundation (NSF)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Packard Foundation(The David & Lucile Packard Foundation); DOD Army(United States Department of Defense); U.S. National Science Foundation(National Science Foundation (NSF)); Moncrief Grand Challenge Award	This work was supported by grants from the U.S. Army Research (58343-MA) to EMM and ISD, from the Cancer Prevention & Research Institute of Texas (CPRIT), U.S. National Science Foundation, United States National Institutes of Health, Welch Foundation (F1515), and the Packard Foundation to EMM, and from DOD Army (W911NF-10-1-0529), U.S. National Science Foundation (CCF-0916309) and the Moncrief Grand Challenge Award to ISD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell GW, 2004, DEV DYNAM, V229, P677, DOI 10.1002/dvdy.10503; Bing L, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P179, DOI 10.1109/icdm.2003.1250918; Cannata D, 2010, MT SINAI J MED, V77, P197, DOI 10.1002/msj.20167; Chen NS, 2005, NUCLEIC ACIDS RES, V33, pD383, DOI 10.1093/nar/gki066; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Estrada E, 2010, SIAM REV, V52, P696, DOI 10.1137/090761070; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoe HS, 2008, J NEUROCHEM, V106, P2263, DOI 10.1111/j.1471-4159.2008.05517.x; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Jong YJI, 2002, INT IMMUNOPHARMACOL, V2, P1833, DOI 10.1016/S1567-5769(02)00168-6; Karni S, 2009, J COMPUT BIOL, V16, P181, DOI 10.1089/cmb.2008.05TT; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; LEBEAU MM, 1983, NEW ENGL J MED, V309, P630, DOI 10.1056/NEJM198309153091103; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee W.S., 2003, P 20 INT C MACH LEAR, P448, DOI DOI 10.1016/J.TCS.2005.09.007; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; *LMMD, MOL MOD DES; McGary KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r258; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Molnar S, 2010, COLLEGIUM ANTROPOL, V34, P1427; MORDELET F, 2010, HAL00523336, P23336; Mordelet F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-389; Mostafavi S, 2010, BIOINFORMATICS, V26, P1759, DOI 10.1093/bioinformatics/btq262; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Page Lawrence, 1999, 199966 STANF INFOLAB; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Saito TL, 2004, NUCLEIC ACIDS RES, V32, pD319, DOI 10.1093/nar/gkh113; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tian WD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s7; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; van Helmond ZK, 2007, NEUROPATH APPL NEURO, V33, P317, DOI 10.1111/j.1365-2990.2006.00815.x; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; YAMANISHI Y, 2008, ISMB, P232; Zhengdong Lu, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P923, DOI 10.1109/ICDM.2010.112	49	102	106	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e58977	10.1371/journal.pone.0058977	http://dx.doi.org/10.1371/journal.pone.0058977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650495	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000004
J	Sun, H; Shi, JP; Li, M; Chen, X				Sun, Hao; Shi, Jingpu; Li, Min; Chen, Xin			Impact of Continuous Positive Airway Pressure Treatment on Left Ventricular Ejection Fraction in Patients with Obstructive Sleep Apnea: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; ACUTE MYOCARDIAL-INFARCTION; DIASTOLIC FUNCTION; THERAPY; DYSFUNCTION; PERFUSION; RECOVERY; RISK; CPAP; BIAS	Background: It has been known for a long time that obstructive sleep apnea (OSA) is associated with a decreased left ventricular ejection fraction (LVEF). Continuous positive airway pressure (CPAP) is the gold standard treatment for OSA; however, it is unknown whether or not CPAP treatment will improve the LVEF. The aim of the current study was to assess whether or not CPAP treatment improves the LVEF. A meta-analysis was conducted to determine the effect of CPAP treatment on the LVEF among patients with OSA. Methods: A literature search of PubMed, the Web of Science, and Cochrane Collaboration's database were utilized to identify eligible reports for this trial. Ten randomized controlled trails were examined and the meta-analysis was performed using STATA 11. Results: A significant improvement in the LVEF was observed after CPAP treatment (weighted mean difference(WMD) = 3.59, 95% CI = 1.74-5.44; P<0.001). Subgroup analysis revealed that patients with OSA and heart failure had a significant improvement in the LVEF after CPAP treatment (WMD = 5.18, 95% CI = 3.27-7.08; P<0.001); however, the LVEF of patients with OSA only increased 1.11% and there was no statistical significance (WMD = 1.11, 95% CI = -1.13-3.35; P = 0.331). Furthermore, based on univariate meta-regression analysis, only the baseline AHI had a statistically significant correlation with the LVEF. Conclusions: Our meta-analysis supports the notion that CPAP may improve the LVEF among patients with OSA.	[Shi, Jingpu] China Med Univ, Affiliated Hosp 1, Inst Cardiovasc Dis, Dept Clin Epidemiol, Shenyang, Peoples R China; China Med Univ, Affiliated Hosp 1, Ctr Evidence Based Med, Shenyang, Peoples R China	China Medical University; China Medical University	Shi, JP (corresponding author), China Med Univ, Affiliated Hosp 1, Inst Cardiovasc Dis, Dept Clin Epidemiol, Shenyang, Peoples R China.	jingpushi56@yahoo.com	Sun, Hao/M-6027-2014					Alchanatis M, 2000, RESPIRATION, V67, P367, DOI 10.1159/000029532; Alchanatis M, 2002, EUR RESPIR J, V20, P1239, DOI 10.1183/09031936.02.00278002; Arias MA, 2005, CIRCULATION, V112, P375, DOI 10.1161/CIRCULATIONAHA.104.501841; Bayram NA, 2009, EUR J ECHOCARDIOGR, V10, P376, DOI 10.1093/ejechocard/jen257; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bellone A, 2010, AM J EMERG MED, V28, P230, DOI 10.1016/j.ajem.2008.11.002; Bradley TD, 2003, CIRCULATION, V107, P1671, DOI 10.1161/01.CIR.0000061757.12581.15; Edwards N, 1998, THORAX, V53, pS12, DOI 10.1136/thx.53.2008.S12; Egea CJ, 2008, SLEEP MED, V9, P660, DOI 10.1016/j.sleep.2007.06.018; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferrier K, 2005, CHEST, V128, P2116, DOI 10.1378/chest.128.4.2116; Ferrier KA, 2008, INTERN MED J, V38, P829, DOI 10.1111/j.1445-5994.2007.01585.x; Gilman MR, 2008, CLIN SCI, V114, P243, DOI 10.1042/CS20070172; Haruki N, 2010, EUR J ECHOCARDIOGR, V11, P352, DOI 10.1093/ejechocard/jep215; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoekema A, 2008, INT J CARDIOL, V128, P232, DOI 10.1016/j.ijcard.2007.06.016; Jackson G, 2012, INT J CLIN PRACT, V66, P421, DOI 10.1111/j.1742-1241.2012.02931.x; JAVAHERI S, 1995, ANN INTERN MED, V122, P487, DOI 10.7326/0003-4819-122-7-199504010-00002; Johnson CB, 2008, CAN J CARDIOL, V24, P697, DOI 10.1016/S0828-282X(08)70668-8; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; Khayat RN, 2008, CHEST, V134, P1162, DOI 10.1378/chest.08-0346; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; MALONE S, 1991, LANCET, V338, P1480; Mansfield DR, 2004, AM J RESP CRIT CARE, V169, P361, DOI 10.1164/rccm.200306-752OC; Martinez D, 2011, SLEEP BREATH; Nguyen PK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-50; Scharf SM, 1996, SLEEP, V19, pS240; Shaw LJ, 1996, AM J CARDIOL, V78, P1327, DOI 10.1016/S0002-9149(96)00653-4; Smith LA, 2007, EUR HEART J, V28, P1221, DOI 10.1093/eurheartj/ehm131; TAYLOR GJ, 1980, CIRCULATION, V62, P960, DOI 10.1161/01.CIR.62.5.960; Usui K, 2005, J AM COLL CARDIOL, V45, P2008, DOI 10.1016/j.jacc.2004.12.080; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	35	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62298	10.1371/journal.pone.0062298	http://dx.doi.org/10.1371/journal.pone.0062298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650511	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000039
J	Heilkenbrinker, U; Dietrich, R; Didier, A; Zhu, K; Lindback, T; Granum, PE; Martlbauer, E				Heilkenbrinker, Uta; Dietrich, Richard; Didier, Andrea; Zhu, Kui; Lindback, Toril; Granum, Per Einar; Maertlbauer, Erwin			Complex Formation between NheB and NheC Is Necessary to Induce Cytotoxic Activity by the Three-Component Bacillus cereus Nhe Enterotoxin	PLOS ONE			English	Article							HEMOLYSIN BL; MONOCLONAL-ANTIBODIES; EMETIC TOXIN; THURINGIENSIS; STRAINS; BINDING; PCR	The nonhemolytic enterotoxin (Nhe) is known as a major pathogenicity factor for the diarrheal type of food poisoning caused by Bacillus cereus. The Nhe complex consists of NheA, NheB and NheC, all of them required to reach maximum cytotoxicity following a specific binding order on cell membranes. Here we show that complexes, formed between NheB and NheC under natural conditions before targeting the host cells, are essential for toxicity in Vero cells. To enable detection of NheC and its interaction with NheB, monoclonal antibodies against NheC were established and characterized. The antibodies allowed detection of recombinant NheC in a sandwich immunoassay at levels below 10 ng ml(-1), but no or only minor amounts of NheC were detectable in natural culture supernatants of B. cereus strains. When NheB- and NheC-specific monoclonal antibodies were combined in a sandwich immunoassay, complexes between NheB and NheC could be demonstrated. The level of these complexes was directly correlated with the relative concentrations of NheB and NheC. Toxicity, however, showed a bell-shaped dose-response curve with a plateau at ratios of NheB and NheC between 50:1 and 5:1. Both lower and higher ratios between NheB and NheC strongly reduced cytotoxicity. When the ratio approached an equimolar ratio, complex formation reached its maximum resulting in decreased binding of NheB to Vero cells. These data indicate that a defined level of NheB-NheC complexes as well as a sufficient amount of free NheB is necessary for efficient cell binding and toxicity. Altogether, the results of this study provide evidence that the interaction of NheB and NheC is a balanced process, necessary to induce, but also able to limit the toxic action of Nhe.	[Heilkenbrinker, Uta; Dietrich, Richard; Didier, Andrea; Zhu, Kui; Maertlbauer, Erwin] Univ Munich, Dept Vet Sci, Oberschleissheim, Germany; [Lindback, Toril; Granum, Per Einar] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway	University of Munich; Norwegian University of Life Sciences	Martlbauer, E (corresponding author), Univ Munich, Dept Vet Sci, Oberschleissheim, Germany.	e.maertlbauer@mh.vetmed.uni-muenchen.de	Märtlbauer, Erwin/I-2897-2016; Märtlbauer, Erwin/Y-8646-2019; Lindbäck, Toril/AAZ-9278-2020	Märtlbauer, Erwin/0000-0003-3390-8173; Märtlbauer, Erwin/0000-0003-3390-8173; Lindback, Toril/0000-0002-5245-1087; Zhu, Kui/0000-0001-8242-3952	German Ministry of Economics and Technology (via AiF); FEI (Forschungskreis der Ernahrungsindustrie e.V., Bonn) [AiF 15047 N]	German Ministry of Economics and Technology (via AiF)(Federal Ministry for Economic Affairs and Energy (BMWi)); FEI (Forschungskreis der Ernahrungsindustrie e.V., Bonn)	This research project was supported by the German Ministry of Economics and Technology (via AiF) and the FEI (Forschungskreis der Ernahrungsindustrie e.V., Bonn), Project AiF 15047 N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATA N, 1995, FEMS MICROBIOL LETT, V129, P17, DOI 10.1016/0378-1097(95)00119-P; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BEECHER DJ, 1995, INFECT IMMUN, V63, P4423, DOI 10.1128/IAI.63.11.4423-4428.1995; BEECHER DJ, 1994, INFECT IMMUN, V62, P980, DOI 10.1128/IAI.62.3.980-986.1994; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Phung D, 2012, FEMS MICROBIOL LETT, V330, P98, DOI 10.1111/j.1574-6968.2012.02538.x; Didier A, 2012, INFECT IMMUN, V80, P832, DOI 10.1128/IAI.05681-11; Dietrich R, 1999, APPL ENVIRON MICROB, V65, P4470; Dietrich R, 2005, APPL ENVIRON MICROB, V71, P8214, DOI 10.1128/AEM.71.12.8214-8220.2005; Ehling-Schulz M, 2005, MICROBIOL-SGM, V151, P183, DOI 10.1099/mic.0.27607-0; Fagerlund A, 2008, MICROBIOL-SGM, V154, P693, DOI 10.1099/mic.0.2007/014134-0; Fagerlund A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-43; Fagerlund A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-304; FRIGUET B, 1983, J IMMUNOL METHODS, V60, P351, DOI 10.1016/0022-1759(83)90292-2; Gohar M, 2005, PROTEOMICS, V5, P3696, DOI 10.1002/pmic.200401225; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Granum PE, 1999, FEMS MICROBIOL LETT, V177, P225, DOI 10.1111/j.1574-6968.1999.tb13736.x; GRANUM PE, 1993, INT J FOOD MICROBIOL, V17, P269, DOI 10.1016/0168-1605(93)90197-O; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; Hansen BM, 2001, APPL ENVIRON MICROB, V67, P185, DOI 10.1128/AEM.67.1.185-189.2001; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Lapidus A, 2008, CHEM-BIOL INTERACT, V171, P236, DOI 10.1016/j.cbi.2007.03.003; Lindback T, 2004, MICROBIOL-SGM, V150, P3959, DOI 10.1099/mic.0.27359-0; Lindback T, 2010, INFECT IMMUN, V78, P3813, DOI 10.1128/IAI.00247-10; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Lund T, 1996, FEMS MICROBIOL LETT, V141, P151, DOI 10.1016/0378-1097(96)00208-X; Madegowda M, 2008, PROTEINS, V71, P534, DOI 10.1002/prot.21888; Moravek M, 2006, FEMS MICROBIOL LETT, V257, P293, DOI 10.1111/j.1574-6968.2006.00185.x; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Stadler V, 2008, ANGEW CHEM INT EDIT, V47, P7132, DOI 10.1002/anie.200801616; Wehrle E, 2009, J MICROBIOL METH, V78, P265, DOI 10.1016/j.mimet.2009.06.013	35	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63104	10.1371/journal.pone.0063104	http://dx.doi.org/10.1371/journal.pone.0063104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646182	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300137
J	Misra, UK; Pizzo, SV				Misra, Uma Kant; Pizzo, Salvatore Vincent			Evidence for a Pro-Proliferative Feedback Loop in Prostate Cancer: The Role of Epac1 and COX-2-Dependent Pathways	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; MTOR COMPLEX 1; CYCLIC-AMP; CELL-PROLIFERATION; REGULATED KINASE; C-MYC; RECEPTOR; INFLAMMATION; ACTIVATION; GROWTH	Objective: In human prostate cancer cells, a selective Epac agonist, 8-CPT-2Me-cAMP, upregulates cell proliferation and survival via activation of Ras-MAPK and PI- 3-kinase-Akt-mTOR signaling cascades. Here we examine the role of inflammatory mediators in Epac1-induced cellular proliferation by determining the expression of the pro-inflammatory markers p-cPLA2, COX-2, and PGE(2) in prostate cancer cells treated with 8-CPT-2Me-cAMP. Methods: We employed inhibitors of COX-2, mTORC1, and mTORC2 to probe cyclic AMP-dependent pathways in human prostate cancer cells. RNAi targeting Epac1, Raptor, and Rictor was also employed in these studies. Results: 8-CPT-2Me-cAMP treatment caused a 2-2.5-fold increase of p-cPLA2(S505), COX-2, and PGE2 levels in human prostate cancer cell lines. Pretreatment of cells with the COX-2 inhibitor SC-58125 or the EP4 antagonist AH-23848, or with an inhibitor of mTORC1 and mTORC2, Torin1, significantly reduced the Epac1-dependent increase of p-cPLA2 and COX-2, p-S6-kinase(T389), and p-AKT(S473). In addition, Epac1-induced protein and DNA synthesis were greatly reduced upon pretreatment of cells with either COX-2, EP4, or mTOR inhibitors. Transfection of prostate cancer cells with Epac1 dsRNA, Raptor dsRNA, or Rictor dsRNA profoundly reduced Epac1-dependent increases in p-cPLA2 and COX-2. Conclusion: We show that Epac1, a downstream effector of cAMP, functions as a pro-inflammatory modulator in prostate cancer cells and promotes cell proliferation and survival by upregulating Ras-MAPK, and PI 3-kinase-Akt-mTOR signaling.	[Misra, Uma Kant; Pizzo, Salvatore Vincent] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Pizzo, SV (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	salvatore.pizzo@duke.edu						AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beasley D, 1999, AM J PHYSIOL-HEART C, V276, pH1369, DOI 10.1152/ajpheart.1999.276.4.H1369; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bundscherer A, 2008, ONCOL REP, V19, P547; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; de Groot DJA, 2007, CRIT REV ONCOL HEMAT, V61, P52, DOI 10.1016/j.critrevonc.2006.07.001; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Fang Y, 2007, J PHARMACOL EXP THER, V322, P1189, DOI 10.1124/jpet.107.119933; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Fujita H, 2002, PROSTATE, V53, P232, DOI 10.1002/pros.10152; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; Ghosh S, 2011, DEV BIOL, V360, P329, DOI 10.1016/j.ydbio.2011.09.027; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; HOFFMAN M, 1988, AGENTS ACTIONS, V25, P360, DOI 10.1007/BF01965043; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Irani J, 1997, J UROLOGY, V157, P1301, DOI 10.1016/S0022-5347(01)64957-7; Jang MW, 2012, J CELL PHYSIOL, V227, P3756, DOI 10.1002/jcp.24084; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Kojima F, 2009, PROSTAG OTH LIPID M, V89, P26, DOI 10.1016/j.prostaglandins.2009.03.001; Krysan K, 2005, CANCER RES, V65, P6275, DOI 10.1158/0008-5472.CAN-05-0216; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Liu XH, 1998, CANCER RES, V58, P4245; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mancini AD, 2011, INFLAMM RES, V60, P1083, DOI 10.1007/s00011-011-0385-7; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McCarty Mark F, 2004, Integr Cancer Ther, V3, P349, DOI 10.1177/1534735404270757; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; MISRA UK, 1993, BIOCHEM J, V290, P885, DOI 10.1042/bj2900885; Misra UK, 2005, J BIOL CHEM, V280, P38276, DOI 10.1074/jbc.M507332200; Misra UK, 2002, J BIOL CHEM, V277, P4069, DOI 10.1074/jbc.M109764200; Misra UK, 2001, ARCH BIOCHEM BIOPHYS, V386, P227, DOI 10.1006/abbi.2000.2199; Misra UK, 2001, CELL SIGNAL, V13, P801, DOI 10.1016/S0898-6568(01)00202-9; Misra UK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051735; Misra UK, 2012, J CELL BIOCHEM, V113, P1488, DOI 10.1002/jcb.24018; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Pruthi RS, 2006, CLIN CANCER RES, V12, P2172, DOI 10.1158/1078-0432.CCR-05-2067; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Salman H, 2012, BIOMED PHARMACOTHER, V66, P330, DOI 10.1016/j.biopha.2012.03.004; Saylor PJ, 2012, ONCOLOGIST, V17, P212, DOI 10.1634/theoncologist.2011-0321; Sciarra A, 2008, J STEROID BIOCHEM, V108, P254, DOI 10.1016/j.jsbmb.2007.09.013; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; SETHI G, 2010, BIOSCIENCE REP, V32, P1; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Terada N, 2010, CANCER RES, V70, P1606, DOI 10.1158/0008-5472.CAN-09-2984; Thill M, 2010, J STEROID BIOCHEM, V121, P387, DOI 10.1016/j.jsbmb.2010.03.049; UHING RJ, 1991, BIOCHIM BIOPHYS ACTA, V1093, P115, DOI 10.1016/0167-4889(91)90111-A; van der Giet M, 2008, BIOL CHEM, V389, P1381, DOI 10.1515/BC.2008.165; Wang CY, 2007, J PHYSIOL-LONDON, V584, P191, DOI 10.1113/jphysiol.2007.135616; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Yu L, 2009, INT J CANCER, V125, P2540, DOI 10.1002/ijc.24607; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	68	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63150	10.1371/journal.pone.0063150	http://dx.doi.org/10.1371/journal.pone.0063150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646189	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300144
J	Strickertsson, JAB; Desler, C; Martin-Bertelsen, T; Machado, AMD; Wadstrom, T; Winther, O; Rasmussen, LJ; Friis-Hansen, L				Strickertsson, Jesper A. B.; Desler, Claus; Martin-Bertelsen, Tomas; Machado, Ana Manuel Dantas; Wadstrom, Torkel; Winther, Ole; Rasmussen, Lene Juel; Friis-Hansen, Lennart			Enterococcus faecalis Infection Causes Inflammation, Intracellular Oxphos-Independent ROS Production, and DNA Damage in Human Gastric Cancer Cells	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; GENERATING NADPH OXIDASES; GENE SET ENRICHMENT; EXTRACELLULAR-SUPEROXIDE; MITOCHONDRIAL-DNA; EPITHELIAL-CELLS; MISMATCH REPAIR; NOX FAMILY; KAPPA-B; EXPRESSION	Background: Achlorhydria caused by e.g. atrophic gastritis allows for bacterial overgrowth, which induces chronic inflammation and damage to the mucosal cells of infected individuals driving gastric malignancies and cancer. Enterococcus faecalis (E. faecalis) can colonize achlohydric stomachs and we therefore wanted to study the impact of E. faecalis infection on inflammatory response, reactive oxygen species (ROS) formation, mitochondrial respiration, and mitochondrial genetic stability in gastric mucosal cells. Methods: To separate the changes induced by bacteria from those of the inflammatory cells we established an in vitro E. faecalis infection model system using the gastric carcinoma cell line MKN74. Total ROS and superoxide was measured by fluorescence microscopy. Cellular oxygen consumption was characterized non-invasively using XF24 microplate based respirometry. Gene expression was examined by microarray, and response pathways were identified by Gene Set Analysis (GSA). Selected gene transcripts were verified by quantitative real-time polymerase chain reaction (qRT-PCR). Mitochondrial mutations were determined by sequencing. Results: Infection of MKN74 cells with E. faecalis induced intracellular ROS production through a pathway independent of oxidative phosphorylation (oxphos). Furthermore, E. faecalis infection induced mitochondrial DNA instability. Following infection, genes coding for inflammatory response proteins were transcriptionally up-regulated while DNA damage repair and cell cycle control genes were down-regulated. Cell growth slowed down when infected with viable E. faecalis and responded in a dose dependent manner to E. faecalis lysate. Conclusions: Infection by E. faecalis induced an oxphos-independent intracellular ROS response and damaged the mitochondrial genome in gastric cell culture. Finally the bacteria induced an NF-kappa B inflammatory response as well as impaired DNA damage response and cell cycle control gene expression.	[Strickertsson, Jesper A. B.; Friis-Hansen, Lennart] Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Strickertsson, Jesper A. B.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Copenhagen, Denmark; [Desler, Claus; Machado, Ana Manuel Dantas; Rasmussen, Lene Juel] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Ageing, Copenhagen, Denmark; [Martin-Bertelsen, Tomas; Winther, Ole] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark; [Martin-Bertelsen, Tomas; Winther, Ole] Univ Copenhagen, Fac Sci, Bioinformat Ctr, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Wadstrom, Torkel] Lund Univ, Dept Clin Microbiol, Lund, Sweden; [Winther, Ole] Tech Univ Denmark, DTU Informat, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Lund University; Technical University of Denmark	Friis-Hansen, L (corresponding author), Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark.	lfh@rh.regionh.dk	Strickertsson, Jesper/G-6814-2016	desler, claus/0000-0002-0125-004X; Rasmussen, Lene Juel/0000-0001-6864-963X; Friis-Hansen, Lennart/0000-0002-7222-0163; Martin-Bertelsen, Tomas/0000-0002-5842-8187	Portuguese Science, Technology Foundation; Danish MRC; Danish Cancer Society; University of Copenhagen SUND; Novo Nordisk Foundation; NORDEA-fonden	Portuguese Science, Technology Foundation; Danish MRC(Danish Medical Research Council); Danish Cancer Society(Danish Cancer Society); University of Copenhagen SUND; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NORDEA-fonden	AMDM is supported by a fellowship from Portuguese Science, Technology Foundation. LFH is supported by the Danish MRC. JABS is supported by the Danish Cancer Society, and University of Copenhagen SUND. TMB and OW are supported by a grant from the Novo Nordisk Foundation to the Bioinformatics Centre. CD and LJR are supported by NORDEA-fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Argent RH, 2008, CLIN CANCER RES, V14, P2227, DOI 10.1158/1078-0432.CCR-07-2022; Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bellance N, 2009, FRONT BIOSCI-LANDMRK, V14, P4015, DOI 10.2741/3509; Boonanantanasarn K, 2012, INFECT IMMUN; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Caruso R, 2007, WORLD J GASTROENTERO, V13, P5547, DOI 10.3748/wjg.v13.i42.5547; CORREA P, 1990, CANCER RES, V50, P4737; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Machado AMD, 2009, CLIN CANCER RES, V15, P2995, DOI 10.1158/1078-0432.CCR-08-2686; DAVIES GR, 1994, GUT, V35, P179, DOI 10.1136/gut.35.2.179; Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0; Ding SZ, 2007, INFECT IMMUN, V75, P4030, DOI 10.1128/IAI.00172-07; El-Omar EM, 2001, GUT, V48, P743, DOI 10.1136/gut.48.6.743; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Friis-Hansen L, 2006, SCAND J CLIN LAB INV, V66, P607, DOI 10.1080/00365510600873894; Friis-Hansen L, 2006, GASTROENTEROLOGY, V131, P246, DOI 10.1053/j.gastro.2006.04.031; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Handa O, 2011, REDOX REP, V16, P1, DOI 10.1179/174329211X12968219310756; Hansson LE, 2000, WORLD J SURG, V24, P315, DOI 10.1007/s002689910050; Hirano T, 2008, J RADIAT RES, V49, P329, DOI 10.1269/jrr.08049; Howlett M, 2005, GASTROENTEROLOGY, V129, P1005, DOI 10.1053/j.gastro.2005.06.068; Howlett M, 2012, GUT, V61, P1398, DOI 10.1136/gutjnl-2011-300539; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Huycke MM, 1996, J INFECT DIS, V173, P743, DOI 10.1093/infdis/173.3.743; Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529; Huycke MM, 2001, MOL MICROBIOL, V42, P729, DOI 10.1046/j.1365-2958.2001.02638.x; Judd LM, 2005, J GASTROEN HEPATOL, V20, P1266, DOI 10.1111/j.1440-1746.2005.03867.x; Kamada T, 2005, ALIMENT PHARM THER, V21, P1121, DOI 10.1111/j.1365-2036.2005.02459.x; Kang WQ, 2005, LAB INVEST, V85, P702, DOI 10.1038/labinvest.3700260; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kido S, 2001, EUR J CANCER, V37, P1482, DOI 10.1016/S0959-8049(01)00147-2; Kim JJ, 2002, GASTROENTEROLOGY, V123, P542, DOI 10.1053/gast.2002.34751; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lee WC, 2004, J ENDODONT, V30, P209, DOI 10.1097/00004770-200404000-00006; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Maximo V, 2001, GENE CHROMOSOME CANC, V32, P136, DOI 10.1002/gcc.1175; Mueller A, 2004, GASTROENTEROLOGY, V127, P1446, DOI 10.1053/j.gastro.2004.08.054; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Park DI, 2005, HELICOBACTER, V10, P179, DOI 10.1111/j.1523-5378.2005.00309.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pillar CM, 2004, FRONT BIOSCI-LANDMRK, V9, P2335, DOI 10.2741/1400; R Development Core Team, 2011, R LANG ENV STAT COMP; Rokutan K, 2006, ANTIOXID REDOX SIGN, V8, P1573, DOI 10.1089/ars.2006.8.1573; Rozen S, 2000, Methods Mol Biol, V132, P365; Salles N, 2005, EXP GERONTOL, V40, P353, DOI 10.1016/j.exger.2005.01.007; Spooner R, 2011, INT J MOL SCI, V12, P334, DOI 10.3390/ijms12010334; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407; Zavros Y, 2002, GASTROENTEROLOGY, V122, P119, DOI 10.1053/gast.2002.30298	68	48	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63147	10.1371/journal.pone.0063147	http://dx.doi.org/10.1371/journal.pone.0063147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646188	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300143
J	Chen, H; Wang, HY; Liu, YF; Dong, L				Chen, Hong; Wang, Haiyang; Liu, Yanfang; Dong, Li			Altitudinal Variations of Ground Tissue and Xylem Tissue in Terminal Shoot of Woody Species: Implications for Treeline Formation	PLOS ONE			English	Article							FUNCTIONAL TRAIT; CAMBIAL ACTIVITY; NORTH-AMERICAN; PLANT HEIGHT; GROWTH; ALLOMETRY; TREES; PATTERNS; FOREST; DIFFERENTIATION	1. The terminal shoot (or current-year shoot), as one of the most active parts on a woody plant, is a basic unit determining plant height and is potentially influenced by a variety of environmental factors. It has been predicted that tissues amount and their allocation in plant stems may play a critical role in determining plant size in alpine regions. The primary structure in terminal shoots is a key to our understanding treeline formation. The existing theories on treeline formation, however, are still largely lacking of evidence at the species level, much less from anatomy for the terminal shoot. 2. The primary structures within terminal shoot were measured quantitatively for 100 species from four elevation zones along the eastern slope of Gongga Mountain, southwestern China; one group was sampled from above the treeline. An allometric approach was employed to examine scaling relationships interspecifically, and a principal components analysis (PCA) was performed to test the relation among primary xylem, ground tissue, species growth form and altitude. 3. The results showed that xylem tissue size was closely correlated with ground tissue size isometrically across species, while undergoing significant y- or/and x-intercept shift in response to altitudinal belts. Further, a conspicuous characteristic of terminal shoot was its allocation of contrasting tissues between primary xylem and ground tissues with increasing elevation. The result of the PCA showed correlations between anatomical variation, species growth form/height classes and environment. 4. The current study presents a comparative assessment of the allocation of tissue in terminal shoot across phylogenically and ecologically diverse species, and analyzes tissue, function and climate associations with plant growth forms and height classes among species. The interspecific connection between primary xylem ratio and plant size along an elevation gradient suggests the importance of primary xylem in explaining the treeline formation.	[Chen, Hong; Wang, Haiyang] Southwest Univ, Inst Landscape Ecol Mountainous Hort, Chongqing, Peoples R China; [Chen, Hong; Liu, Yanfang; Dong, Li] Southwest Univ, Coll Hort & Landscape, Dept Bot, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Chen, H (corresponding author), Southwest Univ, Inst Landscape Ecol Mountainous Hort, Chongqing, Peoples R China.	chenh.swu@gmail.com	liu, yan/HCI-5542-2022		Southwest University [SWU110032]	Southwest University(Southwest University - China)	The research was funded by Southwest University (SWU110032) to Hong Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas P., 2011, CLIMATE CHANGE ECOLO, P141; Baas P., 2004, EVOLUTION PLANT PHYS, DOI DOI 10.1016/B978-012339552-8/50016-0; Bazzaz FA., 1997, PLANT RESOURCE ALLOC; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; [程根伟 Cheng Genwei], 2002, [生态学报, Acta Ecologica Sinica], V22, P1049; Die A, 2012, ANN BOT-LONDON, V110, P861, DOI 10.1093/aob/mcs145; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; Falster D. S., 2006, SMATR STANDARDISED M; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.0022-0477.2005.00992.x; Fan ZX, 2012, J ECOL, V100, P732, DOI 10.1111/j.1365-2745.2011.01939.x; Fonti P, 2012, NEW PHYTOL, V195, P734, DOI 10.1111/j.1469-8137.2012.04252.x; Gartner B.L., 1995, PLANT STEMS PHYSL FU; GLEESON SK, 1992, AM NAT, V139, P1322, DOI 10.1086/285389; Gricar J, 2006, ANN BOT-LONDON, V97, P943, DOI 10.1093/aob/mcl050; Grierson CS, 2011, NEW PHYTOL, V192, P6, DOI 10.1111/j.1469-8137.2011.03859.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Holtmeier F.K., 2009, MOUNTAIN TIMBERLINES, V2nd edn; Iida Y, 2012, FUNCT ECOL, V26, P274, DOI 10.1111/j.1365-2435.2011.01921.x; Ishii H, 2011, TREE PHYSIOL-NETH, V4, P215, DOI 10.1007/978-94-007-1242-3_8; JAMES JC, 1994, J ECOL, V82, P297, DOI 10.2307/2261297; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; King DA, 2011, SIZE AGE RELATED CHA, P175; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Korner C, 2012, ALPINE TREELINES FUN, DOI 10.1007/978-3-0348-0396-0; Leps J, 2003, MULTIVARIATE ANAL EC; Li GY, 2008, FUNCT ECOL, V22, P557, DOI 10.1111/j.1365-2435.2008.01407.x; Li MH, 2008, PLANT CELL ENVIRON, V31, P1377, DOI 10.1111/j.1365-3040.2008.01848.x; Liu Z., 1985, VEGETATION GONGGA MO; Losos JB, 2011, AM NAT, V177, P709, DOI 10.1086/660020; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Niklas KJ, 2007, TREE PHYSIOL, V27, P433, DOI 10.1093/treephys/27.3.433; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; NIKLAS KJ, 1995, ANN BOT-LONDON, V75, P133, DOI 10.1006/anbo.1995.1004; NIKLAS KJ, 1995, ANN BOT-LONDON, V75, P217, DOI 10.1006/anbo.1995.1015; Oberhuber W, 2004, TREE PHYSIOL, V24, P291, DOI 10.1093/treephys/24.3.291; Osada N, 2002, TREE PHYSIOL, V22, P625, DOI 10.1093/treephys/22.9.625; Osada N, 2011, FUNCT ECOL, V25, P777, DOI 10.1111/j.1365-2435.2011.01833.x; Petit G, 2011, NEW PHYTOL, V189, P241, DOI 10.1111/j.1469-8137.2010.03455.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pigliucci M., 2004, PHENOTYPIC INTEGRATI; Pitman EJG, 1939, BIOMETRIKA, V31, P9, DOI 10.2307/2334971; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; Rossi S, 2011, J EXPT BOT; Rossi S, 2008, GLOBAL ECOL BIOGEOGR, V17, P696, DOI 10.1111/j.1466-8238.2008.00417.x; Rossi S, 2007, OECOLOGIA, V152, P1, DOI 10.1007/s00442-006-0625-7; Rowe N, 2005, NEW PHYTOL, V166, P61, DOI 10.1111/j.1469-8137.2004.01309.x; Schweingruber F.H, 2007, WOOD STRUCTURE ENV; [沈泽昊 Shen Zehao], 2004, [生物多样性, Chinese Biodiversity], V12, P89; Song Y.C., 2001, VEGETATION ECOLOGY; SPRUGEL DG, 1991, ANNU REV ECOL SYST, V22, P309, DOI 10.1146/annurev.es.22.110191.001521; Statsoft I, 2001, STATISTICA 6 0; Sterck F, 2011, TREE PHYSIOL, V31, P1024, DOI 10.1093/treephys/tpr065; STEVENS GC, 1991, ANNU REV ECOL SYST, V22, P177, DOI 10.1146/annurev.es.22.110191.001141; Sveinbjornsson B, 2000, AMBIO, V29, P388, DOI 10.1639/0044-7447(2000)029[0388:NAAETE]2.0.CO;2; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Swenson NG, 2010, ECOLOGY, V91, P2234, DOI 10.1890/09-1743.1; Turnbull C., 2005, PLANT ARCHITECTURE I; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452	63	0	1	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62163	10.1371/journal.pone.0062163	http://dx.doi.org/10.1371/journal.pone.0062163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658621	Green Published, gold, Green Submitted			2022-12-27	WOS:000318343700036
J	Nozoye, T; Nakanishi, H; Nishizawa, NK				Nozoye, Tomoko; Nakanishi, Hiromi; Nishizawa, Naoko K.			Characterizing the Crucial Components of Iron Homeostasis in the Maize Mutants ys1 and ys3	PLOS ONE			English	Article							NICOTIANAMINE SYNTHASE GENES; REGULATED METAL TRANSPORTER; LONG-DISTANCE TRANSPORT; FE-DEFICIENT CONDITIONS; GRAMINEOUS PLANTS; PHYTOSIDEROPHORE TRANSPORTER; APOPLASMIC IRON; YELLOW STRIPE1; RICE PLANTS; CLONING	To acquire iron (Fe), graminaceous plants secrete mugineic acid family phytosiderophores through the phytosiderophore efflux transporter TOM1 and take up Fe in the form of Fe(III)-phytosiderophore complexes. Yellow stripe 1 (ys1) and ys3 are recessive mutants of maize (Zea mays L.) that show typical symptoms of Fe deficiency, i.e., interveinal chlorosis of the leaves. The ys1 mutant is defective in the Fe(III)-phytosiderophore transporter YS1 and is therefore unable to take up Fe(III)-phytosiderophore complexes. While the ys3 mutant has been shown to be defective in phytosiderophores release, the causative gene has not been identified. The present study was performed to characterize the expression profiles of the genes in ys1 and ys3 mutants to extend our understanding of Fe homeostasis in maize. Using quantitative real-time polymerase chain reaction, we assessed changes in the levels of gene expression in response to Fe deficiency of genes involved in Fe homeostasis, such as those related to phytosiderophore biosynthesis and Fe transport. As with other crops, these Fe deficiency-inducible genes were also upregulated in maize. In addition, these Fe deficiency-inducible genes were upregulated in both the ys1 and ys3 mutants, even under Fe-sufficient conditions. Indeed, the Fe concentrations in the roots of ys1 and ys3 plants were lower than that of wild-type controls. These results suggest that ys1 and ys3 are Fe-deficient during growth in the presence of Fe. In agreement with previous reports, the level of YS1 expression decreased in the ys1 mutant. Moreover, the expression level of a homolog of TOM1 in maize decreased significantly in the ys3 mutant. Unspliced introns of ZmTOM1 were detected only in ys3, and not in YS1YS3 or ys1, suggesting that ZmTOM1 may be involved in the ys3 phenotype.	[Nozoye, Tomoko; Nakanishi, Hiromi; Nishizawa, Naoko K.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Tokyo, Japan; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan	University of Tokyo; Ishikawa Prefecture University	Nishizawa, NK (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Tokyo, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Nakanishi, Hiromi/C-6461-2015	Nakanishi, Hiromi/0000-0001-5556-5058	Ministry of Education, Culture, Sportes, Science and Technology, Japan [17078008]; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [GMB0001]; Grants-in-Aid for Scientific Research [23248011] Funding Source: KAKEN	Ministry of Education, Culture, Sportes, Science and Technology, Japan; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sportes, Science and Technology, Japan (no. 17078008 to NKN), the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), and a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, GMB0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2009, PLANT MOL BIOL, V70, P681, DOI 10.1007/s11103-009-9500-3; Bashir K, 2006, PLANT SIGNAL BEHAV, V1, P290, DOI 10.4161/psb.1.6.3590; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Bashir K, 2011, SOIL SCI PLANT NUTR, V57, P803, DOI 10.1080/00380768.2011.637305; Bashir K, 2010, RICE, V3, P122, DOI 10.1007/s12284-010-9042-y; BELL WILLIAM D., 1962, BOT GAZ, V124, P1, DOI 10.1086/336166; BELL WILLIAM D., 1958, BOT GAZ, V120, P36, DOI 10.1086/335995; BROWN JC, 1969, SOIL SCI SOC AM PRO, V33, P99, DOI 10.2136/sssaj1969.03615995003300010027x; Bughio N, 2002, J EXP BOT, V53, P1677, DOI 10.1093/jxb/erf004; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; DiDonato RJ, 2004, PLANT J, V39, P403, DOI 10.1111/j.1365-313X.2004.02128.x; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Gendre D, 2007, PLANT J, V49, P1, DOI 10.1111/j.1365-313X.2006.02937.x; Herbik A, 1999, EUR J BIOCHEM, V265, P231, DOI 10.1046/j.1432-1327.1999.00717.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Higuchi K, 2001, PLANT J, V25, P159, DOI 10.1046/j.1365-313x.2001.00951.x; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Inoue H, 2008, PLANT MOL BIOL, V66, P193, DOI 10.1007/s11103-007-9262-8; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2012, SCI REP, V2; Ishimaru Y, 2012, PLANT SIGNALING BEHA, V7; Ishimaru Y, 2011, PLANT SIGNAL BEHAV, V6, P1624, DOI 10.4161/psb.6.10.17694; Ishimaru Y, 2011, J BIOL CHEM, V286, P24649, DOI 10.1074/jbc.M111.221168; Ishimaru Y, 2010, PLANT J, V62, P379, DOI 10.1111/j.1365-313X.2010.04158.x; Kakei Y, 2012, PLANT MOL B IN PRESS; Kobayashi T, 2005, J EXP BOT, V56, P1305, DOI 10.1093/jxb/eri131; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Lanfranchi S, 2002, MAYDICA, V47, P181; Le Jean M, 2005, PLANT J, V44, P769, DOI 10.1111/j.1365-313X.2005.02569.x; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; Ma JF, 1999, J EXP BOT, V50, P723, DOI 10.1093/jexbot/50.334.723; MA JF, 1993, PLANT PHYSIOL, V102, P373, DOI 10.1104/pp.102.2.373; MARSCHNER H, 1986, J PLANT NUTR, V9, P695, DOI 10.1080/01904168609363475; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Mihashi S., 1989, Biology of Metals, V2, P146, DOI 10.1007/BF01142553; Mizuno D, 2003, PLANT PHYSIOL, V132, P1989, DOI 10.1104/pp.102.019869; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; Nozoye T, 2011, J BIOL CHEM, V286, P5446, DOI 10.1074/jbc.M110.180026; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; Ogo Y, 2011, PLANT MOL BIOL, V75, P593, DOI 10.1007/s11103-011-9752-6; Roberts LA, 2004, PLANT PHYSIOL, V135, P112, DOI 10.1104/pp.103.037572; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Schaaf G, 2004, SOIL SCI PLANT NUTR, V50, P989, DOI 10.1080/00380768.2004.10408565; Schaaf G, 2005, PLANT CELL PHYSIOL, V46, P762, DOI 10.1093/pcp/pci081; Schaaf G, 2004, J BIOL CHEM, V279, P9091, DOI 10.1074/jbc.M311799200; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Takahashi R, 2011, J EXP BOT, V62, P4843, DOI 10.1093/jxb/err136; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; VONWIREN N, 1994, PLANT PHYSIOL, V106, P71, DOI 10.1104/pp.106.1.71; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586; Zheng LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-166	59	36	38	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62567	10.1371/journal.pone.0062567	http://dx.doi.org/10.1371/journal.pone.0062567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667491	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600028
J	Li, LX; Chen, L; Meng, XZ; Chen, BH; Chen, SQ; Zhao, Y; Zhao, LF; Liang, Y; Zhang, YH				Li, Lu-Xi; Chen, Li; Meng, Xiang-Zhou; Chen, Bing-Heng; Chen, Shang-Qin; Zhao, Yan; Zhao, Li-Fang; Liang, Yuan; Zhang, Yun-Hui			Exposure Levels of Environmental Endocrine Disruptors in Mother-Newborn Pairs in China and Their Placental Transfer Characteristics	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; UMBILICAL-CORD BLOOD; BROMINATED FLAME RETARDANTS; BREAST-MILK; PHTHALATE METABOLITES; MATERNAL SERUM; ADIPOSE-TISSUE; CHEMICALS; PBDE; POPULATION	There is a growing concern about the potential health effects of exposure to various environmental chemicals during pregnancy and infancy. The placenta is expected to be an effective barrier protecting the developing embryo against some endocrine disruptors (EDs) circulating in maternal blood. The current study was designed to assess in utero exposure levels of non-persistent organic pollutants (non-POPs) and persistent organic pollutants (POPs) in Chinese newborns and potential role of placenta barrier against fetal exposure to these commonly-used environmental endocrine disruptors. A total of 230 newborn-mother pairs were enrolled during 2010-2011, 201 pairs of which were recruited from Shanghai, and the other 29 pairs came from Wenzhou. Maternal blood, cord blood, and meconium specimens were collected in the subject population from Shanghai and analyzed for non-POPs, including mono-2-ethylhexyl phthalate (MEHP), octylphenol (OP) and 4-nonylphenol (4-NP). A total of 19 polybrominated diphenyl ethers (PBDEs) congeners, which belong to POPs, were detected in maternal and cord blood specimens from the other 29 pairs. Fetal-maternal ratios (F-M ratios) and regression coefficients were presented to assess potential function of placenta on barricading the mother/fetal transfer of these EDs. Concentrations of the detected non-POPs in cord blood samples were approximately 20% lower than those in maternal blood, and regression coefficients of which were all over 0.80. In contrast, PBDEs levels in cord blood samples were significantly higher than those in maternal blood. MEHP levels in meconium were much higher than those in cord blood samples, and highly correlated. Therefore, observations demonstrated that the placental barrier slightly decreased the fetal exposure to most non-POPs, while PBDEs seemed to be totally transferred across the placenta and finally reached the fetus. For in utero exposure assessment of Di-2-ethylhexyl phthalate (DEHP), MEHP level in meconium may be a useful biomarker.	[Li, Lu-Xi; Chen, Li; Chen, Bing-Heng; Zhao, Yan; Zhang, Yun-Hui] Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Meng, Xiang-Zhou; Zhao, Li-Fang] Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China; [Chen, Shang-Qin; Liang, Yuan] Wenzhou Med Coll, Affiliated Hosp 2, Wenzhou, Peoples R China	Fudan University; Tongji University; Wenzhou Medical University	Zhang, YH (corresponding author), Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China.	yhzhang@shmu.edu.cn			Natural Science Foundation of China [81072263]; Shanghai Natural Science Foundation [10ZR1402000]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This research was financially supported by the Natural Science Foundation of China (Grant 81072263, to Y.Z.) and Shanghai Natural Science Foundation (Grant 10ZR1402000, to Y.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignac JP, 2009, ENVIRON POLLUT, V157, P164, DOI 10.1016/j.envpol.2008.07.008; Calafat AM, 2006, CHEMOSPHERE, V63, P490, DOI 10.1016/j.chemosphere.2005.08.028; Chao HR, 2007, ENVIRON INT, V33, P239, DOI 10.1016/j.envint.2006.09.013; Chen ML, 2008, CHEMOSPHERE, V73, pS239, DOI 10.1016/j.chemosphere.2007.04.091; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; Duan YP, 2010, ENVIRON SCI POLLUT R, V17, P948, DOI 10.1007/s11356-010-0295-1; Fay M, 1999, TOXICOL IND HEALTH, V15, P651, DOI 10.1177/074823379901500801; Feeley M, 2000, FOOD ADDIT CONTAM, V17, P325, DOI 10.1080/026520300283397; Foster WG, 2011, CHEMOSPHERE, V84, P1301, DOI 10.1016/j.chemosphere.2011.05.028; Frederiksen M, 2010, INT J HYG ENVIR HEAL, V213, P233, DOI 10.1016/j.ijheh.2010.04.008; Gomara B, 2007, ENVIRON SCI TECHNOL, V41, P6961, DOI 10.1021/es0714484; Guvenius DM, ENV HLTH PERSPECT, V111, P1235; Hale RC, 2002, CHEMOSPHERE, V46, P729, DOI 10.1016/S0045-6535(01)00237-5; Herbstman JB, 2010, ENVIRON HEALTH PERSP, V118, P712, DOI 10.1289/ehp.0901340; Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788; Kang CS, 2010, CHEMOSPHERE, V80, P116, DOI 10.1016/j.chemosphere.2010.04.009; Kasper-Sonnenberg M, 2012, INT J HYG ENVIR HEAL, V215, P373, DOI 10.1016/j.ijheh.2011.09.004; Kato K, 2006, ANAL CHEM, V78, P6651, DOI 10.1021/ac0608220; Kawaguchi M, 2004, J CHROMATOGR B, V799, P119, DOI 10.1016/j.jchromb.2003.10.021; Kawashiro Y, 2008, ENDOCR J, V55, P1071, DOI 10.1507/endocrj.K08E-155; Kim TH, 2009, J TOXICOL ENV HEAL A, V72, P1318, DOI 10.1080/15287390903212436; Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300; La Guardia MJ, 2006, ENVIRON SCI TECHNOL, V40, P6247, DOI 10.1021/es060630m; Lee SK, 2005, J TOXICOL ENV HEAL A, V68, P763, DOI 10.1080/15287390590930243; Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073; Mai BX, 2005, ENVIRON SCI TECHNOL, V39, P3521; Mazdai A, 2003, ENVIRON HEALTH PERSP, V111, P1249, DOI 10.1289/ehp.6146; Meijer L, 2008, ENVIRON SCI TECHNOL, V42, P3428, DOI 10.1021/es702446p; Miller KP, 2004, TOXICOL APPL PHARM, V198, P111, DOI 10.1016/j.taap.2003.07.016; Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4; Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3; Tan BLL, 2003, TALANTA, V61, P385, DOI 10.1016/S0039-9140(03)00281-9; Unuvar T, 2012, J CLIN RES PEDIATR E, V4, P51, DOI [10.4274/Jcrpe.569, 10.4274/jcrpe.569]; Vizcaino E, 2011, ENVIRON INT, V37, P152, DOI 10.1016/j.envint.2010.08.011; WILLIAMS CM, 1986, HUM NUTR-CLIN NUTR, V40C, P15; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037; Wu KS, 2010, ENVIRON SCI TECHNOL, V44, P813, DOI 10.1021/es9024518; Zeng F, 2009, J HAZARD MATER, V164, P1171, DOI 10.1016/j.jhazmat.2008.09.029; Zhu LY, 2009, ENVIRON SCI TECHNOL, V43, P6963, DOI 10.1021/es901296t	39	77	84	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62526	10.1371/journal.pone.0062526	http://dx.doi.org/10.1371/journal.pone.0062526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667484	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700042
J	Biron-Pain, K; Grosset, AA; Poirier, F; Gaboury, L; St-Pierre, Y				Biron-Pain, Katherine; Grosset, Andree-Anne; Poirier, Francoise; Gaboury, Louis; St-Pierre, Yves			Expression and Functions of Galectin-7 in Human and Murine Melanomas	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MMP-9 GENE-EXPRESSION; MALIGNANT-MELANOMA; INDUCED APOPTOSIS; PROGRESSION; CANCER; SURVIVAL; MODEL; MECHANISMS; LYMPHOMA	The identification of galectin-7 as a p53-induced gene and its ability to induce apoptosis in many cell types support the hypothesis that galectin-7 has strong antitumor activity. This has been well documented in colon cancer. However, in some cases, such as breast cancer and lymphoma, its high expression level correlates with aggressive subtypes of cancer, suggesting that galectin-7 may have a dual role in cancer progression. In fact, in breast cancer, overexpression of galectin-7 alone is sufficient to promote metastasis to the bone and lung. In the present work, we investigated the expression and function of galectin-7 in melanoma. An analysis of datasets obtained from whole-genome profiling of human melanoma tissues revealed that galectin-7 mRNA was detected in more than 90% of biopsies of patients with nevi while its expression was more rarely found in biopsies collected from patients with malignant melanoma. This frequency, however, was likely due to the presence of normal epidermis tissues in biopsies, as shown our studies at the protein level by immunohistochemical analysis. Using the experimental melanoma B16F1 cell line, we found that melanoma cells can express galectin-7 at the primary tumor site and in lung metastasis. Moreover, we found that overexpression of galectin-7 increased the resistance of melanoma cells to apoptosis while inducing de novo egr-1 expression. Overexpression of galectin-7, however, was insufficient to modulate the growth of tumors induced by the subcutaneous injection of B16F1 cells. It also failed to modulate the dissemination of B16F1 cells to the lung.	[Biron-Pain, Katherine; Grosset, Andree-Anne; St-Pierre, Yves] INRS Inst Armand Frappier, Laval, PQ, Canada; [Poirier, Francoise] Univ Paris Diderot, CNRS, Inst Jacques Monod, Sorbonne Paris Cite,UMR 7592, Paris, France; [Gaboury, Louis] Inst Rech Immunol & Cancerol, Montreal, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal	St-Pierre, Y (corresponding author), INRS Inst Armand Frappier, Laval, PQ, Canada.	yves.st-pierre@iaf.inrs.ca		St-Pierre, Yves/0000-0002-1948-2041	Canadian Institute for Health Research [14 MOP-89697]; Fond de la Recherche en Sante du Quebec (FRSQ); Ligue Contre le Cancer, Comite de Paris	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Fond de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Ligue Contre le Cancer, Comite de Paris(Ligue nationale contre le cancer)	This work was funded by grants to YSP from the Canadian Institute for Health Research (Grant No. 14 MOP-89697). KBP and AAG were supported by studentships from the Fond de la Recherche en Sante du Quebec (FRSQ). FP was supported by a grant from Ligue Contre le Cancer, Comite de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MM, 2004, CURR CANCER DRUG TAR, V4, P43, DOI 10.2174/1568009043481704; Alves PM, 2011, PATHOL RES PRACT, V207, P236, DOI 10.1016/j.prp.2011.02.004; Aoudjit F, 1998, BLOOD, V91, P623, DOI 10.1182/blood.V91.2.623.623_623_629; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Biron-Pain K, 2012, CELL MOL LIFE SCI, V69, P783, DOI 10.1007/s00018-011-0777-4; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Demers M, 2005, CANCER RES, V65, P5205, DOI 10.1158/0008-5472.CAN-05-0134; Demers M, 2007, CANCER RES, V67, P2824, DOI 10.1158/0008-5472.CAN-06-3891; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; FIDLER IJ, 1975, CANCER RES, V35, P218; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; George J, 2011, PROTEOMICS, V11, P4411, DOI 10.1002/pmic.201100233; Hersey P, 2006, CURR OPIN ONCOL, V18, P189, DOI 10.1097/01.cco.0000208794.24228.9f; Ivanov VN, 2003, ONCOGENE, V22, P3152, DOI 10.1038/sj.onc.1206456; Ke HN, 2010, CELL RES, V20, P458, DOI 10.1038/cr.2010.21; Lim JH, 2007, APOPTOSIS, V12, P411, DOI 10.1007/s10495-006-0576-9; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lu JX, 1997, MOL CARCINOGEN, V20, P204, DOI 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M; MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; MAGNALDO T, 1995, DEV BIOL, V168, P259, DOI 10.1006/dbio.1995.1078; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Okamoto I, 2005, NEOPLASIA, V7, P303, DOI 10.1593/neo.04514; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Robbins PF, 2002, J IMMUNOL, V169, P6036, DOI 10.4049/jimmunol.169.10.6036; Rorive S, 2002, MODERN PATHOL, V15, P1294, DOI 10.1097/01.MP.0000037306.19083.28; Sapoznik S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/818214; Saussez S, 2006, ANN SURG ONCOL, V13, P999, DOI 10.1245/ASO.2006.08.033; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; St-Pierre Y, 2012, FRONT BIOSCI-LANDMRK, V17, P438, DOI 10.2741/3937; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Ueda S, 2004, CANCER RES, V64, P5672, DOI 10.1158/0008-5472.CAN-04-0985; Villeneuve C, 2011, MOL BIOL CELL, V22, P999, DOI 10.1091/mbc.E10-06-0534; Wang JL, 2004, BBA-GEN SUBJECTS, V1673, P75, DOI 10.1016/j.bbagen.2004.03.013; Zhu H, 2009, J PROTEOME RES, V8, P3969, DOI 10.1021/pr900287a; Zhu X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-290	40	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63307	10.1371/journal.pone.0063307	http://dx.doi.org/10.1371/journal.pone.0063307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658821	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000321202100061
J	Bruneau, A; Feuilloy, M; Dussaussoy, C; Gagnadoux, F; Leftheriotis, G; Abraham, P				Bruneau, Antoine; Feuilloy, Mathieu; Dussaussoy, Corinne; Gagnadoux, Frederic; Leftheriotis, Georges; Abraham, Pierre			The Walking-Induced Transient Hack Concept Is Valid & Relies on a Transient Early-Exercise Hypoxemia	PLOS ONE			English	Article							INDUCED ARTERIAL HYPOXEMIA; TRANSCUTANEOUS OXYGEN; GAS-EXCHANGE; TREADMILL; DISEASES; HYPOXIA	Background: Decreased arterial oxygen pressure obtained at peak exercise is strong evidence of walking-induced hypoxemia, assuming that the lower pressure occurs just before exercise is stopped. Using empirical predefined models and transcutaneous oximetry, we have shown that some patients reporting exercise intolerance show a minimal value at the onset of walking and a post-exercise overshoot. These changes are referred to as transcutaneous "walking-induced transient hacks''. Methods: In 245 patients, walking-induced transcutaneous oxygen pressure changes in the chest were analyzed using observer-independent clustering techniques. Clustering classes were compared to the profile types previously proposed with the cross-correlation technique. The classifications of patients according to both approaches were compared using kappa statistics. In 10 patients showing a hack on transcutaneous oximetry, we analyzed the results of direct iterative arterial sampling recorded during a new walking treadmill test. Results: Clustering analysis resulted in 4 classes that closely fit the 4 most frequently proposed empirical models (cross-correlation coefficients: 0.93 to 0.97). The kappa between the two classifications was 0.865. In 10 patients showing transcutaneous hacks, the minimal direct arterial oxygen pressure value occurred at exercise onset, and these patients exhibited a recovery overshoot reaching a maximum at two minutes of recovery, confirming the walking-induced transient hypoxemia. Conclusions: In patients reporting exercise intolerance, transcutaneous oximetry could help to detect walking-induced transient hypoxemia, while peak-exercise arterial oximetry might be normal.	[Bruneau, Antoine; Dussaussoy, Corinne; Leftheriotis, Georges; Abraham, Pierre] Univ Nantes Angers Mans, Univ Angers, Ctr Hosp, Lab Vasc Investigat, Angers, France; [Feuilloy, Mathieu] Univ Maine, Grad Sch Engn, CNRS U6613, Acoust Lab,Unite Mixte Rech, Angers, France; [Gagnadoux, Frederic] Ctr Hosp Univ Angers, Dept Resp Dis, Angers, France; [Gagnadoux, Frederic] Univ Nantes Angers Mans, Inst Natl Sante & Rech Med U1063, Angers, France; [Abraham, Pierre] Univ Nantes Angers Mans, CNRS U6214, Unite Mixte Rech, Angers, France; [Abraham, Pierre] Inst Natl Sante & Rech Med, U1083, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Le Mans Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm)	Abraham, P (corresponding author), Univ Nantes Angers Mans, Univ Angers, Ctr Hosp, Lab Vasc Investigat, Angers, France.	piabraham@chu-angers.fr			University Hospital in Angers; Direction departementale de la cohesion sociale; Comite departemental olympique et sportif	University Hospital in Angers; Direction departementale de la cohesion sociale; Comite departemental olympique et sportif	The project was funded and promoted by the University Hospital in Angers, and AB benefits the support of the "Direction departementale de la cohesion sociale'' and "Comite departemental olympique et sportif''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2003, CIRCULATION, V107, P1896, DOI 10.1161/01.CIR.0000060500.60646.E0; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Banerjee M, 2008, CANADIAN J STAT, V27, P3; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Carter R, 2000, RESP MED, V94, P350, DOI 10.1053/rmed.1999.0714; Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001; Daw CS, 2003, REV SCI INSTRUM, V74, P915, DOI 10.1063/1.1531823; DeLorey DS, 2007, APPL PHYSIOL NUTR ME, V32, P1251, DOI 10.1139/H07-121; Everitt B. S., 2001, CLUSTER ANAL; Grouiller F, 2006, INT ANGIOL, V25, P190; Hansen P, 1997, MATH PROGRAM, V79, P191, DOI 10.1007/BF02614317; Heidrich H, 2004, VASA-J VASCULAR DIS, V33, P155, DOI 10.1024/0301-1526.33.3.155; Hopkins SR, 2009, J APPL PHYSIOL, V107, P993, DOI 10.1152/japplphysiol.91489.2008; HUGHES JA, 1984, THORAX, V39, P424, DOI 10.1136/thx.39.6.424; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jain AK., 1988, TECHNOMETRICS; Jaquinandi V, 2007, J VASC SURG, V45, P312, DOI 10.1016/j.jvs.2006.09.050; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Lim CS, 2011, J VASC RES, V48, P185, DOI 10.1159/000320624; Lim CS, 2012, J VASC SURG, V55, P1427, DOI 10.1016/j.jvs.2011.10.111; Lovering AT, 2008, J APPL PHYSIOL, V104, P1418, DOI 10.1152/japplphysiol.00208.2007; Ouedraogo N, 2011, PHYSIOL MEAS, V32, P181, DOI 10.1088/0967-3334/32/2/003; Pancholy S, 2008, CATHETER CARDIO INTE, V72, P335, DOI 10.1002/ccd.21639; Picquet J, 2005, Eur J Intern Med, V16, P575, DOI 10.1016/j.ejim.2005.06.013; Planes C, 2001, ARCH PHYS MED REHAB, V82, P1686, DOI 10.1053/apmr.2001.26248; Popping R, 1988, SOCIOMETRIC RES, P90, DOI DOI 10.1007/978-1-349-19051-5_6; Romer LM, 2006, ADV EXP MED BIOL, V588, P47; Romer LM, 2006, AM J PHYSIOL-REG I, V290, pR365, DOI 10.1152/ajpregu.00332.2005; SABIN S, 1976, CHEST, V69, P437, DOI 10.1378/chest.69.3.437; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Tanabe Y, 2000, J AM COLL CARDIOL, V35, P1228, DOI 10.1016/S0735-1097(00)00517-9; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; vonKemp K, 1997, INT ANGIOL, V16, P114; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141	35	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62651	10.1371/journal.pone.0062651	http://dx.doi.org/10.1371/journal.pone.0062651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658759	Green Submitted, Green Published, gold			2022-12-27	WOS:000321202100027
J	Corey, KE; Misdraji, J; Zheng, H; Malecki, KM; Kneeman, J; Gelrud, L; Chung, RT				Corey, Kathleen E.; Misdraji, Joseph; Zheng, Hui; Malecki, Kyle M.; Kneeman, Jacob; Gelrud, Louis; Chung, Raymond T.			The Absence of Obstructive Sleep Apnea May Protect against Non-Alcoholic Fatty Liver in Patients Undergoing Bariatric Surgery	PLOS ONE			English	Article							CHRONIC INTERMITTENT HYPOXIA; DISEASE; OBESE; STEATOHEPATITIS; RISK	Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide and its progressive form, steatohepatitis, will be the leading indication for liver transplant by 2020. While risk factors for steatohepatitis have been identified, little work has been performed to identify factors protective against NAFLD development. Aim: This study sought to identify factors predictive of normal liver histology in a bariatric cohort. Methods: Patients undergoing weight loss surgery with liver biopsies at the time of surgery were included. Patients with other causes of chronic liver disease were excluded. Results: One hundred fifty-nine patients were included. Forty-nine patients had normal liver histology and 110 patients had NAFLD. Several previously identified factors associated with normal liver histology were found. Black race was the strongest predictor of the absence of NAFLD with an odds ratio (OR) of 6.8, 95% confidence interval (CI) 2.4-18.9. Low HOMA-IR was also associated with normal histology (OR 1.4, 95% CI 1.03-1.9). In contrast, low HDL was associated with a decreased chance of normal histology (OR 0.38, 95% CI 0.05-0.83). Interestingly, a novel protective factor, the absence of obstructive sleep apnea (OSA) was strongly associated with normal histology (OR 5.6, 95% CI 2.0-16.1). In multivariate regression controlling for BMI, black race, absence of OSA, low HOMA-IR and low ALT independently predicted normal liver histology with an area under the ROC curve of 0.85. Conclusions: Our study confirmed several factors associated with normal liver histology, including black race and identified a novel factor, absence of OSA. Further evaluation of these factors will allow for improved understanding of the pathogenesis of NAFLD.	[Corey, Kathleen E.; Malecki, Kyle M.; Kneeman, Jacob; Chung, Raymond T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Misdraji, Joseph] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zheng, Hui] Massachusetts Gen Hosp, MGH Biostat Ctr, Boston, MA 02114 USA; [Corey, Kathleen E.; Zheng, Hui; Gelrud, Louis; Chung, Raymond T.] Harvard Univ, Sch Med, Boston, MA USA; [Gelrud, Louis] Bon Secours Richmond Hlth Syst, Dept Internal Med, Richmond, VA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Corey, KE (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.	kcorey@partners.org; rtchung@partners.org	Misdraji, Joseph/AGX-4779-2022; Misdraji, Joseph/AAD-4588-2019		American Association for the Study of Liver Disease Clinical and Translational Research Award; NIH [2T32DK0007191-37, DK078772]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191, P30DK043351, K24DK078772, K23DK099422] Funding Source: NIH RePORTER	American Association for the Study of Liver Disease Clinical and Translational Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	KEC receives support from the American Association for the Study of Liver Disease Clinical and Translational Research Award. JK receives support from the NIH 2T32DK0007191-37. RTC receives support from NIH DK078772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Charlton M, 2008, HEPATOLOGY, V47, P1431, DOI 10.1002/hep.22246; Corey KE, 2012, CLIN GASTROENTEROL H; Dunn W, 2008, AM J GASTROENTEROL, V103, P2263, DOI 10.1111/j.1572-0241.2008.02034.x; Gholam PM, 2007, AM J GASTROENTEROL, V102, P399, DOI 10.1111/j.1572-0241.2006.01041.x; Greenfield V, 2008, CURR OPIN GASTROEN, V24, P320, DOI 10.1097/MOG.0b013e3282fbccf2; Gupte P, 2004, J GASTROEN HEPATOL, V19, P854, DOI 10.1111/j.1440-1746.2004.03312.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Machado M, 2006, J HEPATOL, V45, P600, DOI 10.1016/j.jhep.2006.06.013; Norman D, 2008, SLEEP, V31, P121, DOI 10.1093/sleep/31.1.121; Piguet AC, 2010, CLIN SCI, V118, P401, DOI 10.1042/CS20090313; Savransky V, 2007, AM J PHYSIOL-GASTR L, V293, pG871, DOI 10.1152/ajpgi.00145.2007; Targher G, 2008, DIABETOLOGIA, V51, P1947, DOI 10.1007/s00125-008-1135-4	13	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62504	10.1371/journal.pone.0062504	http://dx.doi.org/10.1371/journal.pone.0062504			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658732	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100011
J	Ikeda, H; Delargy, AH; Yokogawa, T; Urban, JM; Burgess, HA; Ono, F				Ikeda, Hiromi; Delargy, Alison H.; Yokogawa, Tohei; Urban, Jason M.; Burgess, Harold A.; Ono, Fumihito			Intrinsic Properties of Larval Zebrafish Neurons in Ethanol	PLOS ONE			English	Article							DANIO-RERIO; LOCOMOTOR-ACTIVITY; MODEL SYSTEM; ALCOHOL; HINDBRAIN; BEHAVIOR; APOPTOSIS; EXPOSURE; MAUTHNER; EMBRYOS	The behavioral effects of ethanol have been studied in multiple animal models including zebrafish. Locomotion of zebrafish larvae is resistant to high concentrations of ethanol in bath solution. This resistance has been attributed to a lower systemic concentration of ethanol in zebrafish when compared with bath solution, although the mechanism to maintain such a steep gradient is unclear. Here we examined whether the intrinsic properties of neurons play roles in this resistance. In order to minimize the contribution of metabolism and diffusional barriers, larvae were hemisected and the anterior half immersed in a range of ethanol concentrations thereby ensuring the free access of bath ethanol to the brain. The response to vibrational stimuli of three types of reticulospinal neurons: Mauthner neurons, vestibulospinal neurons, and MiD3 neurons were examined using an intracellular calcium indicator. The intracellular [Ca2+] response in MiD3 neurons decreased in 100 mM ethanol, while Mauthner neurons and vestibulospinal neurons required >300 mM ethanol to elicit similar effects. The ethanol effect in Mauthner neurons was reversible following removal of ethanol. Interestingly, activities of MiD3 neurons displayed spontaneous recovery in 300 mM ethanol, suggestive of acute tolerance. Finally, we examined with mechanical vibration the startle response of free-swimming larvae in 300 mM ethanol. Ethanol treatment abolished long latency startle responses, suggesting a functional change in neural processing. These data support the hypothesis that individual neurons in larval zebrafish brains have distinct patterns of response to ethanol dictated by specific molecular targets.	[Ikeda, Hiromi; Delargy, Alison H.; Urban, Jason M.; Ono, Fumihito] NIAAA, Sect Model Synapt Syst, Lab Mol Physiol, NIH, Rockville, MD 20852 USA; [Yokogawa, Tohei; Burgess, Harold A.] NICHD, Unit Behav Neurogenet, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ono, F (corresponding author), NIAAA, Sect Model Synapt Syst, Lab Mol Physiol, NIH, Rockville, MD 20852 USA.	onof@mail.nih.gov	Burgess, Harold/B-8474-2015	Burgess, Harold/0000-0003-1966-7801; ono, fumihito/0000-0001-7532-5262	intramural program at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000437] Funding Source: NIH RePORTER	intramural program at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the intramural program at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradfield JY, 2006, NEUROTOXICOL TERATOL, V28, P629, DOI 10.1016/j.ntt.2006.06.004; Budick SA, 2000, J EXP BIOL, V203, P2565; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; CHARNESS ME, 1989, NEW ENGL J MED, V321, P442, DOI 10.1056/NEJM198908173210706; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; Dlugos CA, 2003, PHARMACOL BIOCHEM BE, V74, P471, DOI 10.1016/S0091-3057(02)01026-2; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; Mueller T, 2004, BRAIN RES, V1011, P156, DOI 10.1016/j.brainres.2004.02.073; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Pan Y, 2011, BEHAV BRAIN RES, V216, P66, DOI 10.1016/j.bbr.2010.07.017; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; Takahashi M, 2002, J NEUROSCI, V22, P3929, DOI 10.1523/JNEUROSCI.22-10-03929.2002; Tucker B, 2007, ZEBRAFISH, V4, P113, DOI 10.1089/zeb.2007.0508	26	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63318	10.1371/journal.pone.0063318	http://dx.doi.org/10.1371/journal.pone.0063318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658822	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100062
J	Schulz, BL; Jen, FEC; Power, PM; Jones, CE; Fox, KL; Ku, SC; Blanchfield, JT; Jennings, MP				Schulz, Benjamin L.; Jen, Freda E. C.; Power, Peter M.; Jones, Christopher E.; Fox, Kate L.; Ku, Shan C.; Blanchfield, Joanne T.; Jennings, Michael P.			Identification of Bacterial Protein O-Oligosaccharyltransferases and Their Glycoprotein Substrates	PLOS ONE			English	Article							PILIN GLYCOSYLATION; GENETIC-CHARACTERIZATION; LINKED GLYCOSYLATION; SITE; BIOSYNTHESIS; SEQUENCE; REVEALS; PATHWAY; OST6P; OST3P	O-glycosylation of proteins in Neisseria meningitidis is catalyzed by PglL, which belongs to a protein family including WaaL O-antigen ligases. We developed two hidden Markov models that identify 31 novel candidate PglL homologs in diverse bacterial species, and describe several conserved sequence and structural features. Most of these genes are adjacent to possible novel target proteins for glycosylation. We show that in the general glycosylation system of N. meningitidis, efficient glycosylation of additional protein substrates requires local structural similarity to the pilin acceptor site. For some Neisserial PglL substrates identified by sensitive analytical approaches, only a small fraction of the total protein pool is modified in the native organism, whereas others are completely glycosylated. Our results show that bacterial protein O-glycosylation is common, and that substrate selection in the general Neisserial system is dominated by recognition of structural homology.	[Jen, Freda E. C.; Ku, Shan C.; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Schulz, Benjamin L.; Fox, Kate L.; Blanchfield, Joanne T.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Power, Peter M.] Univ Oxford, Dept Paediat, Oxford, Oxon, England; [Jones, Christopher E.] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia	Griffith University; University of Queensland; University of Oxford; Western Sydney University	Jennings, MP (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	m.jennings@griffith.edu.au	Blanchfield, Joanne T/C-1725-2014; Schulz, Benjamin L/B-3911-2009; Jennings, Michael P/G-4822-2013; Jones, Christopher/C-5725-2014	Blanchfield, Joanne T/0000-0003-1338-7446; Schulz, Benjamin L/0000-0002-4823-7758; Jennings, Michael P/0000-0002-1027-4684; 	ARC Discovery Project Grant [DP110101058, 486]; National Health and Medical Research Council (NHMRC) [565526]; NHMRC CDF [APP1031542]	ARC Discovery Project Grant(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC CDF(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by ARC Discovery Project Grant DP110101058 to M.P.J and 486 B.L.S., National Health and Medical Research Council (NHMRC) Program Grant 565526 to M.P.J. and NHMRC CDF APP1031542 to B.L.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonsen JH, 2012, J PROTEOME IN PRESS; Bailey UM, 2012, J PROTEOME RES, V11, P5376, DOI 10.1021/pr300599f; Borud B, 2011, P NATL ACAD SCI USA, V108, P9643, DOI 10.1073/pnas.1103321108; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Charbonneau ME, 2012, MOL MICROBIOL, V83, P894, DOI 10.1111/j.1365-2958.2012.07973.x; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Faridmoayer A, 2008, J BIOL CHEM, V283, P34596, DOI 10.1074/jbc.M807113200; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Gebhart C, 2012, GLYCOBIOLOGY, V22, P962, DOI 10.1093/glycob/cws059; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Hartley MD, 2011, BIOCHEMISTRY-US, V50, P4936, DOI 10.1021/bi2003372; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kline KA, 2007, J BACTERIOL, V189, P3462, DOI 10.1128/JB.01911-06; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Ku SC, 2009, BIOCHEM BIOPH RES CO, V378, P84, DOI 10.1016/j.bbrc.2008.11.025; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lizak C, 2011, BIOCONJUGATE CHEM, V22, P488, DOI 10.1021/bc100511k; Marolda CL, 1999, MICROBIOL-UK, V145, P2485, DOI 10.1099/00221287-145-9-2485; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Perez JM, 2008, MOL MICROBIOL, V70, P1424, DOI 10.1111/j.1365-2958.2008.06490.x; Pinta E, 2012, MOL MICROBIOL, V83, P125, DOI 10.1111/j.1365-2958.2011.07918.x; Porstendorfer D, 2000, J BACTERIOL, V182, P3673, DOI 10.1128/JB.182.13.3673-3680.2000; Power PM, 2006, BIOCHEM BIOPH RES CO, V347, P904, DOI 10.1016/j.bbrc.2006.06.182; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; Power PM, 2003, FEMS MICROBIOL LETT, V218, P211, DOI 10.1111/j.1574-6968.2003.tb11520.x; Power PM, 2000, MICROBIOL-UK, V146, P967, DOI 10.1099/00221287-146-4-967; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; Zalucki YM, 2010, BBA-BIOMEMBRANES, V1798, P1244, DOI 10.1016/j.bbamem.2010.03.010	40	33	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62768	10.1371/journal.pone.0062768	http://dx.doi.org/10.1371/journal.pone.0062768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658772	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100038
J	Tomasicchio, M; Avenant, C; Du Toit, A; Ray, RM; Hapgood, JP				Tomasicchio, Michele; Avenant, Chanel; Du Toit, Andrea; Ray, Roslyn M.; Hapgood, Janet P.			The Progestin-Only Contraceptive Medroxyprogesterone Acetate, but Not Norethisterone Acetate, Enhances HIV-1 Vpr-Mediated Apoptosis in Human CD4(+) T Cells through the Glucocorticoid Receptor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HERPES-SIMPLEX-VIRUS; BLOOD MONONUCLEAR-CELLS; BREAST-CANCER PATIENTS; VITAMIN-A-DEFICIENCY; HORMONAL CONTRACEPTION; DEPOT MEDROXYPROGESTERONE; NUCLEAR-LOCALIZATION; DISEASE PROGRESSION; CYCLE ARREST	The glucocorticoid receptor (GR) regulates several physiological functions, including immune function and apoptosis. The HIV-1 virus accessory protein, viral protein R (Vpr), can modulate the transcriptional response of the GR. Glucocorticoids (GCs) and Vpr have been reported to induce apoptosis in various cells, including T-cells. We have previously shown that the injectable contraceptive, medroxyprogesterone acetate (MPA) is a partial to full agonist for the GR, unlike norethisterone acetate (NET-A). We investigated the functional cross talk between the GR and Vpr in inducing apoptosis in CD4(+) T-cells, in the absence and presence of GCs and these progestins, as well as progesterone. By using flow cytometry, we show that, in contrast to NET-A and progesterone, the synthetic GR ligand dexamethasone (Dex), cortisol and MPA induce apoptosis in primary CD4(+) T-cells. Furthermore, the C-terminal part of the Vpr peptide, or HIV-1 pseudovirus, together with Dex or MPA further increased the apoptotic phenotype, unlike NET-A and progesterone. By a combination of Western blotting, PCR and the use of receptor-selective agonists, we provide evidence that the GR and the estrogen receptor are the only steroid receptors expressed in peripheral blood mononuclear cells. These results, together with the findings that RU486, a GR antagonist, prevents Dex-, MPA- and Vpr-mediated apoptosis, provide evidence for the first time that GR agonists or partial agonists increase apoptosis in primary CD4(+) T-cells via the GR. We show that apoptotic induction involves differential expression of key apoptotic genes by both Vpr and GCs/MPA. This work suggests that contraceptive doses of MPA but not NET-A or physiological doses of progesterone could potentially accelerate depletion of CD4(+) T-cells in a GR-dependent fashion in HIV-1 positive women, thereby contributing to immunodeficiency. The results imply that choice of progestin used in contraception may be critical to susceptibility and progression of diseases such as HIV-1.	[Tomasicchio, Michele; Avenant, Chanel; Du Toit, Andrea; Ray, Roslyn M.; Hapgood, Janet P.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, Western Provinc, South Africa	University of Cape Town	Hapgood, JP (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, Western Provinc, South Africa.	Janet.Hapgood@uct.ac.za	Hapgood, Janet P/P-2549-2018; Ray, Roslyn/AAB-2898-2019	Hapgood, Janet P/0000-0002-4414-4861; Tomasicchio, Michele/0000-0003-2421-7215	LIFElab; South African Government's Department of Science and Technology; Claude Leon Foundation; Carnegie corporation; National Research Foundation; National Research Foundations (NRF); Poliomyelitis Research Foundation (PRF)	LIFElab; South African Government's Department of Science and Technology; Claude Leon Foundation; Carnegie corporation; National Research Foundation; National Research Foundations (NRF); Poliomyelitis Research Foundation (PRF)	This work was funded by LIFElab (www.lifelab.org.za) with funds from the South African Government's Department of Science and Technology, under the SHARP program (South African HIV/AIDS Research and Innovation Platform) by a grant to JPH. Thanks is given to the Claude Leon Foundation for postdoctoral funding to MT, as well as the Carnegie corporation for post-doctoral funding to CA and PhD funding to RMR. RMR was also funded by the National Research Foundation. ADT was supported by scholarships from the National Research Foundations (NRF) and the Poliomyelitis Research Foundation (PRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africander A, 2013, BIOCH BIOPH IN PRESS; Africander D, 2011, STEROIDS, V76, P636, DOI 10.1016/j.steroids.2011.03.001; Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Arunagiri C, 1997, APOPTOSIS, V2, P69, DOI 10.1023/A:1026487609215; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Bandera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010788; Borgne-Sanchez A, 2007, CELL DEATH DIFFER, V14, P422, DOI 10.1038/sj.cdd.4402018; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; Buckingham JC, 2006, BRIT J PHARMACOL, V147, pS258, DOI 10.1038/sj.bjp.0706456; Burleson MH, 1998, PSYCHOSOM MED, V60, P17, DOI 10.1097/00006842-199801000-00004; Busca A, 2012, J BIOL CHEM, V287, P15118, DOI 10.1074/jbc.M111.312660; Chen MZ, 1999, J VIROL, V73, P3236, DOI 10.1128/JVI.73.4.3236-3245.1999; Coeytaux E, 2003, J BIOL CHEM, V278, P18110, DOI 10.1074/jbc.M300248200; Conti L, 2000, J IMMUNOL, V165, P3293, DOI 10.4049/jimmunol.165.6.3293; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Draper BH, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005214.pub2; FOTHERBY K, 1978, CONTRACEPTION, V18, P1, DOI 10.1016/0010-7824(78)90096-3; Gagliardo R, 2000, AM J RESP CRIT CARE, V162, P7, DOI 10.1164/ajrccm.162.1.9911032; Garg H, 2012, VIRUSES-BASEL, V4, P3020, DOI 10.3390/v4113020; Genesca M, 2007, J MED PRIMATOL, V36, P266, DOI 10.1111/j.1600-0684.2007.00244.x; Ghanem KG, 2005, J INFECT DIS, V191, P358, DOI 10.1086/427190; GHOSH K, 1993, VIROLOGY, V194, P858, DOI 10.1006/viro.1993.1331; GOEBELSMANN U, 1979, CONTRACEPTION, V19, P283, DOI 10.1016/0010-7824(79)90022-2; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Gray RH, 2012, LANCET INFECT DIS, V12, P507, DOI 10.1016/S1473-3099(12)70111-1; Hadley KE, 2011, STEROIDS, V76, P1176, DOI 10.1016/j.steroids.2011.05.007; Hapgood J, 2013, REDOCRINOLO IN PRESS; Hapgood JP, 2010, ARCH VIROL, V155, P1009, DOI 10.1007/s00705-010-0678-0; Hapgood JP, 2004, TRENDS PHARMACOL SCI, V25, P554, DOI 10.1016/j.tips.2004.09.005; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Heffron R, 2011, SEX TRANSM INFECT, V87, P283, DOI 10.1136/sti.2010.045617; Hel Z, 2010, ENDOCR REV, V31, P79, DOI 10.1210/er.2009-0018; Henklein P, 2000, J BIOL CHEM, V275, P32016, DOI 10.1074/jbc.M004044200; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; HIROI M, 1975, STEROIDS, V26, P373, DOI 10.1016/0039-128X(75)90082-3; Hoshino S, 2007, AIDS RES HUM RETROV, V23, P391, DOI 10.1089/aid.2006.0124; HOWARD G, 1975, CONTRACEPTION, V12, P45, DOI 10.1016/S0010-7824(75)80035-7; Huijbregts RPH, 2013, ENDOCRINOLOGY, V154, P1282, DOI 10.1210/en.2012-1850; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Jochmann R, 2009, J VIROL, V83, P3704, DOI 10.1128/JVI.01384-08; Kino T, 1999, J EXP MED, V189, P51, DOI 10.1084/jem.189.1.51; KIRTON KT, 1974, CONTRACEPTION, V10, P39, DOI 10.1016/0010-7824(74)90130-9; Kleinschmidt I, 2007, CONTRACEPTION, V75, P461, DOI 10.1016/j.contraception.2007.02.002; Kleynhans L, 2013, INFECT IMMU IN PRESS; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; KONTULA K, 1983, BIOCHEM PHARMACOL, V32, P1511, DOI 10.1016/0006-2952(83)90474-4; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Koubovec D, 2004, MOL CELL ENDOCRINOL, V221, P75, DOI 10.1016/j.mce.2004.03.006; Kumwenda NI, 2008, INT J STD AIDS, V19, P339, DOI 10.1258/ijsa.2007.007165; Lavreys L, 2004, J INFECT DIS, V189, P303, DOI 10.1086/380974; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; LU YL, 1993, J VIROL, V67, P6542, DOI 10.1128/JVI.67.11.6542-6550.1993; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; MAHALINGAM S, 1995, VIROLOGY, V212, P331, DOI 10.1006/viro.1995.1490; MAJUMDER MSI, 1987, NUTR REP INT, V36, P1285; MALLMANN P, 1990, METHOD FIND EXP CLIN, V12, P699; Mann CL, 2000, ENDOCRINOLOGY, V141, P528, DOI 10.1210/en.141.2.528; Miguel RDV, 2012, J IMMUNOL, V189, P3449, DOI 10.4049/jimmunol.1103054; Mishell DR, 1996, J REPROD MED, V41, P381; Mishra S, 2007, J BIOL CHEM, V282, P4288, DOI 10.1074/jbc.M608307200; Miura R, 2006, J PHARMACOL SCI, V102, P288, DOI 10.1254/jphs.FP0060801; Morrison CS, 2012, AIDS, V26, P497, DOI 10.1097/QAD.0b013e32834fa13d; Morrison CS, 2012, LANCET INFECT DIS, V12, P2, DOI 10.1016/S1473-3099(11)70254-7; Morrison CS, 2011, JAIDS-J ACQ IMM DEF, V57, P157, DOI 10.1097/QAI.0b013e318214ba4a; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Morrison CS, 2004, SEX TRANSM DIS, V31, P561, DOI 10.1097/01.olq.0000137904.56037.70; Mostad SB, 1997, LANCET, V350, P922, DOI 10.1016/S0140-6736(97)04240-2; Mostad SB, 2000, J INFECT DIS, V181, P58, DOI 10.1086/315188; Muthumani K, 2005, CELL DEATH DIFFER, V12, P962, DOI 10.1038/sj.cdd.4401583; Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200; Myer L, 2007, INT J EPIDEMIOL, V36, P166, DOI 10.1093/ije/dyl251; Naglieri E, 2002, ANTICANCER RES, V22, P3045; Patel CA, 2000, J VIROL, V74, P9717, DOI 10.1128/JVI.74.20.9717-9726.2000; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piller SC, 1998, P NATL ACAD SCI USA, V95, P4595, DOI 10.1073/pnas.95.8.4595; Pronsato L, 2012, J ENDOCRINOL, V212, P371, DOI 10.1530/JOE-11-0234; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Roumier T, 2002, CELL DEATH DIFFER, V9, P1212, DOI 10.1038/sj.cdd.4401089; Sambrook J., 2001, MOL CLONING LAB MANU; SCAMBIA G, 1988, CANCER-AM CANCER SOC, V61, P2214, DOI 10.1002/1097-0142(19880601)61:11<2214::AID-CNCR2820611115>3.0.CO;2-V; Sherman MP, 2002, VIROLOGY, V302, P95, DOI 10.1006/viro.2002.1576; Sherman MP, 2000, J VIROL, V74, P8159, DOI 10.1128/JVI.74.17.8159-8165.2000; SHRIMANKER K, 1978, J STEROID BIOCHEM, V9, P359, DOI 10.1016/0022-4731(78)90631-3; Sibeko S, 2011, OBSTET GYNECOL, V118, P895, DOI 10.1097/AOG.0b013e31822be512; Snyder A, 2010, AIDS, V24, P1107, DOI 10.1097/QAD.0b013e328337b0ab; Somasundaran M, 2002, P NATL ACAD SCI USA, V99, P9503, DOI 10.1073/pnas.142313699; Stanczyk Frank Z, 2002, Rev Endocr Metab Disord, V3, P211, DOI 10.1023/A:1020072325818; Stanczyk FZ, 2012, ENDOCR REV IN PRESS; Stewart SA, 2000, J VIROL, V74, P3105, DOI 10.1128/JVI.74.7.3105-3111.2000; Stringer EM, 2009, AIDS, V23, pS69, DOI 10.1097/01.aids.0000363779.65827.e0; Stringer EM, 2009, AIDS, V23, P1377, DOI 10.1097/QAD.0b013e32832cbca8; Stringer EM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.031; Tang FM, 2009, J BIOL CHEM, V284, P32353, DOI 10.1074/jbc.M109.042994; Thorsby E, 1970, HISTOCOMPATIBILITY T, P665; Trunova N, 2006, VIROLOGY, V352, P169, DOI 10.1016/j.virol.2006.04.004; Tungaturthi PK, 2003, BIOMED PHARMACOTHER, V57, P20, DOI 10.1016/S0753-3322(02)00328-1; Vasconsuelo A, 2010, CELL STRESS CHAPERON, V15, P183, DOI 10.1007/s12192-009-0132-y; Wand H, 2012, AIDS, V26, P375, DOI 10.1097/QAD.0b013e32834f990f; Wang CC, 2004, AIDS, V18, P205, DOI 10.1097/00002030-200401230-00009; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Watts DH, 2008, CONTRACEPTION, V77, P84, DOI 10.1016/j.contraception.2007.10.002; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Yamashita J, 1996, CANCER, V78, P2346, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2346::AID-CNCR12>3.3.CO;2-1; Yang JH, 2000, FERTIL STERIL, V74, P261, DOI 10.1016/S0015-0282(00)00622-1; Yovel G, 2001, GYNECOL ONCOL, V81, P254, DOI 10.1006/gyno.2001.6153; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	114	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62895	10.1371/journal.pone.0062895	http://dx.doi.org/10.1371/journal.pone.0062895			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658782	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100045
J	Verdier, J; Deroche, L; Allez, M; Loy, C; Biet, F; Bodier, CC; Bay, S; Ganneau, C; Matysiak-Budnik, T; Reyrat, JM; Heyman, M; Cerf-Bensussan, N; Ruemmele, FM; Menard, S				Verdier, Julien; Deroche, Louis; Allez, Matthieu; Loy, Caroline; Biet, Franck; Bodier, Christelle C.; Bay, Sylvie; Ganneau, Christelle; Matysiak-Budnik, Tamara; Reyrat, Jean Marc; Heyman, Martine; Cerf-Bensussan, Nadine; Ruemmele, Frank M.; Menard, Sandrine			Specific IgG Response against Mycobacterium avium paratuberculosis in Children and Adults with Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; SUBSP PARATUBERCULOSIS; PULMONARY-DISEASE; HUMORAL IMMUNITY; LIPID ANTIGENS; CELIAC-DISEASE; TUBERCULOSIS; ANTIBODY; IMMUNOGLOBULIN	Background and Aims: Presence of serum antibodies against Mycobacterium avium paratuberculosis (MAP) in Crohn's Disease (CD) as a disease characteristic remains controversial. In the present work, we assessed antibody reactivity of serum and intestinal fluid against four distinct MAP-antigens, including the recently identified MAP-specific lipopentapeptide (L5P). Methods: Immunoglobulin concentrations and specificity against 3 non MAP-specific antigens: glycosyl-transferase-d (GSD), purified protein derivative from MAP (Johnin-PPD), heparin binding haemagglutinin (MAP-HBHA) and one MAP-specific antigen: synthetic L5P were determined by ELISA in gut lavage fluids from adult controls or patients with CD, and in sera of children or adult controls or patients with CD, ulcerative colitis or celiac disease. Results: Total IgA and IgG concentrations were increased in sera of children with CD but were decreased in sera of adults with CD, thereof specificity against MAP antigens was assessed by normalizing immunoglobulin concentrations between samples. In CD patients, IgG reactivity was increased against the four MAP antigens, including L5P in gut lavage fluids but it was only increased against L5P in sera. By contrast, anti-L5P IgG were not increased in patients with ulcerative colitis or celiac disease. Conclusions: A significant increase in anti-L5P IgG is observed in sera of children and adults with CD but not in patients with other intestinal inflammatory diseases. Anti-L5P antibodies may serve as serological marker for CD.	[Verdier, Julien; Deroche, Louis; Loy, Caroline; Heyman, Martine; Cerf-Bensussan, Nadine; Ruemmele, Frank M.; Menard, Sandrine] INSERM, UMR989, Paris, France; [Verdier, Julien; Deroche, Louis; Loy, Caroline; Reyrat, Jean Marc; Heyman, Martine; Cerf-Bensussan, Nadine; Ruemmele, Frank M.; Menard, Sandrine] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Allez, Matthieu] Hop St Louis, APHP, Dept Gastroenterol, Paris, France; [Biet, Franck; Bodier, Christelle C.] INRA, UMR ISP 1282, Ctr Tours, Nouzilly, France; [Bay, Sylvie; Ganneau, Christelle] Inst Pasteur, Unite Chimie Biomol, Dept Biol Struct & Chimie, Paris, France; [Bay, Sylvie; Ganneau, Christelle] CNRS, UMR 3523, Paris, France; [Matysiak-Budnik, Tamara] CHU Nantes, IMAD, EA BIOMETADYS, Hotel Dieu, Nantes, France; [Reyrat, Jean Marc] INSERM, UMR 570, Unite Pathogenie Infect System, Grp Avenir, Paris, France; [Ruemmele, Frank M.] Hop Necker Enfants Malad, APHP, Serv Gastroenterol, Paris, France; [Menard, Sandrine] INRA, Toxalim Res Ctr, Neurogastroenterol & Nutr Unit, F-31931 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE	Menard, S (corresponding author), INSERM, UMR989, Paris, France.	sandrine.menard@toulouse.inra.fr	Biet, Franck/ABA-4151-2021; Menard, Sandrine/ABF-8935-2021; Cerf-Bensussan, nadine/H-9505-2017; matysiak-budnik, Tamara/K-2705-2015	Biet, Franck/0000-0001-8425-6158; Menard, Sandrine/0000-0001-8867-199X; Cerf-Bensussan, nadine/0000-0003-0665-1245; Verdier, Julien/0000-0002-5618-0579; Allez, Matthieu/0000-0002-2012-7522	foundation Princesse Grace de Monaco; INSERM; Association Francois Aupetit; Bourses de Recherche Fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI)	foundation Princesse Grace de Monaco; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francois Aupetit; Bourses de Recherche Fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI)	The authors acknowledge grants from the foundation Princesse Grace de Monaco, the INSERM, Association Francois Aupetit and Bourses de Recherche Fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ABM, 2008, J MED CHEM, V51, P167, DOI 10.1021/jm701091d; [Anonymous], 2005, J PEDIAT GASTROENTER, V41, P1; Behr MA, 2008, CURR OPIN GASTROEN, V24, P17, DOI 10.1097/MOG.0b013e3282f1dcc4; BENJAMIN RG, 1984, J MED MICROBIOL, V18, P309, DOI 10.1099/00222615-18-3-309; Bernstein CN, 2007, J CLIN MICROBIOL, V45, P968, DOI 10.1128/JCM.02062-06; Biet F, 2008, VACCINE, V26, P257, DOI 10.1016/j.vaccine.2007.10.059; Biet F, 2011, DIGEST DIS SCI, V56, P1794, DOI 10.1007/s10620-010-1523-8; BRANDTZAEG P, 1989, GASTROENTEROLOGY, V97, P1562, DOI 10.1016/0016-5085(89)90406-X; CARTWRIGHT GA, 1995, J IMMUNOL METHODS, V179, P31, DOI 10.1016/0022-1759(94)00267-Z; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; CHIODINI RJ, 1989, CLIN MICROBIOL REV, V2, P90, DOI 10.1128/CMR.2.1.90-117.1989; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Cohavy O, 1999, INFECT IMMUN, V67, P6510; Kotze Lorete Maria da Silva, 2010, Arq. Gastroenterol., V47, P242, DOI 10.1590/S0004-28032010000300006; Eckstein TM, 2006, J BIOL CHEM, V281, P5209, DOI 10.1074/jbc.M512465200; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fujita Y, 2006, J MED MICROBIOL, V55, P189, DOI 10.1099/jmm.0.46087-0; GASPARI MM, 1988, J IMMUNOL METHODS, V110, P85, DOI 10.1016/0022-1759(88)90086-5; Gill CO, 2011, J FOOD PROTECT, V74, P480, DOI 10.4315/0362-028X.JFP-10-301; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kitada S, 2002, CLIN INFECT DIS, V35, P1328, DOI 10.1086/344277; Koets AP, 2001, INFECT IMMUN, V69, P1492, DOI 10.1128/IAI.69.3.1492-1498.2001; Konrad A, 2006, GASTROENTEROLOGY, V130, P2050, DOI 10.1053/j.gastro.2006.02.055; KONST H., 1958, CANADIAN JOUR COMP MED AND VET SCI, V22, P157; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI [10.1099/ijs.0.02037-0, 10.1099/00207713-52-5-1505]; MOMOTANI E, 1986, J COMP PATHOL, V96, P659, DOI 10.1016/0021-9975(86)90062-9; Momotani E, 2012, VET IMMUNOL IMMUNOP, V148, P55, DOI 10.1016/j.vetimm.2012.03.005; Muller S, 2008, WORLD J GASTROENTERO, V14, P3650, DOI 10.3748/wjg.14.3650; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Nishimura T, 2009, CLIN INFECT DIS, V49, P529, DOI 10.1086/600888; OMAHONY S, 1990, GUT, V31, P1341, DOI 10.1136/gut.31.12.1341; OMAHONY S, 1992, ANN RHEUM DIS, V51, P1296, DOI 10.1136/ard.51.12.1296; Pethe K, 2000, J BIOL CHEM, V275, P14273, DOI 10.1074/jbc.275.19.14273; Peyrin-Biroulet L, 2007, INFLAMM BOWEL DIS, V13, P1561, DOI 10.1002/ibd.20226; Pinedo PJ, 2009, VET MICROBIOL, V134, P346, DOI 10.1016/j.vetmic.2008.09.052; Polymeros D, 2006, GASTROENTEROLOGY, V131, P85, DOI 10.1053/j.gastro.2006.04.021; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Qiu B, 2000, BIOPOLYMERS, V55, P319, DOI 10.1002/1097-0282(2000)55:4<319::AID-BIP1005>3.0.CO;2-W; Ruemmele FM, 1998, GASTROENTEROLOGY, V115, P822, DOI 10.1016/S0016-5085(98)70252-5; Ruemmele FM, 2010, CURR OPIN GASTROEN, V26, P332, DOI 10.1097/MOG.0b013e328339ec2d; Sechi LA, 2006, VACCINE, V24, P236, DOI 10.1016/j.vaccine.2005.11.030; THOREL MF, 1990, INT J SYST BACTERIOL, V40, P254, DOI 10.1099/00207713-40-3-254; Tizard M, 1998, MICROBIOL-SGM, V144, P3413, DOI 10.1099/00221287-144-12-3413; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909	54	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62780	10.1371/journal.pone.0062780	http://dx.doi.org/10.1371/journal.pone.0062780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658774	Green Submitted, Green Published, gold			2022-12-27	WOS:000321200500039
J	Blum, CA; Mueller, C; Schuetz, P; Fluri, F; Trummler, M; Mueller, B; Katan, M; Christ-Crain, M				Blum, Claudine A.; Mueller, Cornelia; Schuetz, Philipp; Fluri, Felix; Trummler, Michael; Mueller, Beat; Katan, Mira; Christ-Crain, Mirjam			Prognostic Value of Dehydroepiandrosterone-Sulfate and Other Parameters of Adrenal Function in Acute Ischemic Stroke	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; CORTICOSTEROID INSUFFICIENCY; CARDIOVASCULAR-DISEASE; STIMULATION TEST; FREE CORTISOL; BRAIN-INJURY; ALL-CAUSE; MORTALITY; DHEA; SEVERITY	Background and Purpose: Acute stroke has a high morbidity and mortality. We evaluated the predictive value of adrenal function testing in acute ischemic stroke. Methods: In a cohort of 231 acute ischemic stroke patients, we measured dehydroepiandrosterone (DHEA), DHEA-Sulfate (DHEAS), cortisol at baseline and 30 minutes after stimulation with 1 ug ACTH. Delta cortisol, the amount of rise in the 1 ug ACTH-test, was calculated. Primary endpoint was poor functional outcome defined as modified Rankin scale 3-6 after 1 year. Secondary endpoint was nonsurvival after 1 year. Results: Logistic regression analysis showed that DHEAS (OR 1.21, 95% CI 1.01-1.49), but not DHEA (OR 1.01, 95% CI 0.99-1.04), was predictive for adverse functional outcome. Neither DHEA (OR 0.99, 95% CI 0.96-1.03) nor DHEAS (OR 1.10, 95% CI 0.82-1.44) were associated with mortality. Baseline and stimulated cortisol were predictive for mortality (OR 1.41, 95% CI 1.20-1.71; 1.35, 95% CI 1.15-1.60), but only basal cortisol for functional outcome (OR 1.20, 95% CI 1.04-1.38). Delta cortisol was not predictive for functional outcome (OR 0.86, 95% CI 0.71-1.05) or mortality (OR 0.92, 95% CI 0.72-1.17). The ratios cortisol/DHEA and cortisol/DHEAS discriminated between favorable outcome and nonsurvival (both p<0.0001) and between unfavorable outcome and nonsurvival (p=0.0071 and 0.0029), but are not independent predictors for functional outcome or mortality in multivariate analysis (adjusted OR for functional outcome for both 1.0 (95% CI 0.99-1.0), adjusted OR for mortality for both 1.0 (95% CI 0.99-1.0 and 1.0-1.01, respectively)). Conclusion: DHEAS and the cortisol/DHEAS ratio predicts functional outcome 1 year after stroke whereas cortisol levels predict functional outcome and mortality.	[Blum, Claudine A.; Schuetz, Philipp; Mueller, Beat] Cantonal Hosp, Med Univ Clin, Dept Endocrinol, Aarau, Switzerland; [Mueller, Cornelia; Christ-Crain, Mirjam] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Fluri, Felix] Univ Basel Hosp, Div Neurol, CH-4031 Basel, Switzerland; [Katan, Mira] Univ Zurich Hosp, Neurol Clin, CH-8091 Zurich, Switzerland; [Trummler, Michael] Bioanalytica AG, Luzern, Switzerland	University of Basel; University of Basel; University of Zurich; University Zurich Hospital	Blum, CA (corresponding author), Cantonal Hosp, Med Univ Clin, Dept Endocrinol, Aarau, Switzerland.	claudine.blum@ksa.ch	Müller, Christian/AAB-4783-2022; Mueller, Beat/G-2662-2012; Blum, Claudine Angela A/G-8467-2016; schuetz, philipp/C-8475-2013	Müller, Christian/0000-0002-1120-6405; Blum, Claudine Angela A/0000-0003-0487-5587; schuetz, philipp/0000-0001-6400-4949; Katan, Mira/0000-0002-9265-8066; Christ-Crain, Mirjam/0000-0002-6336-0965	Department of Endocrinology, Diabetology, Clinical Nutrition of the University Hospital of Basel; Medical University Clinic, Aarau, Switzerland; grant for young research scientists of the University of Basel, Switzerland; Bangerter-Rhyner-Foundation, Basel, Switzerland; Swiss National Foundation [PP00P3-12346]	Department of Endocrinology, Diabetology, Clinical Nutrition of the University Hospital of Basel; Medical University Clinic, Aarau, Switzerland; grant for young research scientists of the University of Basel, Switzerland; Bangerter-Rhyner-Foundation, Basel, Switzerland; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by in-house grants from the Department of Endocrinology, Diabetology, Clinical Nutrition of the University Hospital of Basel and the Medical University Clinic, Aarau, Switzerland, as well as by a grant for young research scientists of the University of Basel, Switzerland, and a grant from the Bangerter-Rhyner-Foundation, Basel, Switzerland, to CAB and by research grants of the Swiss National Foundation, PP00P3-12346, to MCC. MT of Bioanalytica AG, Lucerne, Switzerland, granted a discount for analyzing DHEA and DHEAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne M, 2007, CURR NEUROVASC RES, V4, P170, DOI 10.2174/156720207781387169; Arlt W, 2006, J CLIN ENDOCR METAB, V91, P2548, DOI 10.1210/jc.2005-2258; Armanini D, 2003, ENDOCRINE, V22, P113, DOI 10.1385/ENDO:22:2:113; Arnlov J, 2006, ANN INTERN MED, V145, P176, DOI 10.7326/0003-4819-145-3-200608010-00005; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BARRETTCONNOR E, 1986, NEW ENGL J MED, V315, P1519, DOI 10.1056/NEJM198612113152405; Baulieu EE, 1998, P NATL ACAD SCI USA, V95, P4089, DOI 10.1073/pnas.95.8.4089; Baulieu EE, 1999, ACTA PAEDIATR, V88, P78, DOI 10.1111/j.1651-2227.1999.tb14408.x; Beishuizen A, 2002, CRIT CARE, V6, P434, DOI 10.1186/cc1530; BOLOGA L, 1987, J NEUROSCI RES, V17, P225, DOI 10.1002/jnr.490170305; Chehab O, 2007, CR BIOL, V330, P755, DOI 10.1016/j.crvi.2007.08.004; Christensen H, 2004, J NEUROL SCI, V217, P175, DOI 10.1016/j.jns.2003.09.013; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; CORPECHOT C, 1981, P NATL ACAD SCI-BIOL, V78, P4704, DOI 10.1073/pnas.78.8.4704; Creatsa M, 2011, METABOLISM; D'Astous M, 2003, SYNAPSE, V47, P10, DOI 10.1002/syn.10145; de Bruin VMS, 2002, BRAIN COGNITION, V50, P316, DOI 10.1016/S0278-2626(02)00519-5; de Jong Margriet Fleur Charlotte, 2012, J Intensive Care Med, V27, P37, DOI 10.1177/0885066610393456; Delahanty DL, 2005, PSYCHONEUROENDOCRINO, V30, P121, DOI 10.1016/j.psyneuen.2004.06.004; Dickstein G, 2005, J CLIN ENDOCR METAB, V90, P4973, DOI 10.1210/jc.2005-1196; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; FEIBEL JH, 1977, JAMA-J AM MED ASSOC, V238, P1374, DOI 10.1001/jama.238.13.1374; Folan MM, 2001, CRIT CARE MED, V29, P965, DOI 10.1097/00003246-200105000-00012; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Hougaku H, 2006, AM J PHYSIOL-ENDOC M, V290, pE234, DOI 10.1152/ajpendo.00059.2005; Johansson A, 1997, J NEUROL SCI, V147, P43; Kancheva R, 2011, NEUROSCIENCE, V191, P22, DOI 10.1016/j.neuroscience.2011.05.054; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Kolditz M, 2010, EUR RESPIR J, V36, P615, DOI 10.1183/09031936.00191709; Kumpfel T, 1999, NEUROENDOCRINOLOGY, V70, P431, DOI 10.1159/000054505; Lapchak PA, 2000, STROKE, V31, P1953, DOI 10.1161/01.STR.31.8.1953; Laughlin GA, 2000, J CLIN ENDOCR METAB, V85, P3561, DOI 10.1210/jc.85.10.3561; LEVINE A, 1994, J PEDIATR-US, V125, P853, DOI 10.1016/S0022-3476(05)81998-5; Li Z, 2009, J CEREBR BLOOD F MET, V29, P287, DOI 10.1038/jcbfm.2008.118; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marklund N, 2004, J INTERN MED, V256, P15, DOI 10.1111/j.1365-2796.2004.01334.x; Marx C, 2003, CRIT CARE MED, V31, P1382, DOI 10.1097/01.CCM.0000063282.83188.3D; Michalaki M, 2010, EUR J ENDOCRINOL, V162, P341, DOI 10.1530/EJE-09-0883; Miyajima M, 2011, DRUG METAB DISPOS, V39, P814, DOI 10.1124/dmd.110.036863; Moraes RB, 2011, ARQ BRAS ENDOCRINOL, V55, P295, DOI 10.1590/S0004-27302011000500001; Jeckel CMM, 2010, NEUROIMMUNOMODULAT, V17, P9, DOI 10.1159/000243080; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Neidert S, 2011, J INTERN MED, V269, P420, DOI 10.1111/j.1365-2796.2010.02327.x; Ohlsson C, 2010, J CLIN ENDOCR METAB, V95, P4406, DOI 10.1210/jc.2010-0760; Ohtsuki S, 2004, BIOL PHARM BULL, V27, P1489, DOI 10.1248/bpb.27.1489; OLSSON T, 1992, STROKE, V23, P1573, DOI 10.1161/01.STR.23.11.1573; Pappa T, 2012, METABOLISM, V61, P84, DOI 10.1016/j.metabol.2011.06.003; PARKER LN, 1985, J CLIN ENDOCR METAB, V60, P947, DOI 10.1210/jcem-60-5-947; PAVLOV EP, 1986, J CLIN ENDOCR METAB, V62, P767, DOI 10.1210/jcem-62-4-767; Phillips AC, 2010, EUR J ENDOCRINOL, V163, P285, DOI 10.1530/EJE-10-0299; Phillips AC, 2010, EUR J ENDOCRINOL, V162, P919, DOI 10.1530/EJE-09-1078; RANKIN J, 1957, Scott Med J, V2, P200; Rasmuson S, 2001, BIOL PSYCHIAT, V49, P547, DOI 10.1016/S0006-3223(00)01015-5; ROSENFELD RS, 1971, J CLIN ENDOCR METAB, V33, P87, DOI 10.1210/jcem-33-1-87; Salluh JIF, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2010.03.004; Sanders JL, 2010, J AM GERIATR SOC, V58, P421, DOI 10.1111/j.1532-5415.2010.02724.x; Shufelt C, 2010, J CLIN ENDOCR METAB, V95, P4985, DOI 10.1210/jc.2010-0143; Slowik A, 2002, J NEUROL SCI, V196, P27, DOI 10.1016/S0022-510X(02)00018-7; Thijs L, 2003, ACTA CARDIOL, V58, P403, DOI 10.2143/AC.58.5.2005304; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; Urwyler SA, 2010, STROKE, V41, P1564, DOI 10.1161/STROKEAHA.110.584649; Valenti G, 2004, J Endocrinol Invest, V27, P62; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WADE CE, 1988, J CLIN ENDOCR METAB, V67, P223, DOI 10.1210/jcem-67-2-223; Wang L, 2011, ATHEROSCLEROSIS, V214, P47, DOI 10.1016/j.atherosclerosis.2010.07.043; Widmer IE, 2005, J CLIN ENDOCR METAB, V90, P4579, DOI 10.1210/jc.2005-0354; Wolf OT, 1999, BRAIN RES REV, V30, P264, DOI 10.1016/S0165-0173(99)00021-1	72	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63224	10.1371/journal.pone.0063224	http://dx.doi.org/10.1371/journal.pone.0063224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650556	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000319167000101
J	Nagy, NT; Chakraborty, S; Harami, GM; Sellers, JR; Sakamoto, T; Kovacs, M				Nagy, Nikolett T.; Chakraborty, Saikat; Harami, Gabor M.; Sellers, James R.; Sakamoto, Takeshi; Kovacs, Mihaly			A Subdomain Interaction at the Base of the Lever Allosterically Tunes the Mechanochemical Mechanism of Myosin 5a	PLOS ONE			English	Article							VITRO MOTILITY ASSAY; HAND-OVER-HAND; MOTOR DOMAIN; PROCESSIVE TRANSLOCATION; CONFORMATIONAL STATES; FLUORESCENT-PROBE; ATP HYDROLYSIS; NECK LENGTH; ACTIN; ACTOMYOSIN	The motor domain of myosin is the core element performing mechanochemical energy transduction. This domain contains the actin and ATP binding sites and the base of the force-transducing lever. Coordinated subdomain movements within the motor are essential in linking the ATPase chemical cycle to translocation along actin filaments. A dynamic subdomain interface located at the base of the lever was previously shown to exert an allosteric influence on ATP hydrolysis in the non-processive myosin 2 motor. By solution kinetic, spectroscopic and ensemble and single-molecule motility experiments, we determined the role of a class-specific adaptation of this interface in the mechanochemical mechanism of myosin 5a, a processive intracellular transporter. We found that the introduction of a myosin 2-specific repulsive interaction into myosin 5a via the I67K mutation perturbs the strong-binding interaction of myosin 5a with actin, influences the mechanism of ATP binding and facilitates ATP hydrolysis. At the same time, the mutation abolishes the actin-induced activation of ADP release and, in turn, slows down processive motility, especially when myosin experiences mechanical drag exerted by the action of multiple motor molecules bound to the same actin filament. The results highlight that subtle structural adaptations of the common structural scaffold of the myosin motor enable specific allosteric tuning of motor activity shaped by widely differing physiological demands.	[Nagy, Nikolett T.; Harami, Gabor M.; Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, ELTE MTA Eotvos Lorand Univ Hungarian Acad Sci, Momentum Motor Enzymol Res Grp, Budapest, Hungary; [Chakraborty, Saikat; Sakamoto, Takeshi] Wayne State Univ, Dept Phys & Astron, Detroit, MI 48202 USA; [Sellers, James R.] NHLBI, Lab Mol Physiol, Bethesda, MD 20892 USA	Eotvos Lorand University; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kovacs, M (corresponding author), Eotvos Lorand Univ, Dept Biochem, ELTE MTA Eotvos Lorand Univ Hungarian Acad Sci, Momentum Motor Enzymol Res Grp, Budapest, Hungary.	kovacsm@elte.hu	Harami, Gábor/I-2756-2017; Kovacs, Mihaly/A-6841-2011	Harami, Gábor/0000-0001-7234-2710; Kovacs, Mihaly/0000-0002-1200-4741	National Institutes of Health [R00HL089350]; TAMOP Grant [4.2.1/B-09/1/KMR-2010-0003]; Human Frontier Science Program [RGY0072/2010]; "Momentum" Program of the Hungarian Academy of Sciences [LP2011-006/2011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004232, R00HL089350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TAMOP Grant; Human Frontier Science Program(Human Frontier Science Program); "Momentum" Program of the Hungarian Academy of Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health K99/R00 Career grant (R00HL089350) to T.S.; and TAMOP Grant (4.2.1/B-09/1/KMR-2010-0003), the Human Frontier Science Program (RGY0072/2010) and the "Momentum" Program of the Hungarian Academy of Sciences (LP2011-006/2011) to M.K. M.K. is a Bolyai Fellow of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; Bing W, 2000, BIOCHEM J, V350, P693, DOI 10.1042/0264-6021:3500693; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; GEEVES MA, 1988, BIOCHEM J, V256, P41, DOI 10.1042/bj2560041; Greenberg MJ, 2010, CYTOSKELETON, V67, P273, DOI 10.1002/cm.20441; Gyimesi M, 2010, NUCLEIC ACIDS RES, V38, P4404, DOI 10.1093/nar/gkq145; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Jacobs DJ, 2011, J MOL BIOL, V407, P716, DOI 10.1016/j.jmb.2011.02.001; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KONRAD M, 1982, EUR J BIOCHEM, V128, P547; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Malnasi-Csizmadia A, 2001, J BIOL CHEM, V276, P19483, DOI 10.1074/jbc.M010886200; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Malnasi-Csizmadia A, 2007, J BIOL CHEM, V282, P17658, DOI 10.1074/jbc.M701447200; Malnasi-Csizmadia A, 2010, TRENDS BIOCHEM SCI, V35, P684, DOI 10.1016/j.tibs.2010.07.012; Nagy NT, 2010, FASEB J, V24, P4480, DOI 10.1096/fj.10-163998; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sellers J. R., 1999, MYOSINS; Snyder GE, 2004, BIOPHYS J, V87, P1776, DOI 10.1529/biophysj.103.036897; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; Takacs B, 2011, FASEB J, V25, P111, DOI 10.1096/fj.10-164871; Takacs B, 2010, P NATL ACAD SCI USA, V107, P6799, DOI 10.1073/pnas.0907585107; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	40	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62640	10.1371/journal.pone.0062640	http://dx.doi.org/10.1371/journal.pone.0062640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650521	Green Submitted, gold, Green Published			2022-12-27	WOS:000319167000065
J	Davila, W; Basterreche, N; Arrue, A; Zamalloa, MI; Gordo, E; Davila, R; Gonzalez-Torres, MA; Zumarraga, M				Davila, Wendy; Basterreche, Nieves; Arrue, Aurora; Zamalloa, Maria I.; Gordo, Estibaliz; Davila, Ricardo; Gonzalez-Torres, Miguel A.; Zumarraga, Mercedes			The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients	PLOS ONE			English	Article							NOVELTY SEEKING; HARM AVOIDANCE; FUNCTIONAL POLYMORPHISM; CHARACTER DIMENSIONS; II DISORDER; TEMPERAMENT; ASSOCIATION; GENE; SCHIZOPHRENIA; INVENTORY	Introduction: Certain personality traits and genetic polymorphisms are contributing factors to bipolar disorder and its symptomatology, and in turn, this syndrome influences personality. The aim of the present study is to compare the personality traits of euthymic bipolar patients with healthy controls and to investigate the effect of the catechol-O-methyltransferase (COMT) Val158Met genotype on those traits. We recruited thirty seven bipolar I patients in euthymic state following a manic episode and thirty healthy controls and evaluated their personality by means of the Cloninger's Temperament and Character Inventory (version TCI-R-140). We assessed the influence of the polymorphism Val158Met in the COMT gene on the personality of these patients. The patients scored higher than controls in harm avoidance (61.3 +/- 12.5 vs. 55.3 +/- 8.1) and self-transcendence (45.3 +/- 12.8 vs. 32.7 +/- 8.2) and scored lower than controls in self-directedness (68.8 +/- 13.3 vs. 79.3 +/- 8.1), cooperativeness (77.1 +/- 9.1 vs. 83.9 +/- 6.5) and persistence (60.4 +/- 15.1 vs. 67.1 +/- 8.9). The novelty seeking dimension associates with the Val158Met COMT genotype; patients with the low catabolic activity genotype, Met/Met, show a higher score than those with the high catabolic activity genotype, Val/Val. Conclusions: Suffering from bipolar disorder could have an impact on personality. A greater value in harm avoidance may be a genetic marker for a vulnerability to the development of a psychiatric disorder, but not bipolar disorder particularly, while a low value in persistence may characterize affective disorders or a subgroup of bipolar patients. The association between novelty seeking scores and COMT genotype may be linked with the role dopamine plays in the brain's reward circuits.	[Davila, Wendy] AMSA, Bilbao, Spain; [Basterreche, Nieves; Gordo, Estibaliz] Hosp Zamudio, Red Salud Mental Bizkaia, Unidad Hospitalizac Corta Estancia, Zamudio, Bizkaia, Spain; [Basterreche, Nieves; Gonzalez-Torres, Miguel A.] Univ Basque Country, Dept Psiquiatria, Leioa, Bizkaia, Spain; [Arrue, Aurora; Zamalloa, Maria I.; Davila, Ricardo; Zumarraga, Mercedes] Hosp Zamudio, Red Salud Mental Bizkaia, Dept Invest Neuroquim, Zamudio, Bizkaia, Spain; [Gonzalez-Torres, Miguel A.] Hosp Basurto, Dept Psiquiatria, Bilbao, Spain	University of Basque Country; Basurto Hospital	Zumarraga, M (corresponding author), Hosp Zamudio, Red Salud Mental Bizkaia, Dept Invest Neuroquim, Zamudio, Bizkaia, Spain.	mercedes.zumarragaortiz@osakidetza.net	Zumarraga, Mercedes/R-1235-2019	Zumarraga, Mercedes/0000-0003-0073-8198; Gonzalez-Torres, Miguel Angel/0000-0002-4017-2785	Basque Government's Department of Health [2008111051]; Fondo de Investigacion Sanitaria and FEDER Funds, Spain [PS0901760]	Basque Government's Department of Health; Fondo de Investigacion Sanitaria and FEDER Funds, Spain	Supported in part by grant 2008111051 of the Basque Government's Department of Health and by Grant PS0901760 of the Fondo de Investigacion Sanitaria and FEDER Funds, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti V, 2002, J AFFECT DISORDERS, V71, P113, DOI 10.1016/S0165-0327(01)00393-7; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Gonzalez-Torres MA, 2009, J NERV MENT DIS, V197, P514, DOI 10.1097/NMD.0b013e3181aacc1a; Basterreche N, 2008, NEUROPSYCHOBIOLOGY, V58, P111, DOI 10.1159/000170391; Benedetti F, 2010, J AFFECT DISORDERS, V125, P341, DOI 10.1016/j.jad.2010.01.005; Benjamin J, 2000, MOL PSYCHIATR, V5, P96, DOI 10.1038/sj.mp.4000640; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Blairy S, 2000, AM J MED GENET, V96, P360, DOI 10.1002/1096-8628(20000612)96:3<360::AID-AJMG24>3.0.CO;2-E; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cloninger CR, 1994, TCI GUIDE ITS DEV US; Correll CU, 2007, SCHIZOPHRENIA BULL, V33, P703, DOI 10.1093/schbul/sbm028; Cortes MJ, 2009, EUR PSYCHIAT, V24, P476, DOI 10.1016/j.eurpsy.2009.06.002; Demetrovics Z, 2010, COMPR PSYCHIAT, V51, P510, DOI 10.1016/j.comppsych.2009.11.008; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Engstrom C, 2004, J AFFECT DISORDERS, V82, P131, DOI 10.1016/j.jad.2003.09.004; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; Evans L, 2005, J AFFECT DISORDERS, V85, P153, DOI 10.1016/j.jad.2003.10.015; Evans LM, 2008, AM J MED GENET B, V147B, P326, DOI 10.1002/ajmg.b.30601; Gjedde A, 2010, P NATL ACAD SCI USA, V107, P3870, DOI 10.1073/pnas.0912319107; Golimbet V E, 2007, Neurosci Behav Physiol, V37, P601, DOI 10.1007/s11055-007-0058-8; Guillem F, 2002, SCHIZOPHR RES, V56, P137, DOI 10.1016/S0920-9964(01)00257-2; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hansenne M, 1999, J PSYCHIATR RES, V33, P31, DOI 10.1016/S0022-3956(98)00036-3; Harley James A, 2011, Depress Res Treat, V2011, P529638, DOI 10.1155/2011/529638; Hashimoto R, 2007, NEUROSCI LETT, V428, P17, DOI 10.1016/j.neulet.2007.09.036; Henry C, 2010, CURR PSYCHIAT REP, V12, P505, DOI 10.1007/s11920-010-0156-0; Hori H, 2008, PSYCHIAT RES, V160, P175, DOI 10.1016/j.psychres.2007.05.015; Hosak L, 2006, NEUROENDOCRINOL LETT, V27, P799; Ishii G, 2007, EUR PSYCHIAT, V22, P462, DOI 10.1016/j.eurpsy.2007.05.005; Jylha P, 2011, PSYCHOL MED, V41, P1579, DOI 10.1017/S0033291710002606; Kim SJ, 2006, NEUROSCI LETT, V401, P154, DOI 10.1016/j.neulet.2006.03.006; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Light KJ, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-3; Lin CI, 2010, PSYCHIAT RES, V177, P364, DOI 10.1016/j.psychres.2010.03.005; Loftus ST, 2008, J PSYCHIATR RES, V42, P1131, DOI 10.1016/j.jpsychires.2007.11.005; Lovdahl H, 2010, COMPR PSYCHIAT, V51, P607, DOI 10.1016/j.comppsych.2010.03.003; Marijnissen G, 2002, J AFFECT DISORDERS, V70, P219, DOI 10.1016/S0165-0327(01)00364-0; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Miettunen J, 2012, COMPR PSYCHIAT, V53, P152, DOI 10.1016/j.comppsych.2011.03.008; Mikolajczyk E, 2010, BRAIN RES, V1307, P142, DOI 10.1016/j.brainres.2009.10.035; Nery FG, 2008, J PSYCHIATR RES, V42, P569, DOI 10.1016/j.jpsychires.2007.06.004; Nowakowska C, 2005, J AFFECT DISORDERS, V85, P207, DOI 10.1016/j.jad.2003.11.012; Oeltmann T, 2004, AUTON NEUROSCI-BASIC, V116, P1, DOI 10.1016/j.autneu.2004.08.013; Ozgurdal S, 2009, PSYCHOPATHOLOGY, V42, P337, DOI 10.1159/000232977; Osher Y, 1999, J AFFECT DISORDERS, V53, P87, DOI 10.1016/S0165-0327(98)00075-5; Osher Y, 1996, J PSYCHIAT RES, V30, P353, DOI 10.1016/0022-3956(96)00023-4; Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0; Poustka L, 2010, EUR PSYCHIAT, V25, P26, DOI 10.1016/j.eurpsy.2009.09.006; Savitz J, 2008, GENES BRAIN BEHAV, V7, P869, DOI 10.1111/j.1601-183X.2008.00426.x; Sayin A, 2007, COMPR PSYCHIAT, V48, P446, DOI 10.1016/j.comppsych.2007.04.004; Simons CJP, 2009, GENES BRAIN BEHAV, V8, P5, DOI 10.1111/j.1601-183X.2008.00434.x; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Strobel A, 2003, MOL PSYCHIATR, V8, P371, DOI 10.1038/sj.mp.4001253; Tost H, 2010, NEUROSCI BIOBEHAV R, V34, P689, DOI 10.1016/j.neubiorev.2009.06.005; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V50, P153, DOI 10.1159/000079107; Yamano E, 2008, COMPR PSYCHIAT, V49, P503, DOI 10.1016/j.comppsych.2008.03.001; YOUNG LT, 1995, PSYCHIAT RES, V58, P139, DOI 10.1016/0165-1781(95)02684-O; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	59	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62900	10.1371/journal.pone.0062900	http://dx.doi.org/10.1371/journal.pone.0062900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646156	Green Published, gold			2022-12-27	WOS:000319077300110
J	Li, DG; Wang, YY; Wu, HY; Lu, L; Wang, XC; Zhang, JL; Zhang, H; Fan, SJ; Fan, FY; Zhou, DH; Meng, AM				Li, Deguan; Wang, Yueying; Wu, Hongying; Lu, Lu; Wang, Xiaochun; Zhang, Junling; Zhang, Heng; Fan, Saijun; Fan, Feiyue; Zhou, Daohong; Meng, Aimin			The Effects of p38 MAPK Inhibition Combined with G-CSF Administration on the Hematoimmune System in Mice with Irradiation Injury	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ACTIVATED PROTEIN-KINASE; IONIZING RADIATION; SUPPRESSION; APOPTOSIS; P38-ALPHA; PATHWAYS	The acute and residual (or long-term) bone marrow (BM) injury induced by ionizing radiation (IR) is a major clinic concern for patients receiving conventional radiotherapy and victims accidentally exposed to a moderate-to-high dose of IR. In this study, we investigated the effects of the treatment with the p38 inhibitor SB203580 (SB) and/or granulocyte colony-stimulating factor (G-CSF) on the hematoimmune damage induced by IR in a mouse model. Specifically, C57BL/6 mice were exposed to a sublethal dose (6 Gy) of total body irradiation (TBI) and then treated with vehicle, G-CSF, SB, and G-CSF plus SB. G-CSF (1 mu g/mouse) was administrated to mice by intraperitoneal (ip) injection twice a day for six successive days; SB (15 mg/kg) by ip injection every other day for 10 days. It was found that the treatment with SB and/or G-CSF significantly enhanced the recovery of various peripheral blood cell counts and the number of BM mononuclear cells 10 and 30 days after the mice were exposed to TBI compared with vehicle treatment. Moreover, SB and/or G-CSF treatment also increased the clonogenic function of BM hematopoietic progenitor cells (HPCs) and the frequency of BM lineage(-) Sca1(+) c-kit(+) cells (LSK cells) and short-term and long term hematopoietic stem cells (HSCs) 30 days after TBI, in comparison with vehicle treated controls. However, the recovery of peripheral blood B cells and CD4(+) and CD8(+) T cells was not significantly affected by SB and/or G-CSF treatment. These results suggest that the treatment with SB and/or G-CSF can reduce IR-induced BM injury probably in part via promoting HSC and HPC regeneration.	[Li, Deguan; Wang, Yueying; Wu, Hongying; Lu, Lu; Wang, Xiaochun; Zhang, Junling; Zhang, Heng; Fan, Saijun; Fan, Feiyue; Meng, Aimin] Chinese Acad Med Sci, Inst Radiat Med, Tianjin, Peoples R China; [Li, Deguan; Wang, Yueying; Wu, Hongying; Lu, Lu; Wang, Xiaochun; Zhang, Junling; Zhang, Heng; Fan, Saijun; Fan, Feiyue; Meng, Aimin] Peking Union Med Coll, Tianjin Key Lab Mol Nucl Med, Tianjin, Peoples R China; [Zhou, Daohong] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Zhou, Daohong] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Meng, AM (corresponding author), Chinese Acad Med Sci, Inst Radiat Med, Tianjin, Peoples R China.	aiminmeng@irm-cams.ac.cn			National Program on Key Basic Research Project (973 Program) [2011CB964800-G]; National Natural Science Foundation of China [30770645, 81129020, 81102873]; National Institute of Allergy and Infectious Diseases [R01AI080421]; Natural Science Foundation of Tianjin [12JCQNJC09100]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080421] Funding Source: NIH RePORTER	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Program on Key Basic Research Project (973 Program, 2011CB964800-G), the National Natural Science Foundation of China (No 30770645,81129020,81102873), the National Institute of Allergy and Infectious Diseases (R01AI080421), and the Natural Science Foundation of Tianjin(12JCQNJC09100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Beekman R, 2010, BLOOD, V115, P5131, DOI 10.1182/blood-2010-01-234120; Chen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011056; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; Dainiak N, 2010, HEALTH PHYS, V98, P838, DOI 10.1097/HP.0b013e3181b3fce5; Dalmas DA, 2008, TOXICOL PATHOL, V36, P958, DOI 10.1177/0192623308327121; Drouet M, 2010, INT J RADIAT BIOL, V86, P636, DOI 10.3109/09553001003789604; Duarte RF, 2002, LEUKEMIA LYMPHOMA, V43, P1179, DOI 10.1080/10428190290026231; Feng YD, 2009, ARCH PATHOL LAB MED, V133, P1850, DOI 10.1043/1543-2165-133.11.1850; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Griffin J D, 1988, Oncology (Williston Park), V2, P15; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; Kim JS, 2012, FOOD CHEM TOXICOL, V50, P3174, DOI 10.1016/j.fct.2012.05.059; Li DG, 2011, J RADIAT RES, V52, P712, DOI 10.1269/jrr.11007; Meng A, 2003, EXP HEMATOL, V31, P1348, DOI 10.1016/j.exphem.2003.08.014; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Navas T, 2008, LEUKEMIA LYMPHOMA, V49, P1963, DOI 10.1080/10428190802322919; Navas TA, 2006, BLOOD, V108, P4170, DOI 10.1182/blood-2006-05-023093; Pape H, 2006, EUR J MED RES, V11, P322; PATCHEN ML, 1990, INT J CELL CLONING, V8, P107, DOI 10.1002/stem.5530080204; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ren ML, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/310928; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Schindler JF, 2007, J DENT RES, V86, P800, DOI 10.1177/154405910708600902; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; UCKUN FM, 1990, BLOOD, V75, P638; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weiss JF, 2009, INT J RADIAT BIOL, V85, P539, DOI 10.1080/09553000902985144; Xiao Mang, 2009, Curr Mol Pharmacol, V2, P122; Zhou L, 2007, CELL CYCLE, V6, P534, DOI 10.4161/cc.6.5.3921	33	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62921	10.1371/journal.pone.0062921	http://dx.doi.org/10.1371/journal.pone.0062921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646161	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300115
J	Gerstein, H; Hullinger, R; Lindstrom, MJ; Burger, C				Gerstein, Hilary; Hullinger, Rikki; Lindstrom, Mary J.; Burger, Corinna			A Behavioral Paradigm to Evaluate Hippocampal Performance in Aged Rodents for Pharmacological and Genetic Target Validation	PLOS ONE			English	Article							MORRIS WATER MAZE; OBJECT LOCATION MEMORY; INDIVIDUAL-DIFFERENCES; SPATIAL MEMORY; COGNITIVE IMPAIRMENT; CONTEXT RECOGNITION; SYNAPTIC PLASTICITY; BASAL FOREBRAIN; DENTATE GYRUS; TEMPORAL-LOBE	Aged-related cognitive ability is highly variable, ranging from unimpaired to severe impairments. The Morris water maze (a reliable tool for assessing memory) has been used to distinguish aged rodents that are superior learners from those that are learning impaired. This task, however, is not practical for pre- and post-pharmacological treatment, as the memory of the task is long lasting. In contrast, the object location memory task, also a spatial learning paradigm, results in a less robust memory that decays quickly. We demonstrate for the first time how these two paradigms can be used together to assess hippocampal cognitive impairments before and after pharmacological or genetic manipulations in rodents. Rats were first segregated into superior learning and learning impaired groups using the object location memory task, and their performance was correlated with future outcome on this task and on the Morris water maze. This method provides a tool to evaluate the effect of treatments on cognitive impairment associated with aging and neurodegenerative disorders.	[Gerstein, Hilary; Burger, Corinna] Univ Wisconsin, Dept Neurol, Med Sci Ctr, Madison, WI 53706 USA; [Gerstein, Hilary; Hullinger, Rikki] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Lindstrom, Mary J.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burger, C (corresponding author), Univ Wisconsin, Dept Neurol, Med Sci Ctr, Madison, WI 53706 USA.	burger@neurology.wisc.edu	Gerstein, Hertzel C/B-1235-2013	Gerstein, Hertzel C/0000-0001-8072-2836; Burger, Corinna/0000-0002-9432-0114	Department of Neurology, University of Wisconsin-Madison; University of Wisconsin Neuroscience Training Program Grant United States National Institutes of Health (NIH)/NIGMS [T32GM007507]; Clinical and Translational Science Award (CTSA) program [1UL1RR025011]; National Center for Advancing Translational Sciences (NCATS) [9U54TR000021]; UW-Madison Graduate School; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER	Department of Neurology, University of Wisconsin-Madison; University of Wisconsin Neuroscience Training Program Grant United States National Institutes of Health (NIH)/NIGMS; Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); UW-Madison Graduate School; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funds from the Department of Neurology, University of Wisconsin-Madison to C.B. H.G. and R.H. were supported by the University of Wisconsin Neuroscience Training Program Grant United States National Institutes of Health (NIH)/NIGMS T32GM007507. M.J.L. was supported by grant 1UL1RR025011 from the Clinical and Translational Science Award (CTSA) program, previously through the National Center for Research Resources (NCRR), and now by the National Center for Advancing Translational Sciences (NCATS), grant 9U54TR000021. H.G. was also supported by the UW-Madison Graduate School. Finally, we would also like to acknowledge the rat subjects who contributed to this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008; Bizon JL, 2009, NEUROBIOL AGING, V30, P646, DOI 10.1016/j.neurobiolaging.2007.08.004; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Burger C, 2007, NEUROBIOL LEARN MEM, V87, P21, DOI 10.1016/j.nlm.2006.05.003; Burger C, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00140; Colombo PJ, 2002, HIPPOCAMPUS, V12, P285, DOI 10.1002/hipo.10016; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Dellu F, 1997, NEUROBIOL LEARN MEM, V67, P121, DOI 10.1006/nlme.1996.3750; DETOLEDOMORRELL L, 1988, NEUROBIOL AGING, V9, P581, DOI 10.1016/S0197-4580(88)80117-9; Diniz DG, 2010, EUR J NEUROSCI, V32, P509, DOI 10.1111/j.1460-9568.2010.07296.x; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Doyere V, 2000, BEHAV BRAIN RES, V114, P153, DOI 10.1016/S0166-4328(00)00223-0; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; GAGE FH, 1984, NEUROBIOL AGING, V5, P43, DOI 10.1016/0197-4580(84)90084-8; GAGE FH, 1986, J NEUROSCI, V6, P2837; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; GALLAGHER M, 1989, NEUROBIOL AGING, V10, P691, DOI 10.1016/0197-4580(89)90006-7; Gallagher M, 2006, AGE, V28, P221, DOI 10.1007/s11357-006-9017-5; Gerstein H, 2013, NEUROBIOL AGING, DOI [10.1016/j.neurobiolaging.2013.02.006, DOI 10.1016/J.NEUR0BI0LAGING.2013.02.006.[]; Gulinello M, 2009, BEHAV BRAIN RES, V196, P220, DOI 10.1016/j.bbr.2008.09.002; Koh MT, 2010, NEUROPSYCHOPHARMACOL, V35, P1016, DOI 10.1038/npp.2009.207; Lindner MD, 1997, NEUROBIOL LEARN MEM, V68, P203, DOI 10.1006/nlme.1997.3782; Luparini MR, 2000, AGING-CLIN EXP RES, V12, P264, DOI 10.1007/BF03339846; MARKOWSKA AL, 1990, NEUROBIOL AGING, V11, P491, DOI 10.1016/0197-4580(90)90109-D; MARKOWSKA AL, 1989, NEUROBIOL AGING, V10, P31, DOI 10.1016/S0197-4580(89)80008-9; MartinezSerrano A, 1996, P NATL ACAD SCI USA, V93, P6355, DOI 10.1073/pnas.93.13.6355; Matzel LD, 2003, J NEUROSCI, V23, P6423; Matzel LD, 2008, LEARN MEMORY, V15, P733, DOI 10.1101/lm.954808; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Murai T, 2007, PHYSIOL BEHAV, V90, P116, DOI 10.1016/j.physbeh.2006.09.013; Paban V, 2005, NEUROSCIENCE, V132, P13, DOI 10.1016/j.neuroscience.2004.11.024; Paban W, 2005, BEHAV NEUROSCI, V119, P933, DOI 10.1037/0735-7044.119.4.933; Robitsek RJ, 2008, J NEUROSCI, V28, P8945, DOI 10.1523/JNEUROSCI.1893-08.2008; Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607; Schulz D, 2002, EUR J NEUROSCI, V16, P2175, DOI 10.1046/j.1460-9568.2002.02282.x; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Wu K, 2012, NEUROBIOL LEARN MEM, V97, P69, DOI 10.1016/j.nlm.2011.09.006	41	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62360	10.1371/journal.pone.0062360	http://dx.doi.org/10.1371/journal.pone.0062360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667471	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700032
J	Zhang, X; Jia, DY; Liu, HJ; Zhu, N; Zhang, W; Feng, J; Yin, J; Hao, B; Cui, DX; Deng, YZ; Xie, D; He, L; Li, BJ				Zhang, Xin; Jia, Deyong; Liu, Huijuan; Zhu, Na; Zhang, Wei; Feng, Jun; Yin, Jun; Hao, Bin; Cui, Daxiang; Deng, Yuezhen; Xie, Dong; He, Lin; Li, Baojie			Identification of 5-Iodotubercidin as a Genotoxic Drug with Anti-Cancer Potential	PLOS ONE			English	Article							ADENOSINE KINASE INHIBITORS; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; G(2) ARREST; CANCER; P53; ATM; ACTIVATION; TARGET; PHOSPHORYLATION	Tumor suppressor p53, which is activated by various stress and oncogene activation, is a target for anti-cancer drug development. In this study, by screening panels of protein kinase inhibitors and protein phosphatase inhibitors, we identified 5-Iodotubercidin as a strong p53 activator. 5-Iodotubercidin is purine derivative and is used as an inhibitor for various kinases including adenosine kinase. We found that 5-Iodotubercidin could cause DNA damage, verified by induction of DNA breaks and nuclear foci positive for gamma H2AX and TopBP1, activation of Atm and Chk2, and S15 phosphorylation and up-regulation of p53. As such, 5-Iodotubercidin induces G2 cell cycle arrest in a p53-dependent manner. Itu also induces cell death in p53-dependent and -independent manners. DNA breaks were likely generated by incorporation of 5-Iodotubercidin metabolite into DNA. Moreover, 5-Iodotubercidin showed anti-tumor activity as it could reduce the tumor size in carcinoma xenograft mouse models in p53-dependent and -independent manners. These findings reveal 5-Iodotubercidin as a novel genotoxic drug that has chemotherapeutic potential.	[Zhang, Xin; Jia, Deyong; Liu, Huijuan; He, Lin; Li, Baojie] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Zhu, Na] Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai 200030, Peoples R China; [Zhang, Wei; Feng, Jun; Yin, Jun] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Hao, Bin] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Cui, Daxiang] Shanghai Jiao Tong Univ, Res Inst Micro Nano Sci & Technol, Shanghai 200030, Peoples R China; [Deng, Yuezhen; Xie, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, BJ (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	libj@sjtu.edu.cn	Jia, Deyong/GSJ-0327-2022; Jia, Deyong/GQP-9611-2022	Jia, Deyong/0000-0003-2034-0363; Xie, Dong/0000-0002-1150-8657	National Natural Science Foundation of China [81130039, 31071229, 81121001]; Ministry of Science and Technology of China (The National Key Scientific Program) [2012CB966901]; Shanghai Pujiang Program [10PJ1405000]; Cheung Kong Scholars Program of the Ministry of Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China (The National Key Scientific Program); Shanghai Pujiang Program(Shanghai Pujiang Program); Cheung Kong Scholars Program of the Ministry of Education	The work was supported by grants from the National Natural Science Foundation of China (81130039, 31071229, and 81121001), the Ministry of Science and Technology of China (The National Key Scientific Program (2012CB966901, to B.L.)), Shanghai Pujiang Program (10PJ1405000), Cheung Kong Scholars Program of the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boison Detlev, 2010, Open Neurosci J, V4, P93; BRATTAIN MG, 1980, CANCER RES, V40, P2142; Browning JL, 2005, BIOL PSYCHIAT, V57, P617, DOI 10.1016/j.biopsych.2004.12.002; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chau JFL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1832; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; COTTAM HB, 1993, J MED CHEM, V36, P3424, DOI 10.1021/jm00074a024; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; Ewald B, 2007, MOL CANCER THER, V6, P1239, DOI 10.1158/1535-7163.MCT-06-0633; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Fassett JT, 2011, AM J PHYSIOL-HEART C, V300, pH1722, DOI 10.1152/ajpheart.00684.2010; FluckigerIsler R, 1996, BBA-MOL CELL RES, V1311, P77, DOI 10.1016/0167-4889(95)00196-4; FLUCKIGERISLER RE, 1993, BIOCHEM J, V292, P85; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Fujita K, 2010, NAT CELL BIOL, V12, P1205, DOI 10.1038/ncb2123; GOLEMBIOWSKA K, 1995, BRAIN RES, V699, P315, DOI 10.1016/0006-8993(95)00926-H; Gouder N, 2004, J NEUROSCI, V24, P692, DOI 10.1523/JNEUROSCI.4781-03.2004; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang N, 1997, EUR J PHARMACOL, V320, P131, DOI 10.1016/S0014-2999(96)00905-3; Karnitz LM, 2005, MOL PHARMACOL, V68, P1636, DOI 10.1124/mol.105.012716; Lai KP, 2010, EMBO J, V29, P2994, DOI 10.1038/emboj.2010.166; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Li TF, 2008, J CLIN INVEST, V118, P571, DOI 10.1172/JCI33737; Liu XJ, 2008, MOL CANCER THER, V7, P133, DOI 10.1158/1535-7163.MCT-07-0416; Liu XJ, 2005, CANCER RES, V65, P6874, DOI 10.1158/0008-5472.CAN-05-0288; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Ma G, 2012, J MOL CELL BIOL, V4, P118, DOI 10.1093/jmcb/mjs006; MASSILLON D, 1994, BIOCHEM J, V299, P123, DOI 10.1042/bj2990123; Pavet V, 2011, ONCOGENE, V30, P1, DOI 10.1038/onc.2010.460; Peart J, 2001, CARDIOVASC RES, V52, P120, DOI 10.1016/S0008-6363(01)00360-1; Pignataro G, 2007, J CEREBR BLOOD F MET, V27, P1, DOI 10.1038/sj.jcbfm.9600334; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shen ZY, 2011, J MOL CELL BIOL, V3, P1, DOI 10.1093/jmcb/mjq057; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Ugarkar BG, 2000, J MED CHEM, V43, P2883, DOI 10.1021/jm000024g; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Wang ZF, 2010, PROTEIN CELL, V1, P1063, DOI 10.1007/s13238-010-0140-9; Wilson PM, 2011, NUCLEIC ACIDS RES, V39, pE112, DOI 10.1093/nar/gkr350; Zannini L, 2012, J MOL CELL BIOL, V4, P294, DOI 10.1093/jmcb/mjs035; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	48	18	20	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62527	10.1371/journal.pone.0062527	http://dx.doi.org/10.1371/journal.pone.0062527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667485	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700043
J	Powell, TJ; Peng, YC; Berthoud, TK; Blais, ME; Lillie, PJ; Hill, AVS; Rowland-Jones, SL; McMichael, AJ; Gilbert, SC; Dong, T				Powell, Timothy J.; Peng, Yanchun; Berthoud, Tamara K.; Blais, Marie-Eve; Lillie, Patrick J.; Hill, Adrian V. S.; Rowland-Jones, Sarah L.; McMichael, Andrew J.; Gilbert, Sarah C.; Dong, Tao			Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine	PLOS ONE			English	Article							CROSS-REACT; A-VIRUS; PROTECTION; EFFECTOR; INFECTIONS; HUMANS; RECOGNITION; LYMPHOCYTES; RECIPIENTS; PHENOTYPE	Current influenza vaccines stimulate neutralising antibody to the haemagglutinin antigen but as there is antigenic drift in HA it is difficult to prepare a vaccine in advance against an emergent strain. A potential strategy is to induce CD8(+) and CD4(+) T cells that recognize epitopes within internal proteins that are less subject to antigenic drift. Augmenting humoral responses to HA with T cell responses to more conserved antigens may result in a more broadly protective vaccine. In this study, we evaluate the quality of influenza specific T cell responses in a clinical trial using MVA-NP+M1 vaccination followed by influenza virus challenge. In vaccinated volunteers, the expression of Granzyme A, Perforin and CD57 on influenza HLA A*02 M1(58-66) antigen specific cells was higher than non-vaccinated volunteers before and after challenge despite a similar frequency of antigen specific cells. BCL2 expression was lower in vaccinated volunteers. These data indicate that antigen specific T cells are a useful additional measure for use in human vaccination or immunization studies.	[Powell, Timothy J.; Peng, Yanchun; Blais, Marie-Eve; Dong, Tao] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DU, England; [Berthoud, Tamara K.; Lillie, Patrick J.; Hill, Adrian V. S.; Rowland-Jones, Sarah L.; McMichael, Andrew J.; Gilbert, Sarah C.] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; University of Oxford; Jenner Institute	Powell, TJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DU, England.	timothy.powell@imm.ox.ac.uk; tao.dong@imm.ox.ac.uk	Gilbert, Sarah C./H-2857-2019	Gilbert, Sarah C./0000-0002-6823-9750; Powell, Timothy J/0000-0002-9208-674X; Dong, Tao/0000-0003-3545-3758; Lillie, Patrick/0000-0002-4811-4774	Medical Research Council; Wellcome Trust; Isis University Challenge Seed Fund; Oxford Biomedical Research Centre; Oxford Martin School; Medical Research Council [G1000800a, G1000800f, G0600520, G1001046] Funding Source: researchfish; MRC [G1001046, G0600520] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Isis University Challenge Seed Fund; Oxford Biomedical Research Centre; Oxford Martin School; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding came from the Medical Research Council (TD); Wellcome Trust, Isis University Challenge Seed Fund, Oxford Biomedical Research Centre (SCG). SCG is a Jenner Institute Investigator and TKB is supported by the Oxford Martin School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Cerwenka A, 1999, J IMMUNOL, V163, P5535; Co MDT, 2008, VACCINE, V26, P1990, DOI 10.1016/j.vaccine.2008.02.024; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Forrest BD, 2008, CLIN VACCINE IMMUNOL, V15, P1042, DOI 10.1128/CVI.00397-07; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; He XS, 2008, J INFECT DIS, V197, P803, DOI 10.1086/528804; Heidema J, 2008, J IMMUNOL, V181, P5551, DOI 10.4049/jimmunol.181.8.5551; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Makedonas G, 2009, J IMMUNOL, V182, P5560, DOI 10.4049/jimmunol.0803945; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Plotnicky H, 2003, VIROLOGY, V309, P320, DOI 10.1016/S0042-6822(03)00072-2; Powell TJ, 2012, J INFECT DIS, V205, P20, DOI 10.1093/infdis/jir689; Terajima M, 2008, J VIROL, V82, P9283, DOI 10.1128/JVI.01047-08; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612	26	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62778	10.1371/journal.pone.0062778	http://dx.doi.org/10.1371/journal.pone.0062778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658773	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100039
J	Zhang, W; Miao, JF; Wang, SS; Zhang, YS				Zhang, Wei; Miao, Jinfeng; Wang, Shanshan; Zhang, Yuanshu			The Protective Effects of Beta-Casomorphin-7 against Glucose -Induced Renal Oxidative Stress In Vivo and Vitro	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; LIPID-PEROXIDATION; SUPEROXIDE-DISMUTASE; BETA-CASOMORPHINS; KIDNEY-DISEASE; MALONDIALDEHYDE; MELLITUS; CASEIN; INJURY; RAT	Oxidative stress is implicated in the pathogenesis of diabetic nephropathy. The present study aimed to investigate the effect of beta-casomorphin-7 (BCM7) on the oxidative stress occurring in kidney tissue in streptozotocin (STZ)-induced diabetic rats and proximal tubular epithelial cells (NRK-52E) exposure to high glucose (HG) by using biochemical methods. There is a significant decrease in plasma insulin and a significant increase in plasma glucagon in the rats of diabetic group. Oral administration of BCM7 for 30 days to rats with STZ-induced diabetes resulted in a significant increase in serum level of insulin, and a decrease in the level of glucagon. Moreover, rats with STZ-induced diabetes had lower levels of superoxide dismutase (SOD), glutathione peroxidase (GPx) and total antioxidative capacity (T-AOC), higher levels of malondialdehyde (MDA) and hydrogen peroxide (H2O2) in the kidney than that in the control rats. The administration of BCM7 altered the changes of SOD, GPx, T-AOC, MDA and H2O2 in the kidney of diabetic rats. Furthermore, BCM7 alleviated high glucose-induced decreasement in SOD and GPx activity, increasement in MDA contents in the NRK-52E cells. BCM7 ameliorated the changes of angiotensin converting enzyme (ACE) and ACE2 levels in the kidney of diabetic rats and BCM7 lowered the levels of angiotensin (Ang)II in the kidney of diabetic rats and culture medium for cells. Moreover losartan (antagonist of angiotensin II type I receptor) lowered the high glucose-induced oxidative stress in the NRK-52E cells. Our results suggest that administration of BCM7 would alleviate high glucose-induced renal oxidative stress in vivo and in vitro, which may be associated with down regulation of the concentration of Ang II partly.	[Zhang, Wei; Miao, Jinfeng; Wang, Shanshan; Zhang, Yuanshu] Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Zhang, YS (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	zhangyuanshu@njau.edu.cn		Zhang, Wei/0000-0003-0798-667X	National Natural Science Foundation of China [30871838]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Students' Innovative projects of Jiangsu Higher Education Institutions [CXZZ12-0296]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Students' Innovative projects of Jiangsu Higher Education Institutions	This work was supported by a grant (30871838) from National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (http://www.jsnsf.gov.cn/index.aspx); and Graduate Students' Innovative projects of Jiangsu Higher Education Institutions (CXZZ12-0296) (http://www.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOVERIS A, 1984, METHOD ENZYMOL, V105, P429; BRANTL V, 1984, EUR J PHARMACOL, V106, P213, DOI 10.1016/0014-2999(84)90702-7; BRANTL V, 1979, H-S Z PHYSIOL CHEM, V360, P1211, DOI 10.1515/bchm2.1979.360.2.1211; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calderon-Salinas JV, 2011, MOL CELL BIOCHEM, V357, P171, DOI 10.1007/s11010-011-0887-1; Chang SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/521076; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; DeRubertis FR, 2004, DIABETES, V53, P762, DOI 10.2337/diabetes.53.3.762; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Elliott RB, 1999, DIABETOLOGIA, V42, P292, DOI 10.1007/s001250051153; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Griendling KK, 2000, REGUL PEPTIDES, V91, P21, DOI 10.1016/S0167-0115(00)00136-1; Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824; JAIN SK, 1990, METABOLISM, V39, P971, DOI 10.1016/0026-0495(90)90310-9; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jones CA, 2005, KIDNEY INT, V67, P1684, DOI 10.1111/j.1523-1755.2005.00265.x; Kedziora-Kornatowska K, 2008, IUBMB LIFE, V49, P303; Kim S, 2012, PLOS ONE; Lakshmanan AP, 2011, FREE RADICAL RES, V45, P575, DOI 10.3109/10715762.2011.560149; Liu CX, 2011, MOL MED, V17, P59, DOI 10.2119/molmed.2010.00111; Makni M, 2010, FOOD CHEM TOXICOL, V48, P2407, DOI 10.1016/j.fct.2010.05.079; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; MOHANDAS J, 1984, CANCER RES, V44, P5086; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nielsen F, 1997, CLIN CHEM, V43, P1209; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; Obrosova IG, 2003, FREE RADICAL BIO MED, V34, P186, DOI 10.1016/S0891-5849(02)01195-4; Onozato ML, 2002, KIDNEY INT, V61, P186, DOI 10.1046/j.1523-1755.2002.00123.x; Ott IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042623; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9; Song X D, 2009, WORLD J GASTROENTERO, V17, P1947; SOULISLIPAROTA T, 1991, DIABETES, V40, P1328, DOI 10.2337/diabetes.40.10.1328; Takayanagi R, 2011, J CLIN BIOCHEM NUTR, V48, P72, DOI 10.3164/jcbn.11-014FR; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Yin H, 2010, PEPTIDES, V31, P1725, DOI 10.1016/j.peptides.2010.05.016; Zhang W, 2012, PEPTIDES, V36, P186, DOI 10.1016/j.peptides.2012.05.022; Zhou QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047360; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	41	32	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63472	10.1371/journal.pone.0063472	http://dx.doi.org/10.1371/journal.pone.0063472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658831	Green Submitted, Green Published, gold			2022-12-27	WOS:000321202100066
J	Grego, T; Couto, FM				Grego, Tiago; Couto, Francisco M.			Enhancement of Chemical Entity Identification in Text Using Semantic Similarity Validation	PLOS ONE			English	Article							MANUAL CURATION; SYSTEM; INFORMATION; ONTOLOGIES; RESOURCE; DRUGS	With the amount of chemical data being produced and reported in the literature growing at a fast pace, it is increasingly important to efficiently retrieve this information. To tackle this issue text mining tools have been applied, but despite their good performance they still provide many errors that we believe can be filtered by using semantic similarity. Thus, this paper proposes a novel method that receives the results of chemical entity identification systems, such as Whatizit, and exploits the semantic relationships in ChEBI to measure the similarity between the entities found in the text. The method assigns a single validation score to each entity based on its similarities with the other entities also identified in the text. Then, by using a given threshold, the method selects a set of validated entities and a set of outlier entities. We evaluated our method using the results of two state-of-the-art chemical entity identification tools, three semantic similarity measures and two text window sizes. The method was able to increase precision without filtering a significant number of correctly identified entities. This means that the method can effectively discriminate the correctly identified chemical entities, while discarding a significant number of identification errors. For example, selecting a validation set with 75% of all identified entities, we were able to increase the precision by 28% for one of the chemical entity identification tools (Whatizit), maintaining in that subset 97% the correctly identified entities. Our method can be directly used as an add-on by any state-of-the-art entity identification tool that provides mappings to a database, in order to improve their results. The proposed method is included in a freely accessible web tool at www.lasige.di.fc.ul.pt/webtools/ice/.	[Grego, Tiago; Couto, Francisco M.] Univ Lisbon, Fac Cincias, Dept Informt, P-1699 Lisbon, Portugal	Universidade de Lisboa	Grego, T (corresponding author), Univ Lisbon, Fac Cincias, Dept Informt, P-1699 Lisbon, Portugal.	tgrego@fc.ul.pt	Couto, Francisco M/A-4066-2010	Couto, Francisco M/0000-0003-0627-1496; Grego, Tiago/0000-0002-7946-7062	Portuguese Fundacao para a Ciencia e Tecnologia of the SPNet project [PTDC/EIA-EIA/119119/2010]; SOMER project [PTDC/EIA-EIA/119119/2010]; Portuguese Fundacao para a Ciencia e Tecnologia through the LASIGE multi-annual support; European Commission of the EPIWORK project under the Seventh Framework Programme [231807];  [SFRH/BD/36015/2007]	Portuguese Fundacao para a Ciencia e Tecnologia of the SPNet project; SOMER project; Portuguese Fundacao para a Ciencia e Tecnologia through the LASIGE multi-annual support; European Commission of the EPIWORK project under the Seventh Framework Programme; 	Portuguese Fundacao para a Ciencia e Tecnologia (www.fct.pt/) through the financial support of the SPNet project (PTDC/EIA-EIA/119119/2010), the SOMER project (PTDC/EIA-EIA/119119/2010) and the PhD grant SFRH/BD/36015/2007 and through the LASIGE multi-annual support. European Commission (http://ec.europa.eu/) through the financial support of the EPIWORK project under the Seventh Framework Programme (Grant \#231807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banville DL, 2006, DRUG DISCOV TODAY, V11, P35, DOI 10.1016/S1359-6446(05)03682-2; Bota M, 2005, NEUROINFORMATICS, V3, P15, DOI 10.1385/NI:3:1:015; de Matos P, 2010, NUCLEIC ACIDS RES, V38, pD249, DOI 10.1093/nar/gkp886; Erhardt RAA, 2006, DRUG DISCOV TODAY, V11, P315, DOI 10.1016/j.drudis.2006.02.011; Ferreira JD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000937; Fluck Juliane, 2005, Drug Discov Today Technol, V2, P217, DOI 10.1016/j.ddtec.2005.08.013; Gardner Stephen P, 2005, Drug Discov Today Technol, V2, P235, DOI 10.1016/j.ddtec.2005.08.004; Grego T, 2012, ISRN BIOINFORMATICS, V2012, P1; Grego T, 2009, LECT NOTES COMPUT SC, V5518, P942, DOI 10.1007/978-3-642-02481-8_144; Gruning BA, 2011, BIOINFORMATICS, V27, P1341, DOI 10.1093/bioinformatics/btr130; Hettne KM, 2009, BIOINFORMATICS, V25, P2983, DOI 10.1093/bioinformatics/btp535; Li QL, 2010, DRUG DISCOV TODAY, V15, P1052, DOI 10.1016/j.drudis.2010.10.003; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; Pence HE, 2010, J CHEM EDUC, V87, P1123, DOI 10.1021/ed100697w; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Rebholz-Schuhmann D, 2008, BIOINFORMATICS, V24, P296, DOI 10.1093/bioinformatics/btm557; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Resnik P., 1995, P 14 INT JOINT C ART, V1, P448; Rodriguez-Esteban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000597; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Smith L, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s2, 10.1186/gb-2008-9-S2-S2]; Spasic I, 2005, BRIEF BIOINFORM, V6, P239, DOI 10.1093/bib/6.3.239; Vazquez M, 2011, MOL INFORM, V30, P506, DOI 10.1002/minf.201100005; Weisgerber DW, 1997, J AM SOC INFORM SCI, V48, P349, DOI 10.1002/(SICI)1097-4571(199704)48:4<349::AID-ASI8>3.0.CO;2-W; Wiegers TC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-326; Winnenburg R, 2008, BRIEF BIOINFORM, V9, P466, DOI 10.1093/bib/bbn043	27	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62984	10.1371/journal.pone.0062984	http://dx.doi.org/10.1371/journal.pone.0062984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658791	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500048
J	Li, BQ; Huang, T; Zhang, J; Zhang, N; Huang, GH; Liu, L; Cai, YD				Li, Bi-Qing; Huang, Tao; Zhang, Jian; Zhang, Ning; Huang, Guo-Hua; Liu, Lei; Cai, Yu-Dong			An Ensemble Prognostic Model for Colorectal Cancer	PLOS ONE			English	Article							HUMAN COLON; HOMEOSTATIC SWITCH; EXPRESSION; GENE; PREDICTION; GROWTH; OVEREXPRESSION; METHYLATION; ACTIVATION; PROMOTER	Colorectal cancer can be grouped into Dukes A, B, C, and D stages based on its developments. Generally speaking, more advanced patients have poorer prognosis. To integrate progression stage prediction systems with recurrence prediction systems, we proposed an ensemble prognostic model for colorectal cancer. In this model, each patient was assigned a most possible stage and a most possible recurrence status. If a patient was predicted to be recurrence patient in advanced stage, he would be classified into high risk group. The ensemble model considered both progression stages and recurrence status. High risk patients and low risk patients predicted by the ensemble model had a significant different disease free survival (log-rank test p-value, 0.0016) and disease specific survival (log-rank test p-value, 0.0041). The ensemble model can better distinguish the high risk and low risk patients than the stage prediction model and the recurrence prediction model alone. This method could be applied to the studies of other diseases and it could significantly improve the prediction performance by ensembling heterogeneous information.	[Huang, Guo-Hua; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing; Liu, Lei] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Zhang, Jian] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhang, Ning] Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab BME Measurement, Tianjin 300072, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Icahn School of Medicine at Mount Sinai; Shanghai Jiao Tong University; Tianjin University	Liu, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	leiliu@sibs.ac.cn; cai_yud@yahoo.com.cn	Huang, Guohua/A-2215-2019	Huang, Guohua/0000-0001-6954-3933; Zhang, Ning/0000-0002-1559-111X; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]; grant of "The First-class Discipline of Universities in Shanghai"	National Basic Research Program of China(National Basic Research Program of China); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); grant of "The First-class Discipline of Universities in Shanghai"	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101), Innovation Program of Shanghai Municipal Education Commission (12ZZ087), and the grant of "The First-class Discipline of Universities in Shanghai." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516; Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; ASTLER VB, 1954, ANN SURG, V139, P846, DOI 10.1097/00000658-195406000-00015; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015737; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Dukes CE, 1932, J PATHOL BACTERIOL, V35, P323, DOI 10.1002/path.1700350303; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; GAO YF, 2013, MOL BIOSYSTEMS; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Gustavsson E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-187; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028384; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kontani K, 2003, INT J MOL MED, V12, P767; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1733, DOI 10.1111/j.1525-1438.2006.00660.x; Lee JH, 2011, CLIN CANCER RES, V17, P7551, DOI 10.1158/1078-0432.CCR-11-1026; Li BQ, 2013, PROTEIN PEPTIDE LETT, V20, P352; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045854; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043927; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Lin YH, 2007, CLIN CANCER RES, V13, P498, DOI 10.1158/1078-0432.CCR-05-2734; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Naik S, 2009, CLIN CANCER RES, V15, P7529, DOI 10.1158/1078-0432.CCR-09-0336; Patlolla JMR, 2004, ONCOL REP, V11, P957; Paun BC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007715; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Potapenko IO, 2010, MOL ONCOL, V4, P98, DOI 10.1016/j.molonc.2009.12.001; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sotgia F, 2009, AM J PATHOL, V174, P613, DOI 10.2353/ajpath.2009.080653; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Terasaki H, 2002, INT J MOL MED, V9, P107; Von Stein P, 2008, GASTROENTEROLOGY, V134, P1869, DOI 10.1053/j.gastro.2008.02.083; Voronkov AE, 2008, DOKL BIOCHEM BIOPHYS, V419, P75, DOI 10.1134/S1607672908020087; Wang HQ, 2012, BIOCHEM BIOPH RES CO, V417, P62, DOI 10.1016/j.bbrc.2011.11.055; Weigle B, 2005, ONCOL REP, V13, P139; You HH, 2009, CELL CYCLE, V8, P2679, DOI 10.4161/cc.8.17.9327; Zhang N, 2012, MOL BIOSYST, V8, P2946, DOI 10.1039/c2mb25185j; Zhong Haihong, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P1082; Zou HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039379	53	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63494	10.1371/journal.pone.0063494	http://dx.doi.org/10.1371/journal.pone.0063494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658834	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500074
J	Anders, CK; Adamo, B; Karginova, O; Deal, AM; Rawal, S; Darr, D; Schorzman, A; Santos, C; Bash, R; Kafri, T; Carey, L; Miller, CR; Perou, CM; Sharpless, N; Zamboni, WC				Anders, Carey K.; Adamo, Barbara; Karginova, Olga; Deal, Allison M.; Rawal, Sumit; Darr, David; Schorzman, Allison; Santos, Charlene; Bash, Ryan; Kafri, Tal; Carey, Lisa; Miller, C. Ryan; Perou, Charles M.; Sharpless, Norman; Zamboni, William C.			Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer	PLOS ONE			English	Article							NERVOUS-SYSTEM METASTASES; WHOLE-BRAIN RADIOTHERAPY; POLY(ADP-RIBOSE) POLYMERASE; ANTICANCER AGENTS; CKD-602 S-CKD602; TUMOR MODEL; IN-VITRO; INHIBITOR; CHEMOTHERAPY; XENOGRAFTS	Introduction: Breast cancer brain metastases (BCBM) are a challenging consequence of advanced BC. Nanoparticle agents, including liposomes, have shown enhanced delivery to solid tumors and brain. We compared pharmacokinetics (PK) and efficacy of PEGylated liposomal doxorubicin (PLD) with non-liposomal doxorubicin (NonL-doxo) in an intracranial model of BC. Methods: Athymic mice were inoculated intracerebrally with MDA-MB-231-BR-luciferase-expressing cells. Tumor-bearing mice were administered PLD or NonL-doxo at 6mg/kg IVx1 and were euthanized prior to and 0.083, 1, 3, 6, 24, 72 and 96 h post-treatment. Samples were processed to measure sum total doxorubicin via HPLC. PLD and NonL-doxo were administered IV weekly as single agents (6 mg/kg) or in combination (4.5 mg/kg) with the PARP inhibitor, ABT-888, PO 25 mg/kg/day. Efficacy was assessed by survival and bioluminescence. Results: Treatment with PLD resulted in approximately 1,500-fold higher plasma and 20-fold higher intracranial tumor sum total doxorubicin AUC compared with NonL-doxo. PLD was detected at 96 h; NonL-doxo was undetectable after 24 h in plasma and tumor. Median survival of PLD-treated animals was 32 days (d, [CI] 31-38), which was significantly longer than controls (26d [CI 25-28]; p = 0.0012) or NonL-doxo treatment (23.5d [CI 18-28], p = 0.0002). Combination treatment with PLD/ABT-888 yielded improved survival compared to NonL-doxo/ABT-888 (35d [CI 31-38] versus 29.5d [CI 25-34]; p = 0.006). Conclusions: PLD provides both PK and efficacy advantage over NonL-doxo in the treatment of an in vivo model of BCBM. The results provide preclinical rationale to translate findings into early phase trials of PLD, with or without ABT-888, for	[Anders, Carey K.; Carey, Lisa; Sharpless, Norman] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Anders, Carey K.; Adamo, Barbara; Karginova, Olga; Deal, Allison M.; Rawal, Sumit; Darr, David; Schorzman, Allison; Santos, Charlene; Bash, Ryan; Kafri, Tal; Carey, Lisa; Miller, C. Ryan; Perou, Charles M.; Sharpless, Norman; Zamboni, William C.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Adamo, Barbara] Univ Messina, Integrated Therapies Oncol Unit, Dept Human Pathol, Messina, Italy; [Deal, Allison M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biostat, Chapel Hill, NC 27599 USA; [Rawal, Sumit; Schorzman, Allison; Zamboni, William C.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Rawal, Sumit; Zamboni, William C.] Univ N Carolina, Translat Oncol & Nanoparticle Drug Dev Initiat TO, Chapel Hill, NC USA; [Kafri, Tal] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA; [Kafri, Tal] Univ N Carolina, Dept Microbiol & Immnunol, Chapel Hill, NC USA; [Miller, C. Ryan] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Sharpless, Norman] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Zamboni, William C.] Univ N Carolina, Carolina Ctr Canc Nanotechnol Excellence, Chapel Hill, NC USA; [Zamboni, William C.] Univ N Carolina, Inst Pharmacogen & Individualized Therapy, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Messina; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Anders, CK (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	carey_anders@med.unc.edu	Miller, Ryan/B-9365-2008; , Animal Studies Core/ADK-4234-2022; Perou, Charles M/H-9934-2014; , Animal Studies Core/AAF-4432-2022; , Pathology Services Core/CEZ-2246-2022	Miller, Ryan/0000-0002-0096-8762; Perou, Charles M/0000-0001-9827-2247; Sharpless, Norman/0000-0001-7078-9455	National Cancer Institute [K23CA157728]; Breast Cancer Research Foundation-AACR Grant for Translational Breast Cancer Research [10-60-26-ANDE]; Damon Runyon Cancer Research Foundation [CI-64-12]; University Cancer Research Fund; Lineberger Cancer Center; University of North Carolina at Chapel Hill; Lineberger Comprehensive Cancer Center; University of North Carolina SPORE Career Development Award [5P50CA058223]; NATIONAL CANCER INSTITUTE [U54CA151652, K23CA157728, P50CA058223, P30CA016086] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation-AACR Grant for Translational Breast Cancer Research; Damon Runyon Cancer Research Foundation; University Cancer Research Fund; Lineberger Cancer Center; University of North Carolina at Chapel Hill; Lineberger Comprehensive Cancer Center; University of North Carolina SPORE Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding Sources: The project described was supported by Grant Number K23CA157728 (CKA) from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. Research supported by the 2010 Breast Cancer Research Foundation-AACR Grant for Translational Breast Cancer Research, Grant Number 10-60-26-ANDE (CKA). Carey Anders, MD is a Damon Runyon Clinical Investigator supported (in part) by the Damon Runyon Cancer Research Foundation (CI-64-12). Funding also came from The University Cancer Research Fund, Lineberger Cancer Center, University of North Carolina at Chapel Hill (BZ and Mouse Phase I Unit) and Lineberger Comprehensive Cancer Center, University of North Carolina SPORE Career Development Award, 5P50CA058223 (SPORE, CKA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2011, MOL CANCER THER, V10, P2320, DOI 10.1158/1535-7163.MCT-11-0356; AMSELEM S, 1990, J PHARM SCI, V79, P1045, DOI 10.1002/jps.2600791202; Baschnagel A, 2009, MOL CANCER THER, V8, P1589, DOI 10.1158/1535-7163.MCT-09-0038; Beijnen J, 1985, PDA J PHARM SCI TECH, V39, P220; Bendell JC, 2003, CANCER-AM CANCER SOC, V97, P2972, DOI 10.1002/cncr.11436; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coombes RC, 1996, J CLIN ONCOL, V14, P35, DOI 10.1200/JCO.1996.14.1.35; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Ewend Matthew G, 2008, J Natl Compr Canc Netw, V6, P505; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; GABIZON A, 1989, JNCI-J NATL CANCER I, V81, P1484, DOI 10.1093/jnci/81.19.1484; GABIZON AA, 1993, PHARMACEUT RES, V10, P703, DOI 10.1023/A:1018907715905; Gerstner ER, 2007, J CLIN ONCOL, V25, P2306, DOI 10.1200/JCO.2006.10.0677; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Koukourakis MI, 2000, BRIT J CANCER, V83, P1281, DOI 10.1054/bjoc.2000.1459; Lay JC, 2009, THORAX, V64, P313, DOI 10.1136/thx.2008.096222; Lin NU, 2008, CANCER-AM CANCER SOC, V113, P2638, DOI 10.1002/cncr.23930; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Lockman PR, 2010, CLIN CANCER RES, V16, P5664, DOI 10.1158/1078-0432.CCR-10-1564; Madhankumar AB, 2009, MOL CANCER THER, V8, P648, DOI 10.1158/1535-7163.MCT-08-0853; Mason KA, 2008, INVEST NEW DRUG, V26, P1, DOI 10.1007/s10637-007-9072-5; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Niwinska A, 2010, ANN ONCOL, V21, P942, DOI 10.1093/annonc/mdp407; Niwinska A, 2010, CANCER-AM CANCER SOC, V116, P4238, DOI 10.1002/cncr.25391; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; Park JW, 2004, SEMIN ONCOL, V31, P196, DOI 10.1053/j.seminoncol.2004.08.009; Roberts PJ, 2012, CLIN CANCER RES, V18, P5290, DOI 10.1158/1078-0432.CCR-12-0563; Sharma US, 1997, PHARM RES-DORDR, V14, P992, DOI 10.1023/A:1012136925030; Shroff K, 2012, LANGMUIR, V28, P4729, DOI 10.1021/la204466g; SIEGAL T, 1995, J NEUROSURG, V83, P1029, DOI 10.3171/jns.1995.83.6.1029; van Rooijen N, 2007, LIPOSOME TECHNOLOGY, V3, P303; Walsh MD, 2012, CLIN CANCER RES, V18, P2591, DOI 10.1158/1078-0432.CCR-11-1554; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zamboni WC, 2005, CLIN CANCER RES, V11, P8230, DOI 10.1158/1078-0432.CCR-05-1895; Zamboni WC, 2010, DRUG DELIV SYST, V25, P58; Zamboni WC, 2008, ONCOLOGIST, V13, P248, DOI 10.1634/theoncologist.2007-0180; Zamboni WC, 2007, CLIN CANCER RES, V13, P7217, DOI 10.1158/1078-0432.CCR-07-1035; Zamboni WC, 2011, J LIPOSOME RES, V21, P158, DOI 10.3109/08982104.2010.496085; Zamboni WC, 2009, CLIN CANCER RES, V15, P1466, DOI 10.1158/1078-0432.CCR-08-1405	41	73	76	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61359	10.1371/journal.pone.0061359	http://dx.doi.org/10.1371/journal.pone.0061359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650496	gold, Green Published			2022-12-27	WOS:000319167000011
J	Boehlke, C; Kotsis, F; Buchholz, B; Powelske, C; Eckardt, KU; Walz, G; Nitschke, R; Kuehn, EW				Boehlke, Christopher; Kotsis, Fruzsina; Buchholz, Bjoern; Powelske, Christian; Eckardt, Kai-Uwe; Walz, Gerd; Nitschke, Roland; Kuehn, E. Wolfgang			Kif3a Guides Microtubular Dynamics, Migration and Lumen Formation of MDCK Cells	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; ADENOMATOUS POLYPOSIS-COLI; KINESIN SUPERFAMILY; TIGHT JUNCTION; KIDNEY INJURY; PRIMARY CILIA; N-CADHERIN; POLARITY; GROWTH; ENDS	The microtubular motor Kinesin-2 and its subunit Kif3a are essential for the formation of primary cilia, an organelle implicated in a wide spectrum of developmental abnormalities. Outside cilia, Kinesin-2 mediated transport has been implicated in vesicle and N-cadherin transport, but it is unknown if and how extraciliary Kif3a affects basic cellular functions such as migration or the formation of multicellular structures. Here we show that tetracycline inducible depletion of Kif3a in MDCK cells slows epithelial cell migration. Microtubules at the leading edge of Kif3a depleted cells failed to grow perpendicularly into the leading edge and microtubular dynamics were dampened in Kif3a depleted cells. Loss of Kif3a retarded lateral membrane specification and completely prevented the formation of three-dimensional spheres in collagen. These data uncover that Kif3a regulates the microtubular cytoskeleton in the cell periphery and imply that extra-ciliary Kif3a has an unexpected function in morphogenesis.	[Boehlke, Christopher; Kotsis, Fruzsina; Powelske, Christian; Walz, Gerd; Kuehn, E. Wolfgang] Univ Hosp, Dept Nephrol, Freiburg, Germany; [Buchholz, Bjoern; Eckardt, Kai-Uwe] Univ Hosp, Dept Nephrol, Erlangen, Germany; [Walz, Gerd; Nitschke, Roland; Kuehn, E. Wolfgang] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany; [Nitschke, Roland] Univ Freiburg, Life Imaging Ctr, Ctr Biosyst Anal, D-79106 Freiburg, Germany	University of Freiburg; University of Erlangen Nuremberg; University of Freiburg; University of Freiburg	Kuehn, EW (corresponding author), Univ Hosp, Dept Nephrol, Freiburg, Germany.	wolfgang.kuehn@uniklinik-freiburg.de	Boehlke, Christopher/AAZ-6627-2021; Nitschke, Roland/F-9525-2010	Boehlke, Christopher/0000-0002-6985-0201; Nitschke, Roland/0000-0002-9397-8475; Buchholz, Bjoern/0000-0003-3730-5425	DFG [KU 1504, SFB 592 Z2, KFO 201]; BIOSS cluster of excellence 294; European Community [241955]; Interdisciplinary Center of Clinical Research at the University of Erlangen-Nuremberg [J3]	DFG(German Research Foundation (DFG)); BIOSS cluster of excellence 294; European Community(European Commission); Interdisciplinary Center of Clinical Research at the University of Erlangen-Nuremberg	This work was supported by DFG grants KU 1504 (EWK), SFB 592 Z2 (RN) and BIOSS cluster of excellence 294 (RN, EWK, GW). GW is supported by the DFG KFO 201, and by the European Community's Seventh Framework Program (grant agreement number 241955, SYSCILIA). BB is supported by a junior career development grant (J3) of the Interdisciplinary Center of Clinical Research at the University of Erlangen-Nuremberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt-Dias M, 2008, TRENDS CELL BIOL, V18, P8, DOI 10.1016/j.tcb.2007.11.002; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Boehlke C, 2010, J CELL SCI, V123, P1460, DOI 10.1242/jcs.058883; Bowen JR, 2011, J CELL BIOL, V194, P187, DOI 10.1083/jcb.201102076; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Buchholz B, 2011, J MOL MED-JMM, V89, P251, DOI 10.1007/s00109-010-0715-1; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gierke S, 2012, CURR BIOL, V22, P753, DOI 10.1016/j.cub.2012.02.069; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jaulin F, 2010, J CELL BIOL, V190, P443, DOI 10.1083/jcb.201006044; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kotsis F, 2007, PFLUG ARCH EUR J PHY, V453, P819, DOI 10.1007/s00424-006-0168-0; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; Lolkema MP, 2007, FEBS LETT, V581, P4571, DOI 10.1016/j.febslet.2007.08.050; Manneville JB, 2006, BIOL CELL, V98, P557, DOI 10.1042/BC20060017; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; Mattie FJ, 2010, CURR BIOL, V20, P2169, DOI 10.1016/j.cub.2010.11.050; Mimori-Kiyosue Y, 2011, CYTOSKELETON, V68, P603, DOI 10.1002/cm.20540; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Thoma CR, 2010, J CELL BIOL, V190, P991, DOI 10.1083/jcb.201006059; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAP AS, 1995, EXP CELL RES, V218, P540, DOI 10.1006/excr.1995.1189; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9	45	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62165	10.1371/journal.pone.0062165	http://dx.doi.org/10.1371/journal.pone.0062165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658710	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000032
J	Ekins, S; Olechno, J; Williams, AJ				Ekins, Sean; Olechno, Joe; Williams, Antony J.			Dispensing Processes Impact Apparent Biological Activity as Determined by Computational and Statistical Analyses	PLOS ONE			English	Article							CHEMISTRY DATABASES; INHIBITORS; IDENTIFICATION; OPTIMIZATION; DISCOVERY; QUALITY	Dispensing and dilution processes may profoundly influence estimates of biological activity of compounds. Published data show Ephrin type-B receptor 4 IC50 values obtained via tip-based serial dilution and dispensing versus acoustic dispensing with direct dilution differ by orders of magnitude with no correlation or ranking of datasets. We generated computational 3D pharmacophores based on data derived by both acoustic and tip-based transfer. The computed pharmacophores differ significantly depending upon dispensing and dilution methods. The acoustic dispensing-derived pharmacophore correctly identified active compounds in a subsequent test set where the tip-based method failed. Data from acoustic dispensing generates a pharmacophore containing two hydrophobic features, one hydrogen bond donor and one hydrogen bond acceptor. This is consistent with X-ray crystallography studies of ligand-protein interactions and automatically generated pharmacophores derived from this structural data. In contrast, the tip-based data suggest a pharmacophore with two hydrogen bond acceptors, one hydrogen bond donor and no hydrophobic features. This pharmacophore is inconsistent with the X-ray crystallographic studies and automatically generated pharmacophores. In short, traditional dispensing processes are another important source of error in high-throughput screening that impacts computational and statistical analyses. These findings have far-reaching implications in biological research.	[Ekins, Sean] Collaborat Chem, Fuquay Varina, NC USA; [Olechno, Joe] Labcyte Inc, Sunnyvale, CA USA; [Williams, Antony J.] Royal Soc Chem, Wake Forest, NC USA		Ekins, S (corresponding author), Collaborat Chem, Fuquay Varina, NC USA.	ekinssean@yahoo.com	Williams, Antony John/C-3089-2009	Williams, Antony John/0000-0002-2668-4821				Bardelle C, 2008, BIOORG MED CHEM LETT, V18, P5717, DOI 10.1016/j.bmcl.2008.09.087; Bardelle C, 2008, BIOORG MED CHEM LETT, V18, P2776, DOI 10.1016/j.bmcl.2008.04.015; Bardelle C, 2010, BIOORG MED CHEM LETT, V20, P6242, DOI 10.1016/j.bmcl.2010.08.100; Barlaam BC, 2008, N PHENYL N MORPHOLIN; Barlaam BC, 2010, PYRIMIDINE DERIVATIV; Barlaam BC, 2009, 2 4 DIAMINO PYRIMIDI; Barlaam B, 2011, BIOORG MED CHEM LETT, V21, P2207, DOI 10.1016/j.bmcl.2011.03.009; Belaiche C, 2009, CLIN CHEM, V55, P1883, DOI 10.1373/clinchem.2009.130054; Comley J., 2007, DRUG DISCOVERY, P36; Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305; Ekins S, 2002, J PHARMACOL EXP THER, V301, P427, DOI 10.1124/jpet.301.2.427; Ekins S, 2010, LAB CHIP, V10, P13, DOI 10.1039/b917760b; Gilchrist MA, 2008, J BIOMOL SCREEN, V13, P486, DOI 10.1177/1087057108319212; Grant RJ, 2009, J BIOMOL SCREEN, V14, P452, DOI 10.1177/1087057109336588; Harris D, 2010, J BIOMOL SCREEN, V15, P86, DOI 10.1177/1087057109351027; Hubalek F, 2003, ACTA CRYSTALLOGR D, V59, P1874, DOI 10.1107/S0907444903016883; Li J, 2007, J CHEM INF MODEL, V47, P1923, DOI 10.1021/ci700136x; Matson SL, 2009, J BIOMOL SCREEN, V14, P476, DOI 10.1177/1087057109336593; McDonald GR, 2008, SCIENCE, V322, P917, DOI 10.1126/science.1162395; Meslamani J., 2010, J CHEM INF MODEL; PAPKE RL, 1994, J PHARMACOL EXP THER, V268, P718; REUHL TOK, 1990, BRAIN RES BULL, V25, P433, DOI 10.1016/0361-9230(90)90234-Q; Spicer T, 2005, DRUG DISCOVERY TECHN, V384; Turmel M, 2010, JALA-J LAB AUTOM, V15, P297, DOI 10.1016/j.jala.2009.04.002; Watson J, 2009, J BIOMOL SCREEN, V14, P566, DOI 10.1177/1087057109336594; Williams AJ, 2012, DRUG DISCOV TODAY, V17, P685, DOI 10.1016/j.drudis.2012.02.013; Williams AJ, 2011, DRUG DISCOV TODAY, V16, P747, DOI 10.1016/j.drudis.2011.07.007; Wingfield J, 2012, IMPACT ACOUSTIC DISP; Wingfield J., 2008, AM DRUG DISCOV, V3, P24	29	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62325	10.1371/journal.pone.0062325	http://dx.doi.org/10.1371/journal.pone.0062325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658723	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000040
J	Zetterqvist, AV; Mulinari, S				Zetterqvist, Anna V.; Mulinari, Shai			Misleading Advertising for Antidepressants in Sweden: A Failure of Pharmaceutical Industry Self-Regulation	PLOS ONE			English	Article							MEDICAL JOURNALS; ADVERTISEMENTS; PROMOTION; ACCURACY; QUALITY; DRUGS; CODES	Background: The alleged efficacy of pharmaceutical industry self-regulation has been used to repudiate increased government oversight over promotional activity. European politicians and industry have cited Sweden as an excellent example of self-regulation based on an ethical code. This paper considers antidepressant advertising in Sweden to uncover the strengths and weaknesses of self-regulation. Methodology: We analyzed all antidepressant advertisements in the Swedish Medical Journal, 1994-2003. The regulation of these advertisements was analyzed using case reports from self-regulatory bodies. The authors independently reviewed this material to investigate: (1) extent of violative advertising; (2) pattern of code breaches; (3) rate at which the system reacted to violative advertising; (4) prevalence of and oversight over claims regarding antidepressant efficacy and disease causality, and (5) costs for manufactures associated with violative advertising. Principal Findings: Self-regulatory bodies identified numerous code breaches. Nonetheless, they failed to protect doctors from unreliable information on antidepressants, since as many as 247 of 722 (34%) advertisements breached the industry code. Self-regulatory bodies repeatedly failed to challenge inflated claims of antidepressant efficacy, lending evidence of lax oversight. On average, 15 weeks elapsed between printing and censure of a wrongful claim, and in 25% of cases 47 weeks or more elapsed. Industry paid roughly (sic)108000 in fines for violative advertising, adding an estimated additional average cost of 11% to each purchased violative advertisement, or amounting to as little as 0.009% of total antidepressant sales of around (sic)1.2 billion. Conclusions: Lax oversight, combined with lags in the system and low fines for violations, may explain the Swedish system's failure to pressure companies into providing reliable antidepressants information. If these shortcomings prove to be consistent across self-regulatory settings, and if appropriate measures are not taken to amend shortcomings, many countries may want to reconsider the current balance between self-regulation, and legislative control with government oversight.	[Zetterqvist, Anna V.] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Mulinari, Shai] Lund Univ, Dept Gender Studies, Lund, Sweden	Lund University; Lund University	Mulinari, S (corresponding author), Lund Univ, Dept Gender Studies, Lund, Sweden.	shai.mulinari@genus.lu.se		Mulinari, Shai/0000-0001-8773-9796	Riksbankens Jubileumsfond in Sweden	Riksbankens Jubileumsfond in Sweden	SM was supported by Riksbankens Jubileumsfond in Sweden (http://www.rj.se/). AVZ received no funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andree Bengt, 2012, Lakartidningen, V109, P2106; Apoteksbolaget, 1991, ANN REP; Coombes R, 2005, BRIT MED J, V331, P1225, DOI 10.1136/bmj.331.7527.1225-a; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; EFPIA, 2007, EFPIA COD PROM PRESC; European Federation of Pharmaceutical Industries and Associations, 2008, EFPIA CONTR EUR COMM; Fugh-Berman A, 2006, PLOS MED, V3, P762, DOI 10.1371/journal.pmed.0030130; GAO, 2006, IMPR NEED FDAS OV DI; Hakansson J, 2001, LAKARTIDNINGEN, V98, P1834; Healy D., 1997, ANTIDEPRESSANT ERA; Healy D, 1992, DIS NERVOUS SYSTEM C, V1, P815; Heimans L, 2010, NETH J MED, V68, P46; HERXHEIMER A, 1990, BRIT MED J, V300, P307, DOI 10.1136/bmj.300.6720.307; High Level Pharmaceutical Forum, 2008, FIN CONCL REC PHARM; House of Commons Health Committee, 2005, INFL PHARM IND HLTH, V2; Huskamp HA, 2008, PHARMACOECONOMICS, V26, P603, DOI 10.2165/00019053-200826070-00007; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), 2012, IFPMA COD PRACT; International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), 2012, SELF REG PHARM PROM; Charan J, 2011, J PHARM BIOALLIED SC, V3, P403, DOI 10.4103/0975-7406.84449; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Korenstein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023336; Lacasse JR, 2005, PLOS MED, V2, P1211, DOI 10.1371/journal.pmed.0020392; Lal A, 1997, J Indian Med Assoc, V95, P19; Lankinen KS, 2004, PHARMACOEPIDEM DR S, V13, P789, DOI 10.1002/pds.1017; Lennholm B, 2001, LAKARTIDNINGEN, V98, P923; Lexchin J, 1997, CAN MED ASSOC J, V156, P351; Lexchin J, 2003, AM J BIOETHICS, V3, P49, DOI 10.1162/15265160360706570; Lexchin J, 2010, INT J CLIN PRACT, V64, P1015, DOI 10.1111/j.1742-1241.2010.02398.x; Lexchin J, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-24; Liebman M, 2000, MED MARKET MEDIA, V35, P88; Lynch R, 2005, REGULATORY RAPPORTEU, V2, P7; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Melander H, 2008, EUR NEUROPSYCHOPHARM, V18, P623, DOI 10.1016/j.euroneuro.2008.06.003; MENDELS J, 1974, ARCH GEN PSYCHIAT, V30, P447; Mulinari S, 2013, SOCIOL HEALTH ILL, V35, P761, DOI 10.1111/j.1467-9566.2012.01528.x; Mulinari S, 2012, J HIST NEUROSCI, V21, P366, DOI 10.1080/0964704X.2011.623917; Mulinari Shai, 2011, Lakartidningen, V108, P1839; National Institute for Health and Clinical Excellence (NICE), 2018, DEPR AD REC MAN; O'Brien C, 2003, IRISH TIMES     1005; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Othman N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-294; Othman N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006350; Otto Cars Sigvard Molstad, 2012, LAKARTIDNINGEN; PERMAN E, 1990, NEW ENGL J MED, V323, P616, DOI 10.1056/NEJM199008303230921; Ratanawijitrasin S, 2002, EFFECTIVE DRUG REGUL; Roughhead EE, 1999, AUST PRESCR, V22, P78; Ruff TA, 2005, MED J AUSTRALIA, V183, P73, DOI 10.5694/j.1326-5377.2005.tb06926.x; Shorter E., 2009, PROZAC TROUBLED HIST; Simmonds H, 2003, LANCET, V361, P878, DOI 10.1016/S0140-6736(03)12686-4; Spielmans GI, 2008, J NERV MENT DIS, V196, P267, DOI 10.1097/NMD.0b013e31816a436b; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Swedish Association of the Pharmaceutical Industry (LIF), 2011, ETH RUL PHARM IND SW; Swedish Association of the Pharmaceutical Industry (LIF), 2012, IGM NBL DAT; Swedish Association of the Pharmaceutical Industry (LIF), 2011, FORM ADV ACC ETH RUL; The Swedish Pharmaceutical Industry Information Examiner (IGM), 2012, BIANN REP 1994 2003; The Swedish Pharmaceutical Industry Information Examiner (IGM), 2012, BIANN REP IGM 2011 2; The Swedish Riksbank, 2012, ANN AV EXCH RAT; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van Winkelen P, 2006, RHEUMATOLOGY, V45, P1154, DOI 10.1093/rheumatology/kel073; Villanueva P, 2003, LANCET, V361, P27, DOI 10.1016/S0140-6736(03)12118-6	61	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62609	10.1371/journal.pone.0062609	http://dx.doi.org/10.1371/journal.pone.0062609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650519	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000062
J	Remm, L; Lohmus, P; Leis, M; Lohmus, A				Remm, Liina; Lohmus, Piret; Leis, Mare; Lohmus, Asko			Long-Term Impacts of Forest Ditching on Non-Aquatic Biodiversity: Conservation Perspectives for a Novel Ecosystem	PLOS ONE			English	Article							OLD-GROWTH FORESTS; BOREAL SPRUCE FORESTS; ARTIFICIAL-DRAINAGE; SPECIES RICHNESS; STAND STRUCTURE; LAND; HABITAT; TREE; COMMUNITIES; PEATLANDS	Artificial drainage (ditching) is widely used to increase timber yield in northern forests. When the drainage systems are maintained, their environmental impacts are likely to accumulate over time and along accompanying management, notably after logging when new forest develops on decayed peat. Our study provides the first comprehensive documentation of long-term ditching impacts on terrestrial and arboreal biodiversity by comparing natural alder swamps and second-generation drained forests that have evolved from such swamps in Estonia. We explored species composition of four potentially drainage-sensitive taxonomic groups (vascular plants, bryophytes, lichens, and snails), abundance of species of conservation concern, and their relationships with stand structure in two-ha plots representing four management types (ranging from old growth to clearcut). We found that drainage affected plot-scale species richness only weakly but it profoundly changed assemblage composition. Bryophytes and lichens were the taxonomic groups that were most sensitive both to drainage and timber-harvesting; in closed stands they responded to changed microhabitat structure, notably impoverished tree diversity and dead-wood supply. As a result, natural old-growth plots were the most species-rich and hosted several specific species of conservation concern. Because the most influential structural changes are slow, drainage impacts may be long hidden. The results also indicated that even very old drained stands do not provide quality habitats for old-growth species of drier forest types. However, drained forests hosted many threatened species that were less site type specific, including early-successional vascular plants and snails on clearcuts and retention cuts, and bryophytes and lichens of successional and old forests. We conclude that three types of specific science-based management tools are needed to mitigate ditching effects on forest biodiversity: (i) silvicultural techniques to maintain stand structural complexity; (ii) context-dependent spatial analysis and planning of drained landscapes; and (iii) lists of focal species to monitor and guide ditching practices.	[Remm, Liina; Lohmus, Asko] Univ Tartu, Dept Zool, EE-50090 Tartu, Estonia; [Lohmus, Piret] Univ Tartu, Dept Bot, EE-50090 Tartu, Estonia; [Leis, Mare] Estonian Univ Life Sci, Dept Bot, Tartu, Estonia	University of Tartu; University of Tartu; Estonian University of Life Sciences	Lohmus, A (corresponding author), Univ Tartu, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	asko.lohmus@ut.ee		Lohmus, Piret/0000-0003-4664-1682; Lohmus, Asko/0000-0001-7283-8716	Estonian Science Foundation [7402, 7987, 9051]; Estonian Ministry of Education and Science [SF0180012s09, SF0170052s08]; Estonian State Forest Management Centre; herbarium of the Estonian University of Life Sciences (TAA); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)	Estonian Science Foundation; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Estonian State Forest Management Centre; herbarium of the Estonian University of Life Sciences (TAA); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission)	The research was supported by the Estonian Science Foundation (grants 7402, 7987, 9051), the Estonian Ministry of Education and Science (projects SF0180012s09, SF0170052s08), The Estonian State Forest Management Centre, the herbarium of the Estonian University of Life Sciences (TAA), and the European Union through the European Regional Development Fund (Centre of Excellence FIBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERMANN V, 2009, ESTONIAN FORESTS 200; Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; Angelstam Per, 2004, Ecological Bulletins, V51, P1; [Anonymous], 2015, PC ORD MULTIVARIATE; Anshari GZ, 2010, BIOGEOSCIENCES, V7, P3403, DOI 10.5194/bg-7-3403-2010; Asada T, 2004, CAN J FOREST RES, V34, P1730, DOI 10.1139/X04-042; Asplund J, 2010, J ECOL, V98, P218, DOI 10.1111/j.1365-2745.2009.01584.x; Baar J, 2000, PLANT BIOLOGY, V2, P505, DOI 10.1055/s-2000-7468; Baltzinger M, 2011, ANN FOREST SCI, V68, P395, DOI 10.1007/s13595-011-0026-x; Bergstedt J, 2001, FOREST ECOL MANAG, V154, P105, DOI 10.1016/S0378-1127(00)00642-3; Bernes C., 1994, BIOL DIVERSITY SWEDE; Blann KL, 2009, CRIT REV ENV SCI TEC, V39, P909, DOI 10.1080/10643380801977966; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Brinson MM, 2002, ENVIRON CONSERV, V29, P115, DOI 10.1017/S0376892902000085; Cameron RAD, 2005, J CONCHOL, V38, P529; Chapman MG, 2009, OECOLOGIA, V161, P625, DOI 10.1007/s00442-009-1393-y; COPPINS AM, 2002, INDICES ECOLOGICAL C; Doering M, 2010, BOTANY, V88, P144, DOI 10.1139/B09-096; Dolny A, 2012, BIOL CONSERV, V145, P109, DOI 10.1016/j.biocon.2011.10.020; Douda J, 2011, OECOLOGIA, P1; DUBE S, 1995, WATER RESOUR RES, V31, P1741, DOI 10.1029/95WR00427; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dynesius M, 2007, BIOL CONSERV, V135, P423, DOI 10.1016/j.biocon.2006.10.010; Ecke F, 2009, FRESHWATER BIOL, V54, P119, DOI 10.1111/j.1365-2427.2008.02097.x; Ek Tommy, 2001, Svensk Botanisk Tidskrift, V95, P357; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Etverk I, 1974, FORESTS ESTONIA, P40; Fenton NJ, 2008, BIOL CONSERV, V141, P1389, DOI 10.1016/j.biocon.2008.03.019; Furukawa Y, 2005, NUTR CYCL AGROECOSYS, V71, P81, DOI 10.1007/s10705-004-5286-5; Gloer P., 1994, SUSSWASSERMOLLUSKEN; Grigaliunas V, 2011, BALT FOR, V17, P102; GUSTAFSSON L, 1992, LICHENOLOGIST, V24, P255, DOI 10.1017/S0024282992000367; Hanley ME, 2009, ANN BOT-LONDON, V103, P1347, DOI 10.1093/aob/mcp081; Hartley MJ, 2002, FOREST ECOL MANAG, V155, P81, DOI 10.1016/S0378-1127(01)00549-7; Hautala H, 2011, RESTOR ECOL, V19, P418, DOI 10.1111/j.1526-100X.2009.00545.x; Hensgen F, 2011, FLORA, V206, P534, DOI 10.1016/j.flora.2011.01.002; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Holden J, 2004, PROG PHYS GEOG, V28, P95, DOI 10.1191/0309133304pp403ra; Holien H, 1998, NOVA HEDWIGIA, V66, P283; Hollmen A, 2008, J INSECT CONSERV, V12, P163, DOI 10.1007/s10841-007-9076-7; HOLOPAINEN AL, 1992, HYDROBIOLOGIA, V243, P457, DOI 10.1007/BF00007063; Honnay O., 2004, FOREST BIODIVERSITY; Hoover JP, 2006, BIOL CONSERV, V127, P37, DOI 10.1016/j.biocon.2005.07.017; Hornberg G, 1998, BIOSCIENCE, V48, P795, DOI 10.2307/1313391; Horsak M, 2007, ACTA OECOL, V32, P161, DOI 10.1016/j.actao.2007.03.011; Hunter ML, 2002, CONSERV BIOL, V16, P660, DOI 10.1046/j.1523-1739.2002.01108.x; Hylander K, 2004, CONSERV BIOL, V18, P1052, DOI 10.1111/j.1523-1739.2004.00199.x; Ingerpuu N., 1998, KEY ESTONIAN BRYOPHY; Jonsson BG, 2005, SILVA FENN, V39, P289, DOI 10.14214/sf.390; Juriado I, 2009, BIODIVERS CONSERV, V18, P105, DOI 10.1007/s10531-008-9460-y; Jutras S, 2007, FOREST CHRON, V83, P723, DOI 10.5558/tfc83723-5; Jutras Sylvain, 2005, Suo (Helsinki), V56, P95; Kerney M. P., 1979, LAND SNAILS BRITAIN; KRALKA RA, 1986, AM MIDL NAT, V115, P156, DOI 10.2307/2425845; KUKK T, 1999, VASCULAR PLANT FLORA; Kuuluvainen T, 2002, SILVA FENN, V36, P409, DOI 10.14214/sf.572; Kuusinen M, 1996, ECOGRAPHY, V19, P41, DOI 10.1111/j.1600-0587.1996.tb00153.x; Laiho R, 2006, SOIL BIOL BIOCHEM, V38, P2011, DOI 10.1016/j.soilbio.2006.02.017; Laine J, 1995, J APPL ECOL, V32, P785, DOI 10.2307/2404818; Laine Jukka, 1995, Environmental Reviews, V3, P286, DOI 10.1139/a95-015; Lavoie Martin, 2005, Environmental Reviews, V13, P21, DOI 10.1139/a05-006; Lohmus A., 2004, ECOL BULL, V51, P401; Lohmus A, 2011, SILVA FENN, V45, P1015, DOI 10.14214/sf.84; Lohmus A, 2011, CAN J FOREST RES, V41, P1352, DOI [10.1139/X11-047, 10.1139/x11-047]; Lohmus A, 2011, J FOREST RES-JPN, V16, P194, DOI 10.1007/s10310-011-0256-7; Lohmus A, 2010, FOREST ECOL MANAG, V260, P155, DOI 10.1016/j.foreco.2010.04.018; Lohmus E, 1981, ANTHROPOGENOUS CHANG, P77; Lohmus E., 1984, ESTONIAN FOREST SITE; Lohmus P, 2006, CAN J FOREST RES, V36, P1319, DOI 10.1139/X06-032; Lohmus P, 2012, NOVA HEDWIGIA, V95, P493, DOI 10.1127/0029-5035/2012/0064; Lohmus P, 2009, LICHENOLOGIST, V41, P61, DOI 10.1017/S002428290900807X; Ludwig GX, 2008, J APPL ECOL, V45, P325, DOI 10.1111/j.1365-2664.2007.01396.x; Marmor L, 2011, ECOL INDIC, V11, P1270, DOI 10.1016/j.ecolind.2011.01.009; Martin K, 2004, J BIOGEOGR, V31, P531, DOI 10.1046/j.1365-2699.2003.01005.x; Masing V, 2010, WETL ECOL MANAG, V18, P397, DOI 10.1007/s11273-008-9130-6; METLA, 2010, FINN STAT YB FOR 201; Moser M., 1996, P 6 M C CONTR PART B, P21; Nitare J., 2000, SIGNALARTER INDIKATO; Ohlson M, 1997, BIOL CONSERV, V81, P221, DOI 10.1016/S0006-3207(97)00001-3; Ostlund L, 1997, CAN J FOREST RES, V27, P1198, DOI 10.1139/x97-070; Paavilainen E., 1995, PEATLAND FORESTRY EC, Vvol 111; Pilte D, 2003, FINNISH ENV, V485, P216; Prieditis N, 1999, ENVIRON CONSERV, V26, P332, DOI 10.1017/S0376892999000442; Proctor MCF, 2007, BRYOLOGIST, V110, P595, DOI 10.1639/0007-2745(2007)110[595:DIBAR]2.0.CO;2; Pulkki R, 2003, SUSTAINABLE MANAGEME; Pykala J, 2004, APPL VEG SCI, V7, P29, DOI 10.1111/j.1654-109X.2004.tb00592.x; Rajala P., 1982, Suomen Riista, P93; Ray D, 1998, FORESTRY, V71, P169, DOI 10.1093/forestry/71.2.169; Remm J, 2006, FOREST ECOL MANAG, V221, P267, DOI 10.1016/j.foreco.2005.10.015; Richardson PJ, 2010, ECOL APPL, V20, P728, DOI 10.1890/08-1092.1; Rosenvald R, 2011, FOREST ECOL MANAG, V262, P1541, DOI 10.1016/j.foreco.2011.07.002; Santesson R., 2004, LICHEN FORMING LICHE; Schmalholz M, 2011, ECOGRAPHY, V34, P637, DOI 10.1111/j.1600-0587.2010.06652.x; Somermaa A, 1972, ECOLOGY EPIPHYTIC LI; Sorrell B. K., 2007, Wetlands Ecology and Management, V15, P361, DOI 10.1007/s11273-007-9035-9; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Speiser B., 2001, P259, DOI 10.1079/9780851993188.0259; Stokland J.N., 2001, ECOL BULL, V49, P71; Strakova P, 2011, BIOGEOSCIENCES, V8, P2741, DOI 10.5194/bg-8-2741-2011; Suija A, 2011, FOLIA CRYPTOG ESTONI, V48, P154; Suislepp K, 2011, FOREST ECOL MANAG, V262, P1078, DOI 10.1016/j.foreco.2011.06.001; Szybiak K, 2009, POL J ECOL, V57, P525; Tapper PG, 1996, ECOGRAPHY, V19, P237, DOI 10.1111/j.1600-0587.1996.tb01250.x; Trass H, 1999, ANN BOT FENN, V36, P67; Ulevicius Alius, 2011, Ekologija, V57, P47; Uuttera J, 1997, FOREST ECOL MANAG, V96, P125, DOI 10.1016/S0378-1127(97)00035-2; VALOVIRTA I, 1998, J CONCHOL SPECIAL PU, V2, P251; Vellak K., 2007, Forestry Studies / Metsanduslikud Uurimused, V47, P87; Vindigni MA, 2009, FOREST ECOL MANAG, V258, P2056, DOI 10.1016/j.foreco.2009.07.058; Von Arnold K, 2005, FOREST ECOL MANAG, V210, P239, DOI 10.1016/j.foreco.2005.02.031; WOLDA H, 1971, OECOLOGIA, V7, P361, DOI 10.1007/BF00345860; Yule CM, 2010, BIODIVERS CONSERV, V19, P393, DOI 10.1007/s10531-008-9510-5	112	36	36	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63086	10.1371/journal.pone.0063086	http://dx.doi.org/10.1371/journal.pone.0063086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646179	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300134
J	Strnad, L; Peelen, MV; Bedny, M; Caramazza, A				Strnad, Lukas; Peelen, Marius V.; Bedny, Marina; Caramazza, Alfonso			Multivoxel Pattern Analysis Reveals Auditory Motion Information in MT plus of Both Congenitally Blind and Sighted Individuals	PLOS ONE			English	Article							VISUAL-CORTEX; FUNCTIONAL SPECIALIZATION; BRAIN; HUMANS; AREAS; ORGANIZATION; ACTIVATION; EXPERIENCE; DIRECTION; VISION	Cross-modal plasticity refers to the recruitment of cortical regions involved in the processing of one modality (e.g. vision) for processing other modalities (e.g. audition). The principles determining how and where cross-modal plasticity occurs remain poorly understood. Here, we investigate these principles by testing responses to auditory motion in visual motion area MT+ of congenitally blind and sighted individuals. Replicating previous reports, we find that MT+ as a whole shows a strong and selective responses to auditory motion in congenitally blind but not sighted individuals, suggesting that the emergence of this univariate response depends on experience. Importantly, however, multivoxel pattern analyses showed that MT+ contained information about different auditory motion conditions in both blind and sighted individuals. These results were specific to MT+ and not found in early visual cortex. Basic sensitivity to auditory motion in MT+ is thus experience-independent, which may be a basis for the region's strong cross-modal recruitment in congenital blindness.	[Strnad, Lukas; Peelen, Marius V.; Caramazza, Alfonso] Univ Trent, Ctr Mind Brain Sci, Rovereto, Italy; [Strnad, Lukas; Caramazza, Alfonso] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Bedny, Marina] MIT, Brain & Cognit Sci Dept, Cambridge, MA 02139 USA; [Bedny, Marina] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA	University of Trento; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Caramazza, A (corresponding author), Univ Trent, Ctr Mind Brain Sci, Rovereto, Italy.	caram@wjh.harvard.edu	Peelen, Marius V/D-1780-2010	Peelen, Marius V/0000-0002-4026-7303	Fondazione Cassa di Risparmio di Trento e Rovereto	Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro)	The research was financially supported by the Fondazione Cassa di Risparmio di Trento e Rovereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alink A, 2012, HUM BRAIN MAPP, V33, P969, DOI 10.1002/hbm.21263; Amedi A, 2004, NAT NEUROSCI, V7, P1266, DOI 10.1038/nn1328; Bedny M, 2008, J NEUROSCI, V28, P11347, DOI 10.1523/JNEUROSCI.3039-08.2008; Bedny M, 2010, CURR BIOL, V20, P1900, DOI 10.1016/j.cub.2010.09.044; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; Collignon O, 2011, P NATL ACAD SCI USA, V108, P4435, DOI 10.1073/pnas.1013928108; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Downing PE, 2007, J NEUROSCI, V27, P226, DOI 10.1523/JNEUROSCI.3619-06.2007; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Mahon BZ, 2011, TRENDS COGN SCI, V15, P97, DOI 10.1016/j.tics.2011.01.004; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Peelen MV, 2006, NEURON, V49, P815, DOI 10.1016/j.neuron.2006.02.004; Peelen MV, 2013, J COGN NEUROSCI; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Poirier C, 2005, COGNITIVE BRAIN RES, V25, P650, DOI 10.1016/j.cogbrainres.2005.08.015; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Ricciardi E, 2007, CEREB CORTEX, V17, P2933, DOI 10.1093/cercor/bhm018; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Saenz M, 2008, J NEUROSCI, V28, P5141, DOI 10.1523/JNEUROSCI.0803-08.2008; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Wolbers T, 2011, NEUROIMAGE, V56, P681, DOI 10.1016/j.neuroimage.2010.04.266	27	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63198	10.1371/journal.pone.0063198	http://dx.doi.org/10.1371/journal.pone.0063198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646195	Green Published, gold			2022-12-27	WOS:000319077300152
J	Piao, Y; Kimura, A; Urano, S; Saito, Y; Taru, H; Yamamoto, T; Hata, S; Suzuki, T				Piao, Yi; Kimura, Ayano; Urano, Satomi; Saito, Yuhki; Taru, Hidenori; Yamamoto, Tohru; Hata, Saori; Suzuki, Toshiharu			Mechanism of Intramembrane Cleavage of Alcadeins by gamma-Secretase	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CARBOXYL-TERMINAL FRAGMENT; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; BETA-PROTEIN; CELL BIOLOGY; A-BETA; NOTCH; PRESENILIN; MEMBRANE	Background: Alcadein proteins (Alcs; Alc alpha, Alc beta and Alc gamma) are predominantly expressed in neurons, as is Alzheimer's beta-amyloid (A beta) precursor protein (APP). Both Alcs and APP are cleaved by primary alpha-or beta-secretase to generate membrane-associated C-terminal fragments (CTFs). Alc CTFs are further cleaved by gamma-secretase to secrete p3-Alc peptide along with the release of intracellular domain fragment (Alc ICD) from the membrane. In the case of APP, APP CTF beta is initially cleaved at the epsilon-site to release the intracellular domain fragment (AICD) and consequently the gamma-site is determined, by which A beta generates. The initial epsilon-site is thought to define the final gamma-site position, which determines whether A beta 40/43 or A beta 42 is generated. However, initial intracellular e-cleavage sites of Alc CTF to generate Alc ICD and the molecular mechanism that final gamma-site position is determined remains unclear in Alcs. Methodology: Using HEK293 cells expressing Alcs plus presenilin 1 (PS1, a catalytic unit of gamma-secretase) and the membrane fractions of these cells, the generation of p3-Alc possessing C-terminal gamma-cleavage site and Alc ICD possessing N-terminal epsilon-cleavage site were analysed with MALDI-TOF/MS. We determined the initial epsilon-site position of all Alc alpha, Alc beta and Alc gamma, and analyzed the relationship between the initially determined epsilon-site position and the final gamma-cleavage position. Conclusions: The initial epsilon-site position does not always determine the final gamma-cleavage position in Alcs, which differed from APP. No additional gamma-cleavage sites are generated from artificial/non-physiological positions of epsilon-cleavage for Alcs, while the artificial epsilon-cleavage positions can influence in selection of physiological gamma-site positions. Because alteration of gamma-secretase activity is thought to be a pathogenesis of sporadic Alzheimer's disease, Alcs are useful and sensitive substrate to detect the altered cleavage of substrates by gamma-secretase, which may be induced by malfunction of gamma-secretase itself or changes of membrane environment for enzymatic reaction.	[Piao, Yi; Kimura, Ayano; Urano, Satomi; Saito, Yuhki; Yamamoto, Tohru; Hata, Saori; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Sapporo, Hokkaido, Japan; [Taru, Hidenori] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neural Cell Biol, Sapporo, Hokkaido, Japan; [Taru, Hidenori] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Sapporo, Hokkaido, Japan.	tsuzuki@pharm.hokudai.ac.jp	Hata, Saori/AAP-9634-2020; Taru, Hidenori/B-7059-2009; Suzuki, Toshiharu/B-5342-2013; Yamamoto, Tohru/A-3801-2012	Yamamoto, Tohru/0000-0002-1652-0233	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23390017, 24790062]; New Energy and Industrial Technology Development Organization (NEDO) in Japan; Grants-in-Aid for Scientific Research [23790070, 23390017] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO) in Japan(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (23390017 to TS, 24790062 to SH) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a grant from the New Energy and Industrial Technology Development Organization (NEDO) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hata S, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-16; Hata S, 2011, ANN NEUROL, V69, P1026, DOI 10.1002/ana.22343; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; Kakuda N, 2012, EMBO MOL MED, V4, P344, DOI 10.1002/emmm.201200214; Lichtenthaler SF, 2007, EMBO REP, V8, P537, DOI 10.1038/sj.embor.7400978; Mizumaru C, 2009, J NEUROCHEM, V111, P1213, DOI 10.1111/j.1471-4159.2009.06399.x; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2012, CELL REPORTS, V3, P1; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2007, J NEUROCHEM, V100, P1234, DOI 10.1111/j.1471-4159.2006.04302.x	27	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62431	10.1371/journal.pone.0062431	http://dx.doi.org/10.1371/journal.pone.0062431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658629	gold, Green Submitted, Green Published			2022-12-27	WOS:000318343700057
J	Khan, I; Ali, F; Shafie, S				Khan, Ilyas; Ali, Farhad; Shafie, Sharidan			Stokes' Second Problem for Magnetohydrodynamics Flow in a Burgers' Fluid: The Cases gamma = lambda(2)/4 and gamma >lambda(2)/4	PLOS ONE			English	Article							OLDROYD-B FLUID; NON-NEWTONIAN FLUIDS; MHD FLOW; 2ND-GRADE FLUID; 1ST PROBLEM; THERMAL-RADIATION; MAXWELL FLUID; HALL CURRENT	The present work is concerned with exact solutions of Stokes second problem for magnetohydrodynamics (MHD) flow of a Burgers' fluid. The fluid over a flat plate is assumed to be electrically conducting in the presence of a uniform magnetic field applied in outward transverse direction to the flow. The equations governing the flow are modeled and then solved using the Laplace transform technique. The expressions of velocity field and tangential stress are developed when the relaxation time satisfies the condition gamma = lambda(2)/4 or gamma>lambda(2)/4. The obtained closed form solutions are presented in the form of simple or multiple integrals in terms of Bessel functions and terms with only Bessel functions. The numerical integration is performed and the graphical results are displayed for the involved flow parameters. It is found that the velocity decreases whereas the shear stress increases when the Hartmann number is increased. The solutions corresponding to the Stokes' first problem for hydrodynamic Burgers' fluids are obtained as limiting cases of the present solutions. Similar solutions for Stokes' second problem of hydrodynamic Burgers' fluids and those for Newtonian and Oldroyd-B fluids can also be obtained as limiting cases of these solutions.	[Khan, Ilyas; Ali, Farhad; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Malaysia	Universiti Teknologi Malaysia	Khan, I (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Malaysia.	ilyaskhanqau@yahoo.com	Ali, Farhad/Y-5301-2018; SHAFIE, SHARIDAN/A-2210-2013; Khan, Ilyas/C-8770-2019	SHAFIE, SHARIDAN/0000-0001-7795-2278; Khan, Ilyas/0000-0002-2056-9371				ALI F, 2011, EUR J SCI RES, V57, P293; ANDERSSON HI, 1992, ACTA MECH, V95, P227, DOI 10.1007/BF01170814; Christov IC, 2010, MECH RES COMMUN, V37, P717, DOI 10.1016/j.mechrescom.2010.09.006; Ersoy HV, 1999, INT J ENG SCI, V37, P1973, DOI 10.1016/S0020-7225(99)00010-5; Fakhar K, 2011, COMPUT MATH APPL, V61, P980, DOI 10.1016/j.camwa.2010.12.046; Fetecau C, 2011, ACTA MECH, V216, P359, DOI 10.1007/s00707-010-0398-2; Ghasemi E., 2011, INT J PHYS SCI, V6, P5022; Hameed A, 2007, J MATH ANAL APPL, V325, P724, DOI 10.1016/j.jmaa.2006.02.002; Hammouch Z, 2008, EUR J PURE APPL MATH, V1, P11; Hayat T, 2008, NONLINEAR ANAL-REAL, V9, P1619, DOI 10.1016/j.nonrwa.2007.04.006; Hayat T, 2008, PHYS LETT A, V372, P1639, DOI 10.1016/j.physleta.2007.10.036; Hayat T, 2008, J POROUS MEDIA, V11, P389, DOI 10.1615/JPorMedia.v11.i4.50; Hayat T, 2007, TRANSPORT POROUS MED, V68, P249, DOI 10.1007/s11242-006-9043-x; Hayat T, 2007, COMPUT MATH APPL, V54, P407, DOI 10.1016/j.camwa.2006.12.036; Hayat T, 2002, MATH COMPUT MODEL, V36, P987, DOI 10.1016/S0895-7177(02)00252-2; Hayat T, 2010, INT J HEAT MASS TRAN, V53, P4780, DOI 10.1016/j.ijheatmasstransfer.2010.06.014; Hayat T, 2010, Z NATURFORSCH A, V65, P1111, DOI 10.1515/zna-2010-1216; Hayat T, 2010, Z NATURFORSCH A, V65, P950, DOI 10.1515/zna-2010-1107; KASIVISWANATHAN SR, 1992, INT J ENG SCI, V30, P409, DOI 10.1016/0020-7225(92)90033-D; Khan I, 2012, TRANSPORT POROUS MED, V91, P49, DOI 10.1007/s11242-011-9832-8; KHAN I, 2010, WORLD APPL SCI J, V9, P55; Khan I, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.104401; Khan I, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.064401; Khan M, 2011, Z ANGEW MATH PHYS, V62, P749, DOI 10.1007/s00033-011-0141-4; Khan M, 2013, COMMUN THEOR PHYS, V59, P99, DOI 10.1088/0253-6102/59/1/18; Khan M, 2012, NUCL ENG DES, V243, P20, DOI 10.1016/j.nucengdes.2011.11.024; Khan M, 2011, CHEM ENG COMMUN, V198, P1415, DOI 10.1080/00986445.2011.560521; Kumar AS., 2010, J ENG TECH RES, V2, P73; Liu YQ, 2011, COMPUT MATH APPL, V61, P443, DOI 10.1016/j.camwa.2010.11.021; Rana MA, 2008, PHYS LETT A, V372, P562, DOI 10.1016/j.physleta.2007.08.008; RAO AR, 1985, INT J ENG SCI, V23, P1387, DOI 10.1016/0020-7225(85)90117-X; Rathee R, 2011, INT J PHYS SCI, V6, P2497; SARPKAYA T, 1961, AICHE J, V7, P324, DOI 10.1002/aic.690070231; Seth G.S., 2010, INT J ENG SCI TECHNO, V2, P1; Siddiqui AA, 2008, MATH MODEL ANAL, V13, P565, DOI 10.3846/1392-6292.2008.13.565-576; Siddiqui AM, 2008, COMMUN NONLINEAR SCI, V13, P1554, DOI 10.1016/j.cnsns.2006.10.005; SREEHARIREDDY P, 2009, J SCI RES, V1, P220; SURI PK, 1981, INDIAN J PURE AP MAT, V12, P907; Sweet E, 2011, COMMUN NONLINEAR SCI, V16, P266, DOI 10.1016/j.cnsns.2010.03.019; Uddin MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049499; Vieru D, 2008, APPL MATH COMPUT, V197, P76, DOI 10.1016/j.amc.2007.07.033; Zheng LC, 2011, MATH COMPUT MODEL, V54, P780, DOI 10.1016/j.mcm.2011.03.025; Zheng LC, 2012, NONLINEAR ANAL-REAL, V13, P513, DOI 10.1016/j.nonrwa.2011.02.016	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61531	10.1371/journal.pone.0061531	http://dx.doi.org/10.1371/journal.pone.0061531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667442	gold, Green Submitted, Green Published			2022-12-27	WOS:000319055600012
J	Seabury, CM; Dowd, SE; Seabury, PM; Raudsepp, T; Brightsmith, DJ; Liboriussen, P; Halley, Y; Fisher, CA; Owens, E; Viswanathan, G; Tizard, IR				Seabury, Christopher M.; Dowd, Scot E.; Seabury, Paul M.; Raudsepp, Terje; Brightsmith, Donald J.; Liboriussen, Poul; Halley, Yvette; Fisher, Colleen A.; Owens, Elaine; Viswanathan, Ganesh; Tizard, Ian R.			A Multi-Platform Draft de novo Genome Assembly and Comparative Analysis for the Scarlet Macaw (Ara macao)	PLOS ONE			English	Article							WIDE ASSOCIATION SCAN; PARROTS PSITTACIFORMES; SPECIES DIVERGENCE; AFRICAN ANCESTRY; COMMON VARIANTS; AGING RESEARCH; HEART-FAILURE; LIFE-SPAN; GENE; LOCI	Data deposition to NCBI Genomes: This Whole Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession AMXX00000000 (SMACv1.0, unscaffolded genome assembly). The version described in this paper is the first version (AMXX01000000). The scaffolded assembly (SMACv1.1) has been deposited at DDBJ/EMBL/GenBank under the accession AOUJ00000000, and is also the first version (AOUJ01000000). Strong biological interest in traits such as the acquisition and utilization of speech, cognitive abilities, and longevity catalyzed the utilization of two next-generation sequencing platforms to provide the first-draft de novo genome assembly for the large, new world parrot Ara macao (Scarlet Macaw). Despite the challenges associated with genome assembly for an outbred avian species, including 951,507 high-quality putative single nucleotide polymorphisms, the final genome assembly (>1.035 Gb) includes more than 997 Mb of unambiguous sequence data (excluding N's). Cytogenetic analyses including ZooFISH revealed complex rearrangements associated with two scarlet macaw macrochromosomes (AMA6, AMA7), which supports the hypothesis that translocations, fusions, and intragenomic rearrangements are key factors associated with karyotype evolution among parrots. In silico annotation of the scarlet macaw genome provided robust evidence for 14,405 nuclear gene annotation models, their predicted transcripts and proteins, and a complete mitochondrial genome. Comparative analyses involving the scarlet macaw, chicken, and zebra finch genomes revealed high levels of nucleotide-based conservation as well as evidence for overall genome stability among the three highly divergent species. Application of a new whole-genome analysis of divergence involving all three species yielded prioritized candidate genes and noncoding regions for parrot traits of interest (i.e., speech, intelligence, longevity) which were independently supported by the results of previous human GWAS studies. We also observed evidence for genes and noncoding loci that displayed extreme conservation across the three avian lineages, thereby reflecting their likely biological and developmental importance among birds.	[Seabury, Christopher M.; Brightsmith, Donald J.; Halley, Yvette; Fisher, Colleen A.; Owens, Elaine; Viswanathan, Ganesh; Tizard, Ian R.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA; [Seabury, Paul M.] ElanTech Inc, Greenbelt, MD USA; [Raudsepp, Terje] Texas A&M Univ, Coll Vet Med, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Liboriussen, Poul] CLC Bio, Finlandsgade, Katrinebjerg, Denmark	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Seabury, CM (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	cseabury@cvm.tamu.edu; itizard@cvm.tamu.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Brightsmith, Donald/0000-0002-3306-6490; Halley-Schultz, Yvette/0000-0002-5159-6137				Alderton D, 2003, ULTIMATE ENCY CAGED, P234; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Arrington CB, 2010, AM J MED GENET A, V152A, P2919, DOI 10.1002/ajmg.a.33718; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Brightsmith D, 2005, BIOL CONSERV, V121, P465, DOI 10.1016/j.biocon.2004.05.016; Brightsmith DJ, 2005, WILSON BULL, V117, P296, DOI 10.1676/03-087A.1; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Buller C, 2001, HUM MOL GENET, V10, P2775, DOI 10.1093/hmg/10.24.2775; Burish MJ, 2004, BRAIN BEHAV EVOLUT, V63, P107, DOI 10.1159/000075674; Celestino-Soper PBS, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-17; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018139; Choi J, 2012, HUM MOL GENET, V21, P1566, DOI 10.1093/hmg/ddr594; Christidis L, 2008, SYSTEMATICS TAXONOMY, P200; Collar N.J., 1997, HDB BIRDS WORLD, V4, P280; Cooper O, 2008, DEV DYNAM, V237, P1442, DOI 10.1002/dvdy.21490; Cornejo J, 2012, J ANIM PHYSIOL AN N, V96, P947, DOI 10.1111/j.1439-0396.2011.01218.x; Costin GE, 2005, BIOCHEM J, V391, P249, DOI 10.1042/BJ20042070; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Davidson S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-614; Deelen J, 2013, AGE, V35, P235, DOI 10.1007/s11357-011-9340-3; Del Hoyo J, 1997, HDB BIRDS WORLD, V2, P530; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Della-Morte D, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-100; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Ekblom R, 2011, IMMUNOGENETICS, V63, P523, DOI [10.1007/s00251-011-0525-9, 10.1007/s00251-011-0528-6]; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; Ersland KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031687; Escamilla M, 2008, SCHIZOPHR RES, V106, P253, DOI 10.1016/j.schres.2008.09.005; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Frynta D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012568; Fujimura Lisa, 2012, Methods Mol Biol, V839, P173, DOI 10.1007/978-1-61779-510-7_14; Fumagalli M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000849; Gebhardt KJ, 2008, MOL ECOL RESOUR, V8, P835, DOI 10.1111/j.1755-0998.2007.02083.x; Gebhardt KJ, 2009, J FIELD ORNITHOL, V80, P183, DOI 10.1111/j.1557-9263.2009.00221.x; Gianfrancesco F, 2008, NEUROSCIENCE, V155, P345, DOI 10.1016/j.neuroscience.2008.05.030; Granzier H, 2007, AM J PHYSIOL-REG I, V293, pR557, DOI 10.1152/ajpregu.00001.2007; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Gunski RJ, 1998, GENET MOL BIOL, V21, P207, DOI 10.1590/S1415-47571998000200006; Hagg S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000754; Hajdu I, 2011, P NATL ACAD SCI USA, V108, P13130, DOI 10.1073/pnas.1110081108; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Hickey AJR, 2012, AGEING RES REV, V11, P242, DOI 10.1016/j.arr.2011.12.002; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Horn D, 2010, HUM MUTAT, V31, pE1851, DOI 10.1002/humu.21362; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Hughes CR, 2008, IMMUNOGENETICS, V60, P219, DOI 10.1007/s00251-008-0287-1; Hussman JP, 2011, MOL AUTISM, V2, DOI [10.1186/2040-2392-2-1, 10.1186/2040-2392-2-18]; Ichikawa Y, 2012, P NATL ACAD SCI USA, V109, P4152, DOI 10.1073/pnas.1119338109; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Ishihara T, 2008, GENE EXPR PATTERNS, V8, P357, DOI 10.1016/j.gep.2008.01.003; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Iurov I Iu, 2010, Genetika, V46, P1348; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Jochumsen U, 2008, SEX DEV, V2, P302, DOI 10.1159/000195679; Johnson R, 2009, MOL BIOL EVOL, V26, P1491, DOI 10.1093/molbev/msp058; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kaminen N, 2003, J MED GENET, V40, P340, DOI 10.1136/jmg.40.5.340; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kumar S, 2011, BIOINFORMATICS, V27, P2023, DOI 10.1093/bioinformatics/btr315; Kume T, 2009, ADV EXP MED BIOL, V665, P63; Larsson M, 2011, AM J HUM GENET, V89, P334, DOI 10.1016/j.ajhg.2011.07.011; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Liao CY, 2012, CELL RES, V22, P1215, DOI 10.1038/cr.2012.62; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Logue MW, 2011, ARCH NEUROL-CHICAGO, V68, P1569, DOI 10.1001/archneurol.2011.646; Lopez LM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.02.003; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Manning AD, 2007, J BIOGEOGR, V34, P289, DOI 10.1111/j.1365-2699.2006.01603.x; Maron JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037870; Marroni F, 2009, CIRC-CARDIOVASC GENE, V2, P322, DOI 10.1161/CIRCGENETICS.108.833806; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Matuzak GD, 2008, WILSON J ORNITHOL, V120, P353, DOI 10.1676/07-038.1; Mayer C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-277; McDonough CW, 2011, KIDNEY INT, V79, P563, DOI 10.1038/ki.2010.467; Mead S, 2012, HUM MOL GENET, V21, P1897, DOI 10.1093/hmg/ddr607; Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007; Meisler MH, 2001, GENOME RES, V11, P1617, DOI 10.1101/gr.211401; Melville SA, 2012, ANN NEUROL, V72, P65, DOI 10.1002/ana.23644; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; Montgomery MK, 2012, EXP GERONTOL, V47, P203, DOI 10.1016/j.exger.2011.11.006; Montgomery SH, 2011, MOL BIOL EVOL, V28, P625, DOI 10.1093/molbev/msq237; Morrison AC, 2010, CIRC-CARDIOVASC GENE, V3, P248, DOI 10.1161/CIRCGENETICS.109.895995; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Moy SS, 2009, BEHAV BRAIN RES, V205, P123, DOI 10.1016/j.bbr.2009.06.021; Munshi-South J, 2006, AUK, V123, P108, DOI 10.1642/0004-8038(2006)123[0108:DILSIP]2.0.CO;2; Murea M, 2011, AM J NEPHROL, V33, P502, DOI 10.1159/000327985; N'Diaye A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002298; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nanda I, 2007, CYTOGENET GENOME RES, V117, P43, DOI 10.1159/000103164; Nanda I, 2011, CYTOGENET GENOME RES, V132, P165, DOI 10.1159/000322358; NANDA I, 1994, CYTOGENET CELL GENET, V65, P190, DOI 10.1159/000133630; Nei M., 2000, MOL EVOLUTION PHYLOG, p[33, 99]; Norris JM, 2009, OBESITY, V17, P1932, DOI 10.1038/oby.2009.143; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oleksyk TK, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-14; Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575; Pepperberg IM, 2006, ANIM COGN, V9, P377, DOI 10.1007/s10071-006-0034-7; Pfeffer G, 2012, BRAIN, V135, P1695, DOI 10.1093/brain/aws102; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Presti FT, 2011, GENET MOL BIOL, V34, P348, DOI 10.1590/S1415-47572011005000012; Raudsepp T, 2002, CYTOGENET GENOME RES, V98, P54, DOI 10.1159/000068532; Raudsepp T, 1999, CHROMOSOME RES, V7, P103, DOI 10.1023/A:1009234814635; Raz N, 2008, CEREB CORTEX, V18, P718, DOI 10.1093/cercor/bhm108; Reis LM, 2011, MOL VIS, V17, P2527; Ribas CC, 2007, P ROY SOC B-BIOL SCI, V274, P2399, DOI 10.1098/rspb.2007.0613; Rizzi TS, 2011, AM J MED GENET B, V156B, P145, DOI 10.1002/ajmg.b.31149; Rosen GD, 2009, GENES BRAIN BEHAV, V8, P296, DOI 10.1111/j.1601-183X.2009.00473.x; Rosenberg MS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-102; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Seabury CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015811; Sedwick Caitlin, 2011, PLoS Biol, V9, pe1001018, DOI 10.1371/journal.pbio.1001018; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Smith NL, 2010, CIRC-CARDIOVASC GENE, V3, P256, DOI 10.1161/CIRCGENETICS.109.895763; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396; Tavares ES, 2006, SYST BIOL, V55, P454, DOI 10.1080/10635150600697390; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; TIERSCH TR, 1991, J HERED, V82, P363, DOI 10.1093/oxfordjournals.jhered.a111105; Timmermans S, 2000, BRAIN BEHAV EVOLUT, V56, P196, DOI 10.1159/000047204; Tongaonkar P, 2009, J BIOL CHEM, V284, P5602, DOI 10.1074/jbc.M806664200; Tran PX, 2011, BIRTH DEFECTS RES A, V91, P39, DOI 10.1002/bdra.20744; Troyer JL, 2011, J INFECT DIS, V203, P1491, DOI 10.1093/infdis/jir046; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; VANDONGEN MWM, 1984, GENETICA, V65, P109, DOI 10.1007/BF00056768; Vaughan C, 2005, BIRD CONSERV INT, V15, P119; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vigo G, 2011, ORNITOL NEOTROP, V22, P143; Voelbel GT, 2006, BIOL PSYCHIAT, V60, P942, DOI 10.1016/j.biopsych.2006.03.071; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Witt CC, 1998, J STRUCT BIOL, V122, P206, DOI 10.1006/jsbi.1998.3993; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Zhang J, 2011, TISSUE ENG PT A, V17, P1767, DOI 10.1089/ten.tea.2010.0503; Zhang W, 2011, DIS MODEL MECH, V4, P368, DOI 10.1242/dmm.005744; Zhao ZM, 2003, GENE, V312, P207, DOI 10.1016/S0378-1119(03)00670-X	164	45	45	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62415	10.1371/journal.pone.0062415	http://dx.doi.org/10.1371/journal.pone.0062415			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667475	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600025
J	Abd-Alla, AMM; Kariithi, HM; Mohamed, AH; Lapiz, E; Parker, AG; Vreysen, MJB				Abd-Alla, Adly M. M.; Kariithi, Henry M.; Mohamed, Abdul Hasim; Lapiz, Edgardo; Parker, Andrew G.; Vreysen, Marc J. B.			Managing Hytrosavirus Infections in Glossina pallidipes Colonies: Feeding Regime Affects the Prevalence of Salivary Gland Hypertrophy Syndrome	PLOS ONE			English	Article							TSETSE FLIES GLOSSINA; LOP-EARED RABBITS; DNA VIRUS; AUSTENI NEWST; MORSITANS CENTRALIS; LIVING HOST; DIPTERA; MEMBRANE; ABSENCE	Many species of tsetse flies are infected by a virus that causes salivary gland hypertrophy (SGH) syndrome and the virus isolated from Glossina pallidipes (GpSGHV) has recently been sequenced. Flies with SGH have a reduced fecundity and fertility. Due to the deleterious impact of SGHV on G. pallidipes colonies, several approaches were investigated to develop a virus management strategy. Horizontal virus transmission is the major cause of the high prevalence of the GpSGHV in tsetse colonies. Implementation of a "clean feeding'' regime (fresh blood offered to each set of flies so that there is only one feed per membrane), instead of the regular feeding regime (several successive feeds per membrane), was among the proposed approaches to reduce GpSGHV infections. However, due to the absence of disposable feeding equipment (feeding trays and silicone membranes), the implementation of a clean feeding approach remains economically difficult. We developed a new clean feeding approach applicable to large-scale tsetse production facilities using existing resources. The results indicate that implementing this approach is feasible and leads to a significant reduction in virus load from 10(9) virus copies in regular colonies to an average of 10(2.5) and eliminates the SGH syndrome from clean feeding colonies by28 months post implementation of this approach. The clean feeding approach also reduced the virus load from an average of 10(8) virus copy numbers to an average of 10(3) virus copies and SGH prevalence of 10% to 4% in flies fed after the clean fed colony. Taken together, these data indicate that the clean feeding approach is applicable in large-scale G. pallidipes production facilities and eliminates the deleterious effects of the virus and the SGH syndrome in these colonies.	[Abd-Alla, Adly M. M.; Kariithi, Henry M.; Mohamed, Abdul Hasim; Lapiz, Edgardo; Parker, Andrew G.; Vreysen, Marc J. B.] Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Kariithi, Henry M.] Wageningen Univ, Virol Lab, NL-6700 AP Wageningen, Netherlands	International Atomic Energy Agency; Wageningen University & Research	Abd-Alla, AMM (corresponding author), Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.	a.m.m.abd-alla@iaea.org		ABD-ALLA, Adly/0000-0001-7540-4462; Kariithi, Henry/0000-0002-9250-9108; Parker, Andrew Gordon/0000-0001-8187-1278	Netherlands Fellowship Program Grant [CF7548/2011]	Netherlands Fellowship Program Grant	HMK is a recipient of a Netherlands Fellowship Program Grant award CF7548/2011 (www.nuffic.nl) for Sandwich PhD Programme at Wageningen University, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Alla A, 2007, J VIROL METHODS, V139, P143, DOI 10.1016/j.jviromet.2006.09.018; Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Abd-Alla AMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038417; Abd-Alla AMM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001220; Abd-Alla AMM, 2010, VIRUS RES, V150, P103, DOI 10.1016/j.virusres.2010.03.001; Abd-Alla AMM, 2009, ARCH VIROL, V154, P909, DOI 10.1007/s00705-009-0398-5; Abd-Alla AMM, 2009, VIRUS RES, V139, P48, DOI 10.1016/j.virusres.2008.10.006; Alemu T., 2007, P325, DOI 10.1007/978-1-4020-6059-5_30; [Anonymous], 2010, R LANG ENV STAT COMP; Baier T, 2007, COMPUTATION STAT, V22, P91, DOI 10.1007/s00180-007-0023-6; BAUER B, 1976, B ENTOMOL RES, V65, P563, DOI 10.1017/S0007485300006246; Feldmann U, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P701, DOI 10.1007/1-4020-4051-2_27; Feldmann U, 1994, TECHNIQUES INSECT RE, P13; Feldmann U, 1994, TECHNIQUES INSECT RE, P449; Feldmann U, 1992, P SEM JOINTL ORG INT, P167; FELDMANN U, 1993, MANAGEMENT INSECT PE, P579; Geerts S, 2001, TRENDS PARASITOL, V17, P25, DOI 10.1016/S1471-4922(00)01827-4; Gooding R. H., 1997, The molecular biology of insect disease vectors: a methods manual., P41; Hendrichs J., 2007, P3; Jordan A, 1986, TRYPANOSOMIASIS CONT; JORDAN AM, 1968, B ENTOMOL RES, V58, P399, DOI 10.1017/S0007485300056923; JORDAN AM, 1967, ANN TROP MED PARASIT, V61, P182, DOI 10.1080/00034983.1967.11686477; JURA WGZO, 1989, CURR MICROBIOL, V18, P1, DOI 10.1007/BF01568821; Kariithi HM, 2013, J INVERTEBR PATHOL, V112, pS123, DOI 10.1016/j.jip.2012.04.016; Kariithi HM, 2013, J GEN VIROL, V94, P193, DOI 10.1099/vir.0.047423-0; Kariithi HM, 2010, J GEN VIROL, V91, P3065, DOI 10.1099/vir.0.023671-0; LANGLEY PA, 1969, NATURE, V221, P855, DOI 10.1038/221855a0; LANGLEY PA, 1972, T ROY SOC TROP MED H, V66, P310, DOI 10.1016/0035-9203(72)90172-1; LANGLEY PA, 1972, B ENTOMOL RES, V62, P215, DOI 10.1017/S0007485300047672; Leak SGA., 1998, TSETSE BIOL ECOLOGY, DOI [10.1079/9780851993003.0000, DOI 10.1079/9780851993003.0000]; Lietze VU, 2011, ANNU REV ENTOMOL, V56, P63, DOI 10.1146/annurev-ento-120709-144841; MEWS AR, 1977, B ENTOMOL RES, V67, P119, DOI 10.1017/S0007485300010944; Mews AR, 1972, TECHNIQUES USED IAEA, P243; Mutika GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042188; NASH TAM, 1966, ANN TROP MED PARASIT, V60, P39, DOI 10.1080/00034983.1966.11686383; PAGOT J, 1972, CR ACAD SCI D NAT, V275, P911; Sang RC, 1996, J INVERTEBR PATHOL, V68, P253, DOI 10.1006/jipa.1996.0093; Sang RC, 1998, MEM I OSWALDO CRUZ, V93, P861, DOI 10.1590/S0074-02761998000600030; Sokal R. R, 1981, BIOMETRY; STEELMAN CD, 1976, ANNU REV ENTOMOL, V21, P155, DOI 10.1146/annurev.en.21.010176.001103; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; WHO, 2001, WHO TDR COMM REP	42	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61875	10.1371/journal.pone.0061875	http://dx.doi.org/10.1371/journal.pone.0061875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667448	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700017
J	Yang, Y; Liu, Q; Ji, RR; Gao, Y				Yang, You; Liu, Qiong; Ji, Rongrong; Gao, Yue			Remote Dynamic Three-Dimensional Scene Reconstruction	PLOS ONE			English	Article							TECHNOLOGY	Remote dynamic three-dimensional (3D) scene reconstruction renders the motion structure of a 3D scene remotely by means of both the color video and the corresponding depth maps. It has shown a great potential for telepresence applications like remote monitoring and remote medical imaging. Under this circumstance, video-rate and high resolution are two crucial characteristics for building a good depth map, which however mutually contradict during the depth sensor capturing. Therefore, recent works prefer to only transmit the high-resolution color video to the terminal side, and subsequently the scene depth is reconstructed by estimating the motion vectors from the video, typically using the propagation based methods towards a video-rate depth reconstruction. However, in most of the remote transmission systems, only the compressed color video stream is available. As a result, color video restored from the streams has quality losses, and thus the extracted motion vectors are inaccurate for depth reconstruction. In this paper, we propose a precise and robust scheme for dynamic 3D scene reconstruction by using the compressed color video stream and their inaccurate motion vectors. Our method rectifies the inaccurate motion vectors by analyzing and compensating their quality losses, motion vector absence in spatial prediction, and dislocation in near-boundary region. This rectification ensures the depth maps can be compensated in both video-rate and high resolution at the terminal side towards reducing the system consumption on both the compression and transmission. Our experiments validate that the proposed scheme is robust for depth map and dynamic scene reconstruction on long propagation distance, even with high compression ratio, outperforming the benchmark approaches with at least 3.3950 dB quality gains for remote applications.	[Yang, You; Liu, Qiong] Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Hubei, Peoples R China; [Yang, You] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Ji, Rongrong] Xiamen Univ, Dept Cognit Sci, Sch Informat Sci & Engn, Xiamen, Fujian, Peoples R China; [Gao, Yue] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore	Huazhong University of Science & Technology; Tsinghua University; Xiamen University; National University of Singapore	Liu, Q (corresponding author), Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Hubei, Peoples R China.	q.liu@hust.edu.cn; rrji@xmu.edu.cn	Yang, You/A-9497-2019; Yang, You/O-5723-2019	Yang, You/0000-0002-5695-1046; 	National Natural Science Foundation of China [61170194, 61202301]; International S&T Cooperation Program of China [2012DFG12010]; Xiamen University 985 Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China; Xiamen University 985 Project	This work was supported by National Natural Science Foundation of China (No.61170194 and 61202301), International S&T Cooperation Program of China (No.2012DFG12010), and Xiamen University 985 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergrath S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036796; Bjontegaard G., 2001, VCEG M33 CALCULATION; Cho JH, 2008, IEEE T CONSUM ELECTR, V54, P1514, DOI 10.1109/TCE.2008.4711195; Fehn C, 2004, PROC SPIE, V5291, P93, DOI 10.1117/12.524762; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P2269, DOI 10.1109/TIP.2011.2170081; Gao Y, 2010, PATTERN RECOGN, V43, P1142, DOI 10.1016/j.patcog.2009.07.012; Granot Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002075; Harding G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035950; Henry P., 2010, P ADV REAS DEPTH CAM, P1; Jung JH, 2010, OPT EXPRESS, V18, P26373, DOI 10.1364/OE.18.026373; Kitazaki M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003177; Kolb Andreas, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4563159; Lee C, 2008, JTC1SC29WG11 ISOIEC; Leyvand T, 2011, COMPUTER, V44, P94, DOI 10.1109/MC.2011.114; Magara F, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0014094; Meir A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007974; Muller K, 2008, EURASIP J IMAGE VIDE, DOI 10.1155/2008/438148; Ohm JR, 2011, JTC1SC29WG11 ISOIEC; ORCHARD MT, 1994, IEEE T IMAGE PROCESS, V3, P693, DOI 10.1109/83.334974; Smolic A, 2006, INT C MULT EXP; Tanimoto M, 2012, SIGNAL PROCESS-IMAGE, V27, P555, DOI 10.1016/j.image.2012.02.016; Valverde-Islas LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014754; Varekamp C, 2007, 4 EUR C VIS MED PROD, P1; Wang Y., 2002, VIDEO PROCESSING COM; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wiegand T, 2003, IEEE T CIRC SYST VID, V13, P560, DOI 10.1109/TCSVT.2003.815165; Worringham C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014669; Yan X., 2011, 3DTV C TRUE VIS CAPT, P1, DOI DOI 10.1109/3DTV.2011.5877167; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047041	30	7	7	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e55586	10.1371/journal.pone.0055586	http://dx.doi.org/10.1371/journal.pone.0055586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667417	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700001
J	Gierman, LM; van El, B; van der Ham, F; Koudijs, A; Stoop, R; Verheijen, JH; Kloppenburg, M; van Osch, GJVM; Stojanovic-Susulic, V; Huizinga, TWJ; Zuurmond, AM				Gierman, Lobke M.; van El, Benno; van der Ham, Frits; Koudijs, Angela; Stoop, Reinout; Verheijen, Jan H.; Kloppenburg, Margreet; van Osch, Gerjo J. V. M.; Stojanovic-Susulic, Vedrana; Huizinga, Tom W. J.; Zuurmond, Anne-Marie			Profiling the Secretion of Soluble Mediators by End Stage Osteoarthritis Synovial Tissue Explants Reveals a Reduced Responsiveness to an Inflammatory Trigger	PLOS ONE			English	Article							GROWTH-FACTOR; CARTILAGE; DEGRADATION; EXPRESSION; INHIBITION; HYPOXIA; DISEASE	Objective: Evidence is accumulating that synovial tissue plays an active role in osteoarthritis (OA), however, exact understanding of its contribution is lacking. In order to further elucidate its role in the OA process, we aimed to identify the secretion pattern of soluble mediators by synovial tissue and to assess its ability to initiate cartilage degeneration. Methods: Synovial tissue explants (STEs) obtained from donors without history of OA (n = 8) or from end stage OA patients (n = 16) were cultured alone or together with bovine cartilage explants in the absence or presence of IL-1 alpha. The secretion of 48 soluble mediators was measured and the effect on glycosaminoglycan (GAG) release and matrix metalloproteinase (MMP) activity was determined. Results: Normal and OA STEs secreted comparable levels of almost all measured soluble mediators. However, in the presence of IL-1 alpha these mediators were less secreted by OA than by normal STEs of which 15 differed significantly (p<0.01). No effect of normal or OA STEs on GAG release from the cartilage explants was observed, and no differences in MMP activity between OA and normal STEs were detected. Conclusions: Unexpectedly, a comparable secretion profile of soluble mediators was found for OA and normal STEs while the reduced responsiveness of OA STEs to an inflammatory trigger indicates a different state of this tissue in OA patients. The effects could be the result of prolonged exposure to an inflammatory environment in OA development. Further understanding of the pro-inflammatory and inflammation resolving mechanisms during disease progression in synovial tissue may provide valuable targets for therapy in the future.	[Gierman, Lobke M.; van El, Benno; van der Ham, Frits; Koudijs, Angela; Stoop, Reinout; Verheijen, Jan H.; Zuurmond, Anne-Marie] TNO, Leiden, Netherlands; [Gierman, Lobke M.; Kloppenburg, Margreet; Huizinga, Tom W. J.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [van Osch, Gerjo J. V. M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Orthopaed, Rotterdam, Netherlands; [van Osch, Gerjo J. V. M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Otorhinolaryngol, Rotterdam, Netherlands; [Stojanovic-Susulic, Vedrana] Janssen, Pharmaceut R&D, Malvern, PA USA	Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA	Zuurmond, AM (corresponding author), TNO, Leiden, Netherlands.	Anne-Marie.Zuurmond@tno.nl		, Reinout/0000-0002-8773-8248	Top Institute Pharma [T1-213-1]	Top Institute Pharma	This work is financially supported by: Top Institute Pharma, Grant T1-213-1 Generation of models, mechanisms and markers for stratification of osteoarthritis patients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Attur M, 2010, BEST PRACT RES CL RH, V24, P71, DOI 10.1016/j.berh.2009.08.011; Beekhuizen M, 2011, ARTHRITIS RHEUM-US, V63, P1918, DOI 10.1002/art.30364; Beekman B, 1999, ANN NY ACAD SCI, V878, P150, DOI 10.1111/j.1749-6632.1999.tb07681.x; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Bonnet CS, 2005, RHEUMATOLOGY, V44, P7, DOI 10.1093/rheumatology/keh344; Brandt KD, 2006, ANN RHEUM DIS, V65, P1261, DOI 10.1136/ard.2006.058347; Deiters B, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2357; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; GOLDENBERG DL, 1982, J RHEUMATOL, V9, P204; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Hunter DJ, 2009, OSTEOARTHR CARTILAGE, V17, P1402, DOI 10.1016/j.joca.2009.04.014; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Jackson JR, 1997, J RHEUMATOL, V24, P1253; Jacques C, 2006, VITAM HORM, V74, P371, DOI 10.1016/S0083-6729(06)74016-X; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Musumeci G, 2011, KNEE SURG SPORT TR A, V19, P307, DOI 10.1007/s00167-010-1215-0; Ning L, 2011, INT ORTHOP, V35, P831, DOI 10.1007/s00264-010-1045-1; Piecha D, 2010, INFLAMM RES, V59, P379, DOI 10.1007/s00011-009-0112-9; Pretzel D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2618; Roemer FW, 2011, ANN RHEUM DIS, V70, P1804, DOI 10.1136/ard.2011.150243; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Smith MD, 1997, J RHEUMATOL, V24, P365; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153	24	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62634	10.1371/journal.pone.0062634	http://dx.doi.org/10.1371/journal.pone.0062634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658758	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100025
J	Baethge, C; Franklin, J; Mertens, S				Baethge, Christopher; Franklin, Jeremy; Mertens, Stephan			Substantial Agreement of Referee Recommendations at a General Medical Journal - A Peer Review Evaluation at Deutsches Arzteblatt International	PLOS ONE			English	Review							LOW KAPPA; PARADOXES	Background: Peer review is the mainstay of editorial decision making for medical journals. There is a dearth of evaluations of journal peer review with regard to reliability and validity, particularly in the light of the wide variety of medical journals. Studies carried out so far indicate low agreement among reviewers. We present an analysis of the peer review process at a general medical journal, Deutsches Arzteblatt International. Methodology/Principal Findings: 554 reviewer recommendations on 206 manuscripts submitted between 7/2008 and 12/2009 were analyzed: 7% recommended acceptance, 74% revision and 19% rejection. Concerning acceptance (with or without revision) versus rejection, there was a substantial agreement among reviewers (74.3% of pairs of recommendations) that was not reflected by Fleiss' or Cohen's kappa (<0.2). The agreement rate amounted to 84% for acceptance, but was only 31% for rejection. An alternative kappa-statistic, however, Gwet's kappa (AC1), indicated substantial agreement (0.63). Concordance between reviewer recommendation and editorial decision was almost perfect when reviewer recommendations were unanimous. The correlation of reviewer recommendations and citations as counted by Web of Science was low (partial correlation adjusted for year of publication: -0.03, n.s.). Conclusions/Significance: Although our figures are similar to those reported in the literature our conclusion differs from the widely held view that reviewer agreement is low: Based on overall agreement we consider the concordance among reviewers sufficient for the purposes of editorial decision making. We believe that various measures, such as positive and negative agreement or alternative Kappa values are superior to the application of Cohen's or Fleiss' Kappa in the analysis of nominal or ordinal level data regarding reviewer agreement. Also, reviewer recommendations seem to be a poor proxy for citations because, for example, manuscripts will be changed considerably during the revision process.	[Baethge, Christopher; Mertens, Stephan] Deutsch Arzteblatt Int, Editorial Off, Cologne, Germany; [Baethge, Christopher] Univ Cologne, Sch Med, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Franklin, Jeremy] Univ Cologne, Sch Med, Inst Med Stat, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Baethge, C (corresponding author), Deutsch Arzteblatt Int, Editorial Off, Cologne, Germany.	baethge@aerzteblatt.de		Franklin, Jeremy/0000-0003-1536-0925				Adler R., 2008, CITATION STAT REPORT; [Anonymous], 2002, STAT METHODS INTERRA; Baethge C, 2012, DTSCH ARZTEBL INT, V109, P267, DOI 10.3238/arztebl.2012.0267; Bornmann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014331; Bornmann L, 2009, RES EVALUAT, V18, P262, DOI 10.3152/095820209X477520; BURNHAM JC, 1990, JAMA-J AM MED ASSOC, V263, P1323, DOI 10.1001/jama.263.10.1323; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Horobin DF, 1990, JAMA-J AM MED ASSOC, V263, P1438; Kravitz RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010072; KRONICK DA, 1990, JAMA-J AM MED ASSOC, V263, P1321, DOI 10.1001/jama.263.10.1321; Kulkarni AV, 2009, JAMA-J AM MED ASSOC, V302, P1092, DOI 10.1001/jama.2009.1307; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Marusic A, 2002, CROAT MED J, V43, P286; Mertens S, 2012, DTSCH ARZTEBL INT, V109, P900, DOI 10.3238/arztebl.2012.0900; Opthof T, 2002, CARDIOVASC RES, V56, P339, DOI 10.1016/S0008-6363(02)00712-5; Rothwell PM, 2000, BRAIN, V123, P1964, DOI 10.1093/brain/123.9.1964; Yadollahie M, 2004, SAUDI MED J S1, V25, pS36	20	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61401	10.1371/journal.pone.0061401	http://dx.doi.org/10.1371/journal.pone.0061401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658692	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500007
J	Ma, B; Shi, JG; Jia, LS; Yuan, W; Wu, JF; Fu, ZY; Wang, Y; Liu, N; Guan, ZM				Ma, Bin; Shi, Jiangang; Jia, Lianshun; Yuan, Wen; Wu, Jianfeng; Fu, Zhiyi; Wang, Yuan; Liu, Ning; Guan, Zhengmao			Over-Expression of PUMA Correlates with the Apoptosis of Spinal Cord Cells in Rat Neuropathic Intermittent Claudication Model	PLOS ONE			English	Article							CAUDA-EQUINA COMPRESSION; BCL-2 FAMILY-MEMBERS; NEURONAL APOPTOSIS; BAX ACTIVATION; STENOSIS; P53; STRESS; PAIN	Background: Neuropathic intermittent claudication (NIC) is a typical clinical symptom of lumbar spinal stenosis and the apoptosis of neurons caused by cauda equina compression (CEC) has been proposed as an important reason. Whereas, the factors and the mechanism involved in the process of apoptosis induced by CEC remain unclear. Methodology and Results: In our modified rat model of NIC, a trapezoid-shaped silicon rubber was inserted into the epidural space under the L5 and L6 vertebral plate. Obvious apoptosis was observed in spinal cord cells after compression by TUNEL assay. Simultaneously, qRT-PCR and immunohistochemistry showed that the expression levels of PUMA (p53 upregulated modulator of apoptosis) and p53 were upregulated significantly in spinal cord under compression, while the expression of p53 inhibitor MDM2 and SirT2 decreased in the same region. Furthermore, CEC also resulted in the upregulation of Bcl-2 pro-apoptotic genes expression and caspase-3 activation. With the protection of Methylprednisolone, the upregulation of PUMA and p53 expression as well as the decrease of MDM2 and SirT2 in spinal cord were partially rescued in western bolt analysis. Conclusions: These results suggest that over-expression of PUMA correlates with CEC caused apoptosis of spinal cord cells, which is characterized by the increase of p53, Bax and Bad expression. PUMA upregulation might be crucial to induce apoptosis of spinal cord cells through p53-dependent pathway in CEC.	[Ma, Bin] Tongji Univ, East Hosp, Sch Med, Dept Spine Surg,Bone & Joint Med Ctr, Shanghai 200092, Peoples R China; [Shi, Jiangang; Jia, Lianshun; Yuan, Wen; Wu, Jianfeng; Fu, Zhiyi; Wang, Yuan; Liu, Ning; Guan, Zhengmao] Second Mil Med Univ, Changzheng Hosp, Orthoped Inst PLA, Div Orthoped, Shanghai, Peoples R China	Tongji University; Naval Medical University	Shi, JG (corresponding author), Second Mil Med Univ, Changzheng Hosp, Orthoped Inst PLA, Div Orthoped, Shanghai, Peoples R China.	shijiangang616@163.com						BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Coggeshall RE, 1997, NEUROSCIENCE, V77, P1115, DOI 10.1016/S0306-4522(96)00528-3; Cregan SP, 2004, J NEUROSCI, V24, P10003, DOI 10.1523/JNEUROSCI.2114-04.2004; Cregan SP, 1999, J NEUROSCI, V19, P7860; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; EVANS JG, 1964, BRIT MED J, V17, P985; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Ghosh AP, 2009, J NEUROPATH EXP NEUR, V68, P747, DOI 10.1097/NEN.0b013e3181a9d524; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; Kobayashi S, 2007, SPINE, V32, P627, DOI 10.1097/01.brs.0000257559.84494.15; Maione S, 2002, NEUROREPORT, V13, P101, DOI 10.1097/00001756-200201210-00024; Mao GP, 1998, SPINE, V23, P1641, DOI 10.1097/00007632-199808010-00004; Morishita Y, 2009, J SPINAL DISORD TECH, V22, P130, DOI 10.1097/BSD.0b013e318167b054; Murakami M, 1997, J SPINAL DISORD, V10, P499; OLMARKER K, 1989, J ORTHOP RES, V7, P817, DOI 10.1002/jor.1100070607; PORTER RW, 1992, SPINE, V17, P9, DOI 10.1097/00007632-199201000-00002; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sekiguchi M, 2004, SPINE, V29, P1105, DOI 10.1097/00007632-200405150-00011; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; STERMAN AB, 1985, EXP NEUROL, V89, P408, DOI 10.1016/0014-4886(85)90100-1; Takenobu Y, 2001, J NEUROSCI METH, V104, P191, DOI 10.1016/S0165-0270(00)00342-3; Yamaguchi K, 1999, SPINE, V24, P845, DOI 10.1097/00007632-199905010-00003	23	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e56580	10.1371/journal.pone.0056580	http://dx.doi.org/10.1371/journal.pone.0056580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658678	gold, Green Published, Green Submitted			2022-12-27	WOS:000321200500001
J	Takahashi, T; Miyakawa, T; Zenno, S; Nishi, K; Tanokura, M; Ui-Tei, K				Takahashi, Tomoko; Miyakawa, Takuya; Zenno, Shuhei; Nishi, Kenji; Tanokura, Masaru; Ui-Tei, Kumiko			Distinguishable In Vitro Binding Mode of Monomeric TRBP and Dimeric PACT with siRNA	PLOS ONE			English	Article							RNA-INTERFERENCE; HUMAN RISC; PKR ACTIVATION; DICER; PROTEIN; COMPLEX; PHOSPHORYLATION; ARGONAUTE2; SELECTION; DOMAINS	RNA interference (RNAi) is an evolutionally conserved posttranscriptional gene-silencing mechanism whereby small interfering RNA (siRNA) triggers sequence-specific cleavage of its cognate mRNA. Dicer, Argonaute (Ago), and either TAR-RNA binding protein (TRBP) or a protein activator of PKR (PACT) are the primary components of the RNAi pathway, and they comprise the core of a complex termed the RNA-induced silencing complex (RISC)-loading complex (RLC). TRBP and PACT share similar structural features including three dsRNA binding domains (dsRBDs), and a complex containing Dicer and either TRBP or PACT is considered to sense thermodynamic asymmetry of siRNA ends for guide strand selection. Thus, both TRBP and PACT are thought to participate in the RNAi pathway in an indistinguishable manner, but the differences in siRNA binding mode and the functional involvement of TRBP and PACT are poorly understood. Here, we show in vitro binding patterns of human TRBP and PACT to siRNA using electrophoresis mobility shift analysis and gel filtration chromatography. Our results clearly showed that TRBP and PACT have distinct in vitro siRNA binding patterns from each other. The results suggest that monomeric TRBP binds to siRNA at the higher affinity compared to the affinity for own homodimerization. In contrast, the affinity between PACT and siRNA is lower than that of homodimerization or that between TRBP and siRNA. Thus, siRNA may be more readily incorporated into RLC, interacting with TRBP (instead of PACT) in vivo.	[Takahashi, Tomoko; Nishi, Kenji; Ui-Tei, Kumiko] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Zenno, Shuhei] Maebashi Inst Technol, Fac Engn, Dept Biotechnol, Gunma, Japan	University of Tokyo; University of Tokyo	Ui-Tei, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan.	ktei@bi.s.u-tokyo.ac.jp		Tanokura, Masaru/0000-0001-5072-2480; Takahashi, Tomoko/0000-0002-5094-8882	Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research Project for Private University; Research Fellowship for Young Scientists of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21115004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research Project for Private University; Research Fellowship for Young Scientists of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Core Research Project for Private University: matching fund subsidy to K.U.-T. and a Research Fellowship for Young Scientists of the Japan Society for the Promotion of Science to T.T. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Daviet L, 2000, EUR J BIOCHEM, V267, P2419, DOI 10.1046/j.1432-1327.2000.01256.x; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gredell JA, 2010, BIOCHEMISTRY-US, V49, P3148, DOI 10.1021/bi902189s; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Laraki G, 2008, RNA BIOL, V5, P92, DOI 10.4161/rna.5.2.6069; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Noland CL, 2011, MOL CELL, V43, P110, DOI 10.1016/j.molcel.2011.05.028; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001; Peters GA, 2009, BIOCHEMISTRY-US, V48, P7441, DOI 10.1021/bi900433y; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Singh M, 2011, BIOCHEMISTRY-US, V50, P4550, DOI 10.1021/bi200104h; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Yamashita S, 2011, PROTEIN SCI, V20, P118, DOI 10.1002/pro.543; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	33	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63434	10.1371/journal.pone.0063434	http://dx.doi.org/10.1371/journal.pone.0063434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658827	Green Submitted, Green Published, gold			2022-12-27	WOS:000321200500069
J	Vermeulen, CJ; Pedersen, KS; Beck, HC; Petersen, J; Gagalova, KK; Loeschcke, V				Vermeulen, Cornelis J.; Pedersen, Kamilla S.; Beck, Hans C.; Petersen, Jorgen; Gagalova, Kristina Kirilova; Loeschcke, Volker			Proteomic Characterization of Inbreeding-Related Cold Sensitivity in Drosophila melanogaster	PLOS ONE			English	Article							GENE-EXPRESSION; FLESH FLY; PCR DATA; DEPRESSION; SELECTION; STRESS; CONSEQUENCES; EVOLUTIONARY; TEMPERATURES; RESISTANCE	Inbreeding depression is a widespread phenomenon of central importance to agriculture, medicine, conservation biology and evolutionary biology. Although the population genetic principles of inbreeding depression are well understood, we know little about its functional genomic causes. To provide insight into the molecular interplay between intrinsic stress responses, inbreeding depression and temperature tolerance, we performed a proteomic characterization of a well-defined conditional inbreeding effect in a single line of Drosophila melanogaster, which suffers from extreme cold sensitivity and lethality. We identified 48 differentially expressed proteins in a conditional lethal line as compared to two control lines. These proteins were enriched for proteins involved in hexose metabolism, in particular pyruvate metabolism, and many were found to be associated with lipid particles. These processes can be linked to known cold tolerance mechanisms, such as the production of cryoprotectants, membrane remodeling and the build-up of energy reserves. We checked mRNA-expression of seven genes with large differential protein expression. Although protein expression poorly correlated with gene expression, we found a single gene (CG18067) that, after cold shock, was upregulated in the conditional lethal line both at the mRNA and protein level. Expression of CG18067 also increased in control flies after cold shock, and has previously been linked to cold exposure and chill coma recovery time. Many differentially expressed proteins in our study appear to be involved in cold tolerance in non-inbred individuals. This suggest the conditional inbreeding effect to be caused by misregulation of physiological cold tolerance mechanisms.	[Vermeulen, Cornelis J.; Loeschcke, Volker] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark; [Vermeulen, Cornelis J.; Gagalova, Kristina Kirilova] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Pedersen, Kamilla S.] Aarhus Univ, Fac Agr Sci, Dept Genet & Biotechnol, Tjele, Denmark; [Beck, Hans C.] Odense Univ Hosp, Ctr Clin Prote, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Petersen, Jorgen] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Gagalova, Kristina Kirilova] Univ Bologna, Dept Pharm & BioTechnol, Bologna, Italy	Aarhus University; University of Groningen; Aarhus University; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Bologna	Vermeulen, CJ (corresponding author), Aarhus Univ, Dept Biol Sci, Aarhus, Denmark.	C.J.Vermeulen@rug.nl	Beck, Hans Christian/AAK-9147-2021; Loeschcke, Volker/J-2527-2013	Loeschcke, Volker/0000-0003-1450-0754; Beck, Hans Christian/0000-0002-7763-3637; Vermeulen, Corneel/0000-0002-3280-1414	Danish Research Council (FNU); Villum Kann Rasmussen Foundation	Danish Research Council (FNU)(Danish Natural Science Research CouncilDet Frie Forskningsrad (DFF)); Villum Kann Rasmussen Foundation(Villum Fonden)	Funding was provided by the Danish Research Council (FNU) and the Villum Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Ayroles JF, 2009, CONSERV BIOL, V23, P920, DOI 10.1111/j.1523-1739.2009.01186.x; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Biron DG, 2006, PROTEOMICS, V6, P1712, DOI 10.1002/pmic.200500423; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chevalier F, 2004, PROTEOMICS, V4, P1372, DOI 10.1002/pmic.200300750; Colinet H, 2007, INSECT BIOCHEM MOLEC, V37, P1177, DOI 10.1016/j.ibmb.2007.07.004; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dierks A, 2012, POPUL ECOL, V54, P83, DOI 10.1007/s10144-011-0291-4; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Garcia C, 2012, GENETICS, V192, P161, DOI 10.1534/genetics.112.142687; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kristensen TN, 2005, GENETICS, V171, P157, DOI 10.1534/genetics.104.039610; Kristensen TN, 2008, P ROY SOC B-BIOL SCI, V275, P2055, DOI 10.1098/rspb.2008.0426; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; Kristensen TN, 2006, GENETICS, V173, P1329, DOI 10.1534/genetics.105.054486; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Li A, 2008, INSECT MOL BIOL, V17, P565, DOI 10.1111/j.1365-2583.2008.00827.x; Mackay TFC, 2010, PHILOS T R SOC B, V365, P1229, DOI 10.1098/rstb.2009.0315; Mikkelsen K, 2010, CONSERV GENET, V11, P479, DOI 10.1007/s10592-009-0030-y; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Overgaard J, 2005, J INSECT PHYSIOL, V51, P1173, DOI 10.1016/j.jinsphys.2005.06.007; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Paige KN, 2010, BIOSCIENCE, V60, P267, DOI 10.1525/bio.2010.60.4.5; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; Pedersen KS, 2010, HEREDITY, V104, P125, DOI 10.1038/hdy.2009.132; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; R Development Core Team R, 2009, R LANG ENV STAT COMP; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reed DH, 2012, ANN NY ACAD SCI, V1256, P33, DOI 10.1111/j.1749-6632.2012.06548.x; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Rogers S, 2008, BIOINFORMATICS, V24, P2894, DOI 10.1093/bioinformatics/btn553; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sarup P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015644; Sawyer SA, 2007, P NATL ACAD SCI USA, V104, P6504, DOI 10.1073/pnas.0701572104; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorensen JG, 2007, J EVOLUTION BIOL, V20, P1624, DOI 10.1111/j.1420-9101.2007.01326.x; Teets NM, 2012, PHYSIOL GENOMICS, V44, P764, DOI 10.1152/physiolgenomics.00042.2012; Telonis-Scott M, 2009, J INSECT PHYSIOL, V55, P549, DOI 10.1016/j.jinsphys.2009.01.010; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vermeulen CJ, 2008, J EVOLUTION BIOL, V21, P1236, DOI 10.1111/j.1420-9101.2008.01572.x; Vermeulen CJ, 2004, GENETICS, V167, P1241, DOI 10.1534/genetics.103.023721; Vermeulen CJ, 2004, HEREDITY, V92, P275, DOI 10.1038/sj.hdy.6800412; Zhang J, 2011, J EXP BIOL, V214, P4021, DOI 10.1242/jeb.059535	50	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62680	10.1371/journal.pone.0062680	http://dx.doi.org/10.1371/journal.pone.0062680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658762	Green Submitted, Green Published, gold			2022-12-27	WOS:000321200500032
J	Creswell, JD; Dutcher, JM; Klein, WMP; Harris, PR; Levine, JM				Creswell, J. David; Dutcher, Janine M.; Klein, William M. P.; Harris, Peter R.; Levine, John M.			Self-Affirmation Improves Problem-Solving under Stress	PLOS ONE			English	Article							PSYCHOLOGICAL STRESS; ACHIEVEMENT GAP; INTELLECTUAL-PERFORMANCE; STEREOTYPE THREAT; WORKING-MEMORY; RESPONSES; INSIGHT; FLEXIBILITY; DISCOVERY; AROUSAL	High levels of acute and chronic stress are known to impair problem-solving and creativity on a broad range of tasks. Despite this evidence, we know little about protective factors for mitigating the deleterious effects of stress on problem-solving. Building on previous research showing that self-affirmation can buffer stress, we tested whether an experimental manipulation of self-affirmation improves problem-solving performance in chronically stressed participants. Eighty undergraduates indicated their perceived chronic stress over the previous month and were randomly assigned to either a self-affirmation or control condition. They then completed 30 difficult remote associate problem-solving items under time pressure in front of an evaluator. Results showed that self-affirmation improved problem-solving performance in underperforming chronically stressed individuals. This research suggests a novel means for boosting problem-solving under stress and may have important implications for understanding how self-affirmation boosts academic achievement in school settings.	[Creswell, J. David] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Dutcher, Janine M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Klein, William M. P.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Harris, Peter R.] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Levine, John M.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA	Carnegie Mellon University; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Sheffield; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Creswell, JD (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	creswell@cmu.edu	Dutcher, Janine/AAJ-7081-2020	Dutcher, Janine/0000-0002-8678-8585; Harris, Peter/0000-0003-4599-4929	National Science Foundation [924387]; Pittsburgh Life Sciences Greenhouse Opportunity Fund; Direct For Social, Behav & Economic Scie [0924387] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Pittsburgh Life Sciences Greenhouse Opportunity Fund; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by the National Science Foundation under Grant #924387 and the Pittsburgh Life Sciences Greenhouse Opportunity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JK, 2007, J COGNITIVE NEUROSCI, V19, P468, DOI 10.1162/jocn.2007.19.3.468; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beilock SL, 2005, PSYCHOL SCI, V16, P101, DOI 10.1111/j.0956-7976.2005.00789.x; Benschop RJ, 1998, PSYCHOSOM MED, V60, P290, DOI 10.1097/00006842-199805000-00015; Blascovich J, 2004, J EXP SOC PSYCHOL, V40, P683, DOI 10.1016/j.jesp.2003.10.007; Bowden EM, 1998, PSYCHOL SCI, V9, P435, DOI 10.1111/1467-9280.00082; Bowden EM, 2003, BEHAV RES METH INS C, V35, P634, DOI 10.3758/BF03195543; BOWERS KS, 1990, COGNITIVE PSYCHOL, V22, P72, DOI 10.1016/0010-0285(90)90004-N; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Cohen GL, 2009, SCIENCE, V324, P400, DOI 10.1126/science.1170769; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 2012, J APPL SOC PSYCHOL, V42, P1320, DOI 10.1111/j.1559-1816.2012.00900.x; Creswell JD, 2007, PERS SOC PSYCHOL B, V33, P238, DOI 10.1177/0146167206294412; Creswell JD, 2005, PSYCHOL SCI, V16, P846, DOI 10.1111/j.1467-9280.2005.01624.x; Crocker J, 2008, PSYCHOL SCI, V19, P740, DOI 10.1111/j.1467-9280.2008.02150.x; DIENSTBIER RA, 1989, PSYCHOL REV, V96, P84, DOI 10.1037/0033-295X.96.1.84; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Jamieson JP, 2010, J EXP SOC PSYCHOL, V46, P208, DOI 10.1016/j.jesp.2009.08.015; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Martens A, 2006, J EXP SOC PSYCHOL, V42, P236, DOI 10.1016/j.jesp.2005.04.010; MARTINDA.C, 1973, J GENET PSYCHOL, V123, P329, DOI 10.1080/00221325.1973.10532692; McQueen A, 2006, SELF IDENTITY, V5, P289, DOI 10.1080/15298860600805325; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; Miyake A, 2010, SCIENCE, V330, P1234, DOI 10.1126/science.1195996; Nijstad BA, 2010, EUR REV SOC PSYCHOL, V21, P34, DOI 10.1080/10463281003765323; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Sandkuhler S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001459; Schmader T, 2003, J PERS SOC PSYCHOL, V85, P440, DOI 10.1037/0022-3514.85.3.440; Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5; Sherman DK, 2009, HEALTH PSYCHOL, V28, P554, DOI 10.1037/a0014663; STEELE CM, 1993, J PERS SOC PSYCHOL, V64, P885, DOI 10.1037/0022-3514.64.6.885; Steele CM, 1988, ADV EXPT SOCIAL PSYC, P261, DOI DOI 10.1016/S0065-2601(08)60229-4; Wakslak CJ, 2009, J EXP SOC PSYCHOL, V45, P927, DOI 10.1016/j.jesp.2009.05.002; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D, 1999, PANAS X MANUAL POSIT, DOI DOI 10.17077/48VT-M4T2	38	51	53	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62593	10.1371/journal.pone.0062593	http://dx.doi.org/10.1371/journal.pone.0062593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23658751	Green Accepted, gold, Green Published			2022-12-27	WOS:000319167000060
J	Finer, M; Jenkins, CN; Powers, B				Finer, Matt; Jenkins, Clinton N.; Powers, Bill			Potential of Best Practice to Reduce Impacts from Oil and Gas Projects in the Amazon	PLOS ONE			English	Article								The western Amazon continues to be an active and controversial zone of hydrocarbon exploration and production. We argue for the urgent need to implement best practices to reduce the negative environmental and social impacts associated with the sector. Here, we present a three-part study aimed at resolving the major obstacles impeding the advancement of best practice in the region. Our focus is on Loreto, Peru, one of the largest and most dynamic hydrocarbon zones in the Amazon. First, we develop a set of specific best practice guidelines to address the lack of clarity surrounding the issue. These guidelines incorporate both engineering-based criteria and key ecological and social factors. Second, we provide a detailed analysis of existing and planned hydrocarbon activities and infrastructure, overcoming the lack of information that typically hampers large-scale impact analysis. Third, we evaluate the planned activities and infrastructure with respect to the best practice guidelines. We show that Loreto is an extremely active hydrocarbon front, highlighted by a number of recent oil and gas discoveries and a sustained government push for increased exploration. Our analyses reveal that the use of technical best practice could minimize future impacts by greatly reducing the amount of required infrastructure such as drilling platforms and access roads. We also document a critical need to consider more fully the ecological and social factors, as the vast majority of planned infrastructure overlaps sensitive areas such as protected areas, indigenous territories, and key ecosystems and watersheds. Lastly, our cost analysis indicates that following best practice does not impose substantially greater costs than conventional practice, and may in fact reduce overall costs. Barriers to the widespread implementation of best practice in the Amazon clearly exist, but our findings show that there can be great benefits to its implementation.	[Finer, Matt] Ctr Int Environm Law, Biodivers Program, Washington, DC USA; [Jenkins, Clinton N.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Powers, Bill] E Tech Int, Santa Fe, NM USA	University of North Carolina; North Carolina State University	Finer, M (corresponding author), Ctr Int Environm Law, Biodivers Program, Washington, DC USA.	mfiner@ciel.org	Jenkins, Clinton/D-6134-2011	Jenkins, Clinton/0000-0003-2198-0637	Gordon and Betty Moore Foundation; Blue Moon Fund; National Geographic Society; NASA Biodiversity Grant [ROSES-NNX09AK22G]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Blue Moon Fund; National Geographic Society(National Geographic Society); NASA Biodiversity Grant	This work was primarily supported by the Gordon and Betty Moore Foundation. Additional funding came from Blue Moon Fund, National Geographic Society, and NASA Biodiversity Grant (ROSES-NNX09AK22G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores G, 2010, COMPARACIONES CALIDA; Asamre Perenco, 2011, EST IMP AMB FAS DES; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Benavides M, 2009, MAPA AMAZONIA PERUAN; Burlington Resources ConocoPhillips, 2012, PLAN AB PROY PROSP S; Comision de Pueblos Andinos Amazonicos y Afroperuanos Ambiente y Ecologia, 2012, GRUP TRAB SIT IND CU; Daimi Peru Perenco, 2010, EIA PROY CONSTR OL L; Fine PVA, 2010, ANN MO BOT GARD, V97, P283, DOI 10.3417/2008068; Finer M, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014012; Finer M, 2010, BIOTROPICA, V42, P63, DOI 10.1111/j.1744-7429.2009.00587.x; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Goodland R, 2012, I ENV DIPLOMACY SECU, VA1-2012-4; Haselip J, 2011, NAT RESOUR FORUM, V35, P283, DOI 10.1111/j.1477-8947.2011.01404.x; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Instituto del Bien Comun, 2011, SIST INF COM NAT AM; International Labour Organization, 1989, CONV 169 IND TRIB PE; Josse C, 2007, DIGITAL ECOLOGICAL S; Kerr RA, 2010, SCIENCE, V328, P1624, DOI 10.1126/science.328.5986.1624; Killeen TJ, 2007, PERFECT STROM AMAZON; Kolowski JM, 2010, BIOL CONSERV, V143, P917, DOI 10.1016/j.biocon.2009.12.039; Kolowski JM, 2012, INT J PRIMATOL, V33, P958, DOI 10.1007/s10764-012-9627-y; Lee J, 2009, INTRO OFFSHORE PIPEL; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Maple Energy, 2012, OIL GAS EXPL; Mims M, 2002, DRILLING DESIGN IMPL; Ministerio de Energia y Minas del Peru, 2012, LEV OBS EIA PROY FAS; Ministerio de Energia y Minas del Peru, 2007, AUD INT SIST TRANSP; Ministerio de Energia y Minas del Peru, 1999, AN EST HIDR 1999; Ministerio de Energia y Minas del Peru, 2012, LIBR ANN RES HIDR 20; Ministerio de Energia y Minas del Peru, 2011, AN EST HIDR 2011; National Petroleum Council, 2011, 223 NAT PETR COUNC; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orpio Corpi-Sl Fediquep Acodecospat Feconat, 2012, NUESTRAS CONDICIONES; Martinez M, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045006; Orta-Martinez M, 2010, ECOL ECON, V70, P207, DOI 10.1016/j.ecolecon.2010.04.022; Perupetro, 2011, MARC GEN ACT EXPL EX; Perupetro, 2012, NEXT BIDD ROUND 2012; Perupetro, 2011, PLAYS NEW HYDR POT M; Petroperu, 1981, INF EST PETR PER 197; Petroperu, 1989, INF EST ANN 1989; Powers B., 2012, BEST PRACTICES DESIG, V2nd ed; Pueblos Indigenas de Canaan de Cachiyacu y Nuevo Sucre, 2010, QUEJ OMB CAO REL VIO; R. Garcia Consultores SA ARCAN Ingeniera y Construcciones SA Centro de Conservacion de Energia y del Ambiente, 2012, EL NUEV MATR EN SOST; Red Amazonica de Informacion Socioambiental Georreferenciada, 2012, MAP AM 2012 AR PROT; Repsol GEMA, 2011, EIA PROY PROSP SISM; Schlumberger, 2011, 1 BREAK, V29; SERNANP (Servico Nacional de Areas Naturales Protegidas por el Estado), 2009, PLAN DIR AR NAT PROT; The Energy & Biodiversity Initiative, 2003, INT BIOD CONS OIL GA; Thomsen JB, 2001, FOOTPRINTS JUNGLE; Thurber M, 2005, SPE9650499; Tollefson J, 2011, NATURE, V480, P22, DOI 10.1038/480022a; United Nations, 2011, UN DECL RIGHTS IND P; Viale C, 2012, GENERACION DISTRIBUC; Viale C, 2011, RENTA PETROLERA USO; Vriesendorp C, 2006, PERU MATSES RAPID BI; Zahniser A, 2007, CHARACTERIZATION GRE	56	25	25	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63022	10.1371/journal.pone.0063022	http://dx.doi.org/10.1371/journal.pone.0063022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650541	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000086
J	Pathak, AP; McNutt, S; Shah, T; Wildes, F; Raman, V; Bhujwalla, ZM				Pathak, Arvind P.; McNutt, Stephen; Shah, Tariq; Wildes, Flonne; Raman, Venu; Bhujwalla, Zaver M.			In Vivo "MRI Phenotyping'' Reveals Changes in Extracellular Matrix Transport and Vascularization That Mediate VEGF-Driven Increase in Breast Cancer Metastasis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CARCINOMA-CELLS; TUMOR MICROENVIRONMENT; PLASMINOGEN-ACTIVATOR; LYMPHATIC METASTASIS; INDUCED ANGIOGENESIS; INTERSTITIAL FLOW; LYMPHANGIOGENESIS; PERMEABILITY; FLUID	Purpose: To gain new insights into the relationship between angiogenic factors in breast cancer and their effect on extracellular matrix (ECM) remodeling and metastasis, we characterized and validated the "metastatic signature'' of human breast cancer cell lines engineered to overexpress VEGF in terms of in vivo MRI-derived angiogenesis and ECM transport parameters. Methodology: MRI was used to evaluate the effects of overexpressing VEGF-A (VEGF(165)) on tumor angiogenesis and ECM remodeling in vivo, for two differentially metastatic human breast cancer cell lines: MCF-7 and MDA-MB-231. Principal Findings: Overexpression of VEGF elevated vascular volume in both MCF-7-VEGF and MDA-MB-231-VEGF tumors relative to their wild-type counterparts, but vascular permeability was elevated only in MCF-7-VEGF tumors. A significant increase in the volume of extravascular fluid drained as well as the number of ECM drainage voxels was detected in MCF-7-VEGF tumors relative to MCF-7 tumors, but not in MDA-MB-231-VEGF versus MDA-MB-231 tumors. The angiogenic effects of VEGF overexpression in both MCF-7-VEGF and MDA-MB-231-VEGF tumors were validated histologically. MCF-7-VEGF tumors exhibited enhanced invasion and a greater fraction of cancer positive lungs and lymph nodes relative to MCF-7 tumors. Conclusions and Significance: In vivo MRI and histological data demonstrate that VEGF overexpression results in the progression of noninvasive MCF-7 and invasive MDA-MB-321 tumors to a more angiogenic phenotype. However, VEGF overexpression significantly altered ECM integrity only in MCF-7 tumors, causing them to progress to an invasive and metastatic phenotype. This study for the first time demonstrates the concurrent effects of VEGF overexpression and ECM remodeling on metastasis in vivo. Collectively, these findings demonstrate that in vivo MRI can non-invasively monitor changes in the tumor microenvironment that can potentially predict a cancer's ability to metastasize.	[Pathak, Arvind P.; McNutt, Stephen; Shah, Tariq; Wildes, Flonne; Raman, Venu; Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, JHU ICMIC Program,Div Canc Imaging Res, Baltimore, MD 21218 USA	Johns Hopkins University	Pathak, AP (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, JHU ICMIC Program,Div Canc Imaging Res, Baltimore, MD 21218 USA.	pathak@mri.jhu.edu; zaver@mri.jhu.edu			NIH [R01CA90471, R01CA136576, R01CA138515, R01CA73850, R01CA82337, R01CA138264, P50CA103175]; Susan G. Komen for the Cure Career Catalyst Award [KG90640]; NATIONAL CANCER INSTITUTE [R01CA138264, R01CA073850, R01CA090471, P50CA103175, R01CA136576, R01CA082337, R01CA138515] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure Career Catalyst Award(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01CA90471, R01CA136576, R01CA138515, R01CA73850, R01CA82337, R01CA138264, P50CA103175 and a Susan G. Komen for the Cure Career Catalyst Award KG90640. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2007, NEOPLASIA, V9, P222, DOI 10.1593/neo.06673; AUKLAND K, 1981, PHYSIOL REV, V61, P556, DOI 10.1152/physrev.1981.61.3.556; Bachelder RE, 2003, CANCER RES, V63, P5230; Bachelder RE, 2002, CANCER RES, V62, P7203; Balduyck M, 2000, CLIN EXP METASTAS, V18, P171, DOI 10.1023/A:1006762425323; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhujwalla ZM, 2001, NEOPLASIA, V3, P143, DOI 10.1038/sj.neo.7900129; Boudreau N, 2003, BREAST CANCER RES, V5, P140, DOI 10.1186/bcr589; Brown LF, 1999, CLIN CANCER RES, V5, P1041; BUTLER TP, 1975, CANCER RES, V35, P3084; Cao MS, 2009, IEEE T MED IMAGING, V28, P861, DOI 10.1109/TMI.2008.2012035; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dafni H, 2002, NMR BIOMED, V15, P120, DOI 10.1002/nbm.724; Dafni H, 2002, CANCER RES, V62, P6731; Donahue KM, 1997, JMRI-J MAGN RESON IM, V7, P102, DOI 10.1002/jmri.1880070114; Eccles S, 2007, CLIN EXP METASTAS, V24, P619, DOI 10.1007/s10585-007-9123-5; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gasparini G, 2000, Oncologist, V5 Suppl 1, P37; Haessler U, 2012, INTEGR BIOL-UK, V4, P401, DOI 10.1039/c1ib00128k; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Ji RC, 2006, CANCER METAST REV, V25, P677, DOI 10.1007/s10555-006-9026-y; KUREBAYASHI J, 1993, CANCER RES, V53, P2178; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Manders P, 2002, BRIT J CANCER, V87, P772, DOI 10.1038/sj.bjc.6600555; Mercurio AM, 2005, J MAMMARY GLAND BIOL, V10, P283, DOI 10.1007/s10911-006-9001-9; Miralem T, 2001, ONCOGENE, V20, P5511, DOI 10.1038/sj.onc.1204753; Mohammed RAA, 2007, BRIT J CANCER, V96, P1092, DOI 10.1038/sj.bjc.6603678; Monsky WL, 1999, CANCER RES, V59, P4129; Monsky WL, 2002, CLIN CANCER RES, V8, P1008; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Ogan M D, 1988, Invest Radiol, V23, P961, DOI 10.1097/00004424-198812000-00022; Pathak AP, 2005, CANCER RES, V65, P1425, DOI 10.1158/0008-5472.CAN-04-3682; Pathak AP, 2006, CANCER RES, V66, P5151, DOI 10.1158/0008-5472.CAN-05-1788; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; Price DJ, 2001, CELL GROWTH DIFFER, V12, P129; Ratel D, 2007, THROMB RES, V121, P203, DOI 10.1016/j.thromres.2007.03.024; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Russ JC, 1999, CLASSICAL STEREOLOGI, P39; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SHAFIE SM, 1980, CANCER LETT, V11, P81, DOI 10.1016/0304-3835(80)90097-X; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Van den Eynden GG, 2007, J PATHOL, V213, P56, DOI 10.1002/path.2211; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wong SY, 2007, J CELL BIOCHEM, V101, P840, DOI 10.1002/jcb.21146; ZHANG HT, 1995, J NATL CANCER I, V87, P213, DOI 10.1093/jnci/87.3.213	52	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63146	10.1371/journal.pone.0063146	http://dx.doi.org/10.1371/journal.pone.0063146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650550	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000095
J	Qiu, YW; Jiang, GH; Su, HH; Lv, XF; Zhang, XL; Tian, JZ; Zhuo, FZ				Qiu, Yingwei; Jiang, Guihua; Su, Huanhuan; Lv, Xiaofei; Zhang, Xuelin; Tian, Junzhang; Zhuo, Fuzhen			Progressive White Matter Microstructure Damage in Male Chronic Heroin Dependent Individuals: A DTI and TBSS Study	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; VOXELWISE ANALYSIS; DECISION-MAKING; DRUG-ABUSERS; BRAIN-AREAS; NETWORK; COCAINE	Background: To investigate the WM microstructure deficits in heroin dependent individuals (HDIs) with different length of heroin dependence, and to investigate whether these WM deficits can be related to the duration of heroin use and to decision-making deficits in HDIs. Methodology/Principal Findings: Thirty-six HDIs [including eighteen sHDIs (duration of heroin dependent is less than 10 years) and eighteen lHDIs (duration of dependent is between 10,20 years)] and sixteen healthy controls participated in this study. Whole brain voxel-wise analysis of fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (Da) and radial diffusivity (Dr) were performed by tract-based spatial statistics (TBSS) to localize abnormal WM regions among groups. TBSS demonstrated that sHDIs had significantly lower FA than controls in right orbito-frontal WM, bilateral temporal WM and right parietal WM. The lHDIs had significantly lower FA throughout the brain compared with the controls and sHDIs. The lHDIs had significantly lower Da than controls in bilateral inferior frontaloccipital fasciculus, bilateral splenium of corpus callosum, left inferior longitudinal fasciculus, and had significantly higher Dr than controls in bilateral uncinatus fasciculus, bilateral inferior frontaloccipital fasciculus and bilateral cortical spinal fasciculus. Volume-of-interest (VOI) analyses detect the changes of diffusivity indices in the regions with FA abnormalities revealed by control vs sHDIs. In most VOIs, FA reductions were caused by the increase in Dr as well as the decrease in Da. Correlation analysis was used to assess the relationship between FA and behavioral measures in HDIs and controls available. Significantly positively correlations were found between the FA values in the right orbital-frontal WM, right parietal WM and IGT performance. Conclusions: The extent and severity of WM integrity deficits in HDIs was associated with the length of heroin dependent. Furthermore, abnormal WM microstructure may correlate with decision-making impairments in HDIs.	[Qiu, Yingwei; Jiang, Guihua; Su, Huanhuan; Tian, Junzhang] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Lv, Xiaofei] Sun Yat Sen Univ, Ctr Canc, Dept Med Imaging, Guangzhou 510275, Guangdong, Peoples R China; [Lv, Xiaofei] Sun Yat Sen Univ, Ctr Canc, Dept Intervent Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xuelin] Sun Yat Sen Univ, DongGuan KangHua Hosp, Dept Radiol, Donggua, Peoples R China; [Zhuo, Fuzhen] Guangdong 2 Prov Peoples Hosp, Addict Med Div, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Qiu, YW (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	qiuyw1201@gmail.com; tianjz2010@163.com		Tian, Junzhang/0000-0002-6212-1882; Qiu, Yingwei/0000-0003-1298-8506	Natural Scientific Foundation of China [81201084]; Planned Science and Technology Project of Guangdong Province, China [2011B031800044, 2010B031600116]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Planned Science and Technology Project of Guangdong Province, China	This work was supported by the grants from the Natural Scientific Foundation of China [grant number 81201084 for Yingwei Qiu], and the Planned Science and Technology Project of Guangdong Province, China [grant numbers 2011B031800044 and 2010B031600116 for Guihua Jiang]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SN, 1999, FORENSIC SCI INT, V102, P51, DOI 10.1016/S0379-0738(99)00040-7; Barros-Loscertales A, 2011, PSYCHIAT RES-NEUROIM, V194, P111, DOI 10.1016/j.pscychresns.2011.05.001; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bora E, 2012, ADDICT BIOL, V17, P141, DOI 10.1111/j.1369-1600.2010.00266.x; Buttner A, 2006, ADDICTION, V101, P1339, DOI 10.1111/j.1360-0443.2006.01505.x; Daglish MRC, 2003, NEUROIMAGE, V20, P1964, DOI 10.1016/j.neuroimage.2003.07.025; Fingelkurts AA, 2006, PSYCHOPHARMACOLOGY, V188, P42, DOI 10.1007/s00213-006-0474-4; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; GRANT I, 1978, ARCH GEN PSYCHIAT, V35, P1063; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Knapen T, 2011, J NEUROSCI, V31, P10293, DOI 10.1523/JNEUROSCI.1727-11.2011; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Liu HH, 2008, AM J DRUG ALCOHOL AB, V34, P562, DOI 10.1080/00952990802295238; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Ma N, 2011, PLOS ONE, V26; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Murphy ML, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-3; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Schumacher EH, 2005, NEUROPSYCHOLOGIA, V43, P1444, DOI 10.1016/j.neuropsychologia.2005.01.002; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Vassileva J, 2007, DRUG ALCOHOL DEPEN, V86, P287, DOI 10.1016/j.drugalcdep.2006.06.015; Verdejo-Garcia AJ, 2007, ADDICT BEHAV, V32, P950, DOI 10.1016/j.addbeh.2006.06.032; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wang YR, 2011, NEUROSCI LETT, V494, P49, DOI 10.1016/j.neulet.2011.02.053; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014; Zalesky A, 2012, BRAIN, V135, P2245, DOI 10.1093/brain/aws136	38	35	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63212	10.1371/journal.pone.0063212	http://dx.doi.org/10.1371/journal.pone.0063212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650554	gold, Green Submitted, Green Published			2022-12-27	WOS:000319167000099
J	Seppanen, E; Roy, E; Ellis, R; Bou-Gharios, G; Fisk, NM; Khosrotehrani, K				Seppanen, Elke; Roy, Edwige; Ellis, Rebecca; Bou-Gharios, George; Fisk, Nicholas M.; Khosrotehrani, Kiarash			Distant Mesenchymal Progenitors Contribute to Skin Wound Healing and Produce Collagen: Evidence from a Murine Fetal Microchimerism Model	PLOS ONE			English	Article							MARROW-DERIVED CELLS; BONE-MARROW; STEM-CELLS; MATERNAL BLOOD; MOUSE; DIFFERENTIATION; PARTICIPATE; FIBROBLASTS; FIBROCYTES; IDENTIFICATION	The contribution of distant and/or bone marrow-derived endogenous mesenchymal stem cells (MSC) to skin wounds is controversial. Bone marrow transplantation experiments employed to address this have been largely confounded by radiation-resistant host-derived MSC populations. Gestationally-acquired fetal MSC are known to engraft in maternal bone marrow in all pregnancies and persist for decades. These fetal cells home to damaged maternal tissues, mirroring endogenous stem cell behavior. We used fetal microchimerism as a tool to investigate the natural homing and engraftment of distant MSC to skin wounds. Post-partum wild-type mothers that had delivered transgenic pups expressing luciferase under the collagen type I-promoter were wounded. In vivo bioluminescence imaging (BLI) was then used to track recruitment of fetal cells expressing this mesenchymal marker over 14 days of healing. Fetal cells were detected in 9/43 animals using BLI (Fisher exact p = 0.01 versus 1/43 controls). These collagen type I-expressing fetal cells were specifically recruited to maternal wounds in the initial phases of healing, peaking on day 1 (n = 43, p<0.01). This was confirmed by detection of Y-chromosome+ ve fetal cells that displayed fibroblast-like morphology. Histological analyses of day 7 wounds revealed vimentin-expressing fetal cells in dermal tissue. Our results demonstrate the participation of distant mesenchymal cells in skin wounds. These data imply that endogenous MSC populations are likely recruited from bone marrow to wounds to participate in healing.	[Seppanen, Elke; Roy, Edwige; Ellis, Rebecca; Bou-Gharios, George; Fisk, Nicholas M.; Khosrotehrani, Kiarash] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Bou-Gharios, George] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Fisk, Nicholas M.] Royal Brisbane & Womens Hosp, Ctr Adv Prenatal Care, Herston, Qld, Australia	University of Queensland; University of Oxford; Royal Brisbane & Women's Hospital	Khosrotehrani, K (corresponding author), Univ Queensland, UQ Ctr Clin Res, Herston Campus, Brisbane, Qld, Australia.	k.khosrotehrani@uq.edu.au	Seppanen, Elke/AHD-5402-2022; Khosrotehrani, Kiarash/M-8025-2015; Fisk, Nicholas M/B-2126-2009	Khosrotehrani, Kiarash/0000-0002-6406-4076; Fisk, Nicholas M/0000-0003-0031-7975; Seppanen, Elke/0000-0003-1673-4167; roy, edwige/0000-0003-1991-5844	National Health and Medical Research Council in Australia [569822]	National Health and Medical Research Council in Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council in Australia, project grant #569822. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Barisic-Dujmovic T, 2010, J CELL PHYSIOL, V222, P703, DOI 10.1002/jcp.21997; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Bou-Gharios G, 2011, CELLS TISSUES ORGANS; BouGharios G, 1996, J CELL BIOL, V134, P1333, DOI 10.1083/jcb.134.5.1333; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Cilloni D, 2000, BLOOD, V96, P3637; de Almeida PE, 2011, AM J PHYSIOL-HEART C, V301, pH663, DOI 10.1152/ajpheart.00337.2011; Direkze NC, 2003, STEM CELLS, V21, P514, DOI 10.1634/stemcells.21-5-514; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Fujiki Y, 2008, BIOL REPROD, V79, P841, DOI 10.1095/biolreprod.108.068973; Fujiki Y, 2009, BIOL REPROD, V81, P26, DOI 10.1095/biolreprod.108.074468; HATAMOCHI A, 1991, J INVEST DERMATOL, V96, P473, DOI 10.1111/1523-1747.ep12470171; Higashiyama R, 2011, J INVEST DERMATOL, V131, P529, DOI 10.1038/jid.2010.314; Huu SN, 2007, P NATL ACAD SCI USA, V104, P1871, DOI 10.1073/pnas.0606490104; Huu SN, 2009, AM J PATHOL, V174, P630, DOI 10.2353/ajpath.2009.080566; Ishii GH, 2005, STEM CELLS, V23, P699, DOI 10.1634/stemcells.2004-0183; Johnson KL, 2000, BIOTECHNIQUES, V29, P1220, DOI 10.2144/00296st01; Kara RJ, 2012, CIRC RES, V110, P82, DOI 10.1161/CIRCRESAHA.111.249037; Khosrotehrani K, 2005, J REPROD IMMUNOL, V66, P1, DOI 10.1016/j.jri.2005.02.001; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Khosrotehrani K, 2008, J IMMUNOL, V180, P889, DOI 10.4049/jimmunol.180.2.889; Kopecki Z, 2007, J PATHOL, V211, P351, DOI 10.1002/path.2113; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Nassar D, 2012, CHIMERISM, V3; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Nassar D, 2012, FASEB J, V26, P149, DOI 10.1096/fj.11-180695; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; O'Donoghue K, 2003, MOL HUM REPROD, V9, P497, DOI 10.1093/molehr/gag063; O'Donoghue K, 2008, REPROD BIOMED ONLINE, V16, P382, DOI 10.1016/S1472-6483(10)60600-1; Opalenik SR, 2005, FASEB J, V19, P1561, DOI 10.1096/fj.04-2978fje; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Phinney DG, 2013, CYTOTHERAPY, V15, P140, DOI 10.1016/j.jcyt.2012.11.005; Pritchard S, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101147; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Rieger K, 2005, EXP HEMATOL, V33, P605, DOI 10.1016/j.exphem.2005.02.004; Rossi G, 2004, LANCET, V364, P1936, DOI 10.1016/S0140-6736(04)17469-2; Santos MA, 2008, HUM REPROD, V23, P2319, DOI 10.1093/humrep/den261; Sawaya HHB, 2004, RHEUMATOLOGY, V43, P965, DOI 10.1093/rheumatology/keh211; Seppanen E, 2012, J REPROD IM IN PRESS; Seppanen EJ, 2012, STEM CELLS DEV; Shohara R, 2012, CYTOTHERAPY; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4; Sunami R, 2010, J REPROD IMMUNOL, V84, P117, DOI 10.1016/j.jri.2009.11.006; Tan XW, 2005, STEM CELLS, V23, P1443, DOI 10.1634/stemcells.2004-0169; Wang ZC, 2011, KIDNEY INT, V79, P300, DOI 10.1038/ki.2010.326; Zeng XX, 2010, STEM CELLS DEV, V19, P1819, DOI 10.1089/scd.2010.0046	52	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62662	10.1371/journal.pone.0062662	http://dx.doi.org/10.1371/journal.pone.0062662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650524	Green Submitted, gold, Green Published			2022-12-27	WOS:000319167000068
J	Vanzelli, AS; Medeiros, A; Rolim, N; Bartholomeu, JB; Cunha, TF; Bechara, LG; Gomes, ERM; Mattos, KC; Sirvente, R; Salemi, V; Mady, C; Negrao, CE; Guatimosim, S; Brum, PC				Vanzelli, Andrea S.; Medeiros, Alessandra; Rolim, Natale; Bartholomeu, Jan B.; Cunha, Telma F.; Bechara, Luiz G.; Gomes, Eneas R. M.; Mattos, Katt C.; Sirvente, Raquel; Salemi, Vera; Mady, Charles; Negrao, Carlos E.; Guatimosim, Silvia; Brum, Patricia C.			Integrative Effect of Carvedilol and Aerobic Exercise Training Therapies on Improving Cardiac Contractility and Remodeling in Heart Failure Mice	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; OXIDATIVE STRESS; BETA-BLOCKERS; HYPERACTIVITY; ABNORMALITIES; DYSFUNCTION; MORTALITY; SYSTEM; IMPACT	The use of b-blockers is mandatory for counteracting heart failure (HF)-induced chronic sympathetic hyperactivity, cardiac dysfunction and remodeling. Importantly, aerobic exercise training, an efficient nonpharmacological therapy to HF, also counteracts sympathetic hyperactivity in HF and improves exercise tolerance and cardiac contractility; the latter associated with changes in cardiac Ca2+ handling. This study was undertaken to test whether combined b-blocker and aerobic exercise training would integrate the beneficial effects of isolated therapies on cardiac structure, contractility and cardiomyocyte Ca2+ handling in a genetic model of sympathetic hyperactivity-induced HF (alpha(2A)/alpha 2C(-)adrenergic receptor knockout mice, KO). We used a cohort of 5-7 mo male wild-type (WT) and congenic mice (KO) with C57Bl6/J genetic background randomly assigned into 5 groups: control (WT), saline-treated KO (KOS), exercise trained KO (KOT), carvedilol-treated KO (KOC) and, combined carvedilol-treated and exercise-trained KO (KOCT). Isolated and combined therapies reduced mortality compared with KOS mice. Both KOT and KOCT groups had increased exercise tolerance, while groups receiving carvedilol had increased left ventricular fractional shortening and reduced cardiac collagen volume fraction compared with KOS group. Cellular data confirmed that cardiomyocytes from KOS mice displayed abnormal Ca2+ handling. KOT group had increased intracellular peak of Ca2+ transient and reduced diastolic Ca2+ decay compared with KOS group, while KOC had increased Ca2+ decay compared with KOS group. Notably, combined therapies re-established cardiomyocyte Ca2+ transient paralleled by increased SERCA2 expression and SERCA2: PLN ratio toward WT levels. Aerobic exercise trained increased the phosphorylation of PLN at Ser16 and Thr17 residues in both KOT and KOCT groups, but carvedilol treatment reduced lipid peroxidation in KOC and KOCT groups compared with KOS group. The present findings provide evidence that the combination of carvedilol and aerobic exercise training therapies lead to a better integrative outcome than carvedilol or exercise training used in isolation.	[Vanzelli, Andrea S.; Bartholomeu, Jan B.; Cunha, Telma F.; Bechara, Luiz G.; Mattos, Katt C.; Negrao, Carlos E.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Medeiros, Alessandra] Univ Fed Sao Paulo, Dept Biosci, Santos, Brazil; [Rolim, Natale] Dept Circulat & Med Imaging, Trondheim, Norway; [Rolim, Natale] KG Jebsen Ctr Exercise Med, Trondheim, Norway; [Gomes, Eneas R. M.; Guatimosim, Silvia] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Sirvente, Raquel; Salemi, Vera; Mady, Charles; Negrao, Carlos E.] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Minas Gerais; Universidade de Sao Paulo	Brum, PC (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	pcbrum@usp.br	Guatimosim, Silvia/AAN-7441-2021; Bechara, Luiz R G/K-4095-2012; Negrao, Carlos E/C-4281-2012; Brum, Patricia C/E-6605-2011; Salemi, Vera MC/C-9104-2013; Medeiros, Alessandra/E-8132-2012; Cunha, Telma F/I-5222-2016; Salemi, Vera/AAY-5024-2020; Medeiros, Alessandra/F-6149-2014; Gomes, Eneas RM/G-3153-2010; Mady, Charles/C-8870-2012	Guatimosim, Silvia/0000-0001-8386-3722; Brum, Patricia C/0000-0002-4750-6506; Salemi, Vera MC/0000-0002-7152-1810; Medeiros, Alessandra/0000-0002-7962-7185; Medeiros, Alessandra/0000-0002-7962-7185; Gomes, Eneas RM/0000-0001-8528-8741; Mady, Charles/0000-0002-8838-199X; Bechara, Luiz/0000-0002-1642-1008; Negrao, Carlos Eduardo/0000-0003-4652-1226	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo [FAPESP:2010/50048-1]; FAPEMIG and Instituto Milenio (S.G.); Conselho Nacional de Pesquisa e Desenvolvimento; FAPESP [06/56123-0]; CNPq [302201/2011-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPEMIG and Instituto Milenio (S.G.); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo. SP (FAPESP:2010/50048-1), FAPEMIG and Instituto Milenio (S.G.), Conselho Nacional de Pesquisa e Desenvolvimento (CNPq, S.G. and P.C.B.) for funding the present investigation, and Laboratories Baldacci S.A. for donating carvedilol. A.S.V. held a scholarship from FAPESP (06/56123-0). P.C.B. holds a scholarship from CNPq (302201/2011-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos S, 2003, INT J CARDIOL, V90, P1, DOI 10.1016/S0167-5273(02)00504-1; Barretto ACP, 2009, INT J CARDIOL, V135, P302, DOI 10.1016/j.ijcard.2008.03.056; Bartholomeu JB, 2008, J MOL CELL CARDIOL, V45, P240, DOI 10.1016/j.yjmcc.2008.05.011; Brum PC, 2011, BRAZ J MED BIOL RES, V44, P827, DOI 10.1590/S0100-879X2011000900002; Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001; Burger AJ, 2001, J CARD FAIL, V7, P122, DOI 10.1054/jcaf.2001.24964; Chung CJ, 2011, PHYSICIAN SPORTSMED, V39, P37, DOI 10.3810/psm.2011.11.1937; COHN JN, 1988, AM J CARDIOL, V62, pA25, DOI 10.1016/S0002-9149(88)80081-X; De Matos LDNJ, 2004, J CARD FAIL, V10, P496, DOI 10.1016/j.cardfail.2004.03.006; Flesch M, 1999, CIRCULATION, V100, P346, DOI 10.1161/01.CIR.100.4.346; Fraga R, 2007, EUR J HEART FAIL, V9, P630, DOI 10.1016/j.ejheart.2007.03.003; GRASSI G, 1995, CIRCULATION, V92, P3206, DOI 10.1161/01.CIR.92.11.3206; Guatimosim S, 2001, AM J PHYSIOL-CELL PH, V280, pC1327, DOI 10.1152/ajpcell.2001.280.5.C1327; Johns C, 1996, HYPERTENSION, V28, P1064, DOI 10.1161/01.HYP.28.6.1064; Khattar R S, 2003, Minerva Cardioangiol, V51, P143; Koitabashi N, 2005, BIOCHEM BIOPH RES CO, V328, P116, DOI 10.1016/j.bbrc.2004.12.139; LIKOFF MJ, 1987, AM J CARDIOL, V59, P634; Mahon Niall G., 2002, Eur J Intern Med, V13, P96, DOI 10.1016/S0953-6205(02)00010-9; Medeiros A, 2008, BRAZ J MED BIOL RES, V41, P812, DOI 10.1590/S0100-879X2008000900012; Medeiros A, 2008, J APPL PHYSIOL, V104, P103, DOI 10.1152/japplphysiol.00493.2007; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nakahira A, 2010, CIRC J, V74, P1711, DOI 10.1253/circj.CJ-10-0149; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Rolim NPL, 2007, PHYSIOL GENOMICS, V29, P246, DOI 10.1152/physiolgenomics.00188.2006; Vanzelli AS, 2010, ARQ BRAS CARDIOL, V95, P373, DOI 10.1590/S0066-782X2010005000098; Zhuang XF, 2009, J INT MED RES, V37, P1354, DOI 10.1177/147323000903700510; Zucker IH, 2012, HEART FAIL CLIN, V8, P87, DOI 10.1016/j.hfc.2011.08.007	27	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62452	10.1371/journal.pone.0062452	http://dx.doi.org/10.1371/journal.pone.0062452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658728	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000045
J	Young, SD; Szekeres, G; Coates, T				Young, Sean D.; Szekeres, Greg; Coates, Thomas			The Relationship between Online Social Networking and Sexual Risk Behaviors among Men Who Have Sex with Men (MSM)	PLOS ONE			English	Article							INTERNET; TECHNOLOGIES; PARTNERS; BENEFITS	Online social networking usage is growing rapidly, especially among at-risk populations, such as men who have sex with men (MSM). However, little research has studied the relationship between online social networking usage and sexual risk behaviors among at-risk populations. One hundred and eighteen Facebook-registered MSM (60.1% Latino, 28% African American; 11.9% other) were recruited from online (social networking websites and banner advertisements) and offline (local clinics, restaurants and organizations) venues frequented by minority MSM. Inclusion criteria required participants to be men who were 18 years of age or older, had had sex with a man in the past 12 months, were living in Los Angeles, and had a Facebook account. Participants completed an online survey on their social media usage and sexual risk behaviors. Results from a multivariable regression suggest that number of sexual partners met from online social networking technologies is associated with increased: 1) likelihood of having exchanged sex for food, drugs, or a place to stay within the past 3 months; 2) number of new partners within the past 3 months; 3) number of male sex partners within the past 3 months; and 4) frequency of engaging in oral sex within the past 3 months, controlling for age, race, education, and total number of sexual partners. Understanding the relationship between social media sex-seeking and sexual risk behaviors among at-risk populations will help inform population-focused HIV prevention and treatment interventions.	[Young, Sean D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Family Med, Los Angeles, CA 90095 USA; [Szekeres, Greg] Univ Calif Los Angeles, David Geffen Sch Med, Program Global Hlth, Los Angeles, CA 90095 USA; [Coates, Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Program Global Hlth, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Young, SD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Family Med, Los Angeles, CA 90095 USA.	sdyoung@mednet.ucla.edu		Young, Sean D./0000-0001-6052-4875	National Institute of Mental Health, Young PI [K01 MH090884]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH090884, P30MH058107] Funding Source: NIH RePORTER	National Institute of Mental Health, Young PI; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institute of Mental Health, Young PI (K01 MH090884). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tayyib AA, 2009, SEX TRANSM INFECT, V85, P216, DOI 10.1136/sti.2008.032631; [Anonymous], HIV GAY BIS MEN; [Anonymous], STAT STAT SOFTW; Berry M, 2008, AIDS, V22, P787, DOI 10.1097/QAD.0b013e3282f55559; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Grov C, 2012, AIDS EDUC PREV, V24, P102, DOI 10.1521/aeap.2012.24.2.102; Harris Interactive, 2007, GAYS LESB BIS LEAD U; HIV Epidemiology Program Los Angeles County Department of Health Services, 2002, SPEC DAT RUN; HIV Epidemiology Program Los Angeles County Department of Health Services, 2008, SPEC DAT RUN; HIV Epidemiology Program-Los Angeles County Department of Public Health, 2011, 2011 ANN HIV SURV RE; Horrigan JB, 2007, PIP BROADBAND; MacKellar DA, 2011, SEX TRANSM DIS, V38, P419, DOI 10.1097/OLQ.0b013e31820369dd; McFarlane M, 2000, JAMA-J AM MED ASSOC, V284, P443, DOI 10.1001/jama.284.4.443; Mineta NY, 2000, FALLING NET DIGITAL; Rietmeijer CA, 2003, SEX TRANSM DIS, V30, P15, DOI 10.1097/00007435-200301000-00004; Rosser BRS, 2009, AIDS BEHAV, V13, P746, DOI 10.1007/s10461-008-9399-8; Smith A, 2010, PEW INT AM LIF PROJ; Smith A, 2010, MOBILE ACCESS 2010; Smith A, 2011, WHOS WHAT SOCIAL MED; Tashima KT, 2003, INT J STD AIDS, V14, P285, DOI 10.1258/095646203321264926; Young S, INT J STD A IN PRESS; Young S. D., J ADDICTIVE IN PRESS; Young SD, 2012, AIDS BEHAV, V16, P1743, DOI 10.1007/s10461-012-0251-9; Young SD, 2011, AIDS BEHAV, V15, P253, DOI 10.1007/s10461-010-9810-0	24	57	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62271	10.1371/journal.pone.0062271	http://dx.doi.org/10.1371/journal.pone.0062271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658716	gold, Green Published			2022-12-27	WOS:000319167000035
J	Hagmann, CA; Herzner, AM; Abdullah, Z; Zillinger, T; Jakobs, C; Schuberth, C; Coch, C; Higgins, PG; Wisplinghoff, H; Barchet, W; Hornung, V; Hartmann, G; Schlee, M				Hagmann, Cristina Amparo; Herzner, Anna Maria; Abdullah, Zeinab; Zillinger, Thomas; Jakobs, Christopher; Schuberth, Christine; Coch, Christoph; Higgins, Paul G.; Wisplinghoff, Hilmar; Barchet, Winfried; Hornung, Veit; Hartmann, Gunther; Schlee, Martin			RIG-I Detects Triphosphorylated RNA of Listeria monocytogenes during Infection in Non-Immune Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; ANTIVIRAL SIGNALING PROTEIN; ADAPTER PROTEIN; MESSENGER-RNA; DENDRITIC CELLS; IFN-BETA; EPITHELIAL-CELLS; CYTOSOLIC DNA; E-CADHERIN; RECOGNITION	The innate immune system senses pathogens by pattern recognition receptors in different cell compartments. In the endosome, bacteria are generally recognized by TLRs; facultative intracellular bacteria such as Listeria, however, can escape the endosome. Once in the cytosol, they become accessible to cytosolic pattern recognition receptors, which recognize components of the bacterial cell wall, metabolites or bacterial nucleic acids and initiate an immune response in the host cell. Current knowledge has been focused on the type I IFN response to Listeria DNA or Listeria-derived second messenger c-di-AMP via the signaling adaptor STING. Our study focused on the recognition of Listeria RNA in the cytosol. With the aid of a novel labeling technique, we have been able to visualize immediate cytosolic delivery of Listeria RNA upon infection. Infection with Listeria as well as transfection of bacterial RNA induced a type-I-IFN response in human monocytes, epithelial cells or hepatocytes. However, in contrast to monocytes, the type-I-IFN response of epithelial cells and hepatocytes was not triggered by bacterial DNA, indicating a STING-independent Listeria recognition pathway. RIG-I and MAVS knock-down resulted in abolishment of the IFN response in epithelial cells, but the IFN response in monocytic cells remained unaffected. By contrast, knockdown of STING in monocytic cells reduced cytosolic Listeria-mediated type-I-IFN induction. Our results show that detection of Listeria RNA by RIG-I represents a non-redundant cytosolic immunorecognition pathway in nonimmune cells lacking a functional STING dependent signaling pathway.	[Hagmann, Cristina Amparo; Herzner, Anna Maria; Zillinger, Thomas; Jakobs, Christopher; Schuberth, Christine; Coch, Christoph; Barchet, Winfried; Hornung, Veit; Hartmann, Gunther; Schlee, Martin] Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Abdullah, Zeinab] Univ Bonn, Inst Mol Med, Bonn, Germany; [Abdullah, Zeinab] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Higgins, Paul G.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Hornung, Veit; Hartmann, Gunther] German Ctr Infect Res, Cologne, Germany	University of Bonn; University of Bonn; University of Bonn; University of Cologne; German Center for Infection Research; University of Cologne	Schlee, M (corresponding author), Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany.	martin.schlee@uni-bonn.de	Coch, Christoph/AAW-5336-2021; Abdullah, Zeinab/HII-5346-2022; Hartmann, Gunther/P-7492-2017; Higgins, Paul/B-6708-2011; Hornung, Veit/C-3565-2012; Zillinger, Thomas/AAD-7320-2020; Schlee, Martin/AAL-1238-2021	Hartmann, Gunther/0000-0003-1021-2018; Higgins, Paul/0000-0001-8677-9454; Hornung, Veit/0000-0002-4150-194X; Zillinger, Thomas/0000-0002-0866-4835; Barchet, Winfried/0000-0002-6745-6606; Schlee, Martin/0000-0003-3671-7639	BMBF Biofuture [0311896]; BMBF [01KI0771]; Deutsche Forschungsgemeinschaft [SFB670, SFB704, SFB832, KFO177]	BMBF Biofuture(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Grants BMBF Biofuture 0311896, BMBF-grant 01KI0771 (www.bmbf.de/) to GH and from the Deutsche Forschungsgemeinschaft (www.dfg.de; SFB670 to MS, GH and VH, SFB704 to GH, SFB832 and KFO177 to GH). GH, WB and VH are members of the DFG Excellence Cluster ImmunoSensation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Z, 2012, EMBO J, V31, P4153, DOI 10.1038/emboj.2012.274; ABLASSER A, 2009, NAT IMMUNOL; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; BIEGER CD, 1989, J BACTERIOL, V171, P141, DOI 10.1128/jb.171.1.141-147.1989; Burckstummer T, 2009, NAT IMMUNOL; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Coch C, 2009, J LEUKOCYTE BIOL, V86, P663, DOI 10.1189/jlb.0509314; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Fernandes-Alnemri T, 2009, NATURE; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; GREGORY SH, 1992, J LEUKOCYTE BIOL, V51, P421, DOI 10.1002/jlb.51.4.421; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HORNUNG V, 2009, NATURE; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Li XD, 2011, P NATL ACAD SCI USA, V108, P17390, DOI 10.1073/pnas.1107114108; Mackie GA, 2000, J BIOL CHEM, V275, P25069, DOI 10.1074/jbc.C000363200; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Paschen A, 2000, EUR J IMMUNOL, V30, P3447, DOI 10.1002/1521-4141(2000012)30:12<3447::AID-IMMU3447>3.0.CO;2-M; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pizarro-Cerda J, 2012, COLD SPRING HARB PER, P2; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Schlee M, 2010, MOL THER, V18, P1254, DOI 10.1038/mt.2010.90; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seveau S, 2007, MICROBES INFECT, V9, P1167, DOI 10.1016/j.micinf.2007.05.004; Soulat D, 2006, FEBS LETT, V580, P2341, DOI 10.1016/j.febslet.2006.03.057; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tsai HN, 2003, APPL ENVIRON MICROB, V69, P6943, DOI 10.1128/AEM.69.11.6943-6945.2003; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Warren SE, 2010, J IMMUNOL, V185, P818, DOI 10.4049/jimmunol.1000724; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	68	57	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62872	10.1371/journal.pone.0062872	http://dx.doi.org/10.1371/journal.pone.0062872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23653683	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300106
J	Mishra, MK; Chaturvedi, P; Singh, R; Singh, G; Sharma, LK; Pandey, V; Kumari, N; Misra, P				Mishra, Manoj K.; Chaturvedi, Pankaj; Singh, Ruchi; Singh, Gaurav; Sharma, Lokendra K.; Pandey, Vibha; Kumari, Nishi; Misra, Pratibha			Overexpression of WsSGTL1 Gene of Withania somnifera Enhances Salt Tolerance, Heat Tolerance and Cold Acclimation Ability in Transgenic Arabidopsis Plants	PLOS ONE			English	Article							STEROL GLUCOSYLTRANSFERASE; SIGNAL-TRANSDUCTION; MEMBRANE-LIPIDS; PHOTOSYSTEM-II; STRESS; THALIANA; THERMOTOLERANCE; PHOTOSYNTHESIS; EXPRESSION; GLUCOSIDE	Background: Sterol glycosyltrnasferases (SGT) are enzymes that glycosylate sterols which play important role in plant adaptation to stress and are medicinally important in plants like Withania somnifera. The present study aims to find the role of WsSGTL1 which is a sterol glycosyltransferase from W. somnifera, in plant's adaptation to abiotic stress. Methodology: The WsSGTL1 gene was transformed in Arabidopsis thaliana through Agrobacterium mediated transformation, using the binary vector pBI121, by floral dip method. The phenotypic and physiological parameters like germination, root length, shoot weight, relative electrolyte conductivity, MDA content, SOD levels, relative electrolyte leakage and chlorophyll measurements were compared between transgenic and wild type Arabidopsis plants under different abiotic stresses - salt, heat and cold. Biochemical analysis was done by HPLC-TLC and radiolabelled enzyme assay. The promoter of the WsSGTL1 gene was cloned by using Genome Walker kit (Clontech, USA) and the 3D structures were predicted by using Discovery Studio Ver. 2.5. Results: The WsSGTL1 transgenic plants were confirmed to be single copy by Southern and homozygous by segregation analysis. As compared to WT, the transgenic plants showed better germination, salt tolerance, heat and cold tolerance. The level of the transgene WsSGTL1 was elevated in heat, cold and salt stress along with other marker genes such as HSP70, HSP90, RD29, SOS3 and LEA4-5. Biochemical analysis showed the formation of sterol glycosides and increase in enzyme activity. When the promoter of WsSGTL1 gene was cloned from W. somnifera and sequenced, it contained stress responsive elements. Bioinformatics analysis of the 3D structure of the WsSGTL1 protein showed functional similarity with sterol glycosyltransferase AtSGT of A. thaliana. Conclusions: Transformation of WsSGTL1 gene in A. thaliana conferred abiotic stress tolerance. The promoter of the gene in W. somnifera was found to have stress responsive elements. The 3D structure showed functional similarity with sterol glycosyltransferases.	[Mishra, Manoj K.; Singh, Ruchi; Singh, Gaurav; Sharma, Lokendra K.; Pandey, Vibha; Misra, Pratibha] CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India; [Chaturvedi, Pankaj] Sanjay Gandhi Post Grad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Kumari, Nishi] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Sanjay Gandhi Postgraduate Institute of Medical Sciences; Banaras Hindu University (BHU)	Misra, P (corresponding author), CSIR, Natl Bot Res Inst, Rana Pratap Marg, Lucknow, Uttar Pradesh, India.	pratibhaflora@yahoo.com		Singh, Gaurav/0000-0002-3798-2111; SINGH, RUCHI/0000-0003-4696-5150; Kumar Mishra, Manoj/0000-0001-7836-6254; PANDEY, VIBHA/0000-0001-7868-122X	Department of Biotechnology, Government of India [GAP-231225]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Funding provided by Department of Biotechnology, Government of India, for financial support through GAP-231225 project. Website: http://dbtindia.nic.in/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; Bartwal A, 2012, J PLANT GROWTH REGUL, DOI [10.1007/s00344-012-9272, DOI 10.1007/S00344-012-9272]; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Bhattacharya SK, 2000, PHYTOMEDICINE, V7, P463, DOI 10.1016/S0944-7113(00)80030-6; BOUVIERNAVE P, 1984, PLANT SCI LETT, V36, P19, DOI 10.1016/0304-4211(84)90271-2; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaturvedi P, 2012, MOL BIOL REP, V39, P9755, DOI 10.1007/s11033-012-1841-3; Chaturvedi P, 2011, APPL BIOCHEM BIOTECH, V165, P47, DOI 10.1007/s12010-011-9232-0; Chen JP, 2006, PLANT CELL ENVIRON, V29, P1437, DOI 10.1111/j.1365-3040.2006.01527.x; Chen LX, 2011, NAT PROD REP, V28, P705, DOI 10.1039/c0np00045k; Chen RJY, 2009, ACTA PHARMACOL SIN, V30, P61, DOI 10.1038/aps.2008.6; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cui LJ, 2006, BOT STUD, V47, P61; da Silva EN, 2011, SCI AGR, V68, P62, DOI 10.1590/S0103-90162011000100010; DeBolt S, 2009, PLANT PHYSIOL, V151, P78, DOI 10.1104/pp.109.140582; GHOSAL S, 1989, PHYTOTHER RES, V3, P201, DOI 10.1002/ptr.2650030510; Gill T, 2010, J PLANT GENET TRANSG, V1, P1; Glombitza S, 2004, PLANT MOL BIOL, V54, P817, DOI 10.1007/s11103-004-0274-3; Grille S, 2010, PROG LIPID RES, V49, P262, DOI 10.1016/j.plipres.2010.02.001; Hadi MZ, 2002, PLANT CELL REP, V21, P130, DOI 10.1007/s00299-002-0473-9; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Houde M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-149; Husar S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-51; Jayaprakasam B, 2003, TETRAHEDRON, V59, P841, DOI 10.1016/S0040-4020(02)01601-0; Kalaji HM, 2011, ENVIRON EXP BOT, V73, P64, DOI 10.1016/j.envexpbot.2010.10.009; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KINGSTON RE, 1987, MOL CELL BIOL, V7, P1530, DOI 10.1128/MCB.7.4.1530; Kunimoto S, 2000, CELL STRESS CHAPERON, V5, P3, DOI 10.1379/1466-1268(2000)005<0003:EOCGBH>2.0.CO;2; Kunimoto S, 2002, CELL STRUCT FUNCT, V27, P157, DOI 10.1247/csf.27.157; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Lee JY, 2010, J PLANT BIOL, V53, P240, DOI 10.1007/s12374-010-9111-1; Levitt J, 1980, RESPONSES PLANTS ENV, P14; LILJENBERG CS, 1992, PROG LIPID RES, V31, P335, DOI 10.1016/0163-7827(92)90012-8; Lim CC, 1998, J AM SOC HORTIC SCI, V123, P246, DOI 10.21273/JASHS.123.2.246; Lin Fan-Yun, 2008, Yichuan, V30, P1608, DOI 10.3724/SP.J.1005.2008.01608; Lu CM, 2002, PLANT SCI, V163, P1063, DOI 10.1016/S0168-9452(02)00281-9; Madina BR, 2007, BBA-PROTEINS PROTEOM, V1774, P1199, DOI 10.1016/j.bbapap.2007.06.015; Madina BR, 2007, BBA-PROTEINS PROTEOM, V1774, P392, DOI 10.1016/j.bbapap.2006.12.009; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; MurakamiMurofushi K, 1997, J BIOL CHEM, V272, P486; Napoli C, 1997, BASIC RES CARDIOL, V92, P96, DOI 10.1007/BF00805570; Nishiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032124; PALTA JP, 1993, PLANT PHYSIOL, V103, P793, DOI 10.1104/pp.103.3.793; PATTERSON GW, 1993, PHYTOCHEMISTRY, V33, P1381, DOI 10.1016/0031-9422(93)85095-9; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Schaller H, 2003, PROG LIPID RES, V42, P163, DOI 10.1016/S0163-7827(02)00047-4; Schumacher K, 2000, CURR OPIN PLANT BIOL, V3, P79, DOI 10.1016/S1369-5266(99)00038-2; Sharkey TD, 2005, PLANT CELL ENVIRON, V28, P269, DOI 10.1111/j.1365-3040.2005.01324.x; Sharma LK, 2007, ARCH BIOCHEM BIOPHYS, V460, P48, DOI 10.1016/j.abb.2007.01.024; Surjus Durand M, 1996, J EXP BOT, V47, P17; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Zhao J, 2002, CHEM PHARM BULL, V50, P760, DOI 10.1248/cpb.50.760	59	49	51	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63064	10.1371/journal.pone.0063064	http://dx.doi.org/10.1371/journal.pone.0063064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646175	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300130
J	Tonnessen, R; Hauge, AG; Hansen, EF; Rimstad, E; Jonassen, CM				Tonnessen, Ragnhild; Hauge, Anna G.; Hansen, Elisabeth F.; Rimstad, Espen; Jonassen, Christine M.			Host Restrictions of Avian Influenza Viruses: In Silico Analysis of H13 and H16 Specific Signatures in the Internal Proteins	PLOS ONE			English	Article							A-VIRUS; NS1 PROTEIN; HEMAGGLUTININ SUBTYPE; WILD WATERFOWL; PB1 GENE; NUCLEOPROTEIN; EVOLUTION; NUCLEAR; BIRDS; ECOLOGY	Gulls are the primary hosts of H13 and H16 avian influenza viruses (AIVs). The molecular basis for this host restriction is only partially understood. In this study, amino acid sequences from Eurasian gull H13 and H16 AIVs and Eurasian AIVs (non H13 and H16) were compared to determine if specific signatures are present only in the internal proteins of H13 and H16 AIVs, using a bioinformatics approach. Amino acids identified in an initial analysis performed on 15 selected sequences were checked against a comprehensive set of AIV sequences retrieved from Genbank to verify them as H13 and H16 specific signatures. Analysis of protein similarities and prediction of subcellular localization signals were performed to search for possible functions associated with the confirmed signatures. H13 and H16 AIV specific signatures were found in all the internal proteins examined, but most were found in the non-structural protein 1 (NS1) and in the nucleoprotein. A putative functional signature was predicted to be present in the nuclear export protein. Moreover, it was predicted that the NS1 of H13 and H16 AIVs lack one of the nuclear localization signals present in NS1 of other AIV subtypes. These findings suggest that the signatures found in the internal proteins of H13 and H16 viruses are possibly related to host restriction.	[Tonnessen, Ragnhild; Hansen, Elisabeth F.; Rimstad, Espen] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway; [Tonnessen, Ragnhild; Hauge, Anna G.; Jonassen, Christine M.] Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway	Norwegian University of Life Sciences; Norwegian Veterinary Institute	Tonnessen, R (corresponding author), Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway.	ragnhild.tonnessen@vetinst.no			Norwegian Research Council [178275]; Animalia Meat and Poultry Research Centre; Norwegian Food Safety Authority	Norwegian Research Council(Research Council of NorwayEuropean Commission); Animalia Meat and Poultry Research Centre; Norwegian Food Safety Authority	This work was supported by the Norwegian Research Council (www.forskningsradet.no) (project number 178275), Animalia Meat and Poultry Research Centre (www.animalia.no) and the Norwegian Food Safety Authority (www.mattilsynet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BEAN WJ, 1984, VIROLOGY, V133, P438, DOI 10.1016/0042-6822(84)90410-0; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Brown J, 2012, AVIAN DIS, V56, P969, DOI 10.1637/10158-040912-Reg.1; Bui VN, 2012, VIROLOGY, V423, P77, DOI 10.1016/j.virol.2011.11.019; DAOUST PY, 2012, VET PATHOL IN PRESS; Dillon D, 2010, INFECT GENET EVOL, V10, P1085, DOI 10.1016/j.meegid.2010.07.004; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Germundsson A, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-28; GORMAN OT, 1990, J VIROL, V64, P1487, DOI 10.1128/JVI.64.4.1487-1497.1990; GORMAN OT, 1990, J VIROL, V64, P4893, DOI 10.1128/JVI.64.10.4893-4902.1990; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2009, VIROLOGY, V383, P6, DOI 10.1016/j.virol.2008.10.002; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hrincius ER, 2010, CELL MICROBIOL, V12, P831, DOI 10.1111/j.1462-5822.2010.01436.x; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jonassen CM, 2007, AVIAN DIS, V51, P425, DOI 10.1637/7555-033106R1.1; Kawaoka Y, 1998, VIRUS RES, V55, P143, DOI 10.1016/S0168-1702(98)00038-0; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Keawcharoen J, 2010, VACCINE, V28, P5803, DOI 10.1016/j.vaccine.2010.06.072; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lebarbenchon Camille, 2008, J Mol Genet Med, V3, P121; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; Lu XS, 2012, J VIROL, V86, P12861, DOI 10.1128/JVI.01606-12; Manzoor R, 2008, VIRUS GENES, V37, P144, DOI 10.1007/s11262-008-0248-7; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; *NCBI, 2012, INFL VIR RES; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Phipps LP, 2004, J VIROL METHODS, V122, P119, DOI 10.1016/j.jviromet.2004.08.008; Pielak RM, 2011, BBA-BIOMEMBRANES, V1808, P522, DOI 10.1016/j.bbamem.2010.04.015; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tisoncik JR, 2011, J GEN VIROL, V92, P2093, DOI 10.1099/vir.0.032060-0; Toennessen R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-21; Tonnessen R, 2011, AVIAN DIS, V55, P680, DOI 10.1637/9701-030411-ResNote.1; Van Borm S, 2012, ARCH VIROL, V157, P1509, DOI 10.1007/s00705-012-1323-x; Wallensten A, 2005, ARCH VIROL, V150, P1685, DOI 10.1007/s00705-005-0543-8; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Widjaja L, 2004, J VIROL, V78, P8771, DOI 10.1128/JVI.78.16.8771-8779.2004; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; World Health Organization (WHO), 2002, MAN AN INFL DIAGN SU; Yamnikova SS, 2003, AVIAN DIS, V47, P1164, DOI 10.1637/0005-2086-47.s3.1164; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	57	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63270	10.1371/journal.pone.0063270	http://dx.doi.org/10.1371/journal.pone.0063270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646204	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300163
J	Guo, R; Li, Y; Ning, JY; Sun, D; Lin, LJ; Liu, XM				Guo, Rong; Li, Yong; Ning, Jinying; Sun, Dan; Lin, Lianjun; Liu, Xinmin			HnRNP A1/A2 and SF2/ASF Regulate Alternative Splicing of Interferon Regulatory Factor-3 and Affect Immunomodulatory Functions in Human Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; HEPATOCELLULAR-CARCINOMA; NUCLEAR TRANSLOCATION; LINKING INFLAMMATION; ACTIVATION; IRF-3; TRANSCRIPTION; IMMUNITY; SURVIVAL	Heterogeneous nuclear ribonucleoparticule A1/A2 (hnRNP A1/A2) and splicing factor 2/alternative splicing factor (SF2/ASF) are pivotal for precursor messenger RNA (pre-mRNA) splicing. Interferon regulatory factor-3 (IRF-3) plays critical roles in host defense against viral and microbial infection. Truncated IRF-3 proteins resulting from alternative splicing have been identified and characterized as functional antagonists to full-length IRF-3. In this study, we examined the molecular mechanism for splicing regulation of IRF-3 pre-mRNA and first reported the regulatory effect of hnRNP A1/A2 and SF2/ASF on IRF-3 splicing and activation. RNA interference-mediated depletion of hnRNP A1/A2 or SF2/ASF in human non-small cell lung cancer (NSCLC) cells increased exclusion of exons 2 and 3 of IRF-3 gene and reduced expression levels of IRF-3 protein and IRF-3 downstream effector molecules interferon-beta and CXCL10/IP-10. In addition, direct binding of hnRNP A1 and SF2/ASF to specific binding motifs in IRF-3 intron 1 was confirmed by RNA electrophoretic mobility shift assay. Subsequent minigene splicing assay showed that IRF-3 minigenes with mutated hnRNPA 1/A2 or SF2/ASF binding motifs increased exclusion of exons 2 and 3. Moreover, knockdown of hnRNP A1/A2 or SF2/ASF in NSCLC cells reinforced phytohemagglutinin-induced tumor necrosis factor-alpha release by peripheral blood mononuclear cells (PBMC) but suppressed that of interleukin-10 in NSCLC/PBMC co-cultures. Taken together, our results suggest that specific knockdown for hnRNP A1/A2 or SF2/ASF increase exclusion of exons 2 and 3 of IRF-3 pre-mRNA and influence immunomodulatory functions of human NSCLC cells.	[Guo, Rong; Sun, Dan; Lin, Lianjun; Liu, Xinmin] Peking Univ First Hosp, Dept Geriatr, Beijing 100871, Peoples R China; [Li, Yong] Beijing Canc Hosp, Peking Univ Canc Hosp, Beijing Inst Canc Res,Dept Lab Anim, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Ning, Jinying] Crown Biosci Inc Beijing, Dept Cell Biol, Beijing, Peoples R China	Peking University; Peking University	Liu, XM (corresponding author), Peking Univ First Hosp, Dept Geriatr, Beijing 100871, Peoples R China.	lxm2128@163.com			National Natural Science Foundation of China [30572072, 30871366]; Beijing Municipal Natural Science Foundation [5092009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National Natural Science Foundation of China (Grant No. 30572072) to XL and by the Beijing Municipal Natural Science Foundation (Grant No. 5092009) and the National Natural Science Foundation of China (Grant No. 30871366) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altraja S, 2009, RESPIROLOGY, V14, P39, DOI 10.1111/j.1440-1843.2008.01414.x; BRENNAN FM, 1989, LANCET, V2, P244; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4359, DOI 10.1093/nar/gkm444; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; Colobran R, 2007, CLIN EXP IMMUNOL, V150, P1, DOI 10.1111/j.1365-2249.2007.03489.x; Cui HQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-356; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Duguay D, 2002, CANCER RES, V62, P5148; Ezponda T, 2010, CLIN CANCER RES, V16, P4113, DOI 10.1158/1078-0432.CCR-10-0076; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; He YW, 2005, J CELL SCI, V118, P3173, DOI 10.1242/jcs.02448; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Karpova AY, 2001, MOL CELL BIOL, V21, P4169, DOI 10.1128/MCB.21.13.4169-4176.2001; Karpova AY, 2000, GENE DEV, V14, P2813, DOI 10.1101/gad.813800; Kim TY, 2003, J BIOL CHEM, V278, P15272, DOI 10.1074/jbc.M205792200; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; Li QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028683; Li Y, 2011, BBA-GENE REGUL MECH, V1809, P166, DOI 10.1016/j.bbagrm.2011.01.006; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038868; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mole S, 2009, J PATHOL, V219, P383, DOI 10.1002/path.2608; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Navarro L, 1998, MOL CELL BIOL, V18, P3796, DOI 10.1128/MCB.18.7.3796; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Owens BMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041050; Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Sadik CD, 2009, NUCLEIC ACIDS RES, V37, P5041, DOI 10.1093/nar/gkp525; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shen ML, 2012, NUCLEIC ACIDS RES, V40, P428, DOI 10.1093/nar/gkr713; Slattery ML, 2011, CARCINOGENESIS, V32, P1660, DOI 10.1093/carcin/bgr189; Somberg M, 2010, J VIROL, V84, P8219, DOI 10.1128/JVI.00462-10; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tarassishin L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-187; Tauler J, 2009, CURR OPIN PHARMACOL, V9, P384, DOI 10.1016/j.coph.2009.06.004; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Tokunaga T, 2010, BIOCHEM BIOPH RES CO, V397, P202, DOI 10.1016/j.bbrc.2010.05.085; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wang SS, 2009, J INFECT DIS, V199, P20, DOI 10.1086/595563; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhao W, 2012, J IMMUNOL, V188, P3179, DOI 10.4049/jimmunol.1101175; Zhou J, 2001, BREAST CANCER RES TR, V66, P217, DOI 10.1023/A:1010631915831	59	36	40	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62729	10.1371/journal.pone.0062729	http://dx.doi.org/10.1371/journal.pone.0062729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658645	Green Submitted, Green Published, gold			2022-12-27	WOS:000321662800058
J	Menger, R; Dijkerman, HC; Van der Stigchel, S				Menger, Rudmer; Dijkerman, H. Chris; Van der Stigchel, Stefan			The Effect of Similarity: Non-Spatial Features Modulate Obstacle Avoidance	PLOS ONE			English	Article							TO-GRASP MOVEMENTS; EYE-HAND COORDINATION; AUTOMATIC AVOIDANCE; VISUAL AWARENESS; OPTIC ATAXIA; TARGET; REACH; DEVIATIONS; INTERFERENCE; PREHENSION	The introduction of non-target objects into a workspace leads to temporal and spatial adjustments of reaching trajectories towards a target. If the non-target is obstructing the path of the hand towards the target, the reach is adjusted such that collision with the non-target, or obstacle, is avoided. Little is known about the influence of features which are irrelevant for the execution of the movement on avoidance movements, like color similarity between target and non-target objects. In eye movement studies the similarity of non-targets has been revealed to influence oculomotor competition. Because of the tight neural and behavioral coupling between the gaze and reaching system, our aim was to determine the contribution of similarity between target and non-target to avoidance movements. We performed 2 experiments in which participants had to reach to grasp a target object while a non-target was present in the workspace. These non-targets could be either similar or dissimilar in color to the target. The results indicate that the non-spatial feature similarity can further modify the avoidance response and therefore further modify the spatial path of the reach. Indeed, we find that dissimilar pairs have a stronger effect on reaching-to-grasp movements than similar pairs. This effect was most pronounced when the non-target was on the outside of the reaching hand, where it served as more of an obstacle to the trailing arm. We propose that the increased capture of attention by the dissimilar obstacle is responsible for the more robust avoidance response.	[Menger, Rudmer; Dijkerman, H. Chris; Van der Stigchel, Stefan] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands	Utrecht University	Menger, R (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	r.menger@uu.nl		van der Stigchel, Stefan/0000-0002-5918-3521	University Utrecht	University Utrecht	This research was funded by an internal and independent funds of the University Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aidroos N, 2010, VIS COGN, V18, P26, DOI 10.1080/13506280802456939; Biegstraaten M, 2003, EXP BRAIN RES, V149, P530, DOI 10.1007/s00221-003-1374-z; Chapman CS, 2008, EXP BRAIN RES, V191, P83, DOI 10.1007/s00221-008-1499-1; Gentilucci M, 2001, EXP BRAIN RES, V137, P36, DOI 10.1007/s002210000639; Hesse C, 2012, EUR J NEUROSCI, V36, P2383, DOI 10.1111/j.1460-9568.2012.08131.x; Howard LA, 1997, EXP BRAIN RES, V113, P144, DOI 10.1007/BF02454150; JACKSON SR, 1995, EXP BRAIN RES, V102, P519; Jonikaitis D, 2011, PSYCHOL SCI, V22, P339, DOI 10.1177/0956797610397666; Kritikos A, 2000, Q J EXP PSYCHOL-A, V53, P131, DOI 10.1080/027249800390709; Kritikos A, 2001, EXP BRAIN RES, V138, P54, DOI 10.1007/s002210000641; Ludwig CJH, 2003, EXP BRAIN RES, V152, P60, DOI 10.1007/s00221-003-1520-7; Ludwig CJH, 2002, J EXP PSYCHOL HUMAN, V28, P902, DOI 10.1037//0096-1523.28.4.902; McIntosh RD, 2004, P ROY SOC B-BIOL SCI, V271, P15, DOI 10.1098/rspb.2003.2545; Meegan DV, 1998, Q J EXP PSYCHOL-A, V51, P225, DOI 10.1080/02724989843000004; Menger R, 2012, ACTA PSYCHOL, V141, P1, DOI 10.1016/j.actpsy.2012.06.006; Mon-Williams M, 2001, EXP BRAIN RES, V137, P497; Mon-Williams M, 2000, EXP BRAIN RES, V134, P268, DOI 10.1007/s002210000479; Mulckhuyse M, 2009, J NEUROPHYSIOL, V102, P1451, DOI 10.1152/jn.00068.2009; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Rice NJ, 2008, NEUROPSYCHOLOGIA, V46, P1549, DOI 10.1016/j.neuropsychologia.2008.01.012; Rice NJ, 2006, EXP BRAIN RES, V174, P176, DOI 10.1007/s00221-006-0435-5; Sailer U, 2000, EXP BRAIN RES, V134, P163, DOI 10.1007/s002210000457; Saling M, 1998, EXP BRAIN RES, V118, P251, DOI 10.1007/s002210050279; Schenk T, 2005, EXP BRAIN RES, V167, P95, DOI 10.1007/s00221-005-0027-9; Schindler I, 2004, NAT NEUROSCI, V7, P779, DOI 10.1038/nn1273; Schot WD, 2010, J NEUROSCI METH, V187, P147, DOI 10.1016/j.jneumeth.2010.01.004; Song JH, 2009, J NEUROPHYSIOL, V102, P2681, DOI 10.1152/jn.91352.2008; Thompson AA, 2007, NEUROSCI LETT, V426, P111, DOI 10.1016/j.neulet.2007.09.006; Tipper SP, 1997, VIS COGN, V4, P1, DOI 10.1080/713756749; Tresilian JR, 1998, EXP BRAIN RES, V120, P352, DOI 10.1007/s002210050409; Verhagen L, 2008, J NEUROSCI, V28, P4726, DOI 10.1523/JNEUROSCI.0057-08.2008; Welsh TN, 2011, ACTA PSYCHOL, V137, P300, DOI 10.1016/j.actpsy.2011.03.011; Welsh TN, 1999, EXP BRAIN RES, V127, P207, DOI 10.1007/s002210050790	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e59294	10.1371/journal.pone.0059294	http://dx.doi.org/10.1371/journal.pone.0059294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658606	Green Published, Green Submitted, gold			2022-12-27	WOS:000321662800002
J	Eastburn, DJ; Sciambi, A; Abate, AR				Eastburn, Dennis J.; Sciambi, Adam; Abate, Adam R.			Picoinjection Enables Digital Detection of RNA with Droplet RT-PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ELECTROCOALESCENCE; MICROFLUIDICS	The ability to add reagents to drops in a sequential fashion is necessary for numerous applications of microfluidics in biology. An important method for accomplishing this is picoinjection, a technique in which reagents are injected into aqueous drops using an electric field. While picoinjection has been shown to allow the precise addition of reagents to drops, its compatibility with biological reactions is yet to be thoroughly demonstrated. Here, we investigate the compatibility of picoinjection with digital RT-PCR Taqman assays, reactions that incorporate nucleic acids, enzymes, and other common biological reagents. We find that picoinjection is compatible with this assay and enables the detection of RNA transcripts at rates comparable to workflows not incorporating picoinjection. We also find that picoinjection results in negligible transfer of material between drops and that the drops faithfully retain their compartmentalization.	[Eastburn, Dennis J.; Sciambi, Adam; Abate, Adam R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Abate, AR (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	adam.abate@ucsf.edu			Department of Bioengineering and Therapeutic Sciences; California Institute for Quantitative Biosciences [QB3]; Rogers Family Foundation; UCSF/Sandler Foundation; University of California	Department of Bioengineering and Therapeutic Sciences; California Institute for Quantitative Biosciences; Rogers Family Foundation; UCSF/Sandler Foundation; University of California(University of California System)	This work was supported by startup funds from the Department of Bioengineering and Therapeutic Sciences, a Research Award from the California Institute for Quantitative Biosciences (QB3), the Bridging the Gap Award from the Rogers Family Foundation, a New Frontiers Research Award from the UCSF/Sandler Foundation Program for Breakthrough Biomedical Research, and a grant from the University of California Proof of Concept Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate AR, 2010, P NATL ACAD SCI USA, V107, P19163, DOI 10.1073/pnas.1006888107; Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Ahn K, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164911; ATTEN P, 1993, J ELECTROSTAT, V30, P259, DOI 10.1016/0304-3886(93)90080-Q; Beer NR, 2008, ANAL CHEM, V80, P1854, DOI 10.1021/ac800048k; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; Chabert M, 2005, ELECTROPHORESIS, V26, P3706, DOI 10.1002/elps.200500109; Clausell-Tormos J, 2008, CHEM BIOL, V15, P427, DOI 10.1016/j.chembiol.2008.04.004; Garstecki P, 2006, LAB CHIP, V6, P693; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kiss MM, 2008, ANAL CHEM, V80, P8975, DOI 10.1021/ac801276c; Nakano M, 2005, J BIOSCI BIOENG, V99, P293, DOI 10.1263/jbb.99.293; O'Donovan B, 2012, LAB CHIP, V12, P4029, DOI 10.1039/c2lc40693d; PULVERTAFT RJV, 1964, LANCET, V1, P238; Seemann R, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016601; Song H, 2006, ANGEW CHEM INT EDIT, V45, P7336, DOI 10.1002/anie.200601554; Teh SY, 2008, LAB CHIP, V8, P198, DOI 10.1039/b715524g; Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Zheng B, 2004, ANAL CHEM, V76, P4977, DOI 10.1021/ac0495743	20	52	61	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62961	10.1371/journal.pone.0062961	http://dx.doi.org/10.1371/journal.pone.0062961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658657	gold, Green Published, Green Submitted			2022-12-27	WOS:000318343700081
J	Gong, P; Kortus, MG; Nix, JC; Davis, RE; Peersen, OB				Gong, Peng; Kortus, Matthew G.; Nix, Jay C.; Davis, Ralph E.; Peersen, Olve B.			Structures of Coxsackievirus, Rhinovirus, and Poliovirus Polymerase Elongation Complexes Solved by Engineering RNA Mediated Crystal Contacts	PLOS ONE			English	Article							KINETIC-ANALYSIS; VIRUS; MECHANISM; FIDELITY; 3D(POL); TRANSLOCATION; INITIATION; DIVERSITY; INSIGHTS; BINDING	RNA-dependent RNA polymerases play a vital role in the growth of RNA viruses where they are responsible for genome replication, but do so with rather low fidelity that allows for the rapid adaptation to different host cell environments. These polymerases are also a target for antiviral drug development. However, both drug discovery efforts and our understanding of fidelity determinants have been hampered by a lack of detailed structural information about functional polymerase-RNA complexes and the structural changes that take place during the elongation cycle. Many of the molecular details associated with nucleotide selection and catalysis were revealed in our recent structure of the poliovirus polymerase-RNA complex solved by first purifying and then crystallizing stalled elongation complexes. In the work presented here we extend that basic methodology to determine nine new structures of poliovirus, coxsackievirus, and rhinovirus elongation complexes at 2.2-2.9 A resolution. The structures highlight conserved features of picornaviral polymerases and the interactions they make with the template and product RNA strands, including a tight grip on eight basepairs of the nascent duplex, a fully pre-positioned templating nucleotide, and a conserved binding pocket for the +2 position template strand base. At the active site we see a pre-bound magnesium ion and there is conservation of a non-standard backbone conformation of the template strand in an interaction that may aid in triggering RNA translocation via contact with the conserved polymerase motif B. Moreover, by engineering plasticity into RNA-RNA contacts, we obtain crystal forms that are capable of multiple rounds of in-crystal catalysis and RNA translocation. Together, the data demonstrate that engineering flexible RNA contacts to promote crystal lattice formation is a versatile platform that can be used to solve the structures of viral RdRP elongation complexes and their catalytic cycle intermediates.	[Gong, Peng; Kortus, Matthew G.; Peersen, Olve B.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA; [Davis, Ralph E.] Cocrystal Discovery Inc, Mountain View, CA USA	Colorado State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Peersen, OB (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Olve.Peersen@ColoState.edu	Peersen, Olve/P-5587-2016; Gong, Peng/ABD-6333-2021		National Institutes of Health [R01-AI059130]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health research grant R01-AI059130 to O.B.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agudo R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001072; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campagnola G, 2008, J VIROL, V82, P9458, DOI 10.1128/JVI.00647-08; Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Golosov AA, 2010, STRUCTURE, V18, P83, DOI 10.1016/j.str.2009.10.014; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Gong P, 2009, ANAL BIOCHEM, V391, P45, DOI 10.1016/j.ab.2009.04.035; Hobdey SE, 2010, J VIROL, V84, P8072, DOI 10.1128/JVI.02147-09; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530; Kortus MG, 2012, J MOL BIOL, V417, P263, DOI 10.1016/j.jmb.2012.01.049; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Levi LI, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001163; Mosley RT, 2012, J VIROLOGY; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; Pata JD, 2010, STRUCTURE, V18, P4, DOI 10.1016/j.str.2009.12.003; Pfeiffer JK, 2006, P NATL ACAD SCI USA, V103, P5520, DOI 10.1073/pnas.0600834103; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Theobald DL, 2006, P NATL ACAD SCI USA, V103, P18521, DOI 10.1073/pnas.0508445103; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Weeks SA, 2012, J BIOL CHEM, V287, P31618, DOI 10.1074/jbc.C112.401471; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Yang XR, 2010, BIOCHEMISTRY-US, V49, P9361, DOI 10.1021/bi100833r; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	42	55	56	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e60272	10.1371/journal.pone.0060272	http://dx.doi.org/10.1371/journal.pone.0060272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667424	gold, Green Submitted, Green Published			2022-12-27	WOS:000319055600004
J	McDowell, SC; Lopez-Marques, RL; Poulsen, LR; Palmgren, MG; Harper, JF				McDowell, Stephen C.; Lopez-Marques, Rosa L.; Poulsen, Lisbeth R.; Palmgren, Michael G.; Harper, Jeffrey F.			Loss of the Arabidopsis thaliana P-4-ATPase ALA3 Reduces Adaptability to Temperature Stresses and Impairs Vegetative, Pollen, and Ovule Development	PLOS ONE			English	Article							P-TYPE ATPASE; INTRACELLULAR VESICLE TRAFFICKING; FATTY-ACID UNSATURATION; PLASMA-MEMBRANE; SALT TOLERANCE; COLD STRESS; AMINOPHOSPHOLIPID TRANSLOCASES; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; BIOLOGICAL FUNCTIONS	Members of the P-4 subfamily of P-type ATPases are thought to help create asymmetry in lipid bilayers by flipping specific lipids between the leaflets of a membrane. This asymmetry is believed to be central to the formation of vesicles in the secretory and endocytic pathways. In Arabidopsis thaliana, a P-4-ATPase associated with the trans-Golgi network (ALA3) was previously reported to be important for vegetative growth and reproductive success. Here we show that multiple phenotypes for ala3 knockouts are sensitive to growth conditions. For example, ala3 rosette size was observed to be dependent upon both temperature and soil, and varied between 40% and 80% that of wild-type under different conditions. We also demonstrate that ala3 mutants have reduced fecundity resulting from a combination of decreased ovule production and pollen tube growth defects. In-vitro pollen tube growth assays showed that ala3 pollen germinated similar to 2 h slower than wild-type and had approximately 2-fold reductions in both maximal growth rate and overall length. In genetic crosses under conditions of hot days and cold nights, pollen fitness was reduced by at least 90-fold; from similar to 18% transmission efficiency (unstressed) to less than 0.2% (stressed). Together, these results support a model in which ALA3 functions to modify endomembranes in multiple cell types, enabling structural changes, or signaling functions that are critical in plants for normal development and adaptation to varied growth environments.	[McDowell, Stephen C.; Harper, Jeffrey F.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Lopez-Marques, Rosa L.; Poulsen, Lisbeth R.; Palmgren, Michael G.] Univ Copenhagen, Danish Natl Res Fdn, Dept Plant Biol & Biotechnol, Ctr Membrane Pumps Cells & Dis PUMPKIN, Frederiksberg, Denmark	Nevada System of Higher Education (NSHE); University of Nevada Reno; Danmarks Grundforskningsfond; University of Copenhagen	Harper, JF (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA.	jfharper@unr.edu	Marques, Rosa Laura Lopez/AAI-8071-2020; Poulsen, Lisbeth R/I-1843-2014; Palmgren, Michael/A-9808-2013; Lopez-Marques, Rosa L/F-8536-2014; Poulsen, Lisbeth Rosager/AAP-1301-2020	Marques, Rosa Laura Lopez/0000-0002-5663-7903; Poulsen, Lisbeth R/0000-0002-9133-3358; Palmgren, Michael/0000-0002-9982-6114; Lopez-Marques, Rosa L/0000-0002-5663-7903; 	National Science Foundation (NSF) [DBI-0420033]; National Institutes of Health (NIH) [1RO1 GM070813-01]; US Department of Energy [DE-FG03-94ER20152]; INBRE Program of the National Center for Research Resources (NIH grant) [P20 RR-016464]; COBRE program of the National Institutes of Health (NIH COBRE) [RR024210]; Danish Council for Independent Research Natural Sciences (FNU) [10-083406]; Danish National Research Foundation through the PUMPKIN Center of Excellence; National Science Foundation's EPSCoR program [EPS-0236913]; State of Kansas through Kansas Technology Enterprise Corporation; Kansas State University; Danish Government's Globalization Fund; Danish Council for Independent Research, Natural Sciences (FNU) [10-083406]; Danish National Research Foundation (DGF) [DNRF85]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464, P20RR024210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070813, P20GM103554] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); INBRE Program of the National Center for Research Resources (NIH grant); COBRE program of the National Institutes of Health (NIH COBRE); Danish Council for Independent Research Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Danish National Research Foundation through the PUMPKIN Center of Excellence; National Science Foundation's EPSCoR program; State of Kansas through Kansas Technology Enterprise Corporation; Kansas State University; Danish Government's Globalization Fund; Danish Council for Independent Research, Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Danish National Research Foundation (DGF); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to JFH from the National Science Foundation (http://www.nsf.gov, NSF DBI-0420033) for stress-dependent phenotype screens, from the National Institutes of Health (http://www.nih.gov, NIH 1RO1 GM070813-01) for studies on pollen tube tip growth, and from the US Department of Energy (http://www.energy.gov, DE-FG03-94ER20152) for studies on membrane biogenesis and genetic analyses of ALAs. Bioinformatics was made possible by the INBRE Program of the National Center for Research Resources (http://www.nih.gov, NIH grant P20 RR-016464). Confocal microscopy was made possible by support from by the COBRE program of the National Institutes of Health (http://www.nih.gov, NIH COBRE grant RR024210). Funding was also received by RLLM from The Danish Council for Independent Research Natural Sciences (http://en.fi.dk/, FNU project number 10-083406) and by MGP from the Danish National Research Foundation through the PUMPKIN Center of Excellence. The Kansas Lipidomics Research Center was supported by the National Science Foundation's EPSCoR program (http://www.nsf.gov, EPS-0236913) with matching support from the State of Kansas through Kansas Technology Enterprise Corporation and Kansas State University. The Danish Government's Globalization Fund (LRP); The Danish Council for Independent Research, Natural Sciences (FNU, project number 10-083406, RLLM); and the Danish National Research Foundation (DGF, project number DNRF85, MGP). Additional funding during the revision process was provided by: The Danish Government's Globalization Fund (LRP); The Danish Council for Independent Research, Natural Sciences (FNU, project number 10-083406, RLLM); and the Danish National Research Foundation (DGF, project number DNRF85, MGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amiri RM, 2010, J INTEGR PLANT BIOL, V52, P289, DOI 10.1111/j.1744-7909.2010.00890.x; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Boavida LC, 2007, PLANT J, V52, P570, DOI 10.1111/j.1365-313X.2007.03248.x; Bove J, 2008, PLANT PHYSIOL, V147, P1646, DOI 10.1104/pp.108.120212; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; de Win AHN, 1999, BIOPHYS J, V76, P1648, DOI 10.1016/S0006-3495(99)77324-8; Dowhan W, 2012, BBA-BIOMEMBRANES, V1818, P1097, DOI 10.1016/j.bbamem.2011.09.013; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Gomes E, 2000, PLANT CELL, V12, P2441, DOI 10.1105/tpc.12.12.2441; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; Hayward SAL, 2007, ADV EXP MED BIOL, V594, P132; HAZEL JR, 1988, AM J PHYSIOL, V255, pR622, DOI 10.1152/ajpregu.1988.255.4.R622; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ho LW, 2010, FUNCT PLANT BIOL, V37, P962, DOI 10.1071/FP10049; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hua ZL, 2003, MOL BIOL CELL, V14, P4971, DOI 10.1091/mbc.E03-07-0463; HUGLY S, 1992, PLANT PHYSIOL, V99, P197, DOI 10.1104/pp.99.1.197; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; IshizakiNishizawa O, 1996, NAT BIOTECHNOL, V14, P1003, DOI 10.1038/nbt0896-1003; Iwata Y, 2012, TRENDS PLANT SCI; Lee YJ, 2008, CURR OPIN PLANT BIOL, V11, P662, DOI 10.1016/j.pbi.2008.10.002; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; Levine A, 2001, J BIOL CHEM, V276, P46284, DOI 10.1074/jbc.M107375200; Levine A, 2002, PLANT PHYSIOL BIOCH, V40, P531, DOI 10.1016/S0981-9428(02)01398-0; Lindberg S, 2005, PLANT PHYSIOL BIOCH, V43, P261, DOI 10.1016/j.plaphy.2005.02.003; Lopez-Marques RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033042; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Mazel A, 2004, PLANT PHYSIOL, V134, P118, DOI 10.1104/pp.103.025379; MIQUEL M, 1993, P NATL ACAD SCI USA, V90, P6208, DOI 10.1073/pnas.90.13.6208; Moellering ER, 2011, TRENDS PLANT SCI, V16, P98, DOI 10.1016/j.tplants.2010.11.004; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Orlova IV, 2003, PLANT CELL PHYSIOL, V44, P447, DOI 10.1093/pcp/pcg047; OVERSTREET JW, 1979, FERTIL STERIL, V31, P162; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Paulusma CC, 2010, FEBS LETT, V584, P2708, DOI 10.1016/j.febslet.2010.04.071; Pedersen CNS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00031; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Qin Y, 2011, SEMIN CELL DEV BIOL, V22, P816, DOI 10.1016/j.semcdb.2011.06.004; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Richter S, 2009, TRAFFIC, V10, P819, DOI 10.1111/j.1600-0854.2009.00916.x; RIPMASTER TL, 1993, MOL CELL BIOL, V13, P7901, DOI 10.1128/MCB.13.12.7901; ROBERTSON JC, 1995, AM J PHYSIOL-REG I, V269, pR1113, DOI 10.1152/ajpregu.1995.269.5.R1113; Rousseeuw PJ, 1999, AM STAT, V53, P382, DOI 10.2307/2686061; Sakamoto A, 2004, PLANT CELL ENVIRON, V27, P99, DOI 10.1046/j.0016-8025.2003.01131.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Siegmund A, 1998, J BIOL CHEM, V273, P34399, DOI 10.1074/jbc.273.51.34399; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tasseva G, 2004, PLANT PHYSIOL BIOCH, V42, P811, DOI 10.1016/j.plaphy.2004.10.001; TWELL D, 1991, GENE DEV, V5, P496, DOI 10.1101/gad.5.3.496; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Van Meer G, 2011, COLD SPRING HARB PER; WADA H, 1994, P NATL ACAD SCI USA, V91, P4273, DOI 10.1073/pnas.91.10.4273; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Wang LC, 2011, J EXP BOT, V62, P3609, DOI 10.1093/jxb/err060; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yadav SK, 2010, AGRON SUSTAIN DEV, V30, P515, DOI 10.1051/agro/2009050; Zhang X, 2009, PLANT J; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007	80	25	27	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62577	10.1371/journal.pone.0062577	http://dx.doi.org/10.1371/journal.pone.0062577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667493	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700049
J	van de Put, MAJ; Nayebi, F; Croonen, D; Nolte, IM; Japing, WJ; Hooymans, JMM; Los, LI				van de Put, Mathijs A. J.; Nayebi, Fara; Croonen, Danna; Nolte, Ilja M.; Japing, Wouter J.; Hooymans, Johanna M. M.; Los, Leonoor I.			Design and Validation of a Method to Determine the Position of the Fovea by Using the Nerve-Head to Fovea Distance of the Fellow Eye	PLOS ONE			English	Article							OFF RETINAL DETACHMENTS; OPTIC DISK; VISUAL RECOVERY; FUNDUS; SIZE; COVARIATION; PARAMETERS; DIMENSIONS; ULTRASOUND; GLAUCOMA	Purpose: To measure the nerve-head to fovea distance (NFD) on fundus photographs in fellow eyes, and to compare the NFD between fellow eyes. Methods: Diabetic patients without retinopathy, (n = 183) who were screened by fundus photography at the University Medical Center Groningen, the Netherlands from January 1st 2005 until January 1st 2006 were included. The NFD was measured in left and right eyes both from the center and from the rim of the nerve-head. To determine inter-and intra-observer agreement, repeated measurements by one observer (n = 3) were performed on all photographs and by two observers on 60 photographs (30 paired eyes). The effect of age, gender, and refractive error on NFD was analysed. Results: The correlation of NFDs between the left and the right eye was 0.958 when measured from the center of the nerve head (mean difference 0.0078 mm. +/- SD 0.079 (95% limits of agreement -0.147-0.163)) and 0.963 when measured from the rim (mean difference 0.0056 +/- SD 0.073 (95% limits of agreement -0.137-0.149)). Using the NFD between fellow eyes interchangeably, resulted in a standard error of 0.153 mm. Intra- and inter-observer variability was small. We found a significant effect of age (center of the nerve-head (P = 0.006) and rim of the nerve head (P = 0.003)) and refractive error (center of nerve-head (P<0.001) and rim of nerve head (P<0.001)) on NFD. Conclusions: The NFD in one eye provides a confident, reproducible, and valid method to address the position of the fovea in the fellow eye. We recommend using the NFD measured from the center of the nerve-head since the standard error by this method was smallest. Age and refractive error have an effect on NFD.	[van de Put, Mathijs A. J.; Nayebi, Fara; Croonen, Danna; Japing, Wouter J.; Hooymans, Johanna M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Nolte, Ilja M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen	van de Put, MAJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	m.a.j.van.de.put@umcg.nl			Stichting Blindenhulp; Stichting Nederlands Oogheelkundig Onderzoek; Professor Mulder Stichting	Stichting Blindenhulp; Stichting Nederlands Oogheelkundig Onderzoek; Professor Mulder Stichting	Stichting Blindenhulp, Stichting Nederlands Oogheelkundig Onderzoek, and Professor Mulder Stichting. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALAZSI AG, 1984, ARCH OPHTHALMOL-CHIC, V102, P1011, DOI 10.1001/archopht.1984.01040030813022; BENGTSSON B, 1976, ACTA OPHTHALMOL, V54, P804; BENGTSSON B, 1977, ACTA OPHTHALMOL, V55, P123; BENGTSSON B, 1992, GRAEF ARCH CLIN EXP, V230, P24, DOI 10.1007/BF00166758; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; Bronson NR, 1976, OPHTHALMIC CONTACT B, P1; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; CHIHARA E, 1992, OPHTHALMOLOGY, V99, P208; CHIHARA E, 1994, GRAEF ARCH CLIN EXP, V232, P265, DOI 10.1007/BF00194475; CHISHOLM IA, 1975, T OPHTHAL SOC UK, V95, P167; COHEN IJ, 1950, ARCH OPHTHALMOL-CHIC, V44, P419; COLEMAN DJ, 1972, AM J OPHTHALMOL, V73, P501, DOI 10.1016/0002-9394(72)90002-5; Duke-Elder WS, 1964, NORMAL ABNORMAL DE 2; Fletcher DC, 1997, OPHTHALMOLOGY, V104, P632, DOI 10.1016/S0161-6420(97)30260-7; Friedman B, 1942, ARCH OPHTHALMOL-CHIC, V28, P444; Gullstrand A., 1909, PHYSL OPTIK, P299; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P213, DOI 10.1007/BF02181183; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P332, DOI 10.1007/BF02172962; Keilhauer C, 2003, OPHTHALMOLOGE, V100, P164; Levene RZ., 1992, ANN OPHTHALMOL, V14, P617; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; MIKUNI M, 1960, Klin Monbl Augenheilkd Augenarztl Fortbild, V136, P544; Mowatt L, 2010, EYE, V24, P323, DOI 10.1038/eye.2009.74; PAVLIN CJ, 1991, OPHTHALMOLOGY, V98, P287; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; Rohrschneider K, 2004, INVEST OPHTH VIS SCI, V45, P3257, DOI 10.1167/iovs.03-1157; Ross W, 2005, OPHTHALMOLOGY, V112, P1213, DOI 10.1016/j.ophtha.2005.01.040; Ross WH, 1998, OPHTHALMOLOGY, V105, P2149, DOI 10.1016/S0161-6420(98)91142-3; Straatsma BR, 1969, T PHILOS SOC, P1; WILLIAMS TD, 1992, OPTOMETRY VISION SCI, V69, P369, DOI 10.1097/00006324-199205000-00006	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62518	10.1371/journal.pone.0062518	http://dx.doi.org/10.1371/journal.pone.0062518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667483	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700041
J	Cortes, AJ; Monserrate, FA; Ramirez-Villegas, J; Madrinan, S; Blair, MW				Cortes, Andres J.; Monserrate, Fredy A.; Ramirez-Villegas, Julian; Madrinan, Santiago; Blair, Matthew W.			Drought Tolerance in Wild Plant Populations: The Case of Common Beans (Phaseolus vulgaris L.)	PLOS ONE			English	Article							GENETIC DIVERSITY; SELECTION; RESISTANCE; RESPONSES; ECOLOGY; SALT	Reliable estimations of drought tolerance in wild plant populations have proved to be challenging and more accessible alternatives are desirable. With that in mind, an ecological diversity study was conducted based on the geographical origin of 104 wild common bean accessions to estimate drought tolerance in their natural habitats. Our wild population sample covered a range of mesic to very dry habitats from Mexico to Argentina. Two potential evapotranspiration models that considered the effects of temperature and radiation were coupled with the precipitation regimes of the last fifty years for each collection site based on geographical information system analysis. We found that wild accessions were distributed among different precipitation regimes following a latitudinal gradient and that habitat ecological diversity of the collection sites was associated with natural sub-populations. We also detected a broader geographic distribution of wild beans across ecologies compared to cultivated common beans in a reference collection of 297 cultivars. Habitat drought stress index based on the Thornthwaite potential evapotranspiration model was equivalent to the Hamon estimator. Both ecological drought stress indexes would be useful together with population structure for the genealogical analysis of gene families in common bean, for genome-wide genetic-environmental associations, and for postulating the evolutionary history and diversification processes that have occurred for the species. Finally, we propose that wild common bean should be taken into account to exploit variation for drought tolerance in cultivated common bean which is generally considered susceptible as a crop to drought stress.	[Cortes, Andres J.] Uppsala Univ, Evolutionary Biol Ctr, Uppsala, Sweden; [Cortes, Andres J.; Madrinan, Santiago] Univ Los Andes, Lab Bot & Sistemat, Bogota, Colombia; [Monserrate, Fredy A.] Serv Ensenanza Nacl, Ctr Agr, Buga, Colombia; [Ramirez-Villegas, Julian] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Ramirez-Villegas, Julian] CGIAR Program Climate Change Agr & Food Secur CCA, Cali, Colombia; [Blair, Matthew W.] Cornell Univ, Dept Plant Breeding, Ithaca, NY USA	Uppsala University; Universidad de los Andes (Colombia); University of Leeds; CGIAR; Cornell University	Cortes, AJ (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Uppsala, Sweden.	andres.cortes@ebc.uu.se; mwb1@cornell.edu	Ramirez-Villegas, Julian/AAY-8073-2020; Madriñán, Santiago/A-1149-2010	Ramirez-Villegas, Julian/0000-0002-8044-583X; Madriñán, Santiago/0000-0002-0807-6523; Cortes, Andres J./0000-0003-4178-0675	Generation Challenge Program	Generation Challenge Program	This research was supported by the Generation Challenge Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gallegos JA, 2007, CROP SCI, V47, pS44, DOI 10.2135/cropsci2007.04.0008IPBS; Amede T, 2003, ETHIOP J SCI, V26, P137; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Beebe SE, 2008, CROP SCI, V48, P582, DOI 10.2135/cropsci2007.07.0404; Blair MW, 2013, THEOR APPL GENET, V126, P535, DOI 10.1007/s00122-012-1999-z; Blair MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049488; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Chen CN, 2004, MOL PHYLOGENET EVOL, V32, P616, DOI 10.1016/j.ympev.2004.01.015; Cortes AJ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-58; Cortes AJ, 2012, THEOR APPL GENET, V125, P1069, DOI 10.1007/s00122-012-1896-5; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Debouck D.G., 1999, COMMON BEAN IMPROVEM, P25, DOI DOI 10.1007/978-94-015-9211-6_2; Debouck DG, 2000, BIODIVERSITY ECOLOGY, P95; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Frahm MA, 2004, EUPHYTICA, V136, P223, DOI 10.1023/B:euph.0000030671.03694.bb; Galeano CH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-48; Gepts P, 2008, GENOMICS OF TROPICAL; Gepts Paul, 2003, Environmental Biosafety Research, V2, P89, DOI 10.1051/ebr:2003009; Griffiths H, 2002, ANN BOT-LONDON, V89, P801, DOI 10.1093/aob/mcf159; Hamon W.R., 1961, J HYDRAULICS DIVISIO, V87, P107, DOI DOI 10.1061/JYCEAJ.0000599; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Heyman DP, 1990, STOCHASTIC MODELS; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Jarvis A., 2002, Plant Genetic Resources Newsletter, P29; Jarvis A, 2003, CROP SCI, V43, P1100, DOI 10.2135/cropsci2003.1100; Jones P, 2007, SAT EJOURNAL, V4, P1; Kelleher CT, 2012, TREE GENET GENOMES, V8, P821, DOI 10.1007/s11295-012-0467-x; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Kotlik P, 2008, MOL ECOL, V17, P1076, DOI 10.1111/j.1365-294X.2007.03638.x; Lane A., 2007, Journal of SAT Agricultural Research, V4, P1; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Perez JC, 2008, ANNUAL REPORT OUTCOM; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Singh SP, 2005, GENETIC RESOURCES CH; THORNTHWAITE C. W., 1955, PUBLICATIONS CLIMATO, VVIII, DOI DOI 10.1017/CBO9781107339200.011; Thornthwaite C.W., 1957, PUBL CLIMAT, V10, P311, DOI DOI 10.1007/S10584-011-0148-Z; Tiranti B, 2007, MOL ECOL, V16, P4942, DOI 10.1111/j.1365-294X.2007.03566.x; Tohme J, 1996, CROP SCI, V36, P1375, DOI 10.2135/cropsci1996.0011183X003600050048x; Tohme J, 1995, CORE COLLECTIONS OF; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; van der Sluijs I, 2008, PHILOS T R SOC B, V363, P2871, DOI 10.1098/rstb.2008.0045; Vermeulen S, 2012, CURR OPIN ENV SUST, V4, P128, DOI 10.1016/j.cosust.2011.12.004; Xu CY, 2002, WATER RESOUR MANAG, V16, P197, DOI 10.1023/A:1020282515975	45	66	69	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62898	10.1371/journal.pone.0062898	http://dx.doi.org/10.1371/journal.pone.0062898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658783	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100046
J	Hastilestari, BR; Mudersbach, M; Tomala, F; Vogt, H; Biskupek-Korell, B; Van Damme, P; Guretzki, S; Papenbrock, J				Hastilestari, Bernadetta Rina; Mudersbach, Marina; Tomala, Filip; Vogt, Hartmut; Biskupek-Korell, Bettina; Van Damme, Patrick; Guretzki, Sebastian; Papenbrock, Jutta			Euphorbia tirucalli L.-Comprehensive Characterization of a Drought Tolerant Plant with a Potential as Biofuel Source	PLOS ONE			English	Article							CRASSULACEAN ACID METABOLISM; P-ENOLPYRUVATE CARBOXYLASE; CHLOROPHYLL FLUORESCENCE; PHOTOSYNTHETIC PATHWAYS; CAM; EXPRESSION; ENERGY; CARBON; LATEX; PRODUCTIVITY	Of late, decrease in mineral oil supplies has stimulated research on use of biomass as an alternative energy source. Climate change has brought problems such as increased drought and erratic rains. This, together with a rise in land degeneration problems with concomitant loss in soil fertility has inspired the scientific world to look for alternative bio-energy species. Euphorbia tirucalli L., a tree with C-3/CAM metabolism in leaves/stem, can be cultivated on marginal, arid land and could be a good alternative source of biofuel. We analyzed a broad variety of E. tirucalli plants collected from different countries for their genetic diversity using AFLP. Physiological responses to induced drought stress were determined in a number of genotypes by monitoring growth parameters and influence on photosynthesis. For future breeding of economically interesting genotypes, rubber content and biogas production were quantified. Cluster analysis shows that the studied genotypes are divided into two groups, African and mostly non-African genotypes. Different genotypes respond significantly different to various levels of water. Malate measurement indicates that there is induction of CAM in leaves following drought stress. Rubber content varies strongly between genotypes. An investigation of the biogas production capacities of six E. tirucalli genotypes reveals biogas yields higher than from rapeseed but lower than maize silage.	[Hastilestari, Bernadetta Rina; Guretzki, Sebastian; Papenbrock, Jutta] Leibniz Univ Hannover, Inst Bot, D-30167 Hannover, Germany; [Mudersbach, Marina; Tomala, Filip; Vogt, Hartmut; Biskupek-Korell, Bettina] Univ Appl Sci Hannover, Hannover, Germany; [Van Damme, Patrick] Univ Ghent, Dept Plant Prod, Lab Trop & Subtrop Agr & Ethnobotany, B-9000 Ghent, Belgium; [Van Damme, Patrick] Czech Univ Life Sci Prague, Inst Trop & Subtrop, Prague, Czech Republic	Leibniz University Hannover; Ghent University; Czech University of Life Sciences Prague	Papenbrock, J (corresponding author), Leibniz Univ Hannover, Inst Bot, D-30167 Hannover, Germany.	Jutta.Papenbrock@botanik.uni-hannover.de	Van Damme, Patrick/H-6693-2018; , Patrick/AAI-8779-2020	Van Damme, Patrick/0000-0002-2548-633X; 	Katholischer Akademischer Auslander-Dienst (KAAD); Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Leibniz Universitat Hannover	Katholischer Akademischer Auslander-Dienst (KAAD); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Leibniz Universitat Hannover	B.R. Hastilestari was supported by Katholischer Akademischer Auslander-Dienst (KAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Samples from India were kindly provided by Dr. Vijendra Shekhawat, University of Mumbai, India. We would like to thank the gardeners for growing plants and Pamela von Trzebiatowski for malate analysis. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Leibniz Universitat Hannover.	Akpan AU, 2007, J AGR SOC SCI, V3, P1813; Aylward JH, 2008, Treatment of prostate cancer, Patent No. [US 7378445, 7378445]; BATANOUNY KH, 1991, OECOLOGIA, V87, P565, DOI 10.1007/BF00320421; BENDER MM, 1971, PHYTOCHEMISTRY, V10, P1239, DOI 10.1016/S0031-9422(00)84324-1; Binder R, 2009, GEFAHRENPOTENTIAL SC; Blaschek W., 1998, HAGERS HDB PHARM PRA, V5th; BLOOM AJ, 1979, OECOLOGIA, V38, P35, DOI 10.1007/BF00347822; Borland A, 2006, J EXP BOT, V57, P319, DOI 10.1093/jxb/erj028; Borland AM, 1998, PLANTA, V205, P342, DOI 10.1007/s004250050329; Brouwer R., 1963, SOME ASPECTS EQUILIB, P31; Bruyns PV, 2006, TAXON, V55, P397, DOI 10.2307/25065587; CALVIN M, 1978, PURE APPL CHEM, V50, P407, DOI 10.1351/pac197850050407; CALVIN M, 1980, NATURWISSENSCHAFTEN, V67, P525, DOI 10.1007/BF00450661; CUSHMAN JC, 1992, EUR J BIOCHEM, V208, P259, DOI 10.1111/j.1432-1033.1992.tb17181.x; Cushman JC, 2002, PLANT CELL ENVIRON, V25, P295, DOI 10.1046/j.0016-8025.2001.00760.x; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Dias PC, 2007, J PLANT PHYSIOL, V164, P1639, DOI 10.1016/j.jplph.2006.12.004; DITTRICH P, 1973, PLANT PHYSIOL, V52, P357, DOI 10.1104/pp.52.4.357; Duke J. A., 1983, HDB ENERGY CROPS; FURSTENBERGER G, 1977, EXPERIENTIA, V33, P986; GRAVATT DA, 1992, OECOLOGIA, V92, P532, DOI 10.1007/BF00317845; Gurib-Fakim A., 2008, PLANT RESOURCES TROP; Heldt H.-W, 2011, PLANT BIOCH; Herrera A, 2009, ANN BOT-LONDON, V103, P645, DOI 10.1093/aob/mcn145; HOLTUM JAM, 1982, PLANTA, V155, P8, DOI 10.1007/BF00402925; Janssens MJJ, 2009, J AGR RURAL DEV TROP, V110, P39; JEFFERIES RA, 1994, PHYSIOL PLANTARUM, V90, P93, DOI 10.1034/j.1399-3054.1994.900114.x; Kalita D, 2008, RENEW SUST ENERG REV, V12, P455, DOI 10.1016/j.rser.2006.07.008; KLUGE M, 1973, PLANTA, V113, P333, DOI 10.1007/BF00387316; KLUGE M, 1973, PLANTA, V112, P357, DOI 10.1007/BF00390308; KLUGE M, 1971, PLANTA, V98, P20, DOI 10.1007/BF00387020; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kumar A., 1999, SOME POTENTIAL PLANT, P1; Lirio LG, 1998, PHARM BIOL, V36, P357, DOI 10.1076/phbi.36.5.357.4656; Liu F, 2004, SCI HORTIC-AMSTERDAM, V102, P15, DOI 10.1016/j.scienta.2003.11.014; LOESCHEN VS, 1993, INT J PLANT SCI, V154, P100, DOI 10.1086/297095; Loke J., 2011, EUPHORBIA TIRUCALLI; MARTIN CE, 1986, PHOTOSYNTH RES, V8, P17, DOI 10.1007/BF00028473; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Murali R, 1998, INT C DOM COMM NONT; Mwine J., 2011, Scientific Research and Essays, V6, P4905; NIELSEN PE, 1979, PHYTOCHEMISTRY, V18, P103, DOI 10.1016/S0031-9422(00)90923-3; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; NUERNBERGK EL, 1960, PLANTA, V56, P28, DOI 10.1007/BF01894844; Orwa C, 2009, AGROFORESTRY TREE DA; OSMOND CB, 1978, ANNU REV PLANT PHYS, V29, P379, DOI 10.1146/annurev.pp.29.060178.002115; OSTREM JA, 1990, J BIOL CHEM, V265, P3497; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PEARCY RW, 1975, PLANT PHYSIOL, V55, P1054, DOI 10.1104/pp.55.6.1054; Rahuman AA, 2008, PARASITOL RES, V102, P867, DOI 10.1007/s00436-007-0839-6; Scasselati-sforzolini G, 1916, I AGR COLONIALE ITAL, V25, P40; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; Schieder D, 2003, WATER SCI TECHNOL, V48, P209, DOI 10.2166/wst.2003.0256; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Smith B., 1982, CRC HDB BIOSOLAR RES, V1, P99; Souza RP, 2004, ENVIRON EXP BOT, V51, P45, DOI 10.1016/S0098-8472(03)00059-5; SOW D, 1989, MIRCEN J APPL MICROB, V5, P547, DOI 10.1007/BF01741832; Syed M., 2006, Canadian Biosystems Engineering, V48, pB1; Taybi T, 2004, PLANT PHYSIOL, V135, P587, DOI 10.1104/pp.103.036962; TING IP, 1968, PLANT PHYSIOL, V43, P1919, DOI 10.1104/pp.43.12.1919; TING IP, 1993, BOT ACTA, V106, P313, DOI 10.1111/j.1438-8677.1993.tb00754.x; TING IP, 1985, PLANT PHYSIOL, V78, P246, DOI 10.1104/pp.78.2.246; Tomala F, 2012, THESIS U APPL SCI HA; Uchida H, 2009, PLANTA, V229, P1243, DOI 10.1007/s00425-009-0906-6; UZABAKILIHO B, 1987, PHYTOCHEMISTRY, V26, P3041, DOI 10.1016/S0031-9422(00)84589-6; Van Damme P, 1990, AFR FOCUS, V6, P19; Van Damme P., 1989, AFR FOCUS, V5, P176, DOI [10.21825/af.v5i3-4.6476, DOI 10.21825/AF.V5I3-4.6476]; Van Damme PLJ, 2001, COMBATING DESERTIFICATION WITH PLANTS, P169; VASSILIADES G, 1984, REV ELEV MED VET PAY, V37, P32; VDI 4630, 2006, VEREIN DTSCH INGENIE; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WEBSTER G L, 1975, Taxon, V24, P593, DOI 10.2307/1220725; Weiland P, 2003, APPL BIOCHEM BIOTECH, V109, P263, DOI 10.1385/ABAB:109:1-3:263; Zhang JA, 2011, PLANTA, V234, P891, DOI 10.1007/s00425-011-1434-8	74	32	32	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63501	10.1371/journal.pone.0063501	http://dx.doi.org/10.1371/journal.pone.0063501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658836	Green Submitted, Green Published, gold			2022-12-27	WOS:000321202100069
J	Khelaifia, S; Michel, JB; Drancourt, M				Khelaifia, Saber; Michel, Jean Brunel; Drancourt, Michel			In-Vitro Archaeacidal Activity of Biocides against Human-Associated Archaea	PLOS ONE			English	Article							SP-NOV.; METHANOBREVIBACTER-SMITHII; GEN-NOV; METHANOGENS; PREVALENCE; SQUALAMINE; ORGANISMS; BACTERIA; ORALIS	Background: Several methanogenic archaea have been detected in the human intestinal microbiota. These intestinal archaea may contaminate medical devices such as colonoscopes. However, no biocide activity has been reported among these human-associated archaea. Methodology: The minimal archaeacidal concentration (MAC) of peracetic acid, chlorhexidine, squalamine and twelve parent synthetic derivatives reported in this study was determined against five human-associated methanogenic archaea including Methanobrevibacter smithii, Methanobrevibacter oralis, Methanobrevibacter arboriphilicus, Methanosphaera stadtmanae, Methanomassiliicoccus luminyensis and two environmental methanogens Methanobacterium beijingense and Methanosaeta concilii by using a serial dilution technique in Hungates tubes. Principal Findings: MAC of squalamine derivative S1 was 0.05 mg/L against M. smithii strains, M. oralis, M. arboriphilicus, M. concilii and M. beijingense whereas MAC of squalamine and derivatives S2-S12 varied from 0.5 to 5 mg/L. For M. stadtmanae and M. luminyensis, MAC of derivative S1 was 0.1 mg/L and varied from 1 to >= 10 mg/L for squalamine and its parent derivatives S2-S12. Under the same experimental conditions, chlorhexidine and peracetic acid lead to a MAC of 0.2 and 1.5 mg/L, respectively against all tested archaea. Conclusions/Significance: Squalamine derivative S1 exhibited a 10-200 higher archaeacidal activity than other tested squalamine derivatives, on the majority of human-associated archaea. As previously reported and due to their week corrosivity and their wide spectrum of antibacterial and antifungal properties, squalamine and more precisely derivative S1 appear as promising compounds to be further tested for the decontamination of medical devices contaminated by human-associated archaea.	[Khelaifia, Saber; Drancourt, Michel] Aix Marseille Univ, URMITE, Inserm 1095, IRD 198,CNRS UMR63 7278, Marseille, France; [Michel, Jean Brunel] Aix Marseille Univ, CRCM, CNRS, Inst Paoli Calmettes,UMR7258,UM 105,Inserm,U1068, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Drancourt, M (corresponding author), Aix Marseille Univ, URMITE, Inserm 1095, IRD 198,CNRS UMR63 7278, Marseille, France.	Michel.Drancourt@univmed.fr		Khelaifia, Saber/0000-0002-9303-3893; jean michel, brunel/0000-0002-9355-8980				Alhanout K, 2010, J ANTIMICROB CHEMOTH, V65, P1688, DOI 10.1093/jac/dkq213; ASAKAWA S, 1993, INT J SYST BACTERIOL, V43, P683, DOI 10.1099/00207713-43-4-683; BELAY N, 1988, APPL ENVIRON MICROB, V54, P600, DOI 10.1128/AEM.54.2.600-603.1988; Bringuier A, 2013, J CLIN MICROBIOL, V51, P993, DOI 10.1128/JCM.02863-12; de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Dopson M, 2004, APPL ENVIRON MICROB, V70, P2079, DOI 10.1128/AEM.70.4.2079-2088.2004; Dridi B, 2011, INT J SYST EVOL MICR, V62, P1902; Dridi B, 2012, APMIS, V120, P773, DOI 10.1111/j.1600-0463.2012.02899.x; Dridi B, 2011, J ANTIMICROB CHEMOTH, V66, P2038, DOI 10.1093/jac/dkr251; Dridi B, 2011, ANAEROBE, V17, P56, DOI 10.1016/j.anaerobe.2011.03.001; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; FERRARI A, 1994, CURR MICROBIOL, V29, P7, DOI 10.1007/BF01570184; KANDLER O, 1994, J BIOL PHYS, V20, P165; Khelaifia S, 2012, CLIN MICROBIOL INFEC, V18, P841, DOI 10.1111/j.1469-0691.2012.03913.x; Koga Y, 2012, ARCHAEA, V2012, DOI 10.1155/2012/789652; Ma K, 2005, INT J SYST EVOL MICR, V55, P325, DOI 10.1099/ijs.0.63254-0; MILLER TL, 1985, ARCH MICROBIOL, V141, P116, DOI 10.1007/BF00423270; MILLER TL, 1974, APPL MICROBIOL, V27, P985, DOI 10.1128/AEM.27.5.985-987.1974; MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982; MOORE KS, 1993, P NATL ACAD SCI USA, V90, P1354, DOI 10.1073/pnas.90.4.1354; Oxley APA, 2010, ENVIRON MICROBIOL, V12, P2398, DOI 10.1111/j.1462-2920.2010.02212.x; PATEL GB, 1990, INT J SYST BACTERIOL, V40, P79, DOI 10.1099/00207713-40-1-79; Rea S, 2007, INT J SYST EVOL MICR, V57, P450, DOI 10.1099/ijs.0.63984-0; Salmi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002765; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	26	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62738	10.1371/journal.pone.0062738	http://dx.doi.org/10.1371/journal.pone.0062738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658767	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100036
J	Newton, RL; Han, HM; Zderic, T; Hamilton, M				Newton, Robert L., Jr.; Han, Hongmei; Zderic, Theodore; Hamilton, Marc			The Energy Expenditure of Sedentary Behavior: A Whole Room Calorimeter Study	PLOS ONE			English	Article							TELEVISION VIEWING TIME; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; SKELETAL-MUSCLE; RISK-FACTORS; INACTIVITY PHYSIOLOGY; LIFE-STYLE; OBESITY; EXERCISE; COSTS	It has recently been recommended that sedentary behavior be defined as sitting or reclining activities expending less than 1.5 metabolic equivalents (METs), which is distinct from the traditional viewpoint based on insufficient moderate-vigorous activity or formal exercise. This study was designed to determine the energy expenditure associated with common sedentary behaviors. Twenty-five African American adults (BMI 27.8 +/- 5.5) participated in the metabolic chamber study. Participants entered the metabolic chamber in the morning and their basal metabolic rate was estimated. They were fed breakfast and then engaged in four different sedentary behaviors sequentially, lasting 30 minutes each. The activities included reclining, watching TV, reading, and typing on a computer. In the afternoon, the participants were fed lunch and then the activities were repeated. The results show that the energy expenditure values between the morning and afternoon sessions were not significantly different (p = .232). The mean energy expenditure of postprandial reclining (0.97 METs) was slightly, but significantly, lower than postprandial watching TV (p = .021) and typing (p<.001). There were no differences in energy cost (1.03-1.06 METs) between the seated (i.e., reading, typing, watching TV) sedentary activities. The energy expenditure of several common sedentary behaviors was approximately 1.0 METs in the postprandial state. The results support the conclusion that the average energy cost of common sedentary behaviors is narrowly banded around 1.0 METs in the postprandial state.	[Newton, Robert L., Jr.; Han, Hongmei; Zderic, Theodore; Hamilton, Marc] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Newton, RL (corresponding author), Pennington Biomed Res Ctr, Baton Rouge, LA USA.	Robert.Newton@pbrc.edu	Newton, Robert/N-1981-2017	Newton, Robert/0000-0002-6863-913X	National Heart Lung and Blood Institute [K01 HL088723-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL088723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by the National Heart Lung and Blood Institute (K01 HL088723-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bassett DR, 2002, PREV MED, V34, P179, DOI 10.1006/pmed.2001.0969; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Bey L, 2003, PHYSIOL GENOMICS, V13, P157, DOI 10.1152/physiolgenomics.00001.2002; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Crovetti R, 1998, EUR J CLIN NUTR, V52, P482, DOI 10.1038/sj.ejcn.1600578; Dallal CM, 2012, BREAST CANCER RES TR, V134, P1279, DOI 10.1007/s10549-012-2129-y; Dos Anjos LA, 2011, MED SCI SPORT EXER, V43, P2211, DOI 10.1249/MSS.0b013e31821f5798; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Florez H, 2005, DIABETES RES CLIN PR, V69, P63, DOI 10.1016/j.diabres.2004.11.018; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Hamilton MT, 2001, INT J SPORT NUTR EXE, V11, pS97, DOI 10.1123/ijsnem.11.s1.s97; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Javed F, 2010, AM J CLIN NUTR, V91, P907, DOI 10.3945/ajcn.2009.28512; Kanade AN, 2001, EUR J CLIN NUTR, V55, P708, DOI 10.1038/sj.ejcn.1601211; Keogh JB, 2007, EUR J CLIN NUTR, V61, P597, DOI 10.1038/sj.ejcn.1602564; Lanningham-Foster L, 2009, J PEDIATR-US, V154, P819, DOI 10.1016/j.jpeds.2009.01.009; Lante K, 2010, RES DEV DISABIL, V31, P1380, DOI 10.1016/j.ridd.2010.06.022; Levine JA, 2006, ARTERIOSCL THROM VAS, V26, P729, DOI 10.1161/01.ATV.0000205848.83210.73; Levine JA, 2000, AM J CLIN NUTR, V72, P1451; Li TY, 2006, CIRCULATION, V113, P499, DOI 10.1161/CIRCULATIONAHA.105.574087; Luke Amy, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P370, DOI 10.1097/MED.0b013e3282c48a7c; Lyons EJ, 2012, AM J CLIN NUTR, V96, P234, DOI 10.3945/ajcn.111.028423; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; McAlpine DA, 2007, BRIT J SPORT MED, V41, P903, DOI 10.1136/bjsm.2006.034900; McCrady SK, 2009, OBESITY, V17, P2103, DOI 10.1038/oby.2009.117; Nguyen-Duy TB, 2003, AM J PHYSIOL-ENDOC M, V284, pE1065, DOI 10.1152/ajpendo.00442.2002; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Rao S, 2008, PUBLIC HEALTH NUTR, V11, P142, DOI 10.1017/S1368980007000055; Ritz P, 2012, BR J NUTR, P1; Sharp TA, 2002, OBES RES, V10, P726, DOI 10.1038/oby.2002.99; Spittaels H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-149; Steeves JA, 2012, MED SCI SPORT EXER, V44, P330, DOI 10.1249/MSS.0b013e31822d797e; Stephens BR, 2010, METABOLISM; Swartz AM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-69; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Thorp AA, 2010, DIABETES CARE, V33, P327, DOI 10.2337/dc09-0493; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Weyer C, 1999, AM J CLIN NUTR, V70, P13; Yancey AK, 2004, AM J PREV MED, V27, P146, DOI 10.1016/j.amepre.2004.03.012; Zderic TW, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-137; Zderic TW, 2006, J APPL PHYSIOL, V100, P249, DOI 10.1152/japplphysiol.00925.2005	49	45	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63171	10.1371/journal.pone.0063171	http://dx.doi.org/10.1371/journal.pone.0063171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658805	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100054
J	Assmus, J; Kleffe, J; Schmitt, AO; Brockmann, GA				Assmus, Jens; Kleffe, Juergen; Schmitt, Armin O.; Brockmann, Gudrun A.			Equivalent Indels - Ambiguous Functional Classes and Redundancy in Databases	PLOS ONE			English	Article								There is considerable interest in studying sequenced variations. However, while the positions of substitutions are uniquely identifiable by sequence alignment, the location of insertions and deletions still poses problems. Each insertion and deletion causes a change of sequence. Yet, due to low complexity or repetitive sequence structures, the same indel can sometimes be annotated in different ways. Two indels which differ in allele sequence and position can be one and the same, i.e. the alternative sequence of the whole chromosome is identical in both cases and, therefore, the two deletions are biologically equivalent. In such a case, it is impossible to identify the exact position of an indel merely based on sequence alignment. Thus, variation entries in a mutation database are not necessarily uniquely defined. We prove the existence of a contiguous region around an indel in which all deletions of the same length are biologically identical. Databases often show only one of several possible locations for a given variation. Furthermore, different data base entries can represent equivalent variation events. We identified 1,045,590 such problematic entries of insertions and deletions out of 5,860,408 indel entries in the current human database of Ensembl. Equivalent indels are found in sequence regions of different functions like exons, introns or 5' and 3' UTRs. One and the same variation can be assigned to several different functional classifications of which only one is correct. We implemented an algorithm that determines for each indel database entry its complete set of equivalent indels which is uniquely characterized by the indel itself and a given interval of the reference sequence.	[Assmus, Jens; Schmitt, Armin O.; Brockmann, Gudrun A.] Humboldt Univ, D-10099 Berlin, Germany; [Kleffe, Juergen] Charite, Inst Mol Biol & Bioinformat, Berlin, Germany	Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Assmus, J (corresponding author), Humboldt Univ, D-10099 Berlin, Germany.	Jens.Assmus@hu-berlin.de; Gudrun.Brockmann@hu-berlin.de		Schmitt, Armin/0000-0002-4910-9467	German Research Foundation (DFG) through the Collaborative Research Centre 852 [SFB852/1]	German Research Foundation (DFG) through the Collaborative Research Centre 852(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG) through the Collaborative Research Centre 852 (grant no. SFB852/1) (http://www.sfb852.de) (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Assmus Jens, 2011, Advances in Bioinformatics, V2011, P657341, DOI 10.1155/2011/657341; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; BENSON D, 1990, GENOMICS, V6, P389, DOI 10.1016/0888-7543(90)90583-G; Chang YC, 2011, J NEUROCHEM, V118, P288, DOI 10.1111/j.1471-4159.2011.07304.x; Chen YA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-293; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gillespie JJ, 2004, MOL PHYLOGENET EVOL, V33, P936, DOI 10.1016/j.ympev.2004.08.004; Hague SM, 2005, J NEUROL NEUROSUR PS, V76, P1058, DOI 10.1136/jnnp.2004.060186; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Krawitz P, 2010, BIOINFORMATICS, V26, P722, DOI 10.1093/bioinformatics/btq027; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Posso SR, 2010, BRAZ J BIOL, V70, P195, DOI 10.1590/S1519-69842010000100027; Rios D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-238; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yun JY, 2011, PARKINSONISM RELAT D, V17, P338, DOI 10.1016/j.parkreldis.2011.01.015	20	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62803	10.1371/journal.pone.0062803	http://dx.doi.org/10.1371/journal.pone.0062803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658777	Green Submitted, Green Published, gold			2022-12-27	WOS:000321200500040
J	Jackson, ND; Austin, CC				Jackson, Nathan D.; Austin, Christopher C.			Testing the Role of Meander Cutoff in Promoting Gene Flow across a Riverine Barrier in Ground Skinks (Scincella lateralis)	PLOS ONE			English	Article							POPULATION-STRUCTURE; MICROSATELLITE LOCI; GENOTYPING ERRORS; DIFFERENTIATION; EVOLUTION; PHYLOGEOGRAPHY; CONSEQUENCES; LINEAGES; SOFTWARE; PATTERNS	Despite considerable attention, the long-term impact of rivers on species diversification remains uncertain. Meander loop cutoff (MLC) is one river phenomenon that may compromise a river's diversifying effects by passively transferring organisms from one side of the river to the other. However, the ability of MLC to promote gene flow across rivers has not been demonstrated empirically. Here, we test several predictions of MLC-mediated gene flow in populations of North American ground skinks (Scincella lateralis) separated by a well-established riverine barrier, the Mississippi River: 1) individuals collected from within meander cutoffs should be more closely related to individuals across the river than on the same side, 2) individuals within meander cutoffs should contain more immigrants than individuals away from meander cutoffs, 3) immigration rates estimated across the river should be highest in the direction of the cutoff event, and 4) the distribution of alleles native to one side of the river should be better predicted by the historical rather than current path of the river. To test these predictions we sampled 13 microsatellite loci and mitochondrial DNA from ground skinks collected near three ancient meander loops. These predictions were generally supported by genetic data, although support was stronger for mtDNA than for microsatellite data. Partial support for genetic divergence of samples within ancient meander loops also provides evidence for the MLC hypothesis. Although a role for MLC-mediated gene flow was supported here for ground skinks, the transient nature of river channels and morphologies may limit the long-term importance of MLC in stemming population divergence across major rivers.	[Jackson, Nathan D.; Austin, Christopher C.] Louisiana State Univ, Dept Biol Sci, Museum Nat Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Jackson, ND (corresponding author), Louisiana State Univ, Dept Biol Sci, Museum Nat Sci, Baton Rouge, LA 70803 USA.	nathanjackson@glel.carleton.ca			National Science Foundation [DEB 0445213, DBI 0400797, DEB 1146033]	National Science Foundation(National Science Foundation (NSF))	The authors received funding from National Science Foundation Grants DEB 0445213, DBI 0400797, and DEB 1146033 to CCA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin JA, 1998, COPEIA, P519, DOI 10.2307/1447455; [Anonymous], RIVER MEANDERING; Arnold ML, 1994, NATURAL HYBRIDIZATIO; Austin CC, 2010, CONSERV GENET, V11, P889, DOI 10.1007/s10592-009-9931-z; Austin JD, 2004, MOL PHYLOGENET EVOL, V32, P799, DOI 10.1016/j.ympev.2004.03.006; Autin W.J., 1991, QUATERNARY NONGLACIA, P547; BAKER JA, 1991, REV AQUAT SCI, V3, P313; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Benke A.C., 2005, RIVERS N AM; Blum MD, 2000, GEOL SOC AM BULL, V112, P221, DOI 10.1130/0016-7606(2000)112<221:LPEOTL>2.0.CO;2; Brandley MC, 2010, MOL PHYLOGENET EVOL, V57, P552, DOI 10.1016/j.ympev.2010.07.015; BRICE JC, 1974, GEOL SOC AM BULL, V85, P581, DOI 10.1130/0016-7606(1974)85<581:EOML>2.0.CO;2; BROOKS GR, 1967, ECOL MONOGR, V37, P71, DOI 10.2307/2937336; Capparella A.P., 1991, P307; Colwell RK, 2000, P NATL ACAD SCI USA, V97, P13470, DOI 10.1073/pnas.250497697; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DeWoody JA, 2004, BIOTECHNIQUES, V37, P348, DOI 10.2144/04373BM02; Endler J.A., 1977, Monographs in Population Biology, pi; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faubet P, 2008, GENETICS, V178, P1491, DOI 10.1534/genetics.107.082560; Fisk H.N., 1944, GEOLOGICAL INVESTIGA; FITCH HS, 1977, HERPETOLOGICA, V33, P303; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; Fouquet A, 2012, BIOL J LINN SOC, V106, P356, DOI 10.1111/j.1095-8312.2012.01871.x; Frazier DE, 1967, T GULF COAST ASS GEO, V11, P121; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; Gavrilets S, 2000, EVOLUTION, V54, P1126; Gavrilets S, 2003, EVOLUTION, V57, P2197; Goudet, 2002, FSTAT PROGRAM ESTIMA; Guiher TJ, 2008, MOL PHYLOGENET EVOL, V48, P543, DOI 10.1016/j.ympev.2008.04.008; Haffer J, 2008, BRAZ J BIOL, V68, P917, DOI 10.1590/S1519-69842008000500003; Haffer Juergen, 1992, Boletim do Museu Paraense Emilio Goeldi Serie Zoologia, V8, P217; Hayes FE, 2004, J BIOGEOGR, V31, P1809, DOI 10.1111/j.1365-2699.2004.01139.x; Haywood AM, 2001, PALAEONTOL ELECTRON, V4, P1; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jackson ND, 2012, BIOL J LINN SOC, V107, P192, DOI 10.1111/j.1095-8312.2012.01929.x; Jackson ND, 2011, CONSERV GENET RESOUR, V3, P95, DOI 10.1007/s12686-010-9299-x; Jackson ND, 2010, EVOLUTION, V64, P409, DOI 10.1111/j.1558-5646.2009.00840.x; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kesel RH, 2008, GEOMORPHOLOGY, V101, P78, DOI 10.1016/j.geomorph.2008.06.006; Kolb C. R., 1966, DELTAS THEIR GEOLOGI, P17; Li JW, 2010, MOL ECOL, V19, P494, DOI 10.1111/j.1365-294X.2009.04494.x; Makowsky R, 2009, GENETICA, V135, P169, DOI 10.1007/s10709-008-9267-5; MATHER CM, 1970, TEX J SCI, V21, P429; McLuckie AM, 1999, J HERPETOL, V33, P36, DOI 10.2307/1565541; Nei M., 1987, MOL EVOLUTIONARY GEN; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; O'Donnell RP, 2012, CONSERV GENET, V13, P1167, DOI 10.1007/s10592-012-0384-4; O'Reilly PT, 2004, MOL ECOL, V13, P1799, DOI 10.1111/j.1365-294X.2004.02214.x; Paetkau D, 1997, GENETICS, V147, P1943; PEMBERTON JM, 1995, MOL ECOL, V4, P249, DOI 10.1111/j.1365-294X.1995.tb00214.x; Peres CA, 1996, FOLIA PRIMATOL, V67, P113, DOI 10.1159/000157213; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Postma E, 2005, NATURE, V433, P65, DOI 10.1038/nature03083; Pritchard JK, 2000, GENETICS, V155, P945; Pyron RA, 2010, J BIOGEOGR, V37, P2005, DOI 10.1111/j.1365-2699.2010.02336.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Saucier, 1994, GEOMORPHOLOGY QUATER, P399; Saucier RT, 1996, ENG GEOL, V45, P67, DOI 10.1016/S0013-7952(96)00008-7; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smith LM, 1996, ENG GEOL, V45, P139, DOI 10.1016/S0013-7952(96)00011-7; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starkey DE, 2003, EVOLUTION, V57, P119; Stolum HH, 1996, SCIENCE, V271, P1710, DOI 10.1126/science.271.5256.1710; Tatarenkov A, 2010, MOL ECOL, V19, P257, DOI 10.1111/j.1365-294X.2009.04464.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1978, P580; Zamudio KR, 2003, EVOLUTION, V57, P1631; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	83	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62812	10.1371/journal.pone.0062812	http://dx.doi.org/10.1371/journal.pone.0062812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658778	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500041
J	Kaspersson, R; Sundstrom, F; Bohlin, T; Johnsson, JI				Kaspersson, Rasmus; Sundstrom, Fredrik; Bohlin, Torgny; Johnsson, Jorgen I.			Modes of Competition: Adding and Removing Brown Trout in the Wild to Understand the Mechanisms of Density-Dependence	PLOS ONE			English	Article							SALMON SALMO-SALAR; DWELLING ATLANTIC SALMON; EXPLOITATION COMPETITION; BODY-SIZE; INTERSPECIFIC COMPETITION; ASYMMETRICAL COMPETITION; STOCKING EXPERIMENTS; POPULATION-DENSITY; HATCHERY ORIGIN; RAINBOW-TROUT	While the prevalence of density-dependence is well-established in population ecology, few field studies have investigated its underlying mechanisms and their relative population-level importance. Here, we address these issues, and more specifically, how differences in body-size influence population regulation. For this purpose, two experiments were performed in a small coastal stream on the Swedish west coast, using juvenile brown trout (Salmo trutta) as a study species. We manipulated densities of large and small individuals, and observed effects on survival, migration, condition and individual growth rate in a target group of intermediate-sized individuals. The generality of the response was investigated by reducing population densities below and increasing above the natural levels (removing and adding large and small individuals). Reducing the density (relaxing the intensity of competition) had no influence on the response variables, suggesting that stream productivity was not a limiting factor at natural population density. Addition of large individuals resulted in a negative density-dependent response, while no effect was detected when adding small individuals or when maintaining the natural population structure. We found that the density-dependent response was revealed as reduced growth rate rather than increased mortality and movement, an effect that may arise from exclusion to suboptimal habitats or increased stress levels among inferior individuals. Our findings confirm the notion of interference competition as the primary mode of competition in juvenile salmonids, and also show that the feedback-mechanisms of density-dependence are primarily acting when increasing densities above their natural levels.	[Kaspersson, Rasmus; Sundstrom, Fredrik; Bohlin, Torgny; Johnsson, Jorgen I.] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Kaspersson, R (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	rasmus.kaspersson@bioenv.gu.se	Sundstrom, Fred/E-6736-2011	Sundstrom, Fred/0000-0002-3157-7289	Swedish Research Council for Agricultural Research and Spatial Planning	Swedish Research Council for Agricultural Research and Spatial Planning	This work was supported by a grant from the Swedish Research Council for Agricultural Research and Spatial Planning (www.formas.se)(to J.I.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT JC, 1989, BEHAVIOUR, V108, P104, DOI 10.1163/156853989X00079; Alanara A, 1996, J FISH BIOL, V48, P242, DOI 10.1111/j.1095-8649.1996.tb01116.x; Alanara A, 2001, J ANIM ECOL, V70, P980, DOI 10.1046/j.0021-8790.2001.00550.x; Armstrong JD, 2006, J ZOOL, V269, P403, DOI 10.1111/j.1469-7998.2006.00157.x; Baer J, 2008, ECOL FRESHW FISH, V17, P455, DOI 10.1111/j.1600-0633.2008.00297.x; BERG S, 1991, J FISH BIOL, V39, P151, DOI 10.1111/j.1095-8649.1991.tb04353.x; BOHLIN T, 1994, AM NAT, V143, P478, DOI 10.1086/285614; Bohlin T, 2002, J ANIM ECOL, V71, P683, DOI 10.1046/j.1365-2656.2002.00631.x; BOHLIN T, 1989, HYDROBIOLOGIA, V173, P9, DOI 10.1007/BF00008596; Brannas E, 2004, CAN J ZOOL, V82, P1638, DOI 10.1139/Z04-147; Bremset G, 1999, ANIM BEHAV, V58, P1047, DOI 10.1006/anbe.1999.1218; Cameron TC, 2007, J ANIM ECOL, V76, P83, DOI 10.1111/j.1365-2656.2006.01185.x; Davey AJH, 2009, ENVIRON MODEL ASSESS, V14, P555, DOI 10.1007/s10666-008-9171-5; Davey AJH, 2006, CAN J FISH AQUAT SCI, V63, P597, DOI 10.1139/f05-246; Eccard JA, 2002, OIKOS, V99, P580, DOI 10.1034/j.1600-0706.2002.11833.x; Einum S, 2006, OIKOS, V113, P489, DOI 10.1111/j.2006.0030-1299.14806.x; Einum S, 2011, OECOLOGIA, V167, P1017, DOI 10.1007/s00442-011-2055-4; EJIKE C, 1980, T AM FISH SOC, V109, P423, DOI 10.1577/1548-8659(1980)109&lt;423:SASHRI&gt;2.0.CO;2; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; Elliott JM, 2002, J FISH BIOL, V61, P1268, DOI 10.1006/jfbi.2002.2154; Grant JWA, 2005, J FISH BIOL, V67, P100, DOI 10.1111/j.0022-1112.2005.00916.x; GRANT JWA, 1988, BEHAV ECOL SOCIOBIOL, V22, P435, DOI 10.1007/BF00294982; HAMRIN SF, 1986, OIKOS, V47, P223, DOI 10.2307/3566049; HART DD, 1987, OECOLOGIA, V73, P41, DOI 10.1007/BF00376975; Harwood AJ, 2003, BEHAV ECOL, V14, P902, DOI 10.1093/beheco/arg080; Hojesjo J, 2004, BEHAV ECOL SOCIOBIOL, V56, P286, DOI 10.1007/s00265-004-0784-7; HUBERT WA, 1993, HYDROBIOLOGIA, V259, P179, DOI 10.1007/BF00006597; Huntingford F.A., 1987, ANIMAL CONFLICT; Huntingford FA, 1998, J FISH BIOL, V53, P847, DOI 10.1111/j.1095-8649.1998.tb01838.x; Imre I, 2005, J ANIM ECOL, V74, P508, DOI 10.1111/j.1365-2656.2005.00949.x; Jenkins TM, 1999, ECOLOGY, V80, P941, DOI 10.1890/0012-9658(1999)080[0941:EOPDOI]2.0.CO;2; Johnsson JI, 1999, J FISH BIOL, V54, P469, DOI 10.1111/j.1095-8649.1999.tb00846.x; Jonsson N, 1996, FUNCT ECOL, V10, P89, DOI 10.2307/2390266; JORGENSEN J, 1991, J FISH BIOL, V39, P171, DOI 10.1111/j.1095-8649.1991.tb04354.x; Kaspersson R, 2009, J FISH BIOL, V74, P2196, DOI 10.1111/j.1095-8649.2009.02227.x; Kaspersson R, 2012, OECOLOGIA, V169, P733, DOI 10.1007/s00442-012-2248-5; Kaspersson R, 2010, ANIM BEHAV, V79, P709, DOI 10.1016/j.anbehav.2009.12.025; Keddy P., 2001, COMPETITION; Kim JW, 2007, ANIM BEHAV, V73, P275, DOI 10.1016/j.anbehav.2006.08.003; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; METCALFE NB, 1986, J FISH BIOL, V28, P525, DOI 10.1111/j.1095-8649.1986.tb05190.x; NAKANO S, 1995, J ANIM ECOL, V64, P75, DOI 10.2307/5828; OLIVER JD, 1979, T AM FISH SOC, V108, P130, DOI 10.1577/1548-8659(1979)108&lt;130:OMOFSB&gt;2.0.CO;2; PERSSON L, 1985, AM NAT, V126, P261, DOI 10.1086/284413; Pettersson J, 1996, J FISH BIOL, V49, P370, DOI 10.1111/j.1095-8649.1996.tb00033.x; PUCKETT KJ, 1985, BEHAVIOUR, V92, P97, DOI 10.1163/156853985X00398; Scharf I, 2008, POPUL ECOL, V50, P319, DOI 10.1007/s10144-008-0081-9; Sundstrom LF, 2004, J FISH BIOL, V65, P1385, DOI 10.1111/j.0022-1112.2004.00537.x; TILMAN D, 1987, AM NAT, V129, P769, DOI 10.1086/284672; Ward DM, 2007, J ANIM ECOL, V76, P135, DOI 10.1111/j.1365-2656.2006.01169.x; Weir LK, 2004, ETHOLOGY, V110, P63, DOI 10.1046/j.1439-0310.2003.00948.x	51	16	16	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62517	10.1371/journal.pone.0062517	http://dx.doi.org/10.1371/journal.pone.0062517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658736	gold, Green Submitted, Green Published			2022-12-27	WOS:000321200500027
J	Kim, B; Fatayer, H; Hanby, AM; Horgan, K; Perry, SL; Valleley, EMA; Verghese, ET; Williams, BJ; Thorne, JL; Hughes, TA				Kim, Baek; Fatayer, Hiba; Hanby, Andrew M.; Horgan, Kieran; Perry, Sarah L.; Valleley, Elizabeth M. A.; Verghese, Eldo T.; Williams, Bethany J.; Thorne, James L.; Hughes, Thomas A.			Neoadjuvant Chemotherapy Induces Expression Levels of Breast Cancer Resistance Protein That Predict Disease-Free Survival in Breast Cancer	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; MULTIDRUG-RESISTANCE; SYSTEMIC THERAPY; ABC TRANSPORTERS; DRUG-RESISTANCE; GENE-EXPRESSION; CARCINOMA; MDR1; EFFLUX; MRP1	Three main xenobiotic efflux pumps have been implicated in modulating breast cancer chemotherapy responses. These are P-glycoprotein (Pgp), Multidrug Resistance-associated Protein 1 (MRP1), and Breast Cancer Resistance Protein (BCRP). We investigated expression of these proteins in breast cancers before and after neoadjuvant chemotherapy (NAC) to determine whether their levels define response to NAC or subsequent survival. Formalin-fixed paraffin-embedded tissues were collected representing matched pairs of core biopsy (pre-NAC) and surgical specimen (post-NAC) from 45 patients with invasive ductal carcinomas. NAC regimes were anthracyclines +/- taxanes. Immunohistochemistry was performed for Pgp, MRP1 and BCRP and expression was quantified objectively using computer-aided scoring. Pgp and MRP1 were significantly up-regulated after exposure to NAC (Wilcoxon signed-rank p = 0.0024 and p < 0.0001), while BCRP showed more variation in response to NAC, with frequent up- (59% of cases) and down-regulation (41%) contributing to a lack of significant difference overall. Pre-NAC expression of all markers, and post-NAC expression of Pgp and MRP1 did not correlate with NAC response or with disease-free survival (DFS). Post-NAC expression of BCRP did not correlate with NAC response, but correlated significantly with DFS (Log rank p = 0.007), with longer DFS in patients with low post-NAC BCRP expression. In multivariate Cox regression analyses, post-NAC BCRP expression levels proved to predict DFS independently of standard prognostic factors, with high expression associated with a hazard ratio of 4.04 (95% confidence interval 1.3-12.2; p = 0.013). We conclude that NAC-induced expression levels of BCRP predict survival after NAC for breast cancer, while Pgp and MRP1 expression have little predictive value.	[Kim, Baek; Perry, Sarah L.; Valleley, Elizabeth M. A.; Thorne, James L.; Hughes, Thomas A.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Kim, Baek; Fatayer, Hiba; Horgan, Kieran] Leeds Gen Infirm, Dept Breast Surg, Leeds, W Yorkshire, England; [Hanby, Andrew M.; Verghese, Eldo T.; Williams, Bethany J.] St James Univ Hosp, Dept Histopathol, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; Leeds General Infirmary; University of Leeds; Saint James's University Hospital	Hughes, TA (corresponding author), Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England.	t.hughes@leeds.ac.uk	horgan, kieran/I-3892-2016; Horgan, Kieran/AAM-1280-2020; Hughes, Thomas/M-7063-2019; thorne, james/R-9878-2019; Hughes, Thomas A/O-8031-2015	Hughes, Thomas A/0000-0003-1169-3386; Kim, Baek/0000-0001-9759-7533; Williams, Bethany/0000-0002-6641-5503; Thorne, James/0000-0002-3037-8528	Breast Cancer Research Action Group; Leeds Teaching Hospitals Charitable Foundation; Yorkshire Cancer Research; Medical Research Council; Medical Research Council [G0902032] Funding Source: researchfish; MRC [G0902032] Funding Source: UKRI	Breast Cancer Research Action Group; Leeds Teaching Hospitals Charitable Foundation; Yorkshire Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this work was received from the Breast Cancer Research Action Group (http://www.bcrag.org/), the Leeds Teaching Hospitals Charitable Foundation (http://www.leedshospitalsfundraising.org.uk), Yorkshire Cancer Research (http://www.yorkshirecancerresearch.org.uk), and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Aomatsu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045865; Bark H, 2008, FEBS LETT, V582, P2595, DOI 10.1016/j.febslet.2008.06.036; Barry WT, 2010, J CLIN ONCOL, V28, P2198, DOI 10.1200/JCO.2009.26.7245; Burger H, 2003, CLIN CANCER RES, V9, P827; Chintamani, 2005, World J Surg Oncol, V3, P61; Clarke R, 2005, SEMIN ONCOL, V32, pS9, DOI 10.1053/j.seminoncol.2005.09.009; Darb-Esfahani S, 2012, BRIT J CANC; Dexter DW, 1998, CLIN CANCER RES, V4, P1533; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Filipits M, 1996, CLIN CANCER RES, V2, P1231; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Hanrahan EO, 2005, EXPERT OPIN PHARMACO, V6, P1477, DOI 10.1517/14656566.6.9.1477; Kaufmann M, 2012, ANN SURG ONCOL, V19, P1508, DOI 10.1245/s10434-011-2108-2; Larkin A, 2004, INT J CANCER, V112, P286, DOI 10.1002/ijc.20369; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Leonessa F, 2003, ENDOCR-RELAT CANCER, V10, P43, DOI 10.1677/erc.0.0100043; Marinovich ML, 2012, BREAST, V21, P669, DOI 10.1016/j.breast.2012.07.006; Mechetner E, 1998, CLIN CANCER RES, V4, P389; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Mieog JSD, 2007, BRIT J SURG, V94, P1189, DOI 10.1002/bjs.5894; Mo Wei, 2012, Int J Biochem Mol Biol, V3, P1; Morrow CS, 2006, MOL PHARMACOL, V69, P1499, DOI 10.1124/mol.105.017988; Moureau-Zabotto L, 2006, BRIT J CANCER, V94, P473, DOI 10.1038/sj.bjc.6602958; Nakanishi T, 2012, CHIN J CANCER, V31, P73, DOI 10.5732/cjc.011.10320; Rivera E, 2010, BREAST J, V16, P252, DOI 10.1111/j.1524-4741.2009.00896.x; Rudas M, 2003, BREAST CANCER RES TR, V81, P149, DOI 10.1023/A:1025751631115; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Tamura A, 2007, CANCER SCI, V98, P231, DOI 10.1111/j.1349-7006.2006.00371.x; Tanei T, 2011, EJSO-EUR J SURG ONC, V37, P155, DOI 10.1016/j.ejso.2010.10.009; Tsukamoto, 1997, Breast Cancer, V4, P259, DOI 10.1007/BF02966518; van Nes JGH, 2012, BREAST CANCER RES TR, V133, P49, DOI 10.1007/s10549-011-1684-y; Xiang L, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-90	33	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62766	10.1371/journal.pone.0062766	http://dx.doi.org/10.1371/journal.pone.0062766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658771	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500038
J	Hwang, K; Oh, J; Kim, TK; Kim, BK; Yu, DS; Hou, BK; Caetano-Anolles, G; Hong, SG; Kim, KM				Hwang, Kyuin; Oh, Jeongsu; Kim, Tae-Kyung; Kim, Byung Kwon; Yu, Dong Su; Hou, Bo Kyeng; Caetano-Anolles, Gustavo; Hong, Soon Gyu; Kim, Kyung Mo			CLUSTOM: A Novel Method for Clustering 16S rRNA Next Generation Sequences by Overlap Minimization	PLOS ONE			English	Article							RECOMBINATION; ENVIRONMENT; BACTERIA; PROGRAM	The recent nucleic acid sequencing revolution driven by shotgun and high-throughput technologies has led to a rapid increase in the number of sequences for microbial communities. The availability of 16S ribosomal RNA (rRNA) gene sequences from a multitude of natural environments now offers a unique opportunity to study microbial diversity and community structure. The large volume of sequencing data however makes it time consuming to assign individual sequences to phylotypes by searching them against public databases. Since ribosomal sequences have diverged across prokaryotic species, they can be grouped into clusters that represent operational taxonomic units. However, available clustering programs suffer from overlap of sequence spaces in adjacent clusters. In natural environments, gene sequences are homogenous within species but divergent between species. This evolutionary constraint results in an uneven distribution of genetic distances of genes in sequence space. To cluster 16S rRNA sequences more accurately, it is therefore essential to select core sequences that are located at the centers of the distributions represented by the genetic distance of sequences in taxonomic units. Based on this idea, we here describe a novel sequence clustering algorithm named CLUSTOM that minimizes the overlaps between adjacent clusters. The performance of this algorithm was evaluated in a comparative exercise with existing programs, using the reference sequences of the SILVA database as well as published pyrosequencing datasets. The test revealed that our algorithm achieves higher accuracy than ESPRIT-Tree and mothur, few of the best clustering algorithms. Results indicate that the concept of an uneven distribution of sequence distances can effectively and successfully cluster 16S rRNA gene sequences. The algorithm of CLUSTOM has been implemented both as a web and as a standalone command line application, which are available at http://clustom.kribb.re.kr.	[Hwang, Kyuin; Oh, Jeongsu; Kim, Kyung Mo] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Taejon, South Korea; [Hwang, Kyuin; Kim, Kyung Mo] Univ Sci & Technol, Dept Bioinformat, Taejon, South Korea; [Kim, Tae-Kyung; Yu, Dong Su; Hou, Bo Kyeng] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Kim, Byung Kwon] Yonsei Univ, Dept Syst Biol, Seoul 120749, South Korea; [Caetano-Anolles, Gustavo] Univ Illinois, Dept Crop Sci, Evolutionary Bioinformat Lab, Urbana, IL 61801 USA; [Hong, Soon Gyu] Korea Polar Res Inst, Div Polar Life Sci, Inchon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Yonsei University; University of Illinois System; University of Illinois Urbana-Champaign; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Kim, KM (corresponding author), Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Taejon, South Korea.	kmkim@kribb.re.kr		Hou, Bo Kyeng/0000-0002-9324-5263	KRIBB Research Initiative Program; Next-Generation BioGreen 21 Program, Rural Development Administration [PJ0090192013]; KOPRI research program [PE12030]	KRIBB Research Initiative Program; Next-Generation BioGreen 21 Program, Rural Development Administration; KOPRI research program(Korea Polar Research Institute of Marine Research Placement (KOPRI))	Funding: KRIBB Research Initiative Program; the Next-Generation BioGreen 21 Program, Rural Development Administration [PJ0090192013 to K.M.K]; KOPRI research program [PE12030 to S.G.H]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher Y, 2004, J BACTERIOL, V186, P3980, DOI 10.1128/JB.186.12.3980-3990.2004; Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; COLE JR, 2011, HDB MOL MICROBIAL EC, P313, DOI DOI 10.1002/9781118010518.CH36; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Hanage WP, 2006, PHILOS T R SOC B, V361, P2039, DOI 10.1098/rstb.2006.1926; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Lee JH, 2012, J MICROBIOL, V50, P181, DOI 10.1007/s12275-012-1214-6; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Sun YJ, 2012, BRIEF BIOINFORM, V13, P107, DOI 10.1093/bib/bbr009; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Wittkop T, 2010, NAT METHODS, V7, P419, DOI 10.1038/nmeth0610-419; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	29	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62623	10.1371/journal.pone.0062623	http://dx.doi.org/10.1371/journal.pone.0062623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650520	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000063
J	Mackenzie, GG; Huang, LQ; Alston, N; Ouyang, NT; Vrankova, K; Mattheolabakis, G; Constantinides, PP; Rigas, B				Mackenzie, Gerardo G.; Huang, Liqun; Alston, Ninche; Ouyang, Nengtai; Vrankova, Kvetoslava; Mattheolabakis, George; Constantinides, Panayiotis P.; Rigas, Basil			Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice	PLOS ONE			English	Article							HISTONE DEACETYLASE; SIGNAL TRANSDUCER; SULINDAC OXT-328; COLON-CANCER; ACTIVATOR; RECEPTOR; INDUCTION; SUPPORTS	New agents are needed to treat pancreatic cancer, one of the most lethal human malignancies. We synthesized phosphovalproic acid, a novel valproic acid derivative, (P-V; MDC-1112) and evaluated its efficacy in the control of pancreatic cancer. P-V inhibited the growth of human pancreatic cancer xenografts in mice by 60%-97%, and 100% when combined with cimetidine. The dominant molecular target of P-V was STAT3. P-V inhibited the phosphorylation of JAK2 and Src, and the Hsp90-STAT3 association, suppressing the activating phosphorylation of STAT3, which in turn reduced the expression of STAT3-dependent proteins Bcl-x(L), Mcl-1 and survivin. P-V also reduced STAT3 levels in the mitochondria by preventing its translocation from the cytosol, and enhanced the mitochondrial levels of reactive oxygen species, which triggered apoptosis. Inhibition of mitochondrial STAT3 by P-V was required for its anticancer effect; mitochondrial STAT3 overexpression rescued animals from the tumor growth inhibition by P-V. Our results indicate that P-V is a promising candidate drug against pancreatic cancer and establish mitochondrial STAT3 as its key molecular target.	[Mackenzie, Gerardo G.; Huang, Liqun; Alston, Ninche; Ouyang, Nengtai; Vrankova, Kvetoslava; Mattheolabakis, George; Rigas, Basil] SUNY Stony Brook, Dept Med, Canc Prevent Div, Stony Brook, NY 11794 USA; [Ouyang, Nengtai; Constantinides, Panayiotis P.] Medicon Pharmaceut Inc, Stony Brook, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rigas, B (corresponding author), SUNY Stony Brook, Dept Med, Canc Prevent Div, Stony Brook, NY 11794 USA.	basil.rigas@stonybrookmedicine.edu	Mackenzie, Gerardo G/AAW-5114-2020		NIH [2R01 CA92423, R01 CA10101902]; Stony Brook University-Department of Medicine seed-grant; National Cancer Institute (NCI), National Institutes of Health;  [R01 CA154172]; NATIONAL CANCER INSTITUTE [R01CA154172, R01CA092423] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony Brook University-Department of Medicine seed-grant; National Cancer Institute (NCI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the NIH 2R01 CA92423 and R01 CA10101902 to BR and a Stony Brook University-Department of Medicine seed-grant to GGM. This work was also supported in part by grant R01 CA154172 (BR), awarded by the National Cancer Institute (NCI), National Institutes of Health. The study sponsors had no role in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, nor in the decision to submit the manuscript for publication.	Algul H, 2002, J GASTROINTEST CANC, V31, P71, DOI 10.1385/IJGC:31:1-3:71; Barksdale KA, 2009, J NEUROCHEM, V108, P1289, DOI 10.1111/j.1471-4159.2009.05878.x; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Buettner R, 2011, ACS CHEM BIOL, V6, P432, DOI 10.1021/cb100253e; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kashfi K, 2007, BIOCHEM BIOPH RES CO, V358, P1096, DOI 10.1016/j.bbrc.2007.05.038; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Mackenzie GG, 2011, CANCER PREV RES, V4, P1052, DOI 10.1158/1940-6207.CAPR-11-0067; Mackenzie GG, 2010, GASTROENTEROLOGY, V139, P1320, DOI 10.1053/j.gastro.2010.06.044; Mamon HJ, 2011, CANCER-AM CANCER SOC, V117, P2620, DOI 10.1002/cncr.25742; Naito A, 2008, INT J CANCER, V122, P1506, DOI 10.1002/ijc.23235; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Schuller HM, 2008, CANCER-AM CANCER SOC, V112, P767, DOI 10.1002/cncr.23231; Sclabas Guido M, 2003, Int J Gastrointest Cancer, V33, P15, DOI 10.1385/IJGC:33:1:15; Surucu O, 2004, INFLAMM RES, V53, pS39, DOI 10.1007/s00011-003-0318-1; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Wang W, 2009, PANCREAS, V38, pE114, DOI 10.1097/MPA.0b013e3181a0b6f2; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; Yamamoto H, 2011, P NATL ACAD SCI USA, V108, P91, DOI 10.1073/pnas.1014918108; Zhang ZQ, 2006, INT J ONCOL, V29, P185; Zhao WP, 2009, CARCINOGENESIS, V30, P512, DOI 10.1093/carcin/bgp015	31	57	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61532	10.1371/journal.pone.0061532	http://dx.doi.org/10.1371/journal.pone.0061532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650499	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000016
J	Otwinowski, J; Nemenman, I				Otwinowski, Jakub; Nemenman, Ilya			Genotype to Phenotype Mapping and the Fitness Landscape of the E. coli lac Promoter	PLOS ONE			English	Article							DNA-BINDING SITES; BENEFICIAL MUTATIONS; REGULATORY PROTEINS; EPISTASIS; EVOLUTION; SELECTION; YEAST; NETWORKS; MODEL	Genotype-to-phenotype maps and the related fitness landscapes that include epistatic interactions are difficult to measure because of their high dimensional structure. Here we construct such a map using the recently collected corpora of high-throughput sequence data from the 75 base pairs long mutagenized E. coli lac promoter region, where each sequence is associated with its phenotype, the induced transcriptional activity measured by a fluorescent reporter. We find that the additive (non-epistatic) contributions of individual mutations account for about two-thirds of the explainable phenotype variance, while pairwise epistasis explains about 7% of the variance for the full mutagenized sequence and about 15% for the subsequence associated with protein binding sites. Surprisingly, there is no evidence for third order epistatic contributions, and our inferred fitness landscape is essentially single peaked, with a small amount of antagonistic epistasis. There is a significant selective pressure on the wild type, which we deduce to be multi-objective optimal for gene expression in environments with different nutrient sources. We identify transcription factor (CRP) and RNA polymerase binding sites in the promotor region and their interactions without difficult optimization steps. In particular, we observe evidence for previously unexplored genetic regulatory mechanisms, possibly kinetic in nature. We conclude with a cautionary note that inferred properties of fitness landscapes may be severely influenced by biases in the sequence data.	[Otwinowski, Jakub; Nemenman, Ilya] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Otwinowski, Jakub] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Nemenman, Ilya] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Nemenman, Ilya] Emory Univ, Computat & Life Sci Initiat, Atlanta, GA 30322 USA	Emory University; University of Pennsylvania; Emory University; Emory University	Otwinowski, J (corresponding author), Emory Univ, Dept Phys, Atlanta, GA 30322 USA.	jotwinowski@physics.emory.edu; ilya.nemenman@emory.edu	Otwinowski, Jakub/B-1289-2011; Otwinowski, Jacek/W-1159-2018	Otwinowski, Jakub/0000-0002-0341-8790; Otwinowski, Jacek/0000-0002-5471-6595; Nemenman, Ilya/0000-0003-3024-4244	HFSP program; James S. McDonnell Foundation	HFSP program; James S. McDonnell Foundation	The work has been funded, in part, by the HFSP program and the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Bauer AL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001007; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-42; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Cocco S, 2009, P NATL ACAD SCI USA, V106, P14058, DOI 10.1073/pnas.0906705106; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Franke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002134; FRIEDMAN J, 2010, J STAT SOFTWARE, V33; Garcia HG, 2012, CELL REP, V2, P150, DOI 10.1016/j.celrep.2012.06.004; Gerland U, 2002, J MOL EVOL, V55, P386, DOI 10.1007/s00239-002-2335-z; Goldenfeld N, 1999, SCIENCE, V284, P87, DOI 10.1126/science.284.5411.87; Goldenfeld N, 2011, ANNU REV CONDEN MA P, V2, P375, DOI 10.1146/annurev-conmatphys-062910-140509; Green W.H., 2003, ECONOMETRIC ANAL, V6th ed.; Hall DW, 2010, J HERED, V101, pS75, DOI 10.1093/jhered/esq007; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kouyos RD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002551; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Liu B.H., 1997, STAT GENOMICS LINKAG; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; MacKay D. J. C., 2003, INFORM THEORY INFERE; Margolin AA, 2010, IET SYST BIOL, V4, P428, DOI 10.1049/iet-syb.2010.0009; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Mustonen V, 2005, P NATL ACAD SCI USA, V102, P15936, DOI 10.1073/pnas.0505537102; Mustonen V, 2008, P NATL ACAD SCI USA, V105, P12376, DOI 10.1073/pnas.0805909105; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Perfeito L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002160; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Poelwijk FJ, 2011, J THEOR BIOL, V272, P141, DOI 10.1016/j.jtbi.2010.12.015; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Shaw RG, 2010, EVOLUTION, V64, P2510, DOI 10.1111/j.1558-5646.2010.01010.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Szendro I, 2012, ARXIV12024378; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tkacik G, 2006, ARXIVQBIO0611072ARXI; Wall ME, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000614; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	56	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61570	10.1371/journal.pone.0061570	http://dx.doi.org/10.1371/journal.pone.0061570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650500	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000017
J	Pingault, JB; Cote, SM; Lacourse, E; Galera, C; Vitaro, F; Tremblay, RE				Pingault, Jean-Baptiste; Cote, Sylvana M.; Lacourse, Eric; Galera, Cedric; Vitaro, Frank; Tremblay, Richard E.			Childhood Hyperactivity, Physical Aggression and Criminality: A 19-Year Prospective Population-Based Study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; FOLLOW-UP; CONDUCT PROBLEMS; RISK-FACTORS; BOYS; BEHAVIOR; PREDICTORS; IMPULSIVITY; TRAJECTORIES; INATTENTION	Background: Research shows that children with Attention Deficit/Hyperactivity Disorder are at elevated risk of criminality. However, several issues still need to be addressed in order to verify whether hyperactivity in itself plays a role in the prediction of criminality. In particular, co-occurrence with other behaviors as well as the internal heterogeneity in ADHD symptoms (hyperactivity and inattention) should be taken into account. The aim of this study was to assess the unique and interactive contributions of hyperactivity to the development of criminality, whilst considering inattention, physical aggression and family adversity. Methodology/Principal Findings: We monitored the development of a population-based sample of kindergarten children (N = 2,741). Hyperactivity, inattention, and physical aggression were assessed annually between the ages of 6 and 12 years by mothers and teachers. Information on the presence, the age at first charge and the type of criminal charge was obtained from official records when the participants were aged 25 years. We used survival analysis models to predict the development of criminality in adolescence and adulthood: high childhood hyperactivity was highly predictive when bivariate analyses were used; however, with multivariate analyses, high hyperactivity was only marginally significant (Hazard Ratio: 1.38; 95% CI: 0.94-2.02). Sensitivity analyses revealed that hyperactivity was not a consistent predictor. High physical aggression was strongly predictive (Hazard Ratio: 3.44; 95% CI: 2.43-4.87) and its role was consistent in sensitivity analyses and for different types of crime. Inattention was not predictive of later criminality. Conclusions/Significance: Although the contribution of childhood hyperactivity to criminality may be detected in large samples using multi-informant longitudinal designs, our results show that it is not a strong predictor of later criminality. Crime prevention should instead target children with the highest levels of childhood physical aggression and family adversity.	[Pingault, Jean-Baptiste; Cote, Sylvana M.; Lacourse, Eric; Vitaro, Frank; Tremblay, Richard E.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada; [Pingault, Jean-Baptiste; Cote, Sylvana M.; Lacourse, Eric; Vitaro, Frank; Tremblay, Richard E.] St Justine Hosp, Montreal, PQ, Canada; [Pingault, Jean-Baptiste; Cote, Sylvana M.; Tremblay, Richard E.] Univ Montreal, Int Lab Child & Adolescent Mental Hlth Dev, Montreal, PQ, Canada; [Lacourse, Eric] Univ Montreal, Dept Sociol, Montreal, PQ, Canada; [Galera, Cedric] Univ Bordeaux, Charles Perrens Hosp, Child Psychiat Dept Bordeaux, INSERM U897, Bordeaux, France; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland; [Tremblay, Richard E.] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychiat & Psychol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University College Dublin; Universite de Montreal; Universite de Montreal	Cote, SM (corresponding author), Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada.	sylvana.cote@gmail.com	Cote, Silvana Maria/O-1356-2014; Lacourse, Eric/B-3861-2013; Côté, Sylvana M./T-4600-2019; Galera, Cedric/T-4896-2019; Tremblay, Richard E./O-1360-2014	Lacourse, Eric/0000-0002-4779-9900; Côté, Sylvana M./0000-0001-7944-0647; Pingault, Jean-Baptiste/0000-0003-2557-4716; GALERA, CEDRIC/0000-0003-0549-9608	Fonds Quebecois de la Recherche sur la Societe et la Culture; Social Sciences and Humanities Research Council of Canada; Canadian Institutes of Health Research; Universite de Montreal; Government of Canada Post-doctoral Research Fellowship (PDRF); Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la Recherche et de la Sante du Quebec [16031]	Fonds Quebecois de la Recherche sur la Societe et la Culture(FQRNT); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Universite de Montreal; Government of Canada Post-doctoral Research Fellowship (PDRF); Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la Recherche et de la Sante du Quebec	This study was supported by grants from the Fonds Quebecois de la Recherche sur la Societe et la Culture; grants from the Social Sciences and Humanities Research Council of Canada; grants from the Canadian Institutes of Health Research; grants from the Universite de Montreal. Dr Pingault received a Government of Canada Post-doctoral Research Fellowship (PDRF) and a post-doctoral fellowship from the Research Unit on Children's Psychosocial Maladjustment via a grant from the Fonds de la Recherche et de la Sante du Quebec (# 16031) attributed to Dr. Cote. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Arsenio WF, 2004, MONOGR SOC RES CHILD, P1, DOI [DOI 10.1111/J.0037-976X.2004.00312.X, 10.1111/j.0037-976X.2004.00312.x]; Babinski LM, 1999, J CHILD PSYCHOL PSYC, V40, P347, DOI 10.1017/S002196309800362X; Barkley RA, 2004, J CHILD PSYCHOL PSYC, V45, P195, DOI 10.1111/j.1469-7610.2004.00214.x; BEHAR L, 1974, DEV PSYCHOL, V10, P601, DOI 10.1037/h0037058; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Biederman J, 2010, AM J PSYCHIAT, V167, P409, DOI 10.1176/appi.ajp.2009.09050736; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Boots DP, 2010, AGGRESSIVE BEHAV, V36, P141, DOI 10.1002/ab.20338; Copeland WE, 2007, AM J PSYCHIAT, V164, P1668, DOI 10.1176/appi.ajp.2007.06122026; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; Dalteg A, 1998, J FORENSIC PSYCHIATR, V9, P39, DOI 10.1080/09585189808402178; Eklund Jenny M, 2003, Crim Behav Ment Health, V13, P294, DOI 10.1002/cbm.552; ERON LD, 1987, AM PSYCHOL, V42, P435, DOI 10.1037/0003-066X.42.5.435; Essex MJ, 2006, ARCH GEN PSYCHIAT, V63, P1246, DOI 10.1001/archpsyc.63.11.1246; Fletcher J, 2009, J MENT HEALTH POLICY, V12, P119; Fontaine N, 2008, ARCH GEN PSYCHIAT, V65, P320, DOI 10.1001/archgenpsychiatry.2007.41; Galera C, 2011, ARCH GEN PSYCHIAT, V68, P1267, DOI 10.1001/archgenpsychiatry.2011.138; Genolini C, 2013, COMPUT METH PROG BIO, V109, P104, DOI 10.1016/j.cmpb.2012.08.016; Genolini C, 2011, COMPUT METH PROG BIO, V104, pE112, DOI 10.1016/j.cmpb.2011.05.008; Genolini C, 2010, COMPUTATION STAT, V25, P317, DOI 10.1007/s00180-009-0178-4; Huijbregts SCJ, 2007, J ABNORM CHILD PSYCH, V35, P203, DOI 10.1007/s10802-006-9073-4; Lacourse E, 2010, J CHILD PSYCHOL PSYC, V51, P1386, DOI 10.1111/j.1469-7610.2010.02291.x; Lahey B., 2000, HDB DEV PSYCHOPATHOL; Lee SS, 2004, J CLIN CHILD ADOLESC, V33, P705, DOI 10.1207/s15374424jccp3304_6; Lee SS, 2006, J CLIN CHILD ADOLESC, V35, P356, DOI 10.1207/s15374424jccp3503_2; Lynam DR, 2000, J ABNORM PSYCHOL, V109, P563, DOI 10.1037//0021-843X.109.4.563; MANNUZZA S, 1989, ARCH GEN PSYCHIAT, V46, P1073; Mannuzza S, 2008, PSYCHIAT RES, V160, P237, DOI 10.1016/j.psychres.2007.11.003; Martinussen T., 2006, STAT BIOL HEALTH; Mordre M, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-57; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; OLWEUS D, 1979, PSYCHOL BULL, V86, P852, DOI 10.1037/0033-2909.86.4.852; Pardini DA, 2010, J AM ACAD CHILD PSY, V49, P1134, DOI 10.1016/j.jaac.2010.07.010; Pingault J-B, 2013, MOL PSYCHIA IN PRESS, DOI [10.1038/mp.2012.87, DOI 10.1038/MP.2012.87.(IN]; Pingault JB, 2011, AM J PSYCHIAT, V168, P1164, DOI 10.1176/appi.ajp.2011.10121732; Rasmussen P, 2000, J AM ACAD CHILD PSY, V39, P1424, DOI 10.1097/00004583-200011000-00017; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Satterfield JH, 2007, J AM ACAD CHILD PSY, V46, P601, DOI 10.1097/chi.0b013e318033ff59; Schonberg MA, 2007, CLIN CHILD FAM PSYCH, V10, P101, DOI 10.1007/s10567-007-0018-4; Sibley MH, 2010, J ABNORM CHILD PSYCH, V38, P645, DOI 10.1007/s10802-010-9404-3; Simonoff E, 2004, BRIT J PSYCHIAT, V184, P118, DOI 10.1192/bjp.184.2.118; Sourander A, 2006, J AM ACAD CHILD PSY, V45, P578, DOI 10.1097/01.chi0000205699.58626.b5; Stevenson J, 2001, BRIT J PSYCHIAT, V179, P197, DOI 10.1192/bjp.179.3.197; TREMBLAY RE, 1991, J ABNORM CHILD PSYCH, V19, P285, DOI 10.1007/BF00911232; Tremblay RE, 2000, INT J BEHAV DEV, V24, P129, DOI 10.1080/016502500383232; van Buuren S, 2011, J STAT SOFTW, V45, P1	47	39	40	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62594	10.1371/journal.pone.0062594	http://dx.doi.org/10.1371/journal.pone.0062594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23658752	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000061
J	de Almeida, J; Jourdan, I; Murer, MG; Belforte, JE				de Almeida, Julian; Jourdan, Ivan; Gustavo Murer, Mario; Belforte, Juan E.			Refinement of Neuronal Synchronization with Gamma Oscillations in the Medial Prefrontal Cortex after Adolescence	PLOS ONE			English	Article							POSITRON EMISSION TOMOGRAPHY; RISK-TAKING BEHAVIOR; BRAIN MATURATION; SCHIZOPHRENIA-PATIENTS; COGNITIVE-DEVELOPMENT; SOMATOSENSORY CORTEX; NEURAL SYNCHRONY; FRONTAL-CORTEX; DEVELOPMENTAL-CHANGES; NEOCORTICAL NEURONS	The marked anatomical and functional changes taking place in the medial prefrontal cortex (PFC) during adolescence set grounds for the high incidence of neuropsychiatric disorders with adolescent onset. Although circuit refinement through synapse pruning may constitute the anatomical basis for the cognitive differences reported between adolescents and adults, a physiological correlate of circuit refinement at the level of neuronal ensembles has not been demonstrated. We have recorded neuronal activity together with local field potentials in the medial PFC of juvenile and adult mice under anesthesia, which allowed studying local functional connectivity without behavioral or sensorial interference. Entrainment of pyramidal neurons and interneurons to gamma oscillations, but not to theta or beta oscillations, was reduced after adolescence. Interneurons were synchronized to gamma oscillations across a wider area of the PFC than pyramidal neurons, and the span of interneuron synchronization was shorter in adults than juvenile mice. Thus, transition from childhood to adulthood is characterized by reduction of the strength and span of neuronal synchronization specific to gamma oscillations in the mPFC. The more restricted and weak ongoing synchronization in adults may allow a more dynamic rearrangement of neuronal ensembles during behavior and promote parallel processing of information.	[de Almeida, Julian; Jourdan, Ivan; Gustavo Murer, Mario; Belforte, Juan E.] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Neural Circuit Physiol Lab,Syst Neurosci Grp, Buenos Aires, DF, Argentina; [Belforte, Juan E.] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Physiol Anim Behav Lab,Syst Neurosci Grp, Buenos Aires, DF, Argentina; [Jourdan, Ivan] Univ Buenos Aires, Sch Engn, Inst Ingn Biomed, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Belforte, JE (corresponding author), Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Neural Circuit Physiol Lab,Syst Neurosci Grp, Buenos Aires, DF, Argentina.	jbelforte@fmed.uba.ar	Belforte, Juan/Q-6633-2019	Belforte, Juan/0000-0002-6300-5314	Secretaria de Ciencia, Tecnologia e Innovacion Productiva, Fondo para la Investigacion Cientifica y Tecnologica, Argentina [PICT2007-05-01000, PICT2008-05-2205, PICT2011-0521, PICT2009-05-0010, PICT2010-05-1679]; Universidad de Buenos Aires, Argentina [UBACYT 2011-2014 562]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP0077, PIP707]; NARSAD Young Investigator Award from the Brain and Behavior Research Foundation	Secretaria de Ciencia, Tecnologia e Innovacion Productiva, Fondo para la Investigacion Cientifica y Tecnologica, Argentina; Universidad de Buenos Aires, Argentina(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NARSAD Young Investigator Award from the Brain and Behavior Research Foundation(NARSAD)	This work was supported by Secretaria de Ciencia, Tecnologia e Innovacion Productiva, Fondo para la Investigacion Cientifica y Tecnologica, Argentina (PICT2007-05-01000, PICT2008-05-2205, PICT2011-0521 to M.G.M. and PICT2009-05-0010, PICT2010-05-1679 to J.E.B.); Universidad de Buenos Aires, Argentina (UBACYT 2011-2014 562); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP0077 to M.G.M. and PIP707 to J.E.B.); and 2010 NARSAD Young Investigator Award from the Brain and Behavior Research Foundation to J.E.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS I, 1982, BRAIN RES, V239, P349, DOI 10.1016/0006-8993(82)90514-5; Adriani W, 1998, BEHAV NEUROSCI, V112, P1152, DOI 10.1037/0735-7044.112.5.1152; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; ANDERSON SA, 1995, NEUROSCIENCE, V67, P7, DOI 10.1016/0306-4522(95)00051-J; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Basar-Eroglu C, 2007, INT J PSYCHOPHYSIOL, V64, P39, DOI 10.1016/j.ijpsycho.2006.07.007; Blakemore SJ, 2006, DEVELOPMENTAL SCI, V9, P11, DOI 10.1111/j.1467-7687.2005.00456.x; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; Cheetham CEJ, 2010, J NEUROSCI, V30, P12566, DOI 10.1523/JNEUROSCI.2544-10.2010; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Contreras D, 1997, NEUROSCIENCE, V77, P933; Darmani NA, 1996, PHYSIOL BEHAV, V60, P1495, DOI 10.1016/S0031-9384(96)00323-X; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; DYSON SE, 1980, BRAIN RES, V183, P43, DOI 10.1016/0006-8993(80)90118-3; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Erickson SL, 2002, J COMP NEUROL, V448, P186, DOI 10.1002/cne.10249; Feinberg I, 2010, BRAIN COGNITION, V72, P56, DOI 10.1016/j.bandc.2009.09.008; Ferrarelli F, 2008, AM J PSYCHIAT, V165, P996, DOI 10.1176/appi.ajp.2008.07111733; Fisher NI, 1996, STAT ANAL CIRCULAR D; Flynn G, 2008, SCHIZOPHR RES, V105, P262, DOI 10.1016/j.schres.2008.05.029; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Galinanes GL, 2009, J NEUROSCI, V29, P2496, DOI 10.1523/JNEUROSCI.4421-08.2009; Gallinat J, 2004, CLIN NEUROPHYSIOL, V115, P1863, DOI 10.1016/j.clinph.2004.03.013; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Hall MH, 2011, SCHIZOPHRENIA BULL, V37, P778, DOI 10.1093/schbul/sbp134; Harris LW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-28; Hascoet M, 1999, PHYSIOL BEHAV, V66, P567, DOI 10.1016/S0031-9384(98)00333-3; Heng LJ, 2011, SYNAPSE, V65, P278, DOI 10.1002/syn.20844; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JACOBS B, 1995, CEREB CORTEX, V5, P222, DOI 10.1093/cercor/5.3.222; Kasanetz F, 2002, J PHYSIOL-LONDON, V543, P577, DOI 10.1113/jphysiol.2002.0024786; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kikuchi M, 2011, SCHIZOPHR RES, V130, P187, DOI 10.1016/j.schres.2011.06.003; Kremer Y, 2011, J NEUROSCI, V31, P10689, DOI 10.1523/JNEUROSCI.6541-10.2011; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lewis DA, 2011, CURR OPIN NEUROBIOL, V21, P866, DOI 10.1016/j.conb.2011.05.013; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; Macri S, 2002, ANIM BEHAV, V64, P541, DOI 10.1006/anbe.2002.4004; MARKUS EJ, 1987, EXP NEUROL, V96, P262, DOI 10.1016/0014-4886(87)90045-8; Nakazawa K, 2012, NEUROPHARMACOLOGY, V62, P1574, DOI 10.1016/j.neuropharm.2011.01.022; Norra C, 2004, NEUROPSYCHOBIOLOGY, V49, P71, DOI 10.1159/000076413; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Ringli M, 2011, PROG BRAIN RES, V193, P63, DOI 10.1016/B978-0-444-53839-0.00005-3; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Spear LP, 2010, DEV PSYCHOBIOL, V52, P236, DOI 10.1002/dev.20457; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spencer KM, 2008, BIOL PSYCHIAT, V63, P744, DOI 10.1016/j.biopsych.2007.10.017; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Terranova ML, 1998, J COMP PSYCHOL, V112, P3, DOI 10.1037/0735-7036.112.1.3; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31; Van De Werd HJJM, 2010, BRAIN STRUCT FUNCT, V214, P339, DOI 10.1007/s00429-010-0247-z; VANEDEN CG, 1985, J COMP NEUROL, V241, P268, DOI 10.1002/cne.902410303; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Whitford TJ, 2007, HUM BRAIN MAPP, V28, P228, DOI 10.1002/hbm.20273; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; Zecevic N, 1991, CEREB CORTEX, V1, P510, DOI 10.1093/cercor/1.6.510; Zold CL, 2007, EUR J NEUROSCI, V26, P1267, DOI 10.1111/j.1460-9568.2007.05754.x; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	89	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62978	10.1371/journal.pone.0062978	http://dx.doi.org/10.1371/journal.pone.0062978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646166	Green Submitted, Green Published, gold			2022-12-27	WOS:000319077300121
J	Li, HH; Kong, LZ; Wu, XH; Li, L				Li, Huahui; Kong, Lingzhi; Wu, Xihong; Li, Liang			Primitive Auditory Memory Is Correlated with Spatial Unmasking That Is Based on Direct-Reflection Integration	PLOS ONE			English	Article							INTERAURAL CORRELATION; INFORMATIONAL MASKING; BINOCULAR UNMASKING; ENERGETIC MASKING; SPEECH; SEPARATION; NOISE; REVERBERATION; RECOGNITION; RELEASE	In reverberant rooms with multiple-people talking, spatial separation between speech sources improves recognition of attended speech, even though both the head-shadowing and interaural-interaction unmasking cues are limited by numerous reflections. It is the perceptual integration between the direct wave and its reflections that bridges the direct-reflection temporal gaps and results in the spatial unmasking under reverberant conditions. This study further investigated (1) the temporal dynamic of the direct-reflection-integration-based spatial unmasking as a function of the reflection delay, and (2) whether this temporal dynamic is correlated with the listeners' auditory ability to temporally retain raw acoustic signals (i.e., the fast decaying primitive auditory memory, PAM). The results showed that recognition of the target speech against the speech-masker background is a descending exponential function of the delay of the simulated target reflection. In addition, the temporal extent of PAM is frequency dependent and markedly longer than that for perceptual fusion. More importantly, the temporal dynamic of the speech-recognition function is significantly correlated with the temporal extent of the PAM of low-frequency raw signals. Thus, we propose that a chain process, which links the earlier-stage PAM with the later-stage correlation computation, perceptual integration, and attention facilitation, plays a role in spatially unmasking target speech under reverberant conditions.	[Li, Huahui; Kong, Lingzhi; Li, Liang] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Wu, Xihong] Peking Univ, Dept Machine Intelligence, Beijing 100871, Peoples R China; [Wu, Xihong; Li, Liang] Peking Univ, Speech & Hearing Res Ctr, Beijing 100871, Peoples R China; [Wu, Xihong; Li, Liang] Peking Univ, Minist Educ, Key Lab Machine Percept, Beijing 100871, Peoples R China; [Li, Liang] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Li, L (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	liangli@pku.edu.cn			National Natural Science Foundation of China [31170985]; "973'' National Basic Research Program of China [2009CB320901, 2011CB707805]; Peking University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973'' National Basic Research Program of China(National Basic Research Program of China); Peking University(Peking University)	This work was supported by the National Natural Science Foundation of China (31170985), the "973'' National Basic Research Program of China (2009CB320901; 2011CB707805), and "985'' grants from Peking University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd MA, 1999, J ACOUST SOC AM, V105, P2807, DOI 10.1121/1.426897; Arbogast TL, 2002, J ACOUST SOC AM, V112, P2086, DOI 10.1121/1.1510141; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BILSEN FA, 1974, J ACOUST SOC AM, V55, P292, DOI 10.1121/1.1914500; BLAUERT J, 1986, J ACOUST SOC AM, V79, P806, DOI 10.1121/1.393471; Boehnke SE, 2002, J ACOUST SOC AM, V112, P1617, DOI 10.1121/1.1504857; Brungart DS, 2001, J ACOUST SOC AM, V110, P2527, DOI 10.1121/1.1408946; Brungart DS, 2005, J ACOUST SOC AM, V118, P3241, DOI 10.1121/1.2082557; Burger J., 1958, ACTA ACUST UNITED AC, V8, P1; CARTMILL M, 1974, SCIENCE, V184, P436, DOI 10.1126/science.184.4135.436; CHERRY EC, 1954, J ACOUST SOC AM, V26, P554, DOI 10.1121/1.1907373; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341; Culling JF, 2003, J ACOUST SOC AM, V114, P2871, DOI 10.1121/1.1616922; Culling JF, 2001, J ACOUST SOC AM, V110, P1020, DOI 10.1121/1.1383296; Culling JF, 2007, J ACOUST SOC AM, V122, P2803, DOI 10.1121/1.2785035; Darwin CJ, 2000, J ACOUST SOC AM, V108, P335, DOI 10.1121/1.429468; Du Y, 2011, NEUROSCI BIOBEHAV R, V35, P2046, DOI 10.1016/j.neubiorev.2011.05.008; Durlach NI, 2003, J ACOUST SOC AM, V114, P368, DOI 10.1121/1.1577562; FREYMAN RL, 1991, J ACOUST SOC AM, V90, P874, DOI 10.1121/1.401955; Freyman RL, 1999, J ACOUST SOC AM, V106, P3578, DOI 10.1121/1.428211; GABRIEL KJ, 1981, J ACOUST SOC AM, V69, P1394, DOI 10.1121/1.385821; Goupell MJ, 2006, J ACOUST SOC AM, V119, P3971, DOI 10.1121/1.2200147; Hall DA, 2005, J NEUROPHYSIOL, V94, P3181, DOI 10.1152/jn.00271.2005; Heesy CP, 2009, EVOL ANTHROPOL, V18, P21, DOI 10.1002/evan.20195; HENNING GB, 1973, VISION RES, V13, P2455, DOI 10.1016/0042-6989(73)90243-5; Huang Y, 2008, HEARING RES, V244, P51, DOI 10.1016/j.heares.2008.07.006; Huang Y, 2011, J COGNITIVE NEUROSCI, V23, P1003, DOI 10.1162/jocn.2010.21470; Huang Y, 2009, J EXP PSYCHOL HUMAN, V35, P1618, DOI 10.1037/a0015791; Huang Y, 2009, J ACOUST SOC AM, V126, P300, DOI 10.1121/1.3147504; Huang Y, 2008, NEUROREPORT, V19, P1673, DOI 10.1097/WNR.0b013e32831576c7; JULESZ B, 1964, SCIENCE, V145, P356, DOI 10.1126/science.145.3630.356; KAUFMAN L, 1964, AM J PSYCHOL, V77, P393, DOI 10.2307/1421009; Kidd G, 2005, ACTA ACUST UNITED AC, V91, P526; KIDD G, 1994, J ACOUST SOC AM, V95, P3475, DOI 10.1121/1.410023; Koehnke J, 1996, EAR HEARING, V17, P211, DOI 10.1097/00003446-199606000-00004; KOEHNKE J, 1986, J ACOUST SOC AM, V79, P1558, DOI 10.1121/1.393682; Kong LZ, 2012, J ACOUST SOC AM, V132, pEL114, DOI 10.1121/1.4734241; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li L, 2005, HEARING RES, V202, P235, DOI 10.1016/j.heares.2004.10.007; Li L, 2004, J EXP PSYCHOL HUMAN, V30, P1077, DOI 10.1037/0096-1523.30.6.1077; Li L, 2009, EAR HEARING, V30, P273, DOI 10.1097/AUD.0b013e318198703d; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; MASSARO DW, 1972, PSYCHOL REV, V79, P124, DOI 10.1037/h0032264; MORAGLIA G, 1992, VISION RES, V32, P375, DOI 10.1016/0042-6989(92)90146-A; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; OToole AJ, 1997, PERCEPT PSYCHOPHYS, V59, P202, DOI 10.3758/BF03211889; POLLACK I, 1959, J ACOUST SOC AM, V31, P1250, DOI 10.1121/1.1907852; Rakerd B, 2006, J ACOUST SOC AM, V119, P1597, DOI 10.1121/1.2161438; Rakerd B, 2000, J ACOUST SOC AM, V107, P1061, DOI 10.1121/1.428287; Reznikoff I., 2008, J ACOUST SOC AM, V123, P3603, DOI [10.1121/1.2934773, DOI 10.1121/1.2934773]; RITTER W, 1995, EAR HEARING, V16, P52, DOI 10.1097/00003446-199502000-00005; SCHNEIDER B, 1989, SCIENCE, V243, P1479, DOI 10.1126/science.2928782; Schneider BA, 2007, J AM ACAD AUDIOL, V18, P559, DOI 10.3766/jaaa.18.7.4; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; WALLACH H, 1949, AM J PSYCHOL, V62, P315, DOI 10.2307/1418275; Wardle SG, 2010, J VISION, V10, DOI 10.1167/10.14.38; Wu XH, 2005, HEARING RES, V199, P1, DOI 10.1016/j.heares.2004.03.010; Yang ZG, 2007, SPEECH COMMUN, V49, P892, DOI 10.1016/j.specom.2007.05.005; YOST WA, 1981, J ACOUST SOC AM, V70, P397, DOI 10.1121/1.386775; ZUREK PM, 1980, J ACOUST SOC AM, V67, P952, DOI 10.1121/1.383974; Zurek PM, 2004, J ACOUST SOC AM, V115, P1609, DOI 10.1121/1.1650333	63	19	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e63106	10.1371/journal.pone.0063106	http://dx.doi.org/10.1371/journal.pone.0063106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658664	Green Published, gold			2022-12-27	WOS:000321662800076
J	Barry, RL; Coaster, M; Rogers, BP; Newton, AT; Moore, J; Anderson, AW; Zald, DH; Gore, JC				Barry, Robert L.; Coaster, Mariam; Rogers, Baxter P.; Newton, Allen T.; Moore, Jay; Anderson, Adam W.; Zald, David H.; Gore, John C.			On the Origins of Signal Variance in FMRI of the Human Midbrain at High Field	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS DOPAMINE; BRAIN ACTIVATION PATTERNS; CEREBROSPINAL-FLUID FLOW; FUNCTIONAL MRI; PHYSIOLOGICAL NOISE; NAVIGATOR CORRECTION; MAGNETIC-FIELD; IN-VIVO; 1.5 T; RESOLUTION	Functional Magnetic Resonance Imaging (fMRI) in the midbrain at 7 Tesla suffers from unexpectedly low temporal signal to noise ratio (TSNR) compared to other brain regions. Various methodologies were used in this study to quantitatively identify causes of the noise and signal differences in midbrain fMRI data. The influence of physiological noise sources was examined using RETROICOR, phase regression analysis, and power spectral analyses of contributions in the respiratory and cardiac frequency ranges. The impact of between-shot phase shifts in 3-D multi-shot sequences was tested using a one-dimensional (1-D) phase navigator approach. Additionally, the effects of shared noise influences between regions that were temporally, but not functionally, correlated with the midbrain (adjacent white matter and anterior cerebellum) were investigated via analyses with regressors of 'no interest'. These attempts to reduce noise did not improve the overall TSNR in the midbrain. In addition, the steady state signal and noise were measured in the midbrain and the visual cortex for resting state data. We observed comparable steady state signals from both the midbrain and the cortex. However, the noise was 2-3 times higher in the midbrain relative to the cortex, confirming that the low TSNR in the midbrain was not due to low signal but rather a result of large signal variance. These temporal variations did not behave as known physiological or other noise sources, and were not mitigated by conventional strategies. Upon further investigation, resting state functional connectivity analysis in the midbrain showed strong intrinsic fluctuations between homologous midbrain regions. These data suggest that the low TSNR in the midbrain may originate from larger signal fluctuations arising from functional connectivity compared to cortex, rather than simply reflecting physiological noise.	[Barry, Robert L.; Coaster, Mariam; Rogers, Baxter P.; Newton, Allen T.; Moore, Jay; Anderson, Adam W.; Gore, John C.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37203 USA; [Barry, Robert L.; Rogers, Baxter P.; Moore, Jay; Anderson, Adam W.; Gore, John C.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Coaster, Mariam; Zald, David H.; Gore, John C.] Vanderbilt Univ, Neurosci Grad Program, Nashville, TN USA; [Rogers, Baxter P.; Anderson, Adam W.; Gore, John C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Zald, David H.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Zald, David H.] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Barry, RL (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37203 USA.	robert.barry@vanderbilt.edu		Rogers, Baxter/0000-0002-5666-2797	National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R01EB000461]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000461, T32EB001628] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding source: National Institute of Biomedical Imaging and Bioengineering (NIBIB): R01EB000461. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandettini PA, 1994, P SMR 2 ANN M SAN FR, P434; Barry RL, 2005, MAGN RESON MED, V54, P411, DOI 10.1002/mrm.20591; Barry RL, 2008, NEUROIMAGE, V39, P1142, DOI 10.1016/j.neuroimage.2007.09.060; Barry RL, 2012, MAGN RESON MED, V67, P867, DOI 10.1002/mrm.23072; Barry RL, 2011, NEUROIMAGE, V55, P1034, DOI 10.1016/j.neuroimage.2010.12.086; Barry RL, 2010, MAGN RESON IMAGING, V28, P235, DOI 10.1016/j.mri.2009.07.005; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; BRUDER H, 1992, MAGNET RESON MED, V23, P311, DOI 10.1002/mrm.1910230211; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Coaster M, 2012, THESIS VANDERBILT U; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; Duyn JH, 1996, NEUROIMAGE, V4, pS76, DOI 10.1006/nimg.1996.0057; Eapen M, 2011, AM J NEURORADIOL, V32, P688, DOI 10.3174/ajnr.A2355; EHMAN RL, 1989, RADIOLOGY, V173, P255, DOI 10.1148/radiology.173.1.2781017; ENZMANN DR, 1992, RADIOLOGY, V185, P653, DOI 10.1148/radiology.185.3.1438741; FARZANEH F, 1990, MAGNET RESON MED, V14, P123, DOI 10.1002/mrm.1910140112; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gati JS, 1997, MAGNET RESON MED, V38, P296, DOI 10.1002/mrm.1910380220; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Golay X, 2000, MAGNET RESON MED, V43, P779, DOI 10.1002/1522-2594(200006)43:6<779::AID-MRM1>3.0.CO;2-4; GRACE AA, 1984, J NEUROSCI, V4, P2866; GREITZ D, 1992, NEURORADIOLOGY, V34, P370, DOI 10.1007/BF00596493; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; GRUETTER R, 1992, J MAGN RESON, V96, P323, DOI 10.1016/0022-2364(92)90085-L; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Haacke E. M., 1999, MAGNETIC RESONANCE I; HORNAK JP, 1988, MAGNET RESON MED, V6, P158, DOI 10.1002/mrm.1910060204; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Krebs RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008691; Kruger G, 2001, MAGNET RESON MED, V45, P595, DOI 10.1002/mrm.1081; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; LIU GY, 1993, MAGNET RESON MED, V30, P764, DOI 10.1002/mrm.1910300617; Manova ES, 2009, AM J NEURORADIOL, V30, P569, DOI 10.3174/ajnr.A1401; MANSFIELD P, 1994, J COMPUT ASSIST TOMO, V18, P339, DOI 10.1097/00004728-199405000-00001; Menon RS, 2002, MAGNET RESON MED, V47, P1, DOI 10.1002/mrm.10041; Naidich T.P., 2009, DUVERNOYS ATLAS HUMA; Neggers SFW, 2008, NMR BIOMED, V21, P663, DOI 10.1002/nbm.1235; Novak P, 2001, J COMPUT ASSIST TOMO, V25, P242, DOI 10.1097/00004728-200103000-00016; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; PONCELET BP, 1992, RADIOLOGY, V185, P645, DOI 10.1148/radiology.185.3.1438740; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Ramsey NF, 1998, NEUROIMAGE, V8, P240, DOI 10.1006/nimg.1998.0358; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Salamone JD, 1996, J NEUROSCI METH, V64, P137, DOI 10.1016/0165-0270(95)00125-5; SCHNEIDER E, 1991, MAGNET RESON MED, V18, P335, DOI 10.1002/mrm.1910180208; SCHROTH G, 1992, NEURORADIOLOGY, V35, P10, DOI 10.1007/BF00588271; SCHROTH G, 1992, NEURORADIOLOGY, V35, P1, DOI 10.1007/BF00588270; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sexton JA, 2009, P INT SOC MAGN RESON, V1549; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soellinger M, 2007, J MAGN RESON IMAGING, V25, P709, DOI 10.1002/jmri.20882; Stenger VA, 1998, MAGNET RESON MED, V40, P481, DOI 10.1002/mrm.1910400320; Swisher JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034626; Takahashi H, 2004, NEUROIMAGE, V22, P1247, DOI 10.1016/j.neuroimage.2004.03.028; Thomas BP, 2008, J MAGN RESON IMAGING, V28, P1266, DOI 10.1002/jmri.21576; Tomasi D, 2007, BRAIN RES, V1171, P83, DOI 10.1016/j.brainres.2007.06.102; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; van der Meulen P, 1985, Magn Reson Imaging, V3, P297, DOI 10.1016/0730-725X(85)90362-5; VANDERMEULEN P, 1988, MAGN RESON IMAGING, V6, P355, DOI 10.1016/0730-725X(88)90472-9; VANGELDEREN P, 1995, P NATL ACAD SCI USA, V92, P6906, DOI 10.1073/pnas.92.15.6906; Versluis MJ, 2010, NEUROIMAGE, V51, P1082, DOI 10.1016/j.neuroimage.2010.03.048; Weisskoff R., 1993, P ISMRM 12 ANN M, P7; Weisskoff RM, 1996, MAGN RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yamada S, 2008, RADIOLOGY, V249, P644, DOI 10.1148/radiol.2492071985	69	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62708	10.1371/journal.pone.0062708	http://dx.doi.org/10.1371/journal.pone.0062708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658643	gold, Green Submitted, Green Published			2022-12-27	WOS:000318343700067
J	Lin, YH; Chen, YC; Tseng, YH; Lin, MH; Hwang, SJ; Chen, TJ; Chou, LF				Lin, Yi-Hsuan; Chen, Yi-Chun; Tseng, Yen-Han; Lin, Ming-Hwai; Hwang, Shinn-Jang; Chen, Tzeng-Ji; Chou, Li-Fang			Trend of Urban-Rural Disparities in Hospice Utilization in Taiwan	PLOS ONE			English	Article							PALLIATIVE CARE SERVICE; IMPROVING ACCESS; UNITED-STATES; LIFE; CANCER; DETERMINANTS; COMMUNITY; PATTERNS; REGION; DEATH	Aims: The palliative care has spread rapidly worldwide in the recent two decades. The development of hospice services in rural areas usually lags behind that in urban areas. The aim of our study was to investigate whether the urban-rural disparity widens in a country with a hospital-based hospice system. Methods: From the nationwide claims database within the National Health Insurance in Taiwan, admissions to hospices from 2000 to 2006 were identified. Hospices and patients in each year were analyzed according to geographic location and residence. Results: A total of 26,292 cancer patients had been admitted to hospices. The proportion of rural patients to all patients increased with time from 17.8% in 2000 to 25.7% in 2006. Although the numbers of beds and the utilizations in both urban and rural hospices expanded rapidly, the increasing trend in rural areas was more marked than that in urban areas. However, still two-thirds (898/1,357) of rural patients were admitted to urban hospices in 2006. Conclusions: The gap of hospice utilizations between urban and rural areas in Taiwan did not widen with time. There was room for improvement in sufficient supply of rural hospices or efficient referral of rural patients.	[Lin, Yi-Hsuan] Kaohsiung Vet Gen Hosp, Pingtung Branch, Dept Family Med, Pingtung, Taiwan; [Chen, Yi-Chun] Taitung Vet Hosp, Dept Family Med, Taitung, Taiwan; [Tseng, Yen-Han] Taipei Vet Gen Hosp, Resp Therapy Dept, Taipei, Taiwan; [Lin, Ming-Hwai; Hwang, Shinn-Jang; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Ming-Hwai; Hwang, Shinn-Jang; Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chou, Li-Fang] Natl Chengchi Univ, Dept Publ Finance, Taipei 11623, Taiwan	Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Chengchi University	Chen, TJ (corresponding author), Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan.	tjchen@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021		National Science Council in Taiwan [NSC96-2416-H-004-007-MY2]; Taipei Veterans General Hospital [V100C-094, V100D-002-3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was funded by the National Science Council in Taiwan [NSC96-2416-H-004-007-MY2] and Taipei Veterans General Hospital [V100C-094, V100D-002-3]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bureau of National Health Insurance Department of Health, 2012, EXP PALL CAR PAT ADV; Bureau of National Health Insurance Department of Health, PAY REG NAT HLTH INS; Campbell CL, 2009, J NURS SCHOLARSHIP, V41, P420, DOI 10.1111/j.1547-5069.2009.01310.x; Carlson MDA, 2008, J PALLIAT MED, V11, P438, DOI 10.1089/jpm.2007.0152; Centeno C, 2007, PALLIATIVE MED, V21, P463, DOI 10.1177/0269216307081942; Chen TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-54; Chen YC, 2011, BRIT MED J, V342, P297; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Connor SR, 2007, J PAIN SYMPTOM MANAG, V34, P277, DOI 10.1016/j.jpainsymman.2007.03.007; Emanuel EJ, 1996, JAMA-J AM MED ASSOC, V275, P1907, DOI 10.1001/jama.275.24.1907; Glass AP, 2010, J CROSS-CULT GERONTO, V25, P1, DOI 10.1007/s10823-009-9108-8; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Joseph N, 2009, INDIAN J PALLIAT CAR, V15, P122, DOI 10.4103/0973-1075.58457; Lin MH, 2011, TAIWAN J PUBLIC HLTH, V30, P347, DOI DOI 10.6288/TJPH2011-30-04-05; Lin MH, 2008, J CHIN MED ASSOC, V71, P294, DOI 10.1016/S1726-4901(08)70125-4; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; O'Connor M, 2010, ASIA-PAC J CLIN ONCO, V6, P197, DOI 10.1111/j.1743-7563.2010.01315.x; Robinson CA, 2010, J RURAL HEALTH, V26, P78, DOI 10.1111/j.1748-0361.2009.00268.x; Roscoe LA, 2006, J PALLIAT CARE, V22, P46, DOI 10.1177/082585970602200108; Schuurman N, 2010, HEALTH SOC CARE COMM, V18, P537, DOI 10.1111/j.1365-2524.2010.00933.x; Shiozaki M, 2005, PALLIATIVE MED, V19, P319, DOI 10.1191/0269216305pm1015oa; Taiwan Hospice Organization, STAT HOSP RES DISTR; Tang ST, 2010, PSYCHO-ONCOLOGY, V19, P1213, DOI 10.1002/pon.1690; Tang ST, 2003, J PALLIAT CARE, V19, P230, DOI 10.1177/082585970301900403; To T, 2010, INTERN MED J, V40, P772, DOI 10.1111/j.1445-5994.2009.02064.x; Tumwine JK, 2003, INT J ENVIRON HEAL R, V13, P107, DOI 10.1080/0960312031000098035; Virnig BA, 2004, J AM GERIATR SOC, V52, P731, DOI 10.1111/j.1532-5415.2004.52213.x; Weckmann MT, 2012, AM J HOSP PALLIAT CA; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607	29	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62492	10.1371/journal.pone.0062492	http://dx.doi.org/10.1371/journal.pone.0062492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136EF	23658633	Green Published, gold, Green Submitted			2022-12-27	WOS:000318343700059
J	Gracio, F; Cabral, J; Tidor, B				Gracio, Filipe; Cabral, Joaquim; Tidor, Bruce			Modeling Stem Cell Induction Processes	PLOS ONE			English	Article							GENE-EXPRESSION; PLURIPOTENCY; OCT4; STOCHASTICITY; FIBROBLASTS; NANOG; NOISE; SOX2; TRANSCRIPTION; EPIGENETICS	Technology for converting human cells to pluripotent stem cell using induction processes has the potential to revolutionize regenerative medicine. However, the production of these so called iPS cells is still quite inefficient and may be dominated by stochastic effects. In this work we build mass-action models of the core regulatory elements controlling stem cell induction and maintenance. The models include not only the network of transcription factors NANOG, OCT4, SOX2, but also important epigenetic regulatory features of DNA methylation and histone modification. We show that the network topology reported in the literature is consistent with the observed experimental behavior of bistability and inducibility. Based on simulations of stem cell generation protocols, and in particular focusing on changes in epigenetic cellular states, we show that cooperative and independent reaction mechanisms have experimentally identifiable differences in the dynamics of reprogramming, and we analyze such differences and their biological basis. It had been argued that stochastic and elite models of stem cell generation represent distinct fundamental mechanisms. Work presented here suggests an alternative possibility that they represent differences in the amount of information we have about the distribution of cellular states before and during reprogramming protocols. We show further that unpredictability and variation in reprogramming decreases as the cell progresses along the induction process, and that identifiable groups of cells with elite-seeming behavior can come about by a stochastic process. Finally we show how different mechanisms and kinetic properties impact the prospects of improving the efficiency of iPS cell generation protocols.	[Gracio, Filipe; Cabral, Joaquim] Inst Super Tecn, IBB, Ctr Biol & Chem Engn, Lisbon, Portugal; [Gracio, Filipe; Tidor, Bruce] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Tidor, Bruce] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Tidor, Bruce] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Universidade de Lisboa; Instituto Superior Tecnico; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tidor, B (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tidor@mit.edu	Cabral, Joaquim M S/G-2052-2010	Cabral, Joaquim M S/0000-0002-2405-5845; /0000-0002-3320-3969	Fundacao para a Ciencia e Tecnologia [BD 42942]; US National Institutes of Health [CA112967]; Singapore-MIT Alliance for Research and Technology; US National Science Foundation [0821391]; MIT Portugal Program	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT Alliance for Research and Technology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); US National Science Foundation(National Science Foundation (NSF)); MIT Portugal Program	This research was supported by the MIT Portugal Program, Fundacao para a Ciencia e Tecnologia (BD 42942), the US National Institutes of Health (CA112967), the Singapore-MIT Alliance for Research and Technology, the US National Science Foundation (0821391), and a gift of computing hardware from Intel Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Atkinson S, 2008, CELL TISSUE RES, V331, P23, DOI 10.1007/s00441-007-0536-x; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Cover T. M., 1991, ELEMENTS INFORM THEO; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dittami GM, 2012, JOVE-J VIS EXP, DOI 10.3791/3842; Djuric U, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt3; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P18159, DOI 10.1073/pnas.0806084105; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine AD, 2011, CELL STEM CELL, V8, P132, DOI 10.1016/j.stem.2011.01.002; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Li ZH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2059; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loh K, 2009, CELL STEM CELL, V5, P491; MacKay D. J. C., 2003, INFORM THEORY INFERE; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Neuert G, 2013, SCIENCE, V339, P584, DOI 10.1126/science.1231456; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pasi CE, 2011, CELL DEATH DIFFER, V18, P745, DOI 10.1038/cdd.2011.9; Patel M, 2010, STEM CELL REV REP, V6, P367, DOI 10.1007/s12015-010-9123-8; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Rolletschek A, 2009, BIOL CHEM, V390, P845, DOI 10.1515/BC.2009.103; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhurinsky J, 2010, CURR BIOL, V20, P2010, DOI 10.1016/j.cub.2010.10.002	58	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e60240	10.1371/journal.pone.0060240	http://dx.doi.org/10.1371/journal.pone.0060240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667423	gold, Green Published, Green Submitted			2022-12-27	WOS:000319055600003
J	Sheng, YW; Durazo, A; Schumacher, M; Gralla, EB; Cascio, D; Cabelli, DE; Valentine, JS				Sheng, Yuewei; Durazo, Armando; Schumacher, Mikhail; Gralla, Edith Butler; Cascio, Duilio; Cabelli, Diane E.; Valentine, Joan Selverstone			Tetramerization Reinforces the Dimer Interface of MnSOD	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; MALATE-DEHYDROGENASE; CRYSTAL-STRUCTURES; CANDIDA-ALBICANS; PROTEIN; STABILITY; YEAST; CRYSTALLIZATION	Two yeast manganese superoxide dismutases (MnSOD), one from Saccharomyces cerevisiae mitochondria (ScMnSOD) and the other from Candida albicans cytosol (CaMnSODc), have most biochemical and biophysical properties in common, yet ScMnSOD is a tetramer and CaMnSODc is a dimer or "loose tetramer'' in solution. Although CaMnSODc was found to crystallize as a tetramer, there is no indication from the solution properties that the functionality of CaMnSODc in vivo depends upon the formation of the tetrameric structure. To elucidate further the functional significance of MnSOD quaternary structure, wild-type and mutant forms of ScMnSOD (K182R, A183P mutant) and CaMnSODc (K184R, L185P mutant) with the substitutions at dimer interfaces were analyzed with respect to their oligomeric states and resistance to pH, heat, and denaturant. Dimeric CaMnSODc was found to be significantly more subject to thermal or denaturant-induced unfolding than tetrameric ScMnSOD. The residue substitutions at dimer interfaces caused dimeric CaMnSODc but not tetrameric ScMnSOD to dissociate into monomers. We conclude that the tetrameric assembly strongly reinforces the dimer interface, which is critical for MnSOD activity.	[Sheng, Yuewei; Durazo, Armando; Schumacher, Mikhail; Gralla, Edith Butler; Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Cascio, Duilio] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA USA; [Durazo, Armando] Univ Arizona, Dept Chem & Environm Engn, Tucson, AZ USA; [Cabelli, Diane E.] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; [Valentine, Joan Selverstone] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Arizona; United States Department of Energy (DOE); Brookhaven National Laboratory; Ewha Womans University	Cabelli, DE (corresponding author), Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA.	cabelli@bnl.gov; jsv@chem.ucla.edu	Valentine, Joan S/B-6665-2008	Valentine, Joan S/0000-0002-7174-925X	United States Department of Energy; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences;  [DK46828];  [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046828] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences(United States Department of Energy (DOE)); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK46828 to J.S.V. Radiolysis studies were carried out at Center for Radiation Chemistry Research at BNL, which is funded under contract DE-AC02-98CH10886 with the United States Department of Energy and supported by its Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IA, 2008, BIOCHEMISTRY-US, V47, P2350, DOI 10.1021/bi7016206; Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Arroyo-Reyna A, 2004, ANAL BIOCHEM, V328, P123, DOI 10.1016/j.ab.2004.02.021; Barnese K, 2010, J AM CHEM SOC, V132, P12525, DOI 10.1021/ja104179r; Bjork A, 2004, J MOL BIOL, V341, P1215, DOI 10.1016/j.jmb.2004.06.079; Bjork A, 2003, FEBS LETT, V553, P423, DOI 10.1016/S0014-5793(03)01076-7; Borders CL, 1998, BIOCHEMISTRY-US, V37, P11323, DOI 10.1021/bi980167t; BORGSTAHL GEO, 1992, CELL, V71, P107, DOI 10.1016/0092-8674(92)90270-M; Borgstahl GEO, 1996, BIOCHEMISTRY-US, V35, P4287, DOI 10.1021/bi951892w; Edwards RA, 1998, J BIOL INORG CHEM, V3, P161, DOI 10.1007/s007750050217; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fluckiger S, 2002, J IMMUNOL, V168, P1267, DOI 10.4049/jimmunol.168.3.1267; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Greenleaf WB, 2004, BIOCHEMISTRY-US, V43, P7038, DOI 10.1021/bi049888k; Hearn AS, 2004, J BIOL CHEM, V279, P5861, DOI 10.1074/jbc.M311310200; Hernandez-Saavedra D, 2010, FREE RADICAL BIO MED, V48, P1202, DOI 10.1016/j.freeradbiomed.2010.02.001; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsieh JY, 2009, J BIOL CHEM, V284, P18096, DOI 10.1074/jbc.M109.005082; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamarre C, 2001, J BIOL CHEM, V276, P43784, DOI 10.1074/jbc.M108095200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller AF, 2012, FEBS LETT, V586, P585, DOI 10.1016/j.febslet.2011.10.048; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; Muren EM, 1999, J BIOL CHEM, V274, P19397, DOI 10.1074/jbc.274.27.19397; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Rao NA, 2003, BBA-PROTEINS PROTEOM, V1647, P24, DOI 10.1016/S1570-9639(03)00043-8; RAVINDRANATH SD, 1975, J BIOL CHEM, V250, P6107; Schwarz H., BNL PULSE RADIOLYSIS; Sheng YW, 2012, P NATL ACAD SCI USA, V109, P14314, DOI 10.1073/pnas.1212367109; Sheng YW, 2011, J AM CHEM SOC, V133, P20878, DOI 10.1021/ja2077476; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Trinh CH, 2008, ACTA CRYSTALLOGR F, V64, P1110, DOI 10.1107/S1744309108037056; Vance CK, 2001, BIOCHEMISTRY-US, V40, P13079, DOI 10.1021/bi0113317; WAGNER UG, 1993, PROTEIN SCI, V2, P814, DOI 10.1002/pro.5560020511; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Whittaker MM, 2011, ARCH BIOCHEM BIOPHYS, V505, P213, DOI 10.1016/j.abb.2010.10.021; Whittaker MM, 1997, BIOCHEMISTRY-US, V36, P8923, DOI 10.1021/bi9704212; Wichmann C, 2010, BLOOD, V116, P603, DOI 10.1182/blood-2009-10-248047; Zheng J, 2007, BIOCHEMISTRY-US, V46, P14830, DOI 10.1021/bi7014103	45	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62446	10.1371/journal.pone.0062446	http://dx.doi.org/10.1371/journal.pone.0062446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667478	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700037
J	Wu, Q; Wang, HY; Li, J; Zhou, P; Wang, QL; Zhao, L; Fan, R; Wang, YM; Xu, XZ; Yi, DH; Yu, SQ; Pei, JM				Wu, Qi; Wang, Hai-Yan; Li, Juan; Zhou, Peng; Wang, Qiu-Lin; Zhao, Lei; Fan, Rong; Wang, Yue-Min; Xu, Xue-Zeng; Yi, Ding-Hua; Yu, Shi-Qiang; Pei, Jian-Ming			kappa-Opioid Receptor Stimulation Improves Endothelial Function in Hypoxic Pulmonary Hypertension	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; REACTIVE OXYGEN; NADPH OXIDASE; EXPRESSION; ARTERY; RATS; PEROXYNITRITE; CAVEOLIN-1; CHEMISTRY; U50,488H	The present study was designed to investigate the effect of kappa-opioid receptor stimulation with U50,488H on endothelial function and underlying mechanism in rats with hypoxic pulmonary hypertension (HPH). Chronic hypoxia-induced HPH was simulated by exposing the rats to 10% oxygen for 2 wk. After hypoxia, mean pulmonary arterial pressure (mPAP), right ventricular pressure (RVP) and right ventricular hypertrophy index (RVHI) were measured. Relaxation of pulmonary artery in response to acetylcholine (ACh) was determined. Expression and activity of endothelial nitric oxide (NO) synthase (eNOS) and inducible NO synthase (iNOS) with NO production, total antioxidant capacity (T-AOC), gp91(phox) expression and nitrotyrosine content were measured. The effect of U50,488H administration during chronic hypoxia was investigated. Administration of U50,488H significantly decreased mPAP and right ventricular hypertrophy as evidenced by reduction in RVP and RVHI. These effects were mediated by kappa-opioid receptor. In the meantime, treatment with U50,488H significantly improved endothelial function as evidenced by enhanced relaxation in response to ACh. Moreover, U50,488H resulted in a significant increase in eNOS phosphorylation, NO content in serum, and T-AOC in pulmonary artery of HPH rats. In addition, the activity of eNOS was enhanced, but the activity of iNOS was attenuated in the pulmonary artery of chronic hypoxic rats treated with U50,488H. On the other hand, U50,488H markedly blunted HPH-induced elevation of gp91(phox) expression and nitrotyrosine content in pulmonary artery, and these effects were blocked by nor-BNI, a selective kappa-opioid receptor antagonist. These data suggest that kappa-opioid receptor stimulation with U50,488H improves endothelial function in rats with HPH. The mechanism of action might be attributed to the preservation of eNOS activity, enhancement of eNOS phosphorylation, downregulation of iNOS activity and its antioxidative/nitrative effect.	[Wu, Qi; Zhou, Peng; Wang, Qiu-Lin] Chengdu Med Coll, Dept Cardiol, Chengdu, Peoples R China; [Wang, Hai-Yan] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Li, Juan; Zhao, Lei; Fan, Rong; Wang, Yue-Min; Pei, Jian-Ming] Fourth Mil Med Univ, Natl Key Discipline Cell Biol, Dept Physiol, Xian 710032, Peoples R China; [Xu, Xue-Zeng; Yi, Ding-Hua; Yu, Shi-Qiang] Fourth Mil Med Univ, Dept Cardiosurg, Xijing Hosp, Xian 710032, Peoples R China	Chengdu Medical College; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yu, SQ (corresponding author), Fourth Mil Med Univ, Dept Cardiosurg, Xijing Hosp, Xian 710032, Peoples R China.	yushiqiang2009@hotmail.com; jmpei8@fmmu.edu.cn	Zhao, Lei/AAF-3066-2020	Zhao, Lei/0000-0003-1263-1742; Yu, Shiqiang/0000-0003-3519-0943	National Natural Science Foundation of China [30900535, 30971060, 81270402, 30900525]; Shaanxi Province of China [2010K01-195, 2011JM4001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province of China	This work was supported by research grants from the National Natural Science Foundation of China (No.30900535, 30971060, 81270402, 30900525) and grants from Shaanxi Province of China (NOs.2010K01-195, 2011JM4001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2009, HYPERTENSION, V54, P1393, DOI 10.1161/HYPERTENSIONAHA.109.135459; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gallantine EL, 2008, BASIC CLIN PHARMACOL, V103, P419, DOI 10.1111/j.1742-7843.2008.00306.x; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Hampl V, 2000, PHYSIOL REV, V80, P1337, DOI 10.1152/physrev.2000.80.4.1337; HECKER M, 1991, FEBS LETT, V294, P221, DOI 10.1016/0014-5793(91)81434-A; HIRATA K, 1995, HYPERTENSION, V25, P180, DOI 10.1161/01.HYP.25.2.180; JANSSENS SP, 1992, J BIOL CHEM, V267, P14519; Ji LL, 2010, AM J PHYSIOL-ENDOC M, V298, pE871, DOI 10.1152/ajpendo.00623.2009; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Komai H, 2001, CARDIOVASC PATHOL, V10, P29, DOI 10.1016/S1054-8807(00)00063-6; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Li R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1703, DOI 10.1152/ajpendo.00462.2007; Liu JQ, 2005, CHEST, V128, p594S, DOI 10.1378/chest.128.6_suppl.594S; Liu JQ, 2003, AM J PHYSIOL-LUNG C, V285, pL322, DOI 10.1152/ajplung.00337.2002; Mason NA, 1998, J PATHOL, V185, P313, DOI 10.1002/(SICI)1096-9896(199807)185:3<313::AID-PATH93>3.0.CO;2-8; MCQUILLAN LP, 1994, AM J PHYSIOL-HEART C, V267, pH1921; Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; MONCADA S, 1988, HYPERTENSION, V12, P365, DOI 10.1161/01.HYP.12.4.365; Murata T, 2002, J BIOL CHEM, V277, P44085, DOI 10.1074/jbc.M205934200; Nisbet RE, 2009, AM J RESP CELL MOL, V40, P601, DOI 10.1165/2008-0145OC; Osorio H, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/542042; Ostergaard L, 2007, AM J PHYSIOL-HEART C, V293, pH2894, DOI 10.1152/ajpheart.01230.2006; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Patel HH, 2006, AM J PHYSIOL-HEART C, V291, pH344, DOI 10.1152/ajpheart.01100.2005; Pei JM, 2006, J CARDIOVASC PHARM, V47, P594, DOI 10.1097/01.fjc.0000211737.55583.15; Peng P, 2009, ANAT REC, V292, P1062, DOI 10.1002/ar.20911; Rabinovitch M, 2001, J CLIN INVEST, V108, P1109; Rueckschloss U, 2003, ANTIOXID REDOX SIGN, V5, P171, DOI 10.1089/152308603764816532; SESSA WC, 1992, J BIOL CHEM, V267, P15274; Sharon D, 2003, J IMMUNOL, V171, P3225; Sun X, 2006, LIFE SCI, V78, P2516, DOI 10.1016/j.lfs.2005.10.042; Toyoshima H, 1998, J CARDIOVASC PHARM, V32, P543, DOI 10.1097/00005344-199810000-00006; Veyssier-Belot C, 1999, CARDIOVASC RES, V44, P274, DOI 10.1016/S0008-6363(99)00230-8; Voelkel NF, 2000, J CLIN INVEST, V106, P733, DOI 10.1172/JCI11144; Wang J, 1997, J CLIN INVEST, V100, P2347, DOI 10.1172/JCI119774; Weissmann N, 2001, AM J PHYSIOL-LUNG C, V280, pL638, DOI 10.1152/ajplung.2001.280.4.L638; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507	45	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e60850	10.1371/journal.pone.0060850	http://dx.doi.org/10.1371/journal.pone.0060850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667430	gold, Green Submitted, Green Published			2022-12-27	WOS:000319654700008
J	Saidi, O; Ben Mansour, N; O'Flaherty, M; Capewell, S; Critchley, JA; Ben Romdhane, H				Saidi, Olfa; Ben Mansour, Nadia; O'Flaherty, Martin; Capewell, Simon; Critchley, Julia A.; Ben Romdhane, Habiba			Analyzing Recent Coronary Heart Disease Mortality Trends in Tunisia between 1997 and 2009	PLOS ONE			English	Article							PREVENTION; DECREASE; DECLINE	Background: In Tunisia, Cardiovascular Diseases are the leading causes of death (30%), 70% of those are coronary heart disease (CHD) deaths and population studies have demonstrated that major risk factor levels are increasing. Objective: To explain recent CHD trends in Tunisia between 1997 and 2009. Methods: Data Sources: Published and unpublished data were identified by extensive searches, complemented with specifically designed surveys. Analysis: Data were integrated and analyzed using the previously validated IMPACT CHD policy model. Data items included: (i) number of CHD patients in specific groups (including acute coronary syndromes, congestive heart failure and chronic angina)(ii) uptake of specific medical and surgical treatments, and(iii) population trends in major cardiovascular risk factors (smoking, total cholesterol, systolic blood pressure (SBP), body mass index (BMI), diabetes and physical inactivity). Results: CHD mortality rates increased by 11.8% for men and 23.8% for women, resulting in 680 additional CHD deaths in 2009 compared with the 1997 baseline, after adjusting for population change. Almost all (98%) of this rise was explained by risk factor increases, though men and women differed. A large rise in total cholesterol level in men (0.73 mmol/L) generated 440 additional deaths. In women, a fall (-0.43 mmol/L), apparently avoided about 95 deaths. For SBP a rise in men (4 mmHg) generated 270 additional deaths. In women, a 2 mmHg fall avoided 65 deaths. BMI and diabetes increased substantially resulting respectively in 105 and 75 additional deaths. Increased treatment uptake prevented about 450 deaths in 2009. The most important contributions came from secondary prevention following Acute Myocardial Infarction (AMI) (95 fewer deaths), initial AMI treatments (90), antihypertensive medications (80) and unstable angina (75). Conclusions: Recent trends in CHD mortality mainly reflected increases in major modifiable risk factors, notably SBP and cholesterol, BMI and diabetes. Current prevention strategies are mainly focused on treatments but should become more comprehensive.	[Saidi, Olfa; Ben Mansour, Nadia; Ben Romdhane, Habiba] Fac Med Tunis Tunisia, Cardiovasc Epidemiol & Prevent Res Lab, Tunis, Tunisia; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Critchley, Julia A.] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England	University of Liverpool; St Georges University London	Ben Romdhane, H (corresponding author), Fac Med Tunis Tunisia, Cardiovasc Epidemiol & Prevent Res Lab, Tunis, Tunisia.	habibabr@yahoo.fr	Shao, Ruitai/AAU-7642-2021	O'Flaherty, Martin/0000-0001-8944-4131; Critchley, Julia/0000-0002-5248-4188	European Community's Seventh Framework Programme (FP7)-the MedCHAMPS project [223075]; United Kingdom (UK) MRC; UK Higher Education Funding Council; UK Medical Research Council; MRC [G0900847] Funding Source: UKRI; Medical Research Council [G0900847] Funding Source: researchfish	European Community's Seventh Framework Programme (FP7)-the MedCHAMPS project; United Kingdom (UK) MRC; UK Higher Education Funding Council; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 223075-the MedCHAMPS project. MOF was also supported by the United Kingdom (UK) MRC. JC and SC are supported by the UK Higher Education Funding Council. MOF is partly funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The MedCHAMPS team had access to all data sources and has the responsibility for the contents of the report and the decision to submit for publication.	[Anonymous], 2009, TUN EP STUD AC COR S; Ben Ali S, 2011, HTR20110218R1; Ben Romdhane H, 2001, CORONARY HEART DIS E, VI; Ben Romdhane H., 2002, OPT MEDITERRANEENNES, V41, P248; Ben Romdhane H, 2010, AR HLTH URB PROJ BAS; Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bouguerra R, 2007, EUR J CLIN NUTR, V61, P160, DOI 10.1038/sj.ejcn.1602478; Briggs A, 1999, BRIT MED J, V319, P120, DOI 10.1136/bmj.319.7202.120; Capewell S, 1999, EUR HEART J, V20, P1386, DOI 10.1053/euhj.1999.1631; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Critchley JA, 2002, EUR HEART J, V23, P110, DOI 10.1053/euhj.2001.2681; Elasmi M, 2009, REV EPIDEMIOL SANTE, V57, P87, DOI 10.1016/j.respe.2008.12.010; Epidemiological Transition and Health Impact in North Africa, 2006, TAHINA PROJ FIN REP; Fakhfakh R, 2002, B WORLD HEALTH ORGAN, V80, P350; Fakhfakh R, 2000, East Mediterr Health J, V6, P678; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Ghozzi H, 2010, ANN CARDIOL ANGEIOL, V59, P131, DOI 10.1016/j.ancard.2010.04.004; Gupta Rajeev, 2005, Indian Heart J, V57, P632; Hu FB, 2003, LIPIDS, V38, P103, DOI 10.1007/s11745-003-1038-4; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lassoued O, 2012, TRENDS SECONDARY PRE, DOI [10.1016/j.gheart.2012.01.002, DOI 10.1016/J.GHEART.2012.01.002]; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; National Institute of Nutrition and Food Technology, 1998, TREND NUTR STAT TUN; National Institute of Statistics, 2009, TUN YEARLY STAT REP; National Institute of Statistics, 2005, HOUS CONS SURV, VB; National Institute of Statistics Tunisia, 1997, 40 NAT I STAT TUN; National Public Health Institute, 1998, EP CHRON RESP DIS TU; National Public Health Institute, 2011, DEATHS REG 2009; National Public Health Institute Tunisia, 2003, DEATHS REG 2001; Palmieri L, 2010, AM J PUBLIC HEALTH, V100, P684, DOI 10.2105/AJPH.2008.147173; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; The National Policy and Strategic, 2011, PLAN PREV MAN NONC D; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; World Health Organization, 2011, WHO FRAM CONV TOB CO	39	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63202	10.1371/journal.pone.0063202	http://dx.doi.org/10.1371/journal.pone.0063202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658808	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000321202100055
J	Girard, O; Bishop, DJ; Racinais, S				Girard, Olivier; Bishop, David J.; Racinais, Sebastien			Neuromuscular Adjustments of the Quadriceps Muscle after Repeated Cycling Sprints	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MAXIMAL VOLUNTARY CONTRACTIONS; HUMAN KNEE EXTENSORS; HUMAN ELBOW FLEXORS; HUMAN MOTOR CORTEX; TWITCH INTERPOLATION; SUPRASPINAL FATIGUE; VALID MEASURE; ACTIVATION; EXERCISE	Purpose: This study investigated the supraspinal processes of fatigue of the quadriceps muscle in response to repeated cycling sprints. Methods: Twelve active individuals performed 10 x 6-s "all-out'' sprints on a cycle ergometer (recovery = 30 s), followed 6 min later by 5 x 6-s sprints (recovery = 30 s). Transcranial magnetic and electrical femoral nerve stimulations during brief (5-s) and sustained (30-s) isometric contractions of the knee extensors were performed before and 3 min post-exercise. Results: Maximal strength of the knee extensors decreased during brief and sustained contractions (similar to 11% and 9%, respectively; P<0.001). Peripheral and cortical voluntary activation, motor evoked potential amplitude and silent period duration responses measured during briefs contractions were unaltered (P>0.05). While cortical voluntary activation declined (P<0.01) during the sustained maximal contraction in both test sessions, larger reductions occurred (P<0.05) after exercise. Lastly, resting twitch amplitude in response to both femoral nerve and cortical stimulations was largely (> 40%) reduced (P<0.001) following exercise. Conclusion: The capacity of the motor cortex to optimally drive the knee extensors following a repeated-sprint test was shown in sustained, but not brief, maximal isometric contractions. Additionally, peripheral factors were largely involved in the exercise-induced impairment in neuromuscular function, while corticospinal excitability was well-preserved.	[Girard, Olivier; Racinais, Sebastien] Aspetar, Qatar Orthopaed & Sports Med Hosp, Doha, Qatar; [Bishop, David J.] Inst Sport Exercise & Act Living, Melbourne, Vic, Australia; [Bishop, David J.] Sch Sport & Exercise Sci, Melbourne, Vic, Australia	Aspetar Orthopaedic & Sports Medicine Hospital	Girard, O (corresponding author), Aspetar, Qatar Orthopaed & Sports Med Hosp, Doha, Qatar.	oliv.girard@gmail.com	Racinais, Sebastien/N-3052-2019; Bishop, David John/X-9826-2019	Bishop, David John/0000-0002-6956-9188; girard, olivier/0000-0002-4797-182X				Akima H, 2005, INT J SPORTS MED, V26, P245, DOI 10.1055/s-2004-821000; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allen GM, 1998, MUSCLE NERVE, V21, P318, DOI 10.1002/(SICI)1097-4598(199803)21:3<318::AID-MUS5>3.0.CO;2-D; Bishop D, 2004, MED SCI SPORT EXER, V36, P807, DOI 10.1249/01.MSS.0000126392.20025.17; BRASILNETO J, 1993, EXP BRAIN RES, V93, P181; de Haan A, 2009, J APPL PHYSIOL, V107, P355, DOI 10.1152/japplphysiol.91220.2008a; Fernandez-del-Olmo M, 2011, SCAND J MED SCI 0803; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Goodall S, 2009, EXP PHYSIOL, V94, P995, DOI 10.1113/expphysiol.2009.047902; Goodall S, 2012, J PHYSIOL-LONDON, V590, P2767, DOI 10.1113/jphysiol.2012.228890; Goodall S, 2010, J APPL PHYSIOL, V109, P1842, DOI 10.1152/japplphysiol.00458.2010; Herbert RD, 1999, J NEUROPHYSIOL, V82, P2271, DOI 10.1152/jn.1999.82.5.2271; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Kalmar JM, 2006, J APPL PHYSIOL, V100, P1757, DOI 10.1152/japplphysiol.01347.2005; Mendez-Villanueva A, 2008, EUR J APPL PHYSIOL, V103, P411, DOI 10.1007/s00421-008-0723-9; Mendez-Villanueva A, 2007, MED SCI SPORT EXER, V39, P2219, DOI 10.1249/mss.0b013e31815669dc; Perrey S, 2010, EUR J APPL PHYSIOL, V109, P1027, DOI 10.1007/s00421-010-1445-3; Place N, 2008, J PHYSIOL-LONDON, V586, P2799, DOI 10.1113/jphysiol.2008.151910; Place N, 2007, MUSCLE NERVE, V35, P486, DOI 10.1002/mus.20714; Place N, 2010, EUR J APPL PHYSIOL, V110, P1, DOI 10.1007/s00421-010-1480-0; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; Racinais S, 2012, PSYCHOPHYSIOLOGY, V49, P853, DOI 10.1111/j.1469-8986.2012.01360.x; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; Sidhu SK, 2009, J APPL PHYSIOL, V106, P556, DOI 10.1152/japplphysiol.90911.2008; Sidhu SK, 2009, MUSCLE NERVE, V39, P186, DOI 10.1002/mus.21064; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2009, J APPL PHYSIOL, V107, P354, DOI 10.1152/japplphysiol.91220.2008; Taylor JL, 2000, J APPL PHYSIOL, V89, P305, DOI 10.1152/jappl.2000.89.1.305; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519, DOI 10.1113/jphysiol.1996.sp021163; Todd G, 2004, J APPL PHYSIOL, V97, P236, DOI 10.1152/japplphysiol.01336.2003; Todd G, 2003, J PHYSIOL-LONDON, V551, P661, DOI 10.1113/jphysiol.2003.044099; Todd G, 2007, J APPL PHYSIOL, V102, P1756, DOI 10.1152/japplphysiol.00962.2006; Yoon T, 2012, J APPL PHYSIOL, V112, P849, DOI 10.1152/japplphysiol.00799.2011	34	48	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61793	10.1371/journal.pone.0061793	http://dx.doi.org/10.1371/journal.pone.0061793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650503	Green Accepted, gold, Green Published			2022-12-27	WOS:000319167000020
J	Nguyen, HT; Merriman, TR; Black, MA				Hoang Tan Nguyen; Merriman, Tony R.; Black, Michael A.			CNVrd, a Read-Depth Algorithm for Assigning Copy-Number at the FCGR Locus: Population-Specific Tagging of Copy Number Variation at FCGR3B	PLOS ONE			English	Article							RISK-FACTOR; SUSCEPTIBILITY; ASSOCIATION; GENE; ACCURATE; DELETION; FORMAT	The extent of contribution from common gene copy number (CN) variants in human disease is currently unresolved. Part of the reason for this is the technical difficulty in directly measuring CN variation (CNV) using molecular methods, and the lack of single nucleotide polymorphisms (SNPs) that can tag complex CNV that has arisen multiple times on different SNP haplotypes. One CNV locus implicated in human disease is FCGR. Here we aimed to use next-generation sequencing (NGS) data from the 1000 Genomes Project to assign CN at FCGR3A and FCGR3B and to comprehensively assess the ability of SNPs to tag specific CN variants. A read-depth algorithm was developed (CNVrd) and validated on a subset of HapMap samples using CN assignments that had previously been determined using molecular and microarray methods. At 7 out of 9 other complex loci there was >90% concordance with microarray data. However, given that some prior knowledge of CN is required, the generalizability of CNVrd is limited and should be applied to other complex CNV loci with caution. Subsequently, CN was assigned et FCGR3B using CNVrd in a total of 952 samples from the 1000 Genomes Project, using three classes and SNPs that correlated with duplication were identified. The best tag SNP was observed in the Mexican-American sample set for duplication at FCGR3B. This SNP (rs117435514, r(2) = 0.79) also tagged similar duplication in Chinese and Japanese (r(2) = 0.35-0.60), but not in Caucasian or African. No tag SNP for duplication at FCGR3A or deletion at FCGR3B was identified in any population. We conclude that it is possible to tag CNV at the FCGR locus, but CN and SNPs have to be characterized and correlated on a population-specific basis.	[Hoang Tan Nguyen; Merriman, Tony R.; Black, Michael A.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Hoang Tan Nguyen] Univ Otago, Dept Math & Stat, Dunedin, New Zealand	University of Otago; University of Otago	Merriman, TR (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	tony.merriman@otago.ac.nz	Black, Michael/F-1484-2010	Black, Michael/0000-0003-1174-6054; Merriman, Tony/0000-0003-0844-8726	Virtual Institute of Statistical Genetics; New Zealand Foundation of Research, Science and Technology [C04X0804]	Virtual Institute of Statistical Genetics; New Zealand Foundation of Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	The Virtual Institute of Statistical Genetics (www.visg.co.nz) is thanked for funding this research, including the PhD stipend of NH. VISG is supported by a Programme (C04X0804) from New Zealand Foundation of Research, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley RW, 2010, AM J GASTROENTEROL, V105, P354, DOI 10.1038/ajg.2009.582; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Colobran R, 2010, CLIN EXP IMMUNOL, V162, P41, DOI 10.1111/j.1365-2249.2010.04224.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Cukier HN, 2009, ANAL BIOCHEM, V386, P288, DOI 10.1016/j.ab.2008.11.040; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Fernandez-Jimenez N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028910; Field SF, 2009, NAT MED, V15, P1115, DOI 10.1038/nm1009-1115; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hollox EJ, 2010, AM J GASTROENTEROL, V105, P360, DOI 10.1038/ajg.2009.573; Hollox EJ, 2009, HUM MUTAT, V30, P477, DOI 10.1002/humu.20911; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; McKinney C, 2012, GENES IMMUN, V13, P458, DOI 10.1038/gene.2012.15; McKinney C, 2012, HUM MOL GENET, V21, P2370, DOI 10.1093/hmg/dds039; McKinney C, 2010, ANN RHEUM DIS, V69, P1711, DOI 10.1136/ard.2009.123588; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; Niederer HA, 2010, HUM MOL GENET, V19, P3282, DOI 10.1093/hmg/ddq216; Robinson JI, 2012, HUM MUTAT, V33, P741, DOI 10.1002/humu.22031; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Waszak SM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000988; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhou XJ, 2010, INT IMMUNOL, V22, P45, DOI 10.1093/intimm/dxp113	36	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63219	10.1371/journal.pone.0063219	http://dx.doi.org/10.1371/journal.pone.0063219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646200	Green Submitted, Green Published, gold			2022-12-27	WOS:000319077300158
J	Stockert, J; Wolf, A; Kaddatz, K; Schnitzer, E; Finkernagel, F; Meissner, W; Muller-Brusselbach, S; Kracht, M; Muller, R				Stockert, Josefine; Wolf, Alexander; Kaddatz, Kerstin; Schnitzer, Evelyn; Finkernagel, Florian; Meissner, Wolfgang; Mueller-Bruesselbach, Sabine; Kracht, Michael; Mueller, Rolf			Regulation of TAK1/TAB1-Mediated IL-1 beta Signaling by Cytoplasmic PPAR beta/delta	PLOS ONE			English	Article							NF-KAPPA-B; PROLIFERATOR-ACTIVATED RECEPTORS; INDUCED NUCLEAR TRANSLOCATION; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE TAK1; TNF-ALPHA; TGF-BETA; DELTA; EXPRESSION; GROWTH	The peroxisome proliferator-activated receptor subtypes PPAR alpha, PPAR beta/delta, PPAR gamma are members of the steroid hormone receptor superfamily with well-established functions in transcriptional regulation. Here, we describe an unexpected cytoplasmic function of PPAR beta/delta. Silencing of PPAR beta/delta expression interferes with the expression of a large subset of interleukin-1 beta (IL-1 beta)-induced target genes in HeLa cells, which is preceded by an inhibition of the IL-1 beta-induced phosphorylation of TAK1 and its downstream effectors, including the NF kappa B alpha inhibitor I kappa B alpha (NFKBIA) and the NF kappa B alpha subunit p65 (RELA). PPAR beta/delta enhances the interaction between TAK1 and the small heat-shock protein HSP27, a known positive modulator of TAK1-mediated IL-1 beta signaling. Consistent with these findings, PPAR beta/delta physically interacts with both the endogenous cytoplasmic TAK1/TAB1 complex and HSP27, and PPAR beta/delta overexpression increases the TAK1-induced transcriptional activity of NF kappa B. These observations suggest that PPAR beta/delta plays a role in the assembly of a cytoplasmic multi-protein complex containing TAK1, TAB1, HSP27 and PPAR beta/delta, and thereby participates in the NF kappa B response to IL-1 beta.	[Stockert, Josefine; Kaddatz, Kerstin; Schnitzer, Evelyn; Finkernagel, Florian; Meissner, Wolfgang; Mueller-Bruesselbach, Sabine; Mueller, Rolf] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany; [Wolf, Alexander; Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmakol, Giessen, Germany	Philipps University Marburg; Justus Liebig University Giessen	Muller, R (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany.	rmueller@imt.uni-marburg.de	Müller, Rolf/L-4997-2016	Müller, Rolf/0000-0003-3339-4248; Kracht, Michael/0000-0002-8501-043X	Deutsche Forschungsgemeinschaft [SFB-TRR17, MU601/13, SFB-TRR81, KR1143/7]; LOEWE research cluster "Tumor and Inflammation"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE research cluster "Tumor and Inflammation"	This work was supported by grants from the Deutsche Forschungsgemeinschaft to R.M. (SFB-TRR17 and MU601/13) and M.K. (SFB-TRR81 and KR1143/7) and by the LOEWE research cluster "Tumor and Inflammation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016344; Alford KA, 2007, J BIOL CHEM, V282, P6232, DOI 10.1074/jbc.M610987200; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; BRUNETSIMIONI M, ONCOGENE, V28, P3332; Brunmair B, 2006, DIABETOLOGIA, V49, P2713, DOI 10.1007/s00125-006-0357-6; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050059; Chen R, 2012, P NATL ACAD SCI USA, V109, P14128, DOI 10.1073/pnas.1205246109; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; Cristiano L, 2005, NEUROSCIENCE, V131, P577, DOI 10.1016/j.neuroscience.2004.11.008; Dempsey CE, 2000, BBA-GENE STRUCT EXPR, V1517, P46, DOI 10.1016/S0167-4781(00)00258-X; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Ding GL, 2006, J MOL CELL CARDIOL, V40, P821, DOI 10.1016/j.yjmcc.2006.03.422; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Holtmann H, 2001, J BIOL CHEM, V276, P3508, DOI 10.1074/jbc.M004376200; Kaddatz K, 2010, J BIOL CHEM, V285, P29469, DOI 10.1074/jbc.M110.142018; Kanakasabai S, 2010, IMMUNOLOGY, V130, P572, DOI 10.1111/j.1365-2567.2010.03261.x; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Knapinska AM, 2011, MOL CELL BIOL, V31, P1419, DOI 10.1128/MCB.00907-10; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lim H, 2002, ENDOCRINOLOGY, V143, P3207, DOI 10.1210/en.2002-220159; Ma Q, 2008, CELL SIGNAL, V20, P1044, DOI 10.1016/j.cellsig.2008.01.015; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; Muller-Brusselbach S, 2007, EMBO J, V26, P3686, DOI 10.1038/sj.emboj.7601803; Naruhn S, 2011, MOL PHARMACOL, V80, P828, DOI 10.1124/mol.111.074039; Naruhn S, 2010, MOL PHARMACOL, V77, P171, DOI 10.1124/mol.109.060541; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Rival Y, 2002, EUR J PHARMACOL, V435, P143, DOI 10.1016/S0014-2999(01)01589-8; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Russo MP, 2002, AM J PHYSIOL-CELL PH, V283, pC347, DOI 10.1152/ajpcell.00166.2001; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Schmitz ML, 2011, BBA-MOL CELL RES, V1813, P2165, DOI 10.1016/j.bbamcr.2011.06.019; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Stockert J, 2011, NUCLEIC ACIDS RES, V39, P119, DOI 10.1093/nar/gkq773; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Takayama O, 2006, BRIT J CANCER, V95, P889, DOI 10.1038/sj.bjc.6603343; Tan NS, 2004, EMBO J, V23, P4211, DOI 10.1038/sj.emboj.7600437; Thiefes A, 2005, J BIOL CHEM, V280, P27728, DOI 10.1074/jbc.M411657200; Thiefes A, 2006, EMBO REP, V7, P838, DOI 10.1038/sj.embor.7400754; Umemoto T, 2012, GENES CELLS, V17, P576, DOI 10.1111/j.1365-2443.2012.01607.x; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Westergaard M, 2003, J INVEST DERMATOL, V121, P1104, DOI 10.1046/j.1523-1747.2003.12536.x; Wu YF, 2009, CELL SIGNAL, V21, P143, DOI 10.1016/j.cellsig.2008.10.001; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025; YANG X, 2011, PLOS ONE, V6, P1516, DOI DOI 10.1371/J0URNAL.P0NE.0025271.PUBMED:21966476; Zhou Bo, 2011, Zhonghua Shao Shang Za Zhi, V27, P446	65	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63011	10.1371/journal.pone.0063011	http://dx.doi.org/10.1371/journal.pone.0063011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646170	Green Submitted, Green Published, gold			2022-12-27	WOS:000319077300125
J	Wei, SJ; Joseph, T; Sim, AYL; Yurlova, L; Zolghadr, K; Lane, D; Verma, C; Ghadessy, F				Wei, Siau Jia; Joseph, Thomas; Sim, Adelene Y. L.; Yurlova, Larisa; Zolghadr, Kourosh; Lane, David; Verma, Chandra; Ghadessy, Farid			In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PATHWAY; STAPLED P53 PEPTIDE; ZINC-FINGER DOMAIN; N-TERMINAL DOMAIN; PROTEIN INTERACTION; DRUG-RESISTANCE; CANCER-THERAPY; BINDING-SITE; FORCE-FIELD; WILD-TYPE	HDM2 binds to the p53 tumour suppressor and targets it for proteosomal degradation. Presently in clinical trials, the small molecule Nutlin-3A competitively binds to HDM2 and abrogates its repressive function. Using a novel in vitro selection methodology, we simulated the emergence of resistance by evolving HDM2 mutants capable of binding p53 in the presence of Nutlin concentrations that inhibit the wild-type HDM2-p53 interaction. The in vitro phenotypes were recapitulated in ex vivo assays measuring both p53 transactivation function and the direct p53-HDM2 interaction in the presence of Nutlin. Mutations conferring drug resistance were not confined to the N-terminal p53/Nutlin-binding domain, and were additionally seen in the acidic, zinc finger and RING domains. Mechanistic insights gleaned from this broad spectrum of mutations will aid in future drug design and further our understanding of the complex p53-HDM2 interaction.	[Wei, Siau Jia; Lane, David; Ghadessy, Farid] Agcy Sci Technol & Res, P53Lab, Singapore, Singapore; [Wei, Siau Jia; Joseph, Thomas; Sim, Adelene Y. L.; Verma, Chandra] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Yurlova, Larisa; Zolghadr, Kourosh] ChromoTek GmbH, Planegg Martinsried, Germany; [Verma, Chandra] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Verma, Chandra] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Verma, C (corresponding author), Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.	chandra@bii.a-star.edu		Lane, David/0000-0003-0551-3545; Ghadessy, Farid/0000-0001-8559-903X	Agency for Science, Technology and Research (Singapore)	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR))	This work was funded by the Agency for Science, Technology and Research (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Aziz MH, 2011, ONCOGENE, V30, P4678, DOI 10.1038/onc.2011.185; Baek S, 2012, J AM CHEM SOC, V134, P103, DOI 10.1021/ja2090367; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Brown CJ, 2012, ACS CHEM BIOL, P53; Case D.A., 2022, AMBER 2020; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fen CX, 2007, J MOL BIOL, V371, P1238, DOI 10.1016/j.jmb.2007.05.099; Funston G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042642; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Guo TH, 2009, CLIN CANCER RES, V15, P6862, DOI 10.1158/1078-0432.CCR-09-1315; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KASTAN MB, 1991, CANCER RES, V51, P6304; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; LUNA RMD, 1995, NATURE, V378, P203; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Noureddine MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000462; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; Rew Y, 2012, J MED CHEM, V55, P4936, DOI 10.1021/jm300354j; Schlott T, 1997, J PATHOL, V182, P54; Secchiero P, 2011, CURR PHARM DESIGN, V17, P569, DOI 10.2174/138161211795222586; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Showalter SA, 2008, J AM CHEM SOC, V130, P6472, DOI 10.1021/ja800201j; TAKAHASHI T, 1992, CANCER RES, V52, P2340; Tamborini E, 2001, INT J CANCER, V92, P790, DOI 10.1002/ijc.1271; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Worrall Erin G, 2009, J Chem Biol, V2, P113, DOI 10.1007/s12154-009-0019-5; Worralll EG, 2010, J MOL BIOL, V398, P414, DOI 10.1016/j.jmb.2010.03.023; Yu GW, 2006, PROTEIN SCI, V15, P384, DOI 10.1110/ps.051927306; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zaccolo M, 1999, J MOL BIOL, V285, P775, DOI 10.1006/jmbi.1998.2262; Zhou M, 2000, LEUKEMIA, V14, P61, DOI 10.1038/sj.leu.2401619; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	63	27	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62564	10.1371/journal.pone.0062564	http://dx.doi.org/10.1371/journal.pone.0062564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23653682	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300076
J	Bozdag, S; Li, AG; Riddick, G; Kotliarov, Y; Baysan, M; Iwamoto, FM; Cam, MC; Kotliarova, S; Fine, HA				Bozdag, Serdar; Li, Aiguo; Riddick, Gregory; Kotliarov, Yuri; Baysan, Mehmet; Iwamoto, Fabio M.; Cam, Margaret C.; Kotliarova, Svetlana; Fine, Howard A.			Age-Specific Signatures of Glioblastoma at the Genomic, Genetic, and Epigenetic Levels	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; DNA METHYLATION; MOLECULAR SUBTYPES; RADIATION-THERAPY; GLIOMAS REVEALS; EXPRESSION; ANGIOGENESIS; MULTIFORME; SURVIVAL; TRIAL	Age is a powerful predictor of survival in glioblastoma multiforme (GBM) yet the biological basis for the difference in clinical outcome is mostly unknown. Discovering genes and pathways that would explain age-specific survival difference could generate opportunities for novel therapeutics for GBM. Here we have integrated gene expression, exon expression, microRNA expression, copy number alteration, SNP, whole exome sequence, and DNA methylation data sets of a cohort of GBM patients in The Cancer Genome Atlas (TCGA) project to discover age-specific signatures at the transcriptional, genetic, and epigenetic levels and validated our findings on the REMBRANDT data set. We found major age-specific signatures at all levels including age-specific hypermethylation in polycomb group protein target genes and the upregulation of angiogenesis-related genes in older GBMs. These age-specific differences in GBM, which are independent of molecular subtypes, may in part explain the preferential effects of anti-angiogenic agents in older GBM and pave the way to a better understanding of the unique biology and clinical behavior of older versus younger GBMs.	[Bozdag, Serdar; Li, Aiguo; Riddick, Gregory; Kotliarov, Yuri; Baysan, Mehmet; Iwamoto, Fabio M.; Cam, Margaret C.; Kotliarova, Svetlana; Fine, Howard A.] NINDS, Neurooncol Branch, NCI, NIH, Bethesda, MD 20892 USA; [Bozdag, Serdar] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Kotliarov, Yuri] NHLBI, Ctr Human Immunol Autoimmun & Inflammat, NIH, Bethesda, MD 20892 USA; [Iwamoto, Fabio M.] Columbia Univ, Coll Phys & Surg, Neurol Inst New York, New York, NY USA; [Fine, Howard A.] NYU, Inst Canc, Langone Med Ctr, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Neurological Disorders & Stroke (NINDS); Marquette University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Columbia University; New York University; NYU Langone Medical Center	Bozdag, S (corresponding author), NINDS, Neurooncol Branch, NCI, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	serdar.bozdag@marquette.edu	Kotliarov, Yuri/B-6938-2017; baysan, mehmet/O-1710-2018	baysan, mehmet/0000-0001-7359-2965; Kotliarov, Yuri/0000-0002-6558-8883	National Institutes of Health (NIH), National Cancer Institute	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Afra D, 2002, LANCET, V359, P1011; Ahuja N, 1998, CANCER RES, V58, P5489; Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Benjamini Y, 2001, ANN STAT, V29, P1165; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BioDiscovery I, 2009, LOCATING SIGNIFICANT; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Buckner JC, 2006, J CLIN ONCOL, V24, P3871, DOI 10.1200/JCO.2005.04.6979; Chi AS, 2009, ONCOLOGIST, V14, P621, DOI 10.1634/theoncologist.2008-0272; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dweep H, 2011, J BIOMEDICAL INFORM; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; Halperin EC, 1996, INT J RADIAT ONCOL, V34, P793, DOI 10.1016/0360-3016(95)02025-X; He LF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-39; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Katoh M, 2005, ONCOL REP, V14, P1583; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Kesari S, 2011, SEMIN ONCOL, V38, pS2, DOI 10.1053/j.seminoncol.2011.09.005; Kim JH, 2011, BLOOD, V118, P2622, DOI 10.1182/blood-2010-08-299784; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Laffaire J, 2011, NEURO-ONCOLOGY, V13, P84, DOI 10.1093/neuonc/noq110; Lee H-H, 2009, NOVEL AGENT INHIBITS; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li ZY, 2011, TUMOR BIOL, V32, P677, DOI 10.1007/s13277-011-0168-3; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Liu S, 2011, BIOCHIM BIOPHYS ACTA, V1801, P106; Lux Andreas, 2006, BMC Cardiovasc Disord, V6, P13, DOI 10.1186/1471-2261-6-13; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nghiemphu PL, 2009, NEUROLOGY, V72, P1217, DOI 10.1212/01.wnl.0000345668.03039.90; NicAmhlaoibh R, 2001, ONCOGENE, V20, P270, DOI 10.1038/sj.onc.1204075; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; Nutt CL, 2003, CANCER RES, V63, P1602; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Pez F, 2011, CANCER RES, V71, P1647, DOI 10.1158/0008-5472.CAN-10-1516; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; R Development Core Team R. F. F. S. C., 2008, R LANG ENV STAT COMP, V1; Rodriguez P, 2012, CARDIOVASC RES, V93, P232, DOI 10.1093/cvr/cvr296; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; SIMPSON JR, 1993, INT J RADIAT ONCOL, V26, P239, DOI 10.1016/0360-3016(93)90203-8; STEIN S, 1989, GERONTOLOGIST, V29, P224, DOI 10.1093/geront/29.2.224; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Tang M, 2011, P NATL ACAD SCI USA, V108, P15231, DOI 10.1073/pnas.1104662108; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wedding Ulrich, 2007, Cancer Control, V14, P44; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	64	42	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62982	10.1371/journal.pone.0062982	http://dx.doi.org/10.1371/journal.pone.0062982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658659	Green Published, gold			2022-12-27	WOS:000321662800071
J	Schwarzmaier, D; Foell, D; Weinhage, T; Varga, G; Dabritz, J				Schwarzmaier, David; Foell, Dirk; Weinhage, Toni; Varga, Georg; Daebritz, Jan			Peripheral Monocyte Functions and Activation in Patients with Quiescent Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BLOOD MONOCYTES; IMMUNODEFICIENCY; PATHOGENESIS; MACROPHAGES; EXPRESSION; IMMUNITY; RECEPTOR	Recent developments suggest a causal link between inflammation and impaired bacterial clearance in Crohn's disease (CD) due to alterations of intestinal macrophages. Studies suggest that excessive inflammation is the consequence of an underlying immunodeficiency rather than the primary cause of CD pathogenesis. We characterized phenotypic and functional features of peripheral blood monocytes of patients with quiescent CD (n = 18) and healthy controls (n = 19) by analyses of cell surface molecule expression, cell adherence, migration, chemotaxis, phagocytosis, oxidative burst, and cytokine expression and secretion with or without lipopolysaccharide (LPS) priming. Peripheral blood monocytes of patients with inactive CD showed normal expression of cell surface molecules (CD14, CD16, CD116), adherence to plastic surfaces, spontaneous migration, chemotaxis towards LTB4, phagocytosis of E. coli, and production of reactive oxygen species. Interestingly, peripheral blood monocytes of CD patients secreted higher levels of IL1 beta (p,. 05). Upon LPS priming we found a decreased release of IL10 (p<.05) and higher levels of CCL2 (p<.001) and CCL5 (p<.05). The expression and release of TNF alpha, IFN gamma, IL4, IL6, IL8, IL13, IL17, CXCL9, and CXCL10 were not altered compared to healthy controls. Based on our phenotypic and functional studies, peripheral blood monocytes from CD patients in clinical remission were not impaired compared to healthy controls. Our results highlight that defective innate immune mechanisms in CD seems to play a role in the (inflamed) intestinal mucosa rather than in peripheral blood.	[Schwarzmaier, David; Foell, Dirk; Weinhage, Toni; Varga, Georg; Daebritz, Jan] Univ Childrens Hosp Munster, Dept Pediat Rheumatol & Immunol, Munster, NRW, Germany; [Foell, Dirk; Daebritz, Jan] Univ Munster, Interdisciplinary Ctr Clin Res, D-48149 Munster, NRW, Germany; [Daebritz, Jan] Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Parkville, Vic, Australia	University of Munster; University of Munster; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Dabritz, J (corresponding author), Univ Childrens Hosp Munster, Dept Pediat Rheumatol & Immunol, Munster, NRW, Germany.	Jan.Daebritz@uni-muenster.de	Däbritz, Jan/GXG-1969-2022	Dabritz, Jan/0000-0003-4219-5283; Weinhage, Toni/0000-0003-4337-9260	Broad Medical Research Program (BMRP) [IBD0201]; German Research Foundation (DFG) [DA1161/4-1]; Innovative Medical Research Program of the University of Munster (IMF) [DA120904]	Broad Medical Research Program (BMRP); German Research Foundation (DFG)(German Research Foundation (DFG)); Innovative Medical Research Program of the University of Munster (IMF)	The study was supported by grants of the Broad Medical Research Program (BMRP Reference No. IBD0201, to DF and JD), the German Research Foundation (DFG Reference No. DA1161/4-1, to JD and DF), and the Innovative Medical Research Program of the University of Munster (IMF Reference No. DA120904, to JD and DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDASSANO RN, 1993, GASTROENTEROLOGY, V105, P60, DOI 10.1016/0016-5085(93)90010-A; BURGIO VL, 1995, GASTROENTEROLOGY, V109, P1029; Casanova JL, 2009, J EXP MED, V206, P1839, DOI 10.1084/jem.20091683; Dabritz J, 2011, AM J PHYSIOL-GASTR L, V300, pG823, DOI 10.1152/ajpgi.00115.2010; Folwaczny C, 2003, EUR J GASTROEN HEPAT, V15, P621, DOI 10.1097/00042737-200306000-00007; Goldstein JI, 2011, GASTROENTEROLOGY, V141, P208, DOI 10.1053/j.gastro.2011.03.060; GRIMM MC, 1995, CLIN EXP IMMUNOL, V100, P291, DOI 10.1111/j.1365-2249.1995.tb03667.x; Grip O, 2007, INFLAMM BOWEL DIS, V13, P566, DOI 10.1002/ibd.20025; Koch S, 2010, CLIN EXP IMMUNOL, V161, P332, DOI 10.1111/j.1365-2249.2010.04177.x; Korzenik JR, 2007, GUT, V56, P2, DOI 10.1136/gut.2006.095588; Liu ZX, 1997, SCAND J GASTROENTERO, V32, P1241, DOI 10.3109/00365529709028154; Marks DJB, 2011, CURR OPIN GASTROEN, V27, P328, DOI 10.1097/MOG.0b013e3283463b45; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; MEE A, 1980, J CLIN PATHOL, V33, P921, DOI 10.1136/jcp.33.10.921; MEE A, 1980, J CLIN PATHOL, V33, P917, DOI 10.1136/jcp.33.10.917; MIURA M, 1987, J CLIN LAB IMMUNOL, V24, P167; OKABE N, 1990, J CLIN LAB IMMUNOL, V32, P29; OKABE N, 1988, J CLIN LAB IMMUNOL, V25, P69; OKABE N, 1986, J CLIN LAB IMMUNOL, V21, P11; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P512, DOI 10.1053/gast.2002.31072; SEGAL AW, 1976, LANCET, V2, P219; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; WHORWELL PJ, 1981, DIGESTION, V22, P271, DOI 10.1159/000198668; Zhou L, 2009, CELL MOL LIFE SCI, V66, P192, DOI 10.1007/s00018-008-8308-7; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	25	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62761	10.1371/journal.pone.0062761	http://dx.doi.org/10.1371/journal.pone.0062761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658649	gold, Green Published			2022-12-27	WOS:000318343700072
J	Da Re, S; Jaione, V; Charbonnel, N; Beloin, C; Latour-Lambert, P; Faure, P; Turlin, E; Le Bouguenec, C; Renauld-Mongenie, G; Forestier, C; Ghigo, JM				Da Re, Sandra; Jaione, Valle; Charbonnel, Nicolas; Beloin, Christophe; Latour-Lambert, Patricia; Faure, Philippe; Turlin, Evelyne; Le Bouguenec, Chantal; Renauld-Mongenie, Genevieve; Forestier, Christiane; Ghigo, Jean-Marc			Identification of Commensal Escherichia coli Genes Involved in Biofilm Resistance to Pathogen Colonization	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; BACTERIAL BIOFILMS; LOW-TEMPERATURE; HOST; INTESTINE; EXPRESSION; REVEALS; DISEASE; FLORA; POLYSACCHARIDE	Protection provided by host bacterial microbiota against microbial pathogens is a well known but ill-understood property referred to as the barrier effect, or colonization resistance. Despite recent genome-wide analyses of host microbiota and increasing therapeutic interest, molecular analysis of colonization resistance is hampered by the complexity of direct in vivo experiments. Here we developed an in vitro-to-in vivo approach to identification of genes involved in resistance of commensal bacteria to exogenous pathogens. We analyzed genetic responses induced in commensal Escherichia coli upon entry of a diarrheagenic enteroaggregative E. coli or an unrelated Klebsiella pneumoniae pathogen into a biofilm community. We showed that pathogens trigger specific responses in commensal bacteria and we identified genes involved in limiting colonization of incoming pathogens within commensal biofilm. We tested the in vivo relevance of our findings by comparing the extent of intestinal colonization by enteroaggregative E. coli and K. pneumoniae pathogens in mice pre-colonized with E. coli wild type commensal strain, or mutants corresponding to identified colonization resistance genes. We demonstrated that the absence of yiaF and bssS (yceP) differentially alters pathogen colonization in the mouse gut. This study therefore identifies previously uncharacterized colonization resistance genes and provides new approaches to unravelling molecular aspects of commensal/pathogen competitive interactions.	[Da Re, Sandra; Jaione, Valle; Beloin, Christophe; Latour-Lambert, Patricia; Ghigo, Jean-Marc] Inst Pasteur, Dept Microbiol, Unite Genet Biofilms, Paris, France; [Charbonnel, Nicolas; Forestier, Christiane] Univ Auvergne Clermont 1, Bacteriol Lab, Clermont Ferrand, France; [Faure, Philippe] Univ Paris 06, Equipe Neurophysiol & Comportement NPC, UMR 7102, Paris, France; [Turlin, Evelyne] Inst Pasteur, Dept Microbiol, Unite Membranes Bacteriennes, Paris, France; [Le Bouguenec, Chantal] Inst Pasteur, Dept Microbiol, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France; [Renauld-Mongenie, Genevieve] Sanofi Pasteur, Dept Discovery, Marcy Letoile, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Sanofi-Aventis; Sanofi France	Ghigo, JM (corresponding author), Inst Pasteur, Dept Microbiol, Unite Genet Biofilms, Paris, France.	jmghigo@pasteur.fr	BELOIN, Christophe/F-9284-2012; Da Re, Sandra/F-6383-2011; jaione, valle/N-8005-2019; jaione, valle/G-6213-2011; GHIGO, Jean-Marc/AAP-4011-2021	BELOIN, Christophe/0000-0002-0344-3443; Da Re, Sandra/0000-0003-3579-9185; jaione, valle/0000-0003-3115-0207; jaione, valle/0000-0003-3115-0207; GHIGO, Jean-Marc/0000-0001-6528-118X; Faure, Philippe/0000-0003-3573-4971	Sanofi-Pasteur; Institut Pasteur; CNRS (Centre National de la Recherche Scientifique); URA (Unite de echerche Associee) [2172]; Network of Excellence EuroPathoGenomics [LSHB-CT-2005-512061]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	Sanofi-Pasteur; Institut Pasteur(European Commission); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); URA (Unite de echerche Associee); Network of Excellence EuroPathoGenomics; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	SDR was supported by Sanofi-Pasteur. JV was a Marie-Curie Fellow. This work was supported by grants from the Institut Pasteur, CNRS (Centre National de la Recherche Scientifique), URA (Unite de echerche Associee) 2172, the Network of Excellence EuroPathoGenomics; LSHB-CT-2005-512061, and the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DD, 2006, P NATL ACAD SCI USA, V103, P3828, DOI 10.1073/pnas.0511323103; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Balestrino D, 2008, ENVIRON MICROBIOL, V10, P685, DOI 10.1111/j.1462-2920.2007.01491.x; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Bernier C, 2002, INFECT IMMUN, V70, P4302, DOI 10.1128/IAI.70.8.4302-4311.2002; Blango MG, 2009, CURR OPIN MICROBIOL, V12, P177, DOI 10.1016/j.mib.2009.01.011; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Bourlioux P, 2003, AM J CLIN NUTR, V78, P675, DOI 10.1093/ajcn/78.4.675; Campbell A. M., 1996, ESCHERICHIA COLI SAL, P2041; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Conway T, 2004, ESCHERICHIA COLI SAL; Coudeyras S, 2008, INFECT IMMUN, V76, P4633, DOI 10.1128/IAI.00356-08; Da Re S, 2007, APPL ENVIRON MICROB, V73, P3391, DOI 10.1128/AEM.02625-06; Daw MA, 1996, MICRON, V27, P467, DOI 10.1016/S0968-4328(96)00028-5; Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006; Favre-Bonte S, 1999, INFECT IMMUN, V67, P554, DOI 10.1128/IAI.67.2.554-561.1999; Garcia-Contreras R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002394; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gibbs KA, 2008, SCIENCE, V321, P256, DOI 10.1126/science.1160033; Girard V, 2010, J BIOL CHEM, V285, P10616, DOI 10.1074/jbc.M109.069070; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lai EM, 2004, MOL MICROBIOL, V52, P1029, DOI 10.1111/j.1365-2958.2004.04040.x; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Marteau P, 2004, MINI-REV MED CHEM, V4, P889, DOI 10.2174/1389557043403369; Martinez-Jehanne V, 2009, INFECT IMMUN, V77, P1442, DOI 10.1128/IAI.01039-08; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Polissi A, 2003, RES MICROBIOL, V154, P573, DOI 10.1016/S0923-2508(03)00167-0; POULSEN LK, 1994, INFECT IMMUN, V62, P5191, DOI 10.1128/IAI.62.11.5191-5194.1994; Ramsey MM, 2009, P NATL ACAD SCI USA, V106, P1578, DOI 10.1073/pnas.0809533106; Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1; Rendueles O, 2012, FEMS MICROBIOL REV, V36, P972, DOI 10.1111/j.1574-6976.2012.00328.x; Rendueles O, 2011, MBIO, V2, DOI 10.1128/mBio.00043-11; ROLFE RD, 1984, REV INFECT DIS, V6, pS73; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Skurnik M, 2006, INT J MED MICROBIOL, V296, P5, DOI 10.1016/j.ijmm.2005.09.002; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; STOUT V, 1991, J BACTERIOL, V173, P1738, DOI 10.1128/jb.173.5.1738-1747.1991; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tait K, 2002, J APPL MICROBIOL, V93, P345, DOI 10.1046/j.1365-2672.2002.01692.x; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Valle J, 2008, J BACTERIOL, V190, P264, DOI 10.1128/JB.01405-07; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Vianney A, 2005, MICROBIOL-SGM, V151, P2487, DOI 10.1099/mic.0.27913-0; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; Walters M, 2006, INT J MED MICROBIOL, V296, P125, DOI 10.1016/j.ijmm.2006.01.041; White-Ziegler CA, 2008, MICROBIOL-SGM, V154, P148, DOI 10.1099/mic.0.2007/012021-0; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	64	21	21	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61628	10.1371/journal.pone.0061628	http://dx.doi.org/10.1371/journal.pone.0061628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667443	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700015
J	Xu, ZX; Wang, L; Chen, G; Rao, XP; Xu, FQ				Xu, Zhixiang; Wang, Li; Chen, Guo; Rao, Xiaoping; Xu, Fuqiang			Roles of GSK3 beta in Odor Habituation and Spontaneous Neural Activity of the Mouse Olfactory Bulb	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SCHIZOPHRENIC-PATIENTS; ALZHEIMERS-DISEASE; SYNAPTIC VESICLES; LOW GSK-3-BETA; SYSTEM; MEMORY; PHOSPHORYLATION; STIMULATION; DYSFUNCTION	Glycogen synthase kinase 3 beta (GSK3 beta), a multifaceted kinase, is abundantly expressed in the brain, including the olfactory bulb (OB). In resting cells, GSK3 beta is constitutively active, and its over-activation is presumably involved in numerous brain diseases, such as Alzheimer's disease. However, the functions of the constitutively active GSK3 beta in the adult brain under physiological conditions are not well understood. Here, we studied the possible functions of GSK3 beta activity in the OB. Odor stimulation, or blockade of peripheral olfactory inputs caused by either transgenic knock-out or ZnSO4 irrigation to the olfactory epithelium, all affected the expression level of GSK3 beta in the OB. When GSK3 beta activity was reduced by a selective inhibitor, the spontaneous oscillatory activity was significantly decreased in the granule cell layer of the OB. Furthermore, local inhibition of GSK3 beta activity in the OB significantly impaired the odor habituation ability. These results suggest that GSK3 beta plays important roles in both spontaneous neural activity and odor information processing in the OB, deepening our understanding of the potential functions of the constitutively active GSK3 beta in the brain under physiological conditions.	[Xu, Zhixiang; Wang, Li; Rao, Xiaoping; Xu, Fuqiang] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan, Peoples R China; [Xu, Zhixiang; Wang, Li; Rao, Xiaoping] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Guo] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Xu, Fuqiang] Wuhan Natl Lab Optoelect, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University; Huazhong University of Science & Technology	Xu, FQ (corresponding author), Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan, Peoples R China.	fuqiang.xu@wipm.ac.cn	xu, fuqiang/AAI-1571-2019	Xu, Zhixiang/0000-0002-0962-7702; xu, fu qiang/0000-0002-4382-9797	National Natural Science Foundation of China [91132307/H09, 31171061/C090208, 20921004]; Chinese Academy of Science [XDB02050500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences)	The work is supported by National Natural Science Foundation of China (91132307/H09, 31171061/C090208 and 20921004) to FX, Chinese Academy of Science (XDB02050500) to FX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Calof AL, 1998, J NEUROBIOL, V36, P190, DOI 10.1002/(SICI)1097-4695(199808)36:2<190::AID-NEU7>3.0.CO;2-X; Chiang A, 2009, DEVELOPMENT, V136, P1273, DOI 10.1242/dev.031377; Christoffersen GRJ, 1997, PROG NEUROBIOL, V53, P45, DOI 10.1016/S0301-0082(97)00031-2; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Devore S, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00059; Devore S, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00052; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Guerin D, 2008, BEHAV NEUROSCI, V122, P816, DOI 10.1037/a0012522; GUTHRIE KM, 1990, J NEUROSCI, V10, P3402; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; ISSEROFF RG, 1987, BIOL PSYCHIAT, V22, P922, DOI 10.1016/0006-3223(87)90093-X; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kozlovsky N, 2005, EUR NEUROPSYCHOPHARM, V15, P1, DOI 10.1016/j.euroneuro.2004.02.003; Kozlovsky N, 2000, AM J PSYCHIAT, V157, P831, DOI 10.1176/appi.ajp.157.5.831; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; McBride K, 2003, CHEM SENSES, V28, P659, DOI 10.1093/chemse/bjg053; McNamara AM, 2008, LEARN MEMORY, V15, P117, DOI 10.1101/lm.785608; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Murphy C, 1999, PHYSIOL BEHAV, V66, P177, DOI 10.1016/S0031-9384(98)00262-5; Parrish-Aungst S, 2011, BRAIN RES, V1382, P70, DOI 10.1016/j.brainres.2011.01.068; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; RAVEL N, 1994, BEHAV NEUROSCI, V108, P317, DOI 10.1037/0735-7044.108.2.317; Restrepo D, 2004, HORM BEHAV, V46, P247, DOI 10.1016/j.yhbeh.2004.02.009; Salcedo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025441; Shipley MT, 1996, J NEUROBIOL, V30, P123; Turetsky BI, 2000, AM J PSYCHIAT, V157, P828, DOI 10.1176/appi.ajp.157.5.828; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Williams SK, 2004, J COMP NEUROL, V470, P50, DOI 10.1002/cne.11045; Wilson DA, 2008, J NEUROPHYSIOL, V100, P2, DOI 10.1152/jn.90479.2008; Wolf FW, 2007, P NATL ACAD SCI USA, V104, P4653, DOI 10.1073/pnas.0700493104; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xu Z, 2013, NEUROSCI LETT, V20, P00139; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007	45	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63598	10.1371/journal.pone.0063598	http://dx.doi.org/10.1371/journal.pone.0063598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658842	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100073
J	Abahussin, M; Hayes, S; Edelhauser, H; Dawson, DG; Meek, KM				Abahussin, Mohammad; Hayes, Sally; Edelhauser, Henry; Dawson, Daniel G.; Meek, Keith M.			A Microscopy Study of the Structural Features of Post-LASIK Human Corneas	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; PHOTOREFRACTIVE KERATECTOMY; DISLOCATION	Purpose: To study the structural features of human post-LASIK corneas. Methods: A pair of post-mortem donor corneas, from a 55-year old patient who underwent uncomplicated LASIK surgery five years previously, were bisected and fixed in 4% paraformaldehyde. The right cornea and one half of the left cornea were processed for light microscopy and scanning electron microscopy. One half of the right cornea was also examined by transmission electron microscopy. Results: The flap-bed interface could be easily detected several years after LASIK and, although the flap appeared to be in close association with the stromal bed, there was a noticeable absence of reconnection between adjacent severed lamellae. Tissue gaps were evident at the flap margin, which once free of cellular components revealed the presence of a few bridging fibres. Conclusion: Examination of corneas five years after LASIK revealed evidence of primitive reparative scar development at the wound interface, but no reconnection of severed collagen lamellae. Such findings may explain the occurrence of flap dislocation following trauma in some patients months or years after surgery.	[Abahussin, Mohammad; Hayes, Sally; Meek, Keith M.] Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF10 3AX, S Glam, Wales; [Abahussin, Mohammad] King Saud Univ, Coll Appl Med Sci, Dept Optometry, Riyadh, Saudi Arabia; [Edelhauser, Henry; Dawson, Daniel G.] Emory Univ, Emory Eye Ctr, Atlanta, GA 30322 USA; [Dawson, Daniel G.] Univ Florida, Dept Ophthalmol, Gainesville, FL USA	Cardiff University; King Saud University; Emory University; State University System of Florida; University of Florida	Meek, KM (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF10 3AX, S Glam, Wales.	meekkm@cf.ac.uk		Hayes, Sally/0000-0001-8550-0108	United Kingdom Medical Research Council [G0600755]; King Saud University, Riyadh, Saudi Arabia; Royal Society-Wolfson Research Merit Award; MRC [MR/K000837/1, G0600755] Funding Source: UKRI; Medical Research Council [G0600755, MR/K000837/1] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); King Saud University, Riyadh, Saudi Arabia(King Saud University); Royal Society-Wolfson Research Merit Award(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a 5-year United Kingdom Medical Research Council Grant (G0600755 awarded to KMM). MA was the recipient of a scholarship from King Saud University, Riyadh, Saudi Arabia. KMM is a Royal Society-Wolfson Research Merit Award Holder. These funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amm M, 1996, J REFRACT SURG, V12, P758; Behrens A, 2000, AM J OPHTHALMOL, V129, P59, DOI 10.1016/S0002-9394(99)00269-X; Chan Colin C. K., 2006, International Ophthalmology Clinics, V46, P13, DOI 10.1097/00004397-200604630-00004; Dawson DG, 2005, ARCH OPHTHALMOL-CHIC, V123, P741, DOI 10.1001/archopht.123.6.741; Feltham MH, 2008, EYE, V22, P1117, DOI 10.1038/sj.eye.6702856; Hamill MB, 2002, J CATARACT REFR SURG, V28, P328, DOI 10.1016/S0886-3350(01)01248-2; Hayes S, 2007, ANAT REC, V290, P1542, DOI 10.1002/ar.20613; HOELTZEL DA, 1992, J BIOMECH ENG-T ASME, V114, P202, DOI 10.1115/1.2891373; Holt DG, 2012, J CATARACT REFR SURG, V38, P357, DOI 10.1016/j.jcrs.2011.10.024; Huang D, 1999, J REFRACT SURG, V15, P538; Kamma-Lorger CS, 2009, EXP EYE RES, V88, P953, DOI 10.1016/j.exer.2008.12.005; Kim HJ, 2010, J REFRACT SURG, V26, P447, DOI 10.3928/1081597X-20090710-03; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Park CK, 1999, J CATARACT REFR SURG, V25, P842, DOI 10.1016/S0886-3350(99)00047-4; Reinstein DZ, 2012, J REFRACT SURG, V28, P291, DOI 10.3928/1081597X-20120229-01; Roberts C, 2000, J REFRACT SURG, V16, P407; Schmack I, 2005, J REFRACT SURG, V21, P433	17	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63268	10.1371/journal.pone.0063268	http://dx.doi.org/10.1371/journal.pone.0063268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650559	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000319167000104
J	Draper, E; Bissett, SL; Howell-Jones, R; Waight, P; Soldan, K; Jit, M; Andrews, N; Miller, E; Beddows, S				Draper, Eve; Bissett, Sara L.; Howell-Jones, Rebecca; Waight, Pauline; Soldan, Kate; Jit, Mark; Andrews, Nicholas; Miller, Elizabeth; Beddows, Simon			A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix (R) and Gardasil (R) Human Papillomavirus Vaccines in 12-15 Year Old Girls	PLOS ONE			English	Article							HPV-16/18 AS04-ADJUVANTED VACCINE; CERVICAL-CANCER; PARTICLE VACCINE; HPV-6/11/16/18 VACCINE; (HPV)-16/18 VACCINE; SUSTAINED EFFICACY; FOLLOW-UP; HPV TYPES; WOMEN; SAFETY	Background: The current generation of Human Papillomavirus (HPV) vaccines, Cervarix (R) and Gardasil (R), exhibit a high degree of efficacy in clinical trials against the two high-risk (HR) genotypes represented in the vaccines (HPV16 and HPV18). High levels of neutralizing antibodies are elicited against the vaccine types, consistent with preclinical data showing that neutralizing antibodies can mediate type-specific protection in the absence of other immune effectors. The vaccines also confer protection against some closely related non-vaccine HR HPV types, although the vaccines appear to differ in their degree of cross-protection. The mechanism of vaccine-induced cross-protection is unknown. This study sought to compare the breadth and magnitudes of neutralizing antibodies against non-vaccine types elicited by both vaccines and establish whether such antibodies could be detected in the genital secretions of vaccinated individuals. Methods and Findings: Serum and genital samples were collected from 12-15 year old girls following vaccination with either Cervarix (R) (n = 96) or Gardasil (R) (n = 102) HPV vaccine. Serum-neutralizing antibody responses against non-vaccine HPV types were broader and of higher magnitude in the Cervarix (R), compared to the Gardasil (R), vaccinated individuals. Levels of neutralizing and binding antibodies in genital secretions were closely associated with those found in the serum (r = 0.869), with Cervarix (R) having a median 2.5 (inter-quartile range, 1.7-3.5) fold higher geometric mean HPV-specific IgG ratio in serum and genital samples than Gardasil (R) (p = 0.0047). There was a strong positive association between cross-neutralizing antibody seropositivity and available HPV vaccine trial efficacy data against non-vaccine types. Conclusions: These data demonstrate for the first time that cross-neutralizing antibodies can be detected at the genital site of infection and support the possibility that cross-neutralizing antibodies play a role in the cross-protection against HPV infection and disease that has been reported for the current HPV vaccines.	[Draper, Eve; Bissett, Sara L.; Beddows, Simon] Hlth Protect Agcy, Virus Reference Dept, London, England; [Howell-Jones, Rebecca; Soldan, Kate] Hlth Protect Agcy, HIV STI Dept, London, England; [Jit, Mark; Andrews, Nicholas] Hlth Protect Agcy, Stat Modelling & Econ Dept, London, England; [Waight, Pauline; Miller, Elizabeth] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England	Health Protection Agency; Health Protection Agency; Health Protection Agency; Health Protection Agency	Beddows, S (corresponding author), Hlth Protect Agcy, Virus Reference Dept, London, England.	simon.beddows@hpa.org.uk	Jit, Mark/HDM-7797-2022	Soldan, Kate/0000-0002-0361-3174; Beddows, Simon/0000-0002-6879-6215; Jit, Mark/0000-0001-6658-8255	United Kingdom Medical Research Council [G0701217]; Department of Health Research and Development Directorat [039/0031]; Policy Research Programme in the Department of Health, UK; MRC [G0701217] Funding Source: UKRI; Medical Research Council [G0701217] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health Research and Development Directorat; Policy Research Programme in the Department of Health, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the United Kingdom Medical Research Council (grant number G0701217). Fieldwork for the trial was supported by a grant from the Department of Health Research and Development Directorate (039/0031). This work was in part funded by the Policy Research Programme in the Department of Health, UK. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bissett SL, 2012, CLIN VACCINE IMMUNOL, V19, P449, DOI 10.1128/CVI.05641-11; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; BREITBURD F, 1995, J VIROL, V69, P3959, DOI 10.1128/JVI.69.6.3959-3963.1995; Brown DR, 2011, HUM VACCINES, V7, P230, DOI 10.4161/hv.7.2.13948; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Cohen J, 2005, SCIENCE, V308, P618, DOI 10.1126/science.308.5722.618; Day PM, 2010, CELL HOST MICROBE, V8, P260, DOI 10.1016/j.chom.2010.08.003; De Carvalho N, 2010, VACCINE, V28, P6247, DOI 10.1016/j.vaccine.2010.07.007; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Desai S, 2011, SEX TRANSM DIS, V38, P622, DOI 10.1097/OLQ.0b013e31820bc880; Draper E, 2011, VACCINE, V29, P8585, DOI 10.1016/j.vaccine.2011.09.021; Efron B, 1994, INTRO BOOTSTRAP; Einstein MH, 2011, HUM VACCINES, V7, P1359, DOI 10.4161/hv.7.12.18282; Einstein MH, 2011, HUM VACCINES, V7, P1343, DOI 10.4161/hv.7.12.18281; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; GUAN P, 2012, INT J CANC; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Howell-Jones R, 2010, BRIT J CANCER, V103, P209, DOI 10.1038/sj.bjc.6605747; Howell-Jones R, 2012, VACCINE, V30, P3867, DOI 10.1016/j.vaccine.2012.04.006; Huo ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033736; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jit M, 2007, BRIT J CANCER, V97, P989, DOI 10.1038/sj.bjc.6603955; Keam SJ, 2008, DRUGS, V68, P359, DOI 10.2165/00003495-200868030-00007; Kemp TJ, 2008, VACCINE, V26, P3608, DOI 10.1016/j.vaccine.2008.04.074; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Krajden M, 2011, CLIN VACCINE IMMUNOL, V18, P418, DOI 10.1128/CVI.00489-10; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Petaja T, 2009, J ADOLESCENT HEALTH, V44, P33, DOI 10.1016/j.jadohealth.2008.10.002; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; ROBERTS JN, 2007, NAT MED; Romanowski B, 2011, HUM VACCINES, V7, P1374, DOI 10.4161/hv.7.12.18322; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; Schiller JT, 2012, NAT REV MICROBIOL, V10, P681, DOI 10.1038/nrmicro2872; Schiller JT, 2009, J INFECT DIS, V200, P166, DOI 10.1086/599988; Schwarz TF, 2010, HUM VACCINES, V6, P1054, DOI 10.4161/hv.6.12.13399; Siddiqui MAA, 2006, DRUGS, V66, P1263, DOI 10.2165/00003495-200666090-00008; Smith JF, 2007, HUM VACCINES, V3, P109, DOI 10.4161/hv.3.4.4058; Stanley M, 2010, GYNECOL ONCOL, V117, pS5, DOI [10.1016/j.ygyno.2010.01.024, 10.1016/j.ygyno.2010.04.002]; SUZICH JA, 1995, P NATL ACAD SCI USA, V92, P11553, DOI 10.1073/pnas.92.25.11553; Villa LL, 2006, VACCINE, V24, P5571, DOI 10.1016/j.vaccine.2006.04.068; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	48	91	94	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61825	10.1371/journal.pone.0061825	http://dx.doi.org/10.1371/journal.pone.0061825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650505	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000319167000022
J	Guest, JL; Weintrob, AC; Rimland, D; Rentsch, C; Bradley, WP; Agan, BK; Marconi, VC				Guest, Jodie L.; Weintrob, Amy C.; Rimland, David; Rentsch, Christopher; Bradley, William P.; Agan, Brian K.; Marconi, Vincent C.		IDCRPHIV Working Grp	A Comparison of HAART Outcomes between the US Military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS)	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; HEALTH CENTERS; CARE; ACCESS; MORTALITY; AMERICA	Introduction: The Department of Defense (DoD) and the Department of Veterans Affairs (VA) provide comprehensive HIV treatment and care to their beneficiaries with open access and few costs to the patient. Individuals who receive HIV care in the VA have higher rates of substance abuse, homelessness and unemployment than individuals who receive HIV care in the DoD. A comparison between individuals receiving HIV treatment and care from the DoD and the VA provides an opportunity to explore the impact of individual-level characteristics on clinical outcomes within two healthcare systems that are optimized for clinic retention and medication adherence. Methods: Data were collected on 1065 patients from the HIV Atlanta VA Cohort Study (HAVACS) and 1199 patients from the US Military HIV Natural History Study (NHS). Patients were eligible if they had an HIV diagnosis and began HAART between January 1, 1996 and June 30, 2010. The analysis examined the survival from HAART initiation to all-cause mortality or an AIDS event. Results: Although there was substantial between-cohort heterogeneity and the 12-year survival of participants in NHS was significantly higher than in HAVACS in crude analyses, this survival disparity was reduced from 21.5% to 1.6% (mortality only) and 26.8% to 4.1% (combined mortality or AIDS) when controlling for clinical and demographic variables. Conclusion: We assessed the clinical outcomes for individuals with HIV from two very similar government-sponsored healthcare systems that reduced or eliminated many barriers associated with accessing treatment and care. After controlling for clinical and demographic variables, both 12-year survival and AIDS-free survival rates were similar for the two study cohorts who have open access to care and medication despite dramatic differences in socioeconomic and behavioral characteristics.	[Guest, Jodie L.; Rimland, David; Rentsch, Christopher; Marconi, Vincent C.] Atlanta VA Med Ctr, Atlanta, GA USA; [Guest, Jodie L.; Rimland, David; Marconi, Vincent C.] Emory Univ, Sch Med, Atlanta, GA USA; [Guest, Jodie L.; Marconi, Vincent C.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Weintrob, Amy C.; Bradley, William P.; Agan, Brian K.; IDCRPHIV Working Grp] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Weintrob, Amy C.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Emory University; Rollins School Public Health; Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center	Guest, JL (corresponding author), Atlanta VA Med Ctr, Atlanta, GA USA.	Jodie.Guest@va.gov; vcmarco@emory.edu	Marconi, Vincent/N-3210-2014; Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/GRJ-4553-2022	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Agan, Brian/0000-0002-5114-1669; Rentsch, Christopher/0000-0002-1408-7907; Guest, Jodie/0000-0002-3650-3975; Polis, Michael/0000-0002-9151-2268	Infectious Disease Clinical Research Program (IDCRP) [IDCRP-000-24]; Department of Defense program executed through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases; National Institutes of Health (NIH) [Y1-AI-5072]; Emory University's Center for AIDS Research [CFAR P30-AI50409]; IDCRP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, N01AI005072] Funding Source: NIH RePORTER	Infectious Disease Clinical Research Program (IDCRP); Department of Defense program executed through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University's Center for AIDS Research; IDCRP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work (IDCRP-000-24) was provided by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072. The content of this publication is the sole responsibility of the authors and does not necessarily reflect the views or policies of the NIH, Department of Health and Human Services, Department of Defense, Department of Veterans Affairs, or the departments of the Army, Navy, or Air Force. Mention of trade names, or commercial products, or organizations does not imply endorsement by the U.S. Government. This collaboration is funded by a grant from Emory University's Center for AIDS Research (CFAR P30-AI50409) and by the IDCRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson KB, 2004, CLIN INFECT DIS, V39, P1507, DOI 10.1086/425360; [Anonymous], 2012, GUID; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Gallant JE, 2011, CLIN INFECT DIS, V53, P1043, DOI 10.1093/cid/cir689; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Goldie SJ, 2003, AM J MED, V115, P632, DOI 10.1016/j.amjmed.2003.07.007; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Gusmano MK, 2002, HEALTH AFFAIR, V21, P188, DOI 10.1377/hlthaff.21.6.188; Hoerster KD, 2012, AM J PREV MED, V43, P483, DOI 10.1016/j.amepre.2012.07.029; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; McMahon J, 2011, AIDS BEHAV, V15, P1503, DOI 10.1007/s10461-010-9759-z; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Politzer RM, 2001, MED CARE RES REV, V58, P234, DOI 10.1177/107755870105800205; Resch S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025310; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Stosor V, 2005, CLIN INFECT DIS, V41, P1671, DOI 10.1086/498025; Sweeney S, 2012, SEX TRANSM INFECT, V88, P85, DOI 10.1136/sextrans-2011-050199; Tate J, 2012, COMMUNICATION; Weintrob AC, 2009, JAIDS-J ACQ IMM DEF, V52, P574, DOI 10.1097/QAI.0b013e3181b98537	22	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62273	10.1371/journal.pone.0062273	http://dx.doi.org/10.1371/journal.pone.0062273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23658717	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000319167000036
J	Kadouri, DE; To, K; Shanks, RMQ; Doi, Y				Kadouri, Daniel E.; To, Kevin; Shanks, Robert M. Q.; Doi, Yohei			Predatory Bacteria: A Potential Ally against Multidrug-Resistant Gram-Negative Pathogens	PLOS ONE			English	Article							BDELLOVIBRIO-BACTERIOVORUS; MICAVIBRIO-AERUGINOSAVORUS; BETA-LACTAMASE; SUSCEPTIBILITY; INFECTIONS; DIVERSITY; BIOFILMS; CLADE; GEN.	Multidrug-resistant (MDR) Gram-negative bacteria have emerged as a serious threat to human and animal health. Bdellovibrio spp. and Micavibrio spp. are Gram-negative bacteria that prey on other Gram-negative bacteria. In this study, the ability of Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus to prey on MDR Gram-negative clinical strains was examined. Although the potential use of predatory bacteria to attack MDR pathogens has been suggested, the data supporting these claims is lacking. By conducting predation experiments we have established that predatory bacteria have the capacity to attack clinical strains of a variety of beta-lactamase-producing, MDR Gram-negative bacteria. Our observations indicate that predatory bacteria maintained their ability to prey on MDR bacteria regardless of their antimicrobial resistance, hence, might be used as therapeutic agents where other antimicrobial drugs fail.	[Kadouri, Daniel E.; To, Kevin] Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA; [Shanks, Robert M. Q.] Univ Pittsburgh, Dept Ophthalmol, Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA; [Doi, Yohei] Univ Pittsburgh, Div Infect Dis, Sch Med, Pittsburgh, PA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kadouri, DE (corresponding author), Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA.	kadourde@umdnj.edu	Shanks, Robert M. Q./AFO-0831-2022	Shanks, Robert M. Q./0000-0002-7699-5396; Doi, Yohei/0000-0002-9620-2525	Department of the ARMY USAMRAA [W81XWH-12-2-0067]; UMDNJ departmental start-up fund; National Institutes of Health [K22AI080584]; NIH [AI085570, EY08098]; Research to Prevent Blindness Career Development award; NATIONAL EYE INSTITUTE [P30EY008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085570, K22AI080584] Funding Source: NIH RePORTER	Department of the ARMY USAMRAA; UMDNJ departmental start-up fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Career Development award(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the Department of the ARMY USAMRAA #W81XWH-12-2-0067 and by UMDNJ departmental start-up fund to DEK. YD was supported in part through a career development award, the National Institutes of Health (K22AI080584). RMQS was supported by NIH grants AI085570, EY08098, and a Research to Prevent Blindness Career Development award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUS S; Dashiff A, 2011, J APPL MICROBIOL, V110, P431, DOI 10.1111/j.1365-2672.2010.04900.x; Davidov Y, 2004, INT J SYST EVOL MICR, V54, P1439, DOI 10.1099/ijs.0.02978-0; Davidov Y, 2006, ENVIRON MICROBIOL, V8, P2179, DOI 10.1111/j.1462-2920.2006.01101.x; Doi Y, 2009, ANTIMICROB AGENTS CH, V53, P3159, DOI 10.1128/AAC.00133-09; Dwidar M, 2012, BMB REP, V45, P71, DOI 10.5483/BMBRep.2012.45.2.71; Jurkevitch E, 2000, APPL ENVIRON MICROB, V66, P2365, DOI 10.1128/AEM.66.6.2365-2371.2000; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kadouri D, 2007, APPL ENVIRON MICROB, V73, P605, DOI 10.1128/AEM.01893-06; Kallen AJ, 2010, INFECT CONT HOSP EP, V31, pS51, DOI 10.1086/655996; Kim YA, 2012, CLIN INFECT DIS, V55, P224, DOI 10.1093/cid/cis387; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; LAMBINA V A, 1982, Mikrobiologiya, V51, P114; LAMBINA V A, 1983, Mikrobiologiya, V52, P777; Markelova NY, 2010, INT J HYG ENVIR HEAL, V213, P428, DOI 10.1016/j.ijheh.2010.08.004; Martin MO, 2002, J MOL MICROB BIOTECH, V4, P467; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Rogosky AM, 2006, CURR MICROBIOL, V52, P81, DOI 10.1007/s00284-005-0038-6; Sockett RE, 2004, NAT REV MICROBIOL, V2, P669, DOI 10.1038/nrmicro959; Sockett RE, 2009, ANNU REV MICROBIOL, V63, P523, DOI 10.1146/annurev.micro.091208.073346; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; Tian GB, 2011, ANTIMICROB AGENTS CH, V55, P2710, DOI 10.1128/AAC.01660-10; Wang Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-453	23	101	101	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63397	10.1371/journal.pone.0063397	http://dx.doi.org/10.1371/journal.pone.0063397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650563	gold, Green Accepted, Green Published			2022-12-27	WOS:000319167000108
J	Olsen, JR; Oyan, AM; Rostad, K; Hellem, MR; Liu, J; Li, LS; Micklem, DR; Haugen, H; Lorens, JB; Rotter, V; Ke, XS; Lin, BY; Kalland, KH				Olsen, Jan Roger; Oyan, Anne Margrete; Rostad, Kari; Hellem, Margrete R.; Liu, Jie; Li, Lisha; Micklem, David R.; Haugen, Hallvard; Lorens, James B.; Rotter, Varda; Ke, Xi-Song; Lin, Biaoyang; Kalland, Karl-Henning			p63 Attenuates Epithelial to Mesenchymal Potential in an Experimental Prostate Cell Model	PLOS ONE			English	Article							LARGE GENE LISTS; CHIP-SEQ DATA; BINDING-SITES; IN-VITRO; EXPRESSION; CANCER; TRANSITION; GENOME; IDENTIFICATION; HISTONE	The transcription factor p63 is central for epithelial homeostasis and development. In our model of epithelial to mesenchymal transition (EMT) in human prostate cells, p63 was one of the most down-regulated transcription factors during EMT. We therefore investigated the role of p63 in EMT. Over-expression of the predominant epithelial isoform Delta Np63 alpha in mesenchymal type cells of the model led to gain of several epithelial characteristics without resulting in a complete mesenchymal to epithelial transition (MET). This was corroborated by a reciprocal effect when p63 was knocked down in epithelial EP156T cells. Global gene expression analyses showed that Delta Np63 alpha induced gene modules involved in both cell-to-cell and cell-to-extracellular-matrix junctions in mesenchymal type cells. Genome-wide analysis of p63 binding sites using ChIP-seq analyses confirmed binding of p63 to regulatory areas of genes associated with cell adhesion in prostate epithelial cells. DH1 and ZEB1 are two elemental factors in the control of EMT. Over-expression and knock-down of these factors, respectively, were not sufficient alone or in combination with Delta Np63 alpha to reverse completely the mesenchymal phenotype. The partial reversion of epithelial to mesenchymal transition might reflect the ability of Delta Np63 alpha, as a key co-ordinator of several epithelial gene expression modules, to reduce epithelial to mesenchymal plasticity (EMP). The utility of Delta Np63 alpha expression and the potential of reduced EMP in order to counteract metastasis warrant further investigation.	[Olsen, Jan Roger; Oyan, Anne Margrete; Rostad, Kari; Hellem, Margrete R.; Ke, Xi-Song; Kalland, Karl-Henning] Univ Bergen, Gade Inst, Bergen, Norway; [Oyan, Anne Margrete; Ke, Xi-Song; Kalland, Karl-Henning] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Liu, Jie; Li, Lisha; Lin, Biaoyang] Zhejiang Univ, Zhejing Calif Int NanoSyst Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Micklem, David R.; Haugen, Hallvard; Lorens, James B.] BerGenBio AS, Bergen, Norway; [Haugen, Hallvard; Lorens, James B.] Univ Bergen, Dept Biomed, Bergen, Norway; [Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Lin, Biaoyang] Swedish Med Ctr, Seattle, WA USA; [Lin, Biaoyang] Univ Washington, Dept Urol, Seattle, WA 98195 USA	University of Bergen; University of Bergen; Haukeland University Hospital; Zhejiang University; University of Bergen; Weizmann Institute of Science; Swedish Medical Center; University of Washington; University of Washington Seattle	Kalland, KH (corresponding author), Univ Bergen, Gade Inst, Bergen, Norway.	Kalland@gades.uib.no	Lorens, James/B-9737-2017; Kalland, Karl-Henning/B-9445-2017; Lin, Biaoyang/AAA-1258-2020	Lorens, James/0000-0002-6782-3349; Kalland, Karl-Henning/0000-0003-4486-2334; Lin, Biaoyang/0000-0002-2189-0407; Micklem, David/0000-0003-2756-2591	Helse Vest [911626, 911555, 911747]; Bergen Medical Research Foundation and Einar Galtung DAsvig; Trond Mohn and Jan Einar Greve; Norwegian Cancer Society; Chinese NSFC [81230090]	Helse Vest; Bergen Medical Research Foundation and Einar Galtung DAsvig; Trond Mohn and Jan Einar Greve; Norwegian Cancer Society(Norwegian Cancer Society); Chinese NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Helse Vest (911626, 911555, 911747), the Bergen Medical Research Foundation and Einar Galtung DAsvig, Trond Mohn and Jan Einar Greve and the Norwegian Cancer Society and Chinese NSFC (81230090) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Coppola V., 2012, ONCOGENE; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gandellini P, 2012, CELL DEATH DIFFER; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Grisanzio C, 2008, J CELL BIOCHEM, V103, P1354, DOI 10.1002/jcb.21555; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hill L., 2012, INT J CANC; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Ke XS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-669; Ke XS, 2011, EXP CELL RES, V317, P234, DOI 10.1016/j.yexcr.2010.10.009; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li QW, 2008, NEOPLASIA, V10, P1444, DOI 10.1593/neo.08968; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; Parsons JK, 2009, PROSTATE, V69, P559, DOI 10.1002/pros.20904; Petersen K, 2007, ANAL BIOCHEM, V366, P46, DOI 10.1016/j.ab.2007.03.013; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thepot A, 2010, INT J CANCER, V127, P2051, DOI 10.1002/ijc.25221; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	40	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62547	10.1371/journal.pone.0062547	http://dx.doi.org/10.1371/journal.pone.0062547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658742	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000056
J	Zhang, YJ; Lin, HF; Yang, ZH; Wang, J				Zhang, Yijia; Lin, Hongfei; Yang, Zhihao; Wang, Jian			Construction of Ontology Augmented Networks for Protein Complex Prediction	PLOS ONE			English	Article							ATTACHMENT BASED METHOD; FUNCTIONAL MODULES; ALGORITHM; CLIQUES	Protein complexes are of great importance in understanding the principles of cellular organization and function. The increase in available protein-protein interaction data, gene ontology and other resources make it possible to develop computational methods for protein complex prediction. Most existing methods focus mainly on the topological structure of protein-protein interaction networks, and largely ignore the gene ontology annotation information. In this article, we constructed ontology augmented networks with protein-protein interaction data and gene ontology, which effectively unified the topological structure of protein-protein interaction networks and the similarity of gene ontology annotations into unified distance measures. After constructing ontology augmented networks, a novel method (clustering based on ontology augmented networks) was proposed to predict protein complexes, which was capable of taking into account the topological structure of the protein-protein interaction network, as well as the similarity of gene ontology annotations. Our method was applied to two different yeast protein-protein interaction datasets and predicted many well-known complexes. The experimental results showed that (i) ontology augmented networks and the unified distance measure can effectively combine the structure closeness and gene ontology annotation similarity; (ii) our method is valuable in predicting protein complexes and has higher F1 and accuracy compared to other competing methods.	[Zhang, Yijia; Lin, Hongfei; Yang, Zhihao; Wang, Jian] Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Liaoning, Peoples R China	Dalian University of Technology	Zhang, YJ (corresponding author), Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Liaoning, Peoples R China.	zhyj@dlut.edu.cn			Natural Science Foundation of China [61272373, 61070098]; Doctoral Program Foundation of Institutions of Higher Education of China [20090041110002]; Fundamental Research Funds for the Central Universities [DUT10JS09]; Liaoning Province Doctor Startup Fund [20091015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Liaoning Province Doctor Startup Fund	This work is supported by grant from the Natural Science Foundation of China (No. 61272373 and 61070098), Doctoral Program Foundation of Institutions of Higher Education of China (20090041110002), the Fundamental Research Funds for the Central Universities (No. DUT10JS09) and Liaoning Province Doctor Startup Fund (No. 20091015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Chin CH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S25; Chua Hon Nian, 2008, Journal of Bioinformatics and Computational Biology, V6, P435, DOI 10.1142/S0219720008003497; Dongen SV, 2000, THESIS U UTRECHT; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Jung SH, 2010, BIOINFORMATICS, V26, P385, DOI 10.1093/bioinformatics/btp668; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-398; Li Xiao-Li, 2005, Genome Inform, V16, P260; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tomita E, 2006, THEOR COMPUT SCI, V363, P28, DOI 10.1016/j.tcs.2006.06.015; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang J, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-S1-S18; Wu M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-169; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Zhou Y., 2009, PVLDB, V2, P718, DOI DOI 10.14778/1687627.1687709	24	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62077	10.1371/journal.pone.0062077	http://dx.doi.org/10.1371/journal.pone.0062077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650509	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000028
J	Stojadinovic, O; Sawaya, A; Pastar, I; Tomic-Canic, M				Stojadinovic, Olivera; Sawaya, Andrew; Pastar, Irena; Tomic-Canic, Marjana			Glucocorticoid Receptor Localizes to Adherens Junctions at the Plasma Membrane of Keratinocytes	PLOS ONE			English	Article							EPIDERMAL-KERATINOCYTES; CELLS; INHIBITION; ALPHA; SKIN; EPITHELIALIZATION; MECHANISM	Glucocorticoids are important regulators of epidermal tissue homeostasis. As such, their clinical applications are widespread, ranging from inflammatory skin disorders to keloids and cancer. Glucocorticoids exert their effect by binding to glucocorticoid receptor (GR) which translocates to the nucleus and regulates gene expression (genomic effect). In addition, GR has rapid non-genomic effects that are mediated by cell signaling proteins and do not involve gene transcription. Although genomic effects of GR in the epidermis are well documented, the non- genomic effects are not completely understood. Therefore, we utilized immunostaining and immunoprecipitations to determine specific localization of the GR in human keratinocytes that may contribute to non-genomic effects of glucocorticoid action. Here we describe a novel finding of GR localization to the plasma membrane of keratinocytes. Immunocytochemistry showed co-localization of GR with alpha-catenin. Immunoprecipitation of the membranous fraction revealed an association of GR with alpha-catenin, confirming its localization to adherens junctions. We conclude that GR localization to adherens junctions of keratinocytes provides a new mechanism of non- genomic signaling by glucocorticoids which may have significant biological and clinical impact.	[Stojadinovic, Olivera; Sawaya, Andrew; Pastar, Irena; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA; [Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Cellular & Mol Pharmacol Grad Program Biomed Sci, Miami, FL 33136 USA	University of Miami; University of Miami	Tomic-Canic, M (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA.	mtcanic@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198	Department of Dermatology of the University of Miami	Department of Dermatology of the University of Miami	This grant was funded by the sources from the Department of Dermatology of the University of Miami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boldizsar F, 2010, IMMUNOBIOLOGY, V215, P521, DOI 10.1016/j.imbio.2009.10.003; Cirillo N, 2011, J CELL BIOCHEM, V112, P1499, DOI 10.1002/jcb.23081; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; Gametchu B, 1999, STEROIDS, V64, P107, DOI 10.1016/S0039-128X(98)00097-X; Lee B, 2005, J MOL BIOL, V345, P1083, DOI 10.1016/j.jmb.2004.11.027; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Marino M, 2008, STEROIDS, V73, P853, DOI 10.1016/j.steroids.2007.12.003; ORCHINIK M, 1991, SCIENCE, V252, P1848, DOI 10.1126/science.2063198; Radoja N, 2000, MOL CELL BIOL, V20, P4328, DOI 10.1128/MCB.20.12.4328-4339.2000; RANDOLPH RK, 1993, J BIOL CHEM, V268, P9198; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Roozendaal B, 2010, J NEUROSCI, V30, P5037, DOI 10.1523/JNEUROSCI.5717-09.2010; Sevilla LM, 2010, MOL ENDOCRINOL, V24, P2166, DOI 10.1210/me.2010-0183; Song IH, 2006, MOL CELL ENDOCRINOL, V246, P142, DOI 10.1016/j.mce.2005.11.012; Stellacci E, 2009, EXP HEMATOL, V37, P559, DOI 10.1016/j.exphem.2009.02.005; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Terao M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025039; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Vukelic S, 2011, J BIOL CHEM, P286; Vukelic S, 2010, J BIOL CHEM, V285, P1980, DOI 10.1074/jbc.M109.016741; Xiao L, 2010, MOL ENDOCRINOL, V24, P497, DOI 10.1210/me.2009-0422; Yang J, 1996, MOL ENDOCRINOL, V10, P3, DOI 10.1210/me.10.1.3	24	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63453	10.1371/journal.pone.0063453	http://dx.doi.org/10.1371/journal.pone.0063453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646206	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300165
J	Zhang, H; Liu, J; Zhang, QL				Zhang, Hao; Liu, Jia; Zhang, Qinglin			Neural Correlates of the Perception for Novel Objects	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; PRIMARY VISUAL-CORTEX; EVENT-RELATED FMRI; SPATIAL ATTENTION; RHESUS-MONKEY; RECEPTIVE FIELDS; STRIATE CORTEX; OPTIC ATAXIA; NOVELTY; CONNECTIONS	Perception of novel objects is of enormous importance in our lives. People have to perceive or understand novel objects when seeing an original painting, admiring an unconventional construction, and using an inventive device. However, very little is known about neural mechanisms underlying the perception for novel objects. Perception of novel objects relies on the integration of unusual features of novel objects in order to identify what such objects are. In the present study, functional Magnetic Resonance Imaging (MRI) was employed to investigate neural correlates of perception of novel objects. The neuroimaging data on participants engaged in novel object viewing versus ordinary object viewing revealed that perception of novel objects involves significant activation in the left precuneus (Brodmann area 7) and the right visual cortex. The results suggest that the left precuneus is associated with the integration of unusual features of novel objects, while the right visual cortex is sensitive to the detection of such features. Our findings highlight the left precuneus as a crucial component of the neural circuitry underlying perception of novel objects.	[Zhang, Hao; Zhang, Qinglin] Southwest Univ, Sch Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Liu, Jia] Beijing Normal Univ, Imaging Ctr Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China	Southwest University - China; Beijing Normal University	Zhang, QL (corresponding author), Southwest Univ, Sch Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	qrlzhang@gmail.com		Liu, Jia/0000-0003-0383-0934	Natural Science Foundation of China [30970892]; Key Discipline Fund of National 211 Project in China [NSKD08002, NSKD08008, NSKD11020]; Scholar Research Program Fund of Southwest University [SWUB 2007063]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Discipline Fund of National 211 Project in China; Scholar Research Program Fund of Southwest University	The study was supported by the Natural Science Foundation of China (30970892 to QZ), the Key Discipline Fund of National 211 Project in China (NSKD08002, NSKD08008 and NSKD11020 to QZ and HZ), and the Scholar Research Program Fund of Southwest University (SWUB 2007063 to HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Balint R, 1909, MON PSYCHIATR NEUROL, V25, P51; BLUM JS, 1950, J COMP NEUROL, V93, P53, DOI 10.1002/cne.900930105; BODEN MA, 1999, HDB CREATIVITY, P351; Braine M. D. S., 1998, MENTAL LOGIC, DOI [10.4324/9781410603005, DOI 10.4324/9781410603005]; Brodmann K., 1960, SOME PAPERS CEREBRAL, P201; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; CAHILLSOLIS TL, 1994, GENET SOC GEN PSYCH, V120, P393; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cela-Conde CJ, 2009, P NATL ACAD SCI USA, V106, P3847, DOI 10.1073/pnas.0900304106; Critchley M., 1953, PARIETAL LOBES; Cupchik GC, 2009, BRAIN COGNITION, V70, P84, DOI 10.1016/j.bandc.2009.01.003; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Farah Martha J., 1995, P963; Feist G. J., 1999, HDB CREATIVITY, P273; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gillebert CR, 2011, BRAIN, V134, P1694, DOI 10.1093/brain/awr085; Gur RC, 2007, HUM BRAIN MAPP, V28, P263, DOI 10.1002/hbm.20319; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; Jeannerod M., 1988, THE NEURAL AND BEHAV; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Karnath HO, 2005, CEREB CORTEX, V15, P1561, DOI 10.1093/cercor/bhi034; Knauff M, 2003, J COGNITIVE NEUROSCI, V15, P559, DOI 10.1162/089892903321662949; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lubart T. I., 1999, HDB CREATIVITY, P339, DOI [10.1017/CBO9780511807916.019, DOI 10.1017/CBO9780511807916.019]; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Martindale C., 1999, HDB CREATIVITY, P137, DOI [DOI 10.1017/CBO9780511807916.009, 10.1017/CBO9780511807916.009]; Mayer R.E., 1999, HDB CREAT, P449, DOI DOI 10.1017/CBO9780511807916.024; Menon V, 2000, HUM BRAIN MAPP, V11, P117, DOI 10.1002/1097-0193(200010)11:2<117::AID-HBM50>3.0.CO;2-M; Michelon P, 2003, NEUROIMAGE, V19, P1612, DOI 10.1016/S1053-8119(03)00111-3; MIYASHITA Y, 1995, SCIENCE, V268, P1719, DOI 10.1126/science.7792596; Nickerson R.S., 1999, HDB CREATIVITY, P392; Ochse R, 1990, BEFORE THE GATES OF; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rips LJ, 1994, THE PSYCHOLOGY OF PR; SCHMAHMANN JD, 1990, J COMP NEUROL, V295, P299, DOI 10.1002/cne.902950212; Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Steenkamp JBEM, 2003, J CONSUM RES, V30, P368, DOI 10.1086/378615; STENNING K, 1995, COGNITIVE SCI, V19, P97, DOI 10.1207/s15516709cog1901_3; STERNBERG RJ, 1991, HUM DEV, V34, P1, DOI 10.1159/000277029; Stoppel CM, 2009, HUM BRAIN MAPP, V30, P3759, DOI 10.1002/hbm.20804; Strange BA, 2005, NEUROIMAGE, V25, P51, DOI 10.1016/j.neuroimage.2004.12.014; Talairach J, 1988, CO PLANAR STEREOTAXI; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Ungerleider LG, 1982, ANALYSIS OF VISUAL B; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Wittmann BC, 2008, NEURON, V58, P967, DOI 10.1016/j.neuron.2008.04.027; Wittmann BC, 2007, NEUROIMAGE, V38, P194, DOI 10.1016/j.neuroimage.2007.06.038; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; YETERIAN EH, 1985, J COMP NEUROL, V237, P408, DOI 10.1002/cne.902370309; YETERIAN EH, 1993, J COMP NEUROL, V332, P175, DOI 10.1002/cne.903320204; Zhang H, 2013, CORTEX IN PRESS	68	8	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62979	10.1371/journal.pone.0062979	http://dx.doi.org/10.1371/journal.pone.0062979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646167	Green Submitted, Green Published, gold			2022-12-27	WOS:000319077300122
J	Ahnstedt, H; Cao, L; Krause, DN; Warfvinge, K; Saveland, H; Nilsson, OG; Edvinsson, L				Ahnstedt, Hilda; Cao, Lei; Krause, Diana N.; Warfvinge, Karin; Saveland, Hans; Nilsson, Ola G.; Edvinsson, Lars			Male-Female Differences in Upregulation of Vasoconstrictor Responses in Human Cerebral Arteries	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ANGIOTENSIN-II; SUBARACHNOID HEMORRHAGE; B RECEPTORS; CONTRACTILE RECEPTORS; VASCULAR-RESPONSES; GENDER-DIFFERENCES; HYPERTENSIVE-RATS; SEX-DIFFERENCES; BLOOD-FLOW	Background and purpose: Male-female differences may significantly impact stroke prevention and treatment in men women, however underlying mechanisms for sexual dimorphism in stroke are not understood. We previously found males that cerebral ischemia upregulates contractile receptors in cerebral arteries, which is associated with lower flow. The present study investigates if cerebral arteries from men and women differ in cerebrovascular upregulation. Experimental approach: Freshly obtained human cerebral arteries were placed in organ culture, an established model studying receptor upregulation. 5-hydroxtryptamine type 1B (5-HT1B), angiotensin II type 1 (AT(1)) and endothelin-1 type and B (ETA and ETB) receptors were evaluated using wire myograph for contractile responses, real-time PCR for mRNA immunohistochemistry for receptor expression. Key results: Vascular sensitivity to angiotensin II and endothelin-1 was markedly lower in cultured cerebral arteries women as compared to men. ETB receptor-mediated contraction occurred in male but not female arteries. there were similar upregulation in mRNA and expression of 5-HT1B, AT(1), and E-TB receptors and in local expression of Ang II after organ culture. Conclusions and Implications: In spite of receptor upregulation after organ culture in both sexes, cerebral arteries women were significantly less responsive to vasoconstrictors angiotensin II and endothelin-1 as compared to arteries men. This suggests receptor coupling and/or signal transduction mechanisms involved in cerebrovascular contractility be suppressed in females. This is the first study to demonstrate sex differences in the vascular function of human arteries.	[Ahnstedt, Hilda; Cao, Lei; Warfvinge, Karin; Edvinsson, Lars] Lund Univ, Dept Clin Sci, Div Expt Vasc Res, Lund, Sweden; [Krause, Diana N.] Univ Calif Irvine, Dept Pharmacol, Sch Med, Irvine, CA 92717 USA; [Saveland, Hans; Nilsson, Ola G.] Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden	Lund University; University of California System; University of California Irvine; Lund University; Skane University Hospital	Ahnstedt, H (corresponding author), Lund Univ, Dept Clin Sci, Div Expt Vasc Res, Lund, Sweden.	hilda.ahnstedt@med.lu.se		Cao, Lei/0000-0002-9676-7366; Edvinsson, Lars/0000-0002-1805-1346	Swedish Heart Lung Association [2010225]; Swedish Research Council [2011-5414]	Swedish Heart Lung Association(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by grants from the Swedish Heart Lung Association (grant no. 2010225, http://www.hjart-lungfonden.se/ and the Swedish Research Council (grant no. 2011-5414, www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnstedt H, 2012, ACTA PHYSIOL, V205, P266, DOI 10.1111/j.1748-1716.2011.02392.x; Ahnstedt H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-5; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Ansar S, 2013, BMC NEUROSC IN PRESS; Ansar S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-107; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Arnold AP, 2009, J NEUROENDOCRINOL, V21, P377, DOI 10.1111/j.1365-2826.2009.01831.x; Beg SAS, 2006, J CEREBR BLOOD F MET, V26, P846, DOI 10.1038/sj.jcbfm.9600236; CHENG DY, 1992, EUR J PHARMACOL, V215, P171, DOI 10.1016/0014-2999(92)90025-Y; David FL, 2002, BRAZ J MED BIOL RES, V35, P1061, DOI 10.1590/S0100-879X2002000900006; De Silva TM, 2009, STROKE, V40, P1091, DOI 10.1161/STROKEAHA.108.531707; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; Forster A, 2009, STROKE, V40, P2428, DOI 10.1161/STROKEAHA.109.548750; Fu H, 2011, J HYPERTENS, V29, P2210, DOI 10.1097/HJH.0b013e32834bbb30; Geary GG, 1998, AM J PHYSIOL-HEART C, V275, pH292, DOI 10.1152/ajpheart.1998.275.1.H292; Gonzales RJ, 2005, AM J PHYSIOL-HEART C, V289, pH578, DOI 10.1152/ajpheart.00958.2004; Hansen-Schwartz J, 2002, NEUROSURGERY, V50, P127, DOI 10.1097/00006123-200201000-00021; Hansen-Schwartz J, 2003, NEUROSURGERY, V52, P1188, DOI 10.1227/01.NEU.0000058467.82442.64; Henriksson M, 2004, BRIT J PHARMACOL, V142, P1155, DOI 10.1038/sj.bjp.0705803; Henriksson M, 2003, STROKE, V34, P1479, DOI 10.1161/01.STR.0000072984.79136.79; Henriksson M, 2007, EXP BRAIN RES, V178, P470, DOI 10.1007/s00221-006-0753-7; HOGESTATT ED, 1983, ACTA PHYSIOL SCAND, V117, P49, DOI 10.1111/j.1748-1716.1983.tb07178.x; Hosomi N, 2005, NEUROSCIENCE, V134, P225, DOI 10.1016/j.neuroscience.2005.03.054; Hurn PD, 2003, STROKE, V34, P338, DOI 10.1161/01.STR.0000054051.88378.25; Kent DM, 2005, STROKE, V36, P62, DOI 10.1161/01.STR.0000150515.15576.29; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Liao SL, 2001, NEUROSCI LETT, V297, P159, DOI 10.1016/S0304-3940(00)01704-3; Maddahi A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-85; Mugge A, 1997, PHARMACOLOGY, V54, P162, DOI 10.1159/000139483; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nilsson T, 1997, NEUROSURGERY, V40, P346, DOI 10.1097/00006123-199702000-00023; Nilsson T, 1999, BRIT J PHARMACOL, V128, P1133, DOI 10.1038/sj.bjp.0702773; Ospina JA, 2003, AM J PHYSIOL-HEART C, V285, pH241, DOI 10.1152/ajpheart.00018.2003; Passaglia RCAT, 2000, BRIT J PHARMACOL, V130, P1092, DOI 10.1038/sj.bjp.0703389; Povlsen GK, 2012, EXP BRAIN R IN PRESS; Salom JB, 2001, J CEREBR BLOOD F MET, V21, P422, DOI 10.1097/00004647-200104000-00011; Silva-Antonialli MM, 2004, CARDIOVASC RES, V62, P587, DOI 10.1016/j.cardiores.2004.01.020; Turtzo LC, 2010, FUTUR NEUROL, V5, P47, DOI 10.2217/FNL.09.66; Vikman P, 2006, EUR J NEUROL, V13, P1324, DOI 10.1111/j.1468-1331.2006.01496.x; Zuern CS, 2009, SEMIN THROMB HEMOST, V35, P295, DOI 10.1055/s-0029-1222608	41	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62698	10.1371/journal.pone.0062698	http://dx.doi.org/10.1371/journal.pone.0062698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658641	Green Published, gold			2022-12-27	WOS:000321662800056
J	Arooj, M; Sakkiah, S; Kim, S; Arulalapperumal, V; Lee, KW				Arooj, Mahreen; Sakkiah, Sugunadevi; Kim, Songmi; Arulalapperumal, Venkatesh; Lee, Keun Woo			A Combination of Receptor-Based Pharmacophore Modeling & QM Techniques for Identification of Human Chymase Inhibitors	PLOS ONE			English	Article							MAST-CELL CHYMASE; ANGIOTENSIN-II; NONPEPTIDE INHIBITORS; DRUG DISCOVERY; DESIGN; DOCKING; POTENT; MECHANISMS; PROTEASES; TOPOLOGY	Inhibition of chymase is likely to divulge therapeutic ways for the treatment of cardiovascular diseases, and fibrotic disorders. To find novel and potent chymase inhibitors and to provide a new idea for drug design, we used both ligand-based and structure-based methods to perform the virtual screening(VS) of commercially available databases. Different pharmacophore models generated from various crystal structures of enzyme may depict diverse inhibitor binding modes. Therefore, multiple pharmacophore-based approach is applied in this study. X-ray crystallographic data of chymase in complex with different inhibitors were used to generate four structure-based pharmacophore models. One ligand-based pharmacophore model was also developed from experimentally known inhibitors. After successful validation, all pharmacophore models were employed in database screening to retrieve hits with novel chemical scaffolds. Drug-like hit compounds were subjected to molecular docking using GOLD and AutoDock. Finally four structurally diverse compounds with high GOLD score and binding affinity for several crystal structures of chymase were selected as final hits. Identification of final hits by three different pharmacophore models necessitates the use of multiple pharmacophore-based approach in VS process. Quantum mechanical calculation is also conducted for analysis of electrostatic characteristics of compounds which illustrates their significant role in driving the inhibitor to adopt a suitable bioactive conformation oriented in the active site of enzyme. In general, this study is used as example to illustrate how multiple pharmacophore approach can be useful in identifying structurally diverse hits which may bind to all possible bioactive conformations available in the active site of enzyme. The strategy used in the current study could be appropriate to design drugs for other enzymes as well.	[Arooj, Mahreen; Sakkiah, Sugunadevi; Kim, Songmi; Arulalapperumal, Venkatesh; Lee, Keun Woo] Gyeongsang Natl Univ GNU, Plant Mol Biol & Biotechnol Res Ctr PMBBRC, Syst & Synthet Agrobiotech Ctr SSAC, Div Appl Life Sci,Program BK21,Res Inst Nat Sci R, Jinju, South Korea	Gyeongsang National University	Lee, KW (corresponding author), Gyeongsang Natl Univ GNU, Plant Mol Biol & Biotechnol Res Ctr PMBBRC, Syst & Synthet Agrobiotech Ctr SSAC, Div Appl Life Sci,Program BK21,Res Inst Nat Sci R, Jinju, South Korea.	kwlee@gnu.ac.kr	Arooj, Mahreen/AAC-7565-2020	Sakkiah, Suguna Devi/0000-0002-8337-9348; Arooj, Mahreen/0000-0003-1975-5289	National Research Foundation of Korea (NRF) [2012R1A1A4A01013657, 2009-0081539, 2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Rural Development Administration (RDA) of Republic of Korea [PJ009486]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration (RDA) of Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by Basic Science Research Program (2012R1A1A4A01013657), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. And this work was also supported by the Next-Generation BioGreen 21 Program (PJ009486) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 2008, GENET MED, V10, P593, DOI [10.1097/GIM.0b013e3181804b9c, 10.1097GIM.0b013e3181804b9c]; Aoyama Y, 2000, BIOORG MED CHEM LETT, V10, P2397, DOI 10.1016/S0960-894X(00)00488-1; Aoyama Y, 2001, BIOORG MED CHEM LETT, V11, P1691, DOI 10.1016/S0960-894X(01)00264-5; Aoyama Y, 2001, BIOORGAN MED CHEM, V9, P3065, DOI 10.1016/S0968-0896(01)00209-7; Arooj M, 2011, INT J MOL SCI, V12, P9236, DOI 10.3390/ijms12129236; Boda K, 2007, J COMPUT AID MOL DES, V21, P311, DOI 10.1007/s10822-006-9099-2; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; de Garavilla L, 2005, J BIOL CHEM, V280, P18001, DOI 10.1074/jbc.M501302200; Dehez F, 2008, J AM CHEM SOC, V130, P12725, DOI 10.1021/ja8033087; Devereux M, 2009, J CHEM INF MODEL, V49, P1497, DOI 10.1021/ci900085d; Dickson M, 2004, NAT REV DRUG DISCOV, V3, P417, DOI 10.1038/nrd1382; Garcia-Garcia A, 2004, J ANTIMICROB CHEMOTH, V53, P65, DOI 10.1093/jac/dkh014; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Greco MN, 2007, J MED CHEM, V50, P1727, DOI 10.1021/jm0700619; Huang XR, 2003, J AM SOC NEPHROL, V14, P1738, DOI 10.1097/01.ASN.0000071512.93927.4E; Iijima K, 1999, BIOORG MED CHEM LETT, V9, P413, DOI 10.1016/S0960-894X(99)00012-8; Kenny PW, 2009, J CHEM INF MODEL, V49, P1234, DOI 10.1021/ci9000234; Kervinen J, 2010, BIOCHEM PHARMACOL, V80, P1033, DOI 10.1016/j.bcp.2010.06.014; Khedkar SA, 2007, MED CHEM, V3, P187, DOI 10.2174/157340607780059521; Kim S, 2000, PHARMACOL REV, V52, P11; Koide Y, 2003, BIOORG MED CHEM LETT, V13, P25, DOI 10.1016/S0960-894X(02)00853-3; Kruger DM, 2011, ACS MED CHEM LETT, V2, P489, DOI 10.1021/ml100217h; Langer T, 2003, CURR OPIN DRUG DISC, V6, P370; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Levit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027990; Lindsay GA, 2010, ACS SYM SER, V1039, P35; Lo HY, 2011, BIOORG MED CHEM LETT, V21, P4533, DOI 10.1016/j.bmcl.2011.05.126; Nam K, 2008, RNA, V14, P1501, DOI 10.1261/rna.863108; Niwata S, 1997, J MED CHEM, V40, P2156, DOI 10.1021/jm960793t; Omoto Y, 2006, J IMMUNOL, V177, P8315, DOI 10.4049/jimmunol.177.12.8315; Panchmatia PM, 2010, J PHYS CHEM A, V114, P13381, DOI 10.1021/jp106358m; Schuster D, 2011, BIOORGANIC MED CHEM; Takai S, 2005, LETT DRUG DES DISCOV, V2, P19, DOI 10.2174/1570180053398433; Tiwari R, 2009, J CHEM INF MODEL, V49, P1581, DOI 10.1021/ci900031y; Tuccinardi T, 2010, J CHEM INF MODEL, V50, P1432, DOI 10.1021/ci100161z; Urata H, 1996, AM J HYPERTENS, V9, P277, DOI 10.1016/0895-7061(95)00349-5; Vainio MJ, 2009, J CHEM INF MODEL, V49, P492, DOI 10.1021/ci800315d; Vyas VK, 2013, J MOL GRAPHICS MODEL; Zhao WX, 2011, J CHEM INF MODEL, V51, P2147, DOI 10.1021/ci100511v	39	39	39	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e63030	10.1371/journal.pone.0063030	http://dx.doi.org/10.1371/journal.pone.0063030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658661	Green Published, Green Submitted, gold			2022-12-27	WOS:000318343700087
J	Haase, S; Hanssen, E; Matthews, K; Kalanon, M; de Koning-Ward, TF				Haase, Silvia; Hanssen, Eric; Matthews, Kathryn; Kalanon, Ming; de Koning-Ward, Tania F.			The Exported Protein PbCP1 Localises to Cleft-Like Structures in the Rodent Malaria Parasite Plasmodium berghei	PLOS ONE			English	Article							MEMBRANE-PROTEIN; TRAFFICKING; VIRULENCE; SURFACE; FAMILY; CYTOADHERENCE; ERYTHROCYTES; PFEMP1; EXPRESSION; INFECTION	Protein export into the host red blood cell is one of the key processes in the pathobiology of the malaria parasite Plasmodiumtrl falciparum, which extensively remodels the red blood cell to ensure its virulence and survival. In this study, we aimed to shed further light on the protein export mechanisms in the rodent malaria parasite P. berghei and provide further proof of the conserved nature of host cell remodeling in Plasmodium spp. Based on the presence of an export motif (R/KxLxE/Q/D) termed PEXEL (Plasmodium export element), we have generated transgenic P. berghei parasite lines expressing GFP chimera of putatively exported proteins and analysed one of the newly identified exported proteins in detail. This essential protein, termed PbCP1 (P. berghei Cleft-like Protein 1), harbours an atypical PEXEL motif (RxLxY) and is further characterised by two predicted transmembrane domains (2TMD) in the C-terminal end of the protein. We have functionally validated the unusual PEXEL motif in PbCP1 and analysed the role of the 2TMD region, which is required to recruit PbCP1 to discrete membranous structures in the red blood cell cytosol that have a convoluted, vesico-tubular morphology by electron microscopy. Importantly, this study reveals that rodent malaria species also induce modifications to their host red blood cell.	[Haase, Silvia; Matthews, Kathryn; Kalanon, Ming; de Koning-Ward, Tania F.] Deakin Univ, Sch Med, Waurn Ponds, Vic 3217, Australia; [Hanssen, Eric] Univ Melbourne, Inst Bio21, Electron Microscopy Unit, Parkville, Vic 3052, Australia	Deakin University; University of Melbourne	Haase, S (corresponding author), Deakin Univ, Sch Med, Waurn Ponds, Vic 3217, Australia.	haase@wehi.edu.au; taniad@deakin.edu.au	de Koning-Ward, Tania F/N-3572-2017; Hanssen, Eric/A-7217-2013	de Koning-Ward, Tania F/0000-0001-5810-8063; Hanssen, Eric/0000-0002-4064-1844; Haase, Silvia/0000-0003-0870-3715	Australian National Health and Medical Research Council [533811]; Deakin University; Alfred Deakin Fellowship Scheme; NHMRC	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Deakin University; Alfred Deakin Fellowship Scheme; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council (533811) and Deakin University's Central Research Grants Scheme. S. H. acknowledges support from the Alfred Deakin Fellowship Scheme. TdKW is supported by an NHMRC Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bhattacharjee S, 2012, CELL, V148, P201, DOI 10.1016/j.cell.2011.10.051; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Braks JAM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj033; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Cunningham D, 2010, MOL BIOCHEM PARASIT, V170, P65, DOI 10.1016/j.molbiopara.2009.12.010; Curra C, 2012, TRAFFIC, V13, P388, DOI 10.1111/j.1600-0854.2011.01313.x; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Dixon MWA, 2011, MOL MICROBIOL, V81, P982, DOI 10.1111/j.1365-2958.2011.07740.x; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001032; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; Gruring C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1169; Haase S, 2010, CELL MICROBIOL, V12, P580, DOI 10.1111/j.1462-5822.2010.01455.x; Hanssen E, 2008, MOL MICROBIOL, V69, P938, DOI 10.1111/j.1365-2958.2008.06329.x; Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x; Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004; Hawthorne PL, 2004, MOL BIOCHEM PARASIT, V136, P181, DOI 10.1016/j.molbiopara.2004.03.013; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Ingmundson A, 2012, MOL MICROBIOL, V83, P1229, DOI 10.1111/j.1365-2958.2012.08004.x; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; KILEJIAN A, 1979, P NATL ACAD SCI USA, V76, P4650, DOI 10.1073/pnas.76.9.4650; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; Lanzer M, 2006, INT J PARASITOL, V36, P23, DOI 10.1016/j.ijpara.2005.10.001; MacKenzie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002405; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Sam-Yellowe TY, 2009, TRENDS PARASITOL, V25, P277, DOI 10.1016/j.pt.2009.03.009; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Sijwali PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010227; Spielmann T, 2006, MOL BIOL CELL, V17, P3613, DOI 10.1091/mbc.E06-04-0291; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Spycher C, 2003, J BIOL CHEM, V278, P35373, DOI 10.1074/jbc.M305851200; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tilley L, 2008, TRAFFIC, V9, P187, DOI 10.1111/j.1600-0854.2007.00684.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Wong W, 2011, P NATL ACAD SCI USA, V108, P9869, DOI 10.1073/pnas.1018927108	50	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61482	10.1371/journal.pone.0061482	http://dx.doi.org/10.1371/journal.pone.0061482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658610	gold, Green Published			2022-12-27	WOS:000318343700012
J	Stock, AK; Wascher, E; Beste, C				Stock, Ann-Kathrin; Wascher, Edmund; Beste, Christian			Differential Effects of Motor Efference Copies and Proprioceptive Information on Response Evaluation Processes	PLOS ONE			English	Article							MOVEMENT-RELATED POTENTIALS; SPATIAL ATTENTION; SPACE; BRAIN; SCALP; EEG; PERCEPTION; CORTEX; LINKS; COPY	It is well-kown that sensory information influences the way we execute motor responses. However, less is known about if and how sensory and motor information are integrated in the subsequent process of response evaluation. We used a modified Simon Task to investigate how these streams of information are integrated in response evaluation processes, applying an in-depth neurophysiological analysis of event-related potentials (ERPs), time-frequency decomposition and sLORETA. The results show that response evaluation processes are differentially modulated by afferent proprioceptive information and efference copies. While the influence of proprioceptive information is mediated via oscillations in different frequency bands, efference copy based information about the motor execution is specifically mediated via oscillations in the theta frequency band. Stages of visual perception and attention were not modulated by the interaction of proprioception and motor efference copies. Brain areas modulated by the interactive effects of proprioceptive and efference copy based information included the middle frontal gyrus and the supplementary motor area (SMA), suggesting that these areas integrate sensory information for the purpose of response evaluation. The results show how motor response evaluation processes are modulated by information about both the execution and the location of a response.	[Stock, Ann-Kathrin; Beste, Christian] Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Biopsychol, Bochum, Germany; [Wascher, Edmund] Leibnitz Inst Arbeitsforsch TU Dortmund, Dortmund, Germany	Ruhr University Bochum	Stock, AK (corresponding author), Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Biopsychol, Univ Str 150, Bochum, Germany.	Ann-Kathrin.Stock@rub.de	Stock, Ann-Kathrin/G-9536-2019; Stock, Ann-Kathrin/AAT-9168-2020; Wascher, Edmund/N-6848-2019; Wascher, Edmund/B-8457-2019	Stock, Ann-Kathrin/0000-0001-7113-4020; Stock, Ann-Kathrin/0000-0001-7113-4020; Wascher, Edmund/0000-0003-3616-9767	Deutsche Forschungsgemeinschaft (DFG) [BE4045/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a Grant from the Deutsche Forschungsgemeinschaft (DFG) BE4045/10-1 to C. B. Funder's website: www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain S, 2004, CLIN NEUROPHYSIOL, V115, P2014, DOI 10.1016/j.clinph.2004.04.013; ANGEL RW, 1976, NEUROLOGY, V26, P1164, DOI 10.1212/WNL.26.12.1164; Babiloni F, 2001, HUM BRAIN MAPP, V14, P197, DOI 10.1002/hbm.1052; Beaule V, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/627816; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Beste C, 2009, NEUROSCIENCE, V159, P143, DOI 10.1016/j.neuroscience.2008.12.030; Beste C, 2007, NEUROPSYCHOLOGIA, V45, P2922, DOI 10.1016/j.neuropsychologia.2007.06.004; Beste C, 2012, NEUROIMAGE, V62, P137, DOI 10.1016/j.neuroimage.2012.05.019; Beste C, 2010, J NEUROSCI, V30, P10727, DOI 10.1523/JNEUROSCI.2493-10.2010; Beste C, 2010, HUM BRAIN MAPP, V31, P621, DOI 10.1002/hbm.20892; Cui RQ, 1999, NEUROIMAGE, V9, P124, DOI 10.1006/nimg.1998.0388; Danielmeier C, 2009, PSYCHOPHYSIOLOGY, V46, P1288, DOI 10.1111/j.1469-8986.2009.00860.x; Diedrichsen J, 2006, CEREB CORTEX, V16, P1729, DOI 10.1093/cercor/bhj108; Eimer M, 2001, EXP BRAIN RES, V139, P398, DOI 10.1007/s002210100773; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Feldman AG, 2009, EXP BRAIN RES, V194, P39, DOI 10.1007/s00221-008-1667-3; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Fukui T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034985; Gonzalez CC, 2013, EXP BRAIN RES, V224, P189, DOI 10.1007/s00221-012-3298-y; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Gritsenko V, 2007, J NEUROPHYSIOL, V98, P1140, DOI 10.1152/jn.00162.2007; Gruendler TOJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025591; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Hallett M, 1994, Electromyogr Clin Neurophysiol, V34, P5; Heed T, 2012, NEURAL BASES MULTISE; Heed T, 2012, J EXP PSYCHOL HUMAN, V38, P386, DOI 10.1037/a0024059; Heed T, 2010, J COGNITIVE NEUROSCI, V22, P184, DOI 10.1162/jocn.2008.21168; Herz DM, 2012, NEUROIMAGE, V59, P3187, DOI 10.1016/j.neuroimage.2011.11.042; HOCHERMAN S, 1988, EXP BRAIN RES, V73, P256; Hoffmann S, 2012, NEUROSCI LETT, V506, P225, DOI 10.1016/j.neulet.2011.11.011; Hoffmann S, 2010, HUM BRAIN MAPP, V31, P1305, DOI 10.1002/hbm.20937; Holst E. von, 1954, British Journal of Animal Behaviour, V2, P89; IKEDA A, 1995, ELECTROEN CLIN NEURO, V95, P323, DOI 10.1016/0013-4694(95)00086-E; Kennett S, 2001, J COGNITIVE NEUROSCI, V13, P462, DOI 10.1162/08989290152001899; Kim C, 2012, BRAIN RES, V1444, P55, DOI 10.1016/j.brainres.2012.01.023; Leuthold H, 2011, ACTA PSYCHOL, V136, P203, DOI 10.1016/j.actpsy.2010.08.001; Lloyd DM, 2010, BRAIN COGNITION, V73, P102, DOI 10.1016/j.bandc.2010.03.006; Loayza FR, 2011, NEUROIMAGE, V55, P635, DOI 10.1016/j.neuroimage.2010.12.011; LOGAN GD, 1985, ACTA PSYCHOL, V60, P193, DOI 10.1016/0001-6918(85)90055-1; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mead LA, 2002, J INT NEUROPSYCH SOC, V8, P735, DOI 10.1017/S1355617702860015; Muller V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038931; NESHIGE R, 1988, BRAIN, V111, P719; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; NUNEZ PL, 1991, J CLIN NEUROPHYSIOL, V8, P397, DOI 10.1097/00004691-199110000-00005; Ocklenburg S, 2011, NEUROIMAGE, V55, P1771, DOI 10.1016/j.neuroimage.2011.01.035; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons LM, 1998, J NEUROSCI, V18, P6539; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; PERNIER J, 1988, ELECTROEN CLIN NEURO, V69, P385, DOI 10.1016/0013-4694(88)90009-0; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Peterburs J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021517; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; Praamstra P, 1996, ELECTROEN CLIN NEURO, V98, P468, DOI 10.1016/0013-4694(96)95643-6; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Roger C, 2010, NEUROIMAGE, V51, P391, DOI 10.1016/j.neuroimage.2010.02.005; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Semprini G, 2012, J MOTOR BEHAV, V44, P373, DOI 10.1080/00222895.2012.724476; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; Spence C, 2000, J EXP PSYCHOL HUMAN, V26, P1298, DOI 10.1037//0096-1523.26.4.1298; Suchan B, 2003, NEUROSCI LETT, V350, P101, DOI 10.1016/S0304-3940(03)00879-6; TallonBaudry C, 1997, J NEUROSCI, V17, P722; TARKKA IM, 1991, J CLIN NEUROPHYSIOL, V8, P331, DOI 10.1097/00004691-199107010-00009; Therrien AS, 2011, NEUROPSYCHOLOGIA, V49, P2941, DOI 10.1016/j.neuropsychologia.2011.06.023; Tremblay P, 2011, NEUROIMAGE, V57, P1561, DOI 10.1016/j.neuroimage.2011.05.067; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Vakalopoulos C, 2007, MED HYPOTHESES, V68, P574, DOI 10.1016/j.mehy.2006.08.013; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892; Wascher E, 2001, J EXP PSYCHOL HUMAN, V27, P731, DOI 10.1037//0096-1523.27.3.731; Wascher E, 2010, J NEUROPHYSIOL, V103, P1057, DOI 10.1152/jn.00376.2009; Wiegand K, 2007, PSYCHOL RES-PSYCH FO, V71, P401, DOI 10.1007/s00426-005-0027-1; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040; Zhou Y, 2012, J NEUROSCI, V32, P8354, DOI 10.1523/JNEUROSCI.0829-12.2012	80	38	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62335	10.1371/journal.pone.0062335	http://dx.doi.org/10.1371/journal.pone.0062335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658624	gold, Green Published, Green Submitted			2022-12-27	WOS:000318343700048
J	Molto-Puigmarti, C; Jansen, E; Heinrich, J; Standl, M; Mensink, RP; Plat, J; Penders, J; Mommers, M; Koppelman, GH; Postma, DS; Thijs, C				Molto-Puigmarti, Carolina; Jansen, Eugene; Heinrich, Joachim; Standl, Marie; Mensink, Ronald P.; Plat, Jogchum; Penders, John; Mommers, Monique; Koppelman, Gerard H.; Postma, Dirkje S.; Thijs, Carel			Genetic Variation in FADS Genes and Plasma Cholesterol Levels in 2-Year-Old Infants: KOALA Birth Cohort Study	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; CORONARY-ARTERY-DISEASE; PRESCHOOL-CHILDREN; BLOOD CHOLESTEROL; SERUM-CHOLESTEROL; LIPOPROTEIN CONCENTRATIONS; MULTIRACIAL SAMPLE; LIPID-LEVELS; ASSOCIATION; VARIANTS	Objective: Single nucleotide polymorphisms (SNPs) in genes involved in fatty acid metabolism (FADS1 FADS2 gene cluster) are associated with plasma lipid levels. We aimed to investigate whether these associations are already present early in life and compare the relative contribution of FADS SNPs vs traditional (non-genetic) factors as determinants of plasma lipid levels. Methods: Information on infants' plasma total cholesterol levels, genotypes of five FADS SNPs (rs174545, rs174546, rs174556, rs174561, and rs3834458), anthropometric data, maternal characteristics, and breastfeeding history was available for 521 2-year-old children from the KOALA Birth Cohort Study. For 295 of these 521 children, plasma HDLc and non-HDLc levels were also known. Multivariable linear regression analysis was used to study the associations of genetic and nongenetic determinants with cholesterol levels. Results: All FADS SNPs were significantly associated with total cholesterol levels. Heterozygous and homozygous for the minor allele children had about 4% and 8% lower total cholesterol levels than major allele homozygotes. In addition, homozygous for the minor allele children had about 7% lower HDLc levels. This difference reached significance for the SNPs rs174546 and rs3834458. The associations went in the same direction for non-HDLc, but statistical significance was not reached. The percentage of total variance of total cholesterol levels explained by FADS SNPs was relatively low (lower than 3%) but of the same order as that explained by gender and the non-genetic determinants together. Conclusions: FADS SNPs are associated with plasma total cholesterol and HDLc levels in preschool children. This brings a new piece of evidence to explain how blood lipid levels may track from childhood to adulthood. Moreover, the finding that these SNPs explain a similar amount of variance in total cholesterol levels as the non-genetic determinants studied reveals the potential importance of investigating the effects of genetic variations in early life.	[Molto-Puigmarti, Carolina; Penders, John; Mommers, Monique; Thijs, Carel] Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands; [Jansen, Eugene] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands; [Heinrich, Joachim; Standl, Marie] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Standl, Marie] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Mensink, Ronald P.; Plat, Jogchum] Maastricht Univ, Med Ctr, Dept Human Biol, Maastricht, Netherlands; [Penders, John] Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Med Microbiol, Maastricht, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp,GRIAC Res Inst, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Med & TB, GRIAC Res Inst, Groningen, Netherlands	Maastricht University; Netherlands National Institute for Public Health & the Environment; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Maastricht University; Maastricht University; University of Groningen; University of Groningen	Molto-Puigmarti, C (corresponding author), Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands.	Carolina.molto@maastrichtuniversity.nl	Thijs, Carel/H-8340-2019; Penders, John/A-1280-2011; Heinrich, Joachim/N-1720-2013; Koppelman, Gerard/AAG-9187-2020	Thijs, Carel/0000-0001-6646-5458; Penders, John/0000-0001-9146-5919; Heinrich, Joachim/0000-0002-9620-1629; Molto-Puigmarti, Carolina/0000-0001-6831-6210; Standl, Marie/0000-0002-5345-2049; Koppelman, Gerard/0000-0001-8567-3252	Fundacion Alfonso Martin Escudero (Spain); Netherlands Organisation for Scientific Research (NWO); Munich Center of Health Sciences (MCHEALTH); Ministry of Public Health, Welfare and Sport, the Netherlands; AstraZeneca; Chiesi; GSK	Fundacion Alfonso Martin Escudero (Spain); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Munich Center of Health Sciences (MCHEALTH); Ministry of Public Health, Welfare and Sport, the Netherlands; AstraZeneca(AstraZeneca); Chiesi(Chiesi Pharmaceuticals Inc); GSK(GlaxoSmithKline)	Carolina Molto -Puigmarti was supported by a postdoctoral grant from "Fundacion Alfonso Martin Escudero'' (Spain) http://www.fundame.org/.DNA collection was supported by the Netherlands Organisation for Scientific Research (NWO Spinoza award of Prof. D.S. Postma) http://www.nwo.nl/. Genotyping was supported partly by the Munich Center of Health Sciences (MCHEALTH) http://www.en.mc-health.uni-muenchen.de/index.html. Blood lipids determinations were funded by the Ministry of Public Health, Welfare and Sport, the Netherlands http://www.government.nl/ministries/vws (Kennisvraag 5.4.1a, 2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The University of Groningen has received an unrestricted educational grant for research from AstraZeneca, Chiesi, GSK, performed by the group of Prof Postma. Travel to ERS and/or ATS has been partially funded to the University of Groiningen by AstraZeneca, Chiesi, GSK, Nycomed. Fees for consultancies were given to the University of Groningen by AZ, Boehringer Ingelheim, Chiesi, GSK, Nycomed and TEVA. In addition, the authors' confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bastiaanssen JM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-1; Bekkers MBM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025533; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cowin I, 2000, INT J OBESITY, V24, P330, DOI 10.1038/sj.ijo.0801133; Cowin IS, 2001, EUR J CLIN NUTR, V55, P39, DOI 10.1038/sj.ejcn.1601120; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dedoussis GVZ, 2007, AM J MED SCI, V333, P10, DOI 10.1097/00000441-200701000-00002; DESTEFANO F, 1995, EPIDEMIOLOGY, V6, P446, DOI 10.1097/00001648-199507000-00024; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Dumont J, 2011, J NUTR, V141, P1247, DOI 10.3945/jn.111.140392; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; FREEDMAN DS, 1992, PEDIATRICS, V90, P80; FREEDMAN DS, 1992, PREV MED, V21, P162, DOI 10.1016/0091-7435(92)90016-B; FRIEDMAN G, 1975, AM J CLIN NUTR, V28, P42, DOI 10.1093/ajcn/28.1.42; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Hellstrand S, 2012, J LIPID RES, V53, P1183, DOI 10.1194/jlr.P023721; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; KALLIO MJT, 1992, PEDIATRICS, V89, P663; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Kummeling I, 2005, PEDIATR ALLERGY IMMU, V16, P679, DOI 10.1111/j.1399-3038.2005.00333.x; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; LAUER RM, 1992, PEDIATRICS, V89, P495; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lu YC, 2010, AM J CLIN NUTR, V92, P258, DOI 10.3945/ajcn.2009.29130; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; McGill HC, 2000, AM J CLIN NUTR, V72, p1307S, DOI 10.1093/ajcn/72.5.1307s; MIZE CE, 1991, ANN NY ACAD SCI, V623, P455, DOI 10.1111/j.1749-6632.1991.tb43769.x; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Nakayama K, 2010, HUM GENET, V127, P685, DOI 10.1007/s00439-010-0815-6; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Owen CG, 2002, PEDIATRICS, V110, P597, DOI 10.1542/peds.110.3.597; Rona RJ, 1996, J EPIDEMIOL COMMUN H, V50, P512, DOI 10.1136/jech.50.5.512; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Rzehak P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013261; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sambrook J, 2007, MOL CLONING LAB MANU, V3 rd; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Srinivasan SR, 2006, PEDIATRICS, V118, P201, DOI 10.1542/peds.2005-1856; Stancakova A, 2011, DIABETES, V60, P1608, DOI 10.2337/db10-1655; Standl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037780; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Truong H, 2009, AM J CLIN NUTR, V89, P920, DOI 10.3945/ajcn.2008.27107; WARD SD, 1980, AM J CLIN NUTR, V33, P63, DOI 10.1093/ajcn/33.1.63; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020	52	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61671	10.1371/journal.pone.0061671	http://dx.doi.org/10.1371/journal.pone.0061671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667444	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600013
J	Wang, YL; Zhu, BJ; Qi, ZZ; Wang, HJ; Zhou, XD				Wang, Yu-Liang; Zhu, Bing-Jing; Qi, Zhan-Zhong; Wang, Hai-Jing; Zhou, Xiang-Dong			Akt1 Enhances CA916798 Expression through mTOR Pathway	PLOS ONE			English	Article							LUNG-CANCER CELLS; DRUG-RESISTANCE; KINASE; CHEMOTHERAPY; INHIBITION; PI3K/AKT; MECHANISMS; APOPTOSIS; INVASION; PROTEIN	Multi-drug resistance leads to the failure of chemotherapy for cancers. Our previous study showed that overexpression of CA916798 led to multi-drug resistance. However, the underlying mechanisms remain unknown. In the current study, we observed that the levels of phosphorylated AKT, phosphorylated mTOR and CA916798 all increased in the drug resistant human adenocarcinoma samples and paralleled with the change of drug resistance. The results of immunofluorescence and Co-IP indicated that the positive correlation of CA916798 expression with AKT1 activation might be associated with drug resistance of lung adenocarcinoma. Furthermore, AKT1 stimulated CA916798 expression through mTOR pathway in both A549 and A549/CDDP cell lines, which was also observed in the xenografted tumor in nude mice. The results showed that CA916798 located in the downstream of PI3K/AKT/mTOR pathway. Inhibition of PI3K by LY294002 could efficiently reduce CA916798 expression and tumor size in vivo as well. Additionally, LY294002 combined with rapamycin inhibited CA916798 expression and tumor size stronger than LY294002 alone. Our findings may also provide a new explanation for synergistic anti-tumor effects of PI3K and mTORC1 inhibitors.	[Wang, Yu-Liang; Zhu, Bing-Jing; Qi, Zhan-Zhong; Wang, Hai-Jing; Zhou, Xiang-Dong] Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China	Army Medical University	Zhou, XD (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China.	xiangdongzhou@126.com			Chinese National Natural Science Foundation [CA916798, 30971308]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The study was supported by Chinese National Natural Science Foundation: CA916798 induce cisplatin resistance in lung cancer through PI3K/AKT pathway (30971308) [http://www.nsfc.gov.cn/Portal0/default124.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Bocca C, 2010, CHEM-BIOL INTERACT, V183, P187, DOI 10.1016/j.cbi.2009.09.022; Brognard J, 2001, CANCER RES, V61, P3986; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chen JZ, 2010, CHEM-BIOL INTERACT, V186, P250, DOI 10.1016/j.cbi.2010.03.052; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Gu M, 2009, CANCER RES, V69, P9465, DOI 10.1158/0008-5472.CAN-09-2805; Hosoi H, 1999, CANCER RES, V59, P886; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; KOBERLE B, 2010, BIOCH BIOPHYS ACTA; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Liu DX, 2009, CANCER RES, V69, P7311, DOI 10.1158/0008-5472.CAN-09-1077; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Ma Patrick C, 2012, Cleve Clin J Med, V79 Electronic Suppl 1, peS56, DOI 10.3949/ccjm.79.s2.12; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Paez Juan, 2003, Cancer Treat Res, V115, P145; Papadimitrakopoulou V., 2012, J THORAC ONCOL; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; Seufferlein T, 1996, CANCER RES, V56, P3895; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Tsvetkova E, 2012, CURR ONCOL, V19, pS45, DOI 10.3747/co.19.1113; Tykodi SS, 2008, CLIN CANCER RES, V14, P5260, DOI 10.1158/1078-0432.CCR-08-0028; Wang HJ, 2011, ASIAN PAC J CANCER P, V12, P3403; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020899; Yin P, 2012, CELL SIGNAL, V24, P1229, DOI 10.1016/j.cellsig.2012.02.003; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561; Zhou Xiang-dong, 2002, Ai Zheng, V21, P341	35	4	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62327	10.1371/journal.pone.0062327	http://dx.doi.org/10.1371/journal.pone.0062327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667466	gold, Green Submitted, Green Published			2022-12-27	WOS:000319055600021
J	Foster, JM; Moreno, P; Fabregat, A; Hermjakob, H; Steinbeck, C; Apweiler, R; Wakelam, MJO; Vizcaino, JA				Foster, Joseph M.; Moreno, Pablo; Fabregat, Antonio; Hermjakob, Henning; Steinbeck, Christoph; Apweiler, Rolf; Wakelam, Michael J. O.; Vizcaino, Juan Antonio			LipidHome: A Database of Theoretical Lipids Optimized for High Throughput Mass Spectrometry Lipidomics	PLOS ONE			English	Article							ELECTROSPRAY-IONIZATION; PHOSPHOLIPIDS	Protein sequence databases are the pillar upon which modern proteomics is supported, representing a stable reference space of predicted and validated proteins. One example of such resources is UniProt, enriched with both expertly curated and automatic annotations. Taken largely for granted, similar mature resources such as UniProt are not available yet in some other "omics" fields, lipidomics being one of them. While having a seasoned community of wet lab scientists, lipidomics lies significantly behind proteomics in the adoption of data standards and other core bioinformatics concepts. This work aims to reduce the gap by developing an equivalent resource to UniProt called 'LipidHome', providing theoretically generated lipid molecules and useful metadata. Using the 'FASTLipid' Java library, a database was populated with theoretical lipids, generated from a set of community agreed upon chemical bounds. In parallel, a web application was developed to present the information and provide computational access via a web service. Designed specifically to accommodate high throughput mass spectrometry based approaches, lipids are organised into a hierarchy that reflects the variety in the structural resolution of lipid identifications. Additionally, cross-references to other lipid related resources and papers that cite specific lipids were used to annotate lipid records. The web application encompasses a browser for viewing lipid records and a 'tools' section where an MS1 search engine is currently implemented. LipidHome can be accessed at http://www.ebi.ac.uk/apweiler-srv/lipidhome.	[Foster, Joseph M.; Moreno, Pablo; Fabregat, Antonio; Hermjakob, Henning; Steinbeck, Christoph; Apweiler, Rolf; Vizcaino, Juan Antonio] European Bioinformat Inst, EMBL Outstn, Cambridge, England; [Wakelam, Michael J. O.] Babraham Inst, Cambridge, England	European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Foster, JM (corresponding author), European Bioinformat Inst, EMBL Outstn, Wellcome Trust Genome Campus, Cambridge, England.	jfoster@ebi.ac.uk	Vizcaino, Juan Antonio/C-3691-2009; Moreno, Pablo/AAC-7057-2020; Hermjakob, Henning/AFM-3497-2022	Vizcaino, Juan Antonio/0000-0002-3905-4335; Moreno, Pablo/0000-0002-9856-1679; Hermjakob, Henning/0000-0001-8479-0262; Apweiler, Rolf/0000-0001-7078-200X; Steinbeck, Christoph/0000-0001-6966-0814; Wakelam, Michael/0000-0003-4059-9276; Fabregat Mundo, Antonio/0000-0002-3288-8599	BBSRC CASE studentship; BBSRC; Philips; EU FP7 grant LipidomicNet [202272]; EU FP7 grant ProteomeXchange [260558]; Wellcome Trust [WT085949MA]; EMBL Student Fellowship; BBSRC [BBS/E/B/0000S227, BBS/E/B/000C0415] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415, BBS/E/B/0000S227] Funding Source: researchfish	BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Philips; EU FP7 grant LipidomicNet; EU FP7 grant ProteomeXchange; Wellcome Trust(Wellcome TrustEuropean Commission); EMBL Student Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JMF is supported by a BBSRC CASE studentship funded by the BBSRC and Philips. MJOW, AF and JAV are supported by the EU FP7 grant LipidomicNet [grant number 202272]. JAV is also supported by the EU FP7 grant ProteomeXchange [grant number 260558] and by the Wellcome Trust [grant number WT085949MA]. MJOW is also supported by the BBSRC. PM is supported by an EMBL Student Fellowship. (http://www.bbsrc.ac.uk/home/home.aspx; http://www.embl.de; http://cordis.europa.eu/fp7/home_en.html; http://www.research.philips.com/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Brown SHJ, 2011, BBA-MOL CELL BIOL L, V1811, P807, DOI 10.1016/j.bbalip.2011.04.015; CAFFREY M, 1992, CHEM PHYS LIPIDS, V61, P1, DOI 10.1016/0009-3084(92)90002-7; Cotter D, 2006, NUCLEIC ACIDS RES, V34, pD507, DOI 10.1093/nar/gkj122; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; de Matos P, 2010, NUCLEIC ACIDS RES, V38, pD249, DOI 10.1093/nar/gkp886; Fahy E, 2011, BBA-MOL CELL BIOL L, V1811, P637, DOI 10.1016/j.bbalip.2011.06.009; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Gorden DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022775; Han XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021643; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Herzog R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029851; Hsu FF, 2008, J AM SOC MASS SPECTR, V19, P1673, DOI 10.1016/j.jasms.2008.07.007; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Hu CX, 2011, MOL BIOSYST, V7, P3271, DOI 10.1039/c1mb05342f; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KIM HY, 1994, ANAL CHEM, V66, P3977, DOI 10.1021/ac00094a020; Liebisch G, 2013, J LIPID RES IN PRESS; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Oresic M, 2013, SCI NATURE, V2, P26; Oresic M, 2012, GENOME MED, V4, DOI 10.1186/gm300; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Rebholz-Schuhmann D, 2008, BIOINFORMATICS, V24, P296, DOI 10.1093/bioinformatics/btm557; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Sud M, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-23; Watanabe K, 2000, TRENDS GLYCOSCI GLYC, V12, P175, DOI 10.4052/tigg.12.175	29	45	47	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61951	10.1371/journal.pone.0061951	http://dx.doi.org/10.1371/journal.pone.0061951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667450	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700019
J	Singh, H; Ansari, HR; Raghava, GPS				Singh, Harinder; Ansari, Hifzur Rahman; Raghava, Gajendra P. S.			Improved Method for Linear B-Cell Epitope Prediction Using Antigen's Primary Sequence	PLOS ONE			English	Article							PROTEIN; RESIDUES; NETWORK; SETS	One of the major challenges in designing a peptide-based vaccine is the identification of antigenic regions in an antigen that can stimulate B-cell's response, also called B-cell epitopes. In the past, several methods have been developed for the prediction of conformational and linear (or continuous) B-cell epitopes. However, the existing methods for predicting linear B-cell epitopes are far from perfection. In this study, an attempt has been made to develop an improved method for predicting linear B-cell epitopes. We have retrieved experimentally validated B-cell epitopes as well as non B-cell epitopes from Immune Epitope Database and derived two types of datasets called Lbtope_Variable and Lbtope_Fixed length datasets. The Lbtope_Variable dataset contains 14876 B-cell epitope and 23321 non-epitopes of variable length where as Lbtope_Fixed length dataset contains 12063 B-cell epitopes and 20589 non-epitopes of fixed length. We also evaluated the performance of models on above datasets after removing highly identical peptides from the datasets. In addition, we have derived third dataset Lbtope_Confirm having 1042 epitopes and 1795 non-epitopes where each epitope or non-epitope has been experimentally validated in at least two studies. A number of models have been developed to discriminate epitopes and non-epitopes using different machine-learning techniques like Support Vector Machine, and K-Nearest Neighbor. We achieved accuracy from similar to 54% to 86% using diverse s features like binary profile, dipeptide composition, AAP (amino acid pair) profile. In this study, for the first time experimentally validated non B-cell epitopes have been used for developing method for predicting linear B-cell epitopes. In previous studies, random peptides have been used as non B-cell epitopes. In order to provide service to scientific community, a web server LBtope has been developed for predicting and designing B-cell epitopes (http://crdd.osdd.net/raghava/lbtope/).	[Singh, Harinder; Ansari, Hifzur Rahman; Raghava, Gajendra P. S.] Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raghava, GPS (corresponding author), Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.	raghava@imtech.res.in	Singh, Harinder/V-7699-2019; Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009	Singh, Harinder/0000-0003-4897-9759; Raghava, Gajendra P.S./0000-0002-8902-2876; Ansari, Hifzur Rahman/0000-0002-0646-1743	Council of Scientific and Industrial Research (CSIR), Government of India; Department of Biotechnology (DBT), Government of India	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	The authors are thankful to the Council of Scientific and Industrial Research (CSIR) and Department of Biotechnology (DBT), Government of India for financial assistance is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024039; Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Bryson CJ, 2010, BIODRUGS, V24, P1, DOI 10.2165/11318560-000000000-00000; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Dudek NL, 2010, CURR PHARM DESIGN, V16, P3149; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; Huang J, 2007, GENOME INFORM SER, V19, P40; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Steere AC, 2011, CLIN INFECT DIS, V52, pS259, DOI 10.1093/cid/ciq117; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Tomar N, 2010, IMMUNOLOGY, V131, P153, DOI 10.1111/j.1365-2567.2010.03330.x; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Xingdong Y, 2009, REV MED VIROL, V19, P77; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; [No title captured]	22	157	166	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62216	10.1371/journal.pone.0062216	http://dx.doi.org/10.1371/journal.pone.0062216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667458	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700025
J	Brotons, L; Aquilue, N; de Caceres, M; Fortin, MJ; Fall, A				Brotons, Lluis; Aquilue, Nuria; de Caceres, Miquel; Fortin, Marie-Josee; Fall, Andrew			How Fire History, Fire Suppression Practices and Climate Change Affect Wildfire Regimes in Mediterranean Landscapes	PLOS ONE			English	Article							CATALONIA NE SPAIN; MANAGEMENT STRATEGIES; BOREAL FORESTS; WILDLAND FIRE; MODELS; DYNAMICS; FUELS; RISK; REEXAMINATION; ECOSYSTEMS	Available data show that future changes in global change drivers may lead to an increasing impact of fires on terrestrial ecosystems worldwide. Yet, fire regime changes in highly humanised fire-prone regions are difficult to predict because fire effects may be heavily mediated by human activities We investigated the role of fire suppression strategies in synergy with climate change on the resulting fire regimes in Catalonia (north-eastern Spain). We used a spatially-explicit fire-succession model at the landscape level to test whether the use of different firefighting opportunities related to observed reductions in fire spread rates and effective fire sizes, and hence changes in the fire regime. We calibrated this model with data from a period with weak firefighting and later assess the potential for suppression strategies to modify fire regimes expected under different levels of climate change. When comparing simulations with observed fire statistics from an eleven-year period with firefighting strategies in place, our results showed that, at least in two of the three sub-regions analysed, the observed fire regime could not be reproduced unless taking into account the effects of fire suppression. Fire regime descriptors were highly dependent on climate change scenarios, with a general trend, under baseline scenarios without fire suppression, to large-scale increases in area burnt. Fire suppression strategies had a strong capacity to compensate for climate change effects. However, strong active fire suppression was necessary to accomplish such compensation, while more opportunistic fire suppression strategies derived from recent fire history only had a variable, but generally weak, potential for compensation of enhanced fire impacts under climate change. The concept of fire regime in the Mediterranean is probably better interpreted as a highly dynamic process in which the main determinants of fire are rapidly modified by changes in landscape, climate and socioeconomic factors such as fire suppression strategies.	[Brotons, Lluis; Aquilue, Nuria; de Caceres, Miquel] CTFC, Area Biodiversitat, Grp Ecol Paisatge, Solsona, Catalonia, Spain; [Brotons, Lluis; Aquilue, Nuria; de Caceres, Miquel] CREAF, Bellaterra, Spain; [Fortin, Marie-Josee] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Fall, Andrew] Simon Fraser Univ, Lasqueti, BC, Canada; [Fall, Andrew] Gowlland Technol Ltd, Lasqueti, BC, Canada	Centre Tecnologic Forestal de Catalunya (CTFC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Toronto; Simon Fraser University	Brotons, L (corresponding author), CTFC, Area Biodiversitat, Grp Ecol Paisatge, Solsona, Catalonia, Spain.	lluis.brotons@ctfc.cat	Aquilué, Núria/AAA-6149-2020; Brotons, Lluís/D-1570-2009; De Caceres, Miquel/I-1279-2016	Aquilué, Núria/0000-0001-7911-3144; Brotons, Lluís/0000-0002-4826-4457; De Caceres, Miquel/0000-0001-7132-2080	Spanish Ministry of Education and Science (MEC) [CGL2008-05506-C02-01/BOS, CGL2011-29539/BOS, CSD2008-00040]; Catalan government [2010 BE 272]; 'Beatriu de Pinos' Programme [2009 BP-B 00342]	Spanish Ministry of Education and Science (MEC)(Spanish Government); Catalan government; 'Beatriu de Pinos' Programme	This study has received financial support from the projects CGL2008-05506-C02-01/BOS, CGL2011-29539/BOS and Consolider Montes CSD2008-00040 granted by the Spanish Ministry of Education and Science (MEC). Additional funding to LB and MC was received from the Catalan government through projects 2010 BE 272 and the 'Beatriu de Pinos' Programme (2009 BP-B 00342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 01886174.	Arienti MC, 2006, CAN J FOREST RES, V36, P3155, DOI 10.1139/X06-188; BAKER WL, 1992, ECOLOGY, V73, P1879, DOI 10.2307/1940039; Bridge SRJ, 2005, FOREST SCI, V51, P41; Brotons L, 2005, J BIOGEOGR, V32, P789, DOI 10.1111/j.1365-2699.2004.01195.x; Castellnou M, 2009, P 5 C FOR ESP AV SPA; Cui W, 2008, INT J WILDLAND FIRE, V17, P234, DOI 10.1071/WF06145; Cumming SG, 2005, CAN J FOREST RES, V35, P772, DOI 10.1139/X04-174; DeWilde L, 2006, ECOSYSTEMS, V9, P1342, DOI 10.1007/s10021-006-0095-0; Diaz-Delgado R, 2004, LANDSCAPE ECOL, V19, P731, DOI 10.1007/s10980-005-0183-1; Diaz-Delgado R, 2004, INT J WILDLAND FIRE, V13, P89, DOI 10.1071/WF02051; Fall A, 2004, CAN J FOREST RES, V34, P310, DOI [10.1139/x03-143, 10.1139/X03-143]; Fall A, 2001, ECOL MODEL, V141, P1, DOI 10.1016/S0304-3800(01)00334-9; Flannigan MD, 2009, INT J WILDLAND FIRE, V18, P483, DOI 10.1071/WF08187; Gill AM, 2008, INT J WILDLAND FIRE, V17, P688, DOI 10.1071/WF07145; Gonzalez JR, 2007, EUR J FOREST RES, V126, P421, DOI 10.1007/s10342-006-0164-0; Gracia C, 2000, INVENTARI ECOLOGIC F; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hessl AE, 2011, PROG PHYS GEOG, V35, P393, DOI 10.1177/0309133311407654; Ibanez J. J., 2002, PERSPECTIVES TERRITO, V3, P10; James PMA, 2007, ECOSYSTEMS, V10, P1261, DOI 10.1007/s10021-007-9095-y; Keane RE, 2004, ECOL MODEL, V179, P3, DOI 10.1016/j.ecolmodel.2004.03.015; Keeley JE, 1999, SCIENCE, V284, P1829, DOI 10.1126/science.284.5421.1829; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Lloret F, 2007, ECOLOGY, V88, P2270, DOI 10.1890/06-1195.1; Lloret F, 2001, FOREST ECOL MANAG, V141, P155, DOI 10.1016/S0378-1127(00)00323-6; Loepfe L, 2011, ENVIRON MODELL SOFTW, V26, P1028, DOI 10.1016/j.envsoft.2011.02.015; Minnich RA, 2001, CONSERV BIOL, V15, P1549, DOI 10.1046/j.1523-1739.2001.01067.x; Miyanishi K, 2001, CAN J FOREST RES, V31, P1462, DOI 10.1139/cjfr-31-8-1462; Mladenoff DJ, 2004, ECOL MODEL, V180, P7, DOI 10.1016/j.ecolmodel.2004.03.016; Moghaddas JJ, 2007, INT J WILDLAND FIRE, V16, P673, DOI 10.1071/WF06066; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Moriondo M, 2006, CLIM RES, V31, P85, DOI 10.3354/cr031085; Moritz MA, 2003, ECOLOGY, V84, P351, DOI 10.1890/0012-9658(2003)084[0351:SAOCOS]2.0.CO;2; Mouillot F, 2003, LANDSCAPE ECOL, V18, P665, DOI 10.1023/B:LAND.0000004182.22525.a9; Pausas JG, 2012, GLOBAL ECOL BIOGEOGR; Pausas JG, 2011, CLIMATIC CHANGE, P1, DOI [10.1007/s10584-011-0060-6, DOI 10.1007/S10584-011-0060-6]; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Peix J., 1999, FOC VERD 2 PROGRAMA; Pennanen J, 2002, FOREST ECOL MANAG, V164, P157, DOI 10.1016/S0378-1127(01)00608-9; Perry GLW, 2006, PROG PHYS GEOG, V30, P47, DOI 10.1191/0309133306pp469ra; Pinol J, 1998, CLIMATIC CHANGE, V38, P345, DOI 10.1023/A:1005316632105; Pinol J, 2005, ECOL MODEL, V183, P397, DOI 10.1016/j.ecolmodel.2004.09.001; Pinol J, 2007, ECOL MODEL, V207, P34, DOI 10.1016/j.ecolmodel.2007.03.020; Podur J, 2010, ECOL MODEL, V221, P1301, DOI 10.1016/j.ecolmodel.2010.01.013; Preisler HK, 2011, INT J WILDLAND FIRE, V20, P508, DOI 10.1071/WF09087; Rodrigo A, 2004, ECOLOGY, V85, P716, DOI 10.1890/02-0492; Rothermel R., 1972, MATH MODEL PREDICTIN; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Schoennagel T, 2008, INT J WILDLAND FIRE, V17, P742, DOI 10.1071/WF07146; Sharples JJ, 2010, ENVIRON MODELL SOFTW, V25, P1099, DOI 10.1016/j.envsoft.2010.03.016; Sturtevant BR, 2009, ECOSYSTEMS, V12, P445, DOI 10.1007/s10021-009-9234-8; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Telesca L, 2010, NAT HAZARD EARTH SYS, V10, P723, DOI 10.5194/nhess-10-723-2010; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Vallecillo S, 2009, ECOL APPL, V19, P538, DOI 10.1890/08-0348.1; Villanueva JA, 2004, TERCER INVENTARIO FO; Wang Z, 2010, SCIENCE, V330, P1663, DOI 10.1126/science.1197257; Ward PC, 2001, CAN J FOREST RES, V31, P1467, DOI 10.1139/cjfr-31-8-1467; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834	60	118	120	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62392	10.1371/journal.pone.0062392	http://dx.doi.org/10.1371/journal.pone.0062392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658726	gold, Green Submitted, Green Published			2022-12-27	WOS:000321200500025
J	Buarque, DS; Braz, GRC; Martins, RM; Tanaka-Azevedo, AM; Gomes, CM; Oliveira, FAA; Schenkman, S; Tanaka, AS				Buarque, Diego S.; Braz, Gloria R. C.; Martins, Rafael M.; Tanaka-Azevedo, Anita M.; Gomes, Cicera M.; Oliveira, Felipe A. A.; Schenkman, Sergio; Tanaka, Aparecida S.			Differential Expression Profiles in the Midgut of Triatoma infestans Infected with Trypanosoma cruzi	PLOS ONE			English	Article							RHODNIUS-PROLIXUS; BLOODSUCKING BUG; SEQUENCE CHARACTERIZATION; BRASILIENSIS HEMIPTERA; THROMBIN INHIBITOR; SALIVARY-GLANDS; VECTOR; IDENTIFICATION; DATABASE; INSECT	Chagas disease, or American trypanosomiasis, is a parasitic disease caused by the protozoan Trypanosoma cruzi and is transmitted by insects from the Triatominae subfamily. To identify components involved in the protozoan-vector relationship, we constructed and analyzed cDNA libraries from RNA isolated from the midguts of uninfected and T. cruzi-infected Triatoma infestans, which are major vectors of Chagas disease. We generated approximately 440 high-quality Expressed Sequence Tags (ESTs) from each T. infestans midgut cDNA library. The sequences were grouped in 380 clusters, representing an average length of 664.78 base pairs (bp). Many clusters were not classified functionally, representing unknown transcripts. Several transcripts involved in different processes (e. g., detoxification) showed differential expression in response to T. cruzi infection. Lysozyme, cathepsin D, a nitrophorin-like protein and a putative 14 kDa protein were significantly upregulated upon infection, whereas thioredoxin reductase was downregulated. In addition, we identified several transcripts related to metabolic processes or immunity with unchanged expressions, including infestin, lipocalins and defensins. We also detected ESTs encoding juvenile hormone binding protein (JHBP), which seems to be involved in insect development and could be a target in control strategies for the vector. This work demonstrates differential gene expression upon T. cruzi infection in the midgut of T. infestans. These data expand the current knowledge regarding vector-parasite interactions for Chagas disease.	[Buarque, Diego S.; Oliveira, Felipe A. A.; Tanaka, Aparecida S.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biochem, Sao Paulo, Brazil; [Braz, Gloria R. C.] Univ Fed Rio de Janeiro, Inst Quim, Dept Biochem, Rio De Janeiro, Brazil; [Martins, Rafael M.] Inst Pasteur, Biol Host Parasite Interact Unit, Paris, France; [Tanaka-Azevedo, Anita M.; Gomes, Cicera M.] Inst Butantan, Lab Herpetol, Sao Paulo, Brazil; [Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP)	Tanaka, AS (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Biochem, Sao Paulo, Brazil.	tanaka.bioq@epm.br	Schenkman, Sergio/A-9227-2013; Tanaka, Aparecida/ADF-5338-2022; Azevedo, Anita M Tanaka/B-3429-2014; Tanaka, Aparecida S/L-8754-2017; Buarque, Diego S/C-9803-2012	Schenkman, Sergio/0000-0001-9353-8480; Azevedo, Anita M Tanaka/0000-0002-4694-4475; Tanaka, Aparecida S/0000-0001-9407-805X; miyazawa martins, rafael/0000-0001-7449-0696	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/03514-9, 2007/58973-3, 2012/00723-0, 2012/03657-8]; Conselho Nacional de Desenvolvimento Tecnologico (CNPq); INCT - Entomologia Molecular	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT - Entomologia Molecular	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Proc. no. 2005/03514-9; Proc no. 2007/58973-3; Proc. no. 2012/00723-0 and Proc. no. 2012/03657-8), Conselho Nacional de Desenvolvimento Tecnologico (CNPq), and INCT - Entomologia Molecular. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2007, MICROBE; Araujo CAC, 2006, INSECT BIOCHEM MOLEC, V36, P547, DOI 10.1016/j.ibmb.2006.04.003; Araujo RN, 2007, INT J PARASITOL, V37, P1351, DOI 10.1016/j.ijpara.2007.04.017; Ascenzi P, 2002, IUBMB LIFE, V53, P121, DOI [10.1080/10399710290039016, 10.1080/15216540211472]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assumpcao TCF, 2008, INSECT BIOCHEM MOLEC, V38, P213, DOI 10.1016/j.ibmb.2007.11.001; Avila ML, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-39; Balczun C, 2012, INSECT BIOCHEM MOLEC, V42, P240, DOI 10.1016/j.ibmb.2011.12.006; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Blanco E, 2002, CURRENT PROTOCOLS BI; Buarque DS, 2011, BIOCHEM BIOPH RES CO, V413, P241, DOI 10.1016/j.bbrc.2011.08.078; Bussacos ACM, 2011, J PROTEOMICS, V74, P1693, DOI 10.1016/j.jprot.2011.04.028; Campos ITN, 2004, FEBS LETT, V577, P512, DOI 10.1016/j.febslet.2004.10.052; Campos ITN, 2002, INSECT BIOCHEM MOLEC, V32, P991, DOI 10.1016/S0965-1748(02)00035-8; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Guo YJ, 2009, BIOINFORMATICS, V25, P1195, DOI 10.1093/bioinformatics/btp129; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kato H, 2010, INFECT GENET EVOL, V10, P184, DOI 10.1016/j.meegid.2009.10.012; Kollien AH, 1998, AM J TROP MED HYG, V59, P166, DOI 10.4269/ajtmh.1998.59.166; Kollien AH, 2003, ARCH INSECT BIOCHEM, V53, P134, DOI 10.1002/arch.10090; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez L, 2003, INSECT BIOCHEM MOLEC, V33, P439, DOI 10.1016/S0965-1748(03)00008-0; Lovato DV, 2011, EXP PARASITOL, V129, P362, DOI 10.1016/j.exppara.2011.09.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Medeiros MN, 2011, INSECT BIOCHEM MOLEC, V41, P823, DOI 10.1016/j.ibmb.2011.06.004; MELLO CB, 1995, J INVERTEBR PATHOL, V65, P261, DOI 10.1006/jipa.1995.1040; Mesquita RD, 2008, INFECT IMMUN, V76, P5543, DOI 10.1128/IAI.00683-08; Paes Marcia Cristina, 2011, Journal of Parasitology Research, V2011, DOI 10.1155/2011/174614; Piacenza L, 2012, ANTIOXID RE IN PRESS; Raj PA, 2002, FEMS MICROBIOL LETT, V206, P9, DOI 10.1111/j.1574-6968.2002.tb10979.x; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos A, 2007, INSECT BIOCHEM MOLEC, V37, P702, DOI 10.1016/j.ibmb.2007.04.004; Scharfstein Julio, 2008, V47, P140; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Ursic-Bedoya R, 2011, INSECT MOL BIOL, V20, P775, DOI 10.1111/j.1365-2583.2011.01107.x; Ursic-Bedoya RJ, 2008, J INSECT PHYSIOL, V54, P593, DOI 10.1016/j.jinsphys.2007.12.009; Ursic-Bedoya RJ, 2007, DEV COMP IMMUNOL, V31, P109, DOI 10.1016/j.dci.2006.05.008; Waniek PJ, 2011, VECTOR-BORNE ZOONOT, V11, P845, DOI 10.1089/vbz.2010.0020; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; [No title captured]; [No title captured]	51	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61203	10.1371/journal.pone.0061203	http://dx.doi.org/10.1371/journal.pone.0061203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658688	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500005
J	Guerrero, OA; Axtell, RL				Guerrero, Omar A.; Axtell, Robert L.			Employment Growth through Labor Flow Networks	PLOS ONE			English	Article							ECONOMIC NETWORKS; INTERNET; ORIGINS; MODEL	It is conventional in labor economics to treat all workers who are seeking new jobs as belonging to a labor pool, and all firms that have job vacancies as an employer pool, and then match workers to jobs. Here we develop a new approach to study labor and firm dynamics. By combining the emerging science of networks with newly available employment microdata, comprehensive at the level of whole countries, we are able to broadly characterize the process through which workers move between firms. Specifically, for each firm in an economy as a node in a graph, we draw edges between firms if a worker has migrated between them, possibly with a spell of unemployment in between. An economy's overall graph of firm-worker interactions is an object we call the labor flow network (LFN). This is the first study that characterizes a LFN for an entire economy. We explore the properties of this network, including its topology, its community structure, and its relationship to economic variables. It is shown that LFNs can be useful in identifying firms with high growth potential. We relate LFNs to other notions of high performance firms. Specifically, it is shown that fewer than 10% of firms account for nearly 90% of all employment growth. We conclude with a model in which empirically-salient LFNs emerge from the interaction of heterogeneous adaptive agents in a decentralized labor market.	[Guerrero, Omar A.; Axtell, Robert L.] George Mason Univ, Dept Computat Social Sci, Fairfax, VA 22030 USA; [Guerrero, Omar A.; Axtell, Robert L.] George Mason Univ, Ctr Social Complex, Fairfax, VA 22030 USA; [Axtell, Robert L.] Santa Fe Inst, Santa Fe, NM 87501 USA	George Mason University; George Mason University; The Santa Fe Institute	Guerrero, OA (corresponding author), George Mason Univ, Dept Computat Social Sci, Fairfax, VA 22030 USA.	oguerrer@gmail.com	Axtell, Robert/A-4376-2009	Axtell, Robert/0000-0002-7187-2960; Guerrero, Omar A./0000-0003-4039-1811				Acemoglu D, 2012, ECONOMETRICA, V80, P1977, DOI 10.3982/ECTA9623; Acs ZJ, 2011, HANDBOOK OF RESEARCH ON ENTREPRENEURSHIP AND REGIONAL DEVELOPMENT: NATIONAL AND REGIONAL PERSPECTIVES, P133; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Alvarez-Hamelin JI, 2005, ARXIV PREPRINT CS050; Atalay E, 2011, P NATL ACAD SCI USA, V108, P5199, DOI 10.1073/pnas.1015564108; Axtell R, 2011, MANY AGENT FIR UNPUB; Axtell R.J., 1999, EMERGENCE FIRMS POPU; Bala V, 2000, ECONOMETRICA, V68, P1181, DOI 10.1111/1468-0262.00155; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Birch D.G., 1987, JOB CREATION AM OUR; BIRCH DL, 1981, PUBLIC INTEREST, P3; Birch L.D., 1994, LABOR MARKETS EMPLOY, P159, DOI DOI 10.4324/9780429046834-7; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Davis S.J., 1998, JOB CREATION DESTRUC; Fagiolo G, 2013, J ECON INTERACT COOR, V8, P75, DOI 10.1007/s11403-012-0104-7; Fallick Bruce C., 2001, WORKING PAPER; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gabaix X, 2011, ECONOMETRICA, V79, P733, DOI 10.3982/ECTA8769; Galeotti A, 2010, AM ECON REV, V100, P1468, DOI 10.1257/aer.100.4.1468; Gianelle C, 2011, WORKING PAPER; Gibrat R., 1931, INEGALITES EC; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; Haltiwanger John C., 2010, 16300 NAT BUR EC RES; Heckman JJ, 2006, J LABOR ECON, V24, P411, DOI 10.1086/504455; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026107; Ilmakunnas P, 2005, APPL ECON, V37, P1115, DOI 10.1080/00036840500109621; Jackson MO, 1996, J ECON THEORY, V71, P44, DOI 10.1006/jeth.1996.0108; Konno T, 2009, ECONOMICS-KIEL, V3; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Maliranta M, 2008, LABOUR FLOW PATHS IN; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MORTENSEN DT, 1994, REV ECON STUD, V61, P397, DOI 10.2307/2297896; Nagypal E., 2008, WORKER REALLOC UNPUB; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; OECD, 2007, EUROSTAT OECD MAN BU; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Saito YU, 2007, PHYSICA A, V383, P158, DOI 10.1016/j.physa.2007.04.097; Schmutte I, 2010, WORKING PAPER; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Serrano MA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036133; SIMON HA, 1955, BIOMETRIKA, V42, P425; Souma W., 2006, PRACTICAL FRUITS ECO, P307, DOI [10.1007/4-431-28915-1_56, DOI 10.1007/4-431-28915-1_]; Stewart J., 2002, RECENT TRENDS JOB ST; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	50	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e60808	10.1371/journal.pone.0060808	http://dx.doi.org/10.1371/journal.pone.0060808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AF	23658682	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500003
J	Morisset, D; Stebih, D; Milavec, M; Gruden, K; Zel, J				Morisset, Dany; Stebih, Dejan; Milavec, Mojca; Gruden, Kristina; Zel, Jana			Quantitative Analysis of Food and Feed Samples with Droplet Digital PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENETICALLY-MODIFIED ORGANISMS; MODIFIED MAIZE EVENTS; DNA COPY NUMBER; MULTIPLEX PCR; QUANTIFICATION	In this study, the applicability of droplet digital PCR (ddPCR) for routine analysis in food and feed samples was demonstrated with the quantification of genetically modified organisms (GMOs). Real-time quantitative polymerase chain reaction (qPCR) is currently used for quantitative molecular analysis of the presence of GMOs in products. However, its use is limited for detecting and quantifying very small numbers of DNA targets, as in some complex food and feed matrices. Using ddPCR duplex assay, we have measured the absolute numbers of MON810 transgene and hmg maize reference gene copies in DNA samples. Key performance parameters of the assay were determined. The ddPCR system is shown to offer precise absolute and relative quantification of targets, without the need for calibration curves. The sensitivity (five target DNA copies) of the ddPCR assay compares well with those of individual qPCR assays and of the chamber digital PCR (cdPCR) approach. It offers a dynamic range over four orders of magnitude, greater than that of cdPCR. Moreover, when compared to qPCR, the ddPCR assay showed better repeatability at low target concentrations and a greater tolerance to inhibitors. Finally, ddPCR throughput and cost are advantageous relative to those of qPCR for routine GMO quantification. It is thus concluded that ddPCR technology can be applied for routine quantification of GMOs, or any other domain where quantitative analysis of food and feed samples is needed.	[Morisset, Dany; Stebih, Dejan; Milavec, Mojca; Gruden, Kristina; Zel, Jana] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia	National Institute of Biology - Slovenia	Morisset, D (corresponding author), Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia.	dany.morisset@nib.si	Gruden, kristina/AAI-6439-2020; Milavec, Mojca/AAM-2674-2020	Milavec, Mojca/0000-0002-5794-2109; gruden, kristina/0000-0001-5906-8569; Morisset, Dany/0000-0001-8967-9424	Slovenian Research Agency [P4 0165]; Slovenian Ministry of Economic Development and Technology, Metrology Institute (MIRS) [640118/2008/67]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Slovenian Ministry of Economic Development and Technology, Metrology Institute (MIRS)	The work was supported by the Slovenian Research Agency (grant Nos.: P4 0165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We thank Prof. Dr. Roger Pain for reviewing the manuscript. This work was co-financed by the Slovenian Ministry of Economic Development and Technology, Metrology Institute (MIRS) in the frame of the contract no. 640118/2008/67 on performing activities as holder of the national standard MIRS/NIB/FITO for the amount of substance in food of plant origin..	Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; Berdal KG, 2008, EUR FOOD RES TECHNOL, V227, P1149, DOI 10.1007/s00217-008-0830-1; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; Burns MJ, 2010, EUR FOOD RES TECHNOL, V231, P353, DOI 10.1007/s00217-010-1277-8; Cankar K, 2008, ANAL BIOCHEM, V376, P189, DOI 10.1016/j.ab.2008.02.013; Cankar K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-37; Chaouachi M, 2008, J AGR FOOD CHEM, V56, P11596, DOI 10.1021/jf801482r; Codex Alimentarius Commission, 2010, GUIDELINES PERFORMAN; Corbisier P, 2010, ANAL BIOANAL CHEM, V396, P2143, DOI 10.1007/s00216-009-3200-3; Devonshire AS, 2012, METHODS IN PRESS; European Union Reference Laboratory for GM Food and Feed, 2006, CRL ASS VAL EV SPEC; European Union Reference Laboratory for GM Food and Feed, 2008, DEF MIN PERF REQ AN; Gruere G. P., 2007, AgBioForum, V10, P51; Heide BR, 2008, EUR FOOD RES TECHNOL, V227, P1125, DOI 10.1007/s00217-008-0828-8; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Holst-Jensen A, 2009, BIOTECHNOL ADV, V27, P1071, DOI 10.1016/j.biotechadv.2009.05.025; Hoorfar J, 2004, APMIS, V112, P808, DOI 10.1111/j.1600-0463.2004.apm11211-1207.x; International Organization for Standardization, 2005, 215702005 ISO; Lee D, 2010, FOOD CHEM, V118, P974, DOI 10.1016/j.foodchem.2008.05.118; Nadal A, 2006, ELECTROPHORESIS, V27, P3879, DOI 10.1002/elps.200600124; Peccoud J, 1996, BIOPHYS J, V71, P101, DOI 10.1016/S0006-3495(96)79205-6; Pekin D, 2011, LAB CHIP, V11, P2156, DOI 10.1039/c1lc20128j; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c; Settanni L, 2007, J MICROBIOL METH, V69, P1, DOI 10.1016/j.mimet.2006.12.008; Somma M., 2006, TRAINING COURSE ANAL; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Weighardt F., 2006, TRAINING COURSE ANAL, P1; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203	30	180	226	9	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62583	10.1371/journal.pone.0062583	http://dx.doi.org/10.1371/journal.pone.0062583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658750	Green Submitted, Green Published, gold			2022-12-27	WOS:000321200500031
J	Wen, XJ; Xu, SY; Liu, HZ; Zhang, QG; Liang, H; Yang, CX; Wang, HB				Wen, Xianjie; Xu, Shiyuan; Liu, Hongzhen; Zhang, Qinguo; Liang, Hua; Yang, Chenxiang; Wang, Hanbing			RETRACTED: Neurotoxicity Induced by Bupivacaine via T-Type Calcium Channels in SH-SY5Y Cells (Publication with Expression of Concern. See vol. 14, 2019) (Retracted article. See vol. 15, 2020)	PLOS ONE			English	Article; Retracted Publication							DORSAL-ROOT; CHRONIC COMPRESSION; SENSORY NEURONS; CA2+ CHANNELS; ANESTHESIA; EXPRESSION; APOPTOSIS	There is concern regarding neurotoxicity induced by the use of local anesthetics. A previous study showed that an overload of intracellular calcium is involved in the neurotoxic effect of some anesthetics. T-type calcium channels, which lower the threshold of action potentials, can regulate the influx of calcium ions. We hypothesized that T-type calcium channels are involved in bupivacaine-induced neurotoxicity. In this study, we first investigated the effects of different concentrations of bupivacaine on SH-SY5Y cell viability, and established a cell injury model with 1 mM bupivacaine. The cell viability of SH-SY5Y cells was measured following treatment with 1 mM bupivacaine and/or different dosages (10, 50, or 100 mu M) of NNC 55-0396 dihydrochloride, an antagonist of T-type calcium channels for 24 h. In addition, we monitored the release of lactate dehydrogenase, cytosolic Ca2+ ([Ca2+](i)), cell apoptosis and caspase-3 expression. SH-SY5Y cells pretreated with different dosages (10, 50, or 100 mu M) of NNC 55-0396 dihydrochloride improved cell viability, reduced lactate dehydrogenase release, inhibited apoptosis, and reduced caspase-3 expression following bupivacaine exposure. However, the protective effect of NNC 55-0396 dihydrochloride plateaued. Overall, our results suggest that T-type calcium channels may be involved in bupivacaine neurotoxicity. However, identification of the specific subtype of T calcium channels involved requires further investigation.	[Wen, Xianjie; Xu, Shiyuan; Zhang, Qinguo] Southern Med Univ, Zhujiang Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Wen, Xianjie; Liu, Hongzhen; Liang, Hua; Yang, Chenxiang; Wang, Hanbing] Sun Yat Sen Univ, Dept Anesthesiol, Peoples Hosp 1, Foshan & Foshan Hosp, Foshan, Guangdong, Peoples R China	Southern Medical University - China; Sun Yat Sen University	Wen, XJ (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China.	xjwen166@163.com; xushiyuan335@sina.com.cn; 1312713263@qq.com	Wang, Han/GPW-9809-2022		national natural science foundation of China [81100831]; medical research foundation of Guangdong Province [B2011303]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); medical research foundation of Guangdong Province	This study was supported by the national natural science foundation of China (number 81100831) and the medical research foundation of Guangdong Province (number B2011303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black MJ, 2007, ANN SURG ONCOL, V14, P744, DOI 10.1245/s10434-006-9261-z; Capdevila X, 2005, ANESTHESIOLOGY, V103, P1035, DOI 10.1097/00000542-200511000-00018; Cueni L, 2009, PFLUG ARCH EUR J PHY, V457, P1161, DOI 10.1007/s00424-008-0582-6; Dajas-Bailador FA, 2002, J NEUROCHEM, V81, P606, DOI 10.1046/j.1471-4159.2002.00846.x; Franz R, 2011, J CARDIOVASC SURG, V52, P567; Freise H, 2011, BRIT J ANAESTH, V107, P859, DOI 10.1093/bja/aer339; Friederich P, 2002, EUR J ANAESTH, V19, P564, DOI 10.1017/S0265021502000911; Fuchs A, 2007, ANESTHESIOLOGY, V107, P117, DOI 10.1097/01.anes.0000267511.21864.93; Jagodic MM, 2008, J NEUROPHYSIOL, V99, P3151, DOI 10.1152/jn.01031.2007; Johnson ME, 2002, ANESTHESIOLOGY, V97, P1466, DOI 10.1097/00000542-200212000-00019; Kato J, 2011, CAN J ANESTH, V58, P638, DOI 10.1007/s12630-011-9505-7; Kim JA, 2009, EUR J PHARMACOL, V615, P144, DOI 10.1016/j.ejphar.2009.05.007; Kubina P, 1997, REGION ANESTH, V22, P447, DOI 10.1016/S1098-7339(97)80032-6; Leski ML, 1999, BRAIN RES, V828, P27, DOI 10.1016/S0006-8993(99)01270-6; Li M, 2005, CARDIOVASC DRUG REV, V23, P173; Liu YC, 2003, ANAESTH INTENS CARE, V31, P461, DOI 10.1177/0310057X0303100417; Lu J, 2011, EUR J PHARMACOL, V657, P51, DOI 10.1016/j.ejphar.2011.01.055; Lu J, 2011, PHARMACOLOGY, V87, P121, DOI 10.1159/000323402; Mackrill JJ, 1997, BIOCHEM J, V327, P251, DOI 10.1042/bj3270251; Ozcan M, 2010, J RECEPT SIG TRANSD, V30, P115, DOI 10.3109/10799891003630614; Perez-Castro R, 2009, ANESTH ANALG, V108, P997, DOI 10.1213/ane.0b013e31819385e1; Perez-Reyes E, 2006, CELL CALCIUM, V40, P89, DOI 10.1016/j.ceca.2006.04.012; Pollock Julia E, 2003, Best Pract Res Clin Anaesthesiol, V17, P471, DOI 10.1016/S1521-6896(02)00113-1; Wen XJ, 2006, ACTA PHARMACOL SIN, V27, P1547, DOI 10.1111/j.1745-7254.2006.00461.x; Wen XJ, 2010, PHARMACOLOGY, V85, P295, DOI 10.1159/000276981; Wen XJ, 2011, NEURAL REGEN RES, V6, P2410, DOI 10.3969/j.issn.1673-5374.2011.31.002; Yagami T, 2004, BIOCHEM PHARMACOL, V67, P1153, DOI 10.1016/j.bcp.2003.11.005; Yang SF, 2011, REGION ANESTH PAIN M, V36, P444, DOI 10.1097/AAP.0b013e318228c835; Zawadzki A, 2008, DIS COLON RECTUM, V51, P1696, DOI 10.1007/s10350-008-9372-7	29	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62942	10.1371/journal.pone.0062942	http://dx.doi.org/10.1371/journal.pone.0062942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658789	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500046
J	Zhang, JM; Wang, Y; Miao, YJ; Zhang, Y; Wu, YN; Jia, LX; Qi, YF; Du, J				Zhang, Jun-Meng; Wang, Ying; Miao, Yan-Ju; Zhang, Yi; Wu, Yi-Na; Jia, Li-Xin; Qi, Yong-Fen; Du, Jie			Knockout of CD8 Delays Reendothelialization and Accelerates Neointima Formation in Injured Arteries of Mouse via TNF-alpha Inhibiting the Endothelial Cells Migration	PLOS ONE			English	Article							DRUG-ELUTING STENTS; RE-ENDOTHELIALIZATION; VASCULAR INJURY; RESTENOSIS; MODEL; HYPERPLASIA; EXPRESSION; THERAPY; GAMMA	Objective: Delayed or impaired reendothelialization is a major cause of stent thrombosis in the interventional treatment of coronary heart disease. T cells are involved in neointima formation of injured arteries. However, the regulated mechanism of reendothelialization and the role of CD8 T cell in reendothelialization are unclear. Methods and Results: Immunofluorescence staining showed that CD8 positive cells were increased in wire injured femoral artery of mice. On day 21 after injury, elastin staining showed that knockout of CD8 (CD8(-/-)) significantly increased intimal thickness and a ratio of intima to media by 1.8 folds and 1.9 folds respectively in injured arteries. Evans blue staining showed that knockout of CD8 delayed the reendothelialization area on day 7 after injury (18.8+/-0.5% versus 42.1+/-5.6%, p<0.05). In vitro, a migration assay revealed that CD8(-/-) T cells co-cultured with WT macrophages significantly inhibited the migration of the endothelial cells (ECs); compared to CD4(+) T cells, and CD8(+) T cells could promote the ECs migration. Furthermore, real-time PCR analysis showed that knockout of CD8 increased the level of tumor necrosis factor a (TNF-alpha) in injured arteries and cytometric bead cytokine array showed that TNF-alpha was elevated in cultured CD8(-/-) T cells. Finally, a wound-healing assay showed that recombinant TNF-alpha significantly inhibited the migration of ECs. Conclusion: Our study suggested that CD8(+) T cells could promote the reendothelialization and inhibit the neointima formation after the artery wire injury, and this effect is at least partly dependent on decreasing TNF-alpha production promoting ECs migration.	[Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing, Peoples R China; Minist Educ, Inst Heart Lung & Blood Vessel Dis, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China	Capital Medical University	Du, J (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Beijing, Peoples R China.	jdu@bcm.edu		Wang, Ying/0000-0002-7852-386X; Zhang, Junmeng/0000-0003-4670-0670	Chinese Ministry of Science and Technology [2009CB522205, 2012CB517802]; National Science Foundation of China [81230006, 31090363]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1074]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was supported by grants from the Chinese Ministry of Science and Technology (2009CB522205, 2012CB517802), the National Science Foundation of China (81230006, 31090363) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 2010, ARTERIOSCL THROM VAS, V30, P2467, DOI 10.1161/ATVBAHA.110.215723; Brunetti ND, 2008, CORONARY ARTERY DIS, V19, P133, DOI 10.1097/MCA.0b013e3282f3fbcb; Charalambous C, 2005, CANCER RES, V65, P10347, DOI 10.1158/0008-5472.CAN-05-0949; Cole DK, 2012, IMMUNOLOGY, V137, P139, DOI 10.1111/j.1365-2567.2012.03625.x; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Dimayuga PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020214; Dimayuga PC, 2005, ARTERIOSCL THROM VAS, V25, P2528, DOI 10.1161/01.ATV.0000190606.41121.00; Grassia G, 2009, CARDIOVASC RES, V84, P485, DOI 10.1093/cvr/cvp238; Han YL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035506, 10.1371/journal.pone.0048966]; HANCOCK WW, 1994, AM J PATHOL, V145, P1008; HANSSON GK, 1991, P NATL ACAD SCI USA, V88, P10530, DOI 10.1073/pnas.88.23.10530; Hutter R, 2003, CIRCULATION, V107, P1658, DOI 10.1161/01.CIR.0000058169.21850.CE; Indolfi C, 2005, AM J CARDIOL, V95, P1146, DOI 10.1016/j.amjcard.2005.01.040; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kollum M, 2001, INT J RADIAT ONCOL, V50, P495, DOI 10.1016/S0360-3016(01)01497-3; Krasinski K, 2001, CIRCULATION, V104, P1754, DOI 10.1161/hc4001.098046; LANCKI DW, 1991, J IMMUNOL, V146, P3242; Larsen K, 2012, EUR HEART J, V33, P120, DOI 10.1093/eurheartj/ehr196; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Ligresti G, 2011, ARTERIOSCL THROM VAS, V31, P1151, DOI 10.1161/ATVBAHA.111.223917; LINDNER V, 1993, CIRC RES, V73, P792, DOI 10.1161/01.RES.73.5.792; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Newsome LT, 2008, ANESTH ANALG, V107, P552, DOI 10.1213/ane.0b013e3181732049; Raber L, 2011, CIRCULATION, V123, P2819, DOI 10.1161/CIRCULATIONAHA.110.004762; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; Sakuma M, 2010, ARTERIOSCL THROM VAS, V30, P1196, DOI 10.1161/ATVBAHA.110.205559; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Saxena A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051556; Takaoka M, 2010, ARTERIOSCL THROM VAS, V30, P1576, DOI 10.1161/ATVBAHA.110.207175; Tanaka H, 1996, ARTERIOSCL THROM VAS, V16, P12, DOI 10.1161/01.ATV.16.1.12; Tanaka T, 2004, AM J CARDIOL, V93, P1547, DOI 10.1016/j.amjcard.2004.02.070; Zheng SA, 2010, AM J PHYSIOL-CELL PH, V299, pC1485, DOI 10.1152/ajpcell.00173.2010; Zhu BH, 2002, ARTERIOSCL THROM VAS, V22, P450, DOI 10.1161/hq0302.105377; Zimmerman MA, 2002, AM J PHYSIOL-REG I, V283, pR505, DOI 10.1152/ajpregu.00033.2002	36	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62001	10.1371/journal.pone.0062001	http://dx.doi.org/10.1371/journal.pone.0062001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658704	gold, Green Published, Green Submitted			2022-12-27	WOS:000321200500015
J	Davis, FP; Eddy, SR				Davis, Fred P.; Eddy, Sean R.			Transcription Factors That Convert Adult Cell Identity Are Differentially Polycomb Repressed	PLOS ONE			English	Article							STEM-CELLS; MOUSE FIBROBLASTS; DNA METHYLATION; EXPRESSION; LIVER; BETA; ENHANCERS	Transcription factors that can convert adult cells of one type to another are usually discovered empirically by testing factors with a known developmental role in the target cell. Here we show that standard genomic methods (RNA-seq and ChIP-seq) can help identify these factors, as most are more strongly Polycomb repressed in the source cell and more highly expressed in the target cell. This criterion is an effective genome-wide screen that significantly enriches for factors that can transdifferentiate several mammalian cell types including neural stem cells, neurons, pancreatic islets, and hepatocytes. These results suggest that barriers between adult cell types, as depicted in Waddington's "epigenetic landscape'', consist in part of differentially Polycomb-repressed transcription factors. This genomic model of cell identity helps rationalize a growing number of transdifferentiation protocols and may help facilitate the engineering of cell identity for regenerative medicine.	[Davis, Fred P.; Eddy, Sean R.] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Davis, FP (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	davisf@janelia.hhmi.org		Davis, Fred/0000-0001-8294-1610; Eddy, Sean/0000-0001-6676-4706	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Burke ZD, 2006, J CELL PHYSIOL, V206, P147, DOI 10.1002/jcp.20438; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Gefen-Halevi S, 2010, CELL REPROGRAM, V12, P655, DOI 10.1089/cell.2010.0030; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hatcher CJ, 2000, DEV DYNAM, V219, P90, DOI 10.1002/1097-0177(200009)219:1<90::AID-DVDY1033>3.0.CO;2-L; Henry GL, 2012, NUCLEIC ACIDS RES, V40, P9691, DOI 10.1093/nar/gks671; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Holmberg J, 2012, NAT REV GENET, V13, P429, DOI 10.1038/nrg3209; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Lu M, 1997, J BIOL CHEM, V272, P28349, DOI 10.1074/jbc.272.45.28349; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Nilsson J, 2010, CANCER RES, V70, P2020, DOI 10.1158/0008-5472.CAN-09-1677; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Thorvaldsdottir H., 2012, BRIEFINGS BIOINFORMA; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Waddington C., 1957, STRATEGY GENES; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026729; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	64	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63407	10.1371/journal.pone.0063407	http://dx.doi.org/10.1371/journal.pone.0063407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650565	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000110
J	Malfitano, AM; Laezza, C; D'Alessandro, A; Procaccini, C; Saccomanni, G; Tuccinardi, T; Manera, C; Macchia, M; Matarese, G; Gazzerro, P; Bifulco, M				Malfitano, Anna Maria; Laezza, Chiara; D'Alessandro, Alba; Procaccini, Claudio; Saccomanni, Giuseppe; Tuccinardi, Tiziano; Manera, Clementina; Macchia, Marco; Matarese, Giuseppe; Gazzerro, Patrizia; Bifulco, Maurizio			Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis	PLOS ONE			English	Article							CANNABINOID RECEPTOR; BIOLOGICAL EVALUATION; RATIONAL DESIGN; LIGANDS; SYSTEM; 1,8-NAPHTHYRIDIN-4(1H)-ON-3-CARBOXAMIDE; ACTIVATION; EXPRESSION; ARVANIL; BRAIN	The efficacy of cannabinoids in the treatment of multiple sclerosis is widely documented; however their use is limited by psychoactivity mainly ascribed to the activation of the cannabinoid receptor CB1. Emerging findings support as alternative strategy in the treatment of neurodegenerative disorders, the application of compounds targeting the CB2 receptor, since likely unrelated to these side effects. Recently, a novel class of compounds, 1,8-naphthyridine, pyridine and quinoline derivatives have been demonstrated to show high CB2 receptor selectivity and affinity versus the CB1 receptor. Considering that the CB2 receptor is mainly expressed in cell and organs of the immune system, in this study we assessed the potential immune-modulatory effects of these compounds in activated lymphocytes isolated from MS patients with respect to healthy controls. These compounds blocked cell proliferation through a mechanism partially ascribed to the CB2 receptor, down-regulated TNF-alpha production and did not induce cell death. They also down-regulated Akt, Erk and NF-kB phosphorylation. Despite comparable effects observed in patients and healthy controls, these compounds, in particular, 1,8-naphthyridine and quinoline derivatives inhibited cell activation markers in MS patient derived lymphocytes more efficiently than in healthy control derived cells. Indeed, 1,8-naphthyridin-2-one derivative reduced the levels of Cox-2 in lymphocytes from patients whereas no effect was observed in control cells. Our findings suggest potential application of these drugs in neuro-inflammation, supporting further investigations of the effects of compounds in the therapy of MS, particularly on the aspects regarding activation and inflammation.	[Malfitano, Anna Maria; D'Alessandro, Alba; Gazzerro, Patrizia; Bifulco, Maurizio] Univ Salerno, Dipartimento Farm, I-84100 Salerno, Italy; [Malfitano, Anna Maria; D'Alessandro, Alba; Procaccini, Claudio; Matarese, Giuseppe; Bifulco, Maurizio] Univ Salern Fac Med, Dipartimento Med & Chirurg, Salerno, Italy; [Laezza, Chiara] Univ Napoli Federico II, Dipartimento Biol & Patol Cellulare & Mol, Consiglio Nazl Ric IEOS CNR, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Procaccini, Claudio; Matarese, Giuseppe] Univ Napoli Federico II, Dipartimento Biol & Patol Cellulare & Mol, Consiglio Nazl Ric IEOS CNR, Lab Immunol,Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Saccomanni, Giuseppe; Tuccinardi, Tiziano; Manera, Clementina; Macchia, Marco] Univ Pisa, Dipartimento Farm, Pisa, Italy	University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Pisa	Bifulco, M (corresponding author), Univ Salerno, Dipartimento Farm, I-84100 Salerno, Italy.	mbifulco@unisa.it	laez, chi/AAW-4437-2020; Procaccini, Claudio/AAB-3696-2019; Matarese, Giuseppe/AAO-4077-2021; Tuccinardi, Tiziano/M-1232-2015	Matarese, Giuseppe/0000-0001-9429-0616; Tuccinardi, Tiziano/0000-0002-6205-4069; Malfitano, Anna Maria/0000-0002-6193-2835; MACCHIA, MARCO/0000-0002-5565-2044; SACCOMANNI, GIUSEPPE/0000-0002-6230-1023; Bifulco, Maurizio/0000-0002-1771-4531; PROCACCINI, CLAUDIO/0000-0002-2184-0442; MANERA, CLEMENTINA/0000-0002-7379-5743	FISM - Fondazione Italiana Sclerosi Multipla - Cod. [2009/R/3/C1]; Associazione Ricerca Medica Salernitana "ERMES''; FISM - Fondazione Italiana Sclerosi Multipla; EU Ideas Programme; ERC-Starting Independent Grant "menTORingTregs'' [310496]; Telethon-JDRF Grant [GJT08004]; FIRB MERIT Grant [RBNE08HWLZ]	FISM - Fondazione Italiana Sclerosi Multipla - Cod.(Fondazione Italiana Sclerosi Multipla (FISM)); Associazione Ricerca Medica Salernitana "ERMES''; FISM - Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); EU Ideas Programme; ERC-Starting Independent Grant "menTORingTregs''; Telethon-JDRF Grant(Fondazione Telethon); FIRB MERIT Grant	This study was supported by FISM - Fondazione Italiana Sclerosi Multipla - Cod. 2009/R/3/C1 (Grant to M.B.), and Associazione Ricerca Medica Salernitana "ERMES''. A.M.M. was supported by a fellowship from FISM - Fondazione Italiana Sclerosi Multipla. G.M. is supported by grants from the EU Ideas Programme, ERC-Starting Independent Grant "menTORingTregs'' n. 310496, Telethon-JDRF Grant n. GJT08004, FIRB MERIT Grant n. RBNE08HWLZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benavides A, 2009, J NAT PROD, V72, P813, DOI 10.1021/np8006205; Bifulco M, 2007, MULT SCLER J, V13, P133, DOI 10.1177/1352458506071303; Bifulco M, 2008, ENDOCR-RELAT CANCER, V15, P391, DOI 10.1677/ERC-07-0258; Chuchawankul S, 2004, INT IMMUNOPHARMACOL, V4, P265, DOI 10.1016/j.intimp.2003.12.011; Ferrarini PL, 2004, BIOORGAN MED CHEM, V12, P1921, DOI 10.1016/j.bmc.2004.01.035; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Hillard CJ, 2012, NEUROSCIENCE, V204, P207, DOI 10.1016/j.neuroscience.2011.11.020; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jackson SJ, 2005, NEUROSCIENCE, V134, P261, DOI 10.1016/j.neuroscience.2005.02.045; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Lombard C, 2007, CLIN IMMUNOL, V122, P259, DOI 10.1016/j.clim.2006.11.002; Loria F, 2010, NEUROBIOL DIS, V37, P166, DOI 10.1016/j.nbd.2009.09.020; Malfitano AM, 2006, J NEUROIMMUNOL, V171, P110, DOI 10.1016/j.jneuroim.2005.09.005; Malfitano AM, 2007, IMMUNOL LETT, V109, P145, DOI 10.1016/j.imlet.2007.02.004; Malfitano AM, 2005, CNS NEUROL DISORD-DR, V4, P667, DOI 10.2174/156800705774933087; Malfitano AM, 2011, EXPERT OPIN THER TAR, V15, P297, DOI 10.1517/14728222.2011.553606; Malfitano Anna Maria, 2008, Neuropsychiatr Dis Treat, V4, P847; Manera C, 2006, J MED CHEM, V49, P5947, DOI 10.1021/jm0603466; Manera C, 2007, BIOORG MED CHEM LETT, V17, P6505, DOI 10.1016/j.bmcl.2007.09.089; Manera C, 2012, EUR J MED CHEM, V52, P284, DOI 10.1016/j.ejmech.2012.03.031; Manera C, 2009, J MED CHEM, V52, P3644, DOI 10.1021/jm801563d; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mestre L, 2009, MOL CELL NEUROSCI, V40, P258, DOI 10.1016/j.mcn.2008.10.015; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Proto MC, 2012, J CELL PHYSIOL, V227, P250, DOI 10.1002/jcp.22727; Pryce G, 2003, BRAIN, V126, P2191, DOI 10.1093/brain/awg224; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740	31	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62511	10.1371/journal.pone.0062511	http://dx.doi.org/10.1371/journal.pone.0062511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658734	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000053
J	O'Brien, CL; Allison, GE; Grimpen, F; Pavli, P				O'Brien, Claire L.; Allison, Gwen E.; Grimpen, Florian; Pavli, Paul			Impact of Colonoscopy Bowel Preparation on Intestinal Microbiota	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; RIBOSOMAL-RNA GENES; GUT MICROBIOTA; DIVERSITY; COMMUNITY; BACTERIA; PRIMERS; ECOLOGY; DISEASE; FECES	The gut microbiota is important in maintaining human health, but numerous factors have the potential to alter its composition. Our aim was to examine the impact of a standard bowel preparation on the intestinal microbiota using two different techniques. Fifteen subjects undergoing colonoscopy consumed a bowel preparation comprised of 10 mg bisacodyl and 2 L polyethylene glycol. The microbiota of stool samples, collected one month before, one week before (precolonoscopy), and one week, one month, and three to six months after colonoscopy (post-colonoscopy) was evaluated. Two samples were taken three to six months apart from five healthy subjects who did not undergo colonoscopy. Universal primers targeting the V2-V3 region of the 16S rRNA gene were used to PCR amplify all samples for denaturing gradient gel electrophoresis (PCR-DGGE). Pre- and post-colonoscopy samples were compared using Dice's similarity coefficients. Three samples from ten subjects who underwent colonoscopy, and both samples from the five subjects who didn't, were used for high-throughput sequencing of the V1-V3 region of the 16S rRNA gene. Samples were curated and analysed in Mothur. Results of the DGGE analyses show that the fecal microbiota of a small number of subjects had short-term changes. High-throughput sequencing results indicated that the variation between the samples of subjects who underwent colonoscopy was no greater than the variation observed between samples from subjects who did not. We conclude that bowel preparation does not have a lasting effect on the composition of the intestinal microbiota for the majority of subjects.	[O'Brien, Claire L.; Allison, Gwen E.; Pavli, Paul] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Grimpen, Florian] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Herston, Qld, Australia; [Allison, Gwen E.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [O'Brien, Claire L.; Pavli, Paul] Canberra Hosp, Gastroenterol & Hepatol Unit, Canberra, ACT, Australia	Australian National University; Royal Brisbane & Women's Hospital; Australian National University; Australian National University; Canberra Hospital	O'Brien, CL (corresponding author), Australian Natl Univ, Sch Med, Canberra, ACT, Australia.	Claire.Obrien@anu.edu.au	Allison, Gwen E/D-1163-2009; Pavli, Paul/GZL-0607-2022	O'Brien, Claire/0000-0003-1599-9913	Australian Post-Graduate Award scholarship	Australian Post-Graduate Award scholarship	This work was funded by an Australian Post-Graduate Award scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MN, 2007, APPL ENVIRON MICROB, V73, P4532, DOI 10.1128/AEM.02956-06; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; Mai V, 2006, GUT, V55, P1822, DOI 10.1136/gut.2006.108266; Maki T, 2008, AIR QUAL ATMOS HLTH, V1, P81, DOI 10.1007/s11869-008-0016-9; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Menees S, 2007, INFLAMM BOWEL DIS, V13, P12, DOI 10.1002/ibd.20049; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Tourlomousis P, 2010, MICROB ECOL, V59, P776, DOI 10.1007/s00248-009-9613-x; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997; Xing De-feng, 2006, Weishengwu Xuebao, V46, P331; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	32	66	67	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62815	10.1371/journal.pone.0062815	http://dx.doi.org/10.1371/journal.pone.0062815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650530	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000075
J	Park, CW; Yoon, BH; Park, JS; Jun, JK				Park, Chan-Wook; Yoon, Bo Hyun; Park, Joong Shin; Jun, Jong Kwan			A Fetal and an Intra-Amniotic Inflammatory Response Is More Severe in Preterm Labor than in Preterm PROM in the Context of Funisitis: Unexpected Observation in Human Gestations	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-CELL COUNT; PREMATURE RUPTURE; AMNIOTIC-FLUID; CLINICAL-SIGNIFICANCE; INTACT MEMBRANES; INFECTION; WOMEN; CHORIOAMNIONITIS; DIAGNOSIS	Objective: Although intra-amniotic(IA) infection is present in both preterm labor and intact membranes(PTL) and preterm premature rupture of membranes(preterm-PROM), it is more common in preterm-PROM than in PTL. Microorganisms and their products in the amniotic-cavity can elicit an inflammatory-response in fetus as well as in amniotic-cavity in the progression of acute histologic chorioamnionitis(acute-HCA). A fundamental question is whether a fetal and an IA inflammatory-response is more severe in preterm-PROM than in PTL, in the same-context of acute-HCA with or without fetal-involvement. The purpose of current-study was to answer this-question. Study-Design: Study population consisted of 213 singleton preterm-gestations(, 34 weeks) delivered within 4 days of amniocentesis due to PTL(120 cases) or preterm-PROM(93 cases). The intensity of fetal and IA inflammatory-responses was compared between PTL and preterm-PROM, according to placental inflammatory conditions: 1) placenta without inflammatory-lesion; 2) acute-HCA without funisitis; 3) acute-HCA with funisitis. IA inflammatory response was assessed by amniotic-fluid(AF) matrix metalloproteinase-8(MMP-8), and fetal inflammatory response(FIR) by umbilical-cord plasma(UCP) C-reactive protein(CRP) at birth. Results: 1) Patients with preterm-PROM had higher rates of IA infection, acute-HCA, and acute-HCA with funisitis than those with PTL did(p<.01 for each); 2) there were no significant differences in the intensity of fetal and IA inflammatory-responses and the rate of cervical dilatation >= 3 cm or 4 cm between patients with PTL and those with preterm-PROM in the context of both placenta without inflammatory-lesion and acute-HCA without funisitis(p>.05 for each); 3) however, acute-HCA with funisitis was associated with a significantly higher median AF MMP-8 and UCP CRP concentration and higher rate of cervical dilatation >= 3 cm or 4 cm in PTL than in preterm-PROM(AF MMP-8, 675 ng/mlvs. 417 ng/ml; UCP CRP, 969 ng/mlvs. 397 ng/ml; each for p>.05), despite less common IA infection in PTL than in preterm-PROM(29% vs. 57%; p>.05). Conclusions: A fetal and an IA inflammatory-response is more severe in PTL than in preterm-PROM in the context of funisitis, despite less common IA infection. This unexpected observation may indicate the fundamental difference in the pathogenesis between PTL and preterm-PROM.	[Park, Chan-Wook; Yoon, Bo Hyun; Park, Joong Shin; Jun, Jong Kwan] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Seoul National University (SNU)	Park, CW (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	hwpark0803@gmail.com	PARK, Chan-Wook/G-3663-2013; Park, Joong Shin/D-5741-2012; Yoon, Bo Hyun/H-6344-2011	PARK, Chan-Wook/0000-0002-1290-6438; Park, Joong Shin/0000-0002-5246-0477; 	National Research Foundation of Korea (NRF); Korea government (MEST) [2009-0080429]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (number 2009-0080429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baergen R, 2005, MANUAL BENIRSCHKE KA, P279; Been JV, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.025; Benirschuke K, 2006, PATHOLOGY HUMAN PLAC; Blackwell SC, 1999, CURR OPIN OBSTET GYN, V11, P541, DOI 10.1097/00001703-199912000-00001; D'Alquen D, 2005, PEDIATR RES, V57, P263, DOI 10.1203/01.PDR.0000148713.48218.86; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2002, NUTR REV, V60, pS19, DOI 10.1301/00296640260130696; GOMEZ R, 1995, CLIN PERINATOL, V22, P281; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gomez R, 1997, INFECT DIS CLIN N AM, V11, P135, DOI 10.1016/S0891-5520(05)70347-0; HOROWITZ S, 1995, ACTA OBSTET GYN SCAN, V74, P132, DOI 10.3109/00016349509008922; Lee AJX, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.015; Lee SM, 2011, PLACENTA, V32, P516, DOI 10.1016/j.placenta.2011.03.012; Lee SE, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.006; MAZOR M, 1993, J REPROD MED, V38, P799; Murtha AP, 1996, AM J OBSTET GYNECOL, V175, P966, DOI 10.1016/S0002-9378(96)80033-0; NAEYE RL, 1982, EARLY HUM DEV, V6, P91, DOI 10.1016/0378-3782(82)90062-7; Oh KJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.035; Ovalle A, 2000, REV MED CHILE, V128, P985; Park JS, 2001, AM J OBSTET GYNECOL, V185, P1156, DOI 10.1067/mob.2001.117679; ROMERO R, 1990, AM J OBSTET GYNECOL, V163, P968, DOI 10.1016/0002-9378(90)91106-M; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; ROMERO R, 1988, CLIN OBSTET GYNECOL, V31, P553, DOI 10.1097/00003081-198809000-00006; ROMERO R, 1989, AM J OBSTET GYNECOL, V160, P1117, DOI 10.1016/0002-9378(89)90172-5; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; Seong HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.040; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; VINTZILEOS AM, 1986, OBSTET GYNECOL, V68, P488; Yoon B H, 2003, J Matern Fetal Neonatal Med, V14, P85; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Yoon BH, 1996, OBSTET GYNECOL, V87, P231, DOI 10.1016/0029-7844(95)00380-0; Yoon BH, 1996, OBSTET GYNECOL, V88, P1034	35	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62521	10.1371/journal.pone.0062521	http://dx.doi.org/10.1371/journal.pone.0062521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658737	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000054
J	Parvathaneni, S; Stortchevoi, A; Sommers, JA; Brosh, RM; Sharma, S				Parvathaneni, Swetha; Stortchevoi, Alexei; Sommers, Joshua A.; Brosh, Robert M., Jr.; Sharma, Sudha			Human RECQ1 Interacts with Ku70/80 and Modulates DNA End-Joining of Double-Strand Breaks	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; REPAIR PATHWAY CHOICE; CELL-FREE-EXTRACTS; HOMOLOGOUS RECOMBINATION; WERNER PROTEIN; KU PROTEIN; POLY(ADP-RIBOSE) POLYMERASE-1; VERTEBRATE CELLS; MAMMALIAN-CELLS; APLF C2ORF13	Genomic instability is a known precursor to cancer and aging. The RecQ helicases are a highly conserved family of DNA-unwinding enzymes that play key roles in maintaining genome stability in all living organisms. Human RecQ homologs include RECQ1, BLM, WRN, RECQ4, and RECQ5 beta, three of which have been linked to diseases with elevated risk of cancer and growth defects (Bloom Syndrome and Rothmund-Thomson Syndrome) or premature aging (Werner Syndrome). RECQ1, the first RecQ helicase discovered and the most abundant in human cells, is the least well understood of the five human RecQ homologs. We have previously described that knockout of RECQ1 in mice or knockdown of its expression in human cells results in elevated frequency of spontaneous sister chromatid exchanges, chromosomal instability, increased load of DNA damage and heightened sensitivity to ionizing radiation. We have now obtained evidence implicating RECQ1 in the nonhomologous end-joining pathway of DNA double-strand break repair. We show that RECQ1 interacts directly with the Ku70/80 subunit of the DNA-PK complex, and depletion of RECQ1 results in reduced end-joining in cell free extracts. In vitro, RECQ1 binds and unwinds the Ku70/80-bound partial duplex DNA substrate efficiently. Linear DNA is co-bound by RECQ1 and Ku70/80, and DNA binding by Ku70/80 is modulated by RECQ1. Collectively, these results provide the first evidence for an interaction of RECQ1 with Ku70/80 and a role of the human RecQ helicase in double-strand break repair through nonhomologous end-joining.	[Parvathaneni, Swetha; Stortchevoi, Alexei; Sharma, Sudha] Howard Univ, Coll Med, Dept Biochem & Mol Biol, Washington, DC 20059 USA; [Sommers, Joshua A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	Howard University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sharma, S (corresponding author), Howard Univ, Coll Med, Dept Biochem & Mol Biol, Washington, DC 20059 USA.	sudha.sharma@howard.edu	Sharma, Sudha/AAV-6152-2021	Sharma, Sudha/0000-0003-2765-2482	NIH/NIGMS [5SC1GM093999-04]; NIH Intramural Research Program; National Institute on Aging; NIH/NIMHD [G12MD007597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM093999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000753, ZIAAG000741, ZIAAG000752] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work is supported by NIH/NIGMS grant 5SC1GM093999-04 (to SS) and the NIH Intramural Research Program, National Institute on Aging (to RB). Howard University College of Medicine core facilities are supported by the NIH/NIMHD under Award Number G12MD007597. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2002, P NATL ACAD SCI USA, V99, P3758, DOI 10.1073/pnas.052545899; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Bekker-Jensen S, 2007, J BIOL CHEM, V282, P19638, DOI 10.1074/jbc.C700060200; Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Berti M, 2013, NAT STRUCT MOL BIOL; BLIER PR, 1993, J BIOL CHEM, V268, P7594; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cooper MP, 2000, GENE DEV, V14, P907; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; de Oca RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007050; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; Doherty KM, 2005, J BIOL CHEM, V280, P28085, DOI 10.1074/jbc.M500265200; Drouet J, 2005, J BIOL CHEM, V280, P7060, DOI 10.1074/jbc.M410746200; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Karmakar P, 2002, NUCLEIC ACIDS RES, V30, P3583, DOI 10.1093/nar/gkf482; Karmakar P, 2002, J BIOL CHEM, V277, P18291, DOI 10.1074/jbc.M111523200; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Li BM, 2004, J BIOL CHEM, V279, P13659, DOI 10.1074/jbc.M311606200; Li BM, 2001, J BIOL CHEM, V276, P9896, DOI 10.1074/jbc.M008575200; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Macrae CJ, 2008, DNA REPAIR, V7, P292, DOI 10.1016/j.dnarep.2007.10.008; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Mansour W.Y., 2010, NUCL ACIDS RES; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; Oshima J, 2002, CANCER RES, V62, P547; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2008, CELL CYCLE, V7, P989, DOI 10.4161/cc.7.8.5707; Sharma S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001297; Sharma S, 2007, MOL CELL BIOL, V27, P1784, DOI 10.1128/MCB.01620-06; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Sharma S, 2012, DNA REPAIR, V11, P537, DOI 10.1016/j.dnarep.2012.04.003; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Singh DK, 2012, MUTAT RES-FUND MOL M, V736, P15, DOI 10.1016/j.mrfmmm.2011.06.002; Sun J, 2012, J BIOL CHEM, V287, P4936, DOI 10.1074/jbc.M111.306167; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; von Kobbe C, 2004, NUCLEIC ACIDS RES, V32, P4003, DOI 10.1093/nar/gkh721; von Kobbe C, 2003, MOL CELL BIOL, V23, P8601, DOI 10.1128/MCB.23.23.8601-8613.2003; Wang HC, 2003, NUCLEIC ACIDS RES, V31, P5377, DOI 10.1093/nar/gkg728; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Weinstock David M, 2007, Nat Cell Biol, V9, P978; Wu YL, 2010, DNA REPAIR, V9, P315, DOI 10.1016/j.dnarep.2009.12.010; Wyman C, 2004, DNA REPAIR, V3, P827, DOI 10.1016/j.dnarep.2004.03.037; Zhong Q, 2002, CANCER RES, V62, P3966; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	78	41	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62481	10.1371/journal.pone.0062481	http://dx.doi.org/10.1371/journal.pone.0062481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650516	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000050
J	Frickmann, H; Christner, M; Donat, M; Berger, A; Essig, A; Podbielski, A; Hagen, RM; Poppert, S				Frickmann, Hagen; Christner, Martin; Donat, Martina; Berger, Anja; Essig, Andreas; Podbielski, Andreas; Hagen, Ralf Matthias; Poppert, Sven			Rapid Discrimination of Haemophilus influenzae, H. parainfluenzae, and H. haemolyticus by Fluorescence In Situ Hybridization (FISH) and Two Matrix-Assisted Laser-Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF-MS) Platforms	PLOS ONE			English	Article							OLIGONUCLEOTIDE PROBES; RESPIRATORY-TRACT; IDENTIFICATION; BACTERIA; NEISSERIA; STRAINS; MENINGITIS; AEGYPTIUS; SAMPLES; SPP.	Background: Due to considerable differences in pathogenicity, Haemophilus influenzae, H. parainfluenzae and H. haemolyticus have to be reliably discriminated in routine diagnostics. Retrospective analyses suggest frequent misidentifications of commensal H. haemolyticus as H. influenzae. In a multi-center approach, we assessed the suitability of fluorescence in situ hybridization (FISH) and matrix-assisted laser-desorption-ionization time-of-flight mass-spectrometry (MALDI-TOF-MS) for the identification of H. influenzae, H. parainfluenzae and H. haemolyticus to species level. Methodology: A strain collection of 84 Haemophilus spp. comprising 50 H. influenzae, 25 H. parainfluenzae, 7 H. haemolyticus, and 2 H. parahaemolyticus including 77 clinical isolates was analyzed by FISH with newly designed DNA probes, and two different MALDI-TOF-MS systems (Bruker, Shimadzu) with and without prior formic acid extraction. Principal Findings: Among the 84 Haemophilus strains analyzed, FISH led to 71 correct results (85%), 13 uninterpretable results (15%), and no misidentifications. Shimadzu MALDI-TOF-MS resulted in 59 correct identifications (70%), 19 uninterpretable results (23%), and 6 misidentifications (7%), using colony material applied directly. Bruker MALDI-TOF-MS with prior formic acid extraction led to 74 correct results (88%), 4 uninterpretable results (5%) and 6 misidentifications (7%). The Bruker MALDI-TOF-MS misidentifications could be resolved by the addition of a suitable H. haemolyticus reference spectrum to the system's database. In conclusion, no analyzed diagnostic procedure was free of errors. Diagnostic results have to be interpreted carefully and alternative tests should be applied in case of ambiguous test results on isolates from seriously ill patients.	[Frickmann, Hagen; Hagen, Ralf Matthias] German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany; [Frickmann, Hagen; Donat, Martina; Podbielski, Andreas] Univ Rostock, Inst Med Microbiol Virol & Hyg, D-18055 Rostock, Germany; [Christner, Martin] Univ Hosp Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Berger, Anja] Bavarian Food & Hlth Author, Oberschleissheim, Germany; [Essig, Andreas] Univ Ulm, Inst Med Microbiol & Hyg, D-89069 Ulm, Germany; [Poppert, Sven] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Rostock; University of Hamburg; University Medical Center Hamburg-Eppendorf; Bavarian Health & Food Safety Authority; Ulm University; Bernhard Nocht Institut fur Tropenmedizin	Frickmann, H (corresponding author), German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany.	Frickmann@bni-hamburg.de			German Ministry of Defense (MoD) [13K2-S-451215]	German Ministry of Defense (MoD)	The 16S rRNA gene sequencing of the Haemophilus spp. with conflicting results in FISH and MALDI-TOF-MS analysis was funded by the German Ministry of Defense (MoD), scientific project number 13K2-S-451215 "New development/evaluation of diagnostic molecular procedures for the proof of infectious agents and symptom-based diagnostic procedures for tropical infectious diseases.'' The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeldaim GMK, 2009, DIAGN MICR INFEC DIS, V64, P366, DOI 10.1016/j.diagmicrobio.2009.03.030; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Anderson R, 2012, J CLIN MICROBIOL, V50, P2462, DOI 10.1128/JCM.06575-11; BARBE G, 1994, J CLIN MICROBIOL, V32, P187; BRENNER DJ, 1988, J CLIN MICROBIOL, V26, P1524, DOI 10.1128/JCM.26.8.1524-1534.1988; Brook I, 2009, EUR ARCH OTO-RHINO-L, V266, P315, DOI 10.1007/s00405-008-0849-8; Cilia V, 1996, MOL BIOL EVOL, V13, P451, DOI 10.1093/oxfordjournals.molbev.a025606; Clinical and Laboratory Standards Institute, 2008, MM18A CLIN LAB STAND, P30; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Couturier MR, 2011, J CLIN MICROBIOL, V49, P1104, DOI 10.1128/JCM.01777-10; DarrasJoly C, 1997, CLIN INFECT DIS, V24, P1087, DOI 10.1086/513624; Dommerich S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030150; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Frickmann H, 2011, EUR J MICROBIOL IMMU, V1, P289, DOI 10.1556/EuJMI.1.2011.4.4; Frickmann H, 2012, TROP MED INT HEALTH, V17, P1117, DOI 10.1111/j.1365-3156.2012.03024.x; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Haag AM, 1998, J MASS SPECTROM, V33, P750, DOI 10.1002/(SICI)1096-9888(199808)33:8<750::AID-JMS680>3.0.CO;2-1; Hendolin PH, 2000, J CLIN MICROBIOL, V38, P125; Hogardt M, 2000, J CLIN MICROBIOL, V38, P818, DOI 10.1128/JCM.38.2.818-825.2000; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P594, DOI 10.1016/j.anl.2010.02.005; Justesen US, 2010, J CLIN MICROBIOL, V48, P946, DOI 10.1128/JCM.02075-09; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Kilian M, 2002, MOL MICROBIOL, V46, P1367, DOI 10.1046/j.1365-2958.2002.03254.x; KILIAN M, 1974, ACTA PATH MICRO IM B, VB 82, P835; Kirkham LAS, 2010, J CLIN MICROBIOL, V48, P2557, DOI 10.1128/JCM.00069-10; Kumar Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-240; Lakner A, 2011, MYCOSIS, V55; Loy A, 2008, ENVIRON MICROBIOL, V10, P2894, DOI 10.1111/j.1462-2920.2008.01706.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; McCrea KW, 2008, J CLIN MICROBIOL, V46, P406, DOI 10.1128/JCM.01832-07; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Mukundan D, 2007, J CLIN MICROBIOL, V45, P3207, DOI 10.1128/JCM.00492-07; Munson E, 2002, EUR J CLIN MICROBIOL, V21, P196, DOI 10.1007/s10096-001-0688-7; Munson EL, 2007, J CLIN MICROBIOL, V45, P4051, DOI 10.1128/JCM.01663-07; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Nascimento-Carvalho C M, 2001, Braz J Infect Dis, V5, P87; Norskov-Lauritsen N, 2009, J BACTERIOL, V191, P822, DOI 10.1128/JB.00782-08; Olvera A, 2006, MICROBIOL-SGM, V152, P3683, DOI 10.1099/mic.0.29254-0; Peters RPH, 2006, J CLIN MICROBIOL, V44, P4186, DOI 10.1128/JCM.01085-06; PITTMAN M, 1953, J BACTERIOL, V65, P750, DOI 10.1128/JB.65.6.750-751.1953; Poppert S, 2005, J CLIN MICROBIOL, V43, P3390, DOI 10.1128/JCM.43.7.3390-3397.2005; Rennie RP, 2008, J CLIN MICROBIOL, V46, P2681, DOI 10.1128/JCM.00449-08; Tian GZ, 2012, BIOMED ENVIRON SCI, V25, P367, DOI 10.3967/0895-3988.2012.03.016; TOTTEN PA, 1995, INFECT IMMUN, V63, P4409, DOI 10.1128/IAI.63.11.4409-4416.1995; TURK DC, 1984, J MED MICROBIOL, V18, P1, DOI 10.1099/00222615-18-1-1; Valenza G, 2007, J CLIN MICROBIOL, V45, P3493, DOI 10.1128/JCM.00953-07; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; Wellinghausen N, 2005, J CLIN MICROBIOL, V43, P4070, DOI 10.1128/JCM.43.8.4070-4075.2005; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002; Wood-Baker R, 2012, BRIT J BIOMED SCI, V69, P37, DOI 10.1080/09674845.2012.11978244	51	36	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63222	10.1371/journal.pone.0063222	http://dx.doi.org/10.1371/journal.pone.0063222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646201	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300159
J	Reynolds, RM; Phillips, PC				Reynolds, Rose M.; Phillips, Patrick C.			Natural Variation for Lifespan and Stress Response in the Nematode Caenorhabditis remanei	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; NUCLEOTIDE POLYMORPHISM; QUANTITATIVE VARIATION; WILD POPULATIONS; OXIDATIVE DAMAGE; RESISTANCE; GENETICS; ELEGANS; LONGEVITY; HERITABILITY	Genetic approaches (e. g. mutation, RNA interference) in model organisms, particularly the nematode Caenorhabditis elegans, have yielded a wealth of information on cellular processes that can influence lifespan. Although longevity mutants discovered in the lab are instructive of cellular physiology, lab studies might miss important genes that influence health and longevity in the wild. C. elegans has relatively low natural genetic variation and high levels of linkage disequilibrium, and thus is not optimal for studying natural variation in longevity. In contrast, its close relative C. remanei possesses very high levels of molecular genetic variation and low levels of linkage disequilibrium. To determine whether C. remanei may be a good model system for the study of natural genetic variation in aging, we evaluated levels of quantitative genetic variation for longevity and resistance to oxidative, heat and UV stress. Heritability (and the coefficient of additive genetic variation) was high for oxidative and heat stress resistance, low (but significant) for longevity, and essentially zero for UV stress response. Our results suggest that C. remanei may be a powerful system for studying natural genetic variation for longevity and oxidative and heat stress response, as well as an informative model for the study of functional relationships between longevity and stress response.	[Reynolds, Rose M.; Phillips, Patrick C.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA	University of Oregon	Phillips, PC (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	pphil@uoregon.edu		Phillips, Patrick/0000-0001-7271-342X	National Institutes of Health [R03-AG029377, P01-AG022500]; Ellison Medical Foundation; National Institutes of Health (Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship) [AG032900]; NATIONAL INSTITUTE ON AGING [R03AG029377, F32AG032900, P01AG022500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health (Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work received funding support from the National Institutes of Health (R03-AG029377 and P01-AG022500 to PCP; Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship AG032900 to RMR), and the Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Baird SE, 1999, NEMATOLOGY, V1, P471, DOI 10.1163/156854199508478; Barker JSF, 1995, J EVOLUTION BIOL, V8, P689, DOI 10.1046/j.1420-9101.1995.8060689.x; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; Becker W. A, 1984, MANUAL QUANTITATIVE; Biteau B, 2011, EXP GERONTOL, V46, P349, DOI 10.1016/j.exger.2010.11.003; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; Cutter AD, 2006, GENETICS, V174, P901, DOI 10.1534/genetics.106.061879; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Evans DS, 2011, AGEING RES REV, V10, P225, DOI 10.1016/j.arr.2010.04.001; Gaertner BE, 2010, GENET RES, V92, P331, DOI 10.1017/S0016672310000601; Gonzalez-Recio O, 2007, GENET SEL EVOL, V39, P391, DOI 10.1051/gse:2007010; Graustein A, 2002, GENETICS, V161, P99; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harshman LG, 1999, NEUROBIOL AGING, V20, P521, DOI 10.1016/S0197-4580(99)00091-3; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Hoffmann AA, 1998, EVOLUTION, V52, P1207, DOI [10.2307/2411250, 10.1111/j.1558-5646.1998.tb01847.x]; HOULE D, 1992, GENETICS, V130, P195; Imasheva AG, 1998, HEREDITY, V81, P246, DOI 10.1046/j.1365-2540.1998.00384.x; JOHNSON TE, 1986, BEHAV GENET, V16, P221, DOI 10.1007/BF01065487; Johnson TE, 2000, EXP GERONTOL, V35, P687, DOI 10.1016/S0531-5565(00)00138-8; Jovelin R, 2003, MOL ECOL, V12, P1325, DOI 10.1046/j.1365-294X.2003.01805.x; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200; Phillips PC, 1998, BIOLOGY; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; ROSE MR, 1981, GENETICS, V97, P187; SAS Institute, 2002, SAS 9 1 3; SAS Institute Inc, 2004, GEN AN COMPL TRAITS, P292; Sivasundar A, 2003, GENETICS, V163, P147; TANAKA Y, 1993, HEREDITY, V70, P318, DOI 10.1038/hdy.1993.46; Tatar M, 1999, AM NAT, V154, pS67, DOI 10.1086/303284; Willi Y, 2010, EVOL ECOL RES, V12, P761; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Ziv E, 2011, AGEING RES REV, V10, P201, DOI 10.1016/j.arr.2010.09.002	42	16	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e58212	10.1371/journal.pone.0058212	http://dx.doi.org/10.1371/journal.pone.0058212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658604	Green Published, Green Submitted, gold			2022-12-27	WOS:000318343700002
J	Fietz, D; Bakhaus, K; Wapelhorst, B; Grosser, G; Gunther, S; Alber, J; Doring, B; Kliesch, S; Weidner, W; Galuska, CE; Hartmann, MF; Wudy, SA; Bergmann, M; Geyer, J				Fietz, Daniela; Bakhaus, Katharina; Wapelhorst, Britta; Grosser, Gary; Guenther, Sabine; Alber, Joerg; Doering, Barbara; Kliesch, Sabine; Weidner, Wolfgang; Galuska, Christina E.; Hartmann, Michaela F.; Wudy, Stefan A.; Bergmann, Martin; Geyer, Joachim			Membrane Transporters for Sulfated Steroids in the Human Testis - Cellular Localization, Expression Pattern and Functional Analysis	PLOS ONE			English	Article							SOLUTE-CARRIER-PROTEIN; CONJUGATED NEUTRAL STEROIDS; ORGANIC ANION TRANSPORTER; ESTROGEN-RECEPTORS ALPHA; DEHYDROEPIANDROSTERONE-SULFATE; SEMINIFEROUS TUBULES; PREGNENOLONE SULFATE; MESSENGER-RNA; CELLS; RAT	Sulfated steroid hormones are commonly considered to be biologically inactive metabolites, but may be reactivated by the steroid sulfatase into biologically active free steroids, thereby having regulatory function via nuclear androgen and estrogen receptors which are widespread in the testis. However, a prerequisite for this mode of action would be a carrier-mediated import of the hydrophilic steroid sulfate molecules into specific target cells in reproductive tissues such as the testis. In the present study we detected predominant expression of the Sodium-dependent Organic Anion Transporter (SOAT), the Organic Anion Transporting Polypeptide 6A1, and the Organic Solute Carrier Partner 1 in human testis biopsies. All of these showed significantly lower or even absent mRNA expression in severe disorders of spermatogenesis (arrest at the level of spermatocytes or spermatogonia, Sertoli cell only syndrome). Only SOAT was significantly lower expressed in biopsies showing hypospermatogenesis. By use of immunohistochemistry SOAT was localized to germ cells at various stages in human testis biopsies showing normal spermatogenesis. SOAT immunoreactivity was detected in zygotene primary spermatocytes of stage V, pachytene spermatocytes of all stages (I-V), secondary spermatocytes of stage VI, and round spermatids (step 1 and step 2) in stages I and II. Furthermore, SOAT transport function for steroid sulfates was analyzed with a novel liquid chromatography tandem mass spectrometry procedure capable of profiling steroid sulfate molecules from cell lysates. With this technique, the cellular inward-directed SOAT transport was verified for the established substrates dehydroepiandrosterone sulfate and estrone-3-sulfate. Additionally, beta-estradiol-3-sulfate and androstenediol-3-sulfate were identified as novel SOAT substrates.	[Fietz, Daniela; Wapelhorst, Britta; Guenther, Sabine; Bergmann, Martin] Univ Giessen, Inst Vet Anat Histol & Embryol, D-35390 Giessen, Germany; [Bakhaus, Katharina; Grosser, Gary; Alber, Joerg; Doering, Barbara; Geyer, Joachim] Univ Giessen, Inst Vet Pharmacol & Toxicol, D-35390 Giessen, Germany; [Kliesch, Sabine] Univ Hosp Munster, Ctr Reprod Med & Androl, Dept Clin Androl, Munster, Germany; [Weidner, Wolfgang] Univ Giessen, Clin Urol Pediat Urol & Androl, D-35390 Giessen, Germany; [Galuska, Christina E.; Hartmann, Michaela F.; Wudy, Stefan A.] Univ Giessen, Steroid Res & Mass Spectrometry Unit, Div Paediat Endocrinol & Diabetol, Ctr Child & Adolescent Med, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Munster; Justus Liebig University Giessen; Justus Liebig University Giessen	Fietz, D (corresponding author), Univ Giessen, Inst Vet Anat Histol & Embryol, D-35390 Giessen, Germany.	Daniela.Fietz@vetmed.uni-giessen.de	Wudy, Stefan/ABC-7173-2020; Geyer, Joachim/AAQ-4593-2021		German Research Foundation [DFG FOR1369]	German Research Foundation(German Research Foundation (DFG))	The present study has been supported by German Research Foundation grant DFG FOR1369. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMANN M, 1989, CELL TISSUE RES, V256, P183; Bergmann M, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P155, DOI 10.1007/978-3-540-78355-8_11; Carreau S, 2012, ADV MED SCI-POLAND, V57, P31, DOI 10.2478/v10039-012-0005-y; Carreau S, 2011, REPROD BIOL, V11, P174, DOI 10.1016/S1642-431X(12)60065-5; Cavaco JEB, 2009, SYST BIOL REPROD MED, V55, P137, DOI 10.1080/19396360902855733; Galuska CE, 2012, ANAL CHEM UNPUB; Geyer J, 2006, N-S ARCH PHARMACOL, V372, P413, DOI 10.1007/s00210-006-0043-8; Geyer J, 2004, BIOCHEM BIOPH RES CO, V316, P300, DOI 10.1016/j.bbrc.2004.02.048; Geyer J, 2007, J BIOL CHEM, V282, P19728, DOI 10.1074/jbc.M702663200; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; Hess R. A., 2004, Animal Reproduction, V1, P5; Hess Rex A, 2003, Reprod Biol Endocrinol, V1, P52, DOI 10.1186/1477-7827-1-52; Hiratsuka K, 2008, MOL REPROD DEV, V75, P1495, DOI 10.1002/mrd.20893; Hiratsuka K, 2011, HISTOCHEM CELL BIOL, V135, P229, DOI 10.1007/s00418-011-0790-6; Izuno H, 2007, LIFE SCI, V81, P1183, DOI 10.1016/j.lfs.2007.08.012; Kobayashi Y, 2005, J BIOL CHEM, V280, P32332, DOI 10.1074/jbc.M504246200; Kobayashi Y, 2007, DRUG METAB DISPOS, V35, P1239, DOI 10.1124/dmd.107.014795; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; LAATIKAINEN T, 1971, J CLIN ENDOCR METAB, V32, P59, DOI 10.1210/jcem-32-1-59; Labrie F, 2001, FRONT NEUROENDOCRIN, V22, P185, DOI 10.1006/frne.2001.0216; Lekhkota O, 2006, HISTOCHEM CELL BIOL, V125, P259, DOI 10.1007/s00418-005-0008-x; Lekhkota O, 2007, ANATGES2007, P67; LYKKESFELDT G, 1985, CLIN ENDOCRINOL, V23, P385, DOI 10.1111/j.1365-2265.1985.tb01096.x; LYKKESFELDT G, 1985, EUR J PEDIATR, V144, P273, DOI 10.1007/BF00451960; Morris KT, 2001, SURGERY, V130, P947, DOI 10.1067/msy.2001.118378; MOUHADJER N, 1989, REPROD NUTR DEV, V29, P277, DOI 10.1051/rnd:19890305; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; Pasqualini JR, 2005, J STEROID BIOCHEM, V93, P221, DOI 10.1016/j.jsbmb.2005.02.007; PAYNE AH, 1971, J CLIN ENDOCR METAB, V33, P582, DOI 10.1210/jcem-33-4-582; PAYNE AH, 1975, J CLIN ENDOCR METAB, V40, P102, DOI 10.1210/jcem-40-1-102; PAYNE AH, 1973, J CLIN ENDOCR METAB, V37, P448, DOI 10.1210/jcem-37-3-448; PAYNE AH, 1970, ENDOCRINOLOGY, V87, P316, DOI 10.1210/endo-87-2-316; Petzinger E, 2006, N-S ARCH PHARMACOL, V372, P465, DOI 10.1007/s00210-006-0042-9; Pizzagalli F, 2002, MOL ENDOCRINOL, V16, P2283, DOI 10.1210/me.2001-0309; Reed MJ, 2005, ENDOCR REV, V26, P171, DOI 10.1210/er.2004-0003; Robillard KR, 2012, J PHARMACOL EXP THER, V340, P96, DOI 10.1124/jpet.111.186916; RUOKONEN A, 1972, BIOCHEMISTRY-US, V11, P1411, DOI 10.1021/bi00758a013; RUOKONEN A, 1978, J STEROID BIOCHEM, V9, P939, DOI 10.1016/0022-4731(78)90054-7; RUOKONEN AO, 1983, J ANDROL, V4, P104; Schumacher V, 2008, MOL REPROD DEV, V75, P1484, DOI 10.1002/mrd.20889; Selcer KW, 2002, STEROIDS, V67, P821, DOI 10.1016/S0039-128X(02)00030-2; Stanway SJ, 2007, ONCOLOGIST, V12, P370, DOI 10.1634/theoncologist.12-4-370; Steger K, 1998, MOL HUM REPROD, V4, P939, DOI 10.1093/molehr/4.10.939; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Suzuki T, 2003, MOL ENDOCRINOL, V17, P1203, DOI 10.1210/me.2002-0304; Walker WH, 2010, PHILOS T R SOC B, V365, P1557, DOI 10.1098/rstb.2009.0258; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017	47	44	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62638	10.1371/journal.pone.0062638	http://dx.doi.org/10.1371/journal.pone.0062638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667501	Green Submitted, gold, Green Published			2022-12-27	WOS:000319055600036
J	Wells, JCK; Sharp, G; Steer, PJ; Leon, DA				Wells, Jonathan C. K.; Sharp, Georgina; Steer, Philip J.; Leon, David A.			Paternal and Maternal Influences on Differences in Birth Weight between Europeans and Indians Born in the UK	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; BODY-COMPOSITION; NEONATAL ANTHROPOMETRY; ETHNIC-DIFFERENCES; POSTNATAL-GROWTH; EARLY-CHILDHOOD; FETAL; HORSE; LIFE; SIZE	Background: Ethnic groups differ significantly in adult physique and birth weight. We aimed to improve understanding of maternal versus paternal contributions to ethnic differences in birth weight, by comparing the offspring of same-ethnic versus mixed-ethnic unions amongst Europeans and South Asian Indians in the UK. Methodology and principal findings: We used data from the UK Office for National Statistics Longitudinal Study (LS) and the Chelsea and Westminster Hospital (CWH), London. In the combined sample at all gestational ages, average birth weight of offspring with two European parents was significantly greater than that of offspring with two Indian parents [Delta = 344 (95% CI 329, 360) g]. Compared to offspring of European mothers, the offspring of Indian mothers had lower birth weight, whether the father was European [Delta = -152 (95% CI -92, -212) g] or Indian [Delta = -254 (95% -315, -192) g]. After adjustment for various confounding factors, average birth weight of offspring with European father and Indian mother was greater than that of offspring with two Indian parents [LS: Delta = 249 (95% CI 143, 354) g; CWH: Delta = 236 (95% CI 62, 411) g]. Average birth weight of offspring with Indian father and European mother was significantly less than that of offspring with two European parents [LS: Delta = -117 (95% CI -207, -26) g; CWH: Delta = -83 (-206, 40) g]. Conclusions/Significance: Birth weight of offspring with mixed-ethnic parentage was intermediate between that of offspring with two European or two Indian parents, demonstrating a paternal as well as a maternal contribution to ethnic differences in fetal growth. This can be interpreted as demonstrating paternal modulation of maternal investment in offspring. We suggest long-term nutritional experience over generations may drive such ethnic differences through parental co-adaptation.	[Wells, Jonathan C. K.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England; [Sharp, Georgina] Royal Cornwall Hosp NHS Trust, Truro, Cornwall, England; [Steer, Philip J.] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London, England; [Leon, David A.] London Sch Trop Med & Hyg, Dept Noncommunicable Dis Epidemiol Unit, London, England	University of London; University College London; Royal Cornwall Hospital; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Wells, JCK (corresponding author), UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England.	Jonathan.Wells@ucl.ac.uk	Leon, David A/G-2195-2010; Wells, Jonathan/A-4604-2009	Leon, David A/0000-0001-9747-1762; Wells, Jonathan/0000-0003-0411-8025	ESRC/JISC Census of Population Programme [H 507 25 5179]	ESRC/JISC Census of Population Programme	CeLSIUS is supported by the ESRC/JISC Census of Population Programme (Award Ref: H 507 25 5179). No funding was allocated to this specific research project.	Agnihotri B, 2008, INDIAN J PEDIATR, V75, P111, DOI 10.1007/s12098-008-0066-x; Agrawal AF, 2001, SCIENCE, V292, P1710, DOI 10.1126/science.1059910; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Allen WR, 2002, J ENDOCRINOL, V172, P237, DOI 10.1677/joe.0.1720237; Allen WR, 2002, REPRODUCTION, V123, P445, DOI 10.1530/rep.0.1230445; BARKER D, 1992, BRIT MED J; BATRA TR, 1983, CAN J ANIM SCI, V63, P511, DOI 10.4141/cjas83-060; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bogin B, 1999, ANN HUM BIOL, V26, P333; BROOKS AA, 1995, EARLY HUM DEV, V42, P29, DOI 10.1016/0378-3782(95)01637-I; BrooksGunn J, 1996, CHILD DEV, V67, P396; Cole TJ, 2000, P NUTR SOC, V59, P317, DOI 10.1017/S0029665100000355; Davis Mike, 2002, LATE VICTORIAN HOLOC; de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010; De Stavola BL, 2011, AM J EPIDEMIOL, V174, P52, DOI 10.1093/aje/kwr032; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Doniger Wendy, 2009, HINDUS ALTERNATIVE H; Ekelund U, 2006, AM J CLIN NUTR, V83, P324; Fagan B., 1999, FLOODS FAMINES EMPER; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Ganguly P, 1979, STUDY 60 POPULATION, P315; Godfray HCJ, 2000, PHILOS T ROY SOC B, V355, P1581, DOI 10.1098/rstb.2000.0719; Hager R, 2003, NATURE, V421, P533, DOI 10.1038/nature01239; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Hall LML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014197; Hattersley L, 1995, LONGITUDINAL STUDY 1; Hinde CA, 2010, SCIENCE, V327, P1373, DOI 10.1126/science.1186056; Hindmarsh PC, 2000, LANCET, V356, P719, DOI 10.1016/S0140-6736(00)02630-1; JOUBERT D. M., 1958, JOUR AGRIC SCI, V51, P325, DOI 10.1017/S0021859600035140; KARN MN, 1951, ANN EUGENIC, V16, P147, DOI 10.1111/j.1469-1809.1951.tb02469.x; Kelly Y, 2009, J PUBLIC HEALTH-UK, V31, P131, DOI 10.1093/pubmed/fdn057; Krishnaveni GV, 2005, INDIAN PEDIATR, V42, P527; Kuzawa CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040905; Leon DA, 1996, BRIT MED J, V312, P401, DOI 10.1136/bmj.312.7028.401; Leon DA, 2010, J EPIDEMIOL COMMUNIT; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Lukacs JR, 2007, HUMAN BIOL DIVERSITY, P193; Maat GJR, 2005, INT J OSTEOARCHAEOL, V15, P276, DOI 10.1002/oa.785; Magnus P, 2001, J EPIDEMIOL COMMUN H, V55, P873, DOI 10.1136/jech.55.12.873; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Mock D. W., 1997, EVOLUTION SIBLING RI; Modi N, 2009, PEDIATR RES, V65, P584, DOI 10.1203/01.pdr.0000350364.10602.33; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; MORTON NE, 1955, ANN HUM GENET, V20, P125; Moser K, 2008, HLTH STAT Q, V39, P34; Muthayya S, 2006, PUBLIC HEALTH NUTR, V9, P896, DOI 10.1017/PHN2006943; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nystrom MJ, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.065; OUNSTED M, 1986, ANN HUM BIOL, V13, P143, DOI 10.1080/03014468600008281; OUNSTED M, 1966, NATURE, V212, P995, DOI 10.1038/212995a0; PARKER GA, 1978, ANIM BEHAV, V26, P97, DOI 10.1016/0003-3472(78)90009-X; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Petry CJ, 2007, TRENDS MOL MED, V13, P414, DOI 10.1016/j.molmed.2007.07.007; Price KC, 1999, OBSTET GYNECOL, V94, P128, DOI 10.1016/S0029-7844(99)00269-0; Shiono PH, 1997, AM J PUBLIC HEALTH, V87, P787, DOI 10.2105/AJPH.87.5.787; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Singh R, 2007, DIABETIC MED, V24, P195, DOI 10.1111/j.1464-5491.2007.02066.x; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; SMITH DW, 1976, J PEDIATR-US, V89, P225, DOI 10.1016/S0022-3476(76)80453-2; Smith FM, 2006, CYTOGENET GENOME RES, V113, P279, DOI 10.1159/000090843; Stanfield KM, 2012, INT J EPIDEMIOL, V41, P1409, DOI 10.1093/ije/dys139; Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7; TRIVERS RL, 1974, AM ZOOL, V14, P249; van Steijn L, 2009, INT J OBESITY, V33, P1326, DOI 10.1038/ijo.2009.154; VENGE O., 1950, ACTA ZOOL [STOCKHOLM], V31, P1; Walimbe SR, 2007, VERTEBR PALEOBIOL PA, P297, DOI 10.1007/1-4020-5562-5_13; Walton A, 1938, PROC R SOC SER B-BIO, V125, P311, DOI 10.1098/rspb.1938.0029; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; Wells JCK, 2007, BIOL REV, V82, P143, DOI 10.1111/j.1469-185X.2006.00007.x; Wells JCK, 2010, AM J HUM BIOL, V22, P1, DOI 10.1002/ajhb.20994; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219; Yajnik CS, 2004, LANCET, V363, P163, DOI 10.1016/S0140-6736(03)15269-5	74	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61116	10.1371/journal.pone.0061116	http://dx.doi.org/10.1371/journal.pone.0061116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667432	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000319055600008
J	Liu, L; Li, MY; Yang, L; Ju, LR; Tan, BQ; Walker, N; Bryce, J; Campbell, H; Black, RE; Guo, Y				Liu, Li; Li, Mengying; Yang, Li; Ju, Lirong; Tan, Biqin; Walker, Neff; Bryce, Jennifer; Campbell, Harry; Black, Robert E.; Guo, Yan			Measuring Coverage in MNCH: A Validation Study Linking Population Survey Derived Coverage to Maternal, Newborn, and Child Health Care Records in Rural China	PLOS ONE			English	Article							OBSTETRIC COMPLICATIONS; PERINATAL EVENTS; MISCLASSIFICATION; PREGNANCY; AGREEMENT; ACCURACY; RECALL	Background: Accurate data on coverage of key maternal, newborn, and child health (MNCH) interventions are crucial for monitoring progress toward the Millennium Development Goals 4 and 5. Coverage estimates are primarily obtained from routine population surveys through self-reporting, the validity of which is not well understood. We aimed to examine the validity of the coverage of selected MNCH interventions in Gongcheng County, China. Method and Findings: We conducted a validation study by comparing women's self-reported coverage of MNCH interventions relating to antenatal and postnatal care, mode of delivery, and child vaccinations in a community survey with their paper- and electronic-based health care records, treating the health care records as the reference standard. Of 936 women recruited, 914 (97.6%) completed the survey. Results show that self-reported coverage of these interventions had moderate to high sensitivity (0.57 [95% confidence interval (CI): 0.50-0.63] to 0.99 [95% CI: 0.98-1.00]) and low to high specificity (0 to 0.83 [95% CI: 0.80-0.86]). Despite varying overall validity, with the area under the receiver operating characteristic curve (AUC) ranging between 0.49 [95% CI: 0.39-0.57] and 0.90 [95% CI: 0.88-0.92], bias in the coverage estimates at the population level was small to moderate, with the test to actual positive (TAP) ratio ranging between 0.8 and 1.5 for 24 of the 28 indicators examined. Our ability to accurately estimate validity was affected by several caveats associated with the reference standard. Caution should be exercised when generalizing the results to other settings. Conclusions: The overall validity of self-reported coverage was moderate across selected MNCH indicators. However, at the population level, self-reported coverage appears to have small to moderate degree of bias. Accuracy of the coverage was particularly high for indicators with high recorded coverage or low recorded coverage but high specificity. The study provides insights into the accuracy of self-reports based on a population survey in low- and middle-income countries. Similar studies applying an improved reference standard are warranted in the future.	[Liu, Li; Li, Mengying; Walker, Neff; Bryce, Jennifer; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Yang, Li] Guangxi Med Univ, Sch Publ Hlth, Nanning, Peoples R China; [Ju, Lirong] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Tan, Biqin] Gongcheng Cty Maternal & Child Hlth Hosp, Beijing, Gongcheng Count, Peoples R China; [Campbell, Harry] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Guo, Yan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100871, Peoples R China	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Guangxi Medical University; Capital Medical University; University of Edinburgh; Peking University	Guo, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100871, Peoples R China.	guoyan@bjmu.edu.cn	Campbell, Harry/E-2959-2010; liu, li/HGC-0900-2022	Campbell, Harry/0000-0002-6169-6262; Black, Robert/0000-0001-9926-7984	Child Health Epidemiology Reference Group (CHERG) for WHO; UNICEF [50140, 43386]; Bill & Melinda Gates Foundation	Child Health Epidemiology Reference Group (CHERG) for WHO; UNICEF; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was conducted under the auspices of the Child Health Epidemiology Reference Group (CHERG) for WHO and UNICEF (No. 50140 and No. 43386), with financial support from The Bill & Melinda Gates Foundation through their grant to the US Fund for UNICEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; Buka SL, 2004, SCHIZOPHR RES, V71, P417, DOI 10.1016/j.schres.2004.04.004; Campbell H, 2008, CROAT MED J, V49, P402, DOI 10.3325/cmj.2008.3.402; Campbell H, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001422, 10.1371/journal.pmed.1001421]; CASEY R, 1992, CLIN PEDIATR, V31, P200, DOI 10.1177/000992289203100402; Eisele TP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001417; Elkadry E, 2003, AM J OBSTET GYNECOL, V189, P195, DOI 10.1067/mob.2003.371; Filippi V, 2000, STUD FAMILY PLANN, V31, P309, DOI 10.1111/j.1728-4465.2000.00309.x; Glass RI, 2012, JAMA-J AM MED ASSOC, V308, P141, DOI 10.1001/jama.2012.7357; Gongcheng County Department of Health, 2011, MAT CHILD HLTH STAT; Gongcheng Yao Autonomous County Statistics Bureau, 2010, 6 NAT CENS PREL RES; Guilin Economic and Social Statistical Yearbook Editorial Board, 2007, GUIL EC SOC YB 2007; HAKIM RB, 1992, AM J EPIDEMIOL, V136, P566, DOI 10.1093/oxfordjournals.aje.a116534; Hancioglu A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001391; HEWSON D, 1987, AM J EPIDEMIOL, V125, P484, DOI 10.1093/oxfordjournals.aje.a114554; Huang H, 2009, SHANGDONG MED, V49, P89; Institut Superieur des Sciences de la Population (ISSP and Institute for International Programs Johns Hopkins University IIP-JHU), 2012, EV IND PROJ ACC RED; Liao C, 2005, PRENATAL DIAG, V25, P163, DOI 10.1002/pd.1079; Liu YL, 2004, B WORLD HEALTH ORGAN, V82, P532; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Quigley MA, 2007, BJOG-INT J OBSTET GY, V114, P195, DOI 10.1111/j.1471-0528.2006.01203.x; Ronsmans C, 1997, STUD FAMILY PLANN, V28, P203, DOI 10.2307/2137888; Royston P, 2002, STATA J, V2, P151, DOI 10.1177/1536867X0200200204; Sloan NL, 2001, J HEALTH POPUL NUTR, V19, P45; Stanton CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060694; StataCorp L, 2007, STAT DAT AN STAT SOF; The Central People's Government of the People's Republic of China, 2005, GUID NAT CHILD IMM P; The Countdown Group, 2012, BUILD FUT WOM CHILDR; Tourangeau R, 2000, SCIENCE OF SELF-REPORT, P29; Tuncalp O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060761; VECCHIO TJ, 1966, NEW ENGL J MED, V274, P1171, DOI 10.1056/NEJM196605262742104; Willis G, 1999, RESPONSE ERRORS SURV; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	33	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e60762	10.1371/journal.pone.0060762	http://dx.doi.org/10.1371/journal.pone.0060762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667429	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700007
J	Pal, SK; Nelson, RA; Vogelzang, N				Pal, Sumanta K.; Nelson, Rebecca A.; Vogelzang, Nicholas			Disease-Specific Survival in De Novo Metastatic Renal Cell Carcinoma in the Cytokine and Targeted Therapy Era	PLOS ONE			English	Article							INTERFERON-ALPHA; POPULATION	Background: Recent phase III studies of targeted agents for metastatic renal cell carcinoma (mRCC) have generated median survival estimates that far exceed those observed during the cytokine era. However, substantial population-based data does not exist to confirm this trend. We sought to determine whether survival has improved for patients with mRCC diagnosed in the era of targeted therapies, as compared to the era of immunotherapy. Methods: The Surveillance, Epidemiology, and End Results (SEER) Registry was used to identify patients aged 18 and older diagnosed stage IV RCC between 1992 and 2009. Patients had documented clear cell, papillary or chromophobe histology. The Kaplan Meier method and log-rank test were used to compare disease-specific survival (DSS) for patients diagnosed from 1992-2004 (i.e., the cytokine era) and 2005-2009 (i.e., the targeted therapy era). Univariate and multivariate analyses of relevant clinicopathologic characteristics were also performed. Results: Of 5,176 patients identified using the above characteristics, 2,392 patients were diagnosed from 1992-2004 and 2,784 from 2005-2009. Median DSS was improved in those patients diagnosed from 2005-2009 (16 months vs 13 months; P<0.0001). A similar temporal trend towards improving survival was noted in patients with clear cell (P = 0.0006), but not in patients with non-clear cell disease (P = 0.32). Notable findings on multivariate analysis include an association between shorter DSS and the following characteristics: (1) diagnosis from 1992-2004, (2) advanced age (80+), and (3) absence of cytoreductive nephrectomy. Conclusions: These data reflect progress in the management of mRCC, specifically in the era of targeted therapies. Notably, it was inferred that certain treatment strategies were employed during pre-specified time periods, representing a major caveat of the current analysis. Further studies related to the influence of age and race/ethnicity are warranted, as are studies exploring the role of cytoreductive nephrectomy and novel treatments for non-clear cell disease.	[Pal, Sumanta K.] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA; [Nelson, Rebecca A.] City Hope Comprehens Canc Ctr, Dept Informat Sci, Div Biostat, Duarte, CA USA; [Vogelzang, Nicholas] Comprehens Canc Centers, US Oncol Res, Las Vegas, NV USA	City of Hope; City of Hope; US Oncology Network	Pal, SK (corresponding author), City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA.	spal@coh.org	Nelson, Rebecca/C-4438-2014		NIH [K12 2K12CA001727-16A1]; NATIONAL CANCER INSTITUTE [K12CA001727] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH K12 2K12CA001727-16A1 (S.K.P.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SEER MAN ON LIN 20 1, P34; [Anonymous], FDA APPR LETT SUN; [Anonymous], SEER MAN ON LIN; [Anonymous], 1973, RES DAT 1973 2 UNPUB; Edge SB, 2010, AJCC CANC STAGING MA; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Fyfe GA, 1996, J CLIN ONCOL, V14, P2410, DOI 10.1200/JCO.1996.14.8.2410; Harshman LC, 2012, LANCET ONCOL, V13, P927, DOI 10.1016/S1470-2045(12)70285-1; Harzstark AL, 2011, ASCO M ABSTR S15, V29, P4547; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Heng DYC, 2012, ASCO M, V30, P4536; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Manola J, 2011, CLIN CANCER RES, V17, P5443, DOI 10.1158/1078-0432.CCR-11-0553; Matsumoto K, 2007, INT J UROL, V14, P1000, DOI 10.1111/j.1442-2042.2007.01889.x; Motzer R, 2012, ANN ONCOL, V23; Motzer RJ, 2004, CLIN CANCER RES, V10, p6302S, DOI 10.1158/1078-0432.CCR-040031; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Patil S, 2012, J UROL; Plimack ER, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.4604; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Shek D, 2012, CLIN GENITOURIN CANC, V10, P93, DOI 10.1016/j.clgc.2012.01.007; Stafford HS, 2008, J UROLOGY, V179, P1704, DOI 10.1016/j.juro.2008.01.027; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Tripathi RT, 2006, UROLOGY, V68, P296, DOI 10.1016/j.urology.2006.02.036	29	54	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63341	10.1371/journal.pone.0063341	http://dx.doi.org/10.1371/journal.pone.0063341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658823	Green Submitted, Green Published, gold			2022-12-27	WOS:000321202100063
J	Rajapakse, NW; Chong, AL; Zhang, WZ; Kaye, DM				Rajapakse, Niwanthi W.; Chong, Abigail L.; Zhang, Wei-Zheng; Kaye, David M.			Insulin-Mediated Activation of the L-Arginine Nitric Oxide Pathway in Man, and Its Impairment in Diabetes	PLOS ONE			English	Article							HUMAN FOREARM; ENDOTHELIAL DYSFUNCTION; SKELETAL-MUSCLE; HEART-FAILURE; DEPENDENT VASODILATION; CARDIOVASCULAR-DISEASE; STIMULATED PRODUCTION; RESISTANCE; HYPERTENSION; SYNTHASE	Aims/Hypothesis: Impaired L-arginine transport has been reported in cardiovascular diseases, providing a possible mechanism for reduced nitric oxide (NO) production. Given that cardiovascular diseases are also associated with insulin resistance, and insulin is known to induce vasodilation via a NO-dependent pathway, we hypothesised that abnormal insulin modulation of L-arginine transport may contribute to vascular dysfunction in diabetes. Methods: Forearm blood flow (FBF) responses to insulin and sodium nitroprusside (SNP) were measured in control and type 2 diabetic volunteers using venous occlusion plethysmography. Effects of intra-arterial insulin on the forearm veno-arterial flux of arginine and related amino acids were determined by HPLC. The effect of locally delivered insulin on arginine transport was assessed during an intra-arterial infusion of [4,5-H-3] L-arginine. Results: In controls, intrabrachial infusion of 5 mUnits/min insulin lead to a progressive rise in FBF (p<0.001) while this was not evident in diabetics. In support of this observation, we observed a concomitant, significant increase in the flux of N-hydroxy-L-arginine (the NO precursor) in controls (baseline vs. 60 mins insulin: 16.2+/-12.2 vs. 33.0+/-13.1 nmol/100 ml tissue/min; p<0.01), whilst no increase was observed in diabetics. Moreover, insulin augmented the clearance of [H-3] L-arginine from the forearm circulation in controls (baseline vs insulin: 123622 vs. 150628 ml/min; p<0.05) but not in diabetics. Conclusion: These findings suggest that insulin resistance may contribute substantially to the onset and development of cardiovascular disease in type 2 diabetics via abnormal insulin-mediated regulation of L-arginine transport.	[Rajapakse, Niwanthi W.; Chong, Abigail L.; Zhang, Wei-Zheng; Kaye, David M.] Baker IDI Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia; [Rajapakse, Niwanthi W.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; [Kaye, David M.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia	Baker Heart and Diabetes Institute; Monash University; Monash University	Kaye, DM (corresponding author), Baker IDI Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia.	david.kaye@baker.edu.au	Kaye, David/AAF-1202-2021	Rajapakse, Niwanthi/0000-0001-9777-1087; ZHANG, wei zheng/0000-0002-8509-3490; Kaye, David/0000-0003-4058-0372	National Heath and Medical Research Council of Australia; Victorian Government's operational Infrastructure Support Programme	National Heath and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's operational Infrastructure Support Programme	The study was supported by a grant from the National Heath and Medical Research Council of Australia. Dr. Rajapakse is a National Heart Foundation of Australia Post-doctoral Research Fellow (ID: PF09M4668). The study was also supported in part by the Victorian Government's operational Infrastructure Support Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; Cardillo C, 1998, HYPERTENSION, V32, P740, DOI 10.1161/01.HYP.32.4.740; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Chin-Dusting JPF, 1999, CLIN SCI, V96, P439, DOI 10.1042/CS19990033; Coggins M, 2001, DIABETES, V50, P2682, DOI 10.2337/diabetes.50.12.2682; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; DREXLER H, 1992, AM J CARDIOL, V69, P1596, DOI 10.1016/0002-9149(92)90710-G; Fujishima S, 1995, Hypertens Res, V18, P227, DOI 10.1291/hypres.18.227; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gonzalez M, 2011, J CELL PHYSIOL, V226, P2916, DOI 10.1002/jcp.22635; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Hermann TS, 2004, ENDOTHELIUM-J ENDOTH, V11, P231, DOI 10.1080/10623320490904098; Inoue T, 2000, EUR HEART J, V21, P895, DOI 10.1053/euhj.1999.1872; JAMERSON KA, 1993, HYPERTENSION, V21, P618, DOI 10.1161/01.HYP.21.5.618; Katakam PVG, 2005, AM J PHYSIOL-HEART C, V288, pH854, DOI 10.1152/ajpheart.00715.2004; Kaye DM, 2000, CIRCULATION, V102, P2707, DOI 10.1161/01.CIR.102.22.2707; Makimattila S, 1999, DIABETES CARE, V22, P973, DOI 10.2337/diacare.22.6.973; McDonald KK, 1997, J BIOL CHEM, V272, P31213, DOI 10.1074/jbc.272.50.31213; Montagnani M, 2002, MOL ENDOCRINOL, V16, P1931, DOI 10.1210/me.2002-0074; NATALI A, 1990, DIABETES, V39, P490, DOI 10.2337/diabetes.39.4.490; NEAHRING JM, 1993, HYPERTENSION, V22, P584, DOI 10.1161/01.HYP.22.4.584; Ogonowski AA, 2000, AM J PHYSIOL-CELL PH, V278, pC136; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Parsonage W, 2002, AM J CARDIOL, V89, P696, DOI 10.1016/S0002-9149(01)02342-6; Petrie JR, 1996, CIRCULATION, V93, P1331, DOI 10.1161/01.CIR.93.7.1331; Pyorala M, 2000, DIABETES CARE, V23, P1097, DOI 10.2337/diacare.23.8.1097; SAKAI K, 1993, HYPERTENSION, V22, P67, DOI 10.1161/01.HYP.22.1.67; SCHERRER U, 1994, J CLIN INVEST, V94, P2511, DOI 10.1172/JCI117621; Scherrer U, 1997, CIRCULATION, V96, P4104; Schlaich MP, 2004, CIRCULATION, V110, P3680, DOI 10.1161/01.CIR.0000149748.79945.52; SORENSEN KE, 1994, J CLIN INVEST, V93, P50, DOI 10.1172/JCI116983; STEINBERG HO, 1994, J CLIN INVEST, V94, P1172, DOI 10.1172/JCI117433; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Suzuki M, 2004, AM J HYPERTENS, V17, P228, DOI 10.1016/j.amjhyper.2003.11.013; Taddei S, 1996, CIRCULATION, V94, P1298, DOI 10.1161/01.CIR.94.6.1298; Vincent MA, 2005, CLIN EXP PHARMACOL P, V32, P302, DOI 10.1111/j.1440-1681.2005.04188.x; Wheatcroft SB, 2003, DIABETIC MED, V20, P255, DOI 10.1046/j.1464-5491.2003.00869.x; Williams SB, 1996, J AM COLL CARDIOL, V27, P567, DOI 10.1016/0735-1097(95)00522-6; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zhang WZ, 2004, ANAL BIOCHEM, V326, P87, DOI 10.1016/j.ab.2003.11.006	43	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61840	10.1371/journal.pone.0061840	http://dx.doi.org/10.1371/journal.pone.0061840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658699	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500012
J	Yin, JJ; Sharma, S; Shumyak, SP; Wang, ZX; Zhou, ZW; Zhang, YD; Guo, PX; Li, CZ; Kanwar, JR; Yang, TX; Mohapatra, SS; Liu, WQ; Duan, W; Wang, JC; Li, Q; Zhang, XJ; Tan, J; Jia, L; Liang, J; Wei, MQ; Li, XT; Zhou, SF				Yin, Juan-Juan; Sharma, Sonali; Shumyak, Stepan P.; Wang, Zhi-Xin; Zhou, Zhi-Wei; Zhang, Yangde; Guo, Peixuan; Li, Chen-Zhong; Kanwar, Jagat R.; Yang, Tianxin; Mohapatra, Shyam S.; Liu, Wanqing; Duan, Wei; Wang, Jian-Cheng; Li, Qi; Zhang, Xueji; Tan, Jun; Jia, Lee; Liang, Jun; Wei, Ming Q.; Li, Xiaotian; Zhou, Shu-Feng			Synthesis and Biological Evaluation of Novel Folic Acid Receptor-Targeted, beta-Cyclodextrin-Based Drug Complexes for Cancer Treatment	PLOS ONE			English	Article							HUMAN CYTOCHROME-P450 2D6; CHINESE HERBAL MEDICINE; MOLECULAR DOCKING; DELIVERY SYSTEMS; FOLATE; DOXORUBICIN; BINDING; LIGAND; CARDIOTOXICITY; ANTHRACYCLINES	Drug targeting is an active area of research and nano-scaled drug delivery systems hold tremendous potential for the treatment of neoplasms. In this study, a novel cyclodextrin (CD)-based nanoparticle drug delivery system has been assembled and characterized for the therapy of folate receptor-positive [FR(+)] cancer. Water-soluble folic acid (FA)conjugated CD carriers (FACDs) were successfully synthesized and their structures were confirmed by 1D/2D nuclear magnetic resonance (NMR), matrix-assisted laser desorption ionization time-of-flight mass spectrometer (MALDI-TOF-MS), high performance liquid chromatography (HPLC), Fourier transform infrared spectroscopy (FTIR), and circular dichroism. Drug complexes of adamatane (Ada) and cytotoxic doxorubicin (Dox) with FACD were readily obtained by mixed solvent precipitation. The average size of FACD-Ada-Dox was 1.5-2.5 nm. The host-guest association constant K-a was 1,639 M-1 as determined by induced circular dichroism and the hydrophilicity of the FACDs was greatly enhanced compared to unmodified CD. Cellular uptake and FR binding competitive experiments demonstrated an efficient and preferentially targeted delivery of Dox into FR-positive tumor cells and a sustained drug release profile was seen in vitro. The delivery of Dox into FR(+) cancer cells via endocytosis was observed by confocal microscopy and drug uptake of the targeted nanoparticles was 8-fold greater than that of non-targeted drug complexes. Our docking results suggest that FA, FACD and FACD-Ada-Dox could bind human hedgehog interacting protein that contains a FR domain. Mouse cardiomyocytes as well as fibroblast treated with FACD-Ada-Dox had significantly lower levels of reactive oxygen species, with increased content of glutathione and glutathione peroxidase activity, indicating a reduced potential for Dox-induced cardiotoxicity. These results indicate that the targeted drug complex possesses high drug association and sustained drug release properties with good biocompatibility and physiological stability. The novel FA-conjugated beta-CD based drug complex might be promising as an anti-tumor treatment for FR(+) cancer.	[Yin, Juan-Juan; Sharma, Sonali; Shumyak, Stepan P.; Wang, Zhi-Xin; Zhou, Zhi-Wei; Liang, Jun; Zhou, Shu-Feng] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA; [Zhang, Yangde] Cent S Univ, Natl Hepatobiliary & Enter Surg Res Ctr, Changsha, Hunan, Peoples R China; [Guo, Peixuan] Univ Kentucky, Coll Pharm, Nanobiotechnol Ctr & Markey Canc Ctr, Lexington, KY USA; [Li, Chen-Zhong] Florida Int Univ, Nanobioengn & Bioelect Lab, Dept Biomed Engn, Miami, FL 33199 USA; [Kanwar, Jagat R.] Deakin Univ, Nanomed Lab Immunol & Mol Biomed Res LIMBR, Ctr Biotechnol & Interdisciplinary Biosci, Waurn Ponds, Vic, Australia; [Kanwar, Jagat R.] Deakin Univ, Inst Frontier Mat, Waurn Ponds, Vic, Australia; [Yang, Tianxin] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Yang, Tianxin] Salt Lake Vet Affairs Med Ctr, Salt Lake City, UT USA; [Mohapatra, Shyam S.] Univ S Florida, Nanomed Res Ctr, Tampa, FL USA; [Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Div Translat Med, Morsani Coll Med, Tampa, FL 33612 USA; [Liu, Wanqing] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, Indiana, PA USA; [Duan, Wei] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Wang, Jian-Cheng; Jia, Lee] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Li, Qi] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Oncol, Shanghai, Peoples R China; [Zhang, Xueji] Univ Sci & Technol Beijing, Res Ctr Bioengineering & Sensing Technol, Beijing 100083, Peoples R China; [Tan, Jun] James A Haley Vet Adm Hosp, Tampa, FL USA; [Liang, Jun] Univ S Florida, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Morsani Coll Med, Tampa, FL USA; [Tan, Jun] Univ S Florida, Dept Psychiat & Behav Neurosci, Morsani Coll Med, Silver Child Dev Ctr,Rashid Lab Dev Neurobiol, Tampa, FL USA; [Liang, Jun] Fuzhou Univ, Coll Chem & Chem Engn, Canc Metastasis Alert & Prevent Ctr, Fuzhou 350002, Peoples R China; [Wei, Ming Q.] Griffith Univ, Griffith Hlth Inst, Div Mol & Gene Therapies, Sch Med Sci, Nathan, Qld 4111, Australia; [Li, Xiaotian] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Li, Xiaotian] Fudan Univ, Inst Biomed, Shanghai, Peoples R China	State University System of Florida; University of South Florida; Central South University; University of Kentucky; State University System of Florida; Florida International University; Deakin University; Deakin University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Purdue University System; Purdue University; Deakin University; Peking University; Shanghai University of Traditional Chinese Medicine; University of Science & Technology Beijing; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Fuzhou University; Griffith University; Menzies Health Institute Queensland; Fudan University; Fudan University	Zhou, SF (corresponding author), Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA.	szhou@health.usf.edu	zhang, xueji/ABE-6497-2020; Guo, Peixuan/AAE-2573-2022; zhou, zhiwei/J-7878-2015; Li, Chenzhong/F-5087-2016; wang, zhixin/GZH-2500-2022; Mohapatra, Shyam/C-2500-2012; zhang, xueji/B-1904-2010; Li, Xiaotian/ABI-3309-2020; Guo, Peixuan/I-7184-2015; Duan, Wei/A-5181-2015; Zhou, Shu-Feng/E-3166-2013	zhang, xueji/0000-0002-0035-3821; Guo, Peixuan/0000-0001-5706-2833; zhou, zhiwei/0000-0002-8227-2573; Li, Xiaotian/0000-0002-2051-4581; Duan, Wei/0000-0001-5782-9184; Zhou, Shu-Feng/0000-0002-5542-6119; Liu, Wanqing/0000-0001-7727-6900; JIA, LEE/0000-0001-6839-5545	College of Pharmacy, University of South Florida, Tampa, Florida	College of Pharmacy, University of South Florida, Tampa, Florida	Dr JJY is supported by a postdoctoral scholarship from the College of Pharmacy, University of South Florida, 12901 Bruce B Downs Blvd., Tampa, Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Chen G, 2011, CHEM SOC REV, V40, P2254, DOI 10.1039/c0cs00153h; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Dickey JS, 2012, CURR MOL MED, V12, P763; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Fan J, 2012, SMALL; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gatenby RA, 2009, NATURE, V459, P508, DOI 10.1038/459508a; Granadero D, 2010, INT J MOL SCI, V11, P173, DOI 10.3390/ijms11010173; Hanusova V, 2011, DRUG METAB REV, V43, P540, DOI 10.3109/03602532.2011.609174; Hilgenbrink AR, 2005, J PHARM SCI-US, V94, P2135, DOI 10.1002/jps.20457; Hochdorffer K, 2012, J MED CHEM, V55, P7502, DOI 10.1021/jm300493m; Kizek R, 2012, PHARMACOL THERAPEUT, V133, P26, DOI 10.1016/j.pharmthera.2011.07.006; Kratz F, 2012, J CONTROL RELEASE, V164, P221, DOI 10.1016/j.jconrel.2012.05.045; Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063; Legigan T, 2012, J MED CHEM, V55, P4516, DOI 10.1021/jm300348r; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mo SL, 2012, CURR PHARM BIOTECHNO, V13, P1640, DOI 10.2174/138920112800958779; Mo SL, 2012, COMB CHEM HIGH T SCR, V15, P36, DOI 10.2174/138620712798280826; Muro S, 2012, J CONTROL RELEASE, V164, P125, DOI 10.1016/j.jconrel.2012.05.052; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; PETTER RC, 1990, J AM CHEM SOC, V112, P3860, DOI 10.1021/ja00166a021; Roy PP, 2010, MOL SIMULAT, V36, P887, DOI 10.1080/08927022.2010.492834; Sabharanjak S, 2004, ADV DRUG DELIVER REV, V56, P1099, DOI 10.1016/j.addr.2004.01.010; Salas C, 2011, REV INVEST CLIN, V63, P53; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; WEITMAN SD, 1992, CANCER RES, V52, P3396; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yague E, 2005, BRIT J CANCER, V93, P973, DOI 10.1038/sj.bjc.6602821; Zhao XB, 2008, EXPERT OPIN DRUG DEL, V5, P309, DOI [10.1517/17425247.5.3.309, 10.1517/17425247.5.3.309 ]	38	51	52	2	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62289	10.1371/journal.pone.0062289	http://dx.doi.org/10.1371/journal.pone.0062289			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658721	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500022
J	Cui, HX; Zhang, WL; Hu, W; Liu, K; Wang, T; Ma, N; Liu, XH; Liu, YP; Jiang, YH				Cui, Huixia; Zhang, Wenlu; Hu, Wei; Liu, Kun; Wang, Tong; Ma, Nan; Liu, Xiaohui; Liu, Yunpeng; Jiang, Youhong			Recombinant Mammaglobin A Adenovirus-Infected Dendritic Cells Induce Mammaglobin A-Specific CD8(+) Cytotoxic T Lymphocytes against Breast Cancer Cells In Vitro	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CELLULAR IMMUNE-RESPONSES; VIRUS CORE ANTIGEN; INDUCED MATURATION; PERIPHERAL-BLOOD; ACTIVATION; GENERATION; VIVO; IDENTIFICATION; VACCINATION	Mammaglobin A (MGBA) is a novel breast cancer-associated antigen almost exclusively over-expressed in primary and metastatic human breast cancers, making it a potential therapeutic target for breast cancer. The development of dendritic cell (DC)-induced tumor antigen specific CD8(+) cytotoxic T lymphocytes (CTLs) may hold promise in cancer immunotherapy. In this study we constructed recombinant replication-defective adenoviral (Ad) vectors encoding MGBA and evaluated their ability to trigger anti-tumor immunity in vitro. DCs were isolated from the human peripheral blood monocyte cells (PBMCs) of two HLA-A33(+) healthy female volunteers, and infected with adenovirus carrying MGBA cDNA (Ad-MGBA). After that, the Ad-MGBA-infected DCs were used to stimulate CD8(+) CTLs in vitro and the latter was used for co-culture with breast cancer cell lines. The data revealed that infection with Ad-MGBA improved DC maturation and up-regulated the expression of costimulatory molecules and the secretion of interleukin-12 (IL-12), but down-regulated interleukin-10 (IL-10) secretion from DCs. Ad-MGBA-infected DC-stimulated CD8(+) CTLs displayed the highest cytotoxicity towards HLA-A33(+)/MGBA(+) breast cancer MDA-MB-415 cells compared with other CD8(+) CTL populations, and compared with the cytotoxicity towards HLA-A33(-)/MGBA(+) breast cancer HBL-100 cells and HLA-A33(-)/MGBA(-) breast cancer MDA-MB 231 cells. In addition, Ad-MGBA infected DC-stimulated CD8(+) CTLs showed a high level of IFN gamma secretion when stimulated with HLA-A33(+)/MGBA(+) breast cancer MDA-MB-415 cells, but not when stimulated with HLA-A33(-)/MGBA(+) HBL-100 and HLA-A33(-)/MGBA(-)MDA-MB-231 cells. In addition, killing of CD8(+) CTLs against breast cancer was in a major histocompability complex (MHC)-limited pattern. Finally, the data also determined the importance of TNF-alpha in activating DCs and T cells. These data together suggest that MGBA recombinant adenovirus-infected DCs could induce specific anti-tumor immunity against MGBA(+) breast cancers, which could provide a novel strategy in the immunotherapy of breast cancer.	[Cui, Huixia; Hu, Wei; Wang, Tong; Ma, Nan; Liu, Xiaohui; Jiang, Youhong] China Med Univ, Hosp 1, Canc Res Inst, Shenyang, Peoples R China; [Cui, Huixia; Liu, Kun] Liaoning Med Univ, Coll Nursing, Jinzhou, Peoples R China; [Zhang, Wenlu] Liaoning Med Univ, Hosp 1, Dept Oncol, Jinzhou, Peoples R China; [Liu, Yunpeng] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China	China Medical University; Jinzhou Medical University; Jinzhou Medical University; China Medical University	Jiang, YH (corresponding author), China Med Univ, Hosp 1, Canc Res Inst, Shenyang, Peoples R China.	jiangyouhong2000@yahoo.com.cn			Science and Technology project of Liaoning Province [2011415052-3]; Youth Foundation of Liaoning Medical University [Y2012Z013]	Science and Technology project of Liaoning Province; Youth Foundation of Liaoning Medical University	This study was supported by grants from the Science and Technology project of Liaoning Province (No. 2011415052-3) and the Youth Foundation of Liaoning Medical University (No. Y2012Z013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Joudi FS, 2011, INDIAN J PATHOL MICR, V54, P284, DOI 10.4103/0377-4929.81596; Aline F, 2009, VACCINE, V27, P5284, DOI 10.1016/j.vaccine.2009.05.028; Balwin Jr AS, 1995, ANNU REV IMMUNOL, V14, P649; Basha HI, 2011, BREAST CANCER RES TR, V127, P81, DOI 10.1007/s10549-010-0975-z; Bernstein JL, 2005, CLIN CANCER RES, V11, P6528, DOI 10.1158/1078-0432.CCR-05-0415; Ceballos MP, 2011, CLIN BIOCHEM, V44, P1429, DOI 10.1016/j.clinbiochem.2011.08.1140; Chamoto K, 2003, CANCER SCI, V94, P924, DOI 10.1111/j.1349-7006.2003.tb01377.x; Chen BG, 1998, BLOOD, V91, P4652, DOI 10.1182/blood.V91.12.4652.412a03_4652_4661; Chen JH, 2012, WORLD J GASTROENTERO, V18, P1319, DOI 10.3748/wjg.v18.i12.1319; Chen XH, 2008, ACTA BIOCH BIOPH SIN, V40, P996, DOI 10.1111/j.1745-7270.2008.00487.x; Fleming TP, 2000, ANN NY ACAD SCI, V923, P78, DOI 10.1111/j.1749-6632.2000.tb05521.x; Garetto S, 2009, CYTOTHERAPY, V11, P1090, DOI 10.3109/14653240903164971; Ge CY, 2011, INT IMMUNOPHARMACOL, V11, P2200, DOI 10.1016/j.intimp.2011.10.001; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; He Dandan, 2010, CHINA CANC, V19, P108; Herrera OB, 2002, VACCINE, V21, P231, DOI 10.1016/S0264-410X(02)00448-6; Hirata N, 2011, CELL IMMUNOL, V266, P165, DOI 10.1016/j.cellimm.2010.09.012; Hirschowitz EA, 2000, GENE THER, V7, P1112, DOI 10.1038/sj.gt.3301210; Jaramillo A, 2004, BREAST CANCER RES TR, V88, P29, DOI 10.1007/s10549-004-8918-1; [进淑娟 Jin Shujuan], 2010, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V34, P440; Kim J, 2013, FOOD FUNCT, V4, P258, DOI 10.1039/c2fo30209h; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Li A, 2011, DNA CELL BIOL, V30, P883, DOI 10.1089/dna.2011.1222; Manna PP, 2003, BREAST CANCER RES TR, V79, P133, DOI 10.1023/A:1023323509888; Micheva I, 2004, CLIN IMMUNOL, V113, P310, DOI 10.1016/j.clim.2004.08.007; Mikhitarian K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-55; Miyazawa M, 2011, CANCER LETT, V305, P32, DOI 10.1016/j.canlet.2011.02.013; Morelli AE, 2000, J VIROL, V74, P9617, DOI 10.1128/JVI.74.20.9617-9628.2000; Narayanan K, 2004, JNCI-J NATL CANCER I, V96, P1388, DOI 10.1093/jnci/djh261; Noh YW, 2011, BIOMATERIALS, V32, P6254, DOI 10.1016/j.biomaterials.2011.05.013; Philpott NJ, 2004, P NATL ACAD SCI USA, V101, P6200, DOI 10.1073/pnas.0308368101; Smits ELJM, 2009, HUM GENE THER, V20, P1106, DOI 10.1089/hum.2009.145; Tian S, 2009, GENE THER, V16, P1260, DOI 10.1038/gt.2009.110; Tiriveedhi V, 2012, HUM IMMUNOL, V73, P11, DOI 10.1016/j.humimm.2011.10.017; Vujanovic L, 2009, CANCER IMMUNOL IMMUN, V58, P121, DOI 10.1007/s00262-008-0533-2; WATSON MA, 1994, CANCER RES, V54, P4598; Watson MA, 1996, CANCER RES, V56, P860; Wei CH, 2002, HUM IMMUNOL, V63, P821, DOI 10.1016/S0198-8859(02)00454-8; WeiPeng, 2011, VACCINE, V29, P3501, DOI 10.1016/j.vaccine.2011.02.027; Wierecky J, 2006, CANCER IMMUNOL IMMUN, V55, P63, DOI 10.1007/s00262-005-0673-6; Wintermeyer P, 2010, J VIRAL HEPATITIS, V17, P705, DOI 10.1111/j.1365-2893.2009.01228.x; Wu YG, 2010, MED ONCOL, V27, P736, DOI 10.1007/s12032-009-9277-x; Xie LH, 2008, CANCER IMMUNOL IMMUN, V57, P1029, DOI 10.1007/s00262-007-0434-9; Yoon SH, 2009, EXP MOL MED, V41, P161, DOI 10.3858/emm.2009.41.3.019; Young J W, 1999, Curr Opin Hematol, V6, P135, DOI 10.1097/00062752-199905000-00003	45	5	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63055	10.1371/journal.pone.0063055	http://dx.doi.org/10.1371/journal.pone.0063055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650543	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000088
J	Gallego, O; Specht, T; Brach, T; Kumar, A; Gavin, AC; Kaksonen, M				Gallego, Oriol; Specht, Tanja; Brach, Thorsten; Kumar, Arun; Gavin, Anne-Claude; Kaksonen, Marko			Detection and Characterization of Protein Interactions In Vivo by a Simple Live-Cell Imaging Method	PLOS ONE			English	Article							LIVING CELLS; SACCHAROMYCES-CEREVISIAE; YEAST; COMPLEMENTATION; DOMAINS	Over the last decades there has been an explosion of new methodologies to study protein complexes. However, most of the approaches currently used are based on in vitro assays (e.g. nuclear magnetic resonance, X-ray, electron microscopy, isothermal titration calorimetry etc). The accurate measurement of parameters that define protein complexes in a physiological context has been largely limited due to technical constrains. Here, we present PICT (Protein interactions from Imaging of Complexes after Translocation), a new method that provides a simple fluorescence microscopy readout for the study of protein complexes in living cells. We take advantage of the inducible dimerization of FK506-binding protein (FKBP) and FKBP-rapamycin binding (FRB) domain to translocate protein assemblies to membrane associated anchoring platforms in yeast. In this assay, GFP-tagged prey proteins interacting with the FRB-tagged bait will co-translocate to the FKBP-tagged anchor sites upon addition of rapamycin. The interactions are thus encoded into localization changes and can be detected by fluorescence live-cell imaging under different physiological conditions or upon perturbations. PICT can be automated for high-throughput studies and can be used to quantify dissociation rates of protein complexes in vivo. In this work we have used PICT to analyze protein-protein interactions from three biological pathways in the yeast Saccharomyces cerevisiae: Mitogen-activated protein kinase cascade (Ste5-Ste11-Ste50), exocytosis (exocyst complex) and endocytosis (Ede1-Syp1).	[Gallego, Oriol] IRB, Barcelona, Spain; [Gallego, Oriol; Specht, Tanja; Brach, Thorsten; Kumar, Arun; Gavin, Anne-Claude; Kaksonen, Marko] European Mol Biol Lab, Heidelberg, Germany	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; European Molecular Biology Laboratory (EMBL)	Kaksonen, M (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	kaksonen@embl.de	Gallego, Oriol/R-9559-2018; Gallego, Oriol/S-2933-2019	Gallego, Oriol/0000-0001-7479-2563; Gallego, Oriol/0000-0001-7479-2563; Brach, Thorsten/0000-0002-6740-4013; KUMAR, ARUN/0000-0001-8706-8558; Kaksonen, Marko/0000-0003-3645-7689; Gavin, Anne-Claude/0000-0003-4917-2340	Ramon y Cajal program of the Spanish government	Ramon y Cajal program of the Spanish government(Spanish Government)	OG is funded by the Ramon y Cajal program of the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Brach T, 2011, J CELL SCI, V124, P328, DOI 10.1242/jcs.078519; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Charbonnier S, 2008, BIOTECHNOL ANN REV, V14, P1, DOI 10.1016/S1387-2656(08)00001-X; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; CHOI KY, 1994, CELL, V78, P499; Gallego O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.87; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Knop M, 1999, AIDYEA399 3 0 CO 2 W; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7; Periasamy A, 1999, METHOD CELL BIOL, V58, P293; Rad MR, 1998, MOL GEN GENET, V259, P29, DOI 10.1007/s004380050785; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Wehrman T, 2002, P NATL ACAD SCI USA, V99, P3469, DOI 10.1073/pnas.062043699; Young KH, 1998, BIOL REPROD, V58, P302, DOI 10.1095/biolreprod58.2.302; Ziolkowska NE, 2011, NAT STRUCT MOL BIOL, V18, P854, DOI 10.1038/nsmb.2080	23	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62195	10.1371/journal.pone.0062195	http://dx.doi.org/10.1371/journal.pone.0062195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658712	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000033
J	Han, M; Heppel, SC; Su, T; Bogs, J; Zu, YG; An, ZG; Rausch, T				Han, Mei; Heppel, Simon C.; Su, Tao; Bogs, Jochen; Zu, Yuangang; An, Zhigang; Rausch, Thomas			Enzyme Inhibitor Studies Reveal Complex Control of Methyl-D-Erythritol 4-Phosphate (MEP) Pathway Enzyme Expression in Catharanthus roseus	PLOS ONE			English	Article							METHYLERYTHRITOL PHOSPHATE-PATHWAY; 1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE; NON-MEVALONATE PATHWAY; INDOLE ALKALOID PRODUCTION; ISOPRENOID BIOSYNTHESIS; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; MUTANT REVEALS; ACCUMULATION; PLANTS	In Catharanthus roseus, the monoterpene moiety exerts a strong flux control for monoterpene indole alkaloid (MIA) formation. Monoterpene synthesis depends on the methyl-D-erythritol 4-phosphate (MEP) pathway. Here, we have explored the regulation of this pathway in response to developmental and environmental cues and in response to specific enzyme inhibitors. For the MEP pathway entry enzyme 1-deoxy-D-xylulose 5-phosphate synthase (DXS), a new (type I) DXS isoform, CrDXS1, has been cloned, which, in contrast to previous reports on type II CrDXS, was not transcriptionally activated by the transcription factor ORCA3. Regulation of the MEP pathway in response to metabolic perturbations has been explored using the enzyme inhibitors clomazone (precursor of 5-ketochlomazone, inhibitor of DXS) and fosmidomycin (inhibitor of deoxyxylulose 5-phosphate reductoisomerase (DXR)), respectively. Young leaves of non-flowering plants were exposed to both inhibitors, adopting a non-invasive in vivo technique. Transcripts and proteins of DXS (3 isoforms), DXR, and hydroxymethylbutenyl diphosphate synthase (HDS) were monitored, and protein stability was followed in isolated chloroplasts. Transcripts for DXS1 were repressed by both inhibitors, whereas transcripts for DXS2A& B, DXR and HDS increased after clomazone treatment but were barely affected by fosmidomycin treatment. DXS protein accumulated in response to both inhibitors, whereas DXR and HDS proteins were less affected. Fosmidomycin-induced accumulation of DXS protein indicated substantial posttranscriptional regulation. Furthermore, fosmidomycin effectively protected DXR against degradation in planta and in isolated chloroplasts. Thus our results suggest that DXR protein stability may be affected by substrate binding. In summary, the present results provide novel insight into the regulation of DXS expression in C. roseus in response to MEP-pathway perturbation.	[Han, Mei; Heppel, Simon C.; Su, Tao; Rausch, Thomas] Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, Heidelberg, Germany; [Bogs, Jochen] Dienstleistungszentrum Landlicher Raum Rheinpfalz, Neustadt, Germany; [Zu, Yuangang; An, Zhigang] Northeast Forestry Univ, Minist Educ, Key Lab Forest Plant Ecol, Harbin, Peoples R China	Ruprecht Karls University Heidelberg; Northeast Forestry University - China	Rausch, T (corresponding author), Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, Heidelberg, Germany.	thomas.rausch@cos.uni-heidelberg.de	SU, TAO/N-4904-2015; Han, Mei/O-6714-2015; Han, Mei/R-2144-2017	SU, TAO/0000-0003-4267-0574; Han, Mei/0000-0001-7073-7225	Heidelberg University Core; DAAD	Heidelberg University Core; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	Funding came from Heidelberg University Core Funding and a DAAD stipend to Mei Han. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenta L. C., 1991, Revista Brasileira de Fisiologia Vegetal, V3, P69; Burlat V, 2004, PLANT J, V38, P131, DOI 10.1111/j.1365-313X.2004.02030.x; Carretero-Paulet L, 2006, PLANT MOL BIOL, V62, P683, DOI 10.1007/s11103-006-9051-9; Chahed K, 2000, PLANT PHYSIOL BIOCH, V38, P559, DOI 10.1016/S0981-9428(00)00781-6; Contin A, 1998, FEBS LETT, V434, P413, DOI 10.1016/S0014-5793(98)01022-9; Cordoba E, 2011, J EXP BOT, V62, P2023, DOI 10.1093/jxb/erq393; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; Dubey VS, 2003, J BIOSCIENCES, V28, P637, DOI 10.1007/BF02703339; Dutta A, 2007, PLANT CELL REP, V26, P907, DOI 10.1007/s00299-007-0305-z; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Facchini PJ, 2008, PLANT J, V54, P763, DOI 10.1111/j.1365-313X.2008.03438.x; Ferhatoglu Y, 2006, PESTIC BIOCHEM PHYS, V85, P7, DOI 10.1016/j.pestbp.2005.10.002; Flores-Perez U, 2008, PLANT CELL, V20, P1303, DOI 10.1105/tpc.108.058768; Floris M, 2009, INT J MOL SCI, V10, P3168, DOI 10.3390/ijms10073168; Floss DS, 2008, PLANT J, V56, P86, DOI 10.1111/j.1365-313X.2008.03575.x; Gil MJ, 2005, PLANT J, V44, P155, DOI 10.1111/j.1365-313X.2005.02517.x; Guevara-Garcia A, 2005, PLANT CELL, V17, P628, DOI 10.1105/tpc.104.028860; Hedhili Sabah, 2007, Phytochemistry Reviews, V6, P341, DOI 10.1007/s11101-006-9021-5; HELL R, 1990, PLANTA, V180, P603, DOI 10.1007/BF02411460; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Hemmerlin A, 2012, PROG LIPID RES, V51, P95, DOI 10.1016/j.plipres.2011.12.001; Hong SB, 2003, BIOTECHNOL PROGR, V19, P1105, DOI 10.1021/bp034031k; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; JULLIARD JH, 1991, P NATL ACAD SCI USA, V88, P2042, DOI 10.1073/pnas.88.6.2042; Kobayashi K, 2007, PLANT CELL PHYSIOL, V48, P322, DOI 10.1093/pcp/pcm005; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Loyola-Vargas Victor Manuel, 2007, Phytochemistry Reviews, V6, P307, DOI 10.1007/s11101-007-9064-2; Mahmoud SS, 2001, P NATL ACAD SCI USA, V98, P8915, DOI 10.1073/pnas.141237298; Mahroug Samira, 2007, Phytochemistry Reviews, V6, P363, DOI 10.1007/s11101-006-9017-1; Matsue Y, 2010, J ANTIBIOT, V63, P583, DOI 10.1038/ja.2010.100; Mincheva Z, 2005, PHYTOCHEMISTRY, V66, P1797, DOI 10.1016/j.phytochem.2005.06.002; Mueller C, 2000, BIOCHEM SOC T, V28, P792, DOI 10.1042/BST0280792; NORMAN MA, 1990, PLANT PHYSIOL, V92, P777, DOI 10.1104/pp.92.3.777; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Okada A, 2007, PLANT MOL BIOL, V65, P177, DOI 10.1007/s11103-007-9207-2; Oudin Audrey, 2007, Phytochemistry Reviews, V6, P259, DOI 10.1007/s11101-006-9054-9; Oudin A, 2007, PLANT MOL BIOL, V65, P13, DOI 10.1007/s11103-007-9190-7; Paetzold H, 2010, MOL PLANT, V3, P904, DOI 10.1093/mp/ssq032; Pan QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043038; Peebles CAM, 2011, METAB ENG, V13, P234, DOI 10.1016/j.ymben.2010.11.005; Phillips MA, 2007, PLANT MOL BIOL, V65, P243, DOI 10.1007/s11103-007-9212-5; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Rivasseau C, 2009, PLANT CELL ENVIRON, V32, P82, DOI 10.1111/j.1365-3040.2008.01903.x; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rodriguez-Villalon A, 2009, PLANT J, V60, P424, DOI 10.1111/j.1365-313X.2009.03966.x; Sauret-Gueto S, 2006, PLANT PHYSIOL, V141, P75, DOI 10.1104/pp.106.079855; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Umeda T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00009; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veau B, 2000, BBA-GENE STRUCT EXPR, V1517, P159, DOI 10.1016/S0167-4781(00)00240-2; Walter MH, 2002, PLANT J, V31, P243, DOI 10.1046/j.1365-313X.2002.01352.x; Walter MH, 2000, PLANT J, V21, P571, DOI 10.1046/j.1365-313x.2000.00708.x; Xiao YM, 2012, CELL, V149, P1525, DOI 10.1016/j.cell.2012.04.038; Zeidler J, 1998, Z NATURFORSCH C, V53, P980; Zybailov B, 2009, MOL CELL PROTEOMICS, V8, P1789, DOI 10.1074/mcp.M900104-MCP200	62	47	53	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62467	10.1371/journal.pone.0062467	http://dx.doi.org/10.1371/journal.pone.0062467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650515	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000048
J	Kong, XT; Peng, B; Yang, Y; Zhang, PZ; Qin, B; Han, DD; Wang, CJ; Dang, YJ; Liu, JO; Yu, L				Kong, Xiangtao; Peng, Bo; Yang, Yang; Zhang, Pingzhao; Qin, Bo; Han, Dingding; Wang, Chenji; Dang, Yongjun; Liu, Jun O.; Yu, Long			p53 Represses Transcription of RING Finger LIM Domain-Binding Protein RLIM through Sp1	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; TUMOR-SUPPRESSOR P53; WILD-TYPE P53; CELL-LINE; SINA GENE; ACTIVATION; APOPTOSIS; GROWTH; ALPHA; PHOSPHORYLATION	RLIM acts as a negative regulator of LIM-Homeodomain proteins either by recruiting Sin3A/Histone Deacetylase (HDAC) corepressor complex or through degradation of CLIM coactivator, thus playing an important role in embryonic development. Recent studies by different research groups have shown that RLIM acts as an X-encoded, dose-dependent inducer of X chromosome inactivation in mouse embryonic stem cells. However, until now, very little is known about the expression regulation of RLIM gene, and we tried to study the transctriptional regulation of RLIM gene. In the present study, we identified RLIM as a novel target of p53 and demonstrated that p53 repressed both mRNA and protein levels of RLIM. Expression of wild type p53, but not p53 mutants, led to repression of the RLIM promoter activity. We further identified four putative Sp1 elements (S1 to S4) on the RLIM promoter that are essential for p53-mediated repression of RLIM. Although p53 does not directly bind to the RLIM promoter, it physically interacts with and prevents the binding of Sp1 to the RLIM promoter. Thus, RLIM is a novel target of p53, and p53 exerts its inhibitory effect on RLIM expression by interfering with Sp1-mediated transcriptional activation on RLIM. Our results provided data to enlarge the knowledge of transcriptional regulation of RLIM and suggested a new pathway by which physiological and pathological activators of p53 may affect development.	[Kong, Xiangtao; Peng, Bo; Yang, Yang; Zhang, Pingzhao; Qin, Bo; Han, Dingding; Wang, Chenji; Yu, Long] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Pingzhao; Yu, Long] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Dang, Yongjun; Liu, Jun O.] Johns Hopkins Sch Med, Dept Pharmacol, Baltimore, MD USA; [Liu, Jun O.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; [Qin, Bo] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN USA	Fudan University; Fudan University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Mayo Clinic	Yu, L (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	longyu@fudan.edu.cn	Han, Dingding/HGD-2042-2022; dang, yongjun/M-6531-2016	Han, Dingding/0000-0003-0963-6286; dang, yongjun/0000-0001-7237-1132	National 973 program of China [2004CB518605]; National 863 project of China [2006AA020501]; National Key Sci-Tech Special Project of China [2008ZX10002-020]; Project of the Shanghai Municipal Science and Technology Commission [03dz14086]	National 973 program of China(National Basic Research Program of China); National 863 project of China; National Key Sci-Tech Special Project of China; Project of the Shanghai Municipal Science and Technology Commission	This work was supported by the National 973 program of China (2004CB518605), the National 863 project of China (2006AA020501), the National Key Sci-Tech Special Project of China (2008ZX10002-020) and the Project of the Shanghai Municipal Science and Technology Commission (03dz14086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; BORELLINI F, 1993, J BIOL CHEM, V268, P7923; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Gu LB, 2004, J BIOL CHEM, V279, P52141, DOI 10.1074/jbc.M407915200; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Jin SK, 2001, J CELL SCI, V114, P4139; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kim E, 2003, ONCOGENE, V22, P7716, DOI 10.1038/sj.onc.1207155; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Kramer OH, 2008, FASEB J, V22, P1369, DOI 10.1096/fj.06-8050com; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; Linares-Cruz G, 1998, P NATL ACAD SCI USA, V95, P1131, DOI 10.1073/pnas.95.3.1131; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Ohlsson C, 1998, ENDOCRINOLOGY, V139, P1101, DOI 10.1210/en.139.3.1101; Ostendorff HP, 2000, GENOMICS, V69, P120, DOI 10.1006/geno.2000.6311; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Wang LQ, 2001, J BIOL CHEM, V276, P43604, DOI 10.1074/jbc.M106570200; Zhan MC, 2005, J BIOL CHEM, V280, P4825, DOI 10.1074/jbc.M407450200; Zhang LL, 2000, CANCER RES, V60, P3655	31	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62832	10.1371/journal.pone.0062832	http://dx.doi.org/10.1371/journal.pone.0062832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650532	gold, Green Published, Green Submitted			2022-12-27	WOS:000319167000077
J	Krych, L; Hansen, CHF; Hansen, AK; van den Berg, FWJ; Nielsen, DS				Krych, Lukasz y; Hansen, Camilla H. F.; Hansen, Axel K.; van den Berg, Frans W. J.; Nielsen, Dennis S.			Quantitatively Different, yet Qualitatively Alike: A Meta-Analysis of the Mouse Core Gut Microbiome with a View towards the Human Gut Microbiome	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; ANTIBIOTIC-TREATMENT; MICE; PROFILES; BACTERIA; COLONIZATION; PREVALENCE; RESPONSES; RECOVERY; OBESITY	Background: A number of human diseases such as obesity and diabetes are associated with changes or imbalances in the gut microbiota (GM). Laboratory mice are commonly used as experimental models for such disorders. The introduction and dynamic development of next generation sequencing techniques have enabled detailed mapping of the GM of both humans and animal models. Nevertheless there is still a significant knowledge gap regarding the human and mouse common GM core and thus the applicability of the latter as an animal model. The aim of the present study was to identify inter-and intra-individual differences and similarities between the GM composition of particular mouse strains and humans. Methodology/Principal Findings: A total of 1509428 high quality tag-encoded partial 16S rRNA gene sequences determined using 454/FLX Titanium (Roche) pyro-sequencing reflecting the GM composition of 32 human samples from 16 individuals and 88 mouse samples from three laboratory mouse strains commonly used in diabetes research were analyzed using Principal Coordinate Analysis (PCoA), nonparametric multivariate analysis of similarity (ANOSIM) and alpha diversity measures. A reliable cutoff threshold for low abundant taxa estimated on the basis of the present study is recommended for similar trials. Conclusions/Significance: Distinctive quantitative differences in the relative abundance of most taxonomic groups between the examined categories were found. All investigated mouse strains clustered separately, but with a range of shared features when compared to the human GM. However, both mouse fecal, caecal and human fecal samples shared to a large extent not only representatives of the same phyla, but also a substantial fraction of common genera, where the number of shared genera increased with sequencing depth. In conclusion, the GM of mice and humans is quantitatively different (in terms of abundance of specific phyla and species) but share a large qualitatively similar core.	[Krych, Lukasz y; van den Berg, Frans W. J.; Nielsen, Dennis S.] Univ Copenhagen, Fac Sci, Dept Food Sci, Copenhagen, Denmark; [Hansen, Camilla H. F.; Hansen, Axel K.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Krych, L (corresponding author), Univ Copenhagen, Fac Sci, Dept Food Sci, Copenhagen, Denmark.	krych@life.ku.dk	van den Berg, Frans W.J./N-2899-2014; Nielsen, Dennis/A-9769-2015; Krych, Luaksz/F-4446-2015; Berg, Frans/ABB-5814-2021	van den Berg, Frans W.J./0000-0002-9170-9052; Nielsen, Dennis/0000-0001-8121-1114; Krych, Luaksz/0000-0003-3224-1346; Hansen, Camilla Hartmann Friis/0000-0002-1860-385X	Center for Applied Laboratory Animal Research; Chemometric Analysis Centre	Center for Applied Laboratory Animal Research; Chemometric Analysis Centre	LK is supported by Center for Applied Laboratory Animal Research (www.calar.dk) and the Chemometric Analysis Centre www.chance.life.ku.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AD, 2006, MAMM GENOME, V17, P1093, DOI 10.1007/s00335-006-0063-1; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Bendtsen KMB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bleich A, 2012, COMP IMMUNOL MICROB, V35, P81, DOI 10.1016/j.cimid.2011.12.006; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Buhnik-Rosenblau K, 2011, APPL ENVIRON MICROB, V77, P6531, DOI 10.1128/AEM.00324-11; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Choi SE, 2011, J ETHNOPHARMACOL, V136, P406, DOI 10.1016/j.jep.2010.12.024; Conroy ME, 2009, CURR OPIN ALLERGY CL, V9, P197, DOI 10.1097/ACI.0b013e32832b3f1d; de Carcer DA, 2011, APPL ENVIRON MICROB, V77, P8795, DOI 10.1128/AEM.05491-11; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Holmsgaard PN, 2011, SOIL BIOL BIOCHEM, V43, P2152, DOI 10.1016/j.soilbio.2011.06.019; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Khan MT, 2012, ISME J, V6, P1578, DOI 10.1038/ismej.2012.5; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; McMurray F, 2012, CURR DIABETES REP, V12, P651, DOI 10.1007/s11892-012-0323-2; Michael S, 2013, INFLAMM BOWEL DIS, V19, P185, DOI 10.1002/ibd.23006; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Pang WY, 2012, LAB ANIM-UK, V46, P231, DOI 10.1258/la.2012.011128; Patil DP, 2012, J BIOSCIENCES, V37, P647, DOI 10.1007/s12038-012-9244-0; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Robertson BR, 2005, INT J SYST EVOL MICR, V55, P1199, DOI 10.1099/ijs.0.63472-0; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vaahtovuo J, 2003, FEMS MICROBIOL ECOL, V44, P131, DOI 10.1016/S0168-6496(02)00460-9; Vermeiren J, 2012, FEMS MICROBIOL ECOL, V79, P685, DOI 10.1111/j.1574-6941.2011.01252.x; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wang L, 2011, APPL ENVIRON MICROB, V77, P6718, DOI 10.1128/AEM.05212-11; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wilson KH, 2006, ANAEROBE, V12, P249, DOI 10.1016/j.anaerobe.2006.09.002; Wos-Oxley ML, 2012, GUT MICROBES, V3, P234, DOI 10.4161/gmic.19934; Yang JH, 2012, PHYTOTHER RES, V26, P1898, DOI 10.1002/ptr.4658; Yoshida Y, 2009, ANIM SCI J, V80, P709, DOI 10.1111/j.1740-0929.2009.00692.x; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zozaya-Hinchliffe M, 2008, APPL ENVIRON MICROB, V74, P1656, DOI 10.1128/AEM.02127-07	62	142	144	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62578	10.1371/journal.pone.0062578	http://dx.doi.org/10.1371/journal.pone.0062578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658749	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000058
J	Lagha, M; Mayeuf-Louchart, A; Chang, T; Montarras, D; Rocancourt, D; Zalc, A; Kormish, J; Zaret, KS; Buckingham, ME; Relaix, F				Lagha, Mounia; Mayeuf-Louchart, Alicia; Chang, Ted; Montarras, Didier; Rocancourt, Didier; Zalc, Antoine; Kormish, Jay; Zaret, Kenneth S.; Buckingham, Margaret E.; Relaix, Frederic			Itm2a Is a Pax3 Target Gene, Expressed at Sites of Skeletal Muscle Formation In Vivo	PLOS ONE			English	Article							C-MET RECEPTOR; PROGENITOR CELLS; SATELLITE CELLS; STEM-CELL; ACTIVATION; PAX3-FKHR; MYOGENESIS; BRICHOS; DOMAIN; CRE	The paired-box homeodomain transcription factor Pax3 is a key regulator of the nervous system, neural crest and skeletal muscle development. Despite the important role of this transcription factor, very few direct target genes have been characterized. We show that Itm2a, which encodes a type 2 transmembrane protein, is a direct Pax3 target in vivo, by combining genetic approaches and in vivo chromatin immunoprecipitation assays. We have generated a conditional mutant allele for Itm2a, which is an imprinted gene, by flanking exons 2-4 with loxP sites and inserting an IRESnLacZ reporter in the 3' UTR of the gene. The LacZ reporter reproduces the expression profile of Itm2a, and allowed us to further characterize its expression at sites of myogenesis, in the dermomyotome and myotome of somites, and in limb buds, in the mouse embryo. We further show that Itm2a is not only expressed in adult muscle fibres but also in the satellite cells responsible for regeneration. Itm2a mutant mice are viable and fertile with no overt phenotype during skeletal muscle formation or regeneration. Potential compensatory mechanisms are discussed.	[Lagha, Mounia; Mayeuf-Louchart, Alicia; Montarras, Didier; Rocancourt, Didier; Buckingham, Margaret E.] Inst Pasteur, CNRS URA 2578, Dept Dev Biol, Paris, France; [Chang, Ted; Zalc, Antoine; Relaix, Frederic] UPMC Paris 06, UMR S 787, Paris, France; [Chang, Ted; Zalc, Antoine; Relaix, Frederic] INSERM, Avenir Team, Paris, France; [Chang, Ted; Zalc, Antoine; Relaix, Frederic] Inst Myol, Paris, France; [Kormish, Jay; Zaret, Kenneth S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Pennsylvania	Buckingham, ME (corresponding author), Inst Pasteur, CNRS URA 2578, Dept Dev Biol, Paris, France.	margab@pasteur.fr; frelaix@gmail.com	Mayeuf-Louchart, Alicia/AAC-5102-2019; Lagha, Mounia/T-7351-2018	Mayeuf-Louchart, Alicia/0000-0002-3787-7450; Lagha, Mounia/0000-0002-7082-1950; Relaix, Frederic/0000-0003-1270-1472; Zalc, Antoine/0000-0001-6077-0996	INSERM Avenir Program; Association Francaise Contre les Myopathies (AFM); Association Institut de Myologie; Ligue Nationale Contre le Cancer (LNCC); Association pour la Recherche Contre le Cancer (ARC); Fondation pour la Recherche Medicale, Institut National du Cancer (INCa); European Union [241440]; Pasteur Institute; CNRS [URA 2578, 200720]; AFM; Optistem [223098]; Human Frontier Science Program (HFSP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036477] Funding Source: NIH RePORTER	INSERM Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise Contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association Institut de Myologie; Ligue Nationale Contre le Cancer (LNCC)(Ligue nationale contre le cancer); Association pour la Recherche Contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Fondation pour la Recherche Medicale, Institut National du Cancer (INCa); European Union(European Commission); Pasteur Institute; CNRS(Centre National de la Recherche Scientifique (CNRS)); AFM(Association Francaise contre les Myopathies); Optistem; Human Frontier Science Program (HFSP)(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by funding to FR from the INSERM Avenir Program, Association Francaise Contre les Myopathies (AFM), Association Institut de Myologie, the Ligue Nationale Contre le Cancer (LNCC), Association pour la Recherche Contre le Cancer (ARC), Fondation pour la Recherche Medicale, Institut National du Cancer (INCa), and from the European Union Seventh Framework Programme in the project ENDOSTEM (grant agreement number 241440). MB's laboratory was supported by the Pasteur Institute and the CNRS (URA 2578) and by grants from the AFM and the EU 7th PCRD programmes, EuroSyStem (grant agreement number 200720) and Optistem (grant agreement number 223098). ML is currently the recipient of a Human Frontier Science Program (HFSP) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Barber TD, 2002, GENOMICS, V79, P278, DOI 10.1006/geno.2002.6703; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Boeuf S, 2009, DIFFERENTIATION, V78, P108, DOI 10.1016/j.diff.2009.05.007; Brown CB, 2004, DEV BIOL, V267, P190, DOI 10.1016/j.ydbio.2003.10.024; Buckingham M, 2008, CURR OPIN GENET DEV, V18, P330, DOI 10.1016/j.gde.2008.06.005; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Chang THT, 2004, DEV BIOL, V269, P595, DOI 10.1016/j.ydbio.2004.02.013; Clerc P, 2006, CURR OPIN GENET DEV, V16, P246, DOI 10.1016/j.gde.2006.04.001; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cossu G, 1996, DEVELOPMENT, V122, P429; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Fleischer A, 2002, ONCOGENE, V21, P3181, DOI 10.1038/sj.onc.1205464; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; Kirchner J, 1999, J EXP MED, V190, P217, DOI 10.1084/jem.190.2.217; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; Lagha M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-696; Lagha M, 2009, DEV CELL, V17, P892, DOI 10.1016/j.devcel.2009.10.021; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mercado GE, 2007, CURR MOL MED, V7, P47, DOI 10.2174/156652407779940440; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mulugeta S, 2007, AM J PHYSIOL-LUNG C, V293, pL720, DOI 10.1152/ajplung.00025.2007; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Pittois K, 1999, MAMM GENOME, V10, P54, DOI 10.1007/s003359900942; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Rizzoti K, 2004, NAT GENET, V36, P247, DOI 10.1038/ng1309; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tuckermann JP, 2000, J BONE MINER RES, V15, P1257, DOI 10.1359/jbmr.2000.15.7.1257; Van den Plas D, 2004, CELL BIOL INT, V28, P199, DOI 10.1016/j.cellbi.2003.11.019; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Willander H, 2011, FEBS J, V278, P3893, DOI 10.1111/j.1742-4658.2011.08209.x; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	46	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63143	10.1371/journal.pone.0063143	http://dx.doi.org/10.1371/journal.pone.0063143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650549	gold, Green Submitted, Green Published			2022-12-27	WOS:000319167000094
J	Marks, LR; Clementi, EA; Hakansson, AP				Marks, Laura R.; Clementi, Emily A.; Hakansson, Anders P.			Sensitization of Staphylococcus aureus to Methicillin and Other Antibiotics In Vitro and In Vivo in the Presence of HAMLET	PLOS ONE			English	Article							HUMAN ALPHA-LACTALBUMIN; HUMAN-MILK; EFFLUX PUMP; MULTIDRUG-RESISTANCE; BACTERICIDAL ACTIVITY; INTRACELLULAR PH; FOLDING VARIANT; VANCOMYCIN; MECHANISM; APOPTOSIS	HAMLET (human alpha-lactalbumin made lethal to tumor cells) is a protein-lipid complex from human milk with both tumoricidal and bactericidal activities. HAMLET exerts a rather specific bactericidal activity against some respiratory pathogens, with highest activity against Streptococcus pneumoniae, but lacks activity against most other bacterial pathogens, including Staphylococci. Still, ion transport associated with death in S. pneumoniae is also detected to a lower degree in insensitive organisms. In this study we demonstrate that HAMLET acts as an antimicrobial adjuvant that can increase the activity of a broad spectrum of antibiotics (methicillin, vancomycin, gentamicin and erythromycin) against multi-drug resistant Staphylococcus aureus, to a degree where they become sensitive to those same antibiotics, both in antimicrobial assays against planktonic and biofilm bacteria and in an in vivo model of nasopharyngeal colonization. We show that HAMLET exerts these effects specifically by dissipating the proton gradient and inducing a sodium-dependent calcium influx that partially depolarizes the plasma membrane, the same mechanism induced during pneumococcal death. These effects results in an increased cell associated binding and/or uptake of penicillin, gentamicin and vancomycin, especially in resistant stains. Finally, HAMLET inhibits the increased resistance of methicillin seen under antibiotic pressure and the bacteria do not become resistant to the adjuvant, which is a major advantageous feature of the molecule. These results highlight HAMLET as a novel antimicrobial adjuvant with the potential to increase the clinical usefulness of antibiotics against drug resistant strains of S. aureus.	[Marks, Laura R.; Clementi, Emily A.; Hakansson, Anders P.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Clementi, Emily A.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA; [Hakansson, Anders P.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hakansson, AP (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	andersh@buffalo.edu	Hakansson, Anders P/AAX-1225-2020; Hakansson, Anders/H-8190-2014	Hakansson, Anders P/0000-0002-2834-6009; Hakansson, Anders/0000-0002-2834-6009; Marks, Laura/0000-0002-5317-443X	Bill and Melinda Gates Foundation [53085]; JR Oishei Foundation; American Lung Association [RG-123721-N]; National Institutes of Health (NIDCR) [F31DC011218]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011218] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); JR Oishei Foundation; American Lung Association; National Institutes of Health (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Bill and Melinda Gates Foundation (grant 53085), the JR Oishei Foundation, and The American Lung Association (Grant RG-123721-N) to APH, and National Institutes of Health (NIDCR) fellowship F31DC011218 to EAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; [Anonymous], 2011, B WORLD HEALTH ORGAN, V89, P88, DOI 10.2471/BLT.11.030211; Bakar NS, 2012, PAK J PHARM SCI, V25, P633; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Calfee DP, 2012, CURR OPIN INFECT DIS, V25, P385, DOI 10.1097/QCO.0b013e3283553441; Clementi EA, 2012, J BIOL CHEM, V287, P27168, DOI 10.1074/jbc.M112.371070; Corvini PFX, 2000, MICROBIOL-SGM, V146, P2671, DOI 10.1099/00221287-146-10-2671; Cottagnoud P, 2003, ANTIMICROB AGENTS CH, V47, P144, DOI 10.1128/AAC.47.1.144-147.2003; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; Fadli M, 2011, INT J ANTIMICROB AG, V38, P325, DOI 10.1016/j.ijantimicag.2011.05.005; Falcao-Silva VS, 2009, PHYTOTHER RES, V23, P1367, DOI 10.1002/ptr.2695; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Fuchs PC, 2002, J ANTIMICROB CHEMOTH, V49, P467, DOI 10.1093/jac/49.3.467; GLOTZER DJ, 1970, ARCH SURG-CHICAGO, V100, P589; Gould IM, 2012, INT J ANTIMICROB AG, V39, P96, DOI 10.1016/j.ijantimicag.2011.09.028; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 1999, EXP CELL RES, V246, P451, DOI 10.1006/excr.1998.4265; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; Harigaya Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-287; HEINE WE, 1991, J NUTR, V121, P277, DOI 10.1093/jn/121.3.277; Jean SS, 2011, EXPERT OPIN PHARMACO, V12, P2145, DOI 10.1517/14656566.2011.599320; JENSEN RG, 1980, LIPIDS, V15, P345, DOI 10.1007/BF02533550; JENSEN RG, 1990, J DAIRY SCI, V73, P223, DOI 10.3168/jds.S0022-0302(90)78666-3; Kaatz GW, 2003, ANTIMICROB AGENTS CH, V47, P719, DOI 10.1128/AAC.47.2.719-726.2003; Kaatz GW, 2002, J ANTIMICROB CHEMOTH, V50, P833, DOI 10.1093/jac/dkf224; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Kristiansen JE, 2010, IN VIVO, V24, P751; Lemaire S, 2008, J BIOL CHEM, V283, P12769, DOI 10.1074/jbc.M800079200; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Lonnerdal B, 2004, ADV EXP MED BIOL, V554, P11; LONNERDAL B, 1985, AM J CLIN NUTR, V42, P1299; LOVELL DL, 1945, ARCH SURG-CHICAGO, V51, P78, DOI 10.1001/archsurg.1945.01230040083002; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; Margolis E, 2009, J BACTERIOL, V191, P571, DOI 10.1128/JB.00950-08; Markham PN, 1996, ANTIMICROB AGENTS CH, V40, P2673, DOI 10.1128/AAC.40.11.2673; Marks LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043514; Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12; Martins A, 2007, INT J ANTIMICROB AG, V29, P302, DOI 10.1016/j.ijantimicag.2006.10.012; McGavin MJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00066; MONTVILLE TJ, 1994, INT J FOOD MICROBIOL, V24, P53, DOI 10.1016/0168-1605(94)90106-6; MOSS B, 1948, LANCET, V254, P320; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Newburg DS, 2005, J NUTR, V135, P1308, DOI 10.1093/jn/135.5.1308; Newburg DS, 1999, CURR MED CHEM, V6, P117; Nobmann P, 2010, J APPL MICROBIOL, V108, P2152, DOI 10.1111/j.1365-2672.2009.04622.x; Nuryastuti T, 2009, APPL ENVIRON MICROB, V75, P6850, DOI 10.1128/AEM.00875-09; Parra-Ruiz J, 2010, ANTIMICROB AGENTS CH, V54, P4329, DOI 10.1128/AAC.00455-10; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Rafii F, 2008, ARCH MICROBIOL, V190, P417, DOI 10.1007/s00203-008-0385-3; Ramon-Garcia S, 2006, J ANTIMICROB CHEMOTH, V57, P252, DOI 10.1093/jac/dki436; Ramon-Garcia S, 2012, ANTIMICROB AGENTS CH, V56, P2074, DOI 10.1128/AAC.05946-11; Rand KH, 2004, ANTIMICROB AGENTS CH, V48, P2871, DOI 10.1128/AAC.48.8.2871-2875.2004; Reiter KC, 2012, DIAGN MICR INFEC DIS, V74, P101, DOI 10.1016/j.diagmicrobio.2012.05.034; Ricci V, 2006, ANTIMICROB AGENTS CH, V50, P38, DOI 10.1128/AAC.50.1.38-42.2006; ROE E, 1972, LANCET, V2, P109; Rose WE, 2009, J ANTIMICROB CHEMOTH, V63, P485, DOI 10.1093/jac/dkn513; Simor AE, 2011, LANCET INFECT DIS, V11, P952, DOI 10.1016/S1473-3099(11)70281-X; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; Tang HJ, 2011, INT J ANTIMICROB AG, V38, P46, DOI 10.1016/j.ijantimicag.2011.02.013; VARGA DT, 1961, J CLIN INVEST, V40, P2209, DOI 10.1172/JCI104447; Zhang Z, 2010, WORLD J GASTROENTERO, V16, P1279, DOI 10.3748/wjg.v16.i10.1279	70	50	51	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63158	10.1371/journal.pone.0063158	http://dx.doi.org/10.1371/journal.pone.0063158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650551	Green Published, gold			2022-12-27	WOS:000319167000096
J	Sparks, ME; Blackburn, MB; Kuhar, D; Gundersen-Rindal, DE				Sparks, Michael E.; Blackburn, Michael B.; Kuhar, Daniel; Gundersen-Rindal, Dawn E.			Transcriptome of the Lymantria dispar (Gypsy Moth) Larval Midgut in Response to Infection by Bacillus thuringiensis	PLOS ONE			English	Article							HELIOTHIS-VIRESCENS LEPIDOPTERA; ANTIMICROBIAL PEPTIDE; SPODOPTERA-EXIGUA; CRYSTAL PROTEINS; CRY1AB TOXIN; BOMBYX-MORI; PRE-PORE; VIRUS; RESISTANCE; MECHANISM	Transcriptomic profiles of the serious lepidopteran insect pest Lymantria dispar (gypsy moth) were characterized in the larval midgut in response to infection by Bacillus thuringiensis kurstaki, a biopesticide commonly used for its control. RNA-Seq approaches were used to define a set of 49,613 assembled transcript sequences, of which 838, 1,248 and 3,305 were respectively partitioned into high-, mid- and low-quality tiers on the basis of homology information. Digital gene expression profiles suggested genes differentially expressed at 24 hours post infection, and qRT-PCR analyses were performed for verification. The differentially expressed genes primarily associated with digestive function, including alpha-amylase, lipase and carboxypeptidase; immune response, including C-type lectin 4; developmental genes such as arylphorin; as well as a variety of binding proteins: cellular retinoic acid binding protein (lipid-binding), insulin-related peptide binding protein (protein-binding) and ovary C/EBPg transcription factor (nucleic acid-binding). This is the first study conducted to specifically investigate gypsy moth response to a bacterial infection challenge using large-scale sequencing technologies, and the results highlight important genes that could be involved in biopesticide resistance development or could serve as targets for biologically-based control mechanisms of this insect pest.	[Sparks, Michael E.; Blackburn, Michael B.; Kuhar, Daniel; Gundersen-Rindal, Dawn E.] USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA	United States Department of Agriculture (USDA)	Gundersen-Rindal, DE (corresponding author), USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA.	dawn.gundersen-rindal@ars.usda.gov		Sparks, Michael/0000-0001-6251-8559; Blackburn, Michael/0000-0001-5541-4831	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was funded by the United States Department of Agriculture and conducted by the authors as part of their duties. As employees of the US Department of Agriculture, the Federal Government was responsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antony B, 2009, INSECT BIOCHEM MOLEC, V39, P90, DOI 10.1016/j.ibmb.2008.10.008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Axen A, 1997, EUR J BIOCHEM, V247, P614, DOI 10.1111/j.1432-1033.1997.00614.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bell RA., 1981, USDA TECH B, P599; Blackburn MB, 2004, ARCH INSECT BIOCHEM, V55, P26, DOI 10.1002/arch.10119; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Candas M, 2003, MOL CELL PROTEOMICS, V2, P19, DOI 10.1074/mcp.M200069-MCP200; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Eddy Sean R, 2009, Genome Inform, V23, P205; FARRAR RR, 1995, J ENTOMOL SCI, V30, P29, DOI 10.18474/0749-8004-30.1.29; Federici BA, 1998, APPL ENVIRON MICROB, V64, P4368; Forcada C, 1999, ARCH INSECT BIOCHEM, V42, P51, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;51::AID-ARCH6&gt;3.0.CO;2-6; Gao K, 2012, J INVERTEBR PATHOL, V110, P83, DOI 10.1016/j.jip.2012.02.011; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; Hagstrom AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037230; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Hernandez-Martinez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012795; HOFTE H, 1989, MICROBIOL REV, V53, P242; Hwang J, 2011, J INVERTEBR PATHOL, V108, P194, DOI 10.1016/j.jip.2011.09.003; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; Jimenez-Juarez N, 2008, PEPTIDES, V29, P318, DOI 10.1016/j.peptides.2007.09.026; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Leonard D.E., 1981, B US DEP AGR, V1584, P9; Lienard Marjorie A., 2010, Communicative & Integrative Biology, V3, P586, DOI 10.4161/cib.3.6.13177; Loeb MJ, 2001, J INSECT PHYSIOL, V47, P599, DOI 10.1016/S0022-1910(00)00150-5; Ma WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038151; Marrone Pamela G., 1993, P221; Martinez-Ramirez AC, 1999, BIOCONTROL SCI TECHN, V9, P239, DOI 10.1080/09583159929811; Melchionna R, 2012, J INVEST DERMATOL, V132, P1908, DOI 10.1038/jid.2012.51; Moreno-Habel DA, 2012, J INVERTEBR PATHOL, V110, P92, DOI 10.1016/j.jip.2012.02.007; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Oppert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034624; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Smit A, 1996, REPEATMASKER OPEN 30; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Sparks ME, 2011, VIRUSES-BASEL, V3, P2339, DOI 10.3390/v3112339; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhu YC, 2011, J INVERTEBR PATHOL, V106, P296, DOI 10.1016/j.jip.2010.10.007	51	41	42	2	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61190	10.1371/journal.pone.0061190	http://dx.doi.org/10.1371/journal.pone.0061190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658687	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000008
J	Van Dijk, TC; Van Staalduinen, MA; Van der Sluijs, JP				Van Dijk, Tessa C.; Van Staalduinen, Marja A.; Van der Sluijs, Jeroen P.			Macro-Invertebrate Decline in Surface Water Polluted with Imidacloprid	PLOS ONE			English	Article							ACUTE TOXICITY; NEONICOTINOID INSECTICIDES; SYSTEMIC INSECTICIDE; RISK-ASSESSMENT; HONEY-BEES; PESTICIDES; EXPOSURE; FIPRONIL; ECOSYSTEMS	Imidacloprid is one of the most widely used insecticides in the world. Its concentration in surface water exceeds the water quality norms in many parts of the Netherlands. Several studies have demonstrated harmful effects of this neonicotinoid to a wide range of non-target species. Therefore we expected that surface water pollution with imidacloprid would negatively impact aquatic ecosystems. Availability of extensive monitoring data on the abundance of aquatic macro-invertebrate species, and on imidacloprid concentrations in surface water in the Netherlands enabled us to test this hypothesis. Our regression analysis showed a significant negative relationship (P<0.001) between macro-invertebrate abundance and imidacloprid concentration for all species pooled. A significant negative relationship was also found for the orders Amphipoda, Basommatophora, Diptera, Ephemeroptera and Isopoda, and for several species separately. The order Odonata had a negative relationship very close to the significance threshold of 0.05 (P <0.051). However, in accordance with previous research, a positive relationship was found for the order Actinedida. We used the monitoring field data to test whether the existing three water quality norms for imidacloprid in the Netherlands are protective in real conditions. Our data show that macrofauna abundance drops sharply between 13 and 67 ng l(-1). For aquatic ecosystem protection, two of the norms are not protective at all while the strictest norm of 13 ng l(-1) (MTR) seems somewhat protective. In addition to the existing experimental evidence on the negative effects of imidacloprid on invertebrate life, our study, based on data from large-scale field monitoring during multiple years, shows that serious concern about the far-reaching consequences of the abundant use of imidacloprid for aquatic ecosystems is justified.	[Van Dijk, Tessa C.; Van Staalduinen, Marja A.; Van der Sluijs, Jeroen P.] Univ Utrecht, Utrecht, Netherlands	Utrecht University	Van der Sluijs, JP (corresponding author), Univ Utrecht, Utrecht, Netherlands.	j.p.vandersluijs@uu.nl	van der Sluijs, Jeroen P/B-6302-2008	van der Sluijs, Jeroen P/0000-0002-1346-5953	TVD; MVS; Triodos Foundation's Support Fund for Independent Research on Bee Decline and Systemic Pesticides; Adessium Foundation (The Netherlands); Act Beyond Trust (Japan); Universiteit Utrecht (Netherlands); Stichting Triodos Foundation (The Netherlands); Gesellschaft fur Schmetterlingsschutz (Germany); Gravin van Bylandt Stichting (The Netherlands); Zukunft Stiftung Landwirtschaft (Germany); Beekeepers Union ABTB (Netherlands); Study Association Storm (Student Association Environmental Sciences Utrecht University)	TVD; MVS; Triodos Foundation's Support Fund for Independent Research on Bee Decline and Systemic Pesticides; Adessium Foundation (The Netherlands)(Netherlands Government); Act Beyond Trust (Japan); Universiteit Utrecht (Netherlands); Stichting Triodos Foundation (The Netherlands)(Netherlands Government); Gesellschaft fur Schmetterlingsschutz (Germany); Gravin van Bylandt Stichting (The Netherlands)(Netherlands Government); Zukunft Stiftung Landwirtschaft (Germany); Beekeepers Union ABTB (Netherlands); Study Association Storm (Student Association Environmental Sciences Utrecht University)	Financial support was given to TVD and MVS by the Triodos Foundation's Support Fund for Independent Research on Bee Decline and Systemic Pesticides. This Support Fund has been created from donations by Adessium Foundation (The Netherlands), Act Beyond Trust (Japan), Universiteit Utrecht (Netherlands), Stichting Triodos Foundation (The Netherlands), Gesellschaft fur Schmetterlingsschutz (Germany), M.A.O.C. Gravin van Bylandt Stichting (The Netherlands), Zukunft Stiftung Landwirtschaft (Germany), Beekeepers Union ABTB (Netherlands), Study Association Storm (Student Association Environmental Sciences Utrecht University) and citizens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alexander AC, 2007, ENVIRON TOXICOL CHEM, V26, P1726, DOI 10.1897/07-015R.1; [Anonymous], DTSCH PEST ATL; [Anonymous], 2012, PESTICIDE PROPERTIES; [Anonymous], 2011, FINE CHEM IND BUSINE, DOI DOI 10.1002/9780470946404; Beketov MA, 2008, SCI TOTAL ENVIRON, V405, P96, DOI 10.1016/j.scitotenv.2008.07.001; Beketov MA, 2008, ARCH ENVIRON CON TOX, V55, P247, DOI 10.1007/s00244-007-9104-3; Beketov MA, 2008, ENVIRON TOXICOL CHEM, V27, P461, DOI 10.1897/07-322R.1; Bijkerk R., 2010, 201028 STICHT TOEG O; Bonada N, 2004, ENVIRON POLLUT, V132, P509, DOI 10.1016/j.envpol.2004.05.006; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; Buckingham SD, 1997, J EXP BIOL, V200, P2685; Cairns John Jr., 1993, P10; Chen XD, 2009, ECOTOX ENVIRON SAFE, V73, P132; CJAM Posthuma-Doodeman, 2008, 6017160182008 RIVM P; Collier TK, 2003, HUM ECOL RISK ASSESS, V9, P259, DOI 10.1080/713609862; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Thuyet DQ, 2012, SCI TOTAL ENVIRON, V414, P515, DOI 10.1016/j.scitotenv.2011.10.051; De Snoo G. R., 2012, BESTRIJDINGSMIDDELEN; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dijk T. C., 2010, THESIS UTRECHT U UTR; Englert D, 2012, ENVIRON POLLUT, V167, P41, DOI 10.1016/j.envpol.2012.03.024; Felsot AS, 1998, B ENVIRON CONTAM TOX, V60, P363, DOI 10.1007/s001289900635; Feng SL, 2004, CHEMOSPHERE, V56, P457, DOI 10.1016/j.chemosphere.2004.02.010; Gupta S, 2002, B ENVIRON CONTAM TOX, V68, P502, DOI 10.1007/s001280283; GUSTAFSON DI, 1989, ENVIRON TOXICOL CHEM, V8, P339, DOI 10.1897/1552-8618(1989)8[339:GUSASM]2.0.CO;2; Haith DA, 2010, ENVIRON SCI TECHNOL, V44, P6496, DOI 10.1021/es101636y; Hayasaka D, 2012, ECOTOX ENVIRON SAFE, V80, P355, DOI 10.1016/j.ecoenv.2012.04.004; Hayasaka D, 2012, ECOTOXICOLOGY, V21, P421, DOI 10.1007/s10646-011-0802-2; Hayasaka D, 2012, ECOTOXICOLOGY, V21, P191, DOI 10.1007/s10646-011-0778-y; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Key P, 2007, ECOTOX ENVIRON SAFE, V68, P272, DOI 10.1016/j.ecoenv.2006.11.017; Kreutzweiser DP, 2008, B ENVIRON CONTAM TOX, V80, P211, DOI 10.1007/s00128-007-9347-8; Kreutzweiser D, 2007, ECOTOX ENVIRON SAFE, V68, P315, DOI 10.1016/j.ecoenv.2007.04.011; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Liess M, 2011, ECOTOXICOLOGY, V20, P1328, DOI 10.1007/s10646-011-0689-y; Loureiro S, 2010, ENVIRON TOXICOL CHEM, V29, P1716, DOI 10.1002/etc.198; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Maxim L, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014006; Maxim L, 2007, SCI TOTAL ENVIRON, V376, P1, DOI 10.1016/j.scitotenv.2006.12.052; Miranda GRB, 2011, HUM ECOL RISK ASSESS, V17, P981, DOI 10.1080/10807039.2011.588159; Mohr S, 2012, AQUAT TOXICOL, V110, P25, DOI 10.1016/j.aquatox.2011.11.016; Overmyer JP, 2005, B ENVIRON CONTAM TOX, V74, P872, DOI 10.1007/s00128-005-0662-7; Pestana JLT, 2010, CHEMOSPHERE, V78, P241, DOI 10.1016/j.chemosphere.2009.10.066; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Roberts T.R., 1999, METABOLIC PATHWAYS A, DOI [10.1039/9781847551375, DOI 10.1039/9781847551375-00937]; Roessink I, 2013, ENVIRON TOXICOL CHEM, V32, P1096, DOI 10.1002/etc.2201; Rose PH, 2012, ISSUES TOXICOL, V12, P184, DOI 10.1039/9781849733007-00184; Sanchez-Bayo F, 2012, J ENV ANAL TOXICOL S, VS4, pS4; Sanchez-Bayo F, 2009, ECOTOXICOLOGY, V18, P343, DOI 10.1007/s10646-008-0290-1; Sanchez-Bayo F, 2006, ENVIRON TOXICOL CHEM, V25, P1677, DOI 10.1897/05-404R.1; Sanchez-Bayo F, 2006, AQUAT TOXICOL, V78, P262, DOI 10.1016/j.aquatox.2006.03.009; Sardo AM, 2010, ARCH ENVIRON CON TOX, V58, P648, DOI 10.1007/s00244-010-9470-0; Selim HM, 2010, SOIL SCI, V175, P375, DOI 10.1097/SS.0b013e3181ebc9a2; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Stoughton SJ, 2008, ARCH ENVIRON CON TOX, V54, P662, DOI 10.1007/s00244-007-9073-6; Stuijfzand SC, 1999, ARCH ENVIRON CON TOX, V36, P186, DOI 10.1007/s002449900459; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Sur Robin, 2003, Bulletin of Insectology, V56, P35; Szczepaniec A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020018; Tennekes HA, 2011, J ENV ANAL TOXICOL S, VS4, pS4; Tennekes HA, 2010, TOXICOLOGY, V276, P1, DOI 10.1016/j.tox.2010.07.005; Tisler T, 2009, CHEMOSPHERE, V76, P907, DOI 10.1016/j.chemosphere.2009.05.002; TOMIZAWA M, 1992, J PESTIC SCI, V17, P231; Van Wijngaarden RPA, 2005, ECOTOXICOLOGY, V14, P355, DOI 10.1007/s10646-004-6371-x; Verdonschot PFM, 2010, GRAADMETERS AQUATISC; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wu G, 2004, J ECON ENTOMOL, V97, P2057, DOI 10.1603/0022-0493-97.6.2057; Zeng CX, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.2001	73	253	261	10	225	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62374	10.1371/journal.pone.0062374	http://dx.doi.org/10.1371/journal.pone.0062374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650513	gold, Green Published			2022-12-27	WOS:000319167000043
J	Jung, F; Stephan, KE; Backes, H; Moran, R; Gramer, M; Kumagai, T; Graf, R; Endepols, H; Tittgemeyer, M				Jung, Fabienne; Stephan, Klaas Enno; Backes, Heiko; Moran, Rosalyn; Gramer, Markus; Kumagai, Tetsuya; Graf, Rudolf; Endepols, Heike; Tittgemeyer, Marc			Mismatch Responses in the Awake Rat: Evidence from Epidural Recordings of Auditory Cortical Fields	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; EVENT-RELATED POTENTIALS; NEGATIVITY MMN GENERATION; SENSORY MEMORY; FREQUENCY DISCRIMINATION; EVOKED-POTENTIALS; ANESTHETIZED RATS; CORTEX; PROBABILITY; DEVIANCE	Detecting sudden environmental changes is crucial for the survival of humans and animals. In the human auditory system the mismatch negativity (MMN), a component of auditory evoked potentials (AEPs), reflects the violation of predictable stimulus regularities, established by the previous auditory sequence. Given the considerable potentiality of the MMN for clinical applications, establishing valid animal models that allow for detailed investigation of its neurophysiological mechanisms is important. Rodent studies, so far almost exclusively under anesthesia, have not provided decisive evidence whether an MMN analogue exists in rats. This may be due to several factors, including the effect of anesthesia. We therefore used epidural recordings in awake black hooded rats, from two auditory cortical areas in both hemispheres, and with bandpass filtered noise stimuli that were optimized in frequency and duration for eliciting MMN in rats. Using a classical oddball paradigm with frequency deviants, we detected mismatch responses at all four electrodes in primary and secondary auditory cortex, with morphological and functional properties similar to those known in humans, i.e., large amplitude biphasic differences that increased in amplitude with decreasing deviant probability. These mismatch responses significantly diminished in a control condition that removed the predictive context while controlling for presentation rate of the deviants. While our present study does not allow for disambiguating precisely the relative contribution of adaptation and prediction error processing to the observed mismatch responses, it demonstrates that MMN-like potentials can be obtained in awake and unrestrained rats.	[Jung, Fabienne; Backes, Heiko; Gramer, Markus; Graf, Rudolf; Endepols, Heike; Tittgemeyer, Marc] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Stephan, Klaas Enno] Univ Zurich, Inst Biomed Engn, TNU, Zurich, Switzerland; [Stephan, Klaas Enno] Swiss Fed Inst Technol, Zurich, Switzerland; [Stephan, Klaas Enno] Univ Zurich, Lab Social & Neural Syst Res SNS, Zurich, Switzerland; [Stephan, Klaas Enno; Moran, Rosalyn] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Kumagai, Tetsuya] Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan	Max Planck Society; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of London; University College London; Osaka University	Jung, F (corresponding author), Max Planck Inst Neurol Res, Gleueler Str 50, D-50931 Cologne, Germany.	fabienne.jung@nf.mpg.de	Endepols, Heike/AAG-7794-2020	Endepols, Heike/0000-0002-6166-4818; Moran, Rosalyn/0000-0002-2736-2621; Stephan, Klaas Enno/0000-0002-8594-9092	German Research Foundation; clinical research group 219	German Research Foundation(German Research Foundation (DFG)); clinical research group 219	Funding of the German Research Foundation and the clinical research group 219 supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astikainen P, 2006, NEUROREPORT, V17, P1561, DOI 10.1097/01.wnr.0000233097.13032.7d; Astikainen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024208; Baldeweg T, 2006, INT J PSYCHOPHYSIOL, V59, P49, DOI 10.1016/j.ijpsycho.2005.07.014; Baldeweg T, 1999, ANN NEUROL, V45, P495, DOI 10.1002/1531-8249(199904)45:4<495::AID-ANA11>3.0.CO;2-M; BARTH DS, 1990, J NEUROPHYSIOL, V64, P1527, DOI 10.1152/jn.1990.64.5.1527; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BORG E, 1982, HEARING RES, V8, P101, DOI 10.1016/0378-5955(82)90069-7; Cheung SW, 2001, HEARING RES, V156, P115, DOI 10.1016/S0378-5955(01)00272-6; CSEPE V, 1995, EAR HEARING, V16, P91, DOI 10.1097/00003446-199502000-00007; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gaese BH, 2001, J NEUROPHYSIOL, V86, P1062, DOI 10.1152/jn.2001.86.2.1062; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; IMADA T, 1993, ELECTROEN CLIN NEURO, V87, P144, DOI 10.1016/0013-4694(93)90120-K; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; JAVITT DC, 1994, BRAIN RES, V667, P192, DOI 10.1016/0006-8993(94)91496-6; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Javitt DC, 1998, EVOKED POTENTIAL, V108, P143, DOI 10.1016/S0168-5597(97)00073-7; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KRAUS N, 1994, J NEUROPHYSIOL, V72, P1270, DOI 10.1152/jn.1994.72.3.1270; Lazar R, 2003, HEARING RES, V181, P51, DOI 10.1016/S0378-5955(03)00166-7; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Naatanen R, 2003, INT J PSYCHOPHYSIOL, V48, P179, DOI 10.1016/S0167-8760(03)00053-9; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; Naatanen R, 1992, ATTENTION BRAIN FUNC, P193; Naatanen R, PSYCHOL B, V125, P826; Nakamura T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00367; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pincze Z, 2001, CLIN NEUROPHYSIOL, V112, P778, DOI 10.1016/S1388-2457(01)00509-0; Roger C, 2009, PSYCHOPHYSIOLOGY, V46, P1028, DOI 10.1111/j.1469-8986.2009.00840.x; Ruusuvirta T, 1998, NEUROSCI LETT, V248, P45, DOI 10.1016/S0304-3940(98)00330-9; Ruusuvirta T, 1996, NEUROREPORT, V7, P1266, DOI 10.1097/00001756-199605170-00009; Sabri M, 2001, COGNITIVE BRAIN RES, V12, P171, DOI 10.1016/S0926-6410(01)00026-X; SAMS M, 1985, ELECTROEN CLIN NEURO, V62, P437, DOI 10.1016/0168-5597(85)90054-1; Shelley AM, 1999, SCHIZOPHR RES, V37, P65, DOI 10.1016/S0920-9964(98)00138-8; SIMPSON GV, 1993, BRAIN RES, V602, P251, DOI 10.1016/0006-8993(93)90690-O; Sonnadara RR, 2006, BRAIN RES, V1071, P175, DOI 10.1016/j.brainres.2005.11.088; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Tikhonravov D, 2010, NEUROSCIENCE, V167, P1175, DOI 10.1016/j.neuroscience.2010.03.014; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Umbricht D, 2005, CLIN NEUROPHYSIOL, V116, P353, DOI 10.1016/j.clinph.2004.08.015; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Winkler I, 1996, BRAIN RES, V742, P239, DOI 10.1016/S0006-8993(96)01008-6; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; ZURITA P, 1994, NEUROSCI RES, V19, P303, DOI 10.1016/0168-0102(94)90043-4	57	30	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63203	10.1371/journal.pone.0063203	http://dx.doi.org/10.1371/journal.pone.0063203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646197	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000319077300154
J	Zhang, WL; Fang, D; Xing, QC; Zhou, L; Jiang, B; Mu, WM				Zhang, Wenli; Fang, Dan; Xing, Qingchao; Zhou, Leon; Jiang, Bo; Mu, Wanmeng			Characterization of a Novel Metal-Dependent D-Psicose 3-Epimerase from Clostridium scindens 35704	PLOS ONE			English	Article							D-TAGATOSE 3-EPIMERASE; D-FRUCTOSE; AGROBACTERIUM-TUMEFACIENS; PSEUDOMONAS-CICHORII; CELLULOLYTICUM H10; CRYSTAL-STRUCTURES; D-ALLOSE; KETOHEXOSE; ISOMERASE; CLONING	The noncharacterized protein CLOSCI_02528 from Clostridium scindens ATCC 35704 was characterized as D-psicose 3-epimerase. The enzyme showed maximum activity at pH 7.5 and 60 degrees C. The half-life of the enzyme at 50 degrees C was 108 min, suggesting the enzyme was relatively thermostable. It was strictly metal-dependent and required Mn2+ as optimum cofactor for activity. In addition, Mn2+ improved the structural stability during both heat- and urea-induced unfolding. Using circular dichroism measurements, the apparent melting temperature (T-m) and the urea midtransition concentration (C-m) of metal-free enzyme were 64.4 degrees C and 2.68 M. By comparison, the Mn2+-bound enzyme showed higher T-m and C-m with 67.3 degrees C and 5.09 M. The Michaelis-Menten constant (K-m), turnover number (k(cat)), and catalytic efficiency (k(cat)/K-m) values for substrate D-psicose were estimated to be 28.3 mM, 1826.8 s(-1), and 64.5 mM(-1) s(-1), respectively. The enzyme could effectively produce D-psicose from D-fructose with the turnover ratio of 28%.	[Zhang, Wenli; Fang, Dan; Xing, Qingchao; Zhou, Leon; Jiang, Bo; Mu, Wanmeng] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Zhou, Leon] Roquette Amer, Keokuk, IA USA	Jiangnan University	Mu, WM (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	wmmu@jiangnan.edu.cn			NSFC Project [31171705, 21276001]; 973 Project [2012CB720802]; 863 Project [2011AA100904]; Fundamental Research Funds for the Central Universities [JUSRP51304A]; Support Project of Jiangsu Province [BE2011622, BE2011766, BE2010678, BE2010626]	NSFC Project(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); 863 Project(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Support Project of Jiangsu Province	This work was supported by the NSFC Project (No. 31171705 and 21276001), the 973 Project (No. 2012CB720802), the 863 Project (No. 2011AA100904), the Fundamental Research Funds for the Central Universities (No. JUSRP51304A), and the Support Project of Jiangsu Province (No. BE2011622, BE2011766, BE2010678, and BE2010626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan HC, 2012, PROTEIN CELL, V3, P123, DOI 10.1007/s13238-012-2026-5; Choi JG, 2011, APPL ENVIRON MICROB, V77, P7316, DOI 10.1128/AEM.05566-11; Hayashi N, 2010, BIOSCI BIOTECH BIOCH, V74, P510, DOI 10.1271/bbb.90707; Iida T, 2008, J NUTR SCI VITAMINOL, V54, P511, DOI 10.3177/jnsv.54.511; Ishida Y, 1997, J FERMENT BIOENG, V83, P529, DOI 10.1016/S0922-338X(97)81132-4; ITOH H, 1995, J FERMENT BIOENG, V80, P101, DOI 10.1016/0922-338X(95)98186-O; ITOH H, 1994, BIOSCI BIOTECH BIOCH, V58, P2168, DOI 10.1271/bbb.58.2168; IZUMORI K, 1993, BIOSCI BIOTECH BIOCH, V57, P1037, DOI 10.1271/bbb.57.1037; Kim HJ, 2006, APPL ENVIRON MICROB, V72, P981, DOI 10.1128/AEM.72.2.981-985.2006; Kim K, 2006, J MOL BIOL, V361, P920, DOI 10.1016/j.jmb.2006.06.069; Lee DW, 2005, ARCH BIOCHEM BIOPHYS, V434, P333, DOI 10.1016/j.abb.2004.11.004; Lin CJ, 2010, J AGR FOOD CHEM, V58, P10431, DOI 10.1021/jf102063q; Mu WM, 2012, APPL MICROBIOL BIOT, V94, P1461, DOI 10.1007/s00253-012-4093-1; Mu WM, 2011, J AGR FOOD CHEM, V59, P7785, DOI 10.1021/jf201356q; Murata A, 2003, J BIOSCI BIOENG, V96, P89, DOI 10.1016/S1389-1723(03)90104-6; Oshima H, 2006, FOOD SCI TECHNOL RES, V12, P137, DOI 10.3136/fstr.12.137; Park CS, 2007, BIOTECHNOL LETT, V29, P1387, DOI 10.1007/s10529-007-9393-7; Rhimi M, 2006, BBA-GEN SUBJECTS, V1760, P191, DOI 10.1016/j.bbagen.2005.11.007; Sun Y, 2004, J AGR FOOD CHEM, V52, P1293, DOI 10.1021/jf030428s; Sun YX, 2005, J AGR FOOD CHEM, V53, P10205, DOI 10.1021/jf051565n; Suna S, 2007, TOXICOL LETT, V173, P107, DOI 10.1016/j.toxlet.2007.06.015; Takata MK, 2005, J BIOSCI BIOENG, V100, P511, DOI 10.1263/jbb.100.511; Takeshita K, 2000, J BIOSCI BIOENG, V90, P453, DOI 10.1263/jbb.90.453; Yoshida H, 2007, J MOL BIOL, V374, P443, DOI 10.1016/j.jmb.2007.09.033; Zhang LT, 2009, BIOTECHNOL LETT, V31, P857, DOI 10.1007/s10529-009-9942-3; Zhu YM, 2012, BIOTECHNOL LETT, V34, P1901, DOI 10.1007/s10529-012-0986-4	26	35	44	8	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62987	10.1371/journal.pone.0062987	http://dx.doi.org/10.1371/journal.pone.0062987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646168	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300123
J	Liu, HS; Chapman, ER; Dean, C				Liu, Huisheng; Chapman, Edwin R.; Dean, Camin			"Self" versus "Non-Self" Connectivity Dictates Properties of Synaptic Transmission and Plasticity	PLOS ONE			English	Article							READILY RELEASABLE POOL; DENDRITIC PROTEIN-SYNTHESIS; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; NEURONS; VESICLES; PROBABILITY; AUTAPSES; NEUROTRANSMISSION	Autapses are connections between a neuron and itself. These connections are morphologically similar to "normal" synapses between two different neurons, and thus were long thought to have similar properties of synaptic transmission. However, this has not been directly tested. Here, using a micro-island culture assay in which we can define the number of interconnected cells, we directly compared synaptic transmission in excitatory autapses and in two-neuron micronetworks consisting of two excitatory neurons, in which a neuron is connected to one other neuron and to itself. We discovered that autaptic synapses are optimized for maximal transmission, and exhibited enhanced EPSC amplitude, charge, and RRP size compared to interneuronal synapses. However, autapses are deficient in several aspects of synaptic plasticity. Short-term potentiation only became apparent when a neuron was connected to another neuron. This acquisition of plasticity only required reciprocal innervation with one other neuron; micronetworks consisting of just two interconnected neurons exhibited enhanced short-term plasticity in terms of paired pulse ratio (PPR) and release probability (Pr), compared to autapses. Interestingly, when a neuron was connected to another neuron, not only interneuronal synapses, but also the autaptic synapses on itself exhibited a trend toward enhanced short-term plasticity in terms of PPR and Pr. Thus neurons can distinguish whether they are connected via "self" or "non-self" synapses and have the ability to adjust their plasticity parameters when connected to other neurons.	[Liu, Huisheng; Chapman, Edwin R.; Dean, Camin] Univ Wisconsin, Dept Neurosci, Madison, WI 53715 USA; [Liu, Huisheng; Chapman, Edwin R.; Dean, Camin] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI USA; [Dean, Camin] ENI G, Gottingen, Germany	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Liu, HS (corresponding author), Univ Wisconsin, Dept Neurosci, Madison, WI 53715 USA.	hliu@Waisman.Wisc.Edu; c.dean@eni-g.de	889, CRC/L-1607-2018	889, CRC/0000-0002-6678-3138; Chapman, Edwin/0000-0001-9787-8140	National Institute of Health (NIH) [MH61876]; Epilepsy Foundation; Alexander von Humboldt Foundation; European Research Council (ERC) [SytActivity FP7 260916]; Deutsche Forschungsgemeinschaft (DFG) [SFB889, 1951/1-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Research Council (ERC)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a National Institute of Health (NIH) grant MH61876 to E.R.C., and by an Epilepsy Foundation grant, Sofja Kovalevskaja grant from the Alexander von Humboldt Foundation, European Research Council (ERC) starting grant SytActivity FP7 260916, and Deutsche Forschungsgemeinschaft (DFG) grants SFB889 and 1951/1-1 to C.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Bekkers JM, 2003, CURR BIOL, V13, pR433, DOI 10.1016/S0960-9822(03)00363-4; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bekkers JM, 2009, CURR BIOL, V19, pR296, DOI 10.1016/j.cub.2009.02.010; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; de Jong APH, 2012, J CELL BIOL, V197, P327, DOI 10.1083/jcb.201112135; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Feng J, 2002, J NEUROSCI, V22, P4372, DOI 10.1523/JNEUROSCI.22-11-04372.2002; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; Hosoi N, 2007, J NEUROSCI, V27, P14286, DOI 10.1523/JNEUROSCI.4122-07.2007; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Lubke J, 1996, J NEUROSCI, V16, P3209; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Saada R, 2009, CURR BIOL, V19, P479, DOI 10.1016/j.cub.2009.01.060; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Stevens CF, 2007, J NEUROPHYSIOL, V98, P3221, DOI 10.1152/jn.00857.2007; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tamas G, 1997, J NEUROSCI, V17, P6352; Tokuoka H, 2008, P NATL ACAD SCI USA, V105, P14656, DOI 10.1073/pnas.0805705105; Tyler WJ, 2006, J PHYSIOL-LONDON, V574, P787, DOI 10.1113/jphysiol.2006.111310; VANDERLO.H, 1972, BRAIN RES, V48, P355, DOI 10.1016/0006-8993(72)90189-8; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Zhang JC, 2005, BRAIN RES, V1050, P110, DOI 10.1016/j.brainres.2005.05.032; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	42	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62414	10.1371/journal.pone.0062414	http://dx.doi.org/10.1371/journal.pone.0062414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658626	Green Published, gold, Green Submitted			2022-12-27	WOS:000321662800042
J	Forcato, C; Fernandez, RS; Pedreira, ME				Forcato, Cecilia; Fernandez, Rodrigo S.; Pedreira, Maria E.			The Role and Dynamic of Strengthening in the Reconsolidation Process in a Human Declarative Memory: What Decides the Fate of Recent and Older Memories?	PLOS ONE			English	Article							RETROGRADE-AMNESIA; PROTEIN-SYNTHESIS; CONSOLIDATION; RETRIEVAL; REACTIVATION; EXTINCTION; HIPPOCAMPUS; MECHANISMS; DISORDERS; SYSTEMS	Several reports have shown that after specific reminders are presented, consolidated memories pass from a stable state to one in which the memory is reactivated. This reactivation implies that memories are labile and susceptible to amnesic agents. This susceptibility decreases over time and leads to a re-stabilization phase usually known as reconsolidation. With respect to the biological role of reconsolidation, two functions have been proposed. First, the reconsolidation process allows new information to be integrated into the background of the original memory; second, it strengthens the original memory. We have previously demonstrated that both of these functions occur in the reconsolidation of human declarative memories. Our paradigm consisted of learning verbal material (lists of five pairs of nonsense syllables) acquired by a training process (L1-training) on Day 1 of our experiment. After this declarative memory is consolidated, it can be made labile by presenting a specific reminder. After this, the memory passes through a subsequent stabilization process. Strengthening creates a new scenario for the reconsolidation process; this function represents a new factor that may transform the dynamic of memories. First, we analyzed whether the repeated labilization-reconsolidation processes maintained the memory for longer periods of time. We showed that at least one labilization-reconsolidation process strengthens a memory via evaluation 5 days after its re-stabilization. We also demonstrated that this effect is not triggered by retrieval only. We then analyzed the way strengthening modified the effect of an amnesic agent that was presented immediately after repeated labilizations. The repeated labilization-reconsolidation processes made the memory more resistant to interference during re-stabilization. Finally, we evaluated whether the effect of strengthening may depend on the age of the memory. We found that the effect of strengthening did depend on the age of the memory. Forgetting may represent a process that weakens the effect of strengthening.	[Forcato, Cecilia; Fernandez, Rodrigo S.; Pedreira, Maria E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Neurobiol Memoria, Dept Fisiol Biol Mol & Celular,IFIBYNE CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Pedreira, ME (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Neurobiol Memoria, Dept Fisiol Biol Mol & Celular,IFIBYNE CONICET, Buenos Aires, DF, Argentina.	mpedreira@fbmc.fcen.uba.ar	Fernandez, Rodrigo/GRF-1350-2022; Fernández, Rodrigo S/AAP-3748-2021	Fernández, Rodrigo S/0000-0002-0213-9108; FORCATO, CECILIA/0000-0002-5954-4008	FONCYT [PICT2006-01161, PICT2010-0391]	FONCYT(FONCyT)	This work was supported by FONCYT (grant PICT2006-01161 and PICT2010-0391). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; Coccoz V, 2011, NEUROSCIENCE, V185, P61, DOI 10.1016/j.neuroscience.2011.04.023; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Forcato C, 2007, LEARN MEMORY, V14, P295, DOI 10.1101/lm.486107; Forcato C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023305; Forcato C, 2010, NEUROBIOL LEARN MEM, V93, P77, DOI 10.1016/j.nlm.2009.08.006; Foricato C, 2009, NEUROBIOL LEARN MEM, V91, P50, DOI 10.1016/j.nlm.2008.09.011; Bustos SG, 2010, NEUROPSYCHOPHARMACOL, V35, P1097, DOI 10.1038/npp.2009.215; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Inda MC, 2011, J NEUROSCI, V31, P1635, DOI 10.1523/JNEUROSCI.4736-10.2011; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Lehmann H, 2011, LEARN MEMORY, V18, P132, DOI 10.1101/lm.2000811; MacLeod MD, 2001, PSYCHOL SCI, V12, P148, DOI 10.1111/1467-9280.00325; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Muller GE, 1900, Z PSYCHOL S1; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nadel L, 2008, HBK BEHAV NEUROSCI, V18, P43, DOI 10.1016/S1569-7339(08)00204-X; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Rodriguez MLC, 2013, NEUROPHARMACOLOGY, V64, P432, DOI 10.1016/j.neuropharm.2012.06.059; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schwabe L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007519; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350; Wichert S, 2013, NEUROBIOL LEARN MEM, V99, P38, DOI 10.1016/j.nlm.2012.11.001; Wichert S, 2011, BEHAV NEUROSCI, V125, P699, DOI 10.1037/a0025235	38	36	37	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61688	10.1371/journal.pone.0061688	http://dx.doi.org/10.1371/journal.pone.0061688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658614	Green Published, gold			2022-12-27	WOS:000318343700020
J	Bhargava, R; Janssen, W; Altmann, C; Andres-Hernando, A; Okamura, K; Vandivier, RW; Ahuja, N; Faubel, S				Bhargava, Rhea; Janssen, William; Altmann, Christopher; Andres-Hernando, Ana; Okamura, Kayo; Vandivier, R. William; Ahuja, Nilesh; Faubel, Sarah			Intratracheal IL-6 Protects against Lung Inflammation in Direct, but Not Indirect, Causes of Acute Lung Injury in Mice	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ACUTE-RENAL-FAILURE; ALVEOLAR MACROPHAGES; MECHANICAL VENTILATION; PERSISTENT ELEVATION; CLINICAL-TRIAL; INTERLEUKIN-6; CYTOKINES; ARDS; BIOMARKERS	Introduction: Serum and bronchoalveolar fluid IL-6 are increased in patients with acute respiratory distress syndrome (ARDS) and predict prolonged mechanical ventilation and poor outcomes, although the role of intra-alveolar IL-6 in indirect lung injury is unknown. We investigated the role of endogenous and exogenous intra-alveolar IL-6 in AKI-mediated lung injury (indirect lung injury), intraperitoneal (IP) endotoxin administration (indirect lung injury) and, for comparison, intratracheal (IT) endotoxin administration (direct lung injury) with the hypothesis that IL-6 would exert a pro-inflammatory effect in these causes of acute lung inflammation. Methods: Bronchoalveolar cytokines (IL-6, CXCL1, TNF-alpha, IL-1 beta, and IL-10), BAL fluid neutrophils, lung inflammation (lung cytokines, MPO activity [ a biochemical marker of neutrophil infiltration]), and serum cytokines were determined in adult male C57Bl/ 6 mice with no intervention or 4 hours after ischemic AKI (22 minutes of renal pedicle clamping), IP endotoxin (10 mu g), or IT endotoxin (80 mu g) with and without intratracheal (IT) IL-6 (25 ng or 200 ng) treatment. Results: Lung inflammation was similar after AKI, IP endotoxin, and IT endotoxin. BAL fluid IL-6 was markedly increased after IT endotoxin, and not increased after AKI or IP endotoxin. Unexpectedly, IT IL-6 exerted an anti-inflammatory effect in healthy mice characterized by reduced BAL fluid cytokines. IT IL-6 also exerted an anti-inflammatory effect in IT endotoxin characterized by reduced BAL fluid cytokines and lung inflammation; IT IL-6 had no effect on lung inflammation in AKI or IP endotoxin. Conclusion: IL-6 exerts an anti-inflammatory effect in direct lung injury from IT endotoxin, yet has no role in the pathogenesis or treatment of indirect lung injury from AKI or IP endotoxin. Since intra-alveolar inflammation is important in the pathogenesis of direct, but not indirect, causes of lung inflammation, IT anti-inflammatory treatments may have a role in direct, but not indirect, causes of ARDS.	[Bhargava, Rhea; Altmann, Christopher; Andres-Hernando, Ana; Okamura, Kayo; Ahuja, Nilesh] Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, Aurora, CO USA; [Janssen, William] Natl Jewish Hlth, Dept Med, Div Pulm Med, Denver, CO USA; [Vandivier, R. William] Univ Colorado Denver, Div Pulm Med, Dept Med, Aurora, CO USA; [Faubel, Sarah] Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, Aurora, CO USA; [Faubel, Sarah] Denver Vet Affairs Med Ctr, Dept Med, Denver, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Faubel, S (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, Aurora, CO USA.	Sarah.Faubel@ucdenver.edu		Andres-Hernando, Ana/0000-0002-0676-0188	United States National Institutes of Health (NIH); NHLBI [R01 HL095363]; NIH [HL109517]; AHA Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109517, R01HL095363] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Postdoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by United States National Institutes of Health (NIH) funding from NHLBI: R01 HL095363 to S.F., NIH HL109517, and AHA Postdoctoral Fellowship to A.A.-H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja N, 2012, AM J PHYSIOL-RENAL, V303, pF864, DOI 10.1152/ajprenal.00025.2012; Altmann C, 2012, AM J PHYSIOL-RENAL, V302, pF421, DOI 10.1152/ajprenal.00559.2010; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Bhatia M, 2012, AM J RESP CELL MOL, V46, P566, DOI 10.1165/rcmb.2011-0392TR; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Deng JP, 2004, AM J RESP CRIT CARE, V169, P749, DOI 10.1164/rccm.200303-372OC; Diao H, 2005, INFECT IMMUN, V73, P3745, DOI 10.1128/IAI.73.6.3745-3748.2005; Farivar AS, 2006, ANN THORAC SURG, V82, P472, DOI 10.1016/j.athoracsur.2006.03.060; Grigoryev DN, 2008, J AM SOC NEPHROL, V19, P547, DOI 10.1681/ASN.2007040469; Hassoun HT, 2007, AM J PHYSIOL-RENAL, V293, pF30, DOI 10.1152/ajprenal.00023.2007; Heidland A, 1984, Contrib Nephrol, V41, P352; Hoke TS, 2007, J AM SOC NEPHROL, V18, P155, DOI 10.1681/ASN.2006050494; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kim DJ, 2006, RESPIRATION, V73, P815, DOI 10.1159/000095588; Klein C, 2003, EUR J IMMUNOL, V33, P2251, DOI 10.1002/eji.200323651; Klein CL, 2008, KIDNEY INT, V74, P901, DOI 10.1038/ki.2008.314; Kobayashi A, 1998, CHEST, V113, P1632, DOI 10.1378/chest.113.6.1632; Kramer AA, 1999, KIDNEY INT, V55, P2362, DOI 10.1046/j.1523-1755.1999.00460.x; Krause A, 1997, AM J RESP CRIT CARE, V155, P1793, DOI 10.1164/ajrccm.155.5.9154894; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Liu KD, 2007, CRIT CARE MED, V35, P2755, DOI 10.1097/01.CCM.0000291649.72238.6D; Liu KD, 2009, CRIT CARE, V13, DOI 10.1186/cc7940; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Mehta RL, 2011, INTENS CARE MED, V37, P241, DOI 10.1007/s00134-010-2089-9; Meng ZH, 2001, AM J PHYSIOL-CELL PH, V280, pC343, DOI 10.1152/ajpcell.2001.280.2.C343; Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/00003246-200209000-00016; Mommsen P, 2011, CYTOKINE, V53, P60, DOI 10.1016/j.cyto.2010.09.005; Nath KA, 2005, AM J PATHOL, V166, P963, DOI 10.1016/S0002-9440(10)62318-8; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Rabb H, 2003, KIDNEY INT, V63, P600, DOI 10.1046/j.1523-1755.2003.00753.x; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shanley TP, 1997, AM J PATHOL, V151, P193; Simmons EM, 2004, KIDNEY INT, V65, P1357, DOI 10.1111/j.1523-1755.2004.00512.x; Singbartl K, 2011, KIDNEY INT, V80, P633, DOI 10.1038/ki.2011.201; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; ULICH TR, 1991, AM J PATHOL, V138, P521; Vieira JM, 2007, CRIT CARE MED, V35, P184, DOI 10.1097/01.CCM.0000249828.81705.65; Waikar SS, 2007, CURR OPIN NEPHROL HY, V16, P227, DOI 10.1097/MNH.0b013e3280dd8c35; Walcher A, 2011, RENAL FAILURE, V33, P935, DOI 10.3109/0886022X.2011.615964; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zhao MQ, 2006, AM J PHYSIOL-LUNG C, V291, pL1018, DOI 10.1152/ajplung.00086.2006	47	57	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61405	10.1371/journal.pone.0061405	http://dx.doi.org/10.1371/journal.pone.0061405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667439	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600011
J	Fiore-Donno, AM; Clissmann, F; Meyer, M; Schnittler, M; Cavalier-Smith, T				Fiore-Donno, Anna Maria; Clissmann, Fionn; Meyer, Marianne; Schnittler, Martin; Cavalier-Smith, Thomas			Two-Gene Phylogeny of Bright-Spored Myxomycetes (Slime Moulds, Superorder Lucisporidia)	PLOS ONE			English	Article							GROUP-I INTRONS; MULTIGENE ANALYSES; CAPILLITIUM; EVOLUTION; TAXONOMY; LIGHT	Myxomycetes, or plasmodial slime-moulds, are one of the largest groups in phylum Amoebozoa. Nonetheless, only similar to 10% are in the database for the small subunit (SSU) ribosomal RNA gene, the most widely used gene for phylogenetics and barcoding. Most sequences belong to dark-spored Myxomycetes (order Fuscisporida); the 318 species of superorder Lucisporidia (bright-spored) are represented by only eleven genuine sequences. To compensate for this, we provide 66 new sequences, 37 SSU rRNA and 29 elongation factor 1-alpha (EF-1 alpha), for 82% of the genera of Lucisporidia. Phylogenetic analyses of single-and two-gene alignments produce congruent topologies and reveal both morphological characters that have been overemphasised and those that have been overlooked in past classifications. Both classical orders, Liceida and Trichiida, and several families and genera are para/polyphyletic; some previously unrecognised clades emerge. We discuss possible evolutionary pathways. Our study fills a gap in the phylogeny of Amoebozoa and provides an extensive SSU rRNA sequence reference database for environmental sampling and barcoding. We report a new group I intron insertion site for Myxomycetes in one Licea.	[Fiore-Donno, Anna Maria; Cavalier-Smith, Thomas] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Fiore-Donno, Anna Maria; Clissmann, Fionn; Schnittler, Martin] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany	University of Oxford; Ernst Moritz Arndt Universitat Greifswald	Fiore-Donno, AM (corresponding author), Univ Cologne, Inst Zool, Weyertal 119, Cologne, Germany.	afiore-donno6@infomaniak.ch		Fiore-Donno, Anna Maria/0000-0001-6265-1907	Leverhulme Trust research grant [R1008101]; Deutsche Forschungsgemeinschaft grant [SCHN1080-2/1]	Leverhulme Trust research grant(Leverhulme Trust); Deutsche Forschungsgemeinschaft grant(German Research Foundation (DFG))	This work was supported by the Leverhulme Trust research grant R1008101 to the first and last authors and the Deutsche Forschungsgemeinschaft grant SCHN1080-2/1 to the first and fourth authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS CJ, 1960, MYCOLOGIA, V52, P1, DOI 10.2307/3756246; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bhattacharya D, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-68; Bisby GR, 1914, AM J BOT, V1, P274, DOI 10.2307/2435103; BLACKWELL M, 1974, ARCH MICROBIOL, V99, P331, DOI 10.1007/BF00696247; Cannone JJ, 2002, BMC BIOINF; Cavalier-Smith T, 2012, EUR J PROTI IN PRESS, DOI http://dx.doi.org/10.1016/j.ejop.2012.06.001; CHARVAT I, 1973, PROTOPLASMA, V78, P1, DOI 10.1007/BF01281519; CHARVAT I, 1973, PROTOPLASMA, V80, P207, DOI 10.1007/BF01666360; Clark J, 2004, MYCOLOGIA, V96, P36, DOI 10.2307/3761985; ELIASSON U, 1977, BOT NOTISER, V130, P483; ELLIS TT, 1973, T AM MICROSC SOC, V92, P65, DOI 10.2307/3225172; Fiore-Donno AM, 2005, J EUKARYOT MICROBIOL, V52, P201, DOI 10.1111/j.1550-7408.2005.00032.x; Fiore-Donno AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035359; Fiore-Donno AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022872; Fiore-Donno AM, 2010, PROTIST, V161, P55, DOI 10.1016/j.protis.2009.05.002; Fiore-Donno AM, 2009, MYCOLOGIA, V101, P773, DOI 10.3852/08-075; Gilert E, 1997, NORD J BOT, V16, P705; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Harper RA, 1914, ANN BOT-LONDON, V28, P1; Haskins EF, 1978, PUB WISSENSCH FILM S, V11, P1; Hatano Takami, 1999, Hikobia, V13, P47; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2003, J EUKARYOT MICROBIOL, V50, P283, DOI 10.1111/j.1550-7408.2003.tb00135.x; Huelsenbeck JP, MR BAYES V3 0B4; Iwata D, 2003, J NAT PROD, V66, P1611, DOI 10.1021/np030308e; Jobb G, 2008, TREEFINDER VERSION O; Johansen S, 2001, RNA, V7, P935, DOI 10.1017/S1355838201010500; Kalyanasundaram I, 1973, TAXONOMY FUNGI, P9; Lado C, 1997, MYXOMYCETES; Lahr DJG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022780; Lister A, 1894, MONOGRAPH MYCETOZOA; Lundblad EW, 2004, MOL BIOL EVOL, V21, P1283, DOI 10.1093/molbev/msh126; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MIMS CW, 1969, MYCOLOGIA, V61, P784, DOI 10.2307/3757468; MIMS CW, 1975, MYCOLOGIA, V67, P638, DOI 10.2307/3758399; NANNENGABREMEKAMP NE, 1982, P K NED AKAD C BIOL, V85, P541; Neubert H., 1993, MYXOMYCETEN DEUTSCHL, V1; Olive LS, 1975, MYCETOZOANS; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poulain M, 2011, LES MYXOMYCETES; Shadwick LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006754; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stephenson SL, 2011, SOIL BIOL BIOCHEM, V43, P2237, DOI 10.1016/j.soilbio.2011.07.007; Tekle YI, 2008, MOL PHYLOGENET EVOL, V47, P339, DOI 10.1016/j.ympev.2007.11.015; WELDEN AL, 1955, MYCOLOGIA, V47, P714, DOI 10.2307/3755581	49	57	65	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62586	10.1371/journal.pone.0062586	http://dx.doi.org/10.1371/journal.pone.0062586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667494	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700050
J	Oslaj, M; Cluzeau, J; Orkic, D; Kopitar, G; Mrak, P; Casar, Z				Oslaj, Matej; Cluzeau, Jerome; Orkic, Damir; Kopitar, Gregor; Mrak, Peter; Casar, Zdenko			A Highly Productive, Whole-Cell DERA Chemoenzymatic Process for Production of Key Lactonized Side-Chain Intermediates in Statin Synthesis	PLOS ONE			English	Article							HMG-COA REDUCTASE; RECOMBINANT ESCHERICHIA-COLI; ASYMMETRIC ALDOL REACTIONS; INDUSTRIAL BIOCATALYSIS; FINE CHEMICALS; DIRECTED EVOLUTION; 2-DEOXYRIBOSE-5-PHOSPHATE ALDOLASE; DEOXYRIBOSE-5-PHOSPHATE ALDOLASE; ENANTIOSELECTIVE SYNTHESIS; ORGANIC-CHEMISTRY	Employing DERA (2-deoxyribose-5-phosphate aldolase), we developed the first whole-cell biotransformation process for production of chiral lactol intermediates useful for synthesis of optically pure super-statins such as rosuvastatin and pitavastatin. Herein, we report the development of a fed-batch, high-density fermentation with Escherichia coli BL21 (DE3) overexpressing the native E. coli deoC gene. High activity of this biomass allows direct utilization of the fermentation broth as a whole-cell DERA biocatalyst. We further show a highly productive bioconversion processes with this biocatalyst for conversion of 2-substituted acetaldehydes to the corresponding lactols. The process is evaluated in detail for conversion of acetyloxy-acetaldehyde with the first insight into the dynamics of reaction intermediates, side products and enzyme activity, allowing optimization of the feeding strategy of the aldehyde substrates for improved productivities, yields and purities. The resulting process for production of ((2S,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)methyl acetate (acetyloxymethylene-lactol) has a volumetric productivity exceeding 40 g L-1 h(-1) (up to 50 g L(-)1 h(-1)) with >80% yield and >80% chromatographic purity with titers reaching 100 g L-1. Stereochemical selectivity of DERA allows excellent enantiomeric purities (ee >99.9%), which were demonstrated on downstream advanced intermediates. The presented process is highly cost effective and environmentally friendly. To our knowledge, this is the first asymmetric aldol condensation process achieved with whole-cell DERA catalysis and it simplifies and extends previously developed DERA-catalyzed approaches based on the isolated enzyme. Finally, applicability of the presented process is demonstrated by efficient preparation of a key lactol precursor, which fits directly into the lactone pathway to optically pure super-statins.	[Oslaj, Matej; Kopitar, Gregor; Mrak, Peter] Lek Pharmaceut Dd, Genet, Antiinfect, Menges, Slovenia; [Cluzeau, Jerome; Orkic, Damir; Casar, Zdenko] Lek Pharmaceut Dd, API Dev, Sandoz Dev Ctr Slovenia, Menges, Slovenia; [Casar, Zdenko] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia	Novartis; Novartis; Sandoz; University of Ljubljana	Mrak, P (corresponding author), Lek Pharmaceut Dd, Genet, Antiinfect, Menges, Slovenia.	peter.mrak@sandoz.com; zdenko.casar@sandoz.com	Casar, Zdenko/AAJ-1528-2020		Lek pharmaceuticals d.d.a Sandoz company	Lek pharmaceuticals d.d.a Sandoz company	This work nwas funded by Lek pharmaceuticals d.d. a Sandoz company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by Lek pharmaceuticals d.d., a Sandoz company. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors of this work are employed by Lek pharmaceuticals d.d., a Sandoz company. The interests of this commercial funder are pursued through the patent applications: WO2008119810 and WO2009092702. The sole purpose of this work is to share the findings obtained during the development of the described process with the scientific community and the publication has no impact on any products; in development or marketed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide B, 2008, ANGEW CHEM INT EDIT, V47, P4632, DOI 10.1002/anie.200801231; Almuti K, 2006, INT J CARDIOL, V109, P7, DOI 10.1016/j.ijcard.2005.05.056; BARBAS CF, 1990, J AM CHEM SOC, V112, P2013, DOI 10.1021/ja00161a064; Bersano A, 2008, CURR MED CHEM, V15, P2380, DOI 10.2174/092986708785909139; Bertau M, 2002, CURR ORG CHEM, V6, P987, DOI 10.2174/1385272023373752; Bolt A, 2008, ARCH BIOCHEM BIOPHYS, V474, P318, DOI 10.1016/j.abb.2008.01.005; Brautbar A, 2011, NAT REV CARDIOL, V8, P253, DOI 10.1038/nrcardio.2011.2; Casar Z, 2008, CHEM ABSTR, Patent No. WO 2008119810 A2; Casar Z, 2008, SYNLETT, P2036, DOI 10.1055/s-2008-1077957; Casar Z, 2010, J ORG CHEM, V75, P6681, DOI 10.1021/jo101050z; Casar Z, 2010, CURR ORG CHEM, V14, P816, DOI 10.2174/138527210791111858; Casar Z, 2010, ACTA CHIM SLOV, V57, P66; Casar Z, 2009, SYNLETT, P1144, DOI 10.1055/s-0028-1088152; CHEN LR, 1992, J AM CHEM SOC, V114, P741, DOI 10.1021/ja00028a050; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Chuang CY, 2002, CHIRALITY, V14, P151, DOI 10.1002/chir.10050; Clapes P, 2010, CURR OPIN CHEM BIOL, V14, P154, DOI 10.1016/j.cbpa.2009.11.029; CLIVE DLJ, 1988, J AM CHEM SOC, V110, P6914, DOI 10.1021/ja00228a067; Cluzeau J., 2009, PCT Int. Appl., Patent No. [WO2009092702, 2009092702, WO/2009/092702 A2]; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; Crestia D, 2001, J MOL CATAL B-ENZYM, V11, P207, DOI 10.1016/S1381-1177(00)00074-6; DASGIP Technology, 2002, DASGIP APPL NOT HIGH; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; de Maria PD, 2008, ADV SYNTH CATAL, V350, P165, DOI 10.1002/adsc.200700230; Dean SM, 2007, ADV SYNTH CATAL, V349, P1308, DOI 10.1002/adsc.200700115; Ema T, 2008, ADV SYNTH CATAL, V350, P2039, DOI 10.1002/adsc.200800292; ENDO A, 1993, NAT PROD REP, V10, P541, DOI 10.1039/np9931000541; ENDO A, 1976, J ANTIBIOT, V29, P1346, DOI 10.7164/antibiotics.29.1346; ENDO A, 1992, J LIPID RES, V33, P1569; Endo A, 2008, NAT MED, V14, P1050, DOI 10.1038/nm1008-1050; Faber K, 2011, BIOTRANSFORMATIONS O, P9; Fabris J, 2012, SYNTHESIS-STUTTGART, V44, P1700, DOI 10.1055/s-0031-1290916; Franke D, 2004, METHOD ENZYMOL, V388, P224; Fukuda H, 2008, TRENDS BIOTECHNOL, V26, P668, DOI 10.1016/j.tibtech.2008.08.001; GIJSEN HJM, 1995, J AM CHEM SOC, V117, P7585, DOI 10.1021/ja00134a001; Gijsen HJM, 1996, CHEM REV, V96, P443, DOI 10.1021/cr950031q; GIJSEN HJM, 1994, J AM CHEM SOC, V116, P8422, DOI 10.1021/ja00097a082; Greenberg W., 2004, Patent, Patent No. [WO 2004027075, 2004027075, WO 2004/027075 A2]; Greenberg WA, 2004, P NATL ACAD SCI USA, V101, P5788, DOI 10.1073/pnas.0307563101; Groger H, 2007, ADV SYNTH CATAL, V349, P709, DOI 10.1002/adsc.200600606; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Gutsulyak DV, 2012, ADV SYNTH CATAL, V354, P607, DOI 10.1002/adsc.201100693; HABEEB AFS, 1968, ARCH BIOCHEM BIOPHYS, V126, P16, DOI 10.1016/0003-9861(68)90554-7; Heine A, 2004, J MOL BIOL, V343, P1019, DOI 10.1016/j.jmb.2004.08.066; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hudlicky T, 2009, CHEM SOC REV, V38, P3117, DOI 10.1039/b901172m; Ikunaka M, 2007, ORG PROCESS RES DEV, V11, P495, DOI 10.1021/op050161t; Ishige T, 2005, CURR OPIN CHEM BIOL, V9, P174, DOI 10.1016/j.cbpa.2005.02.001; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jennewein Stefan, 2006, Biotechnology Journal, V1, P537, DOI 10.1002/biot.200600020; Kidd J, 2006, NAT REV DRUG DISCOV, V5, P813, DOI 10.1038/nrd2156; Kierkels J. G. T., 2003, DSM IP Assets B.V., Patent No. [WO2003/006656A3, 2003006656]; Koeller KM, 2001, NATURE, V409, P232, DOI 10.1038/35051706; Lahera V, 2007, CURR MED CHEM, V14, P243, DOI 10.2174/092986707779313381; lamparuthi E, 2012, SYNTHETIC COMMUN, V35, P2801; LEE TJ, 1985, TETRAHEDRON LETT, V26, P4995, DOI 10.1016/S0040-4039(01)80835-2; Liese A, 1999, CURR OPIN BIOTECH, V10, P595, DOI 10.1016/S0958-1669(99)00040-3; Liljeblad A, 2009, CURR ORG SYNTH, V6, P362, DOI 10.2174/157017909789108738; Ma SK, 2010, GREEN CHEM, V12, P81, DOI 10.1039/b919115c; Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J; Matsuyama A, 2002, ORG PROCESS RES DEV, V6, P558, DOI 10.1021/op025514s; Mestres R, 2004, GREEN CHEM, V6, P583, DOI 10.1039/b409143b; Mlynarski J, 2008, CHEM SOC REV, V37, P1502, DOI 10.1039/b710577k; MORI Y, 1990, J CHEM SOC PERK T 1, P1809, DOI 10.1039/p19900001809; Muller M, 2005, ANGEW CHEM INT EDIT, V44, P362, DOI 10.1002/anie.200460852; O'Connor CJ, 1998, AUST J CHEM, V51, P455, DOI 10.1071/C97212; Panke S, 2005, CURR OPIN CHEM BIOL, V9, P188, DOI 10.1016/j.cbpa.2005.02.007; Panke S, 2004, CURR OPIN BIOTECH, V15, P272, DOI 10.1016/j.copbio.2004.06.011; Paraskevas KI, 2007, CURR PHARM DESIGN, V13, P3622, DOI 10.2174/138161207782794194; Park CP, 2010, ORG LETT, V12, P2450, DOI 10.1021/ol1001686; Patel RN, 2002, ENZYME MICROB TECH, V31, P804, DOI 10.1016/S0141-0229(02)00186-2; Pollard DJ, 2007, TRENDS BIOTECHNOL, V25, P66, DOI 10.1016/j.tibtech.2006.12.005; PRAVDIC N, 1971, CARBOHYD RES, V19, P339, DOI 10.1016/S0008-6215(00)86164-9; PRICER WE, 1960, J BIOL CHEM, V235, P1292; RACKER E, 1952, J BIOL CHEM, V196, P347; RAJAGOPAL S, 1992, J MOL CATAL, V75, P199, DOI 10.1016/0304-5102(92)80122-W; Sakuraba H, 2007, APPL ENVIRON MICROB, V73, P7427, DOI 10.1128/AEM.01101-07; Samland AK, 2006, APPL MICROBIOL BIOT, V71, P253, DOI 10.1007/s00253-006-0422-6; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; SCHMIDT RR, 1986, TETRAHEDRON LETT, V27, P481, DOI 10.1016/S0040-4039(00)85510-0; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; Schulze B, 1999, CURR OPIN BIOTECH, V10, P609, DOI 10.1016/S0958-1669(99)00042-7; Schurmann M., 2010, GREEN CHEM PHARM IND, P127; Sharma A., 1999, INTRO FLUORESCENCE S; SHARMA M, 1990, CARBOHYD RES, V198, P205, DOI 10.1016/0008-6215(90)84293-4; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; Shojaosadati Seyed Abbas, 2008, Iranian Journal of Biotechnology, V6, P63; Steinfeld J.I., 1999, CHEM KINETICS DYNAMI; Straathof AJJ, 2002, CURR OPIN BIOTECH, V13, P548, DOI 10.1016/S0958-1669(02)00360-9; Suau T, 2005, BIOCATAL BIOTRANSFOR, V23, P241, DOI 10.1080/10242420500208720; Suau T, 2009, BIOCATAL BIOTRANSFOR, V27, P136, DOI 10.1080/10242420802607876; Sukumaran J, 2005, CHEM SOC REV, V34, P530, DOI 10.1039/b412490a; Switzer JA, 2006, EXPERT REV NEUROTHER, V6, P192; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Troiani V, 2011, ORG PROCESS RES DEV, V15, P622, DOI 10.1021/op100341m; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Udovic M, 2011, CHEM ABSTR, Patent No. 2011064249 A1; Vasic-Racki D., 2006, IND BIOTRANSFORMATIO, P1, DOI DOI 10.1002/9783527608188.CH1; Wandrey C, 2000, ORG PROCESS RES DEV, V4, P286, DOI 10.1021/op990101l; Wang AM, 2011, BIORESOURCE TECHNOL, V102, P469, DOI 10.1016/j.biortech.2010.08.048; Whalen LJ, 2006, ALDRICHIM ACTA, V39, P63; WILD R, 1994, TETRAHEDRON-ASYMMETR, V5, P2195, DOI 10.1016/S0957-4166(00)86295-3; Wohlgemuth R, 2009, NEW BIOTECHNOL, V25, P204, DOI 10.1016/j.nbt.2009.01.002; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Yazbeck DR, 2004, TETRAHEDRON-ASYMMETR, V15, P2757, DOI 10.1016/j.tetasy.2004.07.050; Yoshida Y, 2005, CHEM ABSTR, V143; Yuryev R, 2010, CHEMCATCHEM, V2, P103, DOI 10.1002/cctc.200900126; Zaks A, 2001, CURR OPIN CHEM BIOL, V5, P130, DOI 10.1016/S1367-5931(00)00181-2	108	38	39	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62250	10.1371/journal.pone.0062250	http://dx.doi.org/10.1371/journal.pone.0062250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667462	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700028
J	Yu, R; Leung, J; Woo, J				Yu, Ruby; Leung, Jason; Woo, Jean			Housework Reduces All-Cause and Cancer Mortality in Chinese Men	PLOS ONE			English	Article							EXERCISE ACTIVITY THERMOGENESIS; PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; SOCIAL-STATUS; POPULATION; INTENSITY; PATTERNS; HEALTH; WOMEN	Background: Leisure time physical activity has been extensively studied. However, the health benefits of non-leisure time physical activity, particular those undertaken at home on all-cause and cancer mortality are limited, particularly among the elderly. Methods: We studied physical activity in relation to all-cause and cancer mortality in a cohort of 4,000 community-dwelling elderly aged 65 and older. Leisure time physical activity (sport/recreational activity and lawn work/yard care/gardening) and non-leisure time physical activity (housework, home repairs and caring for another person) were self-reported on the Physical Activity Scale for the Elderly. Subjects with heart diseases, stroke, cancer or diabetes at baseline were excluded (n = 1,133). Results: Among the 2,867 subjects with a mean age of 72 years at baseline, 452 died from all-cause and 185 died from cancer during the follow-up period (2001-2012). With the adjustment for age, education level and lifestyle factors, we found an inverse association between risk of all-cause mortality and heavy housework among men, with the adjusted hazard ratio (HR) of 0.72 ( 95%CI = 0.57-0.92). Further adjustment for BMI, frailty index, living arrangement, and leisure time activity did not change the result (HR = 0.71, 95%CI = 0.56-0.91). Among women, however, heavy housework was not associated with all-cause mortality. The risk of cancer mortality was significantly lower among men who participated in heavy housework (HR = 0.52, 95%CI = 0.35-0.78), whereas among women the risk was not significant. Men participated in light housework also were at lower risk of cancer mortality than were their counterparts, however, the association was not significant. Leisure time physical activity was not related to all-cause or cancer mortality in either men or women. Conclusion: Heavy housework is associated with reduced mortality and cancer deaths over a 9-year period. The underlying mechanism needs further study.	[Yu, Ruby; Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Leung, Jason] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Yu, R (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	rubyyu@cuhk.edu.hk	Yu, Ruby/N-5006-2015; Woo, Jean/K-2625-2014	Woo, Jean/0000-0001-7593-3081	SH Ho Centre for Gerontology and Geriatrics, Faculty of Medicine, The Chinese University of Hong Kong	SH Ho Centre for Gerontology and Geriatrics, Faculty of Medicine, The Chinese University of Hong Kong	The authors wish to thank Dr. Edith Lau for setting up the elderly cohort and the support from the SH Ho Centre for Gerontology and Geriatrics, Faculty of Medicine, The Chinese University of Hong Kong.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; *AM COLL SPORTS ME, 2009, GUID EX TEST PRESCR; Besson H, 2008, MED SCI SPORT EXER, V40, P1909, DOI 10.1249/MSS.0b013e318180bcad; *CDP SPORTS SCI PH, 2012, HLTH EX ALL CAMP PHY; Centers for Disease Control and Prevention (CDC); National Center for Health Statistics, 2011, DATA2010 HLTH PEOPL; DALLOSSO HM, 1988, J EPIDEMIOL COMMUN H, V42, P121, DOI 10.1136/jech.42.2.121; Dong Linda, 2004, Int J Behav Nutr Phys Act, V1, P4, DOI 10.1186/1479-5868-1-4; Glass TA, 1999, BRIT MED J, V319, P478, DOI 10.1136/bmj.319.7208.478; Goggins WB, 2005, J GERONTOL A-BIOL, V60, P1046, DOI 10.1093/gerona/60.8.1046; Jurj AL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-213; Lawlor DA, 2002, J EPIDEMIOL COMMUN H, V56, P473, DOI 10.1136/jech.56.6.473; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Levine JA, 2006, ARTERIOSCL THROM VAS, V26, P729, DOI 10.1161/01.ATV.0000205848.83210.73; Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227; Lin YP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-428; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Morley JE, 2009, CURR PHARM DESIGN, V15, P3384, DOI 10.2174/138161209789105045; Moschny A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-559; Sabia S, 2012, AM J PUBLIC HEALTH, V102, P698, DOI 10.2105/AJPH.2011.300257; Scott J, 2012, GENDERED LIVES: GENDER INEQUALITIES IN PRODUCTION AND REPRODUCTION, P1; Stamatakis E, 2009, AM J EPIDEMIOL, V169, P1191, DOI 10.1093/aje/kwp042; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Weller I, 1998, EPIDEMIOLOGY, V9, P632, DOI 10.1097/00001648-199811000-00012; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Woo J, 2008, WOMEN HEALTH, V48, P209, DOI 10.1080/03630240802313563; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x	32	28	30	6	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61529	10.1371/journal.pone.0061529	http://dx.doi.org/10.1371/journal.pone.0061529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667441	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700014
J	Zaremba-Niedzwiedzka, K; Andersson, SGE				Zaremba-Niedzwiedzka, Katarzyna; Andersson, Siv G. E.			No Ancient DNA Damage in Actinobacteria from the Neanderthal Bone	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; INSOLUBLE COLLAGEN; HYDROLYSIS; METAGENOMICS; PATTERNS; RESOURCE; PROTEASE	Background: The Neanderthal genome was recently sequenced using DNA extracted from a 38,000-year-old fossil. At the start of the project, the fraction of mammalian and bacterial DNA in the sample was estimated to be <6% and 9%, respectively. Treatment with restriction enzymes prior to sequencing increased the relative proportion of mammalian DNA to 15%, but the large majority of sequences remain uncharacterized. Principal Findings: Our taxonomic profiling of 3.95 Gb of Neanderthal DNA isolated from the Vindija Neanderthal Vi33.16 fossil showed that 90% of about 50,000 rRNA gene sequence reads were of bacterial origin, of which Actinobacteria accounted for more than 75%. Actinobacteria also represented more than 80% of the PCR-amplified 16S rRNA gene sequences from a cave sediment sample taken from the same G layer as the Neanderthal bone. However, phylogenetic analyses did not identify any sediment clones that were closely related to the bone-derived sequences. We analysed the patterns of nucleotide differences in the individual sequence reads compared to the assembled consensus sequences of the rRNA gene sequences. The typical ancient nucleotide substitution pattern with a majority of C to T changes indicative of DNA damage was observed for the Neanderthal rRNA gene sequences, but not for the Streptomyces-like rRNA gene sequences. Conclusions/Significance: Our analyses suggest that the Actinobacteria, and especially members of the Streptomycetales, contribute the majority of sequences in the DNA extracted from the Neanderthal fossil Vi33.16. The bacterial DNA showed no signs of damage, and we hypothesize that it was derived from bacteria that have been enriched inside the bone. The bioinformatic approach used here paves the way for future studies of microbial compositions and patterns of DNA damage in bacteria from archaeological bones. Such studies can help identify targeted measures to increase the relative amount of endogenous DNA in the sample.	[Zaremba-Niedzwiedzka, Katarzyna; Andersson, Siv G. E.] Uppsala Univ, Biomed Ctr, Dept Mol Evolut, Cell & Mol Biol Sci Life Lab, Uppsala, Sweden	Uppsala University	Andersson, SGE (corresponding author), Uppsala Univ, Biomed Ctr, Dept Mol Evolut, Cell & Mol Biol Sci Life Lab, Uppsala, Sweden.	Siv.Andersson@icm.uu.se		Zaremba-Niedzwiedzka, Katarzyna/0000-0003-1030-8212	Swedish Research Council [315-2004-6676]; Goran Gustafsson Foundation; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Goran Gustafsson Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work has been supported by grants to SGEA from the Swedish Research Council (315-2004-6676), the Goran Gustafsson Foundation, and the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; CHILD AM, 1995, STUD CONSERV, V40, P19, DOI 10.2307/1506608; CHILD AM, 1995, J ARCHAEOL SCI, V22, P165, DOI 10.1006/jasc.1995.0018; Darling A. E., 2010, PLOS ONE, V5; ENSIGN JC, 1978, ANNU REV MICROBIOL, V32, P185, DOI 10.1146/annurev.mi.32.100178.001153; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guy L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003393; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Johnson SS, 2007, P NATL ACAD SCI USA, V104, P14401, DOI 10.1073/pnas.0706787104; KARPENKO HF, 1977, UKR BIOKHIM ZH+, V49, P76; KARPENKO HF, 1977, UKR BIOKHIM ZH+, V49, P80; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; MISHUNIN IF, 1975, UKR BIOKHIM ZH+, V47, P226; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rastogi R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-208; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sawyer S, 2012, PLOS ONE, V7; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Tsyperovich A S, 1973, Ukr Biokhim Zh, V45, P151; Willerslev E, 2004, CURR BIOL, V14, pR9, DOI 10.1016/j.cub.2003.12.012	36	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62799	10.1371/journal.pone.0062799	http://dx.doi.org/10.1371/journal.pone.0062799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658776	Green Submitted, gold, Green Published			2022-12-27	WOS:000321202100042
J	Carmona, L; Pola, M; Gosliner, TM; Cervera, JL				Carmona, Leila; Pola, Marta; Gosliner, Terrence M.; Cervera, Juan Lucas			A Tale That Morphology Fails to Tell: A Molecular Phylogeny of Aeolidiidae (Aeolidida, Nudibranchia, Gastropoda)	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; OPISTHOBRANCHIA MOLLUSCA; BERGHIA-VERRUCICORNIS; EUTHYNEURA MOLLUSCA; SPECIES BOUNDARIES; MAXIMUM-LIKELIHOOD; FAMILY AEOLIDIIDAE; BABAKINA ROLLER; DNA-SEQUENCES; BIOGEOGRAPHY	Aeolidida is one of the largest clades of nudibranchs with at least 560 known species. However, its systematics has not been studied in a comprehensive manner. Phylogenetic analyses of larger clades such as Nudibranchia or Cladobranchia have usually included a poor sample of aeolids. Furthermore, phylogenetic studies at the family or generic level in Aeolidida are a few and far between. The first molecular phylogeny of the aeolid family Aeolidiidae is presented here. This study, the most comprehensive for Aeolidida to date, uses new sequences of two mitochondrial (COI and 16S) genes and one nuclear gene (H3). 251 specimens from members of seven families of Aeolidida, including 39 species of Aeolidiidae were studied. Excluding Pleurolidia juliae, Aeolidiidae is monophyletic. Our results resolve the systematic relationships within the Aeolidiidae at a generic level, requiring changes in the systematics of this family. Spurilla, Anteaeolidiella, Limenandra and Aeolidia are well-supported and monophyletic clades. Aeolidiella stephanieae is transferred to Berghia and Aeolidiopsis ransoni and Spurilla salaamica to Baeolidia, to maintain the monophyletic lineages reflected in this study. The systematics of Cerberilla remains unclear. Some species earlier attributed to Aeolidiella are now grouped in a previously unnamed clade that we designate as Bulbaeolidia gen. nov.	[Carmona, Leila; Cervera, Juan Lucas] Univ Cadiz, Fac Ciencias Mar & Ambientales, Dept Biol, Cadiz, Spain; [Pola, Marta] Autonomous Univ Madrid, Dept Biol Edificio Biol, E-28049 Madrid, Spain; [Gosliner, Terrence M.] Calif Acad Sci, Dept Invertebrate Zool, San Francisco, CA 94118 USA	Universidad de Cadiz; Autonomous University of Madrid; California Academy of Sciences	Carmona, L (corresponding author), Univ Cadiz, Fac Ciencias Mar & Ambientales, Dept Biol, Campus Excelencia Int Mar CEI MAR, Cadiz, Spain.	leila.carmona@uca.es	Carmona, Leila/L-8021-2014; Pola, Marta/K-6054-2014; Cervera, Juan Lucas/D-9733-2018	Carmona, Leila/0000-0002-2070-4684; Cervera, Juan Lucas/0000-0002-8337-2867	University of Cadiz; California Academy of Sciences; National Science Foundation [DEB 0329054]; Spanish Ministry of Economy and Competitiveness (Ministry of Sciences and Innovation) [CGL2006-05182/BOS, CTM2008-05228-E/MAR, CGL2010-17187]; Institut Menorqui d'Estudis, Balearic Is; Bermuda Zoological Society; AECID-PCI (Spanish Agency of International Cooperation and Development) [A/8688/07]	University of Cadiz; California Academy of Sciences; National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Economy and Competitiveness (Ministry of Sciences and Innovation); Institut Menorqui d'Estudis, Balearic Is; Bermuda Zoological Society; AECID-PCI (Spanish Agency of International Cooperation and Development)	This work is supported by the University of Cadiz, the California Academy of Sciences, the National Science Foundation DEB 0329054 to TMG, and grants from the Spanish Ministry of Economy and Competitiveness (includes the early Ministry of Sciences and Innovation) CGL2006-05182/BOS, CTM2008-05228-E/MAR and CGL2010-17187; Institut Menorqui d'Estudis, Balearic Is; Bermuda Zoological Society; AECID-PCI A/8688/07 (Spanish Agency of International Cooperation and Development) to JLC. The funders had no role in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2005, REG C P AM ZOO AQ AS, V43, P218; Avise John C., 2004, P1; Baba K, 1930, VENUS, V2, P117; Baba K, 1955, OPISTHOBRANCHIA SA S; Baba K., 1992, REP SADO MAR BIOL ST, V22, P29; BARNARD K. H., 1927, ANN S AFRICAN MUS, V25, P171; Bebbington A., 1968, Actes de la Societe Linneenne de Bordeaux, V105, P1; Behrens DW, 2008, INDOPACIFIC NUDIBRAN; Bergh R, 1888, REISEN ARCHIPEL PHIL, V3, P755; Bergh R, 1877, ZOOLOGISH BOT GESSEL, V26, P737; Bergh R, 1882, ZOOLOGISH BOT GESELL, V31, P7; Burn R, 1969, J MALACOLOGICAL SOC, V12, P64, DOI DOI 10.1080/00852988.1969.10673833; Burn R, 1966, J MALACOLOGICAL SOC, V10, P21; Burn R, 1964, JOURN CONCHYL CIV, P85; Burn Robert, 2006, Museum Victoria Science Reports, V10, P1; Carmona L, 2011, J MOLLUS STUD, V77, P417, DOI 10.1093/mollus/eyr029; CARROLL DJ, 1990, BIOL BULL, V179, P243, DOI 10.2307/1542315; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Debelius H, 2007, NUDIBRANCHS WORLD; Dinapoli Angela, 2007, Bonner Zoologische Beitraege, V55, P191; Dominguez M, 2008, ZOOL J LINN SOC-LOND, V153, P349, DOI 10.1111/j.1096-3642.2008.00390.x; Drummond A. J., 2009, GENEIOUS V4 6; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EDMUNDS M, 1969, Proceedings of the Malacological Society of London, V38, P451; EDMUNDS M, 1983, J MOLLUS STUD, V49, P185, DOI 10.1093/oxfordjournals.mollus.a065713; Eliot C, 1903, P ZOOL SOC LOND, V1903, P250; Eliot CNE, 1913, J COLL SCI IMP U TOK, V35, P1; Engel H., 1925, Bijdragen tot de Dierkunde, V24, P33; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frey MA, 2008, MOL PHYLOGENET EVOL, V48, P1067, DOI 10.1016/j.ympev.2008.05.009; GARCIA JC, 1985, J MOLLUS STUD, V51, P138; Garcia-Garcia FJ, 2008, OPISTOBRANQUIOS BRAS; GARCIAGOMEZ JC, 1990, J MOLLUS STUD, V56, P323, DOI 10.1093/mollus/56.3.323; Gobbeler K, 2011, THALASSAS, V27, P121; GOSLINER T M, 1985, Annals of the South African Museum, V95, P233; GOSLINER T M, 1990, Proceedings of the California Academy of Sciences, V47, P1; Gosliner TM, 2007, ZOOL J LINN SOC-LOND, V151, P671, DOI 10.1111/j.1096-3642.2007.00331.x; GOSLINER TM, 1979, PAC SCI, V33, P37; GOSLINER TM, 1991, VELIGER, V34, P97; Gosliner TM, 1981, ANN S AFR MUS, V82, P102; Grande C, 2004, MOL PHYLOGENET EVOL, V33, P378, DOI 10.1016/j.ympev.2004.06.008; Grande C, 2004, MOL BIOL EVOL, V21, P303, DOI 10.1093/molbev/msh016; Haefelfinger H. R., 1958, Vie et Milieu, V9, P418; Hamatani Iwao, 2000, Venus the Japanese Journal of Malacology, V59, P263; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KEMPF SC, 1991, J MOLLUS STUD, V57, P75, DOI 10.1093/mollus/57.Supplement_Part_4.75; Kempf SC, 2002, PHOTO BERGHIA VERRUC; Kempf SC, 1996, REG C P AM ZOO AQ AS; Kerstitch A., 1989, pi; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; MacFarland Frank Mace, 1909, Leland Stanford Junior University Publications University Series Stanford University Cal, VNo. 2; MACNAE WILLIAM, 1954, ANN NATAL MUS, V13, P1; MADDISON D. R., 2005, MACCLADE 4 V 4 08 OS; Malaquias MAE, 2009, J BIOGEOGR, V36, P1760, DOI 10.1111/j.1365-2699.2009.02118.x; Marcus E., 1967, Studies in Tropical Oceanography, VNo. 6, P1; Marcus E., 1961, VELIGER            S, V3, P1; MARCUS E., 1957, J LINNEAN SOC ZOOLOG, V43, P390, DOI DOI 10.1111/J.1096-3642.1957.TB01559.X; Marcus E. du B.-R., 1977, Journal moll Stud, V4, P1; Marcus Er., 1970, STUD FAUNA CURACAO, V33, P1; MARCUS ERNST, 1958, AMER MUS NOVITATES, V1906, P1; MARIN A, 1991, J MOLLUS STUD, V57, P87, DOI 10.1093/mollus/57.Supplement_Part_4.87; Martin Rainer, 2010, Open Marine Biology Journal, V4, P96, DOI 10.2174/1874450801004010096; MCDONALD G, 1975, Veliger, V17, P378; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Miller MC, 2001, J NAT HIST, V35, P629, DOI 10.1080/00222930152023081; Moore E, 2009, ZOOTAXA, P30, DOI 10.11646/zootaxa.2201.1.6; Moore EJ, 2011, MOL PHYLOGENET EVOL, V58, P116, DOI 10.1016/j.ympev.2010.11.008; Muniain Claudia, 1999, Avicennia, V10-11, P143; Nylander J.A.A, 2004, MRMODELTEST V2; Odhner N., 1939, KONGELIGE NORSKE VID, V1, P1; Odhner N. H., 1937, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening i Kjobenhavn, V101, P253; Odhner NH., 1968, TRAIT ZOOLOGIE ANATO, V5, P608; Ornelas-Gatdula E, 2011, ZOOL J LINN SOC-LOND, V163, P1077, DOI 10.1111/j.1096-3642.2011.00749.x; Ortea J, 2004, REV ACAD CANAR CIENC, V15, P3; Padula V, 2010, NAUTILUS, V124, P175; Palumbi S.R, 1991, SIMPLE FOOLS GUIDE P; Pola M, 2008, B MAR SCI, V83, P391; Pola M, 2007, MOL PHYLOGENET EVOL, V43, P726, DOI 10.1016/j.ympev.2007.02.003; Pola M, 2010, MOL PHYLOGENET EVOL, V56, P931, DOI 10.1016/j.ympev.2010.05.003; PRUVOT-FOL. A., 1956, BULL MUS NATL HIST NAT, V28, P228; Pruvot-Fol A., 1953, Trav Inat sci Cherifien, VNo. 5, P1; Pruvot-Fol A, 1954, FAUNE FRANCE, V58; Reid DG, 2006, J BIOGEOGR, V33, P990, DOI 10.1111/j.1365-2699.2006.01469.x; RISBEC JEAN, 1928, FAUNE COLONIES FRANC, V2, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUDMAN WB, 1982, ZOOL J LINN SOC-LOND, V74, P147, DOI 10.1111/j.1096-3642.1982.tb01146.x; RUDMAN WB, 1990, J MOLLUS STUD, V56, P505, DOI 10.1093/mollus/56.4.505; Schmekel L, 1982, OPISTHOBRANCHIA MITT; Schrodl M, 2011, THALASSAS, V27, P101; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stimpson W, 1855, P ACAD NAT SCI PHILA, V7, P385, DOI DOI 10.5962/BHL.TITLE.51445; Swennen C, 1961, ZOOLOGISCHE MEDEDELI, V38, P42; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tardy JP, 1965, B I OCEANOGRAPHIQUE, V65, p[1, 1]; Tardy JP, 1962, B I OCEANOGRAPHIQUE, V59, P1; Thollesson M, 1999, P ROY SOC B-BIOL SCI, V266, P75, DOI 10.1098/rspb.1999.0606; Trinchese S., 1878, Memorie Accademia Bologna, V(3), P405; Uribe Roberto A., 2012, Marine Biodiversity Records, V5, P1; Valde 'sA', 2006, CARIBBEAN SEA SLUGS; Valdes A, 2004, B MAR SCI, V75, P381; Vayssie` re A', 1888, ANN MUSEE HIST NATUR, V3, P1; Vayssiere A, 1913, MOLLUSQUES FRANCE RE, V1; Vonnemann V, 2005, J MOLLUS STUD, V71, P113, DOI 10.1093/mollus/eyi014; Waegele Heike, 2008, P385; Wagele H, 2004, ORG DIVERS EVOL, V4, P175, DOI 10.1016/j.ode.2004.03.002; Wagele H, 2003, SM S COMP E, P185; WAGELE H, 1990, ZOOL SCR, V19, P309, DOI 10.1111/j.1463-6409.1990.tb00261.x; Wagele H, 2000, ZOOL J LINN SOC-LOND, V130, P83, DOI 10.1006/zjls.1999.0214; Wagele Heike, 2005, Front Zool, V2, P3, DOI 10.1186/1742-9994-2-3; Wheeler QD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P55; Willan Richard, 2006, Malacological Society of Australasia Newsletter, V130, P3; Williams ST, 2004, EVOLUTION, V58, P2227; Williams ST, 2003, MOL PHYLOGENET EVOL, V28, P60, DOI 10.1016/S1055-7903(03)00038-1; Wollscheid E, 1999, MOL PHYLOGENET EVOL, V13, P215, DOI 10.1006/mpev.1999.0664; Wollscheid-Lengeling E, 2001, ORG DIVERS EVOL, V1, P241, DOI 10.1078/1439-6092-00022	123	92	103	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63000	10.1371/journal.pone.0063000	http://dx.doi.org/10.1371/journal.pone.0063000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658794	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500051
J	Priede, IG; Bergstad, OA; Miller, PI; Vecchione, M; Gebruk, A; Falkenhaug, T; Billett, DSM; Craig, J; Dale, AC; Shields, MA; Tilstone, GH; Sutton, TT; Gooday, AJ; Inall, ME; Jones, DOB; Martinez-Vicente, V; Menezes, GM; Niedzielski, T; Sigurosson, P; Rothe, N; Rogacheva, A; Alt, CHS; Brand, T; Abell, R; Brierley, AS; Cousins, NJ; Crockard, D; Hoelzel, AR; Hoines, A; Letessier, TB; Read, JF; Shimmield, T; Cox, MJ; Galbraith, JK; Gordon, JDM; Horton, T; Neat, F; Lorance, P				Priede, Imants G.; Bergstad, Odd Aksel; Miller, Peter I.; Vecchione, Michael; Gebruk, Andrey; Falkenhaug, Tone; Billett, David S. M.; Craig, Jessica; Dale, Andrew C.; Shields, Mark A.; Tilstone, Gavin H.; Sutton, Tracey T.; Gooday, Andrew J.; Inall, Mark E.; Jones, Daniel O. B.; Martinez-Vicente, Victor; Menezes, Gui M.; Niedzielski, Tomasz; Sigurosson, Porsteinn; Rothe, Nina; Rogacheva, Antonina; Alt, Claudia H. S.; Brand, Timothy; Abell, Richard; Brierley, Andrew S.; Cousins, Nicola J.; Crockard, Deborah; Hoelzel, A. Rus; Hoines, Age; Letessier, Tom B.; Read, Jane F.; Shimmield, Tracy; Cox, Martin J.; Galbraith, John K.; Gordon, John D. M.; Horton, Tammy; Neat, Francis; Lorance, Pascal			Does Presence of a Mid-Ocean Ridge Enhance Biomass and Biodiversity?	PLOS ONE			English	Article							MID-ATLANTIC RIDGE; TEMPERATE NE ATLANTIC; DEEP-WATER FISH; NORTH-ATLANTIC; DEMERSAL FISH; SEA FISH; AREA; BIOLUMINESCENCE; SEAMOUNTS; PATTERNS	In contrast to generally sparse biological communities in open-ocean settings, seamounts and ridges are perceived as areas of elevated productivity and biodiversity capable of supporting commercial fisheries. We investigated the origin of this apparent biological enhancement over a segment of the North Mid-Atlantic Ridge (MAR) using sonar, corers, trawls, traps, and a remotely operated vehicle to survey habitat, biomass, and biodiversity. Satellite remote sensing provided information on flow patterns, thermal fronts, and primary production, while sediment traps measured export flux during 2007-2010. The MAR, 3,704,404 km 2 in area, accounts for 44.7% lower bathyal habitat (800-3500 m depth) in the North Atlantic and is dominated by fine soft sediment substrate (95% of area) on a series of flat terraces with intervening slopes either side of the ridge axis contributing to habitat heterogeneity. The MAR fauna comprises mainly species known from continental margins with no evidence of greater biodiversity. Primary production and export flux over the MAR were not enhanced compared with a nearby reference station over the Porcupine Abyssal Plain. Biomasses of benthic macrofauna and megafauna were similar to global averages at the same depths totalling an estimated 258.9 kt C over the entire lower bathyal north MAR. A hypothetical flat plain at 3500 m depth in place of the MAR would contain 85.6 kt C, implying an increase of 173.3 kt C attributable to the presence of the Ridge. This is approximately equal to 167 kt C of estimated pelagic biomass displaced by the volume of the MAR. There is no enhancement of biological productivity over the MAR; oceanic bathypelagic species are replaced by benthic fauna otherwise unable to survive in the mid ocean. We propose that globally sea floor elevation has no effect on deep sea biomass; pelagic plus benthic biomass is constant within a given surface productivity regime.	[Priede, Imants G.; Craig, Jessica; Shields, Mark A.; Cousins, Nicola J.; Crockard, Deborah] Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Aberdeen, Scotland; [Bergstad, Odd Aksel; Falkenhaug, Tone] Inst Marine Res, Flodevigen, His, Norway; [Miller, Peter I.; Tilstone, Gavin H.; Martinez-Vicente, Victor] Plymouth Marine Lab, Remote Sensing Grp, Plymouth, Devon, England; [Vecchione, Michael] Smithsonian Inst, Natl Museum Nat Hist, Natl Systemat Lab, Natl Marine Fisheries Serv,NOAA, Washington, DC 20560 USA; [Gebruk, Andrey; Rogacheva, Antonina] Russian Acad Sci, PP Shirshov Inst Oceanol, Moscow, Russia; [Billett, David S. M.; Gooday, Andrew J.; Jones, Daniel O. B.; Rothe, Nina; Alt, Claudia H. S.; Read, Jane F.; Horton, Tammy] Natl Oceanog Ctr, Southampton, Hants, England; [Dale, Andrew C.; Inall, Mark E.; Brand, Timothy; Abell, Richard; Shimmield, Tracy; Gordon, John D. M.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Sutton, Tracey T.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA USA; [Menezes, Gui M.] Univ Azores, Dept Oceanog & Fisheries, Horta, Faial, Portugal; [Niedzielski, Tomasz] Univ Wroclaw, Inst Geog & Reg Dev, Dept Geoinformat & Cartog, PL-50138 Wroclaw, Poland; [Sigurosson, Porsteinn] Marine Res Inst, IS-121 Reykjavik, Iceland; [Brierley, Andrew S.] Univ St Andrews, Scottish Oceans Inst, St Andrews KY16 9AJ, Fife, Scotland; [Hoelzel, A. Rus] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Hoines, Age] Inst Marine Res, N-5024 Bergen, Norway; [Letessier, Tom B.] Univ Western Australia, Oceans Inst, Ctr Marine Futures, Perth, WA 6009, Australia; [Cox, Martin J.] Australian Antarctic Div, Southern Ocean Ecosyst Change Dept, Kingston, Tas, Australia; [Galbraith, John K.] NOAA, Northeast Fisheries Sci Ctr, Woods Hole, MA USA; [Neat, Francis] Marine Scotland Sci, Marine Lab, Aberdeen, Scotland; [Lorance, Pascal] IFREMER, Ctr Atlantique, F-44311 Nantes 03, France	University of Aberdeen; Institute of Marine Research - Norway; Plymouth Marine Laboratory; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History; Russian Academy of Sciences; Shirshov Institute of Oceanology; NERC National Oceanography Centre; UHI Millennium Institute; William & Mary; Virginia Institute of Marine Science; Universidade dos Acores; University of Wroclaw; Marine & Freshwater Research Institute (MFRI); University of St Andrews; Durham University; Institute of Marine Research - Norway; University of Western Australia; Australian Antarctic Division; National Oceanic Atmospheric Admin (NOAA) - USA; Marine Scotland Science (MSS); Ifremer	Priede, IG (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Aberdeen, Scotland.	i.g.priede@abdn.ac.uk	Dale, Andrew C/H-4847-2012; Kremenetskaia, Antonina/H-5654-2018; Menezes, Gui M./A-3956-2009; Gebruk, Andrey/A-9041-2016; Niedzielski, Tomasz/AAI-8985-2020; Letessier, Tom Bech/AAV-2759-2020; Jones, Daniel/A-3412-2009; Vicente, Victor Martinez/T-1207-2019; Gooday, Andrew/AAH-8991-2021; Horton, Tammy/G-3590-2010; Inall, Mark/I-4835-2014; Gooday, Andrew/ABB-4267-2020; Martinez-Vicente, Victor/F-5131-2010; Alt, Claudia/B-5439-2014; Miller, Peter I./E-4525-2013; Sutton, Tracey/AAW-7644-2021; Brierley, Andrew/G-8019-2011; Lorance, Pascal/F-4668-2011	Dale, Andrew C/0000-0002-9256-7770; Kremenetskaia, Antonina/0000-0001-8851-3318; Menezes, Gui M./0000-0003-0781-4579; Niedzielski, Tomasz/0000-0001-8236-9861; Letessier, Tom Bech/0000-0003-4011-0207; Jones, Daniel/0000-0001-5218-1649; Horton, Tammy/0000-0003-4250-1068; Inall, Mark/0000-0002-1624-4275; Gooday, Andrew/0000-0002-5661-7371; Martinez-Vicente, Victor/0000-0003-3492-583X; Miller, Peter I./0000-0002-5292-8789; Sutton, Tracey/0000-0002-5280-7071; Priede, Imants/0000-0002-5064-9751; Tilstone, Gavin/0000-0002-9347-1682; Craig, Jessica/0000-0003-3811-7362; Brierley, Andrew/0000-0002-6438-6892; Bergstad, Odd Aksel/0000-0002-4096-0896; Lorance, Pascal/0000-0002-6453-2925	UK Natural Environment Research Council [NE/C512961/1]; Census of Marine Life; NERC [NE/C512988/1, NE/C51297X/1, NE/C512996/1, pml010008, NE/C512961/1, NE/C51300X/1, NE/C513018/1, noc010009] Funding Source: UKRI; Natural Environment Research Council [NE/C512961/1, NE/C51300X/1, NE/C512988/1, pml010008, NE/C513018/1, NE/C51297X/1, noc010009, NE/C512996/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Census of Marine Life; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was funded by the UK Natural Environment Research Council (http://www.nerc.ac.uk/) consortium grant number NE/C512961/1 for a project entitled: ECOMAR; Ecosystem of the Mid Atlantic Ridge at the Sub-Polar Front and Charlie Gibbs Fracture Zone. Funding was also provided by the Census of Marine Life (http://www.coml.org/). Other than selecting the project for funding and approving the resources required, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL MV, 1990, PHILOS T R SOC A, V331, P15, DOI 10.1098/rsta.1990.0053; Bergstad OA, 2012, DEEP-SEA RES PT I, V61, P74, DOI 10.1016/j.dsr.2011.12.002; Craig J, 2011, J MARINE SYST, V88, P563, DOI 10.1016/j.jmarsys.2011.07.006; Doel RE, 2006, J HIST GEOGR, V32, P605, DOI 10.1016/j.jhg.2005.10.011; Flach E, 1996, MAR ECOL PROG SER, V141, P55, DOI 10.3354/meps141055; Ganachaud A, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001333; GEBCO, 2010, GEN BATH CHART OC GE; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P383, DOI 10.1017/S0025315499002088; German CR, 1998, EARTH PLANET SC LETT, V160, P327, DOI 10.1016/S0012-821X(98)00093-4; GIERE O, 2003, ENERGY MASS TRANSFER, P211; Gillibrand EJV, 2007, MAR ECOL PROG SER, V341, P37, DOI 10.3354/meps341037; Gooday AJ, 2013, MAR BIOL RE IN PRESS; GORDON JDM, 1992, J MAR BIOL ASSOC UK, V72, P213, DOI 10.1017/S002531540004889X; Hareide NR, 2001, FISH RES, V51, P297, DOI 10.1016/S0165-7836(01)00253-3; Heezen B. C., 1957, PHYSIOGRAPHIC DIAGRA; HEEZEN BC, 1969, TECTONOPHYSICS, V8, P269, DOI 10.1016/0040-1951(69)90037-7; Heger A, 2008, DEEP-SEA RES PT II, V55, P126, DOI 10.1016/j.dsr2.2007.09.014; HUBBS CARL L., 1959, PACIFIC SCI, V13, P311; Hughes DJ, 2004, PROG OCEANOGR, V63, P29, DOI 10.1016/j.pocean.2004.09.002; Knutsen H, 2012, MAR ECOL PROG SER, V460, P233, DOI 10.3354/meps09728; Koppelmann R, 1999, MAR ECOL PROG SER, V179, P27, DOI 10.3354/meps179027; Kukuev EI, 2004, ARCH FISH MAR RES, V51, P215; Lampitt RS, 2010, DEEP-SEA RES PT II, V57, P1346, DOI 10.1016/j.dsr2.2010.01.011; Lampitt RS, 2001, PROG OCEANOGR, V50, P27, DOI 10.1016/S0079-6611(01)00047-7; Miller P, 2009, J MARINE SYST, V78, P327, DOI 10.1016/j.jmarsys.2008.11.019; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; MOREL A, 1991, PROG OCEANOGR, V26, P263, DOI 10.1016/0079-6611(91)90004-6; Mortensen PB, 2008, DEEP-SEA RES PT II, V55, P142, DOI 10.1016/j.dsr2.2007.09.018; Murray J, 1912, DEPTHS OCEAN; O'Leary BC, 2012, MAR POLICY, V36, P598, DOI 10.1016/j.marpol.2011.11.003; Opdal AF, 2008, DEEP-SEA RES PT II, V55, P45, DOI 10.1016/j.dsr2.2007.09.002; OSPAR, 2008, OSPAR CONV PROT MAR; Pollard RT, 2009, NATURE, V457, P577, DOI 10.1038/nature07716; Priede IG, 2012, INVERTEBR BIOL, V131, P244, DOI 10.1111/j.1744-7410.2012.00266.x; Priede IG, 2010, MAR ECOL-EVOL PERSP, V31, P247, DOI 10.1111/j.1439-0485.2009.00330.x; Read JF, 2010, DEEP-SEA RES PT I, V57, P307, DOI 10.1016/j.dsr.2009.11.010; Rex M.A., 2010, BIOSCIENCE; ROE HSJ, 1988, HYDROBIOLOGIA, V167, P169, DOI 10.1007/BF00026303; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Smyth TJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002784; St Laurent LC, 2007, NATURE, V448, P680, DOI 10.1038/nature06043; Storch D, 2012, NATURE, V488, P78, DOI 10.1038/nature11226; Sutton TT, 2008, DEEP-SEA RES PT II, V55, P161, DOI 10.1016/j.dsr2.2007.09.013; Taylor JR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049312; Tilstone G, 2009, DEEP-SEA RES PT II, V56, P918, DOI 10.1016/j.dsr2.2008.10.034; UNESCO, 2009, IOC TECHN SER, V84; Van Dover CL, 2000, ECOLOGY HYDROTHERMAL; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wenneek TL, 2008, DEEP-SEA RES PT II, V55, P6, DOI 10.1016/j.dsr2.2007.09.017; White TA, 2011, HEREDITY, V106, P690, DOI 10.1038/hdy.2010.108; White TA, 2010, MOL ECOL, V19, P216, DOI 10.1111/j.1365-294X.2009.04446.x; Wolff GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020697	55	55	56	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61550	10.1371/journal.pone.0061550	http://dx.doi.org/10.1371/journal.pone.0061550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658696	Green Accepted, Green Published, gold			2022-12-27	WOS:000321200500009
J	George, J; Jenkins, NE; Blanford, S; Thomas, MB; Baker, TC				George, Justin; Jenkins, Nina E.; Blanford, Simon; Thomas, Matthew B.; Baker, Thomas C.			Malaria Mosquitoes Attracted by Fatal Fungus	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; METARHIZIUM-ANISOPLIAE; ENTOMOPATHOGENIC FUNGUS; BIOLOGICAL-CONTROL; ANOPHELES-GAMBIAE; CULEX-QUINQUEFASCIATUS; MICROBIAL CONTROL; CARBON-DIOXIDE; INFECTION; COLEOPTERA	Insect-killing fungi such as Beauveria bassiana are being evaluated as possible active ingredients for use in novel biopesticides against mosquito vectors that transmit malaria. Fungal pathogens infect through contact and so applications of spores to surfaces such as walls, nets, or other resting sites provide possible routes to infect mosquitoes in and around domestic dwellings. However, some insects can detect and actively avoid fungal spores to reduce infection risk. If true for mosquitoes, such behavior could render the biopesticide approach ineffective. Here we find that the spores of B. bassiana are highly attractive to females of Anopheles stephensi, a major anopheline mosquito vector of human malaria in Asia. We further find that An. stephensi females are preferentially attracted to dead and dying caterpillars infected with B. bassiana, landing on them and subsequently becoming infected with the fungus. Females are also preferentially attracted to cloth sprayed with oil-formulated B. bassiana spores, with 95% of the attracted females becoming infected after a one-minute visit on the cloth. This is the first report of an insect being attracted to a lethal fungal pathogen. The exact mechanisms involved in this behavior remain unclear. Nonetheless, our results indicate that biopesticidal formulations comprising B. bassiana spores will be conducive to attraction and on-source visitation by malaria vectors.	[George, Justin; Jenkins, Nina E.; Blanford, Simon; Thomas, Matthew B.; Baker, Thomas C.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Blanford, Simon; Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Baker, TC (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	tcb10@psu.edu			Pennsylvania State Agricultural Experiment Station; Pennsylvania State University	Pennsylvania State Agricultural Experiment Station; Pennsylvania State University	The Pennsylvania State Agricultural Experiment Station and Pennsylvania State University funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; [Anonymous], 2012, PLOS NEGLECT TROP D, DOI DOI 10.1371/journal.pntd.0001793; [Anonymous], 2004, J INSECT SCI; Arthurs S, 2001, ECOL ENTOMOL, V26, P227, DOI 10.1046/j.1365-2311.2001.00317.x; Barbarin AM, 2012, J INVERTEBR PATHOL, V111, P82, DOI 10.1016/j.jip.2012.04.009; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Blanford S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023591; Carruthers RI, 1997, MEM ENTOMOL SOC CAN, P329, DOI 10.4039/entm129171329-1; Cator LJ, 2012, TRENDS PARASITOL, V28, P466, DOI 10.1016/j.pt.2012.08.004; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Farenhorst M, 2008, AM J TROP MED HYG, V78, P910, DOI 10.4269/ajtmh.2008.78.910; Farenhorst M, 2011, J MED ENTOMOL, V48, P305, DOI 10.1603/ME10134; Fernandes EKK, 2011, VET PARASITOL, V182, P307, DOI 10.1016/j.vetpar.2011.05.046; George J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-219; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; HALL DR, 1984, INSECT SCI APPL, V5, P335, DOI 10.1017/S1742758400008626; HARRIS P, 1969, SCIENCE, V164, P184, DOI 10.1126/science.164.3876.184; Howard AFV, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-87; JENKINS NE, 1998, BIOCONTROL NEWS INFO, V19, P21; Jones WE, 1996, ENVIRON ENTOMOL, V25, P481, DOI 10.1093/ee/25.2.481; Lecuona RE, 2005, J MED ENTOMOL, V42, P332, DOI 10.1603/0022-2585(2005)042[0332:MCOMDD]2.0.CO;2; Liu HP, 2008, BIOCONTROL SCI TECHN, V18, P565, DOI 10.1080/09583150802085331; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Lynch PA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-383; Maehara N, 2007, J ECON ENTOMOL, V100, P49, DOI 10.1603/0022-0493(2007)100[49:MFATOB]2.0.CO;2; Maniania NK, 1998, BIOCONTROL, V43, P311, DOI 10.1023/A:1009939711555; Martel V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025658; Mburu DM, 2009, J INSECT PHYSIOL, V55, P774, DOI 10.1016/j.jinsphys.2009.04.015; Mburu DM, 2011, J EXP BIOL, V214, P956, DOI 10.1242/jeb.050419; Mnyone LL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-87; Muller GC, 2010, MED VET ENTOMOL, V24, P346, DOI 10.1111/j.1365-2915.2010.00876.x; Pedrini N, 2010, J ECON ENTOMOL, V103, P1094, DOI 10.1603/EC10072; Pedrini N, 2009, PLOS NEGLECT TROP D, V3, P1; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; Scholte EJ, 2006, J INVERTEBR PATHOL, V91, P43, DOI 10.1016/j.jip.2005.10.006; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Seyoum E, 2002, J APPL ENTOMOL, V126, P119, DOI 10.1046/j.1439-0418.2002.00609.x; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; WAAGE JK, 1979, BIOL J LINN SOC, V12, P187, DOI 10.1111/j.1095-8312.1979.tb00055.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1	44	28	30	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62632	10.1371/journal.pone.0062632	http://dx.doi.org/10.1371/journal.pone.0062632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658757	gold, Green Submitted, Green Published			2022-12-27	WOS:000319167000064
J	Delaney, NF; Kaczmarek, ME; Ward, LM; Swanson, PK; Lee, MC; Marx, CJ				Delaney, Nigel F.; Kaczmarek, Maria E.; Ward, Lewis M.; Swanson, Paige K.; Lee, Ming-Chun; Marx, Christopher J.			Development of an Optimized Medium, Strain and High-Throughput Culturing Methods for Methylobacterium extorquens	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS AM 1; MICROBIAL-GROWTH; C1 COMPOUNDS; MICROTITER PLATES; GENOME SEQUENCES; METHANOL; DEHYDROGENASE; ADAPTATION; OXIDATION	Methylobacterium extorquens strains are the best-studied methylotrophic model system, and their metabolism of single carbon compounds has been studied for over 50 years. Here we develop a new system for high-throughput batch culture of M. extorquens in microtiter plates by jointly optimizing the properties of the organism, the growth media and the culturing system. After removing cellulose synthase genes in M. extorquens strains AM1 and PA1 to prevent biofilm formation, we found that currently available lab automation equipment, integrated and managed by open source software, makes possible reliable estimates of the exponential growth rate. Using this system, we developed an optimized growth medium for M. extorquens using response surface methodologies. We found that media that used EDTA as a metal chelator inhibited growth and led to inconsistent culture conditions. In contrast, the new medium we developed with a PIPES buffer and metals chelated by citrate allowed for fast and more consistent growth rates. This new Methylobacterium PIPES ('MP') medium was also robust to large deviations in its component ingredients which avoided batch effects from experiments that used media prepared at different times. MP medium allows for faster and more consistent growth than other media used for M. extorquens.	[Delaney, Nigel F.; Kaczmarek, Maria E.; Ward, Lewis M.; Swanson, Paige K.; Lee, Ming-Chun; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Marx, Christopher J.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	cmarx@oeb.harvard.edu		Ward, Lewis/0000-0002-9290-2567	National Science Foundation (NSF); NSF CAREER grant [DEB-0845893]	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD))	NFD was supported by a National Science Foundation (NSF) graduate student fellowship and this research was funded by an NSF CAREER grant awarded to CJM (DEB-0845893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY C, 1964, BIOCHEM J, V92, P614, DOI 10.1042/bj0920614; Atlas RM., 2004, HDB MICROBIOLOGICAL; Blomberg A, 2011, CURR OPIN BIOTECH, V22, P94, DOI 10.1016/j.copbio.2010.10.013; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; BOX G.E.P., 2005, STAT EXPT DESIGN INN; CHAN HTC, 1992, FEMS MICROBIOL LETT, V96, P231, DOI 10.1111/j.1574-6968.1992.tb05422.x; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; CHOI J H, 1989, Korean Journal of Applied Microbiology and Bioengineering, V17, P392; Chou HH, 2012, CELL REP, V1, P133, DOI 10.1016/j.celrep.2011.12.003; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; DALES SL, 1995, BIOCHEM J, V312, P261, DOI 10.1042/bj3120261; Delaney NF, 2012, J LAB AUTOM; Dworkin M, 2006, PROKARYOTES HDB BIOL, P257; Hermann R, 2003, BIOTECHNOL BIOENG, V81, P178, DOI 10.1002/bit.10456; Kensy F, 2005, BIOTECHNOL BIOENG, V89, P698, DOI 10.1002/bit.20373; Kiefer P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007831; Kim P, 2003, WORLD J MICROB BIOT, V19, P357, DOI 10.1023/A:1023969629568; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Knief C, 2010, MICROB ECOL, V60, P440, DOI 10.1007/s00248-010-9725-3; LARGE PJ, 1961, BIOCHEM J, V81, P470, DOI 10.1042/bj0810470; Laukel M, 2003, EUR J BIOCHEM, V270, P325, DOI 10.1046/j.1432-1033.2003.03391.x; Lee MC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002651; Lee MC, 2009, EVOLUTION, V63, P2816, DOI 10.1111/j.1558-5646.2009.00757.x; Marx CJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-109; Marx CJ, 2012, J BACTERIOL, V194, P4746, DOI 10.1128/JB.01009-12; Marx Christopher J, 2008, BMC Res Notes, V1, P1, DOI 10.1186/1756-0500-1-1; Marx CJ, 2004, J BACTERIOL, V186, P2173, DOI 10.1128/JB.186.7.2173-2178.2004; Marx CJ, 2004, MICROBIOL-SGM, V150, P9, DOI 10.1099/mic.0.26587-0; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; Mokhtari-Hosseini ZB, 2009, BIORESOURCE TECHNOL, V100, P2436, DOI 10.1016/j.biortech.2008.11.024; Mokhtari-Hosseini ZB, 2009, IRAN J CHEM CHEM ENG, V28; Morel F. M. M., 1993, PRINCIPLES APPL AQUA; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Overmann J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P80, DOI 10.1007/0-387-30741-9_5; PEEL D, 1961, BIOCHEM J, V81, P465, DOI 10.1042/bj0810465; Peyraud R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-189; Schmidt S, 2010, THESIS ETH ZURICH; Skovran E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014091; SPARKES A, 2010, AUTOM EXP, P2; TSUCHIYA Y, 1980, EUR J APPL MICROBIOL, V9, P121, DOI 10.1007/BF00503507; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wu C. J., 2011, EXPT PLANNING ANAL O	46	72	76	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62957	10.1371/journal.pone.0062957	http://dx.doi.org/10.1371/journal.pone.0062957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646164	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300118
J	Phan, KD; Butler, SJ				Phan, Keith D.; Butler, Samantha J.			Bilaterally Symmetric Populations of Chicken dI1 (Commissural) Axons Cross the Floor Plate Independently of Each Other	PLOS ONE			English	Article							ROOF PLATE; GROWTH CONES; LIM KINASE; EXPRESSION PATTERNS; SONIC HEDGEHOG; CELL-ADHESION; BMP RECEPTOR; F-SPONDIN; NR-CAM; GUIDANCE	Axons use temporal and directional guidance cues at intermediate targets to set the rate and direction of growth towards their synaptic targets. Our recent studies have shown that disrupting the temporal guidance process, by unilaterally accelerating the rate at which spinal dI1 (commissural) axons grow, resulted in turning errors both in the ventral spinal cord and after crossing the floor plate. Here we investigate a mechanistic explanation for these defects: the accelerated dI1 axons arrive in the ventral spinal cord before necessary fasciculation cues from incoming dI1 axons from the opposite side of the spinal cord. The identification of such an interaction would support a model of selective fasciculation whereby the pioneering dI1 axons serve as guides for the processes of the bilaterally symmetrical population of dI1 neurons. To test this model, we first developed the ability to "double'' in ovo electroporate the embryonic chicken spinal cord to independently manipulate the rate of growth of the two bilateral populations of dI1 axons. Second, we examined the requirement for a putative bilateral interaction by unilaterally ablating the dI1 population in cultured explants of chicken embryonic spinal cord. Surprisingly, we find no evidence for a bilateral dI1 axon interaction, rather dI1 axons appear to project independently of each other.	[Phan, Keith D.; Butler, Samantha J.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Butler, SJ (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	butlersj@usc.edu			National Institutes of Health [NS 063999]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institutes of Health (NS 063999) to S.J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1984, DEV RAT SPINAL CORD; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Avraham O, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-21; Bak M, 2003, DEVELOPMENT, V130, P4999, DOI 10.1242/dev.00713; Bamburg JR, 2008, CURR BIOL, V18, pR273, DOI 10.1016/j.cub.2008.02.002; Bourikas D, 2005, NAT NEUROSCI, V8, P297, DOI 10.1038/nn1396; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Butler SJ, 2007, DEVELOPMENT, V134, P439, DOI 10.1242/dev.02762; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Endo M, 2003, J NEUROSCI, V23, P2527; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Hazen VM, 2012, DEV BIOL, V367, P216, DOI 10.1016/j.ydbio.2012.05.014; Hazen VM, 2011, DEV BIOL, V356, P566, DOI 10.1016/j.ydbio.2011.06.017; Hazen VM, 2010, J VIS EXP; Helms AW, 1998, DEVELOPMENT, V125, P919; Helms AW, 2000, DEVELOPMENT, V127, P1185; HOLLEY JA, 1982, J COMP NEUROL, V205, P360, DOI 10.1002/cne.902050405; HOLLEY JA, 1982, J COMP NEUROL, V205, P371, DOI 10.1002/cne.902050406; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Imondi R, 2001, DEVELOPMENT, V128, P4859; JACOBS JR, 1989, J NEUROSCI, V9, P2412; Kadison SR, 2006, J NEUROSCI, V26, P8909, DOI 10.1523/JNEUROSCI.1569-06.2006; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; KRUSHEL LA, 1993, NEUROSCIENCE, V53, P797, DOI 10.1016/0306-4522(93)90625-P; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Marsick BM, 2010, DEV NEUROBIOL, V70, P565, DOI 10.1002/dneu.20800; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; OPPENHEIM RW, 1988, J COMP NEUROL, V275, P159, DOI 10.1002/cne.902750202; Phan KD, 2010, J NEUROSCI, V30, P15430, DOI 10.1523/JNEUROSCI.4117-10.2010; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; RUEGG MA, 1989, EMBO J, V8, P55, DOI 10.1002/j.1460-2075.1989.tb03348.x; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Van Vactor D, 1998, CURR OPIN NEUROBIOL, V8, P80, DOI 10.1016/S0959-4388(98)80011-1; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wightman B, 1997, DEVELOPMENT, V124, P2571; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020; Yamauchi K, 2008, DEVELOPMENT, V135, P1119, DOI 10.1242/dev.012989; Yamauchi K, 2013, DEVELOPMENT, V140, P333, DOI 10.1242/dev.089524	53	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62977	10.1371/journal.pone.0062977	http://dx.doi.org/10.1371/journal.pone.0062977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646165	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300120
J	Wang, T; Huang, XL; Huang, PY; Li, D; Lv, FJ; Zhang, Y; Zhou, LK; Yang, DY; Xie, P				Wang, Tao; Huang, Xiaolan; Huang, Peiyu; Li, Dan; Lv, Fajin; Zhang, Yong; Zhou, Linke; Yang, Deyu; Xie, Peng			Early-Stage Psychotherapy Produces Elevated Frontal White Matter Integrity in Adult Major Depressive Disorder	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; NEURAL MECHANISMS; COGNITIVE MODEL; MOOD DISORDERS; BRAIN; DIFFUSION; THERAPY; ABNORMALITIES	Background: Psychotherapy has demonstrated comparable efficacy to antidepressant medication in the treatment of major depressive disorder. Metabolic alterations in the MDD state and in response to treatment have been detected by functional imaging methods, but the underlying white matter microstructural changes remain unknown. The goal of this study is to apply diffusion tensor imaging techniques to investigate psychotherapy-specific responses in the white matter. Methods: Twenty-one of forty-five outpatients diagnosed with major depression underwent diffusion tensor imaging before and after a four-week course of guided imagery psychotherapy. We compared fractional anisotropy in depressed patients (n = 21) with healthy controls (n = 22), and before-after treatment, using whole brain voxel-wise analysis. Results: Post-treatment, depressed subjects showed a significant reduction in the 17-item Hamilton Depression Rating Scale. As compared to healthy controls, depressed subjects demonstrated significantly increased fractional anisotropy in the right thalamus. Psychopathological changes did not recover post-treatment, but a novel region of increased fractional anisotropy was discovered in the frontal lobe. Conclusions: At an early stage of psychotherapy, higher fractional anisotropy was detected in the frontal emotional regulation-associated region. This finding reveals that psychotherapy may induce white matter changes in the frontal lobe. This remodeling of frontal connections within mood regulation networks positively contributes to the "top-down'' mechanism of psychotherapy.	[Wang, Tao; Huang, Xiaolan; Huang, Peiyu; Li, Dan; Lv, Fajin; Zhang, Yong; Zhou, Linke; Yang, Deyu; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Wang, Tao; Huang, Xiaolan; Huang, Peiyu; Li, Dan; Zhang, Yong; Zhou, Linke; Yang, Deyu; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Wang, Tao; Zhou, Linke; Yang, Deyu; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Lv, Fajin] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn			National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (973 Program, No: 2009CB918300) and the National Natural Science Foundation of China (Grant No. 31271189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; GOLD SR, 1982, J CLIN PSYCHOL, V38, P312, DOI 10.1002/1097-4679(198204)38:2<312::AID-JCLP2270380213>3.0.CO;2-2; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hamilton J. P, 2012, AM J PSYCHIAT; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; JARVINEN PJ, 1981, J CLIN PSYCHOL, V37, P523, DOI 10.1002/1097-4679(198107)37:3<523::AID-JCLP2270370314>3.0.CO;2-O; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kennedy SH, 2007, AM J PSYCHIAT, V164, P778, DOI 10.1176/appi.ajp.164.5.778; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim JH, 2010, NEUROIMAGE, V49, P2375, DOI 10.1016/j.neuroimage.2009.10.016; Kim SD, 2005, CANCER NURS, V28, P79, DOI 10.1097/00002820-200501000-00012; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lisiecka D, 2011, INT J NEUROPSYCHOPH, V14, P521, DOI 10.1017/S1461145710001513; Martin SD, 2001, ARCH GEN PSYCHIAT, V58, P641, DOI 10.1001/archpsyc.58.7.641; Matousek Rose H, 2010, Complement Ther Clin Pract, V16, P13, DOI 10.1016/j.ctcp.2009.06.004; Merali Z, 2004, J NEUROSCI, V24, P1478, DOI 10.1523/JNEUROSCI.4734-03.2004; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nobuhara K, 2004, NEUROPSYCHOBIOLOGY, V50, P48, DOI 10.1159/000077941; Oishi K., 2010, MRI ATLAS HUMAN WHIT; Parker G, 2001, AM J PSYCHIAT, V158, P857, DOI 10.1176/appi.ajp.158.6.857; Peng HJ, 2012, J AFFECT DISORDERS, V136, P249, DOI 10.1016/j.jad.2011.12.006; Pilkington K, 2005, J AFFECT DISORDERS, V89, P13, DOI 10.1016/j.jad.2005.08.013; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rubia K, 2009, BIOL PSYCHOL, V82, P1, DOI 10.1016/j.biopsycho.2009.04.003; Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001; Schultz D, 2003, IMAGE HUM D, P343; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Taylor WD, 2001, BIOL PSYCHIAT, V50, P179, DOI 10.1016/S0006-3223(01)01160-X; Thomas AJ, 2002, ANN NY ACAD SCI, V977, P333, DOI 10.1111/j.1749-6632.2002.tb04835.x; Thomason ME, 2011, ANNU REV CLIN PSYCHO, V7, P63, DOI 10.1146/annurev-clinpsy-032210-104507; van Dixhoorn J, 2005, EUR J CARDIOV PREV R, V12, P193, DOI 10.1097/00149831-200506000-00002; Watanabe Eri, 2005, BMC Complement Altern Med, V5, P21, DOI 10.1186/1472-6882-5-21; Young KA, 2004, AM J PSYCHIAT, V161, P1270, DOI 10.1176/appi.ajp.161.7.1270	56	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63081	10.1371/journal.pone.0063081	http://dx.doi.org/10.1371/journal.pone.0063081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646178	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300133
J	Lopez-Gomez, C; Pino-Angeles, A; Orpez-Zafra, T; Pinto-Medel, MJ; Oliver-Martos, B; Ortega-Pinazo, J; Arnaiz, C; Guijarro-Castro, C; Varade, J; Alvarez-Lafuente, R; Urcelay, E; Sanchez-Jimenez, F; Fernandez, O; Leyva, L				Lopez-Gomez, Carlos; Pino-Angeles, Almudena; Orpez-Zafra, Teresa; Jesus Pinto-Medel, Maria; Oliver-Martos, Begona; Ortega-Pinazo, Jesus; Arnaiz, Carlos; Guijarro-Castro, Cristina; Varade, Jezabel; Alvarez-Lafuente, Roberto; Urcelay, Elena; Sanchez-Jimenez, Francisca; Fernandez, Oscar; Leyva, Laura			Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients	PLOS ONE			English	Article							LIGAND TRAIL; PHARMACOGENOMIC ANALYSIS; APOPTOSIS; DEATH; SUSCEPTIBILITY; CANCER; CELLS; POLYMORPHISMS; EXPRESSION	TRAIL and TRAIL Receptor genes have been implicated in Multiple Sclerosis pathology as well as in the response to IFN beta therapy. The objective of our study was to evaluate the association of these genes in relation to the age at disease onset (AAO) and to the clinical response upon IFN beta treatment in Spanish MS patients. We carried out a candidate gene study of TRAIL, TRAILR-1, TRAILR-2, TRAILR-3 and TRAILR-4 genes. A total of 54 SNPs were analysed in 509 MS patients under IFN beta treatment, and an additional cohort of 226 MS patients was used to validate the results. Associations of rs1047275 in TRAILR-2 and rs7011559 in TRAILR-4 genes with AAO under an additive model did not withstand Bonferroni correction. In contrast, patients with the TRAILR-1 rs20576-CC genotype showed a better clinical response to IFN beta therapy compared with patients carrying the A-allele (recessive model: p = 8.88x10(-4), p(c) = 0.048, OR = 0.30). This SNP resulted in a non synonymous substitution of Glutamic acid to Alanine in position 228 (E228A), a change previously associated with susceptibility to different cancer types and risk of metastases, suggesting a lack of functionality of TRAILR-1. In order to unravel how this amino acid change in TRAILR-1 would affect to death signal, we performed a molecular modelling with both alleles. Neither TRAIL binding sites in the receptor nor the expression levels of TRAILR-1 in peripheral blood mononuclear cell subsets (monocytes, CD4+ and CD8+ T cells) were modified, suggesting that this SNP may be altering the death signal by some other mechanism. These findings show a role for TRAILR-1 gene variations in the clinical outcome of IFN beta therapy that might have relevance as a biomarker to predict the response to IFN beta in MS.	[Lopez-Gomez, Carlos; Orpez-Zafra, Teresa; Jesus Pinto-Medel, Maria; Oliver-Martos, Begona; Ortega-Pinazo, Jesus; Leyva, Laura] Hosp Reg Univ Carlos Haya, Clin Neurosci Inst, Res Lab, Malaga, Spain; [Pino-Angeles, Almudena; Sanchez-Jimenez, Francisca] Univ Malaga, Dept Mol Biol & Biochem, E-29071 Malaga, Spain; [Arnaiz, Carlos; Fernandez, Oscar] Hosp Reg Univ Carlos Haya, Clin Neurosci Inst, Dept Neurol, Malaga, Spain; [Guijarro-Castro, Cristina] Hosp Univ 12 Octubre, Dept Neurol, Madrid, Spain; [Varade, Jezabel; Alvarez-Lafuente, Roberto; Urcelay, Elena] Hosp Clin San Carlos, IdISSC, Multiple Sclerosis Unit, Madrid, Spain; [Pino-Angeles, Almudena; Sanchez-Jimenez, Francisca] CIBERER, Malaga, Spain; [Orpez-Zafra, Teresa; Jesus Pinto-Medel, Maria; Oliver-Martos, Begona; Guijarro-Castro, Cristina; Varade, Jezabel; Alvarez-Lafuente, Roberto; Urcelay, Elena; Fernandez, Oscar; Leyva, Laura] Red Espanola Esclerosis Multiple REEM RD 07 0060, Malaga, Spain	Hospital Carlos Haya; Universidad de Malaga; Hospital Carlos Haya; Hospital Universitario 12 de Octubre; Hospital Clinico San Carlos; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Leyva, L (corresponding author), Hosp Reg Univ Carlos Haya, Clin Neurosci Inst, Res Lab, Malaga, Spain.	leyvafer@gmail.com	varade, jezabel/B-2771-2017; Leyva, Laura/R-2187-2019; Alvarez-Lafuente, Roberto/AAJ-9980-2020; Jiménez, Francisca María Sánchez/H-2513-2015; Varadé, Jezabel/Z-5054-2019; Pino-Angeles, Almudena/L-4975-2014; López-Gómez, Carlos/C-8938-2009; Oliver-Martos, Begoña/U-5444-2019; Leyva, Laura/B-5574-2019	varade, jezabel/0000-0002-3964-110X; Leyva, Laura/0000-0003-0620-9625; Jiménez, Francisca María Sánchez/0000-0002-4958-6060; Varadé, Jezabel/0000-0002-3964-110X; Pino-Angeles, Almudena/0000-0002-8845-8686; López-Gómez, Carlos/0000-0003-2699-451X; Leyva, Laura/0000-0003-0620-9625; Alvarez-Lafuente, Roberto/0000-0002-3132-1486; Urcelay, Elena/0000-0001-8470-8396; Ortega-Pinazo, Jesus/0000-0002-2884-9239; Pinto Medel, Maria Jesus/0000-0002-1129-7415	Fondo de Investigacion Sanitaria & Fondo Europeo de Desarrollo Regional [PS09/01764]; Consejeria de Salud de la Junta de Andalucia [SAS07/0231]; Consejeria de Innovacion [P07-CTS-03223]	Fondo de Investigacion Sanitaria & Fondo Europeo de Desarrollo Regional; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Consejeria de Innovacion	The authors acknowledge the support from Fondo de Investigacion Sanitaria & Fondo Europeo de Desarrollo Regional (PS09/01764) and Consejeria de Salud de la Junta de Andalucia (SAS07/0231) to L. L., and from Consejeria de Innovacion (P07-CTS-03223) to OF. The authors would like to thank Biogen Idec Iberia S. L. for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2007, FRONT BIOSCI-LANDMRK, V12, P2912, DOI 10.2741/2281; Arbour N, 2005, MULT SCLER J, V11, P652, DOI 10.1191/1352458505ms1222oa; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barblu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032874; Byun E, 2008, ARCH NEUROL-CHICAGO, V65, P337, DOI 10.1001/archneurol.2008.47; Chen B, 2009, EUR J CANCER, V45, P2598, DOI 10.1016/j.ejca.2009.06.023; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Comabella M, 2009, ARCH NEUROL-CHICAGO, V66, P972, DOI 10.1001/archneurol.2009.150; Cunningham S, 2005, CLIN PHARMACOL THER, V78, P635, DOI 10.1016/j.clpt.2005.08.018; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doggrell SA, 2010, EXPERT OPIN PHARMACO, V11, P1225, DOI 10.1517/14656561003677390; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fernandez O, 2005, ACTA NEUROL SCAND, V112, P391, DOI 10.1111/j.1600-0404.2005.00415.x; Fernandez O, 2003, ACTA NEUROL SCAND, V107, P7, DOI 10.1034/j.1600-0404.2003.01350.x; Frank B, 2005, CARCINOGENESIS, V26, P1975, DOI 10.1093/carcin/bgi164; Frank B, 2006, CANCER EPIDEM BIOMAR, V15, P2002, DOI 10.1158/1055-9965.EPI-06-0053; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hebb A.L., 2010, AUTOIMMUNE DIS, V2011; Ikeda T, 2010, J IMMUNOL, V185, P5259, DOI 10.4049/jimmunol.0902797; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kawade Y, 2003, J IMMUNOL METHODS, V278, P127, DOI 10.1016/S0022-1759(03)00203-5; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kikuchi S, 2005, J NEUROIMMUNOL, V167, P170, DOI 10.1016/j.jneuroim.2005.06.021; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Langsenlehner T, 2008, PROSTATE, V68, P264, DOI 10.1002/pros.20682; Leyva L, 2005, J NEUROIMMUNOL, V163, P165, DOI 10.1016/j.jneuroim.2005.02.010; Lopez-Gomez G, 2011, PLOS ONE, V6; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; Matysiak M, 2002, BRAIN, V125, P2469, DOI 10.1093/brain/awf254; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McKeage K, 2008, CNS DRUGS, V22, P787, DOI 10.2165/00023210-200822090-00005; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Doherty C, 2009, PHARMACOGENOMICS, V10, P1177, DOI [10.2217/pgs.09.41, 10.2217/PGS.09.41]; Oliver B, 2009, J IMMUNOL METHODS, V351, P41, DOI 10.1016/j.jim.2009.09.005; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Sriram U, 2003, GENES IMMUN, V4, P147, DOI 10.1038/sj.gene.6363946; Valley CC, 2012, J BIOL CHEM, V287, P21265, DOI 10.1074/jbc.M111.306480; Van Weyenbergh J, 2001, J LEUKOCYTE BIOL, V70, P745; Villoslada P, 2002, J NEUROIMMUNOL, V130, P194, DOI 10.1016/S0165-5728(02)00215-1; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Weinstock-Guttman B, 2007, J NEUROIMMUNOL, V182, P236, DOI 10.1016/j.jneuroim.2006.10.011; Wergeland S, 2005, EUR J NEUROL, V12, P171, DOI 10.1111/j.1468-1331.2004.01102.x; WHO Expert Committee on Biological Standardization, 1985, WHO TECH REP SER, V725, P1; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wolf S, 2006, INT J CANCER, V118, P1831, DOI 10.1002/ijc.21502; Zula JA, 2011, P NATL ACAD SCI USA, V108, P19689, DOI 10.1073/pnas.1117347108	51	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62540	10.1371/journal.pone.0062540	http://dx.doi.org/10.1371/journal.pone.0062540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658636	Green Published, gold, Green Submitted			2022-12-27	WOS:000321662800050
J	Wang, E; Chong, K; Yu, M; Akhoundsadegh, N; Granville, DJ; Shapiro, J; McElwee, KJ				Wang, Eddy; Chong, Katy; Yu, Mei; Akhoundsadegh, Noushin; Granville, David J.; Shapiro, Jerry; McElwee, Kevin J.			Development of Autoimmune Hair Loss Disease Alopecia Areata Is Associated with Cardiac Dysfunction in C3H/HeJ Mice	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ADRENOCORTICOTROPIC HORMONE; ANDROGENETIC ALOPECIA; INTERLEUKIN (IL)-18; TROPONIN-I; HPA AXIS; EXPRESSION; IL-18; STRESS; GENE	Alopecia areata (AA) is a chronic autoimmune hair loss disease that affects several million men, women and children worldwide. Previous studies have suggested a link between autoimmunity, stress hormones, and increased cardiovascular disease risk. In the current study, histology, immunohistology, quantitative PCR (qPCR) and ELISAs were used to assess heart health in the C3H/HeJ mouse model for AA and heart tissue response to adrenocorticotropic hormone (ACTH) exposure. Mice with AA exhibited both atrial and ventricular hypertrophy, and increased collagen deposition compared to normal-haired littermates. QPCR revealed significant increases in Il18 (4.6-fold), IL18 receptor-1 (Il18r1; 2.8-fold) and IL18 binding protein (Il18bp; 5.2-fold) in AA hearts. Time course studies revealed a trend towards decreased Il18 in acute AA compared to controls while Il18r1, Il18bp and Casp1 showed similar trends to those of chronic AA affected mice. Immunohistochemistry showed localization of IL18 in chronic AA mouse atria. ELISA indicated cardiac troponin-I (cTnI) was elevated in the serum and significantly increased in AA heart tissue. Cultures of heart atria revealed differential gene expression between AA and control mice in response to ACTH. ACTH treatment induced significant increase in cTnI release into the culture medium in a dose-dependent manner for both AA and control mice. In conclusion, murine AA is associated with structural, biochemical, and gene expression changes consistent with cardiac hypertrophy in response to ACTH exposure.	[Wang, Eddy; Yu, Mei; Akhoundsadegh, Noushin; McElwee, Kevin J.] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Chong, Katy] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Granville, David J.] Univ British Columbia, Dept Pathol & Lab Med, James Hogg Res Ctr, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada; [Shapiro, Jerry] Vancouver Gen Hosp, Dept Dermatol & Skin Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	McElwee, KJ (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	kmcelwee@interchange.ubc.ca	Wang, Eddy Hsi Chun/AAD-2759-2019	Wang, Eddy Hsi Chun/0000-0001-7785-1442; McElwee, Kevin/0000-0003-1020-3832	Canadian Dermatology Foundation (CDF); Canadian Institutes of Health Research (CIHR) [MOP-82927]	Canadian Dermatology Foundation (CDF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Dermatology Foundation (CDF) and the Canadian Institutes of Health Research (CIHR; MOP-82927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JE, 1993, CIRCULATION, V88, P101, DOI 10.1161/01.CIR.88.1.101; Aherrahrou Z, 2004, AM J PATHOL, V164, P1379, DOI 10.1016/S0002-9440(10)63224-5; Ahouansou S, 2007, EUR J DERMATOL, V17, P220; Alikhan A, 2011, J AM ACAD DERMATOL, V65, P473, DOI 10.1016/j.jaad.2010.11.061; Alkhalifah A, 2010, J AM ACAD DERMATOL, V62, P177, DOI 10.1016/j.jaad.2009.10.032; Arias-Santiago S, 2010, BRIT J DERMATOL, V162, P786, DOI 10.1111/j.1365-2133.2009.09588.x; Arias-Santiago S, 2010, J AM ACAD DERMATOL, V63, P420, DOI 10.1016/j.jaad.2009.10.018; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Baran W, 2008, BIOMARKERS, V13, P52, DOI 10.1080/13547500701610273; Bauml MA, 2010, CLEV CLIN J MED, V77, P381, DOI 10.3949/ccjm.77a.09158; Biernacka A, 2011, AGING DIS, V2, P158; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Brade T, 2011, DEVELOPMENT, V138, P139, DOI 10.1242/dev.054239; Caulfield J B, 1997, Technol Health Care, V5, P95; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Chang AN, 2008, BIOCHEM BIOPH RES CO, V369, P74, DOI 10.1016/j.bbrc.2007.12.081; Chu SY, 2012, BRIT J DERMATOL, V166, P525, DOI 10.1111/j.1365-2133.2011.10714.x; Chu SY, 2011, J AM ACAD DERMATOL; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dinarello CA, 2001, ANN RHEUM DIS, V60, pIII18; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; dos Santos JC, 2008, INT IMMUNOPHARMACOL, V8, P1433, DOI 10.1016/j.intimp.2008.05.016; Duprez D, 1999, J HYPERTENS, V17, P1583, DOI 10.1097/00004872-199917110-00012; Eliakim-Raz N, 2008, CARDIOLOGY, V111, P202, DOI 10.1159/000121605; Evans JF, 2012, MOL CELL ENDOCRINOL, V355, P60, DOI 10.1016/j.mce.2012.01.019; Evers AWM, 2010, BRIT J DERMATOL, V163, P986, DOI 10.1111/j.1365-2133.2010.09984.x; Fix C, 2011, CYTOKINE, V53, P19, DOI 10.1016/j.cyto.2010.10.002; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Guo HW, 2011, MED HYPOTHESES, V76, P122, DOI 10.1016/j.mehy.2010.08.048; Guo HW, 2010, EXP DERMATOL, V19, P1020, DOI 10.1111/j.1600-0625.2010.01125.x; Gutersohn T, 2005, DERMATOLOGY, V211, P72, DOI 10.1159/000085583; Hirobe T, 2000, J EXP ZOOL, V286, P632, DOI 10.1002/(SICI)1097-010X(20000501)286:6<632::AID-JEZ10>3.0.CO;2-4; HOLZINGER C, 1995, CIRCULATION, V92, P2876, DOI 10.1161/01.CIR.92.10.2876; Isales CM, 2010, ANN NY ACAD SCI, V1192, P110, DOI 10.1111/j.1749-6632.2009.05231.x; ITO H, 1993, CIRCULATION, V87, P1715, DOI 10.1161/01.CIR.87.5.1715; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Ivandic BT, 1996, P NATL ACAD SCI USA, V93, P5483, DOI 10.1073/pnas.93.11.5483; Jefferis BJMH, 2011, ATHEROSCLEROSIS, V217, P227, DOI 10.1016/j.atherosclerosis.2011.03.015; Johansen C, 2007, J INVEST DERMATOL, V127, P2857, DOI 10.1038/sj.jid.5700922; Jokinen J, 2009, J AFFECT DISORDERS, V116, P88, DOI 10.1016/j.jad.2008.10.025; Kahai S, 2004, MATRIX BIOL, V23, P445, DOI 10.1016/j.matbio.2004.09.004; Kasumagic-Halilovic E, 2008, ACTA DERMATOVENER CR, V16, P123; LANG D, 1984, EUR J PEDIATR, V142, P121, DOI 10.1007/BF00445591; Lee D, 2010, EXP DERMATOL, V19, P145, DOI 10.1111/j.1600-0625.2009.00937.x; Leite SN, 2011, AN BRAS DERMATOL, V86, P681, DOI 10.1590/S0365-05962011000400009; Liao CH, 2010, J CLIN INVEST, V120, P242, DOI 10.1172/JCI39942; Lim W, 2006, AM J CRIT CARE, V15, P280; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorell BH, 2000, CIRCULATION, V102, P470; Luan Y, 2010, EUROPACE, V12, P1713, DOI 10.1093/europace/euq321; MADRI JA, 1988, AM J PATHOL, V132, P18; Mallat Z, 2004, FASEB J, V18, P1752, DOI 10.1096/fj.04-2426fje; Manolache L, 2007, J EUR ACAD DERMATOL, V21, P921, DOI 10.1111/j.1468-3083.2006.02106.x; McElwee KJ, 1998, J INVEST DERMATOL, V111, P797, DOI 10.1046/j.1523-1747.1998.00380.x; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Miller WL, 2007, CIRCULATION, V116, P249, DOI 10.1161/CIRCULATIONAHA.107.694562; Mizuno Y, 2005, J HYPERTENS, V23, P411, DOI 10.1097/00004872-200502000-00024; Mustonen E, 2008, BIOCHEM BIOPH RES CO, V373, P186, DOI 10.1016/j.bbrc.2008.05.164; Naito Y, 2002, HEART, V88, P296, DOI 10.1136/heart.88.3.296; Nellessen U, 2006, CLIN CARDIOL, V29, P219, DOI 10.1002/clc.4960290510; O'Shaughnessy PJ, 2003, ENDOCRINOLOGY, V144, P3279, DOI 10.1210/en.2003-0277; Oiso N, 2011, DERMAT RES PRACT, V2011, DOI 10.1155/2011/518090; Otis M, 2007, J ENDOCRINOL, V193, P331, DOI 10.1677/JOE-07-0055; Pala M, 1998, Cardiologia, V43, P1375; Park HJ, 2007, J INVEST DERMATOL, V127, P1210, DOI 10.1038/sj.jid.5700703; Park JB, 2002, AM J HYPERTENS, V15, P164, DOI 10.1016/S0895-7061(01)02291-9; Petukhova L, 2011, DERMATOL THER, V24, P326, DOI 10.1111/j.1529-8019.2011.01411.x; Platis A, 2008, PERFUSION-UK, V23, P237, DOI 10.1177/0267659108101511; Porrello ER, 2008, CLIN EXP PHARMACOL P, V35, P1358, DOI 10.1111/j.1440-1681.2008.05036.x; Potier M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1237, DOI 10.1152/ajpendo.00451.2002; Ro Byung In, 1995, Journal of Dermatology (Tokyo), V22, P858; Rummery NM, 2002, J HYPERTENS, V20, P247, DOI 10.1097/00004872-200202000-00014; Searle J, 2011, MINERVA CARDIOANGIOL, V59, P203; Sekiyama A, 2005, IMMUNITY, V22, P669, DOI 10.1016/j.immuni.2005.04.006; Sekiyama Atsuo, 2005, J Med Invest, V52 Suppl, P236, DOI 10.2152/jmi.52.236; Sharma S, 2004, J CLIN PATHOL, V57, P1025, DOI 10.1136/jcp.2003.015420; Sharma VK, 1996, INT J DERMATOL, V35, P22, DOI 10.1111/j.1365-4362.1996.tb01610.x; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Stojanovich L, 2008, AUTOIMMUN REV, V7, P209, DOI 10.1016/j.autrev.2007.11.007; Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002; Van Kerckhoven R, 2000, CARDIOVASC RES, V46, P316, DOI 10.1016/S0008-6363(99)00427-7; Vena GA, 2010, DERMATOL THER, V23, P144, DOI 10.1111/j.1529-8019.2010.01308.x; Vogelzangs N, 2010, J CLIN ENDOCR METAB, V95, P4959, DOI 10.1210/jc.2010-0192; Walsh D, 1913, BRIT MED J, V1913, P1007; Wang E, 2011, DERMATOL THER, V24, P337, DOI 10.1111/j.1529-8019.2011.01416.x; Wang MJ, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e318160f215; Wang Shu-fei, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P237; WEN XI, 1985, CANCER RES, V45, P3974; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Woldbaek PR, 2005, AM J PHYSIOL-HEART C, V289, pH708, DOI 10.1152/ajpheart.01179.2004; Xiang Y, 1999, P NATL ACAD SCI USA, V96, P11537, DOI 10.1073/pnas.96.20.11537; Yu M, 2008, J INVEST DERMATOL, V128, P1797, DOI 10.1038/sj.jid.5701243; Zhang XQ, 2009, J INVEST DERMATOL, V129, P1527, DOI 10.1038/jid.2008.371	94	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62935	10.1371/journal.pone.0062935	http://dx.doi.org/10.1371/journal.pone.0062935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658656	gold, Green Submitted, Green Published			2022-12-27	WOS:000318343700080
J	Echeverry-Galvis, MA; Hau, M				Echeverry-Galvis, Maria Angela; Hau, Michaela			Flight Performance and Feather Quality: Paying the Price of Overlapping Moult and Breeding in a Tropical Highland Bird	PLOS ONE			English	Article							CURRENT REPRODUCTIVE EFFORT; EUROPEAN STARLINGS; PIED FLYCATCHERS; BODY CONDITION; TRADE-OFF; ENERGY-EXPENDITURE; MIGRATORY BEHAVIOR; PREDATION RISK; TAKE-OFF; MASS	A temporal separation of energetically costly life history events like reproduction and maintenance of the integumentary system is thought to be promoted by selection to avoid trade-offs and maximize fitness. It has therefore remained somewhat of a paradox that certain vertebrate species can undergo both events simultaneously. Identifying potential costs of overlapping two demanding life history stages will further our understanding of the selection pressures that shape the temporal regulation of life history events in vertebrates. We studied free-living tropical Slaty brush-finches (Atlapetes schistaceus), in which individuals spontaneously overlap reproduction and moult or undergo both events in separation. To assess possible costs of such an overlap we quantified feather quality and flight performance of individuals in different states. We determined individual's life history state by measuring gonad size and scoring moult stage, and collected a newly grown 7 th primary wing feather for later analysis of feather quality. Finally, we quantified flight performance for each individual in the wild. Overlapping individuals produced lighter and shorter wing feathers than individuals just moulting, with females decreasing feather quality more strongly during the overlap than males. Moreover, overlapping individuals had a reduced flight speed during escape flights, while their foraging flight speed was unaffected. Despite overlappers being larger and having a smaller wing area, their lower body mass resulted in a similar wing load as in breeders or moulters. Individuals measured repeatedly in different states also showed significant decreases in feather quality and escape flight speed during the overlap. Reduced escape flight speed may represent a major consequence of the overlap by increasing predation risk. Our data document costs to undergoing two life history stages simultaneously, which likely arise from energetic trade-offs. Impairments in individual quality and performance may represent important factors that select for temporal separation of life history stages in other species.	[Echeverry-Galvis, Maria Angela] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Hau, Michaela] Max Planck Inst Ornithol, Evolutionary Physiol Grp, Radolfzell am Bodensee, Germany; [Hau, Michaela] Univ Konstanz, Dept Biol, Constance, Germany	Princeton University; Max Planck Society; University of Konstanz	Echeverry-Galvis, MA (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	mechever@princeton.edu		Echeverry-Galvis, Maria Angela/0000-0002-5273-8694	Princeton University Program for Latin America Studies and of Ecology and Department of Evolutionary Biology; Max Planck Society	Princeton University Program for Latin America Studies and of Ecology and Department of Evolutionary Biology; Max Planck Society(Max Planck SocietyFoundation CELLEX)	MAEG thanks Princeton University Program for Latin America Studies and of Ecology and Department of Evolutionary Biology for funding, and Pontificia Universidad Javeriana-Bogota for logistical aid. MH acknowledges funding by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; ANKNEY CD, 1980, AUK, V97, P684; Barta Z, 2008, PHILOS T R SOC B, V363, P211, DOI 10.1098/rstb.2007.2136; BENSCH S, 1993, CONDOR, V95, P305, DOI 10.2307/1369353; Bowlin MS, 2007, AUK, V124, P1388, DOI 10.1642/0004-8038(2007)124[1388:SWSAWP]2.0.CO;2; BUTLER LK, 2006, CONDOR, V108, P647, DOI DOI 10.1650/0010-5422(2006)108[647:PMAMMI]2.0.CO;2; Butler LK, 2008, J AVIAN BIOL, V39, P629, DOI 10.1111/j.1600-048X.2008.04432.x; Butler MW, 2010, PHYSIOL BIOCHEM ZOOL, V83, P78, DOI 10.1086/648483; Cleasby Ian R., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-431; Cooper WE, 2011, ACTA HERPETOL, V6, P247; Cooper WE, 2010, REV BIOL TROP, V58, P1199; Corning WR, 1998, J EXP BIOL, V201, P3057; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2003, IBIS, V145, pE69, DOI 10.1046/j.1474-919X.2003.00161.x; de la Hera I, 2010, J AVIAN BIOL, V41, P609, DOI 10.1111/j.1600-048X.2010.05075.x; de la Hera I, 2010, AUK, V127, P647, DOI 10.1525/auk.2010.09120; de la Hera I, 2010, J AVIAN BIOL, V41, P342, DOI 10.1111/j.1600-048X.2009.04835.x; de la Hera I, 2009, J AVIAN BIOL, V40, P461, DOI 10.1111/j.1600-048X.2008.04689.x; de la Hera I, 2009, BIOL J LINN SOC, V97, P98, DOI 10.1111/j.1095-8312.2008.01189.x; DesRochers DW, 2009, COMP BIOCHEM PHYS A, V152, P46, DOI 10.1016/j.cbpa.2008.08.034; Echeverry-Galvis MA, 2008, B B O C, V126, P291; Echeverry-Galvis MA, 2012, J EXP BIOL, V215, P1957, DOI 10.1242/jeb.065474; Echeverry-Galvis MA, 2008, ORNITOL NEOTROP, V19, P197; Fernandez-Juricic E, 2006, EVOL ECOL RES, V8, P731; FOSTER MS, 1975, CONDOR, V77, P304, DOI 10.2307/1366226; FOSTER MS, 1974, EVOLUTION, V28, P182, DOI 10.1111/j.1558-5646.1974.tb00739.x; Gardner JL, 2008, EMU, V108, P90, DOI 10.1071/MU06058; Garlich-Miller J., 2011, STATUS REV PACIFIC W; Ginn HB, 1995, MOULT BIRDS; Hau M, 1998, P ROY SOC B-BIOL SCI, V265, P89, DOI 10.1098/rspb.1998.0268; Hedenstrom A, 2003, J AVIAN BIOL, V34, P324, DOI 10.1111/j.0908-8857.2003.03324.x; Hemborg C, 1999, IBIS, V141, P226, DOI 10.1111/j.1474-919X.1999.tb07545.x; Hemborg C, 1999, J ANIM ECOL, V68, P429, DOI 10.1046/j.1365-2656.1999.00295.x; Higginson AD, 2012, AM NAT, V179, P338, DOI 10.1086/664457; Jenni L., 1994, BIOL MOULT BIRDS; Johnson EI, 2012, J AVIAN BIOL, V43, P141, DOI 10.1111/j.1600-048X.2011.05574.x; Jovani R, 2004, J EVOLUTION BIOL, V17, P294, DOI 10.1111/j.1420-9101.2003.00680.x; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Li CW, 2011, APPL ANIM BEHAV SCI, V129, P146, DOI 10.1016/j.applanim.2010.11.013; Lind J, 2001, P ROY SOC B-BIOL SCI, V268, P1915, DOI 10.1098/rspb.2001.1740; Lind J, 2001, FUNCT ECOL, V15, P29; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; Miller DA, 2011, J AVIAN BIOL, V42, P151, DOI 10.1111/j.1600-048X.2010.05124.x; Moreno J, 2001, OECOLOGIA, V129, P492, DOI 10.1007/s004420100767; Moya-Larano J, 2008, J ANIM ECOL, V77, P1099, DOI 10.1111/j.1365-2656.2008.01433.x; Murphy MT, 2007, AUK, V124, P1010, DOI 10.1642/0004-8038(2007)124[1010:LRSOFE]2.0.CO;2; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Norberg UML, 2002, J MORPHOL, V252, P52, DOI 10.1002/jmor.10013; O'Dwyer TW, 2006, FUNCT ECOL, V20, P806, DOI 10.1111/j.1365-2435.2006.01168.x; Olson KA, 2010, J ARID ENVIRON, V74, P1435, DOI 10.1016/j.jaridenv.2010.05.022; Park KJ, 2001, J EXP BIOL, V204, P2741; Payne R, 1972, MECH CONTROL MOLT, V2, P103; PAYNE RB, 1969, CONDOR, V71, P140, DOI 10.2307/1366075; PAYNTER R A JR, 1972, Bulletin of the Museum of Comparative Zoology, V143, P297; Portugal SJ, 2007, J EXP BIOL, V210, P1391, DOI 10.1242/jeb.004598; Ricklefs RE, 2013, J ORNITHOL, V154, P145, DOI 10.1007/s10336-012-0880-9; Ricklefs RE, 2011, J ORNITHOL, V152, P481, DOI 10.1007/s10336-010-0614-9; Ricklefs T.E., 1974, Publications Nuttall Orn Club, VNo. 15, P152; Rohwer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000132; Schaub M, 2009, J ANIM ECOL, V78, P625, DOI 10.1111/j.1365-2656.2008.01508.x; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Senar JC, 2002, BEHAV ECOL, V13, P725, DOI 10.1093/beheco/13.6.725; Spencer KA, 2010, BEHAV ECOL, V21, P999, DOI 10.1093/beheco/arq090; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Strochlic DE, 2008, COMP BIOCHEM PHYS A, V149, P68, DOI 10.1016/j.cbpa.2007.10.011; Swaddle JP, 1998, J AVIAN BIOL, V29, P172, DOI 10.2307/3677195; Swaddle JP, 1997, CAN J ZOOL, V75, P948, DOI 10.1139/z97-114; Swaddle JP, 1999, J AVIAN BIOL, V30, P351, DOI 10.2307/3677007; Verea C, 2009, ORNITOL NEOTROP, V20, P181; WEBSTER W. D., 1986, OCCASIONAL PAPERS MU, V100, P1; Wiersma P, 2005, J EXP BIOL, V208, P4091, DOI 10.1242/jeb.01854; Williams EV, 2003, J AVIAN BIOL, V34, P371, DOI 10.1111/j.0908-8857.2003.02964.x; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149; Wingfield JC, 2008, PHILOS T R SOC B, V363, P1581, DOI 10.1098/rstb.2007.0012; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	77	39	39	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61106	10.1371/journal.pone.0061106	http://dx.doi.org/10.1371/journal.pone.0061106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667431	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600007
J	Keith, DA; Rodriguez, JP; Rodriguez-Clark, KM; Nicholson, E; Aapala, K; Alonso, A; Asmussen, M; Bachman, S; Basset, A; Barrow, EG; Benson, JS; Bishop, MJ; Bonifacio, R; Brooks, TM; Burgman, MA; Comer, P; Comin, FA; Essl, F; Faber-Langendoen, D; Fairweather, PG; Holdaway, RJ; Jennings, M; Kingsford, RT; Lester, RE; Mac Nally, R; McCarthy, MA; Moat, J; Oliveira-Miranda, MA; Pisanu, P; Poulin, B; Regan, TJ; Riecken, U; Spalding, MD; Zambrano-Martinez, S				Keith, David A.; Rodriguez, Jon Paul; Rodriguez-Clark, Kathryn M.; Nicholson, Emily; Aapala, Kaisu; Alonso, Alfonso; Asmussen, Marianne; Bachman, Steven; Basset, Alberto; Barrow, Edmund G.; Benson, John S.; Bishop, Melanie J.; Bonifacio, Ronald; Brooks, Thomas M.; Burgman, Mark A.; Comer, Patrick; Comin, Francisco A.; Essl, Franz; Faber-Langendoen, Don; Fairweather, Peter G.; Holdaway, Robert J.; Jennings, Michael; Kingsford, Richard T.; Lester, Rebecca E.; Mac Nally, Ralph; McCarthy, Michael A.; Moat, Justin; Oliveira-Miranda, Maria A.; Pisanu, Phil; Poulin, Brigitte; Regan, Tracey J.; Riecken, Uwe; Spalding, Mark D.; Zambrano-Martinez, Sergio			Scientific Foundations for an IUCN Red List of Ecosystems	PLOS ONE			English	Article							EXTINCTION RISK; RELATIVE RESILIENCE; BIODIVERSITY LOSS; GLOBAL SYNTHESIS; PLANT DIVERSITY; FUNCTIONAL-ROLE; CLIMATE-CHANGE; THREAT STATUS; CORAL-REEFS; CONSERVATION	An understanding of risks to biodiversity is needed for planning action to slow current rates of decline and secure ecosystem services for future human use. Although the IUCN Red List criteria provide an effective assessment protocol for species, a standard global assessment of risks to higher levels of biodiversity is currently limited. In 2008, IUCN initiated development of risk assessment criteria to support a global Red List of ecosystems. We present a new conceptual model for ecosystem risk assessment founded on a synthesis of relevant ecological theories. To support the model, we review key elements of ecosystem definition and introduce the concept of ecosystem collapse, an analogue of species extinction. The model identifies four distributional and functional symptoms of ecosystem risk as a basis for assessment criteria: A) rates of decline in ecosystem distribution; B) restricted distributions with continuing declines or threats; C) rates of environmental (abiotic) degradation; and D) rates of disruption to biotic processes. A fifth criterion, E) quantitative estimates of the risk of ecosystem collapse, enables integrated assessment of multiple processes and provides a conceptual anchor for the other criteria. We present the theoretical rationale for the construction and interpretation of each criterion. The assessment protocol and threat categories mirror those of the IUCN Red List of species. A trial of the protocol on terrestrial, subterranean, freshwater and marine ecosystems from around the world shows that its concepts are workable and its outcomes are robust, that required data are available, and that results are consistent with assessments carried out by local experts and authorities. The new protocol provides a consistent, practical and theoretically grounded framework for establishing a systematic Red List of the world's ecosystems. This will complement the Red List of species and strengthen global capacity to report on and monitor the status of biodiversity	[Keith, David A.; Kingsford, Richard T.] Univ New S Wales, Australian Wetlands Rivers & Landscapes Ctr, Sydney, NSW, Australia; [Keith, David A.] New South Wales Off Environm & Heritage, Hurstville, NSW, Australia; [Rodriguez, Jon Paul; Rodriguez-Clark, Kathryn M.; Asmussen, Marianne; Zambrano-Martinez, Sergio] Inst Venezolano Invest Cient, Ctr Ecol, Caracas, Venezuela; [Rodriguez, Jon Paul; Oliveira-Miranda, Maria A.] Provita, Caracas, Venezuela; [Rodriguez, Jon Paul; Asmussen, Marianne] EcoHlth Alliance, New York, NY USA; [Rodriguez, Jon Paul; Brooks, Thomas M.] IUCN Commiss Ecosyst Management, Gland, Switzerland; [Rodriguez, Jon Paul; Brooks, Thomas M.] IUCN Species Survival Commiss, Gland, Switzerland; [Nicholson, Emily; McCarthy, Michael A.; Regan, Tracey J.] Univ Melbourne, Ctr Excellence Environm Decis, Melbourne, Vic 3010, Australia; [Aapala, Kaisu] Finnish Environm Inst, Helsinki, Finland; [Alonso, Alfonso] Smithsonian Inst, Natl Zool Pk, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [Bachman, Steven; Moat, Justin] Royal Bot Gardens, Richmond, England; [Basset, Alberto] Univ Salento, Ecotekne Ctr, Dept Biol & Environm Sci, Lecce, Italy; [Barrow, Edmund G.] IUCN Global Ecosyst Management Programme, Nairobi, Kenya; [Benson, John S.] Royal Bot Gardens Trust, Sydney, NSW, Australia; [Bishop, Melanie J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Bonifacio, Ronald; Pisanu, Phil] Sci Resource Ctr, Dept Environm & Nat Resources, Adelaide, SA, Australia; [Brooks, Thomas M.; Faber-Langendoen, Don] NatureServe, Arlington, VA USA; [Burgman, Mark A.] Univ Melbourne, Australian Ctr Excellence Risk Assessment, Melbourne, Vic 3010, Australia; [Comer, Patrick] NatureServe, Boulder, CO USA; [Comin, Francisco A.] Pyrenean Inst Ecol, Zaragoza, Spain; [Essl, Franz] Environm Agcy Austria, Vienna, Austria; [Essl, Franz] Univ Vienna, Dept Conservat Biol Vegetat & Landscape Ecol, Vienna, Austria; [Fairweather, Peter G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Holdaway, Robert J.] Landcare Res, Lincoln, New Zealand; [Jennings, Michael] Univ Idaho, Dept Geog, Moscow, ID 83843 USA; [Lester, Rebecca E.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Mac Nally, Ralph] Monash Univ, Sch Biol Sci, Australian Ctr Biodivers, Clayton, Vic 3800, Australia; [Poulin, Brigitte] Tour du Valat Res Ctr, Arles, France; [Riecken, Uwe] German Fed Agcy Nat Conservat, Bonn, Germany; [Spalding, Mark D.] Univ Cambridge, Dept Zool, Nat Conservancy & Conservat Sci Grp, Cambridge, England	University of New South Wales Sydney; Office of Environment & Heritage - New South Wales; Venezuelan Institute Science Research; EcoHealth Alliance; University of Melbourne; Finnish Environment Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Royal Botanic Gardens, Kew; University of Salento; Macquarie University; Nature Conservancy; University of Melbourne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); University of Vienna; Flinders University South Australia; Landcare Research - New Zealand; Idaho; University of Idaho; Deakin University; Monash University; University of Cambridge	Keith, DA (corresponding author), Univ New S Wales, Australian Wetlands Rivers & Landscapes Ctr, Sydney, NSW, Australia.	david.keith@unsw.edu.au	Bishop, Melanie/AGA-7862-2022; Rodriguez, Jon P/G-7224-2012; Lester, Rebecca/H-3907-2011; Rodriguez, Jon P/A-1491-2009; Essl, Franz/ABE-7064-2020; Faber-Langendoen, Don/AAU-1071-2021; McCarthy, Michael A/O-5655-2014; Spalding, Mark/GVU-0739-2022; Nicholson, Emily/H-9001-2013	Lester, Rebecca/0000-0003-2682-6495; Rodriguez, Jon P/0000-0001-5019-2870; Essl, Franz/0000-0001-8253-2112; McCarthy, Michael A/0000-0003-1039-7980; Nicholson, Emily/0000-0003-2199-3446; Comer, Patrick/0000-0002-5869-2105; Rodriguez-Clark, Kathryn/0000-0002-1356-9998; Moat, Justin/0000-0002-5513-3615; Aapala, Kaisu/0000-0002-6933-9673; Spalding, Mark/0000-0001-9456-4533; Kingsford, Richard/0000-0001-6565-4134; Bishop, Melanie/0000-0001-8210-6500; Bachman, Steven/0000-0003-1085-6075; Keith, David/0000-0002-7627-4150; Burgman, Mark/0000-0003-0435-4829; Fairweather, Peter/0000-0001-5927-3044; Brooks, Thomas/0000-0001-8159-3116	MAVA Foundation; Gordon and Betty Moore Foundation; Smithsonian Institution; EcoHealth Alliance, Provita; Fulbright Program; Tour du Valat,; Australian Centre of Excellence for Environmental Decisions and Centre de Suive Ecologique	MAVA Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Smithsonian Institution(Smithsonian Institution); EcoHealth Alliance, Provita; Fulbright Program; Tour du Valat,; Australian Centre of Excellence for Environmental Decisions and Centre de Suive Ecologique	The authors gratefully acknowledge funding support from the MAVA Foundation, Gordon and Betty Moore Foundation, Smithsonian Institution, EcoHealth Alliance, Provita, the Fulbright Program, Tour du Valat, the Australian Centre of Excellence for Environmental Decisions and Centre de Suive Ecologique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2000, CONSERV BIOL, V14, P1001, DOI 10.1046/j.1523-1739.2000.99125.x; Allen CR, 2005, ECOSYSTEMS, V8, P958, DOI 10.1007/s10021-005-0147-x; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Andren H, 1996, OIKOS, V76, P235, DOI 10.2307/3546195; Araoz E, 2010, ECOSYSTEMS, V13, P992, DOI 10.1007/s10021-010-9369-7; Ayensu E, 1999, SCIENCE, V286, P685, DOI 10.1126/science.286.5440.685; BAILLIE JEM, 2004, IUCN RED LIST THREAT; Barbone E, 2010, REND LINCEI-SCI FIS, V21, P301, DOI 10.1007/s12210-010-0090-4; Benson J. S., 2006, Cunninghamia, V9, P331; BLAB J, 1995, LANDSCAPE ECOL, V10, P41, DOI 10.1007/BF00158552; Blodgett N, 2010, INT J WILDLAND FIRE, V19, P415, DOI 10.1071/WF08162; Briske DD, 2005, RANGELAND ECOL MANAG, V58, P1, DOI 10.2111/1551-5028(2005)58&lt;1:SMTARH&gt;2.0.CO;2; Burgman M., 2005, RISKS DECISIONS CONS; Burgman MA, 1999, RISK ANAL, V19, P585, DOI 10.1023/A:1007073301150; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Burgman MA, 1993, RISK ASSESSMENT CONS; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Byrne M, 2008, BIOL J LINN SOC, V93, P177, DOI 10.1111/j.1095-8312.2007.00946.x; Cabezas A, 2009, HYDROL EARTH SYST SC, V13, P273, DOI 10.5194/hess-13-273-2009; Calcagno V, 2011, AM NAT, V177, pE1, DOI 10.1086/657436; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter SR, 2003, EXCELLENCE ECOLOGY S; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chytry M, 2002, J VEG SCI, V13, P79, DOI 10.1111/j.1654-1103.2002.tb02025.x; Clarke PJ, 2005, J VEG SCI, V16, P237, DOI 10.1111/j.1654-1103.2005.tb02361.x; Comuin FA., 2010, ECOLOGICAL RESTORATI; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; Costello MJ, 2010, ENVIRON SCI TECHNOL, V44, P8821, DOI 10.1021/es1012752; Cowling RM, 2008, P NATL ACAD SCI USA, V105, P9483, DOI 10.1073/pnas.0706559105; Curran LM, 2006, P NATL ACAD SCI USA, V103, P12663, DOI 10.1073/pnas.0605449103; Czembor CA, 2009, FOREST ECOL MANAG, V259, P165, DOI 10.1016/j.foreco.2009.10.002; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; del Moral R, 2007, J VEG SCI, V18, P479, DOI 10.1111/j.1654-1103.2007.tb02562.x; DIAMOND JM, 1989, PHILOS T ROY SOC B, V325, P469, DOI 10.1098/rstb.1989.0100; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Eisenhauer N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016055; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Arias-Gonzalez JE, 2012, BIODIVERS CONSERV, V21, P115, DOI 10.1007/s10531-011-0169-y; Essl F, 2012, BIODIVERS CONSERV, V21, P655, DOI 10.1007/s10531-011-0206-x; Estes JA, 2009, PHILOS T R SOC B, V364, P1647, DOI 10.1098/rstb.2008.0231; Faber-Langendoen D., 2009, B ECOL SOC AM, V90, P87, DOI DOI 10.1890/0012-9623-90.1.87; Fischer J, 2007, ECOSYSTEMS, V10, P964, DOI 10.1007/s10021-007-9071-6; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Fritz H, 2011, ECOGRAPHY, V34, P196, DOI 10.1111/j.1600-0587.2010.06537.x; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gaston KJ, 1993, RARITY; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Green PT, 2011, ECOLOGY, V92, P1758, DOI 10.1890/11-0050.1; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; Hallenbeck WH, 1986, QUANTITATIVE RISK AS; Hannah J, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007591; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hartley S, 2003, CONSERV BIOL, V17, P1559, DOI 10.1111/j.1523-1739.2003.00015.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hobbs R.J., 2009, NEW MODELS ECOSYSTEM; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; Hong S, 2010, J CLIMATE, V23, P4669, DOI 10.1175/2010JCLI3697.1; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huth N, 2011, J APPL ECOL, V48, P293, DOI 10.1111/j.1365-2664.2010.01936.x; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; IUCN, 2011, GUIDELINES APPL IUCN; IUCNInternational Union for Conservation of Nature, 2001, SPEC SURV COMM INT U; Jacquez GM, 2008, ENVIRON ECOL STAT, V15, P403, DOI 10.1007/s10651-007-0066-4; Jax K, 1998, OIKOS, V82, P253, DOI 10.2307/3546965; Jennings MD, 2009, ECOL MONOGR, V79, P173, DOI 10.1890/07-1804.1; Keith DA, 1998, CONSERV BIOL, V12, P1076, DOI 10.1046/j.1523-1739.1998.97202.x; Keith DA, 2004, BIOL CONSERV, V117, P41, DOI 10.1016/S0006-3207(03)00261-1; Keith DA, 2007, J ECOL, V95, P1324, DOI 10.1111/j.1365-2745.2007.01302.x; Keith DA, 2009, BIOL CONSERV, V142, P1469, DOI 10.1016/j.biocon.2009.02.015; Keith David A., 2009, Ecological Management & Restoration, V10, pS3, DOI 10.1111/j.1442-8903.2009.00453.x; King KJ, 2006, INT J WILDLAND FIRE, V15, P527, DOI 10.1071/WF05076; Klemas V, 2010, J COASTAL RES, V26, P789, DOI 10.2112/10A-00012.1; Kontula T, 2009, BIODIVERS CONSERV, V18, P3861, DOI 10.1007/s10531-009-9684-5; Lapointe NWR, 2010, J FISH BIOL, V76, P446, DOI 10.1111/j.1095-8649.2009.02470.x; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; LEE JK, 1992, PHOTOGRAMM ENG REM S, V58, P1579; Lester RE, 2011, ECOL MODEL, V222, P2690, DOI 10.1016/j.ecolmodel.2011.05.009; Likens GE., 1992, ECOSYSTEM APPROACH I; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P745, DOI 10.1111/j.1442-9993.2011.02351.x; Lindenmayer DB, 2011, ECOSYSTEMS, V14, P47, DOI 10.1007/s10021-010-9394-6; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; Ludwig JA, 2007, ECOL INDIC, V7, P442, DOI 10.1016/j.ecolind.2006.05.001; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Mac Nally R, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010383; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; McCarthy MA, 2008, J APPL ECOL, V45, P1428, DOI 10.1111/j.1365-2664.2008.01521.x; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Mearns A. J., 2010, Water Environment Research, V82, P2001, DOI 10.2175/106143010X12756668802175; Metternicht GI, 2003, REMOTE SENS ENVIRON, V85, P1, DOI 10.1016/S0034-4257(02)00188-8; Micklin P, 2006, EURASIAN GEOGR ECON, V47, P546, DOI 10.2747/1538-7216.47.5.546; Midgley GF, 2010, ECOGRAPHY, V33, P612, DOI 10.1111/j.1600-0587.2009.06000.x; Miller G, 2010, RANGELAND J, V32, P353, DOI 10.1071/RJ09076; Miller RM, 2007, CONSERV BIOL, V21, P684, DOI 10.1111/j.1523-1739.2007.00656.x; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Mucina L., 2006, VEGETATION S AFRICA; Nicholson E, 2009, CONSERV BIOL, V23, P259, DOI 10.1111/j.1523-1739.2008.01158.x; Noss RF, 1996, TRENDS ECOL EVOL, V11, P351, DOI 10.1016/0169-5347(96)20058-8; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Patrick WS, 2010, FISH B-NOAA, V108, P305; Rodriguez JP, 2011, CONSERV BIOL, V25, P21, DOI 10.1111/j.1523-1739.2010.01598.x; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; PICKETT S T A, 1989, P110; Pickett STA, 2002, ECOSYSTEMS, V5, P1, DOI 10.1007/s10021-001-0051-y; Pickett STA, 2001, APPL VEG SCI, V4, P41, DOI 10.1111/j.1654-109X.2001.tb00233.x; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; RACKHAM Oliver, 1986, HIST COUNTRYSIDE; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Riecken U, 2002, NATUR LANDSCHAFT, V77, P397; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodriguez JP, 2007, BIODIVERS CONSERV, V16, P183, DOI 10.1007/s10531-006-9102-1; Rodriguez JP, 2012, SAPIENS, V5, P6; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Rosensweig ML, 1995, SPECIES DIVERSITY SP; Rumpff L, 2011, BIOL CONSERV, V144, P1224, DOI 10.1016/j.biocon.2010.10.026; Sang A, 2010, BIOL CONSERV, V143, P1405, DOI 10.1016/j.biocon.2010.03.015; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Shi JM, 2010, BIODIVERS CONSERV, V19, P1279, DOI 10.1007/s10531-009-9757-5; Solow AR, 2005, MATH BIOSCI, V195, P47, DOI 10.1016/j.mbs.2005.02.001; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Staver AC, 2009, ECOL APPL, V19, P1909, DOI 10.1890/08-1907.1; Stoddard JL, 2008, J N AM BENTHOL SOC, V27, P878, DOI 10.1899/08-053.1; Tansley AG, 1935, ECOLOGY, V16, P284, DOI 10.2307/1930070; Thebault E, 2005, AM NAT, V166, pE95, DOI 10.1086/444403; Thebault E, 2007, OIKOS, V116, P163, DOI 10.1111/j.2006.0030-1299.15007.x; Thompson John N., 1997, P285; Tierney GL, 2009, FRONT ECOL ENVIRON, V7, P308, DOI 10.1890/070176; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Todd BJ, 2006, BENTHIC HABITAT SUN; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Vazquez DP, 2003, ECOL LETT, V6, P1077, DOI 10.1046/j.1461-0248.2003.00534.x; Visconti P, 2010, BIOL CONSERV, V143, P756, DOI 10.1016/j.biocon.2009.12.018; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Willis AJ, 1997, FUNCT ECOL, V11, P268, DOI 10.1111/j.1365-2435.1997.00081.x; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yamano H, 2004, REMOTE SENS ENVIRON, V90, P86, DOI 10.1016/j.rse.2003.12.005; Zhao HL, 2005, J ARID ENVIRON, V62, P309, DOI 10.1016/j.jaridenv.2004.11.009	175	306	328	12	272	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62111	10.1371/journal.pone.0062111	http://dx.doi.org/10.1371/journal.pone.0062111			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667454	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600016
J	Khen-Dunlop, N; Sarnacki, S; Victor, A; Grosos, C; Menard, S; Soret, R; Goudin, N; Pousset, M; Sauvat, F; Revillon, Y; Cerf-Bensussan, N; Neunlist, M				Khen-Dunlop, Naziha; Sarnacki, Sabine; Victor, Anais; Grosos, Celine; Menard, Sandrine; Soret, Rodolphe; Goudin, Nicolas; Pousset, Maud; Sauvat, Frederique; Revillon, Yann; Cerf-Bensussan, Nadine; Neunlist, Michel			Prenatal Intestinal Obstruction Affects the Myenteric Plexus and Causes Functional Bowel Impairment in Fetal Rat Experimental Model of Intestinal Atresia	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; JEJUNOILEAL ATRESIA; POSTNATAL-DEVELOPMENT; SMOOTH-MUSCLE; TRANSPORT; MOUSE; CELLS; ABNORMALITIES; PERMEABILITY; POPULATION	Background: Intestinal atresia is a rare congenital disorder with an incidence of 3/10 000 birth. About one-third of patients have severe intestinal dysfunction after surgical repair. We examined whether prenatal gastrointestinal obstruction might effect on the myenteric plexus and account for subsequent functional disorders. Methodology/Principal Findings: We studied a rat model of surgically induced antenatal atresia, comparing intestinal samples from both sides of the obstruction and with healthy rat pups controls. Whole-mount preparations of the myenteric plexus were stained for choline acetyltransferase (ChAT) and nitric oxide synthase (nNOS). Quantitative reverse transcription PCR was used to analyze mRNAs for inflammatory markers. Functional motility and permeability analyses were performed in vitro. Phenotypic studies were also performed in 8 newborns with intestinal atresia. In the experimental model, the proportion of nNOS-immunoreactive neurons was similar in proximal and distal segments (6.7 +/- 4.6% vs 5.6 +/- 4.2%, p = 0.25), but proximal segments contained a higher proportion of ChAT-immunoreactive neurons (13.2 +/- 6.2% vs 7.5 +/- 4.3%, p = 0.005). Phenotypic changes were associated with a 100-fold lower concentration-dependent contractile response to carbachol and a 1.6-fold higher EFS-induced contractile response in proximal compared to distal segments. Transcellular (p = 0.002) but not paracellular permeability was increased. Comparison with controls showed that modifications involved not only proximal but also distal segments. Phenotypic studies in human atresia confirmed the changes in ChAT expression. Conclusion: Experimental atresia in fetal rat induces differential myenteric plexus phenotypical as well as functional changes (motility and permeability) between the two sides of the obstruction. Delineating these changes might help to identify markers predictive of motility dysfunction and to define guidelines for post-surgical care.	[Khen-Dunlop, Naziha; Sarnacki, Sabine; Victor, Anais; Grosos, Celine; Cerf-Bensussan, Nadine] INSERM, U989, Paris, France; [Khen-Dunlop, Naziha; Sarnacki, Sabine; Menard, Sandrine; Sauvat, Frederique; Revillon, Yann] Hop Necker Enfants Malad, AP HP, Serv Chirurg Pediat, Paris, France; [Khen-Dunlop, Naziha; Sarnacki, Sabine; Victor, Anais; Grosos, Celine; Menard, Sandrine; Pousset, Maud; Sauvat, Frederique; Revillon, Yann; Cerf-Bensussan, Nadine] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Soret, Rodolphe; Neunlist, Michel] INSERM, U913, Nantes, France; [Soret, Rodolphe; Neunlist, Michel] CHU Nantes, Hotel Dieu, Inst Malad Appareil Digestif, F-44035 Nantes 01, France; [Soret, Rodolphe; Neunlist, Michel] Univ Nantes, Fac Med, Nantes, France; [Goudin, Nicolas] Hop Necker Enfants Malad, AP HP, Paris, France; [Pousset, Maud] Hop Necker Enfants Malad, AP HP, Dept Biostat, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Khen-Dunlop, N (corresponding author), INSERM, U989, Paris, France.	naziha.khen-dunlop@nck.aphp.fr	Neunlist, Michel/K-2388-2015; Cerf-Bensussan, nadine/H-9505-2017; Menard, Sandrine/ABF-8935-2021; Sarnacki, Sabine/I-2692-2017	Cerf-Bensussan, nadine/0000-0003-0665-1245; Menard, Sandrine/0000-0001-8867-199X; Sarnacki, Sabine/0000-0003-4304-5578; Khen-Dunlop, Naziha/0000-0003-4537-229X	Fondation de l'Avenir (Paris, France); Fondation pour la Recherche Medicale (Paris, France)	Fondation de l'Avenir (Paris, France); Fondation pour la Recherche Medicale (Paris, France)(Fondation pour la Recherche Medicale)	This work was mainly funded by grants from Fondation de l'Avenir (Paris, France) and Fondation pour la Recherche Medicale (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglaj SM, 2001, J PEDIATR SURG, V36, P1428, DOI 10.1053/jpsu.2001.26392; BERSETH CL, 1989, J PEDIATR-US, V115, P646, DOI 10.1016/S0022-3476(89)80302-6; BISSET WM, 1988, GUT, V29, P483, DOI 10.1136/gut.29.4.483; Burjonrappa SC, 2010, J PERINATOL, V30, P27, DOI 10.1038/jp.2009.102; Cameron HL, 2007, NEUROGASTROENT MOTIL, V19, P47, DOI 10.1111/j.1365-2982.2006.00845.x; Chalazonitis A, 2011, DEV BIOL, V350, P64, DOI 10.1016/j.ydbio.2010.11.017; Chevalier J, 2008, J PHYSIOL-LONDON, V586, P1963, DOI 10.1113/jphysiol.2007.149815; COLONY PC, 1985, GASTROENTEROLOGY, V89, P294, DOI 10.1016/0016-5085(85)90329-4; de Vries P, 2010, AM J PHYSIOL-GASTR L, V299, pG539, DOI 10.1152/ajpgi.00092.2010; Ekblad E, 1998, GUT, V42, P836, DOI 10.1136/gut.42.6.836; Furness JB, 2000, J AUTONOM NERV SYST, V81, P87, DOI 10.1016/S0165-1838(00)00127-2; Gareau MG, 2007, AM J PHYSIOL-GASTR L, V293, pG198, DOI 10.1152/ajpgi.00392.2006; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; HAMDY MH, 1986, J PEDIATR SURG, V21, P17, DOI 10.1016/S0022-3468(86)80643-1; Hao MM, 2010, NEUROGASTROENT MOTIL, V22, pe127, DOI 10.1111/j.1365-2982.2009.01462.x; Hemming V, 2007, PRENATAL DIAG, V27, P1205, DOI 10.1002/pd.1886; Kamm MA, 2000, GUT, V47, P8; Kao K J, 1983, Pediatr Pathol, V1, P443; Kapur RP, 2000, GUT, V47, P81, DOI 10.1136/gut.47.suppl_4.iv81; Khen N, 2004, PEDIATR RES, V56, P975, DOI 10.1203/01.PDR.0000145294.11800.71; Khen-Dunlop N, 2009, J PEDIATR SURG, V44, P1725, DOI 10.1016/j.jpedsurg.2008.12.017; Kiliaan AJ, 1998, AM J PHYSIOL-GASTR L, V275, pG1037, DOI 10.1152/ajpgi.1998.275.5.G1037; KRUGLIAK P, 1994, DIGEST DIS SCI, V39, P796, DOI 10.1007/BF02087426; Lopez de Torre B, 1992, J PEDIATR SURG, V27, P1325; LOUW JH, 1955, LANCET, V2, P1065; Martinez-Frias ML, 2000, AM J MED GENET, V93, P355, DOI 10.1002/1096-8628(20000828)93:5<355::AID-AJMG3>3.0.CO;2-Q; Masumoto K, 1999, J PEDIATR SURG, V34, P1463, DOI 10.1016/S0022-3468(99)90104-5; Masumoto K, 1999, PEDIATR RES, V45, P30, DOI 10.1203/00006450-199901000-00006; Mericskay M, 2007, GASTROENTEROLOGY, V133, P1960, DOI 10.1053/j.gastro.2007.09.010; Roberts RR, 2007, AM J PHYSIOL-GASTR L, V292, pG930, DOI 10.1152/ajpgi.00444.2006; Ruiz MJ, 2009, J PEDIATR SURG, V44, P71, DOI 10.1016/j.jpedsurg.2008.10.010; Sadler TW, 2010, AM J MED GENET A, V152A, P2426, DOI 10.1002/ajmg.a.33636; Schafer KH, 1999, ANAT REC, V256, P20; Schoenberg RA, 2002, J PEDIATR SURG, V37, P735, DOI 10.1053/jpsu.2002.32267; Stollman TH, 2009, J PEDIATR SURG, V44, P217, DOI 10.1016/j.jpedsurg.2008.10.043; Terpend K, 1998, GUT, V42, P538, DOI 10.1136/gut.42.4.538; Tisi DK, 2005, J NUTR, V135, P1667, DOI 10.1093/jn/135.7.1667; von Boyen GBT, 2004, GUT, V53, P222, DOI 10.1136/gut.2003.012625; Walker K, 2008, J PEDIATR SURG, V43, P484, DOI 10.1016/j.jpedsurg.2007.10.028; WALKER MW, 1993, J PEDIATR-US, V123, P93, DOI 10.1016/S0022-3476(05)81547-1; Watanabe Y, 2001, J PEDIATR SURG, V36, P474, DOI 10.1053/jpsu.2001.21618; Wester T, 1999, GUT, V44, P666, DOI 10.1136/gut.44.5.666	42	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62292	10.1371/journal.pone.0062292	http://dx.doi.org/10.1371/journal.pone.0062292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667464	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600020
J	Chung, D; Cha, M; Farkas, J; Westpheling, J				Chung, Daehwan; Cha, Minseok; Farkas, Joel; Westpheling, Janet			Construction of a Stable Replicating Shuttle Vector for Caldicellulosiruptor Species: Use for Extending Genetic Methodologies to Other Members of This Genus	PLOS ONE			English	Article							PLANT BIOMASS; SP-NOV.; BACTERIUM; PLASMID; TRANSFORMATION; DECONSTRUCTION; PRETREATMENT; RESTRICTION; CONVERSION; ENZYMES	The recalcitrance of plant biomass is the most important barrier to its economic conversion by microbes to products of interest. Thermophiles have special advantages for biomass conversion and members of the genus Caldicellulosiruptor are the most thermophilic cellulolytic microbes known. In this study, we report the construction of a replicating shuttle vector for Caldicellulosiruptor species based on pBAS2, the smaller of two native C. bescii plasmids. The entire plasmid was cloned into an E. coli cloning vector containing a pSC101 origin of replication and an apramycin resistance cassette for selection in E. coli. The wild-type C. bescii pyrF locus was cloned under the transcriptional control of the regulatory region of the ribosomal protein S30EA (Cbes2105), and the resulting vector was transformed into a new spontaneous deletion mutant in the pyrFA locus of C. bescii that allowed complementation with the pyrF gene alone. Plasmid DNA was methylated in vitro with a recently described cognate methyltransferase, M. CbeI, and transformants were selected for uracil prototrophy. The plasmid was stably maintained in low copy with selection but rapidly lost without selection. There was no evidence of DNA rearrangement during transformation and replication in C. bescii. A similar approach was used to screen for transformability of other members of this genus using M. CbeI to overcome restriction as a barrier and was successful for transformation of C. hydrothermalis, an attractive species for many applications. Plasmids containing a carbohydrate binding domain (CBM) and linker region from the C. bescii celA gene were maintained with selection and were structurally stable through transformation and replication in C. bescii and E. coli.	[Chung, Daehwan; Cha, Minseok; Farkas, Joel; Westpheling, Janet] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Chung, Daehwan; Cha, Minseok; Farkas, Joel; Westpheling, Janet] Oak Ridge Natl Lab, Dept Energy, BioEnergy Sci Ctr, Oak Ridge, TN USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Westpheling, J (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	janwest@uga.edu			United States Department of Energy Bioenergy Research Center; Office of Biological and Environmental Research in the DOE Office of Science; predoctoral Graduate Training in Genetics grant [NIH 5T32GM007103-30]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER	United States Department of Energy Bioenergy Research Center(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); predoctoral Graduate Training in Genetics grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The BioEnergy Science Center supported by a United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. JF was supported in part by a predoctoral Graduate Training in Genetics grant (NIH 5T32GM007103-30) to the Genetics Department of the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumer-Schuette SE, 2008, CURR OPIN BIOTECH, V19, P210, DOI 10.1016/j.copbio.2008.04.007; Blumer-Schuette SE, 2012, J BACTERIOL, V194, P4015, DOI 10.1128/JB.00266-12; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Bredholt S, 1999, INT J SYST BACTERIOL, V49, P991, DOI 10.1099/00207713-49-3-991; Chung D, 2013, J IND MICROBIOL BIOT, DOI [10.1007/s10295-10013-11244-z, DOI 10.1007/S10295-10013-11244-Z]; Chung DH, 2011, J IND MICROBIOL BIOT, V38, P1867, DOI 10.1007/s10295-011-0976-x; Chung D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043844; Clausen A, 2004, PLASMID, V52, P131, DOI 10.1016/j.plasmid.2004.06.001; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; ESPINOSA M, 1995, FEMS MICROBIOL LETT, V130, P111; Farkas JCD, 2012, J IND MICRO IN PRESS; GRUSS A, 1989, MICROBIOL REV, V53, P231, DOI 10.1128/MMBR.53.2.231-241.1989; Hamilton-Brehm SD, 2010, APPL ENVIRON MICROB, V76, P1014, DOI 10.1128/AEM.01903-09; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Huang CY, 1998, INT J SYST BACTERIOL, V48, P91, DOI 10.1099/00207713-48-1-91; IMANAKA T, 1982, J BACTERIOL, V149, P824, DOI 10.1128/JB.149.3.824-830.1982; Jennert KCB, 2000, MICROBIOL-SGM, V146, P3071, DOI 10.1099/00221287-146-12-3071; Karita S, 2001, BIOSCI BIOTECH BIOCH, V65, P226, DOI 10.1271/bbb.65.226; Kurusu Y, 2001, MAR BIOTECHNOL, V3, P96, DOI 10.1007/s101260000067; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Mai V, 1997, FEMS MICROBIOL LETT, V148, P163, DOI 10.1016/S0378-1097(97)00028-1; McCann MC, 2008, CURR OPIN PLANT BIOL, V11, P314, DOI 10.1016/j.pbi.2008.04.001; Miroshnichenko ML, 2008, INT J SYST EVOL MICR, V58, P1492, DOI 10.1099/ijs.0.65236-0; Negro MJ, 2003, APPL BIOCHEM BIOTECH, V105, P87, DOI 10.1385/ABAB:105:1-3:87; RAINEY FA, 1994, FEMS MICROBIOL LETT, V120, P263, DOI 10.1016/0378-1097(94)90481-2; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Sambrook J., 2001, MOL CLONING LAB MANU; SVETLICHNYI VA, 1990, MICROBIOLOGY+, V59, P598; Tripathi SA, 2010, APPL ENVIRON MICROB, V76, P6591, DOI 10.1128/AEM.01484-10; TSOI T V, 1987, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P18; VanFossen AL, 2011, BIOTECHNOL BIOENG, V108, P1559, DOI 10.1002/bit.23093; Wilson DB, 2008, ANN NY ACAD SCI, V1125, P289, DOI 10.1196/annals.1419.026; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Zhang YHP, 2007, BIOTECHNOL BIOENG, V97, P214, DOI 10.1002/bit.21386; Zwick ME, 2012, GENOME RES, V22, P1512, DOI 10.1101/gr.134437.111	38	47	47	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62881	10.1371/journal.pone.0062881	http://dx.doi.org/10.1371/journal.pone.0062881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658781	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100044
J	Hernandez, AV; Pasupuleti, V; Deshpande, A; Thota, P; Collins, JA; Vidal, JE				Hernandez, Adrian V.; Pasupuleti, Vinay; Deshpande, Abhishek; Thota, Priyaleela; Collins, Jaime A.; Vidal, Jose E.			Deficient Reporting and Interpretation of Non-Inferiority Randomized Clinical Trials in HIV Patients: A Systematic Review	PLOS ONE			English	Review							NAIVE HIV-1-INFECTED PATIENTS; TWICE-DAILY LOPINAVIR/RITONAVIR; ONCE-DAILY ATAZANAVIR/RITONAVIR; ANTIRETROVIRAL THERAPY; NONINFERIORITY TRIALS; MAINTENANCE THERAPY; COMBINATION THERAPY; LOPINAVIR-RITONAVIR; VIROLOGICAL FAILURE; SUPPRESSED PATIENTS	Objectives: Non-inferiority (NI) randomized clinical trials (RCTs) commonly evaluate efficacy of new antiretroviral (ARV) drugs in human immunodeficiency virus (HIV) patients. Their reporting and interpretation have not been systematically evaluated. We evaluated the reporting of NI RCTs in HIV patients according to the CONSORT statement and assessed the degree of misinterpretation of RCTs when NI was inconclusive or not established. Design: Systematic review. Methods: PubMed, Web of Science, and Scopus were reviewed until December 2011. Selection and extraction was performed independently by three reviewers. Results: Of the 42 RCTs (n = 21,919; range 41-3,316) selected, 23 were in ARV-naive and 19 in ARV-experienced patients. Twenty-seven (64%) RCTs provided information about prior RCTs of the active comparator, and 37 (88%) used 2-sided CIs. Two thirds of trials used a NI margin between 10 and 12%, although only 12 explained the method to determine it. Blinding was used in 9 studies only. The main conclusion was based on both intention-to-treat (ITT) and per protocol (PP) analyses in 5 trials, on PP analysis only in 4 studies, and on ITT only in 31 studies. Eleven of 16 studies with NI inconclusive or not established highlighted NI or equivalence, and distracted readers with positive secondary results. Conclusions: There is poor reporting and interpretation of NI RCTs performed in HIV patients. Maximizing the reporting of the method of NI margin determination, use of blinding and both ITT and PP analyses, and interpreting negative NI according to actual primary findings will improve the understanding of results and their translation into clinical practice.	[Hernandez, Adrian V.; Thota, Priyaleela] Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Hlth Outcomes & Clin Epidemiol Sect, Cleveland, OH 44106 USA; [Pasupuleti, Vinay; Deshpande, Abhishek] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Hernandez, Adrian V.] Univ Peruana Ciencias Aplicadas UPC, Postgrad Sch, Lima, Peru; [Collins, Jaime A.] Guillermo Almenara Gen Hosp, EsSalud, Dept Internal Med, HIV AIDS Unit, Lima, Peru; [Vidal, Jose E.] Emilio Ribas Inst Infectol, Dept Infect Dis, Sao Paulo, Brazil	Cleveland Clinic Foundation; Case Western Reserve University; Universidad Peruana de Ciencias Aplicadas (UPC); Seguro Social de Salud del Peru	Hernandez, AV (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Hlth Outcomes & Clin Epidemiol Sect, Cleveland, OH 44106 USA.	adrianhernandezdiaz@gmail.com	Deshpande, Abhishek/A-7695-2012; Vidal, Jose E/D-2186-2014; Hernandez, Adrian V./ABD-4616-2021	Deshpande, Abhishek/0000-0001-5522-2995; Vidal, Jose E/0000-0001-7830-8716; Hernandez, Adrian V./0000-0002-9999-4003	Department of Quantitative Health Sciences, Cleveland Clinic	Department of Quantitative Health Sciences, Cleveland Clinic	This work was funded by the Department of Quantitative Health Sciences, Cleveland Clinic. The funders had no role in study design; data collection, analysis, or interpretation; in writing the report, or in the decision to submit the article for publication. The researchers are all independent from the funding source.	Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Benson CA, 2004, AIDS, V18, P2269, DOI 10.1097/00002030-200411190-00007; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Campo RE, 2010, INT J STD AIDS, V21, P166, DOI 10.1258/ijsa.2009.008487; Clumeck N, 2011, J ANTIMICROB CHEMOTH, V66, P1878, DOI 10.1093/jac/dkr199; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; De Castro N, 2009, CLIN INFECT DIS, V49, P1259, DOI 10.1086/605674; DeJesus E, 2004, CLIN INFECT DIS, V39, P1038, DOI 10.1086/424009; Eron JJ, 2000, AIDS, V14, P671, DOI 10.1097/00002030-200004140-00006; Eron JJ, 2010, LANCET, V375, P396, DOI 10.1016/S0140-6736(09)62041-9; Eron JJ, 2011, LANCET INFECT DIS, V11, P907, DOI 10.1016/S1473-3099(11)70196-7; Joseph E, 2006, LANCET, V368, P476, DOI 10.1016/S0140-6736(06)69155-1; Firnhaber C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021450; Flandre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gathe JC, 2004, AIDS, V18, P1529, DOI 10.1097/01.aids.0000131332.30548.92; Gathe J, 2011, ANTIVIR THER, V16, P759, DOI 10.3851/IMP1803; Girard PM, 2009, J ANTIMICROB CHEMOTH, V64, P126, DOI 10.1093/jac/dkp141; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1172, DOI 10.1001/jama.295.10.1172; Hill A, 2008, AIDS, V22, P913, DOI 10.1097/QAD.0b013e3282f5556d; Johnson MA, 2006, JAIDS-J ACQ IMM DEF, V43, P153, DOI 10.1097/01.qai.0000242449.67155.1a; Kane RL, 2007, J CLIN EPIDEMIOL, V60, P241, DOI 10.1016/j.jclinepi.2006.06.016; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Kumar Princy N, 2009, AIDS Res Ther, V6, P3, DOI 10.1186/1742-6405-6-3; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Le Henanff A, 2006, JAMA-J AM MED ASSOC, V295, P1147, DOI 10.1001/jama.295.10.1147; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Madruga JV, 2007, LANCET, V370, P49, DOI 10.1016/S0140-6736(07)61049-6; Marchou B, 2007, AIDS, V21, P457, DOI 10.1097/QAD.0b013e328013d9eb; Martinez E, 2010, AIDS, V24, P1697, DOI 10.1097/QAD.0b013e32833a608a; Meynard JL, 2010, J ANTIMICROB CHEMOTH, V65, P2436, DOI 10.1093/jac/dkq327; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Molina JM, 2010, JAIDS-J ACQ IMM DEF, V53, P323, DOI 10.1097/QAI.0b013e3181c990bf; Moyle GJ, 2005, JAIDS-J ACQ IMM DEF, V38, P417, DOI 10.1097/01.qai.0000147521.34369.c9; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Nadler JP, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-10; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; Parienti Jean-Jacques, 2006, BMC Med Res Methodol, V6, P46, DOI 10.1186/1471-2288-6-46; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Porter BO, 2009, AIDS, V23, P203, DOI 10.1097/QAD.0b013e32831cc114; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Pulido F, 2008, AIDS, V22, pF1, DOI 10.1097/QAD.0b013e3282f4243b; Rey D, 2009, J ANTIMICROB CHEMOTH, V63, P380, DOI 10.1093/jac/dkn471; Reynolds SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010307; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Sierra-Madero J, 2010, JAIDS-J ACQ IMM DEF, V53, P582, DOI 10.1097/QAI.0b013e3181cae4a1; Soriano V, 2011, ANTIVIR THER, V16, P339, DOI 10.3851/IMP1745; Vibhagool A, 2004, CURR MED RES OPIN, V20, P1103, DOI 10.1185/030079904125004006; Wangge G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013550; Zajdenverg R, 2010, JAIDS-J ACQ IMM DEF, V54, P143, DOI 10.1097/QAI.0b013e3181cbd21e	54	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63272	10.1371/journal.pone.0063272	http://dx.doi.org/10.1371/journal.pone.0063272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658818	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100059
J	Knockel, J; Molina-Cruz, A; Fischer, E; Muratova, O; Haile, A; Barillas-Mury, C; Miller, LH				Knoeckel, Julia; Molina-Cruz, Alvaro; Fischer, Elizabeth; Muratova, Olga; Haile, Ashley; Barillas-Mury, Carolina; Miller, Louis H.			An Impossible Journey? The Development of Plasmodium falciparum NF54 in Culex quinquefasciatus	PLOS ONE			English	Article							COMPLEMENT-LIKE PROTEIN; HUMAN MALARIA PARASITES; VECTOR ANOPHELES-GAMBIAE; VALLEY FEVER VIRUS; OOKINETE INVASION; ENTOMOLOGIC INVESTIGATIONS; REFRACTORY STRAIN; MIDGUT EPITHELIUM; MOSQUITOS DIPTERA; FEEDING PATTERNS	Although Anopheles mosquitoes are the vectors for human Plasmodium spp., there are also other mosquito species-among them culicines (Culex spp., Aedes spp.)-present in malaria-endemic areas. Culicine mosquitoes transmit arboviruses and filarial worms to humans and are vectors for avian Plasmodium spp., but have never been observed to transmit human Plasmodium spp. When ingested by a culicine mosquito, parasites could either face an environment that does not allow development due to biologic incompatibility or be actively killed by the mosquito's immune system. In the latter case, the molecular mechanism of killing must be sufficiently powerful that Plasmodium is not able to overcome it. To investigate how human malaria parasites develop in culicine mosquitoes, we infected Culex quinquefasciatus with Plasmodium falciparum NF54 and monitored development of parasites in the blood bolus and midgut epithelium at different time points. Our results reveal that ookinetes develop in the midgut lumen of C. quinquefasciatus in slightly lower numbers than in Anopheles gambiae G3. After 30 hours, parasites have invaded the midgut and can be observed on the basal side of the midgut epithelium by confocal and transmission electron microscopy. Very few of the parasites in C. quinquefasciatus are alive, most of them are lysed. Eight days after the mosquito's blood meal, no oocysts can be found in C. quinquefasciatus. Our results suggest that the mosquito immune system could be involved in parasite killing early in development after ookinetes have crossed the midgut epithelium and come in contact with the mosquito hemolymph.	[Knoeckel, Julia; Molina-Cruz, Alvaro; Haile, Ashley; Barillas-Mury, Carolina; Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Fischer, Elizabeth] NIAID, Rocky Mt Labs, Elect Microscopy Unit, Res Technol Branch,NIH, Hamilton, MT 59840 USA; [Muratova, Olga] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Knockel, J (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	julia.knoeckel@gmail.com; lmiller@niaid.nih.gov		Vivian, Julia/0000-0001-6688-7714	National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, ZIAAI000947, ZICAI001052] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini A, 1999, PARASITOLOGY, V119, P331, DOI 10.1017/S0031182099004874; Arrighi RBG, 2005, J EXP BIOL, V208, P2497, DOI 10.1242/jeb.01664; Baton LA, 2007, J INVERTEBR PATHOL, V96, P244, DOI 10.1016/j.jip.2007.05.005; Baton LA, 2004, PARASITOLOGY, V129, P663, DOI 10.1017/S0031182004005979; Baton LA, 2012, INT J PARASITOL, V42, P249, DOI 10.1016/j.ijpara.2011.12.005; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; BRIEGEL H, 1979, J MED ENTOMOL, V15, P235, DOI 10.1093/jmedent/15.3.235; CHEONG WH, 1963, SINGAP MED J, V4, P183; Clayton AM, 2013, DEV COMP IMMUNOL, V39, P323, DOI 10.1016/j.dci.2012.10.009; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Devenport Martin, 2005, P297; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver LS, 2008, DEV COMP IMMUNOL, V32, P519, DOI 10.1016/j.dci.2007.09.007; Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Gupta L, 2005, P NATL ACAD SCI USA, V102, P4010, DOI 10.1073/pnas.0409642102; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; HAYNES JD, 1976, NATURE, V263, P767, DOI 10.1038/263767a0; HUFF CG, 1965, EXP PARASITOL, V16, P107, DOI 10.1016/0014-4894(65)90036-6; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Jaswant Singh, 1955, Indian Journal of Malariology, V9, P71; Kwan JL, 2010, AM J TROP MED HYG, V83, P400, DOI 10.4269/ajtmh.2010.10-0076; LENSEN AHW, 1992, PARASITE IMMUNOL, V14, P471, DOI 10.1111/j.1365-3024.1992.tb00021.x; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Lindahl J, 2012, AM J TROP MED HYG, V87, P1076, DOI 10.4269/ajtmh.2012.12-0315; Mackay AJ, 2010, J MED ENTOMOL, V47, P238, DOI 10.1603/ME09168; Menge DM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-44; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Molina-Cruz A, 2012, P NATL ACAD SCI USA, V109, pE1957, DOI 10.1073/pnas.1121183109; Muturi EJ, 2008, PARASITOL RES, V102, P1329, DOI 10.1007/s00436-008-0914-7; Nacer A, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-33; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Norris LC, 2011, J VECTOR ECOL, V36, P411, DOI 10.1111/j.1948-7134.2011.00182.x; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Paskewitz SM, 2005, J MED ENTOMOL, V42, P712, DOI 10.1603/0022-2585(2005)042[0712:BTMRID]2.0.CO;2; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P242, DOI 10.1016/0035-9203(82)90289-9; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319; SAVAGE HM, 1993, AM J TROP MED HYG, V49, P38, DOI 10.4269/ajtmh.1993.49.38; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Turell MJ, 2008, J MED ENTOMOL, V45, P102, DOI 10.1603/0022-2585(2008)45[102:VCOSAM]2.0.CO;2; Unlu I, 2010, J MED ENTOMOL, V47, P625, DOI 10.1603/ME09087; Varma M.G.L., 1989, GEOGRAPHICAL DISTRIB, P35; WARREN M., 1962, MOSQUITO NEWS, V22, P303; WEATHERSBY AB, 1968, J PARASITOL, V54, P1017, DOI 10.2307/3277137; WHARTON R. H., 1962, MOSQUITO NEWS, V22, P304; White G. B., 1989, GEOGRAPHICAL DISTRIB, P23; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Williamson KB, 1937, T ROYAL SOC TROPICAL, VXXXI; YOELI M, 1973, EXP PARASITOL, V34, P448, DOI 10.1016/0014-4894(73)90104-5	56	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63387	10.1371/journal.pone.0063387	http://dx.doi.org/10.1371/journal.pone.0063387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658824	Green Submitted, Green Published, gold			2022-12-27	WOS:000321202100065
J	Cheng, JCH; Yuan, A; Chen, JH; Lu, YC; Cho, KH; Wu, JK; Wu, CJ; Chang, YC; Yang, PC				Cheng, Jason Chia-Hsien; Yuan, Ang; Chen, Jyh-Horng; Lu, Yi-Chien; Cho, Kuan-Hung; Wu, Jian-Kuen; Wu, Chien-Jang; Chang, Yeun-Chung; Yang, Pan-Chyr			Early Detection of Lewis Lung Carcinoma Tumor Control by Irradiation Using Diffusion-Weighted and Dynamic Contrast-Enhanced MRI	PLOS ONE			English	Article							RADIATION-THERAPY; CANCER; RADIOTHERAPY; CHEMOTHERAPY; BIOMARKER	Purpose: To investigate the correlation between diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) derived parameters and radioresponsiveness of Lewis lung carcinoma (LLC) tumor. Materials and Methods: LLC tumor growth in C57BL/6 mouse limb was used for the experiment. The tumors were irradiated with 10 Gy x 5, or 30 Gy x 2 vs. sham irradiation. Fourteen tumors were subjected to DW-MRI and DCE-MRI pre-radiotherapy and weekly imaging after radiotherapy. The temporal changes in apparent diffusion coefficient (ADC) and DCE-MRI derived parameters (K-trans, k(ep), v(e), and v(p)) were correlated with tumor size, and were histologically compared with CD31 staining of resected tumors. Results: The 10 Gy x 5 dose inhibited tumor growth for a week, while 30 Gy x 2 controlled tumor growth for a 3-week observation period. One week after radiotherapy (week 2), irradiated tumors showed significantly higher values of ADC than untreated ones (10 Gy x 5, p = 0.004; 30 Gy x 2, p = 0.01). Significantly higher values of v(e) were shown earlier by 30 Gy x 2 vs. sham (p = 0.01) and 10 Gy x 5 vs. sham irradiation (p = 0.05). Sustained higher v(e) from 10 Gy x 5 compared to sham irradiated tumors was evident at week 3 (p = 0.016) and week 4 (p = 0.046). A 13.8% early increase in ADC for 30 Gy x 2 tumor group (p = 0.002) and a 16.5% increase for 10 Gy x 5 group were noted (p = 0.01) vs. sham irradiation (which showed a 2.2% decrease). No differences were found for K-trans, k(ep), or v(p). Both radiotherapy groups demonstrated significant reduction in microvessel counts. Conclusion: Early increase in ADC and ve correlated with tumor control by irradiation.	[Cheng, Jason Chia-Hsien] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan; [Cheng, Jason Chia-Hsien] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Lu, Yi-Chien; Chang, Yeun-Chung] Natl Taiwan Univ, Coll Med, Dept Radiol, Taipei 10764, Taiwan; [Cheng, Jason Chia-Hsien; Chen, Jyh-Horng] Natl Taiwan Univ, Coll Elect Engn & Comp Sci, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Cheng, Jason Chia-Hsien] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Chang, Yeun-Chung] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yuan, Ang; Yang, Pan-Chyr] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Cho, Kuan-Hung] Natl Yang Ming Univ, Instrumentat Resource Ctr, Taipei 112, Taiwan; [Wu, Jian-Kuen; Wu, Chien-Jang] Natl Taiwan Normal Univ, Inst Electroopt Sci & Technol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Taiwan Normal University	Chang, YC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Radiol, Taipei 10764, Taiwan.	ycc5566@ntu.edu.tw		CHANG, YEUN-CHUNG/0000-0001-9984-5713; CHENG, JASON CHIA-HSIEN/0000-0002-2007-0220; YUAN, ANG/0000-0002-5664-1339; YANG, PAN-CHYR/0000-0001-6330-6048	Department of Health, Taiwan, ROC [DOH102-TD-PB-111-TM009]; National Taiwan University Hospital [NTUH101-S1879, NTUH99-S1274]; National Science Council, Execute Yuan, Taiwan, ROC [NSC98-2627-B-002-016, NSC99-2627-B-002-007, NSC100-2627-B-002-005, NSC95-2627-B-002-013, NSC96-2627-B-002-007, NSC97-2627-B-002-003]	Department of Health, Taiwan, ROC; National Taiwan University Hospital(National Taiwan University); National Science Council, Execute Yuan, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by Department of Health, Taiwan, ROC (DOH102-TD-PB-111-TM009), National Taiwan University Hospital (NTUH101-S1879, NTUH99-S1274), National Science Council, Execute Yuan, Taiwan, ROC (NSC98-2627-B-002-016, NSC99-2627-B-002-007, NSC100-2627-B-002-005, NSC95-2627-B-002-013, NSC96-2627-B-002-007, NSC97-2627-B-002-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mamgani A, 2008, INT J RADIAT ONCOL, V72, P980, DOI 10.1016/j.ijrobp.2008.02.073; Bonekamp S, 2012, J MAGN RESON IMAGING, V35, P257, DOI 10.1002/jmri.22786; Camphausen K, 2001, CANCER RES, V61, P2207; Chang YC, 2012, J MAGN RESON IMAGING, V36, P387, DOI 10.1002/jmri.23660; Chikui T, 2012, J MAGN RESON IMAGING, V36, P589, DOI 10.1002/jmri.23704; Chou CH, 2012, ONCOGENE, V31, P458, DOI 10.1038/onc.2011.240; Connell PP, 2009, CANCER RES, V69, P383, DOI 10.1158/0008-5472.CAN-07-6871; Ding PR, 2012, ANN SURG, V256, P111, DOI 10.1097/SLA.0b013e31825b3a2b; Galban S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035857; KIM JH, 2012, EUR RADIOL; Lo SS, 2010, NAT REV CLIN ONCOL, V7, P44, DOI 10.1038/nrclinonc.2009.188; Loveless ME, 2012, NEOPLASIA, V14, P54, DOI 10.1593/neo.111478; Lovey J, 2003, STRAHLENTHER ONKOL, V179, P812, DOI 10.1007/s00066-003-1051-y; Michalski J, 2012, INT J RADIAT ONCOL, V83, pE363, DOI 10.1016/j.ijrobp.2011.12.070; Nougaret S, 2012, RADIOLOGY, V263, P409, DOI 10.1148/radiol.12111263; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Ovrebo KM, 2012, RADIOTHER ONCOL, V102, P429, DOI 10.1016/j.radonc.2011.11.013; Ovrebo KM, 2011, INT J RADIAT ONCOL, V81, P255, DOI 10.1016/j.ijrobp.2011.04.008; Quon H, 2012, SEMIN RADIAT ONCOL, V22, P220, DOI 10.1016/j.semradonc.2012.03.007; Sinkus R, 2012, EUR J CANCER, V48, P425, DOI 10.1016/j.ejca.2011.11.034; Stinauer MA, 2012, INT J RADIAT ONCOL, V83, pE613, DOI 10.1016/j.ijrobp.2012.02.008; Sun YS, 2011, AM J ROENTGENOL, V197, pW23, DOI 10.2214/AJR.10.4912; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thoeny HC, 2010, J MAGN RESON IMAGING, V32, P2, DOI 10.1002/jmri.22167; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Yabuuchi H, 2011, RADIOLOGY, V261, P598, DOI 10.1148/radiol.11101503	28	4	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62762	10.1371/journal.pone.0062762	http://dx.doi.org/10.1371/journal.pone.0062762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658769	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500036
J	Gao, JZ; Zhang, C; Fu, X; Yi, Q; Tian, FY; Ning, Q; Luo, XP				Gao, Jinzhi; Zhang, Cai; Fu, Xi; Yi, Qin; Tian, Fengyan; Ning, Qin; Luo, Xiaoping			Effects of Targeted Suppression of Glutaryl-CoA Dehydrogenase by Lentivirus-Mediated shRNA and Excessive Intake of Lysine on Apoptosis in Rat Striatal Neurons	PLOS ONE			English	Article							ACIDURIA TYPE-I; ACIDEMIA TYPE-I; BLOOD-BRAIN-BARRIER; 3-HYDROXYGLUTARIC ACID; MOUSE MODEL; YOUNG-RATS; ENERGY-METABOLISM; OXIDATIVE STRESS; CEREBRAL-CORTEX; DEFICIENCY	In glutaric aciduria type 1 (GA1), glutaryl-CoA dehydrogenase (GCDH) deficiency has been shown to be responsible for the accumulation of glutaric acid and striatal degeneration. However, the mechanisms by which GA1 induces striatal degeneration remain unclear. In this study, we aimed to establish a novel neuronal model of GA1 and to investigate the effects of GCDH deficiency and lysine-related metabolites on the viability of rat striatal neurons. Thus we constructed a lentiviral vector containing short hairpin RNA targeted against the GCDH gene expression (lentivirus-shRNA) in neurons. A virus containing a scrambled short hairpin RNA construct served as a control. Addition of lysine (5 mmol/L) was used to mimic hypermetabolism. Cell viability was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. Apoptosis was assessed using Hoechst33342 staining and Annexin V-PE/7-AAD staining. The mitochondrial membrane potential (MPP) was monitored using tetramethylrhodamine methyl ester. The expression levels of caspases 3, 8, and 9 were determined by Western blotting. We found that lentivirus-shRNA induced apoptosis and decreased MMP levels in neurons, and addition of 5 mmol/L lysine enhanced this effect markedly. Lentivirus-shRNA upregulated the protein levels of caspases 3 and 9 regardless of the presence of 5 mmol/L lysine. The expression level of caspase 8 was higher in neurons co-treated with lentivirus- shRNA and 5 mmol/L lysine than in control. Benzyloxy-carbonyl-Val-Ala-Asp(OMe)-fluoromethylketone, a pan-caspase inhibitor, blocked the apoptosis induced by lentivirus-shRNA and 5 mmol/L lysine to a great extent. These results indicate that the targeted suppression of GCDH by lentivirus-mediated shRNA and excessive intake of lysine may be a useful cell model of GA1. These also suggest that GA1-induced striatal degeneration is partially caspase-dependent.	[Gao, Jinzhi; Zhang, Cai; Fu, Xi; Yi, Qin; Tian, Fengyan; Luo, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pediat, Wuhan 430074, Peoples R China; [Ning, Qin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Infect Dis, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Luo, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pediat, Wuhan 430074, Peoples R China.	xpluo@tjh.tjmu.edu.cn	Zhang, Cai/AAO-8788-2021	Zhang, Cai/0000-0001-6005-0905; fu, xi/0000-0001-6928-4396	National Natural Science Foundation of China [81070699]; Twelfth Five-year National Science Supported Planning Project [2012BAI09B04]; Sector Fund from the Ministry of Health of China [201002006]; Innovation Team Development Plan of the Ministry of Education of China [IRT1131]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Twelfth Five-year National Science Supported Planning Project; Sector Fund from the Ministry of Health of China; Innovation Team Development Plan of the Ministry of Education of China	This study is supported by the National Natural Science Foundation of China (No.81070699) [X.L.], Twelfth Five-year National Science Supported Planning Project (No.2012BAI09B04) [X.L.], the Sector Fund from the Ministry of Health of China (No. 201002006) [X.L.], and Innovation Team Development Plan of the Ministry of Education of China (No. IRT1131) [Q.N.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr O, 2002, NEUROLOGY, V59, P1802, DOI 10.1212/01.WNL.0000036616.11962.3C; Bonthuis PJ, 2010, FRONT NEUROENDOCRIN, V31, P341, DOI 10.1016/j.yfrne.2010.05.001; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao ZY, 2010, TOXICOL SCI, V114, P323, DOI 10.1093/toxsci/kfp312; Christensen E, 2004, J INHERIT METAB DIS, V27, P861, DOI 10.1023/B:BOLI.0000045770.93429.3c; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Coutant F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048644; D'Costa J, 2009, CURR OPIN MOL THER, V11, P554; Di Nunzio F, 2012, VACCINE, V30, P2499, DOI 10.1016/j.vaccine.2012.01.089; Dreyer JL, 2010, METHODS MOL BIOL, V614, P3, DOI 10.1007/978-1-60761-533-0_1; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Ferreira GC, 2007, INT J DEV NEUROSCI, V25, P391, DOI 10.1016/j.ijdevneu.2007.05.009; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; Frizzo MES, 2004, NEUROCHEM INT, V44, P345, DOI 10.1016/S0197-0186(03)00169-4; Funk CBR, 2005, BRAIN, V128, P711, DOI 10.1093/brain/awh401; Gerstner B, 2005, PEDIATR RES, V57, P771, DOI 10.1203/01.PDR.0000157727.21503.8D; Gokmen-Ozel H, 2012, J HUM NUTR DIET, V25, P514, DOI 10.1111/j.1365-277X.2012.01269.x; GOODMAN SI, 1975, BIOCHEM MED METAB B, V12, P12, DOI 10.1016/0006-2944(75)90091-5; Harper Scott Q., 2008, V442, P95, DOI 10.1007/978-1-59745-191-8_8; Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112; Hedlund GL, 2006, AM J MED GENET C, V142C, P86, DOI 10.1002/ajmg.c.30088; Hirst WD, 2003, MOL PHARMACOL, V64, P1295, DOI 10.1124/mol.64.6.1295; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Jafari P, 2011, MOL GENET METAB, V104, P425, DOI 10.1016/j.ymgme.2011.08.027; Joshi DC, 2011, JOVE-J VIS EXP, DOI 10.3791/2704; Kamate M, 2012, ANN INDIAN ACAD NEUR, V15, P31, DOI 10.4103/0972-2327.93273; Keyser B, 2008, BBA-MOL BASIS DIS, V1782, P385, DOI 10.1016/j.bbadis.2008.02.008; Keyser B, 2008, HUM MOL GENET, V17, P3854, DOI 10.1093/hmg/ddn284; Kolker S, 2006, BRAIN, V129, pE54, DOI 10.1093/brain/awl137; Kolker S, 2006, PEDIATR RES, V59, P840, DOI 10.1203/01.pdr.0000219387.79887.86; Kolker S, 2012, MOL GENET METAB, V107, P72, DOI 10.1016/j.ymgme.2012.03.021; Kolker S, 2011, J INHERIT METAB DIS, V34, P677, DOI 10.1007/s10545-011-9289-5; Koeller DM, 2004, J INHERIT METAB DIS, V27, P813, DOI 10.1023/B:BOLI.0000045763.52907.5e; Koeller DM, 2002, HUM MOL GENET, V11, P347, DOI 10.1093/hmg/11.4.347; Lamp J, 2011, J BIOL CHEM, V286, P17777, DOI 10.1074/jbc.M111.232744; Latini A, 2005, NEUROSCIENCE, V135, P111, DOI 10.1016/j.neuroscience.2005.05.013; Latini A, 2005, J INHERIT METAB DIS, V28, P57, DOI 10.1007/s10545-005-3677-7; Leipnitz G, 2005, INT J DEV NEUROSCI, V23, P695, DOI 10.1016/j.ijdevneu.2005.08.004; Lin X, 2006, CARCINOGENESIS, V27, P1538, DOI 10.1093/carcin/bgl002; Manilla P, 2005, HUM GENE THER, V16, P17, DOI 10.1089/hum.2005.16.17; Martin E, 2011, HUM MOL GENET, V20, P2422, DOI 10.1093/hmg/ddr148; Molles BE, 2006, J MOL NEUROSCI, V30, P105, DOI 10.1385/JMN:30:1:105; Moran M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009; Muhlhausen C, 2003, J INHERIT METAB DIS, V26, P713, DOI 10.1023/B:BOLI.0000005604.90621.e2; Olivera-Bravo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020831; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; Quincozes-Santos A, 2010, METAB BRAIN DIS, V25, P191, DOI 10.1007/s11011-010-9203-0; Rohn TT, 2010, APOPTOSIS, V15, P1403, DOI 10.1007/s10495-010-0463-2; Ruiz M, 2012, NEUROBIOL DIS, V48, P202, DOI 10.1016/j.nbd.2011.08.023; Sauer SW, 2010, BBA-MOL BASIS DIS, V1802, P552, DOI 10.1016/j.bbadis.2010.03.003; Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x; Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200; Schambach A, 2008, CURR GENE THER, V8, P474, DOI 10.2174/156652308786848049; Seredenina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022231; Sliva K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-248; Tian FY, 2012, J HUAZHONG U SCI-MED, V32, P107, DOI 10.1007/s11596-012-0019-5; van der Watt G, 2010, MOL GENET METAB, V101, P178, DOI 10.1016/j.ymgme.2010.07.018; Wajner M, 2004, J INHERIT METAB DIS, V27, P825, DOI 10.1023/B:BOLI.0000045765.37043.fb; Wajner M, 2011, J BIOENERG BIOMEMBR, V43, P31, DOI 10.1007/s10863-011-9324-0; Yang LL, 2011, MED SCI MONITOR, V17, pPH55, DOI 10.12659/MSM.881834; Zafeiriou DI, 2000, NEUROPEDIATRICS, V31, P303, DOI 10.1055/s-2000-12943; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617; Zinnanti WJ, 2006, BRAIN, V129, P899, DOI 10.1093/brain/awl009	63	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63084	10.1371/journal.pone.0063084	http://dx.doi.org/10.1371/journal.pone.0063084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658800	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500055
J	Iwata, M; Ochi, H; Asou, Y; Haro, H; Aikawa, T; Harada, Y; Nezu, Y; Yogo, T; Tagawa, M; Hara, Y				Iwata, Munetaka; Ochi, Hiroki; Asou, Yoshinori; Haro, Hirotaka; Aikawa, Takeshi; Harada, Yasuji; Nezu, Yoshinori; Yogo, Takuya; Tagawa, Masahiro; Hara, Yasushi			Variations in Gene and Protein Expression in Canine Chondrodystrophic Nucleus Pulposus Cells following Long-Term Three-Dimensional Culture	PLOS ONE			English	Article							INTERVERTEBRAL DISC CELLS; EXTRACELLULAR-MATRIX; ANULUS FIBROSUS; LUMBAR SPINE; CLASSIFICATION; DEGENERATION; BIOCHEMISTRY; METABOLISM; PHENOTYPE; PRODUCE	Intervertebral disc (IVD) degeneration greatly affects quality of life. The nucleus pulposus (NP) of chondrodystrophic dog breeds (CDBs) is similar to the human NP, because the cells disappear with age and are replaced by fibrochondrocyte-like cells. However, because IVD develops as early as within the first year of life, we used canines as a model to investigate in vitro the mechanisms underlying IVD degeneration. Specifically, we evaluated the potential of a three-dimensional (3D) culture of healthy NP as an in vitro model system to investigate the mechanisms of IVD degeneration. Agarose hydrogels were populated with healthy NP cells from beagles after performing magnetic resonance imaging, and mRNA expression profiles and pericellular extracellular matrix (ECM) protein distribution were determined. After 25 days of 3D culture, there was a tendency for redifferentiation into the native NP phenotype, and mRNA levels of Col2A1, COMP, and CK18 were not significantly different from those of freshly isolated cells. Our findings suggest that long-term 3D culture promoted chondrodystrophic NP redifferentiation through reconstruction of the pericellular microenvironment. Further, lipopolysaccharide (LPS) induced expression of TNF-alpha, MMP3, MMP13, VEGF, and PGES mRNA in the 3D cultures, creating a molecular milieu that mimics that of degenerated NP. These results suggest that this in vitro model represents a reliable and cost-effective tool for evaluating new therapies for disc degeneration.	[Iwata, Munetaka; Harada, Yasuji; Nezu, Yoshinori; Yogo, Takuya; Tagawa, Masahiro; Hara, Yasushi] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Sci, Div Vet Surg, Musashino, Tokyo, Japan; [Ochi, Hiroki] Nippon Vet & Life Sci Univ, Fac Vet Sci, Sch Vet Med, Lab Vet Microbiol, Musashino, Tokyo, Japan; [Asou, Yoshinori] Tokyo Med & Dent Univ, Dev Div Adv Orthoped Therapeut, Bunkyo Ku, Tokyo, Japan; [Haro, Hirotaka] Univ Yamanashi, Grad Sch Med & Engn, Dept Orthoped Surg, Chuo, Yamanashi, Japan; [Aikawa, Takeshi] Aikawa Vet Med Ctr, Tokyo, Japan; [Aikawa, Takeshi] Vet Surg Serv Japan, Shinjuku Ku, Tokyo, Japan	Nippon Veterinary & Life Science University; Nippon Veterinary & Life Science University; Tokyo Medical & Dental University (TMDU); University of Yamanashi	Ochi, H (corresponding author), Nippon Vet & Life Sci Univ, Fac Vet Sci, Sch Vet Med, Lab Vet Microbiol, 1-7-1 Kyonancho, Musashino, Tokyo, Japan.	ochi-vet@nvlu.ac.jp		Iwata, Munetaka/0000-0002-5561-4996	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Aota Y, 2006, CELL TISSUE RES, V326, P787, DOI 10.1007/s00441-006-0225-1; Bjornsson S, 1998, ANAL BIOCHEM, V256, P229, DOI 10.1006/abio.1997.2494; BRAUND KG, 1975, RES VET SCI, V19, P167, DOI 10.1016/S0034-5288(18)33527-6; Cappello R, 2006, SPINE, V31, P873, DOI 10.1097/01.brs.0000209302.00820.fd; Cheng CC, 2009, J CELL PHYSIOL, V221, P668, DOI 10.1002/jcp.21904; Chou AI, 2006, SPINE, V31, P1875, DOI 10.1097/01.brs.0000229222.98051.9a; Doita M, 1996, SPINE, V21, P235, DOI 10.1097/00007632-199601150-00015; Gage E. D., 1975, Journal of the American Animal Hospital Association, V11, P167; Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1; HANSEN H J, 1952, Acta Orthop Scand Suppl, V11, P1; Horner HA, 2002, SPINE, V27, P1018, DOI 10.1097/00007632-200205150-00004; Hutton WC, 1999, SPINE, V24, P1507, DOI 10.1097/00007632-199908010-00002; Jimbo K, 2005, J NEUROSURG-SPINE, V2, P589, DOI 10.3171/spi.2005.2.5.0589; KANG JD, 1995, SPINE, V20, P2373, DOI 10.1097/00007632-199511001-00001; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; OEGEMA TR, 1993, CLIN SPORT MED, V12, P419; Oegema TR, 2002, BIOCHEM SOC T, V30, P839, DOI 10.1042/bst0300839; Ono T, 1951, MEDICINE BIOLOGY JAP, V19, P326; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; PRIESTER W A, 1976, Theriogenology, V6, P293, DOI 10.1016/0093-691X(76)90021-2; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Specchia N, 2002, EUR SPINE J, V11, P145, DOI 10.1007/s00586-001-0361-y; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Wang JY, 2001, SPINE, V26, P1747, DOI 10.1097/00007632-200108150-00003; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Wuertz K, 2009, J ORTHOP RES, V27, P1235, DOI 10.1002/jor.20867	30	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63120	10.1371/journal.pone.0063120	http://dx.doi.org/10.1371/journal.pone.0063120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658803	Green Submitted, gold, Green Published			2022-12-27	WOS:000321200500056
J	Arrubla, J; Neuner, I; Hahn, D; Boers, F; Shah, NJ				Arrubla, Jorge; Neuner, Irene; Hahn, David; Boers, Frank; Shah, N. Jon			Recording Visual Evoked Potentials and Auditory Evoked P300 at 9.4T Static Magnetic Field	PLOS ONE			English	Article							FOCAL CORTICAL DYSPLASIA; SIMULTANEOUS EEG-FMRI; BALLISTOCARDIOGRAM ARTIFACT; DYNAMICS; BRAIN; RESPONSES; NETWORKS	Simultaneous recording of electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) has shown a number of advantages that make this multimodal technique superior to fMRI alone. The feasibility of recording EEG at ultra-high static magnetic field up to 9.4T was recently demonstrated and promises to be implemented soon in fMRI studies at ultra high magnetic fields. Recording visual evoked potentials are expected to be amongst the most simple for simultaneous EEG/fMRI at ultra-high magnetic field due to the easy assessment of the visual cortex. Auditory evoked P300 measurements are of interest since it is believed that they represent the earliest stage of cognitive processing. In this study, we investigate the feasibility of recording visual evoked potentials and auditory evoked P300 in a 9.4T static magnetic field. For this purpose, EEG data were recorded from 26 healthy volunteers inside a 9.4T MR scanner using a 32-channel MR compatible EEG system. Visual stimulation and auditory oddball paradigm were presented in order to elicit evoked related potentials (ERP). Recordings made outside the scanner were performed using the same stimuli and EEG system for comparison purposes. We were able to retrieve visual P100 and auditory P300 evoked potentials at 9.4T static magnetic field after correction of the ballistocardiogram artefact using independent component analysis. The latencies of the ERPs recorded at 9.4T were not different from those recorded at 0T. The amplitudes of ERPs were higher at 9.4T when compared to recordings at 0T. Nevertheless, it seems that the increased amplitudes of the ERPs are due to the effect of the ultra-high field on the EEG recording system rather than alteration in the intrinsic processes that generate the electrophysiological responses.	[Arrubla, Jorge; Neuner, Irene; Hahn, David; Boers, Frank; Shah, N. Jon] Forschungszentrum Julich, INM 4, D-52425 Julich, Germany; [Neuner, Irene; Hahn, David] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Neuner, Irene; Shah, N. Jon] JARA BRAIN Translat Med, Aachen, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University	Arrubla, J (corresponding author), Forschungszentrum Julich, INM 4, D-52425 Julich, Germany.	j.arrubla@fz-juelich.de	Neuner, Irene/J-6619-2013; Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Neuner, Irene/0000-0002-5164-8873				Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Bagshaw AP, 2007, NEUROIMAGE, V38, P280, DOI 10.1016/j.neuroimage.2007.07.042; Blinowska K., 2009, COMPUT INTELL NEUROS, DOI DOI 10.1155/2009/813607; De Martino F, 2010, MAGN RESON IMAGING, V28, P1104, DOI 10.1016/j.mri.2009.12.026; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Debener S, 2008, INT J PSYCHOPHYSIOL, V67, P189, DOI 10.1016/j.ijpsycho.2007.05.015; Debener S, 2008, INT J PSYCHOPHYSIOL, V67, P159, DOI 10.1016/j.ijpsycho.2007.07.001; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Debener S, 2011, CLIN NEUROPHYSIOL, V122, P217, DOI 10.1016/j.clinph.2010.07.008; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eichele T, 2005, P NATL ACAD SCI USA, V102, P17798, DOI 10.1073/pnas.0505508102; Heinrich A, 2013, RADIOLOGY, V266, P236, DOI 10.1148/radiol.12112172; Huiskamp GJM, 2005, P ANN INT IEEE EMBS, P3691, DOI 10.1109/IEMBS.2005.1617283; Juckel G, 2012, NEUROIMAGE, V60, P2027, DOI 10.1016/j.neuroimage.2012.02.019; Kim YH, 2011, EPILEPSIA, V52, P722, DOI 10.1111/j.1528-1167.2010.02950.x; Koike T, 2011, NEUROSCI RES, V69, P322, DOI 10.1016/j.neures.2010.12.018; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2012, NEUROIMAGE, V62, P962, DOI 10.1016/j.neuroimage.2012.01.033; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Neuner I, 2013, NEUROIMAGE, V68, P214, DOI 10.1016/j.neuroimage.2012.11.064; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Ostwald D, 2010, NEUROIMAGE, V49, P498, DOI 10.1016/j.neuroimage.2009.07.038; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Schlamann M, 2010, J MAGN RESON IMAGING, V31, P1061, DOI 10.1002/jmri.22065; Thornton R, 2011, ANN NEUROL, V70, P822, DOI 10.1002/ana.22535	30	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62915	10.1371/journal.pone.0062915	http://dx.doi.org/10.1371/journal.pone.0062915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650538	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000083
J	Chandrasekar, G; Vesterlund, L; Hultenby, K; Tapia-Paez, I; Kere, J				Chandrasekar, Gayathri; Vesterlund, Liselotte; Hultenby, Kjell; Tapia-Paez, Isabel; Kere, Juha			The Zebrafish Orthologue of the Dyslexia Candidate Gene DYX1C1 Is Essential for Cilia Growth and Function	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; IN-UTERO RNAI; DEVELOPMENTAL DYSLEXIA; NEURONAL MIGRATION; KUPFFERS VESICLE; JOUBERT-SYNDROME; DYNEIN ARMS; ASSOCIATION; BRAIN; DYSKINESIA	DYX1C1, a susceptibility gene for dyslexia, encodes a tetratricopeptide repeat domain containing protein that has been implicated in neuronal migration in rodent models. The developmental role of this gene remains unexplored. To understand the biological function(s) of zebrafish dyx1c1 during embryonic development, we cloned the zebrafish dyx1c1 and used morpholino-based knockdown strategy. Quantitative real-time PCR analysis revealed the presence of dyx1c1 transcripts in embryos, early larval stages and in a wide range of adult tissues. Using mRNA in situ hybridization, we show here that dyx1c1 is expressed in many ciliated tissues in zebrafish. Inhibition of dyx1c1 produced pleiotropic phenotypes characteristically associated with cilia defects such as body curvature, hydrocephalus, situs inversus and kidney cysts. We also demonstrate that in dyx1c1 morphants, cilia length is reduced in several organs including Kupffer's vesicle, pronephros, spinal canal and olfactory placode. Furthermore, electron microscopic analysis of cilia in dyx1c1 morphants revealed loss of both outer (ODA) and inner dynein arms (IDA) that have been shown to be required for cilia motility. Considering all these results, we propose an essential role for dyx1c1 in cilia growth and function.	[Chandrasekar, Gayathri; Vesterlund, Liselotte; Tapia-Paez, Isabel; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden; [Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Clin Res Ctr, Stockholm, Sweden; [Kere, Juha] Univ Helsinki, Res Programs Unit, Helsinki & Mol Neurol Program, Folkhalsan Inst Genet, Helsinki, Finland; [Kere, Juha] Karolinska Inst, Sci Life Lab, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Helsinki; Karolinska Institutet	Kere, J (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden.	juha.kere@ki.se	Tapia-Páez, Isabel/N-1210-2013; Tapia-Páez, Isabel/ABD-7197-2021; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Vesterlund, Liselotte/0000-0003-3547-9288; Tapia-Paez, Isabel/0000-0002-0535-4233	Swedish Research Council; Swedish Royal Bank Tercentennial Foundation, Swedish Brain Foundation; Center for Biosciences and Sigrid Juselius Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Royal Bank Tercentennial Foundation, Swedish Brain Foundation; Center for Biosciences and Sigrid Juselius Foundation	This work was supported by Swedish Research Council (www.vr.se); Swedish Royal Bank Tercentennial Foundation, Swedish Brain Foundation (Hjarnfonden)(www.hjarnfonden.se); Knut and Alice Wallenberg Foundation (www.wallenberg.com); Center for Biosciences and Sigrid Juselius Foundation(www.sigridjuselius.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Ahmed NT, 2005, MOL BIOL CELL, V16, P5004, DOI 10.1091/mbc.E05-07-0627; Andrews W, 2006, DEVELOPMENT, V133, P2243, DOI 10.1242/dev.02379; Arellano JI, 2012, J COMP NEUROL, V520, P848, DOI 10.1002/cne.22793; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Balci S, 1999, AM J MED GENET, V82, P166, DOI 10.1002/(SICI)1096-8628(19990115)82:2<166::AID-AJMG13>3.0.CO;2-J; Bellini G, 2005, J MOL NEUROSCI, V27, P311, DOI 10.1385/JMN:27:3:311; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Breunig JJ, 2010, NAT NEUROSCI, V13, P654, DOI 10.1038/nn0610-654; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Chandrasekar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009678; Chen YX, 2009, J CANCER RES CLIN, V135, P1265, DOI 10.1007/s00432-009-0568-6; Cope NA, 2005, MOL PSYCHIATR, V10, P237, DOI 10.1038/sj.mp.4001596; Dahdouh F, 2009, PSYCHIAT GENET, V19, P59, DOI 10.1097/YPG.0b013e32832080e1; Darki F, 2012, BIOL PSYCHIAT, V72, P671, DOI 10.1016/j.biopsych.2012.05.008; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Gao CL, 2010, DEV DYNAM, V239, P2190, DOI 10.1002/dvdy.22355; Gorivodsky M, 2009, DEV BIOL, V325, P24, DOI 10.1016/j.ydbio.2008.09.019; GREENSTONE MA, 1984, ARCH DIS CHILD, V59, P481, DOI 10.1136/adc.59.5.481; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; HUMPHREYS P, 1990, ANN NEUROL, V28, P727, DOI 10.1002/ana.410280602; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liang P, 1997, J CELL SCI, V110, P1431; Lim CKP, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-16; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Marino C, 2007, GENES BRAIN BEHAV, V6, P640, DOI 10.1111/j.1601-183X.2006.00291.x; Marino C, 2005, EUR J HUM GENET, V13, P491, DOI 10.1038/sj.ejhg.5201356; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Massinen S, 2009, HUM MOL GENET, V18, P2802, DOI 10.1093/hmg/ddp215; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Meng HY, 2005, HUM GENET, V118, P87, DOI 10.1007/s00439-005-0017-9; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Obara T, 2006, J AM SOC NEPHROL, V17, P2706, DOI 10.1681/ASN.2006040412; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rosen GD, 2007, CEREB CORTEX, V17, P2562, DOI 10.1093/cercor/bhl162; Scerri TS, 2004, J MED GENET, V41, P853, DOI 10.1136/jmg.2004.018341; SCHIDLOW DV, 1994, ANN ALLERGY, V73, P457; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Szalkowski CE, 2011, GENES BRAIN BEHAV, V10, P244, DOI 10.1111/j.1601-183X.2010.00662.x; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Tammimies K, 2013, BIOL PSYCHIAT, V73, P583, DOI 10.1016/j.biopsych.2012.08.012; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Threlkeld SW, 2007, BRAIN RES BULL, V71, P508, DOI 10.1016/j.brainresbull.2006.11.005; TORIKATA C, 1991, AM J PATHOL, V138, P341; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Venkatesh SK, 2011, BEHAV GENET, V41, P105, DOI 10.1007/s10519-010-9441-2; Wang Y, 2006, NEUROSCIENCE, V143, P515, DOI 10.1016/j.neuroscience.2006.08.022; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004	77	40	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63123	10.1371/journal.pone.0063123	http://dx.doi.org/10.1371/journal.pone.0063123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650548	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000093
J	Chen, SA; Chen, JZ; Chen, LJ; Zhang, QA; Luo, XQ; Zhang, WH				Chen, Sheng'an; Chen, Jiazhen; Chen, Lianjun; Zhang, Qiao'an; Luo, Xiaoqun; Zhang, Wenhong			Mycobacterium tuberculosis Infection Is Associated with the Development of Erythema Nodosum and Nodular Vasculitis	PLOS ONE			English	Article							GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; SKIN-TEST; DIAGNOSIS; INDURATUM; PCR; DNA; PULMONARY; LEPROSUM; CHINA	Background: Mycobacterium tuberculosis (MTB) infection has been suggested to contribute to the pathogenesis of erythema nodosum (EN) and nodular vasculitis (NV), the classic forms of panniculitis. However, there is little evidence to demonstrate the presence of MTB in the skin lesions. This study is aimed at evaluating the association between MTB infection and the development of EN and NV in a Chinese population. Methods: A total of 107 patients (36 EN, 27 NV, and 44 others) with vasculitis and 40 control cases with other skin diseases were recruited and their skin lesion samples were subjected to real time polymerase chain reaction (PCR) analysis of the IS6110 and mpt64 gene fragments of MTB. Their blood mononuclear cells were tested for MTB antigen-specific IFN-gamma responses by QuantiFERON (R)-TB Gold In-Tube (IT) assays. Results: PCR analysis revealed that 7/23 (30.4%) and 7/18 (38.9%) of the EN and NV samples were positive for the IS6110 DNA, respectively, which were significantly higher than 3/34 (8.8%) of other vasculitis (OV) and 3/40 (7.5%) of the control samples (p<0.05). The nested Real-Time PCR assay indicated that 6/7 (86%) of the IS6110-positive EN samples, all of the IS6110-positive NV and control samples, but only 1/3 of the IS6110-positive OV samples, were positive for the mpt64 gene. Similarly, 19/32 (59.4%) of the EN patients, 20/26 (76.9%) of the NV patients, and 17/36 (47.2%) of the OV patients were positive for MTB antigen-specific IFN-gamma responses, which were significantly higher than 6/40 (15%) of the controls (p<0.05). Conclusion: Our data strongly suggest that MTB infection and active TB are associated with the development of NV and EN in Chinese.	[Chen, Sheng'an; Chen, Lianjun; Zhang, Qiao'an; Luo, Xiaoqun] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Chen, Jiazhen; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Luo, XQ (corresponding author), Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China.	xiaoqunluo09@gmail.com; zhangwenhong@fudan.edu.cn						Adhe Vijay, 2012, Indian J Dermatol, V57, P114, DOI 10.4103/0019-5154.94278; Angus J, 2007, BRIT J DERMATOL, V157, P1293, DOI 10.1111/j.1365-2133.2007.08227.x; Baselga E, 1997, ARCH DERMATOL, V133, P457, DOI 10.1001/archderm.133.4.457; Broccolo F, 2003, J CLIN MICROBIOL, V41, P4565, DOI 10.1128/JCM.41.10.4565-4572.2003; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Chan CM, 1996, J CLIN PATHOL, V49, P290, DOI 10.1136/jcp.49.4.290; Cho KH, 1996, INT J DERMATOL, V35, P802, DOI 10.1111/j.1365-4362.1996.tb02979.x; Cuevas J, 2007, SEMIN CUTAN MED SURG, V26, P126, DOI 10.1016/j.sder.2007.02.010; El Khechine A, 2009, MICROBIOL-SGM, V155, P2384, DOI 10.1099/mic.0.026484-0; Feng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032652; Garcia-Porrua C, 2000, ARTHRITIS RHEUM, V43, P584, DOI 10.1002/1529-0131(200003)43:3<584::AID-ANR15>3.0.CO;2-6; Gilchrist H, 2010, DERMATOL THER, V23, P320, DOI 10.1111/j.1529-8019.2010.01332.x; Gupta SN, 2002, INT J DERMATOL, V41, P173, DOI 10.1046/j.1365-4362.2002.01390.x; Kalantri Y, 2009, INDIAN J EXP BIOL, V47, P463; KARAT ABA, 1968, BMJ-BRIT MED J, V4, P223, DOI 10.1136/bmj.4.5625.223; Lalvani A, 2010, ENFERM INFEC MICR CL, V28, P245, DOI 10.1016/j.eimc.2009.05.012; Mahan CS, 2011, INT J TUBERC LUNG D, V15, P174; Marker M, 2004, J DTSCH DERMATOL GES, V2, P215; Marker Michael, 2004, J Dtsch Dermatol Ges, V2, P206, DOI 10.1046/j.1439-0353.2004.03627.x; Mert A, 2004, SCAND J INFECT DIS, V36, P424, DOI 10.1080/00365540410027184; Mert A, 2004, J DERMATOL, V31, P66, DOI 10.1111/j.1346-8138.2004.tb00509.x; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Papagrigoraki A, 2010, EUR J DERMATOL, V20, P773, DOI 10.1684/ejd.2010.1116; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Requena L, 2007, SEMIN CUTAN MED SURG, V26, P114, DOI 10.1016/j.sder.2007.02.009; Sarveswari K N, 2001, Indian J Dermatol Venereol Leprol, V67, P287; Segura S, 2008, J AM ACAD DERMATOL, V59, P839, DOI 10.1016/j.jaad.2008.07.030; Sun L, 2010, CHINESE MED J-PEKING, V123, P2786, DOI 10.3760/cma.j.issn.0366-6999.2010.20.007; Takahashi T, 2008, J CLIN MICROBIOL, V46, P1708, DOI 10.1128/JCM.01200-07; Tan SH, 1999, INT J DERMATOL, V38, P122, DOI 10.1046/j.1365-4362.1999.00576.x; Tantisirin Ora, 2003, Journal of the Medical Association of Thailand, V86, P1095; Wan XF DL, 2006, CHIN J DERM VENEREOL, V20, P353; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; Yang YR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1110; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10; Zhao YL, 2012, EXP THER MED, V4, P949, DOI 10.3892/etm.2012.699	38	14	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62653	10.1371/journal.pone.0062653	http://dx.doi.org/10.1371/journal.pone.0062653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650522	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000066
J	Lee, YK; Hou, SW; Lee, CC; Hsu, CY; Huang, YS; Su, YC				Lee, Yi-Kung; Hou, Sheng-Wen; Lee, Ching-Chih; Hsu, Chen-Yang; Huang, Yung-Sung; Su, Yung-Cheng			Increased Risk of Dementia in Patients with Mild Traumatic Brain Injury: A Nationwide Cohort Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; PREVALENCE; ACCURACY	Background: It is known that the risk of dementia in patients with moderate to severe traumatic brain injury (TBI) is higher. However, the relationship between mild traumatic brain injury (mTBI) and dementia has never been established. Objectives: We investigated the incidences of dementia among patients with mTBI in Taiwan to evaluate if there is higher risk compared with general population. Methods: We utilized a sampled National Health Insurance (NHI) claims data containing one million beneficiaries. We followed all adult beneficiaries from January 1, 2005 till December 31, 2009 to see if they had been diagnosed with dementia. We further identify patients with mTBI and compared their risk of dementia with the general population. Results: We identified 28551 patients with mTBI and 692382 without. After controlled for age, gender, urbanization level, socioeconomic status, diabetes, hypertension, coronary artery disease, hyperlipidemia, history of alcohol intoxication, history of ischemic stroke, history of intracranial hemorrhage and Charlson Comorbidity Index Score, the adjusted hazard ratio is 3.26 (95% Confidence interval, 2.69-3.94). Conclusions: TBI is an independent significant risk factor of developing dementia even in the mild type.	[Lee, Yi-Kung; Su, Yung-Cheng] Buddhist Tzu Chi Dalin Gen Hosp, Emergency Dept, Chiayi, Taiwan; [Lee, Yi-Kung; Lee, Ching-Chih; Su, Yung-Cheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hou, Sheng-Wen] Shin Kong Wu Ho Mem Hosp, Emergency Dept, Taipei, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Hsu, Chen-Yang] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Huang, Yung-Sung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Neurol, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Tzu Chi University; Shin Kong Wu Ho Su Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Taiwan University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Su, YC (corresponding author), Buddhist Tzu Chi Dalin Gen Hosp, Emergency Dept, Chiayi, Taiwan.	drsu119@gmail.com						[Anonymous], 1994, AM PSYCHIAT ASS DIAG, V4th; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corrada MM, 2008, NEUROLOGY, V71, P337, DOI 10.1212/01.wnl.0000310773.65918.cd; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fuh J-L., 2008, TAIWAN GERIATR GERON, V3, P169; Hebert LE, 2004, NEUROLOGY, V62, P2021, DOI 10.1212/01.WNL.0000129258.93137.4B; Howards PP, 2012, AM J EPIDEMIOL, V176, P506, DOI 10.1093/aje/kws127; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kovacic JC, 2012, MT SINAI J MED, V79, P664, DOI 10.1002/msj.21347; Lee CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035923; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pouryamout L, 2012, DRUGS, V72, P789, DOI 10.2165/11631830-000000000-00000; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Sattler C, 2012, PSYCHIAT RES, V196, P90, DOI 10.1016/j.psychres.2011.11.012; Schmidt R, 2008, NEUROPSYCHIATRIE, V22, P1; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Shively S, 2012, ARCH NEUROL-CHICAGO, P1; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Tan ZS, 2003, ARCH INTERN MED, V163, P1053, DOI 10.1001/archinte.163.9.1053; Tang BL, 2009, CELL ADHES MIGR, V3, P118, DOI 10.4161/cam.3.1.7254; Xu WL, 2004, NEUROLOGY, V63, P1181, DOI 10.1212/01.WNL.0000140291.86406.D1	25	139	143	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62422	10.1371/journal.pone.0062422	http://dx.doi.org/10.1371/journal.pone.0062422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658727	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000044
J	Zhang, XY; Liu, YY; Yang, M; Zhang, T; Young, AA; Li, XS				Zhang, Xingyu; Liu, Yuanyuan; Yang, Min; Zhang, Tao; Young, Alistair A.; Li, Xiaosong			Comparative Study of Four Time Series Methods in Forecasting Typhoid Fever Incidence in China	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; ANTITYPHOID IMMUNIZATION; EPIDEMIOLOGIC MODEL; PREDICTION; ELMAN; PERFORMANCE; INFECTION	Accurate incidence forecasting of infectious disease is critical for early prevention and for better government strategic planning. In this paper, we present a comprehensive study of different forecasting methods based on the monthly incidence of typhoid fever. The seasonal autoregressive integrated moving average (SARIMA) model and three different models inspired by neural networks, namely, back propagation neural networks (BPNN), radial basis function neural networks (RBFNN), and Elman recurrent neural networks (ERNN) were compared. The differences as well as the advantages and disadvantages, among the SARIMA model and the neural networks were summarized and discussed. The data obtained for 2005 to 2009 and for 2010 from the Chinese Center for Disease Control and Prevention were used as modeling and forecasting samples, respectively. The performances were evaluated based on three metrics: mean absolute error (MAE), mean absolute percentage error (MAPE), and mean square error (MSE). The results showed that RBFNN obtained the smallest MAE, MAPE and MSE in both the modeling and forecasting processes. The performances of the four models ranked in descending order were: RBFNN, ERNN, BPNN and the SARIMA model.	[Zhang, Xingyu; Liu, Yuanyuan; Zhang, Tao; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Dept Med Stat, Chengdu 610064, Sichuan, Peoples R China; [Yang, Min] Univ Nottingham, Sch Community Hlth Sci, Div Psychiat, Nottingham NG7 2RD, England; [Young, Alistair A.] Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand	Sichuan University; University of Nottingham; University of Auckland	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Med Stat, Chengdu 610064, Sichuan, Peoples R China.	lixiaosong1101@126.com	liu, yuanyuan/GWZ-5838-2022	Young, Alistair/0000-0001-5702-4220; Zhang, Xingyu/0000-0001-8108-1997	National Special Foundation for Health Research of China [200802133]	National Special Foundation for Health Research of China	The whole study and the paper were financially supported by the National Special Foundation for Health Research of China (grant no. 200802133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale MH, 2012, NEURAL NETWORK TOOLB; BIANCHINI M, 1995, IEEE T NEURAL NETWOR, V6, P749, DOI 10.1109/72.377979; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Brunelli U, 2008, BUILD ENVIRON, V43, P304, DOI 10.1016/j.buildenv.2006.05.011; Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002; Christodoulos C, 2011, TECHNOL FORECAST SOC, V78, P163, DOI 10.1016/j.techfore.2010.08.007; Cooke FJ, 2007, T ROY SOC TROP MED H, V101, P398, DOI 10.1016/j.trstmh.2006.07.005; CVJETANOVIC B, 1971, B WORLD HEALTH ORGAN, V45, P53; CVJETANOVIC B, 1986, MATH MODELLING, V7, P719, DOI 10.1016/0270-0255(86)90129-6; Dominguez A, 2007, ANN EPIDEMIOL, V17, P654, DOI 10.1016/j.annepidem.2007.03.006; Faruk DO, 2010, ENG APPL ARTIF INTEL, V23, P586, DOI 10.1016/j.engappai.2009.09.015; Fong PW, 2003, COMPUT STAT DATA AN, V43, P369, DOI 10.1016/S0167-9473(02)00298-0; Galbraith JW, 1999, J ECONOMETRICS, V93, P25, DOI 10.1016/S0304-4076(98)00097-9; Gonzalez-Parra G, 2009, COMMUN NONLINEAR SCI, V14, P3967, DOI 10.1016/j.cnsns.2009.02.023; Grahn T., 1995, J TIMES SERIES ANAL, V16, P509, DOI [DOI 10.1111/J.1467-9892.1995.TB00251.X, 10.1111/j.1467-9892.1995.tb00251.x]; Guan P, 2004, WORLD J GASTROENTERO, V10, P3579, DOI 10.3748/wjg.v10.i24.3579; Guo ZH, 2011, KNOWL-BASED SYST, V24, P1048, DOI 10.1016/j.knosys.2011.04.019; Hamzacebi C, 2008, INFORM SCIENCES, V178, P4550, DOI 10.1016/j.ins.2008.07.024; Haykin S., 2008, NEURAL NETWORKS LEAR, P1; HELFENSTEIN U, 1986, STAT MED, V5, P37, DOI 10.1002/sim.4780050107; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Ho SL, 2002, COMPUT IND ENG, V42, P371, DOI 10.1016/S0360-8352(02)00036-0; Huang CM, 2007, IEEE T POWER SYST, V22, P96, DOI 10.1109/TPWRS.2006.889133; Jayawardena A. W., 1998, Computer-Aided Civil and Infrastructure Engineering, V13, P91, DOI 10.1111/0885-9507.00089; Jiang LH, 2011, J IRON STEEL RES INT, V18, P25, DOI 10.1016/S1006-706X(11)60099-X; KOEHLER AB, 1988, J R STAT SOC C-APPL, V37, P187; Kumar ARS, 2005, HYDROL PROCESS, V19, P1277, DOI 10.1002/hyp.5581; Li G, 2010, APPL ENERG, V87, P2313, DOI 10.1016/j.apenergy.2009.12.013; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Liu Hong-mei, 2006, Chinese Journal of Aeronautics, V19, P346, DOI 10.1016/S1000-9361(11)60339-7; Liu K, 2012, ENRGY PROCED, V14, P1918, DOI 10.1016/j.egypro.2011.12.1188; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; Maier HR, 2000, ENVIRON MODELL SOFTW, V15, P101, DOI 10.1016/S1364-8152(99)00007-9; Maqsood I, 2007, APPL SOFT COMPUT, V7, P995, DOI 10.1016/j.asoc.2006.06.005; MOGHRAM I, 1989, IEEE T POWER SYST, V4, P1484, DOI 10.1109/59.41700; Naheed A, 2010, INT J INFECT DIS, V14, pE93, DOI 10.1016/j.ijid.2009.11.023; Ngo L, 1996, AM J EPIDEMIOL, V143, P637; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Pham DT, 1996, INT J SYST SCI, V27, P221, DOI 10.1080/00207729608929207; Portegys TE, 2010, NEURAL NETWORKS, V23, P306, DOI 10.1016/j.neunet.2009.11.002; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; Rios M, 1996, MED CLIN-BARCELONA, V106, P686; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Saini LM, 2002, IEE P-GENER TRANSM D, V149, P578, DOI 10.1049/ip-gtd:20020462; Seker S, 2003, ENG APPL ARTIF INTEL, V16, P647, DOI 10.1016/j.engappai.2003.10.004; Sfetsos A, 2000, RENEW ENERG, V21, P23, DOI 10.1016/S0960-1481(99)00125-1; Sherstinsky A, 1996, IEEE T NEURAL NETWOR, V7, P195, DOI 10.1109/72.478404; Spaeder MC, 2012, EPIDEMIOL INFECT, V140, P602, DOI 10.1017/S0950268811001026; The SAS Company, SAS ETS R 9 2 US GUI; Ture M, 2006, EXPERT SYST APPL, V31, P41, DOI 10.1016/j.eswa.2005.09.002; Wang JZ, 2011, EXPERT SYST APPL, V38, P14346, DOI 10.1016/j.eswa.2011.04.222; Wang Z, 2011, ENRGY PROCED, V12, DOI 10.1016/j.egypro.2011.10.065; Wedding DK, 1996, NEUROCOMPUTING, V10, P149, DOI 10.1016/0925-2312(95)00021-6; Weisent J, 2010, EPIDEMIOL INFECT, V138, P898, DOI 10.1017/S0950268810000154; Wilamowski B., 2011, INTELLIGENT SYSTEMS, P1; Wilamowski BM, 2001, IEEE IJCNN, P1778, DOI 10.1109/IJCNN.2001.938431; Wongkoon S, 2012, ASIAN PAC J TROP MED, V5, P249, DOI 10.1016/S1995-7645(12)60034-0; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7	61	51	55	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63116	10.1371/journal.pone.0063116	http://dx.doi.org/10.1371/journal.pone.0063116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650546	gold, Green Submitted, Green Published			2022-12-27	WOS:000319167000091
J	Aschan, M; Fossheim, M; Greenacre, M; Primicerio, R				Aschan, Michaela; Fossheim, Maria; Greenacre, Michael; Primicerio, Raul			Change in Fish Community Structure in the Barents Sea	PLOS ONE			English	Article							CAPELIN MALLOTUS-VILLOSUS; HERRING CLUPEA-HARENGUS; CLIMATE-CHANGE; REGIME SHIFTS; CONTINENTAL-SHELF; ASSEMBLAGE STRUCTURE; TROPHIC CASCADES; DEMERSAL FISH; MARINE; ECOSYSTEMS	Change in oceanographic conditions causes structural alterations in marine fish communities, but this effect may go undetected as most monitoring programs until recently mainly have focused on oceanography and commercial species rather than on whole ecosystems. In this paper, the objective is to describe the spatial and temporal changes in the Barents Sea fish community in the period 1992-2004 while taking into consideration the observed abundance and biodiversity patterns for all 82 observed fish species. We found that the spatial structure of the Barents Sea fish community was determined by abiotic factors such as temperature and depth. The observed species clustered into a deep assemblage, a warm water southern assemblage, both associated with Atlantic water, and a cold water north-eastern assemblage associated with mixed water. The latitude of the cold water NE and warm water S assemblages varied from year to year, but no obvious northward migration was observed over time. In the period 1996-1999 we observed a significant reduction in total fish biomass, abundance, mean fish weight, and a change in community structure including an increase in the pelagic/demersal ratio. This change in community structure is probably due to extremely cold conditions in 1996 impacting on a fish community exposed to historically high fishing rates. After 1999 the fish community variables such as biomass, abundance, mean weight, P/D ratio as well as community composition did not return to levels of the early 90s, although fishing pressure and climatic conditions returned to earlier levels.	[Aschan, Michaela; Greenacre, Michael; Primicerio, Raul] Univ Tromso, Fac Biosci Fisheries & Econ, Tromso, Norway; [Fossheim, Maria] Inst Marine Res, Tromso, Norway; [Greenacre, Michael] Univ Pompeu Fabra, Dept Econ & Business, Barcelona, Spain	UiT The Arctic University of Tromso; Institute of Marine Research - Norway; Pompeu Fabra University	Aschan, M (corresponding author), Univ Tromso, Fac Biosci Fisheries & Econ, Tromso, Norway.	michaela.aschan@uit.no	Fossheim, Maria/B-7134-2014; Greenacre, Michael J/D-7401-2013	Greenacre, Michael J/0000-0002-0054-3131; Aschan, Michaela/0000-0002-9276-9321	Norwegian Ministry of Fisheries and Coastal Affairs; Norwegian Government through Norwegian Ministry of Fisheries and Coastal Affairs; Norwegian Government through Ministry of Education and Research; Spanish Ministry of Education [MTM2012-37195]	Norwegian Ministry of Fisheries and Coastal Affairs; Norwegian Government through Norwegian Ministry of Fisheries and Coastal Affairs; Norwegian Government through Ministry of Education and Research; Spanish Ministry of Education(Spanish Government)	The data were collected during the former annual shrimp survey conducted by the Norwegian Institute of Fisheries and Aquaculture (NIFA) and the Institute of Marine Research (IMR) in the Barents Sea from 1992 until 2004, and were funded by the Norwegian Ministry of Fisheries and Coastal Affairs. The scientific work was also funded by the Norwegian Government through the above mentioned ministry and through the Ministry of Education and Research. Michael Greenacre's research was partially funded by the BBVA Foundation in Madrid and a grant from the Spanish Ministry of Education MTM2012-37195. The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.	[Anonymous], 2005, ARCTIC CLIMATE IMPAC; [Anonymous], 2010, IMR PINRO JOINT REPO, V4, P108; Asan Z, 2011, FUZZY SET SYST, V183, P57, DOI 10.1016/j.fss.2011.03.007; Aschan M, 1997, ICES COUNCIL M, V7, P23; Aschan M, 2009, DEEP-SEA RES PT II, V56, P2012, DOI 10.1016/j.dsr2.2008.11.012; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Bergstad OA, 1999, SARSIA, V84, P67, DOI 10.1080/00364827.1999.10420452; Bogstad B, 2008, IMR PINRO JOINT REPO; Burgos GE, 1989, BOTTOM FISH COMMUNIT; Byrkjedal I, 2007, POLAR RES, V26, P135, DOI 10.1111/J.1751-8369.2007.00030.x; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cheung WWL, 2008, MODELING PRESENT CLI; Choi JS, 2004, CAN J FISH AQUAT SCI, V61, P505, DOI 10.1139/F04-079; Collie JS, 2008, CAN J FISH AQUAT SCI, V65, P1352, DOI 10.1139/F08-048; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dolgov A. V., 2005, Journal of Northwest Atlantic Fishery Science, V35, P495; Dolgov AV, 2007, ICES CM E, V31, P17; DOMMASNES A, 2002, FISHERIES CTR RES RE, P213; Drinkwater KF, 2011, PROG OCEANOGR, V90, P47, DOI 10.1016/j.pocean.2011.02.006; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1203, DOI 10.1016/j.icesjms.2005.08.008; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Duplisea DE, 2005, ECOSYSTEMS, V8, P899, DOI 10.1007/s10021-005-0011-z; Ehrich S, 2009, FISH OCEANOGR, V18, P36, DOI 10.1111/j.1365-2419.2008.00495.x; Ekman S, 1953, BOREAL FAUNA N ATLAN, P100, DOI Sidgwick and Jackson; Ellingsen IH, 2008, CLIMATIC CHANGE, V87, P155, DOI 10.1007/s10584-007-9369-6; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fossheim A, 2006, MAR BIOL RES, V2, P260, DOI 10.1080/17451000600815698; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FROESE R, 2007, FISHBASE; Gaertner JC, 2005, MAR ECOL PROG SER, V297, P245, DOI 10.3354/meps297245; Gaertner JC, 2002, SCI MAR, V66, P221; Genner MJ, 2004, P ROY SOC B-BIOL SCI, V271, P655, DOI 10.1098/rspb.2003.2651; Gjosaeter H, 2008, FISKEN HAVET SAERN, V1, P200; Gjosaeter H, 2009, MAR BIOL RES, V5, P40, DOI 10.1080/17451000802454866; Greenacre M, 2013, FUZZY CODING CONSTRA; Hallfredsson EH, 2009, CAN J FISH AQUAT SCI, V66, P1693, DOI 10.1139/F09-105; Harbitz A, 1998, FISH RES, V37, P107, DOI 10.1016/S0165-7836(98)00130-1; Hjermann DO, 2007, P ROY SOC B-BIOL SCI, V274, P661, DOI 10.1098/rspb.2006.0069; Hovde SC, 2002, ICES J MAR SCI, V59, P421, DOI 10.1006/jmsc.2002.1171; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Hsieh CH, 2008, CAN J FISH AQUAT SCI, V65, P947, DOI 10.1139/F08-017; Hsieh CH, 2009, GLOBAL CHANGE BIOL, V15, P2137, DOI 10.1111/j.1365-2486.2009.01875.x; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; ICES, 2008, ICES CM 2008 ACOM; ICES (International Council for the Exploration of the Sea), 2011, REP ARCT FISH WORK G; Jennings S, 2010, J MARINE SYST, V79, P418, DOI 10.1016/j.jmarsys.2008.12.016; Johannesen E, 2012, ICES J MARINE SCI J; Johannesen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034924; Kaiser MJ, 2004, FISH RES, V69, P1, DOI 10.1016/j.fishres.2004.05.001; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Lees K, 2006, FISH FISH, V7, P104, DOI 10.1111/j.1467-2979.2006.00215.x; Legendre P., 2012, NUMERICAL ECOLOGY; Levin SA, 2008, BIOSCIENCE, V58, P27, DOI 10.1641/B580107; Loeng H, 2007, DEEP-SEA RES PT II, V54, P2478, DOI 10.1016/j.dsr2.2007.08.013; Mahon R, 1998, CAN J FISH AQUAT SCI, V55, P1704, DOI 10.1139/cjfas-55-7-1704; Moreno JID, 2000, ICES J MAR SCI, V57, P1091, DOI 10.1006/jmsc.2000.0705; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; MURAWSKI SA, 1993, T AM FISH SOC, V122, P647, DOI 10.1577/1548-8659(1993)122<0647:CCAMFD>2.3.CO;2; NILSSEN EM, 1992, ICES MAR SC, V195, P331; Oksanen J., 2011, MULTIVARIATE ANAL EC, P1, DOI DOI 10.1016/0169-5347(88)90124-3; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Overland J, 2008, PROG OCEANOGR, V77, P92, DOI 10.1016/j.pocean.2008.03.016; Pedersen T, 2008, MAR BIOL, V153, P1037, DOI 10.1007/s00227-007-0875-x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Poulard JC, 2005, ICES J MAR SCI, V62, P1436, DOI 10.1016/j.icesjms.2005.04.017; R Core Team, 2020, R LANG ENV STAT COMP; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Shackell NL, 2007, MAR ECOL PROG SER, V336, P235, DOI 10.3354/meps336235; Skogen M, 2007, FISKEN HAVET SAERN, V1, P191; Spielhagen RF, 2011, SCIENCE, V331, P450, DOI 10.1126/science.1197397; Stefansdottir L, 2010, FISH OCEANOGR, V19, P42, DOI 10.1111/j.1365-2419.2009.00527.x; Stige LC, 2010, P ROY SOC B-BIOL SCI, V277, P3411, DOI 10.1098/rspb.2010.0602; Yaragina N, 2009, DEEP SEA RES; Zenkewitch L, 1963, BIOL SEAS USSR	79	15	19	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62748	10.1371/journal.pone.0062748	http://dx.doi.org/10.1371/journal.pone.0062748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658646	Green Published, gold			2022-12-27	WOS:000321662800059
J	Pirman, DA; Efuet, E; Ding, XP; Pan, Y; Tan, L; Fischer, SM; DuBois, RN; Yang, PY				Pirman, David A.; Efuet, Ekem; Ding, Xiao-Ping; Pan, Yong; Tan, Lin; Fischer, Susan M.; DuBois, Raymond N.; Yang, Peiying			Changes in Cancer Cell Metabolism Revealed by Direct Sample Analysis with MALDI Mass Spectrometry	PLOS ONE			English	Article							INTERMEDIATE-PRESSURE MALDI; EICOSAPENTAENOIC ACID; TISSUE-SECTIONS; GROWTH; LUNG; LOCALIZATION; PHOSPHOLIPIDS; METABOANALYST; METASTASIS; SUBTYPES	Biomarker discovery using mass spectrometry (MS) has recently seen a significant increase in applications, mainly driven by the rapidly advancing field of metabolomics. Instrumental and data handling advancements have allowed for untargeted metabolite analyses which simultaneously interrogate multiple biochemical pathways to elucidate disease phenotypes and therapeutic mechanisms. Although most MS-based metabolomic approaches are coupled with liquid chromatography, a few recently published studies used matrix-assisted laser desorption (MALDI), allowing for rapid and direct sample analysis with minimal sample preparation. We and others have reported that prostaglandin E-3 (PGE(3)), derived from COX-2 metabolism of the omega-3 fatty acid eicosapentaenoic acid (EPA), inhibited the proliferation of human lung, colon and pancreatic cancer cells. However, how PGE(3) metabolism is regulated in cancer cells, particularly human non-small cell lung cancer (NSCLC) cells, is not fully understood. Here, we successfully used MALDI to identify differences in lipid metabolism between two human non-small-cell lung cancer (NSCLC) cell lines, A549 and H596, which could contribute to their differential response to EPA treatment. Analysis by MALDI-MS showed that the level of EPA incorporated into phospholipids in H596 cells was 4-fold higher than A549 cells. Intriguingly, H596 cells produced much less PGE(3) than A549 cells even though the expression of COX-2 was similar in these two cell lines. This appears to be due to the relatively lower expression of cytosolic phospholipase A(2) (cPLA(2)) in H596 cells than that of A549 cells. Additionally, the MALDI-MS approach was successfully used on tumor tissue extracts from a K-ras transgenic mouse model of lung cancer to enhance our understanding of the mechanism of action of EPA in the in vivo model. These results highlight the utility of combining a metabolomics workflow with MALDI-MS to identify the biomarkers that may regulate the metabolism of omega-3 fatty acids and ultimately affect their therapeutic potentials.	[Pirman, David A.; Tan, Lin; DuBois, Raymond N.; Yang, Peiying] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Efuet, Ekem; Ding, Xiao-Ping; Pan, Yong; Yang, Peiying] Univ Texas MD Anderson Canc Ctr, Dept Gen Oncol, Houston, TX 77030 USA; [Fischer, Susan M.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yang, PY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	pyang@mdanderson.org	DuBois, Raymond N./AAX-8869-2020		National Institutes of Health [CA144053-01A1]; NATIONAL CANCER INSTITUTE [R01CA144053, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA144053-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar NYR, 2010, ANAL CHEM, V82, P2621, DOI 10.1021/ac100113w; Balog J, 2010, ANAL CHEM, V82, P7343, DOI 10.1021/ac101283x; Benabdellah F, 2009, ANAL CHEM, V81, P5557, DOI 10.1021/ac9005364; Berry KAZ, 2011, J LIPID RES, V52, P1551, DOI 10.1194/jlr.M015750; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Castellino S, 2011, BIOANALYSIS, V3, P2427, DOI [10.4155/bio.11.232, 10.4155/BIO.11.232]; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cho Y-T, 2012, GENOMIC MED BIOMARKE, V4, P3; Cornett DS, 2008, ANAL CHEM, V80, P5648, DOI 10.1021/ac800617s; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Eberlin LS, 2012, CANCER RES, V72, P645, DOI 10.1158/0008-5472.CAN-11-2465; Eberlin LS, 2010, ANGEW CHEM INT EDIT, V49, P5953, DOI 10.1002/anie.201001452; Esquenazi E, 2008, MOL BIOSYST, V4, P562, DOI 10.1039/b720018h; FALCONER JS, 1994, BRIT J CANCER, V69, P826, DOI 10.1038/bjc.1994.161; Fehniger TE, 2011, ANAL CHEM, V83, P8329, DOI 10.1021/ac2014349; Gamez-Pozo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007731; Garrett TJ, 2007, INT J MASS SPECTROM, V260, P166, DOI 10.1016/j.ijms.2006.09.019; Garrett TJ, 2006, ANAL CHEM, V78, P2465, DOI 10.1021/ac0522761; Marko-Varga G, 2011, J PROTEOMICS, V74, P982, DOI 10.1016/j.jprot.2011.03.019; McDonnell LA, 2012, J PROTEOMICS, V75, P5113, DOI 10.1016/j.jprot.2012.05.016; Meding S, 2012, J PROTEOME RES, V11, P1996, DOI 10.1021/pr200784p; MINOURA T, 1988, CANCER RES, V48, P4790; Murphy RC, 2011, BBA-MOL CELL BIOL L, V1811, P970, DOI 10.1016/j.bbalip.2011.04.012; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Rohner TC, 2005, MECH AGEING DEV, V126, P177, DOI 10.1016/j.mad.2004.09.032; ROSE DP, 1995, JNCI-J NATL CANCER I, V87, P587, DOI 10.1093/jnci/87.8.587; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Shimma S, 2007, J CHROMATOGR B, V855, P98, DOI 10.1016/j.jchromb.2007.02.037; Stauber J, 2010, J AM SOC MASS SPECTR, V21, P338, DOI 10.1016/j.jasms.2009.09.016; Strupat K, 2009, J AM SOC MASS SPECTR, V20, P1451, DOI 10.1016/j.jasms.2009.04.013; Vanamala J, 2008, CARCINOGENESIS, V29, P790, DOI 10.1093/carcin/bgm256; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yang PY, 2006, PROSTAG LEUKOTR ESS, V75, P385, DOI 10.1016/j.plefa.2006.07.015; Yang PY, 2004, J LIPID RES, V45, P1030, DOI 10.1194/jlr.M300455-JLR200; Yang PY, 2002, ANAL BIOCHEM, V308, P168, DOI 10.1016/S0003-2697(02)00218-X	36	27	27	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61379	10.1371/journal.pone.0061379	http://dx.doi.org/10.1371/journal.pone.0061379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658609	Green Submitted, gold, Green Published			2022-12-27	WOS:000318343700009
J	Uitdewilligen, JGAML; Wolters, AMA; D'hoop, BB; Borm, TJA; Visser, RGF; van Eck, HJ				Uitdewilligen, Jan G. A. M. L.; Wolters, Anne-Marie A.; D'hoop, Bjorn B.; Borm, Theo J. A.; Visser, Richard G. F.; van Eck, Herman J.			A Next-Generation Sequencing Method for Genotyping-by-Sequencing of Highly Heterozygous Autotetraploid Potato	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; CHLOROPLAST DNA; SOLANUM-TUBEROSUM; AGRONOMIC TRAITS; HYBRID SELECTION; DISCOVERY; ENRICHMENT; RESISTANCE; IDENTIFICATION	Assessment of genomic DNA sequence variation and genotype calling in autotetraploids implies the ability to distinguish among five possible alternative allele copy number states. This study demonstrates the accuracy of genotyping-by-sequencing (GBS) of a large collection of autotetraploid potato cultivars using next-generation sequencing. It is still costly to reach sufficient read depths on a genome wide scale, across the cultivated gene pool. Therefore, we enriched cultivar-specific DNA sequencing libraries using an in-solution hybridisation method (SureSelect). This complexity reduction allowed to confine our study to 807 target genes distributed across the genomes of 83 tetraploid cultivars and one reference (DM 13 511). Indexed sequencing libraries were paired-end sequenced in 7 pools of 12 samples using Illumina HiSeq2000. After filtering and processing the raw sequence data, 12.4 Gigabases of high-quality sequence data was obtained, which mapped to 2.1 Mb of the potato reference genome, with a median average read depth of 63xper cultivar. We detected 129,156 sequence variants and genotyped the allele copy number of each variant for every cultivar. In this cultivar panel a variant density of 1 SNP/24 bp in exons and 1 SNP/15 bp in introns was obtained. The average minor allele frequency (MAF) of a variant was 0.14. Potato germplasm displayed a large number of relatively rare variants and/or haplotypes, with 61% of the variants having a MAF below 0.05. A very high average nucleotide diversity (pi = 0.0107) was observed. Nucleotide diversity varied among potato chromosomes. Several genes under selection were identified. Genotyping-by-sequencing results, with allele copy number estimates, were validated with a KASP genotyping assay. This validation showed that read depths of similar to 60-806 can be used as a lower boundary for reliable assessment of allele copy number of sequence variants in autotetraploids. Genotypic data were associated with traits, and alleles strongly influencing maturity and flesh colour were identified.	[Uitdewilligen, Jan G. A. M. L.; Wolters, Anne-Marie A.; D'hoop, Bjorn B.; Borm, Theo J. A.; Visser, Richard G. F.; van Eck, Herman J.] Wageningen Univ, Lab Plant Breeding, NL-6700 AP Wageningen, Netherlands; [Uitdewilligen, Jan G. A. M. L.; Wolters, Anne-Marie A.; Borm, Theo J. A.; Visser, Richard G. F.; van Eck, Herman J.] Grad Sch Expt Plant Sci, Wageningen, Netherlands; [Visser, Richard G. F.; van Eck, Herman J.] Ctr BioSyst Genom, Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	van Eck, HJ (corresponding author), Wageningen Univ, Lab Plant Breeding, NL-6700 AP Wageningen, Netherlands.	Herman.vanEck@wur.nl	Visser, Richard GF/B-3423-2012; Wolters, Anne-Marie/N-8810-2013; van Eck, Herman/C-5940-2008; Uitdewilligen, Jan/CAF-2748-2022	Visser, Richard GF/0000-0002-0213-4016; van Eck, Herman/0000-0002-6530-0616; Wolters, Anne-Marie/0000-0001-8537-5132	Dutch technology foundation STW [WPB-7926]	Dutch technology foundation STW(Technologiestichting STW)	This research was supported by a grant from the Dutch technology foundation STW, project WPB-7926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anithakumari AM, 2010, MOL BREEDING, V26, P65, DOI 10.1007/s11032-009-9377-5; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker E, 2011, THEOR APPL GENET, V123, P493, DOI 10.1007/s00122-011-1602-z; Berloo R. van, 2007, Potato Research, V50, P45, DOI 10.1007/s11540-007-9028-3; Bertone P, 2006, GENOME RES, V16, P271, DOI 10.1101/gr.4455906; Chen X, 2001, THEOR APPL GENET, V102, P284, DOI 10.1007/s001220051645; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; D'hoop BB, 2008, EUPHYTICA, V161, P47, DOI 10.1007/s10681-007-9565-5; D'hoop BB, 2010, THEOR APPL GENET, V121, P1151, DOI 10.1007/s00122-010-1379-5; Daniell H, 2004, IN VITRO CELL DEV-AN, V40, p18A; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Garrison EaM G, 2012, 12073907 ARXIV; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gonzalez-Schain ND, 2012, PLANT J, V70, P678, DOI 10.1111/j.1365-313X.2012.04909.x; Gore M, 2007, CROP SCI, V47, pS135, DOI 10.2135/cropsci2007.02.0085tpg; Gore MA, 2009, PLANT GENOME-US, V2, P121, DOI 10.3835/plantgenome2009.01.0002; Grattapaglia D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-65; Griffin PC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-19; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; HOSAKA K, 1988, THEOR APPL GENET, V75, P741, DOI 10.1007/BF00265598; Hosaka K, 2004, AM J POTATO RES, V81, P153, DOI 10.1007/BF02853613; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Kenny EM, 2011, DNA RES, V18, P31, DOI 10.1093/dnares/dsq029; Kiss MM, 2008, ANAL CHEM, V80, P8975, DOI 10.1021/ac801276c; Kloosterman B, 2013, NATURE, V495, P246, DOI 10.1038/nature11912; Krumm N, 2012, GENOME RES; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XQ, 2005, THEOR APPL GENET, V110, P1068, DOI 10.1007/s00122-005-1927-6; Lightbourn GJ, 2007, AM J POTATO RES, V84, P425, DOI 10.1007/BF02987188; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mccue KF, 2007, ACTA HORTIC, P343; McGrath JM, 2004, PLANT MOL BIOL REP, V22, P23, DOI 10.1007/BF02773345; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menda N, 2008, PLANT PHYSIOL, V147, P1788, DOI 10.1104/pp.108.119560; Metzker ML, 2005, GENOME RES, V15, P1767, DOI 10.1101/gr.3770505; Meyer S, 2005, NUCLEIC ACIDS RES, V33, pD666, DOI 10.1093/nar/gki018; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Nijman IJ, 2010, NAT METHODS, V7, P913, DOI 10.1038/nmeth.1516; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; POWELL W, 1993, ANN APPL BIOL, V123, P403, DOI 10.1111/j.1744-7348.1993.tb04102.x; Pritchard JK, 2001, NAT GENET, V28, P203, DOI 10.1038/90026; Provan J, 1999, P ROY SOC B-BIOL SCI, V266, P633, DOI 10.1098/rspb.1999.0683; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rickert AM, 2003, PLANT BIOTECHNOL J, V1, P399, DOI 10.1046/j.1467-7652.2003.00036.x; Rickert AM, 2002, BIOTECHNIQUES, V32, P592, DOI 10.2144/02323rr01; Sattarzadeh A, 2006, MOL BREEDING, V18, P301, DOI 10.1007/s11032-006-9026-1; Schlotterer C, 2002, MOL ECOL, V11, P947, DOI 10.1046/j.1365-294X.2002.01491.x; Simko I, 2006, GENETICS, V173, P2237, DOI 10.1534/genetics.106.060905; Spooner DM, 2005, THEOR APPL GENET, V110, P1020, DOI 10.1007/s00122-004-1917-0; Tang JF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-438; Tewhey R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r116; Usuka J, 2000, BIOINFORMATICS, V16, P203, DOI 10.1093/bioinformatics/16.3.203; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; VANECK HJ, 1995, MOL BREEDING, V1, P397, DOI 10.1007/BF01248417; VANECK HJ, 1994, GENETICS, V137, P303; Voorrips RE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-172; Wolters AMA, 2010, PLANT MOL BIOL, V73, P659, DOI 10.1007/s11103-010-9647-y; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zhu YL, 2003, GENETICS, V163, P1123	77	204	212	5	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62355	10.1371/journal.pone.0062355	http://dx.doi.org/10.1371/journal.pone.0062355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667470	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600023
J	Ozcelik, S; Fraser, G; Castets, P; Schaeffer, V; Skachokova, Z; Breu, K; Clavaguera, F; Sinnreich, M; Kappos, L; Goedert, M; Tolnay, M; Winkler, DT				Ozcelik, Sefika; Fraser, Graham; Castets, Perrine; Schaeffer, Veronique; Skachokova, Zhiva; Breu, Karin; Clavaguera, Florence; Sinnreich, Michael; Kappos, Ludwig; Goedert, Michel; Tolnay, Markus; Winkler, David Theo			Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice	PLOS ONE			English	Article							MOUSE MODEL; ALZHEIMERS-DISEASE; MAMMALIAN TARGET; HUMAN TAUOPATHY; AUTOPHAGY INDUCTION; TUBEROUS SCLEROSIS; AMYLOID-BETA; PROTEIN; NEURODEGENERATION; PHOSPHORYLATION	Altered autophagy contributes to the pathogenesis of Alzheimer's disease and other tauopathies, for which curative treatment options are still lacking. We have recently shown that trehalose reduces tau pathology in a tauopathy mouse model by stimulation of autophagy. Here, we studied the effect of the autophagy inducing drug rapamycin on the progression of tau pathology in P301S mutant tau transgenic mice. Rapamycin treatment resulted in a significant reduction in cortical tau tangles, less tau hyperphosphorylation, and lowered levels of insoluble tau in the forebrain. The favourable effect of rapamycin on tau pathology was paralleled by a qualitative reduction in astrogliosis. These effects were visible with early preventive or late treatment. We further noted an accumulation of the autophagy associated proteins p62 and LC3 in aged tangle bearing P301S mice that was lowered upon rapamycin treatment. Thus, rapamycin treatment defers the progression of tau pathology in a tauopathy animal model and autophagy stimulation may constitute a therapeutic approach for patients suffering from tauopathies.	[Ozcelik, Sefika; Skachokova, Zhiva; Breu, Karin; Clavaguera, Florence; Tolnay, Markus; Winkler, David Theo] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Ozcelik, Sefika; Castets, Perrine; Skachokova, Zhiva; Breu, Karin; Sinnreich, Michael; Kappos, Ludwig; Winkler, David Theo] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Fraser, Graham; Schaeffer, Veronique; Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Castets, Perrine; Sinnreich, Michael] Univ Basel Hosp, Dept Biomed, Neuromuscular Res Ctr, CH-4031 Basel, Switzerland	University of Basel; University of Basel; MRC Laboratory Molecular Biology; University of Basel	Winkler, DT (corresponding author), Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland.	winklerd@uhbs.ch		Sinnreich, Michael/0000-0002-9835-1276; Schaeffer, Veronique/0000-0002-2564-9012	Swiss National Science Foundation [310030_135214, 32323B_123812]; Velux Foundation, Switzerland; MRC [MC_U105184291] Funding Source: UKRI; Alzheimers Research UK [ART-PG2004A-5] Funding Source: researchfish; Medical Research Council [MC_U105184291] Funding Source: researchfish; Parkinson&quot;s UK [K-1012] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation, Switzerland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	MT and DTW are supported by the Swiss National Science Foundation (310030_135214 to MT and 32323B_123812 to D.T.W.), and by the Velux Foundation, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; Forman MS, 2005, J NEUROSCI, V25, P3539, DOI 10.1523/JNEUROSCI.0081-05.2005; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Hampton DW, 2010, J NEUROSCI, V30, P9973, DOI 10.1523/JNEUROSCI.0834-10.2010; Hegedus B, 2008, CANCER RES, V68, P1520, DOI 10.1158/0008-5472.CAN-07-5916; Hosokawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052389; JUCKER M, 1994, NEUROSCIENCE, V60, P875, DOI 10.1016/0306-4522(94)90269-0; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416; MAWALDEWAN M, 1994, J BIOL CHEM, V269, P30981; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Mueller DM, 2010, J CHROMATOGR B, V878, P1007, DOI 10.1016/j.jchromb.2010.02.029; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pritchard SM, 2011, J CELL MOL MED, V15, P1621, DOI 10.1111/j.1582-4934.2011.01273.x; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001; Wyttenbach A, 2008, AUTOPHAGY, V4, P542, DOI 10.4161/auto.6059; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	37	151	154	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62459	10.1371/journal.pone.0062459	http://dx.doi.org/10.1371/journal.pone.0062459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667480	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700039
J	Pieters, N; Koppen, G; Smeets, K; Napierska, D; Plusquin, M; De Prins, S; Van de Weghe, H; Nelen, V; Cox, B; Cuypers, A; Hoet, P; Schoeters, G; Nawrot, TS				Pieters, Nicky; Koppen, Gudrun; Smeets, Karen; Napierska, Dorota; Plusquin, Michelle; De Prins, Sofie; Van de Weghe, Hendrik; Nelen, Vera; Cox, Bianca; Cuypers, Ann; Hoet, Peter; Schoeters, Greet; Nawrot, Tim S.			Decreased Mitochondrial DNA Content in Association with Exposure to Polycyclic Aromatic Hydrocarbons in House Dust during Wintertime: From a Population Enquiry to Cell Culture	PLOS ONE			English	Article							INDOOR AIR; POLLUTANTS; DEPLETION; CHILDREN	Polycyclic aromatic hydrocarbons (PAHs) are widespread environmental pollutants that are formed in combustion processes. At the cellular level, exposure to PAHs causes oxidative stress and/or some of it congeners bind to DNA, which may interact with mitochondrial function. However, the influence of these pollutants on mitochondrial DNA (mtDNA) content remains largely unknown. We determined whether indoor exposure to PAHs is associated with mitochondrial damage as represented by blood mtDNA content. Blood mtDNA content (ratio mitochondrial/nuclear DNA copy number) was determined by real-time qPCR in 46 persons, both in winter and summer. Indoor PAH exposure was estimated by measuring PAHs in sedimented house dust, including 6 volatile PAHs and 8 non-volatile PAHs. Biomarkers of oxidative stress at the level of DNA and lipid peroxidation were measured. In addition to the epidemiologic enquiry, we exposed human TK6 cells during 24 h at various concentrations (range: 0 to 500 mu M) of benzo(a) pyrene and determined mtDNA content. Mean blood mtDNA content averaged (+/- SD) 0.95 +/- 0.185. The median PAH content amounted 554.1 ng/g dust (25th-75th percentile: 390.7-767.3) and 1385 ng/g dust (25th-75th percentile: 1000-1980) in winter for volatile and non-volatile PAHs respectively. Independent for gender, age, BMI and the consumption of grilled meat or fish, blood mtDNA content decreased by 9.85% (95% CI: -15.16 to -4.2; p = 0.002) for each doubling of non-volatile PAH content in the house dust in winter. The corresponding estimate for volatile PAHs was -7.3% (95% CI: -13.71 to -0.42; p = 0.04). Measurements of oxidative stress were not correlated with PAH exposure. During summer months no association was found between mtDNA content and PAH concentration. The ability of benzo(a)pyrene (range 0 mu M to 500 mu M) to lower mtDNA content was confirmed in vitro in human TK6 cells. Based on these findings, mtDNA content can be a target of PAH toxicity in humans.	[Pieters, Nicky; Smeets, Karen; Plusquin, Michelle; Cox, Bianca; Cuypers, Ann; Nawrot, Tim S.] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium; [Koppen, Gudrun; De Prins, Sofie; Van de Weghe, Hendrik; Schoeters, Greet] Vlaamse Instelling Technol Onderzoek, Environm Risk & Hlth Unit, B-2400 Mol, Belgium; [Napierska, Dorota; Hoet, Peter; Nawrot, Tim S.] Leuven Univ KU Leuven, Dept Publ Hlth & Primary Care, Louvain, Belgium; [De Prins, Sofie; Schoeters, Greet] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, B-2020 Antwerp, Belgium; [Nelen, Vera] Prov Inst Hyg, Environm & Hlth Unit, Antwerp, Belgium	Hasselt University; VITO; KU Leuven; University of Antwerp	Nawrot, TS (corresponding author), Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium.	tim.nawrot@uhasselt.be	, Karen/N-8133-2019; Koppen, Gudrun/Q-4011-2018; Cuypers, Ann JF/A-3142-2016; Cox, Bianca/A-9480-2015; Hoet, Peter/H-9987-2013; Nawrot, Tim/AAA-4531-2019; Cuypers, Ann/AAH-2053-2019	, Karen/0000-0001-9673-8824; Cuypers, Ann JF/0000-0002-0171-0245; Cox, Bianca/0000-0001-9824-6276; Hoet, Peter/0000-0002-0292-6603; Cuypers, Ann/0000-0002-0171-0245; Nawrot, Tim/0000-0002-3583-3593; Plusquin, Michelle/0000-0002-7271-9722; Schoeters, Greta/0000-0002-6556-4814	Flemish Administration for Environment (Leefmilieu, Natuur Energie); Flemish Scientific Fund [G.0.873.11.N.10/G029212N]; Bijzonder Onderzoeksfonds (BOF) UHasselt	Flemish Administration for Environment (Leefmilieu, Natuur Energie); Flemish Scientific Fund; Bijzonder Onderzoeksfonds (BOF) UHasselt	Study supported by the Flemish Administration for Environment (Leefmilieu, Natuur & Energie) and the Flemish Scientific Fund (G.0.873.11.N.10/G029212N) and Bijzonder Onderzoeksfonds (BOF) UHasselt. Tim Nawrot is holder of a grant from the European Research Council, ERC starting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burstyn I, 2000, ANN OCCUP HYG, V44, P43, DOI 10.1093/annhyg/44.1.43; Cannino G, 2009, MITOCHONDRION, V9, P377, DOI 10.1016/j.mito.2009.08.009; Carugno M, 2011, ENV HLTH PERSPECT, V120; Choi YS, 2001, DIABETES RES CLIN PR, V54, pS3, DOI 10.1016/S0168-8227(01)00330-8; Chuang JC, 1999, J EXPO ANAL ENV EPID, V9, P85, DOI 10.1038/sj.jea.7500003; Cossarizza A, 2003, ANTIVIR THER, V8, P315; Fortune RG, 1999, ENVIRON HEALTH PERSP, V107, P721; Gevao B, 2007, ARCH ENVIRON CON TOX, V53, P503, DOI 10.1007/s00244-006-0261-6; Gianotti TF, 2008, OBESITY, V16, P1591, DOI 10.1038/oby.2008.253; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hou LF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-48; Janssen BG, 2012, ENVIRON HEALTH PERSP, V120, P1346, DOI 10.1289/ehp.1104458; Langer S, 2010, ATMOS ENVIRON, V44, P2294, DOI 10.1016/j.atmosenv.2010.04.001; Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Maertens RM, 2008, ENVIRON SCI TECHNOL, V42, P1747, DOI 10.1021/es702449c; Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210; Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104; MENZIE CA, 1992, ENVIRON SCI TECHNOL, V26, P1278, DOI 10.1021/es00031a002; Mukerjee S, 1997, ENVIRON INT, V23, P657, DOI 10.1016/S0160-4120(97)00068-8; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; NY ET, 1993, AM IND HYG ASSOC J, V54, P277, DOI 10.1202/0002-8894(1993)054<0277:TRBPAH>2.0.CO;2; Penning TM, 1999, CHEM RES TOXICOL, V12, P1, DOI 10.1021/tx980143n; Pleil JD, 2004, J CHROMATOGR A, V1033, P9, DOI 10.1016/j.chroma.2003.12.074; Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Srogi K, 2007, ENVIRON CHEM LETT, V5, P169, DOI 10.1007/s10311-007-0095-0; Stepanov I, 2009, CHEM RES TOXICOL, V22, P406, DOI 10.1021/tx800398x; Tabish AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034674; Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Whitehead T, 2011, J EXPO SCI ENV EPID, V21, P123, DOI 10.1038/jes.2009.68; Wilson NK, 2003, J EXPO ANAL ENV EPID, V13, P187, DOI 10.1038/sj.jea.7500270; Wong J, 2009, DIABETOLOGIA, V52, P1953, DOI 10.1007/s00125-009-1424-6; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454; Xie H, REDUCED MITOCHONDRIA; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955	43	56	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63208	10.1371/journal.pone.0063208	http://dx.doi.org/10.1371/journal.pone.0063208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658810	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100056
J	Cohen, LD; Zuchman, R; Sorokina, O; Muller, A; Dieterich, DC; Armstrong, JD; Ziv, T; Ziv, NE				Cohen, Laurie D.; Zuchman, Rina; Sorokina, Oksana; Mueller, Anke; Dieterich, Daniela C.; Armstrong, J. Douglas; Ziv, Tamar; Ziv, Noam E.			Metabolic Turnover of Synaptic Proteins: Kinetics, Interdependencies and Implications for Synaptic Maintenance	PLOS ONE			English	Article							MESSENGER-RNA; AXONAL-TRANSPORT; MOLECULAR-DYNAMICS; AMPA RECEPTORS; AMINO-ACIDS; SYNAPSIN-I; LOCALIZATION; TRANSLATION; TRAFFICKING; PROTEOME	Chemical synapses contain multitudes of proteins, which in common with all proteins, have finite lifetimes and therefore need to be continuously replaced. Given the huge numbers of synaptic connections typical neurons form, the demand to maintain the protein contents of these connections might be expected to place considerable metabolic demands on each neuron. Moreover, synaptic proteostasis might differ according to distance from global protein synthesis sites, the availability of distributed protein synthesis facilities, trafficking rates and synaptic protein dynamics. To date, the turnover kinetics of synaptic proteins have not been studied or analyzed systematically, and thus metabolic demands or the aforementioned relationships remain largely unknown. In the current study we used dynamic Stable Isotope Labeling with Amino acids in Cell culture (SILAC), mass spectrometry (MS), Fluorescent Non-Canonical Amino acid Tagging (FUNCAT), quantitative immunohistochemistry and bioinformatics to systematically measure the metabolic half-lives of hundreds of synaptic proteins, examine how these depend on their pre/postsynaptic affiliation or their association with particular molecular complexes, and assess the metabolic load of synaptic proteostasis. We found that nearly all synaptic proteins identified here exhibited half-lifetimes in the range of 2-5 days. Unexpectedly, metabolic turnover rates were not significantly different for presynaptic and postsynaptic proteins, or for proteins for which mRNAs are consistently found in dendrites. Some functionally or structurally related proteins exhibited very similar turnover rates, indicating that their biogenesis and degradation might be coupled, a possibility further supported by bioinformatics-based analyses. The relatively low turnover rates measured here (similar to 0.7% of synaptic protein content per hour) are in good agreement with imaging-based studies of synaptic protein trafficking, yet indicate that the metabolic load synaptic protein turnover places on individual neurons is very substantial.	[Cohen, Laurie D.; Ziv, Noam E.] Technion Israel Inst Technol, Technion Fac Med, Lorry Lokey Ctr Life Sci & Engn, Haifa, Israel; [Cohen, Laurie D.; Ziv, Noam E.] Technion Israel Inst Technol, Network Biol Res Labs, Lorry Lokey Ctr Life Sci & Engn, Haifa, Israel; [Zuchman, Rina; Ziv, Tamar] Technion Israel Inst Technol, Fac Biol, Smoler Prote Ctr, Haifa, Israel; [Sorokina, Oksana; Armstrong, J. Douglas] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Mueller, Anke; Dieterich, Daniela C.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Mueller, Anke; Dieterich, Daniela C.] Otto Von Guericke Univ, Inst Pharmacol & Toxicol, Magdeburg, Germany	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Edinburgh; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University	Ziv, NE (corresponding author), Technion Israel Inst Technol, Technion Fac Med, Lorry Lokey Ctr Life Sci & Engn, Haifa, Israel.	noamz@netvision.net.il	Sorokina, Oksana V/B-1800-2010; Ziv, Noam/ABA-6551-2020	Sorokina, Oksana V/0000-0002-6786-9945; Ziv, Noam/0000-0001-9197-326X; Dieterich, Daniela C./0000-0002-9880-1214; Ziv, Tamar/0000-0003-4299-7454; Armstrong, Douglas/0000-0002-5397-3864	United States Israel Binational Science Foundation [2007425]; European Union Seventh Framework Programme [HEALTH-F2-2009-241498]; Deutsch-Israelische-Projektkooperation German-Israeli Project Cooperation foundation	United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); European Union Seventh Framework Programme(European Commission); Deutsch-Israelische-Projektkooperation German-Israeli Project Cooperation foundation	This work has received funding from the United States Israel Binational Science Foundation (2007425), the European Union Seventh Framework Programme under grant agreement nos. HEALTH-F2-2009-241498 ("EUROSPIN"), and the Deutsch-Israelische-Projektkooperation German-Israeli Project Cooperation foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Archibald K, 1998, NEUROPHARMACOLOGY, V37, P1345, DOI 10.1016/S0028-3908(98)00135-X; BAITINGER C, 1987, J NEUROSCI, V7, P3723; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brewer GJ, 1996, NEUROREPORT, V7, P1509, DOI 10.1097/00001756-199606170-00014; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Butko MT, 2012, NAT NEUROSCI, V15, P1742, DOI 10.1038/nn.3246; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deglincerti A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120079; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; Huang F, 2005, J NEUROSCI, V25, P7199, DOI 10.1523/JNEUROSCI.1779-05.2005; Iijima T, 2005, P NATL ACAD SCI USA, V102, P17190, DOI 10.1073/pnas.0504684102; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Kaufman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040980; Kjoller C, 2000, NEUROCHEM INT, V37, P7, DOI 10.1016/S0197-0186(00)00008-5; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; Link AJ, 2007, NAT PROTOC, V2, P1884, DOI 10.1038/nprot.2007.269; Mammen AL, 1997, J NEUROSCI, V17, P7351; Marom S, 2010, PROG NEUROBIOL, V90, P16, DOI 10.1016/j.pneurobio.2009.10.003; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Minerbi A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000136; Mondin M, 2011, J NEUROSCI, V31, P13500, DOI 10.1523/JNEUROSCI.6439-10.2011; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; PETRUCCI TC, 1991, J NEUROSCI, V11, P2938; Pielot Rainer, 2012, Front Synaptic Neurosci, V4, P1, DOI 10.3389/fnsyn.2012.00001; Pontrello Crystal G, 2009, Open Neurosci J, V3, P67; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Ribrault C, 2011, J NEUROSCI, V31, P17590, DOI 10.1523/JNEUROSCI.4065-11.2011; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scott DA, 2011, NEURON, V70, P441, DOI 10.1016/j.neuron.2011.03.022; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Specht CG, 2008, BIOESSAYS, V30, P1062, DOI 10.1002/bies.20831; Spellman DS, 2008, MOL CELL PROTEOMICS, V7, P1067, DOI 10.1074/mcp.M700387-MCP200; Staras K, 2007, TRENDS NEUROSCI, V30, P292, DOI 10.1016/j.tins.2007.04.005; Staras Kevin, 2010, Front Synaptic Neurosci, V2, P20, DOI 10.3389/fnsyn.2010.00020; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; STEWARD O, 1982, J NEUROSCI, V2, P284; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Tsuriel S, 2009, J NEUROSCI, V29, P351, DOI 10.1523/JNEUROSCI.4777-08.2009; VALLEE RB, 1991, ANNU REV NEUROSCI, V14, P59, DOI 10.1146/annurev.ne.14.030191.000423; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Zeidan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042314; Zhang GA, 2012, J NEUROSCI, V32, P599, DOI 10.1523/JNEUROSCI.2463-11.2012; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370; Zukin RS, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.014.2009	85	120	121	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63191	10.1371/journal.pone.0063191	http://dx.doi.org/10.1371/journal.pone.0063191			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658807	Green Submitted, gold, Green Published			2022-12-27	WOS:000321200500059
J	Furley, P; Memmert, D				Furley, Philip; Memmert, Daniel			"Whom Should I Pass To?'' The More Options the More Attentional Guidance from Working Memory	PLOS ONE			English	Article							TACTICAL DECISION-MAKING; GAME-RELATED STATISTICS; VISUAL-ATTENTION; SELECTIVE ATTENTION; INATTENTIONAL BLINDNESS; AUTOMATIC GUIDANCE; REAL-WORLD; CAPTURE; SEARCH; TASK	Three experiments investigated the predictions of the biased competition theory of selective attention in a computer based sport task. According to this theory objects held in the circuitry of working memory (WM) automatically bias attention to objects in a visual scene that match or are related to the WM representation. Specifically, we investigated whether certain players that are activated in the circuitry of WM automatically draw attention and receive a competitive advantage in a computer based sport task. In all three experiments participants had to hold an image of a certain player in WM while engaged in a speeded sport task. In Experiment 1 participants had to identify as quickly as possible which player was in possession of the ball. In Experiment 2 and 3 participants had to decide to which player they would pass to in a cartoon team handball situation and a photo picture basketball situation. The results support the biased competition theory of selective attention and suggest that certain decision options receive a competitive advantage if they are associated with the activated contents in the circuitry of WM and that this effect is more pronounced when more decision options compete for attention. A further extension compared to previous research was that the contents of working memory not only biased attention but also actual decisions that can lead to passing errors in sport. We critically discuss the applied implications of the findings.	[Furley, Philip; Memmert, Daniel] German Sport Univ Cologne, Cologne, Germany	German Sport University Cologne	Furley, P (corresponding author), German Sport Univ Cologne, Cologne, Germany.	p.furley@dshs-koeln.de	Furley, Philip/V-2921-2019	Furley, Philip/0000-0002-1230-2220				Araujo D, 2009, INT J SPORT PSYCHOL, V40; Awh E, 1998, J EXP PSYCHOL HUMAN, V24, P780, DOI 10.1037/0096-1523.24.3.780; Baddeley A., WORKING MEMORY THOUG, DOI [10.1093/acprof:oso/9780198528012.001.0001, DOI 10.1093/ACPROF:OSO/9780198528012.001.0001]; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Belopolsky AV, 2007, PSYCHON B REV, V14, P934, DOI 10.3758/BF03194124; Boucher S., 2008, ADV SPORT PSYCHOL; Broadbent D.E., 1958, PERCEPTION COMMUNICA; Buck SM, 2008, MED SCI SPORT EXER, V40, P166, DOI 10.1249/mss.0b013e318159b035; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Cowan N, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dicks M, 2010, ATTEN PERCEPT PSYCHO, V72, P706, DOI 10.3758/APP.72.3.706; Downing PE, 2000, PSYCHOL SCI, V11, P467, DOI 10.1111/1467-9280.00290; Ericsson KA, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P1, DOI 10.2277/ 0521600812; Furley P. A., 2010, INT REV SPORT EXER P, V3, P171, DOI [10.1080/1750984X.2010.526238, DOI 10.1080/1750984X.2010.526238]; Furley P, 2013, COGN PROCESS, V14, P31, DOI 10.1007/s10339-012-0529-x; Furley P, 2011, PERCEPT MOTOR SKILL, V113, P481, DOI 10.2466/05.23.PMS.113.5.481-488; Furley P, 2010, ATTEN PERCEPT PSYCHO, V72, P1327, DOI 10.3758/APP.72.5.1327; Furley PA, 2012, J SPORT EXERCISE PSY, V34, P322, DOI 10.1123/jsep.34.3.322; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Hernandez M, 2010, ATTEN PERCEPT PSYCHO, V72, P963, DOI 10.3758/APP.72.4.963; Huang LQ, 2007, PSYCHON B REV, V14, P148, DOI 10.3758/BF03194042; Ibanez SJ, 2008, EUR J SPORT SCI, V8, P369, DOI 10.1080/17461390802261470; Kingstone A, 2003, CURR DIR PSYCHOL SCI, V12, P176, DOI 10.1111/1467-8721.01255; Kingstone A, 2008, BRIT J PSYCHOL, V99, P317, DOI 10.1348/000712607X251243; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Lorenzo A, 2010, J SPORT SCI MED, V9, P664; Melnick MJ, 2001, PERCEPT MOTOR SKILL, V92, P595, DOI 10.2466/PMS.92.2.595-602; Memmert D, 2007, J SPORT EXERCISE PSY, V29, P365, DOI 10.1123/jsep.29.3.365; Moores E, 2008, VIS COGN, V16, P675, DOI 10.1080/13506280701229262; Neisser U., 1967, COGNITIVE PSYCHOL; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P1243, DOI 10.1037/0096-1523.32.5.1243; Olivers CNL, 2009, J EXP PSYCHOL HUMAN, V35, P1275, DOI 10.1037/a0013896; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Posner M.I., 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Psychology software tools Inc., 2007, E PRIM VERS 2 0; Risko EF, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00143; Ristic J, 2002, PSYCHON B REV, V9, P507, DOI 10.3758/BF03196306; Sorro D, 2008, PERCEPT PSYCHOPHYS, V70, P924, DOI 10.3758/PP.70.5.924; Soto D, 2005, J EXP PSYCHOL HUMAN, V31, P248, DOI 10.1037/0096-1523.31.2.248; Soto D, 2008, TRENDS COGN SCI, V12, P342, DOI 10.1016/j.tics.2008.05.007; Soto D, 2007, J EXP PSYCHOL HUMAN, V33, P730, DOI 10.1037/0096-1523.33.3.730; Theeuwes J, 2004, PSYCHON B REV, V11, P65, DOI 10.3758/BF03206462; Towse J, 2007, VARIATION WORKING ME; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Williams A. M., 1999, VISUAL PERCEPTION AC; Yong E, 2012, NATURE, V485, P298, DOI 10.1038/485298a	51	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62278	10.1371/journal.pone.0062278	http://dx.doi.org/10.1371/journal.pone.0062278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AF	23658719	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500021
J	Le, OY; Dai, DQ; Zhang, XF				Le Ou-Yang; Dai, Dao-Qing; Zhang, Xiao-Fei			Protein Complex Detection via Weighted Ensemble Clustering Based on Bayesian Nonnegative Matrix Factorization	PLOS ONE			English	Article							INTERACTION NETWORKS; FUNCTIONAL MODULES; GENE ONTOLOGY; ALGORITHM; IDENTIFICATION; INTERACTOME; INTEGRATION; ANNOTATION; PREDICTION; DISCOVERY	Detecting protein complexes from protein-protein interaction (PPI) networks is a challenging task in computational biology. A vast number of computational methods have been proposed to undertake this task. However, each computational method is developed to capture one aspect of the network. The performance of different methods on the same network can differ substantially, even the same method may have different performance on networks with different topological characteristic. The clustering result of each computational method can be regarded as a feature that describes the PPI network from one aspect. It is therefore desirable to utilize these features to produce a more accurate and reliable clustering. In this paper, a novel Bayesian Nonnegative Matrix Factorization(NMF)-based weighted Ensemble Clustering algorithm (EC-BNMF) is proposed to detect protein complexes from PPI networks. We first apply different computational algorithms on a PPI network to generate some base clustering results. Then we integrate these base clustering results into an ensemble PPI network, in the form of weighted combination. Finally, we identify overlapping protein complexes from this network by employing Bayesian NMF model. When generating an ensemble PPI network, EC-BNMF can automatically optimize the values of weights such that the ensemble algorithm can deliver better results. Experimental results on four PPI networks of Saccharomyces cerevisiae well verify the effectiveness of EC-BNMF in detecting protein complexes. EC-BNMF provides an effective way to integrate different clustering results for more accurate and reliable complex detection. Furthermore, EC-BNMF has a high degree of flexibility in the choice of base clustering results. It can be coupled with existing clustering methods to identify protein complexes.	[Le Ou-Yang; Dai, Dao-Qing; Zhang, Xiao-Fei] Sun Yat Sen Univ, Ctr Comp Vis, Guangzhou 510275, Guangdong, Peoples R China; [Le Ou-Yang; Dai, Dao-Qing; Zhang, Xiao-Fei] Sun Yat Sen Univ, Dept Math, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Dai, DQ (corresponding author), Sun Yat Sen Univ, Ctr Comp Vis, Guangzhou 510275, Guangdong, Peoples R China.	stsddq@mail.sysu.edu.cn			National Natural Science Foundation of China (NSFC) [11171354]; Ministry of Education of China [SRFDP-20120171110016]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This project was supported in part by National Natural Science Foundation of China (NSFC) (11171354), the Ministry of Education of China (SRFDP-20120171110016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asur S, 2007, BIOINFORMATICS, V23, pI29, DOI 10.1093/bioinformatics/btm212; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Becker E, 2012, BIOINFORMATICS, V28, P84, DOI 10.1093/bioinformatics/btr621; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cho YR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-265; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Geng B, 2012, IEEE T PATTERN ANAL, V34, P1227, DOI 10.1109/TPAMI.2012.57; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Greene D, 2008, BIOINFORMATICS, V24, P1722, DOI 10.1093/bioinformatics/btn286; Gregory S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103018; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ji JungYoun, 2012, Insecta Mundi, P1; Jiang P, 2010, BIOINFORMATICS, V26, P1105, DOI 10.1093/bioinformatics/btq078; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Li MJ, 2008, IEEE T KNOWL DATA EN, V20, P1519, DOI 10.1109/TKDE.2008.88; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; MACKAY DJC, 1995, NETWORK-COMP NEURAL, V6, P469, DOI 10.1088/0954-898X/6/3/011; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Psorakis I, 2010, NIPS; Qi Y, 2008, BIOINFORMATICS, V24, pI250, DOI 10.1093/bioinformatics/btn164; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rhrissorrakrai K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-192; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Tan V, 2012, IEEE T PATTERN ANAL, P1; Tan Vincent YF, 2009, SPARS 09 SIGNAL PROC; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Topchy A, 2005, IEEE T PATTERN ANAL, V27, P1866, DOI 10.1109/TPAMI.2005.237; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wang JX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S10; Zhang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043092; Zhang XF, 2012, IEEE ACM T COMPUT BI, V9, P857, DOI 10.1109/TCBB.2012.20; Zhang XF, 2012, IEEE ACM T COMPUT BI, V9, P740, DOI 10.1109/TCBB.2011.148	57	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62158	10.1371/journal.pone.0062158	http://dx.doi.org/10.1371/journal.pone.0062158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658709	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500017
J	Muscarella, C; Brintazzoli, G; Gordts, S; Soetens, E; Van den Bussche, E				Muscarella, Charlotte; Brintazzoli, Gigliola; Gordts, Sarah; Soetens, Eric; Van den Bussche, Eva			Short- and Long-Term Effects of Conscious, Minimally Conscious and Unconscious Brand Logos	PLOS ONE			English	Article							VISUAL MASKING; PERCEPTION; METAANALYSIS; RECOGNITION; ACTIVATION; MECHANISMS; AWARENESS; CHOICE	Unconsciously presented information can influence our behavior in an experimental context. However, whether these effects can be translated to a daily life context, such as advertising, is strongly debated. What hampers this translation is the widely accepted notion of the short-livedness of unconscious representations. The effect of unconscious information on behavior is assumed to rapidly vanish within a few hundreds of milliseconds. Using highly familiar brand logos (e. g., the logo of McDonald's) as subliminal and supraliminal primes in two priming experiments, we assessed whether these logos were able to elicit behavioral effects after a short (e. g., 350 ms), a medium (e. g., 1000 ms), and a long (e. g., 5000 ms) interval. Our results demonstrate that when real-life information is presented minimally consciously or even unconsciously, it can influence our subsequent behavior, even when more than five seconds pass between the presentation of the minimally conscious or unconscious information and the behavior on which it exerts its influence.	[Muscarella, Charlotte; Brintazzoli, Gigliola; Gordts, Sarah; Soetens, Eric; Van den Bussche, Eva] Vrije Univ Brussel, Dept Psychol, Brussels, Belgium	Vrije Universiteit Brussel	Van den Bussche, E (corresponding author), Vrije Univ Brussel, Dept Psychol, Brussels, Belgium.	Eva.Van.den.Bussche@vub.ac.be	Van den Bussche, Eva/E-7977-2010; Van den Bussche, Eva/AFU-0195-2022	Van den Bussche, Eva/0000-0003-1894-9380; 				Bermeitinger C, 2009, J EXP SOC PSYCHOL, V45, P320, DOI 10.1016/j.jesp.2008.10.001; Brannon L, 1994, PERSUASION PSYCHOL I, P279; Brintazzoli G, 2012, CONSCIOUS COGN, V21, P824, DOI 10.1016/j.concog.2012.03.006; Broyles SJ, 2006, J CONSUM AFF, V40, P392, DOI 10.1111/j.1745-6606.2006.00063.x; Capa RL, 2011, INT J PSYCHOPHYSIOL, V81, P22, DOI 10.1016/j.ijpsycho.2011.04.001; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dupoux E, 2008, COGNITION, V109, P267, DOI 10.1016/j.cognition.2008.06.012; Duyck W, 2004, BEHAV RES METH INS C, V36, P488, DOI 10.3758/BF03195595; Ferrand L, 1996, ACTA PSYCHOL, V91, P15, DOI 10.1016/0001-6918(95)00010-0; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; GOLDIAMOND I, 1959, AM PSYCHOL, V14, P598, DOI 10.1037/h0039708; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Karremans JC, 2006, J EXP SOC PSYCHOL, V42, P792, DOI 10.1016/j.jesp.2005.12.002; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kouider S, 2010, TRENDS COGN SCI, V14, P301, DOI 10.1016/j.tics.2010.04.006; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P197, DOI 10.1016/0010-0285(83)90009-9; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; REINGOLD EM, 1988, PERCEPT PSYCHOPHYS, V44, P563, DOI 10.3758/BF03207490; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Strahan EJ, 2005, ADVERT CONS, P267; Trappey C, 1996, PSYCHOL MARKET, V13, P517, DOI 10.1002/(SICI)1520-6793(199608)13:5<517::AID-MAR5>3.0.CO;2-C; Van den Bussche E, 2009, EXP PSYCHOL, V56, P295, DOI 10.1027/1618-3169.56.5.295; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; Veltkamp M, 2011, J CONSUM PSYCHOL, V21, P49, DOI 10.1016/j.jcps.2010.09.011; Vermeiren A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031595; Verwijmeren T, 2011, J CONSUM PSYCHOL, V21, P206, DOI 10.1016/j.jcps.2010.11.004	29	12	13	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e57738	10.1371/journal.pone.0057738	http://dx.doi.org/10.1371/journal.pone.0057738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AF	23658681	Green Submitted, gold, Green Published			2022-12-27	WOS:000321200500002
J	Knapp, D; Schulz, H; Rascon, CA; Volkmer, M; Scholz, J; Nacu, E; Le, M; Novozhilov, S; Tazaki, A; Protze, S; Jacob, T; Hubner, N; Habermann, B; Tanaka, EM				Knapp, Dunja yy; Schulz, Herbert; Rascon, Cynthia Alexander; Volkmer, Michael; Scholz, Juliane; Nacu, Eugen; Le, Mu; Novozhilov, Sergey; Tazaki, Akira; Protze, Stephanie; Jacob, Tina; Hubner, Norbert; Habermann, Bianca; Tanaka, Elly M.			Comparative Transcriptional Profiling of the Axolotl Limb Identifies a Tripartite Regeneration-Specific Gene Program	PLOS ONE			English	Article							ZEBRAFISH FIN REGENERATION; CELL SELF-RENEWAL; STEM-CELL; AMBYSTOMA-MEXICANUM; NEUROTROPHIC REGULATION; DIGIT REGENERATION; NERVE DEPENDENCE; MOLECULAR-BASIS; EXPRESSION; PROTEIN	Understanding how the limb blastema is established after the initial wound healing response is an important aspect of regeneration research. Here we performed parallel expression profile time courses of healing lateral wounds versus amputated limbs in axolotl. This comparison between wound healing and regeneration allowed us to identify amputation-specific genes. By clustering the expression profiles of these samples, we could detect three distinguishable phases of gene expression - early wound healing followed by a transition-phase leading to establishment of the limb development program, which correspond to the three phases of limb regeneration that had been defined by morphological criteria. By focusing on the transition-phase, we identified 93 strictly amputation-associated genes many of which are implicated in oxidative-stress response, chromatin modification, epithelial development or limb development. We further classified the genes based on whether they were or were not significantly expressed in the developing limb bud. The specific localization of 53 selected candidates within the blastema was investigated by in situ hybridization. In summary, we identified a set of genes that are expressed specifically during regeneration and are therefore, likely candidates for the regulation of blastema formation.	[Knapp, Dunja yy; Volkmer, Michael; Nacu, Eugen; Tazaki, Akira; Protze, Stephanie; Jacob, Tina; Habermann, Bianca; Tanaka, Elly M.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Schulz, Herbert; Hubner, Norbert] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Volkmer, Michael; Habermann, Bianca] Max Planck Inst Biol Aging, Cologne, Germany; [Knapp, Dunja yy; Rascon, Cynthia Alexander; Scholz, Juliane; Nacu, Eugen; Le, Mu; Novozhilov, Sergey; Tazaki, Akira; Tanaka, Elly M.] Tech Univ Dresden, DFG Res Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany	Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; Technische Universitat Dresden	Tanaka, EM (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	elly.tanaka@crt-dresden.de	Knapp, Dunja/N-2180-2017; Tanaka, Elly M/F-8572-2010; Habermann, Bianca/N-4886-2016	Knapp, Dunja/0000-0002-7533-2208; Habermann, Bianca/0000-0002-2457-7504; Protze, Stephanie/0000-0002-7993-3780; Tazaki, Akira/0000-0002-7151-0089; Nowoshilow, Sergej/0000-0001-8360-5010	Alexander von Humboldt fellowship; DFG [SPP1356]; Max Planck Society; DFG Research Center for Regenerative Therapies	Alexander von Humboldt fellowship(Alexander von Humboldt Foundation); DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG Research Center for Regenerative Therapies	This work was funded by an Alexander von Humboldt fellowship to DK, grant funding from the DFG, SPP1356 "Pluripotency and Reprogramming'', and central funds from the Max Planck Society and the DFG Research Center for Regenerative Therapies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Beek CW, 2006, MECH DEVELOP, V123, P674, DOI 10.1016/j.mod.2006.07.001; BOILLY B, 1991, DEV BIOL, V145, P302, DOI 10.1016/0012-1606(91)90128-P; Bryant SV, 2002, INT J DEV BIOL, V46, P887; Campbell LJ, 2011, DEV DYNAM, V240, P1826, DOI 10.1002/dvdy.22669; Carlson BM, 2003, DEV DYNAM, V226, P167, DOI 10.1002/dvdy.10223; Cazanove O, 2008, BIOCHEMISTRY-US, V47, P8350, DOI 10.1021/bi7008486; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; Christensen RN, 2002, DEV DYNAM, V223, P193, DOI 10.1002/dvdy.10049; Christian KJ, 2008, MOL PHARMACOL, V73, P1558, DOI 10.1124/mol.107.042507; Costa IG, 2005, BIOINFORMATICS, V21, P2544, DOI 10.1093/bioinformatics/bti311; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dungan KM, 2002, J EXP ZOOL, V292, P540, DOI 10.1002/jez.10077; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gardiner DM, 1996, INT J DEV BIOL, V40, P797; Gardiner DM, 2002, SEMIN CELL DEV BIOL, V13, P345, DOI 10.1016/S1084952102000903; Ghosh S, 2008, DEV GROWTH DIFFER, V50, P289, DOI [10.1111/j.1440-169x.2008.01000.x, 10.1111/j.1440-169X.2008.01000.x]; Gorsic M, 2008, J PHYSIOL BIOCHEM, V64, P37, DOI 10.1007/BF03168233; Guimond JC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-15; Habermann B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r67; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hayakawa H, 2010, BIOCHEM BIOPH RES CO, V403, P220, DOI 10.1016/j.bbrc.2010.11.011; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hutchison C, 2007, BONE, V40, P45, DOI 10.1016/j.bone.2006.07.005; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Koshiba K, 1998, J EXP ZOOL, V282, P703, DOI 10.1002/(SICI)1097-010X(19981215)282:6<703::AID-JEZ6>3.0.CO;2-P; Kragl M, 2012, DEV BIOL; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Kumar A, 2010, J ANAT, V217, P16, DOI 10.1111/j.1469-7580.2010.01239.x; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; MADEN M, 1976, J EMBRYOL EXP MORPH, V36, P561; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; Mansharamani M, 2005, J BIOL CHEM, V280, P13863, DOI 10.1074/jbc.M413020200; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Monaghan JR, 2012, BANKER, P1; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Nemeth MJ, 2006, P NATL ACAD SCI USA, V103, P13783, DOI 10.1073/pnas.0604006103; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ohno M, 2011, BIOCHEM J, V437, P531, DOI 10.1042/BJ20101793; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Pecorino LT, 1996, CURR BIOL, V6, P563, DOI 10.1016/S0960-9822(02)00542-0; Putta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-54; Rao N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-83; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Satoh A, 2008, DEV BIOL, V319, P321, DOI 10.1016/j.ydbio.2008.04.030; Satoh A, 2007, DEV BIOL, V312, P231, DOI 10.1016/j.ydbio.2007.09.021; Satoh A, 2010, DEV BIOL, V337, P444, DOI 10.1016/j.ydbio.2009.11.023; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Smith A, 2006, DEV BIOL, V299, P438, DOI 10.1016/j.ydbio.2006.08.016; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stocum DL, 2011, DEV DYNAM, V240, P943, DOI 10.1002/dvdy.22553; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sugiura T, 2009, MECH DEVELOP, V126, P56, DOI 10.1016/j.mod.2008.10.002; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; TASSAVA RA, 1975, DIFFERENTIATION, V4, P23, DOI 10.1111/j.1432-0436.1975.tb01439.x; TASSAVA RA, 1979, J EXP ZOOL, V208, P97, DOI 10.1002/jez.1402080111; Torok MA, 1999, J EXP ZOOL, V284, P197, DOI 10.1002/(SICI)1097-010X(19990701)284:2<197::AID-JEZ9>3.0.CO;2-F; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; Weiss P, 1925, W ROUX ARCH ENTWICKL, V104, P359; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yokoyama H, 2000, DEV BIOL, V219, P18, DOI 10.1006/dbio.1999.9587; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zhu W, 2012, DEV BIOL, V370, P42, DOI 10.1016/j.ydbio.2012.07.021	77	84	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61352	10.1371/journal.pone.0061352	http://dx.doi.org/10.1371/journal.pone.0061352			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658691	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000319167000010
J	Lin, MC; Fu, YC; Jan, SL; Lai, MS				Lin, Ming-Chih; Fu, Yun-Ching; Jan, Sheng-Ling; Lai, Mei-Shu			Comparative Effectiveness of Intravenous Immunoglobulin for Children with Kawasaki Disease: A Nationwide Cohort Study	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; LONG-TERM MANAGEMENT; CORONARY-ARTERY; GAMMA-GLOBULIN; EPIDEMIOLOGIC FEATURES; CARDIOVASCULAR-DISEASE; HEALTH-INSURANCE; RHEUMATIC-FEVER; SMOOTH-MUSCLE; DIAGNOSIS	Introduction: Different immunoglobulin manufacturing processes may influence its effectiveness for Kawasaki disease. However, nationwide studies with longitudinal follow-up are still lacking. The aim of this study was to evaluate the comparative effectiveness of immunoglobulin preparations from a nationwide perspective. Materials and Methods: This is a nationwide retrospective cohort study with a new user design. Data came from the National Health Insurance Research Database of Taiwan. From 1997 to 2008, children under 2 years old who received immunoglobulin therapy for the first time under the main diagnosis of Kawasaki disease were enrolled. The manufacturing processes were divided into beta-propiolactonation, acidification and those containing IgA. The endpoints were immunoglobulin non-responsiveness, acute aneurysm, prolonged use of anti-platelets or anti-coagulants, and recurrence. Results: In total, 3830 children were enrolled. beta-propiolactonation had a relative risk of 1.45 (95% CI 1.08 similar to 1.94) of immunoglobulin non-responsiveness, however, the relative risks for acidification and containing IgA were non-significant. For acute aneurysms, acidification had a relative risk of 1.49 (95% CI 1.17 similar to 1.90), however the relative risks for beta-propiolactonation and containing IgA were non-significant. For prolonged use of anti-platelets or anti-coagulants, beta-propiolactonation had a relative risk of 1.44 (95% CI 1.18 similar to 1.76), and acidification protected against them both with a relative risk of 0.82 (95% CI 0.69 similar to 0.97), whereas the relative risk for containing IgA was non-significant. For recurrence, all three factors were non-significant. Conclusions: The effectiveness of immunoglobulin may differ among different manufacturing processes. beta-propiolactonation had a higher risk of treatment failure and prolonged use of anti-platelets or anti-coagulants. Acidification may increase the risk of acute coronary aneurysms.	[Lin, Ming-Chih; Fu, Yun-Ching; Jan, Sheng-Ling] Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan; [Lin, Ming-Chih; Lai, Mei-Shu] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lin, Ming-Chih; Fu, Yun-Ching; Jan, Sheng-Ling] Natl Yang Ming Univ, Dept Pediat, Taipei 112, Taiwan; [Lin, Ming-Chih; Fu, Yun-Ching; Jan, Sheng-Ling] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lai, Mei-Shu] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Ctr Comparat Cost Effectiveness Res, Taipei, Taiwan	Taichung Veterans General Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital	Lai, MS (corresponding author), Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	mslai@ntu.edu.tw		Lai, Mei-shu/0000-0001-6130-3468	Taichung Veterans General Hospital Research Grant [996501B]	Taichung Veterans General Hospital Research Grant	All phases of this study were supported by Taichung Veterans General Hospital Research Grant No. 996501B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALKJAER C, 1988, J PHYSIOL-LONDON, V402, P391, DOI 10.1113/jphysiol.1988.sp017211; Austin C, 2000, CIRC RES, V86, P355, DOI 10.1161/01.RES.86.3.355; Bonilla FA, 2001, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, P264; Brown TJ, 2001, J INFECT DIS, V184, P940, DOI 10.1086/323155; Chi H, 2010, HUM MOL GENET, V19, P1147, DOI 10.1093/hmg/ddp586; DAJANI AS, 1994, CIRCULATION, V89, P916, DOI 10.1161/01.CIR.89.2.916; DAJANI AS, 1993, CIRCULATION, V87, P1776, DOI 10.1161/01.CIR.87.5.1776; Du ZD, 2007, PEDIATR INFECT DIS J, V26, P449, DOI 10.1097/01.inf.0000261196.79223.18; DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057; Fischer TK, 2007, PEDIATR INFECT DIS J, V26, P411, DOI 10.1097/01.inf.0000259964.47941.00; Gavin PJ, 2003, ARTERIOSCL THROM VAS, V23, P576, DOI 10.1161/01.ATV.0000065385.47152.FD; Gelfand EW, 2006, INT IMMUNOPHARMACOL, V6, P592, DOI 10.1016/j.intimp.2005.11.003; Heaton P, 2006, J PAEDIATR CHILD H, V42, P184, DOI 10.1111/j.1440-1754.2006.00827.x; Holman RC, 2010, PEDIATR INFECT DIS J, V29, P483, DOI 10.1097/INF.0b013e3181cf8705; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; IWATA M, 1987, INFECT IMMUN, V55, P547, DOI 10.1128/IAI.55.3.547-554.1987; JUNGI TW, 1986, VOX SANG, V51, P18, DOI 10.1111/j.1423-0410.1986.tb00203.x; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Kuo HC, 2012, PEDIATR NEONATOL, V53, P4, DOI 10.1016/j.pedneo.2011.11.003; Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370; LEUNG DYM, 1989, LANCET, V2, P1298; Lin MC, 2009, J FORMOS MED ASSOC, V108, P849, DOI 10.1016/S0929-6646(09)60416-2; Lin MT, 2011, PEDIATR INFECT DIS J, V30, P148, DOI 10.1097/INF.0b013e3181f43a4e; Lynch M, 2003, PEDIATR INFECT DIS J, V22, P959, DOI 10.1097/01.inf.0000095194.83814.ee; Ma XJ, 2010, CHINESE MED J-PEKING, V123, P2629, DOI 10.3760/cma.j.issn.0366-6999.2010.19.002; Manlhiot C, 2008, PEDIATRICS, V121, pE626, DOI 10.1542/peds.2007-1218; Manlhiot C, 2010, PEDIAT ALLERG IMM-UK, V21, P515, DOI 10.1111/j.1399-3038.2010.00987.x; NAGATA S, 1993, PEDIATR RES, V33, P557, DOI 10.1203/00006450-199306000-00004; NAGESETTY R, 1994, CIRC RES, V75, P990, DOI 10.1161/01.RES.75.6.990; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; NAOE S, 1991, ACTA PATHOL JAPON, V41, P785; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Ng Y. M., 2005, Hong Kong Medical Journal, V11, P331; NIELSEN H, 1994, ALLERGY, V49, P69, DOI 10.1111/j.1398-9995.1994.tb00802.x; Park YW, 2007, PEDIATR INFECT DIS J, V26, P821, DOI 10.1097/INF.0b013e318124aa1a; ROSENFELD EA, 1995, J PEDIATR-US, V126, P1000, DOI 10.1016/S0022-3476(95)70233-4; Rowley AH, 2000, J INFECT DIS, V182, P1183, DOI 10.1086/315832; Seki M, 2011, PEDIATR INFECT DIS J, V30, P145, DOI 10.1097/INF.0b013e3181f386db; Stiehm ER, 2006, J PEDIATR-US, V148, P6, DOI 10.1016/j.jpeds.2005.09.019; Suzuki A, 2000, CIRCULATION, V101, P2935, DOI 10.1161/01.CIR.101.25.2935; Terai M, 1997, J PEDIATR-US, V131, P888, DOI 10.1016/S0022-3476(97)70038-6; Tsai MH, 2006, J PEDIATR-US, V148, P38, DOI 10.1016/j.jpeds.2005.08.024; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004	45	16	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63399	10.1371/journal.pone.0063399	http://dx.doi.org/10.1371/journal.pone.0063399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650564	gold, Green Submitted, Green Published			2022-12-27	WOS:000319167000109
J	Zhang, GT; Tsang, CM; Deng, W; Yip, YL; Lui, VWY; Wong, SCC; Cheung, ALM; Hau, PM; Zeng, MS; Lung, ML; Chen, HL; Lo, KW; Takada, K; Tsao, SW				Zhang, Guitao; Tsang, Chi Man; Deng, Wen; Yip, Yim Ling; Lui, Vivian Wai-Yan; Wong, Sze Chuen Cesar; Cheung, Annie Lai-Man; Hau, Pok Man; Zeng, Musheng; Lung, Maria Li; Chen, Honglin; Lo, Kwok Wai; Takada, Kenzo; Tsao, Sai Wah			Enhanced IL-6/IL-6R Signaling Promotes Growth and Malignant Properties in EBV-Infected Premalignant and Cancerous Nasopharyngeal Epithelial Cells	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; STAT3 ACTIVATION; GENE-EXPRESSION; IN-VITRO; IL-6; CARCINOMA; LMP1; TRANSCRIPTION; INFLAMMATION; RECEPTOR	Nasopharyngeal carcinoma (NPC) is etiologically associated with Epstein-Barr virus (EBV) infection. However, the exact role of EBV in NPC pathogenesis remains elusive. Activation of signal transducer and activator of transcription 3 (STAT3) is common in human cancers including NPC and plays an important role in the pathogenesis and progression of human cancers. Interleukin-6 (IL-6), a major inflammatory cytokine, is a potent activator of STAT3. In this study, we report that EBV-infected immortalized nasopharyngeal epithelial (NPE) cells often acquire an enhanced response to IL-6-induced STAT3 activation to promote their growth and invasive properties. Interestingly, this enhanced IL-6/STAT3 response was mediated by overexpression of IL-6 receptor (IL-6R). Furthermore, IL-6R overexpression enhanced IL-6-induced STAT3 activation in uninfected immortalized NPE cells in vitro, and promoted growth and tumorigenicity of EBV-positive NPC cell line (C666-1) in vivo. Moreover, it is shown for the first time that IL-6R was overexpressed in clinical specimens of NPC. IL-6 expression could also be strongly detected in the stromal cells of NPC and a higher circulating level of IL-6 was found in the sera of advance-staged NPC patients compared to the control subjects. Therefore, IL-6R overexpression, coupled with enhanced IL6/STAT3 signaling may facilitate the malignant transformation of EBV-infected premalignant NPE cells into cancer cells, and enhance malignant properties of NPC cells.	[Zhang, Guitao; Tsang, Chi Man; Deng, Wen; Yip, Yim Ling; Cheung, Annie Lai-Man; Hau, Pok Man; Tsao, Sai Wah] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Zhang, Guitao] Capital Med Univ, Dept Anat Histol & Embryol, Beijing, Peoples R China; [Lui, Vivian Wai-Yan] Univ Pittsburgh, Sch Med, Dept Otoloaryngol, Pittsburgh, PA USA; [Wong, Sze Chuen Cesar] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Zeng, Musheng] Sun Yat Sen Univ, Inst Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Lung, Maria Li] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Chen, Honglin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Lo, Kwok Wai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Takada, Kenzo] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido, Japan	University of Hong Kong; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hong Kong Polytechnic University; State Key Lab Oncology South China; Sun Yat Sen University; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Hokkaido University	Tsao, SW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	gswtsao@hkucc.hku.hk	Lui, Vivian W. Y./I-5458-2016; Deng, Wen/M-5208-2019; Chen, Honglin/C-4224-2009; Lung, Maria Li/C-4495-2009; /C-4230-2009	Lui, Vivian W. Y./0000-0001-6918-1573; Chen, Honglin/0000-0001-5108-8338; Lung, Maria Li/0000-0003-2559-3626; /0000-0003-3217-1456; WONG, Sze Chuen Cesar/0000-0003-0058-140X	GRF; Hong Kong Research Grant Council [776608M, 779810M, 780911M]; RGC sponsored Area of Excellence Theme [AoE/M-06/08]; Pittsburgh Foundation, USA; Career 512 Development Program of the Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer [5P50CA097190-05]; Head and Neck Cancer SPORE Developmental Research Award [5P50CA097007]	GRF; Hong Kong Research Grant Council(Hong Kong Research Grants Council); RGC sponsored Area of Excellence Theme; Pittsburgh Foundation, USA; Career 512 Development Program of the Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer; Head and Neck Cancer SPORE Developmental Research Award	This project is funded by GRF grants awarded by the Hong Kong Research Grant Council (Grant number: 776608M; 779810M; 780911M to SWT) and the RGC sponsored Area of Excellence Theme (Grant number: AoE/M-06/08 to MLL). VWL is supported by the Patricia L. Knebel Fund of the Pittsburgh Foundation, USA, the Career 512 Development Program of the Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer (5P50CA097190-05), the Head and Neck Cancer SPORE Developmental Research Award (5P50CA097007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; BROOKS L, 1992, J VIROL, V66, P2689, DOI 10.1128/JVI.66.5.2689-2697.1992; Buettner M, 2006, VIRCHOWS ARCH, V449, P513, DOI 10.1007/s00428-006-0294-2; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chen HL, 2003, J VIROL, V77, P4139, DOI 10.1128/JVI.77.7.4139-4148.2003; Chen HL, 2001, J VIROL, V75, P2929, DOI 10.1128/JVI.75.6.2929-2937.2001; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Gourzones C, 2012, SEMINARS CANC BIOL, V22, P127; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; Liu YP, 2008, INT J MOL MED, V21, P153; Lo AKF, 2003, LAB INVEST, V83, P697, DOI 10.1097/01.LAB.0000067480.44925.10; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Lui VWY, 2009, INT J CANCER, V125, P1884, DOI 10.1002/ijc.24567; Ma N, 2008, INT J CANCER, V122, P2517, DOI 10.1002/ijc.23415; Man CH, 2012, J PATHOL, V226, P471, DOI 10.1002/path.2997; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Raab-Traub N, 1992, Semin Cancer Biol, V3, P297; Tsang CM, 2012, P NATL ACAD SCI USA, V109, pE3473, DOI 10.1073/pnas.1202637109; Tsang CM, 2010, INT J CANCER, V127, P1570, DOI 10.1002/ijc.25173; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	33	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62284	10.1371/journal.pone.0062284	http://dx.doi.org/10.1371/journal.pone.0062284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658720	Green Published, Green Accepted, gold			2022-12-27	WOS:000319167000038
J	Amos, W				Amos, William			Variation in Heterozygosity Predicts Variation in Human Substitution Rates between Populations, Individuals and Genomic Regions	PLOS ONE			English	Article							MICROSATELLITE MUTATION-RATE; DEMOGRAPHIC HISTORY; GENETIC DIVERSITY; EUKARYOTES; BOTTLENECK; HYPOTHESIS; FAMILIES; CLUSTERS; SEQUENCE; HOTSPOTS	The "heterozygote instability" (HI) hypothesis suggests that gene conversion events focused on heterozygous sites during meiosis locally increase the mutation rate, but this hypothesis remains largely untested. As humans left Africa they lost variability, which, if HI operates, should have reduced the mutation rate in non-Africans. Relative substitution rates were quantified in diverse humans using aligned whole genome sequences from the 1,000 genomes project. Substitution rate is consistently greater in Africans than in non-Africans, but only in diploid regions of the genome, consistent with a role for heterozygosity. Analysing the same data partitioned into a series of non-overlapping 2 Mb windows reveals a strong, nonlinear correlation between the amount of heterozygosity lost "out of Africa" and the difference in substitution rate between Africans and non-Africans. Putative recent mutations, derived variants that occur only once among the 80 human chromosomes sampled, occur preferentially at the centre of 2 Kb windows that have elevated heterozygosity compared both with the same region in a closely related population and with an immediately adjacent region in the same population. More than half of all substitutions appear attributable to variation in heterozygosity. This observation provides strong support for HI with implications for many branches of evolutionary biology.	Univ Cambridge, Dept Zool, Cambridge, Cambs, England	University of Cambridge	Amos, W (corresponding author), Univ Cambridge, Dept Zool, Cambridge, Cambs, England.	w.amos@zoo.cam.ac.uk						Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amos W, 2010, P R SOC B, V277, P131, DOI 10.1098/rspb.2009.1473; Amos W, 2011, P ROY SOC B-BIOL SCI, V278, P1587, DOI 10.1098/rspb.2010.2056; Amos W, 2011, J MOL EVOL, V72, P215, DOI 10.1007/s00239-010-9423-2; Amos W, 2010, P ROY SOC B-BIOL SCI, V277, P1443, DOI 10.1098/rspb.2009.1757; Amos W, 2010, BIOESSAYS, V32, P82, DOI 10.1002/bies.200900108; Amos W, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-72; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Bromham L, 2011, PHILOS T R SOC B, V366, P2503, DOI 10.1098/rstb.2011.0014; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Drake JW, 2007, CRIT REV BIOCHEM MOL, V42, P247, DOI 10.1080/10409230701495631; Drake JW, 2005, P NATL ACAD SCI USA, V102, P12849, DOI 10.1073/pnas.0503009102; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Gravel S, 2011, P NATL ACAD SCI US; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gronlund F, 2009, TRENDS GENET, V25, P523; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Kimura M., 1983, NEUTRAL THEORY EVOLU; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; McConnell R, 2007, GENETICS, V177, P1499, DOI 10.1534/genetics.107.076067; NAG DK, 1995, GENETICS, V141, P75; Ninio J, 1996, MOL GEN GENET, V251, P503, DOI 10.1007/BF02173638; Nishant KT, 2009, BIOESSAYS, V31, P912, DOI 10.1002/bies.200900017; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Rogozin IB, 2003, MUTAT RES-REV MUTAT, V544, P65, DOI 10.1016/S1383-5742(03)00032-2; ROMANOVSKY MG, 1992, GENETIKA+, V28, P88; Schrider DR, 2011, CURR BIOL, V21, P1051, DOI 10.1016/j.cub.2011.05.013; Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TAJIMA F, 1993, GENETICS, V135, P599; Tenaillon MI, 2008, J EVOLUTION BIOL, V21, P541, DOI 10.1111/j.1420-9101.2007.01490.x; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Woodruff RC, 1989, BIOL J LINN SOC, V36, P281	37	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63048	10.1371/journal.pone.0063048	http://dx.doi.org/10.1371/journal.pone.0063048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646173	Green Submitted, Green Published, gold			2022-12-27	WOS:000319077300128
J	Lai, CH; Liu, XX; Tian, CL; Wu, FM				Lai, Chaohua; Liu, Xiaoxi; Tian, Changlin; Wu, Fangming			Integrin alpha 1 Has a Long Helix, Extending from the Transmembrane Region to the Cytoplasmic Tail in Detergent Micelles	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; NMR; COMPLEX; DOMAIN; SUBUNIT; ACTIVATION; MECHANISM; BINDING	Integrin proteins are very important adhesion receptors that mediate cell-cell and cell-extracellular matrix interactions. They play essential roles in cell signaling and the regulation of cellular shape, motility, and the cell cycle. Here, the transmembrane and cytoplasmic (TMC) domains of integrin alpha 1 and beta 1 were over-expressed and purified in detergent micelles. The structure and backbone relaxations of alpha 1-TMC in LDAO micelles were determined and analyzed using solution NMR. A long helix, extending from the transmembrane region to the cytoplasmic tail, was observed in alpha 1-TMC. Structural comparisons of alpha 1-TMC with reported alpha IIb-TMC domains indicated different conformations in the transmembrane regions and cytoplasmic tails. An NMR titration experiment indicated weak interactions between alpha 1-TMC and beta 1-TMC through several alpha 1-TMC residues located at its N-terminal juxta-transmembrane region and C-terminal extended helix region.	[Lai, Chaohua; Liu, Xiaoxi; Tian, Changlin] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Lai, Chaohua; Liu, Xiaoxi; Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Tian, Changlin; Wu, Fangming] Chinese Acad Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Tian, CL (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	cltian@ustc.edu.cn; fmwu@hmfl.ac.cn	Tian, Changlin/P-1469-2014		Chinese National High-Tech Research Grant [2006AA02A321]; National Natural Science Foundation of China [30970577, 31100538]	Chinese National High-Tech Research Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese National High-Tech Research Grant (2006AA02A321) and the National Natural Science Foundation of China (30970577) to CT, and the National Natural Science Foundation of China (31100538) to FW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abair TD, 2008, BLOOD, V112, P3242, DOI 10.1182/blood-2007-12-126433; Ahrens IG, 2006, EXP CELL RES, V312, P925, DOI 10.1016/j.yexcr.2005.11.036; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ekholm E, 2002, AM J PATHOL, V160, P1779, DOI 10.1016/S0002-9440(10)61124-8; Gardner H A, 1999, Curr Rheumatol Rep, V1, P28, DOI 10.1007/s11926-999-0021-5; Gottschalk KE, 2005, STRUCTURE, V13, P703, DOI 10.1016/j.str.2005.02.014; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kalli AC, 2010, STRUCTURE, V18, P1280, DOI 10.1016/j.str.2010.07.012; Karpusas M, 2003, J MOL BIOL, V327, P1031, DOI 10.1016/S0022-2836(03)00203-1; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Loster K, 2001, BIOCHEM J, V356, P233, DOI 10.1042/0264-6021:3560233; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P631, DOI 10.1021/bi201435d; McBrien NA, 2006, INVEST OPHTH VIS SCI, V47, P4674, DOI 10.1167/iovs.05-1150; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Metcalf DG, 2009, J MOL BIOL, V392, P1087, DOI 10.1016/j.jmb.2009.06.032; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Rentala S, 2010, ASIAN J ANDROL, V12, P548, DOI 10.1038/aja.2010.20; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smerling C, 2007, EXP CELL RES, V313, P3153, DOI 10.1016/j.yexcr.2007.06.003; Suk JE, 2012, J AM CHEM SOC, V134, P9030, DOI 10.1021/ja304247f; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vossmeyer D, 2000, EXP CELL RES, V256, P321, DOI 10.1006/excr.2000.4831; Vossmeyer D, 2002, J BIOL CHEM, V277, P4636, DOI 10.1074/jbc.M105415200; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	44	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62954	10.1371/journal.pone.0062954	http://dx.doi.org/10.1371/journal.pone.0062954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646163	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300117
J	Vizzini, A; Bonura, A; Parrinello, D; Sanfratello, MA; Longo, V; Colombo, P				Vizzini, Aiti; Bonura, Angela; Parrinello, Daniela; Sanfratello, Maria Antonietta; Longo, Valeria; Colombo, Paolo			LPS Challenge Regulates Gene Expression and Tissue Localization of a Ciona intestinalis Gene through an Alternative Polyadenylation Mechanism	PLOS ONE			English	Article							MESSENGER-RNA POLYADENYLATION; INFLAMMATORY-LIKE REACTION; SYSTEM; PROLIFERATION; TUNICATA; COLLAGEN; PHARYNX; CLONING	A subtractive hybridization strategy for the identification of differentially expressed genes was performed between LPS-challenged and naive Ciona intestinalis. This strategy allowed the characterization of two transcripts (Ci8short and Ci8long) generated by the use of two Alternative Polyadenylation sites. The Ci8long transcript contains a protein domain with relevant homology to several components of the Receptor Transporting Protein (RTP) family not present in the Ci8short mRNA. By means of Real Time PCR and Northern Blot, the Ci8short and Ci8long transcripts showed a different pattern of gene expression with the Ci8short mRNA being strongly activated after LPS injection in the pharynx. In situ hybridization analysis demonstrated that the activation of the APA site also influenced the tissue localization of the Ci8short transcript. This analysis showed that the Ci8long mRNA was expressed in hemocytes meanwhile the Ci8short mRNA was highly transcribed also in vessel endothelial cells and in the epithelium of pharynx. These findings demonstrated that regulation of gene expression based on different polyadenylation sites is an ancestral powerful strategy influencing both the level of expression and tissue distribution of alternative transcripts.	[Vizzini, Aiti; Parrinello, Daniela; Sanfratello, Maria Antonietta] Dipartimento Sci & Tecnol Biol Chim & Farmaceut, Palermo, Italy; [Bonura, Angela; Longo, Valeria; Colombo, Paolo] CNR, Ist Biomed & Immunol Mol Alberto Monroy, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Colombo, P (corresponding author), CNR, Ist Biomed & Immunol Mol Alberto Monroy, Palermo, Italy.	paolo.colombo@ibim.cnr.it	Colombo, Paolo/ABD-2985-2020; Bonura, Angela/AAY-6091-2020; Colombo, Paolo/O-7284-2019	Colombo, Paolo/0000-0002-0908-1359; VIZZINI, Aiti/0000-0002-0786-7294; LONGO, VALERIA/0000-0002-8328-0698; BONURA, ANGELA/0000-0002-7006-9279	Bando Prin; MIUR Progetto PRIN	Bando Prin; MIUR Progetto PRIN(Ministry of Education, Universities and Research (MIUR))	This work was supported by Bando Prin 2010-2011, and by a grant from: MIUR Progetto PRIN 2010-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonura A, 2010, CELL TISSUE RES, V342, P411, DOI 10.1007/s00441-010-1072-7; Bonura A, 2009, MOL IMMUNOL, V46, P2389, DOI 10.1016/j.molimm.2009.04.035; Cammarata M, 2008, CELL TISSUE RES, V333, P481, DOI 10.1007/s00441-008-0649-x; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Giacomelli S, 2012, FISH SHELLFISH IMMUN, V33, P946, DOI 10.1016/j.fsi.2012.08.003; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Lutz CS, 2011, WIRES RNA, V2, P22, DOI 10.1002/wrna.47; Mainland J, 2012, ADV EXP MED BIOL, V744, P75, DOI 10.1007/978-1-4614-2364-5_7; MARTINUCCI GB, 1988, TISSUE CELL, V20, P119, DOI 10.1016/0040-8166(88)90012-2; PARRINELLO N, 1984, BIOL BULL, V167, P238, DOI 10.2307/1541351; PARRINELLO N, 1984, BIOL BULL, V167, P229, DOI 10.2307/1541350; PARRINELLO N, 1981, DEV COMP IMMUNOL, V5, P33, DOI 10.1016/S0145-305X(81)80005-5; Parrinello N., 2010, CELL TISSUE RES; Parrinello N, 2008, CELL TISSUE RES, V334, P305, DOI 10.1007/s00441-008-0695-4; Parrinello N, 2007, CELL TISSUE RES, V329, P379, DOI 10.1007/s00441-007-0415-5; Pinto MR, 2003, J IMMUNOL, V171, P5521, DOI 10.4049/jimmunol.171.10.5521; RAFTOS DA, 1991, P NATL ACAD SCI USA, V88, P9518, DOI 10.1073/pnas.88.21.9518; RAFTOS DA, 1991, IMMUNOL CELL BIOL, V69, P225, DOI 10.1038/icb.1991.33; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Vizzini A, 2002, BBA-GENE STRUCT EXPR, V1577, P38, DOI 10.1016/S0167-4781(02)00403-7; Vizzini A, 2008, DEV COMP IMMUNOL, V32, P682, DOI 10.1016/j.dci.2007.10.006; Vizzini A, 2012, FISH SHELLFISH IMMUN, V32, P101, DOI 10.1016/j.fsi.2011.10.028; Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63235	10.1371/journal.pone.0063235	http://dx.doi.org/10.1371/journal.pone.0063235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646203	Green Submitted, gold, Green Published			2022-12-27	WOS:000319077300161
J	Zhang, CY; Lu, XJ; Du, XQ; Jian, J; Shu, L; Ma, Y				Zhang, Chun-Ying; Lu, Xiao-Jun; Du, Xiao-Qing; Jian, Jun; Shu, Ling; Ma, Ying			Phylogenetic and Evolutionary Analysis of Chinese Leishmania Isolates Based on Multilocus Sequence Typing	PLOS ONE			English	Article							DONOVANI COMPLEX; EPIDEMIOLOGY; POPULATIONS; GENOTYPES; GENETICS; TAXONOMY; STRAINS	Leishmaniasis is a debilitating infectious disease that has a variety of clinical forms. In China, visceral leishmaniasis (VL) is the most common symptom, and L. donovani and/or L. infantum are the likely pathogens. In this study, multilocus sequence typing (MLST) of five enzyme-coding genes (fh, g6pdh, icd, mpi, pgd) and two conserved genes (hsp70, lack) was used to investigate the phylogenetic relationships of Chinese Leishmania strains. Concatenated alignment of the nucleotide sequences of the seven genes was analyzed and phylogenetic trees were constructed using neighbor-joining and maximum parsimony models. A set of additional sequences from 25 strains (24 strains belong to the L. donovani complex and one strain belongs to L. gerbilli) were retrieved from GenBank to infer the molecular evolutionary history of Leishmania from China and other endemic areas worldwide. Phylogenetic analyses consolidated Chinese Leishmania into four groups: (i) one clade A population comprised 13 isolates from different foci in China, which were pathogenic to humans and canines. This population was subdivided into two subclades, clade A1 and clade A2, which comprised sister organisms to the remaining members of the worldwide L. donovani complex; (ii) a population in clade B consisted of one reference strain of L. turanica and five Chinese strains from Xinjiang; (iii) clade C (SELF-7 and EJNI-154) formed a population that was closely related to clade B, and both isolates were identified as L. gerbilli; and (iv) the final group, clade D, included Sauroleishmania (LIZRD and KXG-E) and was distinct from the other strains. We hypothesize that the phylogeny of Chinese Leishmania is associated with the geographical origins rather than with the clinical forms (VL or CL) of leishmaniasis. To conclude, this study provides further molecular information on Chinese Leishmania isolates and the Chinese isolates appear to have a more complex evolutionary history than previously thought.	[Zhang, Chun-Ying; Lu, Xiao-Jun; Du, Xiao-Qing; Jian, Jun; Shu, Ling; Ma, Ying] Sichuan Univ, West China Hosp, Dept Lab Med, Div Clin Microbiol, Chengdu 610064, Peoples R China	Sichuan University	Ma, Y (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Div Clin Microbiol, Chengdu 610064, Peoples R China.	majiying72@hotmail.com			National Nature Science Foundations of China [81071425]	National Nature Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundations of China(81071425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Cao DP, 2011, PARASITOL RES, V109, P163, DOI 10.1007/s00436-010-2239-6; Cruz I, 2006, INDIAN J MED RES, V123, P357; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Fraga J, 2010, INFECT GENET EVOL, V10, P238, DOI 10.1016/j.meegid.2009.11.007; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; Guan Li-Ren, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P394; Guan LiRen, 2000, Endemic Diseases Bulletin, V15, P49; Guan LiRen, 2003, Chinese Journal of Parasitology and Parasitic Diseases, V21, P285; Guan LR, 1982, CHINESE J EPIDEMIOLO, V4, P261; Hu Y.D., 1976, STUDY EPIDEMIC DIS C, V3, P225; Kuhls K, 2005, MICROBES INFECT, V7, P1224, DOI 10.1016/j.micinf.2005.04.009; Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009; Lu Dian-mei, 2001, Chinese Journal of Parasitology and Parasitic Diseases, V19, P290; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Mauricio IL, 2006, INT J PARASITOL, V36, P757, DOI 10.1016/j.ijpara.2006.03.006; Ochsenreither S, 2006, J CLIN MICROBIOL, V44, P495, DOI 10.1128/JCM.44.2.495-503.2006; Osman Y., 2011, Endemic Diseases Bulletin / Di Fang Bing Tong Bao, V26, P3; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reale S, 2010, TRANSBOUND EMERG DIS, V57, P37, DOI 10.1111/j.1865-1682.2010.01131.x; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Schonian G, 2011, PARASITOLOGY, V138, P405, DOI 10.1017/S0031182010001538; Schonian G, 2008, TRENDS PARASITOL, V24, P135, DOI 10.1016/j.pt.2007.12.006; Schonian G, 2010, TRENDS PARASITOL, V26, P466, DOI 10.1016/j.pt.2010.06.013; Schonian G, 1996, MOL BIOCHEM PARASIT, V77, P19, DOI 10.1016/0166-6851(96)02572-8; Segatto M, 2012, MEM I OSWALDO CRUZ, V107, P39, DOI 10.1590/S0074-02762012000100006; Sun K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-75; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049; Tsukayama P, 2009, INT J PARASITOL, V39, P355, DOI 10.1016/j.ijpara.2008.08.004; Waki K, 2007, EUKARYOT CELL, V6, P198, DOI 10.1128/EC.00282-06; Wang JY, 2010, PARASITOL INT, V59, P331, DOI 10.1016/j.parint.2010.04.002; Wang Y, 2010, PARASITOL RES, V106, P1385, DOI 10.1007/s00436-010-1814-1; Yan Lei, 1995, Endemic Diseases Bulletin, V10, P4; Yang BB, 2010, PARASITOL RES, V107, P1049, DOI 10.1007/s00436-010-1969-9; Zemanova E, 2007, INT J PARASITOL, V37, P149, DOI 10.1016/j.ijpara.2006.08.008; Zhou XD, 2009, INT J ORAL SCI, V1, P1	40	28	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63124	10.1371/journal.pone.0063124	http://dx.doi.org/10.1371/journal.pone.0063124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646184	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300139
J	Juang, JH; Shen, CR; Wang, JJ; Kuo, CH; Chien, YW; Kuo, HY; Chen, FR; Chen, MH; Yen, TC; Tsai, ZT				Juang, Jyuhn-Huarng; Shen, Chia-Rui; Wang, Jiun-Jie; Kuo, Chien-Hung; Chien, Yu-Wen; Kuo, Hsiao-Yunn; Chen, Fu-Rong; Chen, Ming H.; Yen, Tzu-Chen; Tsai, Zei-Tsan			Magnetic Resonance Imaging of Mouse Islet Grafts Labeled with Novel Chitosan-Coated Superparamagnetic Iron Oxide Nanoparticles	PLOS ONE			English	Article							PANCREATIC-ISLETS; IN-VIVO; TRANSPLANTED ISLETS; DIABETES-MELLITUS; LIVER; MRI; PARTICLES; SURVIVAL	Object: To better understand the fate of islet isografts and allografts, we utilized a magnetic resonance (MR) imaging technique to monitor mouse islets labeled with a novel MR contrast agent, chitosan-coated superparamagnetic iron oxide (CSPIO) nanoparticles. Materials and Methods: After being incubated with and without CSPIO (10 mu g/ml), C57BL/6 mouse islets were examined under transmission electron microscope (TEM) and their insulin secretion was measured. Cytotoxicity was examined in alpha (alpha TC1) and beta (NIT-1 and beta TC) cell lines as well as islets. C57BL/6 mice were used as donors and inbred C57BL/6 and Balb/c mice were used as recipients of islet transplantation. Three hundred islets were transplanted under the left kidney capsule of each mouse and then MR was performed in the recipients periodically. At the end of study, the islet graft was removed for histology and TEM studies. Results: After incubation of mouse islets with CSPIO (10 mu g/mL), TEM showed CSPIO in endocytotic vesicles of alpha- and beta-cells at 8 h. Incubation with CSPIO did not affect insulin secretion from islets and death rates of alpha TC1, NIT-1 and beta TC cell lines as well as islets. After syngeneic and allogeneic transplantation, grafts of CSPIO-labeled islets were visualized on MR scans as persistent hypointense areas. At 8 weeks after syngeneic transplantation and 31 days after allogeneic transplantation, histology of CSPIO-labeled islet grafts showed colocalized insulin and iron staining in the same areas but the size of allografts decreased with time. TEM with elementary iron mapping demonstrated CSPIO distributed in the cytoplasm of islet cells, which maintained intact ultrastructure. Conclusion: Our results indicate that after syngeneic and allogeneic transplantation, islets labeled with CSPIO nanoparticles can be effectively and safely imaged by MR.	[Juang, Jyuhn-Huarng; Chien, Yu-Wen] Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Tao Yuan, Taiwan; [Juang, Jyuhn-Huarng; Chien, Yu-Wen] Chang Gung Univ, Coll Med, Dept Med, Tao Yuan, Taiwan; [Shen, Chia-Rui; Kuo, Hsiao-Yunn] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Shen, Chia-Rui; Yen, Tzu-Chen; Tsai, Zei-Tsan] Chang Gung Mem Hosp, Mol Imaging Ctr, Tao Yuan, Taiwan; [Wang, Jiun-Jie; Yen, Tzu-Chen] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Kuo, Chien-Hung] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chen, Fu-Rong] Natl Tsing Hua Univ, Ctr Transmiss Microscopy, Hsinchu, Taiwan; [Chen, Ming H.] Univ Alberta, Surg Med Res Inst, Edmonton, AB, Canada; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; National Tsing Hua University; University of Alberta; Chang Gung Memorial Hospital	Juang, JH (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Tao Yuan, Taiwan.	jjuang@adm.cgmh.org.tw; zeitsan@ms9.hinet.net	Chou, Jung-Chuan/I-5924-2019	Chou, Jung-Chuan/0000-0002-8829-3404; Wang, Jiun-Jie/0000-0002-2422-9059; Shen, Chia-Rui/0000-0002-8386-3965; CHEN, Fu-Rong/0000-0003-4707-6590	Chang Gung Memorial Hospital [CMRPG370361-2, CMRPG370871-2, CMRPG391701-2]; National Science Council of Taiwan, ROC [NSC 96-2314-B-182A-039-MY3, 99-2314-B-182A-010-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang Gung Memorial Hospital (CMRPG370361-2, CMRPG370871-2, CMRPG391701-2) and the National Science Council (NSC 96-2314-B-182A-039-MY3, 99-2314-B-182A-010-MY3) of Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkova Z, 2005, TRANSPL P, V37, P3496, DOI 10.1016/j.transproceed.2005.09.052; Berkova Z, 2008, TRANSPLANTATION, V85, P155, DOI 10.1097/01.tp.0000297247.08627.ff; Briley-Saebo KC, 2006, INVEST RADIOL, V41, P560, DOI 10.1097/01.rli.0000221321.90261.09; Brillet PY, 2005, EUR RADIOL, V15, P1369, DOI 10.1007/s00330-004-2586-8; Cher T, 2010, APPL RADIOL, V39, P26; Di Gialleonardo V, 2012, ENDOCR REV, V33, P892, DOI 10.1210/er.2011-1041; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Evgenov NV, 2008, TRANSPLANTATION, V85, P1091, DOI 10.1097/TP.0b013e31816b183e; Evgenov NV, 2006, DIABETES, V55, P2419, DOI 10.2337/db06-0484; Evgenov NV, 2006, NAT MED, V12, P144, DOI 10.1038/nm1316; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; Hathout E, 2009, PEDIATR TRANSPLANT, V13, P892, DOI 10.1111/j.1399-3046.2008.01088.x; Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x; Jiao Y, 2008, ANAT REC, V291, P1684, DOI 10.1002/ar.20770; Jirak D, 2004, MAGN RESON MED, V52, P1228, DOI 10.1002/mrm.20282; Juang JH, 2010, TRANSPL P, V42, P4217, DOI 10.1016/j.transproceed.2010.09.089; Juang JH, 2010, TRANSPL P, V42, P2104, DOI 10.1016/j.transproceed.2010.05.103; Juang JH, 2001, CELL TRANSPLANT, V10, P277, DOI 10.3727/000000001783986738; Kriz J, 2008, TRANSPL P, V40, P444, DOI 10.1016/j.transproceed.2008.02.018; Kriz J, 2005, TRANSPLANTATION, V80, P1596, DOI 10.1097/01.tp.0000183959.73681.b9; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; Malosio ML, 2009, AM J TRANSPLANT, V9, P2372, DOI 10.1111/j.1600-6143.2009.02791.x; Marzola P, 2009, CONTRAST MEDIA MOL I, V4, P135, DOI 10.1002/cmmi.274; Medarova Z, 2009, NAT REV ENDOCRINOL, V5, P444, DOI 10.1038/nrendo.2009.130; Medarova Z, 2009, TRANSPLANTATION, V87, P1659, DOI 10.1097/TP.0b013e3181a5cbc0; Meloche RM, 2007, WORLD J GASTROENTERO, V13, P6347, DOI 10.3748/wjg.13.6347; Muller K, 2007, BIOMATERIALS, V28, P1629, DOI 10.1016/j.biomaterials.2006.12.002; Paty BW, 2004, TRANSPLANTATION, V77, P1133, DOI 10.1097/01.TP.0000113231.90613.0E; ROSS DD, 1989, CANCER RES, V49, P3776; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Saudek F, 2010, TRANSPLANTATION, V90, P1602, DOI 10.1097/TP.0b013e3181ffba5e; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Tai JH, 2006, DIABETES, V55, P2931, DOI 10.2337/db06-0393; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; Tsai ZT, 2010, J MAGN MAGN MATER, V322, P208, DOI 10.1016/j.jmmm.2009.08.049; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Zhang SZ, 2009, PANCREAS, V38, P293, DOI 10.1097/MPA.0b013e318190d77a	38	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62626	10.1371/journal.pone.0062626	http://dx.doi.org/10.1371/journal.pone.0062626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658638	gold, Green Published, Green Submitted			2022-12-27	WOS:000321662800052
J	Kim, W; Tengra, FK; Young, Z; Shong, J; Marchand, N; Chan, HK; Pangule, RC; Parra, M; Dordick, JS; Plawsky, JL; Collins, CH				Kim, Wooseong; Tengra, Farah K.; Young, Zachary; Shong, Jasmine; Marchand, Nicholas; Chan, Hon Kit; Pangule, Ravindra C.; Parra, Macarena; Dordick, Jonathan S.; Plawsky, Joel L.; Collins, Cynthia H.			Spaceflight Promotes Biofilm Formation by Pseudomonas aeruginosa	PLOS ONE			English	Article							SHEAR MODELED MICROGRAVITY; MULTICELLULAR STRUCTURES; ESCHERICHIA-COLI; GENE-EXPRESSION; IV PILI; MOTILITY; GROWTH; VIRULENCE; FLAGELLAR; SYSTEM	Understanding the effects of spaceflight on microbial communities is crucial for the success of long-term, manned space missions. Surface-associated bacterial communities, known as biofilms, were abundant on the Mir space station and continue to be a challenge on the International Space Station. The health and safety hazards linked to the development of biofilms are of particular concern due to the suppression of immune function observed during spaceflight. While planktonic cultures of microbes have indicated that spaceflight can lead to increases in growth and virulence, the effects of spaceflight on biofilm development and physiology remain unclear. To address this issue, Pseudomonas aeruginosa was cultured during two Space Shuttle Atlantis missions: STS-132 and STS-135, and the biofilms formed during spaceflight were characterized. Spaceflight was observed to increase the number of viable cells, biofilm biomass, and thickness relative to normal gravity controls. Moreover, the biofilms formed during spaceflight exhibited a column-and-canopy structure that has not been observed on Earth. The increase in the amount of biofilms and the formation of the novel architecture during spaceflight were observed to be independent of carbon source and phosphate concentrations in the media. However, flagella-driven motility was shown to be essential for the formation of this biofilm architecture during spaceflight. These findings represent the first evidence that spaceflight affects community-level behaviors of bacteria and highlight the importance of understanding how both harmful and beneficial human-microbe interactions may be altered during spaceflight.	[Kim, Wooseong; Tengra, Farah K.; Young, Zachary; Shong, Jasmine; Marchand, Nicholas; Chan, Hon Kit; Pangule, Ravindra C.; Dordick, Jonathan S.; Plawsky, Joel L.; Collins, Cynthia H.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Kim, Wooseong; Tengra, Farah K.; Shong, Jasmine; Marchand, Nicholas; Pangule, Ravindra C.; Dordick, Jonathan S.; Collins, Cynthia H.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Parra, Macarena] Lockheed Martin, Ames Res Ctr, Moffett Field, CA USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Collins, CH (corresponding author), Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA.	ccollins@rpi.edu	Young, Zachary D/V-5031-2017; Kim, Wooseong/AAQ-3221-2020; Kim, Wooseong/A-9256-2017	Young, Zachary D/0000-0002-3781-1101; Kim, Wooseong/0000-0002-4597-8374; Kim, Wooseong/0000-0002-4597-8374; Collins, Cynthia/0000-0003-1647-860X	NASA [NNX09AI70G]	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NASA Grant NNX09AI70G to CHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Benoit MR, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046007; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Castaneda RJ., 2007, J EXP MICROBIOL IMMU, V11, P23; Crabbe A, 2008, ENVIRON MICROBIOL, V10, P2098, DOI 10.1111/j.1462-2920.2008.01631.x; Crabbe A, 2011, APPL ENVIRON MICROB, V77, P1221, DOI 10.1128/AEM.01582-10; Crabbe A, 2010, ENVIRON MICROBIOL, V12, P1545, DOI 10.1111/j.1462-2920.2010.02184.x; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; England LS, 2003, BBA-GEN SUBJECTS, V1624, P76, DOI 10.1016/j.bbagen.2003.09.012; Gu JD, 1998, INT BIODETER BIODEGR, V41, P25, DOI 10.1016/S0964-8305(97)00070-X; Guadarrama S, 2005, Gravit Space Biol Bull, V18, P85; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harmsen M, 2010, FEMS IMMUNOL MED MIC, V59, P253, DOI 10.1111/j.1574-695X.2010.00690.x; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hogardt M, 2004, MICROBIOL-SGM, V150, P843, DOI 10.1099/mic.0.26703-0; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Klaus D, 1997, MICROBIOL-SGM, V143, P449, DOI 10.1099/00221287-143-2-449; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Lynch SV, 2006, APPL ENVIRON MICROB, V72, P7701, DOI 10.1128/AEM.01294-06; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; McLean RJC, 2001, FEMS MICROBIOL LETT, V195, P115, DOI 10.1016/S0378-1097(00)00549-8; Merritt JH, 2005, CURR PROTOC MICROBIO, V1; Nelson Emily S, 2004, J Gravit Physiol, V11, P1; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; Sternberg Claus, 2006, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b02s00; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; Storrs-Mabilat M, 2001, STUDY MICROBIAL DETE; Toutain CM, 2005, J BACTERIOL, V187, P771, DOI 10.1128/JB.187.2.771-777.2005; Videla HA, 2005, INT MICROBIOL, V8, P169; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003923	34	111	123	8	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62437	10.1371/journal.pone.0062437	http://dx.doi.org/10.1371/journal.pone.0062437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658630	Green Submitted, Green Published, gold			2022-12-27	WOS:000321662800045
J	Aragam, NR; Thayer, KM; Nge, N; Hoffman, I; Martinson, F; Kamwendo, D; Lin, FC; Sutherland, C; Bailey, JA; Juliano, JJ				Aragam, Nagesh R.; Thayer, Kelly M.; Nge, Nabi; Hoffman, Irving; Martinson, Francis; Kamwendo, Debbie; Lin, Feng-Chang; Sutherland, Colin; Bailey, Jeffrey A.; Juliano, Jonathan J.			Diversity of T Cell Epitopes in Plasmodium falciparum Circumsporozoite Protein Likely Due to Protein-Protein Interactions	PLOS ONE			English	Article							MALARIA VACCINE; SELECTION; CANDIDATE; POLYMORPHISMS; SPOROZOITES; RECOGNITION; CHLOROQUINE; SOFTWARE; EFFICACY; PARASITE	Circumsporozoite protein (CS) is a leading vaccine antigen for falciparum malaria, but is highly polymorphic in natural parasite populations. The factors driving this diversity are unclear, but non-random assortment of the T cell epitopes TH2 and TH3 has been observed in a Kenyan parasite population. The recent publication of the crystal structure of the variable C terminal region of the protein allows the assessment of the impact of diversity on protein structure and T cell epitope assortment. Using data from the Gambia (55 isolates) and Malawi (235 isolates), we evaluated the patterns of diversity within and between epitopes in these two distantly-separated populations. Only non-synonymous mutations were observed with the vast majority in both populations at similar frequencies suggesting strong selection on this region. A non-random pattern of T cell epitope assortment was seen in Malawi and in the Gambia, but structural analysis indicates no intramolecular spatial interactions. Using the information from these parasite populations, structural analysis reveals that polymorphic amino acids within TH2 and TH3 colocalize to one side of the protein, surround, but do not involve, the hydrophobic pocket in CS, and predominately involve charge switches. In addition, free energy analysis suggests residues forming and behind the novel pocket within CS are tightly constrained and well conserved in all alleles. In addition, free energy analysis shows polymorphic residues tend to be populated by energetically unfavorable amino acids. In combination, these findings suggest the diversity of T cell epitopes in CS may be primarily an evolutionary response to intermolecular interactions at the surface of the protein potentially counteracting antibody-mediated immune recognition or evolving host receptor diversity.	[Aragam, Nagesh R.; Hoffman, Irving; Juliano, Jonathan J.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA; [Thayer, Kelly M.; Bailey, Jeffrey A.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Nge, Nabi; Sutherland, Colin] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Martinson, Francis; Kamwendo, Debbie] UNC Project Malawi, Lilongwe, Malawi; [Lin, Feng-Chang] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Bailey, Jeffrey A.] Univ Massachusetts, Sch Med, Div Transfus Med, Worcester, MA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Massachusetts System; University of Massachusetts Worcester	Bailey, JA (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA.	jeffrey.bailey@umassmed.edu	Sutherland, Colin/AAN-3939-2020; Lin, Feng-Chang/ABE-9659-2020	Sutherland, Colin/0000-0003-1592-6407; 	National Institutes of Health [1R01AI0898119, KL2RR025746, UL1RR025747]; UK Health Protection Agency;  [1KL2RR031981]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000161, KL2TR000160] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031981, UL1RR025747, KL2RR025746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Health Protection Agency; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health [grant numbers: 1R01AI0898119, KL2RR025746, and UL1RR025747]. JAB is specifically supported by 1KL2RR031981. CJS is supported by the UK Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Agresti A, 2007, INTRO CATEGORICAL DA; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alloueche A, 2000, MOL BIOCHEM PARASIT, V106, P273, DOI 10.1016/S0166-6851(99)00221-2; Bailey JA, 2012, J INFECT DIS, V206, P580, DOI 10.1093/infdis/jis329; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Chenet SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-93; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DNASTAR Inc, 2008, SEQ AN US DNASTARS L; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gonzalez-Ceron L, 1999, INFECT IMMUN, V67, P410, DOI 10.1128/IAI.67.1.410-412.1999; GOOD MF, 1988, ANNU REV IMMUNOL, V6, P663, DOI 10.1146/annurev.iy.06.040188.003311; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; HOFFMAN SL, 1989, J IMMUNOL, V142, P1299; Hudson RR, 2000, GENETICS, V155, P2011; HUGHES AL, 1991, GENETICS, V127, P345; JONGWUTIWES S, 1994, AM J TROP MED HYG, V51, P659, DOI 10.4269/ajtmh.1994.51.659; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Ord R, 2007, J INFECT DIS, V196, P1613, DOI 10.1086/522154; Publishing SAS, 2010, SAS 9 2 LANGUAGE REF; Rathore D, 2000, P NATL ACAD SCI USA, V97, P8530, DOI 10.1073/pnas.140224597; RILEY EM, 1990, T ROY SOC TROP MED H, V84, P648, DOI 10.1016/0035-9203(90)90133-Y; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SINNIS P, 1994, J EXP MED, V180, P297, DOI 10.1084/jem.180.1.297; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; Stiebritz MT, 2006, ACTA CRYSTALLOGR D, V62, P648, DOI 10.1107/S0907444906013333; Sutherland CJ, 2003, AM J TROP MED HYG, V69, P19, DOI 10.4269/ajtmh.2003.69.19; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62427	10.1371/journal.pone.0062427	http://dx.doi.org/10.1371/journal.pone.0062427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667476	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000319654700035
J	Spitzen, J; Spoor, CW; Grieco, F; ter Braak, C; Beeuwkes, J; van Brugge, SP; Kranenbarg, S; Noldus, LPJJ; van Leeuwen, JL; Takken, W				Spitzen, Jeroen; Spoor, Cornelis W.; Grieco, Fabrizio; ter Braak, Cajo; Beeuwkes, Jacob; van Brugge, Sjaak P.; Kranenbarg, Sander; Noldus, Lucas P. J. J.; van Leeuwen, Johan L.; Takken, Willem			A 3D Analysis of Flight Behavior of Anopheles gambiae sensu stricto Malaria Mosquitoes in Response to Human Odor and Heat	PLOS ONE			English	Article							FEMALE CULEX-QUINQUEFASCIATUS; FINE-SCALE STRUCTURE; MM-X TRAPS; CARBON-DIOXIDE; UPWIND FLIGHT; HOST ODOR; PHEROMONE PLUMES; TSETSE-FLIES; ORIENTATION; DIPTERA	Female mosquitoes use odor and heat as cues to navigate to a suitable landing site on their blood host. The way these cues affect flight behavior and modulate anemotactic responses, however, is poorly understood. We studied in-flight behavioral responses of females of the nocturnal malaria mosquito Anopheles gambiae sensu stricto to human odor and heat. Flight-path characteristics in a wind tunnel (flow 20 cm/s) were quantified in three dimensions. With wind as the only stimulus (control), short and close to straight upwind flights were recorded. With heat alone, flights were similarly short and direct. The presence of human odor, in contrast, caused prolonged and highly convoluted flight patterns. The combination of odor+heat resulted in longer flights with more landings on the source than to either cue alone. Flight speed was greatest (mean groundspeed 27.2 cm/s) for odor+heat. Odor alone resulted in decreased flight speed when mosquitoes arrived within 30 cm of the source whereas mosquitoes exposed to odor+heat maintained a high flight speed while flying in the odor plume, until they arrived within 15 cm of the source. Human odor evoked an increase in crosswind flights with an additive effect of heat at close range (<15 cm) to the source. This was found for both horizontal and vertical flight components. However, mosquitoes nevertheless made upwind progress when flying in the odor+heat generated plume, suggesting that mosquitoes scan their environment intensively while they progress upwind towards their host. These observations may help to improve the efficacy of trapping systems for malaria mosquitoes by (1) optimizing the site of odor release relative to trap entry and (2) adding a heat source which enhances a landing response.	[Spitzen, Jeroen; Beeuwkes, Jacob; Takken, Willem] Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands; [Spoor, Cornelis W.; Kranenbarg, Sander; van Leeuwen, Johan L.] Wageningen Univ, Expt Zool Grp, NL-6700 AP Wageningen, Netherlands; [Grieco, Fabrizio] Noldus Informat Technol BV, Wageningen, Netherlands; [ter Braak, Cajo] Wageningen UR, Dept Math & Stat Methods, Biometris, Wageningen, Netherlands; [van Brugge, Sjaak P.] Wageningen Univ, Facil Serv, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Takken, W (corresponding author), Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands.	willem.takken@wur.nl	Spitzen, Jeroen/B-3098-2012; van Leeuwen, Johan L/B-7897-2011; van Leeuwen, Johan/N-3437-2019; Braak, Cajo J. F. ter/G-7006-2011	Spitzen, Jeroen/0000-0003-0455-7511; van Leeuwen, Johan/0000-0002-4433-880X; Braak, Cajo J. F. ter/0000-0002-0414-8745	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH) [121]	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH#121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkenius A, 2010, J EXP BIOL, V213, P3741, DOI 10.1242/jeb.043760; Bhasin A, 2001, MED VET ENTOMOL, V15, P147, DOI 10.1046/j.1365-2915.2001.00285.x; Braks MAH, 2005, MEASURING BEHAV 2005; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Carde RT, 2010, ECOL CONT VECTOR-BOR, V2, P115; Carde RT., 1995, CHEM ECOLOGY INSECTS; Cooperband MF, 2006, MED VET ENTOMOL, V20, P11, DOI 10.1111/j.1365-2915.2006.00613.x; Cummins B, 2012, PLOS COMPUTATIONAL B, V8, DOI [10.1371/journal.pcbi.1002500, DOI 10.1371/J0URNAL.PCBI.1002500)]; David C.T., 1989, P17; David C.T., 1986, P49; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dekker T, 2011, J EXP BIOL, V214, P3480, DOI 10.1242/jeb.055186; Faiman R, 2011, ACTA TROP, V120, P110, DOI 10.1016/j.actatropica.2011.06.015; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; GIBSON G, 1988, PHYSIOL ENTOMOL, V13, P29, DOI 10.1111/j.1365-3032.1988.tb00906.x; GIBSON G, 1991, PHYSIOL ENTOMOL, V16, P47, DOI 10.1111/j.1365-3032.1991.tb00542.x; GIBSON G, 1995, PHYSIOL ENTOMOL, V20, P224, DOI 10.1111/j.1365-3032.1995.tb00005.x; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; GILLIES MT, 1970, B ENTOMOL RES, V60, P225, DOI 10.1017/S000748530004075X; Healy TP, 2000, MED VET ENTOMOL, V14, P195, DOI 10.1046/j.1365-2915.2000.00238.x; Healy TP, 2002, MED VET ENTOMOL, V16, P126, DOI 10.1046/j.1365-2915.2002.00353.x; Howlett F. M., 1910, Parasitology Cambridge, V3; KELLOG F. E., 1962, CANADIAN ENTOMOL, V94, P1009; Krcmar S, 2005, J VECTOR ECOL, V30, P133; Laarman J. J., 1958, Tropical and Geographical Medicine Amsterdam, V10, P293; Lacey ES, 2011, MED VET ENTOMOL, V25, P94, DOI 10.1111/j.1365-2915.2010.00921.x; Lacey ES, 2012, PHYSIOL ENTOMOL, V37, P153, DOI 10.1111/j.1365-3032.2011.00829.x; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; MAFRANETO A, 1995, PHYSIOL ENTOMOL, V20, P117, DOI 10.1111/j.1365-3032.1995.tb00808.x; MAFRANETO A, 1995, PHYSIOL ENTOMOL, V20, P229, DOI 10.1111/j.1365-3032.1995.tb00006.x; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Olanga EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-6; PETERSON DG, 1951, B ENTOMOL RES, V42, P535, DOI 10.1017/S0007485300028935; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015; Spitzen J, 2008, MEAS BEH 6 INT C MEA, P133; Stewart FJ, 2010, J EXP BIOL, V213, P1886, DOI 10.1242/jeb.026526; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Takken W, 1997, J INSECT BEHAV, V10, P395, DOI 10.1007/BF02765606; Verhulst NO, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, DOI 10.1371/J0URNAL.P0NE.0028991)]; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; VISSER JH, 1978, ENTOMOL EXP APPL, V24, P738, DOI 10.1007/BF02385130; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; Webster B, 2012, PHYSIOL ENTOMOL, V37, P10, DOI 10.1111/j.1365-3032.2011.00791.x; Williams CR, 2006, J AM MOSQUITO CONTR, V22, P641, DOI 10.2987/8756-971X(2006)22[641:LAFAOS]2.0.CO;2	48	64	65	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62995	10.1371/journal.pone.0062995	http://dx.doi.org/10.1371/journal.pone.0062995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658792	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500049
J	Arribas-Gonzalez, E; Alonso-Torres, P; Aragon, C; Lopez-Corcuera, B				Arribas-Gonzalez, Esther; Alonso-Torres, Pablo; Aragon, Carmen; Lopez-Corcuera, Beatriz			Calnexin-Assisted Biogenesis of the Neuronal Glycine Transporter 2 (GlyT2)	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; STARTLE DISEASE; PLASMA-MEMBRANE; GLUCOSIDASE-II; PROTEIN; HYPEREKPLEXIA; MUTATIONS; ER; SLC6A5	The neuronal transporter GlyT2 is a polytopic, 12-transmembrane domain, plasma membrane glycoprotein involved in the removal and recycling of synaptic glycine from inhibitory synapses. Mutations in the human GlyT2 gene (SLC6A5) that cause deficient glycine transport or defective GlyT2 trafficking are the second most common cause of hyperekplexia or startle disease. In this study we examined several aspects of GlyT2 biogenesis that involve the endoplasmic reticulum chaperone calnexin (CNX). CNX binds transiently to an intermediate under-glycosylated transporter precursor and facilitates GlyT2 processing. In cells expressing GlyT2, transporter accumulation and transport activity were attenuated by siRNA-mediated CNX knockdown and enhanced by CNX overexpression. GlyT2 binding to CNX was mediated by glycan and polypeptide-based interactions as revealed by pharmacological approaches and the behavior of GlyT2 N-glycan-deficient mutants. Moreover, transporter folding appeared to be stabilized by N-glycans. Co-expression of CNX and a fully non-glycosylated mutant rescues glycine transport but not mutant surface expression. Hence, CNX discriminates between different conformational states of GlyT2 displaying a lectin-independent chaperone activity. GlyT2 wild-type and mutant transporters were finally degraded in the lysosome. Our findings provide further insight into GlyT2 biogenesis, and a useful framework for the study of newly synthesized GlyT2 transporters bearing hyperekplexia mutations.	[Arribas-Gonzalez, Esther; Alonso-Torres, Pablo; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, CSIC, Dept Biol Mol, Madrid, Spain; [Arribas-Gonzalez, Esther; Alonso-Torres, Pablo; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Aragon, Carmen; Lopez-Corcuera, Beatriz] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Arribas-Gonzalez, Esther; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, IdiPAZ Hosp Univ La Paz, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; Hospital Universitario La Paz	Lopez-Corcuera, B (corresponding author), Univ Autonoma Madrid, CSIC, Dept Biol Mol, Madrid, Spain.	blopez@cbm.uam.es	Aragon, Carmen/K-9783-2014; Corcuera, Beatriz López/D-5188-2009	Aragon, Carmen/0000-0001-8287-9386; Corcuera, Beatriz López/0000-0002-0383-4241; Arribas Gonzalez, Esther/0000-0001-6579-3396	Spanish 'Direccion General de Ensenanza Superior e Investigacion Cientifica' [BFU2005-05931/BMC, BIO2005-05786]; Ministerio de Ciencia e Innovacion [SAF2008-05436]; Comunidad Autonoma de Madrid [11/BCB/010, S-SAL-0253/2006]; Ministerio de Economia y Competitividad [SAF2011-28674]; CIBERER [U-751/U-753]; Fundacion Ramon Areces	Spanish 'Direccion General de Ensenanza Superior e Investigacion Cientifica'; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Economia y Competitividad(Spanish Government); CIBERER; Fundacion Ramon Areces	This work was supported by the Spanish 'Direccion General de Ensenanza Superior e Investigacion Cientifica' (BFU2005-05931/BMC and BIO2005-05786), 'Ministerio de Ciencia e Innovacion' (SAF2008-05436), 'Comunidad Autonoma de Madrid' (11/BCB/010 and S-SAL-0253/2006), Ministerio de Economia y Competitividad (SAF2011-28674), CIBERER (intramural project U-751/U-753), by an institutional grant from the 'Fundacion Ramon Areces'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Compain P., 2007, IMINOSUGARS SYNTHESI; de Juan-Sanz J, 2011, TRAFFIC, V12, P1850, DOI 10.1111/j.1600-0854.2011.01278.x; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Esapa CT, 2005, HUM MOL GENET, V14, P295, DOI 10.1093/hmg/ddi026; Eulenburg V, 2006, BIOCHEM BIOPH RES CO, V348, P400, DOI 10.1016/j.bbrc.2006.07.080; Freeze H, 2010, CURRENT PROTOCOLS IM; Gimenez C, 2012, J BIOL CHEM, V287, P28986, DOI 10.1074/jbc.M111.319244; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Jimenez E, 2011, J BIOL CHEM, V286, P10712, DOI 10.1074/jbc.M110.167056; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KAUSHAL GP, 1990, J BIOL CHEM, V265, P16271; Korkhov VM, 2008, J MOL BIOL, V378, P337, DOI 10.1016/j.jmb.2008.02.056; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Lopez-Corcuera B, 2001, J BIOL CHEM, V276, P43463, DOI 10.1074/jbc.M107438200; Lopez-Corcuera B, 1998, J NEUROCHEM, V71, P2211; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Morello JP, 2001, BIOCHEMISTRY-US, V40, P6766, DOI 10.1021/bi002699r; Nunez E, 2008, J NEUROCHEM, V105, P2080, DOI 10.1111/j.1471-4159.2008.05292.x; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; OLIVARES L, 1994, J BIOL CHEM, V269, P28400; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Perez-Siles G, 2012, BIOCHEM J, V442, P323, DOI 10.1042/BJ20110247; Perez-Siles G, 2011, J NEUROCHEM, V118, P195, DOI 10.1111/j.1471-4159.2011.07309.x; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Rousseau F, 2008, J NEUROSCI, V28, P9755, DOI 10.1523/JNEUROSCI.0509-08.2008; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; SUHREN O, 1966, J NEUROL SCI, V3, P577, DOI 10.1016/0022-510X(66)90047-5; Tate CG, 1999, BIOCHEM SOC T, V27, P932, DOI 10.1042/bst0270932; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x	52	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63230	10.1371/journal.pone.0063230	http://dx.doi.org/10.1371/journal.pone.0063230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650557	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000102
J	Alpert, MH; Alford, S				Alpert, Michael H.; Alford, Simon			Synaptic NMDA Receptor-Dependent Ca2+ Entry Drives Membrane Potential and Ca2+ Oscillations in Spinal Ventral Horn Neurons	PLOS ONE			English	Article							METHYL-D-ASPARTATE; POTASSIUM CHANNELS; ELECTROPHYSIOLOGICAL PROPERTIES; RETICULOSPINAL NEURONS; CALCIUM-CHANNELS; SK CHANNELS; LATE AFTERHYPERPOLARIZATION; VOLTAGE OSCILLATIONS; PATTERN GENERATION; FICTIVE LOCOMOTION	During vertebrate locomotion, spinal neurons act as oscillators when initiated by glutamate release from descending systems. Activation of NMDA receptors initiates Ca2+-mediated intrinsic membrane potential oscillations in central pattern generator (CPG) neurons. NMDA receptor-dependent intrinsic oscillations require Ca2+-dependent K+ (K(Ca)2) channels for burst termination. However, the location of Ca2+ entry mediating K(Ca)2 channel activation, and type of Ca2+ channel - which includes NMDA receptors and voltage-gated Ca2+ channels (VGCCs) - remains elusive. NMDA receptor-dependent Ca2+ entry necessitates presynaptic release of glutamate, implying a location at active synapses within dendrites, whereas VGCC-dependent Ca2+ entry is not similarly constrained. Where Ca2+ enters relative to K(Ca)2 channels is crucial to information processing of synaptic inputs necessary to coordinate locomotion. We demonstrate that Ca2+ permeating NMDA receptors is the dominant source of Ca2+ during NMDA-dependent oscillations in lamprey spinal neurons. This Ca2+ entry is synaptically located, NMDA receptor-dependent, and sufficient to activate K(Ca)2 channels at excitatory interneuron synapses onto other CPG neurons. Selective blockade of VGCCs reduces whole-cell Ca2+ entry but leaves membrane potential and Ca2+ oscillations unaffected. Furthermore, repetitive oscillations are prevented by fast, but not slow, Ca2+ chelation. Taken together, these results demonstrate that K(Ca)2 channels are closely located to NMDA receptor-dependent Ca2+ entry. The close spatial relationship between NMDA receptors and K(Ca)2 channels provides an intrinsic mechanism whereby synaptic excitation both excites and subsequently inhibits ventral horn neurons of the spinal motor system. This places the components necessary for oscillation generation, and hence locomotion, at glutamatergic synapses.	[Alpert, Michael H.; Alford, Simon] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alford, S (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	sta@uic.edu		Alford, Simon/0000-0002-0454-4246	National Institutes of Health [RO1 MH 084874]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institutes of Health Grant RO1 MH 084874; http://www.nimh.nih.gov/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER EM, 1991, J NEUROSCI, V11, P1496; ALFORD S, 1990, BRAIN RES, V506, P297, DOI 10.1016/0006-8993(90)91266-J; Alford S, 2003, NEUROSCIENTIST, V9, P217, DOI 10.1177/1073858403009003014; ALFORD S, 1989, J NEUROSCI, V9, P2792; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; BACSKAI BJ, 1995, NEURON, V14, P19, DOI 10.1016/0896-6273(95)90237-6; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; BRODIN L, 1988, ARCH ITAL BIOL, V126, P317; BUCHANAN JT, 1993, J NEUROPHYSIOL, V70, P2313, DOI 10.1152/jn.1993.70.6.2313; BUCHANAN JT, 1989, J NEUROPHYSIOL, V62, P59, DOI 10.1152/jn.1989.62.1.59; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P948, DOI 10.1152/jn.1982.47.5.948; BUCHANAN JT, 1987, BRAIN RES, V408, P321, DOI 10.1016/0006-8993(87)90397-0; Buchanan JT, 2001, PROG NEUROBIOL, V63, P441, DOI 10.1016/S0301-0082(00)00050-2; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P961, DOI 10.1152/jn.1982.47.5.961; BUCHANAN JT, 1987, SCIENCE, V236, P312, DOI 10.1126/science.3563512; Bussieres N, 1999, BRAIN RES, V847, P175, DOI 10.1016/S0006-8993(99)02002-8; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cangiano L, 2002, J NEUROPHYSIOL, V88, P289, DOI 10.1152/jn.2002.88.1.289; Di Prisco GV, 2004, J NEUROPHYSIOL, V92, P1796, DOI 10.1152/jn.00138.2004; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; ElManira A, 1997, J NEUROPHYSIOL, V78, P1334; ELMANIRA A, 1994, J NEUROPHYSIOL, V72, P1852, DOI 10.1152/jn.1994.72.4.1852; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Faber ESL, 2010, J PHYSIOL-LONDON, V588, P1281, DOI 10.1113/jphysiol.2009.185645; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Guertin PA, 1998, J NEUROPHYSIOL, V80, P3380, DOI 10.1152/jn.1998.80.6.3380; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Han P, 2007, J NEUROSCI, V27, P13192, DOI 10.1523/JNEUROSCI.1279-07.2007; Harris-Warrick RM, 2002, CURR OPIN NEUROBIOL, V12, P646, DOI 10.1016/S0959-4388(02)00377-X; Herlitze S, 2003, J BIOENERG BIOMEMBR, V35, P621, DOI 10.1023/B:JOBB.0000008027.19384.c0; Hess D, 2001, P NATL ACAD SCI USA, V98, P5276, DOI 10.1073/pnas.091096198; HILL R, 1992, NEUROREPORT, V3, P943, DOI 10.1097/00001756-199210000-00032; HILL RH, 1989, BRAIN RES, V499, P388, DOI 10.1016/0006-8993(89)90790-7; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P2559, DOI 10.1152/jn.1994.72.5.2559; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P575, DOI 10.1113/jphysiol.1988.sp017058; Huss M, 2007, J NEUROPHYSIOL, V97, P2696, DOI 10.1152/jn.00528.2006; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Isope P, 2012, CEREBELLUM, V11, P651, DOI 10.1007/s12311-010-0195-4; KASICKI S, 1989, BRAIN RES, V484, P203, DOI 10.1016/0006-8993(89)90363-6; Kettunen P, 2002, J NEUROSCI, V22, P1868, DOI 10.1523/JNEUROSCI.22-05-01868.2002; Krieger P, 2000, J NEUROSCI, V20, P5382, DOI 10.1523/JNEUROSCI.20-14-05382.2000; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; Li X, 2007, J NEUROPHYSIOL, V97, P3314, DOI 10.1152/jn.01068.2006; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCCLELLAN AD, 1988, BRAIN RES, V457, P338, DOI 10.1016/0006-8993(88)90704-4; McClellan AD, 2008, J NEUROSCI, V28, P650, DOI 10.1523/JNEUROSCI.3840-07.2008; MEER DP, 1992, NEUROSCI LETT, V143, P1, DOI 10.1016/0304-3940(92)90219-W; MILLS LR, 1994, J NEUROSCI, V14, P6815; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; MOORE LE, 1995, BIOPHYS J, V68, P96, DOI 10.1016/S0006-3495(95)80163-3; Moore LE, 1999, J NEUROSCI, V19, P8271; Nanou E, 2013, J NEUROPHYS IN PRESS; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; REGEHR WG, 1992, J NEUROSCI, V12, P4202; Sah P, 1996, J NEUROSCI, V16, P4537; Shah MM, 2002, J NEUROPHYSIOL, V87, P2983, DOI 10.1152/jn.2002.87.6.2983; Sirota MG, 2000, EUR J NEUROSCI, V12, P4081, DOI 10.1046/j.1460-9568.2000.00301.x; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stackman RW, 2002, J NEUROSCI, V22, P10163; Takahashi M, 2001, J PHYSIOL-LONDON, V532, P323, DOI 10.1111/j.1469-7793.2001.0323f.x; Tognoli E, 2009, PROG NEUROBIOL, V87, P31, DOI 10.1016/j.pneurobio.2008.09.014; WALL MJ, 1995, J PHYSIOL-LONDON, V487, P557, DOI 10.1113/jphysiol.1995.sp020900; WALLEN P, 1989, J NEUROPHYSIOL, V61, P759, DOI 10.1152/jn.1989.61.4.759; WALLEN P, 1987, J NEUROSCI, V7, P2745; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Wikstrom MA, 1998, EUR J NEUROSCI, V10, P1528; WILLIAMS TL, 1990, J NEUROPHYSIOL, V64, P862, DOI 10.1152/jn.1990.64.3.862; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	79	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63154	10.1371/journal.pone.0063154	http://dx.doi.org/10.1371/journal.pone.0063154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646190	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300145
J	Itoh, TQ; Matsumoto, A; Tanimura, T				Itoh, Taichi Q.; Matsumoto, Akira; Tanimura, Teiichi			C-Terminal Binding Protein (CtBP) Activates the Expression of E-Box Clock Genes with CLOCK/CYCLE in Drosophila	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; TRANSCRIPTIONAL REPRESSION; COACTIVATOR; TAKEOUT; NEURONS; PDP1-EPSILON; COREPRESSOR; OSCILLATOR; PHENOTYPES; REVEALS	In Drosophila, CLOCK/CYCLE heterodimer (CLK/CYC) is the primary activator of circadian clock genes that contain the E-box sequence in their promoter regions (hereafter referred to as "E-box clock genes''). Although extensive studies have investigated the feedback regulation of clock genes, little is known regarding other factors acting with CLK/CYC. Here we show that Drosophila C-terminal binding protein (dCtBP), a transcriptional co-factor, is involved in the regulation of the E-box clock genes. In vivo overexpression of dCtBP in clock cells lengthened or abolished circadian locomotor rhythm with upregulation of a subset of the E-box clock genes, period (per), vrille (vri), and PAR domain protein 1 epsilon (Pdp1 epsilon). Co-expression of dCtBP with CLK in vitro also increased the promoter activity of per, vri, Pdp1 epsilon and cwo depending on the amount of dCtBP expression, whereas no effect was observed without CLK. The activation of these clock genes in vitro was not observed when we used mutated dCtBP which carries amino acid substitutions in NAD(+) domain. These results suggest that dCtBP generally acts as a putative co-activator of CLK/CYC through the E-box sequence.	[Itoh, Taichi Q.; Tanimura, Teiichi] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Matsumoto, Akira] Juntendo Univ, Sch Med, Dept Biol, Chiba, Japan	Kyushu University; Juntendo University	Tanimura, T (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	tanimura@kyudai.jp	Itoh, Taichi/AAV-1976-2021	Itoh, Taichi/0000-0003-0794-1711	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [24570199] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to TT and AM, and the Japan Society for the Promotion of Science (JSPS) to TQI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Benito J, 2007, J NEUROSCI, V27, P2539, DOI 10.1523/JNEUROSCI.4870-06.2007; Benito J, 2010, P NATL ACAD SCI USA, V107, P2544, DOI 10.1073/pnas.0906422107; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Hardin PE, 2006, CURR OPIN NEUROBIOL, V16, P686, DOI 10.1016/j.conb.2006.09.001; Hung HC, 2007, J BIOL CHEM, V282, P31349, DOI 10.1074/jbc.M702319200; Itoh TQ, 2011, APPL ENTOMOL ZOOL, V46, P391, DOI 10.1007/s13355-011-0052-z; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kuppuswamy M, 2007, MOL CELL BIOL, V28, P259; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lim C, 2007, MOL CELL BIOL, V27, P4876, DOI 10.1128/MCB.02155-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani-Telang P, 2007, FEBS LETT, V581, P5241, DOI 10.1016/j.febslet.2007.10.011; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Matsumoto A, 2011, BIOTECHNIQUES, V51, P55, DOI 10.2144/000113705; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353	39	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63113	10.1371/journal.pone.0063113	http://dx.doi.org/10.1371/journal.pone.0063113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646183	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300138
J	Smircich, P; Forteza, D; El-Sayed, NM; Garat, B				Smircich, Pablo; Forteza, Diego; El-Sayed, Najib M.; Garat, Beatriz			Genomic Analysis of Sequence-Dependent DNA Curvature in Leishmania	PLOS ONE			English	Article							GENE-EXPRESSION; 3'-UNTRANSLATED REGION; RNA GENE; DEVELOPMENTAL REGULATION; REPLICATION ORIGINS; TRANSCRIPTION; ORGANIZATION; ELEMENTS; IDENTIFICATION; TERMINATION	Leishmania major is a flagellated protozoan parasite of medical importance. Like other members of the Trypanosomatidae family, it possesses unique mechanisms of gene expression such as constitutive polycistronic transcription of directional gene clusters, gene amplification, mRNA trans-splicing, and extensive editing of mitochondrial transcripts. The molecular signals underlying most of these processes remain under investigation. In order to investigate the role of DNA secondary structure signals in gene expression, we carried out a genome-wide in silico analysis of the intrinsic DNA curvature. The L. major genome revealed a lower frequency of high intrinsic curvature regions as well as inter- and intra- chromosomal distribution heterogeneity, when compared to prokaryotic and eukaryotic organisms. Using a novel method aimed at detecting region-integrated intrinsic curvature (RIIC), high DNA curvature was found to be associated with regions implicated in transcription initiation. Those include divergent strand-switch regions between directional gene clusters and regions linked to markers of active transcription initiation such as acetylated H3 histone, TRF4 and SNAP50. These findings suggest a role for DNA curvature in transcription initiation in Leishmania supporting the relevance of DNA secondary structures signals.	[Smircich, Pablo; Forteza, Diego; Garat, Beatriz] Fac Ciencias, Lab Interacc Mol, Montevideo, Uruguay; [Smircich, Pablo] Fac Med, Dept Genet, Montevideo, Uruguay; [El-Sayed, Najib M.] Univ Maryland Coll Pk, Dept Cell Biol & Mol Genet, College Pk, MD USA; [El-Sayed, Najib M.] Univ Maryland Coll Pk, Ctr Bioinformat & Computat Biol, College Pk, MD USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Garat, B (corresponding author), Fac Ciencias, Lab Interacc Mol, Montevideo, Uruguay.	bgarat@fcien.edu.uy	El-Sayed, Najib M.A./K-7266-2015	El-Sayed, Najib M.A./0000-0001-7970-3312; Smircich, Pablo/0000-0002-3856-3920; Garat, Beatriz/0000-0003-2679-8244	Fondo Clemente Estable (Agencia Nacional de Investigacion e Innovacion); Comision Sectorial de Investigacion Cientifica (Universidad de la Republica); Programa de Desarrollo de Ciencias Basicas; PhD fellowship (Agencia Nacional de Investigacion e Innovacion); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094773] Funding Source: NIH RePORTER	Fondo Clemente Estable (Agencia Nacional de Investigacion e Innovacion); Comision Sectorial de Investigacion Cientifica (Universidad de la Republica); Programa de Desarrollo de Ciencias Basicas; PhD fellowship (Agencia Nacional de Investigacion e Innovacion); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Fondo Clemente Estable (Agencia Nacional de Investigacion e Innovacion); Comision Sectorial de Investigacion Cientifica (Universidad de la Republica) and Programa de Desarrollo de Ciencias Basicas. PS received a PhD fellowship (Agencia Nacional de Investigacion e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaui V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001021; AGAMI R, 1994, NUCLEIC ACIDS RES, V22, P1959, DOI 10.1093/nar/22.11.1959; Alcolea PJ, 2011, J EUKARYOT MICROBIOL, V58, P352, DOI 10.1111/j.1550-7408.2011.00549.x; Alcolea PJ, 2009, GENOMICS, V93, P551, DOI 10.1016/j.ygeno.2009.01.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANTON H, 1999, CALCULUS NEW HORIZON, V32, P1130; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boucher N, 2004, NUCLEIC ACIDS RES, V32, P2925, DOI 10.1093/nar/gkh617; Boucher N, 2002, J BIOL CHEM, V277, P19511, DOI 10.1074/jbc.M200500200; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casagrande L, 2005, INT J PARASITOL, V35, P973, DOI 10.1016/j.ijpara.2005.04.004; Choi J, 2012, PARASITE IMMUNOL, V34, P72, DOI 10.1111/j.1365-3024.2011.01347.x; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Cuervo P, 2010, J PROTEOMICS, V73, P845, DOI 10.1016/j.jprot.2009.12.012; Daenen F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-332; Das A, 2008, EUKARYOT CELL, V7, P429, DOI 10.1128/EC.00297-07; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Duhagon MA, 2011, GENE, V487, P29, DOI 10.1016/j.gene.2011.07.022; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Gabrielian A, 1997, FEBS LETT, V406, P69, DOI 10.1016/S0014-5793(97)00236-6; Ghedin E, 2004, MOL BIOCHEM PARASIT, V134, P183, DOI 10.1016/j.molbiopara.2003.11.012; Ghedira K, 2011, INFECT GENET EVOL, V11, P769, DOI 10.1016/j.meegid.2010.10.015; Gimenes F, 2008, GENET MOL RES, V7, P549, DOI 10.4238/vol7-2gmr461; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kiyama R, 2002, FEBS LETT, V523, P7, DOI 10.1016/S0014-5793(02)02937-X; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liu HD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-72; Marilley M, 2000, MOL GEN GENET, V263, P854, DOI 10.1007/s004380000253; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Martinez-Calvillo S, 2004, EUKARYOT CELL, V3, P506, DOI 10.1128/EC.3.2.506-517.2004; Martinez-Calvillo S, 2001, MOL BIOCHEM PARASIT, V116, P147, DOI 10.1016/S0166-6851(01)00310-3; Martinez-Calvillo S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525241; McDonagh PD, 2000, NUCLEIC ACIDS RES, V28, P2800, DOI 10.1093/nar/28.14.2800; McNicoll F, 2005, J BIOL CHEM, V280, P35238, DOI 10.1074/jbc.M507511200; Mukherjee A, 2011, NUCLEIC ACIDS RES, V39, P7499, DOI 10.1093/nar/gkr494; Nilsson D, 2005, EXP PARASITOL, V109, P143, DOI 10.1016/j.exppara.2004.12.004; NTAMBI JM, 1984, MOL BIOCHEM PARASIT, V12, P273, DOI 10.1016/0166-6851(84)90084-7; Ohyama T., 2005, DNA CONFORMATION TRA; Padilla-Mejia NE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-232; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Potaman VN, 2005, MOL B INT U, P3; Puechberty J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-57; Quijada L, 2000, MOL BIOCHEM PARASIT, V110, P79, DOI 10.1016/S0166-6851(00)00258-9; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rana T, 2011, J BIOL CHEM, V286, P6614, DOI 10.1074/jbc.M110.181735; Requena JM, 1997, MOL BIOCHEM PARASIT, V84, P101, DOI 10.1016/S0166-6851(96)02785-5; Requena JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-263; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; SAITO RM, 1994, EMBO J, V13, P5460, DOI 10.1002/j.1460-2075.1994.tb06881.x; Smith M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-240; Stempliuk VD, 2002, INT J PARASITOL, V32, P437, DOI 10.1016/S0020-7519(01)00371-X; Sturm NR, 1999, MOL CELL BIOL, V19, P1595; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; Tosato V, 2001, CURR GENET, V40, P186, DOI 10.1007/s002940100246; Tsigankov P, 2012, PARASITOLOGY, V139, P1146, DOI 10.1017/S0031182012000157; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; van Luenen HGAM, 2012, CELL, V150, P909, DOI 10.1016/j.cell.2012.07.030; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P4201, DOI 10.1093/nar/gkg469; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; Zilka A, 2001, J BIOL CHEM, V276, P47922, DOI 10.1074/jbc.M108271200	67	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63068	10.1371/journal.pone.0063068	http://dx.doi.org/10.1371/journal.pone.0063068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646176	Green Submitted, Green Published, gold			2022-12-27	WOS:000319077300131
J	Rueda, AJV; Mistchenko, AS; Viegas, M				Velez Rueda, Ana Julia; Susana Mistchenko, Alicia; Viegas, Mariana			Phylogenetic and Phylodynamic Analyses of Human Metapneumovirus in Buenos Aires (Argentina) for a Three-Year Period (2009-2011)	PLOS ONE			English	Article							GENETIC-VARIABILITY; MONOCLONAL-ANTIBODIES; INFECTION; CHILDREN; PHYLOGEOGRAPHY; PREDICTION; GENOTYPE; SEQUENCE; VIRUSES; PROTEIN	Human metapneumovirus, which belongs to the Paramyxoviridae family and has been classified as a member of the Pneumovirus genus, is genetically and clinically similar to other family members such as human respiratory syncytial virus. A total of 1146 nasopharyngeal aspirates from pediatric patients with moderate and severe acute lower respiratory tract infections, hospitalized at the Ricardo Gutierrez Childrens Hospital (Buenos Aires, Argentina), were tested by real time RT-PCR for human metapneumovirus. Results showed that 168 (14.65%) were positive. Thirty-six of these 168 samples were randomly selected to characterize positive cases molecularly. The phylogenetic analysis of the sequences of the G and F genes showed that genotypes A2 and B2 cocirculated during 2009 and 2010 and that only genotype A2 circulated in 2011 in Argentina. Genotype A2 prevailed during the study period, a fact supported by a higher effective population size (Net) and higher diversity as compared to that of genotype B2 (10.9% (SE 1.3%) vs. 1.7% (SE 0.4%), respectively). The phylogeographic analysis of the G protein gene sequences showed that this virus has no geographical restrictions and can travel globally harbored in hosts. The selection pressure analysis of the F protein showed that although this protein has regions with polymorphisms, it has vast structural and functional constraints. In addition, the predicted B-linear epitopes and the sites recognized by previously described monoclonal antibodies were conserved in all Argentine sequences. This points out this protein as a potential candidate to be the target of future humanized antibodies or vaccines.	[Velez Rueda, Ana Julia; Susana Mistchenko, Alicia; Viegas, Mariana] Hosp Ninos Dr Ricardo Gutierrez, Virol Lab, Buenos Aires, DF, Argentina; [Velez Rueda, Ana Julia; Susana Mistchenko, Alicia] CIC, La Plata, Buenos Aires, Argentina; [Viegas, Mariana] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Viegas, M (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Virol Lab, Buenos Aires, DF, Argentina.	viegasmariana@hotmail.com			ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina [PICT1624/07]	ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina(ANPCyT)	This work was supported by ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina (grant PICT1624/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aberle JH, 2010, PEDIATR INFECT DIS J, V29, P1016, DOI 10.1097/INF.0b013e3181e3331a; Agapov E, 2006, J INFECT DIS, V193, P396, DOI 10.1086/499310; Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; ARNOTT A, 2011, INFECT GENET EV 0201, P1; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Cai YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033156; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; El-Manzalawy Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003268; Galiano M, 2006, J MED VIROL, V78, P631, DOI 10.1002/jmv.20586; Garcia J, 2012, ARCH VIROL, V157, P563, DOI 10.1007/s00705-011-1204-8; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herfst S, 2004, J VIROL, V78, P8264, DOI 10.1128/JVI.78.15.8264-8270.2004; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; Holmes EC, 2009, J CLIN INVEST, V119, P2488, DOI 10.1172/JCI38050; Huck B, 2006, EMERG INFECT DIS, V12, P147, DOI 10.3201/eid1201.050772; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Klein MI, 2006, J INFECT DIS, V193, P1544, DOI 10.1086/503806; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; KOUNI S, 2012, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12015.[; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ludewick HP, 2005, EMERG INFECT DIS, V11, P1074, DOI 10.3201/eid1107.050050; ORVELL C, 1987, J GEN VIROL, V68, P3125, DOI 10.1099/0022-1317-68-12-3125; Pavlin JA, 2008, J INFECT DIS, V198, P836, DOI 10.1086/591186; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Souza JS, 2013, J MED VIROL, V85, P530, DOI 10.1002/jmv.23477; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulbrandt ND, 2006, J VIROL, V80, P7799, DOI 10.1128/JVI.00318-06; Ulbrandt ND, 2008, J GEN VIROL, V89, P3113, DOI 10.1099/vir.0.2008/005199-0; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2004, EMERG INFECT DIS, V10, P658, DOI 10.3201/eid1004.030393; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; Van den Hoogen BG, 2004, PEDIATR INFECT DIS J, V23, pS25, DOI 10.1097/01.inf.0000108190.09824.e8; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Vicente D, 2006, CLIN INFECT DIS, V42, pE111, DOI 10.1086/504378; Wang YQ, 2013, ARCH VIROL, V158, P417, DOI 10.1007/s00705-012-1492-7; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63070	10.1371/journal.pone.0063070	http://dx.doi.org/10.1371/journal.pone.0063070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646177	Green Published, gold			2022-12-27	WOS:000319077300132
J	Brady, RA; Mocca, CP; Prabhakara, R; Plaut, RD; Shirtliff, ME; Merkel, TJ; Burns, DL				Brady, Rebecca A.; Mocca, Christopher P.; Prabhakara, Ranjani; Plaut, Roger D.; Shirtliff, Mark E.; Merkel, Tod J.; Burns, Drusilla L.			Evaluation of Genetically Inactivated Alpha Toxin for Protection in Multiple Mouse Models of Staphylococcus aureus Infection	PLOS ONE			English	Article							CLUMPING FACTOR-A; NASAL CARRIAGE; INDUCED MASTITIS; GENE-EXPRESSION; IMMUNE-RESPONSE; BINDING PROTEIN; VACCINE; IMMUNIZATION; IDENTIFICATION; COLONIZATION	Staphylococcus aureus is a major human pathogen and a leading cause of nosocomial and community-acquired infections. Development of a vaccine against this pathogen is an important goal. While S. aureus protective antigens have been identified in the literature, the majority have only been tested in a single animal model of disease. We wished to evaluate the ability of one S. aureus vaccine antigen to protect in multiple mouse models, thus assessing whether protection in one model translates to protection in other models encompassing the full breadth of infections the pathogen can cause. We chose to focus on genetically inactivated alpha toxin mutant HlaH35L. We evaluated the protection afforded by this antigen in three models of infection using the same vaccine dose, regimen, route of immunization, adjuvant, and challenge strain. When mice were immunized with HlaH35L and challenged via a skin and soft tissue infection model, HlaH35L immunization led to a less severe infection and decreased S. aureus levels at the challenge site when compared to controls. Challenge of HlaH35L-immunized mice using a systemic infection model resulted in a limited, but statistically significant decrease in bacterial colonization as compared to that observed with control mice. In contrast, in a prosthetic implant model of chronic biofilm infection, there was no significant difference in bacterial levels when compared to controls. These results demonstrate that vaccines may confer protection against one form of S. aureus disease without conferring protection against other disease presentations and thus underscore a significant challenge in S. aureus vaccine development.	[Brady, Rebecca A.; Mocca, Christopher P.; Prabhakara, Ranjani; Plaut, Roger D.; Merkel, Tod J.; Burns, Drusilla L.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA; [Shirtliff, Mark E.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Shirtliff, Mark E.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Burns, DL (corresponding author), US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA.	drusilla.burns@fda.hhs.gov	Shirtliff, Mark E/H-2563-2017; Plaut, Roger D./B-2340-2013	Shirtliff, Mark E/0000-0002-8913-3445; Plaut, Roger D./0000-0002-0883-972X	Center for Biologics Evaluation and Research; Food and Drug Administration; National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01AI69568, ARRA AI69568]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007540, R01AI069568, N01AI095359] Funding Source: NIH RePORTER	Center for Biologics Evaluation and Research(United States Department of Health & Human Services); Food and Drug Administration(United States Department of Health & Human Services); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Center for Biologics Evaluation and Research, Food and Drug Administration, and by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (grants R01AI69568 and ARRA AI69568 to MES). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Anderson AS, 2012, J INFECT DIS, V205, P1688, DOI 10.1093/infdis/jis272; Arrecubieta C, 2008, J INFECT DIS, V198, P571, DOI 10.1086/590210; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Brady RA, 2011, INFECT IMMUN, V79, P1797, DOI 10.1128/IAI.00451-10; Brouillette E, 2002, VACCINE, V20, P2348, DOI 10.1016/S0264-410X(02)00100-7; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Cook J, 2009, HUM VACCINES, V5, P254, DOI 10.4161/hv.5.4.6765; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09; Glowalla E, 2009, INFECT IMMUN, V77, P2719, DOI 10.1128/IAI.00617-08; Gong R, 2010, CLIN VACCINE IMMUNOL, V17, P1746, DOI 10.1128/CVI.00162-10; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Ho MM, 2006, HUM VACCINES, V2, P89, DOI 10.4161/hv.2755; Hu DL, 2009, VACCINE, V27, P4867, DOI 10.1016/j.vaccine.2009.04.053; Hume EBH, 2000, INFECT IMMUN, V68, P6052, DOI 10.1128/IAI.68.10.6052-6055.2000; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Josefsson E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002206; Joshi A, 2012, HUM VACC IMMUNOTHER, V8, P336, DOI DOI 10.4161/HV.18946; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krespi YP, 2012, AM J OTOLARYNG, V33, P572, DOI 10.1016/j.amjoto.2012.02.002; Li D, 2008, J ORTHOP RES, V26, P96, DOI 10.1002/jor.20452; MAMO W, 1994, FEMS IMMUNOL MED MIC, V10, P47, DOI 10.1111/j.1574-695X.1994.tb00010.x; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Narita K, 2008, FEMS IMMUNOL MED MIC, V52, P389, DOI 10.1111/j.1574-695X.2008.00384.x; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Prabhakara R, 2013, INFECT IMMUN; Prabhakara R, 2011, INFECT IMMUN, V79, P1789, DOI 10.1128/IAI.01386-10; Rauch S, 2012, INFECT IMMUN, V80, P3721, DOI 10.1128/IAI.00442-12; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Schaffer AC, 2006, INFECT IMMUN, V74, P2145, DOI 10.1128/IAI.74.4.2145-2153.2006; Shannon O, 2006, SCAND J IMMUNOL, V63, P184, DOI 10.1111/j.1365-3083.2006.01735.x; Shkreta L, 2004, VACCINE, V23, P114, DOI 10.1016/j.vaccine.2004.05.002; STEMMER WPC, 1992, BIOTECHNIQUES, V13, P214; Ster C, 2010, VET IMMUNOL IMMUNOP, V136, P311, DOI 10.1016/j.vetimm.2010.03.010; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Zhou H, 2006, VACCINE, V24, P4830, DOI 10.1016/j.vaccine.2006.03.020	46	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e63040	10.1371/journal.pone.0063040	http://dx.doi.org/10.1371/journal.pone.0063040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658662	Green Submitted, Green Published, gold			2022-12-27	WOS:000321662800074
J	Gobron, N; Waszczak, C; Simon, M; Hiard, S; Boivin, S; Charif, D; Ducamp, A; Wenes, E; Budar, F				Gobron, Nicolas; Waszczak, Cezary; Simon, Matthieu; Hiard, Sophie; Boivin, Stephane; Charif, Delphine; Ducamp, Aloise; Wenes, Estelle; Budar, Francoise			A Cryptic Cytoplasmic Male Sterility Unveils a Possible Gynodioecious Past for Arabidopsis thaliana	PLOS ONE			English	Article							MITOCHONDRIAL GENOMES; SELF-COMPATIBILITY; NUCLEAR; EVOLUTION; FERTILITY; DNA; INCOMPATIBILITY; SELECTION; ALIGNMENT; CONFLICT	Gynodioecy, the coexistence of hermaphrodites and females (i.e. male-sterile plants) in natural plant populations, most often results from polymorphism at genetic loci involved in a particular interaction between the nuclear and cytoplasmic genetic compartments (cytonuclear epistasis): cytoplasmic male sterility (CMS). Although CMS clearly contributes to the coevolution of involved nuclear loci and cytoplasmic genomes in gynodioecious species, the occurrence of CMS genetic factors in the absence of sexual polymorphism (cryptic CMS) is not easily detected and rarely taken in consideration. We found cryptic CMS in the model plant Arabidopsis thaliana after crossing distantly related accessions, Sha and Mr-0. Male sterility resulted from an interaction between the Sha cytoplasm and two Mr-0 genomic regions located on chromosome 1 and chromosome 3. Additional accessions with either nuclear sterility maintainers or sterilizing cytoplasms were identified from crosses with either Sha or Mr-0. By comparing two very closely related cytoplasms with different male-sterility inducing abilities, we identified a novel mitochondrial ORF, named orf117Sha, that is most likely the sterilizing factor of the Sha cytoplasm. The presence of orf117Sha was investigated in worldwide natural accessions. It was found mainly associated with a single chlorotype in accessions belonging to a clade predominantly originating from Central Asia. More than one-third of accessions from this clade carried orf117Sha, indicating that the sterilizing-inducing cytoplasm had spread in this lineage. We also report the coexistence of the sterilizing cytoplasm with a non-sterilizing cytoplasm at a small, local scale in a natural population; in addition a correlation between cytotype and nuclear haplotype was detected in this population. Our results suggest that this CMS system induced sexual polymorphism in A. thaliana populations, at the time when the species was mainly outcrossing.	[Gobron, Nicolas; Waszczak, Cezary; Simon, Matthieu; Hiard, Sophie; Boivin, Stephane; Charif, Delphine; Ducamp, Aloise; Wenes, Estelle; Budar, Francoise] INRA, UMR1318, IJPB, F-78026 Versailles, France; [Gobron, Nicolas; Waszczak, Cezary; Simon, Matthieu; Hiard, Sophie; Boivin, Stephane; Charif, Delphine; Ducamp, Aloise; Wenes, Estelle; Budar, Francoise] AgroParisTech, IJPB, Versailles, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Budar, F (corresponding author), INRA, UMR1318, IJPB, F-78026 Versailles, France.	Francoise.Budar@versailles.inra.fr	BUDAR, Françoise/G-1221-2013; Waszczak, Cezary/AAA-8882-2019	BUDAR, Françoise/0000-0002-4328-5670; Waszczak, Cezary/0000-0002-5978-7560; BOIVIN, Stephane/0000-0002-4084-2312	French Ministry in charge of Research; VERT Marie Curie Early Training Site	French Ministry in charge of Research; VERT Marie Curie Early Training Site	NG was funded by the French Ministry in charge of Research. CW was funded by the VERT Marie Curie Early Training Site. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashutosh, 2008, PLANT CELL PHYSIOL, V49, P284, DOI 10.1093/pcp/pcm182; Bailey MF, 2003, AM NAT, V161, P762, DOI 10.1086/374803; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Boggs NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000426; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2010, PHILOS T R SOC B, V365, P1815, DOI 10.1098/rstb.2009.0304; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Bouchez D, 1996, PLANT MOL BIOL REP, V14, P115, DOI 10.1007/BF02684900; Budar F, 2003, GENETICA, V117, P3, DOI 10.1023/A:1022381016145; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Caruso CM, 2012, TRENDS PLANT SCI, V17, P638, DOI 10.1016/j.tplants.2012.06.006; Case AL, 2008, EVOLUTION, V62, P1026, DOI 10.1111/j.1558-5646.2008.00360.x; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Darwin C, 1877, EFFECTS CROSS SELF F; Davila JI, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-64; Delph LF, 2007, TRENDS ECOL EVOL, V22, P17, DOI 10.1016/j.tree.2006.09.013; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Drouaud J, 2011, METHODS MOL BIOL, V745, P223, DOI 10.1007/978-1-61779-129-1_14; Ducos E, 2001, PLANT J, V26, P171, DOI 10.1046/j.1365-313x.2001.01017.x; Dufay M, 2007, HEREDITY, V99, P349, DOI 10.1038/sj.hdy.6801009; Fishman L, 2006, EVOLUTION, V60, P1372, DOI 10.1111/j.0014-3820.2006.tb01216.x; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Giancola S, 2007, THEOR APPL GENET, V114, P1333, DOI 10.1007/s00122-007-0520-6; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Jacobs MS, 2003, AM NAT, V161, P837, DOI 10.1086/375174; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Kronholm I, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-33; Kubo T, 2011, CRIT REV PLANT SCI, V30, P378, DOI 10.1080/07352689.2011.587727; Kumar P, 2012, J EXP BOT, V63, P2921, DOI 10.1093/jxb/err459; Leppala J, 2011, EVOLUTION, V65, P2959, DOI 10.1111/j.1558-5646.2011.01361.x; LEWIS D., 1941, NEW PHYTOT, V40, P56, DOI 10.1111/j.1469-8137.1941.tb07028.x; LHomme Y, 1997, CURR GENET, V31, P325, DOI 10.1007/s002940050212; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Moison M, 2010, PLANT J, V63, P728, DOI 10.1111/j.1365-313X.2010.04275.x; Nasrallah JB, 2002, SCIENCE, V296, P305, DOI 10.1126/science.296.5566.305; Nasrallah ME, 2004, P NATL ACAD SCI USA, V101, P16070, DOI 10.1073/pnas.0406970101; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Scotti N., 2001, Plant Molecular Biology Reporter, V19, P67, DOI 10.1007/BF02824080; Shimizu KK, 2008, MOL ECOL, V17, P704, DOI 10.1111/j.1365-294X.2007.03605.x; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776; Silveira AB, 2013, PLOS GENET IN PRESS; Simon M, 2012, PLANT J, V69, P1094, DOI 10.1111/j.1365-313X.2011.04852.x; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Smith LM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002164; Tang CL, 2007, SCIENCE, V317, P1070, DOI 10.1126/science.1143153; Tang HV, 1996, PLANT J, V10, P123, DOI 10.1046/j.1365-313X.1996.10010123.x; Touzet P, 2012, ADV BOT RES, V63, P71, DOI 10.1016/B978-0-12-394279-1.00004-1; van Wyhe J, 2006, NOTES REC ROY SOC, V60, P87, DOI 10.1098/rsnr.2005.0128; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wen LY, 2003, GENETICS, V165, P771; Yamagishi H, 2001, THEOR APPL GENET, V103, P725, DOI 10.1007/s001220100614	58	22	22	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62450	10.1371/journal.pone.0062450	http://dx.doi.org/10.1371/journal.pone.0062450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658632	gold, Green Published, Green Submitted			2022-12-27	WOS:000321662800047
J	Palova-Jelinkova, L; Danova, K; Drasarova, H; Dvorak, M; Funda, DP; Fundova, P; Kotrbova-Kozak, A; Cerna, M; Kamanova, J; Martin, SF; Freudenberg, M; Tuckova, L				Palova-Jelinkova, Lenka; Danova, Klara; Drasarova, Hana; Dvorak, Milos; Funda, David P.; Fundova, Petra; Kotrbova-Kozak, Anna; Cerna, Marie; Kamanova, Jana; Martin, Stefan F.; Freudenberg, Marina; Tuckova, Ludmila			Pepsin Digest of Wheat Gliadin Fraction Increases Production of IL-1 beta via TLR4/MyD88/TRIF/MAPK/NF-kappa B Signaling Pathway and an NLRP3 Inflammasome Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; CELIAC-DISEASE; DIFFERENTIAL REQUIREMENT; CASPASE-1 ACTIVATION; BLOOD MONOCYTES; IMMUNE-RESPONSE; NITRIC-OXIDE; GLUTEN; INNATE; SECRETION	Celiac disease (CD) is a gluten-responsive, chronic inflammatory enteropathy. IL-1 cytokine family members IL-1 beta and IL-18 have been associated with the inflammatory conditions in CD patients. However, the mechanisms of IL-1 molecule activation in CD have not yet been elucidated. We show in this study that peripheral blood mononuclear cells (PBMC) and monocytes from celiac patients responded to pepsin digest of wheat gliadin fraction (PDWGF) by a robust secretion of IL-1 beta and IL-1 alpha and a slightly elevated production of IL-18. The analysis of the upstream mechanisms underlying PDWGF-induced IL-1 beta production in celiac PBMC show that PDWGF-induced de novo pro-IL-1 beta synthesis, followed by a caspase-1 dependent processing and the secretion of mature IL-1 beta. This was promoted by K+ efflux and oxidative stress, and was independent of P2X7 receptor signaling. The PDWGF-induced IL-1 beta release was dependent on Nod-like receptor family containing pyrin domain 3 (NLRP3) and apoptosis-associated speck like protein (ASC) as shown by stimulation of bone marrow derived dendritic cells (BMDC) from NLRP3(-/-) and ASC(-/-) knockout mice. Moreover, treatment of human PBMC as well as MyD88(-/-) and Toll-interleukin-1 receptor domain-containing adaptor-inducing interferon-beta (TRIF)(-/-) BMDC illustrated that prior to the activation of caspase-1, the PDWGF-triggered signal constitutes the activation of the MyD88/TRIF/MAPK/NF-kappa B pathway. Moreover, our results indicate that the combined action of TLR2 and TLR4 may be required for optimal induction of IL-1 beta in response to PDWGF. Thus, innate immune pathways, such as TLR2/4/MyD88/TRIF/MAPK/NF-kB and an NLRP3 inflammasome activation are involved in wheat proteins signaling and may play an important role in the pathogenesis of CD.	[Palova-Jelinkova, Lenka; Danova, Klara; Drasarova, Hana; Funda, David P.; Fundova, Petra; Kamanova, Jana; Tuckova, Ludmila] Acad Sci Czech Republ, Inst Microbiol, Dept Immunol, Prague, Czech Republic; [Dvorak, Milos] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Kotrbova-Kozak, Anna; Cerna, Marie] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Martin, Stefan F.] Univ Med Ctr Freiburg, Dept Dermatol, Allergy Res Grp, Freiburg, Germany; [Freudenberg, Marina] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; University of Freiburg; Max Planck Society	Palova-Jelinkova, L (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Dept Immunol, Prague, Czech Republic.	lenicka@biomed.cas.cz	Fundova, Petra/J-8670-2014; Kotrbova Kozak, Anna/HFZ-7610-2022; Funda, David/J-8669-2014; Kamanova, Jana/Q-4477-2017; Dvorak, Milos/Q-2942-2016; Drasarova, Hana/M-4238-2014; Černá, Marie/G-8372-2016	Kamanova, Jana/0000-0001-6574-4404; Dvorak, Milos/0000-0002-3043-8711; Černá, Marie/0000-0002-1208-5588; Funda, David/0000-0001-8327-6931; Freudenberg, Marina Alexandra/0000-0001-5894-1805	Grant Agency of the Czech Republic [310/09/1640, 310/07/0414]; Institutional Research Concept [RVO: 61388971]; Charles University through University Research Centre [UNCE 204015]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institutional Research Concept; Charles University through University Research Centre	This work was supported by grants from the Grant Agency of the Czech Republic (no. 310/09/1640, 310/07/0414) and by Institutional Research Concept RVO: 61388971. A.K.K. gratefully acknowledges support of the Charles University through University Research Centre program UNCE 204015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2011, J IMMUNOL, V186, P2714, DOI 10.4049/jimmunol.1002657; Garrote JA, 2008, J PEDIATR GASTR NUTR, V47, pS27, DOI 10.1097/MPG.0b013e3181818fb9; Barone MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017039; Beckett CG, 1999, EUR J GASTROEN HEPAT, V11, P529, DOI 10.1097/00042737-199905000-00011; Chartrand LJ, 1997, J AM DIET ASSOC, V97, P612, DOI 10.1016/S0002-8223(97)00156-9; Chladkova B, 2011, J CELL MOL MED, V15, P938, DOI 10.1111/j.1582-4934.2010.01066.x; Cinova J, 2007, J CLIN IMMUNOL, V27, P201, DOI 10.1007/s10875-006-9061-z; Cseh A, 2011, DIGEST DIS SCI, V56, P792, DOI 10.1007/s10620-010-1363-6; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Freudenberg MA, 2008, IMMUNOBIOLOGY, V213, P193, DOI 10.1016/j.imbio.2007.11.008; Harris KM, 2008, J IMMUNOL, V181, P4457, DOI 10.4049/jimmunol.181.7.4457; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Junker Y, 2012, J EXP MED, V209, P2395, DOI 10.1084/jem.20102660; Kalliomaki M, 2012, J PEDIATR GASTR NUTR, V54, P727, DOI 10.1097/MPG.0b013e318241cfa8; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Lammers KM, 2003, GASTROENTEROLOGY, V135, P194; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Londei M, 2005, MOL IMMUNOL, V42, P913, DOI 10.1016/j.molimm.2004.12.005; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Manavalan JS, 2010, HUM IMMUNOL, V71, P50, DOI 10.1016/j.humimm.2009.09.351; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Matysiak-Budnik T, 2003, GASTROENTEROLOGY, V125, P696, DOI 10.1016/S0016-5085(03)01049-7; Mazzarella G, 2003, GUT, V52, P57, DOI 10.1136/gut.52.1.57; McCoy AJ, 2010, J IMMUNOL, V185, P7077, DOI 10.4049/jimmunol.1002165; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Nikulina M, 2004, J IMMUNOL, V173, P1925, DOI 10.4049/jimmunol.173.3.1925; Palova-Jelinkova L, 2005, J IMMUNOL, V175, P7038, DOI 10.4049/jimmunol.175.10.7038; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Pontillo A, 2011, AM J GASTROENTEROL, V106, P539, DOI 10.1038/ajg.2010.474; Salvati VM, 2002, GUT, V50, P186, DOI 10.1136/gut.50.2.186; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Szebeni B, 2007, J PEDIATR GASTR NUTR, V45, P187, DOI 10.1097/MPG.0b013e318064514a; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Tuckova L, 2000, J LEUKOCYTE BIOL, V67, P312, DOI 10.1002/jlb.67.3.312; Ward JR, 2010, J BIOL CHEM, V285, P23145, DOI 10.1074/jbc.M109.072793	47	82	86	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62426	10.1371/journal.pone.0062426	http://dx.doi.org/10.1371/journal.pone.0062426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658628	gold, Green Published, Green Submitted			2022-12-27	WOS:000321662800044
J	Ortner, CNM; de Koning, M				Ortner, Catherine N. M.; de Koning, Monica			Effects of Regulating Positive Emotions through Reappraisal and Suppression on Verbal and Non-Verbal Recognition Memory	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; COGNITIVE REAPPRAISAL; WORKING-MEMORY; CONSEQUENCES; EXPERIENCE; CAPACITY	Previous research has suggested that regulating emotions through reappraisal does not incur cognitive costs. However, in those experiments, cognitive costs were often assessed by recognition memory for information that was contextually related to the emotionally evocative stimuli and may have been incorporated into the reappraisal script, facilitating memory. Furthermore, there is little research on the cognitive correlates of regulating positive emotions. In the current experiment, we tested memory for information that was contextually unrelated to the emotional stimuli and could not easily be related to the reappraisal. Participants viewed neutral and mildly positive slides and either reappraised, suppressed their emotions, or viewed the images with no emotion regulation instruction. At the same time, they heard abstract words that were unrelated to the picture stimuli. Subsequent verbal recognition memory was lower after reappraising than viewing, whereas non-verbal recognition memory ( of the slides) was higher after reappraising, but only for positive pictures and when participants viewed the positive pictures first. Suppression had no significant effect on either verbal or non-verbal recognition scores, although there was a trend towards poorer recognition of verbal information. The findings support the notion that reappraisal is effortful and draws on limited cognitive resources, causing decrements in performance in a concurrent memory task.	[Ortner, Catherine N. M.; de Koning, Monica] Thompson Rivers Univ, Kamloops, BC, Canada		Ortner, CNM (corresponding author), Thompson Rivers Univ, Kamloops, BC, Canada.	cortner@tru.ca						Aldao A., 2010, CLIN PSYCHOL REV, V30, P217, DOI [10.1016/j.cpr.2009.11.004, DOI 10.1016/j.cpr.2009.11.004, DOI 10.1016/J.CPR.2009.11.004]; Bumgardner J, 2005, KRAZYDADS FREE PRINT; Dillon DG, 2007, EMOTION, V7, P354, DOI 10.1037/1528-3542.7.2.354; Forbes EE, 2009, BIOL PSYCHIAT, V66, P199, DOI 10.1016/j.biopsych.2009.05.001; Giuliani NR, 2008, EMOTION, V8, P714, DOI 10.1037/a0013236; Gross J.J., 2014, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Kim SH, 2012, INT J PSYCHOPHYSIOL, V83, P348, DOI 10.1016/j.ijpsycho.2011.12.001; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; Kron A, 2010, J EXP PSYCHOL GEN, V139, P520, DOI 10.1037/a0020008; Lang P.J., 2008, A8 U FLOR; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Logie RH, 2011, CURR DIR PSYCHOL SCI, V20, P240, DOI 10.1177/0963721411415340; McRae K, 2012, J RES PERS, V46, P2, DOI 10.1016/j.jrp.2011.10.003; Menne-Lothmann C, 2012, BEHAV GENET, V42, P778, DOI 10.1007/s10519-012-9553-y; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ortner CNM, 2013, MOTIV EMOTION, V37, P346, DOI 10.1007/s11031-012-9310-9; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Richards JM, 1999, PERS SOC PSYCHOL B, V25, P1033, DOI 10.1177/01461672992511010; Schmeichel BJ, 2008, J PERS SOC PSYCHOL, V95, P1526, DOI 10.1037/a0013345; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594	23	9	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62750	10.1371/journal.pone.0062750	http://dx.doi.org/10.1371/journal.pone.0062750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136EF	23658647	gold, Green Submitted, Green Published			2022-12-27	WOS:000318343700071
J	Wang, WQ; Cheng, HY; Song, SQ				Wang, Wei-Qing; Cheng, Hong-Yan; Song, Song-Quan			Development of a Threshold Model to Predict Germination of Populus tomentosa Seeds after Harvest and Storage under Ambient Condition	PLOS ONE			English	Article							HYDROTHERMAL TIME; RIPARIAN COTTONWOODS; INSTREAM FLOWS; TEMPERATURE; RIVER; DECLINE; SALICACEAE; DISPERSAL; EXPLAINS; LEGUMES	Effects of temperature, storage time and their combination on germination of aspen (Populus tomentosa) seeds were investigated. Aspen seeds were germinated at 5 to 30 degrees C at 5 degrees C intervals after storage for a period of time under 28 degrees C and 75% relative humidity. The effect of temperature on aspen seed germination could not be effectively described by the thermal time (TT) model, which underestimated the germination rate at 5 degrees C and poorly predicted the time courses of germination at 10, 20, 25 and 30 degrees C. A modified TT model (MTT) which assumed a two-phased linear relationship between germination rate and temperature was more accurate in predicting the germination rate and percentage and had a higher likelihood of being correct than the TT model. The maximum lifetime threshold (MLT) model accurately described the effect of storage time on seed germination across all the germination temperatures. An aging thermal time (ATT) model combining both the TT and MLT models was developed to describe the effect of both temperature and storage time on seed germination. When the ATT model was applied to germination data across all the temperatures and storage times, it produced a relatively poor fit. Adjusting the ATT model to separately fit germination data at low and high temperatures in the suboptimal range increased the models accuracy for predicting seed germination. Both the MLT and ATT models indicate that germination of aspen seeds have distinct physiological responses to temperature within a suboptimal range.	[Wang, Wei-Qing; Cheng, Hong-Yan; Song, Song-Quan] Chinese Acad Sci, Inst Bot, Key Lab Plant Resource, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Song, SQ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resource, Beijing, Peoples R China.	sqsong@ibcas.ac.cn			National Science and Technology Support Program [2012BAC01B05]; National Science Foundation of China [30870223]	National Science and Technology Support Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funds for this study were provided by the National Science and Technology Support Program (2012BAC01B05) and National Science Foundation of China (30870223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alvarado V, 2002, PLANT CELL ENVIRON, V25, P1061, DOI 10.1046/j.1365-3040.2002.00894.x; Bloomberg M, 2009, SEED SCI RES, V19, P171, DOI 10.1017/S0960258509990031; Borset O., 1960, Scottish Forestry, V14, P68; Braatne JH, 2007, RIVER RES APPL, V23, P247, DOI 10.1002/rra.978; Bradford KJ, 1994, SEED SCI RES, V4, P63, DOI 10.1017/S0960258500002038; BRADFORD KJ, 1993, J EXP BOT, V44, P1225, DOI 10.1093/jxb/44.7.1225; Chantre GR, 2009, ANN BOT-LONDON, V103, P1291, DOI 10.1093/aob/mcp070; COVELL S, 1986, J EXP BOT, V37, P705, DOI 10.1093/jxb/37.5.705; ELLIS RH, 1988, J EXP BOT, V39, P935, DOI 10.1093/jxb/39.7.935; Fang CF, 2006, FLORA CHINA, P17; Forcella F, 2000, FIELD CROP RES, V67, P123, DOI 10.1016/S0378-4290(00)00088-5; GARCIAHUIDOBRO J, 1982, J EXP BOT, V33, P297, DOI 10.1093/jxb/33.2.297; Gonzalez E, 2010, TREES-STRUCT FUNCT, V24, P151, DOI 10.1007/s00468-009-0388-y; Grundy AC, 2000, NEW PHYTOL, V148, P433, DOI 10.1046/j.1469-8137.2000.00778.x; Guilloy-Froget H, 2002, WETLANDS, V22, P478, DOI 10.1672/0277-5212(2002)022[0478:DGASOP]2.0.CO;2; Hardegree SP, 1999, ENVIRON EXP BOT, V41, P209, DOI 10.1016/S0098-8472(99)00004-0; Hardegree SP, 1999, J RANGE MANAGE, V52, P83, DOI 10.2307/4003496; Hardegree SP, 2008, ENVIRON EXP BOT, V62, P120, DOI 10.1016/j.envexpbot.2007.07.010; Hardegree SP, 2006, ANN BOT-LONDON, V97, P1115, DOI 10.1093/aob/mcl071; International Seed Testing Association, 1999, SEED SCI TECHNOL, V27, P47; Karrenberg S, 2003, AM J BOT, V90, P749, DOI 10.3732/ajb.90.5.749; Kebreab E, 1999, J EXP BOT, V50, P655, DOI 10.1093/jexbot/50.334.655; Kobayashi K, 2000, AGRON J, V92, P345, DOI 10.1007/s100870050043; McDonald CK, 2002, AUST J EXP AGR, V42, P407, DOI 10.1071/EA00188; Merritt DM, 2000, REGUL RIVER, V16, P543, DOI 10.1002/1099-1646(200011/12)16:6&lt;543::AID-RRR590&gt;3.0.CO;2-N; Moss EH, 1937, BOT GAZ, V99, P529; Probert RJ, 1992, SEEDS ECOLOGY REGENE; R Development Core Team, 2007, R LANG ENV STAT COMP; ROOD SB, 1989, CAN J BOT, V67, P1744, DOI 10.1139/b89-221; ROOD SB, 1995, CAN J BOT, V73, P1250, DOI 10.1139/b95-136; Rood SB, 1998, WETLANDS, V18, P557, DOI 10.1007/BF03161672; Rowse HR, 2003, NEW PHYTOL, V158, P101, DOI 10.1046/j.1469-8137.2003.00707.x; VANSPLUNDER I, 1995, ACTA BOT NEERL, V44, P269; Windauer LB, 2012, ANN BOT-LONDON, V109, P265, DOI 10.1093/aob/mcr242	35	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62868	10.1371/journal.pone.0062868	http://dx.doi.org/10.1371/journal.pone.0062868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658654	Green Published, gold			2022-12-27	WOS:000318343700077
J	Briscoe, AG; Goodacre, S; Masta, SE; Taylor, MI; Arnedo, MA; Penney, D; Kenny, J; Creer, S				Briscoe, Andrew G.; Goodacre, Sara; Masta, Susan E.; Taylor, Martin I.; Arnedo, Miquel A.; Penney, David; Kenny, John; Creer, Simon			Can Long-Range PCR Be Used to Amplify Genetically Divergent Mitochondrial Genomes for Comparative Phylogenetics? A Case Study within Spiders (Arthropoda: Araneae)	PLOS ONE			English	Article							CONTROL-REGION; DNA-SEQUENCE; GENE ORDER; EVOLUTION; AMPLIFICATION; SYSTEMATICS; TOOL; UTILITY; BIRDS; FIELD	The development of second generation sequencing technology has resulted in the rapid production of large volumes of sequence data for relatively little cost, thereby substantially increasing the quantity of data available for phylogenetic studies. Despite these technological advances, assembling longer sequences, such as that of entire mitochondrial genomes, has not been straightforward. Existing studies have been limited to using only incomplete or nominally intra-specific datasets resulting in a bottleneck between mitogenome amplification and downstream high-throughput sequencing. Here we assess the effectiveness of a wide range of targeted long-range PCR strategies, encapsulating single and dual fragment primer design approaches to provide full mitogenomic coverage within the Araneae (Spiders). Despite extensive rounds of optimisation, full mitochondrial genome PCR amplifications were stochastic in most taxa, although 454 Roche sequencing confirmed the successful amplification of 10 mitochondrial genomes out of the 33 trialled species. The low success rates of amplification using long-Range PCR highlights the difficulties in consistently obtaining genomic amplifications using currently available DNA polymerases optimised for large genomic amplifications and suggests that there may be opportunities for the use of alternative amplification methods.	[Briscoe, Andrew G.; Taylor, Martin I.; Creer, Simon] Bangor Univ, Coll Nat Sci, Environm Ctr Wales Bldg, Mol Ecol & Fisheries Genet Lab,Sch Biol Sci, Bangor, Gwynedd, Wales; [Goodacre, Sara] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2RD, England; [Masta, Susan E.] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Arnedo, Miquel A.] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Penney, David] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Kenny, John] Univ Liverpool, Sch Biol Sci, Ctr Genom Res, Liverpool L69 3BX, Merseyside, England	Bangor University; University of Nottingham; Portland State University; University of Barcelona; University of Manchester; University of Liverpool	Creer, S (corresponding author), Bangor Univ, Coll Nat Sci, Environm Ctr Wales Bldg, Mol Ecol & Fisheries Genet Lab,Sch Biol Sci, Bangor, Gwynedd, Wales.	s.creer@bangor.ac.uk	Arnedo, Miquel/E-9086-2011; Kenny, John/HCI-1952-2022	Arnedo, Miquel/0000-0003-1402-4727; Kenny, John/0000-0003-2994-6169; Briscoe, Andrew/0000-0002-9422-6056; Goodacre, Sara L./0000-0002-0887-6563	CoSyst Grant; Bangor University; Natural Environment Research Council [NBAF010002] Funding Source: researchfish; NERC [NBAF010002] Funding Source: UKRI	CoSyst Grant; Bangor University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a CoSyst Grant awarded to SC and a Bangor University funded PhD studentship to AGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Benjamin SP, 2008, CLADISTICS, V24, P708, DOI 10.1111/j.1096-0031.2008.00202.x; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; Bodner MR, 2012, MOL PHYLOGENET EVOL, V65, P213, DOI 10.1016/j.ympev.2012.06.005; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Corp. I, 2011, CORP 1 REL 2011 IBM; CUMMINGS MP, 1995, MOL BIOL EVOL, V12, P814; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dermauw W, 2010, GENOME, V53, P285, DOI [10.1139/g10-004, 10.1139/G10-004]; Dimitrov D, 2013, CLADISTICS, V29, P132, DOI 10.1111/j.1096-0031.2012.00419.x; Dimitrov D, 2012, P ROY SOC B-BIOL SCI, V279, P1341, DOI 10.1098/rspb.2011.2011; Dordel J, 2010, J ZOOL SYST EVOL RES, V48, P197, DOI 10.1111/j.1439-0469.2010.00567.x; Ernsting BR, 2009, EXP APPL ACAROL, V49, P305, DOI 10.1007/s10493-009-9263-1; Gai YH, 2008, MOL PHYLOGENET EVOL, V49, P574, DOI 10.1016/j.ympev.2008.08.010; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Goodacre SL, 2006, MOL ECOL, V15, P517, DOI 10.1111/j.1365-294X.2005.02802.x; Groenenberg DSJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-114; Hosseini R, 2007, BIOL CONTROL, V40, P128, DOI 10.1016/j.biocontrol.2006.10.007; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Hwang UW, 2001, MOL PHYLOGENET EVOL, V19, P345, DOI 10.1006/mpev.2001.0940; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Kane N, 2012, AM J BOT, V99, P320, DOI 10.3732/ajb.1100570; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mardulyn P, 2003, J MOL EVOL, V56, P38, DOI 10.1007/s00239-002-2378-1; Masta SE, 2004, MOL BIOL EVOL, V21, P893, DOI 10.1093/molbev/msh096; Masta SE, 2008, MOL BIOL EVOL, V25, P949, DOI 10.1093/molbev/msn051; Masta SE, 2010, MOL PHYLOGENET EVOL, V57, P59, DOI 10.1016/j.ympev.2010.06.020; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Penney D., 2011, FOSSIL SPIDERS EVOLU; Penney D, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.192.3093; Platnick NI, 2012, WORLD SPIDER CATALOG, DOI [10.5531/db.iz.0001, DOI 10.5531/DB.IZ.0001:AMERICAN]; Prosdocimi F, 2012, MOL BIOL REP, V39, P2767, DOI 10.1007/s11033-011-1034-5; QUINN TW, 1993, J MOL EVOL, V37, P417; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; SUNDERLAND KD, 1986, J APPL ECOL, V23, P433, DOI 10.2307/2404027; Tang S, 2005, J NEMATOL, V37, P236; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Venkatesh B, 1999, P NATL ACAD SCI USA, V96, P10267, DOI 10.1073/pnas.96.18.10267; WENINK PW, 1994, MOL BIOL EVOL, V11, P22; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Willerslev E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-95; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhang HH, 2011, MOL BIOL REP, V38, P1651, DOI 10.1007/s11033-010-0276-y	56	10	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62404	10.1371/journal.pone.0062404	http://dx.doi.org/10.1371/journal.pone.0062404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667474	gold, Green Published, Green Submitted			2022-12-27	WOS:000319055600024
J	Marcolino-Gomes, J; Rodrigues, FA; Oliveira, MCN; Farias, JRB; Neumaier, N; Abdelnoor, RV; Marcelino-Guimaraes, FC; Nepomuceno, AL				Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Neves Oliveira, Maria Cristina; Boucas Farias, Jose Renato; Neumaier, Norman; Abdelnoor, Ricardo Vilela; Marcelino-Guimaraes, Francismar Correa; Nepomuceno, Alexandre Lima			Expression Patterns of GmAP2/EREB-Like Transcription Factors Involved in Soybean Responses to Water Deficit	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ERF GENE FAMILY; FUNCTIONAL-ANALYSIS; DROUGHT; ARABIDOPSIS; RICE; PCR; OVEREXPRESSION; NORMALIZATION; ORGANIZATION	Soybean farming has faced several losses in productivity due to drought events in the last few decades. However, plants have molecular mechanisms to prevent and protect against water deficit injuries, and transcription factors play an important role in triggering different defense mechanisms. Understanding the expression patterns of transcription factors in response to water deficit and to environmental diurnal changes is very important for unveiling water deficit stress tolerance mechanisms. Here, we analyzed the expression patterns of ten APETALA2/Ethylene Responsive Element Binding-like (AP2/EREB-like) transcription factors in two soybean genotypes (BR16: drought-sensitive; and Embrapa 48: drought-tolerant). According to phylogenetic and domain analyses, these genes can be included in the DREB and ERF subfamilies. We also analyzed a GmDRIP-like gene that encodes a DREB negative regulator. We detected the up-regulation of 9 GmAP2/EREB-like genes and identified transcriptional differences that were dependent on the levels of the stress applied and the tissue type analyzed (the expression of the GmDREB1F-like gene, for example, was four times higher in roots than in leaves). The GmDRIP-like gene was not induced by water deficit in BR16 during the longest periods of stress, but was significantly induced in Embrapa 48; this suggests a possible genetic/molecular difference between the responses of these cultivars to water deficit stress. Additionally, RNAseq gene expression analysis over a 24-h time course indicates that the expression patterns of several GmDREB-like genes are subject to oscillation over the course of the day, indicating a possible circadian regulation.	[Marcolino-Gomes, Juliana] Univ Estadual Londrina, Dept Biol, Londrina, Brazil; [Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Neves Oliveira, Maria Cristina; Boucas Farias, Jose Renato; Neumaier, Norman; Abdelnoor, Ricardo Vilela; Marcelino-Guimaraes, Francismar Correa; Nepomuceno, Alexandre Lima] Brazilian Enterprise Agr Res Embrapa Soybean, Londrina, Brazil; [Nepomuceno, Alexandre Lima] ARS, Embrapa LABEX US Plant Biotechnol, USDA, Ctr Plant Gene Express, Albany, NY USA	Universidade Estadual de Londrina; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); United States Department of Agriculture (USDA)	Nepomuceno, AL (corresponding author), Brazilian Enterprise Agr Res Embrapa Soybean, Londrina, Brazil.	nepo@cnpso.embrapa.br	Abdelnoor, Ricardo V/F-7707-2017; Abdelnoor, Ricardo V/F-7011-2012; Neumaier, Norman/I-9545-2014; Marcelino Guimaraes, Francismar/F-9973-2017	Marcelino Guimaraes, Francismar/0000-0002-5828-7249	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [552735/2007-8]; Coordenacao de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq [http://www.cnpq.br/] Genosoja grant 552735/2007-8) and Coordenacao de Pessoal de Nivel Superior (CAPES [http://www.capes.gov.br/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AM, 2007, IN VITRO CELL DEV-PL, V43, P167, DOI 10.1007/s11627-006-9024-3; Almoguera C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-75; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baerenfaller K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.39; Bates B, 2008, INTRO CLIMATE CHANGE; Chen M, 2009, J EXP BOT, V60, P121, DOI 10.1093/jxb/ern269; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; do Nascimento LC, 2012, GENET MOL BIOL, V35, P203, DOI 10.1590/S1415-47572012000200002; Dong CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-47; FEHR W. R., 1971, Crop science, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Hand ML, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-94; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Hudson KA, 2010, PLANT GENOME-US, V3, P3, DOI 10.3835/plantgenome2009.08.0025; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Y, 2011, RUSS J PLANT PHYSL+, V58, P928, DOI 10.1134/S1021443711040066; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Kuriakose B, 2009, PLANT SCI, V177, P390, DOI 10.1016/j.plantsci.2009.06.016; Lee YP, 2009, PLANT BIOLOGY, V11, P273, DOI 10.1111/j.1438-8677.2008.00122.x; Lin R, 2007, PHYSIOL MOL PLANT P, V70, P60, DOI 10.1016/j.pmpp.2007.06.002; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Martins PK, 2008, GENET MOL BIOL, V31, P512, DOI 10.1590/S1415-47572008000300019; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Oh SJ, 2009, PLANT PHYSIOL, V150, P1368, DOI 10.1104/pp.109.137554; Oya T, 2004, PLANT PROD SCI, V7, P129, DOI 10.1626/pps.7.129; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polizel AM, 2011, GENET MOL RES, V10, P3641, DOI 10.4238/2011.October.21.4; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Rodrigues FA, 2012, GENET MOL BIOL, V35, P304, DOI 10.1590/S1415-47572012000200011; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Silva EN, 2010, ENVIRON EXP BOT, V69, P279, DOI 10.1016/j.envexpbot.2010.05.001; Stolf-Moreira R, 2011, PESQUI AGROPECU BRAS, V46, P58, DOI 10.1590/S0100-204X2011000100008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Uzilday B, 2012, PLANT SCI, V182, P59, DOI 10.1016/j.plantsci.2011.03.015; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang SC, 2009, PLANT MOL BIOL, V69, P167, DOI 10.1007/s11103-008-9414-5; Wang XM, 2010, PLANT MOL BIOL REP, V28, P664, DOI 10.1007/s11105-010-0196-y; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087; Zhuang J, 2009, SCI HORTIC-AMSTERDAM, V123, P73, DOI 10.1016/j.scienta.2009.08.002	47	24	24	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62294	10.1371/journal.pone.0062294	http://dx.doi.org/10.1371/journal.pone.0062294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667465	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700029
J	Roy, C; Gupta, A; Fisette, A; Lapointe, M; Poursharifi, P; Richard, D; Lu, HL; Lu, B; Gerard, N; Gerard, C; Cianflone, K				Roy, Christian; Gupta, Abhishek; Fisette, Alexandre; Lapointe, Marc; Poursharifi, Pegah; Richard, Denis; Lu, HuiLing; Lu, Bao; Gerard, Norma; Gerard, Craig; Cianflone, Katherine			C5a Receptor Deficiency Alters Energy Utilization and Fat Storage	PLOS ONE			English	Article							ADIPOSE-TISSUE; CHEMOATTRACTANT RECEPTOR; INSULIN-RESISTANCE; COMPLEMENT; C5L2; ADIPOCYTE; PROTEIN; SYSTEM; INFLAMMATION; EXPRESSION	Objective: To investigate the impact of whole body C5a receptor (C5aR) deficiency on energy metabolism and fat storage. Design: Male wildtype (WT) and C5aR knockout (C5aRKO) mice were fed a low fat (CHOW) or a high fat high sucrose diet-induced obesity (DIO) diet for 14 weeks. Body weight and food intake were measured weekly. Indirect calorimetry, dietary fatload clearance, insulin and glucose tolerance tests were also evaluated. Liver, muscle and adipose tissue mRNA gene expression were measured by RT-PCR. Results: At week one and 12, C5aRKO mice on DIO had increased oxygen consumption. After 12 weeks, although food intake was comparable, C5aRKO mice had lower body weight (-7% CHOW, -12% DIO) as well as smaller gonadal (-38% CHOW, -36% DIO) and inguinal (-29% CHOW, -30% DIO) fat pads than their WT counterparts. Conversely, in WT mice, C5aR was upregulated in DIO vs CHOW diets in gonadal adipose tissue, muscle and liver, while C5L2 mRNA expression was lower in C5aRKO on both diet. Furthermore, blood analysis showed lower plasma triglyceride and non-esterified fatty acid levels in both C5aRKO groups, with faster postprandial triglyceride clearance after a fatload. Additionally, C5aRKO mice showed lower CD36 expression in gonadal and muscle on both diets, while DGAT1 expression was higher in gonadal (CHOW) and liver (CHOW and DIO) and PPAR gamma was increased in muscle and liver. Conclusion: These observations point towards a role (either direct or indirect) for C5aR in energy expenditure and fat storage, suggesting a dual role for C5aR in metabolism as well as in immunity.	[Roy, Christian; Gupta, Abhishek; Fisette, Alexandre; Lapointe, Marc; Poursharifi, Pegah; Richard, Denis; Lu, HuiLing; Cianflone, Katherine] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Lu, Bao; Gerard, Norma; Gerard, Craig] Harvard Univ, Childrens Hosp, Sch Med, Ina Sue Perlmutter Lab, Boston, MA 02115 USA	Laval University; Harvard University; Boston Children's Hospital; Harvard Medical School	Cianflone, K (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	katherine.cianflone@criucpq.ulaval.ca	Poursharifi, Pegah/K-4420-2019	Poursharifi, Pegah/0000-0002-7804-4359; Fisette, Alexandre/0000-0002-0466-0845; Lapointe, Marc/0000-0003-0461-2576	CIHR (Canadian Institutes of Health Research) [77532]; CIHR-HOPE fellowship	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); CIHR-HOPE fellowship	Funding for this study was provided by a grant from CIHR (Canadian Institutes of Health Research www.cihr-irsc.gc.ca/) #77532 to KC. KC holds a Canada Research Chair in Adipose Tissue. CR and AF are both supported by CIHR doctoral fellowships. AG is supported by a CIHR-HOPE fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Cui W, 2009, MOL IMMUNOL, V46, P3207, DOI 10.1016/j.molimm.2009.08.013; Fisette A, 2013, IMMUNOBIOLOGY, V218, P127, DOI 10.1016/j.imbio.2012.04.001; FLIER JS, 1989, RECENT PROG HORM RES, V45, P567; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gauvreau D, 2012, MOL IMMUNOL, V51, P73, DOI 10.1016/j.molimm.2012.02.110; Gavrilyuk V, 2005, J NEUROCHEM, V92, P1140, DOI 10.1111/j.1471-4159.2004.02942.x; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Moreno-Navarrete JM, 2010, DIABETES, V59, P200, DOI 10.2337/db09-0700; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Maslowska M, 2006, J LIPID RES, V47, P643, DOI 10.1194/jlr.M500500-JLR200; Maslowska M, 2005, VITAM HORM, V70, P309, DOI 10.1016/S0083-6729(05)70010-8; MCLEAN RH, 1980, HUM HERED, V30, P149, DOI 10.1159/000153119; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Muscari A, 2007, DIABETES CARE, V30, P2362, DOI 10.2337/dc07-0637; Nataf S, 1999, TRENDS NEUROSCI, V22, P397, DOI 10.1016/S0166-2236(98)01390-3; O'Barr SA, 2001, J IMMUNOL, V166, P4154, DOI 10.4049/jimmunol.166.6.4154; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Paglialunga S, 2008, AM J PHYSIOL-ENDOC M, V294, pE521, DOI 10.1152/ajpendo.00590.2007; Paglialunga S, 2007, J ENDOCRINOL, V194, P293, DOI 10.1677/JOE-07-0205; Pattrick M, 2009, MOL IMMUNOL, V46, P755, DOI 10.1016/j.molimm.2008.09.013; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Poursharifi P, 2013, CELL SIGNAL, V25, P910, DOI 10.1016/j.cellsig.2012.12.010; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Roy C, 2008, AM J PHYSIOL-ENDOC M, V294, pE1051, DOI 10.1152/ajpendo.00689.2007; Roy C, 2011, AM J PHYSIOL-ENDOC M, V301, pE232, DOI 10.1152/ajpendo.00476.2010; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; SISSONS JGP, 1976, NEW ENGL J MED, V294, P461, DOI 10.1056/NEJM197602262940902; Tokodai K, 2011, TRANSPL P, V43, P3179, DOI 10.1016/j.transproceed.2011.10.006; VOGT W, 1986, Complement, V3, P177; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; WILLIAMS CA, 1985, J NEUROIMMUNOL, V9, P29, DOI 10.1016/S0165-5728(85)80004-7; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yuan J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3873	46	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62531	10.1371/journal.pone.0062531	http://dx.doi.org/10.1371/journal.pone.0062531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667486	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700044
J	Stebbing, J; Payne, R; Reise, J; Frampton, AE; Avery, M; Woodley, L; Di Leo, A; Pestrin, M; Krell, J; Coombes, RC				Stebbing, Justin; Payne, Rachel; Reise, Justine; Frampton, Adam E.; Avery, Miranda; Woodley, Laura; Di Leo, Angelo; Pestrin, Marta; Krell, Jonathan; Coombes, R. Charles			The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; DISEASE PROGRESSION; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; DOUBLE-BLIND; PHASE-II; PLACEBO; GEFITINIB; HETEROGENEITY; ANASTROZOLE	Background: Analysis of circulating tumor cells (CTCs) provides real-time measures of cancer sub-populations with potential for CTC-directed therapeutics. We examined whether lapatinib which binds both HER2 and EGFR could induce depletion of the EGFR-positive pool of CTCs, which may in turn lead to clinical benefits. Patients and Methods: Patients with metastatic breast cancer and HER2 non-amplified primary tumors with EGFR-positive CTCs were recruited and lapatinib 1500 mg daily was administered, in a standard two step phase 2 trial. Results: There were no responses leading to termination at the first analysis with 16 patients recruited out of 43 screened. In 6 out of 14 (43%) individuals eligible for the efficacy analysis, a decrease in CTCs was observed with most of these having a greater decrease in their EGFR-positive CTC pool. Conclusions: This is one of the first studies of CTC-directed therapeutics and suggests that lapatinib monotherapy is not having any demonstrable clinical effects by reducing the EGFR-positive pool of CTCs in HER2 non-amplified primary tumors. Our attempt to expand the pool of patients eligible for a targeted therapy was unsuccessful; the role of clonal populations in cancer biology and therapeutic strategies to control them will require extensive evaluation in years to come.	[Stebbing, Justin; Payne, Rachel; Reise, Justine; Frampton, Adam E.; Avery, Miranda; Woodley, Laura; Krell, Jonathan; Coombes, R. Charles] Charing Cross Hosp, Imperial Coll Healthcare Natl Hlth Serv Trust, Dept Oncol, London, England; [Di Leo, Angelo; Pestrin, Marta] Ist Tosacano Tumori, Sandro Pitigliani Med Oncol Unit, Prato, Italy	Imperial College London; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Stebbing, J (corresponding author), Charing Cross Hosp, Imperial Coll Healthcare Natl Hlth Serv Trust, Dept Oncol, London, England.	j.stebbing@imperial.ac.uk	Di Leo, Angelo/AAM-1267-2020	Di Leo, Angelo/0000-0002-3665-9056; Stebbing, Justin/0000-0002-1117-6947; Coombes, Raoul Charles/0000-0002-4811-1100	Imperial ECMC; BRC; GlaxoSmithKline; Cancer Research UK [14549, 12011] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish	Imperial ECMC; BRC; GlaxoSmithKline(GlaxoSmithKline); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors are grateful to GlaxoSmithKline for their help with this study. The Imperial ECMC and BRC supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from a commercial source, GlaxoSmithKline. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arteaga CL, 2008, CLIN CANCER RES, V14, P6277, DOI 10.1158/1078-0432.CCR-08-0482; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Cristofanilli M, 2010, CLIN CANCER RES, V16, P1904, DOI 10.1158/1078-0432.CCR-09-2282; Di Leo A, 2007, BREAST, V16, pS120, DOI 10.1016/j.breast.2007.07.021; Di Leo A, 2008, J CLIN ONCOL, V26, P5544, DOI 10.1200/JCO.2008.16.2578; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Finn RS, 2009, J CLIN ONCOL, V27, P5552, DOI 10.1200/JCO.2008.21.1763; Finn RS, 2009, J CLIN ONCOL, V27, P3908, DOI 10.1200/JCO.2008.18.1925; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Ignatiadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015624; Jacob J, 2011, EXPERT REV ANTICANC, V11, P1345, DOI [10.1586/ERA.11.133, 10.1586/era.11.133]; Lipton A, 2005, CANCER, V104, P257, DOI 10.1002/cncr.21202; Liu ZA, 2010, CANCER BIOL THER, V10, P864, DOI 10.4161/cbt.10.9.13323; Lorico A, 2011, J ONCOL, V2011, DOI 10.1155/2011/135039; Lydon JP, 2010, NATURE, V465, P695, DOI 10.1038/465695a; Lyons JG, 2008, CLIN EXP METASTAS, V25, P665, DOI 10.1007/s10585-007-9134-2; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Payne RE, 2009, PHARMACOGENOMICS, V10, P51, DOI 10.2217/14622416.10.1.51; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pestrin M, 2012, BREAST CANC RES TREA; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Polychronis A, 2005, LANCET ONCOL, V6, P383, DOI 10.1016/S1470-2045(05)70176-5; Rajendra TK, 2010, COLD SH Q B, V75, P365, DOI 10.1101/sqb.2010.75.043; Rexer BN, 2009, CELL CYCLE, V8, P18, DOI 10.4161/cc.8.1.7324; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Smith BM, 2000, J CLIN ONCOL, V18, P1432, DOI 10.1200/JCO.2000.18.7.1432; Stebbing J, 2011, J CLIN PATHOL, V64, P829, DOI 10.1136/jcp.2011.089433; Stebbing J, 2009, LANCET ONCOL, V10, P1138, DOI 10.1016/S1470-2045(09)70260-8; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Veronesi U, 2005, LANCET, V365, P1727, DOI 10.1016/S0140-6736(05)66546-4; Walker RA, 2008, J CLIN PATHOL, V61, P818, DOI 10.1136/jcp.2007.054866; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	36	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62543	10.1371/journal.pone.0062543	http://dx.doi.org/10.1371/journal.pone.0062543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667487	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700045
J	Levas, SJ; Grottoli, AG; Hughes, A; Osburn, CL; Matsui, Y				Levas, Stephen J.; Grottoli, Andrea G.; Hughes, Adam; Osburn, Christopher L.; Matsui, Yohei			Physiological and Biogeochemical Traits of Bleaching and Recovery in the Mounding Species of Coral Porites lobata: Implications for Resilience in Mouding Corals	PLOS ONE			English	Article							ORGANIC-MATTER RELEASE; EASTERN PACIFIC CORALS; REEF CORALS; MONTASTREA-ANNULARIS; SCLERACTINIAN CORAL; CLIMATE-CHANGE; STYLOPHORA-PISTILLATA; SKELETAL DELTA-C-13; THERMAL TOLERANCE; MORTALITY RISK	Mounding corals survive bleaching events in greater numbers than branching corals. However, no study to date has determined the underlying physiological and biogeochemical trait(s) that are responsible for mounding coral holobiont resilience to bleaching. Furthermore, the potential of dissolved organic carbon (DOC) as a source of fixed carbon to bleached corals has never been determined. Here, Porites lobata corals were experimentally bleached for 23 days and then allowed to recover for 0, 1, 5, and 11 months. At each recovery interval a suite of analyses were performed to assess their recovery (photosynthesis, respiration, chlorophyll a, energy reserves, tissue biomass, calcification, delta C-13 of the skeletal, delta C-13, and delta N-15 of the animal host and endosymbiont fractions). Furthermore, at 0 months of recovery, the assimilation of photosynthetically acquired and zooplankton-feeding acquired carbon into the animal host, endosymbiont, skeleton, and coral-mediated DOC were measured via C-13-pulse-chase labeling. During the first month of recovery, energy reserves and tissue biomass in bleached corals were maintained despite reductions in chlorophyll a, photosynthesis, and the assimilation of photosynthetically fixed carbon. At the same time, P. lobata corals catabolized carbon acquired from zooplankton and seemed to take up DOC as a source of fixed carbon. All variables that were negatively affected by bleaching recovered within 5 to 11 months. Thus, bleaching resilience in the mounding coral P. lobata is driven by its ability to actively catabolize zooplankton-acquired carbon and seemingly utilize DOC as a significant fixed carbon source, facilitating the maintenance of energy reserves and tissue biomass. With the frequency and intensity of bleaching events expected to increase over the next century, coral diversity on future reefs may favor not only mounding morphologies but species like P. lobata, which have the ability to utilize heterotrophic sources of fixed carbon that minimize the impact of bleaching and promote fast recovery.	[Levas, Stephen J.; Grottoli, Andrea G.; Matsui, Yohei] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Hughes, Adam] Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Osburn, Christopher L.] Naval Res Lab, Div Chem, Washington, DC USA	University System of Ohio; Ohio State University; UHI Millennium Institute; United States Department of Defense; United States Navy; Naval Research Laboratory	Levas, SJ (corresponding author), Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA.	levas.1@osu.edu	Hughes, Adam D/J-7867-2013; Hughes, Adam D/L-1088-2016; Grottoli, Andrea/C-9736-2009; Levas, Stephen/AAA-6774-2020	Osburn, Christopher/0000-0002-9334-4202	National Science Foundation divisions of Biological Oceanography [0542415]; Chemical Oceanography [0610487]; Mellon Foundation; Ford Foundation Diversity Fellowship; Direct For Biological Sciences [1041124] Funding Source: National Science Foundation	National Science Foundation divisions of Biological Oceanography(National Science Foundation (NSF)); Chemical Oceanography(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Mellon Foundation; Ford Foundation Diversity Fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Science Foundation divisions of Biological Oceanography (Grant No. 0542415) and Chemical Oceanography (Grant No. 0610487) (http://www.nsf.gov), the Mellon Foundation (http://www.mellon.org), and the Ford Foundation Diversity Fellowship (http://sites.nationalacademies.org/pga/fordfellowships/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch-Gottlib L, 2002, J BIOCH PHYS METH, V50, P187; Al-Horani FA, 2003, J EXP MAR BIOL ECOL, V288, P1, DOI 10.1016/S0022-0981(02)00578-6; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Barnes DJ, 1999, CORAL REEFS, V18, P213, DOI 10.1007/s003380050185; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; CHALKER BE, 1975, PROC R SOC SER B-BIO, V190, P323, DOI 10.1098/rspb.1975.0096; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Cortes J, 1998, REV BIOL TROP, V46, P55; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; D'Croz L, 2001, B MAR SCI, V69, P203; Dinsdale EA, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P231, DOI 10.1007/978-94-007-0114-4_16; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dunne RP, 2001, CORAL REEFS, V20, P201; Edmunds PJ, 2008, B MAR SCI, V83, P453; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; Ferrier-Pages C, 1998, MAR ECOL PROG SER, V172, P265, DOI 10.3354/meps172265; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; GOREAU TJ, 1990, CORAL REEFS, V8, P211, DOI 10.1007/BF00265013; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Grottoli AG, 2002, GEOCHIM COSMOCHIM AC, V66, P1955, DOI 10.1016/S0016-7037(01)00901-2; Grottoli AG, 1999, CORAL REEFS, V18, P29, DOI 10.1007/s003380050150; Grover R, 2003, LIMNOL OCEANOGR, V48, P2266, DOI 10.4319/lo.2003.48.6.2266; Guest JR, 2010, PLOS ONE, V7, P8; GUZMAN HM, 1993, REV BIOL TROP, V41, P535; Haas AF, 2010, J EXP MAR BIOL ECOL, V389, P53, DOI 10.1016/j.jembe.2010.03.018; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; Heikoop JM, 2000, MAR POLLUT BULL, V40, P628, DOI 10.1016/S0025-326X(00)00006-0; Hoegh-Guldberg O, 2004, MAR ECOL PROG SER, V280, P105, DOI 10.3354/meps280105; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Hueerkamp C, 2001, B MAR SCI, V69, P215; Hughes AD, 2010, MAR ECOL PROG SER, V420, P91, DOI 10.3354/meps08866; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jimenez IM, 2012, LIMNOL OCEANOGR, V57, P1816, DOI 10.4319/lo.2012.57.6.1816; Jokiel P.L., 1978, Monographs on Oceanographic Methodology, P529; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LEDER JJ, 1991, CORAL REEFS, V10, P19, DOI 10.1007/BF00301902; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; LEWIS JB, 1976, MAR BIOL, V36, P147, DOI 10.1007/BF00388437; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Lucas JM, 1997, J EXP BIOL, V200, P2653; MARSH J A JR, 1970, Ecology (Washington D C), V51, P255, DOI 10.2307/1933661; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Muller-Parker G., 1994, Pacific Science, V48, P273; Muscatine L., 1994, Pacific Science, V48, P304; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; MUSCATINE L, 1989, MAR BIOL, V100, P185, DOI 10.1007/BF00391957; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; Niggl W, 2008, 1 EVIDENCE CORAL BLE, P905; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Osburn CL, 2007, LIMNOL OCEANOGR-METH, V5, P296, DOI 10.4319/lom.2007.5.296; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rodrigues LJ, 2006, GEOCHIM COSMOCHIM AC, V70, P2781, DOI 10.1016/j.gca.2006.02.014; Sheppard A, 2008, IUCN 2012 IUCN RED L; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suzuki A, 2000, GEOCHEM J, V34, P321, DOI 10.2343/geochemj.34.321; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Tambutte E, 1996, J EXP BIOL, V199, P1029; Tanaka Y, 2008, B MAR SCI, V82, P237; Tanaka Y, 2007, LIMNOL OCEANOGR, V52, P1139, DOI 10.4319/lo.2007.52.3.1139; Tanaka Y, 2009, J EXP MAR BIOL ECOL, V377, P101, DOI 10.1016/j.jembe.2009.06.023; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Thornhill DJ, 2011, PLOS ONE, V6, P13; Tremblay P, 2012, MAR ECOL PROG SER, V453, P63, DOI 10.3354/meps09640; Ulstrup KE, 2011, AQUAT BIOL, V12, P241, DOI 10.3354/ab00338; van Duyl FC, 2001, AQUAT MICROB ECOL, V24, P17, DOI 10.3354/ame024017; van Woesik R, 2012, CORAL REEFS, V31, P633, DOI 10.1007/s00338-012-0911-2; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Wang JT, 2012, ZOOL STUD, V51, P137; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Wild C, 2008, MAR ECOL PROG SER, V372, P67, DOI 10.3354/meps07724; Wilkinson C, 2008, STATUS CORAL REEFS W; Yamazaki A, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001697	96	72	73	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63267	10.1371/journal.pone.0063267	http://dx.doi.org/10.1371/journal.pone.0063267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658817	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500065
J	Lockwood, WW; Chandel, SK; Stewart, GL; Erdjument-Bromage, H; Beverly, LJ				Lockwood, William W.; Chandel, Sahiba K.; Stewart, Greg L.; Erdjument-Bromage, Hediye; Beverly, Levi J.			The Novel Ubiquitin Ligase Complex, SCFFbxw4, Interacts with the COP9 Signalosome in an F-Box Dependent Manner, Is Mutated, Lost and Under-Expressed in Human Cancers	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HAND FOOT MALFORMATION; BETA-CATENIN; PROTEIN; GENE; SHFM3; PROTEOLYSIS; 10Q24; NOTCH; FBW7	Identification of novel proteins that can potentially contribute to carcinogenesis is a requisite venture. Herein, we report the first biochemical characterization of the novel F-box and WD40 containing protein, FBXW4. We have identified interacting protein partners and demonstrated that FBXW4 is part of a ubiquitin ligase complex. Furthermore, the Fbxw4 locus is a common site of proviral insertion in a variety of retroviral insertional mutagenesis murine cancer models and Fbxw4 mRNA is highly expressed in the involuting murine mammary gland. To begin to characterize the biochemical function of Fbxw4, we used proteomic analysis to demonstrate that Fbxw4 interacts with Skp1 (SKP1), Cullin1 (CUL1), Ring-box1 (RBX1) and all components of the COP9 signalosome. All of these interactions are dependent on an intact F-box domain of Fbxw4. Furthermore, Fbxw4 is capable of interacting with ubiquitinated proteins within cells in an F-box dependent manner. Finally, we demonstrate that FBXW4 is mutated, lost and under-expressed in a variety of human cancer cell lines and clinical patient samples. Importantly, expression of FBXW4 correlates with survival of patients with non-small cell lung cancer. Taken together, we suggest that FBXW4 may be a novel tumor suppressor that regulates important cellular processes.	[Chandel, Sahiba K.; Beverly, Levi J.] Univ Louisville, James Graham Brown Canc Ctr, Div Hematol & Oncol, Dept Med, Louisville, KY 40292 USA; [Lockwood, William W.] NHGRI, Canc Biol & Genet Sect, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Stewart, Greg L.] Columbia Canc Res Ctr, Vancouver, BC, Canada; [Erdjument-Bromage, Hediye] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	University of Louisville; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Memorial Sloan Kettering Cancer Center	Beverly, LJ (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Div Hematol & Oncol, Dept Med, Louisville, KY 40292 USA.	Levi.Beverly@Louisville.edu		Erdjument-Bromage, Hediye/0000-0003-0224-3594	National Institutes of Health (NIH), Molecular Targets COBRE [8P20GM103482-10]; Wendy Will Case Cancer Fund [GB220413]; Kosair Pediatric Cancer Research Program award; NCI [P30 CA08748]; NIH [P01 CA94060, PO1 CA129243-01]; NIH intramural NCI; NHGRI; NATIONAL CANCER INSTITUTE [P01CA094060, P01CA129243, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103482] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Molecular Targets COBRE; Wendy Will Case Cancer Fund; Kosair Pediatric Cancer Research Program award; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH intramural NCI; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH), Molecular Targets COBRE, 8P20GM103482-10 (to LJB), Wendy Will Case Cancer Fund, GB220413 (to LJB), Kosair Pediatric Cancer Research Program award (to LJB). This work was also supported by NCI Cancer Center support grant P30 CA08748 to Microchemistry and Proteomics Core Laboratory (to HEB), Memorial Sloan-Kettering Cancer Center. This work was also supported, in part, by NIH Grant P01 CA94060 and PO1 CA129243-01 (to Harold Varmus) and by NIH intramural NCI and NHGRI funds (to Harold Varmus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2009, MOL CANCER RES, V7, P841, DOI 10.1158/1541-7786.MCR-08-0555; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Basel D, 2003, CLIN GENET, V64, P350, DOI 10.1034/j.1399-0004.2003.00153.x; Beverly LJ, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1119167109; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; CHAMOVITZ DA, 1995, CELL, V82, P353, DOI 10.1016/0092-8674(95)90423-9; de Mollerat XJ, 2003, HUM MOL GENET, V12, P1959, DOI 10.1093/hmg/ddg212; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Duijf PHG, 2003, HUM MOL GENET, V12, pR51, DOI 10.1093/hmg/ddg090; Elliott AM, 2005, CLIN GENET, V68, P501, DOI 10.1111/j.1399-0004.2005.00530.x; Gurrieri F, 1996, AM J MED GENET, V62, P427; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ianakiev P, 1999, BIOCHEM BIOPH RES CO, V261, P64, DOI 10.1006/bbrc.1999.0963; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kano H, 2007, P NATL ACAD SCI USA, V104, P19034, DOI 10.1073/pnas.0705483104; Kawakami K, 2000, CURR BIOL, V10, P463, DOI 10.1016/S0960-9822(00)00444-9; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Lau AW, 2012, FRONT BIOSCI-LANDMRK, V17, P2197, DOI 10.2741/4045; Lee M. H., 2011, CELL CYCLE, V10, P3057, DOI [DOI 10.4161/CC.10.18, 10.4161/cc.10.18.17320, DOI 10.4161/CC.10.18.17320]; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Malyukova A, 2007, CANCER RES, V67, P5611, DOI 10.1158/0008-5472.CAN-06-4381; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Ozen RS, 1999, AM J HUM GENET, V64, P1646, DOI 10.1086/302403; Palomero T, 2009, CLIN LYMPHOMA MYELOM, V9, pS205, DOI 10.3816/CLM.2009.s.013; RaasRothschild A, 1996, J MED GENET, V33, P996, DOI 10.1136/jmg.33.12.996; Richardson KS, 2005, MOL CANCER RES, V3, P645, DOI 10.1158/1541-7786.MCR-05-0233; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Schwechheimer C, 2004, BBA-MOL CELL RES, V1695, P45, DOI 10.1016/j.bbamcr.2004.09.023; Sidow A, 1999, NAT GENET, V23, P104, DOI 10.1038/12709; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270	37	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63610	10.1371/journal.pone.0063610	http://dx.doi.org/10.1371/journal.pone.0063610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658844	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500078
J	Mahen, R; Hattori, H; Lee, M; Sharma, P; Jeyasekharan, AD; Venkitaraman, AR				Mahen, Robert; Hattori, Hiroyoshi; Lee, Miyoung; Sharma, Pooja; Jeyasekharan, Anand D.; Venkitaraman, Ashok R.			A-Type Lamins Maintain the Positional Stability of DNA Damage Repair Foci in Mammalian Nuclei	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; GILFORD PROGERIA SYNDROME; ORGANIZATION; RECOMBINATION; MOBILITY; CELLS; CHROMOSOMES; EXPRESSION; DYNAMICS; PATHWAY	A-type lamins encoded by LMNA form a structural fibrillar meshwork within the mammalian nucleus. How this nuclear organization may influence the execution of biological processes involving DNA transactions remains unclear. Here, we characterize changes in the dynamics and biochemical interactions of lamin A/C after DNA damage. We find that DNA breakage reduces the mobility of nucleoplasmic GFP-lamin A throughout the nucleus as measured by dynamic fluorescence imaging and spectroscopy in living cells, suggestive of incorporation into stable macromolecular complexes, but does not induce the focal accumulation of GFP-lamin A at damage sites. Using a proximity ligation assay and biochemical analyses, we show that lamin A engages chromatin via histone H2AX and its phosphorylated form (gamma H2AX) induced by DNA damage, and that these interactions are enhanced after DNA damage. Finally, we use three-dimensional time-lapse imaging to show that LMNA inactivation significantly reduces the positional stability of DNA repair foci in living cells. This defect is partially rescued by the stable expression of GFP-lamin A. Thus collectively, our findings suggest that the dynamic structural meshwork formed by A-type lamins anchors sites of DNA repair in mammalian nuclei, providing fresh insight into the control of DNA transactions by nuclear structural organization.	[Mahen, Robert; Hattori, Hiroyoshi; Lee, Miyoung; Sharma, Pooja; Jeyasekharan, Anand D.; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge, England		Venkitaraman, AR (corresponding author), Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge, England.	arv22@hutchison-mrc.cam.ac.uk	Jeyasekharan, Anand/O-3398-2019; Lee, MiYoung/G-3748-2014	Mahen, Robert/0000-0002-4748-3690; Jeyasekharan, Anand/0000-0001-9816-6137	Medical Research Council; GIA-Cancer Cell Unit (RG); Wellcome Trust (RG); MRC [G1001522, G0600332, MC_UU_12022/8, MC_U105359877, G1001521] Funding Source: UKRI; Medical Research Council [MC_UU_12022/8, MC_U105359877, G0600332, G1001522, G1001521] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GIA-Cancer Cell Unit (RG); Wellcome Trust (RG)(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Medical Research Council (http://www.mrc.ac.uk/index.htm) and the GIA-Cancer Cell Unit (RG) and the The Wellcome Trust (http://www.wellcome.ac.uk/) (RG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Broers JLV, 1999, J CELL SCI, V112, P3463; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Dechat T, 2010, COLD SH Q B, V75, P533, DOI 10.1101/sqb.2010.75.018; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Goldberg M, 1999, P NATL ACAD SCI USA, V96, P2852, DOI 10.1073/pnas.96.6.2852; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gonzalez-Suarez I, 2011, EMBO J, V30, P3383, DOI 10.1038/emboj.2011.225; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HOZAK P, 1995, J CELL SCI, V108, P635; Jahn D, 2012, NUCLEUS-AUSTIN, V3, P463, DOI 10.4161/nucl.21676; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Lee DC, 2009, EXP CELL RES, V315, P996, DOI 10.1016/j.yexcr.2009.01.003; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Mahen R, 2011, P NATL ACAD SCI USA, V108, P9310, DOI 10.1073/pnas.1101112108; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mattout A, 2007, J CELL SCI, V120, P77, DOI 10.1242/jcs.03325; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08	37	36	39	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61893	10.1371/journal.pone.0061893	http://dx.doi.org/10.1371/journal.pone.0061893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658700	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500013
J	Cohen, D; Cassel, RS; Saint-Georges, C; Mahdhaoui, A; Laznik, MC; Apicella, F; Muratori, P; Maestro, S; Muratori, F; Chetouani, M				Cohen, David; Cassel, Raquel S.; Saint-Georges, Catherine; Mahdhaoui, Ammar; Laznik, Marie-Christine; Apicella, Fabio; Muratori, Pietro; Maestro, Sandra; Muratori, Filippo; Chetouani, Mohamed			Do Parentese Prosody and Fathers' Involvement in Interacting Facilitate Social Interaction in Infants Who Later Develop Autism?	PLOS ONE			English	Article							CHILD-DIRECTED SPEECH; PHYSIOLOGICAL PRECURSORS; SPECTRUM DISORDER; COMMUNICATION; SYNCHRONY; RESPONSES; RECOGNITION; PREFERENCES; PREDICTORS; PERCEPTION	Background: Whether development of autism impacts the interactive process between an infant and his/her parents remains an unexplored issue. Methodology and Principal Findings: Using computational analysis taking into account synchronic behaviors and emotional prosody (parentese), we assessed the course of infants' responses to parents' type of speech in home movies from typically developing (TD) infants and infants who will subsequently develop autism aged less than 18 months. Our findings indicate: that parentese was significantly associated with infant responses to parental vocalizations involving orientation towards other people and with infant receptive behaviours; that parents of infants developing autism displayed more intense solicitations that were rich in parentese; that fathers of infants developing autism spoke to their infants more than fathers of TD infants; and that fathers' vocalizations were significantly associated with intersubjective responses and active behaviours in infants who subsequently developed autism. Conclusion: The parents of infants who will later develop autism change their interactive pattern of behaviour by both increasing parentese and father's involvement in interacting with infants; both are significantly associated with infant's social responses. We stress the possible therapeutic implications of these findings and its implication for Dean Falk's theory regarding pre-linguistic evolution in early hominins.	[Cohen, David; Cassel, Raquel S.; Saint-Georges, Catherine] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Dept Child & Adolescent Psychiat, Paris, France; [Cohen, David; Cassel, Raquel S.; Saint-Georges, Catherine; Mahdhaoui, Ammar; Chetouani, Mohamed] Univ Paris 06, Ctr Natl Rech Sci UMR 7222, Inst Syst Intelligents & Robot, Paris, France; [Laznik, Marie-Christine] Assoc Sante Mentale 13Eme, Dept Child & Adolescent Psychiat, Paris, France; [Apicella, Fabio; Muratori, Pietro; Maestro, Sandra; Muratori, Filippo] Univ Pisa, Stella Maris Sci Inst, Div Child Neurol & Psychiat, Calambrone, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; IRCCS Fondazione Stella Maris; University of Pisa	Cohen, D (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Dept Child & Adolescent Psychiat, Paris, France.	david.cohen@psl.aphp.fr	Bargagna, Stefania/AAB-7603-2019; CHETOUANI, Mohamed/F-5854-2010; Maestro, Sandra/AAB-9297-2022; Muratori, Pietro/J-3538-2016; Muratori, Filippo/K-3187-2018; Maestro, Sandra/AAA-7386-2021; Apicella, Fabio/ABF-4304-2020; Muratori, Pietro/AAH-9232-2021	Bargagna, Stefania/0000-0001-6430-9494; CHETOUANI, Mohamed/0000-0002-2920-4539; Maestro, Sandra/0000-0003-3929-1573; Muratori, Pietro/0000-0001-7779-779X; Muratori, Filippo/0000-0001-9598-0096; Maestro, Sandra/0000-0003-3929-1573; Apicella, Fabio/0000-0001-7390-3241; Muratori, Pietro/0000-0001-7779-779X	Italian Ministry of Instruction, University, and Research; Fondation de France [2008005170]; Universite Pierre et Marie Curie; European Commission [288241]; fund "Entreprendre pour aider"	Italian Ministry of Instruction, University, and Research(Ministry of Education, Universities and Research (MIUR)); Fondation de France(Fondation de France); Universite Pierre et Marie Curie; European Commission(European CommissionEuropean Commission Joint Research Centre); fund "Entreprendre pour aider"	The Pisa "home video in autism" project was supported by grants PRIN 2003-2005 and PRIN 2005-2007 from the Italian Ministry of Instruction, University, and Research. The current study was supported by a grant (no2008005170) from the Fondation de France given to MC and DC, by the Universite Pierre et Marie Curie (Projet Emergence 2010) the European Commission (FP7: Michelangelo under grant agreement no 288241), and the fund "Entreprendre pour aider". The funding agencies and the University were not involved in the study design, collection, analysis and interpretation of data, writing of the paper, or the decision to submit for publication.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Atzil S, 2012, J AM ACAD CHILD PSY, V51, P798, DOI 10.1016/j.jaac.2012.06.008; Bickerton D, 2002, TRANSITION LANGUAGE, P207; Boddaert N, 2004, AM J PSYCHIAT, V161, P2117, DOI 10.1176/appi.ajp.161.11.2117; Braarud HC, 2008, SOC DEV, V17, P1074, DOI 10.1111/j.1467-9507.2007.00455.x; Cassel RS, INTERACTION STUDIES; Chaby L, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P950, DOI 10.1109/SocialCom-PASSAT.2012.111; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Crown CL, 2002, J PSYCHOLINGUIST RES, V31, P1, DOI 10.1023/A:1014301303616; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Elsabbagh M, 2010, TRENDS COGN SCI, V14, P81, DOI 10.1016/j.tics.2009.12.005; Falk D, 2004, BEHAV BRAIN SCI, V27, P491; Falk D, 2004, BEHAV BRAIN SCI, V27, P83; Falk D, 2009, FINDINGS OUR TONGUES; Feldman R, 2006, DEV PSYCHOL, V42, P175, DOI 10.1037/0012-1649.42.1.175; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; Fivaz-Depeursinge E, 1996, New Dir Child Dev, P27; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Goldstein MH, 2009, CHILD DEV, V80, P636, DOI 10.1111/j.1467-8624.2009.01287.x; Groen W, 2008, J AUTISM DEV DISORD, V38, P1819, DOI 10.1007/s10803-008-0572-8; Groenen M., 1996, LEROI GOURHAN ESSENC; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Guinchat V, 2012, RES AUTISM SPECT DIS, V6, P589, DOI 10.1016/j.rasd.2011.10.005; HIRSHPASEK K, 1987, COGNITION, V26, P269, DOI 10.1016/S0010-0277(87)80002-1; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Laznik M, 2005, COMMENCEMENT ETAIT V; Mahdhaoui A, 2011, INT J METH PSYCH RES, V20, pE6, DOI 10.1002/mpr.332; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Muratori F, 2011, RES AUTISM SPECT DIS, V5, P408, DOI 10.1016/j.rasd.2010.06.003; Niwano K, 2003, PSYCHOL REP, V92, P481, DOI 10.2466/PR0.92.2.481-487; Paul R, 2007, J SPEECH LANG HEAR R, V50, P1350, DOI 10.1044/1092-4388(2007/094); Plooij FX., 1984, BEHAV DEV FREE LIVIN; Ramchandani PG, 2013, J CHILD PSYCHOL PSYC, V54, P56, DOI 10.1111/j.1469-7610.2012.02583.x; Rutter M., 2003, AUTISM DIAGNOSTIC IN, DOI DOI 10.1002/aur.1329; Saint-Georges C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022393; Saint-Georges C, 2010, RES AUTISM SPECT DIS, V4, P355, DOI 10.1016/j.rasd.2009.10.017; Schopler E, 1998, CHILDHOOD AUTISM RAT; Schuller B, 2007, P INTERSPEECH; Small Meredith, 1998, OUR BABIES OURSELVES; STONE WL, 1994, ARCH PEDIAT ADOL MED, V148, P174, DOI 10.1001/archpedi.1994.02170020060010; Stormark KM, 2004, INFANT BEHAV DEV, V27, P195, DOI 10.1016/j.infbeh.2003.09.004; Toth K, 2006, J AUTISM DEV DISORD, V36, P993, DOI 10.1007/s10803-006-0137-7; Viaux-Savelon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030935; Wan MW, 2013, J CHILD PSYCHOL PSYC, V54, P763, DOI 10.1111/jcpp.12032; Wan MW, 2012, RES DEV DISABIL, V33, P924, DOI 10.1016/j.ridd.2011.12.011; Warlaumont AS, 2009, P 32 ANN C COGN SCI, P121; Watson LR, 2012, J AUTISM DEV DISORD, V42, P1616, DOI 10.1007/s10803-011-1401-z; Watson LR, 2010, J SPEECH LANG HEAR R, V53, P1052, DOI 10.1044/1092-4388(2009/09-0096); Werner E, 2000, J AUTISM DEV DISORD, V30, P157, DOI 10.1023/A:1005463707029; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	55	68	70	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61402	10.1371/journal.pone.0061402	http://dx.doi.org/10.1371/journal.pone.0061402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23650498	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000013
J	Golubchik, T; Batty, EM; Miller, RR; Farr, H; Young, BC; Larner-Svensson, H; Fung, R; Godwin, H; Knox, K; Votintseva, A; Everitt, RG; Street, T; Cule, M; Ip, CLC; Didelot, X; Peto, TEA; Harding, RM; Wilson, DJ; Crook, DW; Bowden, R				Golubchik, Tanya; Batty, Elizabeth M.; Miller, Ruth R.; Farr, Helen; Young, Bernadette C.; Larner-Svensson, Hanna; Fung, Rowena; Godwin, Heather; Knox, Kyle; Votintseva, Antonina; Everitt, Richard G.; Street, Teresa; Cule, Madeleine; Ip, Camilla L. C.; Didelot, Xavier; Peto, Timothy E. A.; Harding, Rosalind M.; Wilson, Daniel J.; Crook, Derrick W.; Bowden, Rory			Within-Host Evolution of Staphylococcus aureus during Asymptomatic Carriage	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; NASAL CARRIAGE; LINKAGE DISEQUILIBRIUM; NUCLEOTIDE-SEQUENCE; RECOMBINATION; DYNAMICS; BACTEREMIA; POPULATION; PROTEIN	Background: Staphylococcus aureus is a major cause of healthcare associated mortality, but like many important bacterial pathogens, it is a common constituent of the normal human body flora. Around a third of healthy adults are carriers. Recent evidence suggests that evolution of S. aureus during nasal carriage may be associated with progression to invasive disease. However, a more detailed understanding of within-host evolution under natural conditions is required to appreciate the evolutionary and mechanistic reasons why commensal bacteria such as S. aureus cause disease. Therefore we examined in detail the evolutionary dynamics of normal, asymptomatic carriage. Sequencing a total of 131 genomes across 13 singly colonized hosts using the Illumina platform, we investigated diversity, selection, population dynamics and transmission during the short-term evolution of S. aureus. Principal Findings: We characterized the processes by which the raw material for evolution is generated: micro-mutation (point mutation and small insertions/deletions), macro-mutation (large insertions/deletions) and the loss or acquisition of mobile elements (plasmids and bacteriophages). Through an analysis of synonymous, non-synonymous and intergenic mutations we discovered a fitness landscape dominated by purifying selection, with rare examples of adaptive change in genes encoding surface-anchored proteins and an enterotoxin. We found evidence for dramatic, hundred-fold fluctuations in the size of the within-host population over time, which we related to the cycle of colonization and clearance. Using a newly-developed population genetics approach to detect recent transmission among hosts, we revealed evidence for recent transmission between some of our subjects, including a husband and wife both carrying populations of methicillin-resistant S. aureus (MRSA). Significance: This investigation begins to paint a picture of the within-host evolution of an important bacterial pathogen during its prevailing natural state, asymptomatic carriage. These results also have wider significance as a benchmark for future systematic studies of evolution during invasive S. aureus disease.	[Golubchik, Tanya; Batty, Elizabeth M.; Street, Teresa; Cule, Madeleine; Ip, Camilla L. C.; Didelot, Xavier; Bowden, Rory] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Miller, Ruth R.; Farr, Helen; Young, Bernadette C.; Fung, Rowena; Votintseva, Antonina; Everitt, Richard G.; Peto, Timothy E. A.; Wilson, Daniel J.; Crook, Derrick W.] Univ Oxford, Nuffield Dept Clin Med, Div Expt Med, Oxford, England; [Miller, Ruth R.; Farr, Helen; Larner-Svensson, Hanna; Fung, Rowena; Votintseva, Antonina; Peto, Timothy E. A.; Crook, Derrick W.; Bowden, Rory] Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford, England; [Larner-Svensson, Hanna; Wilson, Daniel J.; Bowden, Rory] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Godwin, Heather] Natl Hlth Serv Trust, Oxford Univ Hosp, Oxford, England; [Knox, Kyle] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Harding, Rosalind M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Wilson, DJ (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Div Expt Med, Oxford, England.	daniel.wilson@ndm.ox.ac.uk; bowden@stats.ox.ac.uk	Young, Bernadette Carmel/AAB-4157-2019; Didelot, Xavier/P-4282-2019; Wilson, Daniel J/AAE-8975-2019; Golubchik, Tanya/B-4226-2018; Didelot, Xavier/H-1608-2013	Young, Bernadette Carmel/0000-0001-6071-6770; Didelot, Xavier/0000-0003-1885-500X; Wilson, Daniel J/0000-0002-0940-3311; Golubchik, Tanya/0000-0003-2765-9828; Didelot, Xavier/0000-0003-1885-500X; peto, tim/0000-0003-3477-8307; Batty, Liz/0000-0001-8559-452X; Everitt, Richard/0000-0002-0822-5648	Oxford National Institute for Health Research (NIHR) Biomedical Research Centre; United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council, Biotechnology and Biological Sciences Research Council; National Institute for Health Research on behalf of the Department of Health [G0800778]; Wellcome Trust [087646/Z/08/Z, 090532/Z/09/Z]; MRC [G0800778, MR/K010174/1] Funding Source: UKRI; Medical Research Council [G0600719B, MR/K010174/1, MR/K010174/1B, G0800778] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10279, ACF-2009-13-009, NF-SI-0512-10047] Funding Source: researchfish	Oxford National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research on behalf of the Department of Health; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Oxford National Institute for Health Research (NIHR) Biomedical Research Centre and the United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium, the latter funded under the UKCRC Translational Infection Research Initiative supported by Medical Research Council, Biotechnology and Biological Sciences Research Council and the National Institute for Health Research on behalf of the Department of Health (Grant G0800778) and the Wellcome Trust (Grant 087646/Z/08/Z). The authors acknowledge the support of Wellcome Trust core funding (Grant 090532/Z/09/Z). TEP and DWC are NIHR Oxford Biomedical Research Centre senior investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Achtman M, 2012, PHILOS T R SOC B, V367, P860, DOI 10.1098/rstb.2011.0303; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Castillo-Ramirez S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002129; CATCHPOLE I, 1988, J GEN MICROBIOL, V134, P697; Cespedes C, 2005, J INFECT DIS, V191, P444, DOI 10.1086/427240; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Cordova SP, 2004, J HOSP INFECT, V56, P22, DOI 10.1016/j.jhin.2003.10.009; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Das I, 2007, J HOSP INFECT, V65, P117, DOI 10.1016/j.jhin.2006.09.022; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; DIDELOT X, GENOME RES UNPUB; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Drake JW, 1998, GENETICS, V148, P1667; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Goerke C, 2004, J INFECT DIS, V189, P724, DOI 10.1086/381502; Goerke C, 2007, ENVIRON MICROBIOL, V9, P3134, DOI 10.1111/j.1462-2920.2007.01423.x; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Griffiths RC, 2003, THEOR POPUL BIOL, V64, P241, DOI 10.1016/S0040-5809(03)00075-3; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; HUDSON RR, 1985, GENETICS, V111, P147; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MacKinnon MM, 2000, J HOSP INFECT, V46, P216, DOI [10.1053/jhin.2000.0807, 10.1016/S0195-6701(00)90807-7]; McAdam PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024301; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean G, 2002, GENETICS, V160, P1231; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Meunier J, 2001, MOL BIOL EVOL, V18, P2132, DOI 10.1093/oxfordjournals.molbev.a003756; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Moxon ER, 2005, TRENDS MICROBIOL, V13, P563, DOI 10.1016/j.tim.2005.10.004; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; NICOLAISEN LA, 2012, MOL BIOL EV IN PRESS; Panton PN, 1932, LANCET, V1, P506; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; SANFORD MD, 1994, CLIN INFECT DIS, V19, P1123, DOI 10.1093/clinids/19.6.1123; SCHAEFFER SW, 1993, GENETICS, V135, P541; SLATKIN M, 1991, GENETICS, V129, P555; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sokal R. R., 1981, BIOMETRY; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Tacconelli E, 2004, J ANTIMICROB CHEMOTH, V53, P474, DOI 10.1093/jac/dkh107; VandenBergh MFQ, 1999, J CLIN MICROBIOL, V37, P3133, DOI 10.1128/JCM.37.10.3133-3140.1999; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Vriens MR, 2005, INFECT CONT HOSP EP, V26, P629, DOI 10.1086/502592; Wakeley J, 2004, MOL ECOL, V13, P865, DOI 10.1111/j.1365-294X.2004.02086.x; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; WILSON DJ, 2012, PLOS PATHOG IN PRESS; World Health Organization, 2011, WHO MORT DAT ICD 10; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wright S, 1931, GENETICS, V16, P0097; Wyllie DH, 2007, J HOSP INFECT, V67, P301, DOI 10.1016/j.jhin.2007.08.018; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	81	141	143	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61319	10.1371/journal.pone.0061319	http://dx.doi.org/10.1371/journal.pone.0061319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658690	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000319167000009
J	Haralambieva, IH; Oberg, AL; Ovsyannikova, IG; Kennedy, RB; Grill, DE; Middha, S; Bot, BM; Wang, VW; Smith, DI; Jacobson, RM; Poland, GA				Haralambieva, Iana H.; Oberg, Ann L.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Grill, Diane E.; Middha, Sumit; Bot, Brian M.; Wang, Vivian W.; Smith, David I.; Jacobson, Robert M.; Poland, Gregory A.			Genome-Wide Characterization of Transcriptional Patterns in High and Low Antibody Responders to Rubella Vaccination	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; GENE-EXPRESSION; CYTOKINE PRODUCTION; MEASLES; POLYMORPHISMS; ASSOCIATIONS; CELLS; MUMPS; VACCINOMICS; MICROARRAY	Immune responses to current rubella vaccines demonstrate significant inter-individual variability. We performed mRNA-Seq profiling on PBMCs from high and low antibody responders to rubella vaccination to delineate transcriptional differences upon viral stimulation. Generalized linear models were used to assess the per gene fold change (FC) for stimulated versus unstimulated samples or the interaction between outcome and stimulation. Model results were evaluated by both FC and p-value. Pathway analysis and self-contained gene set tests were performed for assessment of gene group effects. Of 17,566 detected genes, we identified 1,080 highly significant differentially expressed genes upon viral stimulation (p<1.00E(-15), FDR<1.00E(-14)), including various immune function and inflammation-related genes, genes involved in cell signaling, cell regulation and transcription, and genes with unknown function. Analysis by immune outcome and stimulation status identified 27 genes (p <= 0.0006 and FDR <= 0.30) that responded differently to viral stimulation in high vs. low antibody responders, including major histocompatibility complex (MHC) class I genes (HLA-A, HLA-B and B2M with p = 0.0001, p = 0.0005 and p = 0.0002, respectively), and two genes related to innate immunity and inflammation (EMR3 and MEFV with p = 1.46E(-08) and p = 0.0004, respectively). Pathway and gene set analysis also revealed transcriptional differences in antigen presentation and innate/inflammatory gene sets and pathways between high and low responders. Using mRNA-Seq genome-wide transcriptional profiling, we identified antigen presentation and innate/inflammatory genes that may assist in explaining rubella vaccine-induced immune response variations. Such information may provide new scientific insights into vaccine-induced immunity useful in rational vaccine development and immune response monitoring.	[Haralambieva, Iana H.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Jacobson, Robert M.; Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA; [Haralambieva, Iana H.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Jacobson, Robert M.; Poland, Gregory A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA; [Oberg, Ann L.; Grill, Diane E.; Middha, Sumit] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Jacobson, Robert M.; Poland, Gregory A.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; [Bot, Brian M.] Sage Bionetworks, Seattle, WA USA; [Wang, Vivian W.; Smith, David I.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Middha, Sumit/0000-0003-4135-6268; Jacobson, Robert/0000-0002-6355-8752; Kennedy, Rick/0000-0001-6164-4967; Bot, Brian/0000-0002-2412-6826	National Institutes of Health (NIH) [AI33144, AI48793 501]; National Institute of Aging [R01 AG034676]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033144, R01AI048793, R37AI048793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding support was provided by National Institutes of Health (NIH) grants AI33144, AI48793 501 (which recently received a MERIT Award), and recruitment was made possible by the Rochester Epidemiology Project (Grant Number R01 AG034676) from the National Institute of Aging. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo MP, 2008, VIROLOGY, V370, P1, DOI 10.1016/j.virol.2007.08.003; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Dhiman N, 2008, TISSUE ANTIGENS, V72, P211, DOI 10.1111/j.1399-0039.2008.01097.x; Dhiman N, 2010, CYTOKINE, V50, P24, DOI 10.1016/j.cyto.2009.12.002; Dhiman N, 2010, IMMUNOGENETICS, V62, P197, DOI 10.1007/s00251-010-0423-6; Dhiman N, 2009, EXPERT REV VACCINES, V8, P963, DOI [10.1586/erv.09.67, 10.1586/ERV.09.67]; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012693; FROME EL, 1985, AM J EPIDEMIOL, V121, P309, DOI 10.1093/oxfordjournals.aje.a114001; Haralambieva IH, 2010, FUTURE MICROBIOL, V5, P1757, DOI [10.2217/fmb.10.146, 10.2217/FMB.10.146]; Haralambieva IH, 2010, J MED VIROL, V82, P1966, DOI 10.1002/jmv.21899; Haralambieva IH, 2010, HUM IMMUNOL, V71, P383, DOI 10.1016/j.humimm.2010.01.004; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Kanazawa N, 2012, J DERMATOL SCI, V66, P183, DOI 10.1016/j.jdermsci.2012.01.004; Lawrence T, 2007, BIOCHEM SOC T, V35, P270, DOI 10.1042/BST0350270; Lee J, 2011, CANCER INFORM, V10, P205, DOI 10.4137/CIN.S7473; Leonardi S, 2009, VACCINE, V27, P6030, DOI 10.1016/j.vaccine.2009.07.099; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Matmati M, 2007, J LEUKOCYTE BIOL, V81, P440, DOI 10.1189/jlb.0406276; McCullagh P, 1983, GEN LINEAR MODELS 19; Mo XY, 2007, J MED VIROL, V79, P1783, DOI 10.1002/jmv.20942; Oberg AL, 2012, BMC GENOMICS, V13, P2, DOI 10.1186/1471-2164-13-304; Oberg AL, 2011, J IMMUNOL METHODS, V366, P69, DOI 10.1016/j.jim.2011.01.011; Ovsyannikova IG, 2006, J INFECT DIS, V193, P655, DOI 10.1086/500144; Ovsyannikova IG, 2004, HUM IMMUNOL, V65, P1506, DOI 10.1016/j.humimm.2004.07.001; Ovsyannikova IG, 2007, VACCINE, V25, P3090, DOI 10.1016/j.vaccine.2007.01.020; Ovsyannikova IG, 2007, CLIN VACCINE IMMUNOL, V14, P115, DOI 10.1128/CVI.00247-06; Ovsyannikova IG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011806; Ovsyannikova IG, 2010, HUM GENET, V127, P207, DOI 10.1007/s00439-009-0763-1; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Ovsyannikova IG, 2009, VACCINE, V27, P6926, DOI 10.1016/j.vaccine.2009.08.109; Ovsyannikova IG, 2009, VACCINE, V27, P3359, DOI 10.1016/j.vaccine.2009.01.079; Ovsyannikova IG, 2009, VACCINE, V27, P3349, DOI 10.1016/j.vaccine.2009.01.080; Pankratz VS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-48; Peng XX, 2009, CURR OPIN MICROBIOL, V12, P432, DOI 10.1016/j.mib.2009.06.003; Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415; Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032; R Development Core Team, 2011, R LANG ENV STAT COMP; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romeo PH, 2002, ADV EXP MED BIOL, V515, P49; Stacey M, 2001, J BIOL CHEM, V276, P18863, DOI 10.1074/jbc.M101147200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0; Thibault S, 2009, VIROLOGY, V389, P20, DOI 10.1016/j.virol.2009.04.019; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107	53	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62149	10.1371/journal.pone.0062149	http://dx.doi.org/10.1371/journal.pone.0062149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658707	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000031
J	Ludt, S; Urban, E; Eckardt, J; Wache, S; Broge, B; Kaufmann-Kolle, P; Heller, G; Miksch, A; Glassen, K; Hermann, K; Bolter, R; Ose, D; Campbell, SM; Wensing, M; Szecsenyi, J				Ludt, Sabine; Urban, Elisabeth; Eckardt, Joerg; Wache, Stefanie; Broge, Bjoern; Kaufmann-Kolle, Petra; Heller, Guenther; Miksch, Antje; Glassen, Katharina; Hermann, Katja; Boelter, Regine; Ose, Dominik; Campbell, Stephen M.; Wensing, Michel; Szecsenyi, Joachim			Evaluating the Quality of Colorectal Cancer Care across the Interface of Healthcare Sectors	PLOS ONE			English	Article							INDICATORS; FRAMEWORK; UK	Colorectal cancer (CRC) has a high prevalence in western countries. Diagnosis and treatment of CRC is complex and requires multidisciplinary collaboration across the interface of health care sectors. In Germany, a new nationwide established program aims to provide quality information of healthcare delivery across different sectors. Within this context, this study describes the development of a set of quality indicators charting the whole pathway of CRC-care including data specifications that are necessary to operationalize these indicators before practice testing. Methods: Indicators were developed following a systematic 10 step modified 'RAND/UCLA Appropriateness Method' which involved a multidisciplinary panel of thirteen participants. For each indicator in the final set, data specifications relating to sources of quality information, data collection procedures, analysis and feedback were described. Results: The final indicator set included 52 indicators covering diagnostic procedures (11 indicators), therapeutic management (28 indicators) and follow-up (6 indicators). In addition, 7 indicators represented patient perspectives. Primary surgical tumor resection and pre-operative radiation (rectum carcinoma only) were perceived as most useful tracer procedures initiating quality data collection. To assess the quality of CRC care across sectors, various data sources were identified: medical records, administrative inpatient and outpatient data, sickness-funds billing code systems and patient survey. Conclusion: In Germany, a set of 52 quality indicators, covering necessary aspects across the interfaces and pathways relevant to CRC-care has been developed. Combining different sectors and sources of health care in quality assessment is an innovative and challenging approach but reflects better the reality of the patient pathway and experience of CRC-care.	[Ludt, Sabine; Urban, Elisabeth; Miksch, Antje; Glassen, Katharina; Hermann, Katja; Boelter, Regine; Ose, Dominik; Campbell, Stephen M.; Wensing, Michel; Szecsenyi, Joachim] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Eckardt, Joerg; Wache, Stefanie; Broge, Bjoern; Kaufmann-Kolle, Petra; Heller, Guenther; Szecsenyi, Joachim] AQUA Inst Appl Qual Improvement & Res Healthcare, Gottingen, Germany; [Campbell, Stephen M.] Univ Manchester, Inst Populat Hlth, Ctr Primary Care, Manchester, Lancs, England; [Wensing, Michel] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands	Ruprecht Karls University Heidelberg; University of Manchester; Radboud University Nijmegen	Ludt, S (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	sabine.ludt@med.uni-heidelberg.de	Wensing, Michel/H-8113-2014; Ose, Dominik/L-4250-2019; Ose, Dominik J/F-7691-2013	Wensing, Michel/0000-0001-6569-8137; Ose, Dominik/0000-0002-5079-2152; Ose, Dominik J/0000-0002-5079-2152; Glassen, Ronald/0000-0003-3195-5718; Campbell, Stephen/0000-0002-2328-4136	Federal Joint Committee (G-BA) under the German Social Code; Federal Joint Committee	Federal Joint Committee (G-BA) under the German Social Code; Federal Joint Committee	The SQG program and the work of the AQUA-Institute in this field are funded by the Federal Joint Committee (G-BA) under the German Social Code Book V, 137a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JS is a director and shareholder of the AQUA-institute which is responsible for the development of the SQG program by contract with the Federal Joint Committee. SL, EU, AM, KG, KH, RB, and DO are employees of the department of General Practice and Health Services Research at the University Hospital of Heidelberg. The department is a contract partner of the AQUA-Institute. SMC is an expert in the field of indicator development and has a contract with the department of General Practice and Health Services Research. BB, JE, SW, PK-K and GH are employees and MW's institute has a contract with the AQUAinstitute. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	*AM MED ASS, 2010, MEAS TEST PROT PHYS; [Anonymous], 2010, GERMAN POLICY STUDIE; *AQUA I, 2012, CROSS SECT QUAL HLTH; Arah OA, 2006, INT J QUAL HEALTH C, V18, P5, DOI 10.1093/intqhc/mzl024; ARDEN M, 2011, BMJ, V343; Busse R, 2009, HEALTH AFFAIR, V28, pW294, DOI 10.1377/hlthaff.28.2.w294; Campbell SM, 2004, QUAL SAF HEALTH CARE, V13, P428, DOI 10.1136/qshc.2003.007815; Campbell SM, 2002, QUAL SAF HEALTH CARE, V11, P358, DOI 10.1136/qhc.11.4.358; Campbell SM, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-85; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Demetter P, 2011, ACTA GASTRO-ENT BELG, V74, P445; Dente K, 2009, NAT MED, V15, P825, DOI 10.1038/nm0809-825; DERSCHULENBURG JM, 2010, EUR J HEALTH ECON, V10, P21; Desch CE, 2008, J CLIN ONCOL, V26, P3631, DOI 10.1200/JCO.2008.16.5068; Dixon E, 2009, J SURG RES, V156, P32, DOI 10.1016/j.jss.2009.03.084; Elwyn G, 2007, BRIT MED J, V335, P1021, DOI 10.1136/bmj.39339.490301.AD; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fitch K., 2001, RAND UCLA APPR METH; Heller G, 2007, JAMA-J AM MED ASSOC, V297, P1983, DOI 10.1001/jama.297.18.1983; Hermens RPMG, 2006, LUNG CANCER, V54, P117, DOI 10.1016/j.lungcan.2006.07.001; Institute of Medicine (US) Committee, 2001, CROSSING QUALITY CHA, P1, DOI [DOI 10.17226/10027, 10.17226/10027]; Kotter T, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-21; Kube R, 2009, ONKOLOGIE, V32, P25, DOI 10.1159/000185572; Malin JL, 2000, CANCER-AM CANCER SOC, V88, P701, DOI 10.1002/(SICI)1097-0142(20000201)88:3<701::AID-CNCR29>3.0.CO;2-V; Marshall MN, 2003, QUAL SAF HEALTH CARE, V12, P8, DOI 10.1136/qhc.12.1.8; McGory ML, 2006, J NATL CANCER I, V98, P1623, DOI 10.1093/jnci/djj438; *ORG EC CO DEV, 2012, OECD HLTH DAT 2012; Patwardhan Meenal B, 2006, Evid Rep Technol Assess (Full Rep), P1; Pena A, 2010, INT J QUAL HEALTH C, V22, P201, DOI 10.1093/intqhc/mzq018; Prosnitz RG, 2006, CANCER-AM CANCER SOC, V107, P2352, DOI 10.1002/cncr.22278; Rubin HR, 2001, INT J QUAL HEALTH C, V13, P489, DOI 10.1093/intqhc/13.6.489; Schmiegel W, 2004, Z GASTROENTEROL, V42, P1129, DOI 10.1055/s-2004-813699; Spinks T, 2012, CANCER-AM CANCER SOC, V118, P2571, DOI 10.1002/cncr.26536; Steel N, 2004, QUAL SAF HEALTH CARE, V13, P260, DOI 10.1136/qshc.2004.010280; Szecsenyi J, 2012, INT J QUAL HEALTH C, V24, P101, DOI 10.1093/intqhc/mzr086; Uphoff EPMM, 2012, CANCER NURS, V35, P29, DOI 10.1097/NCC.0b013e318210e3a2; van Gijn W, 2010, Eur J Surg Oncol, V36 Suppl 1, pS23, DOI 10.1016/j.ejso.2010.06.026; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Wollersheim H, 2007, NETH J MED, V65, P15	41	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e60947	10.1371/journal.pone.0060947	http://dx.doi.org/10.1371/journal.pone.0060947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23658684	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000006
J	Yu, Q; Su, YK; Lu, B; Ma, Y; Zhao, XQ; Yang, XM; Dong, HY; Liu, Y; Lian, LL; Wan, L; Wu, YM; Wan, KL				Yu, Qin; Su, Yunkai; Lu, Bing; Ma, Yan; Zhao, Xiuqin; Yang, Xiaomin; Dong, Haiyan; Liu, Yao; Lian, Lulu; Wan, Li; Wu, Yimou; Wan, Kanglin			Genetic Diversity of Mycobacterium tuberculosis Isolates from Inner Mongolia, China	PLOS ONE			English	Article							BEIJING FAMILY; MOLECULAR EPIDEMIOLOGY; STRAINS; GENOTYPE; RESISTANT	Background: Tuberculosis (TB) is a serious public health problem in China, and within China, Inner Mongolia has a high prevalence area of TB. Though studies on the genetic diversity of Mycobacterium tuberculosis (MTB) have been reported in many provinces, there are no such studies to date in Inner Mongolia. In this study, we investigated the genetic diversity of MTB in Inner Mongolia. Methodology/Principal Findings: In this study, we analyzed 372 clinical MTB isolates with 22-loci mycobacterial interspersed repetitive unit and variable-number tandem repeats (MIRU-VNTR), spoligotyping, large sequence polymorphism (LSP), and NTF region analysis to understand the TB genotypes prevalent in Inner Mongolia. We found that the Beijing family was the most prevalent genotype (85.48%, 318/372), and the "modern'' sublineage accounted for 76.73% (244/318) of the isolates. Our data also showed that there was no statistically significant association between the two major nationalities and the Beijing genotype (chi(2) = 3.612, P = 0.057; P > 0.05). Conclusion/Significance: The Beijing genotype is the most prevalent family of M. tuberculosis in Inner Mongolia, and we do not find any correlation between the Beijing genotype and the major nationalities.	[Yu, Qin; Lu, Bing; Zhao, Xiuqin; Dong, Haiyan; Lian, Lulu; Wan, Li; Wan, Kanglin] Chinese Ctr Dis Control & Prevention, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Yu, Qin; Lian, Lulu; Wu, Yimou; Wan, Kanglin] Univ South China, Pathogen Biol Inst, Hengyang, Hunan, Peoples R China; [Su, Yunkai; Ma, Yan; Yang, Xiaomin; Liu, Yao] Inner Mongolia Inst TB Control & Prevent, Hohhot, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of South China	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevention, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	wankanglin@icdc.cn			project "Transmission Mode of Tuberculosis'' of the National Key Program of Mega Infectious Disease [2008ZX100/03-010-02]; project of the State Key Laboratory for Infectious Disease Prevention and Control [2011SKLID208]	project "Transmission Mode of Tuberculosis'' of the National Key Program of Mega Infectious Disease; project of the State Key Laboratory for Infectious Disease Prevention and Control	This work was funded by the project "Transmission Mode of Tuberculosis'' (2008ZX100/03-010-02) of the National Key Program of Mega Infectious Disease and by the project of the State Key Laboratory for Infectious Disease Prevention and Control (2011SKLID208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Chai Li-Quan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P785; Dong HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033904; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jiao WW, 2007, CHINESE MED J-PEKING, V120, P814, DOI 10.1097/00029330-200705010-00014; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kang HY, 2010, J MED MICROBIOL, V59, P1191, DOI 10.1099/jmm.0.022103-0; Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003; Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409; Liu Q, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-288; Maeda S, 2010, INT J TUBERC LUNG D, V14, P1201; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Mokrousov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041318; Nagai Y, 2012, JPN J INFECT DIS, V65, P341, DOI 10.7883/yoken.65.341; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; The national tuberculosis epidemiology sampling technology steering group, 1992, CHIN J TUBERC RESP D, V15, P69; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; WHO, 2010, GLOB TUB CONTR 2010; Zhao CL, 2010, INNER MONGOLIA MINOR	30	15	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e57660	10.1371/journal.pone.0057660	http://dx.doi.org/10.1371/journal.pone.0057660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658680	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000003
J	Wijnans, L; Dieleman, J; Voordouw, B; Sturkenboom, M				Wijnans, Leonoor; Dieleman, Jeanne; Voordouw, Bettie; Sturkenboom, Miriam			Effectiveness of MF59 (TM) Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands	PLOS ONE			English	Article							PATIENT RECORDS; INFECTIONS; ENGLAND	Background: The aim of the present study was to estimate the effectiveness of the MF59 (TM)-adjuvanted influenza A(H1N1)pdm09 vaccine against medically attended influenza-like illness and RT-PCR confirmed influenza in the at-risk population and persons over 60 in the Netherlands. Methods: We conducted a retrospective cohort study in a Dutch based GP medical record database between 30 November 2009 and 1 March 2010 to estimate the vaccine effectiveness against influenza-like illness. Within the cohort we nested a test negative case-control study to estimate the effectiveness against laboratory confirmed influenza. Results: The crude effectiveness in preventing diagnosed or possible influenza-like illness was 17.3% (95%CI: -8.5%-36.9%). Of the measured covariates, age, the severity of disease and health seeking behaviour through devised proxies confounded the association between vaccination and influenza-like illness. The adjusted vaccine effectiveness was 20.8% (95%CI: -5.4%, 40.5%) and varied significantly by age, being highest in adults up to 50 years (59%, 95%CI: 23%, 78%), and non-detectable in adults over 50 years. The number of cases in the nested case control study was too limited to validly estimate the VE against confirmed influenza. Conclusions: With our study we demonstrated that the approach of combining a cohort study in a primary health care database with field sampling is a feasible and useful option to monitor VE of influenza vaccines in the future.	[Wijnans, Leonoor; Dieleman, Jeanne; Sturkenboom, Miriam] Erasmus MC, Rotterdam, Netherlands; [Wijnans, Leonoor; Voordouw, Bettie] Med Evaluat Board, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC	Wijnans, L (corresponding author), Erasmus MC, Rotterdam, Netherlands.	e.wijnans@erasmusmc.nl			European Centre for Disease Control and Prevention (ECDC)	European Centre for Disease Control and Prevention (ECDC)	This work has been undertaken as part of a European Centre for Disease Control and Prevention (ECDC) funded project "I-MOVE''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2011, J INFECT DIS, V203, P32, DOI 10.1093/infdis/jiq014; Castilla J, 2011, VACCINE, V29, P5919, DOI 10.1016/j.vaccine.2011.06.063; Coordination Group for Mutual Recognition and Decentralised Procedures Human, 2009, COR SPC TRIV INFL VA; European Medicines Agency, 2010, SUMM PROD CHAR FOC I; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hardelid P, 2011, EUROSURVEILLANCE, V16, P12; Johansen K, 2009, EUROSURVEILLANCE, V14, P12; Monto AS, 2009, VACCINE, V27, P5043, DOI 10.1016/j.vaccine.2009.06.032; Ortqvist A, 2011, CLIN INFECT DIS, V52, P1203, DOI 10.1093/cid/cir182; Pelat C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019621; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Savulescu C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-899; Simpson CR, 2010, HEALTH TECHNOL ASSES, V14, P323, DOI 10.3310/hta14340-05; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Song JY, 2011, VACCINE, V29, P1395, DOI 10.1016/j.vaccine.2010.12.050; Steens A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-196; Uphoff H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019932; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; VANDERLEI J, 1993, ANN INTERN MED, V119, P1036, DOI 10.7326/0003-4819-119-10-199311150-00011; Vlug AE, 1999, METHOD INFORM MED, V38, P339; Voordouw BCG, 2006, ARCH INTERN MED, V166, P1980, DOI 10.1001/archinte.166.18.1980; Wichmann O, 2010, EUROSURVEILLANCE, V15, P2	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63156	10.1371/journal.pone.0063156	http://dx.doi.org/10.1371/journal.pone.0063156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646191	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300146
J	Perovic, VR; Muller, CP; Niman, HL; Veljkovic, N; Dietrich, U; Tosic, DD; Glisic, S; Veljkovic, V				Perovic, Vladimir R.; Muller, Claude P.; Niman, Henry L.; Veljkovic, Nevena; Dietrich, Ursula; Tosic, Dusan D.; Glisic, Sanja; Veljkovic, Veljko			Novel Phylogenetic Algorithm to Monitor Human Tropism in Egyptian H5N1-HPAIV Reveals Evolution toward Efficient Human-to-Human Transmission	PLOS ONE			English	Article							AVIAN INFLUENZA H5N1; RECEPTOR-BINDING; A VIRUSES; HEMAGGLUTININ; IDENTIFICATION; MUTATIONS; SEQUENCES; DOMAIN	Years of endemic infections with highly pathogenic avian influenza (HPAI) A subtype H5N1 virus in poultry and high numbers of infections in humans provide ample opportunity in Egypt for H5N1-HPAIV to develop pandemic potential. In an effort to better understand the viral determinants that facilitate human infections of the Egyptian H5N1-HPAIVvirus, we developed a new phylogenetic algorithm based on a new distance measure derived from the informational spectrum method (ISM). This new approach, which describes functional aspects of the evolution of the hemagglutinin subunit 1 (HA1), revealed a growing group G2 of H5N1-HPAIV in Egypt after 2009 that acquired new informational spectrum (IS) properties suggestive of an increased human tropism and pandemic potential. While in 2006 all viruses in Egypt belonged to the G1 group, by 2011 these viruses were virtually replaced by G2 viruses. All of the G2 viruses displayed four characteristic mutations (D43N, S120(D,N), (S,L)129 Delta and I151T), three of which were previously reported to increase binding to the human receptor. Already in 2006-2008 G2 viruses were significantly (p<0.02) more often found in humans than expected from their overall prevalence and this further increased in 2009-2011 (p<0.007). Our approach also identified viruses that acquired additional mutations that we predict to further enhance their human tropism. The extensive evolution of Egyptian H5N1-HPAIV towards a preferential human tropism underlines an urgent need to closely monitor these viruses with respect to molecular determinants of virulence.	[Perovic, Vladimir R.; Veljkovic, Nevena; Glisic, Sanja; Veljkovic, Veljko] Univ Belgrade, Inst Nucl Sci Vinca, Ctr Multidisciplinary Res, Belgrade, Serbia; [Muller, Claude P.] Inst Immunol, Ctr Rech Publ Sante, Lab Natl Sante, Luxembourg, Luxembourg; [Niman, Henry L.] Recombinom Inc, Pittsburgh, PA USA; [Dietrich, Ursula] Inst Biomed Res, Frankfurt, Germany; [Tosic, Dusan D.] Univ Belgrade, Fac Math, Belgrade, Serbia	University of Belgrade; Luxembourg Institute of Health; University of Belgrade	Muller, CP (corresponding author), Inst Immunol, Ctr Rech Publ Sante, Lab Natl Sante, Luxembourg, Luxembourg.	claude.muller@crp-sante.lu	Glisic, Sanja/AAE-8590-2019; Dietrich, Ursula/AAD-5704-2020	Glisic, Sanja/0000-0001-5691-1055; Dietrich, Ursula/0000-0003-2491-4758; Perovic, Vladimir/0000-0002-3700-6452; Veljkovic, Nevena/0000-0001-6562-5800	Ministry of Science and Technological Development of the Republic of Serbia [173001]; Ministry of Foreign Affairs, Luxembourg	Ministry of Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); Ministry of Foreign Affairs, Luxembourg	This work was supported by the Ministry of Science and Technological Development of the Republic of Serbia (Grant no. 173001, www.mpn.gov.rs) and the Ministry of Foreign Affairs, Luxembourg. They had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Abdel-Moneim AS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-283; Abdelwhab E.M., 2010, SEQUENCING, DOI [DOI 10.1155/2010/450823, 10.1155/2010/450823]; Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; Arafa A, 2010, AVIAN DIS, V54, P345, DOI 10.1637/8927-051509-ResNote.1; Bahgat MM, 2009, J VIROL METHODS, V159, P244, DOI 10.1016/j.jviromet.2009.04.008; Cao ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038126; Cattoli G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004842; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; David WM, 2001, BIOINFORMATICS SEQUE, P6; Epstein S, 2012, J INFECT DIS, V205, P4, DOI 10.1093/infdis/jir692; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; Feng DF, 1996, METHOD ENZYMOL, V266, P368; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Garcia JM, 2009, PLOS MED, V6; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kayali G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017730; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kongchanagul A, 2008, J GEN VIROL, V89, P1805, DOI 10.1099/vir.0.2008/002469-0; Li Z, 2011, ARCH VIROL, V156, P1803, DOI 10.1007/s00705-011-1056-2; Lycett SJ, 2009, J VIROL, V83, P9901, DOI 10.1128/JVI.00608-09; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Mau B, 1996, 961 U WISC MAD STAT; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sankoff D, 1983, TIME WARPS STRING ED, P253; Su Y, 2008, ARCH VIROL, V153, P2253, DOI 10.1007/s00705-008-0255-y; Veljkovic N, 2008, CURR PROTEIN PEPT SC, V9, P493, DOI 10.2174/138920308785915245; Veljkovic V, 2007, CURR MED CHEM, V14, P441, DOI 10.2174/092986707779941014; VELJKOVIC V, 1985, IEEE T BIO-MED ENG, V32, P337, DOI 10.1109/TBME.1985.325549; VELJKOVIC V, 1973, PHYS LETT A, VA 45, P41, DOI 10.1016/0375-9601(73)90497-0; VELJKOVIC V, 1972, PHYS REV LETT, V29, P105, DOI 10.1103/PhysRevLett.29.105; Veljkovic V., 1980, THEORETICAL APPROACH; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-62; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-21; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; [WHO] World Health Organization, INFL HUM AN INT HAI; World Health Organization (WHO), 2011, AV NEW REC A H5N1 CA; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yong E, 2012, NATURE	43	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61572	10.1371/journal.pone.0061572	http://dx.doi.org/10.1371/journal.pone.0061572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658611	Green Published, Green Submitted, gold			2022-12-27	WOS:000318343700013
J	Schierack, P; Rodiger, S; Kuhl, C; Hiemann, R; Roggenbuck, D; Li, G; Weinreich, J; Berger, E; Nolan, LK; Nicholson, B; Romer, A; Frommel, U; Wieler, LH; Schroder, C				Schierack, Peter; Roediger, Stefan; Kuhl, Christoph; Hiemann, Rico; Roggenbuck, Dirk; Li, Ganwu; Weinreich, Joerg; Berger, Enrico; Nolan, Lisa K.; Nicholson, Bryon; Roemer, Antje; Froemmel, Ulrike; Wieler, Lothar H.; Schroeder, Christian			Porcine E. coli: Virulence-Associated Genes, Resistance Genes and Adhesion and Probiotic Activity Tested by a New Screening Method	PLOS ONE			English	Article							INTESTINAL ESCHERICHIA-COLI; FIELD GEL-ELECTROPHORESIS; STRAIN NISSLE-1917; ANTIMICROBIAL RESISTANCE; COMPARATIVE GENOMICS; EPITHELIAL-CELLS; DNA-SEQUENCE; IN-VITRO; SWINE; COLONIZATION	We established an automated screening method to characterize adhesion of Escherichia coli to intestinal porcine epithelial cells (IPEC-J2) and their probiotic activity against infection by enteropathogenic E. coli (EPEC). 104 intestinal E. coli isolates from domestic pigs were tested by PCR for the occurrence of virulence-associated genes, genes coding for resistances to antimicrobial agents and metals, and for phylogenetic origin by PCR. Adhesion rates and probiotic activity were examined for correlation with the presence of these genes. Finally, data were compared with those from 93 E. coli isolates from wild boars. Isolates from domestic pigs carried a broad variety of all tested genes and showed great diversity in gene patterns. Adhesions varied with a maximum of 18.3 or 24.2 mean bacteria adherence per epithelial cell after 2 or 6 hours respectively. Most isolates from domestic pigs and wild boars showed low adherence, with no correlation between adhesion/probiotic activity and E. coli genes or gene clusters. The gene sfa/foc, encoding for a subunit of F1C fimbriae did show a positive correlative association with adherence and probiotic activity; however E. coli isolates from wild boars with the sfa/foc gene showed less adhesion and probiotic activity than E. coli with the sfa/foc gene isolated from domestic pigs after 6 hour incubation. In conclusion, screening porcine E. coli for virulence associated genes genes, adhesion to intestinal epithelial cells, and probiotic activity revealed a single important adhesion factor, several probiotic candidates, and showed important differences between E. coli of domestic pigs and wild boars.	[Schierack, Peter; Roediger, Stefan; Kuhl, Christoph; Hiemann, Rico; Roggenbuck, Dirk; Weinreich, Joerg; Berger, Enrico; Froemmel, Ulrike; Schroeder, Christian] Hsch Lausitz FH, Fak Nat Wissensch, Senftenberg, Germany; [Li, Ganwu; Nolan, Lisa K.; Nicholson, Bryon] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Roemer, Antje] Fed Off Consumer Protect & Food Safety, Berlin, Germany; [Wieler, Lothar H.] Free Univ Berlin, Inst Mikrobiol & Tierseuchen, Berlin, Germany	Brandenburg University of Technology Cottbus; Iowa State University; Free University of Berlin	Schierack, P (corresponding author), Hsch Lausitz FH, Fak Nat Wissensch, Senftenberg, Germany.	Peter.Schierack@HS-Lausitz.de	Rödiger, Stefan J/G-6107-2016; Rödiger, Stefan/O-4633-2019; Li, Ganwu/AAC-7423-2020	Rödiger, Stefan J/0000-0002-1441-6512; Rödiger, Stefan/0000-0002-1441-6512; Wieler, Lothar H./0000-0003-4365-3717; Roggenbuck, Dirk/0000-0002-6861-6827	InnoProfile [IP 03 IP 611]; Bundesministerium f (A) over tilde1/4r Bildung und Forschung (BMBF, Germany); Collaborative Research Group "Nutrition and intestinal microbiota - host interactions in the pig" [(SFB) 852]; Deutsche Forschungsgemeinschaft (DFG)	InnoProfile; Bundesministerium f (A) over tilde1/4r Bildung und Forschung (BMBF, Germany)(Federal Ministry of Education & Research (BMBF)); Collaborative Research Group "Nutrition and intestinal microbiota - host interactions in the pig"; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by InnoProfile IP 03 IP 611 funded by the Bundesministerium f (A) over tilde1/4r Bildung und Forschung (BMBF, Germany) and by Collaborative Research Group (SFB) 852 "Nutrition and intestinal microbiota - host interactions in the pig" funded by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoefer A, 2004, FEMS IMMUNOL MED MIC, V40, P223, DOI 10.1016/S0928-8244(03)00368-7; Barth S, 2007, BERL MUNCH TIERARZTL, V120, P307, DOI 10.2376/0005-9366-120-307; Bass L, 1999, ANTIMICROB AGENTS CH, V43, P2925, DOI 10.1128/AAC.43.12.2925; Bean DC, 2009, ANTIMICROB AGENTS CH, V53, P1088, DOI 10.1128/AAC.00800-08; Bjorkman J, 2000, DRUG RESIST UPDATE, V3, P237, DOI 10.1054/drup.2000.0147; Boerlin P, 2005, APPL ENVIRON MICROB, V71, P6753, DOI 10.1128/AEM.71.11.6753-6761.2005; Borkow G, 2004, FASEB J, V18, P1728, DOI 10.1096/fj.04-2029fje; Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; Chen J, 1998, LETT APPL MICROBIOL, V27, P369, DOI 10.1046/j.1472-765X.1998.00445.x; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; DIORIO C, 1995, J BACTERIOL, V177, P2050, DOI 10.1128/jb.177.8.2050-2056.1995; Egerer K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2949; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2009, ENV MICROBIOL REP, V1, P510, DOI 10.1111/j.1758-2229.2009.00058.x; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Grossmann K, 2011, CYTOM PART A, V79A, P118, DOI 10.1002/cyto.a.21009; Guenther S, 2010, VET MICROBIOL, V142, P352, DOI 10.1016/j.vetmic.2009.10.004; Henker J, 2008, PEDIATR INFECT DIS J, V27, P494, DOI 10.1097/INF.0b013e318169034c; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Huebner C, 2011, APPL ENVIRON MICROB, V77, P2541, DOI 10.1128/AEM.01601-10; Johnson AM, 2009, J BACTERIOL, V191, P178, DOI 10.1128/JB.00822-08; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2006, ANTIMICROB AGENTS CH, V50, P3929, DOI 10.1128/AAC.00569-06; Johnson TJ, 2010, INFECT IMMUN, V78, P1931, DOI 10.1128/IAI.01174-09; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Johnson TJ, 2004, AVIAN DIS, V48, P351, DOI 10.1637/7121; Kivity S, 2012, CLIN RHEUMATOL, V31, P503, DOI 10.1007/s10067-011-1884-1; Kleta S, 2006, J APPL MICROBIOL, V101, P1357, DOI 10.1111/j.1365-2672.2006.03019.x; Kleta S, 2008, THESIS HUMBOLDT U BE; Krammer HJ, 2006, Z GASTROENTEROL, V44, P651, DOI 10.1055/s-2006-926909; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lasaro MA, 2009, APPL ENVIRON MICROB, V75, P246, DOI 10.1128/AEM.01144-08; Liesegang A, 2002, INT J MED MICROBIOL, V291, P645, DOI 10.1078/1438-4221-00180; Merlino J, 1996, J CLIN MICROBIOL, V34, P1788, DOI 10.1128/JCM.34.7.1788-1793.1996; Monteiro C, 2009, ENVIRON MICROBIOL, V11, P1105, DOI 10.1111/j.1462-2920.2008.01840.x; Moon HW, 1999, J VET DIAGN INVEST, V11, P557, DOI 10.1177/104063879901100617; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Osek J, 1999, VET MICROBIOL, V68, P209, DOI 10.1016/S0378-1135(99)00109-1; Rodiger S, 2012, ADV BIOCHEM ENG BIOT, V23; Rodiger S, 2012, J STAT SOFTW, V49, P1; Roggenbuck D, 2011, CLIN CHIM ACTA, V412, P2011, DOI 10.1016/j.cca.2011.07.005; Romer A, 2012, VET MICROBIOL, V17, P122; Romer A, 2009, THESIS FREIE U BERLI; Runge R, 2012, INT J RADIAT BIOL, V88, P439, DOI 10.3109/09553002.2012.658468; Sanders ME, 2008, CLIN INFECT DIS, V46, pS58, DOI 10.1086/523341; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Schierack P, 2008, ENVIRON MICROBIOL, V10, P1742, DOI 10.1111/j.1462-2920.2008.01595.x; Schierack P, 2007, MICROBIOL-SGM, V153, P3830, DOI 10.1099/mic.0.2007/010173-0; Schierack P, 2011, APPL ENVIRON MICROB, V77, P8451, DOI 10.1128/AEM.05289-11; Schierack P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014712; Schierack P, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-18; Schierack P, 2009, APPL ENVIRON MICROB, V75, P695, DOI 10.1128/AEM.01650-08; Schroeder B, 2006, DIGEST DIS SCI, V51, P724, DOI 10.1007/s10620-006-3198-8; Schultz M, 2004, CLIN DIAGN LAB IMMUN, V11, P372, DOI 10.1128/CDLI.11.2.372-378.2004; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; von Buenau R, 2005, J DAIRY SCI, V88, P317, DOI 10.3168/jds.S0022-0302(05)72690-4; WINKLE S, 1979, MIKROBIOLOGISCHE SER; ZHU C, 1994, INFECT IMMUN, V62, P4153, DOI 10.1128/IAI.62.10.4153-4159.1994; Zihler A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-264	59	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e59242	10.1371/journal.pone.0059242	http://dx.doi.org/10.1371/journal.pone.0059242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658605	Green Submitted, Green Published, gold			2022-12-27	WOS:000318343700003
J	Volodyaev, IV; Krasilnikova, EN; Ivanovsky, RN				Volodyaev, Ilya V.; Krasilnikova, Elena N.; Ivanovsky, Ruslan N.			CO2 Mediated Interaction in Yeast Stimulates Budding and Growth on Minimal Media	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; CELL COMMUNICATION; ADENYLYL-CYCLASE; BACTERIA; VIRULENCE; COLONIES; MEIOSIS	Here we show that carbon dioxide (CO2) stimulates budding and shortens the lag-period of Saccharomyces cerevisiae cultures, grown on specific weak media. CO2 can be both exogenous and secreted by another growing yeast culture. We also show that this effect can be observed only in the lag-period, and demonstrate minimal doses and duration of culture exposition to CO2. Opposite to the effects of CO2 sensitivity, previously shown for pathogens, where increased concentration of CO2 suppressed mitosis and stimulated cell differentiation and invasion, here it stimulates budding and culture growth.	[Volodyaev, Ilya V.; Krasilnikova, Elena N.; Ivanovsky, Ruslan N.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Microbiol, Moscow, Russia	Lomonosov Moscow State University	Volodyaev, IV (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Microbiol, Moscow, Russia.	ivolodyaev@gmail.com						Acs L., 1932, CENTR F BAKT 1, V120, P216; Audubert R, 1939, T FARADAY SOC, V35, P0197, DOI 10.1039/tf9393500197; Bahn YS, 2005, CURR BIOL, V15, P2013, DOI 10.1016/j.cub.2005.09.047; Baron M., 1930, PLANTA, V10, P28, DOI 10.1007/BF01911536; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; CREANOR J, 1982, J CELL SCI, V58, P263; FOWELL RR, 1969, YEASTS, V1, P303; Frank G, 1931, NATURWISSENSCHAFTEN, V19, P659, DOI DOI 10.1007/BF01516035; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gurwitsch A., 1932, MITOGENETISCHE STRAH; Hall RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001193; Hammer A, 2006, BIOCHEM J, V396, P215, DOI 10.1042/BJ20060372; Hayashi M, 1998, YEAST, V14, P905; Hogan DA, 2006, EUKARYOT CELL, V5, P613, DOI 10.1128/EC.5.4.613-619.2006; Hollaender A, 1937, EXPT STUDY PROBLEM M; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Mitchell AP, 2005, CURR BIOL, V15, pR934, DOI 10.1016/j.cub.2005.10.064; Nekrasov K, 2010, 10 INT C PATT REC IM, P335; NOVAK B, 1988, J CELL SCI, V89, P433; Ohkuni K, 1998, YEAST, V14, P623, DOI 10.1002/(SICI)1097-0061(199805)14:7<623::AID-YEA264>3.3.CO;2-4; OURA E, 1980, J GEN MICROBIOL, V118, P51; Palkova Z, 2000, J CELL SCI, V113, P1923; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; QUICKENDEN TI, 1976, PHOTOCHEM PHOTOBIOL, V23, P201, DOI 10.1111/j.1751-1097.1976.tb07242.x; Rahn O., 1936, INVISIBLE RAD ORGANI; Ras G., 1931, CENTR BACT 1, V123, P257; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Trushin MV, 2004, MICROBIOL RES, V159, P1, DOI 10.1016/j.micres.2003.11.001; TUTHILL JOHN B., 1933, ARCH MIKROBIOL, V4, P565, DOI 10.1007/BF00407562; UENO T, 1964, Nihon Seirigaku Zasshi, V26, P156; Visick KL, 2005, J BACTERIOL, V187, P5507, DOI 10.1128/JB.187.16.5507-5519.2005; Wuster A, 2010, MOL BIOSYST, V6, P134, DOI 10.1039/b913579k	33	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62808	10.1371/journal.pone.0062808	http://dx.doi.org/10.1371/journal.pone.0062808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658652	Green Submitted, gold, Green Published			2022-12-27	WOS:000318343700075
J	Fukata, M; Ishikawa, F; Najima, Y; Yamauchi, T; Saito, Y; Takenaka, K; Miyawaki, K; Shimazu, H; Shimoda, K; Kanemaru, T; Nakamura, K; Odashiro, K; Nagafuji, K; Harada, M; Akashi, K				Fukata, Mitsuhiro; Ishikawa, Fumihiko; Najima, Yuho; Yamauchi, Takuji; Saito, Yoriko; Takenaka, Katsuto; Miyawaki, Kohta; Shimazu, Hideki; Shimoda, Kazuya; Kanemaru, Takaaki; Nakamura, Kei-ichiro; Odashiro, Keita; Nagafuji, Koji; Harada, Mine; Akashi, Koichi			Contribution of Bone Marrow-Derived Hematopoietic Stem/Progenitor Cells to the Generation of Donor-Marker(+) Cardiomyocytes In Vivo	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; VASCULAR ENDOTHELIUM; MYELOMONOCYTIC CELLS; PURKINJE NEURONS; PROGENITOR CELLS; SKELETAL-MUSCLE; HOST ORIGIN; FUSION; HEART	Background: Definite identification of the cell types and the mechanism relevant to cardiomyogenesis is essential for effective cardiac regenerative medicine. We aimed to identify the cell populations that can generate cardiomyocytes and to clarify whether generation of donor-marker(+) cardiomyocytes requires cell fusion between BM-derived cells and recipient cardiomyocytes. Methodology/Principal Findings: Purified BM stem/progenitor cells from green fluorescence protein (GFP) mice were transplanted into C57BL/6 mice or cyan fluorescence protein (CFP)-transgenic mice. Purified human hematopoietic stem cells (HSCs) from cord blood were transplanted into immune-compromised NOD/SCID/IL2r gamma(null) mice. GFP(+) cells in the cardiac tissue were analyzed for the antigenecity of a cardiomyocyte by confocal microscopy following immunofluorescence staining. GFP(+) donor-derived cells, GFP(+)CFP(+) fused cells, and CFP+ recipient-derived cells were distinguished by linear unmixing analysis. Hearts of xenogeneic recipients were evaluated for the expression of human cardiomyocyte genes by real-time quantitative polymerase chain reaction. In C57BL/6 recipients, Lin(-/low)CD45(+) hematopoietic cells generated greater number of GFP(+) cardiomyocytes than Lin(-/low)CD45(-) mesenchymal cells (37.0+/-23.9 vs 0.00+/-0.00 GFP(+) cardiomyocytes per a recipient, P = 0.0095). The number of transplanted purified HSCs (Lin(-/low)Sca-1(+) or Lin(-)Sca-1(+)c-Kit(+) or CD34(-)Lin(-)Sca-1(+)c-Kit(+)) showed correlation to the number of GFP(+) cardiomyocytes (P<0.05 in each cell fraction), and the incidence of GFP(+) cardiomyocytes per injected cell dose was greatest in CD34(-)Lin(-)Sca-1(+)c-Kit(+) recipients. Of the hematopoietic progenitors, total myeloid progenitors generated greater number of GFP(+) cardiomyocytes than common lymphoid progenitors (12.8+/-10.7 vs 0.67+/-1.00 GFP(+) cardiomyocytes per a recipient, P = 0.0021). In CFP recipients, all GFP(+) cardiomyocytes examined coexpressed CFP. Human troponin C and myosin heavy chain 6 transcripts were detected in the cardiac tissue of some of the xenogeneic recipients. Conclusions/Significance: Our results indicate that HSCs resulted in the generation of cardiomyocytes via myeloid intermediates by fusion-dependent mechanism. The use of myeloid derivatives as donor cells could potentially allow more effective cell-based therapy for cardiac repair.	[Fukata, Mitsuhiro; Ishikawa, Fumihiko; Yamauchi, Takuji; Takenaka, Katsuto; Miyawaki, Kohta; Shimazu, Hideki; Odashiro, Keita; Harada, Mine; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Ishikawa, Fumihiko; Najima, Yuho; Saito, Yoriko] RIKEN Res Ctr Allergy & Immunol, Lab Human Dis Models, Yokohama, Kanagawa, Japan; [Shimoda, Kazuya] Miyazaki Univ, Fac Med, Dept Gastroenterol & Hematol, Miyazaki, Japan; [Kanemaru, Takaaki] Kyushu Univ, Morphol Core, Fukuoka 812, Japan; [Nakamura, Kei-ichiro] Kurume Univ, Sch Med, Dept Anat 2, Kurume, Fukuoka 830, Japan; [Nagafuji, Koji] Kurume Univ, Sch Med, Dept Med, Div Hematol & Oncol, Kurume, Fukuoka 830, Japan; [Akashi, Koichi] Kyushu Univ Hosp, Ctr Cellular & Mol Med, Fukuoka 812, Japan	Kyushu University; RIKEN; University of Miyazaki; Kyushu University; Kurume University; Kurume University; Kyushu University	Fukata, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan.	mfukata-circ@umin.net; f_ishika@rcai.riken.jp	Najima, Yuho/W-3858-2019; 石川, 文彦/L-4488-2014	Najima, Yuho/0000-0001-8910-0021; Odashiro, Keita/0000-0003-0347-6330	Grants-in-Aid for Scientific Research [24659463] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Barile L, 2011, J CELL MOL MED, V15, P63, DOI 10.1111/j.1582-4934.2009.00968.x; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Camargo FD, 2004, J CLIN INVEST, V113, P1266, DOI 10.1172/JCI200421301; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Doyonnas R, 2004, P NATL ACAD SCI USA, V101, P13507, DOI 10.1073/pnas.0405361101; Ferreira-Martins J, 2012, CIRC RES, V110, P701, DOI 10.1161/CIRCRESAHA.111.259507; Genead R, 2010, STEM CELLS DEV, V19, P1601, DOI 10.1089/scd.2009.0483; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012; Herzog EL, 2007, FASEB J, V21, P2592, DOI 10.1096/fj.06-7861com; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2006, FASEB J, V20, P950, DOI 10.1096/fj.05-4863fje; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Koide Y, 2007, STEM CELLS, V25, P1213, DOI 10.1634/stemcells.2006-0325; Kucia M, 2007, LEUKEMIA, V21, P297, DOI 10.1038/sj.leu.2404470; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; LAVER J, 1987, BLOOD, V70, P1966; Metzele R, 2011, FASEB J, V25, P830, DOI 10.1096/fj.09-153221; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Muller P, 2002, CIRCULATION, V106, P31, DOI 10.1161/01.CIR.0000022405.68464.CA; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Neijssen J, 2007, PROG BIOPHYS MOL BIO, V94, P207, DOI 10.1016/j.pbiomolbio.2007.03.008; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Rose RA, 2008, STEM CELLS, V26, P2884, DOI 10.1634/stemcells.2008-0329; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SIMMONS PJ, 1987, NATURE, V328, P429, DOI 10.1038/328429a0; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Yamauchi T, 2013, BLOOD, V121, P1316, DOI 10.1182/blood-2012-06-440354	50	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62506	10.1371/journal.pone.0062506	http://dx.doi.org/10.1371/journal.pone.0062506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667482	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700040
J	Bijveld, MMC; van Genderen, MM; Hoeben, FP; Katzin, AA; van Nispen, RMA; Riemslag, FCC; Kappers, AML				Bijveld, Mieke M. C.; van Genderen, Maria M.; Hoeben, Frank P.; Katzin, Amir A.; van Nispen, Ruth M. A.; Riemslag, Frans C. C.; Kappers, Astrid M. L.			Assessment of Night Vision Problems in Patients with Congenital Stationary Night Blindness	PLOS ONE			English	Article							ISLAND EYE DISEASE; INDEPENDENT MOBILITY; LOW LUMINANCE; MUTATIONS; CONE; ELECTRORETINOGRAM; ABNORMALITIES; NYCTALOPIN; CACNA1F; MOUSE	Congenital Stationary Night Blindness (CSNB) is a retinal disorder caused by a signal transmission defect between photoreceptors and bipolar cells. CSNB can be subdivided in CSNB2 (rod signal transmission reduced) and CSNB1 (rod signal transmission absent). The present study is the first in which night vision problems are assessed in CSNB patients in a systematic way, with the purpose of improving rehabilitation for these patients. We assessed the night vision problems of 13 CSNB2 patients and 9 CSNB1 patients by means of a questionnaire on low luminance situations. We furthermore investigated their dark adapted visual functions by the Goldmann Weekers dark adaptation curve, a dark adapted static visual field, and a two-dimensional version of the "Light Lab". In the latter test, a digital image of a living room with objects was projected on a screen. While increasing the luminance of the image, we asked the patients to report on detection and recognition of objects. The questionnaire showed that the CSNB2 patients hardly experienced any night vision problems, while all CSNB1 patients experienced some problems although they generally did not describe them as severe. The three scotopic tests showed minimally to moderately decreased dark adapted visual functions in the CSNB2 patients, with differences between patients. In contrast, the dark adapted visual functions of the CSNB1 patients were more severely affected, but showed almost no differences between patients. The results from the "2D Light Lab showed that all CSNB1 patients were blind at low intensities (equal to starlight), but quickly regained vision at higher intensities (full moonlight). Just above their dark adapted thresholds both CSNB1 and CSNB2 patients had normal visual fields. From the results we conclude that night vision problems in CSNB, in contrast to what the name suggests, are not conspicuous and generally not disabling.	[Bijveld, Mieke M. C.; van Genderen, Maria M.; Hoeben, Frank P.; Katzin, Amir A.; Riemslag, Frans C. C.] Bartimeus Inst Visually Impaired, Zeist, Netherlands; [Bijveld, Mieke M. C.; Kappers, Astrid M. L.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst, Amsterdam, Netherlands; [van Nispen, Ruth M. A.] Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [van Nispen, Ruth M. A.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Riemslag, Frans C. C.] Rotterdam Eye Hosp, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Rotterdam Eye Hospital	Bijveld, MMC (corresponding author), Bartimeus Inst Visually Impaired, Zeist, Netherlands.	mbijveld@bartimeus.nl		van Nispen, Ruth M.A./0000-0003-1227-1177	ODAS Stichting	ODAS Stichting	This study is partially funded by ODAS Stichting: http://www.odasstichting.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen LE, 2003, BRIT J OPHTHALMOL, V87, P1413, DOI 10.1136/bjo.87.11.1413; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bijveld M, 2013, OPHTHALMOLO IN PRESS; Boycott KM, 2000, CAN J OPHTHALMOL, V35, P204, DOI 10.1016/S0008-4182(00)80031-9; Bradshaw K, 2004, DOC OPHTHALMOL, V108, P135, DOI 10.1023/B:DOOP.0000036786.22179.44; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; CORNELISSEN FW, 1995, VISION RES, V35, P161, DOI 10.1016/0042-6989(94)00183-M; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; ESTERMAN B, 1982, OPHTHALMOLOGY, V89, P1226; Finger RP, 2011, INVEST OPHTH VIS SCI, V52, P8241, DOI 10.1167/iovs.11-7858; GLASS IA, 1993, J MED GENET, V30, P1044, DOI 10.1136/jmg.30.12.1044; Gregg RG, 2007, J NEUROPHYSIOL, V98, P3023, DOI 10.1152/jn.00608.2007; HAWKSWORTH NR, 1995, BRIT J OPHTHALMOL, V79, P424, DOI 10.1136/bjo.79.5.424; Hope CI, 2005, CLIN EXP OPHTHALMOL, V33, P129, DOI 10.1111/j.1442-9071.2005.00987.x; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Littink KW, 2009, INVEST OPHTH VIS SCI, V50, P2344, DOI 10.1167/iovs.08-2553; Makous W, 1998, VISION RES PRACTICAL, P1; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Nakamura M, 2001, INVEST OPHTH VIS SCI, V42, P1610; Owsley C, 2006, INVEST OPHTH VIS SCI, V47, P528, DOI 10.1167/iovs.05-1222; PEARCE WG, 1990, CAN J OPHTHALMOL, V25, P3; Peters A. Y., 2000, Documenta Ophthalmologica, V101, P1, DOI 10.1023/A:1002765024774; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Riemslag FCC, 2009, DOC OPHTHALMOL, V119, P1, DOI 10.1007/s10633-008-9161-6; Rotenstreich Y, 2004, OPHTHALMOLOGY, V111, P1222, DOI 10.1016/j.ophtha.2003.10.025; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; TREMBLAY F, 1995, VISION RES, V35, P2383, DOI 10.1016/0042-6989(95)00006-L; Turano KA, 2002, INVEST OPHTH VIS SCI, V43, P2874; Turano KA, 1999, INVEST OPHTH VIS SCI, V40, P865; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067	34	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62927	10.1371/journal.pone.0062927	http://dx.doi.org/10.1371/journal.pone.0062927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658786	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100047
J	Murata, T; Iwata, S; Siddiquey, MNA; Kanazawa, T; Goshima, F; Kawashima, D; Kimura, H; Tsurumi, T				Murata, Takayuki; Iwata, Seiko; Siddiquey, Mohammed Nure Alam; Kanazawa, Tetsuhiro; Goshima, Fumi; Kawashima, Daisuke; Kimura, Hiroshi; Tsurumi, Tatsuya			Heat Shock Protein 90 Inhibitors Repress Latent Membrane Protein 1 (LMP1) Expression and Proliferation of Epstein-Barr Virus-Positive Natural Killer Cell Lymphoma	PLOS ONE			English	Article							SIGNAL BINDING-PROTEIN; J-KAPPA; GENE-EXPRESSION; TRANSCRIPTION FACTORS; HSP90 INHIBITORS; HODGKIN LYMPHOMA; DOWN-REGULATION; NK CELLS; B-CELLS; LINES	Epstein-Barr virus (EBV) LMP1 is a major oncoprotein expressed in latent infection. It functions as a TNFR family member and constitutively activates cellular signals, such as NFkB, MAPK, JAK/STAT and AKT. We here screened small molecule inhibitors and isolated HSP90 inhibitors, Radicicol and 17-AAG, as candidates that suppress LMP1 expression and cell proliferation not only in EBV-positive SNK6 Natural Killer (NK) cell lymphoma cells, but also in B and T cells. Tumor formation in immunodefficient NOD/Shi-scid/IL-2R gamma(null) (NOG) mice was also retarded. These results suggest that HSP90 inhibitors can be alternative treatments for patients with EBV-positive malignancies.	[Murata, Takayuki; Kawashima, Daisuke; Tsurumi, Tatsuya] Aichi Canc Ctr, Res Inst, Div Virol, Nagoya, Aichi 464, Japan; [Iwata, Seiko; Siddiquey, Mohammed Nure Alam; Kanazawa, Tetsuhiro; Goshima, Fumi; Kimura, Hiroshi] Nagoya Univ, Dept Virol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Aichi Cancer Center; Nagoya University	Kimura, H (corresponding author), Nagoya Univ, Dept Virol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	hkimura@med.nagoya-u.ac.jp; ttsurumi@aichi-cc.jp	Murata, Takayuki/I-2621-2013; Kimura, Hiroshi/I-2246-2012; GOSHIMA, Fumi/I-7241-2014	Murata, Takayuki/0000-0001-7228-0839; Kimura, Hiroshi/0000-0001-8063-5660; Siddiquey, Mohammed Nure Alam/0000-0001-8803-3242	Ministry of Education, Science, Sports, Culture and Technology [20390137, 21022055]; Ministry of Health, Labour, and Welfare; Uehara Memorial Research Fund; Takeda Science Foundation; Yasuda Medical Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senshin Medical Research Foundation; Kanae Foundation for Promotion of Medical Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Research Fund(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yasuda Medical Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Kanae Foundation for Promotion of Medical Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology (no. 20390137, 21022055 to T. T.), the Ministry of Health, Labour, and Welfare (to T. T. & H. K.) and partly by the Uehara Memorial Research Fund (to T. T. & T. M.), the Takeda Science Foundation (to T. T. & T. M.), the Yasuda Medical Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Senshin Medical Research Foundation, and the Kanae Foundation for Promotion of Medical Science (to T. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. N. Shimizu for SNK6 and SNT13 cells. Panels of small molecule inhibitors were kindly provided by the Screening Committee of Anticancer Drugs (SCADS), which is supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Scientific Support Programs for Cancer Research, from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We would further like to express our appreciation to T. Kanda & T. Gamano for technical assistance.	Chen HL, 2003, J VIROL, V77, P4139, DOI 10.1128/JVI.77.7.4139-4148.2003; Chen HL, 2001, J VIROL, V75, P2929, DOI 10.1128/JVI.75.6.2929-2937.2001; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Fox Christopher P, 2011, Herpesviridae, V2, P8, DOI 10.1186/2042-4280-2-8; GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568; Imadome KI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002326; Jeon YK, 2007, J PATHOL, V213, P170, DOI 10.1002/path.2219; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; JOHANNSEN E, 1995, J VIROL, V69, P253, DOI 10.1128/JVI.69.1.253-262.1995; Kawa K, 2001, BLOOD, V98, P3173, DOI 10.1182/blood.V98.10.3173; Kieser A, 1999, EMBO J, V18, P2511, DOI 10.1093/emboj/18.9.2511; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Kimura H, 2006, REV MED VIROL, V16, P251, DOI 10.1002/rmv.505; Kimura M, 2008, FEBS LETT, V582, P2833, DOI 10.1016/j.febslet.2008.07.033; Kis LL, 2006, BLOOD, V107, P2928, DOI 10.1182/blood-2005-06-2569; Kis LL, 2011, BLOOD, V117, P165, DOI 10.1182/blood-2010-01-265272; Kis LL, 2010, P NATL ACAD SCI USA, V107, P872, DOI 10.1073/pnas.0912920107; Konforte D, 2008, VIROLOGY, V374, P100, DOI 10.1016/j.virol.2007.12.027; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Kwong YL, 2005, LEUKEMIA, V19, P2186, DOI 10.1038/sj.leu.2403955; Lam N, 2003, EMBO J, V22, P3027, DOI 10.1093/emboj/cdg284; Lam N, 2003, CELL SIGNAL, V15, P9, DOI 10.1016/S0898-6568(02)00083-9; LAUX G, 1994, EMBO J, V13, P5624, DOI 10.1002/j.1460-2075.1994.tb06900.x; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Morceau F, 2008, BIOFACTORS, V34, P313, DOI [10.1002/biof.5520340407, 10.3233/BIO-2009-1085]; Murata T, 2012, J VIROL, V86, P4752, DOI 10.1128/JVI.06768-11; Nagata H, 2001, BLOOD, V97, P708, DOI 10.1182/blood.V97.3.708; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Noda C, 2011, J BIOL CHEM, V286, P42524, DOI 10.1074/jbc.M111.271734; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; PAINE E, 1995, J VIROL, V69, P4572, DOI 10.1128/JVI.69.7.4572-4576.1995; Rakitina TV, 2003, CANCER RES, V63, P8600; Schoof N, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-17; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; SJOBLOM A, 1995, J GEN VIROL, V76, P2679, DOI 10.1099/0022-1317-76-11-2679; SJOBLOM A, 1995, J GEN VIROL, V76, P2669, DOI 10.1099/0022-1317-76-11-2669; Soni V, 2007, ADV EXP MED BIOL, V597, P173; Sun XP, 2010, P NATL ACAD SCI USA, V107, P3146, DOI 10.1073/pnas.0910717107; Takahara M, 2006, INT J CANCER, V119, P2775, DOI 10.1002/ijc.22139; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Usmani Saad Z, 2011, Clin Lymphoma Myeloma Leuk, V11 Suppl 1, pS77, DOI 10.1016/j.clml.2011.03.027; WALTZER L, 1994, EMBO J, V13, P5633, DOI 10.1002/j.1460-2075.1994.tb06901.x; Wang X, 2006, CANCER RES, V66, P1089, DOI 10.1158/0008-5472.CAN-05-2698; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Zhang Y, 2003, BRIT J HAEMATOL, V121, P805, DOI 10.1046/j.1365-2141.2003.04359.x; Zhou J, 2002, J IMMUNOL, V169, P1319, DOI 10.4049/jimmunol.169.3.1319	48	30	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63566	10.1371/journal.pone.0063566	http://dx.doi.org/10.1371/journal.pone.0063566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658841	Green Submitted, Green Published, gold			2022-12-27	WOS:000321202100072
J	Witasp, A; Ryden, M; Carrero, JJ; Qureshi, AR; Nordfors, L; Naslund, E; Hammarqvist, F; Arefin, S; Kublickiene, K; Stenvinkel, P				Witasp, Anna; Ryden, Mikael; Carrero, Juan Jesus; Qureshi, Abdul Rashid; Nordfors, Louise; Naslund, Erik; Hammarqvist, Folke; Arefin, Samsul; Kublickiene, Karolina; Stenvinkel, Peter			Elevated Circulating Levels and Tissue Expression of Pentraxin 3 in Uremia: A Reflection of Endothelial Dysfunction	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; C-REACTIVE PROTEIN; ACUTE MYOCARDIAL-INFARCTION; RECOGNITION RECEPTOR PTX3; HUMAN ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; HEMODIALYSIS-PATIENTS; INFLAMMATORY MARKER; INSULIN-RESISTANCE	Elevated systemic pentraxin 3 (PTX3) levels appear to be a powerful marker of inflammatory status and a superior outcome predictor in patients with chronic kidney disease (CKD). As previous data imply that PTX3 is involved in vascular pathology and that adipose tissue mass may influence circulating PTX3 levels, we aimed to study the importance of adipose tissue expression of PTX3 in the uremic milieu and its relation to endothelial dysfunction parameters. Plasma PTX3 and abdominal subcutaneous adipose tissue (SAT) PTX3 mRNA levels were quantified in 56 stage 5 CKD patients (median age 57 [range 25-75] years, 30 males) and 40 age and gender matched controls (median age 58 [range 20-79] years, 27 males). Associations between PTX3 measures and an extensive panel of clinical parameters, including surrogate markers of endothelial function, were assessed. Functional ex vivo studies on endothelial status and immunohistochemical staining for PTX3 were conducted in resistance subcutaneous arteries isolated from SAT. SAT PTX3 mRNA expression correlated with plasma PTX3 concentrations (rho = 0.54, p = 0.0001) and was increased (3.7 [0.4-70.3] vs. 1.2 [0.2-49.3] RQ, p = 0.02) in CKD patients with cardiovascular disease (CVD), but was not significantly different between patients and controls. The association to CVD was lost after adjustments. SAT PTX3 mRNA levels were independently correlated to asymmetric dimethylarginine and basal resistance artery tone developed after inhibition with nitric oxide synthase and cyclooxygenase (rho = -0.58, p = 0.002). Apparent positive PTX3 immunoreactivity was observed in both patient and control arteries. In conclusion, fat PTX3 mRNA levels are associated with measures of endothelial cell function in patients with CKD. PTX3 may be involved in adipose tissue-orchestrated mechanisms that are restricted to the uremic milieu and modify inflammation and vascular complications in CKD patients.	[Witasp, Anna; Carrero, Juan Jesus; Qureshi, Abdul Rashid; Nordfors, Louise; Stenvinkel, Peter] Karolinska Inst, Div Renal Med & Baxter Novum, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Ryden, Mikael] Karolinska Inst, Dept Med H7, Stockholm, Sweden; [Carrero, Juan Jesus; Nordfors, Louise] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Carrero, Juan Jesus; Nordfors, Louise] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Naslund, Erik] Karolinska Inst, Ctr Gender Med, Stockholm, Sweden; [Hammarqvist, Folke] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Stockholm, Sweden; [Hammarqvist, Folke] Karolinska Inst, Div Surg, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Arefin, Samsul; Kublickiene, Karolina] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Obstet & Gynecol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Stenvinkel, P (corresponding author), Karolinska Inst, Div Renal Med & Baxter Novum, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	peter.stenvinkel@ki.se	; Qureshi, Abdul Rashid Tony/G-1358-2010	Carrero, Juan Jesus/0000-0003-4763-2024; Kublickiene, Karolina/0000-0002-4841-6836; Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Stenvinkel, Peter/0000-0002-8785-4820	Strategic Research Programme in Diabetes at Karolinska Institutet (Swedish Research Council) [2009-1068]; Swedish Research Council [15320-07-6, 2011-2349]; Centre for Gender Medicine at Karolinska Institutet; Stiftelsen Olle Engkvist Byggare	Strategic Research Programme in Diabetes at Karolinska Institutet (Swedish Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Gender Medicine at Karolinska Institutet(Karolinska Institutet); Stiftelsen Olle Engkvist Byggare(Swedish Research Council)	This study is supported by The Strategic Research Programme in Diabetes at Karolinska Institutet (Swedish Research Council 2009-1068) and grants from Swedish Research Council (15320-07-6; 2011-2349) (PS, JJS), Centre for Gender Medicine at Karolinska Institutet (PS, JJS, KK) as well as from Stiftelsen Olle Engkvist Byggare (FH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti L, 2009, ATHEROSCLEROSIS, V202, P455, DOI 10.1016/j.atherosclerosis.2008.05.015; ALLES VV, 1994, BLOOD, V84, P3483; Arner P, 2008, J CLIN ENDOCR METAB, V93, P2249, DOI 10.1210/jc.2008-0206; Axelsson J, 2004, AM J CLIN NUTR, V80, P1222, DOI 10.1093/ajcn/80.5.1222; Axelsson J, 2006, AM J KIDNEY DIS, V48, P916, DOI 10.1053/j.ajkd.2006.08.022; Aydogdu A, 2012, GYNECOL ENDOCRINOL, V28, P722, DOI 10.3109/09513590.2011.652719; Boehme M, 2007, NEPHROL DIAL TRANSPL, V22, P2224, DOI 10.1093/ndt/gfl747; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Brugger-Andersen T, 2009, THROMB HAEMOSTASIS, V102, P555, DOI 10.1160/TH09-02-0137; Bussolati B, 2003, J IMMUNOL, V170, P1466, DOI 10.4049/jimmunol.170.3.1466; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Carrero JJ, 2012, CLIN J AM SOC NEPHRO, V7, P207, DOI 10.2215/CJN.06840711; Cieslik P, 2012, AUTOIMMUNITY, V45, P119, DOI 10.3109/08916934.2011.611549; Cordeiro AC, 2010, NEPHROL DIAL TRANSPL, V25, P562, DOI 10.1093/ndt/gfp492; Cozzi V, 2012, PLACENTA, V33, P1039, DOI 10.1016/j.placenta.2012.09.009; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Dubin R, 2012, AM HEART J, V163, P274, DOI 10.1016/j.ahj.2011.11.007; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Garlanda C, 2011, CURR PHARM DESIGN, V17, P38, DOI 10.2174/138161211795049750; Imperatore G, 1998, DIABETES, V47, P821, DOI 10.2337/diabetes.47.5.821; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Klouche M, 2004, ATHEROSCLEROSIS, V175, P221, DOI 10.1016/j.atherosclerosis.2004.03.020; Kume N, 2011, J CARDIOL, V58, P38, DOI 10.1016/j.jjcc.2011.03.006; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; LEE GW, 1993, J IMMUNOL, V150, P1804; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; Luksha L, 2008, AM J PHYSIOL-REG I, V294, pR510, DOI 10.1152/ajpregu.00458.2007; Luksha L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036056; Luksha R, 2011, CLIN SCI, V120, P525, DOI 10.1042/CS20100277; Manfredi AA, 2008, CURR OPIN IMMUNOL, V20, P538, DOI 10.1016/j.coi.2008.05.004; Miyaki A, 2010, J ATHEROSCLER THROMB, V17, P278, DOI 10.5551/jat.2741; Miyamoto T, 2011, CLIN J AM SOC NEPHRO, V6, P2785, DOI 10.2215/CJN.02320311; Moczulski DK, 1998, DIABETES, V47, P1164, DOI 10.2337/diabetes.47.7.1164; Morishita T, 2012, J ATHEROSCLER THROMB, V19, P149, DOI 10.5551/jat.10074; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Ogawa T, 2010, OBESITY, V18, P1871, DOI 10.1038/oby.2009.507; Osorio-Conles O, 2011, AM J PHYSIOL-ENDOC M, V301, pE1254, DOI 10.1152/ajpendo.00163.2011; Ramkumar N, 2004, J RENAL NUTR, V14, P201, DOI 10.1053/j.jm.2004.07.009; Ramos LF, 2008, J AM SOC NEPHROL, V19, P593, DOI 10.1681/ASN.2007030355; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Roubicek T, 2009, NUTRITION, V25, P762, DOI 10.1016/j.nut.2008.12.012; Ryu WS, 2012, ATHEROSCLEROSIS, V220, P581, DOI 10.1016/j.atherosclerosis.2011.11.036; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Sanches FMR, 2008, AM J KIDNEY DIS, V52, P66, DOI 10.1053/j.ajkd.2008.02.004; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Stenvinkel P, 2001, NEPHROL DIAL TRANSPL, V16, P1968, DOI 10.1093/ndt/16.10.1968; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Suliman ME, 2008, QJM-INT J MED, V101, P397, DOI 10.1093/qjmed/hcn019; Suliman ME, 2008, CLIN J AM SOC NEPHRO, V3, P976, DOI 10.2215/CJN.03960907; Teplan V, 2010, WIEN KLIN WOCHENSCHR, V122, P466, DOI 10.1007/s00508-010-1409-y; Tong M, 2007, CLIN J AM SOC NEPHRO, V2, P889, DOI 10.2215/CJN.00870207; Tsimikas S, 2006, J AM COLL CARDIOL, V47, pC19, DOI 10.1016/j.jacc.2005.10.066; van Rossum AP, 2006, ARTHRITIS RHEUM-US, V54, P986, DOI 10.1002/art.21669; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Witasp A, 2011, J INTERN MED, V269, P410, DOI 10.1111/j.1365-2796.2010.02293.x; Yilmaz MI, 2011, CLIN J AM SOC NEPHRO, V6, P785, DOI 10.2215/CJN.09231010; Yilmaz MI, 2009, CLIN J AM SOC NEPHRO, V4, P535, DOI 10.2215/CJN.04330808	60	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63493	10.1371/journal.pone.0063493	http://dx.doi.org/10.1371/journal.pone.0063493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658833	gold, Green Published, Green Submitted			2022-12-27	WOS:000321202100067
J	Chai, JT; Digby, JE; Ruparelia, N; Jefferson, A; Handa, A; Choudhury, RP				Chai, Joshua T.; Digby, Janet E.; Ruparelia, Neil; Jefferson, Andrew; Handa, Ashok; Choudhury, Robin P.			Nicotinic Acid Receptor GPR109A Is Down-Regulated in Human Macrophage-Derived Foam Cells	PLOS ONE			English	Article							EXTENDED-RELEASE NIACIN; PROTEIN-COUPLED RECEPTOR; PPAR-GAMMA; CHOLESTEROL EFFLUX; ARTERIAL BIOLOGY; IN-VITRO; PUMA-G; ATHEROSCLEROSIS; EXPRESSION; ADIPOPHILIN	Nicotinic acid (NA) regresses atherosclerosis in human imaging studies and reduces atherosclerosis in mice, mediated by myeloid cells, independent of lipoproteins. Since GPR109A is expressed by human monocytes, we hypothesized that NA may drive cholesterol efflux from foam cells. In THP-1 cells NA suppressed LPS-induced mRNA transcription of MCP-1 by 76.6 +/- 12.2% (P<0.01) and TNF alpha by 56.1 +/- 11.5% (P<0.01), yet restored LPS-induced suppression of PPAR gamma-transcription by 536.5 +/- 46.4% (P<0.001) and its downstream effector CD36 by 116.8 +/- 19.8% (P<0.01). Whilst direct PPAR gamma-agonism promoted cholesterol efflux from THP-1 derived foam cells by 37.7 +/- 3.1% (P<0.01) and stimulated transcription of LXR alpha by 87.9 +/- 9.5% (P<0.001) and ABCG1 by 101.2 +/- 15.5% (P<0.01), NA showed no effect in foam cells on either cholesterol efflux or key RCT genes transcription. Upon foam cell induction, NA lost its effect on PPAR gamma and cAMP pathways, since its receptor, GPR109A, was down-regulated by foam cell transformation. This observation was confirmed in explanted human carotid plaques. In conclusion, despite NA's anti-inflammatory effect on human macrophages, it has no effect on foam cells in reverse cholesterol transport; due to GPR109A down-regulation.	[Chai, Joshua T.; Digby, Janet E.; Ruparelia, Neil; Jefferson, Andrew; Choudhury, Robin P.] Univ Oxford, Div Cardiovasc Med, Oxford, England; [Handa, Ashok] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England	University of Oxford; University of Oxford	Choudhury, RP (corresponding author), Univ Oxford, Div Cardiovasc Med, Oxford, England.	robin.choudhury@cardiov.ox.ac.uk			British Heart Foundation; MRC [MR/K00266X/1] Funding Source: UKRI; Medical Research Council [MR/K00266X/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors' laboratory is supported by the British Heart Foundation; RPC is a Wellcome Trust Senior Research Fellow in Clinical Science; JTC is an MRC Clinical Research Training Fellow; the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Bruckert E, 2010, ATHEROSCLEROSIS, V210, P353, DOI 10.1016/j.atherosclerosis.2009.12.023; Buechler C, 2001, BBA-MOL CELL BIOL L, V1532, P97, DOI 10.1016/S1388-1981(01)00121-4; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; CASHINHEMPHILL L, 1990, JAMA-J AM MED ASSOC, V264, P3013, DOI 10.1001/jama.264.23.3013; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P582, DOI 10.1161/ATVBAHA.111.236315; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; FATEMI SH, 1986, BIOMED BIOCHIM ACTA, V45, P539; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Kajita K, 2004, DIABETES RES CLIN PR, V66, pS79, DOI 10.1016/j.diabres.2003.09.022; Knowles HJ, 2006, BIOCHEM PHARMACOL, V71, P646, DOI 10.1016/j.bcp.2005.11.019; Kritharides L, 1998, ARTERIOSCL THROM VAS, V18, P1589, DOI 10.1161/01.ATV.18.10.1589; LACASA D, 1986, FEBS LETT, V202, P260, DOI 10.1016/0014-5793(86)80698-6; Lavigne PM, 2012, J AM COLL CARDIOL, V59, pE1687, DOI 10.1016/S0735-1097(12)61688-X; Lee JMS, 2009, J AM COLL CARDIOL, V54, P1787, DOI 10.1016/j.jacc.2009.06.036; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Masuda R, 2005, J NEUROSCI RES, V80, P501, DOI 10.1002/jnr.20464; Nuotio K, 2007, STROKE, V38, P1791, DOI 10.1161/STROKEAHA.106.478867; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; Offermanns S, 2011, PHARMACOL REV, V63, P269, DOI 10.1124/pr.110.003301; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ozasa H, 2011, ATHEROSCLEROSIS, V219, P141, DOI 10.1016/j.atherosclerosis.2011.07.113; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plutzky J, 2011, CIRC RES, V108, P1002, DOI 10.1161/CIRCRESAHA.110.226860; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Robinet P, 2010, J LIPID RES, V51, P3364, DOI 10.1194/jlr.D007336; Rosenson RS, 2012, AM HEART J, V164, P672, DOI 10.1016/j.ahj.2012.06.023; Rubic T, 2004, BIOCHEM PHARMACOL, V67, P411, DOI 10.1016/j.bcp.2003.09.014; Samoilova M, 2010, J NEUROCHEM, V113, P826, DOI 10.1111/j.1471-4159.2010.06645.x; SENIOR B, 1968, NATURE, V219, P83, DOI 10.1038/219083a0; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Taylor AJ, 2006, CURR MED RES OPIN, V22, P2243, DOI 10.1185/030079906X148508; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Villines TC, 2012, CURR ATHEROSCLER REP, V14, P49, DOI 10.1007/s11883-011-0212-1; Villines TC, 2010, J AM COLL CARDIOL, V55, P2721, DOI 10.1016/j.jacc.2010.03.017; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wang XK, 1999, FEBS LETT, V462, P145, DOI 10.1016/S0014-5793(99)01521-5; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Wu ZH, 2009, PHARMACOLOGY, V84, P282, DOI 10.1159/000242999; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068; Zhang YY, 2005, BIOCHEM BIOPH RES CO, V334, P729, DOI 10.1016/j.bbrc.2005.06.141	54	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62934	10.1371/journal.pone.0062934	http://dx.doi.org/10.1371/journal.pone.0062934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658787	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500045
J	Zhu, Z; Wang, JN; Sun, Z; Sun, XR; Wang, ZN; Xu, HM				Zhu, Zhi; Wang, Jinou; Sun, Zhe; Sun, Xuren; Wang, Zhenning; Xu, Huimian			Flotillin2 Expression Correlates with HER2 Levels and Poor Prognosis in Gastric Cancer	PLOS ONE			English	Article							BREAST-CANCER; DEOXYRIBONUCLEOSIDE KINASE; SURVIVAL; PROTEIN; MICROARRAYS; MELANOMA	Objective: Flotillin gene is known as a tumor promoter or suppressor, depending on the tumor type or tumor stage. We aimed to investigate the clinical significance of flotillin2 protein expression in gastric cancer. Methods: We examined flotillin2 and erbB2 levels in tissue microarray of 282 gastric cancer samples and analyzed the association between flotillin2 levels, clinicopathologic factors and prognosis. The regulation of erbB2 by flotillin2 was examined with flotillin2 siRNA-transfected gastric cancer cells. Results: Flotillin2 partially co-localized with erbB2 at the plasma membrane as detected by confocal microscopy, levels of erbB2 were reduced after flotillin knockdown in SGC-7901 cancer cells, and the expression of flotillin2 was positively correlated with that of erbB2. In non-neoplastic gastric mucosa, flotillin2 was not expressed in the epithelial compartment. In gastric cancer, positive staining of flotillin2 was shown in 129 (45.7%) of 282 cases, also, it was significantly associated with a Lauren grade, histologic type, lymphovascular invasion and tumor location. Moreover, survival analysis showed that flotillin2 expression was an independent prognostic factor of poor survival (p<0.001). Conclusions: These results indicate that a positive correlation exists between flotillin2 and erbB2 expression levels, flotillin2 maybe involved in the stabilization of erbB2 at the plasma membrane, flotillin2 is significantly correlated with cancer progression and poor prognosis in gastric cancer.	[Zhu, Zhi; Sun, Zhe; Wang, Zhenning; Xu, Huimian] China Med Univ, Hosp 1, Dept Gen Surg, Dept Surg Oncol, Shenyang, Peoples R China; [Wang, Jinou] China Med Univ, Dept Pathol, Shengjing Hosp, Shenyang, Peoples R China; [Sun, Xuren] China Med Univ, Hosp 1, Dept Digest, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Xu, HM (corresponding author), China Med Univ, Hosp 1, Dept Gen Surg, Dept Surg Oncol, Shenyang, Peoples R China.	xuhuimian@126.com	Gao, Peng/B-8031-2013; wang, zhen ning/E-1878-2011	wang, zhen ning/0000-0003-0557-3097	National Natural Science Foundation of China [81272718]; Young Scholars' Research Fund for the Doctoral Program of Higher Education of China [20122104120008]; Fund for Scientific Research of the First Hospital of China Medical University [FSFH1208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Scholars' Research Fund for the Doctoral Program of Higher Education of China; Fund for Scientific Research of the First Hospital of China Medical University	This work was supported by grants from the National Natural Science Foundation of China (81272718), Young Scholars' Research Fund for the Doctoral Program of Higher Education of China (20122104120008) and Fund for Scientific Research of the First Hospital of China Medical University (FSFH1208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Berger T, 2012, ONCOGENE; Doherty SD, 2006, MELANOMA RES, V16, P461, DOI 10.1097/01.cmr.0000222592.75858.20; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Heskamp S, 2012, J NUCL MED, V53, P146, DOI 10.2967/jnumed.111.093047; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Punyadeera C, 2005, CELL MOL LIFE SCI, V62, P239, DOI 10.1007/s00018-004-4435-y; Pust S., 2012, ONCOGENE; Pust S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008844; Sasaki Y, 2008, MOL CANCER RES, V6, P395, DOI 10.1158/1541-7786.MCR-07-0108; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Takano N, 2002, CANCER LETT, V176, P129, DOI 10.1016/S0304-3835(01)00739-X; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; Untch M, 2011, J CLIN ONCOL, V29, P3351, DOI 10.1200/JCO.2010.31.4930; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479; Zhu Z, 2011, CANCER BIOL THER, V11, P874, DOI 10.4161/cbt.11.10.15182; Zhu Z, 2010, ANTICANCER RES, V30, P2641	21	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62365	10.1371/journal.pone.0062365	http://dx.doi.org/10.1371/journal.pone.0062365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658725	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500024
J	Heydari, H; Wee, WY; Lokanathan, N; Hari, R; Yusoff, AM; Beh, CY; Yazdi, AH; Wong, GJ; Ngeow, YF; Choo, SW				Heydari, Hamed; Wee, Wei Yee; Lokanathan, Naline; Hari, Ranjeev; Yusoff, Aini Mohamed; Beh, Ching Yew; Yazdi, Amir Hessam; Wong, Guat Jah; Ngeow, Yun Fong; Choo, Siew Woh			MabsBase: A Mycobacterium abscessus Genome and Annotation Database	PLOS ONE			English	Article							SEQUENCE; MASSILIENSE; INFECTION; BOLLETII	Mycobacterium abscessus is a rapidly growing non-tuberculous mycobacterial species that has been associated with a wide spectrum of human infections. As the classification and biology of this organism is still not well understood, comparative genomic analysis on members of this species may provide further insights on their taxonomy, phylogeny, pathogenicity and other information that may contribute to better management of infections. The MabsBase described in this paper is a user-friendly database providing access to whole-genome sequences of newly discovered M. abscessus strains as well as resources for whole-genome annotations and computational predictions, to support the expanding scientific community interested in M. abscessus research. The MabsBase is freely available at http://mabscessus.um.edu.my.	[Ngeow, Yun Fong] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Heydari, Hamed; Wee, Wei Yee; Lokanathan, Naline; Hari, Ranjeev; Yusoff, Aini Mohamed; Beh, Ching Yew; Yazdi, Amir Hessam; Wong, Guat Jah; Choo, Siew Woh] Univ Malaya, Fac Dent, Dent Res & Training Unit, Kuala Lumpur, Malaysia; [Heydari, Hamed] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Software Engn, Kuala Lumpur, Malaysia; [Yazdi, Amir Hessam] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Comp Syst & Technol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Choo, SW (corresponding author), Univ Malaya, Fac Dent, Dent Res & Training Unit, Kuala Lumpur, Malaysia.	lchoo@um.edu.my	Choo, Siew Woh/E-3406-2010; NGEOW, YUN FONG/B-9237-2010	Ngeow, Yun Fong/0000-0002-1011-762X	Ministry of Higher Education; University of Malaya, Malaysia [UM.C/HIR/MOHE/08, UM.C/625/1/HIR/004]	Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); University of Malaya, Malaysia(Universiti Malaya)	This work was supported by the Ministry of Higher Education and University of Malaya [grant numbers UM.C/HIR/MOHE/08, UM.C/625/1/HIR/004], Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Choo SW, 2012, J BACTERIOL, V194, P5724, DOI 10.1128/JB.01407-12; Choo SW, 2012, J BACTERIOL, V194, P5128, DOI 10.1128/JB.01096-12; Choo SW, 2012, J BACTERIOL, V194, P4778, DOI 10.1128/JB.01043-12; Choo SW, 2012, J BACTERIOL, V194, P3278, DOI 10.1128/JB.00492-12; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271, DOI 10.1164/ajrccm/147.5.1271; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; KUSUNOKI S, 1992, INT J SYST BACTERIOL, V42, P240, DOI 10.1099/00207713-42-2-240; Laing C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698; MOORE M, 1953, J INVEST DERMATOL, V20, P133, DOI 10.1038/jid.1953.18; Ngeow YF, 2012, J BACTERIOL, V194, P6662, DOI 10.1128/JB.01846-12; Ngeow YF, 2012, J BACTERIOL, V194, P6002, DOI 10.1128/JB.01455-12; Ngeow YF, 2012, J BACTERIOL, V194, P4786, DOI 10.1128/JB.01104-12; Ngeow YF, 2012, J BACTERIOL, V194, P4125, DOI 10.1128/JB.00712-12; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Sanguinetti M, 2001, J CLIN MICROBIOL, V39, P816, DOI 10.1128/JCM.39.2.816-819.2001; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Varshney RK, 2012, FIELD CROP RES, V126, P171, DOI 10.1016/j.fcr.2011.10.008; Wong VL, 2012, J BACTERIOL, V194, P4475, DOI 10.1128/JB.00916-12; Yakrus MA, 2001, J CLIN MICROBIOL, V39, P4103, DOI 10.1128/JCM.39.11.4103-4110.2001; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	28	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62443	10.1371/journal.pone.0062443	http://dx.doi.org/10.1371/journal.pone.0062443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658631	Green Published, gold, Green Submitted			2022-12-27	WOS:000321662800046
J	Jauregui, AR; Savalia, D; Lowry, VK; Farrell, CM; Wathelet, MG				Jauregui, Andrew R.; Savalia, Dhruti; Lowry, Virginia K.; Farrell, Cara M.; Wathelet, Marc G.			Identification of Residues of SARS-CoV nsp1 That Differentially Affect Inhibition of Gene Expression and Antiviral Signaling	PLOS ONE			English	Article							I INTERFERON; CORONAVIRUS; PROTEIN; INDUCTION; DOMAIN	An epidemic of Severe Acute Respiratory Syndrome (SARS) led to the identification of an associated coronavirus, SARS-CoV. This virus evades the host innate immune response in part through the expression of its non-structural protein (nsp) 1, which inhibits both host gene expression and virus-and interferon (IFN)-dependent signaling. Thus, nsp1 is a promising target for drugs, as inhibition of nsp1 would make SARS-CoV more susceptible to the host antiviral defenses. To gain a better understanding of nsp1 mode of action, we generated and analyzed 38 mutants of the SARS-CoV nsp1, targeting 62 solvent exposed residues out of the 180 amino acid protein. From this work, we identified six classes of mutants that abolished, attenuated or increased nsp1 inhibition of host gene expression and/or antiviral signaling. Each class of mutants clustered on SARS-CoV nsp1 surface and suggested nsp1 interacts with distinct host factors to exert its inhibitory activities. Identification of the nsp1 residues critical for its activities and the pathways involved in these activities should help in the design of drugs targeting nsp1. Significantly, several point mutants increased the inhibitory activity of nsp1, suggesting that coronaviruses could evolve a greater ability to evade the host response through mutations of such residues.	[Jauregui, Andrew R.; Savalia, Dhruti; Lowry, Virginia K.; Farrell, Cara M.; Wathelet, Marc G.] Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA; [Wathelet, Marc G.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico	Wathelet, MG (corresponding author), Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA.	mwathelet@lrri.org			National Institutes of Health [RO1 HL084171, HL084171-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants RO1 HL084171 and HL084171-S1 to MGW ( http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agol VI, 2010, NAT REV MICROBIOL, V8, P867, DOI 10.1038/nrmicro2452; Almeida MS, 2007, J VIROL, V81, P3151, DOI 10.1128/JVI.01939-06; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Fang XN, 2007, J MED VIROL, V79, P1431, DOI 10.1002/jmv.20953; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Harlow E., 1988, ANTIBODIES LAB MANUA; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Li SW, 2011, J GEN VIROL, V92, P1127, DOI 10.1099/vir.0.028936-0; Lu XL, 2011, VIRUS GENES, V42, P37, DOI 10.1007/s11262-010-0544-x; Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Osterhaus ADME, 2004, PHILOS T ROY SOC B, V359, P1081, DOI 10.1098/rstb.2004.1489; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030802; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wang YJ, 2010, INFECT GENET EVOL, V10, P919, DOI 10.1016/j.meegid.2010.05.014; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wevers BA, 2009, CLIN LAB MED, V29, P715, DOI 10.1016/j.cll.2009.07.007; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yang HM, 2002, EUR J BIOCHEM, V269, P6142, DOI 10.1046/j.1432-1033.2002.03330.x; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	45	54	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62416	10.1371/journal.pone.0062416	http://dx.doi.org/10.1371/journal.pone.0062416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658627	gold, Green Published, Green Submitted			2022-12-27	WOS:000321662800043
J	Kempf, C; Staudt, T; Bingen, P; Horstmann, H; Engelhardt, J; Hell, SW; Kuner, T				Kempf, Christian; Staudt, Thorsten; Bingen, Pit; Horstmann, Heinz; Engelhardt, Johann; Hell, Stefan W.; Kuner, Thomas			Tissue Multicolor STED Nanoscopy of Presynaptic Proteins in the Calyx of Held	PLOS ONE			English	Article							GTP-BINDING PROTEIN; ACTIVE ZONE; SYNAPTIC VESICLES; RELEASE; RECONSTRUCTION; LOCALIZATION; MICROSCOPY; POOL	The calyx of Held, a large glutamatergic terminal in the mammalian auditory brainstem has been extensively employed to study presynaptic structure and function in the central nervous system. Nevertheless, the nanoarchitecture of presynaptic proteins and subcellular components in the calyx terminal and its relation to functional properties of synaptic transmission is only poorly understood. Here, we use stimulated emission depletion (STED) nanoscopy of calyces in thin sections of aldehyde-fixed rat brain tissue to visualize immuno-labeled synaptic proteins including VGluT1, synaptophysin, Rab3A and synapsin with a lateral resolution of approximately 40 nm. Excitation multiplexing of suitable fluorescent dyes deciphered the spatial arrangement of the presynaptic phospho-protein synapsin relative to synaptic vesicles labeled with anti-VGluT1. Both predominantly occupied the same focal volume, yet may exist in exclusive domains containing either VGluT1 or synapsin immunoreactivity. While the latter have been observed with diffraction-limited fluorescence microscopy, STED microscopy for the first time revealed VGluT1-positive domains lacking synapsins. This observation supports the hypothesis that molecularly and structurally distinct synaptic vesicle pools operate in presynaptic nerve terminals.	[Kempf, Christian; Horstmann, Heinz; Kuner, Thomas] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany; [Staudt, Thorsten; Bingen, Pit; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; [Staudt, Thorsten; Bingen, Pit; Engelhardt, Johann; Hell, Stefan W.] Heidelberg Univ, Bioquant Ctr, Heidelberg, Germany; [Staudt, Thorsten; Bingen, Pit; Engelhardt, Johann; Hell, Stefan W.] German Canc Res Ctr, Opt Nanoscopy Div, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Kuner, T (corresponding author), Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany.	kuner@uni-heidelberg.de			CellNetworks Cluster of Excellence [EXC81]	CellNetworks Cluster of Excellence	This work has been partially supported by the CellNetworks Cluster of Excellence (EXC81, T.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ayelet O, 2012, J NEUROCHEM, V120, P248, DOI 10.1111/j.1471-4159.2011.07579.x; Billups B, 2005, NEUROSCI LETT, V382, P66, DOI 10.1016/j.neulet.2005.02.071; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Denker A, 2010, FRONTIERS SYNAPTIC N, V2; Denker A, 2011, P NATL ACAD SCI USA, V108, P17183, DOI 10.1073/pnas.1112690108; Dondzillo A, 2010, J COMP NEUROL, V518, P1008, DOI 10.1002/cne.22260; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; Pavlos Nathan J, 2011, Small GTPases, V2, P77; Punge A, 2008, MICROSC RES TECHNIQ, V71, P644, DOI 10.1002/jemt.20602; Satzler K, 2002, J NEUROSCI, V22, P10567; Schmidt R, 2008, NAT METHODS, V5, P539, DOI 10.1038/nmeth.1214; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vasileva M, 2012, EUROPEAN J NEUROSCIE; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; Welzel O, 2011, BIOPHYS J, V100, P593, DOI 10.1016/j.bpj.2010.12.3706	22	25	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62893	10.1371/journal.pone.0062893	http://dx.doi.org/10.1371/journal.pone.0062893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658655	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000318343700079
J	Lobsien, D; Dreyer, AY; Stroh, A; Boltze, J; Hoffmann, KT				Lobsien, Donald; Dreyer, Antje Y.; Stroh, Albrecht; Boltze, Johannes; Hoffmann, Karl-Titus			Imaging of VSOP Labeled Stem Cells in Agarose Phantoms with Susceptibility Weighted and T2*Weighted MR Imaging	PLOS ONE			English	Article							IRON-OXIDE PARTICLES; IN-VIVO; CLINICAL-APPLICATIONS; ISCHEMIC-STROKE; BRAIN; TRACKING; NANOPARTICLES; RAT; GUIDELINES; MANAGEMENT	Objective: This study aimed to evaluate the detectability of stem cells labeled with very small iron oxide particles (VSOP) at 3T with susceptibility weighted (SWI) and T2* weighted imaging as a methodological basis for subsequent examinations in a large animal stroke model (sheep). Materials and Methods: We examined ovine mesenchymal stem cells labeled with VSOP in agarose layer phantoms. The experiments were performed in 2 different groups, with quantities of 0-100,000 labeled cells per layer. 15 different SWI-and T2*-weighted sequences and 3 RF coils were used. All measurements were carried out on a clinical 3T MRI. Images of Group A were analyzed by four radiologists blinded for the number of cells, and rated for detectability according to a four-step scale. Images of Group B were subject to a ROI-based analysis of signal intensities. Signal deviations of more than the 0.95 confidence interval in cell containing layers as compared to the mean of the signal intensity of non cell bearing layers were considered significant. Results: Group A: 500 or more labeled cells were judged as confidently visible when examined with a SWI-sequence with 0.15 mm slice thickness. Group B: 500 or more labeled cells showed a significant signal reduction in SWI sequences with a slice thickness of 0.25 mm. Slice thickness and cell number per layer had a significant influence on the amount of detected signal reduction. Conclusion: 500 VSOP labeled stem cells could be detected with SWI imaging at 3 Tesla using an experimental design suitable for large animal models.	[Lobsien, Donald; Hoffmann, Karl-Titus] Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany; [Dreyer, Antje Y.; Boltze, Johannes] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Dreyer, Antje Y.; Boltze, Johannes] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Stroh, Albrecht] Johannes Gutenberg Univ Mainz, Res Grp Mol Imaging & Optogenet, Inst Microscop Anat & Neurobiol, Focus Program Translat Neurosci, D-55122 Mainz, Germany; [Boltze, Johannes] Massachusetts Gen Hosp, Charlestown, MA USA; [Boltze, Johannes] Harvard Univ, Sch Med, Ctr Neurosci, Charlestown, MA USA	Leipzig University; Fraunhofer Gesellschaft; Leipzig University; Johannes Gutenberg University of Mainz; Harvard University; Massachusetts General Hospital; Harvard University	Lobsien, D (corresponding author), Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany.	donald.lobsien@medizin.uni-leipzig.de	Stroh, Albrecht/AAE-8004-2021	Stroh, Albrecht/0000-0001-9410-4086; Hoffmann, Karl-Titus/0000-0001-7693-887X; Boltze, Johannes/0000-0003-3956-4164				Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Berman SMC, 2011, WIRES NANOMED NANOBI, V3, P343, DOI 10.1002/wnan.140; Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89; Burns TC, 2011, EXPERT OPIN BIOL TH, V11, P447, DOI 10.1517/14712598.2011.552883; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Carpenter CR, 2011, J EMERG MED, V40, P82, DOI 10.1016/j.jemermed.2010.05.009; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Chen CL, 2011, MOL IMAGING BIOL, V13, P825, DOI 10.1007/s11307-010-0430-x; Daadi MM, 2012, CELL TRANSPLANT; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; Deistung A, 2006, Z MED PHYS, V16, P261, DOI 10.1078/0939-3889-00324; Denic A, 2011, NEUROTHERAPEUTICS, V8, P3, DOI 10.1007/s13311-010-0002-4; Dreyer A, 2012, ADV PRECLINICAL STUD, P21; Eibofner F, 2010, MAGN RESON MED, V64, P1027, DOI 10.1002/mrm.22498; England T, 2009, INT J STROKE, V4, P101, DOI 10.1111/j.1747-4949.2009.00253.x; Fleige G, 2002, INVEST RADIOL, V37, P482, DOI 10.1097/00004424-200209000-00002; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Heymer A, 2008, BIOMATERIALS, V29, P1473, DOI 10.1016/j.biomaterials.2007.12.003; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Jendelova P, 2003, MAGNET RESON MED, V50, P767, DOI 10.1002/mrm.10585; Kalladka D, 2011, NEUROCHEM INT, V59, P367, DOI 10.1016/j.neuint.2011.03.016; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Liu YP, 2009, ACTA NEUROPATHOL, V117, P469, DOI 10.1007/s00401-009-0516-1; Magnitsky S, 2005, NEUROIMAGE, V26, P744, DOI 10.1016/j.neuroimage.2005.02.029; Mahmoudi M, 2011, CHEM REV, V111, P253, DOI 10.1021/cr1001832; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Pillai DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016091; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Stroh A, 2005, NEUROIMAGE, V24, P635, DOI 10.1016/j.neuroimage.2004.09.014; Stroh A, 2004, FREE RADICAL BIO MED, V36, P976, DOI 10.1016/j.freeradbiomed.2004.01.016; Stroh A, 2006, NEUROIMAGE, V33, P886, DOI 10.1016/j.neuroimage.2006.07.009; Takahashi M, 2003, EUR J RADIOL, V46, P45, DOI 10.1016/S0720-048X(02)00331-5; Taupitz M, 2000, J MAGN RESON IMAGING, V12, P905, DOI 10.1002/1522-2586(200012)12:6<905::AID-JMRI14>3.0.CO;2-5; The STEPS Participants, 2008, STROKE, V40, P510; Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140; Wu SY, 2010, CYTOTHERAPY, V12, P859, DOI 10.3109/14653241003587652	40	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62644	10.1371/journal.pone.0062644	http://dx.doi.org/10.1371/journal.pone.0062644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667503	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600037
J	Boeker, M; Jansen, L; Grewe, N; Rohl, J; Schober, D; Seddig-Raufie, D; Schulz, S				Boeker, Martin; Jansen, Ludger; Grewe, Niels; Roehl, Johannes; Schober, Daniel; Seddig-Raufie, Djamila; Schulz, Stefan			Effects of Guideline-Based Training on the Quality of Formal Ontologies: A Randomized Controlled Trial	PLOS ONE			English	Article							NATIONAL-CENTER; BIOMEDICAL-ONTOLOGY; OBO FOUNDRY; PHENOTYPE; GENOTYPE	Background: The importance of ontologies in the biomedical domain is generally recognized. However, their quality is often too poor for large-scale use in critical applications, at least partially due to insufficient training of ontology developers. Objective: To show the efficacy of guideline-based ontology development training on the performance of ontology developers. The hypothesis was that students who received training on top-level ontologies and design patterns perform better than those who only received training in the basic principles of formal ontology engineering. Methods: A curriculum was implemented based on a guideline for ontology design. A randomized controlled trial on the efficacy of this curriculum was performed with 24 students from bioinformatics and related fields. After joint training on the fundamentals of ontology development the students were randomly allocated to two groups. During the intervention, each group received training on different topics in ontology development. In the assessment phase, all students were asked to solve modeling problems on topics taught differentially in the intervention phase. Primary outcome was the similarity of the students' ontology artefacts compared with gold standard ontologies developed by the authors before the experiment; secondary outcome was the intra-group similarity of group members' ontologies. Results: The experiment showed no significant effect of the guideline-based training on the performance of ontology developers (a) the ontologies developed after specific training were only slightly but not significantly closer to the gold standard ontologies than the ontologies developed without prior specific training; (b) although significant differences for certain ontologies were detected, the intra-group similarity was not consistently influenced in one direction by the differential training. Conclusion: Methodologically limited, this study cannot be interpreted as a general failure of a guideline-based approach to ontology development. Further research is needed to increase insight into whether specific development guidelines and practices in ontology design are effective.	[Boeker, Martin; Schober, Daniel; Seddig-Raufie, Djamila; Schulz, Stefan] Univ Freiburg, Inst Med Biometry & Med Informat, D-79106 Freiburg, Germany; [Jansen, Ludger; Grewe, Niels; Roehl, Johannes] Univ Rostock, Inst Philosophy, D-18055 Rostock, Germany; [Schulz, Stefan] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	University of Freiburg; University of Rostock; Medical University of Graz	Boeker, M (corresponding author), Univ Freiburg, Inst Med Biometry & Med Informat, Hugstetter Str 55, D-79106 Freiburg, Germany.	martin.boeker@uniklinik-freiburg.de	Boeker, Martin/N-3854-2016; Jansen, Ludger/AAE-9325-2020	Boeker, Martin/0000-0003-2972-2042; Jansen, Ludger/0000-0002-0097-6359; Schober, Daniel/0000-0001-8014-6648	Deutsche Forschungsgemeinschaft (DFG) within the GoodOD project (Good Ontology Design) [JA 1904/2-1, SCHU 2515/1-1]; DFG	Deutsche Forschungsgemeinschaft (DFG) within the GoodOD project (Good Ontology Design)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) within the GoodOD project (Good Ontology Design), grant JA 1904/2-1 and SCHU 2515/1-1, http://purl.org/goodod. The open access publication of this work was supported by the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beisswanger E, 2008, APPL ONTOL, V3, P205, DOI 10.3233/AO-2008-0057; Bodenreider O, 2008, Yearb Med Inform, P67; Boeker M, 2012, KR MED SERIES, V897; Boeker M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-456; Bowker GC., 2000, SORTING THINGS OUT C; Ceusters W, 2005, METHOD INFORM MED, V44, P498; Ceusters W, 2004, ST HEAL T, V107, P482; Cleophas T J M, 2002, Am J Ther, V9, P69, DOI 10.1097/00045391-200201000-00011; Cook DA, 2005, ACAD MED, V80, P541, DOI 10.1097/00001888-200506000-00005; Cook DA, 2008, ADV HLTH SCI ED THEO, V15, P455; Coulet A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S3; d'Aquin M, 2012, J WEB SEMANT, V11, P96, DOI 10.1016/j.websem.2011.08.005; David J, 2008, LECT NOTES COMPUT SC, V5318, P245, DOI 10.1007/978-3-540-88564-1_16; Dellschaft K, 2006, LECT NOTES COMPUT SC, V4273, P228; Duque-Ramos A, 2011, J RES PRACT INF TECH, V43, P159; Euzenat Jerome, 2011, Journal on Data Semantics XV: LNCS 6720, P158, DOI 10.1007/978-3-642-22630-4_6; Euzenat J, 2009, NEON2009D334V11; Fahad M, 2007, GRC: 2007 IEEE INTERNATIONAL CONFERENCE ON GRANULAR COMPUTING, PROCEEDINGS, P283; Fowler M, 2003, UML DISTILLED BRIEF; Fraser K, 2012, MED EDUC, V46, P299, DOI 10.1111/j.1365-2923.2011.04181.x; Gamma E., 1994, DESIGN PATTERNS; Gangemi A., 2005, SWAP, V166, P16; Gangemi A, 2006, LECT NOTES COMPUT SC, V4011, P140; Gomez-Perez A, 1999, P BANFF KNOWL ACQ KN; Grenon P, 2003, 062003 IFOMIS U LEIP; Grewe N, 2012, IMISE REPORTS, V1; Gruninger M., 1994, P IFIP WG5, P212; Harland L, 2011, DRUG DISCOV TODAY, V16, P940, DOI 10.1016/j.drudis.2011.09.013; Hartmann J, 2004, IST2004507482 KWEB; Henry CS, 2011, BBA-GEN SUBJECTS, V1810, P967, DOI 10.1016/j.bbagen.2011.03.010; Herre H, 2006, TECHNICAL REPORT; Hills M, 2004, BRIT J CLIN PHARMACO, V58, pS703, DOI 10.1111/j.1365-2125.2004.02275.x; Hoehndorf R., 2012, BRIEFINGS BIOINFORMA; Hofweber T., 2013, STANFORD ENCY PHILOS; Horridge M, 2011, PRACTICAL GUIDE BUIL; International Organization for Standardization, 2005, 25000 ISOIEC; Kern D, 1998, CURRICULUM DEV MED E; Masolo C., 2003, WONDERWEB DELIVERABL; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Musen MA, 2012, J AM MED INFORM ASSN, V19, P190, DOI 10.1136/amiajnl-2011-000523; Parsia B., 2005, P 14 INT C WORLD WID, P633, DOI [1010.1145/1060745.1060837, DOI 10.1145/1060745.1060837.URL]; Poveda Villalon M, 2010, DOUBLE CLASSI CATION; R Core Team, 2012, R LANG ENV STAT COMP; Rector A, 2004, LECT NOTES COMPUT SC, V3257, P63; Rogers JE, 2006, METHOD INFORM MED, V45, P267; Rubin DL, 2006, OMICS, V10, P185, DOI 10.1089/omi.2006.10.185; Schober D, 2012, KR MED SERIES; Schober D, 2012, P 4 WORKSH GI WORKGR, V1/2012; Schober D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-125; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Straus SGP., 2010, EVIDENCE BASED MED P; Tartir S., 2005, ONTOQA METRIC BASED; Vrandecic D, 2007, LECT NOTES COMPUT SC, V4519, P311; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469	56	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61425	10.1371/journal.pone.0061425	http://dx.doi.org/10.1371/journal.pone.0061425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667440	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700013
J	Srivastava, A; Mohanty, SK				Srivastava, Akanksha; Mohanty, Sanjay K.			Age and Sex Pattern of Cardiovascular Mortality, Hospitalisation and Associated Cost in India	PLOS ONE			English	Article							PREVENTING CHRONIC DISEASES; MIDDLE-INCOME COUNTRIES; RISK-FACTORS; DETERMINANTS; OUTCOMES; CONTEXT; DEATH	Context: Though the cardiovascular diseases are the leading cause of mortality in India, little is known about the human and economic loss attributed to the disease. The aim of this paper is to account the age and sex pattern of mortality, hospitalisation and the cost of hospitalisation for cardiovascular diseases in India. Data and Methods: Data for the present study has been drawn from multiple sources; 52nd and 60th rounds of the National Sample Survey, Special Survey of Death, 2001-03 and the Sample Registration System 2004-2010. Under the changing demographics and constant assumptions of mortality, hospitalisation and cost of hospitalisation, we have estimated the deaths, hospitalisation and cost of hospitalisation for cardiovascular diseases in India during 2004 to 2021. Descriptive analyses and multivariate techniques were used to understand the socio-economic differentials in cost of hospitalisation for cardiovascular diseases in India. Findings: In India, the cardiovascular diseases accounted for an estimated 1.4 million deaths in 2004 and it is likely to be 2.1 million in 2021. An estimated 6.7 million people were hospitalised for cardiovascular diseases in 2004, and projected to be 10.9 million by 2021. Unlike mortality, majority of the hospitalisation due to cardiovascular diseases will be in the prime working age group (25-59). The estimated cost of hospitalisation for cardiovascular diseases was 94/- billion rupees in 2004 and expected to be 152/- billion rupees by 2021, at 2004 prices. The cost of hospitalisation for cardiovascular diseases was significantly high in private health centres, high fertility states and among high socio-economic groups. Conclusion: The cardiovascular mortality and hospitalisation will be largely concentrated in the prime working age group and the cost of hospitalisation is expected to increase substantially in coming years. This calls for mobilising resources, increasing access to health insurance and devising strategies for the prevention, control and treatment of cardiovascular diseases in India.	[Srivastava, Akanksha] Int Inst Populat Sci, Bombay, Maharashtra, India; [Mohanty, Sanjay K.] Int Inst Populat Sci, Dept Fertil Studies, Bombay, Maharashtra, India	International Institute for Population Sciences; International Institute for Population Sciences	Srivastava, A (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	akankshaleo@gmail.com	Mohanty, Sanjay K/AAR-7658-2020	Mohanty, Sanjay K/0000-0001-9041-5952				Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; Ala L, 2004, J HUM HYPERTENS, V18, P775, DOI 10.1038/sj.jhh.1001750; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; [Anonymous], 2005, UPDATED PROJECTIONS; [Anonymous], 2011, CENSUS INDIA 2011 PR, P1; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; AZAMBUJA MIR, 2008, EC BURDEN SEVERE CAR; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Bhutta ZA, 2006, PLOS MED, V3, P163, DOI 10.1371/journal.pmed.0030103; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chadha SL, 1997, B WORLD HEALTH ORGAN, V75, P31; Ezeamama AE, 2006, SOC SCI MED, V63, P2533, DOI 10.1016/j.socscimed.2006.06.023; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Goyal A, 2006, INDIAN J MED RES, V124, P235; Gupta R, 1995, Indian Heart J, V47, P331; HEINDENREICH PA, FORECASTING FUTURE C; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Jeemon P, 2010, INDIAN J MED RES, V132, P617; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; JORDAN JEE, 2005, LANCET, V366, P1667; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Leeder S, 2004, RACE TIME CHALLENGE; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Ministry of Health and Family Welfare Government of India, NAT PROGR PREV CONTR; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; *NSSO, 2006, 507602501 NSSO GOV I; *NSSO, 1998, 441522501 NSSO GOV I; Office of the Registrar General and Census Commissioner (ORGI), 2006, POP PROJ IND STAT 20; Office of the Registrar General (RGI) India, 2009, REP CAUS DEATH IND 2; *ORGI, 2006, SAMPL REG SYST STAT; *ORGI, 2012, SAMPL REG SYST STAT; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; PEDNEKAR MS, 2011, ILLITERACY LOW ED ST; *PLANN COMM GOVT I, 2011, HIGH LEV EXP GROUP R; Rao KD, 2011, INDIAN J MED RES, V133, P57; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; REDDY KS, 1998, CIRCULATION, V70, P945; Reddy N Krishna, 2002, Indian Heart J, V54, P697; *RGI, 1990, MED CERT CAUS DEATH; *RGI, 2004, MED CERT CAUS DEATH; RISSAM HS, 2001, INDIAN ACAD CLIN MED, V2, P128; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; SARVOTHHAM SG, 1968, CIRCULATION, V32; Stanciole A., 2006, ESTIMATION EC IMPACT; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; SUGATHAN TN, 2008, BEHAV RISK FACTORS N; SUHRCKE M, 2006, 1845 CESIFO; Taylor M., 2009, WHAT IS SENSITIVITY; United Nations Department of Economic and Social Affairs, 2010, WORLD POP PROSP; United Nations Department of Economic and Social Affairs Population Division, 2010, WORLD POP PROSP 2010; Vorster HH, 2002, PUBLIC HEALTH NUTR, V5, P239, DOI 10.1079/PHN2001299; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; WHO, 2011, NCD COUNTR PROF; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; YANG L, 2012, ESTIMATES CANC INCID; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhou BF, 2003, AM J PUBLIC HEALTH, V93, P2049, DOI 10.2105/AJPH.93.12.2049	60	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62134	10.1371/journal.pone.0062134	http://dx.doi.org/10.1371/journal.pone.0062134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667455	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700023
J	Ren, XF; Nevo, E; Sun, DF; Sun, GL				Ren, Xifeng; Nevo, Eviatar; Sun, Dongfa; Sun, Genlou			Tibet as a Potential Domestication Center of Cultivated Barley of China	PLOS ONE			English	Article							GRAIN PROTEIN-CONTENT; GENETIC DIVERSITY ANALYSIS; WILD CLOSE RELATIVES; THIOREDOXIN; SEQUENCE; ORIGIN; EAST; EVOLUTION; POLYMORPHISM; POPULATIONS	The importance of wild barley from Qinghai-Tibet Plateau in the origin and domestication of cultivated barley has long been underestimated. Population-based phylogenetic analyses were performed to study the origin and genetic diversity of Chinese domesticated barley, and address the possibility that the Tibetan region in China was an independent center of barley domestication. Wild barley (Hordeum vulgare ssp. spontaneum) populations from Southwest Asia, Central Asia, and Tibet along with domesticated barley from China were analyzed using two nuclear genes. Our results showed that Tibetan wild barley distinctly diverged from Southwest Asian (Near East) wild barley, that Central Asian wild barley is related to Southwest Asian wild barley, and that Chinese domesticated barley shares the same haplotypes with Tibetan wild barley. Phylogenetic analysis showed a close relationship between Chinese domesticated barley and the Tibetan wild barley, suggesting that Tibetan wild barley was the ancestor of Chinese domesticated barley. Our results favor the polyphyletic origin for cultivated barley.	[Ren, Xifeng; Sun, Dongfa; Sun, Genlou] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Ren, Xifeng; Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada; [Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel	Huazhong Agricultural University; Saint Marys University - Canada; University of Haifa	Sun, DF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	sundongfa1@mail.hzau.edu.cn; genlou.sun@smu.ca			National Natural Science Foundation of China [31228017]; Postdoctoral Science Foundation [2012M511627]; earmarked fund for China Agriculture Research System [CARS-5]; Natural Sciences and Engineering Research Council of Canada [238425]; Senate Research Grant at Saint Mary's University, Canada	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation(China Postdoctoral Science Foundation); earmarked fund for China Agriculture Research System; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Senate Research Grant at Saint Mary's University, Canada	This project was supported in part by the National Natural Science Foundation of China (31228017), the Postdoctoral Science Foundation (2012M511627), an earmarked fund for China Agriculture Research System (CARS-5), a discovery grant (238425) from the Natural Sciences and Engineering Research Council of Canada, and a Senate Research Grant at Saint Mary's University, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhaguvel P, 2007, ANN BOT-LONDON, V100, P1009, DOI 10.1093/aob/mcm129; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; Bjornstad A, 2010, CROP SCI, V50, P1579, DOI 10.2135/cropsci2009.12.0719; BUCHANAN BB, 1994, ARCH BIOCHEM BIOPHYS, V314, P257, DOI 10.1006/abbi.1994.1439; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Distelfeld A, 2008, MOL BREEDING, V22, P25, DOI 10.1007/s11032-007-9153-3; Ellis RP, 2000, J EXP BOT, V51, P9, DOI 10.1093/jexbot/51.342.9; Emebiri LC, 2005, J CEREAL SCI, V41, P107, DOI 10.1016/j.jcs.2004.08.012; Feng Zong-Yun, 2006, Acta Genetica Sinica, V33, P917, DOI 10.1016/S0379-4172(06)60126-1; FU YX, 1993, GENETICS, V133, P693; Gelhaye E, 2004, PLANT PHYSIOL BIOCH, V42, P265, DOI 10.1016/j.plaphy.2004.03.002; Harlan J. R., 1971, Barley genetics II. Proceedings of Second International Barley Genetics Symposium. Washington State University, Pulman, 1970., P45; Harlan J. R., 1976, Evolution of crop plants., P93; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Ivandic V, 2002, PLANT MOL BIOL, V48, P511, DOI 10.1023/A:1014875800036; Jamar C, 2010, J PLANT PHYSIOL, V167, P497, DOI 10.1016/j.jplph.2009.10.014; Jin XL, 2011, J CEREAL SCI, V53, P59, DOI 10.1016/j.jcs.2010.09.006; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Juttner J, 2000, EUR J BIOCHEM, V267, P7109, DOI 10.1046/j.1432-1327.2000.01811.x; KAHLER AL, 1981, THEOR APPL GENET, V59, P101, DOI 10.1007/BF00285898; Kakeda K, 2009, BREEDING SCI, V59, P595, DOI 10.1270/jsbbs.59.595; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Maeso I, 2012, GENOME BIOL EVOL, V4, P486, DOI 10.1093/gbe/evs022; MAROOF MAS, 1994, P NATL ACAD SCI USA, V91, P5466, DOI 10.1073/pnas.91.12.5466; Molina-Cano JL, 2005, THEOR APPL GENET, V110, P613, DOI 10.1007/s00122-004-1878-3; Molina-Cano JL, 2002, BARLEY SCI RECENT AD; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Nevo E, 2004, CEREAL GENOMICS, P135; NEVO E, 1986, BIOL J LINN SOC, V27, P355, DOI 10.1111/j.1095-8312.1986.tb01742.x; NEVO E, 1984, EUPHYTICA, V33, P737, DOI 10.1007/BF00021901; Nevo E, 2013, ADV BARLEY SCI, P1, DOI 10.1007/978-94-007-4682-4_1; Nevo Eviatar, 2006, Plant Genetic Resources Characterization and Utilization, V4, P36, DOI 10.1079/PGR2006108; Nuruzzaman M, 2008, MOL GENET GENOMICS, V280, P139, DOI 10.1007/s00438-008-0351-4; Orabi J, 2009, PLANT BREEDING, V128, P606, DOI 10.1111/j.1439-0523.2009.01637.x; Raines C, 2005, J EXP BOT, V56, pIV, DOI 10.1093/jxb/eri183; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rozas J., 2005, DNA SEQUENCE POLYMOR; Saisho D, 2007, GENETICS, V177, P1765, DOI 10.1534/genetics.107.079491; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; See D, 2002, CROP SCI, V42, P680, DOI 10.2135/cropsci2002.0680; Shao QQ, 1975, ACTA GENET SIN, V2, P123; Shao QQ, 1982, WILD BARLEY TIBET, P1; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Swofford D, 2003, PAUP VERSION 4 BETA; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHASHI R, 1955, ADV GENET, V7, P227, DOI 10.1016/S0065-2660(08)60097-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vavilov N. I., 1926, B APPL BOT GEN PB, V14, P1; Vavilov NI, 1951, CHRON BOT, V13, P1, DOI DOI 10.1097/00010694-195112000-00018; von Bothmer R., 2011, BARLEY PRODUCTION IM, P14, DOI DOI 10.1002/9780470958636.CH2; von Bothmer R, 1985, SVERIGES UTSADESFORE, V95, P71; VONBOTHMER R, 1995, SYSTEMATIC ECOGEOGRA, V7; Wang AH, 2009, CR BIOL, V332, P393, DOI 10.1016/j.crvi.2008.11.007; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; XU T, 1982, Acta Genetica Sinica, V9, P440; XU TW, 1986, P CHIN BARL SCI, P34; Xu TW, 1985, BARLEY NEWSLET, V29, P105; Xu TW, 1975, ACTA GENET SIN, V2, P129; Xu TW, 1984, J SICHUAN AGR COLL, V2, P11; Yang J. L., 1985, Sveriges Utsadesforenings Tidskrift, V95, P71; Yang ShiDong, 2008, Agricultural Sciences in China, V7, P796, DOI 10.1016/S1671-2927(08)60116-9; YAO Z, 1982, Acta Genetica Sinica, V9, P160; Yin YQ, 2003, THEOR APPL GENET, V107, P837, DOI 10.1007/s00122-003-1328-7; ZHANG QF, 1990, P NATL ACAD SCI USA, V87, P8741, DOI 10.1073/pnas.87.22.8741; ZHANG QF, 1994, GENOME, V37, P631, DOI 10.1139/g94-090; ZHANG QF, 1992, THEOR APPL GENET, V84, P682, DOI 10.1007/BF00224168; Zhang Qifa, 1992, Acta Genetica Sinica, V19, P236; ZHOU Z, 1981, Acta Genetica Sinica, V8, P344; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	72	28	38	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62700	10.1371/journal.pone.0062700	http://dx.doi.org/10.1371/journal.pone.0062700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658764	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100034
J	Tao, WJ; Yuan, J; Zhou, LY; Sun, LN; Sun, YL; Yang, SJ; Li, MH; Zeng, S; Huang, BF; Wang, DH				Tao, Wenjing; Yuan, Jing; Zhou, Linyan; Sun, Lina; Sun, Yunlv; Yang, Shijie; Li, Minghui; Zeng, Sheng; Huang, Baofeng; Wang, Deshou			Characterization of Gonadal Transcriptomes from Nile Tilapia (Oreochromis niloticus) Reveals Differentially Expressed Genes	PLOS ONE			English	Article							SEX-DETERMINING REGION; DM-DOMAIN GENE; RAINBOW-TROUT; MOLECULAR-CLONING; RNA-SEQ; REVERSAL; AROMATASE; FISH; OVARY; DISCOVERY	Four pairs of XX and XY gonads from Nile tilapia were sequenced at four developmental stages, 5, 30, 90, and 180 days after hatching (dah) using Illumina Hiseq (TM) technology. This produced 28 Gb sequences, which were mapped to 21,334 genes. Of these, 259 genes were found to be specifically expressed in XY gonads, and 69 were found to be specific to XX gonads. Totally, 187 XX- and 1,358 XY-enhanced genes were identified, and 2,978 genes were found to be co-expressed in XX and XY gonads. Almost all steroidogenic enzymes, including cyp19a1a, were up-regulated in XX gonads at 5 dah; but in XY gonads these enzymes, including cyp11b2, were significantly up-regulated at 90 dah, indicating that, at a time critical to sex determination, the XX fish produced estrogen and the XY fish did not produce androgens. The most pronounced expression of steroidogenic enzyme genes was observed at 30 and 90 dah for XX and XY gonads, corresponding to the initiation of germ cell meiosis in the female and male gonads, respectively. Both estrogen and androgen receptors were found to be expressed in XX gonads, but only estrogen receptors were expressed in XY gonads at 5 dah. This could explain why exogenous steroid treatment induced XX and XY sex reversal. The XX-enhanced expression of cyp19a1a and cyp19a1b at all stages suggests an important role for estrogen in female sex determination and maintenance of phenotypic sex. This work is the largest collection of gonadal transcriptome data in tilapia and lays the foundation for future studies into the molecular mechanisms of sex determination and maintenance of phenotypic sex in non-model teleosts.	[Tao, Wenjing; Yuan, Jing; Zhou, Linyan; Sun, Lina; Sun, Yunlv; Yang, Shijie; Li, Minghui; Zeng, Sheng; Huang, Baofeng; Wang, Deshou] Southwest Univ, Sch Life Sci, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Key Lab Aquat Sci Chongqing, Chongqing, Peoples R China	Southwest University - China	Wang, DH (corresponding author), Southwest Univ, Sch Life Sci, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Key Lab Aquat Sci Chongqing, Chongqing, Peoples R China.	wdeshou@swu.edu.cn	Wang, Deshou/ABD-6014-2021	Wang, Deshou/0000-0002-4967-524X	National Natural Science Foundation of China [31030063, 30871905]; NSFC-RGC Joint Research Scheme from the National Science Foundation of China [NSFC:30831160508]; National Basic Research Program of China [2009CB941200, 2010CB134405, 2012CB723205]; National High Technology Research and Development Program (863 program) of China [2011AA100404]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0859]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090182110008]; Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission [CQ CSTC 2008BB1006, 2008AC1016]; Excellent Ph.D Thesis Fellowship of Southwest University [kb2010009, kb2011007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-RGC Joint Research Scheme from the National Science Foundation of China; National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program (863 program) of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission; Excellent Ph.D Thesis Fellowship of Southwest University	This work was supported by grants 31030063 and 30871905 from the National Natural Science Foundation of China; the NSFC-RGC Joint Research Scheme from the National Science Foundation of China (NSFC:30831160508); grants 2009CB941200, 2010CB134405, and 2012CB723205 from the National Basic Research Program of China; grant 2011AA100404 from the National High Technology Research and Development Program (863 program) of China; grant IRT0859 from the Program for Changjiang Scholars and Innovative Research Team in University; grant 20090182110008 from the Specialized Research Fund for the Doctoral Program of Higher Education of China; grants CQ CSTC 2008BB1006 and 2008AC1016 from the Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission, and grants kb2010009 and kb2011007 from the Excellent Ph.D Thesis Fellowship of Southwest University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Afonso LOB, 2001, J EXP ZOOL, V290, P177, DOI 10.1002/jez.1047; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baroiller JF, 2009, SEX DEV, V3, P118, DOI 10.1159/000223077; BAROILLER JF, 1995, J EXP ZOOL, V273, P216, DOI 10.1002/jez.1402730306; Baron D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-357; Beardmore JA, 2001, AQUACULTURE, V197, P283, DOI 10.1016/S0044-8486(01)00590-7; Benjamini Y, 2001, ANN STAT, V29, P1165; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Bhandari RK, 2006, GEN COMP ENDOCR, V145, P20, DOI 10.1016/j.ygcen.2005.06.014; Chen WB, 2012, FISH PHYSIOL BIOCHEM, V38, P1843, DOI 10.1007/s10695-012-9681-6; Chu SL, 2006, AQUACULTURE, V251, P537, DOI 10.1016/j.aquaculture.2005.05.040; Clement TM, 2007, REPRODUCTION, V134, P455, DOI 10.1530/REP-06-0341; Coveney D, 2001, BIOL REPROD, V65, P613, DOI 10.1095/biolreprod65.2.613; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Duncan FE, 2005, DEV BIOL, V280, P38, DOI 10.1016/j.ydbio.2004.12.034; Eddy EM, 1999, REV REPROD, V4, P23, DOI 10.1530/revreprod/4.1.23; Eshel O, 2012, G3-GENES GENOM GENET, V2, P35, DOI 10.1534/g3.111.001545; Eshel O, 2011, ANIM GENET, V42, P222, DOI 10.1111/j.1365-2052.2010.02128.x; Ezaz MT, 2004, MAR BIOTECHNOL, V6, P435, DOI 10.1007/s10126-004-3004-6; Ghiselli F, 2012, MOL BIOL EVOL, V29, P771, DOI 10.1093/molbev/msr248; Guiguen Y, 1999, MOL REPROD DEV, V54, P154, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;154::AID-MRD7&gt;3.0.CO;2-5; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Harvey SC, 2003, CYTOGENET GENOME RES, V101, P314, DOI 10.1159/000074355; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; Heikkila M, 2001, J EXP ZOOL, V290, P616, DOI 10.1002/jez.1112; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Kanai Y, 2005, J BIOCHEM, V138, P13, DOI 10.1093/jb/mvi098; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Kobayashi T, 2003, CYTOGENET GENOME RES, V101, P289, DOI 10.1159/000074351; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lee BY, 2011, MAR BIOTECHNOL, V13, P557, DOI 10.1007/s10126-010-9326-7; Lee BY, 2003, ANIM GENET, V34, P379, DOI 10.1046/j.1365-2052.2003.01035.x; Lee TL, 2010, BIOINFORMATICS, V26, P585, DOI 10.1093/bioinformatics/btp695; Li MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096248; Lin YT, 2006, RNA, V12, P1486, DOI 10.1261/rna.42206; Liu ZH, 2007, J ENDOCRINOL, V194, P223, DOI 10.1677/JOE-07-0135; Lui WY, 2003, BBA-MOL CELL RES, V1593, P121, DOI 10.1016/S0167-4889(02)00348-8; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagahama Y, 2000, INT S REPR PHYS FIS, P211; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Ocalewicz K, 2009, CHROMOSOME RES, V17, P773, DOI 10.1007/s10577-009-9071-9; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Schwartz TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-694; Senthikumaran B, 2009, MOL CELL ENDOCRINOL, V299, P146, DOI 10.1016/j.mce.2008.11.008; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Small CM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-579; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Sun YL, 2012, FISH PHYSIOL BIOCHEM, V38, P1427, DOI 10.1007/s10695-012-9630-4; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Wang DS, 2005, FISH PHYSIOL BIOCHEM, V31, P255, DOI 10.1007/s10695-006-0033-2; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wen CM, 2005, DEV DYNAM, V232, P171, DOI 10.1002/dvdy.20210; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu YJ, 2011, CELL TISSUE RES, V344, P355, DOI 10.1007/s00441-011-1151-4; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Yano A, 2011, MOL REPROD DEV, V78, P172, DOI 10.1002/mrd.21279; Ybot-Gonzalez P, 2005, DEV DYNAM, V233, P1013, DOI 10.1002/dvdy.20383; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; Yoshiura Y, 2003, BIOL REPROD, V68, P1545, DOI 10.1095/biolreprod.102.010843; Zhang WL, 2010, GEN COMP ENDOCR, V165, P34, DOI 10.1016/j.ygcen.2009.05.018; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379; Zhou LY, 2007, ENDOCRINOLOGY, V148, P4282, DOI 10.1210/en.2007-0487	76	154	161	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63604	10.1371/journal.pone.0063604	http://dx.doi.org/10.1371/journal.pone.0063604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658843	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100074
J	Brenner, C; Bomans, K; Habicht, J; Simon, MM; Wallich, R				Brenner, Christiane; Bomans, Katharina; Habicht, Jueri; Simon, Markus M.; Wallich, Reinhard			Mapping the Ligand-Binding Region of Borrelia hermsii Fibronectin-Binding Protein	PLOS ONE			English	Article							BORNE RELAPSING FEVER; HUMAN-COMPLEMENT REGULATORS; OUTER-MEMBRANE PROTEIN; H-LIKE PROTEIN-1; SURFACE PROTEIN; FUNCTIONAL-CHARACTERIZATION; SPIROCHETAL LIPOPROTEINS; EXTRACELLULAR-MATRIX; C4B-BINDING PROTEIN; ANTIGENIC VARIATION	Many pathogenic microorganisms express fibronectin-binding molecules that facilitate their adherence to the extracellular matrix and/or entry into mammalian cells. We have previously described a Borrelia recurrentis gene, cihC that encodes a 40-kDa surface receptor for both, fibronectin and the complement inhibitors C4bp and C1-Inh. We now provide evidence for the expression of a group of highly homologues surface proteins, termed FbpA, in three B. hermsii isolates and two tick-borne relapsing fever spirochetes, B. parkeri and B. turicatae. When expressed in Escherichia coli or B. burgdorferi, four out of five proteins were shown to selectively bind fibronectin, whereas none of five proteins were able to bind the human complement regulators, C4bp and C1-Inh. By applying deletion mutants of the B. hermsii fibronectin-binding proteins a putative high-affinity binding site for fibronectin was mapped to its central region. In addition, the fibronectin-binding proteins of B. hermsii were found to share sequence homology with BBK32 of the Lyme disease spirochete B. burgdorferi with similar function suggesting its involvement in persistence and/or virulence of relapsing fever spirochetes.	[Brenner, Christiane; Bomans, Katharina; Habicht, Jueri; Simon, Markus M.; Wallich, Reinhard] Heidelberg Univ, Inst Immunol, Infect Immunol Grp, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Wallich, R (corresponding author), Heidelberg Univ, Inst Immunol, Infect Immunol Grp, Neuenheimer Feld 305, Heidelberg, Germany.	wallich@uni-hd.de		Glosse, Katharina/0000-0002-5517-5786	Grimminger-Stiftung fur Zoonosenforschung	Grimminger-Stiftung fur Zoonosenforschung	The authors are indebted for the financial support of the Grimminger-Stiftung fur Zoonosenforschung to Dr. Wallich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR AG, 1990, ANNU REV MICROBIOL, V44, P155, DOI 10.1146/annurev.mi.44.100190.001103; BARBOUR AG, 1991, INFECT IMMUN, V59, P390, DOI 10.1128/IAI.59.1.390-397.1991; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Brinkman MB, 2008, INFECT IMMUN, V76, P1848, DOI 10.1128/IAI.01424-07; Brissette CA, 2008, INFECT IMMUN; Cutler SJ, 1997, INT J SYST BACTERIOL, V47, P958, DOI 10.1099/00207713-47-4-958; Davis H, 2002, PEDIATR INFECT DIS J, V21, P703, DOI 10.1097/00006454-200207000-00020; Dworkin MS, 1998, CLIN INFECT DIS, V26, P122, DOI 10.1086/516273; Fikrig E, 2000, J IMMUNOL, V164, P5344, DOI 10.4049/jimmunol.164.10.5344; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Grab DJ, 1998, BBA-MOL BASIS DIS, V1407, P135, DOI 10.1016/S0925-4439(98)00038-6; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; Grosskinsky S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000698; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Hovis KM, 2006, INFECT IMMUN, V74, P2007, DOI 10.1128/IAI.74.4.2007-2014.2006; Hovis KM, 2004, J BACTERIOL, V186, P2612, DOI 10.1128/JB.186.9.2612-2618.2004; Hyde JA, 2011, MOL MICROBIOLOGY; JOH HJ, 1994, BIOCHEMISTRY-US, V33, P6086, DOI 10.1021/bi00186a007; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; KUHN S, 1995, J IMMUNOL, V155, P5663; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meri T, 2006, INFECT IMMUN, V74, P4157, DOI 10.1128/IAI.00007-06; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Naito M, 1998, J BIOL CHEM, V273, P2905, DOI 10.1074/jbc.273.5.2905; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Porcella SF, 2005, INFECT IMMUN, V73, P6647, DOI 10.1128/IAI.73.10.6647-6658.2005; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Rawlings J A, 1995, Tex Med, V91, P56; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; Schorey JS, 1996, MOL MICROBIOL, V21, P321, DOI 10.1046/j.1365-2958.1996.6381353.x; Schott M, 2010, INFECT IMMUN, V78, P2199, DOI 10.1128/IAI.00089-10; Schwan TG, 2005, J CLIN MICROBIOL, V43, P3851, DOI 10.1128/JCM.43.8.3851-3859.2005; Schwan TG, 2007, EMERG INFECT DIS, V13, P436, DOI 10.3201/eid1303.060958; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699; Walker RL, 2002, J CLIN MICROBIOL, V40, P1558, DOI 10.1128/JCM.40.4.1558-1562.2002; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; WESTERLUND B, 1993, MOL MICROBIOL, V9, P687, DOI 10.1111/j.1365-2958.1993.tb01729.x; Whitney MS, 2007, VET CLIN PATH, V36, P212, DOI 10.1111/j.1939-165X.2007.tb00213.x; Zuckert WR, 2004, INFECT IMMUN, V72, P1463, DOI 10.1128/IAI.72.3.1463-1469.2004; Zuckert WR, 1999, INFECT IMMUN, V67, P3257	53	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63437	10.1371/journal.pone.0063437	http://dx.doi.org/10.1371/journal.pone.0063437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658828	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500070
J	Ulrich, CT; Fung, C; Vatter, H; Setzer, M; Gueresir, E; Seifert, V; Beck, J; Raabe, A				Ulrich, Christian T.; Fung, Christian; Vatter, Hartmut; Setzer, Matthias; Gueresir, Erdem; Seifert, Volker; Beck, Juergen; Raabe, Andreas			Occurrence of Vasospasm and Infarction in Relation to a Focal Monitoring Sensor in Patients after SAH: Placing a Bet when Placing a Probe?	PLOS ONE			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL VASOSPASM; BEDSIDE MICRODIALYSIS; INTRACRANIAL ANEURYSMS; NEUROLOGICAL DEFICITS; SYMPTOMATIC VASOSPASM; TRANSCRANIAL DOPPLER; ARTERIAL SPASM; PREDICTORS; PREVENTION	Introduction: Vasospastic brain infarction is a devastating complication of aneurysmal subarachnoid hemorrhage (SAH). Using a probe for invasive monitoring of brain tissue oxygenation or blood flow is highly focal and may miss the site of cerebral vasospasm (CVS). Probe placement is based on the assumption that the spasm will occur either at the dependent vessel territory of the parent artery of the ruptured aneurysm or at the artery exposed to the focal thick blood clot. We investigated the likelihood of a focal monitoring sensor being placed in vasospasm or infarction territory on a hypothetical basis. Methods: From our database we retrospectively selected consecutive SAH patients with angiographically proven (day 7-14) severe CVS (narrowing of vessel lumen >50%). Depending on the aneurysm location we applied a standard protocol of probe placement to detect the most probable site of severe CVS or infarction. We analyzed whether the placement was congruent with existing CVS/infarction. Results: We analyzed 100 patients after SAH caused by aneurysms located in the following locations: MCA (n = 14), ICA (n = 30), A1CA (n = 4), AcoA or A2CA (n = 33), and VBA (n = 19). Sensor location corresponded with CVS territory in 93% of MCA, 87% of ICA, 76% of AcoA or A2CA, but only 50% of A1CA and 42% of VBA aneurysms. The focal probe was located inside the infarction territory in 95% of ICA, 89% of MCA, 78% of ACoA or A2CA, 50% of A1CA and 23% of VBA aneurysms. Conclusion: The probability that a single focal probe will be situated in the territory of severe CVS and infarction varies. It seems to be reasonably accurate for MCA and ICA aneurysms, but not for ACA or VBA aneurysms.	[Ulrich, Christian T.; Fung, Christian; Beck, Juergen; Raabe, Andreas] Univ Hosp Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland; [Vatter, Hartmut; Setzer, Matthias; Gueresir, Erdem; Seifert, Volker] Goethe Univ Frankfurt, Dept Neurosurg, D-60054 Frankfurt, Germany	University of Bern; University Hospital of Bern; Goethe University Frankfurt	Ulrich, CT (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland.	christian.ulrich@insel.ch	Setzer, Matthias/P-3266-2014; Güresir, Erdem/AAL-4484-2020; Güresir, Erdem/AAV-7224-2021	Güresir, Erdem/0000-0001-8319-0847; Beck, Jurgen/0000-0002-7687-6098	Bern University Hospital; Goethe University Frankfurt/Main	Bern University Hospital; Goethe University Frankfurt/Main	This work was supported by the Bern University Hospital and Goethe University Frankfurt/Main. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bonilha L, 2001, ARQ NEURO-PSIQUIAT, V59, P676, DOI 10.1590/S0004-282X2001000500004; BOTTERELL EH, 1956, J NEUROSURG, V13, P1, DOI 10.3171/jns.1956.13.1.0001; Carrera E, 2009, NEUROSURGERY, V65, P316, DOI 10.1227/01.NEU.0000349209.69973.88; Charpentier C, 1999, STROKE, V30, P1402, DOI 10.1161/01.STR.30.7.1402; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; FINDLAY JM, 1991, CEREBROVAS BRAIN MET, V3, P336; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GRAF CJ, 1974, STROKE, V5, P557, DOI 10.1161/01.STR.5.4.557; Harrod CG, 2005, NEUROSURGERY, V56, P633, DOI 10.1227/01.NEU.0000156644.45384.92; Kivisaari RP, 2001, AM J NEURORADIOL, V22, P1143; Kreiter KT, 2009, STROKE, V40, P2362, DOI 10.1161/STROKEAHA.109.547331; Lasner TM, 1997, J NEUROSURG, V87, P381, DOI 10.3171/jns.1997.87.3.0381; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; McGirt MJ, 2004, NEUROSURGERY, V54, P1369, DOI 10.1227/01.NEU.0000125016.37332.50; McGirt MJ, 2003, J NEUROSURG, V98, P1222, DOI 10.3171/jns.2003.98.6.1222; Raabe A, 2005, J NEUROSURG, V103, P974, DOI 10.3171/jns.2005.103.6.0974; RABB CH, 1994, ACTA NEUROCHIR, V127, P27, DOI 10.1007/BF01808542; Rabinstein AA, 2005, STROKE, V36, P992, DOI 10.1161/01.STR.0000163090.59350.5a; Rabinstein AA, 2004, AM J NEURORADIOL, V25, P1778; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; SAITO I, 1979, Neurologia Medico-Chirurgica, V19, P103, DOI 10.2176/nmc.19.103; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Suarez JI, 2002, CRIT CARE MED, V30, P1348, DOI 10.1097/00003246-200206000-00035; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Weidauer S, 2007, STROKE, V38, P1831, DOI 10.1161/STROKEAHA.106.477976; Weir B, 1998, SUBARACHNOID HEMORRH; WILKINS RH, 1986, NEUROSURGERY, V18, P808, DOI 10.1227/00006123-198606000-00026; WILKINS RH, 1980, NEUROSURGERY, V6, P198, DOI 10.1227/00006123-198002000-00016; Yanaka K, 2001, DRUGS TODAY, V37, P573, DOI 10.1358/dot.2001.37.8.844172; ZABRAMSKI JM, 1986, NEUROSURGERY, V18, P1	35	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62754	10.1371/journal.pone.0062754	http://dx.doi.org/10.1371/journal.pone.0062754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658768	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500035
J	Giroud, S; Frare, C; Strijkstra, A; Boerema, A; Arnold, W; Ruf, T				Giroud, Sylvain; Frare, Carla; Strijkstra, Arjen; Boerema, Ate; Arnold, Walter; Ruf, Thomas			Membrane Phospholipid Fatty Acid Composition Regulates Cardiac SERCA Activity in a Hibernator, the Syrian Hamster (Mesocricetus auratus)	PLOS ONE			English	Article							SQUIRRELS SPERMOPHILUS-LATERALIS; SARCOPLASMIC-RETICULUM; GROUND-SQUIRRELS; DAILY TORPOR; CA-2+-ATPASE ACTIVITY; MARMOTA-FLAVIVENTRIS; ADAPTIVE-MECHANISMS; BODY-TEMPERATURE; CALCIUM-UPTAKE; MAMMALS	Polyunsaturated fatty acids (PUFA) have strong effects on hibernation and daily torpor. Increased dietary uptake of PUFA of the n-6 class, particularly of Linoleic acid (LA, C18:2 n-6) lengthens torpor bout duration and enables animals to reach lower body temperatures (T-b) and metabolic rates. As previously hypothesized, this well-known influence of PUFA may be mediated via effects of the membrane fatty acid composition on sarcoplasmic reticulum (SR) Ca2+- ATPase 2a (SERCA) in the heart of hibernators. We tested the hypotheses that high proportions of n-6 PUFA in general, or specifically high proportions of LA (C18:2 n-6) in SR phospholipids (PL) should be associated with increased cardiac SERCA activity, and should allow animals to reach lower minimum T-b in torpor. We measured activity of SERCA from hearts of hibernating and non-hibernating Syrian hamsters (Mesocricetus auratus) in vitro at 35 degrees C. Further, we determined the PL fatty acid composition of the SR membrane of these hearts. We found that SERCA activity strongly increased as the proportion of LA in SR PL increased but was negatively affected by the content of Docosahexaenoic acid (DHA; C22:6 n-3). SR PL from hibernating hamsters were characterized by high proportions of LA and low proportions of DHA. As a result, SERCA activity was significantly higher during entrance into torpor and in torpor compared to inter-bout arousal. Also, animals with increased SERCA activity reached lower T-b during torpor. Interestingly, a subgroup of hamsters which never entered torpor but remained euthermic throughout winter displayed a phenotype similar to animals in summer. This was characterized by lower proportions of LA and increased proportions of DHA in SR membranes, which is apparently incompatible with torpor. We conclude that the PUFA composition of SR membranes affects cardiac function via modulating SERCA activity, and hence determines the minimum T-b tolerated by hibernators.	[Giroud, Sylvain; Frare, Carla; Arnold, Walter; Ruf, Thomas] Univ Vet Med, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria; [Strijkstra, Arjen] Univ Groningen, Univ Med Ctr Groningen, Dept Chronobiol, Groningen, Netherlands; [Strijkstra, Arjen] Univ Groningen, Univ Med Ctr Groningen, Dept Mol Neurobiol, Groningen, Netherlands; [Strijkstra, Arjen; Boerema, Ate] Univ Groningen, Dept Chronobiol, Groningen, Netherlands; [Strijkstra, Arjen] Univ Appl Sci Van Hall Larenstein, Leeuwarden, Netherlands; [Boerema, Ate] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands	University of Veterinary Medicine Vienna; University of Groningen; University of Groningen; University of Groningen; Wageningen University & Research; University of Groningen	Giroud, S (corresponding author), Univ Vet Med, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria.	sylvain.giroud@vetmeduni.ac.at	Arnold, Walter/C-3394-2013; Boerema, A.S./W-9810-2018; Giroud, Sylvain/AAG-6430-2019	Arnold, Walter/0000-0001-6785-5685; Boerema, A.S./0000-0002-4771-5156; Giroud, Sylvain/0000-0001-6621-7462; Ruf, Thomas/0000-0002-9235-7079; Frare, Carla/0000-0001-8822-5893	University of Veterinary Medicine Vienna (Austria)	University of Veterinary Medicine Vienna (Austria)	SG and this research work were financially supported by a postdoctoral fellowship of the University of Veterinary Medicine Vienna (Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia RC, 1979, CHEM ZOOL, V11; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Arnold W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018641; BELKE DD, 1991, CRYOBIOLOGY, V28, P354, DOI 10.1016/0011-2240(91)90042-M; BELKE DD, 1987, J THERM BIOL, V12, P53, DOI 10.1016/0306-4565(87)90035-0; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Boerema A. S, 2012, THESIS U GRONINGEN N; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; Braulke LJ, 2010, CRYOBIOLOGY, V60, P198, DOI 10.1016/j.cryobiol.2009.11.001; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Bruns U, 2000, LIFE IN THE COLD, P215; Chritie WW, 1996, LIPID ANAL; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; EDER K, 1995, J CHROMATOGR B, V671, P113, DOI 10.1016/0378-4347(95)00142-6; Elvert R, 2005, J EXP BIOL, V208, P1373, DOI 10.1242/jeb.01546; FLORANT GL, 1993, AM J PHYSIOL, V264, pR747, DOI 10.1152/ajpregu.1993.264.4.R747; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRANK CL, 1992, PHYSIOL ZOOL, V65, P906, DOI 10.1086/physzool.65.5.30158549; FRANK CL, 1995, J COMP PHYSIOL B, V164, P536; Frank CL, 2004, 12 INT HIB S BIOL PA, P71; GEISER F, 1993, CAN J ZOOL, V71, P1182, DOI 10.1139/z93-161; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; GEISER F, 1987, AM J PHYSIOL, V252, pR897, DOI 10.1152/ajpregu.1987.252.5.R897; Geiser F, 2007, NATURWISSENSCHAFTEN, V94, P319, DOI 10.1007/s00114-006-0193-z; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Hampton M, 2010, AM J PHYSIOL-REG I, V299, pR1478, DOI 10.1152/ajpregu.00273.2010; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Hill VL, 2000, PHYSIOL BEHAV, V68, P431, DOI 10.1016/S0031-9384(99)00177-8; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Johansson BW, 1996, CARDIOVASC RES, V31, P826, DOI 10.1016/S0008-6363(95)00192-1; Leaf A, 2003, PHARMACOL THERAPEUT, V98, P355, DOI 10.1016/S0163-7258(03)00039-1; LINDEMANN JP, 1983, J BIOL CHEM, V258, P464; Liu B, 1997, AM J PHYSIOL-REG I, V272, pR1121, DOI 10.1152/ajpregu.1997.272.4.R1121; LYMAN CHARLES P., 1960, BULL MUS COMP ZOOL HARVARD UNIV, V124, P353; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Milsom WK, 1999, COMP BIOCHEM PHYS A, V124, P383, DOI 10.1016/S1095-6433(99)00130-0; MROSOVSKY N, 1978, STRATEGIES COLD NATU, P21; Oklejewicz M, 2001, J COMP PHYSIOL B, V171, P431; Ortmann S, 2000, AM J PHYSIOL-REG I, V278, pR698, DOI 10.1152/ajpregu.2000.278.3.R698; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; R Core Team, 2020, R LANG ENV STAT COMP; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Ruf T, 2008, AM J PHYSIOL-REG I, V294, pR1044, DOI 10.1152/ajpregu.00688.2007; SIMONIDES WS, 1990, ANAL BIOCHEM, V191, P321, DOI 10.1016/0003-2697(90)90226-Y; STRUMWASSER F, 1959, AM J PHYSIOL, V196, P15, DOI 10.1152/ajplegacy.1958.196.1.15; SWANSON JE, 1989, J NUTR, V119, P364, DOI 10.1093/jn/119.3.364; TAFFET GE, 1993, J MEMBRANE BIOL, V131, P35, DOI 10.1007/BF02258532; Talaei F, 2011, J EXP BIOL, V214, P1276, DOI 10.1242/jeb.052704; THORP CR, 1994, PHYSIOL ZOOL, V67, P1213, DOI 10.1086/physzool.67.5.30163890; Ushio H, 1997, COMP BIOCHEM PHYS B, V118, P681, DOI 10.1016/S0305-0491(97)00229-0; Wang SQ, 2002, J EXP BIOL, V205, P2957; Yatani A, 2004, AM J PHYSIOL-HEART C, V286, pH2219, DOI 10.1152/ajpheart.01096.2003; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; [No title captured]	55	62	64	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63111	10.1371/journal.pone.0063111	http://dx.doi.org/10.1371/journal.pone.0063111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650545	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000090
J	Gravina, HD; Antonelli, L; Gazzinelli, RT; Ropert, C				Gravina, Humberto D.; Antonelli, Lis; Gazzinelli, Ricardo T.; Ropert, Catherine			Differential Use of TLR2 and TLR9 in the Regulation of Immune Responses during the Infection with Trypanosoma cruzi	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; DENDRITIC CELLS; CUTTING EDGE; SIGNALING PATHWAYS; GAMMA-INTERFERON; ACTIVATION; MACROPHAGES; EXPRESSION; MICE; COOPERATION	Pathogens express ligands for several TLRs that may play a role in the induction or control of the inflammatory response during infection. Concerning Trypanosoma cruzi, the agent of Chagas disease, we have previously characterized glycosylphosphatidylinositol (GPI) anchored mucin-like glycoproteins (tGPI-mucin) and unmethylated CpG DNA sequences as TLR2 and TLR9 agonists, respectively. Here we sought to determine how these TLRs may modulate the inflammatory response in the following cell populations: F4/80(+)CD11b(+) (macrophages), F4/80(low)CD11b(+) (monocytes) and MHCII+ CD11-c(high) (dendritic cells). For this purpose, TLR2(-/-) and TLR9(-/-) mice were infected with Y strain of T. cruzi and different immunological parameters were evaluated. According to our previous data, a crucial role of TLR9 was evidenced in the establishment of Th1 response, whereas TLR2 appeared to act as immunoregulator in the early stage of infection. More precisely, we demonstrated here that TLR2 was mainly used by F4/80(+)CD11b(+) cells for the production of TNF-alpha. In the absence of TLR2, an increased production of IL-12/IL-23p40 and IFN-gamma was noted suggesting that TLR2 negatively controls the Th1 response. In contrast, TLR9 was committed to IL-12/IL-23p40 production by MHCII(+)CD11c(high) cells that constitute the main source of IL-12/IL-23p40 during infection. Importantly, a down-regulation of TLR9 response was observed in F4/80(+)CD11b(+) and F4/80(low)CD11b(+) populations that correlated with the decreased TLR9 expression level in these cells. Interestingly, these cells recovered their capacity to respond to TLR9 agonist when MHCII(+)CD11c(high) cells were impeded from producing IL-12/IL-23p40, thereby indicating possible cross-talk between these populations. The differential use of TLR2 and TLR9 by the immune cells during the acute phase of the infection explains why TLR9-but not TLR2-deficient mice are susceptible to T. cruzi infection.	[Antonelli, Lis; Gazzinelli, Ricardo T.; Ropert, Catherine] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Gravina, Humberto D.; Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; University of Massachusetts System; University of Massachusetts Worcester	Ropert, C (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	cropert@hotmail.com	Ropert, Catherine/AAL-7302-2021; Antonelli, Lis/G-2907-2012; Gravina, H D/F-2831-2016; Antonelli, Lis/R-4910-2019; Antonelli, Guido/K-7915-2016; Ropert, Catherine/G-2463-2012	Ropert, Catherine/0000-0002-3077-714X; Gravina, H D/0000-0002-5006-8869; Antonelli, Lis/0000-0002-4969-8812; Gazzinelli, Ricardo/0000-0003-2427-7699	Rede Mineira de Biomoleculas - Fundacao de Amparo as Pesquisa do Estado de Minas Gerais (FAPEMIG); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV) - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Atlantic Philanthropies Program of Clinical Discovery from the Ludwig Institute of Cancer Research	Rede Mineira de Biomoleculas - Fundacao de Amparo as Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV) - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Atlantic Philanthropies Program of Clinical Discovery from the Ludwig Institute of Cancer Research	This study was funded by Rede Mineira de Biomoleculas - Fundacao de Amparo as Pesquisa do Estado de Minas Gerais (FAPEMIG), the Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV) - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and by the Atlantic Philanthropies Program of Clinical Discovery from the Ludwig Institute of Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2006, J IMMUNOL, V176, P5788, DOI 10.4049/jimmunol.176.10.5788; Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Bartholomeu DC, 2008, J IMMUNOL, V181, P1333, DOI 10.4049/jimmunol.181.2.1333; Bhan U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009896; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Cardillo F, 1996, INFECT IMMUN, V64, P128, DOI 10.1128/IAI.64.1.128-134.1996; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Ford AQ, 2009, J IMMUNOL S, V182, P79; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Hou BD, 2011, P NATL ACAD SCI USA, V108, P278, DOI 10.1073/pnas.1011549108; Hunter CA, 1997, J IMMUNOL, V158, P3311; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; Lima ESL, 2007, INFECT IMMUN, V65, P457; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Pompei L, 2007, J IMMUNOL, V178, P5192, DOI 10.4049/jimmunol.178.8.5192; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rodrigues Mauricio M., 2012, Journal of Parasitology Research, P507874, DOI 10.1155/2012/507874; Ropert C, 2004, J ENDOTOXIN RES, V10, P425, DOI 10.1179/096805104225006507; Sengupta D, 2010, J IMMUNOL, V184, P956, DOI 10.4049/jimmunol.0902008; Sieve AN, 2010, EUR J IMMUNOL, V40, P2236, DOI 10.1002/eji.200939759; Silva GK, 2010, J IMMUNOL, V184, P1148, DOI 10.4049/jimmunol.0902254; SILVA JS, 1995, INFECT IMMUN, V63, P4862, DOI 10.1128/IAI.63.12.4862-4867.1995; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Wang J, 2009, MICROBES INFECT, V11, P321, DOI 10.1016/j.micinf.2008.12.011; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713	41	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63100	10.1371/journal.pone.0063100	http://dx.doi.org/10.1371/journal.pone.0063100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650544	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000089
J	Ke, JT; Zhong, R; Zhang, T; Liu, LF; Rui, R; Shen, N; Sun, Y; Liu, L; Cheng, LM; Miao, XP				Ke, Juntao; Zhong, Rong; Zhang, Ti; Liu, Lifeng; Rui, Rui; Shen, Na; Sun, Yu; Liu, Li; Cheng, Liming; Miao, Xiao-Ping			Replication Study in Chinese Population and Meta-Analysis Supports Association of the 5p15.33 Locus with Lung Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIATION; SUSCEPTIBILITY LOCUS; VARIANTS; RISK; POLYMORPHISMS; TELOMERASE; EXPRESSION; IMPACT; TERT	Background: Common genetic polymorphisms on chromosome 5p15.33, including rs401681 in cleft lip and palate transmembrane 1-like gene (CLPTM1L), have been implicated in susceptibility to lung cancer through genome-wide association studies (GWAS); however, subsequent replication studies yielded controversial results. Methodology and Findings: A hospital-based case-control study in a Chinese population was conducted to replicate the association, and then a meta-analysis combining our non-overlapping new data and previously published data was performed to clearly discern the real effect of lung cancer susceptibility. In our study with 611 cases and 1062 controls, the minor allele T carrier (TT plus CT) group conferred an OR of 0.801 (95% CI = 0.654-0.981) under the dominant model. The meta-analysis comprising 9111 cases and 11424 controls further confirmed the significant association in the dominant model (OR = 0.842, 95% CI = 0.795-0.891). By stratified analysis, we revealed that ethnicity and study design might constitute the source of between-study heterogeneity. Besides, the sensitivity and cumulative analyses indicated the high stability of the results. Conclusion: The results from our case-control study and meta-analysis provide convincing evidence that rs401681 is significantly associated with lung cancer risk.	[Ke, Juntao; Zhong, Rong; Zhang, Ti; Liu, Lifeng; Rui, Rui; Shen, Na; Sun, Yu; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat,Tongji Med Co, Minist Environm Protect,Key Lab Environm & Hlth, Minist Educ,Dept Epidemiol & Biostat,Sch Publ Hlt, Wuhan 430074, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China; [Cheng, Liming] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Guangdong Pharmaceutical University; Huazhong University of Science & Technology	Liu, L (corresponding author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China.	pupuliu919@gmail.com; chengliming@tjh.tjmu.edu.cn; miaoxp@mail.hust.edu.cn	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011; Xiao, Hu/GMX-0258-2022	miao, xiaoping/0000-0002-6818-9722; 	Program for New Century Excellent Talents in University [NCET-10-0388]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the Program for New Century Excellent Talents in University [NCET-10-0388 to MX]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Asakura T, 2005, ONCOL REP, V14, P601; Bae EY, 2012, RESPIROLOGY, V17, P699, DOI 10.1111/j.1440-1843.2012.02165.x; Baird DM, 2010, EXPERT REV MOL MED, P12; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Chen Wan-qing, 2009, Zhonghua Zhong Liu Za Zhi, V31, P664; Chen XF, 2012, GENET MOL RES, V11, P370, DOI 10.4238/2012.February.16.2; Colombo J, 2009, ONCOL REP, V21, P649, DOI 10.3892/or_00000268; Crawford DC, 2012, PLOS ONE, V7; Deb SP, 2012, PLOS ONE, V7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kohno T, 2010, CARCINOGENESIS, V31, P834, DOI 10.1093/carcin/bgq003; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; MANTEL N, 1959, J NATL CANCER I, V22, P719; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Mullen B, 2001, PERS SOC PSYCHOL B, V27, P1450, DOI 10.1177/01461672012711006; Pabalan NA, 2010, ASIAN PAC J CANCER P, V11, P33; Pande M, 2011, CARCINOGENESIS, V32, P1493, DOI 10.1093/carcin/bgr136; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yoon KA, 2010, HUM MOL GENET, V19, P4948, DOI 10.1093/hmg/ddq421; Yoshiura K, 1998, GENOMICS, V54, P231, DOI 10.1006/geno.1998.5577; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zhong H, 2009, GENETIC EPIDEMIOLOGY, pn/a; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	41	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62485	10.1371/journal.pone.0062485	http://dx.doi.org/10.1371/journal.pone.0062485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23653681	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300066
J	Vincelette, RL; Roth, CC; McConnell, MP; Payne, JA; Beier, HT; Ibey, BL				Vincelette, Rebecca L.; Roth, Caleb C.; McConnell, Maureen P.; Payne, Jason A.; Beier, Hope T.; Ibey, Bennett L.			Thresholds for Phosphatidylserine Externalization in Chinese Hamster Ovarian Cells following Exposure to Nanosecond Pulsed Electrical Fields (nsPEF)	PLOS ONE			English	Article							PLASMA-MEMBRANE PERMEABILIZATION; ERYTHROCYTE-MEMBRANE; MAMMALIAN-CELLS; ELECTROPORATION; PHOSPHOLIPIDS; SUBMICROSECOND; TRANSLOCATION; MECHANISMS; TISSUES	High-amplitude, MV/m, nanosecond pulsed electric fields (nsPEF) have been hypothesized to cause nanoporation of the plasma membrane. Phosphatidylserine (PS) externalization has been observed on the outer leaflet of the membrane shortly after nsPEF exposure, suggesting local structural changes in the membrane. In this study, we utilized fluorescently-tagged Annexin V to observe the externalization of PS on the plasma membrane of isolated Chinese Hamster Ovary (CHO) cells following exposure to nsPEF. A series of experiments were performed to determine the dosimetric trends of PS expression caused by nsPEF as a function of pulse duration, tau, delivered field strength, E-D, and pulse number, n. To accurately estimate dose thresholds for cellular response, data were reduced to a set of binary responses and ED50s were estimated using Probit analysis. Probit analysis results revealed that PS externalization followed the non-linear trend of (tau*E-D(2))(-1) for high amplitudes, but failed to predict low amplitude responses. A second set of experiments was performed to determine the nsPEF parameters necessary to cause observable calcium uptake, using cells preloaded with calcium green (CaGr), and membrane permeability, using FM1-43 dye. Calcium influx and FM1-43 uptake were found to always be observed at lower nsPEF exposure parameters compared to PS externalization. These findings suggest that multiple, higher amplitude and longer pulse exposures may generate pores of larger diameter enabling lateral diffusion of PS; whereas, smaller pores induced by fewer, lower amplitude and short pulse width exposures may only allow extracellular calcium and FM1-43 uptake.	[Vincelette, Rebecca L.; Beier, Hope T.] CNR, Ft Sam Houston, TX USA; [Roth, Caleb C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol Sci, San Antonio, TX 78229 USA; [McConnell, Maureen P.; Payne, Jason A.; Ibey, Bennett L.] Air Force Res Lab, Radio Frequency Bioeffects Branch, Ft Sam Houston, TX USA	University of Texas System; University of Texas Health San Antonio	Ibey, BL (corresponding author), Air Force Res Lab, Radio Frequency Bioeffects Branch, Ft Sam Houston, TX USA.	BennettIbey@gmail.com	Roth, Caleb/Y-1487-2019	Roth, Caleb/0000-0001-8962-1097; Beier, Hope/0000-0002-6291-118X	Air Force Office of Scientific Research [AFOSR-LRIR 09RH09COR]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This study was supported by a grant from the Air Force Office of Scientific Research (AFOSR-LRIR 09RH09COR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PHYS BIOL, V3, P233; Cain C. P., 1996, USAF TECHNICAL REPOR; *CLIPP CONTR INC, 2005, DIEL CONST REF GUID; DRESSLER V, 1983, BIOCHIM BIOPHYS ACTA, V732, P304, DOI 10.1016/0005-2736(83)90216-X; Finney D.J., 1971, PROBIT ANAL; Foster KR, 1998, BIOELECTROMAGNETICS, V19, P420, DOI 10.1002/(SICI)1521-186X(1998)19:7<420::AID-BEM3>3.0.CO;2-3; Haest CWM, 1997, BBA-BIOMEMBRANES, V1325, P17, DOI 10.1016/S0005-2736(96)00239-8; HIBINO M, 1993, BIOPHYS J, V64, P1789, DOI 10.1016/S0006-3495(93)81550-9; Hu Q, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031902; Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; Ibey BL, 2009, BIOELECTROMAGNETICS, V30, P92, DOI 10.1002/bem.20451; Kim JM, 2005, J MICROMECH MICROENG, V15, P543, DOI 10.1088/0960-1317/15/3/015; Krassowska W, 2007, BIOPHYS J, V92, P404, DOI 10.1529/biophysj.106.094235; Levine ZA, 2010, J MEMBRANE BIOL; Neumann E., 1989, ELECTROPORATION ELEC; Pakhomov AG, 2010, ADV ELECTROPORATION; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Saulis G, 1999, Biomed Sci Instrum, V35, P409; Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468; Schoenbach KH, 2002, IEEE T PLASMA SCI, V30, P293, DOI 10.1109/TPS.2002.1003873; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Smith KC, BIOCH BIOPHYSICAL RE, V412, P8; Smith KC, 2008, BIOPHYS J, V95, P1547, DOI 10.1529/biophysj.107.121921; Sun YH, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2187970; Taflove A., 1995, COMPUTATIONAL ELECTR; Teissie J, 1999, ADV DRUG DELIVER REV, V35, P3, DOI 10.1016/S0169-409X(98)00060-X; TEKLE E, 1991, P NATL ACAD SCI USA, V88, P4230, DOI 10.1073/pnas.88.10.4230; Tekle E, 2001, BIOPHYS J, V81, P960, DOI 10.1016/S0006-3495(01)75754-2; Vasilkoski Z, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021904; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Vernier PT, 2008, BIOELECTROCHEMISTRY, V73, P1, DOI 10.1016/j.bioelechem.2008.02.003; Vernier PT, 2006, J AM CHEM SOC, V128, P6288, DOI 10.1021/ja0588306; Vernier PT, 2004, FEBS LETT, V572, P103, DOI 10.1016/j.febslet.2004.07.021; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Weaver JC, 2003, IEEE T DIELECT EL IN, V10, P754, DOI 10.1109/TDEI.2003.1237325; Wu Y, 2011, BIOCHEMISTRY-US, V50, P7493, DOI 10.1021/bi2006288; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Zaharoff DA, 2008, EXP BIOL MED, V233, P94, DOI 10.3181/0704-RM-113; Zimmeramann U, 1996, EFFECT HIGH INTENSIT	44	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e63122	10.1371/journal.pone.0063122	http://dx.doi.org/10.1371/journal.pone.0063122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658665	Green Published, gold, Green Submitted			2022-12-27	WOS:000321662800077
J	Wang, BB; Zhe, MJ; Chen, ZY; Li, CF; Meng, CC; Zhang, MT; Liu, GQ				Wang, Binbin; Zhe, Mingjia; Chen, Zongyan; Li, Chuanfeng; Meng, Chunchun; Zhang, Miaotao; Liu, Guangqing			Construction and Applications of Rabbit Hemorrhagic Disease Virus Replicon	PLOS ONE			English	Article							GENOME-LINKED PROTEIN; 3C-LIKE PROTEASE; VPG; IDENTIFICATION; CALICIVIRUS; SYSTEM; RNAS	The study of rabbit hemorrhagic disease virus (RHDV) has long been hindered by the absence of an in vitro culture system. In this study, using RHDV as a model, a series of DNA-based reporter replicons were constructed in which the firefly luciferase (Fluc) gene was fused in-frame with the open reading frame of the replicon. In this construct, the Fluc gene was inserted where the coding region of viral structural protein was deleted and was under the control of a minimal cytomegalovirus (CMV) immediate-early promoter. Fluc activity analysis showed that these reporter replicons replicate efficiently in mammalian cells. On the basis of the replicon, 5'non-coding regions (5'NCR) and genome-linked protein (VPg) were deleted, and the effect on the expression of replicon was analyzed. The results showed that the expression level of Fluc was reduced in the absence of 5'NCR and VPg, suggesting that the 5'NCR and VPg may play an important role in replication and/or translation of RHDV. To further verify the speculation, we also constructed a replication deficient mutant (pRHDV-luc/Delta 3D), and the impact of 5'NCR and VPg deletion on viral translation efficiency was analyzed, our results indicated that both VPg and 5'NCR were involved in RHDV translation.	[Wang, Binbin; Zhe, Mingjia; Chen, Zongyan; Li, Chuanfeng; Meng, Chunchun; Liu, Guangqing] CAAS, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Wang, Binbin; Zhe, Mingjia; Zhang, Miaotao] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Northwest A&F University - China	Liu, GQ (corresponding author), CAAS, Shanghai Vet Res Inst, Shanghai, Peoples R China.	liugq@shvri.ac.cn	chen, zongyan/ABG-9170-2021		Chinese Natural Sciences Foundation [31270194, 31101848]; Fundamental Research Funds for the Central Institutes program [2011JB06, 2011JB13]; Special Fund for Agro-scientific Research in the Public Interest [201003012]; National Advanced Technology Research and Development Program of China (863 Program) [2011AA10A200]	Chinese Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Institutes program; Special Fund for Agro-scientific Research in the Public Interest; National Advanced Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Chinese Natural Sciences Foundation (31270194, 31101848), the Fundamental Research Funds for the Central Institutes program (2011JB06, 2011JB13), Special Fund for Agro-scientific Research in the Public Interest (201003012), and the National Advanced Technology Research and Development Program of China (863 Program) (2011AA10A200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-12; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Clarke IN, 1997, J GEN VIROL, V78, P291, DOI 10.1099/0022-1317-78-2-291; CUBBIT D, 1995, ARCH VIROL         S, V10, P359; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; Han KR, 2010, J GEN VIROL, V91, P1711, DOI 10.1099/vir.0.020461-0; Hass M, 2004, J VIROL, V78, P13793, DOI 10.1128/JVI.78.24.13793-13803.2004; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; Joubert P, 2000, J GEN VIROL, V81, P481, DOI 10.1099/0022-1317-81-2-481; LAWSON M, 1995, NATURE, V378, P531, DOI 10.1038/378531b0; Liu GQ, 2006, CHINESE SCI BULL, V51, P1698, DOI 10.1007/s11434-006-2044-x; Liu GQ, 2008, J GEN VIROL, V89, P3080, DOI 10.1099/vir.0.2008/003525-0; Machin A, 2001, J BIOL CHEM, V276, P27787, DOI 10.1074/jbc.M100707200; MEYERS G, 1991, VIROLOGY, V184, P677, DOI 10.1016/0042-6822(91)90437-G; Mitra T, 2004, J VIROL, V78, P4931, DOI 10.1128/JVI.78.9.4931-4935.2004; RASSCHAERT D, 1995, VIRUS GENES, V9, P121, DOI 10.1007/BF01702655; Thiel HJ, 1999, VET MICROBIOL, V69, P55, DOI 10.1016/S0378-1135(99)00088-7; WIRBLICH C, 1995, J VIROL, V69, P7159, DOI 10.1128/JVI.69.11.7159-7168.1995	20	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e60316	10.1371/journal.pone.0060316	http://dx.doi.org/10.1371/journal.pone.0060316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667425	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600005
J	Barbosa, CEA; Misiewicz, TM; Fine, PVA; Costa, FRC				Barbosa, Carlos Eduardo A.; Misiewicz, Tracy M.; Fine, Paul V. A.; Costa, Flavia R. C.			Plant Ontogeny, Spatial Distance, and Soil Type Influence Patterns of Relatedness in a Common Amazonian Tree	PLOS ONE			English	Article							MESOSCALE DISTRIBUTION PATTERNS; RAIN-FOREST TREE; GENETIC-STRUCTURE; NEOTROPICAL TREE; SEED DISPERSAL; TROPICAL TREE; COMPUTER-PROGRAM; HABITAT SPECIALIZATION; SCALE; POPULATION	The formation of spatial genetic structure (SGS) may originate from different patterns of seed deposition in the landscape, and is mostly determined by seed dispersal limitation. After dispersal, mechanisms such as filtering by environmental factors or attack by herbivores/pathogens throughout plant development stages, and potentially either disrupt or intensify SGS patterns. We investigated how the genotype of Protium subserratum (Burseraceae), a common tree species in the Ducke Reserve, Brazil, is distributed across the landscape. We used seven microsatellite markers to assess the SGS among plants at different life stages and in different environments. By quantifying the patterns of relatedness among plants of different sizes, we inferred the ontogenetic stage in which SGS changes occurred, and compared these effects across soil types. Relatedness among seedlings decreased when distance between seedlings increased, especially for the youngest seedlings. However, this trend was not continued by older plants, as relatedness values were higher among neighboring individuals of the juvenile and adult size class. Contrasting relatedness patterns between seedlings and larger individuals suggests a trade-off between the negative effects of being near closely-related adults (e. g. due to herbivore and pathogen attack) and the advantage of being in a site favorable to establishment. We also found that soil texture strongly influenced density-dependence patterns, as young seedlings in clay soils were more related to each other than were seedlings in bottomland sandy soils, suggesting that the mechanisms that create and maintain patterns of SGS within a population may interact with environmental heterogeneity.	[Barbosa, Carlos Eduardo A.] INPA, Grad Program Ecol, Manaus, Amazonas, Brazil; [Misiewicz, Tracy M.; Fine, Paul V. A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Costa, Flavia R. C.] INPA, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; University of California System; University of California Berkeley; Institute Nacional de Pesquisas da Amazonia	Barbosa, CEA (corresponding author), INPA, Grad Program Ecol, Manaus, Amazonas, Brazil.	cadubarbosa@gmail.com	Costa, Flavia/K-4386-2014; de Araujo Barbosa, Carlos Eduardo/E-2232-2012	Costa, Flavia/0000-0002-9600-4625; Fine, Paul/0000-0002-0550-5628; Misiewicz, Tracy/0000-0002-2683-8405	Brazilian National Research Council (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq/Universal [473447/2008-5]; CNPq/CT-Amazonia [575637/2008-0]; National Science Foundation [DEB 0919567]; Vincent Coates Fund at the University of California, Berkeley	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/CT-Amazonia(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF)); Vincent Coates Fund at the University of California, Berkeley(University of California System)	This study was funded with a PhD fellowship from the Brazilian National Research Council (CNPq) to CEAB during field work and manuscript elaboration and a Sandwich fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) throughout laboratory work. Financial support was granted by CNPq/Universal (473447/2008-5) to FRCC, CNPq/CT-Amazonia (575637/2008-0) to Bruce W. Nelson, the National Science Foundation (DEB 0919567) and the Vincent Coates Fund at the University of California, Berkeley to PVAF. Logistical support was provided by Instituto Nacional de Pesquisas da Amazonia (INPA) and Brazilian Biodiversity Research Program (PPBio). Data repositories are maintained by PPBio, Brazilian Long-Term Ecological Research Program (PELD) and the National Institute of Science and Technology for Amazonian Biodiversity (INCT - CENBAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Loayza P, 2011, J ECOL, V99, P1045, DOI 10.1111/j.1365-2745.2011.01835.x; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Born C, 2008, MOL ECOL, V17, P2041, DOI 10.1111/j.1365-294X.2007.03685.x; Brenes-Arguedas T, 2005, OIKOS, V108, P410, DOI 10.1111/j.0030-1299.2005.13473.x; Costa FRC, 2010, NAT CONSERVACAO, V8, P3, DOI 10.4322/natcon.00801001; Choo J, 2012, MOL ECOL, V21, P1019, DOI 10.1111/j.1365-294X.2011.05425.x; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; CONNELL J H, 1971, P298; Costa FRC, 2009, J VEG SCI, V20, P69, DOI 10.1111/j.1654-1103.2009.05314.x; Costa FRC, 2005, J ECOL, V93, P863, DOI 10.1111/j.1365-2745.2005.01020.x; CRAWLEY MJ, 1990, PHILOS T R SOC B, V330, P125, DOI 10.1098/rstb.1990.0187; Daly DC, 2011, SYST BOT, V36, P939, DOI 10.1600/036364411X604958; De Steven D, 2002, ECOLOGY, V83, P2315, DOI 10.1890/0012-9658(2002)083[2315:COVRFS]2.0.CO;2; Epperson Bryan K., 2000, Plant Species Biology, V15, P269, DOI 10.1046/j.1442-1984.2000.00046.x; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Fine PVA, 2013, J BIOGEOGR, V40, P646, DOI 10.1111/j.1365-2699.2011.02645.x; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Fisher R.A., 1958, STAT METHODS RES WOR; Gonzales E, 2010, J HERED, V101, P133, DOI 10.1093/jhered/esp101; GUILLAUMET J-L, 1982, Acta Amazonica, V12, P61; Hampe A, 2010, MOL ECOL, V19, P459, DOI 10.1111/j.1365-294X.2009.04492.x; Hamrick JL, 2011, ACTA OECOL, V37, P641, DOI 10.1016/j.actao.2011.05.008; HAMRICK JL, 1993, VEGETATIO, V108, P281; Hardesty BD, 2005, HEREDITY, V95, P290, DOI 10.1038/sj.hdy.6800714; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jones FA, 2006, MOL ECOL, V15, P3205, DOI 10.1111/j.1365-294X.2006.03023.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karubian J, 2010, MOL ECOL, V19, P1745, DOI 10.1111/j.1365-294X.2010.04600.x; Kinupp VF, 2005, J TROP ECOL, V21, P363, DOI 10.1017/S0266467405002440; LANGENHEIM JH, 1983, BIOCHEM SYST ECOL, V11, P97, DOI 10.1016/0305-1978(83)90006-6; Latouche-Halle C, 2003, HEREDITY, V91, P181, DOI 10.1038/sj.hdy.6800296; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Misiewicz TM, 2012, AM J BOT, V99, pE465, DOI 10.3732/ajb.1200229; MOLOFSKY J, 1992, ECOLOGY, V73, P68, DOI 10.2307/1938721; Muller-Landau H. C., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P35, DOI 10.1079/9780851995250.0035; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Poorter L, 2007, AM NAT, V169, P433, DOI 10.1086/512045; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schupp E. W., 2007, Seed dispersal: theory and its application in a changing world, P445, DOI 10.1079/9781845931650.0445; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Schurr FM, 2008, J ECOL, V96, P628, DOI 10.1111/j.1365-2745.2008.01371.x; Sezen UU, 2009, P ROY SOC B-BIOL SCI, V276, P2037, DOI 10.1098/rspb.2008.1793; Smith DS, 2012, PLANT SOIL, V352, P243, DOI 10.1007/s11104-011-0992-7; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Steinitz O, 2011, MOL ECOL, V20, P4152, DOI 10.1111/j.1365-294X.2011.05203.x; Thomas SC, 1996, EVOL ECOL, V10, P517, DOI 10.1007/BF01237882; Troupin D, 2006, MOL ECOL, V15, P3617, DOI 10.1111/j.1365-294X.2006.03047.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zhou HP, 2010, J ECOL, V98, P1168, DOI 10.1111/j.1365-2745.2010.01683.x	63	4	4	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62639	10.1371/journal.pone.0062639	http://dx.doi.org/10.1371/journal.pone.0062639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667502	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700052
J	Khoury, DS; Barron, AB; Myerscough, MR				Khoury, David S.; Barron, Andrew B.; Myerscough, Mary R.			Modelling Food and Population Dynamics in Honey Bee Colonies	PLOS ONE			English	Article							DIVISION-OF-LABOR; BEHAVIORAL MATURATION; SURVIVAL; TEMPERATURE; NUTRITION; WORK	Honey bees (Apis mellifera) are increasingly in demand as pollinators for various key agricultural food crops, but globally honey bee populations are in decline, and honey bee colony failure rates have increased. This scenario highlights a need to understand the conditions in which colonies flourish and in which colonies fail. To aid this investigation we present a compartment model of bee population dynamics to explore how food availability and bee death rates interact to determine colony growth and development. Our model uses simple differential equations to represent the transitions of eggs laid by the queen to brood, then hive bees and finally forager bees, and the process of social inhibition that regulates the rate at which hive bees begin to forage. We assume that food availability can influence both the number of brood successfully reared to adulthood and the rate at which bees transition from hive duties to foraging. The model predicts complex interactions between food availability and forager death rates in shaping colony fate. Low death rates and high food availability results in stable bee populations at equilibrium (with population size strongly determined by forager death rate) but consistently increasing food reserves. At higher death rates food stores in a colony settle at a finite equilibrium reflecting the balance of food collection and food use. When forager death rates exceed a critical threshold the colony fails but residual food remains. Our model presents a simple mathematical framework for exploring the interactions of food and forager mortality on colony fate, and provides the mathematical basis for more involved simulation models of hive performance.	[Khoury, David S.; Myerscough, Mary R.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Barron, Andrew B.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Myerscough, Mary R.] Univ Sydney, Ctr Math Biol, Sydney, NSW 2006, Australia	University of Sydney; Macquarie University; University of Sydney	Myerscough, MR (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia.	mary.myerscough@sydney.edu.au	Khoury, David/AAD-8772-2020	Khoury, David/0000-0002-2663-1551; Barron, Andrew/0000-0002-8135-6628; Myerscough, Mary/0000-0002-4993-765X	Hermon Slade Foundation grant	Hermon Slade Foundation grant	This work was supported by a Hermon Slade Foundation grant to ABB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher MA, 2010, ECOL MODEL, V221, P769, DOI 10.1016/j.ecolmodel.2009.11.016; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Blaschon B, 1999, ENTOMOL GEN, V24, P49; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; DEGRANDIHOFFMAN G, 1989, ECOL MODEL, V45, P133, DOI 10.1016/0304-3800(89)90088-4; Fahrbach SE, 1996, DEV NEUROSCI-BASEL, V18, P102, DOI 10.1159/000111474; FRANKS NR, 1994, ANIM BEHAV, V48, P470, DOI 10.1006/anbe.1994.1261; HARBO JR, 1993, J APICULT RES, V32, P11, DOI 10.1080/00218839.1993.11101282; HARBO JR, 1986, J APICULT RES, V25, P22, DOI 10.1080/00218839.1986.11100687; Huang ZY, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P165; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; Kearns C. A., 1993, TECHNIQUES POLLINATI; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Lindauer M., 1971, COMMUNICATION SOCIAL, DOI 10.4159/harvard.9780674424531; MAKELA ME, 1993, ECOL MODEL, V67, P259, DOI 10.1016/0304-3800(93)90009-H; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; ROBINSON GE, 1992, ETHOLOGY, V90, P336, DOI 10.1111/j.1439-0310.1992.tb00844.x; Robson SK, 1997, ANIM BEHAV, V53, P214, DOI 10.1006/anbe.1996.0290; Rosenkranz P., 2008, REPORT LANDESANSTALT; Russell R, 2013, ECOLOGICAL IN PRESS; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Seeley T., 1995, WISDOM HIVE SOCIAL P; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Watanabe ME, 2008, BIOSCIENCE, V58, P384, DOI 10.1641/B580503	31	99	100	6	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e59084	10.1371/journal.pone.0059084	http://dx.doi.org/10.1371/journal.pone.0059084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667418	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700002
J	Zhang, SL; Fujita, H; Mitsui, H; Yanofsky, VR; Fuentes-Duculan, J; Pettersen, JS; Suarez-Farinas, M; Gonzalez, J; Wang, CQF; Krueger, JG; Felsen, D; Carucci, JA				Zhang, Shali; Fujita, Hideki; Mitsui, Hiroshi; Yanofsky, Valerie R.; Fuentes-Duculan, Judilyn; Pettersen, Julia S.; Suarez-Farinas, Mayte; Gonzalez, Juana; Wang, Claire Q. F.; Krueger, James G.; Felsen, Diane; Carucci, John A.			Increased Tc22 and Treg/CD8 Ratio Contribute to Aggressive Growth of Transplant Associated Squamous Cell Carcinoma	PLOS ONE			English	Article							REGULATORY T-CELLS; SKIN-CANCER; SIGNAL TRANSDUCER; DENDRITIC CELLS; TRANSCRIPTION 3; EXPRESSION; INTERLEUKIN-22; RECIPIENTS; ACTIVATION; IL-22	Immune suppressed organ transplant recipients suffer increased morbidity and mortality from primary cutaneous SCC. We studied tumor microenvironment in transplant-associated SCC (TSCC), immune-competent SCC and normal skin by IHC, IF and RT-PCR on surgical discard. We determined T cell polarization in TSCC and SCC by intracellular cytokine staining of T cell crawl outs from human skin explants. We studied the effects of IL-22, an inducer of keratinocyte proliferation, on SCC proliferation in vitro. SCC and TSCC are both associated with significantly higher numbers of CD3(+) and CD8(+) T cells compared to normal skin. TSCC showed a higher proportion of Foxp3(+) T regs to CD8(+) T cells compared to SCC and a lower percentage of IFN-gamma producing CD4(+) T cells. TSCC, however, had a higher percentage of IL-22 producing CD8(+) T cells compared to SCC. TSCC showed more diffuse Ki67 and IL-22 receptor (IL-22R) expression by IHC. IL-2 induced SCC proliferation in vitro despite serum starvation. Diminished cytotoxic T cell function in TSCC due to decreased CD8/T-reg ratio may permit tumor progression. Increased IL-22 and IL-22R expression could accelerate tumor growth in transplant patients. IL-22 may be an attractive candidate for targeted therapy of SCC without endangering allograft survival.	[Zhang, Shali; Carucci, John A.] NYU, Ronald O Perelman Dept Dermatol, Langone Med Ctr, New York, NY 10003 USA; [Fujita, Hideki; Mitsui, Hiroshi; Fuentes-Duculan, Judilyn; Suarez-Farinas, Mayte; Wang, Claire Q. F.; Krueger, James G.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Yanofsky, Valerie R.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Pettersen, Julia S.] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA; [Gonzalez, Juana] Rockefeller Univ, Translat Immunomonitoring Resource Ctr, New York, NY 10021 USA; [Felsen, Diane] Weill Cornell Med Coll, Inst Pediat Urol, New York, NY USA	New York University; NYU Langone Medical Center; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Cornell University; Rockefeller University; Cornell University	Carucci, JA (corresponding author), NYU, Ronald O Perelman Dept Dermatol, Langone Med Ctr, New York, NY 10003 USA.	john.carucci@nyumc.org	Suarez-Farinas, Mayte/I-3558-2012	Suarez-Farinas, Mayte/0000-0001-8712-3553; carucci, john/0000-0001-6817-9439	Dana Foundation Human Immunology Consortium Grant; Milstein Medical Program; National Institutes of Health (NIH) [8 KL2 TR000151]; National Center for Research Resources, NIH [8 UL1 TR000043]; NIH from National Center for Advancing Translational Sciences [8 UL1b TR000043]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043, KL2TR000151] Funding Source: NIH RePORTER	Dana Foundation Human Immunology Consortium Grant; Milstein Medical Program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH from National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the Dana Foundation Human Immunology Consortium Grant (JAC, JSP). HM, MSF, CQFW, and JGK were supported by the Milstein Medical Program and in part by the National Institutes of Health (NIH) grant 8 KL2 TR000151. JFD is supported in part by grant # 8 UL1 TR000043 from the National Center for Research Resources, NIH. JG is supported by the NIH grant 8 UL1b TR000043 from National Center for Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune G, 2011, INT J CLIN EXP PATHO, V4, P444; Bard JD, 2008, LEUKEMIA, V22, P1595, DOI 10.1038/leu.2008.129; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Beyer M, 2006, BLOOD, V107, P3940, DOI 10.1182/blood-2005-09-3671; Bluth MJ, 2009, J INVEST DERMATOL, V129, P2451, DOI 10.1038/jid.2009.96; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Carucci JA, 2004, J INVEST DERMATOL, V123, P809, DOI 10.1111/j.1523-1747.2004.23440.x; Chan KS, 2008, ONCOGENE, V27, P1087, DOI 10.1038/sj.onc.1210726; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Curd LM, 2012, CLIN EXP IMMUNOL, V168, P192, DOI 10.1111/j.1365-2249.2012.04570.x; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Dumoutier L, 2000, GENES IMMUN, V1, P488, DOI 10.1038/sj.gene.6363716; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Gelebart P, 2011, TRANSL ONCOL, V4, P9, DOI 10.1593/tlo.10172; Guba M, 2004, TRANSPLANTATION, V77, P1777, DOI 10.1097/01.tp.0000120181.89206.54; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jabbari A, 2011, GIORN ITAL DERMAT V, V146, P17; Jensen P, 1999, J AM ACAD DERMATOL, V40, P177, DOI 10.1016/S0190-9622(99)70185-4; Jiang RQ, 2011, HEPATOLOGY, V54, P900, DOI 10.1002/hep.24486; Kaporis HG, 2007, J INVEST DERMATOL, V127, P2391, DOI 10.1038/sj.jid.5700884; Kim DJ, 2009, ONCOGENE, V28, P950, DOI 10.1038/onc.2008.453; Kim ST, 2012, AM J CLIN ONCOL; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Krynitz B, 2012, INT J CANC; Ladstein RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-140; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Patel GK, 2012, J INVEST DERMATOL, V132, P401, DOI 10.1038/jid.2011.317; Pettersen JS, 2011, J INVEST DERMATOL, V131, P1322, DOI [10.1038/jid.2011.9, 10.103/jid.2011.9]; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Rosenberg SA, 2005, NAT CLIN PRACT ONCOL, V2, P115, DOI 10.1038/ncponc0101; Rutella S, 2004, IMMUNOL LETT, V94, P11, DOI 10.1016/j.imlet.2004.04.015; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Tamai H, 2008, CLIN IMMUNOL, V127, P66, DOI 10.1016/j.clim.2007.12.001; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Ulrich C, 2008, AM J TRANSPLANT, V8, P2192, DOI 10.1111/j.1600-6143.2008.02386.x; UNOS, 2012, DATABASE; Warner CL, 2011, AM J CLIN DERMATOL, V12, P147, DOI 10.2165/11539420-000000000-00000; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Yu P, 2006, LAB INVEST, V86, P231, DOI 10.1038/labinvest.3700389; Zhang N, 2011, MOL CELL BIOCHEM, V353, P41, DOI 10.1007/s11010-011-0772-y; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Ziesche E, 2007, J BIOL CHEM, V282, P16006, DOI 10.1074/jbc.M611040200; Zwald FO, 2011, J AM ACAD DERMATOL, V65, P253, DOI 10.1016/j.jaad.2010.11.062; Zwald FO, 2011, J AM ACAD DERMATOL, V65, P263, DOI 10.1016/j.jaad.2010.11.063; Zwald FO, 2011, J AM ACAD DERMATOL, V65, P280	63	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62154	10.1371/journal.pone.0062154	http://dx.doi.org/10.1371/journal.pone.0062154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667456	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700024
J	Denoel, M; Perez, A; Cornet, Y; Ficetola, GF				Denoel, Mathieu; Perez, Amelie; Cornet, Yves; Ficetola, Gentile Francesco			Similar Local and Landscape Processes Affect Both a Common and a Rare Newt Species	PLOS ONE			English	Article							TRITURUS-CRISTATUS; MODEL SELECTION; HABITAT DETERMINANTS; AMPHIBIAN OCCURRENCE; BEHAVIORAL ECOLOGY; MICROHABITAT USE; POND; CONSERVATION; FISH; TERRESTRIAL	Although rare species are often the focus of conservation measures, more common species may experience similar decline and suffer from the same threatening processes. We tested this hypothesis by examining, through an information-theoretic approach, the importance of ecological processes at multiple scales in the great crested newt Triturus cristatus, regionally endangered and protected in Europe, and the more common smooth newt, Lissotriton vulgaris. Both species were similarly affected by the same processes, i.e. suitability of aquatic and terrestrial components of their habitat at different scales, connectivity among breeding sites, and the presence of introduced fish. T. cristatus depended more on water depth and aquatic vegetation than L. vulgaris. The results show that environmental pressures threaten both common and rare species, and therefore the more widespread species should not be neglected in conservation programs. Because environmental trends are leading to a deterioration of aquatic and terrestrial habitat features required by newt populations, populations of the common species may follow the fate of the rarest species. This could have substantial conservation implications because of the numerical importance of common species in ecosystems and because commonness could be a transient state moving towards rarity. On the other hand, in agreement with the umbrella species concept, targeting conservation efforts on the most demanding species would also protect part of the populations of the most common species.	[Denoel, Mathieu; Perez, Amelie] Univ Liege, Dept Ecol & Evolut Biol, Behav Biol Unit, Lab Fish & Amphibian Ethol, Liege, Belgium; [Cornet, Yves] Univ Liege, Geomat Unit, Liege, Belgium; [Ficetola, Gentile Francesco] Univ Milano Bicocca, Dept Environm Sci, Milan, Italy	University of Liege; University of Liege; University of Milano-Bicocca	Denoel, M (corresponding author), Univ Liege, Dept Ecol & Evolut Biol, Behav Biol Unit, Lab Fish & Amphibian Ethol, Liege, Belgium.	Mathieu.Denoel@ulg.ac.be	Ficetola, Gentile Francesco/A-2813-2008	Ficetola, Gentile Francesco/0000-0003-3414-5155; Denoel, Mathieu/0000-0002-3586-8323	University of Milano-Bicocca; public grant of Service Public de Wallonie; Contrat de riviere du sous-bassin hydrographique de la Vesdre, F.R.S. - FNRS (Credit au chercheur) [1.5.040.10]; Fonds Speciaux pour la Recherche (University of Liege) [C11/23]	University of Milano-Bicocca; public grant of Service Public de Wallonie; Contrat de riviere du sous-bassin hydrographique de la Vesdre, F.R.S. - FNRS (Credit au chercheur)(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux pour la Recherche (University of Liege)(University of Liege)	MD is a Research Associate at the F.R.S. - Fonds de la Recherche Scientifique (Belgium). GFF was funded by a scholarship of the University of Milano-Bicocca. This research benefited from a public grant of Service Public de Wallonie, Contrat de riviere du sous-bassin hydrographique de la Vesdre, F.R.S. - FNRS (Credit au chercheur 1.5.040.10) and Fonds Speciaux pour la Recherche (C11/23 - University of Liege). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arntzen JW, 2002, J HERPETOL, V36, P272, DOI 10.1670/0022-1511(2002)036[0272:TFECOT]2.0.CO;2; Arntzen JW, 2008, IUCN RED LIST THREAT; BEEBEE T J C, 1985, Amphibia-Reptilia, V6, P35, DOI 10.1163/156853885X00164; Bonardi A, 2011, BIOL CONSERV, V144, P2328, DOI 10.1016/j.biocon.2011.06.011; Boothby J., 1998, PONDS POND LANDSCAPE, P1; Branton M, 2011, CONSERV BIOL, V25, P9, DOI 10.1111/j.1523-1739.2010.01606.x; BRAZ E, 1994, ARCH HYDROBIOL, V131, P129; Breheny, 2020, PACKAGE VISREGR PACK; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; COOKE AS, 1976, J ZOOL, V178, P223; Curado N, 2011, BIOL CONSERV, V144, P1610, DOI 10.1016/j.biocon.2011.02.011; Denoel M, 2005, CONSERV BIOL, V19, P162, DOI 10.1111/j.1523-1739.2005.00001.x; Denoel M, 2003, BELG J ZOOL, V133, P95; Denoel M, 2009, BIOL CONSERV, V142, P509, DOI 10.1016/j.biocon.2008.11.008; Denoel M, 2008, AQUAT CONSERV, V18, P714, DOI 10.1002/aqc.853; Denoel M, 2007, ECOL APPL, V17, P302, DOI 10.1890/1051-0761(2007)017[0302:LTANC]2.0.CO;2; Denoel Mathieu, 2004, Bulletin de la Societe Herpetologique de France, V111-112, P49; Denoel M, 2006, BIOL CONSERV, V130, P495, DOI 10.1016/j.biocon.2006.01.009; Denoel M, 2012, BIODIVERS CONSERV, V21, P2887, DOI 10.1007/s10531-012-0343-x; DOLMEN D, 1982, Fauna Norvegica Series A, V3, P12; Edgar P., 2005, ACTION PLAN CONSERVA; Egea-Serrano A, 2011, ECOTOXICOLOGY, V20, P1246, DOI 10.1007/s10646-011-0673-6; Ficetola GF, 2011, DIVERS DISTRIB, V17, P1141, DOI 10.1111/j.1472-4642.2011.00797.x; Ficetola GF, 2011, ECOL APPL, V21, P1272, DOI 10.1890/10-0431.1; Ficetola GF, 2009, CONSERV BIOL, V23, P114, DOI 10.1111/j.1523-1739.2008.01081.x; Ficetola GF, 2004, BIOL CONSERV, V119, P219, DOI 10.1016/j.biocon.2003.11.004; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Gaston KJ, 2011, BIOSCIENCE, V61, P354, DOI 10.1525/bio.2011.61.5.4; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Gent T, 2001, RANA, V4, P295; Griffiths RA, 2010, BIOL CONSERV, V143, P485, DOI 10.1016/j.biocon.2009.11.017; Gustafson DH, 2009, J HERPETOL, V43, P300, DOI 10.1670/07-216R1.1; Halley JM, 1996, J APPL ECOL, V33, P455, DOI 10.2307/2404977; Hartel T, 2007, HYDROBIOLOGIA, V583, P173, DOI 10.1007/s10750-006-0490-8; Hartel T, 2010, ENVIRON CONSERV, V37, P195, DOI 10.1017/S037689291000055X; Hartel T, 2010, BIOL CONSERV, V143, P1118, DOI 10.1016/j.biocon.2010.02.006; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Jehle R, 2005, J EVOLUTION BIOL, V18, P619, DOI 10.1111/j.1420-9101.2004.00864.x; Jehle R, 2000, HERPETOL J, V10, P137; Jehle R., 2011, CRESTED NEWT DWINDLI; Johnson PTJ, 2011, CONSERV BIOL, V25, P556, DOI 10.1111/j.1523-1739.2010.01645.x; Joly P, 2001, CONSERV BIOL, V15, P239, DOI 10.1046/j.1523-1739.2001.99200.x; Kopecky O, 2010, AMPHIBIA-REPTILIA, V31, P109, DOI 10.1163/156853810790457821; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; Leu T, 2009, AMPHIBIA-REPTILIA, V30, P290, DOI 10.1163/156853809788201153; Lindenmayer DB, 2002, CONSERV BIOL, V16, P338, DOI 10.1046/j.1523-1739.2002.00450.x; Maletzky A, 2007, ANN LIMNOL-INT J LIM, V43, P107, DOI 10.1051/limn/2007017; Malmgren JC, 2002, HERPETOL J, V12, P29; Marnell F, 1998, J ZOOL, V244, P1; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Meyer A., 2009, AMPHIBIENS REPTILES, P257; MIAUD C, 1994, COPEIA, P535; MIAUD C, 1993, J ZOOL, V231, P575, DOI 10.1111/j.1469-7998.1993.tb01939.x; Monello RJ, 2001, J HERPETOL, V35, P350, DOI 10.2307/1566132; Perret N, 2003, J ANIM ECOL, V72, P567, DOI 10.1046/j.1365-2656.2003.00726.x; Piha H, 2007, ECOL APPL, V17, P2298, DOI 10.1890/06-1509.1; Rannap R, 2009, HYDROBIOLOGIA, V634, P87, DOI 10.1007/s10750-009-9884-8; Rannap R, 2009, DIVERS DISTRIB, V15, P692, DOI 10.1111/j.1472-4642.2009.00575.x; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Schabetsberger R, 2004, BIOL CONSERV, V117, P95, DOI 10.1016/S0006-3207(03)00268-4; Schmidt B, 2005, LISTA ROSSA SPECIE M; Schmidt BR, 2005, J EVOLUTION BIOL, V18, P415, DOI 10.1111/j.1420-9101.2004.00822.x; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; Skei JK, 2006, AMPHIBIA-REPTILIA, V27, P309, DOI 10.1163/156853806778189972; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Sztatecsny M, 2004, HERPETOL J, V14, P89; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; Vredenburg VT, 2004, P NATL ACAD SCI USA, V101, P7646, DOI 10.1073/pnas.0402321101; Wagner N, 2011, AMPHIBIA-REPTILIA, V32, P323, DOI 10.1163/017353711X579768; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wilbur HM, 1997, ECOLOGY, V78, P2279, DOI 10.1890/0012-9658(1997)078[2279:EEOFWC]2.0.CO;2; Winandy L, 2013, ETHOLOGY, V119, P121, DOI 10.1111/eth.12043; Wood PJ, 2003, AREA, V35, P206, DOI 10.1111/1475-4762.00249; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x	78	42	42	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62727	10.1371/journal.pone.0062727	http://dx.doi.org/10.1371/journal.pone.0062727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658765	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100035
J	Fan, LL; Song, B; Sun, GP; Ma, T; Zhong, F; Wei, W				Fan, Lulu; Song, Bing; Sun, Guoping; Ma, Tai; Zhong, Fei; Wei, Wei			Endoplasmic Reticulum Stress-Induced Resistance to Doxorubicin Is Reversed by Paeonol Treatment in Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; APOPTOSIS INDUCTION; CANCER; CYCLOOXYGENASE-2; LINES; ANTIPROLIFERATION; CISPLATIN; THERAPY; BIOLOGY	Background: Endoplasmic reticulum stress (ER stress) is generally activated in solid tumors and results in tumor cell antiapoptosis and drug resistance. Paeonol (Pae, 2-hydroxy-4-methoxyacetophenone), is a natural product extracted from the root of Paeonia Suffruticosa Andrew. Although Pae displays anti-neoplastic activity and increases the efficacy of chemotherapeutic drugs in various cell lines and in animal models, studies related to the effect of Pae on ER stress-induced resistance to chemotherapeutic agents in hepatocellular carcinoma (HCC) are poorly understood. Methodology/Principal Findings: In this study, we investigated the effect of the endoplasmic reticulum (ER) stress response during resistance of human hepatocellular carcinoma cells to doxorubicin. Treatment with the ER stress-inducer tunicamycin (TM) before the addition of doxorubicin reduced the rate of apoptosis induced by doxorubicin. Interestingly, co-pretreatment with tunicamycin and Pae significantly increased apoptosis induced by doxorubicin. Furthermore, induction of ER stress resulted in increasing expression of COX-2 concomitant with inactivation of Akt and up-regulation of the proapoptotic transcription factor CHOP (GADD153) in HepG2 cells. These cellular changes in gene expression and Akt activation may be an important resistance mechanism against doxorubicin in hepatocellular carcinoma cells undergoing ER stress. However, co-pretreatment with tunicamycin and Pae decreased the expression of COX-2 and levels of activation of Akt as well as increasing the levels of CHOP in HCC cells. Conclusions/Significance: Our results demonstrate that Pae reverses ER stress-induced resistance to doxorubicin in human hepatocellular carcinoma cells by targeting COX-2 mediated inactivation of PI3K/AKT/CHOP.	[Fan, Lulu; Sun, Guoping; Ma, Tai; Zhong, Fei] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Anhui, Peoples R China; [Song, Bing] Anhui Med Univ, Affiliated Hosp 1, Dept Cardiovasol, Hefei, Anhui, Peoples R China; [Wei, Wei] Anhui Med Univ, Inst Clin Pharmacol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Sun, GP (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Anhui, Peoples R China.	sunguoping@ahmu.edu.cn			Natural Science Foundation of China [81071986]; Research Fund for the Dectoral Program of Higher Education [20113420110002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Dectoral Program of Higher Education	This work was supported by the Natural Science Foundation of China (No. 81071986) and Research Fund for the Dectoral Program of Higher Education (NO. 20113420110002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catalano RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019209; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Diehl JA, 2011, GASTROENTEROLOGY, V141, P38, DOI 10.1053/j.gastro.2011.05.018; Hersey P, 2008, PIGM CELL MELANOMA R, V21, P358, DOI 10.1111/j.1755-148X.2008.00467.x; Hinz B, 2002, J PHARMACOL EXP THER, V300, P367, DOI 10.1124/jpet.300.2.367; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Jiang S P, 1994, Zhongguo Zhong Yao Za Zhi, V19, P311; Kanaoka S, 2007, ADV CLIN CHEM, V43, P59, DOI 10.1016/S0065-2423(06)43002-X; Kapoor A, 2009, CLIN LIVER DIS, V13, P581, DOI 10.1016/j.cld.2009.07.004; Lee HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012358; Lencioni R, 2010, ONCOLOGIST, V15, P42, DOI 10.1634/theoncologist.2010-S4-42; Li N, 2010, WORLD J GASTROENTERO, V16, P4483, DOI 10.3748/wjg.v16.i35.4483; Liao ZX, 2007, DRUGS, V67, P821, DOI 10.2165/00003495-200767060-00001; Mendizabal M, 2009, MED CLIN N AM, V93, P885, DOI 10.1016/j.mcna.2009.03.004; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Mujcic H, 2009, RADIOTHER ONCOL, V92, P450, DOI 10.1016/j.radonc.2009.08.017; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Riley CM, 1989, J CHROMATOGR, V489, P427; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Sun GP, 2008, DIS ESOPHAGUS, V21, P723, DOI 10.1111/j.1442-2050.2008.00840.x; Sun GP, 2008, EUR J PHARMACOL, V584, P246, DOI 10.1016/j.ejphar.2008.02.016; Wan XA, 2008, DIGEST LIVER DIS, V40, P531, DOI 10.1016/j.dld.2008.01.012; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Xu SP, 2007, ACTA PHARMACOL SIN, V28, P869, DOI 10.1111/j.1745-7254.2007.00564.x; Xu SP, 2007, WORLD J GASTROENTERO, V13, P250, DOI 10.3748/wjg.v13.i2.250; 孙言才, 2004, [中成药, Chinese Traditional Patent Medicine], V26, P579	30	44	53	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62627	10.1371/journal.pone.0062627	http://dx.doi.org/10.1371/journal.pone.0062627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658755	Green Submitted, Green Published, gold			2022-12-27	WOS:000321202100023
J	Gelderblom, M; Neumann, M; Ludewig, P; Bernreuther, C; Krasemann, S; Arunachalam, P; Gerloff, C; Glatzel, M; Magnus, T				Gelderblom, Mathias; Neumann, Melanie; Ludewig, Peter; Bernreuther, Christian; Krasemann, Susanne; Arunachalam, Priyadharshini; Gerloff, Christian; Glatzel, Markus; Magnus, Tim			Deficiency in Serine Protease Inhibitor Neuroserpin Exacerbates Ischemic Brain Injury by Increased Postischemic Inflammation	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; FOCAL CEREBRAL-ISCHEMIA; NECROSIS-FACTOR-ALPHA; MICROGLIAL ACTIVATION; STROKE; NEURONS; ACCUMULATION; ASSOCIATION; ALTEPLASE; BARRIER	The only approved pharmacological treatment for ischemic stroke is intravenous administration of plasminogen activator (tPA) to re-canalize the occluded cerebral vessel. Not only reperfusion but also tPA itself can induce an inflammatory response. Microglia are the innate immune cells of the central nervous system and the first immune cells to become activated in stroke. Neuroserpin, an endogenous inhibitor of tPA, is up-regulated following cerebral ischemia. To examine neuroserpin-dependent mechanisms of neuroprotection in stroke, we studied neuroserpin deficient (Ns(-/-)) mice in an animal model of temporal focal ischemic stroke. Infarct size and neurological outcome were worse in neuroserpin deficient mice even though the fibrinolytic activity in the ischemic brain was increased. The increased infarct size was paralleled by a selective increase in proinflammatory microglia activation in Ns(-/-) mice. Our results show excessive microglial activation in Ns(-/-) mice mediated by an increased activity of tPA. This activation results in a worse outcome further underscoring the potential detrimental proinflammatory effects of tPA.	[Gelderblom, Mathias; Ludewig, Peter; Arunachalam, Priyadharshini; Gerloff, Christian; Magnus, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Neumann, Melanie; Bernreuther, Christian; Krasemann, Susanne; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Magnus, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	t.magnus@uke.de	Glatzel, Markus/V-8844-2019; Glatzel, Markus/G-3356-2011	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Gerloff, Christian/0000-0002-6484-8882; Krasemann, Susanne/0000-0001-8795-818X	Landesexzellenzinitiative Hamburg; ERANET/NANOSTROKE	Landesexzellenzinitiative Hamburg; ERANET/NANOSTROKE	This work was supported by grants from the Landesexzellenzinitiative Hamburg (M.G., T.M. and C.G) and ERANET/NANOSTROKE (T.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Cole JW, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-37; Copin JC, 2011, EUR J NEUROSCI, V34, P1085, DOI 10.1111/j.1460-9568.2011.07843.x; del Zoppo GJ, 2007, STROKE, V38, P646, DOI 10.1161/01.STR.0000254477.34231.cb; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Galliciotti G, 2007, AM J PATHOL, V170, P1305, DOI 10.2353/ajpath.2007.060910; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Osterwalder T, 1998, J BIOL CHEM, V273, P2312, DOI 10.1074/jbc.273.4.2312; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Rodriguez-Gonzalez R, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-58; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Siao CJ, 2003, J NEUROSCI, V23, P3234; Siao CJ, 2002, J NEUROSCI, V22, P3352; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tjarnlund-Wolf A, 2011, J NEUROL, V258, P1885, DOI 10.1007/s00415-011-6022-0; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2000, BLOOD, V96, P569; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Zhang C, 2009, J CEREBR BLOOD F MET, V29, P1946, DOI 10.1038/jcbfm.2009.174; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661	32	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63118	10.1371/journal.pone.0063118	http://dx.doi.org/10.1371/journal.pone.0063118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658802	gold, Green Published, Green Submitted			2022-12-27	WOS:000321202100053
J	Mirabella, G; Iaconelli, S; Modugno, N; Giannini, G; Lena, F; Cantore, G				Mirabella, Giovanni; Iaconelli, Sara; Modugno, Nicola; Giannini, Giorgio; Lena, Francesco; Cantore, Gianpaolo			Stimulation of Subthalamic Nuclei Restores a Near Normal Planning Strategy in Parkinson's Patients	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; CHOICE-REACTION-TIME; OF-NO-RETURN; RESPONSE-INHIBITION; AIMING MOVEMENTS; DISEASE; EXECUTION; MEDICATION; SEQUENCES; SIGNS	A fundamental function of the motor system is to gather key information from the environment in order to implement behavioral strategies appropriate to the context. Although several lines of evidence indicate that Parkinson's disease affects the ability to modify behavior according to task requirements, it is currently unknown whether deep brain stimulation (DBS) of the subthalamic nucleus (STN) affects context-related planning. To explore this issue, we asked 12 Parkinson's patients with bilateral STN DBS and 13 healthy subjects to execute similar arm reaching movements in two different paradigms: go-only and countermanding tasks. In the former task patients had to perform speeded reaching movements to a peripheral target. In contrast, in the countermanding task participants had to perform the same reaches unless an infrequent and unpredictable stop-signal was shown during the reaction time (RT) indicating that they should withhold the ongoing action. We compared the performance of Parkinson's patients in different DBS conditions. We found that patients with both DBS-ON behaved similarly to healthy subjects, in that RTs of no-stop trial increased while movement times (MTs) decreased with respect to those of go-only-trials. However, when both DBS were off, both RTs and MTs were longer in no-stop trials than in go-only trials. These findings indicate that bilateral DBS of STN can partially restore the appropriate motor strategy according to the given cognitive contexts.	[Mirabella, Giovanni; Iaconelli, Sara; Modugno, Nicola; Giannini, Giorgio; Lena, Francesco; Cantore, Gianpaolo] Ist Neurol Mediterraneo Neuromed, Dept Neurosci, Pozzilli, IS, Italy; [Mirabella, Giovanni] Univ Roma La Sapienza, Dept Physiol & Pharmacol V Erspamer, I-00185 Rome, Italy	IRCCS Neuromed; Sapienza University Rome	Mirabella, G (corresponding author), Ist Neurol Mediterraneo Neuromed, Dept Neurosci, Pozzilli, IS, Italy.	giovanni.mirabella@uniroma1.it	modugno, nicola/AAN-8889-2020; lena, francesco/AAE-3229-2020; Mirabella, Giovanni/AAB-2818-2019; Modugno, Nicola/AAB-3527-2019	modugno, nicola/0000-0001-5243-1775; lena, francesco/0000-0001-5528-319X; Mirabella, Giovanni/0000-0002-4405-2609; 	Italian Ministry of Work, Health and Social Policies (Bando Giovani ricercatori); Italian Ministry of University and Research [2008_RBFNLH_005]	Italian Ministry of Work, Health and Social Policies (Bando Giovani ricercatori); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This research was supported by (i) the Italian Ministry of Work, Health and Social Policies (Bando Giovani ricercatori 2007 to GM); (ii) Italian Ministry of University and Research (PRIN n.2008_RBFNLH_005 to GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JJ, 2000, J EXP PSYCHOL HUMAN, V26, P295, DOI 10.1037/0096-1523.26.1.295; AGOSTINO R, 1992, BRAIN, V115, P1481, DOI 10.1093/brain/115.5.1481; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; BENECKE R, 1987, BRAIN, V110, P361, DOI 10.1093/brain/110.2.361; Brown LA, 2007, NEUROSCI LETT, V418, P292, DOI 10.1016/j.neulet.2007.03.040; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Doan JB, 2010, BEHAV BRAIN RES, V214, P135, DOI 10.1016/j.bbr.2010.05.006; EIDELBERG D, 1990, MOVEMENT DISORD, V5, P203, DOI 10.1002/mds.870050304; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Garcia L, 2005, TRENDS NEUROSCI, V28, P209, DOI 10.1016/j.tins.2005.02.005; HENRY FM, 1960, RES QUART, V31, P448, DOI 10.1080/10671188.1960.10762052; Khan MA, 2006, Q J EXP PSYCHOL, V59, P524, DOI 10.1080/02724980443000809; Klapp ST, 1996, REACTION TIME ANAL C, P13; Leis BC, 2005, EXP NEUROL, V194, P393, DOI 10.1016/j.expneurol.2005.02.014; Levitt H, 1971, J ACOUST SOC AM S, V49; Logan G. D., 1981, ATTENTION PERFORM, VIX, P205; Lopiano L, 2003, EUR NEUROL, V50, P94, DOI 10.1159/000072506; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Mirabella G, 2012, CEREB CORTEX, V22, P1124, DOI 10.1093/cercor/bhr187; Mirabella G, 2009, EXP BRAIN RES, V192, P199, DOI 10.1007/s00221-008-1570-y; Mirabella G, 2006, EXP BRAIN RES, V174, P240, DOI 10.1007/s00221-006-0456-0; Mirabella G, 2008, COGN NEUROPSYCHOL, V25, P996, DOI 10.1080/02643290802003216; Moro E, 1999, NEUROLOGY, V53, P85, DOI 10.1212/WNL.53.1.85; MUNGAS D, 1991, GERIATRICS, V46, P54; OSMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P183, DOI 10.1037/0096-1523.16.1.183; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; Rand MK, 2002, EXP BRAIN RES, V143, P383, DOI 10.1007/s00221-002-1000-5; Ray NJ, 2009, NEUROPSYCHOLOGIA, V47, P2828, DOI 10.1016/j.neuropsychologia.2009.06.011; ROSENBAUM DA, 1987, J EXP PSYCHOL HUMAN, V13, P193, DOI 10.1037/0096-1523.13.2.193; Scangos KW, 2010, J NEUROSCI, V30, P1968, DOI 10.1523/JNEUROSCI.4509-09.2010; Smiley-Oyen AL, 2007, J MOTOR BEHAV, V39, P103, DOI 10.3200/JMBR.39.2.103-114; Stancanello J, 2008, MED PHYS, V35, P3069, DOI 10.1118/1.2936229; Stancanello J, 2006, MED PHYS, V33, P1603, DOI 10.1118/1.2198588; STELMACH GE, 1987, INT J NEUROSCI, V36, P55, DOI 10.3109/00207458709002139; Sternberg S, 1978, LATENCY DURATION RAP, P117; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; Sturman MM, 2008, MOVEMENT DISORD, V23, P866, DOI 10.1002/mds.21979; Swann N, 2011, J NEUROSCI, V31, P5721, DOI 10.1523/JNEUROSCI.6135-10.2011; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Toth C, 2004, MOVEMENT DISORD, V19, P151, DOI 10.1002/mds.10685; van den Wildenberg WPM, 2006, J COGNITIVE NEUROSCI, V18, P626, DOI 10.1162/jocn.2006.18.4.626; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Vindras P, 2005, EXP BRAIN RES, V160, P141, DOI 10.1007/s00221-004-1995-x; Weiss P, 1997, BRAIN, V120, P91, DOI 10.1093/brain/120.1.91; Wylie SA, 2010, BRAIN, V133, P3611, DOI 10.1093/brain/awq239; Zandbelt BB, 2011, BIOL PSYCHIAT, V70, P1151, DOI 10.1016/j.biopsych.2011.07.028; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	50	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62793	10.1371/journal.pone.0062793	http://dx.doi.org/10.1371/journal.pone.0062793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658775	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100041
J	Deng, W; Putkey, JA; Li, RH				Deng, Wei; Putkey, John A.; Li, Renhao			Calmodulin Adopts an Extended Conformation when Interacting with L-Selectin in Membranes	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; TARGET RECOGNITION; CYTOPLASMIC DOMAIN; BILAYER THICKNESS; CONVERTING ENZYME; CRYSTAL-STRUCTURE; PEPTIDE COMPLEX; BINDING DOMAIN; CROSS-LINKING; KINASE-II	Calmodulin, an intracellular calcium-binding protein, is thought to regulate ectodomain shedding of many membrane proteins, but the underlying molecular mechanism has remained unclear. Basing on a solution structure of calcium-loaded calmodulin in complex with a L-selectin fragment that contains a portion of its transmembrane domain, Gifford et al. (University of Calgary) recently suggested that calmodulin regulates L-selectin shedding by binding directly to a portion of the L-selectin transmembrane domain in a compact conformation. Using fluorescently labeled calmodulin, we show however that calmodulin adopts a distinctly different and much more extended conformation when it binds to the CLS peptide (i.e. the entire transmembrane and cytoplasmic domains of L-selectin) reconstituted in the phosphatidylcholine liposome with micromolar dissociation constant and in a calcium-independent manner. Calmodulin adopts a similarly extended conformation in a ternary complex with the N-terminal FERM domain of moesin and CLS reconstituted in the phospholipid liposome that mimics the native membrane environment. These results indicate that calmodulin does not bind directly to the transmembrane domain of L-selectin. Understanding the association of calmodulin with L-selectin helps to shed light on the mechanisms underlying regulation of ectodomain shedding.	[Deng, Wei; Li, Renhao] Emory Univ, Sch Med, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA; [Putkey, John A.] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Emory University; University of Texas System; University of Texas Health Science Center Houston	Li, RH (corresponding author), Emory Univ, Sch Med, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA.	renhao.li@emory.edu	Li, Renhao/B-1257-2012	Li, Renhao/0000-0002-5806-5080	NIH [GM084175]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM084175. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFSHAR M, 1994, J MOL BIOL, V244, P554, DOI 10.1006/jmbi.1994.1752; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Blobel CP, 2002, INFLAMM RES, V51, P83, DOI 10.1007/BF02684007; Chattopadhyay S, 2005, J BIOL CHEM, V280, P33847, DOI 10.1074/jbc.M501718200; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Deng W, 2011, J MOL BIOL, V411, P220, DOI 10.1016/j.jmb.2011.05.041; Diaz-Rodriguez E, 2000, BIOCHEM J, V346, P359, DOI 10.1042/0264-6021:3460359; Dong JY, 2000, J BIOL CHEM, V275, P557, DOI 10.1074/jbc.275.1.557; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Gardiner EE, 2004, BLOOD, V104, P3611, DOI 10.1182/blood-2004-04-1549; Gawrisch K, 2007, EUR BIOPHYS J BIOPHY, V36, P281, DOI 10.1007/s00249-007-0142-6; Gifford JL, 2012, J BIOL CHEM, V287, P26513, DOI 10.1074/jbc.M112.373373; Gopalan V, 1997, J MOL BIOL, V267, P765, DOI 10.1006/jmbi.1997.0907; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Killock DJ, 2009, J BIOL CHEM, V284, P8824, DOI 10.1074/jbc.M806983200; Kleerekoper QK, 2009, J BIOL CHEM, V284, P7455, DOI 10.1074/jbc.M808067200; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; LAKOWICZ JR, 1983, J BIOL CHEM, V258, P5519; Lambert DW, 2008, FEBS LETT, V582, P385, DOI 10.1016/j.febslet.2007.11.085; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Luo SZ, 2007, BLOOD, V109, P603, DOI 10.1182/blood-2006-05-024091; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; MATSUMOTO S, 1975, BIOCHEMISTRY-US, V14, P214, DOI 10.1021/bi00673a004; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALECANDA A, 1992, EUR J IMMUNOL, V22, P1279, DOI 10.1002/eji.1830220524; PERSECHINI A, 1988, J BIOL CHEM, V263, P12175; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schlondorff J, 1999, J CELL SCI, V112, P3603; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; SIMON SI, 1995, J IMMUNOL, V155, P1502; Srinivasan S, 2011, BBA-BIOMEMBRANES, V1808, P1709, DOI 10.1016/j.bbamem.2011.02.006; Walcheck B, 1996, NATURE, V380, P720, DOI 10.1038/380720a0; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; WEINSTEIN H, 1994, ANNU REV PHYSIOL, V56, P213, DOI 10.1146/annurev.ph.56.030194.001241; Wong MX, 2004, FEBS LETT, V568, P70, DOI 10.1016/j.febslet.2004.04.094; WU PG, 1994, BIOCHEMISTRY-US, V33, P10457, DOI 10.1021/bi00200a029; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200	62	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62861	10.1371/journal.pone.0062861	http://dx.doi.org/10.1371/journal.pone.0062861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658780	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500042
J	O'Flaherty, JT; Wooten, RE; Samuel, MP; Thomas, MJ; Levine, EA; Case, LD; Akman, SA; Edwards, IJ				O'Flaherty, Joseph T.; Wooten, Rhonda E.; Samuel, Michael P.; Thomas, Michael J.; Levine, Edward A.; Case, L. Douglas; Akman, Steven A.; Edwards, Iris J.			Fatty Acid Metabolites in Rapidly Proliferating Breast Cancer	PLOS ONE			English	Article							COX-2 EXPRESSION; LINOLEIC-ACID; PROGNOSTIC PARAMETERS; DUCTAL CARCINOMA; NUDE-MICE; PROSTAGLANDIN; CELLS; SURVIVAL; CYCLOOXYGENASE-2; LIPOXYGENASES	Purpose: Breast cancers that over-express a lipoxygenase or cyclooxygenase are associated with poor survival possibly because they overproduce metabolites that alter the cancer's malignant behaviors. However, these metabolites and behaviors have not been identified. We here identify which metabolites among those that stimulate breast cancer cell proliferation in vitro are associated with rapidly proliferating breast cancer. Experimental Design: We used selective ion monitoring-mass spectrometry to quantify in the cancer and normal breast tissue of 27 patients metabolites that stimulate (15-, 12-, 5-hydroxy-, and 5-oxo-eicosatetraenoate, 13-hydroxy-octadecaenoate [HODE]) or inhibit (prostaglandin [PG]E-2 and D-2) breast cancer cell proliferation. We then related their levels to each cancer's proliferation rate as defined by its Mib1 score. Results: 13-HODE was the only metabolite strongly, significantly, and positively associated with Mib1 scores. It was similarly associated with aggressive grade and a key component of grade, mitosis, and also trended to be associated with lymph node metastasis. PGE(2) and PGD(2) trended to be negatively associated with these markers. No other metabolite in cancer and no metabolite in normal tissue had this profile of associations. Conclusions: Our data fit a model wherein the overproduction of 13-HODE by 15- lipoxygenase-1 shortens breast cancer survival by stimulating its cells to proliferate and possibly metastasize; no other oxygenase-metabolite pathway, including cyclooxygenase-PGE(2)/D-2 pathways, uses this specific mechanism to shorten survival.	[O'Flaherty, Joseph T.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA; [Wooten, Rhonda E.; Samuel, Michael P.; Thomas, Michael J.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Levine, Edward A.] Wake Forest Sch Med, Dept Surg Oncol, Winston Salem, NC USA; [Case, L. Douglas] Wake Forest Sch Med, Dept Publ Hlth Sci, Winston Salem, NC USA; [Akman, Steven A.] Wake Forest Sch Med, Dept Hematol & Oncol & Canc Biol, Winston Salem, NC USA; [Edwards, Iris J.] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Edwards, IJ (corresponding author), Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA.	iedwards@wakehealth.edu			Golfers Against Cancer; NSF [BIR-9414018]; NIH Shared Instrumentation Program [1S10RR13875]; National Institutes of Health [P01 CA106742, R01 CA 115958, U10 CA081851, P30 CA12197, U1O CA76001, R01 AI064609, R01 CA135288]; NATIONAL CANCER INSTITUTE [U10CA081851, U10CA076001, R01CA115958, P30CA012197, P01CA106742, R01CA135288] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064609] Funding Source: NIH RePORTER	Golfers Against Cancer; NSF(National Science Foundation (NSF)); NIH Shared Instrumentation Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Golfers Against Cancer and National Institutes of Health (grant numbers P01 CA106742, R01 CA 115958, U10 CA081851, P30 CA12197, U1O CA76001, R01 AI064609, and R01 CA135288); the Quattro II mass spectrometer was acquired using funds from the NSF (BIR-9414018, MJT) and the 600 MHz Bruker NMR was purchased in part with funds from the NIH Shared Instrumentation Program (1S10RR13875, MJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avis I, 2001, FASEB J, V15, P2007, DOI 10.1096/fj.00-0866fje; Bardia A, 2011, BREAST CANCER RES TR, V126, P149, DOI 10.1007/s10549-010-1074-x; Barisik NO, 2011, MED ONCOL, V28, P703, DOI 10.1007/s12032-010-9503-6; BENNETT A, 1989, BRIT J CANCER, V59, P268, DOI 10.1038/bjc.1989.56; Brash AR, 1999, ADV EXP MED BIOL, V447, P29; Brueggemeier RW, 1999, CANCER LETT, V140, P27, DOI 10.1016/S0304-3835(99)00050-6; Caly M, 2004, ANTICANCER RES, V24, P3283; Connolly JM, 1996, NUTR CANCER, V25, P231, DOI 10.1080/01635589609514447; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Edwards IJ, 2004, CLIN CANCER RES, V10, P8275, DOI 10.1158/1078-0432.CCR-04-1357; Fentiman I S, 1984, Mol Biol Med, V2, P81; FULTON AM, 1986, INVAS METAST, V6, P83; FUNK CD, 1983, BIOCHIM BIOPHYS ACTA, V754, P57; Hamberg M, 1998, ARCH BIOCHEM BIOPHYS, V349, P376, DOI 10.1006/abbi.1997.0443; Holmes MD, 2011, BREAST CANCER RES TR, V130, P657, DOI 10.1007/s10549-011-1651-7; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P235, DOI 10.1016/j.plefa.2006.01.009; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P125, DOI 10.1016/j.plefa.2005.10.005; Jiang WG, 2003, PROSTAG LEUKOTR ESS, V69, P275, DOI 10.1016/S0952-3278(03)00110-8; KARMALI RA, 1983, BRIT J CANCER, V48, P689, DOI 10.1038/bjc.1983.251; Kawakami Y, 2009, PROSTAG LEUKOTR ESS, V80, P239, DOI 10.1016/j.plefa.2009.04.006; Kelavkar Uddhav, 2006, J Carcinog, V5, P9, DOI 10.1186/1477-3163-5-9; Kelavkar Uddhav, 2002, Curr Urol Rep, V3, P207, DOI 10.1007/s11934-002-0066-8; Kelly LM, 2003, EUR J SURG ONCOL, V29, P707, DOI 10.1016/j.ejso.2003.07.001; Kerlikowske K, 2010, JNCI-J NATL CANCER I, V102, P627, DOI 10.1093/jnci/djq101; KORT WJ, 1992, PROSTAG LEUKOTR ESS, V45, P319, DOI 10.1016/0952-3278(92)90090-6; Liu XH, 1996, CANCER LETT, V109, P223, DOI 10.1016/S0304-3835(96)04462-X; Mohammad A M, 2006, Indian J Cancer, V43, P163; Nassar A, 2007, APPL IMMUNOHISTO M M, V15, P255, DOI 10.1097/01.pai.0000213130.63417.b3; Nie D, 2007, FRONT BIOSCI, V12, P1574, DOI 10.2741/2170; O'Flaherty JT, 2005, BBA-MOL CELL BIOL L, V1736, P228, DOI 10.1016/j.bbalip.2005.08.009; Offersen BV, 2008, ACTA ONCOL, V47, P618, DOI 10.1080/02841860801958295; OFLAHERTY JT, 1985, PROSTA LEUKOTR MED, V17, P199, DOI 10.1016/0262-1746(85)90107-6; OFLAHERTY JT, 1994, BBA-GEN SUBJECTS, V1201, P505, DOI 10.1016/0304-4165(94)90083-3; Park BW, 2012, BREAST CANCER RES TR, V133, P741, DOI 10.1007/s10549-012-1971-2; PLANCHON P, 1995, LIFE SCI, V57, P1233, DOI 10.1016/0024-3205(95)02069-U; Reno F, 2004, PROSTAG OTH LIPID M, V73, P237, DOI 10.1016/j.prostaglandins.2004.03.002; Schneider C, 2011, CANCER METAST REV, V30, P277, DOI 10.1007/s10555-011-9310-3; Tong WG, 2002, BIOCHEM BIOPH RES CO, V296, P942, DOI 10.1016/S0006-291X(02)02014-4; Vangaveti V, 2010, THER ADV ENDOCRINOL, V1, P51, DOI 10.1177/2042018810375656; Wecksler AT, 2008, BIOCHEMISTRY-US, V47, P7364, DOI 10.1021/bi800550n; Wernli KJ, 2011, PHARMACOEPIDEM DR S, V20, P131, DOI 10.1002/pds.2064; Wulfing P, 2003, J CANCER RES CLIN, V129, P375, DOI 10.1007/s00432-003-0459-1; Zeeneldin A. A., 2009, Indian Journal of Cancer, V46, P54, DOI 10.4103/0019-509X.48597	44	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63076	10.1371/journal.pone.0063076	http://dx.doi.org/10.1371/journal.pone.0063076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658799	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500054
J	Leblanc, L; Rubinoff, D; Wright, MG				Leblanc, Luc; Rubinoff, Daniel; Wright, Mark G.			Conservation Implications of Changes in Endemic Hawaiian Drosophilidae Diversity across Land Use Gradients	PLOS ONE			English	Article							PICTURE-WINGED DROSOPHILA; DIPTERA-DROSOPHILIDAE; RAIN-FOREST; TEPHRITIDAE; ATTRACTION	Endemic Hawaiian Drosophilidae, a radiation of nearly 1000 species including 13 federally listed as endangered, occur mostly in intact native forest, 500-1500 m above sea level. But their persistence in disturbed forest and agricultural areas has not been documented. Thus, control efforts for agricultural pests may impact endemic species if previously undocumented refugia in agricultural areas may play a role in their conservation. To quantify whether invasive plants and agriculture habitats may harbor endemic Drosophilidae, we established standardized trapping arrays, with traps typically designed to control invasive fruit flies (Tephritidae), with 81 sites across native, disturbed and agricultural land use gradients on the islands of Hawai'i and Maui. We collected and identified, to species level, over 22,000 specimens. We found 121 of the possible 292 species expected to occur in the sampled areas, and the majority (91%) of the captured specimens belonged to 24 common species. Species diversity and numbers were greatest in the native forest, but 55% of the species occurred in the invasive strawberry guava belt and plantation forest, adjacent to and almost 500 m from native forest, and 22 species were collected in orchards and nonnative forest as far as 10 km from native habitats. Their persistence outside of native forest suggests that more careful management of disturbed forest and a reassessment of its conservation value are in order. Conservation efforts and assessments of native forest integrity should include the subset of species restricted to intact native forest, since these species are highly localized and particularly sensitive. Additionally, future efforts to control invasive pest fruit flies should consider the nontarget impacts of maintaining traps in and near native forest. This survey project demonstrates the utility of thorough biotic surveys and taxonomic expertise in developing both sensitive species lists and baseline diversity indices for future conservation and monitoring efforts.	[Leblanc, Luc; Rubinoff, Daniel; Wright, Mark G.] Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA	University of Hawaii System	Rubinoff, D (corresponding author), Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.	rubinoff@hawaii.edu		Wright, Mark/0000-0002-1643-7560	U.S. Department of Agriculture-Agricultural Research Service through a Specific Cooperative Agreement with University of Hawaii CTAHR [0500-00044-016-07]; Study of Attraction of Nontarget Organisms to Fruit Fly Female Attractants and Male Lures in Hawaii; USDA-National Institute of Food and Agriculture Agreement [58-5320-9430]; Hatch projects [HAW00942-H, HAW00956-H]; College of Tropical Agriculture and Human Resources; University of Hawaii at Manoa	U.S. Department of Agriculture-Agricultural Research Service through a Specific Cooperative Agreement with University of Hawaii CTAHR; Study of Attraction of Nontarget Organisms to Fruit Fly Female Attractants and Male Lures in Hawaii; USDA-National Institute of Food and Agriculture Agreement; Hatch projects(United States Department of Agriculture (USDA)); College of Tropical Agriculture and Human Resources; University of Hawaii at Manoa	This study was made possible with funding from U.S. Department of Agriculture-Agricultural Research Service through a Specific Cooperative Agreement with University of Hawaii CTAHR under Project Number: 0500-00044-016-07, "Study of Attraction of Nontarget Organisms to Fruit Fly Female Attractants and Male Lures in Hawaii''. Additional research funding was provided by USDA-National Institute of Food and Agriculture Agreement No. 58-5320-9430, and Hatch projects HAW00942-H and HAW00956-H, administered by the College of Tropical Agriculture and Human Resources, University of Hawaii at Manoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazelet CS, 2011, LANDSCAPE ECOL, V26, P341, DOI 10.1007/s10980-010-9557-z; Carson H. L., 1970, ESSAYS EVOLUTION GEN, P437, DOI DOI 10.1007/978-1-4615-9585-4_15; Carson HL, 1986, P 3 C NAT SCI HAW VO, P3; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Foote David, 1995, P368; Fosberg FT, 1972, 10 PAC SCI C; Gerrish G, 1992, 85 U HAW MAN; HARDY DE, 1965, SERIES SCHIZOPHORA, V12; Heed WB, 1968, U TEXAS PUBLICATIONS, V6818, P387; HOWARTH F G, 1990, Bishop Museum Occasional Papers, V30, P4; Kaneshiro Kenneth Y., 1993, American Entomologist, V39, P23; Kaneshiro Kenneth Y., 1997, Pacific Science, V51, P450; KANESHIRO KY, 1983, ANNU REV ENTOMOL, V28, P161, DOI 10.1146/annurev.en.28.010183.001113; KANESHIRO KY, 1977, DROS INFORM SERV, V52, P85; Kitching RL, 2004, J BIOGEOGR, V31, P1185, DOI 10.1111/j.1365-2699.2004.01096.x; Krushelnycky Paul D., 2005, Proceedings of the Hawaiian Entomological Society, V37, P1; Leblanc Luc, 2009, Proceedings of the Hawaiian Entomological Society, V41, P121; Leblanc L, 2010, ENVIRON ENTOMOL, V39, P989, DOI 10.1603/EN09287; Leblanc L, 2009, ENVIRON ENTOMOL, V38, P1446, DOI 10.1603/022.038.0513; Magnacca KN, 2008, ZOOTAXA, P1; Magnacca KN, 2012, ZOOTAXA, P1; Magnacca KN, 2009, U CALIF PUBL ENTOMOL, V130; Meyer WM, 2011, SOIL BIOL BIOCHEM, V43, P206, DOI 10.1016/j.soilbio.2010.10.005; MONTGOMERY SL, 1975, P HAWAII ENTOMOL SOC, V22, P65; Muir C, 2008, MOL PHYLOGENET EVOL, V47, P1173, DOI 10.1016/j.ympev.2008.02.007; O'Grady P.M., 2010, Bishop Museum Occasional Papers, V108, P1; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; Paulay G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019916; PIMM SL, 1994, PHILOS T ROY SOC B, V344, P27, DOI 10.1098/rstb.1994.0047; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Rubinoff D, 2001, CONSERV BIOL, V15, P1374, DOI 10.1046/j.1523-1739.2001.00176.x; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Vargas RI, 2008, AREAWIDE PEST MANAGEMENT: THEORY AND IMPLEMENTATION, P300, DOI 10.1079/9781845933722.0300; Vorsino AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051885; [No title captured]	35	4	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62464	10.1371/journal.pone.0062464	http://dx.doi.org/10.1371/journal.pone.0062464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650514	gold, Green Submitted, Green Published			2022-12-27	WOS:000319167000047
J	McInnes, L; Jones, FA; Orme, CDL; Sobkowiak, B; Barraclough, TG; Chase, MW; Govaerts, R; Soltis, DE; Soltis, PS; Savolainen, V				McInnes, Lynsey; Jones, F. Andrew; Orme, C. David L.; Sobkowiak, Benjamin; Barraclough, Timothy G.; Chase, Mark W.; Govaerts, Rafael; Soltis, Douglas E.; Soltis, Pamela S.; Savolainen, Vincent			Do Global Diversity Patterns of Vertebrates Reflect Those of Monocots?	PLOS ONE			English	Article							SPECIES RICHNESS; PLANT DIVERSITY; GEOGRAPHIC PATTERNS; WOODY PLANT; CONSERVATION; HOTSPOTS; BIODIVERSITY; EVOLUTION; LAND; DIVERSIFICATION	Few studies of global diversity gradients in plants exist, largely because the data are not available for all species involved. Instead, most global studies have focussed on vertebrates, as these taxa have historically been associated with the most complete data. Here, we address this shortfall by first investigating global diversity gradients in monocots, a morphologically and functionally diverse clade representing a quarter of flowering plant diversity, and then assessing congruence between monocot and vertebrate diversity patterns. To do this, we create a new dataset that merges biomelevel associations for all monocot genera with country-level associations for almost all similar to 70,000 species. We then assess the evidence for direct versus indirect effects of this plant diversity on vertebrate diversity using a combination of linear regression and structural equation modelling (SEM). Finally, we also calculate overlap of diversity hotspots for monocots and each vertebrate taxon. Monocots follow a latitudinal gradient although with pockets of extra-tropical diversity, mirroring patterns in vertebrates. Monocot diversity is positively associated with vertebrate diversity, but the strength of correlation varies depending on the clades being compared. Monocot diversity explains marginal amounts of variance (< 10%) after environmental factors have been accounted for. However, correlations remain among model residuals, and SEMs apparently reveal some direct effects of monocot richness. Our results suggest that collinear responses to environmental gradients are behind much of the congruence observed, but that there is some evidence for direct effects of producer diversity on consumer diversity. Much remains to be done before broad-scale diversity gradients among taxa are fully explained. Our dataset of monocot distributions will aid in this endeavour.	[McInnes, Lynsey; Jones, F. Andrew; Orme, C. David L.; Sobkowiak, Benjamin; Barraclough, Timothy G.; Savolainen, Vincent] Imperial Coll London, Div Ecol & Evolut, Ascot, Berks, England; [Chase, Mark W.; Govaerts, Rafael; Savolainen, Vincent] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Soltis, Douglas E.] Univ Florida, Dept Biol, Gainesville, FL USA; [Soltis, Pamela S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Imperial College London; Royal Botanic Gardens, Kew; State University System of Florida; University of Florida; State University System of Florida; University of Florida	McInnes, L (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	lynsey.mcinnes@gmail.com; v.savolainen@imperial.ac.uk	Chase, Mark W/A-6642-2011; Sobkowiak, Ben/GYD-7396-2022; Soltis, Pamela S/L-5184-2015; Soltis, Douglas/L-5957-2015; Soltis, Pamela S/GNH-5557-2022	Sobkowiak, Ben/0000-0002-1382-1137; Soltis, Pamela S/0000-0001-9310-8659; Savolainen, Vincent/0000-0001-5350-9984; Barraclough, Timothy/0000-0002-8084-2640; BUNNEFELD, LYNSEY/0000-0002-9226-7153	Leverhulme Trust [ID20070432]; United States National Science Foundation [EF-0431266]; Royal Society [15927]; European Research Council [16675]; Natural Environment Research Council [NE/F002769/1]; NERC [NE/I013776/1, NE/F002769/1] Funding Source: UKRI; Natural Environment Research Council [NE/I013776/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); United States National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by Leverhulme Trust: ID20070432 (http://www.leverhulme.ac.uk/), United States National Science Foundation: EF- 0431266 (www.nsf.gov); Royal Society: 15927 (royalsociety.org); European Research Council: 16675 (erc.europa.eu); Natural Environment Research Council: NE/F002769/1 (www.nerc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; Barthlott W, 2007, ERDKUNDE, V61, P305, DOI 10.3112/erdkunde.2007.04.01; Benzing D.H., 1990, VASCULAR EPIPHYTES G; Bouchenak-Khelladi Y, 2009, GLOBAL CHANGE BIOL, V15, P2397, DOI 10.1111/j.1365-2486.2009.01860.x; Brummitt R.K., 2001, WORLD GEOGRAPHIC SCH, V2; Cantino PD, 2007, TAXON, V56, P822, DOI 10.2307/25065865; Carwardine J, 2008, P NATL ACAD SCI USA, V105, P11446, DOI 10.1073/pnas.0707157105; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Govaerts R, 2004, TAXON, V53, P144, DOI 10.2307/4135499; Gravendeel B, 2004, PHILOS T ROY SOC B, V359, P1523, DOI 10.1098/rstb.2004.1529; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Hawkins BA, 2011, J BIOGEOGR, V38, P1253, DOI 10.1111/j.1365-2699.2011.02490.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kisel Y, 2011, PHILOS T R SOC B, V366, P2514, DOI 10.1098/rstb.2011.0022; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P327, DOI 10.1111/j.1466-8238.2007.00379.x; Kissling WD, 2012, GLOBAL ECOL BIOGEOGR, V21, P909, DOI 10.1111/j.1466-8238.2011.00728.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Qian H, 2008, ECOL LETT, V11, P547, DOI 10.1111/j.1461-0248.2008.01168.x; R Development Core Team, 2021, R PROJECT STAT COMPU; Raven P.H., 2005, BIOL PLANTS; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schuldt A, 2009, ECOGRAPHY, V32, P1019, DOI 10.1111/j.1600-0587.2009.05973.x; Sommer JH, 2010, P ROY SOC B-BIOL SCI, V277, P2271, DOI 10.1098/rspb.2010.0120; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; USGS, 2003, GLOB 30 ARC 2 EL DAT; Wang ZH, 2011, P ROY SOC B-BIOL SCI, V278, P2122, DOI 10.1098/rspb.2010.1897	50	8	9	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e56979	10.1371/journal.pone.0056979	http://dx.doi.org/10.1371/journal.pone.0056979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658679	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000002
J	Vazquez-Marrufo, M; Gonzalez-Rosa, JJ; Galvao-Carmona, A; Hidalgo-Munoz, A; Borges, M; Pena, JLR; Izquierdo, G				Vazquez-Marrufo, Manuel; Gonzalez-Rosa, Javier J.; Galvao-Carmona, Alejandro; Hidalgo-Munoz, Antonio; Borges, Monica; Ruiz Pena, Juan Luis; Izquierdo, Guillermo			Retest Reliability of Individual P3 Topography Assessed by High Density Electroencephalography	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TEMPORAL STABILITY; TASK-DIFFICULTY; DETERMINANTS; LATENCY; YOUNG; ERPS	Background: Some controversy remains about the potential applicability of cognitive potentials for evaluating the cerebral activity associated with cognitive capacity. A fundamental requirement is that these neurophysiological parameters show a high level of stability over time. Previous studies have shown that the reliability of diverse parameters of the P3 component (latency and amplitude) ranges between moderate and high. However, few studies have paid attention to the retest reliability of the P3 topography in groups or individuals. Considering that changes in P3 topography have been related to different pathologies and healthy aging, the main objective of this article was to evaluate in a longitudinal study (two sessions) the reliability of P3 topography in a group and at the individual level. Results: The correlation between sessions for P3 topography in the grand average of groups was high (r = 0.977, p<0.001). The within-subject correlation values ranged from 0.626 to 0.981 (mean: 0.888). In the between-subjects topography comparisons, the correlation was always lower for comparisons between different subjects than for within-subjects correlations in the first session but not in the second session. Conclusions: The present study shows that P3 topography is highly reliable for group analysis (comprising the same subjects) in different sessions. The results also confirmed that retest reliability for individual P3 maps is suitable for follow-up studies for a particular subject. Moreover, P3 topography appears to be a specific marker considering that the betweensubjects correlations were lower than the within-subject correlations. However, P3 topography appears more similar between subjects in the second session, demonstrating that is modulated by experience. Possible clinical applications of all these results are discussed.	[Vazquez-Marrufo, Manuel; Galvao-Carmona, Alejandro; Hidalgo-Munoz, Antonio] Univ Seville, Fac Psychol, Dept Expt Psychol, Seville, Spain; [Borges, Monica; Ruiz Pena, Juan Luis; Izquierdo, Guillermo] Virgen Macarena Hosp, Multiple Sclerosis Unit, Seville, Spain; [Gonzalez-Rosa, Javier J.] Tech Univ Madrid UPM, Ctr Biomed Technol CTB, Lab Clin Neurosci, Madrid, Spain	University of Sevilla; Hospital Universitario Virgen Macarena; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB)	Vazquez-Marrufo, M (corresponding author), Univ Seville, Fac Psychol, Dept Expt Psychol, Seville, Spain.	marrufo@us.es	Hidalgo-Muñoz, Antonio R./ABG-5286-2020; Galvao-Carmona, Alejandro/A-1725-2015; Gonzalez-Rosa, Javier J./K-1291-2014; Marrufo, Manuel Vazquez/Y-8460-2019	Galvao-Carmona, Alejandro/0000-0002-5126-1273; Gonzalez-Rosa, Javier J./0000-0002-5609-1103; Marrufo, Manuel Vazquez/0000-0002-0456-7165; Borges Guerra, Monica/0000-0002-4258-2390; Hidalgo-Munoz, Antonio R/0000-0002-0457-5114	Ministerio de Economia, Gobierno de Espana [SEJ2007-65343]; Asociacion Neuroinvest	Ministerio de Economia, Gobierno de Espana; Asociacion Neuroinvest	Funding came from Ministerio de Economia, Gobierno de Espana, SEJ2007-65343, Asociacion Neuroinvest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JE, 1994, INT J PSYCHOPHYSIOL, V17, P35, DOI 10.1016/0167-8760(94)90053-1; BURGESS A, 1993, ELECTROEN CLIN NEURO, V86, P219, DOI 10.1016/0013-4694(93)90101-Z; Burgess AP, 1997, INT J PSYCHOPHYSIOL, V26, P113, DOI 10.1016/S0167-8760(97)00759-9; Cassidy SM, 2012, PSYCHOPHYSIOLOGY, V49, P659, DOI 10.1111/j.1469-8986.2011.01349.x; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; DUSTMAN RE, 1963, SCIENCE, V142, P1480, DOI 10.1126/science.142.3598.1480; DUSTMAN RE, 1965, ELECTROEN CLIN NEURO, V19, P570, DOI 10.1016/0013-4694(65)90242-7; Fallgatter AJ, 2002, J CLIN NEUROPHYSIOL, V19, P61, DOI 10.1097/00004691-200201000-00008; GOODIN D, 1994, ELECTROEN CLIN NEURO, V91, P18, DOI 10.1016/0013-4694(94)90014-0; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gruendler TOJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025591; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Helmstadter G. C., 1964, PRINCIPLES PSYCHOL M; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; KARNISKI W, 1989, ELECTROEN CLIN NEURO, V72, P373, DOI 10.1016/0013-4694(89)90043-6; KILENY PR, 1987, EAR HEARING, V8, P110, DOI 10.1097/00003446-198704000-00008; Kinoshita S, 1996, PHYSIOL BEHAV, V60, P1087, DOI 10.1016/0031-9384(96)00130-8; LEWIS GW, 1984, INT J NEUROSCI, V25, P131, DOI 10.3109/00207458408985595; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Neuhaus AH, 2010, INT J PSYCHOPHYSIOL, V76, P72, DOI 10.1016/j.ijpsycho.2010.02.005; Nuwer MR, 1999, EEG CL N SU, V50, P150; POLICH J, 1986, PSYCHOPHYSIOLOGY, V23, P590, DOI 10.1111/j.1469-8986.1986.tb00677.x; POLICH J, 1986, ELECTROEN CLIN NEURO, V65, P236, DOI 10.1016/0168-5597(86)90059-6; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Pratt H, 2000, CLIN NEUROPHYSIOL, V111, P1425, DOI 10.1016/S1388-2457(00)00344-8; Sandman CA, 2000, CLIN NEUROPHYSIOL, V111, P1427, DOI 10.1016/S1388-2457(00)00320-5; SEGALOWITZ SJ, 1993, PSYCHOPHYSIOLOGY, V30, P451, DOI 10.1111/j.1469-8986.1993.tb02068.x; SKLARE DA, 1984, ELECTROEN CLIN NEURO, V59, P420, DOI 10.1016/0168-5597(84)90043-1; Smit DJA, 2007, TWIN RES HUM GENET, V10, P335, DOI 10.1375/twin.10.2.335; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Walhovd KB, 2002, INT J PSYCHOPHYSIOL, V46, P29, DOI 10.1016/S0167-8760(02)00039-9; ZAMRINI EY, 1991, INT J NEUROSCI, V61, P113, DOI 10.3109/00207459108986279	34	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62523	10.1371/journal.pone.0062523	http://dx.doi.org/10.1371/journal.pone.0062523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658739	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000055
J	Calven, J; Yudina, Y; Uller, L				Calven, Jenny; Yudina, Yuliana; Uller, Lena			Rhinovirus and dsRNA Induce RIG-I-Like Receptors and Expression of Interferon beta and lambda(1) in Human Bronchial Smooth Muscle Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; THYMIC STROMAL LYMPHOPOIETIN; AIRWAY EPITHELIAL-CELLS; ASTHMA EXACERBATIONS; SECONDARY NECROSIS; ANTIVIRAL RESPONSE; INFECTION; RECOGNITION; TLR3	Rhinovirus (RV) infections cause exacerbations and development of severe asthma highlighting the importance of antiviral interferon (IFN) defence by airway cells. Little is known about bronchial smooth muscle cell (BSMC) production of IFNs and whether BSMCs have dsRNA-sensing receptors besides TLR3. dsRNA is a rhinoviral replication intermediate and necrotic cell effect mimic that mediates innate immune responses in bronchial epithelial cells. We have explored dsRNA-evoked IFN-beta and IFN-lambda(1) production in human BSMCs and potential involvement of TLR3 and RIG-I-like receptors (RLRs). Primary BSMCs were stimulated with 0.1-10 mu g/ml dsRNA, 0.1-1 mu g/ml dsRNA in complex with the transfection agent LyoVec (dsRNA/LyoVec; selectively activating cytosolic RLRs) or infected with 0.05-0.5 MOI RV1B. Both dsRNA stimuli evoked early (3 h), concentration-dependent IFN-b and IFN-lambda(1) mRNA expression, which with dsRNA/LyoVec was much greater, and with dsRNA was much less, after 24 h. The effects were inhibited by dexamethasone. Further, dsRNA and dsRNA/LyoVec concentration-dependently upregulated RIG-I and MDA5 mRNA and protein. dsRNA and particularly dsRNA/LyoVec caused IFN-b and IFN-lambda(1) protein production (24 h). dsRNA-but not dsRNA/LyoVec-induced IFN expression was partly inhibited by chloroquine that suppresses endosomal TLR3 activation. RV1B dose-dependently increased BSMC expression of RIG-I, MDA5, IFN-b, and IFN-lambda(1) mRNA. We suggest that BSMCs express functional RLRs and that both RLRs and TLR3 are involved in viral stimulus-induced BSMC expression of IFN-b and IFN-lambda(1).	[Calven, Jenny; Yudina, Yuliana; Uller, Lena] Lund Univ, Dept Expt Med Sci, Unit Resp Immunopharmacol, Lund, Sweden	Lund University	Uller, L (corresponding author), Lund Univ, Dept Expt Med Sci, Unit Resp Immunopharmacol, Lund, Sweden.	lena.uller@med.lu.se			Swedish Medical Research Council, Vinnova; Swedish Heart and Lung foundation	Swedish Medical Research Council, Vinnova; Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation)	This study was funded by the Swedish Medical Research Council, Vinnova, Swedish Heart and Lung foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedke N, 2009, J IMMUNOL, V182, P3660, DOI 10.4049/jimmunol.0802471; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Calven J, 2012, J INNATE IMMUN, V4, P86, DOI 10.1159/000329131; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Cooper PR, 2009, AM J PHYSIOL-LUNG C, V297, pL530, DOI 10.1152/ajplung.00133.2009; Damera G, 2009, PULM PHARMACOL THER, V22, P353, DOI 10.1016/j.pupt.2008.12.006; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Gern JE, 2012, AM J RESP CRIT CARE, V185, P468, DOI 10.1164/rccm.201112-2195ED; JOHNSTON SL, 1993, J CLIN MICROBIOL, V31, P111, DOI 10.1128/JCM.31.1.111-117.1993; Joubert P, 2005, J ALLERGY CLIN IMMUN, V116, P713, DOI 10.1016/j.jaci.2005.05.042; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Leung TF, 2010, CHEST, V137, P348, DOI 10.1378/chest.09-1250; Lim DM, 2011, AM J PHYSIOL-GASTR L, V301, pG91, DOI 10.1152/ajpgi.00471.2010; Liu JJ, 2012, EXP HEMATOL, V40, P330, DOI 10.1016/j.exphem.2011.12.002; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Miller EK, 2012, AM J RESP CRIT CARE, V185, P508, DOI 10.1164/rccm.201108-1462OC; Niimi K, 2007, J IMMUNOL, V178, P489, DOI 10.4049/jimmunol.178.1.489; Oliver BGG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-71; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Persson CGA, 2008, PULM PHARMACOL THER, V21, P1, DOI 10.1016/j.pupt.2006.10.017; Pritchard AL, 2012, J IMMUNOL, V188, P5898, DOI 10.4049/jimmunol.1103507; Rodel J, 2001, FEMS IMMUNOL MED MIC, V32, P9; Roth M, 2010, ANN ALLERG ASTHMA IM, V104, P152, DOI 10.1016/j.anai.2009.11.022; Rydell-Tormanen K, 2006, EUR RESPIR J, V28, P268, DOI 10.1183/09031936.06.00126905; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Solarewicz-Madejek K, 2009, CLIN EXP ALLERGY, V39, P845, DOI 10.1111/j.1365-2222.2009.03244.x; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Takeda N, 2009, CLIN EXP ALLERGY, V39, P1018, DOI 10.1111/j.1365-2222.2009.03238.x; Tliba O, 2003, J BIOL CHEM, V278, P50615, DOI 10.1074/jbc.M303680200; Uller L, 2004, AM J RESP CRIT CARE, V170, P742, DOI 10.1164/rccm.200402-240OC; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; Van Ly David, 2011, J Allergy (Cairo), V2011, P457169, DOI 10.1155/2011/457169; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302	45	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62718	10.1371/journal.pone.0062718	http://dx.doi.org/10.1371/journal.pone.0062718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658644	Green Published, gold, Green Submitted			2022-12-27	WOS:000321662800057
J	Dalai, S; Pakrashi, S; Chandrasekaran, N; Mukherjee, A				Dalai, Swayamprava; Pakrashi, Sunandan; Chandrasekaran, Natarajan; Mukherjee, Amitava			Acute Toxicity of TiO2 Nanoparticles to Ceriodaphnia dubia under Visible Light and Dark Conditions in a Freshwater System	PLOS ONE			English	Article							DAPHNIA-MAGNA; TITANIUM-DIOXIDE; ENGINEERED NANOPARTICLES; OXIDE NANOPARTICLES; CYTOTOXICITY; ECOTOXICITY; BEHAVIOR; AGGREGATION; PARTICLES; ALGAE	The ever increasing industrial and consumer applications of titanium dioxide nanoparticles (TiO2 NPs) raise concern over the possible risk associated with their environmental exposure. Still, the knowledge regarding nanoparticle behavior in a freshwater ecosystem is lacking. The current study focuses on the toxicity of TiO2 NPs towards Ceriodaphnia dubia (a dominant daphnid isolated from the freshwater) under two different conditions; (1) light and dark photoperiod (16:8 h) and (2) continuous dark conditions, for a period of 48 h. An increase in toxicity was observed with an increase in the concentration, until a certain threshold level (under both photoperiod and dark conditions), and beyond which, reduction was noted. The decrease in toxicity would have resulted from the aggregation and settling of NPs, making them less bioavailable. The oxidative stress was one of the major contributors towards cytotoxicity under both photoperiod and dark conditions. The slow depuration of TiO2 NPs under the photoperiod conditions confirmed a higher NP bioaccumulation and thus a higher bioconcentration factor (BCF) compared to dark conditions. The transmission electron micrographs confirmed the bioaccumulation of NPs and damage of tissues in the gut lining.	[Dalai, Swayamprava; Pakrashi, Sunandan; Chandrasekaran, Natarajan; Mukherjee, Amitava] VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Mukherjee, A (corresponding author), VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India.	amitav@vit.ac.in	Dalai, Swayamprava/AAD-8677-2021; Mukherjee, Amitava/H-5560-2011; Chandrasekaran, Natarajan/F-2312-2018	Mukherjee, Amitava/0000-0001-8682-4278; Chandrasekaran, Natarajan/0000-0002-0586-134X; Dalai, Swayamprava/0000-0001-5311-4763	VIT University	VIT University	The study is funded by institutional support from VIT University (www.vit.ac.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiano I, 2012, ENVIRON TOXICOL CHEM, V31, P2564, DOI 10.1002/etc.1981; Bennett SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048719; Bundschuh M, 2011, CHEMOSPHERE, V85, P1563, DOI 10.1016/j.chemosphere.2011.07.060; Dabrunz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020112; Dalai S, 2012, TOXICOL RES-UK, V1, P116, DOI 10.1039/c2tx00012a; Fenoglio I, 2009, CHEM-EUR J, V15, P4614, DOI 10.1002/chem.200802542; Frohlich E, 2009, J TOXICOL SCI, V34, P363; Gomes RL, 2004, ENVIRON TOXICOL CHEM, V23, P105, DOI 10.1897/02-613; Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706; Heinlaan M, 2011, WATER RES, V45, P179, DOI 10.1016/j.watres.2010.08.026; Hong JL, 2006, J BIOSCI BIOENG, V101, P185, DOI 10.1263/jbb.101.185; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; Hussain M, 2010, CHEM ENG J, V157, P45, DOI 10.1016/j.cej.2009.10.043; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim KT, 2010, SCI TOTAL ENVIRON, V408, P2268, DOI 10.1016/j.scitotenv.2010.01.041; Leung TY, 2008, WATER RES, V42, P4827, DOI 10.1016/j.watres.2008.08.031; Lewinski NA, 2010, ENVIRON SCI TECHNOL, V44, P1841, DOI 10.1021/es902728a; Lipovsky A, 2012, PHOTOCHEM PHOTOBIOL, V88, P14, DOI 10.1111/j.1751-1097.2011.01015.x; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; Marcone GPS, 2012, J HAZARD MATER, V211, P436, DOI 10.1016/j.jhazmat.2011.12.075; Mendonca E, 2011, J HAZARD MATER, V186, P265, DOI 10.1016/j.jhazmat.2010.10.115; Miller RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030321, 10.1371/journal.pone.0033885]; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; OECD, 2004, OECD GUID TEST CHEM, DOI 10.1787/9789264069947-en; Pinheiro T, 2013, NUCL INSTRUM METH B, V306, P117, DOI 10.1016/j.nimb.2012.12.049; Robertson PKJ, 2012, J HAZARD MATER, V211, P161, DOI 10.1016/j.jhazmat.2011.11.058; Rothen-Rutishauser Barbara, 2007, Part Fibre Toxicol, V4, P9; Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197; Scientific Committee on Emerging or Newly-Identified Health Risks, 2007, OP SCI ASP EX PROP D; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Sharma VK, 2009, J ENVIRON SCI HEAL A, V44, P1485, DOI 10.1080/10934520903263231; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Warheit DB, 2007, TOXICOL LETT, V171, P99, DOI 10.1016/j.toxlet.2007.04.008; Wiench K, 2009, CHEMOSPHERE, V76, P1356, DOI 10.1016/j.chemosphere.2009.06.025; WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013	40	38	39	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62970	10.1371/journal.pone.0062970	http://dx.doi.org/10.1371/journal.pone.0062970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658658	Green Published, Green Submitted, gold			2022-12-27	WOS:000321662800070
J	Coumans, FAW; van Dalum, G; Beck, M; Terstappen, LWMM				Coumans, Frank A. W.; van Dalum, Guus; Beck, Markus; Terstappen, Leon W. M. M.			Filtration Parameters Influencing Circulating Tumor Cell Enrichment from Whole Blood	PLOS ONE			English	Article							CANCER-PATIENTS; PERIPHERAL-BLOOD; BREAST-CANCER; HUMAN NEUTROPHILS; PROSTATE-CANCER; LUNG-CANCER; FLOW; SUSPENSIONS; SURVIVAL; ENUMERATION	Filtration can achieve circulating tumor cell (CTC) enrichment from blood. Key parameters such as flow-rate, applied pressure, and fixation, vary largely between assays and their influence is not well understood. Here, we used a filtration system, to monitor these parameters and determine their relationships. Whole blood, or its components, with and without spiked tumor cells were filtered through track-etched filters. We characterize cells passing through filter pores by their apparent viscosity; the viscosity of a fluid that would pass with the same flow. We measured a ratio of 5 center dot 10(4):10(2):1 for the apparent viscosities of 15 mu m diameter MDA-231 cells, 10 mu m white cells and 90 fl red cells passing through a 5 mu m pore. Fixation increases the pressure needed to pass cells through 8 mu m pores 25-fold and halves the recovery of spiked tumor cells. Filtration should be performed on unfixed samples at a pressure of similar to 10 mbar for a 1 cm(2) track-etched filter with 5 mu m pores. At this pressure MDA-231 cells move through the filter in 1 hour. If fixation is needed for sample preservation, a gentle fixative should be selected. The difference in apparent viscosity between CTC and blood cells is key in optimizing recovery of CTC.	[Coumans, Frank A. W.; van Dalum, Guus; Beck, Markus; Terstappen, Leon W. M. M.] Univ Twente, MIRA Inst, NL-7500 AE Enschede, Netherlands	University of Twente	Terstappen, LWMM (corresponding author), Univ Twente, MIRA Inst, POB 217, NL-7500 AE Enschede, Netherlands.	l.w.m.m.terstappen@utwente.nl	terstappen, leon/O-4923-2018	terstappen, leon/0000-0001-5944-3787; Beck, Markus/0000-0003-1298-4775	Veridex LLC; European Research Council	Veridex LLC; European Research Council(European Research Council (ERC)European Commission)	This work was supported by Veridex LLC (http://www.veridex.com/). MB was supported by a European Research Council starting grant (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2011, ISOLATION CIRCULATIN; Alix-Panabieres C, 2005, CLIN CHEM, V51, P1538, DOI 10.1373/clinchem.2005.049445; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; BAGGE U, 1977, ADV MICROCIRCULAT, V7, P18; CHIEN S, 1983, BIORHEOLOGY, V20, P11; Chung YK, 2011, BIOSENS BIOELECTRON, V26, P2520, DOI 10.1016/j.bios.2010.10.048; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2013, METHODS MOL BIOL CIR; Coumans FAW, 2013, PLOS ONE IN PRESS; Coumans FAW, 2012, CLIN CANCER RES, V18, P5711, DOI 10.1158/1078-0432.CCR-12-1585; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; DAGAN Z, 1983, CHEM ENG SCI, V38, P583, DOI 10.1016/0009-2509(83)80118-3; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Desitter I, 2011, ANTICANCER RES, V31, P427; Dharmasiri U, 2011, ANAL CHEM, V83, P2301, DOI 10.1021/ac103172y; DONG C, 1988, J BIOMECH ENG-T ASME, V110, P27, DOI 10.1115/1.3108402; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; EVANS E, 1984, BLOOD, V64, P1028; FRANK RS, 1990, J BIOMECH ENG-T ASME, V112, P277, DOI 10.1115/1.2891185; Hiltermann TJN, 2012, ANN ONCOL, V23, P2937, DOI 10.1093/annonc/mds138; HOCHMUTH RM, 1990, BIORHEOLOGY, V27, P817; Holdich R, 2006, PHILOS T ROY SOC A, V364, P161, DOI 10.1098/rsta.2005.1090; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Hsieh HB, 2006, BIOSENS BIOELECTRON, V21, P1893, DOI 10.1016/j.bios.2005.12.024; JONES JG, 1984, BRIT J HAEMATOL, V57, P457, DOI 10.1111/j.1365-2141.1984.tb02920.x; Kahn HJ, 2004, BREAST CANCER RES TR, V86, P237, DOI 10.1023/B:BREA.0000036897.92513.72; KHATO J, 1979, TOHOKU J EXP MED, V128, P273, DOI 10.1620/tjem.128.273; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Kuiper S, 2002, J MEMBRANE SCI, V196, P149, DOI 10.1016/S0376-7388(01)00552-X; Lee G.R., 1993, WINTROBES CLIN HEMAT, V9th; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; Matsusaka S, 2010, CANCER SCI, V101, P1067, DOI 10.1111/j.1349-7006.2010.01492.x; MERRILL EW, 1969, PHYSIOL REV, V49, P863, DOI 10.1152/physrev.1969.49.4.863; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; NEEDHAM D, 1990, J BIOMECH ENG-T ASME, V112, P269, DOI 10.1115/1.2891184; Ntouroupi TG, 2008, BRIT J CANCER, V99, P789, DOI 10.1038/sj.bjc.6604545; Rao C, 2011, INT J ONCOL, V38, P755, DOI 10.3892/ijo.2011.896; Rao CG, 2005, INT J ONCOL, V27, P49; ROMSDAHL MM, 1965, JAMA-J AM MED ASSOC, V193, P1087; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; SEAL SH, 1964, CANCER, V17, P637, DOI 10.1002/1097-0142(196405)17:5<637::AID-CNCR2820170512>3.0.CO;2-I; SKALAK R, 1987, BIORHEOLOGY, V24, P35; SKALAK R, 1983, BIORHEOLOGY, V20, P41; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Tan SJ, 2010, BIOSENS BIOELECTRON, V26, P1701, DOI 10.1016/j.bios.2010.07.054; Tan SJ, 2009, BIOMED MICRODEVICES, V11, P883, DOI 10.1007/s10544-009-9305-9; TSAI MA, 1993, BIOPHYS J, V65, P2078, DOI 10.1016/S0006-3495(93)81238-4; VALBERG PA, 1985, J CELL BIOL, V101, P130, DOI 10.1083/jcb.101.1.130; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; WEISS L, 1989, CELL BIOPHYS, V14, P187, DOI 10.1007/BF02797133; YEUNG A, 1989, BIOPHYS J, V56, P139, DOI 10.1016/S0006-3495(89)82659-1; Zheng S, 2007, J CHROMATOGR A, V1162, P154, DOI 10.1016/j.chroma.2007.05.064; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	55	73	79	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61774	10.1371/journal.pone.0061774	http://dx.doi.org/10.1371/journal.pone.0061774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658615	Green Published, Green Submitted, gold			2022-12-27	WOS:000318343700021
J	Yang, L; Niu, HJ; Gao, XJ; Wang, QS; Han, G; Cao, LM; Cai, CQ; Weiler, J; Yin, HF				Yang, Lu; Niu, Hongjing; Gao, Xianjun; Wang, Qingsong; Han, Gang; Cao, Limin; Cai, Chunquan; Weiler, Jan; Yin, Haifang			Effective Exon Skipping and Dystrophin Restoration by 2 '-O-Methoxyethyl Antisense Oligonucleotide in Dystrophin-Deficient Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CELL-PENETRATING PEPTIDE; NECROSIS-FACTOR-ALPHA; PHASE-II TRIAL; MESSENGER-RNA; CUSTIRSEN OGX-011; SPLICE-CORRECTION; APOLIPOPROTEIN-B; PROSTATE-CANCER; MUSCLE-CELLS	Antisense oligonucleotide (AO)-mediated exon-skipping therapy is one of the most promising therapeutic strategies for Duchenne Muscular Dystrophy (DMD) and several AO chemistries have been rigorously investigated. In this report, we focused on the effect of 2'-O-methoxyethyl oligonucleotides (MOE) on exon skipping in cultured mdx myoblasts and mice. Efficient dose-dependent skipping of targeted exon 23 was achieved in myoblasts with MOE AOs of different lengths and backbone chemistries. Furthermore, we established that 25-mer MOE phosphorothioate (PS) AOs provided the greatest exon-skipping efficacy. When compared with 2'O methyl phosphorothioate (2'OmePS) AOs, 25-mer MOE (PS) AOs also showed higher exon-skipping activity in vitro and in mdx mice after intramuscular injections. Characterization of uptake in vitro corroborated with exon-skipping results, suggesting that increased uptake of 25-mer MOE PS AOs might partly contribute to the difference in exon-skipping activity observed in vitro and in mdx mice. Our findings demonstrate the substantial potential for MOE PS AOs as an alternative option for the treatment of DMD.	[Yang, Lu; Niu, Hongjing; Gao, Xianjun; Wang, Qingsong; Han, Gang; Cao, Limin; Cai, Chunquan; Yin, Haifang] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China; [Weiler, Jan] Novartis Inst BioMed Res Inc, NIBR Biol Ctr, Cambridge, MA USA	Tianjin Medical University; Novartis	Yin, HF (corresponding author), Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China.	haifangyin@tmu.edu.cn			National Natural Science Foundation of China [81101340]; Research Fund for the Doctoral Program of Higher Education of China [20111202110002]; Program for New Century Excellent Talents [NCET-10-0957]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (Grant No. 81101340), Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20111202110002) and Program for New Century Excellent Talents (NCET-10-0957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Akdim F, 2010, J AM COLL CARDIOL, V55, P1611, DOI 10.1016/j.jacc.2009.11.069; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Chi KN, 2005, J NATL CANCER I, V97, P1287, DOI 10.1093/jnci/dji252; Chia S, 2009, CLIN CANCER RES, V15, P708, DOI 10.1158/1078-0432.CCR-08-1159; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; El-Andaloussi S, 2007, MOL THER, V15, P1820, DOI 10.1038/sj.mt.6300255; Geary RS, 2003, DRUG METAB DISPOS, V31, P1419, DOI 10.1124/dmd.31.11.1419; Geary RS, 2001, J PHARMACOL EXP THER, V296, P890; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Heemskerk H, 2009, ANN NY ACAD SCI, V1175, P71, DOI 10.1111/j.1749-6632.2009.04973.x; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Laskin JJ, 2012, J THORAC ONCOL, V7, P579, DOI 10.1097/JTO.0b013e31823f459c; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Manoharan M, 1999, BBA-GENE STRUCT EXPR, V1489, P117, DOI 10.1016/S0167-4781(99)00138-4; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Moulton HM, 2012, METHODS MOL BIOL, V867, P407, DOI 10.1007/978-1-61779-767-5_26; Mountoni F, 2011, NAT REV, V10, P621; NATT F, 2000, Patent No. 2000240734; Natt F, Patents, Patent No. [CAN 132:279477, 132279477]; Natt F, Patents, Patent No. [EP 991-19768, 99119768]; Natt F, Patents, Patent No. [US 981-68447, 98168447]; Saad F, 2011, CLIN CANCER RES, V17, P5765, DOI 10.1158/1078-0432.CCR-11-0859; Sazani P, 2002, NAT BIOTECHNOL, V20, P1228, DOI 10.1038/nbt759; Sewell KL, 2002, J PHARMACOL EXP THER, V303, P1334, DOI 10.1124/jpet.102.036749; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wang QS, 2010, J GENE MED, V12, P354, DOI 10.1002/jgm.1446; Wilton SD, 1999, NEUROMUSCULAR DISORD, V9, P330, DOI 10.1016/S0960-8966(99)00010-3; Wood MJA, 2010, BRAIN, V133, P957, DOI 10.1093/brain/awq002; Yin HF, 2008, MOL THER, V16, P38, DOI 10.1038/sj.mt.6300329; Yin HF, 2010, MOL THER, V18, P819, DOI 10.1038/mt.2009.310; Yin HF, 2009, HUM MOL GENET, V18, P4405, DOI 10.1093/hmg/ddp395; Yin H, 2008, HUM MOL GENET, V17, P3909, DOI 10.1093/hmg/ddn293; Yu RZ, 2007, DRUG METAB DISPOS, V35, P460, DOI 10.1124/dmd.106.012401; Yu RZ, 2001, J PHARMACOL EXP THER, V296, P388	40	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61584	10.1371/journal.pone.0061584	http://dx.doi.org/10.1371/journal.pone.0061584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658612	Green Published, Green Submitted, gold			2022-12-27	WOS:000318343700016
J	Lewis, KB; Hughes, RJ; Epstein, MS; Josephson, NC; Kempton, CL; Kessler, CM; Key, NS; Howard, TE; Kruse-Jarres, R; Lusher, JM; Walsh, CE; Watts, RG; Ettinger, RA; Pratt, KP				Lewis, Kenneth B.; Hughes, Richard J.; Epstein, Melinda S.; Josephson, Neil C.; Kempton, Christine L.; Kessler, Craig M.; Key, Nigel S.; Howard, Tom E.; Kruse-Jarres, Rebecca; Lusher, Jeanne M.; Walsh, Christopher E.; Watts, Raymond G.; Ettinger, Ruth A.; Pratt, Kathleen P.		PATH Personalized Alternative	Phenotypes of Allo- and Autoimmune Antibody Responses to FVIII Characterized by Surface Plasmon Resonance	PLOS ONE			English	Article							FACTOR-VIII ANTIBODIES; HEMOPHILIA-A; IGG4 ANTIBODIES; BETHESDA ASSAY; B-CELL; MONOCLONAL-ANTIBODIES; INHIBITOR ANTIBODIES; DOMAIN ANTIBODIES; IMMUNOGLOBULIN-G; EPITOPE	Evidence of antibody isotype/ subtype switching may provide prognostic value regarding the state of immune responses to therapeutic proteins, e.g. anti-factor VIII (FVIII) antibodies that develop in many hemophilia A patients, clinically termed "inhibitors''. A sensitive, high-information-content surface plasmon resonance (SPR) assay has been developed to quantify IgG subtype distributions and the domain specificity of anti-drug antibodies. Plasma samples from 22 subjects with an alloor auto-immune reaction to FVIII were analyzed. Pre-analytical treatment protocols were developed to minimize nonspecific binding and specific matrix interference due to von Willebrand factor-FVIII interactions. The dynamic range for IgG quantification was 0.2-5 mu g/ml (similar to 1-33 nM), allowing characterization of inhibitor-positive samples. Subtype-specific monoclonal antibodies were used to quantify the IgG subtype distribution of FVIII-specific antibodies. Most samples obtained from multiply-infused inhibitor subjects contained IgG(4) antibodies. Several distinct phenotypes were assigned based on the IgG subtype distribution: IgG(1), IgG(4), IgG(1) & IgG(4), and IgG(1), IgG(2) & IgG(4). An IgG(1)-only response was found in mild/moderate HA subjects during early FVIII infusions, and analysis of serial samples followed antibody class switching as several subjects' immune responses developed. Competition studies utilizing a recombinant FVIII-C2 domain indicated 40-80% of FVIII-specific antibodies in most samples were directed against this domain.	[Lewis, Kenneth B.; Josephson, Neil C.; Ettinger, Ruth A.; Pratt, Kathleen P.] Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA; [Hughes, Richard J.; Epstein, Melinda S.; Howard, Tom E.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Josephson, Neil C.; Pratt, Kathleen P.] Univ Washington, Div Hematol, Seattle, WA 98195 USA; [Kempton, Christine L.] Emory Univ, Atlanta, GA 30322 USA; [Kessler, Craig M.] Georgetown Univ, Washington, DC USA; [Key, Nigel S.] Univ N Carolina, Chapel Hill, NC USA; [Howard, Tom E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Howard, Tom E.] USC, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA; [Kruse-Jarres, Rebecca] Tulane Univ, New Orleans, LA 70118 USA; [Lusher, Jeanne M.] Wayne State Univ, Detroit, MI USA; [Walsh, Christopher E.] Mt Sinai Sch Med, New York, NY USA; [Watts, Raymond G.] Univ Alabama Birmingham, Birmingham, AL USA	Puget Sound Blood Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Washington; University of Washington Seattle; Emory University; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of Southern California Keck Hospital; Tulane University; Wayne State University; Icahn School of Medicine at Mount Sinai; University of Alabama System; University of Alabama Birmingham	Pratt, KP (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	KathleenP@psbc.org	Kempton, Christine/ABG-4398-2020; Pratt, Kathleen P/E-9489-2019	Kempton, Christine/0000-0002-2391-2016; Curran, Joanne/0000-0002-6898-155X; Carless, Melanie/0000-0001-8350-2302; Pratt, Kathleen/0000-0001-6837-6133	NHLBI [1RC2 HL101851]; Bayer HealthCare LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101851] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bayer HealthCare LLC(Bayer AGBayer Healthcare Pharmaceuticals); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Major support for this work was from NHLBI 1RC2 HL101851: "Mechanisms of Race-Based Differences in Factor VIII Immunogenicity in Hemophilia A" (PIs TE Howard and KP Pratt). Minor support for this work was from: 1. Unrestricted research support was received under a CSL Behring Foundation Hemophilia grant: "Do Non-Synonymous Single Nucleotide Polymorphisms in Factor VIII Lead to T-Cell Responses and Subsequent Inhibitor Development in Black Hemophilia A Patients?" (PI: KP Pratt), funder: CSL Behring Foundation for Research and Advancement of Patient Health, http://www.cslbehringfoundation.com/.2. Unrestricted research support was received from a Bayer Healthcare LLC grant: "Repository for Human HLA-restricted T-Cell Clones" (PI: KP Pratt), funder: Bayer HealthCare LLC, http://grants-contributions.bayerweb.com/en/home/index. php, 800 Dwight Way, Berkeley, California 94710. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Dr's. Pratt and Lewis are inventors on a patent describing the SPR methodology described in this study. Dr. Pratt received travel support from GE Health Sciences to present preliminary SPR studies at the 2011 DiPia meeting in Boston, Massachusetts. This study was partly funded by Bayer HealthCare LLC. The authors thank Dr. Jason Schuman (GE Health Sciences) for technical advice and Bill Church (Green Mountain Antibodies, Burlington, Vermont) for donations of monoclonal antibodies. Drs. Lewis and Pratt are inventors on the following patent: International Patent Application No. PCT/US2012/61/553, 660, Title: Antibody Response Phenotyping, Filed: October 31, 2012, Inventors: Kathleen Pratt, PhD; Kenneth Lewis, PhD. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	AALBERSE RC, 1983, J IMMUNOL, V130, P722; Albert T, 2008, THROMB HAEMOSTASIS, V99, P634, DOI 10.1160/TH07-06-0400; Barrow RT, 2000, BLOOD, V95, P564, DOI 10.1182/blood.V95.2.564; Bergmann-Leitner ES, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-129; EHRENFORTH S, 1992, LANCET, V339, P594, DOI 10.1016/0140-6736(92)90874-3; Ejima D, 2005, ANAL BIOCHEM, V345, P250, DOI 10.1016/j.ab.2005.07.004; FULCHER CA, 1987, BLOOD, V69, P1475; FULCHER CA, 1988, BLOOD, V72, P1348; Gibbs E, 2008, J INTERF CYTOK RES, V28, P713, DOI 10.1089/jir.2008.0144; GILLES JGG, 1993, BLOOD, V82, P2452; Gouw SC, 2007, BLOOD, V109, P4693, DOI 10.1182/blood-2006-11-056317; HAMILTON RG, 1993, J IMMUNOL METHODS, V158, P107, DOI 10.1016/0022-1759(93)90263-7; Irigoyen MB, 2011, HAEMOPHILIA, V17, P267, DOI 10.1111/j.1365-2516.2010.02406.x; Jacquemin MG, 1998, BLOOD, V92, P496, DOI 10.1182/blood.V92.2.496.414k16_496_506; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Kessel C, 2008, MOL IMMUNOL, V46, P8, DOI 10.1016/j.molimm.2008.06.015; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Kopecky EM, 2006, J IMMUNOL METHODS, V308, P90, DOI 10.1016/j.jim.2005.10.016; Krudysz-Amblo J, 2009, BLOOD, V113, P2587, DOI 10.1182/blood-2008-08-174987; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Lavigne-Lissalde G, 2008, THROMB HAEMOSTASIS, V99, P1090, DOI 10.1160/TH07-08-0497; Lewis KB, 2009, MOL IMMUNOL, V46, P3488, DOI 10.1016/j.molimm.2009.07.009; Ling M, 2001, BRIT J HAEMATOL, V114, P861, DOI 10.1046/j.1365-2141.2001.03067.x; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; Lollar P, 1997, THROMB HAEMOSTASIS, V78, P647; Meeks SL, 2008, BLOOD, V112, P1151, DOI 10.1182/blood-2008-01-132639; Meeks SL, 2007, BLOOD, V110, P4234, DOI 10.1182/blood-2007-06-096842; Narita M, 1997, CLIN DIAGN VIROL, V8, P233, DOI 10.1016/S0928-0197(97)10007-1; Parkkinen J, 2006, VOX SANG, V90, P97, DOI 10.1111/j.1423-0410.2005.00731.x; Paschal RD, 2013, HAEMOPHILIA IN PRESS; Pratt K, 2009, CLIN REV ALLERG IMMU, V37, P80, DOI 10.1007/s12016-009-8120-7; Prescott R, 1997, BLOOD, V89, P3663, DOI 10.1182/blood.V89.10.3663.3663_3663_3671; Raut S, 2003, THROMB HAEMOSTASIS, V90, P385, DOI 10.1160/TH02-09-0086; Reding MT, 2002, THROMB HAEMOSTASIS, V88, P568; Sahud MA, 2007, HAEMOPHILIA, V13, P317, DOI 10.1111/j.1365-2516.2007.01450.x; SANCHEZCUENCA JM, 1990, THROMB RES, V57, P897, DOI 10.1016/0049-3848(90)90156-7; SCANDELLA D, 1989, BLOOD, V74, P1618; SCANDELLA D, 1995, BLOOD, V86, P1811, DOI 10.1182/blood.V86.5.1811.bloodjournal8651811; Shetty S, 2003, ACTA HAEMATOL-BASEL, V109, P18, DOI 10.1159/000067272; Towfighi F, 2005, ACTA HAEMATOL-BASEL, V114, P84, DOI 10.1159/000086580; van Helden PMW, 2008, BRIT J HAEMATOL, V142, P644, DOI 10.1111/j.1365-2141.2008.07232.x; VERBRUGGEN B, 1995, THROMB HAEMOSTASIS, V73, P247; Zakarija A, 2011, HAEMOPHILIA, V17, P636, DOI 10.1111/j.1365-2516.2010.02468.x	43	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61120	10.1371/journal.pone.0061120	http://dx.doi.org/10.1371/journal.pone.0061120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667433	Green Submitted, gold, Green Published			2022-12-27	WOS:000319055600009
J	Zhong, J; Sakaki, M; Okada, H; Ahrens, ET				Zhong, Jia; Sakaki, Masashi; Okada, Hideho; Ahrens, Eric T.			In Vivo Intracellular Oxygen Dynamics in Murine Brain Glioma and Immunotherapeutic Response of Cytotoxic T Cells Observed by Fluorine-19 Magnetic Resonance Imaging	PLOS ONE			English	Article							TUMOR OXYGENATION; TENSION; HYPOXIA; VACCINATION; SPECTROSCOPY; RESISTANCE; REGRESSION; RELAXATION; SURVIVAL	Noninvasive biomarkers of anti-tumoral efficacy are of great importance to the development of therapeutic agents. Tumor oxygenation has been shown to be an important indicator of therapeutic response. We report the use of intracellular labeling of tumor cells with perfluorocarbon (PFC) molecules, combined with quantitative F-19 spin-lattice relaxation rate (R-1) measurements, to assay tumor cell oxygen dynamics in situ. In a murine central nervous system (CNS) GL261 glioma model, we visualized the impact of Pmel-1 cytotoxic T cell immunotherapy, delivered intravenously, on intracellular tumor oxygen levels. GL261 glioma cells were labeled ex vivo with PFC and inoculated into the mouse striatum. The R-1 of F-19 labeled cells was measured using localized single-voxel magnetic resonance spectroscopy, and the absolute intracellular partial pressure of oxygen (pO(2)) was ascertained. Three days after tumor implantation, mice were treated with 2x10(7) cytotoxic T cells intravenously. At day five, a transient spike in pO(2) was observed indicating an influx of T cells into the CNS and putative tumor cell apoptosis. Immunohistochemistry and quantitative flow cytometry analysis confirmed that the pO(2) was causally related to the T cells infiltration. Surprisingly, the pO(2) spike was detected even though few (similar to 4x10(4)) T cells actually ingress into the CNS and with minimal tumor shrinkage. These results indicate the high sensitivity of this approach and its utility as a non-invasive surrogate biomarker of anti-cancer immunotherapeutic response in preclinical models.	[Zhong, Jia; Ahrens, Eric T.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Zhong, Jia; Ahrens, Eric T.] Carnegie Mellon Univ, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; [Sakaki, Masashi; Okada, Hideho] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Brain Tumor Program,Canc Inst, Pittsburgh, PA 15261 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahrens, ET (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	eta@andrew.cmu.edu	Sakaki, Masashi/ABA-6069-2021	Sakaki, Masashi/0000-0002-4431-3493	National Institutes of Health; Dana Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation	This work is supported in part by grants from the National Institutes of Health and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Baldwin NJ, 1996, MAGN RESON IMAGING, V14, P541, DOI 10.1016/0730-725X(96)00049-5; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Bruce A., 2002, MOL BIOL CELL, V4th ed.; DARDZINSKI BJ, 1994, MAGNET RESON MED, V32, P88, DOI 10.1002/mrm.1910320112; di Carlo E, 2007, CANCER IMMUNOL IMMUN, V56, P1323, DOI 10.1007/s00262-007-0326-z; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; El Andaloussi A, 2006, J NEUROSURG, V105, P430, DOI 10.3171/jns.2006.105.3.430; Fujita M, 2009, CANCER RES, V69, P1587, DOI 10.1158/0008-5472.CAN-08-2915; GUO QZ, 1994, ARTIF CELL BLOOD SUB, V22, P1449, DOI 10.3109/10731199409138849; HEES PS, 1993, MAGNET RESON MED, V29, P303, DOI 10.1002/mrm.1910290305; HOLLADAY FP, 1992, NEUROSURGERY, V31, P528, DOI 10.1227/00006123-199209000-00015; Hou HA, 2003, ANESTH ANALG, V96, P1467, DOI 10.1213/01.ANE.0000055648.41152.63; Iwadate Y, 2003, INT J ONCOL, V23, P483; Kadayakkara DKK, 2010, MAGN RESON MED, V64, P1252, DOI 10.1002/mrm.22506; Kalinski P, 2010, SEMIN IMMUNOL, V22, P173, DOI 10.1016/j.smim.2010.03.002; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Laukemper-Ostendorf S, 2002, MAGN RESON MED, V47, P82, DOI 10.1002/mrm.10008; Lyng H, 1997, RADIOTHER ONCOL, V44, P163, DOI 10.1016/S0167-8140(97)01920-8; Maes W, 2009, NEURO-ONCOLOGY, V11, P529, DOI 10.1215/15228517-2009-004; MASON RP, 1993, MAGNET RESON MED, V29, P296, DOI 10.1002/mrm.1910290304; MASON RP, 1994, INT J RADIAT ONCOL, V29, P95, DOI 10.1016/0360-3016(94)90231-3; Matsumoto S, 2008, J CLIN INVEST, V118, P1965, DOI 10.1172/JCI34928; NASTALA CL, 1994, J IMMUNOL, V153, P1697; Nishimura F, 2006, CANCER RES, V66, P4478, DOI 10.1158/0008-5472.CAN-05-3825; O I, 2002, ANTICANCER RES, V22, P613; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Okada H, 2009, CRIT REV IMMUNOL, V29, P1; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; PARHAMI P, 1983, J PHYS CHEM-US, V87, P1928, DOI 10.1021/j100234a020; Perret R, 2008, TISSUE ANTIGENS, V72, P187, DOI 10.1111/j.1399-0039.2008.01088.x; Prins RM, 2003, CANCER RES, V63, P8487; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324; TEICHER BA, 1995, HEMATOL ONCOL CLIN N, V9, P475; Van der Sanden BPJ, 1999, INT J RADIAT ONCOL, V44, P649, DOI 10.1016/S0360-3016(98)00555-0; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xia MN, 2006, PHYS MED BIOL, V51, P45, DOI 10.1088/0031-9155/51/1/004; Yu JS, 2001, CANCER RES, V61, P842; Yu JX, 2005, CURR MED CHEM, V12, P819, DOI 10.2174/0929867053507342; Zhao DW, 2009, MAGN RESON MED, V62, P357, DOI 10.1002/mrm.22020; Zhao DW, 2004, METHOD ENZYMOL, V386, P378; Zhu XM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-10	45	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e59479	10.1371/journal.pone.0059479	http://dx.doi.org/10.1371/journal.pone.0059479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667419	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000319055600001
J	Auguy, F; Fahr, M; Moulin, P; Brugel, A; Laplaze, L; El Mzibri, M; Filali-Maltouf, A; Doumas, P; Smouni, A				Auguy, Florence; Fahr, Mouna; Moulin, Patricia; Brugel, Anais; Laplaze, Laurent; El Mzibri, Mohamed; Filali-Maltouf, Abdelkarim; Doumas, Patrick; Smouni, Abdelaziz			Lead Tolerance and Accumulation in Hirschfeldia incana, a Mediterranean Brassicaceae from Metalliferous Mine Spoils	PLOS ONE			English	Article							METAL HYPERACCUMULATION; ARABIDOPSIS METALLOTHIONEINS; P-1B-TYPE ATPASE; TRACE-ELEMENTS; CADMIUM; PLANT; GENE; ZINC; EXPRESSION; DETOXIFICATION	Lead is a heavy metal of particular concern with respect to environmental quality and health. The lack of plant species that accumulate and tolerate Pb is a limiting factor to understand the molecular mechanisms involved in Pb tolerance. In this study we identified Hirschfeldia incana, a Brassicaceae collected from metalliferous mine spoils in Morocco, as a Pb accumulator plant. H. incana exhibited high Pb accumulation in mine soils and in hydroponic cultures. Major Pb accumulation occurred in the roots and a part of Pb translocated from the roots to the shoots, even to the siliques. These findings demonstrated that H. incana is a Pb accumulator species. The expression of several candidate genes after Pb-exposure was measured by quantitative PCR and two of them, HiHMA4 and HiMT2a, coding respectively for a P1B-type ATPase and a metallothionein, were particularly induced by Pb-exposure in both roots and leaves. The functional characterization of HiHMA4 and HiMT2a was achieved using Arabidopsis T-DNA insertional mutants. Pb content and primary root growth analysis confirmed the role of these two genes in Pb tolerance and accumulation. H. incana could be considered as a good experimental model to identify genes involved in lead tolerance and accumulation in plants.	[Auguy, Florence; Brugel, Anais; Laplaze, Laurent; Doumas, Patrick] Inst Rech Dev, Unite Mixte Rech Diversite Adaptat & Dev Plantes, Montpellier, France; [Auguy, Florence; Fahr, Mouna; El Mzibri, Mohamed; Doumas, Patrick; Smouni, Abdelaziz] Ctr Natl Energie Sci & Tech Nucl, Lab Biotechnol Plantes, Rabat, Morocco; [Auguy, Florence; Fahr, Mouna; Moulin, Patricia; El Mzibri, Mohamed; Filali-Maltouf, Abdelkarim; Doumas, Patrick] Univ Mohammed V Agdal, Lab Mixte Int, Rabat, Morocco; [Fahr, Mouna; Smouni, Abdelaziz] Univ Mohammed V Agdal, Lab Physiol & Biotechnol Vegetale, Rabat, Morocco; [Moulin, Patricia] Univ Mohammed V Agdal, Inst Rech Dev, Unite Serv Instrumentat Moyens Analyt Observ Geop, Lab Microbiol & Biol Mol, Rabat, Morocco; [Laplaze, Laurent] Inst Rech Dev, Lab Mixte Int Adaptat Plantes & Microorganismes A, Lab Commun Microbiol, Dakar, Senegal; [Filali-Maltouf, Abdelkarim] Univ Mohammed V Agdal, Lab Microbiol & Biol Mol, Rabat, Morocco; [Doumas, Patrick] INRA, Unite Mixte Rech Biochim & Physiol Mol Plantes, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Mohammed V University in Rabat; Mohammed V University in Rabat; Institut de Recherche pour le Developpement (IRD); Mohammed V University in Rabat; Institut de Recherche pour le Developpement (IRD); Mohammed V University in Rabat; INRAE; Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Doumas, P (corresponding author), Inst Rech Dev, Unite Mixte Rech Diversite Adaptat & Dev Plantes, Montpellier, France.	patrick.doumas@supagro.inra.fr	FAHR, Mouna/AAF-4184-2020; SMOUNI, Abdelaziz/GQZ-1979-2022; Laplaze, Laurent/I-5435-2016; Filali-Maltouf, Abdelkarim/AAD-3681-2022	Laplaze, Laurent/0000-0002-6568-6504; Filali-Maltouf, Abdelkarim/0000-0002-2727-3389; Fahr, Mouna/0000-0002-3818-7304; Smouni, Abdelaziz/0000-0003-2456-038X; Doumas, Patrick/0000-0002-6340-2651	International Joint Laboratory "Laboratoire de Biotechnologie Microbienne et Vegetale"; Centre National de l'Energie, des Sciences et Techniques Nucleaires (CNESTEN)/Institut de Recherche pour le Developpement (IRD)/Universite Mohamed V Agdal, Rabat, Morocco; IRD through a BESCD	International Joint Laboratory "Laboratoire de Biotechnologie Microbienne et Vegetale"; Centre National de l'Energie, des Sciences et Techniques Nucleaires (CNESTEN)/Institut de Recherche pour le Developpement (IRD)/Universite Mohamed V Agdal, Rabat, Morocco; IRD through a BESCD	This research was supported by grants from the International Joint Laboratory "Laboratoire de Biotechnologie Microbienne et Vegetale", Centre National de l'Energie, des Sciences et Techniques Nucleaires (CNESTEN)/Institut de Recherche pour le Developpement (IRD)/Universite Mohamed V Agdal, Rabat, Morocco. Abdelaziz Smouni gratefully acknowledges the support from IRD through a BESCD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CWN, 1999, J GEOCHEM EXPLOR, V67, P407, DOI 10.1016/S0375-6742(99)00055-2; BAKER A J M, 1989, Biorecovery, V1, P81; BAKER AJM, 1994, NEW PHYTOL, V127, P61, DOI 10.1111/j.1469-8137.1994.tb04259.x; Bernard C, 2004, FEBS LETT, V569, P140, DOI 10.1016/j.febslet.2004.05.036; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Deng DM, 2008, J INTEGR PLANT BIOL, V50, P691, DOI 10.1111/j.1744-7909.2008.00669.x; Dong CJ, 2010, J INTEGR PLANT BIOL, V52, P914, DOI 10.1111/j.1744-7909.2010.00966.x; Gisbert C, 2006, ENVIRON EXP BOT, V56, P19, DOI 10.1016/j.envexpbot.2004.12.002; Gravot A, 2004, FEBS LETT, V561, P22, DOI 10.1016/S0014-5793(04)00072-9; Guo WJ, 2008, PLANT PHYSIOL, V146, P1697, DOI 10.1104/pp.108.115782; Gupta DK, 2010, J HAZARD MATER, V177, P437, DOI 10.1016/j.jhazmat.2009.12.052; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Huang GY, 2009, CHEMOSPHERE, V77, P1026, DOI 10.1016/j.chemosphere.2009.07.073; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Jin SM, 2006, BIOTECHNOL LETT, V28, P1749, DOI 10.1007/s10529-006-9152-1; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Kim DY, 2006, PLANT PHYSIOL, V140, P922, DOI 10.1104/pp.105.074146; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Lee J, 2004, PLANT MOL BIOL, V54, P805, DOI 10.1007/s11103-004-0190-6; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Ma M, 2003, PLANT SCI, V164, P51, DOI 10.1016/S0168-9452(02)00334-5; Madejon P, 2007, CHEMOSPHERE, V67, P20, DOI 10.1016/j.chemosphere.2006.10.008; Margui E, 2005, ANAL CHIM ACTA, V549, P197, DOI 10.1016/j.aca.2005.06.035; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murphy A, PLANT PHYSL, V109, P945; Papoyan A, 2004, PLANT PHYSIOL, V136, P3814, DOI 10.1104/pp.104.044503; Poschenrieder C, 2001, PLANT SOIL, V230, P247, DOI 10.1023/A:1010374732486; Pourrut B, 2011, REV ENVIRON CONTAM T, V213, P113, DOI 10.1007/978-1-4419-9860-6_4; Reeves R, 2006, NATO SCI S SS IV EAR, V68, P25; Roosens NH, 2004, FEBS LETT, V577, P9, DOI 10.1016/j.febslet.2004.08.084; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Smouni A, 2010, CAH AGRIC, V19, P273, DOI 10.1684/agr.2010.0413; Sunkar R, 2000, PLANT J, V24, P533, DOI 10.1046/j.1365-313x.2000.00901.x; Temminghoff E.J., 2004, PLANT ANAL PROCEDURE, V2nd, P16; Van Nevel L, 2007, ENVIRON POLLUT, V150, P34, DOI 10.1016/j.envpol.2007.05.024; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Walker DJ, 2004, WATER AIR SOIL POLL, V151, P361, DOI 10.1023/B:WATE.0000009901.89000.40; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x; Xiao S, 2008, PLANT J, V54, P141, DOI 10.1111/j.1365-313X.2008.03402.x; Xiao S, 2008, PLANT SIGNAL BEHAV, V3, P693, DOI 10.4161/psb.3.9.5845; Xu YF, 2007, CHINESE SCI BULL, V52, P2203, DOI 10.1007/s11434-007-0335-5; Yanqun Z., 2004, CHINA ENV INT, V30, P567, DOI DOI 10.1016/J.ENVINT.2003.10.012; Yu LH, 1998, GENE, V206, P29, DOI 10.1016/S0378-1119(97)00577-5; Zhu W, 2009, J PLANT BIOL, V52, P585, DOI 10.1007/s12374-009-9076-0; Zientara K, 2009, J BIOTECHNOL, V139, P258, DOI 10.1016/j.jbiotec.2008.12.001	53	26	26	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61932	10.1371/journal.pone.0061932	http://dx.doi.org/10.1371/journal.pone.0061932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667449	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700018
J	Zhang, T; Kedzierska-Mieszkowska, S; Liu, HT; Cheng, CM; Ganta, RR; Zolkiewski, M				Zhang, Ting; Kedzierska-Mieszkowska, Sabina; Liu, Huitao; Cheng, Chuanmin; Ganta, Roman R.; Zolkiewski, Michal			Aggregate-Reactivation Activity of the Molecular Chaperone ClpB from Ehrlichia chaffeensis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; AMINO-TERMINAL DOMAIN; ESCHERICHIA-COLI; BACTERIAL-INFECTION; HSP100 CHAPERONES; STRESS TOLERANCE; MIDDLE DOMAIN; ATPASE CLPB; THERMOTOLERANCE; DISAGGREGATION	Rickettsiale diseases, including human monocytic ehrlichiosis caused by Ehrlichia chaffeensis, are the second leading cause of the tick-borne infections in the USA and a growing health concern. Little is known about how E. chaffeensis survives the host-induced stress in vertebrate and tick hosts. A molecular chaperone ClpB from several microorganisms has been reported to reactivate aggregated proteins in cooperation with the co-chaperones DnaK/DnaJ/GrpE (KJE). In this study, we performed the first biochemical characterization of ClpB from E. chaffeensis. The transcript of E. chaffeensis ClpB (EhClpB) is strongly upregulated after infection of cultured macrophages and its level remains high during the Ehrlichia replicative stage. EhClpB forms ATP-dependent oligomers and catalyzes the ATP hydrolysis, similar to E. coli ClpB (EcClpB), but its ATPase activity is insensitive to the EcClpB activators, casein and poly-lysine. EhClpB in the presence of E. coli KJE efficiently reactivates the aggregated glucose-6-phosphate dehydrogenase (G6PDH) and firefly luciferase. Unlike EcClpB, which requires the co-chaperones for aggregate reactivation, EhClpB reactivates G6PDH even in the absence of KJE. Moreover, EhClpB is functionally distinct from EcClpB as evidenced by its failure to rescue a temperature-sensitive phenotype of the clpB-null E. coli. The clpB expression pattern during the E. chaffeensis infection progression correlates with the pathogen's replicating stage inside host cells and suggests an essential role of the disaggregase activity of ClpB in the pathogen's response to the host-induced stress. This study sets the stage for assessing the importance of the chaperone activity of ClpB for E. chaffeensis growth within the mammalian and tick hosts.	[Zhang, Ting; Zolkiewski, Michal] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Kedzierska-Mieszkowska, Sabina] Univ Gdansk, Dept Biochem, PL-80952 Gdansk, Poland; [Liu, Huitao; Cheng, Chuanmin; Ganta, Roman R.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Fahrenheit Universities; University of Gdansk; Kansas State University	Zolkiewski, M (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	michalz@ksu.edu	Kędzierska-Mieszkowska, Sabina/AAF-2737-2021	Kędzierska-Mieszkowska, Sabina/0000-0001-5756-3013	National Institutes of Health [AI070908]; Kansas Agricultural Experiment Station [13-184-J]; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas Agricultural Experiment Station; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant AI070908 and by the Kansas Agricultural Experiment Station (contribution 13-184-J). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020; Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; ANDERSON BE, 1991, J CLIN MICROBIOL, V29, P2838, DOI 10.1128/JCM.29.12.2838-2842.1991; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Cheng C, 2008, CURR PROTOC MICROBIO, V9; DAWSON JE, 1992, AM J VET RES, V53, P1322; Dawson JE, 1996, J PARASITOL, V82, P52, DOI 10.2307/3284115; Dedonder SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036749; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Dumler JS, 1998, ANNU REV MED, V49, P201, DOI 10.1146/annurev.med.49.1.201; DUMLER JS, 1995, J CLIN MICROBIOL, V33, P1704, DOI 10.1128/JCM.33.7.1704-1711.1995; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Ganta RR, 2009, FRONT BIOSCI-LANDMRK, V14, P3259, DOI 10.2741/3449; Gayle A, 2001, AM FAM PHYSICIAN, V64, P461; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Kannan TR, 2008, INFECT IMMUN, V76, P5082, DOI 10.1128/IAI.00698-08; Kedzierska S, 2003, BIOCHEMISTRY-US, V42, P14242, DOI 10.1021/bi035573d; Krobitsch S, 1999, CELL STRESS CHAPERON, V4, P191; Lindquist S, 1996, P NATL ACAD SCI USA, V93, P5301, DOI 10.1073/pnas.93.11.5301; Liu ZH, 2002, J MOL BIOL, V321, P111, DOI 10.1016/S0022-2836(02)00591-0; Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; de Oliveira NEM, 2011, MICROBIOL-SGM, V157, P656, DOI 10.1099/mic.0.041897-0; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Nagy M, 2010, J MOL BIOL, V396, P697, DOI 10.1016/j.jmb.2009.11.059; Nagy M, 2009, PROTEIN SCI, V18, P287, DOI 10.1002/pro.36; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Neuwald AF, 1999, GENOME RES, V9, P27; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; POPOV VL, 1995, J MED MICROBIOL, V43, P411, DOI 10.1099/00222615-43-6-411; Rikihisa Y, 1997, J INFECT DIS, V175, P210, DOI 10.1093/infdis/175.1.210; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Stafford III WF, 1994, SEDIMENTATION BOUNDA, P119; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stewart GR, 2004, CURR OPIN IMMUNOL, V16, P506, DOI 10.1016/j.coi.2004.05.007; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Walker DH, 2008, MED CLIN N AM, V92, P1345, DOI 10.1016/j.mcna.2008.06.002; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; WELLMAN ML, 1988, IN VITRO CELL DEV B, V24, P223, DOI 10.1007/BF02623551; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Zhang JZ, 2007, CELL MICROBIOL, V9, P610, DOI 10.1111/j.1462-5822.2006.00812.x; Zhang T, 2012, PROTEINS, V80, P2758, DOI 10.1002/prot.24159; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012	62	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62454	10.1371/journal.pone.0062454	http://dx.doi.org/10.1371/journal.pone.0062454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667479	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700038
J	Ames, RM; MacPherson, JI; Pinney, JW; Lovell, SC; Robertson, DL				Ames, Ryan M.; MacPherson, Jamie I.; Pinney, John W.; Lovell, Simon C.; Robertson, David L.			Modular Biological Function Is Most Effectively Captured by Combining Molecular Interaction Data Types	PLOS ONE			English	Article							GENE ONTOLOGY; DISCOVERY; NETWORKS	Large-scale molecular interaction data sets have the potential to provide a comprehensive, system-wide understanding of biological function. Although individual molecules can be promiscuous in terms of their contribution to function, molecular functions emerge from the specific interactions of molecules giving rise to modular organisation. As functions often derive from a range of mechanisms, we demonstrate that they are best studied using networks derived from different sources. Implementing a graph partitioning algorithm we identify subnetworks in yeast protein-protein interaction (PPI), genetic interaction and gene co-regulation networks. Among these subnetworks we identify cohesive subgraphs that we expect to represent functional modules in the different data types. We demonstrate significant overlap between the subgraphs generated from the different data types and show these overlaps can represent related functions as represented by the Gene Ontology (GO). Next, we investigate the correspondence between our subgraphs and the Gene Ontology. This revealed varying degrees of coverage of the biological process, molecular function and cellular component ontologies, dependent on the data type. For example, subgraphs from the PPI show enrichment for 84%, 58% and 93% of annotated GO terms, respectively. Integrating the interaction data into a combined network increases the coverage of GO. Furthermore, the different annotation types of GO are not predominantly associated with one of the interaction data types. Collectively our results demonstrate that successful capture of functional relationships by network data depends on both the specific biological function being characterised and the type of network data being used. We identify functions that require integrated information to be accurately represented, demonstrating the limitations of individual data types. Combining interaction subnetworks across data types is therefore essential for fully understanding the complex and emergent nature of biological function.	[Ames, Ryan M.; MacPherson, Jamie I.; Lovell, Simon C.; Robertson, David L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Pinney, John W.] Univ London Imperial Coll Sci Technol & Med, Ctr Integrat Syst Biol & Bioinformat, Div Mol Biosci, London, England	University of Manchester; Imperial College London	Ames, RM (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	ryan.ames@manchester.ac.uk		Lovell, Simon/0000-0002-4092-8458; Ames, Ryan/0000-0002-1432-5629	Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship; Pfizer	Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer)	JIM was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship with industry partner Pfizer and RMA by a BBSRC studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dutkowski J, 2013, NAT BIOTECHNOL, V31, P38, DOI 10.1038/nbt.2463; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Karypis G, 1998, SIAM J SCI COMPUT, V20, P359, DOI 10.1137/S1064827595287997; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Michaut M, 2011, PLOS COMPUTATIONAL B, V7; Mostafavi S, 2012, PROTEOMICS, V12, P1687, DOI 10.1002/pmic.201100607; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Srivas R, 2011, NAT PROTOC, V6, P1308, DOI 10.1038/nprot.2011.368; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wang JX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S10; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Xiao Guanghua, 2005, Journal of Bioinformatics and Computational Biology, V3, P1371, DOI 10.1142/S0219720005001612; Zainudin S, 2008, ISDA 2008: EIGHTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND APPLICATIONS, VOL 2, PROCEEDINGS, P557, DOI 10.1109/ISDA.2008.183; Zhou XD, 2011, IEEE INT C BIO BIO W, P235, DOI 10.1109/BIBMW.2011.6112380	28	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62670	10.1371/journal.pone.0062670	http://dx.doi.org/10.1371/journal.pone.0062670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658761	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000321202100030
J	Cai, M; Dai, H; Qiu, YY; Zhao, Y; Zhang, RY; Chu, MJ; Dai, JC; Hu, ZB; Shen, HB; Chen, F				Cai, Min; Dai, Hui; Qiu, Yongyong; Zhao, Yang; Zhang, Ruyang; Chu, Minjie; Dai, Juncheng; Hu, Zhibin; Shen, Hongbing; Chen, Feng			SNP Set Association Analysis for Genome-Wide Association Studies	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; CANCER SUSCEPTIBILITY LOCI; LUNG-CANCER; GENE; MULTIPLE; SURVIVAL; DISEASE; VARIANT; TESTS	Genome-wide association study (GWAS) is a promising approach for identifying common genetic variants of the diseases on the basis of millions of single nucleotide polymorphisms (SNPs). In order to avoid low power caused by overmuch correction for multiple comparisons in single locus association study, some methods have been proposed by grouping SNPs together into a SNP set based on genomic features, then testing the joint effect of the SNP set. We compare the performances of principal component analysis (PCA), supervised principal component analysis (SPCA), kernel principal component analysis (KPCA), and sliced inverse regression (SIR). Simulated SNP sets are generated under scenarios of 0, 1 and >= 2 causal SNPs model. Our simulation results show that all of these methods can control the type I error at the nominal significance level. SPCA is always more powerful than the other methods at different settings of linkage disequilibrium structures and minor allele frequency of the simulated datasets. We also apply these four methods to a real GWAS of non-small cell lung cancer (NSCLC) in Han Chinese population	[Cai, Min; Dai, Hui; Qiu, Yongyong; Zhao, Yang; Zhang, Ruyang; Chu, Minjie; Dai, Juncheng; Hu, Zhibin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Chen, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn		Chen, Feng/0000-0002-2699-7190	National Natural Science Foundation of China [81072389, 30901232]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [11KJA330001, 10KJA33034]; Research Fund for the Doctoral Program of Higher Education of China [211323411002]; Research and the Innovation Project for College Graduates of Jiangsu Province [CXZZ11_0733]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research and the Innovation Project for College Graduates of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (grant numbers 81072389 to FC, 30901232 to YZ), Key Grant of Natural Science Foundation of the Jiangsu Higher Education Institutions of China (11KJA330001 and 10KJA33034), the Research Fund for the Doctoral Program of Higher Education of China (211323411002), the Research and the Innovation Project for College Graduates of Jiangsu Province (CXZZ11_0733) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or prepararion of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Buil Alfonso, 2009, BMC Proc, V3 Suppl 7, pS130; Butkiewicz D, 2012, INT J CANCER, V131, pE1100, DOI 10.1002/ijc.27596; Chen X, 2008, BIOINFORMATICS, V24, P2474, DOI 10.1093/bioinformatics/btn458; Chen X, 2010, GENET EPIDEMIOL, V34, P716, DOI 10.1002/gepi.20532; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; Gao QS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-75; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hendricks AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040925; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Li Ang, 2005, Zhonghua Yi Xue Za Zhi, V85, P2623; Li KerChau, 1991, J AM STAT ASSOC, V86, P316; Liao WY, 2012, J THORAC ONCOL, V7, P973, DOI 10.1097/JTO.0b013e31824fe98c; Liu PY, 2010, CANCER EPIDEM BIOMAR, V19, P517, DOI 10.1158/1055-9965.EPI-09-0791; Liu ZQ, 2005, J BIOMED BIOTECHNOL, P155, DOI 10.1155/JBB.2005.155; Lo SH, 2008, P NATL ACAD SCI USA, V105, P12387, DOI 10.1073/pnas.0805242105; McKeen HD, 2011, BIOCHEM SOC T, V39, P663, DOI 10.1042/BST0390663; Montana G, 2005, BIOINFORMATICS, V21, P4309, DOI 10.1093/bioinformatics/bti689; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Orr N, 2012, NAT GENET, V44, P1182, DOI 10.1038/ng.2417; Peng QQ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-6; Qiao B, 2009, BMC P S7, V3, pS132; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266; Wang Xuexia, 2009, BMC Proc, V3 Suppl 7, pS28; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044978; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	37	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62495	10.1371/journal.pone.0062495	http://dx.doi.org/10.1371/journal.pone.0062495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658731	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100010
J	Eappen, AG; Smith, RC; Jacobs-Lorena, M				Eappen, Abraham G.; Smith, Ryan C.; Jacobs-Lorena, Marcelo			Enterobacter-Activated Mosquito Immune Responses to Plasmodium Involve Activation of SRPN6 in Anopheles stephensi	PLOS ONE			English	Article							COMPLEMENT-LIKE PROTEIN; GRAM-NEGATIVE-BACTERIA; AEDES-AEGYPTI; SPOROGONIC DEVELOPMENT; PERITROPHIC MATRIX; GAMBIAE MOSQUITOS; MALARIA PARASITES; VECTOR; SYSTEM; INFECTION	Successful development of Plasmodium in the mosquito is essential for the transmission of malaria. A major bottleneck in parasite numbers occurs during midgut invasion, partly as a consequence of the complex interactions between the endogenous microbiota and the mosquito immune response. We previously identified SRPN6 as an immune component which restricts Plasmodium berghei development in the mosquito. Here we demonstrate that SRPN6 is differentially activated by bacteria in Anopheles stephensi, but only when bacteria exposure occurs on the lumenal surface of the midgut epithelium. Our data indicate that AsSRPN6 is strongly induced following exposure to Enterobacter cloacae, a common component of the mosquito midgut microbiota. We conclude that AsSRPN6 is a vital component of the E. cloacae-mediated immune response that restricts Plasmodium development in the mosquito An. stephensi.	[Eappen, Abraham G.; Smith, Ryan C.; Jacobs-Lorena, Marcelo] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jacobs-Lorena, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD USA.	mlorena@jhsph.edu	Smith, Ryan C./H-9360-2019	Smith, Ryan C./0000-0003-0245-2265	National Research Service Award [F32AI088835]; Johns Hopkins Malaria Research Institute pilot grant; National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01AI031478]; Calvin S. and Helen H. Lang Post-Doctoral Fellowship; Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; National Institutes of Health Grant [RR00052]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI088835, R01AI031478] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute pilot grant; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Calvin S. and Helen H. Lang Post-Doctoral Fellowship; Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a National Research Service Award F32AI088835 (to R.C.S.), a Johns Hopkins Malaria Research Institute pilot grant (to M.J.L.), and by grant R01AI031478 (to M.J.L.) from the National Institutes of Health/National Institute of Allergy and Infectious Diseases. Additional support was provided by a Calvin S. and Helen H. Lang Post-Doctoral Fellowship (to R.C.S) and from the Johns Hopkins Malaria Research Institute and the Bloomberg Family Foundation. Supply of human blood was supported by National Institutes of Health Grant RR00052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2004, J BIOL CHEM, V279, P5573, DOI 10.1074/jbc.M307582200; Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; An CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048689; An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; Augustin R, 2009, DEV COMP IMMUNOL, V33, P830, DOI 10.1016/j.dci.2009.01.009; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; Ceraul SM, 2011, INFECT IMMUN, V79, P321, DOI 10.1128/IAI.00362-10; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Edwards MJ, 1997, INSECT BIOCHEM MOLEC, V27, P1063, DOI 10.1016/S0965-1748(97)00093-3; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Moskalyk LA, 1996, INSECT MOL BIOL, V5, P261, DOI 10.1111/j.1365-2583.1996.tb00100.x; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Opota O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002259; Pinto SB, 2008, CELL MICROBIOL, V10, P891, DOI 10.1111/j.1462-5822.2007.01091.x; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Shao L, 2001, ARCH INSECT BIOCHEM, V47, P119, DOI 10.1002/arch.1042; SINDEN RE, 1985, PARASITOLOGY, V91, P227, DOI 10.1017/S0031182000057334; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; Smith RC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002965; Srinivasan P, 2004, J BIOL CHEM, V279, P5581, DOI 10.1074/jbc.M307587200; Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798; Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Warr E, 2008, INSECT MOL BIOL, V17, P39, DOI 10.1111/j.1365-2583.2008.00778.x; Whitten MMA, 2006, PARASITE IMMUNOL, V28, P121, DOI 10.1111/j.1365-3024.2006.00804.x; Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011	43	39	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62937	10.1371/journal.pone.0062937	http://dx.doi.org/10.1371/journal.pone.0062937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658788	Green Published, gold			2022-12-27	WOS:000321202100048
J	Luo, Q; Wang, Q; Lu, ZX; Liu, JA				Luo, Qing; Wang, Qi; Lu, Zuxun; Liu, Junan			Evaluation of Responsiveness of Community Health Services in Urban China: A Quantitative Study in Wuhan City	PLOS ONE			English	Article							SYSTEM; PHYSICIANS; CARE	Background: With the objective of the national health services systems reform to move care to the community, community health services (CHS) are becoming the gateways of the health system in China. This study aims to evaluate the levels and distributions of the responsiveness of CHS in urban China and identify the relevant features to provide the government with policy advice on the improvement of CHS responsiveness. Methods: A total of 872 face-to-face interviews were conducted in community health centers (CHCs) from 2007 to 2009. Indicators of responsiveness that were recommended by the World Health Organization were adopted, and non-conditional logistic regression analysis was performed to explore the factors associated with the levels and distributions of the responsiveness of CHS. Results: The responsiveness scored at a fairly 'good' level of 7.45, 7.45, and 7.46 for CHS in years 2007, 2008, and 2009, respectively. The representative responsiveness inequality indexes were 0.097, 0.101, and 0.109, respectively, indicating the moderately balanced distributions of responsiveness in these three years. During this period, the scores of responsiveness elements were highest at 7.44 to 8.34 in "dignity'', "communication'', and "social support'', while lowest at 6.76 to 7.54 in "autonomy'', "confidentiality'', and "basic amenities''. The results of the logistic regression analysis suggested that five elements (OR value), namely, "dignity'' (1.414-3.345), "communication'' (1.218-3.655), "basic amenities'' (1.251-2.362), "prompt attention'' (1.098-1.590), and "autonomy'' (1.416-2.173), had significant associations with CHS responsiveness. Conclusions: The responsiveness of CHS in Wuhan City was fairly good but still requires further improvement, particularly on the working conditions of CHCs and communication skills trainings among CHS workers.	[Luo, Qing; Lu, Zuxun; Liu, Junan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430074, Hubei Province, Peoples R China; [Luo, Qing; Lu, Zuxun; Liu, Junan] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, JA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430074, Hubei Province, Peoples R China.	lja10_11@163.com		Luo, Qing/0000-0003-1643-0307; Liu, Junan/0000-0003-1740-1161				[Anonymous], GPE DISCUSSION PAPER, V37; CARDOZO RN, 1965, J MARKETING RES, V2, P244, DOI 10.2307/3150182; Darby C, 2001, GPE DISCUSSION PAPER, V23; De Silva A, GPE DISCUSSION PAPER, V21; de Silva A, 2000, GPE DISCUSSION PAPER, V32; Forouzan AS, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-325; Gostin L, 2003, DOMAINS HLTH RESPONS; Gouveia Giselle Campozana, 2005, Cad. Saúde Pública, V21, pS109, DOI 10.1590/S0102-311X2005000700012; Hsu CC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-72; HULKA BS, 1970, MED CARE, V8, P429, DOI 10.1097/00005650-197009000-00010; Jamar S D, 1994, South Univ Law Rev, V22, P1; Jiang Q, 2002, CHINESE HLTH SERVICE, V168, P324; Ma Q., 2009, CHIN PRIM HLTH CARE, V23, P26; Mann Jonathan M, 1994, Health Hum Rights, V1, P6; MOH, 2011, NAT MED SERV RES JAN; MURPHYCULLEN CL, 1984, SOC SCI MED, V19, P163, DOI 10.1016/0277-9536(84)90283-1; Navarro V, 2001, INT J HEALTH SERV, V31, P23, DOI 10.2190/3LM8-A37Q-FKJ4-TE0R; Njeru MK, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-243; Peltzer K, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-117; Peng Dan, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P158; Qu J, 2001, HLTH EC RES, V5, P9; Satistics Bureau of Wuhan Municipality, 2010, WUH STAT YB 2010, P264; Savedoff W., 2003, HLTH SYSTEMS PERFORM; Smith C, 1992, Qual Assur Health Care, V4, P171; Valentine NB, 2000, GPE DISCUSSION PAPER, V22; Valentine N, 2008, SOC SCI MED, V66, P1939, DOI 10.1016/j.socscimed.2007.12.002; Wang X., 2008, CHIN PRIM HLTH CARE, V22, P18; World Health Organization, 2000, HLTH SYST IMPR PERF; Yan Y., 2009, CHIN J SOC MED, V26, P184; Yang D., 2005, CHIN GEN PRACT, V8, P359; Zhang J., 2007, CHIN PRIM HLTH CARE, V21, P28	31	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62923	10.1371/journal.pone.0062923	http://dx.doi.org/10.1371/journal.pone.0062923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AF	23658785	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500044
J	Wang, BR; Choi, IY; Kim, KJ; Kwon, YD				Wang, Bo-Ram; Choi, In Young; Kim, Kwang-Jum; Kwon, Young Dae			Use of Traditional Korean Medicine by Patients with Musculoskeletal Disorders	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; UNITED-STATES; COMPLEMENTARY; ADULTS; PREVALENCE; PATTERNS; CARE; DETERMINANTS; POPULATION; THERAPIES	Background: South Korea has maintained a dual healthcare delivery system that incorporates both traditional Korean and Western medicine. In this research, we identified the determinants of the frequency of using traditional Korean medicine among musculoskeletal patients, who are known to be the most frequent users of complementary and alternative medicine. Methods: In this research, we reviewed 2 consecutive years of nationally representative survey data from the 2008 and 2009 Korea Health Panel Survey. We analyzed the utilization of outpatient services by musculoskeletal patients within 12 months of the 2009 survey date. A two-part model was used because some patients did not use traditional Korean medicine and skewness was present in the data on traditional Korean medicine use. In the first part, logistic regression analysis was performed to investigate the use of traditional Korean medicine. In the second part, multiple regression analysis was performed to analyze the frequency of traditional Korean medicine usage among the subjects who visited traditional Korean medical institutions. Results: The frequency of traditional Korean medicine usage was positively associated with ages of 40-49 years and over 60, restrictions on daily life, a greater number of chronic diseases, not being hospitalized, and more frequent visits (more than five times) to conventional hospitals or clinics for musculoskeletal disorders. Conclusions: The important determinants of the frequency of traditional Korean medicine usage were age, activity restrictions, the number of chronic diseases, hospitalization history, and the number of visits to conventional hospitals for musculoskeletal disorders. The results contribute to our understanding of the characteristics of traditional Korean medicine users and may be used as a basic resource for related policymaking by government officials and medical professionals.	[Wang, Bo-Ram; Choi, In Young; Kim, Kwang-Jum; Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea; [Wang, Bo-Ram; Choi, In Young; Kim, Kwang-Jum] Catholic Univ Korea, Grad Sch Healthcare Management & Policy, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kwon, YD (corresponding author), Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea.	snukyd1@naver.com	Kwon, Young Dae/T-1591-2017	Kwon, Young Dae/0000-0002-8781-6832				ADAMS EK, 1991, HEALTH SERV RES, V26, P583; Al-Windi A, 2004, COMPLEMENT THER MED, V12, P99, DOI 10.1016/j.ctim.2004.09.007; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Barnes Patricia M, 2004, Adv Data, P1; Branch L, 1981, J Community Health, V7, P80, DOI 10.1007/BF01323227; Burke A, 2006, J ALTERN COMPLEM MED, V12, P639, DOI 10.1089/acm.2006.12.639; Caswell AM, 2002, J BACK MUSCULOSKELET, V16, P121, DOI 10.3233/BMR-2002-16402; Conboy L, 2005, J ALTERN COMPLEM MED, V11, P977, DOI 10.1089/acm.2005.11.977; Duan N., 1983, J BUS STAT, V1, P115, DOI DOI 10.2307/1391852; Egede LE, 2002, DIABETES CARE, V25, P324, DOI 10.2337/diacare.25.2.324; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Garrow D, 2006, J ALTERN COMPLEM MED, V12, P895, DOI 10.1089/acm.2006.12.895; Gha YS, 2007, RES I HEALTHCARE POL, V5, P51; Goldstein MS, 2005, EVID-BASED COMPL ALT, V2, P557, DOI 10.1093/ecam/neh138; Graham RE, 2005, J NATL MED ASSOC, V97, P535; Hanssen B, 2005, SCAND J PRIM HEALTH, V23, P57, DOI 10.1080/02813430510018419; Honda K, 2005, PREV MED, V40, P46, DOI 10.1016/j.ypmed.2004.05.001; Hori S, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-14; Kim HJ, 2003, J KOREAN GERIATR SOC, V7, P295; Kim Jinhyun, 2007, [Society of Preventive Korean Medicine, 대한예방한의학회지], V11, P139; Kim Myunghwa, 2010, J Prev Med Public Health, V43, P496, DOI 10.3961/jpmph.2010.43.6.496; Ko SJ, 2011, 3 C KOR HLTH PAN, P267; Korea Health Industry Development Institute (KHIDI), 2012, MED RES STAT HDB 201; Korea Institute for Health and Social Affairs, 2010, HLTH WELFARE ISSUE F, V58, P1; Korea Institute for Health and Social Affairs (KIHASA), STUD DES; Korea Ministry of Health & Welfare, 2011, NAT SURV OR MED UT H; Lachenbruch PA, 2002, STAT METHODS MED RES, V11, P297, DOI 10.1191/0962280202sm289ra; 이윤정, 2007, [Journal of Korean Academy of Community Health Nursing, 지역사회간호학회지], V18, P102; Lane P M, 1988, J Health Care Mark, V8, P5; Lawrence Dana J, 2007, Chiropr Osteopat, V15, P2, DOI 10.1186/1746-1340-15-2; Lee J, 2011, J KOREAN ACAD NURS, V41, P18, DOI 10.4040/jkan.2011.41.1.18; Lee Sang jeong, 2009, [Journal of Industrial Property, 산업재산권], V29, P1; Lim MK, 2005, COMPLEMENT THER MED, V13, P16, DOI 10.1016/j.ctim.2004.11.002; MacLennan AH, 1996, LANCET, V347, P569, DOI 10.1016/S0140-6736(96)91271-4; MacPherson H, 2006, COMPLEMENT THER MED, V14, P20, DOI 10.1016/j.ctim.2005.07.006; Molassiotis A, 2005, ANN ONCOL, V16, P655, DOI 10.1093/annonc/mdi110; Muhajarine N, 2000, CAN J PUBLIC HEALTH, V91, P449, DOI 10.1007/BF03404827; NCCAM. NIH, NCCAM NCCAM HIST CHR; Ock SM, 2009, J KOREAN MED SCI, V24, P1, DOI 10.3346/jkms.2009.24.1.1; Owens JE, 1999, J ALTERN COMPLEM MED, V5, P529, DOI 10.1089/acm.1999.5.529; Park AJ, 2003, KOREAN J RURAL MED, V28, P107; Pinchuck T, 1984, MED BEGINNERS; Reilly D, 1999, INT S COMM 10 ANN AS, P61; Saper RB, 2004, ALTERN THER HEALTH M, V10, P44; Shin WY, 2011, J AEROSPACE MED CTR, V58, P43; Son AHK, 1999, SOC SCI MED, V49, P543, DOI 10.1016/S0277-9536(99)00151-3; STURM R, 1995, HEALTH SERV RES, V30, P319; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; Vos L, 2010, MARK INTELL PLAN, V28, P349, DOI 10.1108/02634501011041462; Yamashita H, 2002, COMPLEMENT THER MED, V10, P84, DOI 10.1054/ctim.2002.0519; 김성영, 2012, [The Korean Journal of Health Service Management, 보건의료산업학회지], V6, P27; Yoo Jong Hyang, 2011, [Journal of Physiology & Pathology in Korean Medicine, 동의생리병리학회지], V25, P582; Yoon BB, 2007, RES I HEALTHCARE POL, V5, P29; Yoon TH, 2005, KOREAN J FAM MED, V26, P203; 이백휴, 2011, [THE KOREAN SOCIETY OF LAW AND MEDICINE, 의료법학], V12, P123	55	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63209	10.1371/journal.pone.0063209	http://dx.doi.org/10.1371/journal.pone.0063209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658811	Green Submitted, Green Published, gold			2022-12-27	WOS:000321200500061
J	Chen, TY; Chen, DY; Wen, HW; Ou, JL; Chiou, SS; Chen, JM; Wong, ML; Hsu, WL				Chen, Tzu-Yen; Chen, Da-Yuan; Wen, Hsiao-Wei; Ou, Jun-Lin; Chiou, Shyan-Song; Chen, Jo-Mei; Wong, Min-Liang; Hsu, Wei-Li			Inhibition of Enveloped Viruses Infectivity by Curcumin	PLOS ONE			English	Article							KAPPA-B; GENE-EXPRESSION; APOPTOSIS; CELLS; INDUCTION; MEMBRANE; KINASE; REPLICATION; INTEGRASE; PATHWAY	Curcumin, a natural compound and ingredient in curry, has antiinflammatory, antioxidant, and anticarcinogenic properties. Previously, we reported that curcumin abrogated influenza virus infectivity by inhibiting hemagglutination (HA) activity. This study demonstrates a novel mechanism by which curcumin inhibits the infectivity of enveloped viruses. In all analyzed enveloped viruses, including the influenza virus, curcumin inhibited plaque formation. In contrast, the nonenveloped enterovirus 71 remained unaffected by curcumin treatment. We evaluated the effects of curcumin on the membrane structure using fluorescent dye (sulforhodamine B; SRB)-containing liposomes that mimic the viral envelope. Curcumin treatment induced the leakage of SRB from these liposomes and the addition of the influenza virus reduced the leakage, indicating that curcumin disrupts the integrity of the membranes of viral envelopes and of liposomes. When testing liposomes of various diameters, we detected higher levels of SRB leakage from the smaller-sized liposomes than from the larger liposomes. Interestingly, the curcumin concentration required to reduce plaque formation was lower for the influenza virus (approximately 100 nm in diameter) than for the pseudorabies virus (approximately 180 nm) and the vaccinia virus (roughly 335 x 200 x 200 nm). These data provide insights on the molecular antiviral mechanisms of curcumin and its potential use as an antiviral agent for enveloped viruses.	[Chen, Tzu-Yen; Wong, Min-Liang] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Chen, Da-Yuan; Ou, Jun-Lin; Chiou, Shyan-Song; Chen, Jo-Mei; Hsu, Wei-Li] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan; [Wen, Hsiao-Wei] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Hsu, WL (corresponding author), Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan.	wlhsu@dragon.nchu.edu.tw	Chen, Da-Yuan/GLR-1178-2022; Hsu, Wei-Li/CAF-3821-2022	Chen, Da-Yuan/0000-0002-1957-3330; Hsu, Wei-Li/0000-0002-1392-163X; Wen, Hsiao-Wei/0000-0003-3427-1768	National Science Council [98-2313-B-005-015-MY3, 101-2321-B-005-005]; National Chung-Hsing University [TCVGH-NCHU1017612]; National Science Council, Taiwan [101-2321-B-005-005, 98-2313- B-005-015-MY3]	National Science Council(Ministry of Science and Technology, Taiwan); National Chung-Hsing University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council (98-2313-B-005-015-MY3, 101-2321-B-005-005) and National Chung-Hsing University (TCVGH-NCHU1017612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Kuan-Hsun Lin for the technique support. This study was supported partially by National Science Council, Taiwan (98-2313- B-005-015-MY3, 101-2321-B-005-005) and National Chung-Hsing University (TCVGH-NCHU1017612).	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anuchapreeda S, 2002, BIOCHEM PHARMACOL, V64, P573, DOI 10.1016/S0006-2952(02)01224-8; Bernard N., 1996, FUNDAMENTAL VIROLOGY; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; BROUET I, 1995, BIOCHEM BIOPH RES CO, V206, P533, DOI 10.1006/bbrc.1995.1076; Chaudhury LR, 2003, J CELL BIOCHEM, V89, P1, DOI 10.1002/jcb.10495; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; Chen DY, 2010, FOOD CHEM, V119, P1346, DOI 10.1016/j.foodchem.2009.09.011; DONATUS IA, 1990, BIOCHEM PHARMACOL, V39, P1869, DOI 10.1016/0006-2952(90)90603-I; Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2; FUJII T, 1979, BIOCHEM PHARMACOL, V28, P613; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Ingolfsson HI, 2007, BIOCHEMISTRY-US, V46, P10384, DOI 10.1021/bi701013n; Jana NR, 2004, J BIOL CHEM, V279, P11680, DOI 10.1074/jbc.M310369200; Jaruga E, 1998, EXP CELL RES, V245, P303, DOI 10.1006/excr.1998.4225; Jaruga E, 1998, FEBS LETT, V433, P287, DOI 10.1016/S0014-5793(98)00919-3; Kim K, 2010, FEBS LETT, V584, P707, DOI 10.1016/j.febslet.2009.12.019; Knipe DM, 2007, FIELDS VIROLOGY; Kutluay SB, 2008, VIROLOGY, V373, P239, DOI 10.1016/j.virol.2007.11.028; Li Y, 2003, AM J PATHOL, V163, P1167, DOI 10.1016/S0002-9440(10)63476-1; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; MAZUMDER A, 1995, BIOCHEM PHARMACOL, V49, P1165, DOI 10.1016/0006-2952(95)98514-A; Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Rechtman MM, 2010, FEBS LETT, V584, P2485, DOI 10.1016/j.febslet.2010.04.067; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Si XN, 2007, J VIROL, V81, P3142, DOI 10.1128/JVI.02028-06; Squires MS, 2003, BIOCHEM PHARMACOL, V65, P361, DOI 10.1016/S0006-2952(02)01517-4; Sreejayan Rao MN, 1997, J PHARM PHARMACOL, V49, P105; Sui Z, 1993, Bioorg Med Chem, V1, P415, DOI 10.1016/S0968-0896(00)82152-5; Vajragupta O, 2005, BIOORG MED CHEM LETT, V15, P3364, DOI 10.1016/j.bmcl.2005.05.032; Wen HW, 2005, ANAL BIOANAL CHEM, V382, P1217, DOI 10.1007/s00216-005-3292-3	32	85	88	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62482	10.1371/journal.pone.0062482	http://dx.doi.org/10.1371/journal.pone.0062482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658730	gold, Green Published, Green Submitted			2022-12-27	WOS:000319167000051
J	Veatch-Blohm, ME; Roche, BM; Campbell, M				Veatch-Blohm, Maren E.; Roche, Bernadette M.; Campbell, MaryJean			Evidence for Cross-Tolerance to Nutrient Deficiency in Three Disjunct Populations of Arabidopsis lyrata ssp lyrata in Response to Substrate Calcium to Magnesium Ratio	PLOS ONE			English	Article							CARBONIFEROUS LIMESTONE SOILS; PHENOTYPIC PLASTICITY; LOCAL ADAPTATION; SERPENTINE TOLERANCE; ADJACENT SERPENTINE; GRANITE OUTCROPS; USE EFFICIENCY; FESTUCA-RUBRA; CA/MG RATIO; SOUTH-WALES	Species with widespread distributions that grow in varied habitats may consist of ecotypes adapted to a particular habitat, or may exhibit cross-tolerance that enables them to exploit a variety of habitats. Populations of Arabidopsis lyrata ssp. lyrata (L.) O'Kane & Al-Shehbaz grow in a wide variety of edaphic settings including serpentine soil, limestone sand, and alluvial flood plains. While all three of these environments share some stressors, a crucial difference among these environments is soil calcium to magnesium ratio, which ranges from 25:1 in the limestone sand to 0.2:1 in serpentine soil. The three populations found on these substrates were subjected to three different Ca to Mg ratios under controlled environmental conditions during germination and rosette growth. Response to Ca to Mg ratio was evaluated through germination success and radicle growth rate, rosette growth rate, and the content of Ca and Mg in the rosette. All three populations were particularly efficient in fueling growth under nutrient deficiency, with the highest nutrient efficiency ratio for Ca under Ca deficiency and for Mg under Mg deficiency. Although the serpentine population had significantly higher leaf Ca to Mg ratio than the limestone or flood plain populations under all three Ca to Mg ratios, this increase did not result in any advantage in growth or appearance of the serpentine plants, during early life stages before the onset of flowering, even in the high Mg substrate. The three populations showed no population by substrate interaction for any of the parameters measured indicating that these populations may have cross-tolerance to substrate Ca to Mg ratio.	[Veatch-Blohm, Maren E.; Roche, Bernadette M.; Campbell, MaryJean] Loyola Univ Maryland, Dept Biol, Baltimore, MD USA	Loyola University Maryland	Veatch-Blohm, ME (corresponding author), Loyola Univ Maryland, Dept Biol, Baltimore, MD USA.	mblohm@loyola.edu			Loyola University Maryland	Loyola University Maryland	Funding provided by Loyola University Maryland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker BL, 2011, EVOLUTION, V65, P365, DOI 10.1111/j.1558-5646.2010.01114.x; [Anonymous], 1989, JMP VERS 8; Asemaneh T, 2007, PLANT SOIL, V293, P49, DOI 10.1007/s11104-006-9147-7; Baligar VC, 2001, COMMUN SOIL SCI PLAN, V32, P921, DOI 10.1081/CSS-100104098; Baythavong BS, 2011, AM NAT, V178, P75, DOI 10.1086/660281; Bennington CC, 2012, J ECOL, V100, P841, DOI 10.1111/j.1365-2745.2012.01984.x; Bert V, 2000, NEW PHYTOL, V146, P225, DOI 10.1046/j.1469-8137.2000.00634.x; Bischoff A, 2010, OIKOS, V119, P445, DOI 10.1111/j.1600-0706.2009.17776.x; Bogeat-Triboulot MB, 2007, PLANT PHYSIOL, V143, P876, DOI 10.1104/pp.106.088708; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bradshaw HD, 2005, NEW PHYTOL, V167, P81, DOI 10.1111/j.1469-8137.2005.01408.x; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Briscoe LRE, 2009, RHODORA, V111, P1, DOI 10.3119/07-31.1; Chaney RL, 2008, PLANT SOIL, V311, P131, DOI 10.1007/s11104-008-9664-7; Clauss MJ, 2006, J CHEM ECOL, V32, P2351, DOI 10.1007/s10886-006-9150-8; COOPER A, 1976, J ECOL, V64, P147, DOI 10.2307/2258687; COOPER A, 1974, J ECOL, V62, P179, DOI 10.2307/2258887; Enoki T, 1997, ECOL RES, V12, P191, DOI 10.1007/BF02523784; Epstein E., 2005, MINERAL NUTR PLANTS, P31; Galloway LF, 2000, EVOLUTION, V54, P1173, DOI 10.1111/j.0014-3820.2000.tb00552.x; Ghasemi R, 2009, ENVIRON EXP BOT, V67, P260, DOI 10.1016/j.envexpbot.2009.06.016; Going BM, 2009, OECOLOGIA, V159, P839, DOI 10.1007/s00442-008-1264-y; GRUSAK MA, 1994, PLANT PHYSIOL, V104, P649, DOI 10.1104/pp.104.2.649; Harris R. C, 2009, OPUSCULA PHILOLICHEN, V6, P149; Harrison S, 2010, ECOLOGY, V91, P2141, DOI 10.1890/09-0742.1; HART R, 1980, ECOLOGY, V61, P688, DOI 10.2307/1937434; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; JOHNSTON WR, 1981, J ECOL, V69, P855, DOI 10.2307/2259641; JOHNSTON WR, 1984, NEW PHYTOL, V96, P95, DOI 10.1111/j.1469-8137.1984.tb03546.x; Kataeva MN, 2004, GEODERMA, V122, P257, DOI 10.1016/j.geoderma.2004.01.012; KHAN H, 1994, ESTUARIES, V17, P345, DOI 10.2307/1352668; Kingsolver JG, 2002, TRENDS ECOL EVOL, V17, P540, DOI 10.1016/S0169-5347(02)02641-1; Kooijman AM, 2005, CATENA, V59, P55, DOI 10.1016/j.catena.2004.05.004; Lloyd MW, 2011, CASTANEA, V76, P28, DOI 10.2179/10-002.1; Loe G, 2007, OIKOS, V116, P134, DOI 10.1111/j.2006.0030-1299.15022.x; Lombini A, 2003, J PLANT PHYSIOL, V160, P1451, DOI 10.1078/0176-1617-01002; Lortie CJ, 1996, INT J PLANT SCI, V157, P484, DOI 10.1086/297365; LYON GL, 1971, J ECOL, V59, P421, DOI 10.2307/2258322; Mable BK, 2007, MOL ECOL, V16, P3565, DOI 10.1111/j.1365-294X.2007.03416.x; Mable BK, 2005, EVOLUTION, V59, P1437, DOI 10.1111/j.0014-3820.2005.tb01794.x; MAGUIRE JAMES D., 1962, CROP SCI, V2, P176, DOI 10.2135/cropsci1962.0011183X000200020033x; MAIN JL, 1974, AM J BOT, V61, P931, DOI 10.2307/2441983; MAIN JL, 1981, AM MIDL NAT, V105, P196, DOI 10.2307/2425026; Marques L, 2004, NEW PHYTOL, V164, P289, DOI 10.1111/j.1469-8137.2004.01178.x; MARRS RH, 1976, J ECOL, V64, P953, DOI 10.2307/2258817; McGahan DG, 2009, SOIL SCI SOC AM J, V73, P2087, DOI 10.2136/sssaj2008.0087; Mitchell-Olds T, 2001, TRENDS ECOL EVOL, V16, P693, DOI 10.1016/S0169-5347(01)02291-1; Mleczek M, 2012, INT J PHYTOREMEDIAT, V14, P75, DOI 10.1080/15226514.2011.573824; Murren CJ, 2006, ECOLOGY, V87, P2591, DOI 10.1890/0012-9658(2006)87[2591:IACEOM]2.0.CO;2; MUSTART PJ, 1993, ECOLOGY, V74, P1490, DOI 10.2307/1940077; O'Dell RE, 2006, PLANT SOIL, V280, P49, DOI 10.1007/s11104-005-3502-y; OKane SL, 1997, NOVON, V7, P323, DOI 10.2307/3391949; Olsen KG, 2001, J CHEM EDUC, V78, P941, DOI 10.1021/ed078p941; Palm E, 2012, FUNCT PLANT BIOL, V39, P679, DOI 10.1071/FP12059; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pomper KW, 2004, J AM SOC HORTIC SCI, V129, P890, DOI 10.21273/JASHS.129.6.0890; Pope N, 2010, RHODORA, V112, P105, DOI 10.3119/09-02.1; Powell KI, 2009, INT J PLANT SCI, V170, P918, DOI 10.1086/600140; Proctor J, 1999, TRENDS ECOL EVOL, V14, P334, DOI 10.1016/S0169-5347(99)01698-5; Rajakaruna N, 2003, NEW PHYTOL, V157, P93, DOI 10.1046/j.1469-8137.2003.00648.x; Rasband W.S., 1997, IMAGEJ; REEVES RD, 1984, NEW PHYTOL, V98, P191; Reiss C, 1994, EXPT PLANT PHYSL, P24; Riihimaki M, 2004, AM J BOT, V91, P1036, DOI 10.3732/ajb.91.7.1036; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Schlotterer C, 2002, CURR OPIN GENET DEV, V12, P683, DOI 10.1016/S0959-437X(02)00349-0; SHAW AJ, 1991, AM J BOT, V78, P1487, DOI 10.2307/2444973; SHEWRY PR, 1975, J APPL ECOL, V12, P381, DOI 10.2307/2401740; SILANDER JA, 1985, EVOLUTION, V39, P1034, DOI 10.1111/j.1558-5646.1985.tb00445.x; SINGH SP, 1992, J VEG SCI, V3, P573, DOI 10.2307/3235823; SPENCE D. H. N., 1963, JOUR ECOL, V51, P333, DOI 10.2307/2257688; SULTAN SE, 1993, EVOLUTION, V47, P1050, DOI [10.2307/2409974, 10.1111/j.1558-5646.1993.tb02134.x]; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Turner TL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003183; Veatch-Blohm ME, 2011, CASTANEA, V76, P199, DOI 10.2179/10-003.1; Walck JL, 1999, AM J BOT, V86, P820, DOI 10.2307/2656703; WOODELL SRJ, 1975, B TORREY BOT CLUB, V102, P232, DOI 10.2307/2484139; Wright JW, 2007, NEW PHYTOL, V173, P354, DOI 10.1111/j.1469-8137.2006.01925.x	78	5	5	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63117	10.1371/journal.pone.0063117	http://dx.doi.org/10.1371/journal.pone.0063117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650547	gold, Green Published, Green Submitted			2022-12-27	WOS:000319167000092
J	Kurlbaum, M; Mulek, M; Hogger, P				Kurlbaum, Max; Muelek, Melanie; Hoegger, Petra			Facilitated Uptake of a Bioactive Metabolite of Maritime Pine Bark Extract (Pycnogenol) into Human Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; GLUCOSE-TRANSPORTER; MASS-SPECTROMETRY; ANTIOXIDANT ACTIVITY; URINARY METABOLITES; GLUTATHIONE; QUERCETIN; POLYPHENOLS; BINDING; PHARMACOKINETICS	Many plant secondary metabolites exhibit some degree of biological activity in humans. It is a common observation that individual plant-derived compounds in vivo are present in the nanomolar concentration range at which they usually fail to display measurable activity in vitro. While it is debatable that compounds detected in plasma are not the key effectors of bioactivity, an alternative hypothesis may take into consideration that measurable concentrations also reside in compartments other than plasma. We analysed the binding of constituents and the metabolite delta-(3,4-dihydroxy-phenyl)-gamma-valerolactone (M1), that had been previously detected in plasma samples of human consumers of pine bark extract Pycnogenol, to human erythrocytes. We found that caffeic acid, taxifolin, and ferulic acid passively bind to red blood cells, but only the bioactive metabolite M1 revealed pronounced accumulation. The partitioning of M1 into erythrocytes was significantly diminished at higher concentrations of M1 and in the presence of glucose, suggesting a facilitated transport of M1 via GLUT-1 transporter. This concept was further supported by structural similarities between the natural substrate alpha-D-glucose and the S-isomer of M1. After cellular uptake, M1 underwent further metabolism by conjugation with glutathione. We present strong indication for a transporter-mediated accumulation of a flavonoid metabolite in human erythrocytes and subsequent formation of a novel glutathione adduct. The physiologic role of the adduct remains to be elucidated.	[Kurlbaum, Max; Muelek, Melanie; Hoegger, Petra] Univ Wurzburg, Inst Pharm & Lebensmittelchem, D-97070 Wurzburg, Germany	University of Wurzburg	Hogger, P (corresponding author), Univ Wurzburg, Inst Pharm & Lebensmittelchem, D-97070 Wurzburg, Germany.	hogger@pzlc.uni-wuerzburg.de	Kurlbaum, Max/ABV-8275-2022		German Research Foundation (DFG); University of Wurzburg in the funding programme Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg in the funding programme Open Access Publishing	This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso GL, 2007, J BIOL PHYS, V33, P485, DOI 10.1007/s10867-008-9104-1; Awad HM, 2003, CHEM RES TOXICOL, V16, P822, DOI 10.1021/tx020079g; AWASTHI YC, 1983, BRIT J HAEMATOL, V55, P419, DOI 10.1111/j.1365-2141.1983.tb02156.x; BAILLIE TA, 1993, BIOL MASS SPECTROM, V22, P319, DOI 10.1002/bms.1200220602; Biasutto L, 2010, MOLECULES, V15, P6570, DOI 10.3390/molecules15096570; Boots AW, 2005, BIOCHEM BIOPH RES CO, V338, P923, DOI 10.1016/j.bbrc.2005.10.031; Castro-Perez J, 2005, RAPID COMMUN MASS SP, V19, P798, DOI 10.1002/rcm.1855; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; DAS NP, 1971, BIOCHEM PHARMACOL, V20, P3435, DOI 10.1016/0006-2952(71)90449-7; Duweler KG, 2000, PHARMAZIE, V55, P364; Fan HT, 2001, BRIT J PHARMACOL, V133, P1096, DOI 10.1038/sj.bjp.0704159; GALBRAITH DA, 1980, BIOCHEM J, V191, P63, DOI 10.1042/bj1910063; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Grimm T, 2004, FREE RADICAL BIO MED, V36, P811, DOI 10.1016/j.freeradbiomed.2003.12.017; Grimm Tanja, 2006, BMC Clin Pharmacol, V6, P4, DOI 10.1186/1472-6904-6-4; Grimm Tanja, 2006, J Inflamm (Lond), V3, P1, DOI 10.1186/1476-9255-3-1; Hapner CD, 2010, CHEM-BIOL INTERACT, V186, P275, DOI 10.1016/j.cbi.2010.05.010; Highley MS, 1996, PHARM RES-DORDR, V13, P186, DOI 10.1023/A:1016074627293; Hinderling PH, 1997, PHARMACOL REV, V49, P279; JACOBS H, 2011, FREE RADIC BIOL MED, DOI DOI 10.1016/J.FREERADBI0MED.2011.09.013; Kalsi KK, 2008, PFLUG ARCH EUR J PHY, V456, P991, DOI 10.1007/s00424-008-0459-8; Koren E, 2010, EXP BIOL MED, V235, P689, DOI 10.1258/ebm.2010.009370; Kurlbaum M, 2011, J PHARMACEUT BIOMED, V54, P127, DOI 10.1016/j.jpba.2010.07.038; LAGERQUIST HC, 2003, J BIOCHEM BIOPH METH, V55, P127; Leitch JM, 2009, AM J PHYSIOL-CELL PH, V296, pC151, DOI 10.1152/ajpcell.00359.2008; Li C, 2000, CHEM RES TOXICOL, V13, P177, DOI 10.1021/tx9901837; Li CA, 2001, CHEM RES TOXICOL, V14, P702, DOI 10.1021/tx0002536; Maimoona A, 2011, J ETHNOPHARMACOL, V133, P261, DOI 10.1016/j.jep.2010.10.041; *MAR PIN EXTR, 2011, US PHARM, P1196; MARCUS CJ, 1978, ARCH BIOCHEM BIOPHYS, V188, P287, DOI 10.1016/S0003-9861(78)80011-3; Martial S, 1996, AM J PHYSIOL-RENAL, V271, pF1264, DOI 10.1152/ajprenal.1996.271.6.F1264; Martin HJ, 2003, CHEM-BIOL INTERACT, V146, P225, DOI 10.1016/j.cbi.2003.06.001; Montel-Hagen A, 2008, CELL, V132, P1039, DOI 10.1016/j.cell.2008.01.042; Montel-Hagen A, 2009, CURR OPIN HEMATOL, V16, P165, DOI 10.1097/MOH.0b013e328329905c; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Perez A, 2011, BIOCHEMISTRY-US, V50, P8834, DOI 10.1021/bi200748b; Raja MM, 2003, J BIOL CHEM, V278, P49154, DOI 10.1074/jbc.M306881200; RAPPOLD M, 2010, THESIS U WURZBURG WU, P11; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; SALAUZE D, 1994, COMP HAEMATOL INT, V4, P34, DOI 10.1007/BF00368264; Sana TR, 2008, J CHROMATOGR B, V871, P314, DOI 10.1016/j.jchromb.2008.04.030; Schrijvers D, 2003, CLIN PHARMACOKINET, V42, P779, DOI 10.2165/00003088-200342090-00001; Sugano K, 2010, NAT REV DRUG DISCOV, V9, P597, DOI 10.1038/nrd3187; Thorens B, 1996, AM J PHYSIOL-GASTR L, V270, pG541, DOI 10.1152/ajpgi.1996.270.4.G541; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Uhlenhut K, 2012, FREE RADICAL BIO MED, V53, P305, DOI 10.1016/j.freeradbiomed.2012.04.013; van Bladeren PJ, 2000, CHEM-BIOL INTERACT, V129, P61, DOI 10.1016/S0009-2797(00)00214-3; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Yang BX, 2001, J BIOL CHEM, V276, P624, DOI 10.1074/jbc.M008664200; Yu SX, 2005, RAPID COMMUN MASS SP, V19, P250, DOI 10.1002/rcm.1777; Zhang JZ, 1999, ARCH BIOCHEM BIOPHYS, V372, P173, DOI 10.1006/abbi.1999.1489; Zhang JZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1277, DOI 10.1152/ajpcell.2001.280.5.C1277	55	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63197	10.1371/journal.pone.0063197	http://dx.doi.org/10.1371/journal.pone.0063197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646194	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300151
J	Leon, LJ; Pasupuleti, N; Gorin, F; Carraway, KL				Leon, Leonardo J.; Pasupuleti, Nagarekha; Gorin, Fredric; Carraway, Kermit L., III			A Cell-Permeant Amiloride Derivative Induces Caspase-Independent, AIF-Mediated Programmed Necrotic Death of Breast Cancer Cells	PLOS ONE			English	Article							EXCHANGE INHIBITION; GLIOBLASTOMA CELLS; NA+/H+ EXCHANGER; APOPTOSIS; MECHANISMS; AUTOPHAGY; MACROPINOCYTOSIS; ACTIVATION; INDUCTION; DIVERSITY	Amiloride is a potassium-sparing diuretic that has been used as an anti-kaliuretic for the chronic management of hypertension and heart failure. Several studies have identified a potential anti-cancer role for amiloride, however the mechanisms underlying its anti-tumor effects remain to be fully delineated. Our group previously demonstrated that amiloride triggers caspase-independent cytotoxic cell death in human glioblastoma cell lines but not in primary astrocytes. To delineate the cellular mechanisms underlying amiloride's anti-cancer cytotoxicity, cell permeant and cell impermeant derivatives of amiloride were synthesized that exhibit markedly different potencies in cancer cell death assays. Here we compare the cytotoxicities of 5-benzylglycinyl amiloride (UCD38B) and its free acid 5-glycinyl amiloride (UCD74A) toward human breast cancer cells. UCD74A exhibits poor cell permeability and has very little cytotoxic activity, while UCD38B is cell permeant and induces the caspase-independent death of proliferating and non-proliferating breast cancer cells. UCD38B treatment of human breast cancer cells promotes autophagy reflected in LC3 conversion, and induces the dramatic swelling of the endoplasmic reticulum, however these events do not appear to be the cause of cell death. Surprisingly, UCD38B but not UCD74A induces efficient AIF translocation from the mitochondria to the nucleus, and AIF function is necessary for the efficient induction of cancer cell death. Our observations indicate that UCD38B induces programmed necrosis through AIF translocation, and suggest that its cytosolic accessibility may facilitate drug action.	[Leon, Leonardo J.; Carraway, Kermit L., III] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Pasupuleti, Nagarekha; Gorin, Fredric] UC Davis Sch Med, Dept Neurol, Sacramento, CA USA; [Leon, Leonardo J.; Gorin, Fredric; Carraway, Kermit L., III] UC Davis Sch Med, UC Davis Comprehens Canc Ctr, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Carraway, KL (corresponding author), Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA.	klcarraway@ucdavis.edu	gorin, fredric a/GSJ-0273-2022; Pasupuleti, Nagarekha/B-5763-2015		Komen for Cure [KG090626]; NIH grant [NS060880]; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0138]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060880] Funding Source: NIH RePORTER	Komen for Cure(Susan G. Komen Breast Cancer Foundation); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grant KG090626 from Komen for Cure (Carraway), NIH grant NS060880 (Gorin), and predoctoral fellowship W81XWH-10-1-0138 from the Department of Defense Breast Cancer Research Program (Leon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; Deng JY, 2009, CHEM RES TOXICOL, V22, P1817, DOI 10.1021/tx9002275; Garcia-Canero R, 1999, TOXICOL LETT, V106, P215, DOI 10.1016/S0378-4274(99)00072-7; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Harley W, 2010, BRAIN RES, V1363, P159, DOI 10.1016/j.brainres.2010.09.059; Hegde M, 2004, J PHARMACOL EXP THER, V310, P67, DOI 10.1124/jpet.103.065029; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lorenzo HK, 2007, DRUG RESIST UPDATE, V10, P235, DOI 10.1016/j.drup.2007.11.001; Mandlekar S, 2000, CANCER RES, V60, P6601; Massey AP, 2012, BIOORG MED CHEM LETT, V22, P2635, DOI 10.1016/j.bmcl.2011.12.123; Matthews H, 2011, INT J CANCER, V129, P2051, DOI 10.1002/ijc.26156; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Overmeyer JH, 2008, MOL CANCER RES, V6, P965, DOI 10.1158/1541-7786.MCR-07-2036; Overmeyer JH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-69; Palandoken H, 2005, J PHARMACOL EXP THER, V312, P961, DOI 10.1124/jpet.104.076984; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; Rich IN, 2000, BLOOD, V95, P1427, DOI 10.1182/blood.V95.4.1427.004k48_1427_1434; Samadder P, 2009, BIOCHEM CELL BIOL, V87, P401, DOI [10.1139/O08-147, 10.1139/o08-147]; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Wilson TR, 2006, ANN ONCOL, V17, pX315, DOI 10.1093/annonc/mdl280; Xu XS, 2007, J NEUROCHEM, V103, P2004, DOI 10.1111/j.1471-4159.2007.04884.x; Yang XK, 2011, J GASTROEN HEPATOL, V26, P364, DOI 10.1111/j.1440-1746.2010.06382.x; Yang XK, 2010, CANCER LETT, V295, P198, DOI 10.1016/j.canlet.2010.03.001; Yichuan Wang, 2011, SCI SIGNAL, pP4; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9	35	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63038	10.1371/journal.pone.0063038	http://dx.doi.org/10.1371/journal.pone.0063038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646172	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300127
J	Matsuki, T; Pedron, T; Regnault, B; Mulet, C; Hara, T; Sansonetti, PJ				Matsuki, Takahiro; Pedron, Thierry; Regnault, Beatrice; Mulet, Celine; Hara, Taeko; Sansonetti, Philippe J.			Epithelial Cell Proliferation Arrest Induced by Lactate and Acetate from Lactobacillus casei and Bifidobacterium breve	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GUT MICROBIOTA; INTESTINAL MICROBIOTA; ESCHERICHIA-COLI; CYCLE ARREST; GERM-FREE; EXPRESSION; RECEPTOR; MODULATE; CANCER	In an attempt to identify and characterize how symbiotic bacteria of the gut microbiota affect the molecular and cellular mechanisms of epithelial homeostasis, intestinal epithelial cells were co-cultured with either Lactobacillus or Bifidobacterium as bona fide symbionts to examine potential gene modulations. In addition to genes involved in the innate immune response, genes encoding check-point molecules controlling the cell cycle were among the most modulated in the course of these interactions. In the m-ICcl2 murine cell line, genes encoding cyclin E1 and cyclin D1 were strongly down regulated by L. casei and B. breve respectively. Cell proliferation arrest was accordingly confirmed. Short chain fatty acids (SCFA) were the effectors of this modulation, alone or in conjunction with the acidic pH they generated. These results demonstrate that the production of SCFAs, a characteristic of these symbiotic microorganisms, is potentially an essential regulatory effector of epithelial proliferation in the gut.	[Matsuki, Takahiro; Pedron, Thierry; Mulet, Celine; Sansonetti, Philippe J.] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Pedron, Thierry; Mulet, Celine; Sansonetti, Philippe J.] Inst Pasteur, INSERM, U786, F-75724 Paris, France; [Sansonetti, Philippe J.] Coll France, Chaire Microbiol & Malad Infect, F-75231 Paris, France; [Regnault, Beatrice] Inst Pasteur, Genopole, Paris, France; [Matsuki, Takahiro; Hara, Taeko] Yakult Cent Inst Microbiol Res, Tokyo, Japan	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; Yakult Honsha Company, Limited	Sansonetti, PJ (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France.	philippe.sansonetti@pasteur.fr		REGNAULT, Beatrice/0000-0002-3914-1914	European Research Council; Danone Research; Yakult Research	European Research Council(European Research Council (ERC)European Commission); Danone Research(Danone Nutricia); Yakult Research	This work was supported by the European Research Council and from grants from Danone Research and Yakult Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Takahiro Matsuki and Taeko Hara are employees of Yakult Central Institute for Microbiological Research. Danone Research provided a grant for this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Boidot R, 2012, CANCER RES, V72, P939, DOI 10.1158/0008-5472.CAN-11-2474; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; BROWN D, 2012, AM J PHYSL IN PRESS; Bruno MEC, 2005, J IMMUNOL, V174, P7278, DOI 10.4049/jimmunol.174.11.7278; Chang YJ, 2006, CELL MICROBIOL, V8, P1740, DOI 10.1111/j.1462-5822.2006.00743.x; CHU SY, 1995, P NATL ACAD SCI USA, V92, P3303, DOI 10.1073/pnas.92.8.3303; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cover TL, 2003, CANCER RES, V63, P951; Faith JJ, 2010, ISME J, V4, P1094, DOI 10.1038/ismej.2010.110; Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gartel AL, 2003, ONCOL RES, V13, P405; Gray MC, 2011, CELL MICROBIOL, V13, P123, DOI 10.1111/j.1462-5822.2010.01525.x; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8796, DOI 10.1073/pnas.88.19.8796; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Keeney KM, 2011, CURR OPIN MICROBIOL, V14, P92, DOI 10.1016/j.mib.2010.12.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LUPTON JR, 1993, J NUTR, V123, P1522, DOI 10.1093/jn/123.9.1522; Matsumoto K, 2010, J BIOSCI BIOENG, V110, P547, DOI 10.1016/j.jbiosc.2010.05.016; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Morinaga N, 2008, CELL MICROBIOL, V10, P921, DOI 10.1111/j.1462-5822.2007.01094.x; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Ohnmacht C, 2011, CELL MICROBIOL, V13, P653, DOI 10.1111/j.1462-5822.2011.01577.x; Olsen L, 2005, AM J PHYSIOL-GASTR L, V289, pG220, DOI 10.1152/ajpgi.00449.2004; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Samba-Louaka A, 2009, FUTURE MICROBIOL, V4, P867, DOI [10.2217/fmb.09.60, 10.2217/FMB.09.60]; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sengupta S, 2006, J GASTROEN HEPATOL, V21, P209, DOI 10.1111/j.1440-1746.2006.04213.x; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Turpin W, 2010, INT J FOOD MICROBIOL, V143, P87, DOI 10.1016/j.ijfoodmicro.2010.07.032; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002	48	58	62	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63053	10.1371/journal.pone.0063053	http://dx.doi.org/10.1371/journal.pone.0063053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646174	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300129
J	Oikonomou, G; Teixeira, AGV; Foditsch, C; Bicalho, ML; Machado, VS; Bicalho, RC				Oikonomou, Georgios; Teixeira, Andre Gustavo Vieira; Foditsch, Carla; Bicalho, Marcela Lucas; Machado, Vinicius Silva; Bicalho, Rodrigo Carvalho			Fecal Microbial Diversity in Pre-Weaned Dairy Calves as Described by Pyrosequencing of Metagenomic 16S rDNA. Associations of Faecalibacterium Species with Health and Growth	PLOS ONE			English	Article							FED MILK REPLACERS; INTESTINAL MICROBIOTA; SYMBIOTIC BACTERIA	In this study, we use barcoded pyrosequencing of the 16S rRNA gene to characterize the fecal microbiota of neonatal calves and identify possible relationships of certain microbiota profiles with health and weight gain. Fecal samples were obtained weekly from 61 calves from birth until weaning (seventh week of the calves' life). Firmicutes was the most prevalent phylum, with a prevalence ranging from 63.84% to 81.90%, followed by Bacteroidetes (8.36% to 23.93%), Proteobacteria (3.72% to 9.75%), Fusobacteria (0.76% to 5.67%), and Actinobacteria (1.02% to 2.35%). Chao1 index gradually increased from the first to the seventh postnatal week. Chao1 index was lower during the third, fourth, and fifth week of life in calves that suffered from pneumonia and were treated with antibiotics. Diarrhea incidence during the first four weeks of the calves' life was also associated with a reduction of microbial diversity during the third week of life. Increased fecal microbial diversity after the second week of life was associated with higher weight gain. Using discriminant analysis we were able to show differences in the microbiota profiles between different weeks of life, between high and low weight gain groups of calves, and between calves affected and not affected with diarrhea during the first four weeks life. The prevalence of Faecalibacterium spp. in the first week of life was associated with weight gain and the incidence of diarrhea, with higher prevalence being associated with higher weight gain and less diarrhea. Representative sequences from Faecalibacterium spp. were closely affiliated to Faecalibacterium prausnitzii. Results presented here provide new information regarding the intestinal microbiota of neonatal calves and its association with health and growth. Fecal microbial diversity was associated with calf age, disease status and growth rates. Results suggesting a possible beneficial effect of Faecalibacterium spp. on health and growth are promising.	[Oikonomou, Georgios; Teixeira, Andre Gustavo Vieira; Foditsch, Carla; Bicalho, Marcela Lucas; Machado, Vinicius Silva; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Teixeira, Andre Gustavo/B-2177-2017	Teixeira, Andre Gustavo/0000-0002-8620-1422	United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds [NYC-478838, NE-1028]	United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds	Funding was provided by United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds project NYC-478838 hatch/multistate project NE-1028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bach A, 2007, J DAIRY SCI, V90, P3028, DOI 10.3168/jds.2006-761; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Balamurugan R, 2010, BRIT J NUTR, V103, P335, DOI 10.1017/S0007114509992182; Baldwin RL, 2000, J ANIM SCI, V78, P771; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Donovan DC, 2002, J DAIRY SCI, V85, P947, DOI 10.3168/jds.S0022-0302(02)74153-2; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Edrington TS, 2012, J DAIRY SCI, V95, P4519, DOI 10.3168/jds.2011-5119; Guan LL, 2008, FEMS MICROBIOL LETT, V288, P85, DOI 10.1111/j.1574-6968.2008.01343.x; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Maynard L.A., 1979, ANIM NUTR; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mentschel J, 2001, ARCH ANIM NUTR, V55, P85, DOI 10.1080/17450390109386185; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Soberon F, 2012, J DAIRY SCI, V95, P783, DOI 10.3168/jds.2011-4391; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Timmerman HM, 2005, J DAIRY SCI, V88, P2154, DOI 10.3168/jds.S0022-0302(05)72891-5; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Wu S., 2012, METAGENOMICS, V1, P1	33	162	173	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63157	10.1371/journal.pone.0063157	http://dx.doi.org/10.1371/journal.pone.0063157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646192	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300147
J	Smelt, MJ; de Haan, BJ; Bron, PA; van Swam, I; Meijerink, M; Wells, JM; Kleerebezem, M; Faas, MM; de Vos, P				Smelt, Maaike J.; de Haan, Bart J.; Bron, Peter A.; van Swam, Iris; Meijerink, Marjolein; Wells, Jerry M.; Kleerebezem, Michiel; Faas, Marijke M.; de Vos, Paul			The Impact of Lactobacillus plantarum WCFS1 Teichoic Acid D-Alanylation on the Generation of Effector and Regulatory T-cells in Healthy Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LIPOTEICHOIC ACID; DOUBLE-BLIND; DENDRITIC CELLS; MAINTAINING REMISSION; ACIDOPHILUS DEFICIENT; ULCERATIVE-COLITIS; PROBIOTIC THERAPY; RESPONSES; GG	To date it remains unclear how probiotics affect the immune system. Bacterial envelope components may play an essential role, as these are the first to establish bacterial-host cell interactions. Teichoic acids (TAs), and especially lipoteichoic acids, are the most pro-inflammatory components of the gram-positive bacterial envelope. This effect is dependent on D-alanyl substitution of the TA backbone and interactions with TLR2 on host cells. Although the pro-inflammatory properties of TAs have been established in vitro, it remains unclear how TAs affect immunomodulation in vivo. In this study, we investigated the role of TA D-alanylation on L. plantarum-induced intestinal and systemic immunomodulation in vivo. For this, we compared the effect of L. plantarum WCFS1 and its TA D-Alanylation negative derivative (dltX-D) on the distribution of dendritic cell and T cell populations and responses in healthy mice. We demonstrated that the majority of the L. plantarum-induced in vivo immunomodulatory effects were dependent on D-alanylation (D-Ala), as some L. plantarum WCFS1-induced immune changes were not observed in the dltX-D-treated group and some were only observed after treatment with dltX-D. Strikingly, not only pro-inflammatory immune responses were abolished in the absence of D-Ala substitution, but also anti-inflammatory responses, such as the L. plantarum-induced generation of regulatory T cells in the spleen. With this study we provide insight in host-microbe interactions, by demonstrating the involvement of D-alanylation of TAs on the bacterial membrane in intestinal and systemic immunomodulation in healthy mice.	[Smelt, Maaike J.; Bron, Peter A.; van Swam, Iris; Meijerink, Marjolein; Wells, Jerry M.; Kleerebezem, Michiel; de Vos, Paul] Top Inst Food & Nutr, Wageningen, Netherlands; [Smelt, Maaike J.; de Haan, Bart J.; Faas, Marijke M.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Smelt, Maaike J.; de Haan, Bart J.; Faas, Marijke M.; de Vos, Paul] Univ Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Bron, Peter A.; van Swam, Iris; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [Meijerink, Marjolein; Wells, Jerry M.; Kleerebezem, Michiel] Wageningen Univ, Dept Host Microbe Interact Grp, NL-6700 AP Wageningen, Netherlands; [Bron, Peter A.] Kluyver Ctr Fermentat & Genom, Delft, Netherlands	Top Institute Food & Nutrition; University of Groningen; University of Groningen; NIZO Food Research; Wageningen University & Research	de Vos, P (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	p.de.vos@umcg.nl	Kleerebezem, Michiel/AAT-2078-2021; de Vos, Paul/A-3170-2013; Meijerink, Marjolein/B-9258-2014	Meijerink, Marjolein/0000-0003-3994-9785; de vos, paul/0000-0001-9618-2408; Kleerebezem, Michiel/0000-0001-8552-2235	Top Institute Food and Nutrition, Wageningen, The Netherlands	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government)	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Boge T, 2009, VACCINE, V27, P5677, DOI 10.1016/j.vaccine.2009.06.094; Bron PA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-123; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; CAMPBELL LK, 1978, INFECT IMMUN, V22, P842, DOI 10.1128/IAI.22.3.842-851.1978; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Claes IJJ, 2010, CLIN EXP IMMUNOL, V162, P306, DOI 10.1111/j.1365-2249.2010.04228.x; Davidson LE, 2011, EUR J CLIN NUTR, V65, P501, DOI 10.1038/ejcn.2010.289; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Foligne B, 2007, GASTROENTEROLOGY, V133, P862, DOI 10.1053/j.gastro.2007.06.018; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Gosselink MP, 2004, DIS COLON RECTUM, V47, P876, DOI 10.1007/s10350-004-0525-z; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Guandalini S, 2002, DIGEST LIVER DIS, V34, pS63, DOI 10.1016/S1590-8658(02)80167-0; Guandalini S, 2010, J PEDIATR GASTR NUTR, V51, P24, DOI 10.1097/MPG.0b013e3181ca4d95; Hansson GC, 2010, GUT MICROBES, V1, P51, DOI 10.4161/gmic.1.1.10470; Hatakka K, 2001, BMJ-BRIT MED J, V322, P1327, DOI 10.1136/bmj.322.7298.1327; Hirose Y, 2010, MICROBIOL IMMUNOL, V54, P143, DOI 10.1111/j.1348-0421.2009.00189.x; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x; Jacobo P, 2011, REPRODUCTION, V141, P249, DOI 10.1530/REP-10-0362; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kang SS, 2011, MOL IMMUNOL, V48, P2170, DOI 10.1016/j.molimm.2011.07.009; Khazaie K, 2012, P NATL ACAD SCI USA, V109, P10462, DOI 10.1073/pnas.1207230109; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; KNOX KW, 1972, INFECT IMMUN, V6, P43, DOI 10.1128/IAI.6.1.43-49.1972; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; Marco ML, 2006, CURR OPIN BIOTECH, V17, P204, DOI 10.1016/j.copbio.2006.02.005; Matsumoto S, 2005, CLIN EXP IMMUNOL, V140, P417, DOI 10.1111/j.1365-2249.2005.02790.x; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Miettinen M, 1998, INFECT IMMUN, V66, P6058, DOI 10.1128/IAI.66.12.6058-6062.1998; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Mohamadzadeh M, 2011, P NATL ACAD SCI USA, V108, P4623, DOI 10.1073/pnas.1005066107; Morath S, 2005, J ENDOTOXIN RES, V11, P348, DOI 10.1179/096805105X67328; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Niers LEM, 2005, CLIN EXP ALLERGY, V35, P1481, DOI 10.1111/j.1365-2222.2005.02375.x; O'Flaherty S, 2010, GUT MICROBES, V1, P293, DOI 10.4161/gmic.1.5.12924; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; Paineau D, 2008, FEMS IMMUNOL MED MIC, V53, P107, DOI 10.1111/j.1574-695X.2008.00413.x; Palumbo E, 2006, J BACTERIOL, V188, P3709, DOI 10.1128/JB.188.10.3709-3715.2006; Remus DM, 2011, EUR J PHARMACOL, V668, pS33, DOI 10.1016/j.ejphar.2011.07.012; Rockel C, 2011, IMMUNOBIOLOGY, V216, P316, DOI 10.1016/j.imbio.2010.08.001; Ryu YH, 2009, INT IMMUNOPHARMACOL, V9, P127, DOI 10.1016/j.intimp.2008.10.014; Saber R, 2011, IMMUNOTHERAPY-UK, V3, P337, DOI 10.2217/IMT.10.119; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tsilingiri K, 2012, GUT, V61, P1007, DOI 10.1136/gutjnl-2011-300971; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Tursi A, 2004, MED SCI MONITOR, V10, pPI126; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van der Waaij LA, 2005, INFLAMM BOWEL DIS, V11, P865, DOI 10.1097/01.mib.0000179212.80778.d3; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Vaughan EE, 2002, ANTON LEEUW INT J G, V82, P341, DOI 10.1023/A:1020672724450; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; Yamazaki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018833; Zadeh M, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-7; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	75	37	39	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63099	10.1371/journal.pone.0063099	http://dx.doi.org/10.1371/journal.pone.0063099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646181	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300136
J	Hernandez, M; Guerrero, GD; Cecilia, JM; Garcia, JM; Inuggi, A; Jbabdi, S; Behrens, TEJ; Sotiropoulos, SN				Hernandez, Moises; Guerrero, Gines D.; Cecilia, Jose M.; Garcia, Jose M.; Inuggi, Alberto; Jbabdi, Saad; Behrens, Timothy E. J.; Sotiropoulos, Stamatios N.			Accelerating Fibre Orientation Estimation from Diffusion Weighted Magnetic Resonance Imaging Using GPUs	PLOS ONE			English	Article							TRACTOGRAPHY; GRAPHICS; BRAIN; CONNECTIVITY; TENSOR; TESLA	With the performance of central processing units (CPUs) having effectively reached a limit, parallel processing offers an alternative for applications with high computational demands. Modern graphics processing units (GPUs) are massively parallel processors that can execute simultaneously thousands of light-weight processes. In this study, we propose and implement a parallel GPU-based design of a popular method that is used for the analysis of brain magnetic resonance imaging (MRI). More specifically, we are concerned with a model-based approach for extracting tissue structural information from diffusion-weighted (DW) MRI data. DW-MRI offers, through tractography approaches, the only way to study brain structural connectivity, non-invasively and in-vivo. We parallelise the Bayesian inference framework for the ball & stick model, as it is implemented in the tractography toolbox of the popular FSL software package (University of Oxford). For our implementation, we utilise the Compute Unified Device Architecture (CUDA) programming model. We show that the parameter estimation, performed through Markov Chain Monte Carlo (MCMC), is accelerated by at least two orders of magnitude, when comparing a single GPU with the respective sequential single-core CPU version. We also illustrate similar speed-up factors (up to 120x) when comparing a multi-GPU with a multi-CPU implementation.	[Hernandez, Moises; Guerrero, Gines D.; Garcia, Jose M.] Univ Murcia, Dept Comp Sci, Murcia, Spain; [Cecilia, Jose M.] Catholic Univ Murcia, Dept Comp Sci, Murcia, Spain; [Inuggi, Alberto] Basque Ctr Cognit Brain & Language, San Sebastian, Spain; [Hernandez, Moises; Jbabdi, Saad; Behrens, Timothy E. J.; Sotiropoulos, Stamatios N.] Univ Oxford, Ctr Funct MRI Brain FMRIB, Oxford, England	University of Murcia; Universidad Catolica de Murcia; University of Oxford	Hernandez, M (corresponding author), Univ Murcia, Dept Comp Sci, Murcia, Spain.	moises.hernandez@um.es	Sotiropoulos, Stamatios/I-1163-2019; Inuggi, Alberto/AAF-8510-2019; Inuggi, Alberto/K-6261-2014; Garcia, Jose M/J-5734-2017; Cecilia, Jose Maria/G-3177-2015	Sotiropoulos, Stamatios/0000-0003-4735-5776; Inuggi, Alberto/0000-0002-8840-5197; Inuggi, Alberto/0000-0002-8840-5197; Garcia, Jose M/0000-0002-6388-2835; Cecilia, Jose Maria/0000-0001-5648-214X; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892; Behrens, Timothy/0000-0003-0048-1177; Jbabdi, Saad/0000-0003-3234-5639	Fundacion Seneca (Agencia Regional de Ciencia y Tecnologia, Region de Murcia) [15290/PI/2010]; European Commission FEDER (Fonds Europeen de Developpement Regional) [TIN2009-14475-C04, TIN2012-31345]; Human Connectome Project from the 16 National Institutes of Health Institutes and Centers [1U54MH091657-01]; Spanish Ministerio de Educacion y Ciencia; Medical Research Council [G0800578] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; MRC [G0800578] Funding Source: UKRI	Fundacion Seneca (Agencia Regional de Ciencia y Tecnologia, Region de Murcia)(Fundacion Seneca); European Commission FEDER (Fonds Europeen de Developpement Regional); Human Connectome Project from the 16 National Institutes of Health Institutes and Centers; Spanish Ministerio de Educacion y Ciencia(Spanish Government); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by Fundacion Seneca (Agencia Regional de Ciencia y Tecnologia, Region de Murcia) under grant 15290/PI/2010, and by the Spanish Ministerio de Educacion y Ciencia and European Commission FEDER (Fonds Europeen de Developpement Regional) under grants TIN2009-14475-C04 and TIN2012-31345. Funding also comes from the Human Connectome Project (1U54MH091657-01) from the 16 National Institutes of Health Institutes and Centers that support the NIH Blueprint for Neuroscience Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu C, 2003, MACH LEARN, V50, P5, DOI 10.1023/A:1020281327116; [Anonymous], 2012, NVIDIA CUDA C PROGR; [Anonymous], 2012, CUDA C BEST PRACT GU; Asanovic K., 2006, LANDSCAPE PARALLEL C; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Behrens TEJ, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P333, DOI 10.1016/B978-0-12-374709-9.00015-8; Cecilia JM, 2012, J PARALLEL IN PRESS; Che S, 2008, J PARALLEL DISTR COM, V68, P1370, DOI 10.1016/j.jpdc.2008.05.014; Chen W, 2009, IEEE T VIS COMPUT GR, V15, P1433, DOI 10.1109/TVCG.2009.112; Chi JR, 2011, IEEE T BIO-MED ENG, V58, P1789, DOI 10.1109/TBME.2011.2116020; Clark CA, 2003, NEUROIMAGE, V20, P1601, DOI 10.1016/j.neuroimage.2003.07.022; Garland M, 2008, IEEE MICRO, V28, P13, DOI 10.1109/MM.2008.57; Hernandez M., 2012, Proceedings of the 2012 20th Euromicro International Conference on Parallel, Distributed and Network-Based Processing (PDP 2012), P622, DOI 10.1109/PDP.2012.46; Hwu WW., 2011, GPU COMPUTING GEMS; Jbabdi S, 2012, MAGN RESON MED, V68, P1846, DOI 10.1002/mrm.24204; Jeong WK, 2007, IEEE T VIS COMPUT GR, V13, P1480, DOI 10.1109/TVCG.2007.70571; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Jones DK., 2011, DIFFUSION MRI THEORY; Karimi K, 2011, PERFORMANCE COMP CUD; Keckler SW, 2011, IEEE MICRO, V31, P7, DOI 10.1109/MM.2011.89; Khronos OpenCL Working Group, 2012, OPENCL SPECIFICATION; Kohn A, 2009, P SPIE MED IM VIS IM, V7261; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lindholm E, 2008, IEEE MICRO, V28, P39, DOI 10.1109/MM.2008.31; Mittmann A, 2011, J DIGIT IMAGING, V24, P339, DOI 10.1007/s10278-009-9266-9; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Murphy M, 2012, IEEE T MED IMAGING, V31, P1250, DOI 10.1109/TMI.2012.2188039; NVIDIA, 2012, NVIDIAS NEXT GEN CUD; NVIDIA Corporation, 2011, TESL M2090 DUAL SLOT; NVIDIA Corporation, 2009, NVIDIAS NEXT GENERAT; NVIDIA Corporation, 2010, TESL M2050 TESL M207; Owens JD, 2008, P IEEE, V96, P879, DOI 10.1109/JPROC.2008.917757; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Petrovic V, 2007, IEEE T VISUALIZATION, V13, P742; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Platform Computing IBM, 2010, PLATF LSF 8 HPC WORK; Press W. H., 1992, ART SCI COMPUTING; Seunarine KK, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P55, DOI 10.1016/B978-0-12-374709-9.00004-3; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorensen TS, 2008, IEEE T MED IMAGING, V27, P538, DOI 10.1109/TMI.2007.909834; Sotiropoulos SN, 2012, NEUROIMAGE, V60, P1412, DOI 10.1016/j.neuroimage.2012.01.056; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stone SS, 2008, J PARALLEL DISTR COM, V68, P1307, DOI 10.1016/j.jpdc.2008.05.013; Sun Microsystems, 2007, SUN N1 GRID ENG 6 1; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Whitehead N., 2011, PRECISION PERFORMANC; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Xu M, 2012, IEEE SYM PARA DISTR, P742, DOI 10.1109/IPDPSW.2012.92	52	92	92	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61892	10.1371/journal.pone.0061892	http://dx.doi.org/10.1371/journal.pone.0061892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658616	Green Published, gold			2022-12-27	WOS:000321662800016
J	Kim, G; Jang, MS; Son, YM; Seo, MJ; Ji, SY; Han, SH; Jung, ID; Park, YM; Jung, HJ; Yun, CH				Kim, Girak; Jang, Mi Seon; Son, Young Min; Seo, Min Ji; Ji, Sang Yun; Han, Seung Hyun; Jung, In Duk; Park, Yeong-Min; Jung, Hyun Jung; Yun, Cheol-Heui			Curcumin Inhibits CD4(+) T Cell Activation, but Augments CD69 Expression and TGF-beta 1-Mediated Generation of Regulatory T Cells at Late Phase	PLOS ONE			English	Article							NF-KAPPA-B; DENDRITIC CELLS; LYMPHOCYTE-PROLIFERATION; ANTIGEN CD69; MODULATION; PATHWAY; S1P(1); BETA; AUTOIMMUNE; INDUCTION	Background: Curcumin is a promising candidate for a natural medicinal agent to treat chronic inflammatory diseases. Although CD4(+) T cells have been implicated in the pathogenesis of chronic inflammation, whether curcumin directly regulates CD4(+) T cells has not been definitively established. Here, we showed curcumin-mediated regulation of CD2/CD3/CD28-initiated CD4(+) T cell activation in vitro. Methodology/Principal Findings: Primary human CD4(+) T cells were stimulated with anti-CD2/CD3/CD28 antibody-coated beads as an in vitro surrogate system for antigen presenting cell-T cell interaction and treated with curcumin. We found that curcumin suppresses CD2/CD3/CD28-initiated CD4(+) T cell activation by inhibiting cell proliferation, differentiation and cytokine production. On the other hand, curcumin attenuated the spontaneous decline of CD69 expression and indirectly increased expression of CCR7, L-selectin and Transforming growth factor-beta 1 (TGF-beta 1) at the late phase of CD2/CD3/CD28-initiated T cell activation. Curcumin-mediated up-regulation of CD69 at late phase was associated with ERK1/2 signaling. Furthermore, TGF-beta 1 was involved in curcumin-mediated regulation of T cell activation and late-phase generation of regulatory T cells. Conclusions/Significance: Curcumin not merely blocks, but regulates CD2/CD3/CD28-initiated CD4(+) T cell activation by augmenting CD69, CCR7, L-selectin and TGF-beta 1 expression followed by regulatory T cell generation. These results suggest that curcumin could directly reduce T cell-dependent inflammatory stress by modulating CD4(+) T cell activation at multiple levels.	[Kim, Girak; Jang, Mi Seon; Son, Young Min; Seo, Min Ji; Ji, Sang Yun] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Girak; Jang, Mi Seon; Son, Young Min; Seo, Min Ji; Ji, Sang Yun] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Han, Seung Hyun] Seoul Natl Univ, Dept Oral Microbiol & Immunol, Program BK21, Seoul, South Korea; [Han, Seung Hyun] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul, South Korea; [Jung, In Duk; Park, Yeong-Min] Konkuk Univ, Coll Med, Seoul, South Korea; [Ji, Sang Yun; Jung, Hyun Jung] Natl Inst Anim Sci, Suwon, Gyeonggi Do, South Korea; [Yun, Cheol-Heui] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Yun, Cheol-Heui] Seoul Natl Univ, World Class Univ Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Konkuk University; Konkuk University Medical Center; National Institute of Animal Science, Republic of Korea; Seoul National University (SNU); Seoul National University (SNU)	Yun, CH (corresponding author), Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea.	cyun@snu.ac.kr	YUN, Cheol-Heui/AAR-2775-2020	YUN, Cheol-Heui/0000-0002-0041-2887; KIM, Girak/0000-0003-2613-1140	National Research Foundation (NRF) [2010-0027222, 2010-0003291, R31-10056]; Rural Development Administration [PJ008127012011]; R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	National Research Foundation (NRF); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by Basic Science Research Program through the National Research Foundation (NRF) (2010-0027222, 2010-0003291 World Class University program (R31-10056)) and a grant from the Next-Generation BioGreen 21 Program (PJ008127012011), Rural Development Administration and by R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Castellanos MD, 2002, EUR J IMMUNOL, V32, P3108; Castellanos MD, 1997, J IMMUNOL, V159, P5463; Churchill M, 2000, J SURG RES, V89, P169, DOI 10.1006/jsre.2000.5826; Cipriani B, 2001, J IMMUNOL, V167, P3454, DOI 10.4049/jimmunol.167.6.3454; Cong YZ, 2009, EUR J IMMUNOL, V39, P3134, DOI 10.1002/eji.200939052; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337; Fahey AJ, 2007, J CELL MOL MED, V11, P1129, DOI 10.1111/j.1582-4934.2007.00089.x; Forward NA, 2011, BIOCHEM BIOPH RES CO, V407, P801, DOI 10.1016/j.bbrc.2011.03.103; Gandhi R, 2010, J IMMUNOL, V184, P4620, DOI 10.4049/jimmunol.0903329; Goronzy JJ, 2001, TRENDS IMMUNOL, V22, P251, DOI 10.1016/S1471-4906(00)01841-X; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Ishikawa S, 1998, J IMMUNOL, V161, P1267; Jagetia GC, 2007, J CLIN IMMUNOL, V27, P19, DOI 10.1007/s10875-006-9066-7; Jeong YI, 2009, J BIOL CHEM, V284, P3700, DOI 10.1074/jbc.M807328200; Kang BY, 1999, BRIT J PHARMACOL, V128, P380, DOI 10.1038/sj.bjp.0702803; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Li Xinjian, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P137; Liang G, 2009, J CELL MOL MED, V13, P3370, DOI 10.1111/j.1582-4934.2009.00711.x; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Martin P, 2010, J ALLERGY CLIN IMMUN; Martin P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001825; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Natarajan C, 2002, J IMMUNOL, V168, P6506, DOI 10.4049/jimmunol.168.12.6506; Ortiz AM, 2002, RHEUMATOL INT, V21, P182, DOI 10.1007/s00296-001-0161-z; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Ranjan D, 1998, J SURG RES, V77, P174, DOI 10.1006/jsre.1998.5374; Ranjan D, 2004, J SURG RES, V121, P171, DOI 10.1016/j.jss.2004.04.004; Rogers NM, 2010, CLIN EXP IMMUNOL, V162, P460, DOI 10.1111/j.1365-2249.2010.04232.x; Saldanha-Araujo F, 2011, J CELL MOL MED; Sancho D, 1999, BLOOD, V93, P886, DOI 10.1182/blood.V93.3.886.403k10_886_896; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Seo MJ, 2011, MOL IMMUNOL, V48, P1744, DOI 10.1016/j.molimm.2011.04.018; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; TaylorFishwick DA, 1995, EUR J IMMUNOL, V25, P3215, DOI 10.1002/eji.1830251203; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Villalba M, 2000, EUR J IMMUNOL, V30, P1587, DOI 10.1002/1521-4141(200006)30:6<1587::AID-IMMU1587>3.0.CO;2-T; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Yadav VS, 2005, IMMUNOPHARM IMMUNOT, V27, P485, DOI 10.1080/08923970500242244; YASNI S, 1993, J NUTR SCI VITAMINOL, V39, P345, DOI 10.3177/jnsv.39.345	48	20	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62300	10.1371/journal.pone.0062300	http://dx.doi.org/10.1371/journal.pone.0062300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658623	Green Published, Green Submitted, gold			2022-12-27	WOS:000318343700047
J	Yang, CK; Yen, P				Yang, Chi-Kai; Yen, Pauline			Differential Translation of Dazap1 Transcripts during Spermatogenesis	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; GENE-EXPRESSION; GERM-CELLS; IN-VIVO; DAZL; TESTIS; IDENTIFICATION; SPERMIOGENESIS; SEQUENCE	Deleted in AZoospermia Associated Protein 1 (DAZAP1) is a ubiquitous hnRNP protein that has been implicated in RNA transcription, splicing, and translation. It is highly expressed in testes, predominantly in late stage spermatocytes and postmeiotic spermatids. Dazap1 deficiency in mice results in growth retardation and spermatogenic arrest. The gene produces two major transcripts of 2.4 and 1.8 kb, designated Dazap1-L and Dazap1-S, respectively. Results of our previous RNA in situ hybridization and immunostaining suggested translational regulation of the Dazap1 transcripts during spermatogenesis. The main objectives of the study were to determine the origin of the two Dazap1 transcripts and to investigate whether they were similarly translated. Our Northern and 3' RACE analyses showed that the two transcripts were generated through alternative polyadenylation. In mouse testes, the levels of both transcripts were low at postnatal day 12 (P12), increased significantly at P18, and reached maximum at P27. Sucrose gradient analyses showed that at P12 both transcripts were actively translated. Afterward, an increasing portion of Dazap1-S became associated with the translationally inactive mRNPs, and the translational repression was accompanied by an increase in the length of its poly(A) tail. A much smaller portion of Dazap1-L was also sequestered to mRNPs as testes matured, but there was no changes in its poly(A) tail length. Using RNA pull-down followed by mass spectrometry, we identified DAZL, a germ-cell specific translation regulator, as one of the proteins that bound to the 3'UTR region specific for Dazap1-L. We further showed that DAZL preferentially bound to Dazap1-L in testis lysates and stimulated the translation of a reporter gene carrying Dazap1-L 3'UTR. In summary, our study shows that the translation of the two Dazap1 transcripts is differentially regulated. It also provides a new example of translational repression associated with poly(A) tail elongation during spermatogenesis.	[Yang, Chi-Kai; Yen, Pauline] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Yang, Chi-Kai; Yen, Pauline] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan	Yen, P (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	pyen@ibms.sinica.edu.tw			National Science Council [96-2311-B-001-026-MY3]; Academia Sinica in Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica in Taiwan(Academia Sinica - Taiwan)	This work was supported by the National Science Council (grant number 96-2311-B-001-026-MY3) and the Academia Sinica in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAER BW, 1980, P NATL ACAD SCI-BIOL, V77, P1890, DOI 10.1073/pnas.77.4.1890; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; BRAUN RE, 1989, GENE DEV, V3, P793, DOI 10.1101/gad.3.6.793; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Braun RE, 2000, INT J ANDROL, V23, P92, DOI 10.1046/j.1365-2605.2000.00027.x; Brook M, 2009, REPRODUCTION, V137, P595, DOI 10.1530/REP-08-0524; Chen J, 2011, GENE DEV, V25, P755, DOI 10.1101/gad.2028911; Chi MN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004900; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Dai T, 2001, BMC Genomics, V2, P6, DOI 10.1186/1471-2164-2-6; Davies HG, 2000, DEV BIOL, V221, P87, DOI 10.1006/dbio.2000.9658; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; FUJIMOTO H, 1988, Molecular Reproduction and Development, V1, P27, DOI 10.1002/mrd.1080010106; Goina E, 2008, MOL CELL BIOL, V28, P3850, DOI 10.1128/MCB.02253-07; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hsu LCL, 2008, RNA, V14, P1814, DOI 10.1261/rna.1152808; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Janicke A, 2012, RNA, V18, P1289, DOI 10.1261/rna.031898.111; Jenkins HT, 2011, P NATL ACAD SCI USA, V108, P18266, DOI 10.1073/pnas.1105211108; Jiao XF, 2002, BIOL REPROD, V66, P475, DOI 10.1095/biolreprod66.2.475; Kini HK, 2010, J CLIN INVEST, V120, P3090, DOI 10.1172/JCI44091; Kleene KC, 2003, CYTOGENET GENOME RES, V103, P217, DOI 10.1159/000076807; KLEENE KC, 1993, DEV BIOL, V159, P720, DOI 10.1006/dbio.1993.1277; KLEENE KC, 1989, DEVELOPMENT, V106, P367; Kleene KC, 2003, EXP CELL RES, V291, P101, DOI 10.1016/S0014-4827(03)00339-2; KLEENE KC, 1984, DEV BIOL, V105, P71, DOI 10.1016/0012-1606(84)90262-8; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lee K, 1995, P NATL ACAD SCI USA, V92, P12451, DOI 10.1073/pnas.92.26.12451; Lin YT, 2006, RNA, V12, P1486, DOI 10.1261/rna.42206; Liu DL, 2007, NUCLEIC ACIDS RES, V35, P234, DOI 10.1093/nar/gkl919; Maegawa S, 2002, GENES CELLS, V7, P971, DOI 10.1046/j.1365-2443.2002.00576.x; Pastor T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023349; Pero R, 2003, MOL REPROD DEV, V66, P1, DOI 10.1002/mrd.10322; Prima V, 2005, LEUKEMIA, V19, P806, DOI 10.1038/sj.leu.2403684; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Reynolds N, 2007, RNA, V13, P974, DOI 10.1261/rna.465507; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Skoko N, 2008, FEBS LETT, V582, P2231, DOI 10.1016/j.febslet.2008.05.018; Smith RWP, 2011, RNA, V17, P1282, DOI 10.1261/rna.2717711; Tsui SL, 2000, GENOMICS, V65, P266, DOI 10.1006/geno.2000.6169; Tsui SL, 2000, BIOL REPROD, V62, P1655, DOI 10.1095/biolreprod62.6.1655; Vangompel Michael J W, 2011, Spermatogenesis, V1, P36; Venables JP, 2001, NUCLEIC ACIDS RES, V29, P2479, DOI 10.1093/nar/29.12.2479; Vera Y, 2002, J ANDROL, V23, P622; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Xu MG, 2007, BIOL REPROD, V76, P1025, DOI 10.1095/biolreprod.107.060079; Yanagiya A, 2010, J CLIN INVEST, V120, P3389, DOI 10.1172/JCI43350; Yen PH, 2004, INT J ANDROL, V27, P125, DOI 10.1111/j.1365-2605.2004.00469.x; Yen PH, 1996, HUM MOL GENET, V5, P2013, DOI 10.1093/hmg/5.12.2013; Yuki Y, 2004, CANCER SCI, V95, P503, DOI 10.1111/j.1349-7006.2004.tb03240.x; Zeng M, 2009, MOL BIOL REP, V36, P2399, DOI 10.1007/s11033-009-9470-1; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684	60	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e60873	10.1371/journal.pone.0060873	http://dx.doi.org/10.1371/journal.pone.0060873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658607	Green Submitted, Green Published, gold			2022-12-27	WOS:000318343700007
J	Cummings, AC; Torstenson, E; Davis, MF; D'Aoust, LN; Scott, WK; Pericak-Vance, MA; Bush, WS; Haines, JL				Cummings, Anna C.; Torstenson, Eric; Davis, Mary F.; D'Aoust, Laura N.; Scott, William K.; Pericak-Vance, Margaret A.; Bush, William S.; Haines, Jonathan L.			Evaluating Power and Type 1 Error in Large Pedigree Analyses of Binary Traits	PLOS ONE			English	Article							ONSET ALZHEIMER-DISEASE; LINKAGE ANALYSIS; DISEQUILIBRIUM TEST; GENERAL PEDIGREES; ASSOCIATION; AMISH; POPULATION; DEMENTIA; ALLEGRO; SCREEN	Studying population isolates with large, complex pedigrees has many advantages for discovering genetic susceptibility loci; however, statistical analyses can be computationally challenging. Allelic association tests need to be corrected for relatedness among study participants, and linkage analyses require subdividing and simplifying the pedigree structures. We have extended GenomeSIMLA to simulate SNP data in complex pedigree structures based on an Amish pedigree to generate the same structure and distribution of sampled individuals. We evaluated type 1 error rates when no disease SNP was simulated and power when disease SNPs with recessive, additive, and dominant modes of inheritance and odds ratios of 1.1, 1.5, 2.0, and 5.0 were simulated. We generated subpedigrees with a maximum bit-size of 24 using PedCut and performed two-point and multipoint linkage using Merlin. We also ran MQLS on the subpedigrees and unified pedigree. We saw no inflation of type 1 error when running MQLS on either the whole pedigrees or the sub-pedigrees, and we saw low type 1 error for two-point and multipoint linkage. Power was reduced when running MQLS on the subpedigrees versus the whole pedigree, and power was low for two-point and multipoint linkage analyses of the subpedigrees. These data suggest that MQLS has appropriate type 1 error rates in our Amish pedigree structure, and while type 1 error does not seem to be affected when dividing the pedigree prior to linkage analysis, power to detect linkage is diminished when the pedigree is divided.	[Cummings, Anna C.; Torstenson, Eric; Davis, Mary F.; D'Aoust, Laura N.; Bush, William S.; Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Scott, William K.; Pericak-Vance, Margaret A.] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL 33136 USA; [Scott, William K.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA	Vanderbilt University; University of Miami; University of Miami	Haines, JL (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, 221 Kirkland Hall, Nashville, TN 37235 USA.	jonathan@chgr.mc.vanderbilt.edu	Haines, Jonathan/C-3374-2012; Bush, William/N-1369-2019	Haines, Jonathan/0000-0002-4351-4728; Bush, William/0000-0002-9729-6519; Scott, William/0000-0001-9336-6404	National Institutes of Health [AG019085, AG019726]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, T32GM080178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019085, R01AG019726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health grants AG019085 (to JLH and MPV) and AG019726 (to WKS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Agarwala R, 2003, AM J MED GENET C, V121C, P32, DOI 10.1002/ajmg.c.20004; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Cummings AC, 2012, ANN HUM GENET, V76, P342, DOI 10.1111/j.1469-1809.2012.00721.x; Cummings AC, 2011, ANN HUM GENET, V75, P351, DOI 10.1111/j.1469-1809.2011.00643.x; Edwards TL, 2008, LECT NOTES COMPUT SC, V4973, P24, DOI 10.1007/978-3-540-78757-0_3; Fishelson M, 2005, HUM HERED, V59, P41, DOI 10.1159/000084736; Fishelson M, 2004, J COMPUT BIOL, V11, P263, DOI 10.1089/1066527041410409; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hahs DW, 2006, AM J MED GENET B, V141B, P160, DOI 10.1002/ajmg.b.30257; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lee SL, 2008, ANN HUM GENET, V72, P621, DOI 10.1111/j.1469-1809.2008.00452.x; Liu F, 2006, ANN HUM GENET, V70, P965, DOI 10.1111/j.1469-1809.2006.00279.x; Liu F, 2008, EUR J HUM GENET, V16, P854, DOI 10.1038/ejhg.2008.24; Liu F, 2007, AM J HUM GENET, V81, P17, DOI 10.1086/518720; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; McArdle PF, 2007, HUM HERED, V64, P234, DOI 10.1159/000103861; McCauley JL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-19; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106	27	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62615	10.1371/journal.pone.0062615	http://dx.doi.org/10.1371/journal.pone.0062615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658753	gold, Green Published, Green Submitted			2022-12-27	WOS:000321202100020
J	Givnish, TJ; Bean, GJ; Ames, M; Lyon, SP; Sytsma, KJ				Givnish, Thomas J.; Bean, Gregory J.; Ames, Mercedes; Lyon, Stephanie P.; Sytsma, Kenneth J.			Phylogeny, Floral Evolution, and Inter-Island Dispersal in Hawaiian Clermontia (Campanulaceae) Based on ISSR Variation and Plastid Spacer Sequences	PLOS ONE			English	Article							GIANT LOBELIAS; GENETIC-RELATIONSHIPS; ADAPTIVE RADIATION; AFLP MARKERS; INFERENCE; BIOGEOGRAPHY; DIVERGENCE; ACCURACY; DIVERSIFICATION; LOBELIOIDEAE	Previous studies based on DNA restriction-site and sequence variation have shown that the Hawaiian lobeliads are monophyletic and that the two largest genera, Cyanea and Clermontia, diverged from each other ca. 9.7 Mya. Sequence divergence among species of Clermontia is quite limited, however, and extensive hybridization is suspected, which has interfered with production of a well-resolved molecular phylogeny for the genus. Clermontia is of considerable interest because several species posses petal-like sepals, raising the question of whether such a homeotic mutation has arisen once or several times. In addition, morphological and molecular studies have implied different patterns of inter-island dispersal within the genus. Here we use nuclear ISSRs (inter-simple sequence repeat polymorphisms) and five plastid non-coding sequences to derive biparental and maternal phylogenies for Clermontia. Our findings imply that (1) Clermontia is not monophyletic, with Cl. pyrularia nested within Cyanea and apparently an intergeneric hybrid; (2) the earliest divergent clades within Clermontia are native to Kauai, then Oahu, then Maui, supporting the progression rule of dispersal down the chain toward progressively younger islands, although that rule is violated in later-evolving taxa in the ISSR tree; (3) almost no sequence divergence among several Clermontia species in 4.5 kb of rapidly evolving plastid DNA; (4) several apparent cases of hybridization/introgression or incomplete lineage sorting (i.e., Cl. oblongifolia, peleana, persicifolia, pyrularia, samuelii, tuberculata), based on extensive conflict between the ISSR and plastid phylogenies; and (5) two origins and two losses of petaloid sepals, or-perhaps more plausibly-a single origin and two losses of this homeotic mutation, with its introgression into Cl. persicifolia. Our phylogenies are better resolved and geographically more informative than others based on ITS and 5S-NTS sequences and nuclear SNPs, but agree with them in supporting Clermontia's origin on Kauai or some older island and dispersal down the chain subsequently.	[Givnish, Thomas J.; Bean, Gregory J.; Lyon, Stephanie P.; Sytsma, Kenneth J.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Bean, Gregory J.] Chesterfield Village Res Ctr, Chesterfield Village, MO USA; [Ames, Mercedes] Promega North Amer, Fitchburg, WI USA	University of Wisconsin System; University of Wisconsin Madison	Givnish, TJ (corresponding author), Univ Wisconsin, Dept Bot, Madison, WI 53706 USA.	givnish@wisc.edu		Lyon, Stephanie/0000-0002-9950-1977	National Science Foundation (NSF) [DEB-9509550, DEB-0431233, DEB-0830836]; Division Of Environmental Biology [0830036] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by National Science Foundation (NSF) grants DEB-9509550 to TJG and KJS, DEB-0431233 to KJS, and DEB-0830836 to TJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2008, MOL PHYLOGENET EVOL, V46, P1, DOI 10.1016/j.ympev.2007.06.015; Antonelli A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-82; Bacon CD, 2011, TAXON, V60, P733, DOI 10.1002/tax.603009; Beardsley PM, 2003, EVOLUTION, V57, P1397, DOI 10.1111/j.0014-3820.2003.tb00347.x; Brant SV, 2000, J PARASITOL, V86, P545, DOI 10.1645/0022-3395(2000)086[0545:POSOTG]2.0.CO;2; Cacho NI, 2010, AM J BOT, V97, P493, DOI 10.3732/ajb.0900090; Carlquist S., 1970, HAWAII NATURAL HIST; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; Clague DA, 1987, VOLCANISM HAWAII, V1350, P5; Clague David A., 1996, P35; Dasmahapatra KK, 2009, HEREDITY, V103, P168, DOI 10.1038/hdy.2009.25; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Esselman EJ, 2000, AM J BOT, V87, P591, DOI 10.2307/2656603; Fang DQ, 1997, THEOR APPL GENET, V95, P211, DOI 10.1007/s001220050550; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; Funk V. A., 1995, P379; Garcia-Pereira MJ, 2011, J EVOLUTION BIOL, V24, P2346, DOI 10.1111/j.1420-9101.2011.02361.x; Gaudeul M, 2012, AM J BOT, V99, P68, DOI 10.3732/ajb.1100321; Givnish Thomas J., 1995, P288; Givnish Thomas J., 1998, P281; Givnish TJ, 2010, TAXON, V59, P1326, DOI 10.1002/tax.595003; Givnish TJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-3; Givnish TJ, 2009, P ROY SOC B-BIOL SCI, V276, P407, DOI 10.1098/rspb.2008.1204; GIVNISH TJ, 1994, P NATL ACAD SCI USA, V91, P2810, DOI 10.1073/pnas.91.7.2810; Givnish TJ, 2004, AM J BOT, V91, P228, DOI 10.3732/ajb.91.2.228; Hipp AL, 2004, SYST BIOL, V53, P81, DOI 10.1080/10635150490264752; Hofer KA, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-26; Ipek M, 2006, GENOME, V49, P1246, DOI 10.1139/G06-092; Jabaily RS, 2013, BOT J LINN SOC, V171, P201, DOI 10.1111/j.1095-8339.2012.01307.x; Garcia-Pereira MJ, 2010, MOL BIOL EVOL, V27, P988, DOI 10.1093/molbev/msp315; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; Kropf M, 2003, MOL ECOL, V12, P931, DOI 10.1046/j.1365-294X.2003.01781.x; Kropf M, 2009, MOL ECOL, V18, P697, DOI 10.1111/j.1365-294X.2008.04053.x; Lammers T.G., 1999, MANUAL FLOWERING PLA, P420; LAMMERS TG, 1992, ANN MO BOT GARD, V79, P388, DOI 10.2307/2399776; LAMMERS TG, 1991, SYSTEMATIC BOT MONOG, V32, P1, DOI DOI 10.2307/25027798; Lammers Thomas G., 1995, P338; MABBERLEY D J, 1974, Kew Bulletin, V29, P535, DOI 10.2307/4108000; MABBERLEY DJ, 1975, NEW PHYTOL, V74, P365, DOI 10.1111/j.1469-8137.1975.tb02623.x; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Martin JP, 2000, THEOR APPL GENET, V101, P1234, DOI 10.1007/s001220051602; Miller M.A., 2010, CIPRES PORTALS; Montgomery RA, 2008, FUNCT PLANT BIOL, V35, P595, DOI 10.1071/FP08031; Mort ME, 2003, TAXON, V52, P511, DOI 10.2307/3647449; Pagel M., 2007, BAYESTRAITS VERSION; Pellmyr O, 2007, MOL PHYLOGENET EVOL, V43, P493, DOI 10.1016/j.ympev.2006.12.015; Pillon Y, 2012, SOC STUD EV 2012  M; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ren TH, 2011, GENOME, V54, P316, DOI [10.1139/G10-121, 10.1139/g10-121]; Richardson JE, 2003, EVOLUTION, V57, P816; Rieseberg LH, 1996, MOL ECOL, V5, P99, DOI 10.1111/j.1365-294X.1996.tb00295.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schenk MF, 2008, TREE GENET GENOMES, V4, P911, DOI 10.1007/s11295-008-0162-0; Spooner DM, 2005, TAXON, V54, P43, DOI 10.2307/25065301; Stamatakis A, 2005, LECT NOTES COMPUT SC, V3606, P288, DOI 10.1007/11535294_25; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stuessy TF, 2003, BASIC APPL ECOL, V4, P287, DOI 10.1078/1439-1791-00160; Swofford DL, 2002, PAUP PHYLOGENETIC AN; THORMANN CE, 1994, THEOR APPL GENET, V88, P973, DOI 10.1007/BF00220804; Tsumura Y, 1996, THEOR APPL GENET, V92, P40, DOI 10.1007/BF00222949; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016728; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801; Zwickl DJ., 2006, THESIS	68	15	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62566	10.1371/journal.pone.0062566	http://dx.doi.org/10.1371/journal.pone.0062566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658747	Green Published, gold			2022-12-27	WOS:000321200500030
J	Marret, S; Marchand-Martin, L; Picaud, JC; Hascoet, JM; Arnaud, C; Roze, JC; Truffert, P; Larroque, B; Kaminski, M; Ancei, PY				Marret, Stephane; Marchand-Martin, Laetitia; Picaud, Jean-Charles; Hascoet, Jean-Michel; Arnaud, Catherine; Roze, Jean-Christophe; Truffert, Patrick; Larroque, Beatrice; Kaminski, Monique; Ancei, Pierre-Yves		EPIPAGE Study Grp	Brain Injury in Very Preterm Children and Neurosensory and Cognitive Disabilities during Childhood: The EPIPAGE Cohort Study	PLOS ONE			English	Article							PREMATURELY BORN CHILDREN; CEREBRAL-PALSY; ULTRASOUND ABNORMALITIES; GESTATIONAL-AGE; INFANTS; BIRTH; PREVALENCE; ATTAINMENT; MORTALITY; OUTCOMES	Objective: To investigate the association of motor and cognitive/learning deficiencies and overall disabilities in very preterm (VPT) children and their relations to gestational age (GA) and brain lesions. Design, Setting, and Participants: EPIPAGE is a longitudinal population-based cohort study of children born before 33 weeks' gestation (WG) in 9 French regions in 1997-1998. Cumulating data from all follow up stages, neurodevelopmental outcomes were available for 90% of the 2480 VPT survivors at 8 years. Main outcomes were association of motor and cognitive deficiencies and existence of at least one deficiency (motor, cognitive, behavioral/ psychiatric, epileptic, visual, and/or hearing deficiencies) in three GA groups (24-26, 27-28, and 29-32WG) and four groups of brain lesions (none, minor, moderate, or severe). Results: VPT had high rates of motor (14%) and cognitive (31%) deficiencies. Only 6% had an isolated motor deficiency, 23% an isolated cognitive one and 8% both types. This rate reached 20% among extremely preterm. Psychiatric disorders and epilepsy were observed in 6% and 2% of children, respectively. The risks of at least one severe or moderate deficiency were 11 and 29%. These risks increased as GA decreased; only 36% of children born extremely preterm had no reported deficiency. Among children with major white matter injury (WMI), deficiency rates reached 71% at 24-26WG, 88% at 2728WG, and 80% at 29-32WG; more than 40% had associated motor and cognitive deficiencies. By contrast, isolated cognitive deficiency was the most frequent problem among children without major lesions. Conclusions: In VPT, the lower the GA, the higher the neurodisability rate. Cerebral palsy is common. Impaired cognitive development is more frequent. Its occurrence in case without WMI or early motor disorders makes long-term follow up necessary. The strong association between motor impairments, when they exist, and later cognitive dysfunction supports the hypothesis of a common origin of these difficulties.	[Marret, Stephane] Univ Rouen, Rouen Univ Hosp, Dept Neonatal Med, Rouen, France; [Marret, Stephane] Univ Rouen, Inst Biomed Res & Innovat, Reg INSERM Team, ERI 28,NeoVasc, Rouen, France; [Marchand-Martin, Laetitia; Larroque, Beatrice; Kaminski, Monique; Ancei, Pierre-Yves] Hop Tenon, INSERM, UMR S953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Paris, France; [Marchand-Martin, Laetitia; Larroque, Beatrice; Kaminski, Monique; Ancei, Pierre-Yves] Univ Paris 06, UMR S 953, Paris, France; [Picaud, Jean-Charles] Hosp Civils, Hop Croix Rousse, Dept Neonatal, Lyon, France; [Hascoet, Jean-Michel] Neonatal Dept, Nancy, France; [Arnaud, Catherine] Univ Toulouse 3, INSERM, UMR U558, Res Unit Perinatal Epidemiol Child Hlth & Dev, F-31062 Toulouse, France; [Truffert, Patrick] Hop Jeanne de Flandres, Dept Neonatal Med, Lille, France; [Roze, Jean-Christophe] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France	CHU de Rouen; Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Lille - ISITE; CHU Lille; Nantes Universite; CHU de Nantes	Marret, S (corresponding author), Univ Rouen, Rouen Univ Hosp, Dept Neonatal Med, Rouen, France.	stephane.marret@chu-rouen.fr	Blondel, Beatrice/G-5011-2017; Rozé, Jean-Christophe/AAS-1314-2021; EGO, Anne/G-7071-2011; ARNAUD, Catherine/AAC-5646-2019	EGO, Anne/0000-0002-1025-910X; ARNAUD, Catherine/0000-0002-4002-802X; Roze, Jean-Christophe/0000-0003-3367-512X; burguet, antoine/0000-0001-5140-2884; breart, gerard/0000-0003-3142-9128; ANCEL, pierre-yves/0000-0001-9632-7494; Marret, Stephane/0000-0002-2858-148X; Marchand-Martin, Laetitia/0000-0002-8036-8387; CAMBONIE, GILLES/0000-0002-1360-7915; pierrat, veronique/0000-0001-7435-5144	INSERM (National Institute of Health and Medical Research); Directorate General for Health at the Ministry for Social Affairs, Merck-Sharp and Dohme-Chibret; Medical Research Foundation; "Hospital Program for Clinical Research" of the French Ministry of Health [AOM01117, 2004/054/HP]; Wyeth Foundation for Children and Adolescents; FEDER "European Funds for Regional Development" of Haute-Normandie; Merck-Sharp; Dohme-Chibret	INSERM (National Institute of Health and Medical Research)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Directorate General for Health at the Ministry for Social Affairs, Merck-Sharp and Dohme-Chibret; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); "Hospital Program for Clinical Research" of the French Ministry of Health; Wyeth Foundation for Children and Adolescents; FEDER "European Funds for Regional Development" of Haute-Normandie; Merck-Sharp(Merck & Company); Dohme-Chibret	The EPIPAGE study was supprted by grants from INSERM (National Institute of Health and Medical Research), the Directorate General for Health at the Ministry for Social Affairs, Merck-Sharp and Dohme-Chibret, the Medical Research Foundation, and "Hospital Program for Clinical Research 2001 noAOM01117" of the French Ministry of Health. The 8-year follow-up was supported by the "Hospital Program for Clinical Research 2004/054/HP" of the French Ministry of Health, the Wyeth Foundation for Children and Adolescents, and the FEDER "European Funds for Regional Development" of Haute-Normandie 2010-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In particular, the commercial funder (Merck-Sharp and Dohme-Chibret) does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ancel PY, 2006, PEDIATRICS, V117, P828, DOI 10.1542/peds.2005-0091; Arnaud C, 2007, ARCH PEDIAT ADOL MED, V161, P1053, DOI 10.1001/archpedi.161.11.1053; Ball G, 2012, CEREB CORTEX, V22, P1016, DOI 10.1093/cercor/bhr176; Beaino G, 2011, ACTA PAEDIATR, V100, P370, DOI 10.1111/j.1651-2227.2010.02064.x; Beiano G, 2010, DEV MED CHILD NEUROL, V52, pe119; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Blakemore SJ, 2010, NEURON, V65, P744, DOI 10.1016/j.neuron.2010.03.004; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; De Vries LS, 2004, J PEDIATR-US, V144, P815, DOI 10.1016/j.jpeds.2004.03.034; Doyle LW, 2009, OBSTET GYNECOL, V113, P1327, DOI 10.1097/AOG.0b013e3181a60495; Foix-L'Helias L, 2008, BJOG-INT J OBSTET GY, V115, P275, DOI 10.1111/j.1471-0528.2007.01566.x; Gozzo Y, 2009, NEUROIMAGE, V48, P458, DOI 10.1016/j.neuroimage.2009.06.046; Himmelmann K, 2010, ACTA PAEDIATR, V99, P1337, DOI 10.1111/j.1651-2227.2010.01819.x; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2011, PEDIATR RES, V69, p11R, DOI 10.1203/PDR.0b013e318212faa0; KAUFMANN AS, 1983, KAUFMANN ASSESSMENT; Kuban KCK, 2009, J CHILD NEUROL, V24, P63, DOI [10.1177/0883073808121048, 10.1177/0883073808321048]; Langen M, 2012, CORTEX, V48, P183, DOI 10.1016/j.cortex.2011.05.018; Larroque B, 2003, J PEDIATR-US, V143, P477, DOI 10.1067/S0022-3476(03)00417-7; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Larroque B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021361; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Peterson BS, 2002, PEDIATRICS, V110, P1153, DOI 10.1542/peds.110.6.1153; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schipul SE, 2012, CEREB CORTEX, V22, P937, DOI 10.1093/cercor/bhr162; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Weisglas-Kuperus N, 2009, ARCH DIS CHILD-FETAL, V94, pF196, DOI 10.1136/adc.2007.135095; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201	32	99	104	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62683	10.1371/journal.pone.0062683	http://dx.doi.org/10.1371/journal.pone.0062683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658763	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500033
J	Van Daele, CM; De Meyer, T; De Buyzere, ML; Gillebert, TC; Denil, SLIJ; Bekaert, S; Chirinos, JA; Segers, P; De Backer, GG; De Bacquer, D; Rietzschel, ER				Van Daele, Caroline M.; De Meyer, Tim; De Buyzere, Marc L.; Gillebert, Thierry C.; Denil, Simon L. I. J.; Bekaert, Sofie; Chirinos, Julio A.; Segers, Patrick; De Backer, Guy G.; De Bacquer, Dirk; Rietzschel, Ernst R.		Asklepios Investigators	Addition of a Novel, Protective Family History Category Allows Better Profiling of Cardiovascular Risk and Atherosclerotic Burden in the General Population. The Asklepios Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGED ADULTS; LOW-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; PARENTAL-HISTORY; STROKE; HEALTH; STATEMENT; MEDICINE	Objectives: Whereas the importance of family history (FH) is widely recognized in cardiovascular risk assessment, its full potential could be underutilized, when applied with its current simple guidelines-based definition (cFH): presence of premature cardiovascular disease (CVD) in a first-degree relative. We tested the added value of a new, extended family history definition (eFH), also taking into account later onset of disease, second-degree relatives and number of affected relatives, on profiling cardiovascular risk and atherosclerotic burden in the general population. Design: longitudinal population study. Setting: random, representative population sample from Erpe-Mere and Nieuwerkerken (Belgium, primary care). Subjects: 2524 male/female volunteers, aged 35-55 years, free from overt CVD. Main outcome measures: Subjects were extensively phenotyped including presence of atherosclerosis (ultrasound) and a newly developed FH questionnaire (4 generations). Results: Compared to cFH, eFH was superior in predicting an adverse risk profile (glycemic state, elevated blood pressure, lipid abnormalities, presence of metabolic syndrome components) and presence of atherosclerosis (all age & sex-adjusted p<0.05). Unlike cFH, eFH remained a significant predictor of subclinical atherosclerosis after adjusting for confounders. Most relations with eFH were not graded but showed clear informational breakpoints, with absence of CVD (including late onset) in any first-degree relative being a negative predictor of atherosclerosis, and a particularly interesting phenotype for further study. Conclusions: A novel, extended FH definition is superior to the conventional definition in profiling cardiovascular risk and atherosclerotic burden in the general population. There remain clear opportunities to refine and increase the performance and informational content of this simple, readily-available inexpensive tool.	[Van Daele, Caroline M.; De Buyzere, Marc L.; Gillebert, Thierry C.; Rietzschel, Ernst R.] Ghent Univ Hosp, Dept Cardiovasc Dis, Ghent, Belgium; [De Meyer, Tim; Denil, Simon L. I. J.] Univ Ghent, Fac Biosci Engn, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium; [Bekaert, Sofie] Ghent Univ Hosp, Clin Res Ctr Ghent, Bimetra, Ghent, Belgium; [Chirinos, Julio A.] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Chirinos, Julio A.] Univ Penn, Philadelphia, PA 19104 USA; [Segers, Patrick] Univ Ghent, Inst Biomed Technol IbiTech, B-9000 Ghent, Belgium; [De Backer, Guy G.; De Bacquer, Dirk; Rietzschel, Ernst R.] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Ghent University; Ghent University	Van Daele, CM (corresponding author), Ghent Univ Hosp, Dept Cardiovasc Dis, Ghent, Belgium.	Caroline.Vandaele@UGent.be	De Bacquer, Dirk/HGU-3191-2022; De Backer, Guy/AAI-4607-2021; Gillebert, Thierry C/F-5551-2014; Segers, Patrick/AAA-7844-2020; De Meyer, Tim/D-3892-2011	Gillebert, Thierry C/0000-0002-3832-919X; Segers, Patrick/0000-0003-3870-3409; De Meyer, Tim/0000-0003-2994-9693; De Bacquer, Dirk/0000-0002-3202-7238	Fund for Scientific Research - Flanders (FWO) [G042703, G083810N]	Fund for Scientific Research - Flanders (FWO)(FWO)	The Asklepios Study is supported by the Fund for Scientific Research - Flanders (FWO research grants G042703 and G083810N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresdottir MB, 2002, EUR HEART J, V23, P1655, DOI 10.1053/euhj.2002.3235; Assimes TL, 2011, J AM COLL CARDIOL, V57, P628, DOI 10.1016/j.jacc.2010.09.036; Banerjee A, 2012, INT J CLIN PRACT, V66, P536, DOI 10.1111/j.1742-1241.2012.02908.x; BARRETTCONNOR E, 1984, CIRCULATION, V69, P1065, DOI 10.1161/01.CIR.69.6.1065; Bensen JT, 1999, GENET EPIDEMIOL, V17, P141, DOI 10.1002/(SICI)1098-2272(1999)17:2<141::AID-GEPI4>3.0.CO;2-Q; Berg AO, 2012, ANN INTERN MED, V156, P315, DOI 10.7326/0003-4819-156-4-201202210-00012; Berg AO, 2009, ANN INTERN MED, V151, P872, DOI [10.7326/0000605-200912150-00165, 10.7326/0003-4819-151-12-200912150-00165]; Chow CK, 2011, J AM COLL CARDIOL, V57, P619, DOI 10.1016/j.jacc.2010.07.054; de Giorgis T, 2009, J HYPERTENS, V27, P822, DOI 10.1097/HJH.0b013e328325d81b; De Meyer T, 2012, ARTERIOSCL THROM VAS, V32, P3076, DOI 10.1161/ATVBAHA.112.300341; DEBACKER G, 1986, AM HEART J, V112, P478, DOI 10.1016/0002-8703(86)90510-7; Elis A, 2008, EUR J CARDIOV PREV R, V15, P325, DOI 10.1097/HJR.0b013e3282f50ed8; Ford ES, 2005, AM J PREV MED, V29, P57, DOI 10.1016/j.amepre.2005.07.018; Frezzo TM, 2003, GENET MED, V5, P84, DOI 10.1097/01.GIM.0000055197.23822.5E; Friedlander Y, 2001, ATHEROSCLEROSIS, V156, P201, DOI 10.1016/S0021-9150(00)00635-3; Gabioud A, 2012, INT J CARDI IN PRESS; Gaeta G, 2000, NEW ENGL J MED, V343, P840, DOI 10.1056/NEJM200009213431203; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hamer M, 2009, J HYPERTENS, V27, P1966, DOI 10.1097/HJH.0b013e32832f0d6f; HELLER RF, 1983, J EPIDEMIOL COMMUN H, V37, P29, DOI 10.1136/jech.37.1.29; Kinra S, 2003, HEART, V89, P834, DOI 10.1136/heart.89.8.834; Kip KE, 2002, AM J PREV MED, V22, P258, DOI 10.1016/S0749-3797(02)00416-6; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Langlois MR, 2008, ARTERIOSCL THROM VAS, V28, P1563, DOI 10.1161/ATVBAHA.108.167346; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Mills JD, 2002, ARTERIOSCL THROM VAS, V22, P704, DOI 10.1161/hq0402.105902; Murabito JM, 2005, JAMA-J AM MED ASSOC, V294, P3117, DOI 10.1001/jama.294.24.3117; Nasir K, 2004, CIRCULATION, V110, P2150, DOI 10.1161/01.CIR.0000144464.11080.14; Pankow JS, 1997, THROMB HAEMOSTASIS, V77, P87; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Qureshi N, 2012, ANN INTERN MED, V156, P253, DOI 10.7326/0003-4819-156-4-201202210-00002; Rietzschel ER, 2008, HYPERTENSION, V52, P535, DOI 10.1161/HYPERTENSIONAHA.108.114439; Rietzschel ER, 2007, EUR J CARDIOV PREV R, V14, P179, DOI 10.1097/HJR.0b013e328012c380; Scheuner MT, 2006, GENET MED, V8, P491, DOI 10.1097/01.gim.0000232582.91028.03; Scheuner MT, 2006, GENET MED, V8, P525, DOI 10.1097/01.gim.0000232480.00293.00; Scheuner MT, 2008, GENET MED, V10, P879, DOI 10.1097/GIM.0b013e31818e639b; Scheuner MT, 1997, AM J MED GENET, V71, P315, DOI 10.1002/(SICI)1096-8628(19970822)71:3<315::AID-AJMG12>3.0.CO;2-N; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; Silberberg J, 1999, GENET EPIDEMIOL, V16, P344, DOI 10.1002/(SICI)1098-2272(1999)16:4<344::AID-GEPI2>3.0.CO;2-Q; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1123; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1133; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; Vermeersch SJ, 2007, J HUM HYPERTENS, V21, P976, DOI 10.1038/sj.jhh.1002251; Viera AJ, 2005, FAM MED, V37, P360; Waters D, 2010, CARDIOLOGY; Williams RR, 2001, AM J CARDIOL, V87, P129, DOI 10.1016/S0002-9149(00)01303-5; Wilson BJ, 2009, ANN INTERN MED, V151, P878, DOI [10.7326/0000605-200912150-00177, 10.7326/0003-4819-151-12-200912150-00177]; Wong LSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023118; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	52	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63185	10.1371/journal.pone.0063185	http://dx.doi.org/10.1371/journal.pone.0063185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658806	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500058
J	Fischer, M; Grundke, I; Sohr, S; Quaas, M; Hoffmann, S; Knorck, A; Gumhold, C; Rother, K				Fischer, Martin; Grundke, Inga; Sohr, Sindy; Quaas, Marianne; Hoffmann, Saskia; Knoerck, Arne; Gumhold, Catalina; Rother, Karen			p53 and Cell Cycle Dependent Transcription of kinesin family member 23 (KIF23) Is Controlled Via a CHR Promoter Element Bound by DREAM and MMB Complexes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; DNA-DAMAGE; B-MYB; REPRESS TRANSCRIPTION; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; P53-REGULATED GENES; G(2)/M GENES; PROTEIN; BINDING	The microtubule-dependent molecular motor KIF23 (Kinesin family member 23) is one of two components of the centralspindlin complex assembled during late stages of mitosis. Formation of this complex is known as an essential step for cytokinesis. Here, we identified KIF23 as a new transcriptional target gene of the tumor suppressor protein p53. We showed that p53 reduces expression of KIF23 on the mRNA as well as the protein level in different cell types. Promoter reporter assays revealed that this repression results from downregulation of KIF23 promoter activity. CDK inhibitor p21(WAF1/CIP1) was shown to be necessary to mediate p53-dependent repression. Furthermore, we identified the highly conserved cell cycle genes homology region (CHR) in the KIF23 promoter to be strictly required for p53-dependent repression as well as for cell cycle-dependent expression of KIF23. Cell cycle-and p53-dependent regulation of KIF23 appeared to be controlled by differential binding of DREAM and MMB complexes to the CHR element. With this study, we describe a new mechanism for transcriptional regulation of KIF23. Considering the strongly supporting function of KIF23 in cytokinesis, its p53-dependent repression may contribute to the prevention of uncontrolled cell growth.	[Fischer, Martin; Grundke, Inga; Sohr, Sindy; Quaas, Marianne; Hoffmann, Saskia] Univ Leipzig, Sch Med, D-04109 Leipzig, Germany; [Knoerck, Arne; Gumhold, Catalina; Rother, Karen] Univ Saarland, Med Ctr, Ctr Human & Mol Biol, Dept Med Biochem & Mol Biol, Homburg, Germany	Leipzig University; Saarland University	Rother, K (corresponding author), Univ Saarland, Med Ctr, Ctr Human & Mol Biol, Dept Med Biochem & Mol Biol, Homburg, Germany.	karen.rother@uks.eu	Fischer, Martin/I-4825-2014; Rother, Karen/GQI-3786-2022	Fischer, Martin/0000-0002-3429-1876; Quaas, Marianne/0000-0002-2781-1968; Hoffmann, Saskia/0000-0003-4835-0504	Freistaat Sachsen; Medical School at the University of Leipzig; Fonds der Chemische Industrie; Forschungsausschuss of the Saarland University	Freistaat Sachsen; Medical School at the University of Leipzig; Fonds der Chemische Industrie; Forschungsausschuss of the Saarland University	MQ is recipient of graduate fellowship awarded by the Freistaat Sachsen, SS was supported by a junior research grant and IG was the recipient of thesis support grant awarded by the Medical School at the University of Leipzig. This work was supported by grants from the Fonds der Chemische Industrie and the Forschungsausschuss of the Saarland University (to KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Barboza JA, 2006, P NATL ACAD SCI USA, V103, P19842, DOI 10.1073/pnas.0606343104; Bashir T, 2005, NAT CELL BIOL, V7, P779, DOI 10.1038/ncb0805-779; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Bohlig L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464916; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Calvisi DF, 2011, HEPATOLOGY, V53, P1226, DOI 10.1002/hep.24174; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Esteve PO, 2005, P NATL ACAD SCI USA, V102, P1000, DOI 10.1073/pnas.0407729102; Fukasawa K, 2008, BBA-REV CANCER, V1786, P15, DOI 10.1016/j.bbcan.2008.04.002; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Helmbold H, 2009, ONCOGENE, V28, P3456, DOI 10.1038/onc.2009.222; Hutterer A, 2009, CURR BIOL, V19, P2043, DOI 10.1016/j.cub.2009.10.050; Imbriano C, 2012, BBA-REV CANCER, V1825, P131, DOI 10.1016/j.bbcan.2011.11.001; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; KASTAN MB, 1991, CANCER RES, V51, P6304; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mannefeld M, 2009, CANCER RES, V69, P4073, DOI 10.1158/0008-5472.CAN-08-4156; Muller GA, 2012, NUCLEIC ACIDS RES, V40, P1561, DOI 10.1093/nar/gkr793; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Pietrzak M, 2008, BIOL CHEM, V389, P383, DOI 10.1515/BC.2008.039; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Quaas M, 2012, CELL CYCLE, V11, P4661, DOI 10.4161/cc.22917; Reichert N, 2010, MOL CELL BIOL, V30, P2896, DOI 10.1128/MCB.00028-10; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Schuldt A, 2010, NAT REV MOL CELL BIO, V11, P602, DOI 10.1038/nrm2965; Scian MJ, 2008, ONCOGENE, V27, P2583, DOI 10.1038/sj.onc.1210898; Seguin L, 2009, MOL CELL BIOL, V29, P570, DOI 10.1128/MCB.01275-08; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Sohr S, 2008, CELL CYCLE, V7, P3448, DOI 10.4161/cc.7.21.7014; Sohr S, 2011, CELL CYCLE, V10, P3758, DOI 10.4161/cc.10.21.17946; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Takahashi S, 2012, J NEURO-ONCOL, V106, P519, DOI 10.1007/s11060-011-0706-2; Tavner F, 2007, ONCOGENE, V26, P2727, DOI 10.1038/sj.onc.1210087; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; van Bodegom D, 2010, BBA-GENE REGUL MECH, V1799, P502, DOI 10.1016/j.bbagrm.2010.04.001; Wang SM, 2011, CLIN CANCER RES, V17, P6040, DOI 10.1158/1078-0432.CCR-11-0557; Wasner M, 2003, GENE, V312, P225, DOI 10.1016/S0378-1119(03)00618-8; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517	64	35	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63187	10.1371/journal.pone.0063187	http://dx.doi.org/10.1371/journal.pone.0063187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650552	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000319167000097
J	Maguire, SE; Schmidt, MF; White, DJ				Maguire, Sarah E.; Schmidt, Marc F.; White, David J.			Social Brains in Context: Lesions Targeted to the Song Control System in Female Cowbirds Affect Their Social Network	PLOS ONE			English	Article							BROWN-HEADED COWBIRDS; MALE COMPETITION; SERINUS-CANARIA; HVC; PERCEPTION; SIGNALS; SELECTIVITY; MECHANISMS; RESPONSES; DISPLAYS	Social experiences can organize physiological, neural, and reproductive function, but there are few experimental preparations that allow one to study the effect individuals have in structuring their social environment. We examined the connections between mechanisms underlying individual behavior and social dynamics in flocks of brown-headed cowbirds (Molothrus ater). We conducted targeted inactivations of the neural song control system in female subjects. Playback tests revealed that the lesions affected females' song preferences: lesioned females were no longer selective for high quality conspecific song. Instead, they reacted to all cowbird songs vigorously. When lesioned females were introduced into mixed-sex captive flocks, they were less likely to form strong pair-bonds, and they no longer showed preferences for dominant males. This in turn created a cascade of effects through the groups. Social network analyses showed that the introduction of the lesioned females created instabilities in the social structure: males in the groups changed their dominance status and their courtship patterns, and even the competitive behavior of other female group-mates was affected. These results reveal that inactivation of the song control system in female cowbirds not only affects individual behavior, but also exerts widespread effects on the stability of the entire social system.	[Maguire, Sarah E.; Schmidt, Marc F.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Maguire, Sarah E.; Schmidt, Marc F.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [White, David J.] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada	University of Pennsylvania; University of Pennsylvania; Wilfrid Laurier University	White, DJ (corresponding author), Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada.	dwhite@wlu.ca	Schmidt, Marc/B-1597-2008		National Science Foundation (NSF) [1021801]; National Institutes of Health (NIH) [DC006102]; NSF IGERT Traineeship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006102] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IGERT Traineeship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Work was supported by National Science Foundation (NSF) 1021801 (DJW), National Institutes of Health (NIH) DC006102 (MFS) and an NSF IGERT Traineeship (SEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andalman AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025461; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; Burt JM, 2000, J NEUROBIOL, V42, P1, DOI 10.1002/(SICI)1097-4695(200001)42:1<1::AID-NEU1>3.0.CO;2-6; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; COX CR, 1977, AM NAT, V111, P317, DOI 10.1086/283163; Del Negro C, 1998, BEHAV BRAIN RES, V96, P151, DOI 10.1016/S0166-4328(98)00009-6; Del Negro C, 2000, BEHAV NEUROSCI, V114, P526; DUFTY AM, 1986, BEHAV ECOL SOCIOBIOL, V19, P49, DOI 10.1007/BF00303842; Freed-Brown SG, 2006, BEHAVIOUR, V143, P1293, DOI 10.1163/156853906778987533; Gersick AS, 2012, ANIM BEHAV, V83, P1171, DOI 10.1016/j.anbehav.2012.02.005; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Halle F, 2002, J NEUROBIOL, V52, P1, DOI 10.1002/neu.10058; King AP, 2003, ANIM BEHAV, V66, P817, DOI 10.1006/anbe.2003.2280; KING AP, 1986, ETHOLOGY, V72, P89; KING AP, 1983, Z TIERPSYCHOL, V63, P37; Knudsen DP, 2010, BRAIN LANG, V115, P59, DOI 10.1016/j.bandl.2009.09.008; Leitner S, 2002, J NEUROBIOL, V52, P294, DOI 10.1002/neu.10085; Mendez JM, 2012, J NEUROPHYSIOL, V107, P2971, DOI 10.1152/jn.00646.2011; Miller JL, 2008, ANIM BEHAV, V76, P931, DOI 10.1016/j.anbehav.2008.05.011; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; Riters LV, 2003, BRAIN RES, V978, P91, DOI 10.1016/S0006-8993(03)02771-9; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Smith VA, 2000, ANIM BEHAV, V60, P599, DOI 10.1006/anbe.2000.1531; Snowdon C.T., 1997, SOCIAL INFLUENCES VO, DOI [10.1017/CBO9780511758843, DOI 10.1017/CBO9780511758843]; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; WATSON PJ, 1990, BEHAV ECOL SOCIOBIOL, V26, P77; WEST MJ, 1985, Z TIERPSYCHOL, V70, P225; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0; White DJ, 2010, BEHAV ECOL, V21, P211, DOI 10.1093/beheco/arp178; White DJ, 2010, ANIM BEHAV, V79, P385, DOI 10.1016/j.anbehav.2009.11.014; Woolley SMN, 2010, DEV NEUROBIOL, V70, P235, DOI 10.1002/dneu.20783	34	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63239	10.1371/journal.pone.0063239	http://dx.doi.org/10.1371/journal.pone.0063239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650558	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000103
J	Wang, X; Chang, SM; Yu, GR; Rao, ZT				Wang, Xin; Chang, Shi-min; Yu, Guang-rong; Rao, Zhi-tao			Clinical Value of the Ottawa Ankle Rules for Diagnosis of Fractures in Acute Ankle Injuries	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DECISION RULES; EMERGENCY-DEPARTMENT; EXCLUDE FRACTURES; FOOT RULES; IMPLEMENTATION; RADIOGRAPHY; VALIDATION; ACCURACY; CHILDREN	Background: The Ottawa ankle rules (OAR) are clinical decision guidelines used to identify whether patients with ankle injuries need to undergo radiography. The OAR have been proven that their application reduces unnecessary radiography. They have nearly perfect sensitivity for identifying clinically significant ankle fractures. Objectives: The purpose of this study was to assess the applicability of the OAR in China, to examine their accuracy for the diagnosis of fractures in patients with acute ankle sprains, and to assess their clinical utility for the detection of occult fractures. Methods: In this prospective study, patients with acute ankle injuries were enrolled during a 6-month period. The eligible patients were examined by emergency orthopedic specialists using the OAR, and then underwent ankle radiography. The results of examination using the OAR were compared with the radiographic results to assess the accuracy of the OAR for ankle fractures. Patients with OAR results highly suggestive of fracture, but no evidence of a fracture on radiographs, were advised to undergo 3-dimensional computed tomography (3D-CT). Results: 183 patients with ankle injuries were enrolled in the study and 63 of these injuries involved fractures. The pooled sensitivity, specificity, positive predictive value and negative predictive value of the OAR for detection of fractures of the ankle were 96.8%, 45.8%, 48.4% and 96.5%, respectively. Our results suggest that clinical application of the OAR could decrease unnecessary radiographs by 31.1%. Of the 21 patients with positive OAR results and negative radiographic findings who underwent 3D-CT examination, five had occult fractures of the lateral malleolus. Conclusions: The OAR are applicable in the Chinese population, and have high sensitivity and modest specificity for the diagnosis of fractures associated with acute ankle injury. They may detect some occult fractures of the malleoli that are not visible on radiographs.	[Wang, Xin; Chang, Shi-min; Yu, Guang-rong; Rao, Zhi-tao] Tongji Univ, Sch Med, Tongji Hosp, Dept Orthoped, Shanghai 200092, Peoples R China	Tongji University	Wang, X (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Dept Orthoped, Shanghai 200092, Peoples R China.	wangxin1681@126.com						Auleley Guy-Robert, 1997, JAMA (Journal of the American Medical Association), V277, P1935, DOI 10.1001/jama.277.24.1935; Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Bessen T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3056; Blackham JEJ, 2008, EMERG MED J, V25, P750, DOI 10.1136/emj.2008.057877; Can U, 2008, SWISS MED WKLY, V138, P292, DOI 10.57187/smw.2008.12061; Canagasabey MD, 2011, EMERG MED J, V28, P838, DOI 10.1136/emj.2009.088286; Chandra A, 2001, UNFALLCHIRURG, V104, P617, DOI 10.1007/s001130170092; COCKSHOTT WP, 1983, CAN MED ASSOC J, V129, P129; Derksen RJ, 2005, AM J EMERG MED, V23, P725, DOI 10.1016/j.ajem.2005.02.054; Dowling S, 2009, ACAD EMERG MED, V16, P277, DOI 10.1111/j.1553-2712.2008.00333.x; Fiesseler F, 2004, AM J EMERG MED, V22, P145, DOI 10.1016/j.ajem.2004.02.001; Glas AS, 2002, CAN MED ASSOC J, V166, P727; GRATTON MC, 1990, ANN EMERG MED, V19, P497, DOI 10.1016/S0196-0644(05)82175-4; Gravel J, 2010, ACAD EMERG MED, V17, P859, DOI 10.1111/j.1553-2712.2010.00731.x; Heyworth J, 2003, BRIT J SPORT MED, V37, P194, DOI 10.1136/bjsm.37.3.194; Knudsen R, 2010, DAN MED BULL, V57; Leddy JJ, 2002, MED SCI SPORT EXER, V34, P57, DOI 10.1097/00005768-200201000-00010; LUCCHESI GM, 1995, ANN EMERG MED, V26, P1, DOI 10.1016/S0196-0644(95)70229-6; PIGMAN EC, 1994, ANN EMERG MED, V24, P41, DOI 10.1016/S0196-0644(94)70160-1; Plint AC, 1999, ACAD EMERG MED, V6, P1005, DOI 10.1111/j.1553-2712.1999.tb01183.x; Stiell I, 1996, CAN FAM PHYSICIAN, V42, P478; STIELL I, 1995, BRIT MED J, V311, P594, DOI 10.1136/bmj.311.7005.594; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; Yuen MC, 2001, AM J EMERG MED, V19, P429, DOI 10.1053/ajem.2001.24474	27	14	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63228	10.1371/journal.pone.0063228	http://dx.doi.org/10.1371/journal.pone.0063228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646202	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300160
J	Borley, DW; Mahapatra, M; Paton, DJ; Esnouf, RM; Stuart, DI; Fry, EE				Borley, Daryl W.; Mahapatra, Mana; Paton, David J.; Esnouf, Robert M.; Stuart, David I.; Fry, Elizabeth E.			Evaluation and Use of In-Silico Structure-Based Epitope Prediction with Foot-and-Mouth Disease Virus	PLOS ONE			English	Article							NEUTRALIZING ANTIGENIC SITES; AMINO-ACID SUBSTITUTIONS; MONOCLONAL-ANTIBODIES; 3-DIMENSIONAL STRUCTURE; CAPSID PROTEINS; SEROTYPE; IDENTIFICATION; SERVER; PROTECTION; LOCATION	Understanding virus antigenicity is of fundamental importance for the development of better, more cross-reactive vaccines. However, as far as we are aware, no systematic work has yet been conducted using the 3D structure of a virus to identify novel epitopes. Therefore we have extended several existing structural prediction algorithms to build a method for identifying epitopes on the appropriate outer surface of intact virus capsids (which are structurally different from globular proteins in both shape and arrangement of multiple repeated elements) and applied it here as a proof of principle concept to the capsid of foot-and-mouth disease virus (FMDV). We have analysed how reliably several freely available structure-based B cell epitope prediction programs can identify already known viral epitopes of FMDV in the context of the viral capsid. To do this we constructed a simple objective metric to measure the sensitivity and discrimination of such algorithms. After optimising the parameters for five methods using an independent training set we used this measure to evaluate the methods. Individually any one algorithm performed rather poorly (three performing better than the other two) suggesting that there may be value in developing virus-specific software. Taking a very conservative approach requiring a consensus between all three top methods predicts a number of previously described antigenic residues as potential epitopes on more than one serotype of FMDV, consistent with experimental results. The consensus results identified novel residues as potential epitopes on more than one serotype. These include residues 190-192 of VP2 (not previously determined to be antigenic), residues 69-71 and 193-197 of VP3 spanning the pentamer-pentamer interface, and another region incorporating residues 83, 84 and 169-174 of VP1 (all only previously experimentally defined on serotype A). The computer programs needed to create a semi-automated procedure for carrying out this epitope prediction method are presented.	[Borley, Daryl W.; Mahapatra, Mana; Paton, David J.] Pirbright Inst, Pirbright, England; [Borley, Daryl W.; Esnouf, Robert M.; Stuart, David I.; Fry, Elizabeth E.] Univ Oxford, Div Struct Biol, Oxford, England; [Stuart, David I.] Diamond Light Source, Harwell, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford; Diamond Light Source	Borley, DW (corresponding author), Pirbright Inst, Pirbright, England.	daryl.borley@pirbright.ac.uk; liz@strubi.ox.ac.uk		Mahapatra, Mana/0000-0002-3977-1465; Fry, Elizabeth/0000-0001-9754-5303; Stuart, David/0000-0002-3426-4210	Biotechnology and Biological Sciences Research Council UK [BB/G529532/1]; Medical Research Council; Wellcome Trust Core Award Grant [090532/Z/09/Z]; MRC [G1000099] Funding Source: UKRI; Medical Research Council [G1100525, G1000099] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Core Award Grant(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work performed at the Institute for Animal Health is supported by the Biotechnology and Biological Sciences Research Council UK (Grant number BB/G529532/1). The work performed at Oxford is supported by the Medical Research Council and by Wellcome Trust Core Award Grant Number 090532/Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; Aktas S, 2000, REV SCI TECH OIE, V19, P744, DOI 10.20506/rst.19.3.1244; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; ARNOLD E, 1988, ACTA CRYSTALLOGR A, V44, P270, DOI 10.1107/S0108767387011875; Barnett PV, 1998, J GEN VIROL, V79, P1687, DOI 10.1099/0022-1317-79-7-1687; BAXT B, 1989, J VIROL, V63, P2143, DOI 10.1128/JVI.63.5.2143-2151.1989; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Brehm KE, 2008, VACCINE, V26, P1681, DOI 10.1016/j.vaccine.2008.01.038; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; CROWTHER JR, 1993, EPIDEMIOL INFECT, V111, P391, DOI 10.1017/S0950268800057083; CROWTHER JR, 1993, J GEN VIROL, V74, P1547, DOI 10.1099/0022-1317-74-8-1547; DIAMOND DC, 1985, SCIENCE, V229, P1090, DOI 10.1126/science.2412292; DIEZ J, 1990, J VIROL, V64, P5519; Dunn CS, 1998, VIROLOGY, V247, P51, DOI 10.1006/viro.1998.9175; FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625; Fry E, 1990, SEMIN VIROL, V1, P439; Fry EE, 2005, J GEN VIROL, V86, P1909, DOI 10.1099/vir.0.80730-0; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grazioli S, 2004, SESS RES GP STAND TE, P277; Grazioli S., 2006, REPORT SESSION RES F, P287; Hewat EA, 1997, EMBO J, V16, P1492, DOI 10.1093/emboj/16.7.1492; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Juleff N, 2009, J VIROL, V83, P3626, DOI 10.1128/JVI.02613-08; KITSON JDA, 1990, VIROLOGY, V179, P26, DOI 10.1016/0042-6822(90)90269-W; Kleywegt G.J., 2001, INT TABLES CRYSTALLO, V353-356, P366; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEA S, 1994, STRUCTURE, V2, P123, DOI 10.1016/S0969-2126(00)00014-9; LEA S, 1995, STRUCTURE, V3, P571, DOI 10.1016/S0969-2126(01)00191-5; Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; Mahapatra M, 2008, VET MICROBIOL, V126, P40, DOI 10.1016/j.vetmic.2007.06.022; Mahapatra M, 2011, VET MICROBIOL, V149, P242, DOI 10.1016/j.vetmic.2010.11.003; Maree FF, 2011, J GEN VIROL, V92, P2297, DOI 10.1099/vir.0.032839-0; MATEU MG, 1994, J VIROL, V68, P1407, DOI 10.1128/JVI.68.3.1407-1417.1994; MATEU MG, 1990, J GEN VIROL, V71, P629, DOI 10.1099/0022-1317-71-3-629; Miller ST, 2001, J MOL BIOL, V307, P499, DOI 10.1006/jmbi.2001.4485; Minor P. D., 1990, Current Topics in Microbiology and Immunology, P121; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; MINOR PD, 1983, NATURE, V301, P674, DOI 10.1038/301674a0; MINOR PD, 1986, MICROBIOL SCI, V3, P141; Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602; PAGE GS, 1988, J VIROL, V62, P1781, DOI 10.1128/JVI.62.5.1781-1794.1988; Paton DJ, 2010, VET REC, V166, P569, DOI 10.1136/vr.c2300; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Reeve R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001027; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287; SAIZ JC, 1989, VIRUS RES, V13, P45, DOI 10.1016/0168-1702(89)90086-5; SAIZ JC, 1991, J VIROL, V65, P2518, DOI 10.1128/JVI.65.5.2518-2524.1991; SHERRY B, 1986, J VIROL, V57, P246, DOI 10.1128/JVI.57.1.246-257.1986; SHERRY B, 1985, J VIROL, V53, P137, DOI 10.1128/JVI.53.1.137-143.1985; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMAS AAM, 1988, J VIROL, V62, P2782, DOI 10.1128/JVI.62.8.2782-2789.1988; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valdazo-Gonzalez B, 2011, VET REC, V168, P247, DOI 10.1136/vr.d1352; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054; WIEGERS K, 1989, VIROLOGY, V170, P583, DOI 10.1016/0042-6822(89)90452-2; Xiao CA, 2007, J STRUCT BIOL, V158, P182, DOI 10.1016/j.jsb.2006.10.013; Yang M, 2007, VET IMMUNOL IMMUNOP, V115, P126, DOI 10.1016/j.vetimm.2006.10.002; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602	65	30	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61122	10.1371/journal.pone.0061122	http://dx.doi.org/10.1371/journal.pone.0061122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667434	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700009
J	Smeets, MFMA; Chan, AC; Dagger, S; Bradley, CK; Wei, A; Izon, DJ				Smeets, Monique F. M. A.; Chan, Angela C.; Dagger, Samantha; Bradley, Cara K.; Wei, Andrew; Izon, David J.			Fli-1 Overexpression in Hematopoietic Progenitors Deregulates T Cell Development and Induces Pre-T Cell Lymphoblastic Leukaemia/Lymphoma	PLOS ONE			English	Article							GENE-TARGETED MICE; TRANSCRIPTION FACTOR; LINEAGE COMMITMENT; RAPID DEVELOPMENT; NOTCH1 MUTATIONS; ACTIVATED RAS; ETS FAMILY; LEUKEMIA; THYMOCYTES; EXPRESSION	The Ets transcription factor Fli-1 is preferentially expressed in hematopoietic tissues and cells, including immature T cells, but the role of Fli-1 in T cell development has not been closely examined. To address this we retrovirally overexpressed Fli-1 in various in vitro and in vivo settings and analysed its effect on T cell development. We found that Fli-1 overexpression perturbed the DN to DP transition and inhibited CD4 development whilst enhancing CD8 development both in vitro and in vivo. Surprisingly, Fli-1 overexpression in vivo eventuated in development of pre-T cell lymphoblastic leukaemia/lymphoma (pre-T LBL). Known Fli-1 target genes such as the pro-survival Bcl-2 family members were not found to be upregulated. In contrast, we found increased NOTCH1 expression in all Fli-1 T cells and detected Notch1 mutations in all tumours. These data show a novel function for Fli-1 in T cell development and leukaemogenesis and provide a new mouse model of pre-T LBL to identify treatment options that target the Fli-1 and Notch1 signalling pathways.	[Smeets, Monique F. M. A.; Izon, David J.] Univ Melbourne, St Vincents Inst, Haematol & Leukaemia Unit, Fitzroy, Vic 3065, Australia; [Chan, Angela C.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Dagger, Samantha] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia; [Bradley, Cara K.] Gennea, Sydney, NSW, Australia; [Wei, Andrew] Monash Univ, Alfred Hosp, Dept Clin Haematol, Melbourne, Vic 3181, Australia; [Wei, Andrew] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia	St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; University of Western Australia; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University	Izon, DJ (corresponding author), Univ Melbourne, St Vincents Inst, Haematol & Leukaemia Unit, Fitzroy, Vic 3065, Australia.	dizon@svi.edu.au		Bradley, Cara/0000-0001-9677-3363; Wei, Andrew/0000-0002-7514-3298	NHMRC [559004]; Victorian Government's OIS Program; Cancer Council of Victoria; Leukaemia Foundation of Australia; Victorian Cancer Agency	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's OIS Program; Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukaemia Foundation of Australia; Victorian Cancer Agency	This work was supported by an NHMRC Project Grant #559004 and in part by the Victorian Government's OIS Program. DI receives support from the Cancer Council of Victoria and the Leukaemia Foundation of Australia. AW receives support from the Leukaemia Foundation of Australia and the Victorian Cancer Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM KM, 1991, P NATL ACAD SCI USA, V88, P3977, DOI 10.1073/pnas.88.9.3977; Anderson G, 2000, SEMIN IMMUNOL, V12, P457, DOI 10.1006/smim.2000.0260; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; Carlyle JR, 1997, J EXP MED, V186, P173, DOI 10.1084/jem.186.2.173; Craig FE, 2008, BLOOD, V111, P3941, DOI 10.1182/blood-2007-11-120535; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Feng H, 2010, CANCER CELL, V18, P353, DOI 10.1016/j.ccr.2010.09.009; Folpe AL, 2000, AM J SURG PATHOL, V24, P1657, DOI 10.1097/00000478-200012000-00010; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; GODFREY DI, 1994, J IMMUNOL, V152, P4783; Gothert JR, 2007, BLOOD, V110, P3753, DOI 10.1182/blood-2006-12-063644; Grohar PJ, 2011, JNCI-J NATL CANCER I, V103, P962, DOI 10.1093/jnci/djr156; HAWLEY RG, 1995, ONCOGENE, V11, P1113; Haydu JE, 2012, BLOOD, V119, P5211, DOI 10.1182/blood-2011-10-388504; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jeannet R, 2010, BLOOD, V116, P5443, DOI 10.1182/blood-2010-05-286658; Kamstrup MR, 2008, BRIT J DERMATOL, V158, P747, DOI 10.1111/j.1365-2133.2007.08427.x; Kawada H, 2001, INT J HEMATOL, V73, P463, DOI 10.1007/BF02994008; Kawamoto H, 2003, EUR J IMMUNOL, V33, P606, DOI 10.1002/eji.200323461; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Li YJ, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2011.52; Lin YW, 2006, BLOOD, V107, P2540, DOI 10.1182/blood-2005-07-3013; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Masuya M, 2005, BLOOD, V105, P95, DOI 10.1182/blood-2003-12-4345; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Mhawech-Fauceglia P, 2007, J CLIN PATHOL, V60, P694, DOI 10.1136/jcp.2006.039230; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Nie L, 2008, J BIOL CHEM, V283, P684, DOI 10.1074/jbc.M704981200; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Palomero T, 2006, BLOOD, V108, P986, DOI 10.1182/blood-2005-08-3482; Pereira R, 1999, ONCOGENE, V18, P1597, DOI 10.1038/sj.onc.1202534; Quick CM, 2006, J CUTAN PATHOL, V33, P642, DOI 10.1111/j.1600-0560.2006.00535.x; Reschly EJ, 2006, BLOOD, V107, P4115, DOI 10.1182/blood-2005-09-3551; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Starck J, 2010, BLOOD, V116, P4795, DOI 10.1182/blood-2010-02-270405; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; Tremblay M, 2010, GENE DEV, V24, P1093, DOI 10.1101/gad.1897910; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson A, 1989, Int Immunol, V1, P605, DOI 10.1093/intimm/1.6.605; Wilson NK, CELL STEM CELL, V7, P532; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; ZHANG LQ, 1995, MOL CELL BIOL, V15, P6961; Zhang XK, 2008, J IMMUNOL, V181, P1644, DOI 10.4049/jimmunol.181.3.1644	56	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62346	10.1371/journal.pone.0062346	http://dx.doi.org/10.1371/journal.pone.0062346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667468	Green Published, gold			2022-12-27	WOS:000319654700030
J	Valdes, JJ; Schwarz, A; de Vaca, IC; Calvo, E; Pedra, JHF; Guallar, V; Kotsyfakis, M				Valdes, James J.; Schwarz, Alexandra; Cabeza de Vaca, Israel; Calvo, Eric; Pedra, Joao H. F.; Guallar, Victor; Kotsyfakis, Michalis			Tryptogalinin Is a Tick Kunitz Serine Protease Inhibitor with a Unique Intrinsic Disorder	PLOS ONE			English	Article							MAST-CELL TRYPTASE; SOFT TICK; IXODES-SCAPULARIS; STRUCTURE PREDICTION; SIALOSTATIN-L; DOCKING; SIALOME; SERVER; EVOLUTION; SEQUENCE	Background: A salivary proteome-transcriptome project on the hard tick Ixodes scapularis revealed that Kunitz peptides are the most abundant salivary proteins. Ticks use Kunitz peptides (among other salivary proteins) to combat host defense mechanisms and to obtain a blood meal. Most of these Kunitz peptides, however, remain functionally uncharacterized, thus limiting our knowledge about their biochemical interactions. Results: We discovered an unusual cysteine motif in a Kunitz peptide. This peptide inhibits several serine proteases with high affinity and was named tryptogalinin due to its high affinity for beta-tryptase. Compared with other functionally described peptides from the Acari subclass, we showed that tryptogalinin is phylogenetically related to a Kunitz peptide from Rhipicephalus appendiculatus, also reported to have a high affinity for b-tryptase. Using homology-based modeling (and other protein prediction programs) we were able to model and explain the multifaceted function of tryptogalinin. The N-terminus of the modeled tryptogalinin is detached from the rest of the peptide and exhibits intrinsic disorder allowing an increased flexibility for its high affinity with its inhibiting partners (i.e., serine proteases). Conclusions: By incorporating experimental and computational methods our data not only describes the function of a Kunitz peptide from Ixodes scapularis, but also allows us to hypothesize about the molecular basis of this function at the atomic level.	[Valdes, James J.; Schwarz, Alexandra; Kotsyfakis, Michalis] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Cabeza de Vaca, Israel; Guallar, Victor] Barcelona Supercomp Ctr, Res Program Computat Biol, Inst Res Biomed BSC IRB, Joint Barcelona Supercomp Ctr, Barcelona, Spain; [Cabeza de Vaca, Israel; Guallar, Victor] ICREA, Barcelona, Spain; [Calvo, Eric] NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Pedra, Joao H. F.] Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA; [Pedra, Joao H. F.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); ICREA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Riverside; University of California System; University of California Riverside	Valdes, JJ (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	valdjj@gmail.com	Valdés, James/G-9812-2014; Calvo, Eric/ABB-4935-2021; Kotsyfakis, Michail/G-9525-2014; Guallar, Victor/B-1579-2013	Valdés, James/0000-0002-0237-8061; Calvo, Eric/0000-0001-7880-2730; Kotsyfakis, Michail/0000-0002-7526-1876; Guallar, Victor/0000-0002-4580-1114; Pedra, Joao/0000-0001-8740-2667	European Social Fund; state budget of the Czech Republic; Grant Agency of the Czech Republic [P302/11/P798]; Ministry of Education, Youth and Sports of the Czech Republic [LH12002]; Academy of Sciences of the Czech Republic; European Project [ERC-2009-Adg 25027-PELE]; Academy of Sciences of the Czech Republic [Z60220518, P502/12/2409]; European Union [PIRG07-GA-2010-268177]; National Institutes of Health, USA;  [CZ.1.07/2.3.00/30.0032]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093653] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); European Project; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); European Union(European Commission); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	JJV was sponsored by project CZ.1.07/2.3.00/30.0032, co-financed by the European Social Fund and the state budget of the Czech Republic. AS was funded by the Grant Agency of the Czech Republic (Grant No. P302/11/P798) and the Ministry of Education, Youth and Sports of the Czech Republic (KONTAKT II grant no. LH12002), and MK received support from the Academy of Sciences of the Czech Republic (Jan Evangelista Purkyne Fellowship). Computational resources were provided by the Barcelona Supercomputing Center and the work was supported by the ERC-2009-Adg 25027-PELE European Project. The authors also want to acknowledge the financial support of the Academy of Sciences of the Czech Republic (grant no. Z60220518 and P502/12/2409), the 7th Framework Program of the European Union (Marie Curie Reintegration grant, grant no. PIRG07-GA-2010-268177). Because Extramural Funds from the National Institutes of Health, USA, supported this work and because EC is a government employee, this is also considered a government work (in the USA public domain). Notwithstanding any other agreements, the NIH reserves the right to provide the work to PubMed Central for display and use by the public. PubMed Central may tag or modify the work consistent with its customary practices. Rights can be established outside of the USA subject to a government use license.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alim MA, 2012, INSECT BIOCHEM MOLEC, V42, P925, DOI 10.1016/j.ibmb.2012.09.005; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; Basdevant N, 2007, J PHYS CHEM B, V111, P9390, DOI 10.1021/jp0727190; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chmelar J, 2012, J PROTEOMICS, V75, P3842, DOI 10.1016/j.jprot.2012.04.026; Chmelar J, 2011, BLOOD, V117, P736, DOI 10.1182/blood-2010-06-293241; Chmelar J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-233; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Dai SX, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-4; DiMarco S, 1997, STRUCTURE, V5, P1465; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Eswar N., 2001, CURRENT PROTOCOLS PR; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Francischetti IMB, 2008, INSECT BIOCHEM MOLEC, V38, P1, DOI 10.1016/j.ibmb.2007.09.009; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Francischetti IMB, 2008, J PROTEOMICS, V71, P493, DOI 10.1016/j.jprot.2008.07.006; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Heyman P, 2010, EXPERT REV ANTI-INFE, V8, P33, DOI 10.1586/ERI.09.118; Joubert AM, 1998, EXP APPL ACAROL, V22, P603, DOI 10.1023/A:1006198713791; KARCZEWSKI J, 1994, J BIOL CHEM, V269, P6702; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kotsyfakis M, 2008, J IMMUNOL, V181, P5209, DOI 10.4049/jimmunol.181.8.5209; Kotsyfakis M, 2007, J BIOL CHEM, V282, P29256, DOI 10.1074/jbc.M703143200; Kotsyfakis M, 2006, J BIOL CHEM, V281, P26298, DOI 10.1074/jbc.M513010200; Kotsyfakis M, 2010, MOL MICROBIOL, V77, P456, DOI 10.1111/j.1365-2958.2010.07220.x; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Kunitz M, 1936, J GEN PHYSIOL, V19, P991, DOI 10.1085/jgp.19.6.991; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Li X, 2007, PROTEINS, V66, P824, DOI 10.1002/prot.21125; Lima CA, 2010, VET PARASITOL, V167, P279, DOI 10.1016/j.vetpar.2009.09.030; Ma DY, 2009, MOL CELL PROTEOMICS, V8, P2071, DOI 10.1074/mcp.M900186-MCP200; Macedo-Ribeiro S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001624; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P22, DOI 10.1016/j.ibmb.2007.09.002; Mans BJ, 2002, J BIOL CHEM, V277, P21371, DOI 10.1074/jbc.M112060200; Masone D, 2012, PROTEINS, V80, P818, DOI 10.1002/prot.23239; Paesen GC, 2007, J MOL BIOL, V368, P1172, DOI 10.1016/j.jmb.2007.03.011; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Payne V, 2004, ANAESTHESIA, V59, P695, DOI 10.1111/j.1365-2044.2004.03757.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ranasinghe S, 2013, DEV COMP IMMUNOL, V39, P219, DOI 10.1016/j.dci.2012.10.005; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Rost Burkhard, 1994, Current Opinion in Biotechnology, V5, P372, DOI 10.1016/0958-1669(94)90045-0; Sa-Nunes A, 2009, J IMMUNOL, V182, P7422, DOI 10.4049/jimmunol.0900075; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schaschke N, 2001, CHEM BIOL, V8, P313, DOI 10.1016/S1074-5521(01)00011-4; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sommerhoff CP, 2000, BBA-PROTEIN STRUCT M, V1477, P75, DOI 10.1016/S0167-4838(99)00265-4; Sommerhoff CP, 2009, BIOL CHEM H-S, V375, P685; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Tsujimoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029964; Valenzuela JG, 1999, BIOCHEMISTRY-US, V38, P11209, DOI 10.1021/bi990761i; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Vallat BK, 2009, PROTEINS, V76, P930, DOI 10.1002/prot.22401; WAXMAN L, 1990, SCIENCE, V248, P593, DOI 10.1126/science.2333510; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028000; Xu XQ, 2008, MOL CELL PROTEOMICS, V7, P582, DOI 10.1074/mcp.M700497-MCP200; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	79	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62562	10.1371/journal.pone.0062562	http://dx.doi.org/10.1371/journal.pone.0062562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658744	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100017
J	Budimir, N; de Haan, A; Meijerhof, T; Waijer, S; Boon, L; Gostick, E; Price, DA; Wilschut, J; Huckriede, A				Budimir, Natalija; de Haan, Aalzen; Meijerhof, Tjarko; Waijer, Simke; Boon, Louis; Gostick, Emma; Price, David A.; Wilschut, Jan; Huckriede, Anke			Critical Role of TLR7 Signaling in the Priming of Cross-Protective Cytotoxic T Lymphocyte Responses by a Whole Inactivated Influenza Virus Vaccine	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; ANTIGEN-PRESENTING CELLS; RIG-I; ANTIVIRAL RESPONSES; ANTIBODY-RESPONSE; IMMUNE-RESPONSES; INFECTION; CD8(+); ACTIVATION; INDUCTION	Current influenza vaccines fail to induce protection against antigenically distinct virus strains. Accordingly, there is a need for the development of cross-protective vaccines. Previously, we and others have shown that vaccination with whole inactivated virus (WIV) induces cross-protective cellular immunity in mice. To probe the mechanistic basis for this finding, we investigated the role of TLR7, a receptor for single-stranded RNA, in induction of cross-protection. Vaccination of TLR7-/- mice with influenza WIV failed to protect against a lethal heterosubtypic challenge; in contrast, wild-type mice were fully protected. The lack of protection in TLR7-/- mice was associated with high viral load and a relative paucity of influenza-specific CD8+ cytotoxic T lymphocyte (CTL) responses. Dendritic cells (DCs) from TLR7-/- mice were unable to cross-present WIV-derived antigen to influenza-specific CTLs in vitro. Similarly, TLR7-/- DCs failed to mature and become activated in response to WIV, as determined by the assessment of surface marker expression and cytokine production. Plasmacytoid DCs (pDCs) derived from wild-type mice responded directly to WIV while purified conventional DCs (cDCs) did not respond to WIV in isolation, but were responsive in mixed pDC/cDC cultures. Depletion of pDCs prior to and during WIV immunization resulted in reduced numbers of influenza-specific CTLs and impaired protection from heterosubtypic challenge. Thus, TLR7 plays a critical role in the induction of cross-protective immunity upon vaccination with WIV. The initial target cells for WIV appear to be pDCs which by direct or indirect mechanisms promote activation of robust CTL responses against conserved influenza epitopes.	[Budimir, Natalija; de Haan, Aalzen; Meijerhof, Tjarko; Waijer, Simke; Wilschut, Jan; Huckriede, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, Groningen, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Gostick, Emma; Price, David A.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	University of Groningen; Bioceros B.V.; Cardiff University	Huckriede, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, Groningen, Netherlands.	a.l.w.huckriede@umcg.nl	Price, David A/C-7876-2013; Boon, Laurence/HCI-3629-2022; Huckriede, Anke/P-3558-2019	Price, David A/0000-0001-9416-2737; Huckriede, Anke/0000-0002-2646-5143; Boon, Louis/0000-0002-0937-9171; Waijer, Simke W/0000-0003-1717-0463	TI Pharma grant [T4-214-1]; Jan Kornelis de Cock Stichting grant; Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish	TI Pharma grant; Jan Kornelis de Cock Stichting grant; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was financially supported by TI Pharma grant (T4-214-1) and Jan Kornelis de Cock Stichting grant (http://www.decockstichting.nl/subsidies.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 0120050158 EUR PHARM; Aoshi T, 2011, CURR OPIN VIROLGY, V1, P1; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Budimir N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030898; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; den Haan JMM, 2001, CURR OPIN IMMUNOL, V13, P437, DOI 10.1016/S0952-7915(00)00238-7; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Furuya Y, 2010, J VIROL, V84, P4212, DOI 10.1128/JVI.02508-09; Geeraedts F, 2010, AAPS J, V12, P215, DOI 10.1208/s12248-010-9179-z; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Gil-Torregrosa BC, 2004, EUR J IMMUNOL, V34, P398, DOI 10.1002/eji.200324508; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Hickman-Miller HD, 2006, NAT IMMUNOL, V7, P125, DOI 10.1038/ni0206-125; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Ichinohe T, 2010, EXPERT REV VACCINES, V9, P1315, DOI 10.1586/ERV.10.118; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Kratky W, 2011, P NATL ACAD SCI USA, V108, P17414, DOI 10.1073/pnas.1108945108; Lattanzi L, 2011, IMMUNOBIOLOGY, V216, P537, DOI 10.1016/j.imbio.2010.10.003; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Mouries J, 2008, BLOOD, V112, P3713, DOI 10.1182/blood-2008-03-146290; Ni K, 1997, IMMUNOL CELL BIOL, V75, P223, DOI 10.1038/icb.1997.35; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Qi H, 2003, INFECT IMMUN, V71, P3337, DOI 10.1128/IAI.71.6.3337-3342.2003; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sawai T, 2008, IMMUNOLOGY, V124, P155, DOI 10.1111/j.1365-2567.2007.02745.x; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Spadaro F, 2012, BLOOD, V119, P1407, DOI 10.1182/blood-2011-06-363564; Storni T, 2002, J IMMUNOL, V168, P2880, DOI 10.4049/jimmunol.168.6.2880; Wagner H, 2009, ADV DRUG DELIVER REV, V61, P243, DOI 10.1016/j.addr.2008.12.010; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63163	10.1371/journal.pone.0063163	http://dx.doi.org/10.1371/journal.pone.0063163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658804	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000321200500057
J	Muhle, C; Huttner, HB; Walter, S; Reichel, M; Canneva, F; Lewczuk, P; Gulbins, E; Kornhuber, J				Muehle, Christiane; Huttner, Hagen B.; Walter, Silke; Reichel, Martin; Canneva, Fabio; Lewczuk, Piotr; Gulbins, Erich; Kornhuber, Johannes			Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; SECRETORY SPHINGOMYELINASE; ALZHEIMERS-DISEASE; LYSOSOMAL SPHINGOMYELINASE; SPHINGOSINE 1-PHOSPHATE; ENZYME-ACTIVITY; CERAMIDE; APOPTOSIS; MICE; EXPRESSION	Background: As a key enzyme in sphingolipid metabolism, acid sphingomyelinase (ASM) is involved in the regulation of cell fate and signaling via hydrolysis of sphingomyelin to form ceramide. While increased activity of the lysosomal form has been associated with various pathological conditions, there are few studies on secretory ASM limited only to cell models, plasma or serum. Methods: An optimized assay based on a fluorescent substrate was applied to measure the ASM activity in cerebrospinal fluid (CSF) collected from mice and from 42 patients who were classified as controls based on normal routine CSF values. Results: We have detected ASM activity in human CSF, established a sensitive quantitative assay and characterized the enzyme's properties. The enzyme resembles plasmatic ASM including protein stability and Zn2+-dependence but the assays differ considerably in the optimal detergent concentration. Significantly increased activities in the CSF of ASM transgenic mice and undetectable levels in ASM knock-out mice prove that the measured ASM activity originates from the ASM-encoding gene SMPD1. CSF localized ASM activities were comparable to corresponding serum ASM levels at their respective optimal reaction conditions, but no correlation was observed. The large variance in ASM activity was independent of sex, age or analyzed routine CSF parameters. Conclusions: Human and mouse CSF contain detectable levels of secretory ASM, which are unrelated to serum ASM activities. Further investigations in humans and in animal models will help to elucidate the role of this enzyme in human disease and to assess its value as a potential biomarker for disease type, severity, progress or therapeutic success.	[Muehle, Christiane; Reichel, Martin; Lewczuk, Piotr; Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Huttner, Hagen B.] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany; [Walter, Silke] Univ Saarland, Dept Neurol, Homburg, Germany; [Canneva, Fabio] Univ Erlangen Nurnberg, Franz Penzoldt Ctr, D-91054 Erlangen, Germany; [Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Saarland University; University of Erlangen Nuremberg; University of Duisburg Essen	Muhle, C (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany.	christiane.muehle@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014; Gulbins, Erich/L-6989-2014; MÃhle, Christiane/AAE-7043-2019	Kornhuber, Johannes/0000-0002-8096-3987; Gulbins, Erich/0000-0002-3117-1342; Muhle, Christiane/0000-0001-7517-9154; Reichel, Martin/0000-0001-7886-2784; Walter, Silke/0000-0002-1176-2911	DFG [KO 947/11-1, GU 335/23-1]	DFG(German Research Foundation (DFG))	The work was supported by DFG (www.dfg.de) grant KO 947/11-1 and GU 335/23-1 (to JK and EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenz C, 2010, CELL PHYSIOL BIOCHEM, V26, P1, DOI 10.1159/000315100; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; BOWSER PA, 1978, J INVEST DERMATOL, V70, P331, DOI 10.1111/1523-1747.ep12543516; Carmody W. R., 1961, J CHEM EDUC, V38, P559, DOI DOI 10.1021/ED038P559; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; Filippov V, 2012, J ALZHEIMERS DIS, V29, P537, DOI 10.3233/JAD-2011-111202; Fujii S, 2004, BIOL PHARM BULL, V27, P1725, DOI 10.1248/bpb.27.1725; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; JONES CS, 1981, BIOCHEM J, V195, P373, DOI 10.1042/bj1950373; Kinnunen PKJ, 2002, TRENDS CARDIOVAS MED, V12, P37, DOI 10.1016/S1050-1738(01)00143-8; Kornhuber J, 2005, J NEURAL TRANSM, V112, P1583, DOI 10.1007/s00702-005-0374-5; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023852; Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101; KORNHUBER ME, 1986, J NEUROSCI METH, V17, P63, DOI 10.1016/0165-0270(86)90035-X; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Lewczuk P, 2009, J NEURAL TRANSM, V116, P1163, DOI 10.1007/s00702-009-0277-y; Liu L, 2008, J VIS EXP, V21; Marathe S, 2000, HUM MOL GENET, V9, P1967, DOI 10.1093/hmg/9.13.1967; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Mikati MA, 2008, EPILEPSY RES, V81, P161, DOI 10.1016/j.eplepsyres.2008.05.009; Qiu HW, 2003, J BIOL CHEM, V278, P32744, DOI 10.1074/jbc.M303022200; Reichel M, 2011, ALCOHOL CLIN EXP RES, V35, P1852, DOI 10.1111/j.1530-0277.2011.01529.x; Reichel M, 2010, ALCOHOL CLIN EXP RES, V34, P46, DOI 10.1111/j.1530-0277.2009.01064.x; Rhein C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035467; Sacket SJ, 2009, ACTA PHARMACOL SIN, V30, P1454, DOI 10.1038/aps.2009.136; Satoi H, 2005, NEUROSCIENCE, V130, P657, DOI 10.1016/j.neuroscience.2004.08.056; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Schuchman EH, 2007, J INHERIT METAB DIS, V30, P654, DOI 10.1007/s10545-007-0632-9; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Takahashi I, 2000, TOHOKU J EXP MED, V192, P61, DOI 10.1620/tjem.192.61; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Zhang Y, 2009, BBA-BIOMEMBRANES, V1788, P178, DOI 10.1016/j.bbamem.2008.07.030	41	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62912	10.1371/journal.pone.0062912	http://dx.doi.org/10.1371/journal.pone.0062912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658784	gold, Green Published			2022-12-27	WOS:000321200500043
J	Mak, GK; Antle, MC; Dyck, RH; Weiss, S				Mak, Gloria K. y; Antle, Michael C.; Dyck, Richard H.; Weiss, Samuel			Bi-Parental Care Contributes to Sexually Dimorphic Neural Cell Genesis in the Adult Mammalian Brain	PLOS ONE			English	Article							WATER MAZE TASK; SPATIAL WORKING-MEMORY; LONG-TERM POTENTIATION; MATERNAL-CARE; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; ESTROUS-CYCLE; STEM-CELLS; STIMULATED NEUROGENESIS; SYNAPTIC PLASTICITY	Early life events can modulate brain development to produce persistent physiological and behavioural phenotypes that are transmissible across generations. However, whether neural precursor cells are altered by early life events, to produce persistent and transmissible behavioural changes, is unknown. Here, we show that bi-parental care, in early life, increases neural cell genesis in the adult rodent brain in a sexually dimorphic manner. Bi-parentally raised male mice display enhanced adult dentate gyrus neurogenesis, which improves hippocampal neurogenesis-dependent learning and memory. Female mice display enhanced adult white matter oligodendrocyte production, which increases proficiency in bilateral motor coordination and preference for social investigation. Surprisingly, single parent-raised male and female offspring, whose fathers and mothers received bi-parental care, respectively, display a similar enhancement in adult neural cell genesis and phenotypic behaviour. Therefore, neural plasticity and behavioural effects due to bi-parental care persist throughout life and are transmitted to the next generation.	[Mak, Gloria K. y; Dyck, Richard H.; Weiss, Samuel] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Fac Med, Calgary, AB, Canada; [Antle, Michael C.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Fac Med, Calgary, AB, Canada; [Antle, Michael C.; Dyck, Richard H.] Univ Calgary, Hotchkiss Brain Inst, Fac Arts, Dept Psychol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Weiss, S (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Fac Med, Calgary, AB, Canada.	weiss@ucalgary.ca		Antle, Michael/0000-0001-5178-4683; Dyck, Richard/0000-0002-3254-8332	Canadian Institutes of Health Research and studentship; Alberta Innovates Health Solutions	Canadian Institutes of Health Research and studentship; Alberta Innovates Health Solutions	This work was funded by the Canadian Institutes of Health Research and studentship (GKM) and scientist (SW) awards from Alberta Innovates Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the mnauscript.	Antle MC, 2007, J BIOL RHYTHM, V22, P524, DOI 10.1177/0748730407306882; Arai JA, 2009, J NEUROSCI, V29, P1496, DOI 10.1523/JNEUROSCI.5057-08.2009; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Berry B, 1997, BEHAV NEUROSCI, V111, P267, DOI 10.1037/0735-7044.111.2.267; Bonzano L, 2008, J NEUROSCI, V28, P3227, DOI 10.1523/JNEUROSCI.4076-07.2008; Branchi I, 2006, J NEUROSCI RES, V83, P965, DOI 10.1002/jnr.20789; Branchi I, 2009, NEUROSCI BIOBEHAV R, V33, P551, DOI 10.1016/j.neubiorev.2008.03.011; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; Buss C, 2007, J NEUROSCI, V27, P2592, DOI 10.1523/JNEUROSCI.3252-06.2007; Cameron N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002210; Carter DB, 2002, COMPARATIVE MED, V52, P452; Cerghet M, 2009, J NEUROL SCI, V286, P76, DOI 10.1016/j.jns.2009.06.039; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Champagne FA, 2009, NEUROSCI BIOBEHAV R, V33, P593, DOI 10.1016/j.neubiorev.2007.10.009; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Curley JP, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.025.2009; D'Amato FR, 2011, HIPPOCAMPUS, V21, P298, DOI 10.1002/hipo.20750; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Fairless AH, 2008, BRAIN RES, V1230, P211, DOI 10.1016/j.brainres.2008.07.025; Frick KM, 2000, NEUROREPORT, V11, P3461, DOI 10.1097/00001756-200011090-00013; FRYE CA, 1995, PHYSIOL BEHAV, V57, P5, DOI 10.1016/0031-9384(94)00197-D; Fugger HN, 1998, HORM BEHAV, V34, P163, DOI 10.1006/hbeh.1998.1475; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Hernandez-Rabaza V, 2009, NEUROSCIENCE, V159, P59, DOI 10.1016/j.neuroscience.2008.11.054; Hodes GE, 2010, J PHARMACOL EXP THER, V332, P266, DOI 10.1124/jpet.109.158717; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Kerr AL, 2010, NEUROSCIENCE, V171, P214, DOI 10.1016/j.neuroscience.2010.08.008; KIERNAN JA, 1984, J MICROSC-OXFORD, V134, P25, DOI 10.1111/j.1365-2818.1984.tb00501.x; Lagace DC, 2007, HIPPOCAMPUS, V17, P175, DOI 10.1002/hipo.20265; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Liu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030803; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Mak GK, 2010, NAT NEUROSCI, V13, P753, DOI 10.1038/nn.2550; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; Markham JA, 2009, BRAIN RES, V1288, P9, DOI 10.1016/j.brainres.2009.06.087; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; MOORE CL, 1979, J COMP PHYSIOL PSYCH, V93, P677, DOI 10.1037/h0077599; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Mychasiuk R, 2012, BEHAV BRAIN RES, V228, P294, DOI 10.1016/j.bbr.2011.11.036; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; O'Hearn K, 2008, DEV PSYCHOPATHOL, V20, P1103, DOI 10.1017/S0954579408000527; Oomen CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003675; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049622; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050455; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; POLEY W, 1974, ANIM LEARN BEHAV, V2, P241, DOI 10.3758/BF03199187; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; Richards S, 2012, BEHAV BRAIN RES, V231, P86, DOI 10.1016/j.bbr.2012.02.043; Rissanen A, 1999, NEUROREPORT, V10, P1369, DOI 10.1097/00001756-199904260-00039; Rizzi S, 2011, BRAIN RES, V1415, P23, DOI 10.1016/j.brainres.2011.08.007; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; Sgado P, 2006, P NATL ACAD SCI USA, V103, P15242, DOI 10.1073/pnas.0602116103; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Stackman RW, 1997, NEUROBIOL LEARN MEM, V67, P167, DOI 10.1006/nlme.1996.3753; Stone SSD, 2011, HIPPOCAMPUS, V21, P1348, DOI 10.1002/hipo.20845; Tang AC, 2003, J NEUROSCI, V23, P8254; Tang AC, 2006, P NATL ACAD SCI USA, V103, P15716, DOI 10.1073/pnas.0607374103; van Gaalen MM, 2000, BEHAV BRAIN RES, V115, P95, DOI 10.1016/S0166-4328(00)00240-0; van Hasselt FN, 2012, J NEUROENDOCRINOL, V24, P331, DOI 10.1111/j.1365-2826.2011.02233.x; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wachs TD, 2006, ANN NY ACAD SCI, V1094, P28, DOI 10.1196/annals.1376.004; Warren SG, 1997, BEHAV NEUROSCI, V111, P259, DOI 10.1037/0735-7044.111.2.259; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24; WHITTEN WK, 1959, J ENDOCRINOL, V18, P102, DOI 10.1677/joe.0.0180102; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Zakharova E, 2012, BEHAV BRAIN RES, V230, P92, DOI 10.1016/j.bbr.2012.01.052; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhu ZL, 2004, J NEUROSCI RES, V78, P837, DOI 10.1002/jnr.20338	85	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62701	10.1371/journal.pone.0062701	http://dx.doi.org/10.1371/journal.pone.0062701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650527	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000072
J	Sabo, JK; Aumann, TD; Kilpatrick, TJ; Cate, HS				Sabo, Jennifer K.; Aumann, Tim D.; Kilpatrick, Trevor J.; Cate, Holly S.			Investigation of Sequential Growth Factor Delivery during Cuprizone Challenge in Mice Aimed to Enhance Oligodendrogliogenesis and Myelin Repair	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FACTOR-I; OLIGODENDROCYTE LINEAGE; INDUCED DEMYELINATION; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; CELL-SURVIVAL; IGF-I; REMYELINATION; DIFFERENTIATION	Repair in multiple sclerosis involves remyelination, a process in which axons are provided with a new myelin sheath by new oligodendrocytes. Bone morphogenic proteins (BMPs) are a family of growth factors that have been shown to influence the response of oligodendrocyte progenitor cells (OPCs) in vivo during demyelination and remyelination in the adult brain. We have previously shown that BMP4 infusion increases numbers of OPCs during cuprizone-induced demyelination, while infusion of Noggin, an endogenenous antagonist of BMP4 increases numbers of mature oligodendrocytes and remyelinated axons following recovery. Additional studies have shown that insulin-like growth factor-1 (IGF-1) promotes the survival of OPCs during cuprizone-induced demyelination. Based on these data, we investigated whether myelin repair could be further enhanced by sequential infusion of these agents firstly, BMP4 to increase OPC numbers, followed by either Noggin or IGF-1 to increase the differentiation and survival of the newly generated OPCs. We identified that sequential delivery of BMP4 and IGF-1 during cuprizone challenge increased the number of mature oligodendrocytes and decreased astrocyte numbers following recovery compared with vehicle infused mice, but did not alter remyelination. However, sequential delivery of BMP4 and Noggin during cuprizone challenge did not alter numbers of oligodendrocytes or astrocytes in the corpus callosum compared with vehicle infused mice. Furthermore, electron microscopy analysis revealed no change in average myelin thickness in the corpus callosum between vehicle infused and BMP4-Noggin infused mice. Our results suggest that while single delivery of Noggin or IGF-1 increased the production of mature oligodendrocytes in vivo in the context of demyelination, only Noggin infusion promoted remyelination. Thus, sequential delivery of BMP4 and Noggin or IGF-1 does not further enhance myelin repair above what occurs with delivery of Noggin alone.	[Sabo, Jennifer K.; Kilpatrick, Trevor J.; Cate, Holly S.] Univ Melbourne, Neurosci Res Ctr, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Sabo, Jennifer K.; Aumann, Tim D.; Kilpatrick, Trevor J.; Cate, Holly S.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Cate, HS (corresponding author), Univ Melbourne, Neurosci Res Ctr, Dept Anat & Neurosci, Melbourne, Vic, Australia.	hcate@unimelb.edu.au		Kilpatrick, Trevor/0000-0003-3999-085X; Cate, Holly/0000-0001-6392-9640	National Health and Medical Research Council of Australia (NHMRC); Multiple Sclerosis Research Australia (MSRA); Holloway Family Trust; Victorian Operational Infrastructure Support Program	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia (MSRA); Holloway Family Trust; Victorian Operational Infrastructure Support Program	This work was supported by the National Health and Medical Research Council of Australia (NHMRC), Multiple Sclerosis Research Australia (MSRA), the Holloway Family Trust and the Victorian Operational Infrastructure Support Program. J.K.S. was supported by a MSRA Postgraduate Scholarship and H.S.C. was supported by NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Armstrong RC, 2002, J NEUROSCI, V22, P8574; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; Cannella B, 2000, AM J PATHOL, V157, P933, DOI 10.1016/S0002-9440(10)64606-8; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; Cate HS, 2010, J NEUROCHEM, V115, P11, DOI 10.1111/j.1471-4159.2010.06660.x; Dummula K, 2011, J NEUROSCI, V31, P12068, DOI 10.1523/JNEUROSCI.0013-11.2011; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Frank JA, 2002, MULT SCLER, V8, P24, DOI 10.1191/1352458502ms768oa; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Genoud S, 2005, J NEUROIMMUNOL, V168, P40, DOI 10.1016/j.jneuroim.2005.06.033; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kuhl NM, 2002, J NEUROSCI RES, V69, P207, DOI 10.1002/jnr.10293; Mason JL, 2000, J NEUROSCI, V20, P5703, DOI 10.1523/JNEUROSCI.20-15-05703.2000; Mason JL, 2003, J NEUROSCI, V23, P7710; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P1238, DOI 10.1210/me.2008-0001; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; O'Leary MT, 2002, MOL CELL NEUROSCI, V19, P32, DOI 10.1006/mcne.2001.1062; Pang Y, 2007, GLIA, V55, P1099, DOI 10.1002/glia.20530; Peters I, 2006, J AM SOC NEPHROL, V17, P1644, DOI 10.1681/ASN.2005111209; Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097; Sabo JK, 2011, J NEUROSCI, V31, P4504, DOI 10.1523/JNEUROSCI.5859-10.2011; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Song K, 2011, INJURY, V42, P796, DOI 10.1016/j.injury.2011.02.003; Tengood JE, 2011, TISSUE ENG PT A, V17, P1181, DOI [10.1089/ten.tea.2010.0551, 10.1089/ten.TEA.2010.0551]; VonDran MW, 2011, J NEUROSCI, V31, P14182, DOI 10.1523/JNEUROSCI.6595-10.2011; Wahdan-Alaswad RS, 2010, CANCER RES, V70, P9106, DOI 10.1158/0008-5472.CAN-10-1119; YAO DL, 1995, P NATL ACAD SCI USA, V92, P6190, DOI 10.1073/pnas.92.13.6190; YE P, 1995, J NEUROSCI, V15, P7344; Zhu SG, 2010, J IMMUNOL, V184, P2348, DOI 10.4049/jimmunol.0902371	34	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63415	10.1371/journal.pone.0063415	http://dx.doi.org/10.1371/journal.pone.0063415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650566	Green Published, gold			2022-12-27	WOS:000319167000111
J	Spronk, M; Vogel, EK; Jonkman, LM				Spronk, Marjolein; Vogel, Edward K.; Jonkman, Lisa M.			No Behavioral or ERP Evidence for a Developmental Lag in Visual Working Memory Capacity or Filtering in Adolescents and Adults with ADHD	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY-DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; SELECTIVE ATTENTION; IRRELEVANT INFORMATION; DEFAULT NETWORK; NEURAL MEASURES; AGE-DIFFERENCES; CHILDREN	Attention-deficit/hyperactivity disorder (ADHD) patients have both working memory (WM) and attention problems. Good attention skills are important for WM performance; individuals have higher WM capacity when being able to prevent storage of irrelevant information through efficient filtering. Since it is unknown how filtering ability is associated with WM performance in ADHD, this was investigated in the present study. A visuospatial working memory (VSWM) change detection task with distracting stimuli was administered to adolescents (12-16 years old) and adults (20-46 years old) with and without ADHD matched on education/IQ. Besides performance, contralateral delay activity (CDA) was measured; a neural correlate of the number of targets and distracters encoded and maintained in WM during the retention interval. Performance data showed similar WM-load, WM-distracter interference and developmental effects in ADHD and control groups. Adolescents' performance on the WM task deteriorated more than that of adults in the presence of distracters and with higher WM-load, irrespective of Diagnosis. The CDA data suggested that initially all groups encoded/maintained distracting information, but only adults were able to bounce this information from memory later in the retention interval, leading to better WM performance. The only effect of Diagnosis was a smaller CDA in adolescents and adults with ADHD than in age/IQ-matched controls when maintaining a low 1-item load, which was possibly related to an inability to keep attention focused at cued stimuli with low task demands. Overall, the development of filtering efficiency and VSWM storage capacity in adolescents with ADHD was not different from that in typically developing peers.	[Spronk, Marjolein; Jonkman, Lisa M.] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Vogel, Edward K.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	Maastricht University; University of Oregon	Jonkman, LM (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.	l.jonkman@maastrichtuniversity.nl	Vogel, Edward K/AAW-9466-2021		Netherlands Organization of Scientific Research (NWO) [400-05-132]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Netherlands Organization of Scientific Research (NWO), Open Competition programme, grant number 400-05-132 awarded to L.M. Jonkman (http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 2003, MANUAL ASEBA ADULT F; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arend AM, 2011, J COGNITIVE NEUROSCI, V23, P4048, DOI 10.1162/jocn_a_00068; Barkley RA, 1998, SCI AM, V279, P66, DOI 10.1038/scientificamerican0998-66; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 1996, J ATTEN DISORD, V1, P41, DOI DOI 10.1177/108705479600100104; Biederman J, 1996, J AM ACAD CHILD PSY, V35, P343, DOI 10.1097/00004583-199603000-00016; Biederman J, 2008, DEV NEUROPSYCHOL, V33, P44, DOI 10.1080/87565640701729755; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Brodeur DA, 2001, J ABNORM CHILD PSYCH, V29, P229, DOI 10.1023/A:1010381731658; Carr L, 2010, J CLIN CHILD ADOLESC, V39, P726, DOI 10.1080/15374416.2010.517168; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Chamberlain SR, 2011, BIOL PSYCHIAT, V69, P1192, DOI 10.1016/j.biopsych.2010.08.019; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Cowan N, 2010, DEVELOPMENTAL SCI, V13, P120, DOI 10.1111/j.1467-7687.2009.00864.x; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Delvenne JF, 2011, PSYCHOPHYSIOLOGY, V48, P333, DOI 10.1111/j.1469-8986.2010.01079.x; Dige N, 2010, J ATTEN DISORD, V13, P677, DOI 10.1177/1087054709347245; Doehnert M, 2010, BIOL PSYCHIAT, V67, P608, DOI 10.1016/j.biopsych.2009.07.038; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Forster S, 2007, PSYCHOL SCI, V18, P377, DOI 10.1111/j.1467-9280.2007.01908.x; Friedman-Hill SR, 2010, COGNITION, V115, P93, DOI 10.1016/j.cognition.2009.11.013; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gomarus HK, 2009, CLIN NEUROPHYSIOL, V120, P60, DOI 10.1016/j.clinph.2008.10.018; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Jeyakumar SLE, 2004, EDUC PSYCHOL MEAS, V64, P71, DOI 10.1177/0013164403258407; Jonkman LM, 2004, CLIN NEUROPHYSIOL, V115, P1537, DOI 10.1016/j.clinph.2004.01.022; Jonkman LM, 1999, PSYCHOPHYSIOLOGY, V36, P419; Jonkman LM, 1997, BIOL PSYCHIAT, V41, P595, DOI 10.1016/S0006-3223(96)00073-X; Jost K, 2011, CEREB CORTEX, V21, P1147, DOI 10.1093/cercor/bhq185; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kofler MJ, 2010, J ABNORM CHILD PSYCH, V38, P149, DOI 10.1007/s10802-009-9357-6; Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X; Kuo BC, 2012, J COGNITIVE NEUROSCI, V24, P51, DOI 10.1162/jocn_a_00087; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; Lee EY, 2010, BRAIN, V133, P2677, DOI 10.1093/brain/awq197; Lewis-Peacock JA, 2012, J COGNITIVE NEUROSCI, V24, P61, DOI 10.1162/jocn_a_00140; Lui M, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-12; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; Mariani MA, 1997, DEV NEUROPSYCHOL, V13, P111, DOI 10.1080/87565649709540671; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; McVay JC, 2009, PSYCHON B REV, V16, P857, DOI 10.3758/PBR.16.5.857; Peterson BS, 2009, AM J PSYCHIAT, V166, P1286, DOI 10.1176/appi.ajp.2009.08050724; Polanczyk G, 2008, CHILD ADOLESC PSYCHI, V17, pvii; Polanczyk G, 2008, CHILD ADOL PSYCH CL, V17, P245, DOI 10.1016/j.chc.2007.11.006; Rapport LJ, 2001, CLIN NEUROPSYCHOL, V15, P479, DOI 10.1076/clin.15.4.479.1878; Riggs KJ, 2006, J EXP CHILD PSYCHOL, V95, P18, DOI 10.1016/j.jecp.2006.03.009; Rogers M, 2011, CHILD NEUROPSYCHOL, V17, P444, DOI 10.1080/09297049.2010.544648; Romer D, 2011, DEVELOPMENTAL SCI, V14, P1119, DOI 10.1111/j.1467-7687.2011.01061.x; Romer D, 2009, NEUROPSYCHOLOGIA, V47, P2916, DOI 10.1016/j.neuropsychologia.2009.06.019; Rommelse NNJ, 2008, J NEURAL TRANSM, V115, P249, DOI 10.1007/s00702-007-0865-7; Sander MC, 2011, CEREB CORTEX, V21, P2809, DOI 10.1093/cercor/bhr076; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Sowerby P, 2011, J ATTEN DISORD, V15, P461, DOI 10.1177/1087054710370674; Spreen O, 1998, COMPENDIUM NEUROPSYC; Spronk M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042262; Tian LX, 2008, BRAIN DEV-JPN, V30, P342, DOI 10.1016/j.braindev.2007.10.005; Tillman C, 2011, DEV NEUROPSYCHOL, V36, P181, DOI 10.1080/87565641.2010.549981; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Westerberg H, 2004, CHILD NEUROPSYCHOL, V10, P155, DOI 10.1080/09297040490911014	74	20	20	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62673	10.1371/journal.pone.0062673	http://dx.doi.org/10.1371/journal.pone.0062673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23650525	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000070
J	Urabe, J; Suzuki, T; Nishita, T; Makino, W				Urabe, Jotaro; Suzuki, Takao; Nishita, Tatsuki; Makino, Wataru			Immediate Ecological Impacts of the 2011 Tohoku Earthquake Tsunami on Intertidal Flat Communities	PLOS ONE			English	Article							QUALITY; FAUNA	Following the Great East Japan Earthquake in 2011, a large tsunami developed and struck the Pacific coast of eastern Japan. To assess the immediate impacts of the tsunami on coastal communities, changes in taxon composition and richness of macrobenthic animals before and after the tsunami were examined at nine intertidal flats in Sendai Bay and the Sanriku Ria coast. The results showed that 30-80% of taxa indigenously inhabiting intertidal flats disappeared after the tsunami. Among animal types, endobenthic and sessile epibenthic animals were more vulnerable to the tsunami than mobile epibenthic animals like shore crabs and snails. For all the intertidal flats examined, animals that were originally dwellers in lower tidal zones and not recorded before the tsunami were also found right after the tsunami, indicating that the tsunami not only took away many benthic taxa from the intertidal flats but also brought in some taxa from elsewhere. However, overall changes in taxon community composition were greater for intertidal flats that experienced larger inundation heights. These results showed that the ecological impacts of the tsunami were proportional to the physical impacts as gauged by wave height and that mobile epibenthic animals were less vulnerable to the tsunami.	[Urabe, Jotaro; Suzuki, Takao; Nishita, Tatsuki; Makino, Wataru] Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Sendai, Miyagi, Japan	Tohoku University	Urabe, J (corresponding author), Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Sendai, Miyagi, Japan.	urabe@m.tohoku.ac.jp	Urabe, Jotaro/ABI-7692-2020; Urabe, Jotaro/A-6256-2012	Urabe, Jotaro/0000-0001-5111-687X; Urabe, Jotaro/0000-0001-5111-687X	Mitsui & Co., Ltd. Environment Fund [F11-F1-020]; Tohoku Ecosystem-Associated Marine Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [24570018] Funding Source: KAKEN	Mitsui & Co., Ltd. Environment Fund; Tohoku Ecosystem-Associated Marine Science; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by Mitsui & Co., Ltd. Environment Fund (F11-F1-020), and research project funds, Tohoku Ecosystem-Associated Marine Science, from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balthis WL, 2006, ENVIRON MONIT ASSESS, V119, P367, DOI 10.1007/s10661-005-9031-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cyranoski D, 2012, NATURE, V483, P141, DOI 10.1038/483141a; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; Fujioka Y, 2008, P 11 INT COR REEF S, P1225; Jan FGBL, 2007, SEDIMENT GEOL, V199, P1, DOI 10.1016/j.sedgeo.2006.12.007; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; Kanaya Gen, 2012, Japanese Journal of Benthology, V67, P20; Kanaya G, 2011, ESTUAR COAST SHELF S, V92, P169, DOI 10.1016/j.ecss.2010.12.029; Krishnankutty N, 2006, CURR SCI INDIA, V90, P772; Legendre P., 1998, NUMERICAL ECOLOGY; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; Mallin MA, 1999, ECOL APPL, V9, P350, DOI 10.1890/1051-0761(1999)009[0350:HEOWQA]2.0.CO;2; Mori N, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500015; Noda A, 2007, SEDIMENT GEOL, V200, P314, DOI 10.1016/j.sedgeo.2007.01.010; Norio O, 2011, INT J DISAST RISK SC, V2, P34, DOI 10.1007/s13753-011-0004-9; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schlacher TA, 2011, ESTUAR COAST, V34, P937, DOI 10.1007/s12237-010-9354-6; Suzuki Takao, 2010, Plankton & Benthos Research, V5, P221; Thibault KM, 2008, P NATL ACAD SCI USA, V105, P3410, DOI 10.1073/pnas.0712282105; Whanpetch N, 2010, ESTUAR COAST SHELF S, V87, P246, DOI 10.1016/j.ecss.2010.01.001	21	65	66	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62779	10.1371/journal.pone.0062779	http://dx.doi.org/10.1371/journal.pone.0062779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650529	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000074
J	Wolff, JO; Nentwig, W; Gorb, SN				Wolff, Jonas O.; Nentwig, Wolfgang; Gorb, Stanislav N.			The Great Silk Alternative: Multiple Co-Evolution of Web Loss and Sticky Hairs in Spiders	PLOS ONE			English	Article							ARANEAE; EVOLUTION; SENSILLA; CAPTURE	Spiders are the most important terrestrial predators among arthropods. Their ecological success is reflected by a high biodiversity and the conquest of nearly every terrestrial habitat. Spiders are closely associated with silk, a material, often seen to be responsible for their great ecological success and gaining high attention in life sciences. However, it is often overlooked that more than half of all Recent spider species have abandoned web building or never developed such an adaptation. These species must have found other, more economic solutions for prey capture and retention, compensating the higher energy costs of increased locomotion activity. Here we show that hairy adhesive pads (scopulae) are closely associated with the convergent evolution of a vagrant life style, resulting in highly diversified lineages of at least, equal importance as the derived web building taxa. Previous studies often highlighted the idea that scopulae have the primary function of assisting locomotion, neglecting the fact that only the distal most pads (claw tufts) are suitable for those purposes. The former observations, that scopulae are used in prey capture, are largely overlooked. Our results suggest the scopulae evolved as a substitute for silk in controlling prey and that the claw tufts are, in most cases, a secondary development. Evolutionary trends towards specialized claw tufts and their composition from a low number of enlarged setae to a dense array of slender ones, as well as the secondary loss of those pads are discussed further. Hypotheses about the origin of the adhesive setae and their diversification throughout evolution are provided.	[Wolff, Jonas O.; Gorb, Stanislav N.] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Nentwig, Wolfgang] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland	University of Kiel; University of Bern	Wolff, JO (corresponding author), Univ Kiel, Inst Zool, D-24098 Kiel, Germany.	jwolff@zoologie.uni-kiel.de	Nentwig, Wolfgang/A-6624-2011	Wolff, Jonas/0000-0003-2326-0326	German Science Foundation (DFG) Initiative "Bionik" [GO995/7-1]	German Science Foundation (DFG) Initiative "Bionik"(German Research Foundation (DFG))	This work was supported by the German Science Foundation (DFG) Initiative "Bionik" (DFG grant GO995/7-1 to SNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2013, J ZOOL SYST EVOL RES, V51, P100, DOI 10.1111/jzs.12007; Alderweireldt M, 2005, ACTA ZOOL BULGAR, V2005, P125; Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; Briceno RD, 2012, NATURWISSENSCHAFTEN, V99, P337, DOI 10.1007/s00114-012-0901-9; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Coddington JA, 2005, SPIDERS N AM IDENTIF, P18; Dunlop JA, 1995, NETH J ZOOL, V45, P513; FOELIX R, 1984, Revue Arachnologique, V5, P329; Foelix R. F, 2011, BIOL SPIDERS; Foelix R.F., 1975, P 6 INT AR C 1974, P156; FOELIX RF, 1970, J EXP ZOOL, V175, P99, DOI 10.1002/jez.1401750106; FORSTER RR, 1970, SPIDERS NZ 3; Gamble C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039429, 10.1371/journal.pone.0035982]; Gasparetto A, 2008, 066201 EUR SPAC AG A; Gertsch W.J., 1975, American Museum Novitates, VNo. 2580, P1; Gorb SN, 2001, NATURWISSENSCHAFTEN, V88, P530, DOI 10.1007/s00114-001-0274-y; Hawthorn AC, 2003, J EXP BIOL, V206, P3905, DOI 10.1242/jeb.00618; HENSCHEL JR, 1995, J NAT HIST, V29, P137, DOI 10.1080/00222939500770071; Hill DE, 2006, JUMPING SPIDER FEET, P1; HOMANN H, 1957, NATURWISSENSCHAFTEN, V44, P318, DOI 10.1007/BF00630926; Jager P, 2012, ARACHN MITT, V43, P5; Jeffree CE, 1986, INSECTS PLANT SURFAC, P23; Joque R., 2007, SPIDER FAMILIES WORL; Kesel AB, 2003, J EXP BIOL, V206, P2733, DOI 10.1242/jeb.00478; Li YS, 2012, ROBOTICA, V30, P79, DOI 10.1017/S0263574711000373; Logunov Dmitri V., 1996, Bulletin of the British Arachnological Society, V10, P171; Maddison W.P., 2008, MESQUITE MODULAR SYS; MELCHERS MECHTHILD, 1967, Z MORPHOL OKOL TIERE, V58, P321, DOI 10.1007/BF00407384; Miller G.L., 1988, Bulletin of the British Arachnological Society, V7, P213; NENTWIG W, 1986, OECOLOGIA, V68, P595, DOI 10.1007/BF00378777; Nentwig W, 2012, ARANEAE SPIDERS EURO; Nentwig W, 2013, SPIDER ECOP IN PRESS; Niederegger S, 2006, J COMP PHYSIOL A, V192, P1223, DOI 10.1007/s00359-006-0157-y; Opell B, 2008, BIOL J LINN SOC, V62, P443; Peattie AM, 2007, P NATL ACAD SCI USA, V104, P18595, DOI 10.1073/pnas.0707591104; Peattie AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020485; Pekar S, 2011, NATURWISSENSCHAFTEN, V98, P593, DOI 10.1007/s00114-011-0804-1; PENNEY D, 2011, MONOGRAPH SERIES, V1; PEREZMILES F, 1994, J ARACHNOL, V22, P46; Platnick N.I., 1975, American Museum Novitates, VNo. 2575, P1; Platnick NI, 2012, WORLD SPIDER CATLOG; PRESTWICH KN, 1977, COMP BIOCHEM PHYS A, V57, P321, DOI 10.1016/0300-9629(77)90199-2; Pretto I, 2008, J BIONIC ENG, V5, P98, DOI 10.1016/S1672-6529(08)60079-7; Pugno N., 2011, PHYS PROPERTIES CERA, P111; R Development Core Team, 2011, R LANG ENV STAT COMP; RAVEN RJ, 1986, J ARACHNOL, V14, P357; Roscoe D.T., 1991, Bulletin of the British Arachnological Society, V8, P224; Rovner J.S., 1978, Symposia of the Zoological Society of London, P99; ROVNER JS, 1980, J ARACHNOL, V8, P201; Sahni V, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1019; Sameoto D, 2014, J ADHES SCI TECHNOL, V28, P354, DOI 10.1080/01694243.2012.693809; SPECK J, 1982, J COMP PHYSIOL, V148, P187, DOI 10.1007/BF00619125; TANAKA K, 1989, OECOLOGIA, V81, P459, DOI 10.1007/BF00378952; TURNBULL AL, 1973, ANNU REV ENTOMOL, V18, P305, DOI 10.1146/annurev.en.18.010173.001513; Ubick D, 2005, J ARACHNOL, V33, P63, DOI 10.1636/H03-24; Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221; Wolff JO, 2013, SCI REP IN PRESS; Wolff JO, 2012, ARTHROPOD STRUCT DEV, V41, P419, DOI 10.1016/j.asd.2012.04.004; Wolff JO, 2012, J EXP BIOL, V215, P179, DOI 10.1242/jeb.061507	61	38	39	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62682	10.1371/journal.pone.0062682	http://dx.doi.org/10.1371/journal.pone.0062682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650526	Green Published, gold			2022-12-27	WOS:000319167000071
J	Yu, Y; Wang, YS; Tong, Q; Liu, X; Su, F; Quan, FS; Guo, ZK; Zhang, Y				Yu, Yuan; Wang, Yongsheng; Tong, Qi; Liu, Xu; Su, Feng; Quan, Fusheng; Guo, Zekun; Zhang, Yong			A Site-Specific Recombinase-Based Method to Produce Antibiotic Selectable Marker Free Transgenic Cattle	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; PHAGE PHI-C31 INTEGRASE; PLURIPOTENT STEM-CELLS; NUCLEAR TRANSFER EMBRYOS; IN-VITRO DEVELOPMENT; CRE RECOMBINASE; STAPHYLOCOCCUS-AUREUS; HUMAN BETA-DEFENSIN-3; MAMMALIAN-CELLS; GENE-EXPRESSION	Antibiotic selectable marker genes have been widely used to generate transgenic animals. Once transgenic animals have been obtained, the selectable marker is no longer necessary but raises public concerns regarding biological safety. The aim of this study was to prepare competent antibiotic selectable marker free transgenic cells for somatic cell nuclear transfer (SCNT). PhiC31 intergrase was used to insert a transgene cassette into a "safe harbor'' in the bovine genome. Then, Cre recombinase was employed to excise the selectable marker under the monitoring of a fluorescent double reporter. By visually tracking the phenotypic switch from red to green fluorescence, antibiotic selectable marker free cells were easily detected and sorted by fluorescence-activated cell sorting. For safety, we used phiC31 mRNA and cell-permeant Cre protein in this study. When used as donor nuclei for SCNT, these safe harbor integrated marker-free transgenic cells supported a similar developmental competence of SCNT embryos compared with that of non-transgenic cells. After embryo transfer, antibiotic selectable marker free transgenic cattle were generated and anti-bacterial recombinant human b-defensin-3 in milk was detected during their lactation period. Thus, this approach offers a rapid and safe alternative to produce antibiotic selectable marker free transgenic farm animals, thereby making it a valuable tool to promote the healthy development and welfare of transgenic farm animals.	[Yu, Yuan; Wang, Yongsheng; Tong, Qi; Liu, Xu; Su, Feng; Quan, Fusheng; Guo, Zekun; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	zhangynwsuaf@gmail.com	Yu, Yuan/ABI-3655-2020; Zhang, Yong/K-7945-2016	Zhang, Yong/0000-0001-8642-4071	National Major Project for Production of Transgenic Breeding [2011ZX08007- 004]; National High Technology Research and Development Program of China (863 Program) [2011AA100303]	National Major Project for Production of Transgenic Breeding; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National Major Project for Production of Transgenic Breeding (No. 2011ZX08007- 004) and the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arat S, 2002, BIOL REPROD, V66, P1768, DOI 10.1095/biolreprod66.6.1768; Baba Y, 2005, MICROBIOL IMMUNOL, V49, P559, DOI 10.1111/j.1348-0421.2005.tb03753.x; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Bannerman DD, 2004, CLIN DIAGN LAB IMMUN, V11, P463, DOI 10.1128/CDLI.11.3.463-472.2004; Batchelder CA, 2005, CLONING STEM CELLS, V7, P238, DOI 10.1089/clo.2005.7.238; Bhak JS, 2006, ANIM REPROD SCI, V92, P37, DOI 10.1016/j.anireprosci.2005.04.016; Bordignon V, 2003, BIOL REPROD, V68, P2013, DOI 10.1095/biolreprod.102.010066; Brophy B, 2003, NAT BIOTECHNOL, V21, P157, DOI 10.1038/nbt783; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chen SH, 2002, BIOL REPROD, V67, P1488, DOI 10.1095/biolreprod.102.006981; Chen XJ, 2005, J DERMATOL SCI, V40, P123, DOI 10.1016/j.jdermsci.2005.03.014; Clark AJ, 1997, NUCLEIC ACIDS RES, V25, P1009, DOI 10.1093/nar/25.5.1009; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Dobie KW, 1996, P NATL ACAD SCI USA, V93, P6659, DOI 10.1073/pnas.93.13.6659; Dunsche A, 2002, EUR J ORAL SCI, V110, P121, DOI 10.1034/j.1600-0722.2002.11186.x; Edwards JL, 2003, AM J REPROD IMMUNOL, V50, P113, DOI 10.1034/j.1600-0897.2003.00064.x; Endo S, 2002, PLANT J, V30, P115, DOI 10.1046/j.1365-313X.2002.01272.x; Gorman C, 2000, CURR OPIN BIOTECH, V11, P455, DOI 10.1016/S0958-1669(00)00127-0; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Heyman Y., 2002, Cloning and Stem Cells, V4, P47, DOI 10.1089/153623002753632048; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Huang SS, 2004, TRANSGENIC RES, V13, P451, DOI 10.1007/s11248-004-1453-3; Huber RC, 2011, TRANSGENIC RES; Hyun S, 2003, BIOL REPROD, V69, P1060, DOI 10.1095/biolreprod.102.014886; Iamtham S, 2000, NAT BIOTECHNOL, V18, P1172, DOI 10.1038/81161; Ishikawa Y, 2006, J GENE MED, V8, P646, DOI 10.1002/jgm.891; Joly S, 2004, J CLIN MICROBIOL, V42, P1024, DOI 10.1128/JCM.42.3.1024-1029.2004; Jura J, 2007, J ANIM FEED SCI, V16, P636, DOI 10.22358/jafs/66820/2007; Karow M, 2011, STEM CELLS, V29, P1696, DOI 10.1002/stem.730; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; Kind A, 2008, TRANSGENIC RES, V17, P1025, DOI 10.1007/s11248-008-9206-3; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Krepulat F, 2005, ONCOGENE, V24, P4645, DOI 10.1038/sj.onc.1208557; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Li B, 2010, J BIOTECHNOL, V145, P206, DOI 10.1016/j.jbiotec.2009.11.010; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Lim KT, 2007, THERIOGENOLOGY, V67, P293, DOI 10.1016/j.theriogenology.2006.07.011; Liu J, 2006, GENE THER, V13, P1188, DOI 10.1038/sj.gt.3302789; Liu J, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-31; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Ma QW, 2006, BIOCHEM BIOPH RES CO, V345, P984, DOI 10.1016/j.bbrc.2006.04.145; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; Midorikawa K, 2003, INFECT IMMUN, V71, P3730, DOI 10.1128/IAI.71.7.3730-3739.2003; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Nolden L, 2006, NAT METHODS, V3, P461, DOI 10.1038/NMETH884; Oback Bjorn, 2002, Cloning and Stem Cells, V4, P147, DOI 10.1089/153623002320253328; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Ou HL, 2009, FEBS J, V276, P155, DOI 10.1111/j.1742-4658.2008.06762.x; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Pilbrough W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008432; Qu LJ, 2012, J GENET GENOMICS, V39, P217, DOI 10.1016/j.jgg.2012.03.004; Quenneville SP, 2004, MOL THER, V10, P679, DOI 10.1016/j.ymthe.2004.05.034; Ramirez A, 2001, GENETICS, V158, P341; Rizos D, 2005, THERIOGENOLOGY, V63, P939, DOI 10.1016/j.theriogenology.2004.05.008; Roh S, 2000, REPROD FERT DEVELOP, V12, P1, DOI 10.1071/RD00021; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sendai Y, 2006, TRANSPLANTATION, V81, P760, DOI 10.1097/01.tp.0000190422.66657.f1; Shin MR, 2002, MOL REPROD DEV, V62, P74, DOI 10.1002/mrd.10069; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; TAKAHASHI Y, 1992, THERIOGENOLOGY, V37, P963, DOI 10.1016/0093-691X(92)90096-A; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; VANDEURSEN J, 1995, P NATL ACAD SCI USA, V92, P7376, DOI 10.1073/pnas.92.16.7376; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang S, 2009, THERIOGENOLOGY, V72, P535, DOI 10.1016/j.theriogenology.2009.04.009; Wang YS, 2011, CELL REPROGRAM, V13, P297, DOI 10.1089/cell.2010.0098; Wheeler MB, 2007, TRENDS BIOTECHNOL, V25, P204, DOI 10.1016/j.tibtech.2007.03.006; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wuensch A, 2007, BIOL REPROD, V76, P983, DOI 10.1095/biolreprod.106.058776; Xu YY, 2008, GENE, V419, P70, DOI 10.1016/j.gene.2008.04.020; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Ye L, 2010, P NATL ACAD SCI USA, V107, P19467, DOI 10.1073/pnas.1012677107; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zakhartchenko V, 2001, MOL REPROD DEV, V60, P362, DOI 10.1002/mrd.1098; Zhang Y, 2009, TRANSGENIC RES, V18, P607, DOI 10.1007/s11248-009-9251-6	79	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62457	10.1371/journal.pone.0062457	http://dx.doi.org/10.1371/journal.pone.0062457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658729	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000046
J	Branchi, I; Santarelli, S; Capoccia, S; Poggini, S; D'Andrea, I; Cirulli, F; Alleva, E				Branchi, Igor; Santarelli, Sara; Capoccia, Sara; Poggini, Silvia; D'Andrea, Ivana; Cirulli, Francesca; Alleva, Enrico			Antidepressant Treatment Outcome Depends on the Quality of the Living Environment: A Pre-Clinical Investigation in Mice	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; DEPRESSION-LIKE BEHAVIORS; ELEMENT-BINDING PROTEIN; CHRONIC FLUOXETINE; MESSENGER-RNA; SOCIOECONOMIC-STATUS; TREATMENT RESPONSE; RAT-BRAIN; STRESS; EXPRESSION	Antidepressants represent the standard treatment for major depression. However, their efficacy is variable and incomplete. A growing number of studies suggest that the environment plays a major role in determining the efficacy of these drugs, specifically of selective serotonin reuptake inhibitors (SSRI). A recent hypothesis posits that the increase in serotonin levels induced by SSRI may not affect mood per se, but enhances neural plasticity and, consequently, renders the individual more susceptible to the influence of the environment. Thus, SSRI administration in a favorable environment would lead to a reduction of symptoms, while in a stressful environment might lead to a worse prognosis. To test this hypothesis, we treated C57BL/6 adult male mice with chronic fluoxetine while exposing them to either (i) an enriched environment, after exposure to a chronic stress period aimed at inducing a depression-like phenotype, or (ii) a stressful environment. Anhedonia, brain BDNF and circulating corticosterone levels, considered endophenotypes of depression, were investigated. Mice treated with fluoxetine in an enriched condition improved their depression-like phenotype compared to controls, displaying higher saccharin preference, higher brain BDNF levels and reduced corticosterone levels. By contrast, when chronic fluoxetine administration occurred in a stressful condition, mice showed a more distinct worsening of the depression-like profile, displaying a faster decrease of saccharin preference, lower brain BDNF levels and increased corticosterone levels. Our findings suggest that the effect of SSRI on depression-like phenotypes in mice is not determined by the drug per se but is induced by the drug and driven by the environment. These findings may be helpful to explain variable effects of SSRI found in clinical practice and to device strategies aimed at enhancing their efficacy by means of controlling environmental conditions.	[Branchi, Igor; Santarelli, Sara; Capoccia, Sara; Poggini, Silvia; Cirulli, Francesca; Alleva, Enrico] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Branchi, Igor] Univ Zurich, Inst Anat, Zurich, Switzerland; [D'Andrea, Ivana] Neuromed Insitute Technol Pk, Dept Neuro & Cardiovasc Pathol, Pozzilli, Italy	Istituto Superiore di Sanita (ISS); University of Zurich; IRCCS Neuromed	Branchi, I (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	branchi@iss.it	Cirulli, Francesca/B-1581-2013; Poggini, Silvia/H-9286-2018; Branchi, Igor/N-9897-2017	Cirulli, Francesca/0000-0001-9440-1873; Poggini, Silvia/0000-0002-3711-3725; Branchi, Igor/0000-0003-4484-3598; Alleva, Enrico/0000-0002-9633-7657	Italian Ministry of Health; EU; Marie Curie IEF fellowship [302881 - Acronym: MODELMOOD]	Italian Ministry of Health(Ministry of Health, Italy); EU(European Commission); Marie Curie IEF fellowship(European Commission)	Funding for this study was provided by the Italian Ministry of Health, Ricerca Finalizzata 2009, Fasc. 12AF to FC and Ricerca Finalizzata 2008, Fasc. 10BF to EA, and Fondazione Veronesi 2012 to FC. IB was supported by EU, Marie Curie IEF fellowship for Experienced Researcher n: 302881 - Acronym: MODELMOOD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alboni S, 2010, EUR J PHARMACOL, V643, P180, DOI 10.1016/j.ejphar.2010.06.028; Altieri M, 2004, BRAIN RES, V1000, P148, DOI 10.1016/j.brainres.2003.12.028; Anacker C, 2011, PSYCHONEUROENDOCRINO, V36, P415, DOI 10.1016/j.psyneuen.2010.03.007; Angell M, 2008, JAMA-J AM MED ASSOC, V300, P1069, DOI 10.1001/jama.300.9.1069; Balak N, 2007, EUR J NEUROL, V14, pE9, DOI 10.1111/j.1468-1331.2006.01570.x; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Berry A, 2012, PSYCHONEUROENDOCRINO, V37, P762, DOI 10.1016/j.psyneuen.2011.09.007; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Branchi I, 2011, PSYCHONEUROENDOCRINO, V36, P339, DOI 10.1016/j.psyneuen.2010.08.011; Branchi I, 2010, PSYCHONEUROENDOCRINO, V35, P743, DOI 10.1016/j.psyneuen.2009.10.016; Brenes JC, 2009, BEHAV BRAIN RES, V198, P199, DOI 10.1016/j.bbr.2008.10.036; Brummett BH, 2008, BEHAV GENET, V38, P34, DOI 10.1007/s10519-007-9172-1; Chourbaji S, 2012, NEUROSCIENCE, V220, P267, DOI 10.1016/j.neuroscience.2012.06.016; Chourbaji S, 2008, STRESS, V11, P170, DOI 10.1080/10253890701560119; Chourbaji S, 2011, NEUROSCI BIOBEHAV R, V35, P599, DOI 10.1016/j.neubiorev.2010.07.003; Cirulli F, 2009, FRONT NEUROENDOCRIN, V30, P379, DOI 10.1016/j.yfrne.2009.05.002; Cohen A, 2006, ARCH GEN PSYCHIAT, V63, P50, DOI 10.1001/archpsyc.63.1.50; Cohen A, 2009, SOC PSYCH PSYCH EPID, V44, P272, DOI 10.1007/s00127-008-0436-8; Conti AC, 2002, J NEUROSCI, V22, P3262, DOI 10.1523/JNEUROSCI.22-08-03262.2002; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Feifel David, 2008, Psychiatry (Edgmont), V5, P35; Fountoulakis KN, 2011, INT J NEUROPSYCHOPH, V14, P405, DOI 10.1017/S1461145710000957; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Goekint M, 2011, NEUROSCI LETT, V494, P150, DOI 10.1016/j.neulet.2011.03.001; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hellweg R, 2008, PHARMACOPSYCHIATRY, V41, P66, DOI 10.1055/s-2007-1004594; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Homberg JR, 2012, BEHAV BRAIN SCI, V35, P368, DOI 10.1017/S0140525X1200101X; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Jacobsen JPR, 2006, BRAIN RES, V1110, P221, DOI 10.1016/j.brainres.2006.06.077; Jacobsen JPR, 2004, BRAIN RES, V1024, P183, DOI 10.1016/j.brainres.2004.07.065; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; Kirsch I, 2010, EMPERORS NEW DRUGS E; Kirsch I, 2002, PREV TREAT, V5; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kiser D, 2011, NEUROSCI BIOBEHAV RE; Knapska E, 2006, LEARN MEMORY, V13, P192, DOI 10.1101/lm.54706; Kozisek ME, 2008, PHARMACOL THERAPEUT, V117, P30, DOI 10.1016/j.pharmthera.2007.07.001; Kramer, 1994, LISTENING PROZAC PSY; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McAllister-Williams RH, 2008, EVID-BASED MENT HEAL, V11, P66, DOI 10.1136/ebmh.11.3.66; Mechan AO, 2009, J NEUROSCI METH, V180, P43, DOI 10.1016/j.jneumeth.2009.02.018; Miro X, 2002, NEUROPHARMACOLOGY, V43, P1148, DOI 10.1016/S0028-3908(02)00220-4; Moncrieff J, 2005, BMJ-BRIT MED J, V331, P155, DOI 10.1136/bmj.331.7509.155; Moncrieff J, 2003, INT J METH PSYCH RES, V12, P117, DOI 10.1002/mpr.148; Moncrieff J, 2005, COCHRANE LIB, P4; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Nibuya M, 1996, J NEUROSCI, V16, P2365; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Pariante CM, 2004, PSYCHONEUROENDOCRINO, V29, P423, DOI 10.1016/j.psyneuen.2003.10.009; Prendergast Mark A, 2002, Med Sci Monit, V8, pBR385; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Rygula R, 2006, BEHAV PHARMACOL, V17, P19, DOI 10.1097/01.fbp.0000186631.53851.71; Sammut S, 2002, PHYSIOL BEHAV, V75, P765, DOI 10.1016/S0031-9384(02)00677-7; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shen QY, 2010, BIOL PSYCHIAT, V68, P512, DOI 10.1016/j.biopsych.2010.04.024; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Tonissaar M, 2008, PROG NEURO-PSYCHOPH, V32, P164, DOI 10.1016/j.pnpbp.2007.08.001; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Uys JDK, 2006, NEUROSCIENCE, V137, P619, DOI 10.1016/j.neuroscience.2005.08.089; Weber CC, 2006, NEUROPSYCHOPHARMACOL, V31, P2443, DOI 10.1038/sj.npp.1301076; Wiles N., 2012, LANCET; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; World Health Organization, 2010, EQUI HLTH; World Health Organization, 2008, GLOB BURD DIS 2004 U; Zetterstrom TSC, 1999, NEUROPHARMACOLOGY, V38, P1063, DOI 10.1016/S0028-3908(99)00022-2	72	68	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62226	10.1371/journal.pone.0062226	http://dx.doi.org/10.1371/journal.pone.0062226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23653679	Green Submitted, Green Published, gold			2022-12-27	WOS:000319077300031
J	Lombardi, G; Lanteri, P; Fiorella, PL; Simonetto, L; Impellizzeri, FM; Bonifazi, M; Banfi, G; Locatelli, M				Lombardi, Giovanni; Lanteri, Patrizia; Fiorella, Pier Luigi; Simonetto, Luigi; Impellizzeri, Franco M.; Bonifazi, Marco; Banfi, Giuseppe; Locatelli, Massimo			Comparison of the Hematological Profile of Elite Road Cyclists during the 2010 and 2012 GiroBio Ten-Day Stage Races and Relationships with Final Ranking	PLOS ONE			English	Article							IMMATURE RETICULOCYTE FRACTION; DETECT ERYTHROPOIETIN ABUSE; PROFESSIONAL CYCLISTS; HEMOGLOBIN MASS; VALUES; PARAMETERS; STABILITY; MARKERS	Cycling stage races are strenuous endurance events during which exercise-induced variations in hematological parameters are consistently observed. However, specific literature on such changes is scarce and published data have been derived from small samples of athletes. The aims of this study were: (1) to determine the hematological response to middle-term strenuous endurance; and (2) to determine whether a relationship exists between the athlete-specific hematological profile and final placement in a cycling stage race. The study population was male professional cyclists (n = 253) competing in the 2010 (n = 144) and 2012 (n = 109) GiroBio 10-day stage races. Blood draws taken before the start of the race, at mid-race, and at end-race were performed in strict compliance with academic and anti-doping pre-analytical warnings. Blood chemistry included white blood cell, red blood cell, hemoglobin concentration, hematocrit, mean corpuscular volume (MCV), mean hemoglobin content (MCH), mean corpuscular hemoglobin content (MCHC), platelets, and reticulocyte relative and absolute counts. Compared to baseline values, erythrocyte, hemoglobin, hematocrit, MCHC, platelet and reticulocyte counts were all consistently lower at mid-race, but returned to normal by race-end, while leukocytes were increased in the final phase. MCV increased during both events. MCH increased in the first part to then return to baseline in the 2012 race. The calculated OFF-score consistently decreased in the first half of the race before increasing, but remained lower than the baseline value. The trends of variation in hematological parameters were substantially similar in both events. There was an inverse, albeit weak, relationship between placement and erythrocyte, platelet, hemoglobin, hematocrit and OFF-score values in the 2010, but not in the 2012 race. In conclusion, the data confirm that, in this large series of elite road cyclists, the strenuous effort a rider sustains during a stage race induces appreciable changes in the hematological profile.	[Lombardi, Giovanni; Lanteri, Patrizia; Banfi, Giuseppe] IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Milan, Italy; [Fiorella, Pier Luigi; Simonetto, Luigi; Impellizzeri, Franco M.] Commiss Tutela Salute Federaz Ciclist Italiana, Rome, Italy; [Bonifazi, Marco] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy; [Banfi, Giuseppe] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Locatelli, Massimo] Univ Milan, Osped San Raffaele, I-20127 Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; University of Siena; University of Milan; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Lombardi, G (corresponding author), IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Milan, Italy.	giovanni.lombardi@grupposandonato.it	Lombardi, Giovanni/I-2414-2012; Impellizzeri, Franco M./M-6980-2019; Banfi, Giuseppe/K-6585-2015	Lombardi, Giovanni/0000-0002-8365-985X; Impellizzeri, Franco M./0000-0002-1703-2573; Banfi, Giuseppe/0000-0001-9578-5338; Bonifazi, Marco/0000-0001-6937-9109	Presidenza del Consiglio dei Ministri - Dipartimento per le politiche giovanili e le attivita sportive	Presidenza del Consiglio dei Ministri - Dipartimento per le politiche giovanili e le attivita sportive	This research was supported by the Presidenza del Consiglio dei Ministri - Dipartimento per le politiche giovanili e le attivita sportive. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altehoefer C, 2002, J MAGN RESON IMAGING, V16, P284, DOI 10.1002/jmri.10157; Banfi G, 2004, CLIN LAB HAEMATOL, V26, P241, DOI 10.1111/j.1365-2257.2004.00610.x; Banfi G, 2003, J SPORT MED PHYS FIT, V43, P223; Banfi G, 2008, SPORTS MED, V38, P187, DOI 10.2165/00007256-200838030-00002; Banfi G, 2011, CLIN CHEM LAB MED, V49, P1417, DOI 10.1515/CCLM.2011.633; Banfi G, 2011, EUR J APPL PHYSIOL, V111, P9, DOI 10.1007/s00421-010-1641-1; CAMPANINI S, 1988, HAEMATOLOGICA, V73, P111; Corsetti R, 2012, CLIN CHEM LAB MED, V50, P949, DOI 10.1515/cclm-2011-0857; Garvican LA, 2010, CLIN J SPORT MED, V20, P200, DOI 10.1097/JSM.0b013e3181ddcd5b; Gore CJ, 2003, HAEMATOLOGICA, V88, P333; GORE CJ, 2012, CLIN CHEM LAB MED; Hue O, 2006, INT J SPORTS MED, V27, P690, DOI 10.1055/s-2005-872919; Lentillon-Kaestner V, 2012, SCAND J MED SCI SPOR, V22, P596, DOI 10.1111/j.1600-0838.2010.01281.x; LOMBARDI G, 2013, CLIN CHEM LAB MED; LOMBARDI G, 2012, BLOOD TRANS IN PRESS; Lombardi G, 2013, ADV CLIN CHEM, V59, P125, DOI 10.1016/B978-0-12-405211-6.00005-X; Lombardi G, 2011, SPORTS MED, V41, P1033, DOI 10.2165/11591460-000000000-00000; Marotte H, 2009, ANN RHEUM DIS, V68, P1197, DOI 10.1136/ard.2008.096057; Mercer KW, 2005, CLIN SPORT MED, V24, P599, DOI 10.1016/j.csm.2005.03.006; MERCER KW, 2005, CLIN SPORTS MED, V24, pR9; Morkeberg JS, 2009, INT J SPORTS MED, V30, P130, DOI 10.1055/s-2008-1038842; Nadarajan VS, 2010, INT J LAB HEMATOL, V32, P82, DOI 10.1111/j.1751-553X.2008.01132.x; Parisotto R, 2000, HAEMATOLOGICA, V85, P564; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Saris WHM, 1998, LANCET, V352, P1758, DOI 10.1016/S0140-6736(05)79832-9; Schmidt W, 2000, INT J SPORTS MED, V21, P133, DOI 10.1055/s-2000-8871; Schumacher YO, 2008, INT J SPORTS MED, V29, P372, DOI 10.1055/s-2007-965335; Schumacher YO, 2010, DRUG TEST ANAL, V2, P469, DOI 10.1002/dta.180; Sebastian-Gambaro MA, 1997, EUR J CLIN CHEM CLIN, V35, P845; Sharpe K, 2006, HAEMATOLOGICA, V91, P356; Sottas P-E., 2008, LAW PROBAB RISK, V7, P191, DOI [DOI 10.1093/LPR/MGM042, 10.1093/lpr/mgm042]; Sottas PE, 2011, CLIN CHEM, V57, P969, DOI 10.1373/clinchem.2011.162271; *UCI, UCI ANT PROC GUID 7; WADA, 2011, REQ PASSP OP INT STA	34	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63092	10.1371/journal.pone.0063092	http://dx.doi.org/10.1371/journal.pone.0063092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646180	gold, Green Published			2022-12-27	WOS:000319077300135
J	Chandler, JA; James, PM				Chandler, James Angus; James, Pamela M.			Discovery of Trypanosomatid Parasites in Globally Distributed Drosophila Species	PLOS ONE			English	Article							INSECT TRYPANOSOMATIDS; COSTA-RICA; HETEROPTERA; WOLBACHIA; DENGUE; MODEL; DIVERSITY; EVOLUTION; INFECTION; SYMBIONT	Microbial parasites of animals include bacteria, viruses, and various unicellular eukaryotes. Because of the difficulty in studying these microorganisms in both humans and disease vectors, laboratory models are commonly used for experimental analysis of host-parasite interactions. Drosophila is one such model that has made significant contributions to our knowledge of bacterial, fungal, and viral infections. Despite this, less is known about other potential parasites associated with natural Drosophila populations. Here, we surveyed sixteen Drosophila populations comprising thirteen species from four continents and Hawaii and found that they are associated with an extensive diversity of trypanosomatids (Euglenozoa, Kinetoplastea). Phylogenetic analysis finds that Drosophila-associated trypanosomatids are closely related to taxa that are responsible for various types of leishmaniases and more distantly related to the taxa responsible for human African trypanosomiasis and Chagas disease. We suggest that Drosophila may provide a powerful system for studying the interactions between trypanosomatids and their hosts.	[Chandler, James Angus] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Chandler, JA (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	jschandler@ucdavis.edu			UC-Davis Center for Population Biology Graduate Student Research Award; UC-Davis President's Undergraduate Fellowship; NSF [IOS-0815141]; REU; Alfred P. Sloan Foundation grant	UC-Davis Center for Population Biology Graduate Student Research Award; UC-Davis President's Undergraduate Fellowship; NSF(National Science Foundation (NSF)); REU; Alfred P. Sloan Foundation grant	This work was supported by a UC-Davis Center for Population Biology Graduate Student Research Award to JAC, a UC-Davis President's Undergraduate Fellowship to PMJ, NSF grant IOS-0815141 and REU supplement to Artyom Kopp, and an Alfred P. Sloan Foundation grant to Jonathan A. Eisen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Boulanger N, 2001, INSECT BIOCHEM MOLEC, V31, P129, DOI 10.1016/S0965-1748(00)00096-5; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; Brandt SM, 2008, GENETICS, V180, P1671, DOI 10.1534/genetics.108.089748; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandler JA, 2012, APPL ENVIRON MICROB, V78, P7327, DOI 10.1128/AEM.01741-12; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chatton E, 1908, CR HEBD ACAD SCI, V64, P3; Crompton DWT, 2010, WORK OV GLOB IMP NEG, Vix; Ebbert MA, 2001, J INVERTEBR PATHOL, V77, P27, DOI 10.1006/jipa.2000.4989; Farikou O, 2010, INFECT GENET EVOL, V10, P115, DOI 10.1016/j.meegid.2009.10.008; FERNANDES AP, 1993, P NATL ACAD SCI USA, V90, P11608, DOI 10.1073/pnas.90.24.11608; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jirku M, 2012, J EUKARYOTIC MICROBI; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Maslov DA, 2007, J EUKARYOT MICROBIOL, V54, P57, DOI 10.1111/j.1550-7408.2006.00150.x; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; Maslov DA, 2010, J EUKARYOT MICROBIOL, V57, P177, DOI 10.1111/j.1550-7408.2009.00464.x; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Newman T, 2011, EXPERT OPIN DRUG DIS, V6, P129, DOI 10.1517/17460441.2011.549124; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Podlipaev S, 2001, INT J PARASITOL, V31, P648, DOI 10.1016/S0020-7519(01)00139-4; Podlipaev SA, 1990, LEN P ZOOL I USSR AC; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rogers GB, 2011, J CYST FIBROS, V10, P387, DOI 10.1016/j.jcf.2011.06.014; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWTON ED, 1978, J PROTOZOOL, V25, P232, DOI 10.1111/j.1550-7408.1978.tb04402.x; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; VICKERMAN K, 1988, BIOL CELL, V64, P109, DOI 10.1016/0248-4900(88)90070-6; Votypka J, 2012, PROTIST, V163, P616, DOI 10.1016/j.protis.2011.12.004; Votypka J, 2012, INT J PARASITOL, V42, P489, DOI 10.1016/j.ijpara.2012.03.007; Votypka J, 2010, MOL PHYLOGENET EVOL, V54, P243, DOI 10.1016/j.ympev.2009.10.014; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Westenberger SJ, 2004, PARASITOLOGY, V129, P537, DOI 10.1017/S003118200400592X; Wilfert L, 2011, PARASITOLOGY, V138, P858, DOI 10.1017/S0031182011000485; Yurchenko VY, 2006, PARASITOLOGY, V133, P537, DOI 10.1017/S0031182006000746	57	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61937	10.1371/journal.pone.0061937	http://dx.doi.org/10.1371/journal.pone.0061937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658617	gold, Green Submitted, Green Published			2022-12-27	WOS:000321662800017
J	Remenyi, J; van den Bosch, MWM; Palygin, O; Mistry, RB; McKenzie, C; Macdonald, A; Hutvagner, G; Arthur, JSC; Frenguelli, BG; Pankratov, Y				Remenyi, Judit; van den Bosch, Mirjam W. M.; Palygin, Oleg; Mistry, Rajen B.; McKenzie, Colin; Macdonald, Andrew; Hutvagner, Gyorgy; Arthur, J. Simon C.; Frenguelli, Bruno G.; Pankratov, Yuriy			miR-132/212 Knockout Mice Reveal Roles for These miRNAs in Regulating Cortical Synaptic Transmission and Plasticity	PLOS ONE			English	Article							COCAINE INTAKE; MICRORNA; CREB; MSK1; ACTIVATION; EXPRESSION; PHOSPHORYLATION; TRANSCRIPTION; HIPPOCAMPUS; GENERATION	miR-132 and miR-212 are two closely related miRNAs encoded in the same intron of a small non-coding gene, which have been suggested to play roles in both immune and neuronal function. We describe here the generation and initial characterisation of a miR-132/212 double knockout mouse. These mice were viable and fertile with no overt adverse phenotype. Analysis of innate immune responses, including TLR-induced cytokine production and IFN beta induction in response to viral infection of primary fibroblasts did not reveal any phenotype in the knockouts. In contrast, the loss of miR-132 and miR-212, while not overtly affecting neuronal morphology, did affect synaptic function. In both hippocampal and neocortical slices miR-132/212 knockout reduced basal synaptic transmission, without affecting paired-pulse facilitation. Hippocampal long-term potentiation (LTP) induced by tetanic stimulation was not affected by miR-132/212 deletion, whilst theta burst LTP was enhanced. In contrast, neocortical theta burst-induced LTP was inhibited by loss of miR-132/212. Together these results indicate that miR-132 and/or miR-212 play a significant role in synaptic function, possibly by regulating the number of postsynaptic AMPA receptors under basal conditions and during activity-dependent synaptic plasticity.	[Remenyi, Judit; Hutvagner, Gyorgy] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat, Dundee, Scotland; [van den Bosch, Mirjam W. M.; Arthur, J. Simon C.] Univ Dundee, MRC Prot Phosphorylat Unit, Coll Life Sci, Dundee, Scotland; [Palygin, Oleg; Mistry, Rajen B.; McKenzie, Colin; Frenguelli, Bruno G.; Pankratov, Yuriy] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Macdonald, Andrew] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Arthur, J. Simon C.] Univ Dundee, Div Cell Signalling & Immunol, Coll Life Sci, Dundee, Scotland	University of Dundee; University of Dundee; University of Warwick; University of Leeds; University of Dundee	Arthur, JSC (corresponding author), Univ Dundee, MRC Prot Phosphorylat Unit, Coll Life Sci, Dundee, Scotland.	j.s.c.arthur@dundee.ac.uk; B.G.Frenguelli@warwick.ac.uk; Y.Pankratov@warwick.ac.uk	Palygin, Oleg/AAT-3047-2020; Frenguelli, Bruno/C-5007-2015	Palygin, Oleg/0000-0002-3680-5527; Frenguelli, Bruno/0000-0001-7214-3172; Macdonald, Andrew/0000-0002-5978-4693; Arthur, Simon/0000-0002-8135-1958; Hutvagner, Gyorgy/0000-0002-7231-9446	Medical Research Council; Biotechnology and Biological Sciences Research Council; Wellcome Trust; European Union Sixth Framework Programme (FP6, SIROCCO); BBSRC [BB/F021445/1] Funding Source: UKRI; MRC [MC_U127081014] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F021445/1] Funding Source: researchfish; Medical Research Council [MC_U127081014] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); European Union Sixth Framework Programme (FP6, SIROCCO); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Medical Research Council, Biotechnology and Biological Sciences Research Council, Wellcome Trust and European Union Sixth Framework Programme (FP6, SIROCCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Clovis YM, 2012, DEVELOPMENT, V139, P3332, DOI 10.1242/dev.078063; Correa SAL, 2012, J NEUROSCI, V32, P13039, DOI 10.1523/JNEUROSCI.0930-12.2012; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; Delaney KR, 2002, CURR PROTOC NEUROSCI; Deplagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018645; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lambert TJ, 2011, PLOS ONE, V5; Lee HK, 2011, SEMIN CELL DEV BIOL, V22, P514, DOI 10.1016/j.semcdb.2011.06.007; Luikart BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019077; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Molnar V, 2012, CELL MOL LIFE SCI, V69, P793, DOI 10.1007/s00018-011-0786-3; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; O'Neill LAJ, 2009, IMMUNITY, V31, P854, DOI 10.1016/j.immuni.2009.11.004; Pankratov Y, 2007, J GEN PHYSIOL, V129, P257, DOI 10.1085/jgp.200609693; Pankratov YV, 2003, BIOPHYS J, V85, P3375, DOI 10.1016/S0006-3495(03)74757-2; Pathania M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038174; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tognini P, 2011, NAT NEUROSCI, V14, P1237, DOI 10.1038/nn.2920; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wingate AD, 2009, GENESIS, V47, P688, DOI 10.1002/dvg.20548; Zaragoza R, 2010, BIOCHEM J, V428, P451, DOI 10.1042/BJ20091091	48	103	106	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62509	10.1371/journal.pone.0062509	http://dx.doi.org/10.1371/journal.pone.0062509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658634	Green Published, gold, Green Submitted			2022-12-27	WOS:000318343700060
J	Spindler, MJ; Burmeister, BT; Huang, Y; Hsiao, EC; Salomonis, N; Scott, MJ; Srivastava, D; Carnegie, GK; Conklin, BR				Spindler, Matthew J.; Burmeister, Brian T.; Huang, Yu; Hsiao, Edward C.; Salomonis, Nathan; Scott, Mark J.; Srivastava, Deepak; Carnegie, Graeme K.; Conklin, Bruce R.			AKAP13 Rho-GEF and PKD-Binding Domain Deficient Mice Develop Normally but Have an Abnormal Response to beta-Adrenergic-Induced Cardiac Hypertrophy	PLOS ONE			English	Article							PROTEIN-KINASE-A; INDUCED CARDIOMYOCYTE HYPERTROPHY; EXCHANGE FACTOR AKAP13; ANCHORING PROTEIN; SIGNALING COMPLEX; CELL INVASIVENESS; HEART-FAILURE; BREAST-CANCER; RECEPTOR; MOUSE	Background: A-kinase anchoring proteins (AKAPs) are scaffolding molecules that coordinate and integrate G-protein signaling events to regulate development, physiology, and disease. One family member, AKAP13, encodes for multiple protein isoforms that contain binding sites for protein kinase A (PKA) and D (PKD) and an active Rho-guanine nucleotide exchange factor (Rho-GEF) domain. In mice, AKAP13 is required for development as null embryos die by embryonic day 10.5 with cardiovascular phenotypes. Additionally, the AKAP13 Rho-GEF and PKD-binding domains mediate cardiomyocyte hypertrophy in cell culture. However, the requirements for the Rho-GEF and PKD-binding domains during development and cardiac hypertrophy are unknown. Methodology/Principal Findings: To determine if these AKAP13 protein domains are required for development, we used gene-trap events to create mutant mice that lacked the Rho-GEF and/or the protein kinase D-binding domains. Surprisingly, heterozygous matings produced mutant mice at Mendelian ratios that had normal viability and fertility. The adult mutant mice also had normal cardiac structure and electrocardiograms. To determine the role of these domains during beta-adrenergic-induced cardiac hypertrophy, we stressed the mice with isoproterenol. We found that heart size was increased similarly in mice lacking the Rho-GEF and PKD-binding domains and wild-type controls. However, the mutant hearts had abnormal cardiac contractility as measured by fractional shortening and ejection fraction. Conclusions: These results indicate that the Rho-GEF and PKD-binding domains of AKAP13 are not required for mouse development, normal cardiac architecture, or beta-adrenergic-induced cardiac hypertrophic remodeling. However, these domains regulate aspects of beta-adrenergic-induced cardiac hypertrophy.	[Spindler, Matthew J.; Huang, Yu; Scott, Mark J.; Srivastava, Deepak; Conklin, Bruce R.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Spindler, Matthew J.; Conklin, Bruce R.] Univ Calif San Francisco, Grad Program Pharmaceut Sci & Pharmacogen, San Francisco, CA 94143 USA; [Burmeister, Brian T.; Carnegie, Graeme K.] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Hsiao, Edward C.] Univ Calif San Francisco, Dept Med, Div Endocrinol & Metab, San Francisco, CA USA; [Hsiao, Edward C.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Salomonis, Nathan] Calif Pacif Med Ctr Res Inst, San Francisco, CA USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Pacific Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Spindler, MJ (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA USA.	mspindler@gladstone.ucsf.edu	Conklin, Bruce/E-4738-2019	Conklin, Bruce/0000-0003-1463-6061	National Institutes of Health [RO1 HL60664, UO1 HL100406, 7 K08 AR056299-02, P01HL089707]; University of Illinois at Chicago Department of Cardiology [5T32HL072742-09]; American Heart Association Western States Predoctoral Fellowship [0715027Y]; National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences Grant [UL1TR000050]; California Institute of Regenerative Medicine; Younger Family Foundation; L.K. Whittier Foundation; Eugene Roddenberry Foundation; National Center for Research Resources [RR18928]; American Heart Association [11SDG5230003]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060664, T32HL072742, U01HL100406, P01HL089707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR056299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago Department of Cardiology; American Heart Association Western States Predoctoral Fellowship; National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences Grant; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Younger Family Foundation; L.K. Whittier Foundation; Eugene Roddenberry Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health grants RO1 HL60664 and UO1 HL100406 (to BRC), 7 K08 AR056299-02 (to ECH), and T32 Training Grant 5T32HL072742-09 through the University of Illinois at Chicago Department of Cardiology (BTB). Fellowship support was provided by the American Heart Association Western States Predoctoral Fellowship 0715027Y (to MJSpindler). GKC received funding from the American Heart Association Grant 11SDG5230003 and the National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences Grant UL1TR000050. DS received funding from the National Institutes of Health grant P01HL089707, the California Institute of Regenerative Medicine, the Younger Family Foundation, the L.K. Whittier Foundation and the Eugene Roddenberry Foundation. The J. David Gladstone Institutes received support from a National Center for Research Resources Grant RR18928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Azorsa DO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-25; Bonuccelli G, 2009, AM J PATHOL, V174, P1650, DOI 10.2353/ajpath.2009.080648; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Burmeister BT, 2012, J BIOL CHEM, V287, P40535, DOI 10.1074/jbc.M112.385641; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Edwards HV, 2012, BIOCHEM J, V446, P437, DOI 10.1042/BJ20120570; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Fujita P. A., 2010, NUCL ACIDS RES; Gelman IH, 2000, HISTOCHEM J, V32, P13, DOI 10.1023/A:1003950027529; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hu JK, 2010, CLIN EXP MED, V10, P41, DOI 10.1007/s10238-009-0065-x; Jaehnig EJ, 2006, MOL CELL BIOL, V26, P9315, DOI 10.1128/MCB.00482-06; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kino T, 2006, J BIOL CHEM, V281, P9118, DOI 10.1074/jbc.M509339200; Klingbeil P, 2001, MECH DEVELOP, V100, P323, DOI 10.1016/S0925-4773(00)00527-X; Klussmann E, 2001, FEBS LETT, V507, P264, DOI 10.1016/S0014-5793(01)02995-7; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; MCCARTNEY S, 1995, J BIOL CHEM, V270, P9327, DOI 10.1074/jbc.270.16.9327; McConnell BK, 2009, J BIOL CHEM, V284, P1583, DOI 10.1074/jbc.M806321200; Newhall KJ, 2006, CURR BIOL, V16, P321, DOI 10.1016/j.cub.2005.12.031; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Nuyens D, 2001, NAT MED, V7, P1021, DOI 10.1038/nm0901-1021; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; Porchia F, 2008, J RECEPT SIG TRANSD, V28, P265, DOI [10.1080/10799890802084515, 10.1080/10799890802084515 ]; Raeker MO, 2010, DEV BIOL, V337, P432, DOI 10.1016/j.ydbio.2009.11.018; Rawe VY, 2004, DEV BIOL, V276, P253, DOI 10.1016/j.ydbio.2004.07.043; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Shibolet O, 2007, J BIOL CHEM, V282, P35308, DOI 10.1074/jbc.M704426200; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Tanabe S, 2004, METHOD ENZYMOL, V390, P285; Tingley WG, 2007, P NATL ACAD SCI USA, V104, P8461, DOI 10.1073/pnas.0610393104; TOKSOZ D, 1994, ONCOGENE, V9, P621; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Vitart V, 2010, HUM MOL GENET, V19, P4304, DOI 10.1093/hmg/ddq349; Weiser DC, 2007, GENE DEV, V21, P1559, DOI 10.1101/gad.1535007; Wirtenberger M, 2006, CARCINOGENESIS, V27, P593, DOI 10.1093/carcin/bgi245; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yin ZR, 2008, CIRCULATION, V117, P1414, DOI 10.1161/CIRCULATIONAHA.107.759233; Zhang Y, 2007, AM J PHYSIOL-HEART C, V292, pH1187, DOI 10.1152/ajpheart.00895.2006; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	63	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62705	10.1371/journal.pone.0062705	http://dx.doi.org/10.1371/journal.pone.0062705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658642	gold, Green Published, Green Submitted			2022-12-27	WOS:000318343700066
J	Mulinge, M; Lemaire, M; Servais, JY; Rybicki, A; Struck, D; da Silva, ES; Verhofstede, C; Lie, Y; Seguin-Devaux, C; Schmit, JC; Bercoff, DP				Mulinge, Martin; Lemaire, Morgane; Servais, Jean-Yves; Rybicki, Arkadiusz; Struck, Daniel; da Silva, Eveline Santos; Verhofstede, Chris; Lie, Yolanda; Seguin-Devaux, Carole; Schmit, Jean-Claude; Bercoff, Danielle Perez			HIV-1 Tropism Determination Using a Phenotypic Env Recombinant Viral Assay Highlights Overestimation of CXCR4-Usage by Genotypic Prediction Algorithms for CRRF01_AE and CRF02_AG	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; N-LINKED GLYCOSYLATION; T-CELL-LINE; CORECEPTOR USAGE; CHEMOKINE RECEPTORS; DRUG-RESISTANCE; V3 LOOP; GP120; TOOLS; INFECTION	Background: Human Immunodeficiency virus type-1 (HIV) entry into target cells involves binding of the viral envelope (Env) to CD4 and a coreceptor, mainly CCR5 or CXCR4. The only currently licensed HIV entry inhibitor, maraviroc, targets CCR5, and the presence of CXCX4-using strains must be excluded prior to treatment. Co-receptor usage can be assessed by phenotypic assays or through genotypic prediction. Here we compared the performance of a phenotypic Env-Recombinant Viral Assay (RVA) to the two most widely used genotypic prediction algorithms, Geno2Pheno([coreceptor]) and webPSSM. Methods: Co-receptor tropism of samples from 73 subtype B and 219 non-B infections was measured phenotypically using a luciferase-tagged, NL4-3-based, RVA targeting Env. In parallel, tropism was inferred genotypically from the corresponding V3-loop sequences using Geno2Pheno([coreceptor]) (5-20% FPR) and webPSSM-R5X4. For discordant samples, phenotypic outcome was retested using co-receptor antagonists or the validated Trofile (R) Enhanced-Sensitivity-Tropism-Assay. Results: The lower detection limit of the RVA was 2.5% and 5% for X4 and R5 minority variants respectively. A phenotype/genotype result was obtained for 210 samples. Overall, concordance of phenotypic results with Geno2Pheno([coreceptor]) was 85.2% and concordance with webPSSM was 79.5%. For subtype B, concordance with Geno2pheno([coreceptor]) was 94.4% and concordance with webPSSM was 79.6%. High concordance of genotypic tools with phenotypic outcome was seen for subtype C (90% for both tools). Main discordances involved CRF01_AE and CRF02_AG for both algorithms (CRF01_AE: 35.9% discordances with Geno2Pheno([coreceptor]) and 28.2% with webPSSM; CRF02_AG: 20.7% for both algorithms). Genotypic prediction overestimated CXCR4-usage for both CRFs. For webPSSM, 40% discordance was observed for subtype A. Conclusions: Phenotypic assays remain the most accurate for most non-B subtypes and new subtype-specific rules should be developed for non-B subtypes, as research studies more and more draw conclusions from genotypically-inferred tropism, and to avoid unnecessarily precluding patients with limited treatment options from receiving maraviroc or other entry inhibitors.	[Mulinge, Martin; Lemaire, Morgane; Servais, Jean-Yves; Rybicki, Arkadiusz; Struck, Daniel; da Silva, Eveline Santos; Seguin-Devaux, Carole; Schmit, Jean-Claude; Bercoff, Danielle Perez] Ctr Rech Publ Sante, Lab Retrovirol, Luxembourg, Luxembourg; [Schmit, Jean-Claude] Ctr Hosp Luxembourg, Serv Natl Malad Infect, Luxembourg, Luxembourg; [Verhofstede, Chris] Univ Ghent, AIDS Reference Lab, B-9000 Ghent, Belgium; [Lie, Yolanda] Monogram Biosci Inc, San Francisco, CA USA	Luxembourg Institute of Health; Luxembourg Hospital Center; Ghent University	Bercoff, DP (corresponding author), Ctr Rech Publ Sante, Lab Retrovirol, Luxembourg, Luxembourg.	danielle.perezbercoff@crp-sante.lu	Mulinge, Martin/GWU-7942-2022	Seguin-Devaux, Carole/0000-0003-0636-5222; Perez Bercoff, Danielle/0000-0003-4415-0150; mulinge, martin/0000-0001-9613-5425	Luxembourg Ministry of Research and Education [MCESR LRTV20081003]; Fonds National de la Recherche [PHD08-074, PHD-09-115]	Luxembourg Ministry of Research and Education; Fonds National de la Recherche(Luxembourg National Research Fund)	This work was supported by the Luxembourg Ministry of Research and Education Grant #MCESR LRTV20081003. MM and ESS were supported by PhD scholarships from the Fonds National de la Recherche (# AFR grant PHD08-074 and AFR grant PHD-09-115, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Baatz F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021535; Batra M, 2000, AIDS RES HUM RETROV, V16, P973, DOI 10.1089/08892220050058399; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Bjorndal A, 1997, J VIROL, V71, P7478; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Bratt G, 1998, AIDS, V12, P2193, DOI 10.1097/00002030-199816000-00015; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chakrabarti Ayan K, 2009, AIDS Res Ther, V6, P20, DOI 10.1186/1742-6405-6-20; Chalmet K, 2011, J INFECT DIS; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Chueca N, 2009, J MED VIROL, V81, P763, DOI 10.1002/jmv.21425; Clevestig P, 2005, AIDS RES HUM RETROV, V21, P371, DOI 10.1089/aid.2005.21.371; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; de Mendoza C, 2008, JAIDS-J ACQ IMM DEF, V48, P241, DOI 10.1097/QAI.0b013e3181734f0e; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Delgado E, 2012, J ANTIMICROB CHEMOTH, V67, P25, DOI 10.1093/jac/dkr438; Delobel P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fenyo EM, 2011, J INTERN MED, V270, P520, DOI 10.1111/j.1365-2796.2011.02455.x; Garrido C, 2008, J CLIN MICROBIOL, V46, P887, DOI 10.1128/JCM.01611-07; Gonzalez N, 2010, J ANTIMICROB CHEMOTH, V65, P2493, DOI 10.1093/jac/dkq379; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hamy F., 2007, 5 EUR HIV DRUG RES W; Harrigan PR, 2011, AIDS, V25, P257, DOI 10.1097/QAD.0b013e32834113f9; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Rodriguez JJ, 2011, ENFERM INFEC MICR CL, V29, P4, DOI 10.1016/j.eimc.2010.08.013; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Kuhmann SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/annurev.pharmtox.48.113006.094847; Lin NH, 2010, J VIROL METHODS, V169, P39, DOI 10.1016/j.jviromet.2010.06.012; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; McGovern RA, 2010, J VIS EXP, pe2531; Nabatov AA, 2004, J VIROL, V78, P524, DOI 10.1128/JVI.78.1.524-530.2004; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Poveda E, 2007, AIDS, V21, P1487, DOI 10.1097/QAD.0b013e32826fb741; Poveda E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/jac/dkp063; Pugach P, 2007, VIROLOGY, V361, P212, DOI 10.1016/j.virol.2006.11.004; Qu SL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-280; Raymond S, 2012, J CLIN MICROBIOL, V5, P5; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-56; Raymond S, 2010, J CLIN VIROL, V47, P126, DOI 10.1016/j.jcv.2009.11.018; Raymond S, 2009, J CLIN MICROBIOL, V47, P2292, DOI 10.1128/JCM.02439-08; Recordon-Pinson P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10; Reeves JD, 2009, J VIRAL ENTRY, V3, P94; Rose JD, 2009, CURR OPIN HIV AIDS, V4, P136, DOI 10.1097/COH.0b013e328322f973; Ross TM, 1998, P NATL ACAD SCI USA, V95, P7682, DOI 10.1073/pnas.95.13.7682; Schuitemaker H, 2011, J TRANSL MED, V9, P1; Seclen E, 2010, J ANTIMICROB CHEMOTH, V65, P1486, DOI 10.1093/jac/dkq137; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; Swenson LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0b013e3181d0558f; Trouplin V, 2001, J VIROL, V75, P251, DOI 10.1128/JVI.75.1.251-259.2001; Van Baelen K, 2007, J VIROL METHODS, V146, P61, DOI 10.1016/j.jviromet.2007.06.003; Van Laethem K, 2005, J VIROL METHODS, V123, P25, DOI 10.1016/j.jviromet.2004.09.003; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Verhofstede C, 2011, HIV MED, V12, P544, DOI 10.1111/j.1468-1293.2011.00922.x; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	72	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e60566	10.1371/journal.pone.0060566	http://dx.doi.org/10.1371/journal.pone.0060566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667426	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600006
J	Shih, HC; Hwang, TL; Chen, HC; Kuo, PC; Lee, EJ; Lee, KH; Wu, TS				Shih, Hung-Cheng; Hwang, Tsong-Long; Chen, Hung-Chung; Kuo, Ping-Chung; Lee, E-Jian; Lee, Kuo-Hsiung; Wu, Tian-Shung			Honokiol Dimers and Magnolol Derivatives with New Carbon Skeletons from the Roots of Magnolia officinalis and Their Inhibitory Effects on Superoxide Anion Generation and Elastase Release	PLOS ONE			English	Article							STEM BARK; NEOLIGNANS; MICE; EXTRACT; CELLS; PLANT	Two honokiol dimers, houpulins A and B (1 and 2), and two magnolol derivatives, houpulins C and D (3 and 4), were isolated and characterized from an ethanol extract obtained from the roots of Magnolia officinalis. The chemical structures were determined based on spectroscopic and physicochemical analyses, which included 1D and 2D NMR, as well as mass spectrometry data. These four oligomers possess new carbon skeletons postulated to be biosynthesized from the coupling of three or four C-6-C-3 subunits. In addition, the new oligomers were evaluated for inhibition of superoxide anion generation and elastase release, and houpulin B (2) was identified as a new anti-inflammatory lead compound.	[Shih, Hung-Cheng; Chen, Hung-Chung; Wu, Tian-Shung] Natl Cheng Kung Univ, Dept Chem, Tainan 70101, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Grad Inst Nat Prod, Coll Med, Tao Yuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Chinese Herbal Med Res Team, Hlth Aging Res Ctr, Coll Med, Tao Yuan, Taiwan; [Kuo, Ping-Chung] Natl Formosa Univ, Dept Biotechnol, Yunlin, Taiwan; [Lee, E-Jian] Natl Cheng Kung Univ, Med Ctr, Dept Surg, Tainan 70101, Taiwan; [Lee, E-Jian] Natl Cheng Kung Univ, Med Ctr, Dept Anesthesiol, Tainan 70101, Taiwan; [Lee, E-Jian] Natl Cheng Kung Univ, Med Ctr, Inst Biomed Engn, Tainan 70101, Taiwan; [Lee, E-Jian] Sch Med, Tainan, Taiwan; [Lee, Kuo-Hsiung] Univ N Carolina, Nat Prod Res Labs, UNC Eshelman Sch Pharm, Chapel Hill, NC USA; [Lee, Kuo-Hsiung; Wu, Tian-Shung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan; [Wu, Tian-Shung] China Med Univ, Dept Pharm, Taichung, Taiwan	National Cheng Kung University; Chang Gung University; Chang Gung University; National Formosa University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; University of North Carolina; University of North Carolina Chapel Hill; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Wu, TS (corresponding author), Natl Cheng Kung Univ, Dept Chem, Tainan 70101, Taiwan.	tswu@mail.ncku.edu.tw	Hwang, Tsong-Long/AAE-6944-2020	Hwang, Tsong-Long/0000-0002-5780-3977; Kuo, Ping-Chung/0000-0003-3019-1138	National Science Council, Taiwan, Republic of China; National Cheng Kung University	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); National Cheng Kung University	This work was supported by a grant from the National Science Council, Taiwan, Republic of China, which was awarded to T.S. Wu. This study was also supported, in part, by the National Cheng Kung University. The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript.	Antus S, 2001, CHIRALITY, V13, P493, DOI 10.1002/chir.1067; Bae FA, 1998, BIOL PHARM BULL, V21, P990, DOI 10.1248/bpb.21.990; Chao LK, 2010, J AGR FOOD CHEM, V58, P3472, DOI 10.1021/jf904207m; Chen CR, 2011, BRIT J PHARMACOL, V164, P1534, DOI 10.1111/j.1476-5381.2011.01456.x; Ho KY, 2001, PHYTOTHER RES, V15, P139, DOI 10.1002/ptr.736; Hu YJ, 2011, J SCI FOOD AGR, V91, P1050, DOI 10.1002/jsfa.4280; KONOSHIMA T, 1991, J NAT PROD, V54, P816, DOI 10.1021/np50075a010; KOUNO I, 1994, CHEM PHARM BULL, V42, P112, DOI 10.1248/cpb.42.112; KOUNO I, 1989, CHEM PHARM BULL, V37, P1291; Munroe ME, 2010, J IMMUNOL, V185, P5586, DOI 10.4049/jimmunol.1000630; Nakazawa T, 2003, J PHARM PHARMACOL, V55, P1583, DOI 10.1211/0022357022188; Shen CC, 2009, J NAT PROD, V72, P168, DOI 10.1021/np800494e; Shigemura K, 2007, CANCER-AM CANCER SOC, V109, P1279, DOI 10.1002/cncr.22551; Sy LK, 1998, J CHEM RES-S, P476, DOI 10.1039/a801620h; Syu WJ, 2004, CHEM BIODIVERS, V1, P530, DOI 10.1002/cbdv.200490046; Tintinger Gregory R, 2009, Drug Des Devel Ther, V2, P95; Vaid M, 2010, CARCINOGENESIS, V31, P2004, DOI 10.1093/carcin/bgq186; Wang YM, 2005, PHYTOTHER RES, V19, P526, DOI 10.1002/ptr.1697; YAHARA S, 1991, CHEM PHARM BULL, V39, P2024, DOI 10.1248/cpb.39.2024; Yang ML, 2011, BIOORGAN MED CHEM, V19, P1674, DOI 10.1016/j.bmc.2011.01.034; Yang SE, 2003, BRIT J PHARMACOL, V138, P193, DOI 10.1038/sj.bjp.0705024; Yang Y, 2010, J ASIAN NAT PROD RES, V12, P194, DOI 10.1080/10286020903501577; Youn UJ, 2007, J NAT PROD, V70, P1687, DOI 10.1021/np070388c	23	20	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e59502	10.1371/journal.pone.0059502	http://dx.doi.org/10.1371/journal.pone.0059502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667420	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700003
J	Stanton, CK; Rawlins, B; Drake, M; dos Anjos, M; Cantor, D; Chongo, L; Chavane, L; Vaz, MD; Ricca, J				Stanton, Cynthia K.; Rawlins, Barbara; Drake, Mary; dos Anjos, Matias; Cantor, David; Chongo, Lidia; Chavane, Leonardo; Vaz, Maria da Luz; Ricca, Jim			Measuring Coverage in MNCH: Testing the Validity of Women's Self-Report of Key Maternal and Newborn Health Interventions during the Peripartum Period in Mozambique	PLOS ONE			English	Article							MEDICAL-RECORDS; OBSTETRIC COMPLICATIONS; PERINATAL EVENTS; BIRTH-WEIGHT; RECALL BIAS; PREGNANCY; AGREEMENT; MOTHERS; CHILDBIRTH; VALIDATION	Background: As low-income countries strive to meet targets for Millennium Development Goals 4 and 5, there is growing need to track coverage and quality of high-impact peripartum interventions. At present, nationally representative household surveys conducted in low-income settings primarily measure contact with the health system, shedding little light on content or quality of care. The objective of this study is to validate the ability of women in Mozambique to report on facility-based care they and their newborns received during labor and one hour postpartum. Methods and Findings: The study involved household interviews with women in Mozambique whose births were observed eight to ten months previously as part of a survey of the quality of maternal and newborn care at government health facilities. Of 487 women whose births were observed and who agreed to a follow-up interview, 304 were interviewed (62.4%). The validity of 34 indicators was tested using two measures: area under receiver operator characteristic curve (AUC) and inflation factor (IF); 27 indicators had sufficient numbers for robust analysis, of which four met acceptability criteria for both (AUC >0.6 and 0.75<IF<1.25). Two of these indicators are considered high demand and are recommended for incorporation into international survey programs: presence of a support person during labor/delivery and placement of the newborn skin to skin against the mother. Nine indicators met acceptability criteria for one of the validity measures. All 13 indicators are recommended for use in in-depth maternal/newborn health surveys. Conclusions: Women are able to report on some aspects of peripartum care. Larger studies may be able to validate some indicators that this study could not assess due to the sample size. Future qualitative research may assist in improving question formulation for some indicators. Studies of similar design in other low-income settings are needed to confirm these results.	[Stanton, Cynthia K.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Rawlins, Barbara; Drake, Mary; Cantor, David; Ricca, Jim] Maternal & Child Hlth Integrated Program, Washington, DC USA; [dos Anjos, Matias; Chavane, Leonardo; Vaz, Maria da Luz] Maternal & Child Hlth Integrated Program, Maputo, Mozambique; [Chongo, Lidia] Mozamb Minist Hlth, Maputo, Mozambique	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Stanton, CK (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.	cstanton@jhsph.edu	Chavane, Leonardo António/M-3198-2019	Chavane, Leonardo António/0000-0001-7382-0665	Maternal and Child Health Integrated Program; United States Agency for International Development in Washington, D.C.; Bill & Melinda Gates Foundation	Maternal and Child Health Integrated Program; United States Agency for International Development in Washington, D.C.(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Maternal and Child Health Integrated Program, led by Jhpiego, via their funding from the United States Agency for International Development in Washington, D.C. Technical assistance was provided by the Child Health Epidemiology Reference Group (CHERG) for WHO and UNICEF, with financial support from The Bill & Melinda Gates Foundation through their grant to the US Fund for UNICEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WOMENS RECALL DELIVE; BENNETT A, 1985, BIRTH-ISS PERINAT C, V12, P153, DOI 10.1111/j.1523-536X.1985.tb00954.x; Brhlikova P, 2009, J HLTH STUD, V2, P33; BRYANT HE, 1989, AM J PUBLIC HEALTH, V79, P78, DOI 10.2105/AJPH.79.1.78; Bryce J, 2012, COUNTDOWN 2015 MATER; Buka SL, 2004, SCHIZOPHR RES, V71, P417, DOI 10.1016/j.schres.2004.04.004; Campbell H, 2008, CROAT MED J, V49, P402, DOI 10.3325/cmj.2008.3.402; CASEY R, 1992, CLIN PEDIATR, V31, P200, DOI 10.1177/000992289203100402; DELGADORODRIGUEZ M, 1995, J CLIN EPIDEMIOL, V48, P1133, DOI 10.1016/0895-4356(94)00241-H; Elkadry E, 2003, AM J OBSTET GYNECOL, V189, P195, DOI 10.1067/mob.2003.371; Elliott JP, 2010, POPUL HEALTH MANAG, V13, P27, DOI 10.1089/pop.2009.0008; Filippi V, 2000, STUD FAMILY PLANN, V31, P309, DOI 10.1111/j.1728-4465.2000.00309.x; GITHENS PB, 1993, BIRTH-ISS PERINAT C, V20, P136, DOI 10.1111/j.1523-536X.1993.tb00438.x; HAKIM RB, 1992, AM J EPIDEMIOL, V136, P566, DOI 10.1093/oxfordjournals.aje.a116534; HEWSON D, 1987, AM J EPIDEMIOL, V125, P484, DOI 10.1093/oxfordjournals.aje.a114554; Instituto Nacional de Estatistica Mocambique MEASURE DHS.ICF International, 2012, MOC AMBIQUE INQ DEM; Lederman S A, 1998, Matern Child Health J, V2, P123; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060762; MCHIP, 2012, ASS QUAL HUM MAT ANC; Moran AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001415; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Pacque M, 2005, SAVING NEWBORN LIVES; Pepe M. S., 2003, STAT EVALUATION MED; Quigley MA, 2007, BJOG-INT J OBSTET GY, V114, P195, DOI 10.1111/j.1471-0528.2006.01203.x; Rice F, 2007, EARLY HUM DEV, V83, P497, DOI 10.1016/j.earlhumdev.2006.09.015; Ronsmans C, 1997, STUD FAMILY PLANN, V28, P203, DOI 10.2307/2137888; Seoane G, 1998, INT J GYNECOL OBSTET, V62, P229, DOI 10.1016/S0020-7292(98)00104-0; Sloan NL, 2001, J HEALTH POPUL NUTR, V19, P45; Stewart MK, 1996, STUD FAMILY PLANN, V27, P29, DOI 10.2307/2138075; STEWART MK, 1995, INT J GYNECOL OBSTET, V48, pS53, DOI 10.1016/0020-7292(95)02320-C; Tate AR, 2005, INT J EPIDEMIOL, V34, P688, DOI 10.1093/ije/dyi029; TILLEY BC, 1985, AM J EPIDEMIOL, V121, P269, DOI 10.1093/oxfordjournals.aje.a113997; Troude P, 2008, EUR J EPIDEMIOL, V23, P557, DOI 10.1007/s10654-008-9268-9; United Nations, 2013, COUNTR PROF MOZ; VECCHIO TJ, 1966, NEW ENGL J MED, V274, P1171, DOI 10.1056/NEJM196605262742104; WHO, 2012, ACC MAT NEWB CHILD S; WHO UNICEF UNFPA, 2003, PREGN CHILDB POSTP N; World Health Organization, 2000, MAN COMPL PREGN CHIL; Yawn BP, 1998, J CLIN EPIDEMIOL, V51, P399, DOI 10.1016/S0895-4356(97)00304-1; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	40	100	100	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e60694	10.1371/journal.pone.0060694	http://dx.doi.org/10.1371/journal.pone.0060694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667427	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700005
J	Quiblier, C; Seidl, K; Roschitzki, B; Zinkernagel, AS; Berger-Bachi, B; Senn, MM				Quiblier, Chantal; Seidl, Kati; Roschitzki, Bernd; Zinkernagel, Annelies S.; Berger-Baechi, Brigitte; Senn, Maria M.			Secretome Analysis Defines the Major Role of SecDF in Staphylococcus aureus Virulence	PLOS ONE			English	Article							FIBRONECTIN-BINDING-PROTEINS; CELL-WALL; EXPERIMENTAL ENDOCARDITIS; SUBCELLULAR-LOCALIZATION; ENDOTHELIAL-CELLS; SURFACE-PROTEINS; EXPRESSION; IDENTIFICATION; VANCOMYCIN; GENES	The Sec pathway plays a prominent role in protein export and membrane insertion, including the secretion of major bacterial virulence determinants. The accessory Sec constituent SecDF has been proposed to contribute to protein export. Deletion of Staphylococcus aureus secDF has previously been shown to reduce resistance, to alter cell separation, and to change the expression of certain virulence factors. To analyse the impact of the secDF deletion in S. aureus on protein secretion, a quantitative secretome analysis was performed. Numerous Sec signal containing proteins involved in virulence were found to be decreased in the supernatant of the secDF mutant. However, two Sec-dependent hydrolases were increased in comparison to the wild type, suggesting additional indirect, regulatory effects to occur upon deletion of secDF. Adhesion, invasion, and cytotoxicity of the secDF mutant were reduced in human umbilical vein endothelial cells. Virulence was significantly reduced using a Galleria mellonella insect model. Altogether, SecDF is a promising therapeutic target for controlling S. aureus infections.	[Quiblier, Chantal; Berger-Baechi, Brigitte; Senn, Maria M.] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland; [Seidl, Kati; Zinkernagel, Annelies S.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Roschitzki, Bernd] Swiss Fed Inst Technol, Funct Genom Ctr Zurich, Zurich, Switzerland; [Roschitzki, Bernd] Univ Zurich, Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Senn, MM (corresponding author), Univ Zurich, Inst Med Microbiol, Zurich, Switzerland.	msenn@imm.uzh.ch	Zinkernagel, Annelies S/F-1780-2017	Zinkernagel, Annelies S/0000-0003-4700-1118	Gottfried und Julia Bangerter-Rhyner-Stiftung; Foundation for Research at the Medical Faculty, University of Zurich; Matching Funds of the Clinical Trials Center, University Hospital Zurich; European Union Seventh Framework Programme (FP7) [241446]	Gottfried und Julia Bangerter-Rhyner-Stiftung; Foundation for Research at the Medical Faculty, University of Zurich; Matching Funds of the Clinical Trials Center, University Hospital Zurich; European Union Seventh Framework Programme (FP7)	This study was supported by the Gottfried und Julia Bangerter-Rhyner-Stiftung to CQ and by grants of the Foundation for Research at the Medical Faculty, University of Zurich and Matching Funds of the Clinical Trials Center, University Hospital Zurich to KS. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241446 (project ANTIRESDEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chatterjee SS, 2013, NAT MED, V19, P364, DOI 10.1038/nm.3047; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; Cheung A.L, 2007, CURRENT PROTOCOLS MI; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; Dengler V, 2012, FEMS MICROBIOL LETT, V333, P109, DOI 10.1111/j.1574-6968.2012.02603.x; Desbois AP, 2011, J ANTIMICROB CHEMOTH, V66, P1785, DOI 10.1093/jac/dkr198; Diederen BMW, 2006, J INFECTION, V52, P157, DOI 10.1016/j.jinf.2005.09.001; Dreisbach A, 2011, PROTEOMICS, V11, P3154, DOI 10.1002/pmic.201000823; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Ender M, 2008, THESIS U ZURICH SWIT; Ender M, 2008, INT J MED MICROBIOL, V298, P607, DOI 10.1016/j.ijmm.2008.01.015; Ender M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-62; FILLER SG, 1995, INFECT IMMUN, V63, P976, DOI 10.1128/IAI.63.3.976-983.1995; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Gagnaire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040660; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Haggar A, 2003, INFECT IMMUN, V71, P2310, DOI 10.1128/IAI.71.5.2310-2317.2003; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kouwen TRHM, 2009, PROTEOMICS, V9, P1018, DOI 10.1002/pmic.200800580; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krut O, 2003, INFECT IMMUN, V71, P2716, DOI 10.1128/IAI.71.5.2716-2723.2003; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; Latimer J, 2012, ANTIMICROB AGENTS CH, V56, P3092, DOI 10.1128/AAC.05904-11; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; MCDEVITT D, 1992, INFECT IMMUN, V60, P1514, DOI 10.1128/IAI.60.4.1514-1523.1992; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Over B, 2011, FEMS MICROBIOL LETT, V320, P142, DOI 10.1111/j.1574-6968.2011.02303.x; Palma M, 1999, J BACTERIOL, V181, P2840, DOI 10.1128/JB.181.9.2840-2845.1999; Palma M, 1998, J BIOL CHEM, V273, P13177, DOI 10.1074/jbc.273.21.13177; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Peleg AY, 2009, J INFECT DIS, V199, P532, DOI 10.1086/596511; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POGLIANO KJ, 1994, J BACTERIOL, V176, P804, DOI 10.1128/jb.176.3.804-814.1994; Purves J, 2010, INFECT IMMUN, V78, P5223, DOI 10.1128/IAI.00762-10; Qi W, 2005, J CLIN MICROBIOL, V43, P5164, DOI 10.1128/JCM.43.10.5164-5170.2005; Quiblier C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-72; Ramadurai L, 1997, J BACTERIOL, V179, P3625, DOI 10.1128/jb.179.11.3625-3631.1997; Ramadurai L, 1999, MICROBIOL-UK, V145, P801, DOI 10.1099/13500872-145-4-801; Ravipaty S, 2010, MOL CELL PROTEOMICS, V9, P1898, DOI 10.1074/mcp.M900494-MCP200; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; Salzet M, 2001, TRENDS IMMUNOL, V22, P285, DOI 10.1016/S1471-4906(01)01895-6; Seidl K, 2013, J MICROBIOL METH, V92, P307, DOI 10.1016/j.mimet.2012.12.018; Seidl K, 2011, ANTIMICROB AGENTS CH, V55, P5631, DOI 10.1128/AAC.05251-11; Seidl K, 2011, CELL MICROBIOL, V13, P1530, DOI 10.1111/j.1462-5822.2011.01639.x; Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Sibbald MJJB, 2010, J BACTERIOL, V192, P3788, DOI 10.1128/JB.01452-09; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; TAURA T, 1994, MOL GEN GENET, V243, P261, DOI 10.1007/BF00301061; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; VANN JM, 1987, INFECT IMMUN, V55, P2155, DOI 10.1128/IAI.55.9.2155-2163.1987; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	94	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63513	10.1371/journal.pone.0063513	http://dx.doi.org/10.1371/journal.pone.0063513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658837	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321202100070
J	Dong, XJ; Pan, RL; Zhang, H; Yang, C; Shao, JZ; Xiang, LX				Dong, Xuejun; Pan, Ruolang; Zhang, Hui; Yang, Chao; Shao, Jianzhong; Xiang, Lixin			Modification of Histone Acetylation Facilitates Hepatic Differentiation of Human Bone Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; HEPATOCYTE-LIKE CELLS; DEACETYLASE INHIBITORS; PROGENITOR CELLS; STROMAL CELLS; PLASTICITY; PROLIFERATION; INDUCTION	The multi-potentiality of mesenchymal stem cells makes them excellent options for future tissue engineering and clinical therapy, including liver injury. In this study, we investigated the effects of valproic acid (VPA), a direct inhibitor of histone deacetylase (HDAC), on the hepatic differentiation of human bone marrow mesenchymal stem cells (BMMSCs). The cells were found to differentiate into a more homogeneous hepatocyte-like population when pretreated with 5 mM VPA for 72 h. The expression of liver-specific markers was significantly upregulated in the VPA-treated group at the mRNA and protein levels. VPA treatment also significantly enhanced the hepatic functions of the differentiated cells, including glycogen storage, cytochrome P450 activity, AFP and ALB synthesis, and urea production. Further analysis showed that treatment with 5 mM of VPA for 72 h greatly improved the histones H3 and H4 acetylation. These results demonstrated that VPA could considerably improve the hepatic differentiation of human BMMSCs, probably because the chromatin-acetylated state changes upon VPA treatment through its HDAC inhibitory effect. Thus, this study provides a direct research model for producing human hepatocytes for clinical purposes.	[Dong, Xuejun; Zhang, Hui; Yang, Chao] Zhejiang Univ, Shaoxing Hosp, Shaoxing Peoples Hosp, Shaoxing, Zhejiang, Peoples R China; [Pan, Ruolang; Shao, Jianzhong; Xiang, Lixin] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Ruolang; Shao, Jianzhong] Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hui; Yang, Chao] Wenzhou Med Coll, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Wenzhou Medical University	Shao, JZ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	shaojz@zju.edu.cn; xianglx@zju.edu.cn			Science and Technology Foundation of Ministry of Health of the People's Republic of China [WKJ2007-2-037]; National Basic Research Program of China [2012CB967900]; Key Discipline of Shaoxing Province [GJSX-010-003]; Key Discipline of Zhejiang Province [GJSX-010-003]; Key Science and Technology Innovation Team of Zhejiang Province [2010R50048]; Shaoxing key project for Science and technology [2007A23008, 2005141]; grant of medicine and health key project of Zhejiang Province	Science and Technology Foundation of Ministry of Health of the People's Republic of China; National Basic Research Program of China(National Basic Research Program of China); Key Discipline of Shaoxing Province; Key Discipline of Zhejiang Province; Key Science and Technology Innovation Team of Zhejiang Province; Shaoxing key project for Science and technology; grant of medicine and health key project of Zhejiang Province	This work was supported by the grant of medicine and health key project of Zhejiang Province, Science and Technology Foundation of Ministry of Health of the People's Republic of China WKJ2007-2-037; National Basic Research Program of China 2012CB967900; Key Disciplines of Shaoxing and Zhejiang Province GJSX-010-003; Key Science and Technology Innovation Team of Zhejiang Province (2010R50048); Shaoxing key project for Science and technology 2007A23008 and 2005141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian AR, 2007, J CELL BIOCHEM, V100, P362, DOI 10.1002/jcb.21029; Bedada FB, 2006, CELL CYCLE, V5, P223, DOI 10.4161/cc.5.3.2364; Bernardo ME, 2007, CONNECT TISSUE RES, V48, P132, DOI 10.1080/03008200701228464; Chen JH, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-71; Chen Y, 2007, J CELL BIOCHEM, V102, P52, DOI 10.1002/jcb.21275; Chen Y, 2009, J CELL MOL MED, V13, P2582, DOI 10.1111/j.1582-4934.2008.00471.x; Cho HH, 2005, J CELL BIOCHEM, V96, P533, DOI 10.1002/jcb.20544; Horwitz EM, 2003, ARCH MED RES, V34, P600, DOI 10.1016/j.arcmed.2003.09.006; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; KOEBE HG, 1994, INT J ARTIF ORGANS, V17, P95, DOI 10.1177/039139889401700207; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Lehrmann H, 2002, ADV CANCER RES, V86, P41, DOI 10.1016/S0065-230X(02)86002-X; Luk JM, 2005, J IMMUNOL METHODS, V305, P39, DOI 10.1016/j.jim.2005.07.006; Nussler A, 2006, J HEPATOL, V45, P144, DOI 10.1016/j.jhep.2006.04.002; Oh SH, 2007, GASTROENTEROLOGY, V132, P1077, DOI 10.1053/j.gastro.2007.01.001; Pan RL, 2008, CYTOTHERAPY, V10, P668, DOI 10.1080/14653240802360704; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quesenberry PJ, 2005, EXP HEMATOL, V33, P389, DOI 10.1016/j.exphem.2004.11.005; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Snykers S, 2006, TOXICOL SCI, V94, P330, DOI 10.1093/toxsci/kfl058; Turhan AG, 2003, TRANSFUS CLIN BIOL, V10, P103, DOI 10.1016/S1246-7820(03)00040-5; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9	24	23	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63405	10.1371/journal.pone.0063405	http://dx.doi.org/10.1371/journal.pone.0063405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658825	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500067
J	Huang, YH; Wu, HY; Wu, KM; Liu, TT; Liou, RF; Tsai, SF; Shiao, MS; Ho, LT; Tzean, SS; Yang, UC				Huang, Yen-Hua; Wu, Hung-Yi; Wu, Keh-Ming; Liu, Tze-Tze; Liou, Ruey-Fen; Tsai, Shih-Feng; Shiao, Ming-Shi; Ho, Low-Tone; Tzean, Shean-Shong; Yang, Ueng-Cheng			Generation and Analysis of the Expressed Sequence Tags from the Mycelium of Ganoderma lucidum	PLOS ONE			English	Article							C HEME LYASE; ANTITUMOR ACTIVITIES; INTRON DEFINITION; CYTOCHROME-C; PREDICTION; IMPORT; SITE; POLYSACCHARIDES; HYDROPHOBINS; ANNOTATION	Ganoderma lucidum (G. lucidum) is a medicinal mushroom renowned in East Asia for its potential biological effects. To enable a systematic exploration of the genes associated with the various phenotypes of the fungus, the genome consortium of G. lucidum has carried out an expressed sequence tag (EST) sequencing project. Using a Sanger sequencing based approach, 47,285 ESTs were obtained from in vitro cultures of G. lucidum mycelium of various durations. These ESTs were further clustered and merged into 7,774 non-redundant expressed loci. The features of these expressed contigs were explored in terms of over-representation, alternative splicing, and natural antisense transcripts. Our results provide an invaluable information resource for exploring the G. lucidum transcriptome and its regulation. Many cases of the genes over-represented in fast-growing dikaryotic mycelium are closely related to growth, such as cell wall and bioactive compound synthesis. In addition, the EST-genome alignments containing putative cassette exons and retained introns were manually curated and then used to make inferences about the predominating splice-site recognition mechanism of G. lucidum. Moreover, a number of putative antisense transcripts have been pinpointed, from which we noticed that two cases are likely to reveal hitherto undiscovered biological pathways. To allow users to access the data and the initial analysis of the results of this project, a dedicated web site has been created at http://csb2.ym.edu.tw/est/.	[Huang, Yen-Hua] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Biochem, Taipei 112, Taiwan; [Wu, Keh-Ming; Liu, Tze-Tze; Tsai, Shih-Feng] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 112, Taiwan; [Yang, Ueng-Cheng] Natl Yang Ming Univ, Coll Life Sci, Inst Biomed Informat, Taipei 112, Taiwan; [Huang, Yen-Hua; Yang, Ueng-Cheng] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Wu, Hung-Yi; Liou, Ruey-Fen; Tzean, Shean-Shong] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Shiao, Ming-Shi; Ho, Low-Tone] Taipei Vet Gen Hosp, Med Res & Educ Dept, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; Taipei Veterans General Hospital	Tzean, SS (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan.	sst@ntu.edu.tw; yang@ym.edu.tw		LIOU, RUEY-FEN/0000-0001-7799-9287	Taipei Veterans General Hospital (Taiwan, Republic of China) [VGH92-378]; National Science Council (Taiwan, Republic of China) [NSC99-3112-B-010-019]	Taipei Veterans General Hospital (Taiwan, Republic of China)(Taipei Veterans General Hospital); National Science Council (Taiwan, Republic of China)(Ministry of Science and Technology, Taiwan)	This project was supported by VGH92-378 from the Taipei Veterans General Hospital (http://www.vghtpe.gov.tw/) (Taiwan, Republic of China) and also by NSC99-3112-B-010-019 from the National Science Council (http://web1.nsc.gov.tw/) (Taiwan, Republic of China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2004, AM J HUM GENET, V74, P83, DOI 10.1086/381039; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bidon N, 2001, GENE, V274, P253, DOI 10.1016/S0378-1119(01)00598-4; Boisson M, 2001, EMBO J, V20, P1010, DOI 10.1093/emboj/20.5.1010; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Clegg N, 2004, PROSTATE, V60, P227, DOI 10.1002/pros.20055; De Young MP, 2002, IN VIVO, V16, P239; DUMONT ME, 1991, MOL CELL BIOL, V11, P5487, DOI 10.1128/MCB.11.11.5487; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Eyras E, 2004, GENOME RES, V14, P976, DOI 10.1101/gr.1862204; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Hajjaj H, 2005, APPL ENVIRON MICROB, V71, P3653, DOI 10.1128/AEM.71.7.3653-3658.2005; Harrow J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-201; Huang Zhi Gang, 2006, Chin J Dig Dis, V7, P97, DOI 10.1111/j.1443-9573.2006.00254.x; Hutu DP, 2008, MOL BIOL CELL, V19, P2642, DOI 10.1091/mbc.E07-12-1226; Jensen Britt G, 2010, BMC Res Notes, V3, P344, DOI 10.1186/1756-0500-3-344; Jones SJM, 2006, ANNU REV GENOM HUM G, V7, P315, DOI 10.1146/annurev.genom.7.080505.115745; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Liang CZ, 2009, GENOME RES, V19, P1912, DOI 10.1101/gr.088997.108; LILL R, 1992, EMBO J, V11, P449, DOI 10.1002/j.1460-2075.1992.tb05074.x; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Luo Hongmei, 2010, Chin Med, V5, P9, DOI 10.1186/1749-8546-5-9; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; Meng Ling-xin, 2007, Zhonghua Wei Chang Wai Ke Za Zhi, V10, P169; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Moore MJ, 2002, CELL, V108, P431, DOI 10.1016/S0092-8674(02)00645-1; Moriwaki K, 2010, WORLD J HEPATOL, V2, P151, DOI 10.4254/wjh.v2.i4.151; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Potter SC, 2004, GENOME RES, V14, P934, DOI 10.1101/gr.1859804; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; SHIAO MS, 1987, J NAT PROD, V50, P886, DOI 10.1021/np50053a019; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smith CA, 2008, CURR GENET, V54, P241, DOI 10.1007/s00294-008-0215-9; SONE Y, 1985, AGR BIOL CHEM TOKYO, V49, P2641, DOI 10.1080/00021369.1985.10867134; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stalker J, 2004, GENOME RES, V14, P951, DOI 10.1101/gr.1863004; TALERICO M, 1994, MOL CELL BIOL, V14, P3434, DOI 10.1128/MCB.14.5.3434; TALERICO M, 1990, MOL CELL BIOL, V10, P6299, DOI 10.1128/MCB.10.12.6299; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; van Wetter MA, 2000, MOL MICROBIOL, V36, P201, DOI 10.1046/j.1365-2958.2000.01848.x; Wang BC, 1991, CULTURAL ATLAS SOME; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; Wang YY, 2002, BIOORGAN MED CHEM, V10, P1057, DOI 10.1016/S0968-0896(01)00377-7; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wessels JGH, 1997, ADV MICROB PHYSIOL, V38, P1; Xing Y, 2004, GENOME RES, V14, P426, DOI 10.1101/gr.1304504; Yang FC, 1998, PROCESS BIOCHEM, V33, P547, DOI 10.1016/S0032-9592(98)00023-5; Ye LB, 2008, CARBOHYD RES, V343, P746, DOI 10.1016/j.carres.2007.12.004; Yousef GM, 2004, BRIT J CANCER, V90, P167, DOI 10.1038/sj.bjc.6601451	59	8	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61127	10.1371/journal.pone.0061127	http://dx.doi.org/10.1371/journal.pone.0061127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658685	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500004
J	Bhasin, MK; Dusek, JA; Chang, BH; Joseph, MG; Denninger, JW; Fricchione, GL; Benson, H; Libermann, TA				Bhasin, Manoj K.; Dusek, Jeffery A.; Chang, Bei-Hung; Joseph, Marie G.; Denninger, John W.; Fricchione, Gregory L.; Benson, Herbert; Libermann, Towia A.			Relaxation Response Induces Temporal Transcriptome Changes in Energy Metabolism, Insulin Secretion and Inflammatory Pathways	PLOS ONE			English	Article							PROTEIN REFERENCE DATABASE; SET ENRICHMENT ANALYSIS; NF-KAPPA-B; NITRIC-OXIDE; OXIDATIVE-STRESS; PSYCHOLOGICAL STRESS; RISK-FACTORS; GENOME-WIDE; EXPRESSION; MEDITATION	The relaxation response (RR) is the counterpart of the stress response. Millennia-old practices evoking the RR include meditation, yoga and repetitive prayer. Although RR elicitation is an effective therapeutic intervention that counteracts the adverse clinical effects of stress in disorders including hypertension, anxiety, insomnia and aging, the underlying molecular mechanisms that explain these clinical benefits remain undetermined. To assess rapid time-dependent (temporal) genomic changes during one session of RR practice among healthy practitioners with years of RR practice and also in novices before and after 8 weeks of RR training, we measured the transcriptome in peripheral blood prior to, immediately after, and 15 minutes after listening to an RR-eliciting or a health education CD. Both short-term and long-term practitioners evoked significant temporal gene expression changes with greater significance in the latter as compared to novices. RR practice enhanced expression of genes associated with energy metabolism, mitochondrial function, insulin secretion and telomere maintenance, and reduced expression of genes linked to inflammatory response and stress-related pathways. Interactive network analyses of RR-affected pathways identified mitochondrial ATP synthase and insulin (INS) as top upregulated critical molecules (focus hubs) and NF-kappa B pathway genes as top downregulated focus hubs. Our results for the first time indicate that RR elicitation, particularly after long-term practice, may evoke its downstream health benefits by improving mitochondrial energy production and utilization and thus promoting mitochondrial resiliency through upregulation of ATPase and insulin function. Mitochondrial resiliency might also be promoted by RR-induced downregulation of NF-kappa B-associated upstream and downstream targets that mitigates stress.	[Bhasin, Manoj K.; Denninger, John W.; Fricchione, Gregory L.; Benson, Herbert; Libermann, Towia A.] Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Boston, MA 02114 USA; [Denninger, John W.; Fricchione, Gregory L.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Benson, Herbert] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp, Boston, MA USA; [Bhasin, Manoj K.; Libermann, Towia A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Bhasin, Manoj K.; Joseph, Marie G.; Libermann, Towia A.] Beth Israel Deaconess Med Ctr, BIDMC Genom & Prote Ctr, Boston, MA 02215 USA; [Dusek, Jeffery A.] Abbott NW Hosp, Inst Hlth & Healing, Minneapolis, MN 55407 USA; [Chang, Bei-Hung] VA Boston Healthcare Syst, Boston, MA USA; [Chang, Bei-Hung] Boston Univ, Dept Hlth Policy & Management, Sch Publ Hlth, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University	Libermann, TA (corresponding author), Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Boston, MA 02114 USA.	tliberma@bidmc.harvard.edu		Chang, Bei-Hung/0000-0001-9632-9713; Dusek, Jeffery/0000-0001-9581-0564; Libermann, Towia/0000-0002-4006-8179; Bhasin, Manoj/0000-0001-5172-420X	Centers for Disease Control and Prevention (CDC) [H75/CCH123424, R01 DP000339]; National Center for Complementary and Alternative Medicine (NCCAM) [RO1 AT006464-01]; NCRR, National Institutes of Health (The Harvard-Thorndike GCRC) [M01 RR01032]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R01DP000339] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006464] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCRR, National Institutes of Health (The Harvard-Thorndike GCRC); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was funded by grants H75/CCH123424 and R01 DP000339 from the Centers for Disease Control and Prevention (CDC) (HB), RO1 AT006464-01 from the National Center for Complementary and Alternative Medicine (NCCAM) (HB) and grant M01 RR01032 from the NCRR, National Institutes of Health (The Harvard-Thorndike GCRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2007, ANN NY ACAD SCI, V1113, P256, DOI 10.1196/annals.1391.015; Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; ALEXANDER CN, 1989, J PERS SOC PSYCHOL, V57, P950, DOI 10.1037/0022-3514.57.6.950; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Antoni MH, 2012, BIOL PSYCHIAT, V71, P366, DOI 10.1016/j.biopsych.2011.10.007; ARCHER S, 1993, FASEB J, V7, P349, DOI 10.1096/fasebj.7.2.8440411; Astin JA, 2002, ARTHRIT RHEUM-ARTHR, V47, P291, DOI 10.1002/art.10416; BENSON H, 1978, PSYCHOTHER PSYCHOSOM, V30, P229, DOI 10.1159/000287304; BENSON H, 1974, PSYCHIATRY, V37, P37, DOI 10.1080/00332747.1974.11023785; Benson H., 1975, RELAXATION RESPONSE; Benson H., 2011, RELAXATION REVOLUTIO; Bierhaus A, 2004, PEDIATR NEPHROL, V19, P1189, DOI 10.1007/s00467-004-1603-0; Black D.S., 2012, PSYCHONEUROENDOCRINO; Chang BH, 2011, PSYCHOSOMATICS, V52, P550, DOI 10.1016/j.psym.2011.05.001; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Dusek JA, 2006, MED SCI MONITOR, V12, pCR1; Dusek JA, 2008, J ALTERN COMPLEM MED, V14, P129, DOI 10.1089/acm.2007.0623; Dusek Jeffery A, 2009, Minn Med, V92, P47; Dusek JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002576; Epel E, 2009, ANN NY ACAD SCI, V1172, P34, DOI 10.1111/j.1749-6632.2009.04414.x; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; FREEMAN BA, 1995, AM J PHYSIOL-LUNG C, V268, pL697, DOI 10.1152/ajplung.1995.268.5.L697; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Galvin Jennifer A, 2006, Complement Ther Clin Pract, V12, P186, DOI 10.1016/j.ctcp.2006.02.004; Hasegawa Y, 2012, CIRCULATION, V125, P1122, DOI 10.1161/CIRCULATIONAHA.111.054346; Hegde SV, 2011, DIABETES CARE, V34, P2208, DOI 10.2337/dc10-2430; HOFFMAN DW, 1980, J NEUROCHEM, V34, P1785, DOI 10.1111/j.1471-4159.1980.tb11279.x; Hofmann MA, 1999, DIABETOLOGIA, V42, P222, DOI 10.1007/s001250051142; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; JACOBS GD, 1993, BEHAV MODIF, V17, P498, DOI 10.1177/01454455930174005; Jacobs GD, 1996, AM J MED, V100, P212, DOI 10.1016/S0002-9343(97)89461-2; Jacobs TL, 2011, PSYCHONEUROENDOCRINO, V36, P664, DOI 10.1016/j.psyneuen.2010.09.010; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; Lazar SW, 2000, NEUROREPORT, V11, P1581, DOI 10.1097/00001756-200005150-00041; LEONE AM, 1994, BIOCHEM BIOPH RES CO, V201, P883, DOI 10.1006/bbrc.1994.1784; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Mitchell Brett M, 2002, Biol Res Nurs, V4, P16, DOI 10.1177/1099800402004001003; MORIN CM, 1992, SLEEP, V15, P302, DOI 10.1093/sleep/15.4.302; Morita K, 2005, NEUROSCI LETT, V381, P57, DOI 10.1016/j.neulet.2005.01.081; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nagabhushan M, 2001, BRAIN BEHAV IMMUN, V15, P78, DOI 10.1006/brbi.2000.0589; Nakao M, 2001, PSYCHOTHER PSYCHOSOM, V70, P50, DOI 10.1159/000056225; Peng CK, 2004, INT J CARDIOL, V95, P19, DOI 10.1016/j.ijcard.2003.02.006; Perron NR, 2013, J BIOENERG BIOMEMBR, V45, P101, DOI 10.1007/s10863-012-9477-5; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Saleh MC, 2008, DIABETES-METAB RES, V24, P392, DOI 10.1002/dmrr.819; Segman RH, 2010, MOL PSYCHIATR, V15, P93, DOI 10.1038/mp.2009.65; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stefano GB, 2001, INT J MOL MED, V7, P119; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tamashiro KLK, 2011, ANN NY ACAD SCI, V1231, P46, DOI 10.1111/j.1749-6632.2011.06134.x; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; WALLACE RK, 1971, AM J PHYSIOL, V221, P795, DOI 10.1152/ajplegacy.1971.221.3.795; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	69	137	137	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62817	10.1371/journal.pone.0062817	http://dx.doi.org/10.1371/journal.pone.0062817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650531	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000076
J	de Moraes, ACF; Carvalho, HB; Rey-Lopez, JP; Gracia-Marco, L; Beghin, L; Kafatos, A; Jimenez-Pavon, D; Molnar, D; De Henauw, S; Manios, Y; Widhalm, K; Ruiz, JR; Ortega, FB; Sjostrom, M; Polito, A; Pedrero-Chamizo, R; Marcos, A; Gottrand, F; Moreno, LA				Ferreira de Moraes, Augusto Cesar; Carvalho, Heraclito Barbosa; Rey-Lopez, Juan Pablo; Gracia-Marco, Luis; Beghin, Laurent; Kafatos, Anthony; Jimenez-Pavon, David; Molnar, Denes; De Henauw, Stefaan; Manios, Yannis; Widhalm, Kurt; Ruiz, Jonatan R.; Ortega, Francisco B.; Sjostrom, Michael; Polito, Angela; Pedrero-Chamizo, Raquel; Marcos, Ascension; Gottrand, Frederic; Moreno, Luis A.			Independent and Combined Effects of Physical Activity and Sedentary Behavior on Blood Pressure in Adolescents: Gender Differences in Two Cross-Sectional Studies	PLOS ONE			English	Article							EUROPEAN ADOLESCENTS; RISK-FACTORS; LIFE-STYLE; SOCIOECONOMIC-STATUS; BONE MASS; TIME; DETERMINANTS; FITNESS; CHILDREN; HEALTH	Objectives: To examine the independent and combined association of physical activity (PA) and sedentary behavior (SB) on both systolic (SBP) and diastolic blood pressure (DBP) in adolescents from two observational studies. Methods: Participants from two cross-sectional studies, one conducted in Europe (n = 3,308; HELENA study) and the other in Brazil (n = 991; BRACAH study), were selected by complex sampling. Systolic and diastolic blood pressure (outcomes), PA and SB, both independently and combined, and potential confounders were analyzed. Associations were examined by multilevel linear regression. Results: Performing the recommended amount of PA (>= 60 min/d) attenuated the effect of SB on DBP in BRACAH study girls and in boys from both studies. In contrast, PA did not attenuate the effects of SB on the SBP of girls in the HELENA study. The combination of less than recommended levels of PA with 2-4 h/d of sedentary behavior was found to be associated with increased SBP in boys from both studies. Conclusions: Meeting current PA recommendations could mediate the association between SB and DBP in both sexes. In boys, the joint effect of low levels of PA and excessive sedentary activity increases SBP levels. Longitudinal studies are required to confirm these findings.	[Ferreira de Moraes, Augusto Cesar; Carvalho, Heraclito Barbosa; Rey-Lopez, Juan Pablo; Moreno, Luis A.] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Carlos, SP, Brazil; [Ferreira de Moraes, Augusto Cesar] Pontificia Univ Catolica Parana PUCPR, GEPECIN Sci Nutr Grp Res, Curitiba, Parana, Brazil; [Ferreira de Moraes, Augusto Cesar; Rey-Lopez, Juan Pablo; Gracia-Marco, Luis; Jimenez-Pavon, David; Moreno, Luis A.] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev, Zaragoza, Spain; [Moreno, Luis A.] Univ Zaragoza, Sch Hlth Sci, Zaragoza, Spain; [Beghin, Laurent; Gottrand, Frederic] Unite Inserm U995, Lille, France; [Beghin, Laurent; Gottrand, Frederic] Univ Lille Nord France, Lille, France; [Kafatos, Anthony] Univ Crete, Sch Med, Prevent Med & Nutr Unit, Iraklion, Crete, Greece; [Jimenez-Pavon, David; Ruiz, Jonatan R.; Ortega, Francisco B.] Univ Granada, Sch Sport Sci, Dept Phys Educ & Sports, PROFITH Grp, Granada, Spain; [Molnar, Denes] Univ Pecs, Fac Med, Dept Paediat, Pecs, Hungary; [De Henauw, Stefaan] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Widhalm, Kurt] Med Univ Vienna, Dept Pediat, Div Nutr & Metab, Vienna, Austria; [Ruiz, Jonatan R.; Ortega, Francisco B.; Sjostrom, Michael] Karolinska Inst, Dept Biosci, Unit Prevent Nutr, Stockholm, Sweden; [Polito, Angela] Natl Inst Food & Nutr Res, Rome, Italy; [Pedrero-Chamizo, Raquel] Univ Politecn Madrid, Madrid, Spain; [Marcos, Ascension] Spanish Natl Res Council, Food Sci & Technol & Nutr Inst, Dept Metab & Nutr, Immunonutr Res Grp, Madrid, Spain; [Gracia-Marco, Luis] Univ Exeter, Sch Sport & Hlth Sci, Exeter, Devon, England; [Beghin, Laurent; Gottrand, Frederic] Ctr Invest Clin, Inserm CH& U, CIC 9301, Lille, France; [Ferreira de Moraes, Augusto Cesar] Univ Estadual Paulista, GICRAF Sci Res Grp Related Phys Act, Sao Paulo, Brazil	Universidade de Sao Paulo; Pontificia Universidade Catolica do Parana; University of Zaragoza; University of Zaragoza; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of Crete; University of Granada; University of Pecs; Ghent University; Harokopio University Athens; Medical University of Vienna; Karolinska Institutet; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); University of Exeter; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universidade Estadual Paulista	de Moraes, ACF (corresponding author), Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Carlos, SP, Brazil.	augustocesar.demoraes@usp.br	Gracia-Marco, Luis/A-8845-2018; Gracia-Marco, Luis/R-4899-2019; Ortega, Francisco B/B-4002-2010; Manios, Yannis/AAM-8953-2021; Polito, Angela/B-1363-2016; gottrand, frederic F/G-7370-2015; RUIZ, JONATAN R/M-1338-2015; Carvalho, Heráclito/C-1334-2012; Jiménez-Pavón, David/AAA-2970-2020; Molnár, Dénes/AAB-6820-2022; Polito, Angela/AAO-1596-2020; Jiménez-Pavón, David/M-9005-2015; BEGHIN, Laurent R/D-4294-2011; Pedrero-Chamizo, Raquel/Z-3738-2019; Moreno, Luis/S-1780-2019; Ortega, Francisco B./AAG-5195-2021; Sanchez, Ascension Marcos/K-4965-2014; Ferreira De Moraes, Augusto César/D-2198-2009	Gracia-Marco, Luis/0000-0002-4020-0256; Gracia-Marco, Luis/0000-0002-4020-0256; Ortega, Francisco B/0000-0003-2001-1121; Manios, Yannis/0000-0001-6486-114X; Polito, Angela/0000-0003-4898-796X; gottrand, frederic F/0000-0002-5290-0436; RUIZ, JONATAN R/0000-0002-7548-7138; Carvalho, Heráclito/0000-0002-7037-5655; Jiménez-Pavón, David/0000-0002-8977-4744; Polito, Angela/0000-0003-4898-796X; Jiménez-Pavón, David/0000-0002-8977-4744; BEGHIN, Laurent R/0000-0001-5369-3910; Moreno, Luis/0000-0003-0454-653X; Ortega, Francisco B./0000-0003-2001-1121; Sanchez, Ascension Marcos/0000-0002-8022-9563; Ferreira De Moraes, Augusto César/0000-0002-5763-435X; Rey Lopez, Juan Pablo/0000-0002-7201-2006; Pedrero-Chamizo, Raquel/0000-0002-3866-4692	European Community [FOOD-CT-2005-007034]; Spanish Ministry of Health: Maternal, Child Health and Development Network [RD08/0072]; Spanish Ministry of Education [EX-2008-0641]; Swedish Heart-Lung Foundation [20090635]; Sao Paulo State Research Foundation (FAPESP) [2011/11137-1, 2011/20662-2]	European Community(European Commission); Spanish Ministry of Health: Maternal, Child Health and Development Network(Spanish Government); Spanish Ministry of Education(Spanish Government); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The HELENA Study received financial support from the European Community Sixth RTD Framework Programme (contract FOOD-CT-2005-007034). The writing group takes sole responsibility for the content of this article. This study was also supported by grants from the Spanish Ministry of Health: Maternal, Child Health and Development Network (number RD08/0072), the Spanish Ministry of Education (EX-2008-0641) and the Swedish Heart-Lung Foundation (20090635). The BRACAH survey received no funding. ACFM received a scholarship from the Sao Paulo State Research Foundation (FAPESP: proc. 2011/11137-1 and 2011/20662-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEP, 2006, BRAZ CRIT EC CLASS; Beaglehole R, 2010, LANCET, V376, P1619, DOI 10.1016/S0140-6736(10)61929-0; Bringolf-Isler B, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-50; Christofaro DGD, 2013, SCAND J MED SCI SPOR, V23, P317, DOI 10.1111/j.1600-0838.2011.01382.x; CLELAND V, 2011, BR J SPORTS MED; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; DEMORAES AC, 2012, APPETITE; Christofaro DGD, 2009, ARQ BRAS CARDIOL, V92, P9, DOI 10.1590/S0066-782X2009000100003; Ding D, 2011, AM J PREV MED, V41, P442, DOI 10.1016/j.amepre.2011.06.036; Dodd LJ, 2010, PREV MED, V51, P73, DOI 10.1016/j.ypmed.2010.04.005; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Edwardson CL, 2010, PSYCHOL SPORT EXERC, V11, P522, DOI 10.1016/j.psychsport.2010.05.001; Ekelund U, 2004, AM J CLIN NUTR, V80, P584; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; de Moraes ACF, 2011, CLINICS, V66, P1149, DOI 10.1590/S1807-59322011000700005; Gracia-Marco L, 2012, J ADOLESCENT HEALTH, V50, P484, DOI 10.1016/j.jadohealth.2011.08.018; Gracia-Marco L, 2011, AM J PREV MED, V40, P599, DOI 10.1016/j.amepre.2011.03.001; Hagstromer M, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.182; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Iliescu C, 2008, INT J OBESITY, V32, pS19, DOI 10.1038/ijo.2008.178; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Pavon DJ, 2010, NUTR HOSP, V25, P311, DOI 10.3305/nh.2010.25.2.4596; Kingwell BA, 2000, FASEB J, V14, P1685, DOI 10.1096/fj.99-0896rev; LAUER RM, 1989, PEDIATRICS, V84, P633; Lazarou C, 2009, J HUM HYPERTENS, V23, P456, DOI 10.1038/jhh.2008.151; Malcon MC, 2003, REV SAUDE PUBL, V37, P1, DOI 10.1590/S0034-89102003000100003; Marmot M, 2009, INT J PUBLIC HEALTH, V54, P125, DOI 10.1007/s00038-009-5402-z; Martinez-Gomez D, 2012, ATHEROSCLEROSIS, V221, P260, DOI 10.1016/j.atherosclerosis.2011.12.032; Martinez-Gomez D, 2011, ARCH DIS CHILD, V96, P240, DOI 10.1136/adc.2010.187161; Martinez-Gomez D, 2010, REV ESP CARDIOL, V63, P277, DOI 10.1016/S0300-8932(10)70086-5; Moreno LA, 2008, INT J OBESITY, V32, pS4, DOI 10.1038/ijo.2008.177; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Parker BA, 2010, EUR J APPL PHYSIOL, V110, P235, DOI 10.1007/s00421-010-1506-7; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Rey-Lopez JP, 2011, EUR J PUBLIC HEALTH, V21, P151, DOI 10.1093/eurpub/ckq035; REYLOPEZ JP, 2012, PEDIAT OBES; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Roux AVD, 2008, J EPIDEMIOL COMMUN H, V62, P957, DOI 10.1136/jech.2007.064311; Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068; Seabra AF, 2008, CAD SAUDE PUBLICA, V24, P721, DOI 10.1590/S0102-311X2008000400002; Sirard JR, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-82; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Topouchian JA, 2006, BLOOD PRESS MONIT, V11, P165, DOI 10.1097/01.mbp.0000209078.17246.34; TRILK J, 2012, CLUSTER ANAL PHYS AC; Tsioufis C, 2011, EUR J PUBLIC HEALTH, V21, P63, DOI 10.1093/eurpub/ckq006; *US, 2008, KEY GUID CHILDR AD; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Wijndaele K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020058; Zago Anderson Saranz, 2006, Arq. Bras. Cardiol., V87, pe264, DOI 10.1590/S0066-782X2006001900029	52	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62006	10.1371/journal.pone.0062006	http://dx.doi.org/10.1371/journal.pone.0062006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23650506	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000025
J	Kujala, MV; Tornqvist, H; Somppi, S; Hanninen, L; Krause, CM; Vainio, O; Kujala, J				Kujala, Miiamaaria V.; Tornqvist, Heini; Somppi, Sanni; Hanninen, Laura; Krause, Christina M.; Vainio, Outi; Kujala, Jan			Reactivity of Dogs' Brain Oscillations to Visual Stimuli Measured with Non-Invasive Electroencephalography	PLOS ONE			English	Article							MONKEY MOTOR CORTEX; RHYTHMIC ACTIVITY; AWAKE CHIMPANZEE; MEMORY PROCESSES; ALPHA-RHYTHM; RESPONSES; TASK; CAT; SYNCHRONIZATION; ATTENTION	Studying cognition of domestic dogs has gone through a renaissance within the last decades. However, although the behavioral studies of dogs are beginning to be common in the field of animal cognition, the neural events underlying cognition remain unknown. Here, we employed a non-invasive electroencephalography, with adhesive electrodes attached to the top of the skin, to measure brain activity of from 8 domestic dogs (Canis familiaris) while they stayed still to observe photos of dog and human faces. Spontaneous oscillatory activity of the dogs, peaking in the sensors over the parieto-occipital cortex, was suppressed statistically significantly during visual task compared with resting activity at the frequency of 15-30 Hz. Moreover, a stimulus-induced low-frequency (similar to 2-6 Hz) suppression locked to the stimulus onset was evident at the frontal sensors, possibly reflecting a motor rhythm guiding the exploratory eye movements. The results suggest task-related reactivity of the macroscopic oscillatory activity in the dog brain. To our knowledge, the study is the first to reveal non-invasively measured reactivity of brain electrophysiological oscillations in healthy dogs, and it has been based purely on positive operant conditional training, without the need for movement restriction or medication.	[Kujala, Miiamaaria V.; Kujala, Jan] INSERM, Lyon Neurosci Res Ctr, CNRS UMR5292, U1028, F-69500 Bron, France; [Kujala, Miiamaaria V.; Tornqvist, Heini; Somppi, Sanni; Vainio, Outi] Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, Helsinki, Finland; [Kujala, Miiamaaria V.] Aalto Univ, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Tornqvist, Heini; Somppi, Sanni; Hanninen, Laura; Vainio, Outi] Univ Helsinki, Fac Vet Med, Res Ctr Anim Welf, Helsinki, Finland; [Tornqvist, Heini; Krause, Christina M.] Univ Helsinki, Fac Behav Sci, Inst Behav Sci, Helsinki, Finland; [Hanninen, Laura] Univ Helsinki, Fac Vet Med, Dept Prod Anim Med, Helsinki, Finland; [Kujala, Jan] Aalto Univ, OV Lounasmaa Lab, Brain Res Unit, Espoo, Finland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Helsinki; Aalto University; University of Helsinki; University of Helsinki; University of Helsinki; Aalto University	Kujala, MV (corresponding author), INSERM, Lyon Neurosci Res Ctr, CNRS UMR5292, U1028, F-69500 Bron, France.	miiamaaria.kujala@helsinki.fi	Hänninen, Laura Talvikki/E-6683-2011; Kujala, Jan/J-3092-2012	Hänninen, Laura Talvikki/0000-0001-5118-8451; Kujala, Jan/0000-0002-3056-753X; Kujala, Miiamaaria/0000-0002-1377-2187; Vainio, Outi Maritta/0000-0003-3467-2246	Academy of Finland [137931, 115215, 137511]; University of Helsinki; Foundations' Post Doc Pool (Kone Foundation); BRAHE neuroscience collaboration between the Aalto University; Finnish Cultural Foundation; Advancement of Technology Foundation; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); University of Helsinki; Foundations' Post Doc Pool (Kone Foundation); BRAHE neuroscience collaboration between the Aalto University; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Advancement of Technology Foundation; Emil Aaltonen Foundation	This study was supported by the Academy of Finland (project #137931 to OV; #115215 and #137511 to CMK), research grant from the University of Helsinki, Foundations' Post Doc Pool (Kone Foundation), BRAHE neuroscience collaboration between the Aalto University and the University of Helsinki, Finnish Cultural Foundation, Advancement of Technology Foundation and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Bekisz M, 2003, EUR J NEUROSCI, V17, P421, DOI 10.1046/j.1460-9568.2003.02454.x; Bekisz Marek, 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P175; Berns GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038027; BICHSEL P, 1988, J VET INTERN MED, V2, P145, DOI 10.1111/j.1939-1676.1988.tb02811.x; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; BOUYER JJ, 1981, ELECTROEN CLIN NEURO, V51, P244, DOI 10.1016/0013-4694(81)90138-3; BOUYER JJ, 1987, NEUROSCIENCE, V22, P863, DOI 10.1016/0306-4522(87)92965-4; BUTTERWORTH G, 1980, INT J BEHAV DEV, V3, P253, DOI 10.1177/016502548000300303; Caton R, 1875, BRIT MED J, V2, P278, DOI DOI 10.1080/00029238.1970.11080764; CHATILA M, 1992, ELECTROEN CLIN NEURO, V83, P217, DOI 10.1016/0013-4694(92)90147-A; DASILVA FHL, 1977, NEUROSCI LETT, V6, P237, DOI 10.1016/0304-3940(77)90024-6; Fukushima H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013366; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gevins A, 1998, HUM FACTORS, V40, P79, DOI 10.1518/001872098779480578; GOKHBLIT I. I., 1958, BIULL EKSPTL BIOL I MED [TRANSL], V46, P790, DOI 10.1007/BF00837789; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Hanninen L, 2008, APPL ANIM BEHAV SCI, V111, P235, DOI 10.1016/j.applanim.2007.06.009; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B., 1998, EVOL COMMUN, V2, P137; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Howell TJ, 2012, BEHAV PROCESS, V89, P8, DOI 10.1016/j.beproc.2011.09.009; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jackson A, 2002, J PHYSIOL-LONDON, V541, P685, DOI 10.1113/jphysiol.2001.015099; Jensen O., 2010, MEG INTRO METHODS, P156; Kaminski J, 2008, ANIM COGN, V11, P367, DOI 10.1007/s10071-007-0124-1; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; Krause CM, 2006, PROG BRAIN RES, V159, P197, DOI 10.1016/S0079-6123(06)59013-2; Krause CM, 2010, INT J PSYCHOPHYSIOL, V77, P305, DOI 10.1016/j.ijpsycho.2010.06.203; Kronland-Martinet R, 1987, INT J PATTERN RECOGN, V1, P273, DOI DOI 10.1142/S0218001487000205; Kujala J, 2012, CEREB CORTEX, V22, P2305, DOI 10.1093/cercor/bhr307; Kujala MV, 2009, HUM BRAIN MAPP, V30, P3910, DOI 10.1002/hbm.20816; Laaksonen H, 2008, NEUROIMAGE, V42, P207, DOI 10.1016/j.neuroimage.2008.04.175; Liljestrom M, 2005, NEUROIMAGE, V25, P734, DOI 10.1016/j.neuroimage.2004.11.034; Lima B, 2010, CEREB CORTEX, V20, P1556, DOI 10.1093/cercor/bhp218; LOPESDASILVA FH, 1970, ELECTROEN CLIN NEURO, V29, P246, DOI 10.1016/0013-4694(70)90137-9; LOPESDASILVA FH, 1970, ELECTROEN CLIN NEURO, V29, P260, DOI 10.1016/0013-4694(70)90138-0; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Medendorp WP, 2007, CEREB CORTEX, V17, P2364, DOI 10.1093/cercor/bhl145; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Pellegrino FC, 2004, CLIN NEUROPHYSIOL, V115, P477, DOI 10.1016/S1388-2457(03)00347-X; PFURTSCHELLER G, 1994, INT J PSYCHOPHYSIOL, V16, P147, DOI 10.1016/0167-8760(89)90041-X; Range F, 2007, CURR BIOL, V17, P868, DOI 10.1016/j.cub.2007.04.026; Salenius S, 1995, ELECTROEN CLIN NEURO, V95, P453, DOI 10.1016/0013-4694(95)00155-7; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Sams M, 1997, NEUROSCIENCE, V77, P49, DOI 10.1016/S0306-4522(96)00419-8; Somppi S, 2012, ANIM COGN, V15, P163, DOI 10.1007/s10071-011-0442-1; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tanskanen T, 2007, NEUROIMAGE, V35, P1636, DOI 10.1016/j.neuroimage.2007.01.023; Tomasello M, 2009, SCIENCE, V325, P1213, DOI 10.1126/science.1179670; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Tornqvist H, 2012, 3 CAN SCI FOR BARC; Ueno A, 2010, BIOL LETTERS, V6, P311, DOI 10.1098/rsbl.2009.0864; Ueno A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001442; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wrobel A, 2000, ACTA NEUROBIOL EXP, V60, P247	63	23	23	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61818	10.1371/journal.pone.0061818	http://dx.doi.org/10.1371/journal.pone.0061818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650504	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000021
J	Kurata, K; Morioka, T; Yokoi, K; Matsubayashi, M				Kurata, Keiko; Morioka, Tomoko; Yokoi, Keiko; Matsubayashi, Mamiko			Remarkable Growth of Open Access in the Biomedical Field: Analysis of PubMed Articles from 2006 to 2010	PLOS ONE			English	Article								Introduction: This study clarifies the trends observed in open access (OA) in the biomedical field between 2006 and 2010, and explores the possible explanations for the differences in OA rates revealed in recent surveys. Methods: The study consists of a main survey and two supplementary surveys. In the main survey, a manual Google search was performed to investigate whether full-text versions of articles from PubMed were freely available. Target samples were articles published in 2005, 2007, and 2009; the searches were performed a year after publication in 2006, 2008, and 2010, respectively. Using the search results, we classified the OA provision methods into seven categories. The supplementary surveys calculated the OA rate using two search functions on PubMed: "LinkOut'' and "Limits.'' Results: The main survey concluded that the OA rate increased significantly between 2006 and 2010: the OA rate in 2010 (50.2%) was twice that in 2006 (26.3%). Furthermore, majority of OA articles were available from OA journal (OAJ) websites, indicating that OAJs have consistently been a significant contributor to OA throughout the period. OA availability through the PubMed Central (PMC) repository also increased significantly. OA rates obtained from two supplementary surveys were lower than those found in the main survey. "LinkOut'' could find only 40% of OA articles in the main survey. Discussion: OA articles in the biomedical field have more than a 50% share. OA has been achieved through OAJs. The reason why the OA rates in our surveys are different from those in recent surveys seems to be the difference in sampling methods and verification procedures.	[Kurata, Keiko] Keio Univ, Sch Lib & Informat Sci, Tokyo, Japan; [Morioka, Tomoko] Kunitachi Coll Music Lib, Tokyo, Japan; [Yokoi, Keiko] Tokyo Inst Technol Lib, Tokyo, Japan; [Matsubayashi, Mamiko] Univ Tsukuba, Fac Lib Informat & Media Studies, Ibaraki, Japan	Keio University; University of Tsukuba	Matsubayashi, M (corresponding author), Univ Tsukuba, Fac Lib Informat & Media Studies, Ibaraki, Japan.	mamiko@slis.tsukuba.ac.jp		Yokoi, Keiko/0000-0002-2546-347X; kurata, keiko/0000-0002-8486-2438	Japan Society for the Promotion of Science [17500160, 23300089]; Grants-in-Aid for Scientific Research [23300089] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research is partly funded by the Japan Society for the Promotion of Science (Grants-In-Aid for Scientific Research, grant nos. 17500160 & 23300089). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjork BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011273; Frantsvag JE, 2011, SCIECOM INF, V7, P1652; HAJJEM C, 2005, IEEE DATA ENG B, V28, P39; Kurata K, 2009, LIBR INFORM SC, P59; Laakso M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-124; Laakso M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020961; Lu ZY, 2009, J BIOMED INFORM, V42, P831, DOI 10.1016/j.jbi.2008.12.006; Matsubayashi M, 2009, J MED LIBR ASSOC, V97, P4, DOI 10.3163/1536-5050.97.1.002; Miyairi N, 2005, CURR AWARE, V2005, P284; Noorden RV, 2012, NATURE, V486, P7403; Walters WH, 2011, COLL RES LIBR, V72, P372, DOI 10.5860/crl-132; Way D, 2010, COLL RES LIBR, V71, P302, DOI 10.5860/crl-38r1; Xia JF, 2012, PORTAL-LIBR ACAD, V12, P85	13	43	44	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e60925	10.1371/journal.pone.0060925	http://dx.doi.org/10.1371/journal.pone.0060925			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658683	gold, Green Published, Green Submitted			2022-12-27	WOS:000319167000005
J	Cheng, SF; Tsai, MS; Huang, CL; Huang, YP; Chen, IH; Lin, NS; Hsu, YH; Tsai, CH; Cheng, CP				Cheng, Shun-Fang; Tsai, Meng-Shan; Huang, Chia-Lin; Huang, Ying-Ping; Chen, I-Hsuan; Lin, Na-Sheng; Hsu, Yau-Heiu; Tsai, Ching-Hsiu; Cheng, Chi-Ping			Ser/Thr Kinase-Like Protein of Nicotiana benthamiana Is Involved in the Cell-to-Cell Movement of Bamboo mosaic virus	PLOS ONE			English	Article							TRIPLE-GENE-BLOCK; N-TERMINAL REGION; VIRAL MOVEMENT; COAT PROTEIN; IN-VITRO; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; REPLICATION PROTEIN; P-33 REPLICATION; RNA-BINDING	To investigate the plant genes affected by Bamboo mosaic virus (BaMV) infection, we applied a cDNA-amplified fragment length polymorphism technique to screen genes with differential expression. A serine/threonine kinase-like (NbSTKL) gene of Nicotiana benthamiana is upregulated after BaMV infection. NbSTKL contains the homologous domain of Ser/Thr kinase. Knocking down the expression of NbSTKL by virus-induced gene silencing reduced the accumulation of BaMV in the inoculated leaves but not in the protoplasts. The spread of GFP-expressing BaMV in the inoculated leaves is also impeded by a reduced expression of NbSTKL. These data imply that NbSTKL facilitates the cell-to-cell movement of BaMV. The subcellular localization of NbSTKL is mainly on the cell membrane, which has been confirmed by mutagenesis and fractionation experiments. Combined with the results showing that active site mutation of NbSTKL does not change its subcellular localization but significantly affects BaMV accumulation, we conclude that NbSTKL may regulate BaMV movement on the cell membrane by its kinase-like activity. Moreover, the transient expression of NbSTKL does not significantly affect the accumulation of Cucumber mosaic virus (CMV) and Potato virus X (PVX); thus, NbSTKL might be a specific protein facilitating BaMV movement.	[Tsai, Meng-Shan; Cheng, Chi-Ping] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Cheng, Shun-Fang; Huang, Chia-Lin; Huang, Ying-Ping; Chen, I-Hsuan; Hsu, Yau-Heiu; Tsai, Ching-Hsiu] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Lin, Na-Sheng] Acad Sinica, Inst Plant & Microbial Biol, Nankang, Taiwan	Tzu Chi University; National Chung Hsing University; Academia Sinica - Taiwan	Tsai, CH (corresponding author), Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan.	chtsai1@dragon.nchu.edu.tw; cp1103@mail.tcu.edu.tw			National Science Council [NSC 97-2313-B-320-001-MY3, NSC 99-2321-B-005-003-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council NSC 97-2313-B-320-001-MY3 and NSC 99-2321-B-005-003-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Modena NA, 2008, VIRUS RES, V137, P16, DOI 10.1016/j.virusres.2008.04.007; Beachy RN, 2000, TRAFFIC, V1, P540, DOI 10.1034/j.1600-0854.2000.010703.x; Champagne J, 2007, MOL PLANT MICROBE IN, V20, P648, DOI 10.1094/MPMI-20-6-0648; Chang BY, 1997, J GEN VIROL, V78, P1175, DOI 10.1099/0022-1317-78-5-1175; Cheng SF, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-286; Chowda-Reddy RV, 2008, VIRUS RES, V135, P115, DOI 10.1016/j.virusres.2008.02.014; Guenoune-Gelbart D, 2008, MOL PLANT MICROBE IN, V21, P335, DOI 10.1094/MPMI-21-3-0335; Heinlein M, 1998, PLANT CELL, V10, P1107, DOI 10.1105/tpc.10.7.1107; Karger EM, 2003, J GEN VIROL, V84, P727, DOI 10.1099/vir.0.18972-0; Kleinow T, 2009, VIROLOGY, V390, P89, DOI 10.1016/j.virol.2009.04.018; Lan P, 2010, MOL PLANT MICROBE IN, V23, P903, DOI 10.1094/MPMI-23-7-0903; Lee CC, 2011, J VIROL, V85, P12022, DOI 10.1128/JVI.05595-11; Lee JY, 2005, PLANT CELL, V17, P2817, DOI 10.1105/tpc.105.034330; Lee JY, 2001, TRENDS MICROBIOL, V9, P5, DOI 10.1016/S0966-842X(00)01901-6; Lewsey M, 2009, MOL PLANT MICROBE IN, V22, P642, DOI 10.1094/MPMI-22-6-0642; Li YI, 1998, J VIROL, V72, P10093, DOI 10.1128/JVI.72.12.10093-10099.1998; Li YI, 2001, J VIROL, V75, P782, DOI 10.1128/JVI.75.2.782-788.2001; Lin JW, 2007, NUCLEIC ACIDS RES, V35, P424, DOI 10.1093/nar/gkl1061; Lin MK, 2004, J GEN VIROL, V85, P251, DOI 10.1099/vir.0.19442-0; LIN NS, 1994, J GEN VIROL, V75, P2513, DOI 10.1099/0022-1317-75-9-2513; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; Martin-Belmonte F, 2000, BIOCHEMISTRY-US, V39, P1083, DOI 10.1021/bi992132e; Mas P, 1999, J CELL BIOL, V147, P945, DOI 10.1083/jcb.147.5.945; Matsushita Y, 2003, J GEN VIROL, V84, P497, DOI 10.1099/vir.0.18839-0; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; Meng L, 2010, P NATL ACAD SCI USA, V107, P3900, DOI 10.1073/pnas.0913759107; Munter S., 2006, SCI STKE, V2006, pre5, DOI DOI 10.1126/STKE.3352006RE5; Ouko MO, 2010, PLANT J, V62, P829, DOI 10.1111/j.1365-313X.2010.04195.x; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Schoelz JE, 2011, MOL PLANT, V4, P813, DOI 10.1093/mp/ssr070; Shapka N, 2005, VIROLOGY, V343, P65, DOI 10.1016/j.virol.2005.08.006; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Stork J, 2005, VIROLOGY, V343, P79, DOI 10.1016/j.virol.2005.08.005; Trutnyeva K, 2005, VIROLOGY, V332, P563, DOI 10.1016/j.virol.2004.11.040; Tsai CH, 1999, J VIROL, V73, P2703, DOI 10.1128/JVI.73.4.2703-2709.1999; Verchot-Lubicz J, 2010, MOL PLANT MICROBE IN, V23, P1231, DOI 10.1094/MPMI-04-10-0086; Waigmann E, 2000, EMBO J, V19, P4875, DOI 10.1093/emboj/19.18.4875; Yalovsky S, 1999, TRENDS PLANT SCI, V4, P439, DOI 10.1016/S1360-1385(99)01492-2; YEH CC, 1993, COUNCIL AGR PLANT PR, V1, P275; Zayakina O, 2008, MOL PLANT PATHOL, V9, P37, DOI [10.1111/J.1364-3703.2007.00445.X, 10.1111/j.1364-3703.2007.00445.x]	41	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62907	10.1371/journal.pone.0062907	http://dx.doi.org/10.1371/journal.pone.0062907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646157	gold, Green Published, Green Submitted			2022-12-27	WOS:000319077300111
J	Leunert, F; Grossart, HP; Gerhardt, V; Eckert, W				Leunert, Franziska; Grossart, Hans-Peter; Gerhardt, Volkmar; Eckert, Werner			Toxicant Induced Changes on Delayed Fluorescence Decay Kinetics of Cyanobacteria and Green Algae: A Rapid and Sensitive Biotest	PLOS ONE			English	Article							PHOTOSYSTEM-II; MICROCYSTIS-AERUGINOSA; ELECTRON-TRANSPORT; UNICELLULAR ALGAE; CHLOROPHYLL-A; TOXICITY; GROWTH; COPPER; LIGHT; LUMINESCENCE	Algal tests have developed into routine tools for testing toxicity of pollutants in aquatic environments. Meanwhile, in addition to algal growth rates, an increasing number of fluorescence based methods are used for rapid and sensitive toxicity measures. The present study stresses the suitability of delayed fluorescence (DF) as a promising parameter for biotests. DF is based on the recombination fluorescence at the reaction centre of photosystem II, which is emitted only by photosynthetically active cells. We analyzed the effects of three chemicals (3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU), 3,5 Dichlorophenol (3,5 DCP) and copper) on the shape of the DF decay kinetics for potential use in phytoplankton toxicity tests. The short incubation tests were done with four phytoplankton species, with special emphasis on the cyanobacterium Microcystis aeruginosa. All species exhibited a high sensitivity to DCMU, but cyanobacteria were more affected by copper and less by 3,5 DCP than the tested green algae. Analyses of changes in the DF decay curve in response to the added chemicals indicated the feasibility of the DF decay approach as a rapid and sensitive testing tool.	[Leunert, Franziska; Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Gerhardt, Volkmar] Univ Regensburg, Dept Phys, D-93053 Regensburg, Germany; [Eckert, Werner] Israel Oceanog & Limnol Res, Yigal Allon Kinneret Limnol Lab, Migdal, Israel	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam; University of Regensburg; Israel Oceanographic & Limnological Research Institute	Leunert, F (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany.	leunert@igb-berlin.de	Eckert, Werner/AAP-9335-2021	Eckert, Werner/0000-0002-2361-6911	Deutsche Forschungsgemeinschaft [PA1655/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (PA1655/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEMA DMM, 1978, HYDROBIOLOGIA, V59, P125, DOI 10.1007/BF00020773; [Anonymous], OECD GUIDELINES TEST, P221; Berden-Zrimec M, 2007, CENT EUR J BIOL, V2, P169, DOI 10.2478/s11535-007-0014-1; BLANCK H, 1984, ECOTOX ENVIRON SAFE, V8, P339, DOI 10.1016/0147-6513(84)90003-4; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CONRAD R, 1993, J APPL PHYCOL, V5, P505, DOI 10.1007/BF02182509; de Kuhn RM, 2006, WATER RES, V40, P2695, DOI 10.1016/j.watres.2006.04.045; Deniz F, 2011, B ENVIRON CONTAM TOX, V87, P11, DOI 10.1007/s00128-011-0300-5; DESAI TS, 1983, BIOCHIM BIOPHYS ACTA, V724, P485, DOI 10.1016/0005-2728(83)90109-3; Dziallas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025569; Eisentraeger A, 2003, ECOTOX ENVIRON SAFE, V54, P346, DOI 10.1016/S0147-6513(02)00099-4; Escher BI, 2008, J ENVIRON MONITOR, V10, P622, DOI 10.1039/b800951a; FERNANDES JC, 1991, BOT REV, V57, P246, DOI 10.1007/BF02858564; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Friedrich G, 2009, LIMNOLOGICA, V39, P14, DOI 10.1016/j.limno.2008.03.006; FUJITA Y, 1987, PLANT CELL PHYSIOL, V28, P283; Gerhardt V., 1998, Limnologica, V28, P313; Gerhardt V, 1989, DORTMUNDER BEITRAGE, V37, P87; Gerhardt V, 1993, ENTWICKLUNG IMPLEMEN; Goltsev V, 2003, J THEOR BIOL, V225, P171, DOI 10.1016/S0022-5193(03)00236-4; Greisberger S, 2007, J PHYCOL, V43, P1108, DOI 10.1111/j.1529-8817.2007.00404.x; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Hakanson L, 2003, ECOL MODEL, V169, P179, DOI 10.1016/S0304-3800(03)00269-2; HENNING M, 1991, INT REV GES HYDROBIO, V76, P37, DOI 10.1002/iroh.19910760105; HIDEG E, 1991, PHOTOSYNTH RES, V29, P107, DOI 10.1007/BF00035381; HIRANO M, 1980, Photosynthesis Research, V1, P149, DOI 10.1007/BF00020594; ID, 1996, METH US FREEZ DRI 2F; Istanovics V, 2005, FRESHWATER BIOL, V50, P1950, DOI 10.1111/j.1365-2427.2005.01442.x; JOLIOT P, 1971, PHOTOCHEM PHOTOBIOL, V14, P287, DOI 10.1111/j.1751-1097.1971.tb06174.x; Juneau P, 2001, CHEMOSPHERE, V45, P589, DOI 10.1016/S0045-6535(01)00034-0; Jursinic P.A., 1986, LIGHT EMISSION PLANT, V1st ed., P291; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Katsumata M, 2006, WATER RES, V40, P3393, DOI 10.1016/j.watres.2006.07.016; Katsumata M, 2009, B ENVIRON CONTAM TOX, V83, P484, DOI 10.1007/s00128-009-9826-1; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; Lombardi AT, 2011, PHOTOSYNTH RES, V108, P77, DOI 10.1007/s11120-011-9655-z; Marten M, 2002, FIELD SCREENING EUROPE 2001, P221; MELLVIG S, 1986, PHYSIOL PLANTARUM, V68, P180, DOI 10.1111/j.1399-3054.1986.tb01912.x; MOHANTY N, 1989, PLANT PHYSIOL, V90, P175, DOI 10.1104/pp.90.1.175; Morgan E.L., 1984, P75; OECD, 2011, OECD GUID TEST CHEM, DOI 10.1787/9789264069923-en; OECD (Organization for Economic Cooperation and Development), 2016, GUID TEST CHEM; PARSONS TR, 1963, J MAR RES, V21, P155; PETERSON HG, 1994, AQUAT TOXICOL, V28, P275, DOI 10.1016/0166-445X(94)90038-8; PUTT M, 1987, CAN J FISH AQUAT SCI, V44, P2144, DOI 10.1139/f87-263; Qian HF, 2010, AQUAT TOXICOL, V99, P405, DOI 10.1016/j.aquatox.2010.05.018; Rojickova-Padrtova R, 1999, CHEMOSPHERE, V38, P3329, DOI 10.1016/S0045-6535(98)00566-9; SANDMANN G, 1980, PLANT PHYSIOL, V66, P797, DOI 10.1104/pp.66.5.797; SCHAFER H, 1994, ECOTOX ENVIRON SAFE, V27, P64, DOI 10.1006/eesa.1994.1007; SCHERER S, 1990, TRENDS BIOCHEM SCI, V15, P458, DOI 10.1016/0968-0004(90)90296-N; Schreiber U, 2002, PHOTOSYNTH RES, V74, P317, DOI 10.1023/A:1021276003145; Schwarzenbach RP, 2010, ANNU REV ENV RESOUR, V35, P109, DOI 10.1146/annurev-environ-100809-125342; Shao CY, 2002, APPL ENVIRON MICROB, V68, P5026, DOI 10.1128/AEM.68.10.5026-5033.2002; Sherry ND, 2001, DEEP-SEA RES PT II, V48, P1263, DOI 10.1016/S0967-0645(00)00138-7; Streeb C, 2002, CURRENT TOPICS PLANT, V3, P131; STREHLER BL, 1951, J GEN PHYSIOL, V34, P809, DOI 10.1085/jgp.34.6.809; Thompson JA, 1997, CHEMOSPHERE, V35, P2027, DOI 10.1016/S0045-6535(97)00226-9; Vallotton N, 2008, ENVIRON TOXICOL CHEM, V27, P1399, DOI 10.1897/07-197; WANGBERG SA, 1988, ECOTOX ENVIRON SAFE, V16, P72, DOI 10.1016/0147-6513(88)90018-8; Wood AM., 2005, ALGAL CULTURING TECH, P269, DOI DOI 10.1016/B978-012088426-1/50019-6; Yacobi YZ, 1998, WATER RES, V32, P2577, DOI 10.1016/S0043-1354(98)00032-3; ZEHNDER A, 1960, CAN J MICROBIOL, V6, P645, DOI 10.1139/m60-077	63	14	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63127	10.1371/journal.pone.0063127	http://dx.doi.org/10.1371/journal.pone.0063127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646185	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300140
J	Lin, AHY; Li, RWS; Ho, EYW; Leung, GPH; Leung, SWS; Vanhoutte, PM; Man, RYK				Lin, Amanda H. Y.; Li, Rachel W. S.; Ho, Eva Y. W.; Leung, George P. H.; Leung, Susan W. S.; Vanhoutte, Paul M.; Man, Ricky Y. K.			Differential Ligand Binding Affinities of Human Estrogen Receptor-alpha Isoforms	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; ER-ALPHA; MEMBRANE LOCALIZATION; CANCER-CELLS; VARIANT; 17-BETA-ESTRADIOL; BETA; ACTIVATION; EXPRESSION	Rapid non-genomic effects of 17 beta-estradiol are elicited by the activation of different estrogen receptor-alpha isoforms. Presence of surface binding sites for estrogen have been identified in cells transfected with full-length estrogen receptor-alpha 66 (ER66) and the truncated isoforms, estrogen receptor-alpha 46 (ER46) and estrogen receptor-alpha 36 (ER36). However, the binding affinities of the membrane estrogen receptors (mERs) remain unknown due to the difficulty of developing of stable mER-transfected cell lines with sufficient mER density, which has largely hampered biochemical binding studies. The present study utilized cell-free expression systems to determine the binding affinities of 17 beta-estradiol to mERs, and the relationship among palmitoylation, membrane insertion and binding affinities. Saturation binding assays of human mERs revealed that [H-3]-17 beta-estradiol bound ER66 and ER46 with K-d values of 68.81 and 60.72 pM, respectively, whereas ER36 displayed no specific binding within the tested concentration range. Inhibition of palmitoylation or removal of the nanolipoprotein particles, used as membrane substitute, reduced the binding affinities of ER66 and ER46 to 17b-estradiol. Moreover, ER66 and ER46 bound differentially with some estrogen receptor agonists and antagonists, and phytoestrogens. In particular, the classical estrogen receptor antagonist, ICI 182,780, had a higher affinity for ER66 than ER46. In summary, the present study defines the binding affinities for human estrogen receptor-alpha isoforms, and demonstrates that ER66 and ER46 show characteristics of mERs. The present data also indicates that palmitoylation and membrane insertion of mERs are important for proper receptor conformation allowing 17 beta-estradiol binding. The differential binding of ER66 and ER46 with certain compounds substantiates the prospect of developing mER-selective drugs.	[Lin, Amanda H. Y.; Li, Rachel W. S.; Ho, Eva Y. W.; Leung, George P. H.; Leung, Susan W. S.; Vanhoutte, Paul M.; Man, Ricky Y. K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Man, RYK (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Pokfulam, Hong Kong, Peoples R China.	rykman@hkucc.hku.hk	Lin, Amanda/C-6964-2014		General Research Fund of the Research Grant Council of Hong Kong [HKU 772307M]	General Research Fund of the Research Grant Council of Hong Kong	The work was supported by the General Research Fund (HKU 772307M) of the Research Grant Council of Hong Kong (http://www.ugc.edu.hk/eng/rgc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Acconcia F, 2004, BIOCHEM BIOPH RES CO, V316, P878, DOI 10.1016/j.bbrc.2004.02.129; ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; Billon-Gales A, 2009, P NATL ACAD SCI USA, V106, P2053, DOI 10.1073/pnas.0808742106; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Figtree GA, 2003, CIRCULATION, V107, P120, DOI 10.1161/01.CIR.0000043805.11780.F5; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Ho KJ, 2002, ARTERIOSCL THROM VAS, V22, P1952, DOI 10.1161/01.ATV.0000041200.85946.4A; Hulme E. C., 1992, RECEPTOR LIGAND INTE, P63; JIANG SY, 1992, JNCI-J NATL CANCER I, V84, P580, DOI 10.1093/jnci/84.8.580; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Katzen F, 2009, TRENDS BIOTECHNOL, V27, P455, DOI 10.1016/j.tibtech.2009.05.005; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Keung W, 2005, BRIT J PHARMACOL, V146, P1148, DOI 10.1038/sj.bjp.0706422; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; KUSHNER PJ, 1990, MOL ENDOCRINOL, V4, P1465, DOI 10.1210/mend-4-10-1465; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Lin AHY, 2011, PHARMACOL RES, V63, P181, DOI 10.1016/j.phrs.2010.11.007; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Morello KC, 2002, CRIT REV ONCOL HEMAT, V43, P63, DOI 10.1016/S1040-8428(02)00022-7; MURDOCH FE, 1991, MOL CELL ENDOCRINOL, V78, pC103, DOI 10.1016/0303-7207(91)90114-8; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; PAPPAS TC, 1995, FASEB J, V9, P404, DOI 10.1096/fasebj.9.5.7896011; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; SALOMONSSON M, 1994, J STEROID BIOCHEM, V50, P313, DOI 10.1016/0960-0760(94)90137-6; Schults JR, 1988, BIOPHARMACEUTICAL ST, P21; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; SZEGO CM, 1967, P NATL ACAD SCI USA, V58, P1711, DOI 10.1073/pnas.58.4.1711; Teoh H, 2000, MOL CELL BIOCHEM, V207, P65, DOI 10.1023/A:1007090113551; TESARIK J, 1995, J CLIN ENDOCR METAB, V80, P1438, DOI 10.1210/jc.80.4.1438; Vera R, 2005, J PHARMACOL EXP THER, V314, P1300, DOI 10.1124/jpet.105.085530; WAKELING AE, 1991, CANCER RES, V51, P3867; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; WEBB P, 1992, MOL ENDOCRINOL, V6, P157, DOI 10.1210/me.6.2.157; Wells J. W., 1992, RECEPTOR LIGAND INTE, P289; Xu YC, 2006, MOL CELL BIOCHEM, V287, P61, DOI 10.1007/s11010-005-9061-y	54	62	64	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63199	10.1371/journal.pone.0063199	http://dx.doi.org/10.1371/journal.pone.0063199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646196	Green Submitted, Green Published, gold			2022-12-27	WOS:000319077300153
J	Shinohara, M; Shinohara, A				Shinohara, Miki; Shinohara, Akira			Multiple Pathways Suppress Non-Allelic Homologous Recombination during Meiosis in Saccharomyces cerevisiae	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; BREAK-INDUCED REPLICATION; MEIOTIC GENE CONVERSION; DOUBLE-STRAND BREAKS; DNA-DAMAGE; CROSSING-OVER; CROSSOVER INTERFERENCE; HOLLIDAY JUNCTIONS; SLIDING CLAMP; MUTS HOMOLOG	Recombination during meiosis in the form of crossover events promotes the segregation of homologous chromosomes by providing the only physical linkage between these chromosomes. Recombination occurs not only between allelic sites but also between non-allelic (ectopic) sites. Ectopic recombination is often suppressed to prevent non-productive linkages. In this study, we examined the effects of various mutations in genes involved in meiotic recombination on ectopic recombination during meiosis. RAD24, a DNA damage checkpoint clamp-loader gene, suppressed ectopic recombination in wild type in the same pathway as RAD51. In the absence of RAD24, a meiosis-specific recA homolog, DMC1, suppressed the recombination. Homology search and strand exchange in ectopic recombination occurred when either the RAD51 or the DMC1 recA homolog was absent, but was promoted by RAD52. Unexpectedly, the zip1 mutant, which is defective in chromosome synapsis, showed a decrease, rather than an increase, in ectopic recombination. Our results provide evidence for two types of ectopic recombination: one that occurs in wild-type cells and a second that occurs predominantly when the checkpoint pathway is inactivated.	[Shinohara, Miki; Shinohara, Akira] Osaka Univ, Inst Prot Res, Div Integrated Prot Funct, Suita, Osaka 565, Japan; [Shinohara, Miki; Shinohara, Akira] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka, Japan	Osaka University; Osaka University	Shinohara, M (corresponding author), Osaka Univ, Inst Prot Res, Div Integrated Prot Funct, Suita, Osaka 565, Japan.	mikis@protein.osaka-u.ac.jp; ashino@protein.osaka-u.ac.jp	Shinohara, Miki/E-7151-2013	Shinohara, Miki/0000-0002-7413-8235	Ministry of Education, Science, Sport and Culture; Asahi-Glass Science Foundation; Uehara Science Foundation; Mochida Medical Science Foundation; Takeda Science Foundation; Japanese Society for the Promotion of Science through the "Next Generation World-Leading Researchers'' program; Council for Science and Technology Policy	Ministry of Education, Science, Sport and Culture; Asahi-Glass Science Foundation; Uehara Science Foundation(Uehara Memorial Foundation); Mochida Medical Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society for the Promotion of Science through the "Next Generation World-Leading Researchers'' program; Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP))	This work was supported by a Grant-in-Aid from the Ministry of Education, Science, Sport and Culture to AS and MS, as well as grants from the Asahi-Glass Science Foundation, the Uehara Science Foundation, the Mochida Medical Science Foundation and the Takeda Science Foundation to AS. MS was supported by the Japanese Society for the Promotion of Science through the "Next Generation World-Leading Researchers'' program, initiated by the Council for Science and Technology Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Goldman ASH, 2000, P NATL ACAD SCI USA, V97, P9537, DOI 10.1073/pnas.97.17.9537; Goldman ASH, 1996, GENETICS, V144, P43; Grushcow JM, 1999, GENETICS, V153, P607; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; JINKSROBERTSON S, 1985, P NATL ACAD SCI USA, V82, P3350, DOI 10.1073/pnas.82.10.3350; KADYK LC, 1992, GENETICS, V132, P387; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Klein HL, 1997, GENETICS, V147, P1533; KUPIEC M, 1988, MOL CELL BIOL, V8, P2942, DOI 10.1128/MCB.8.7.2942; Kurzbauer MT, 2012, PLANT CELL, V24, P2058, DOI 10.1105/tpc.112.098459; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; LICHTEN M, 1987, GENETICS, V115, P233; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Malkova A, 2001, GENE DEV, V15, P1055, DOI 10.1101/gad.875901; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; SASANUMA H, 2013, NAT COMMS IN PRESS; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 2003, GENETICS, V164, P855; Shinohara M, 1997, GENETICS, V147, P1545; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Signon L, 2001, MOL CELL BIOL, V21, P2048, DOI 10.1128/MCB.21.6.2048-2056.2001; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Thompson DA, 1999, GENETICS, V153, P621; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Tsubouchi T, 2006, DEV CELL, V10, P809, DOI 10.1016/j.devcel.2006.04.003; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	63	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63144	10.1371/journal.pone.0063144	http://dx.doi.org/10.1371/journal.pone.0063144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646187	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300142
J	Bryant, RA; McGrath, C; Felmingham, KL				Bryant, Richard A.; McGrath, Chloe; Felmingham, Kim L.			The Roles of Noradrenergic and Glucocorticoid Activation in the Development of Intrusive Memories	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; DECLARATIVE MEMORY; STRESS-DISORDER; SEX-DIFFERENCES; CONSOLIDATION; CORTISOL; AMYGDALA; HUMANS; WOMEN; AXIS	Intrusive memories are a common feature of many psychological disorders. Recent evidence has potentially extended cognitive models of intrusions by identifying the role of biological markers of arousal at the time of consolidation in subsequent memory for emotional events. This study investigated the role of arousal during consolidation in the development of intrusive memories. Seventy-eight university students (37 men and 41 women) viewed 20 negative and 20 neutral images. Half the participants then underwent a cold pressor test (High Stress), immersing their hand in ice water, while the remaining participants immersed their hand in warm water (Low Stress). Samples of salivary alpha-amylase (sAA) and cortisol were collected from participants at baseline and following the stressor challenge. Participants completed a delayed free recall test and intrusion questionnaires two days later. Participants in the High Stress condition reported more intrusions of negative images than participants in the Low Stress condition. An interaction variable in a linear regression of increased noradrenergic and cortisol values predicted intrusive memories of emotional stimuli for men but not women. These findings are consistent with recent evidence of the combined effects of noradrenaline and corticoid responses to stress on emotional memories, and also with increasing evidence of gender differences in how stress hormones influence formation of emotional memories. These findings point to possible mechanisms by which development of intrusions may be prevented after consolidation of traumatic experiences.	[Bryant, Richard A.; McGrath, Chloe] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Felmingham, Kim L.] Univ Tasmania, Sch Psychol, Hobart, Tas, Australia	University of New South Wales Sydney; University of Tasmania	Bryant, RA (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	r.bryant@unsw.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X	Australian Research Council [DP110105274]	Australian Research Council(Australian Research Council)	This project was funded by an Australian Research Council Discovery grant (DP110105274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie HC, 2006, PSYCHONEUROENDOCRINO, V31, P187, DOI 10.1016/j.psyneuen.2005.06.008; Abercrombie HC, 2003, BEHAV NEUROSCI, V117, P505, DOI 10.1037/0735-7044.117.3.505; Andreano JM, 2006, PSYCHOL SCI, V17, P466, DOI 10.1111/j.1467-9280.2006.01729.x; Andreano JM, 2008, PSYCHONEUROENDOCRINO, V33, P874, DOI 10.1016/j.psyneuen.2008.03.009; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Bryant RA, 2011, J AFFECT DISORDERS, V131, P398, DOI 10.1016/j.jad.2010.10.049; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1996, CURR OPIN NEUROBIOL, V6, P237, DOI 10.1016/S0959-4388(96)80078-X; Cahill L, 2001, TRENDS NEUROSCI, V24, P578, DOI 10.1016/S0166-2236(00)01885-3; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; Clark D.A., 2005, INTRUSIVE THOUGHTS C; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlert U, 2006, J CLIN ENDOCR METAB, V91, P5130, DOI 10.1210/jc.2006-0461; Erickson K, 2003, NEUROSCI BIOBEHAV R, V27, P233, DOI 10.1016/S0149-7634(03)00033-2; Felmingham K.L., 2012, PSYCHONEUROENDOCRINO; Felmingham KL, 2012, BIOL PSYCHOL, V89, P539, DOI 10.1016/j.biopsycho.2011.12.006; Ferree NK, 2009, CONSCIOUS COGN, V18, P126, DOI 10.1016/j.concog.2008.11.008; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; Hagenaars MA, 2010, MEMORY, V18, P76, DOI 10.1080/09658210903476522; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Katanje E, 2006, PSYCHONEUROENDOCRINO, V31, P151; Klinger E., 1996, LEA SER PER CLIN PSY, P3; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Kukolja J, 2011, PSYCHOL MED, V41, P2167, DOI 10.1017/S0033291711000183; Kukolja J, 2008, J NEUROSCI, V28, P12868, DOI 10.1523/JNEUROSCI.3592-08.2008; Lang PJ, 2008, INT AFFECTIVE PICTUR; Lupien SJ, 1999, BEHAV NEUROSCI, V113, P420, DOI 10.1037/0735-7044.113.3.420; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; Roca CA, 2003, J CLIN ENDOCR METAB, V88, P3057, DOI 10.1210/jc.2002-021570; Rohleder N, 2009, INT J PSYCHOPHYSIOL, V72, P74, DOI 10.1016/j.ijpsycho.2008.03.010; Roozendaal B, 2002, EUR J NEUROSCI, V15, P553, DOI 10.1046/j.0953-816x.2001.01876.x; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Segal SK, 2009, PSYCHONEUROENDOCRINO, V34, P1263, DOI 10.1016/j.psyneuen.2009.04.020; van Stegeren AH, 2005, NEUROIMAGE, V24, P898, DOI 10.1016/j.neuroimage.2004.09.011; Wenzlaff EM, 2000, ANNU REV PSYCHOL, V51, P59, DOI 10.1146/annurev.psych.51.1.59; Wolf OT, 2009, BRAIN RES, V1293, P142, DOI 10.1016/j.brainres.2009.04.013	42	39	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62675	10.1371/journal.pone.0062675	http://dx.doi.org/10.1371/journal.pone.0062675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658640	gold, Green Submitted, Green Published			2022-12-27	WOS:000321662800054
J	Neuman, Y; Assaf, D; Cohen, Y; Last, M; Argamon, S; Howard, N; Frieder, O				Neuman, Yair; Assaf, Dan; Cohen, Yohai; Last, Mark; Argamon, Shlomo; Howard, Newton; Frieder, Ophir			Metaphor Identification in Large Texts Corpora	PLOS ONE			English	Article							LANGUAGE; COMPREHENSION; DESIGN; CORPUS	Identifying metaphorical language-use (e.g., sweet child) is one of the challenges facing natural language processing. This paper describes three novel algorithms for automatic metaphor identification. The algorithms are variations of the same core algorithm. We evaluate the algorithms on two corpora of Reuters and the New York Times articles. The paper presents the most comprehensive study of metaphor identification in terms of scope of metaphorical phrases and annotated corpora size. Algorithms' performance in identifying linguistic phrases as metaphorical or literal has been compared to human judgment. Overall, the algorithms outperform the state-of-the-art algorithm with 71% precision and 27% averaged improvement in prediction over the base-rate of metaphors in the corpus.	[Neuman, Yair; Assaf, Dan] Ben Gurion Univ Negev, Dept Educ, IL-84105 Beer Sheva, Israel; [Cohen, Yohai] Gilasio Coding Ltd, Tel Aviv, Israel; [Last, Mark] Ben Gurion Univ Negev, Dept Informat Syst, IL-84105 Beer Sheva, Israel; [Argamon, Shlomo] IIT, Dept Comp Sci, Chicago, IL 60616 USA; [Howard, Newton] MIT, Synthet Intelligence Lab, Boston, MA USA; [Frieder, Ophir] Georgetown Univ, Dept Comp Sci, Washington, DC USA	Ben Gurion University; Ben Gurion University; Illinois Institute of Technology; Massachusetts Institute of Technology (MIT); Georgetown University	Neuman, Y (corresponding author), Ben Gurion Univ Negev, Dept Educ, IL-84105 Beer Sheva, Israel.	yneuman@bgu.ac.il	Argamon, Shlomo/AAM-4515-2020; Last, Mark/AAF-8443-2020	Howard, Newton/0000-0002-8503-3973	Intelligence Advanced Research Projects Activity (IARPA) via Department of Defense US Army Research Laboratory [W911NF-12-C-0021]	Intelligence Advanced Research Projects Activity (IARPA) via Department of Defense US Army Research Laboratory	This work is supported by the Intelligence Advanced Research Projects Activity (IARPA) via Department of Defense US Army Research Laboratory contract number W911NF-12-C-0021. The U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright annotation thereon. Disclaimer: The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of IARPA, DoD/ARL, or the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaf D, 2013, P IEEE S SE IN PRESS; Banea Carmen, 2011, P 9 INT C COMP SEM I, P25; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Birke Julia, 2006, EACL 2006 11 C EUR C; Birke Julia, 2007, P WORKSH COMP APPR F, P21; Cardillo ER, 2010, BEHAV RES METHODS, V42, P651, DOI 10.3758/BRM.42.3.651; Davies M, 2009, INT J CORPUS LINGUIS, V14, P159, DOI 10.1075/ijcl.14.2.02dav; De Marneffe M.-C., 2008, COL 2008 P WORKSH CR; Dolan W. B., 1995, P REPR ACQ LEX KNOWL, P27; Fass D., 1991, Computational Linguistics, V17, P49; Gibbs RW, 2004, J PRAGMATICS, V36, P1189, DOI 10.1016/j.pragma.2003.10.009; Goatly A, 1997, LANGUAGE METAPHORS; Gruber T, 2008, J WEB SEMANT, V6, P4, DOI 10.1016/j.websem.2007.11.011; Hashimoto C, 2009, LANG RESOUR EVAL, V43, P355, DOI 10.1007/s10579-009-9104-1; Hoey M, 1995, LEXICAL PRIMING NEW; January D, 2007, COGNITION, V104, P417, DOI 10.1016/j.cognition.2006.07.008; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; Kintsch W, 2000, PSYCHON B REV, V7, P257, DOI 10.3758/BF03212981; Klepousniotou E, 2008, J EXP PSYCHOL LEARN, V34, P1534, DOI 10.1037/a0013012; Krishnakumaran S., 2007, P WORKSHOP COMPUTATI, P13; Lakoff G., 1999, PHILOS FLESH; Lakoff George, 2003, METAPHOR WE LIVE BY; Levy P., 2011, SEMANTIC SPHERE 1; Light M, 2002, COGNITIVE SCI, V26, P269, DOI 10.1207/s15516709cog2603_4; MARTIN JH, 1992, COGNITIVE SCI, V16, P233, DOI 10.1207/s15516709cog1602_4; Mason ZJ, 2004, COMPUT LINGUIST, V30, P23, DOI 10.1162/089120104773633376; Murphy GL, 1996, COGNITION, V60, P173, DOI 10.1016/0010-0277(96)00711-1; Navigli R, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1459352.1459355; Neuman Y, 2013, INFORM FUSI IN PRESS, DOI DOI 10.1016/J.INFFUS.2012.02.001.IN; Neuman Y, 2012, INTEGR PSYCHOL BEHAV, V46, P129, DOI 10.1007/s12124-011-9165-8; Neuman Y, 2009, INFORM SCIENCES, V179, P2719, DOI 10.1016/j.ins.2009.04.011; Nissim M, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P56; Pinker S., 2007, PUBLIC POLICY RES, V14, P59; Shutova E., 2012, COMPUTIONAL IN PRESS, V2, P301, DOI [10.1162/COLI_a_00124, DOI 10.1162/C0LI_A_00124]; Shutova E, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P688; Thibodeau PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016782; Toutanova K, 2003, HLT-NAACL 2003: HUMAN LANGUAGE TECHNOLOGY CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE MAIN CONFERENCE, P252, DOI 10.3115/1073445.1073478; Turney Peter, 2011, P C EMP METH NAT LAN, P680; WILKS Y, 1978, ARTIF INTELL, V11, P197, DOI 10.1016/0004-3702(78)90001-2; WILKS Y, 1975, ARTIF INTELL, V6, P53, DOI 10.1016/0004-3702(75)90016-8	42	49	53	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62343	10.1371/journal.pone.0062343	http://dx.doi.org/10.1371/journal.pone.0062343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	181JC	23658625	Green Published, Green Submitted, gold			2022-12-27	WOS:000321662800037
J	Orsini, M; Carcangiu, S; Cuccuru, G; Uva, P; Tramontano, A				Orsini, Massimiliano; Carcangiu, Simone; Cuccuru, Gianmauro; Uva, Paolo; Tramontano, Anna			The PARIGA Server for Real Time Filtering and Analysis of Reciprocal BLAST Results	PLOS ONE			English	Article							IDENTIFICATION; EXPRESSION; OPTIONS	BLAST-based similarity searches are commonly used in several applications involving both nucleotide and protein sequences. These applications span from simple tasks such as mapping sequences over a database to more complex procedures as clustering or annotation processes. When the amount of analysed data increases, manual inspection of BLAST results become a tedious procedure. Tools for parsing or filtering BLAST results for different purposes are then required. We describe here PARIGA (http://resources.bioinformatica.crs4.it/pariga/), a server that enables users to perform all-against-all BLAST searches on two sets of sequences selected by the user. Moreover, since it stores the two BLAST output in a python-serialized-objects database, results can be filtered according to several parameters in real-time fashion, without re-running the process and avoiding additional programming efforts. Results can be interrogated by the user using logical operations, for example to retrieve cases where two queries match same targets, or when sequences from the two datasets are reciprocal best hits, or when a query matches a target in multiple regions. The Pariga web server is designed to be a helpful tool for managing the results of sequence similarity searches. The design and implementation of the server renders all operations very fast and easy to use.	[Orsini, Massimiliano; Carcangiu, Simone; Cuccuru, Gianmauro; Uva, Paolo] CRS4 Bioinformat Lab, Pula, Italy; [Tramontano, Anna] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	Sapienza University Rome	Orsini, M (corresponding author), CRS4 Bioinformat Lab, Sci & Technol Pk Polaris, Pula, Italy.	orsini@crs4.it	orsini, massimiliano/AAB-1887-2019; Orsini, Massimiliano/C-2337-2016; Uva, Paolo/A-2877-2011; Tramontano, anna/D-5378-2009	orsini, massimiliano/0000-0003-0087-3349; Orsini, Massimiliano/0000-0003-0087-3349; Uva, Paolo/0000-0002-9524-8492; Tramontano, anna/0000-0002-5610-3338; cuccuru, gianmauro/0000-0002-5335-545X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bryson K, 2007, CURR PROTEIN PEPT SC, V8, P181, DOI 10.2174/138920307780363415; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Diener SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-147; Ghamsari L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S4; Gollapudi R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-414; Hahn P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-293; He J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-53; Lagnel J, 2009, BIOINFORMATICS, V25, P824, DOI 10.1093/bioinformatics/btp067; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mica E, 2006, J EXP BOT, V57, P2601, DOI 10.1093/jxb/erl013; Moon EK, 2008, EXP PARASITOL, V119, P111, DOI 10.1016/j.exppara.2008.01.001; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Orsini M, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-4; Paquola ACM, 2003, BIOINFORMATICS, V19, P1035, DOI 10.1093/bioinformatics/btg122; Pirooznia M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S10; Pospisil H, 2004, NUCLEIC ACIDS RES, V32, pD70, DOI 10.1093/nar/gkh136; Sen A, 2012, ARCH MICROBIOL, V194, P35, DOI 10.1007/s00203-011-0731-8; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Steinhauser D, 2004, BIOINFORMATICS, V20, P1928, DOI 10.1093/bioinformatics/bth182; Steward GF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-287; Tharakaraman K, 2005, BIOINFORMATICS, V21, pI440, DOI 10.1093/bioinformatics/bti1028; Xing LQ, 2001, BIOINFORMATICS, V17, P744, DOI 10.1093/bioinformatics/17.8.744	25	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62224	10.1371/journal.pone.0062224	http://dx.doi.org/10.1371/journal.pone.0062224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667459	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700026
J	Tuncalp, O; Stanton, C; Castro, A; Adanu, R; Heymann, M; Adu-Bonsaffoh, K; Lattof, SR; Blanc, A; Langer, A				Tuncalp, Oezge; Stanton, Cynthia; Castro, Arachu; Adanu, Richard; Heymann, Marilyn; Adu-Bonsaffoh, Kwame; Lattof, Samantha R.; Blanc, Ann; Langer, Ana			Measuring Coverage in MNCH: Validating Women's Self-Report of Emergency Cesarean Sections in Ghana and the Dominican Republic	PLOS ONE			English	Article							RATES	Background: Cesarean section is the only surgery for which we have nearly global population-based data. However, few surveys provide additional data related to cesarean sections. Given weaknesses in many health information systems, health planners in developing countries will likely rely on nationally representative surveys for the foreseeable future. The objective is to validate self-reported data on the emergency status of cesarean sections among women delivering in teaching hospitals in the capitals of two contrasting countries: Accra, Ghana and Santo Domingo, Dominican Republic (DR). Methods and Findings: This study compares hospital-based data, considered the reference standard, against women's self-report for two definitions of emergency cesarean section based on the timing of the decision to operate and the timing of the cesarean section relative to onset of labor. Hospital data were abstracted from individual medical records, and hospital discharge interviews were conducted with women who had undergone cesarean section in two hospitals. The study assessed sensitivity, specificity, and positive predictive value of responses to questions regarding emergency versus non-emergency cesarean section and estimated the percent of emergency cesarean sections that would be obtained from a survey, given the observed prevalence, sensitivity, and specificity from this study. Hospital data were matched with exit interviews for 659 women delivered via cesarean section for Ghana and 1,531 for the Dominican Republic. In Ghana and the Dominican Republic, sensitivity and specificity for emergency cesarean section defined by decision time were 79% and 82%, and 50% and 80%, respectively. The validity of emergency cesarean defined by operation time showed less favorable results than decision time in Ghana and slightly more favorable results in the Dominican Republic. Conclusions: Questions used in this study to identify emergency cesarean section are promising but insufficient to promote for inclusion in international survey questionnaires. Additional studies which confirm the accuracy of key facility-based indicators in advance of data collection and which use a longer recall period are warranted.	[Tuncalp, Oezge; Stanton, Cynthia] Johns Hopkins Bloomberg Sch Publ Hlth Baltimore, Baltimore, MD USA; [Castro, Arachu; Heymann, Marilyn] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Adanu, Richard] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Adu-Bonsaffoh, Kwame] Univ Ghana, Korle Bu Teaching Hosp, Accra, Ghana; [Lattof, Samantha R.; Langer, Ana] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA; [Blanc, Ann] Populat Council, New York, NY 10021 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; University of Ghana; University of Ghana; Harvard University; Harvard T.H. Chan School of Public Health; Population Council	Tuncalp, O (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth Baltimore, Baltimore, MD USA.	otuncalp@jhsph.edu	Adu-Bonsaffoh, Kwame/AAH-5560-2020; Tunçalp, Ӧzge/Y-2724-2018; Castro, Arachu/L-6664-2014	Tunçalp, Ӧzge/0000-0002-5370-682X; Castro, Arachu/0000-0003-0428-9174; Lattof, Samantha R./0000-0003-0934-1488; ADU-BONSAFFOH, KWAME/0000-0002-3741-6646	Maternal Health Task Force at EngenderHealth [PSA-007-01, GMH-012-02]; Bill & Melinda Gates Foundation	Maternal Health Task Force at EngenderHealth; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Maternal Health Task Force at EngenderHealth (PSA-007-01 made to Stanton-Hill Research LLC and GMH-012-02 made to Harvard Medical School), via their funding from The Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; OT and CS conducted this work under Stanton-Hill Research LLC, funded by Maternal Health Task Force at EngenderHealth. AC is a member of the Editorial Board of PLOS Medicine. All of the other authors declare no competing interests associated with the work supporting this manuscript.	Barros AJD, 2011, REV SAUDE PUBL, V45, P635, DOI 10.1590/S0034-89102011005000039; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Campbell H, 2008, CROAT MED J, V49, P402, DOI 10.3325/cmj.2008.3.402; Castro A, 2010, CHALLENGES POSED HIV; Coulter A, 1985, Community Med, V7, P186; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Direccion General de Informacion y Estadistica de Salud, 2008, DIR GEN INF EST SAL; Holtz S, 2007, CLUSTERING CESAREAN; ICDDRB NM-E, 2011, BANGL MAT MORT HLTH; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060762; MA CHERG, 2010, EXP LIST IND REG CES; Macro International, 2011, MEAS DHS STATCOMPILE; Macro International Ghana Statistical Service Services. GH, 2009, GHAN MAT HLTH SURV 2; Ronsmans C, 1997, STUD FAMILY PLANN, V28, P203, DOI 10.2307/2137888; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Schauberger CW, 2009, AM J PERINAT, V26, P221, DOI 10.1055/s-0028-1103033; Stanton CK, 2005, B WORLD HEALTH ORGAN, V83, P449; Stanton CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060694; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; VECCHIO TJ, 1966, NEW ENGL J MED, V274, P1171, DOI 10.1056/NEJM196605262742104; Witter S, 2007, REPROD HEALTH MATTER, V15, P61, DOI 10.1016/S0968-8080(07)30325-X; World Health Organization, 2012, WORLD HLTH STAT	22	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e60761	10.1371/journal.pone.0060761	http://dx.doi.org/10.1371/journal.pone.0060761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667428	Green Published, gold			2022-12-27	WOS:000319654700006
J	Bockelmann, AC; Tams, V; Ploog, J; Schubert, PR; Reusch, TBH				Bockelmann, Anna-Christina; Tams, Verena; Ploog, Jana; Schubert, Philipp R.; Reusch, Thorsten B. H.			Quantitative PCR Reveals Strong Spatial and Temporal Variation of the Wasting Disease Pathogen, Labyrinthula zosterae in Northern European Eelgrass (Zostera marina) Beds	PLOS ONE			English	Article							SEAGRASS-PATHOGEN; WADDEN SEA; SYSTEMIC RESISTANCE; PLANT SYMBIOSES; ECOSYSTEMS; TEMPERATURE; SALINITY; PARASITISM; INDUCTION; EVOLUTION	Seagrass beds are the foundation species of functionally important coastal ecosystems worldwide. The world's largest losses of the widespread seagrass Zostera marina (eelgrass) have been reported as a consequence of wasting disease, an infection with the endophytic protist Labyrinthula zosterae. During one of the most extended epidemics in the marine realm, similar to 90% of East and Western Atlantic eelgrass beds died-off between 1932 and 1934. Today, small outbreaks continue to be reported, but the current extent of L. zosterae in European meadows is completely unknown. In this study we quantify the abundance and prevalence of the wasting disease pathogen among 19 Z. marina populations in northern European coastal waters, using quantitative PCR (QPCR) with primers targeting a species specific portion of the internally transcribed spacer (ITS1) of L. zosterae. Spatially, we found marked variation among sites with abundances varying between 0 and 126 cells mg(-1) Z. marina dry weight (mean: 5.7 L. zosterae cells mg(-1) Z. marina dry weight 61.9 SE) and prevalences ranged from 0-88.9%. Temporarily, abundances varied between 0 and 271 cells mg(-1) Z. marina dry weight (mean: 8.5+/-2.6 SE), while prevalences ranged from zero in winter and early spring to 96% in summer. Field concentrations accessed via bulk DNA extraction and subsequent QPCR correlated well with prevalence data estimated via isolation and cultivation from live plant tissue. L. zosterae was not only detectable in black lesions, a sign of Labyrinthula-induced necrosis, but also occurred in green, apparently healthy tissue. We conclude that L. zosterae infection is common (84% infected populations) in (northern) European eelgrass populations with highest abundances during the summer months. In the light of global climate change and increasing rate of marine diseases our data provide a baseline for further studies on the causes of pathogenic outbreaks of L. zosterae.	[Bockelmann, Anna-Christina; Tams, Verena; Ploog, Jana; Schubert, Philipp R.; Reusch, Thorsten B. H.] Helmholtz Ctr Ocean Res GEOMAR, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Bockelmann, AC (corresponding author), Helmholtz Ctr Ocean Res GEOMAR, Kiel, Germany.	abockelmann@geomar.de	Schubert, Philipp/D-6141-2016; Reusch, Thorsten B.H./G-4141-2011; Reusch, Thorsten B. H./B-9311-2019	Schubert, Philipp/0000-0003-1838-7250; Tams, Verena/0000-0002-9539-2603; Reusch, Thorsten B. H./0000-0002-8961-4337	Excellence Cluster 'The Future Ocean' (GEOMAR, Kiel, Germany); Ministry for Agriculture, Nature Conservation and Rural Development of Schleswig-Holstein (LLUR, Germany)	Excellence Cluster 'The Future Ocean' (GEOMAR, Kiel, Germany); Ministry for Agriculture, Nature Conservation and Rural Development of Schleswig-Holstein (LLUR, Germany)	Funding was provided by Excellence Cluster 'The Future Ocean' (GEOMAR, Kiel, Germany), and the Ministry for Agriculture, Nature Conservation and Rural Development of Schleswig-Holstein (LLUR, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy C. E., 1944, JOUR WILDLIFE MANAGEMENT, V8, P269, DOI 10.2307/3796019; AMON JP, 1968, J PROTOZOOL, V15, P543, DOI 10.1111/j.1550-7408.1968.tb02172.x; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; BARTSCH G, 1971, Z ALLG MIKROBIOL, V11, P79; Bergmann N, 2011, MOL ECOL RESOUR, V11, P1076, DOI 10.1111/j.1755-0998.2011.03051.x; Blegvad H, 1935, BERETNING MINETERIET, P1; Blois JC, 1961, CAH BIOL MAR, V2, P223; Bockelmann AC, 2012, MAR ECOL PROG SER, V445, P109, DOI 10.3354/meps09398; Bostrom C., 2003, WORLD ATLAS SEAGRASS, P27; Bowles JW, 2004, MAR ECOL PROG SER, V283, P127, DOI 10.3354/meps283127; BURDICK DM, 1993, MAR ECOL PROG SER, V94, P83, DOI 10.3354/meps094083; Butcher RW, 1934, J CONSEIL, V9; Chapman D. J., 1990, HDB PROTOCTISTA; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; Cook T, 1998, ESTUAR COAST SHELF S, V46, P587, DOI 10.1006/ecss.1997.0283; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; COTTAM C., 1933, Plant Disease Reporter, V17, P46; Cotton AD, 1933, NATURE, V132, P483, DOI 10.1038/132483b0; de Jonge VN, 1996, J COAST CONSERV, V2, P149; DENHARTOG C, 1989, DIS AQUAT ORGAN, V7, P223, DOI 10.3354/dao007223; Dolch T, 2009, SEEGRAS MONITORING S; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Fischer-Piette E, 1932, CR HEBD ACAD SCI, V195, P1420; Garrett KA, 2006, ANNU REV PHYTOPATHOL, V44, P489, DOI 10.1146/annurev.phyto.44.070505.143420; GIESEN WBJT, 1990, NETH J SEA RES, V25, P395, DOI 10.1016/0077-7579(90)90047-K; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Godet L, 2008, DIS AQUAT ORGAN, V79, P249, DOI 10.3354/dao01897; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hily C, 2002, AQUAT BOT, V72, P37, DOI 10.1016/S0304-3770(01)00195-4; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Karvonen A, 2010, INT J PARASITOL, V40, P1483, DOI 10.1016/j.ijpara.2010.04.015; Kastler T., 1997, BERICHT FORSCHUNGSST, V41, P119; Kniskern JM, 2006, ECOLOGY, V87, P675, DOI 10.1890/05-1327; Martin DL, 2009, MYCOLOGIA, V101, P632, DOI 10.3852/08-171; McKone KL, 2009, MAR ECOL PROG SER, V377, P123, DOI 10.3354/meps07860; Meyer T, 2006, ROSTOCKER MEERESBIOL, V15, P105; MUEHLSTEIN LK, 1988, MAR BIOL, V99, P465, DOI 10.1007/BF00392553; MUEHLSTEIN LK, 1989, DIS AQUAT ORGAN, V7, P211, DOI 10.3354/dao007211; MUEHLSTEIN LK, 1991, MYCOLOGIA, V83, P180, DOI 10.2307/3759933; Oetjen K, 2007, MOL ECOL, V16, P5156, DOI 10.1111/j.1365-294X.2007.03577.x; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Paszkowski U, 2006, CURR OPIN PLANT BIOL, V9, P364, DOI 10.1016/j.pbi.2006.05.008; POKORNY KS, 1967, J PROTOZOOL, V14, P697, DOI 10.1111/j.1550-7408.1967.tb02065.x; Raghukumar S, 2011, BOT MAR, V54, P3, DOI 10.1515/BOT.2011.008; Ralph PJ, 2002, MAR ECOL PROG SER, V226, P265, DOI 10.3354/meps226265; Ramamoorthy V, 2001, CROP PROT, V20, P1, DOI 10.1016/S0261-2194(00)00056-9; RASMUSSEN E, 1977, SEAGRASS ECOSYSTEMS, P00001; REISE K, 1989, HELGOLANDER MEERESUN, V43, P417, DOI 10.1007/BF02365901; Reise K, 2008, HELGOLAND MAR RES, V62, P77, DOI 10.1007/s10152-007-0088-1; Renn CE, 1936, BIOL BULL-US, V70, P148, DOI 10.2307/1537320; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; SCHMOLLER H, 1960, ARCH MIKROBIOL, V36, P365, DOI 10.1007/BF00418643; SHORT FT, 1988, AQUAT BOT, V30, P295, DOI 10.1016/0304-3770(88)90062-9; SHORT FT, 1987, BIOL BULL, V173, P557, DOI 10.2307/1541701; Steele L, 2005, MAR ECOL PROG SER, V303, P123, DOI 10.3354/meps303123; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; VAN DER WERFF A., 1938, Chronica botanica, V4, P498; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; VERGEER LHT, 1995, AQUAT BOT, V52, P35, DOI 10.1016/0304-3770(95)00480-N; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wohlenberg E, 1935, SONDERDRUCK NORDELBI, V11, P1; Wyllie-Echeverria S, 1999, ECON BOT, V53, P419	64	34	34	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62169	10.1371/journal.pone.0062169	http://dx.doi.org/10.1371/journal.pone.0062169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658711	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000321200500018
J	Fujii, M; Nishimori, H; Awazu, A				Fujii, Masashi; Nishimori, Hiraku; Awazu, Akinori			Influences of Excluded Volume of Molecules on Signaling Processes on the Biomembrane	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; EPIDERMAL-GROWTH-FACTOR; MAP KINASE; LATERAL DIFFUSION; HOP DIFFUSION; MEMBRANE; TRANSDUCTION; CELLS; RATES; EQUILIBRIA	We investigate the influences of the excluded volume of molecules on biochemical reaction processes on 2-dimensional surfaces using a model of signal transduction processes on biomembranes. We perform simulations of the 2-dimensional cell-based model, which describes the reactions and diffusion of the receptors, signaling proteins, target proteins, and crowders on the cell membrane. The signaling proteins are activated by receptors, and these activated signaling proteins activate target proteins that bind autonomously from the cytoplasm to the membrane, and unbind from the membrane if activated. If the target proteins bind frequently, the volume fraction of molecules on the membrane becomes so large that the excluded volume of the molecules for the reaction and diffusion dynamics cannot be negligible. We find that such excluded volume effects of the molecules induce non-trivial variations of the signal flow, defined as the activation frequency of target proteins, as follows. With an increase in the binding rate of target proteins, the signal flow varies by i) monotonically increasing; ii) increasing then decreasing in a bell-shaped curve; or iii) increasing, decreasing, then increasing in an S-shaped curve. We further demonstrate that the excluded volume of molecules influences the hierarchical molecular distributions throughout the reaction processes. In particular, when the system exhibits a large signal flow, the signaling proteins tend to surround the receptors to form receptor-signaling protein clusters, and the target proteins tend to become distributed around such clusters. To explain these phenomena, we analyze the stochastic model of the local motions of molecules around the receptor.	[Fujii, Masashi; Nishimori, Hiraku; Awazu, Akinori] Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima, Hiroshima 724, Japan	Hiroshima University	Fujii, M (corresponding author), Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima, Hiroshima 724, Japan.	mfujii0123@hiroshima-u.ac.jp	Awazu, Akinori/G-8980-2019; Fujii, Masashi/S-1516-2019	Fujii, Masashi/0000-0002-1586-6435	Japan Society for the Promotion of Science for Young Scientists; Global Center of Excellence Program G14 (Formation and Development of Mathematical Sciences Based on Modeling and Analysis) of Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; MEXT of Japan [3306, 24115515]; Grants-in-Aid for Scientific Research [24115515] Funding Source: KAKEN	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence Program G14 (Formation and Development of Mathematical Sciences Based on Modeling and Analysis) of Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists to MF (www.jsps.go.jp), by the Global Center of Excellence Program G14 (Formation and Development of Mathematical Sciences Based on Modeling and Analysis) of Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan to HN (www.jsps.go.jp), and by the Grant-in-Aid for Scientific Research on Innovative Areas (Spying minority in biological phenomena (No. 3306) (24115515)) of MEXT of Japan to AA (www.jsps.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal M, 2009, PRAMANA, V71, P359; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bhide SY, 2000, J PHYS CHEM B, V104, P2607, DOI 10.1021/jp993287z; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Daumas F, 2003, BIOPHYS J, V84, P356, DOI 10.1016/S0006-3495(03)74856-5; Dreux AC, 2006, ATHEROSCLEROSIS, V186, P38, DOI 10.1016/j.atherosclerosis.2005.06.038; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Fernandez C, 2011, J PHYS CHEM B, V115, P1289, DOI 10.1021/jp110285b; Fritsch CC, 2011, CHROMOSOME RES, V19, P63, DOI 10.1007/s10577-010-9168-1; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; JANSSENS PMW, 1987, MICROBIOL REV, V51, P396, DOI 10.1128/MMBR.51.4.396-418.1987; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; Kilburn D, 2010, J AM CHEM SOC, V132, P8690, DOI 10.1021/ja101500g; Kim JS, 2009, BIOPHYS J, V96, P1333, DOI 10.1016/j.bpj.2008.11.030; Kinjo AR, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051902; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lill Y, 2005, CHEMPHYSCHEM, V6, P1633, DOI 10.1002/cphc.200500111; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Mashanov GI, 2006, BIOCHEM SOC T, V34, P983, DOI 10.1042/BST0340983; Matsuoka S, 2006, J CELL SCI, V119, P1071, DOI 10.1242/jcs.02824; Matsuoka S, 2009, BIOPHYS J, V97, P1115, DOI 10.1016/j.bpj.2009.06.007; Mayawala K, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-41; Minton AP, 2010, ANAL BIOCHEM, V397, P247, DOI 10.1016/j.ab.2009.10.023; Minton AP, 1998, METHOD ENZYMOL, V295, P127; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; MINTON AP, 1992, P NATL ACAD SCI USA, V89, P10504, DOI 10.1073/pnas.89.21.10504; Miyanaga Y, 2007, BIOSYSTEMS, V88, P251, DOI 10.1016/j.biosystems.2006.07.011; Nagarajan S, 2011, BIOPHYS J, V100, P2991, DOI 10.1016/j.bpj.2011.03.065; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Takahashi K, 2005, FEBS LETT, V579, P1783, DOI 10.1016/j.febslet.2005.01.072; van der Woning SP, 2009, BIOCHEM BIOPH RES CO, V378, P285, DOI 10.1016/j.bbrc.2008.11.034; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; White DA, 2010, J AM CHEM SOC, V132, P5170, DOI 10.1021/ja909997e; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	54	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62218	10.1371/journal.pone.0062218	http://dx.doi.org/10.1371/journal.pone.0062218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658714	Green Submitted, Green Published, gold			2022-12-27	WOS:000321200500019
J	Lin, WP; Chen, XW; Zhang, LQ; Wu, CY; Huang, ZD; Lin, JH				Lin, Wen-Ping; Chen, Xuan-Wei; Zhang, Li-Qun; Wu, Chao-Yang; Huang, Zi-Da; Lin, Jian-Hua			Effect of Neuroglobin Genetically Modified Bone Marrow Mesenchymal Stem Cells Transplantation on Spinal Cord Injury in Rabbits	PLOS ONE			English	Article							STROMAL CELLS; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; NITRIC-OXIDE; PROMOTE REGENERATION; OXIDATIVE STRESS; GLOBIN FAMILY; GENE-TRANSFER; ADULT-RAT; IN-VIVO	Objective: This study aims to investigate the potentially protective effect of neuroglobin (Ngb) gene-modified bone marrow mesenchymal stem cells (BMSCs) on traumatic spinal cord injury (SCI) in rabbits. Methods: A lentiviral vector containing an Ngb gene was constructed and used to deliver Ngb to BMSCs. Ngb gene-modified BMSCs were then injected at the SCI sites 24 hours after SCI. The motor functions of the rabbits were evaluated by the Basso-Beattie-Bresnahan rating scale. Fluorescence microscopy, quantitative real-time PCRs, Western blots, malondialdehyde (MDA) tests, and terminal deoxynucleotidyltransferase-mediated UTP end labeling assays were also performed. Results: Ngb expression in the Ngb-BMSC group increased significantly. A more significant functional improvement was observed in the Ngb-BMSC group compared with those in the other groups. Traumatic SCI seemingly led to an increase in MDA level and number of apoptotic cells, which can be prevented by Ngb-BMSC treatment. Conclusion: This study demonstrates that Ngb gene-modified BMSCs can strengthen the therapeutic benefits of BMSCs in reducing secondary damage and improving the neurological outcome after traumatic SCI. Therefore, the combined strategy of BMSC transplantation and Ngb gene therapy can be used to treat traumatic SCI.	[Lin, Wen-Ping] Fujian Med Univ, Affiliated Hosp 2, Dept Orthoped Surg, Quanzhou, Fujian Province, Peoples R China; [Chen, Xuan-Wei; Zhang, Li-Qun; Wu, Chao-Yang; Huang, Zi-Da; Lin, Jian-Hua] Fujian Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University; Fujian Medical University	Lin, JH (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Fuzhou, Fujian Province, Peoples R China.	jianhua0918@126.com		Lin, Wenping/0000-0001-5029-5466; Zhang, Liqun/0000-0002-2937-2743; Lin, Jianhua/0000-0003-0698-0292	Specialized Research Fund for the Doctoral Program of Higher Education of China [20060392003]	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by a grant from the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant number: 20060392003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos-Afonso F, 2004, J CELL SCI, V117, P5655, DOI 10.1242/jcs.01488; Aslan A, 2009, EUR SPINE J, V18, P1442, DOI 10.1007/s00586-009-1033-6; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Ates O, 2006, ACTA PHARMACOL SIN, V27, P1317, DOI 10.1111/j.1745-7254.2006.00416.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2; Brittain T, 2010, INT J MOL SCI, V11, P2306, DOI 10.3390/ijms11062306; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Brunori M, 2006, FASEB J, V20, P2192, DOI 10.1096/fj.06-6643rev; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Buege J A, 1978, Methods Enzymol, V52, P302; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Cayli SR, 2006, INT J DEV NEUROSCI, V24, P233, DOI 10.1016/j.ijdevneu.2006.04.003; Chang YP, 2006, J CELL BIOCHEM, V97, P501, DOI 10.1002/jcb.20646; Chen WH, 2005, NEUROSCI LETT, V384, P117, DOI 10.1016/j.neulet.2005.04.070; Chen YJ, 2010, EXP MOL PATHOL, V88, P311, DOI 10.1016/j.yexmp.2009.12.002; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Duong TTH, 2009, J NEUROCHEM, V108, P1143, DOI 10.1111/j.1471-4159.2008.05846.x; Fago A, 2008, IUBMB LIFE, V60, P398, DOI 10.1002/iub.35; Fago A, 2006, J INORG BIOCHEM, V100, P1339, DOI 10.1016/j.jinorgbio.2006.03.009; Fischer-Rasokat U, 2009, CIRC-HEART FAIL, V2, P417, DOI 10.1161/CIRCHEARTFAILURE.109.855023; Fordel E, 2007, FEBS J, V274, P1312, DOI 10.1111/j.1742-4658.2007.05679.x; Garry DJ, 2003, LANCET, V362, P342, DOI 10.1016/S0140-6736(03)14055-X; Gnecchi M, 2009, STEM CELLS, V27, P971, DOI 10.1002/stem.12; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hendriks WTJ, 2004, PROG BRAIN RES, V146, P451; Herold S, 2005, COMP BIOCHEM PHYS A, V142, P124, DOI 10.1016/j.cbpb.2005.06.009; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Jakob M, 2010, STEM CELLS DEV, V19, P635, DOI 10.1089/scd.2009.0245; Jin KL, 2008, NEUROSCI LETT, V430, P135, DOI 10.1016/j.neulet.2007.10.031; Kamishina H, 2006, AM J VET RES, V67, P1921, DOI 10.2460/ajvr.67.11.1921; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kim S, 2006, BRAIN RES, V1123, P27, DOI 10.1016/j.brainres.2006.09.044; Koda M, 2002, J NEUROTRAUM, V19, P777, DOI 10.1089/08977150260139147; Koda M, 2007, EUR SPINE J, V16, P2206, DOI 10.1007/s00586-007-0499-3; Laufs TL, 2004, NEUROSCI LETT, V362, P83, DOI 10.1016/j.neulet.2004.02.072; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Li XM, 2000, RESTOR NEUROL NEUROS, V17, P203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammen PPA, 2002, J HISTOCHEM CYTOCHEM, V50, P1591, DOI 10.1177/002215540205001203; Martin DR, 2002, EXP HEMATOL, V30, P879, DOI 10.1016/S0301-472X(02)00864-0; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Murray M, 2004, PROG BRAIN RES, V143, P133, DOI 10.1016/S0079-6123(03)43013-6; Nakahara S, 1999, J NEUROPATH EXP NEUR, V58, P442, DOI 10.1097/00005072-199905000-00003; Nakajima H, 2010, SPINE, V35, P497, DOI 10.1097/BRS.0b013e3181b8e89b; Nienhaus K, 2007, IUBMB LIFE, V59, P490, DOI 10.1080/15216540601188538; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ramer MS, 2000, SPINAL CORD, V38, P449, DOI 10.1038/sj.sc.3101055; Ray SK, 1999, ANN NY ACAD SCI, V890, P261, DOI 10.1111/j.1749-6632.1999.tb08001.x; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Szymanski M, 2010, NEUROBIOL AGING, V31, P1835, DOI 10.1016/j.neurobiolaging.2008.10.003; Wakasugi K, 2005, ANN NY ACAD SCI, V1053, P220, DOI 10.1196/annals.1344.020; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Wang Z, 2006, TISSUE ENG, V12, P1753, DOI 10.1089/ten.2006.12.1753; Weber T, 2003, BIOCHEMISTRY-US, V42, P4277, DOI 10.1021/bi020527j; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu SF, 2003, J NEUROSCI RES, V72, P343, DOI 10.1002/jnr.10587; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Yune TY, 2008, FREE RADICAL BIO MED, V45, P1190, DOI 10.1016/j.freeradbiomed.2008.07.016; Zhang W, 2010, BRAIN RES, V1359, P256, DOI 10.1016/j.brainres.2010.08.072	71	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63444	10.1371/journal.pone.0063444	http://dx.doi.org/10.1371/journal.pone.0063444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658829	Green Submitted, gold, Green Published			2022-12-27	WOS:000321200500071
J	Campbell, HA; Dwyer, RG; Irwin, TR; Franklin, CE				Campbell, Hamish A.; Dwyer, Ross G.; Irwin, Terri R.; Franklin, Craig E.			Home Range Utilisation and Long-Range Movement of Estuarine Crocodiles during the Breeding and Nesting Season	PLOS ONE			English	Article							CROCODYLUS-POROSUS; NORTHERN-TERRITORY; ABUNDANCE; RIVERS; PERTURBATION; JOHNSTONI; BEHAVIOR; TACTICS	The estuarine crocodile (Crocodylus porosus) is the apex-predator in waterways and coastlines throughout south-east Asia and Australasia. C. porosus pose a potential risk to humans, and management strategies are implemented to control their movement and distribution. Here we used GPS-based telemetry to accurately record geographical location of adult C. porosus during the breeding and nesting season. The purpose of the study was to assess how C. porosus movement and distribution may be influenced by localised social conditions. During breeding, the females (2.92 +/- 0.013 metres total length (TL), mean +/- S.E., n = 4) occupied an area < 1 km length of river, but to nest they travelled up to 54 km away from the breeding area. All tagged male C. porosus sustained high rates of movement (6.49 +/- 0.9 km d(-1); n = 8) during the breeding and nesting period. The orientation of the daily movements differed between individuals revealing two discontinuous behavioural strategies. Five tagged male C. porosus (4.17 +/- 0.14 m TL) exhibited a 'site-fidelic' strategy and moved within well-defined zones around the female home range areas. In contrast, three males (3.81 +/- 0.08 m TL) exhibited 'nomadic' behaviour where they travelled continually throughout hundreds of kilometres of waterway. We argue that the 'site-fidelic' males patrolled territories around the female home ranges to maximise reproductive success, whilst the 'nomadic' males were subordinate animals that were forced to range over a far greater area in search of unguarded females. We conclude that C. porosus are highly mobile animals existing within a complex social system, and mate/con-specific interactions are likely to have a profound effect upon population density and distribution, and an individual's travel potential. We recommend that impacts on socio-spatial behaviour are considered prior to the implementation of management interventions.	[Campbell, Hamish A.; Dwyer, Ross G.; Franklin, Craig E.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Irwin, Terri R.] Australia Zoo, Beerwah, Australia	University of Queensland	Campbell, HA (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	hamish.campbell@uq.edu.au	Franklin, Craig/G-7343-2012	Franklin, Craig/0000-0003-1315-3797; Dwyer, Ross/0000-0003-1136-5489; Campbell, Hamish/0000-0003-1428-1686	Australian Research Council linkage scheme	Australian Research Council linkage scheme(Australian Research Council)	This study was supported by the Australian Research Council linkage scheme with Australia Zoo as industrial partners, and funds donated by the golfer Greg Norman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GR, 1974, COPEIA, P553; Bivand, 2012, RGEOS INTERFACE GEOM; Bivand RS, 2008, USE R, P1; Brien ML, 2008, WILDLIFE RES, V35, P140, DOI 10.1071/WR06116; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Campbell HA, 2010, J ANIM ECOL, V79, P955, DOI 10.1111/j.1365-2656.2010.01709.x; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Davidson Z, 2011, BIOL CONSERV, V144, P114, DOI 10.1016/j.biocon.2010.08.005; Di Pierro E, 2008, ECOL RES, V23, P529, DOI 10.1007/s11284-007-0401-0; Donovan TM, 2011, BIOL CONSERV, V144, P2799, DOI 10.1016/j.biocon.2011.06.026; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Franklin CE, 2009, MAR FRESHWATER RES, V60, P284, DOI 10.1071/MF08153; Fukuda Y, 2010, SALTWATER CROCODILE; Fukuda Y, 2007, WILDLIFE RES, V34, P167, DOI 10.1071/WR06110; Fukuda Y, 2011, J WILDLIFE MANAGE, V75, P1253, DOI 10.1002/jwmg.191; GOODWIN TM, 1979, J HERPETOL, V13, P157, DOI 10.2307/1563922; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; JOHNSON CR, 1973, ZOOL J LINN SOC-LOND, V52, P315, DOI 10.1111/j.1096-3642.1973.tb01887.x; Kay W, 2005, POPULATION ECOLOGY C; Kay WR, 2004, WILDLIFE RES, V31, P495, DOI 10.1071/WR04037; Keitt TH, 2012, RGDAL BINDINGS GEOSP; Krebs JR., 1997, BEHAV ECOLOGY EVOLUT; Lang JW, 1987, CROCODILES ALLIGATOR, P279; Letnic M, 2006, WILDLIFE RES, V33, P529, DOI 10.1071/WR05090; Lewis JL, 2012, J HERPETOLO IN PRESS; MACDONALD DW, 1982, COMP IMMUNOL MICROB, V5, P247, DOI 10.1016/0147-9571(82)90045-5; MAGNUSSON WE, 1980, AUST WILDLIFE RES, V7, P149; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; Messel H, 1980, SURVEYS TIDAL WATERW; R Development Core Team, 2010, R LANG ENV STAT COMP; Read MA, 2004, WILDLIFE RES, V31, P527, DOI 10.1071/WR02025; Read MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000949; Reid ML, 1997, AM NAT, V150, P98, DOI 10.1086/286058; Robles CI, 2010, HERPETOL J, V20, P243; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Rooney SM, 1998, MAMMAL REV, V28, P89, DOI 10.1046/j.1365-2907.1998.00028.x; Rosenblatt AE, 2011, J ANIM ECOL, V80, P786, DOI 10.1111/j.1365-2656.2011.01830.x; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Sullivan S, 2010, REPORT DISTRIBUTION; Taborsky M, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P537, DOI 10.1007/978-3-642-02624-9_18; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tucker AD, 1997, J HERPETOL, V31, P114, DOI 10.2307/1565339; van Etten J., 2011, GDISTANCE DISTANCES; Vokoun JC, 2003, N AM J FISH MANAGE, V23, P1020, DOI 10.1577/M02-141; Walsh B., 1987, P249; Webb G., 1989, CROCODILES AUSTR; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P263, DOI 10.1071/WR9780263; WEBB GJW, 1977, COPEIA, P238; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	51	42	46	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62127	10.1371/journal.pone.0062127	http://dx.doi.org/10.1371/journal.pone.0062127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650510	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000030
J	Chen, YJJ; Vogt, D; Wang, YL; Visel, A; Silberberg, SN; Nicholas, CR; Danjo, T; Pollack, JL; Pennacchio, LA; Anderson, S; Sasai, Y; Baraban, SC; Kriegstein, AR; Alvarez-Buylla, A; Rubenstein, JLR				Chen, Ying-Jiun J.; Vogt, Daniel; Wang, Yanling; Visel, Axel; Silberberg, Shanni N.; Nicholas, Cory R.; Danjo, Teruko; Pollack, Joshua L.; Pennacchio, Len A.; Anderson, Stewart; Sasai, Yoshiki; Baraban, Scott C.; Kriegstein, Arnold R.; Alvarez-Buylla, Arturo; Rubenstein, John L. R.			Use of ''MGE Enhancers'' for Labeling and Selection of Embryonic Stem Cell-Derived Medial Ganglionic Eminence (MGE) Progenitors and Neurons	PLOS ONE			English	Article							HOMEOBOX GENE; INTERNEURON PRECURSORS; GABAERGIC INTERNEURONS; SUBVENTRICULAR ZONE; SPECIFICATION; EXPRESSION; ADULT; FOREBRAIN; DIFFERENTIATION; REQUIREMENT	The medial ganglionic eminence (MGE) is an embryonic forebrain structure that generates the majority of cortical interneurons. MGE transplantation into specific regions of the postnatal central nervous system modifies circuit function and improves deficits in mouse models of epilepsy, Parkinson's disease, pain, and phencyclidine-induced cognitive deficits. Herein, we describe approaches to generate MGE-like progenitor cells from mouse embryonic stem (ES) cells. Using a modified embryoid body method, we provided gene expression evidence that mouse ES-derived Lhx6(+) cells closely resemble immature interneurons generated from authentic MGE-derived Lhx6(+) cells. We hypothesized that enhancers that are active in the mouse MGE would be useful tools in detecting when ES cells differentiate into MGE cells. Here we demonstrate the utility of enhancer elements [422 (DlxI12b), Lhx6, 692, 1056, and 1538] as tools to mark MGE-like cells in ES cell differentiation experiments. We found that enhancers DlxI12b, 692, and 1538 are active in Lhx6-GFP(+) cells, while enhancer 1056 is active in Olig2(+) cells. These data demonstrate unique techniques to follow and purify MGE-like derivatives from ES cells, including GABAergic cortical interneurons and oligodendrocytes, for use in stem cell-based therapeutic assays and treatments.	[Chen, Ying-Jiun J.; Vogt, Daniel; Wang, Yanling; Silberberg, Shanni N.; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Chen, Ying-Jiun J.; Vogt, Daniel; Wang, Yanling; Silberberg, Shanni N.; Rubenstein, John L. R.] Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; [Visel, Axel; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA USA; [Visel, Axel; Pennacchio, Len A.] Dept Energy Joint Genome Inst, Walnut Creek, CA USA; [Anderson, Stewart] Univ Penn, Sch Med, Childrens Hosp Philadelphia 3, Philadelphia, PA 19104 USA; [Pollack, Joshua L.; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Neurogenesis & Organogenesis Grp, Kobe, Hyogo, Japan; [Baraban, Scott C.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Nicholas, Cory R.; Kriegstein, Arnold R.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Pollack, Joshua L.] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; RIKEN; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chen, YJJ (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	nyc600@gmail.com; john.rubenstein@ucsf.edu	Visel, Axel/A-9398-2009	Visel, Axel/0000-0002-4130-7784; /0000-0002-8589-4239; Pennacchio, Len/0000-0002-8748-3732; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Vogt, Daniel/0000-0003-1876-5936	California Institute of Regenerative Medicine; Weston Havens Foundation; Brain & Behavior Research foundation [NIMH R01 MH081880, NIMH R37 MH049428]; Nina Ireland; NIH/NCRR UCSF-CTSI [UL1 RR024131];  [NINDS R01 NS062859A];  [NHGRI R01 HG003988];  [NINDS R01 NS071785]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428, R01MH081880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071785] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Weston Havens Foundation; Brain & Behavior Research foundation(NARSAD); Nina Ireland; NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the research grants to JLRR from California Institute of Regenerative Medicine, Nina Ireland, Weston Havens Foundation, and NIMH R01 MH081880, and NIMH R37 MH049428; to YJC from Brain & Behavior Research foundation (formerly National Alliance for Research on Schizophrenia and Depression); NINDS R01 NS062859A and NHGRI R01 HG003988 to AV and LAP; NINDS R01 NS071785 to SCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The RNA microarray was done at the Sandler Asthma Basic Research Center Functional Genomics Core Facility (NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131; core director: David Erle, core manager: Andrea Barczak, Core Analyst: Joshua Pollack, Core staff: Rebecca Barbeau). LAP and AV conducted research at the E.O. Lawrence Berkeley National Laboratory, performed under DOE DE-AC02-05CH11231, University of California.	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Bardet SM, 2008, BRAIN RES BULL, V75, P231, DOI 10.1016/j.brainresbull.2007.10.037; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Braz JM, 2012, NEURON, V74, P663, DOI 10.1016/j.neuron.2012.02.033; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Chen L, 2010, J NEUROSCI, V30, P14824, DOI 10.1523/JNEUROSCI.3742-10.2010; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Daadi MM, 2009, CELL TRANSPLANT, V18, P815, DOI 10.3727/096368909X470829; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; De la Cruz E, 2011, NEUROTHERAPEUTICS, V8, P763, DOI 10.1007/s13311-011-0058-9; Du TG, 2008, DEVELOPMENT, V135, P1559, DOI 10.1242/dev.015123; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elshatory Y, 2008, J NEUROSCI, V28, P3291, DOI 10.1523/JNEUROSCI.5730-07.2008; Fischer AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010774; Flandin P, 2011, NEURON, V70, P939, DOI 10.1016/j.neuron.2011.04.020; Flandin P, 2010, J NEUROSCI, V30, P2812, DOI 10.1523/JNEUROSCI.4228-09.2010; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; Ghanem N, 2007, J NEUROSCI, V27, P5012, DOI 10.1523/JNEUROSCI.4725-06.2007; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Maroof AM, 2010, J NEUROSCI, V30, P4667, DOI 10.1523/JNEUROSCI.4255-09.2010; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; McKinsey GL, 2013, NEURON, V77, P83, DOI 10.1016/j.neuron.2012.11.035; Medina-Martinez O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004513; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Polley DB, 2006, HEARING RES, V214, P84, DOI 10.1016/j.heares.2006.02.008; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Sebe JY, 2011, DEV NEUROBIOL, V71, P107, DOI 10.1002/dneu.20813; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Stanley EM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.014; Stuhmer T, 2002, CEREB CORTEX, V12, P75, DOI 10.1093/cercor/12.1.75; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tanaka DH, 2011, J NEUROSCI, V31, P14116, DOI 10.1523/JNEUROSCI.2786-11.2011; Turksen K, 2006, METH MOL B, V331, P1; VISEL A, 2013, CELL            0131; Waldau B, 2010, STEM CELLS, V28, P1153, DOI 10.1002/stem.446; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772; Zipancic I, 2010, CELL TRANSPLANT, V19, P549, DOI 10.3727/096368910X491383	68	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61956	10.1371/journal.pone.0061956	http://dx.doi.org/10.1371/journal.pone.0061956			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658702	Green Submitted, gold, Green Published			2022-12-27	WOS:000319167000024
J	Katargina, O; Russakova, S; Geller, J; Kondrusik, M; Zajkowska, J; Zygutiene, M; Bormane, A; Trofimova, J; Golovljova, I				Katargina, Olga; Russakova, Stanislava; Geller, Julia; Kondrusik, Macije; Zajkowska, Joanna; Zygutiene, Milda; Bormane, Antra; Trofimova, Julia; Golovljova, Irina			Detection and Characterization of Tick-Borne Encephalitis Virus in Baltic Countries and Eastern Poland	PLOS ONE			English	Article							SOUTH-KOREA; MITOCHONDRIAL-DNA; LATVIA; EPIDEMIOLOGY; FLAVIVIRUSES; LITHUANIA; FOCI	Ticks were collected from the vegetation in the Baltic countries Estonia, Latvia, Lithuania and eastern Poland and analyzed for the presence of tick-borne encephalitis virus (TBEV) by amplification of the partial E and NS3 genes. In Estonia we found statistically significant differences in the TBEV prevalence between I. persulcatus and I. ricinus ticks (4.23% and 0.42%, respectively). In Latvia, the difference in TBEV prevalence between the two species was not statistically significant (1.02% for I. persulcatus and 1.51% for I. ricinus, respectively). In Lithuania and Poland TBEV was detected in 0.24% and 0.11% of I. ricinus ticks, respectively. Genetic characterization of the partial E and NS3 sequences demonstrated that the TBEV strains belonged to the European subtype in all countries, as well as to the Siberian subtype in Estonia. We also found that in areas where ranges of two tick species overlap, the TBEV subtypes may be detected not only in their natural vector, but also in sympatric tick species.	[Katargina, Olga; Russakova, Stanislava; Geller, Julia; Golovljova, Irina] Natl Inst Hlth Dev, Dept Virol, Tallinn, Estonia; [Geller, Julia] Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia; [Kondrusik, Macije; Zajkowska, Joanna] Med Univ, Dept Infect Dis & Neuroinfect, Bialystok, Poland; [Zygutiene, Milda] Ctr Communicable Dis & AIDS, Dept Epidemiol Surveillance, Vilnius, Lithuania; [Bormane, Antra] Ctr Dis Prevent & Control Latvia, Infect Dis Surveillance & Immunisat Unit, Riga, Latvia; [Trofimova, Julia] East Univ Hosp, Latvian Ctr Infect Dis, Mol Biol Bacterial Infect Unit, Riga, Latvia	National Institute for Health Development - Estonia; Tallinn University of Technology; Medical University of Bialystok; Centre for Communicable Diseases & AIDS (ULAC) - Lithuania	Golovljova, I (corresponding author), Natl Inst Hlth Dev, Dept Virol, Tallinn, Estonia.	irina.golovljova@tai.ee	Geller, Julia/A-7889-2019	Geller, Julia/0000-0001-6496-9687; Kondrusik, Maciej/0000-0002-6376-5604	European Union [Goce-2003-010284 EDEN]; Estonian Science Foundation [ETF 8691]; Estonian Ministry of Education and Research [SF0940033s09]; European Regional Development Fund (Estonian Research Council, programme TerVE) [3.2.1002.11-0002]	European Union(European Commission); Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Regional Development Fund (Estonian Research Council, programme TerVE)(Estonian Research Council)	This work was supported by the the European Union Grant Goce-2003-010284 EDEN, the Estonian Science Foundation (Grant ETF 8691), Estonian Ministry of Education and Research (project SF0940033s09) and the European Regional Development Fund (Estonian Research Council, programme TerVE, project ZoonRisk 3.2.1002.11-0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEKSEEV AN, 1993, ZH MIKROB EPID IMMUN, P113; Caporale DA, 1995, MOL PHYLOGENET EVOL, V4, P361, DOI 10.1006/mpev.1995.1033; Demina TV, 2010, J MED VIROL, V82, P965, DOI 10.1002/jmv.21765; Dobler G, 2008, INT J MED MICROBIOL, V298, P94, DOI 10.1016/j.ijmm.2008.03.011; Durmisi E, 2011, VECTOR-BORNE ZOONOT, V11, P659, DOI 10.1089/vbz.2010.0054; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; Evstafyev I. L., 2001, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P111; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Geller J, 2012, VECTOR BORN IN PRESS; Golovljova I, 2004, J MED VIROL, V74, P580, DOI 10.1002/jmv.20224; GOLOVLJOVA I, 2008, INT J MED MICROBIOL; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Hall TA, 1999, NUCL ACIDS S; Han HQ, 2001, J MED VIROL, V64, P21, DOI 10.1002/jmv.1012; Han XQ, 2005, J MED VIROL, V77, P249, DOI 10.1002/jmv.20444; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Jaaskelainen AE, 2011, EMERG INFECT DIS, V17, P323, DOI 10.3201/eid1702.101487; Karelis G, 2012, EUR J NEUROL, V19, P62, DOI 10.1111/j.1468-1331.2011.03434.x; Khasnatinov MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007295; Kim SY, 2009, MED VET ENTOMOL, V23, P15, DOI 10.1111/j.1365-2915.2008.00755.x; Kim SY, 2008, VECTOR-BORNE ZOONOT, V8, P7, DOI 10.1089/vbz.2006.0634; KISLENKO GS, 1987, PARAZITOLOGIYA+, V21, P730; Ko S, 2010, J VET SCI, V11, P197, DOI 10.4142/jvs.2010.11.3.197; Korenberg E.I., 1999, Parazitologiya (St. Petersburg), V33, P273; KOZUCH O, 1990, ACTA VIROL, V34, P537; LABUDA M, 1993, MED VET ENTOMOL, V7, P339, DOI 10.1111/j.1365-2915.1993.tb00702.x; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Lundkvist A, 2001, J MED VIROL, V65, P730, DOI 10.1002/jmv.2097; Mavtchoutko V, 2000, J MED VIROL, V60, P216, DOI 10.1002/(SICI)1096-9071(200002)60:2&lt;216::AID-JMV18&gt;3.0.CO;2-Z; Mickiene A, 2001, EUR J CLIN MICROBIOL, V20, P886, DOI 10.1007/s10096-001-0637-5; Pogodina V. V., 2005, Voprosy Virusologii, V50, P7; Randolph S, 1999, TROP MED INT HEALTH, V4, pA34, DOI 10.1046/j.1365-3156.1999.00449.x; Rice MC., 2007, FIELDS VIROLOGY, P1112; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3; Skarpaas T, 2006, EMERG INFECT DIS, V12, P1136, DOI 10.3201/eid1207.051567; Suess J, 2006, INT J MED MICROBIOL, V296, P63, DOI 10.1016/j.ijmm.2005.12.005; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Suss J, 2003, VACCINE, V21, pS19, DOI 10.1016/S0264-410X(02)00812-5; Suss J, 2002, INT J MED MICROBIOL, V291, P34; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wojcik-Fatla A, 2011, TICKS TICK-BORNE DIS, V2, P16, DOI 10.1016/j.ttbdis.2010.10.001; Yun SM, 2009, VECTOR-BORNE ZOONOT, V9, P287, DOI 10.1089/vbz.2008.0085	43	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61374	10.1371/journal.pone.0061374	http://dx.doi.org/10.1371/journal.pone.0061374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650497	gold, Green Published, Green Submitted			2022-12-27	WOS:000319167000012
J	Navarro, J; Votier, SC; Aguzzi, J; Chiesa, JJ; Forero, MG; Phillips, RA				Navarro, Joan; Votier, Stephen C.; Aguzzi, Jacopo; Chiesa, Juan J.; Forero, Manuela G.; Phillips, Richard A.			Ecological Segregation in Space, Time and Trophic Niche of Sympatric Planktivorous Petrels	PLOS ONE			English	Article							COMMON DIVING PETRELS; MAXIMUM DIVE DEPTHS; FEEDING ECOLOGY; SOUTH-GEORGIA; PELECANOIDES-GEORGICUS; HALOBAENA-CAERULEA; SEABIRD COMMUNITY; ANTARCTIC KRILL; ILES-KERGUELEN; BLUE PETRELS	The principle of competitive exclusion postulates that ecologically-similar species are expected to partition their use of resources, leading to niche divergence. The most likely mechanisms allowing such coexistence are considered to be segregation in a horizontal, vertical or temporal dimension, or, where these overlap, a difference in trophic niche. Here, by combining information obtained from tracking devices (geolocator-immersion and time depth recorders), stable isotope analyses of blood, and conventional morphometry, we provide a detailed investigation of the ecological mechanisms that explain the coexistence of four species of abundant, zooplanktivorous seabirds in Southern Ocean ecosystems (blue petrel Halobaena caerulea, Antarctic prion Pachyptila desolata, common diving petrel Pelecanoides urinatrix and South Georgian diving petrel P. georgicus). The results revealed a combination of horizontal, vertical and temporal foraging segregation during the breeding season. The stable isotope and morphological analyses reinforced this conclusion, indicating that each species occupied a distinct trophic space, and that this appears to reflect adaptations in terms of flight performance. In conclusion, the present study indicated that although there was a degree of overlap in some measures of foraging behaviour, overall the four taxa operated in very different ecological space despite breeding in close proximity. We therefore provide important insight into the mechanisms allowing these very large populations of ecologically-similar predators to coexist.	[Navarro, Joan; Aguzzi, Jacopo] CSIC, ICM, Barcelona, Spain; [Votier, Stephen C.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Chiesa, Juan J.] Univ Nacl Quilmes, CONICET, Dept Ciencia & Tecnol, Lab Cronobiol, Buenos Aires, DF, Argentina; [Forero, Manuela G.] CSIC, EBD, Dept Biol Conservac, E-41080 Seville, Spain; [Phillips, Richard A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Plymouth; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Navarro, J (corresponding author), CSIC, ICM, Barcelona, Spain.	joan@icm.csic.es	Navarro, Joan/C-2119-2009; Votier, Stephen C/G-2348-2014; Aguzzi, Jacopo/D-6574-2012	Navarro, Joan/0000-0002-5756-9543; Votier, Stephen C/0000-0002-0976-0167; Aguzzi, Jacopo/0000-0002-1484-8219	Juan de la Cierva program (Spanish Ministry of Economy and Competitiveness); Ramon y Cajal program (Spanish Ministry of Economy and Competitiveness); Natural Environment Research Council [bas0100025, NE/I023503/1] Funding Source: researchfish; NERC [bas0100025, NE/I023503/1] Funding Source: UKRI	Juan de la Cierva program (Spanish Ministry of Economy and Competitiveness); Ramon y Cajal program (Spanish Ministry of Economy and Competitiveness); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Logistical support in Bird Island was provided by the Collaborative Gearing Scheme of the Natural Environment Research Council Antarctic Funding Initiative (AFI-NERC). JN and JA were supported by a postdoctoral contract of the Juan de la Cierva program and Ramon y Cajal program, respectively (Spanish Ministry of Economy and Competitiveness). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi J, 2010, MAR ECOL PROG SER, V418, P47, DOI 10.3354/meps08835; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Batschelet E, 1981, CIRCULAR STAT BIOL; Bocher P, 2000, J ZOOL, V251, P517, DOI 10.1111/j.1469-7998.2000.tb00807.x; Bocher P, 2000, MAR ECOL PROG SER, V208, P249, DOI 10.3354/meps208249; Brooke M, 2004, ALBATROSSES PETRELS; BROOKE MD, 1989, IBIS, V131, P290, DOI 10.1111/j.1474-919X.1989.tb02772.x; BURGER AE, 1988, J FIELD ORNITHOL, V59, P345; CHASTEL O, 1994, POLAR BIOL, V14, P211; Chastel O, 1996, CONDOR, V98, P627, DOI 10.2307/1369575; Cherel Y, 2008, MAR ECOL PROG SER, V366, P281, DOI 10.3354/meps07587; Cherel Y, 2006, BIOL LETTERS, V2, P301, DOI 10.1098/rsbl.2006.0445; Cherel Y, 2002, MAR ECOL PROG SER, V228, P263, DOI 10.3354/meps228263; Cherel Y, 2002, MAR ECOL PROG SER, V228, P283, DOI 10.3354/meps228283; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Collins MA, 2012, DEEP-SEA RES PT II, V59, P189, DOI 10.1016/j.dsr2.2011.07.003; CROXALL JP, 1980, BIOL J LINN SOC, V14, P103, DOI 10.1111/j.1095-8312.1980.tb00101.x; Croxall JP, 1997, J ZOOL, V242, P531, DOI 10.1111/j.1469-7998.1997.tb03854.x; Elliott KH, 2009, WATERBIRDS, V32, P183, DOI 10.1675/063.032.0123; Forero MG, 2004, J ANIM ECOL, V73, P789, DOI 10.1111/j.0021-8790.2004.00852.x; Gause G.F, 1973, STRUGGLE EXISTENCE; Grant P.R., 1975, J EVOLUTION BIOL, V8, P237; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Guinet C, 1996, ANTARCT SCI, V8, P23, DOI 10.1017/S0954102096000053; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Luque SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015850; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Martin GR, 2001, BRAIN BEHAV EVOLUT, V57, P33, DOI 10.1159/000047224; MASELLO JF, 2012, MAR BIOL, V159, P1809; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; Navarro J, 2009, BIOL LETTERS, V5, P545, DOI 10.1098/rsbl.2009.0150; Passos C, 2010, AUK, V127, P100, DOI 10.1525/auk.2009.09036; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Phillips RA, 2007, AQUAT CONSERV, V17, pS6, DOI 10.1002/aqc.906; Phillips RA, 2005, MAR ECOL PROG SER, V285, P259, DOI 10.3354/meps285259; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2011, MAR BIOL, V158, P2199, DOI 10.1007/s00227-011-1725-4; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Pianka E. R., 2000, EVOLUTIONARY ECOLOGY; PRINCE PA, 1980, J ZOOL, V190, P59, DOI 10.1111/j.1469-7998.1980.tb01423.x; PRINCE PA, 1992, ANTARCT SCI, V4, P433, DOI 10.1017/S0954102092000646; Prince PA., 1982, B BR ANTARCT SURV, V56, P49; Ramos R, 2012, FRONT ECOL ENVIRON, V10, P258, DOI 10.1890/110140; Regular PM, 2010, MAR ECOL PROG SER, V415, P295, DOI 10.3354/meps08752; Reid K, 1997, POLAR BIOL, V17, P17, DOI 10.1007/s003000050100; Schmidt K, 2003, LIMNOL OCEANOGR, V48, P277, DOI 10.4319/lo.2003.48.1.0277; Schmidt K, 2006, LIMNOL OCEANOGR, V51, P2409, DOI 10.4319/lo.2006.51.5.2409; Schreiber EA, 2001, BIOL MARINE BIRDS; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; VEIT RR, 1993, J ANIM ECOL, V62, P551, DOI 10.2307/5204; WEIMERSKIRCH H, 1986, IBIS, V128, P195, DOI 10.1111/j.1474-919X.1986.tb02669.x; Wilson RP, 2010, FUNCT ECOL, V24, P646, DOI 10.1111/j.1365-2435.2009.01654.x	56	94	100	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62897	10.1371/journal.pone.0062897	http://dx.doi.org/10.1371/journal.pone.0062897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646155	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000319077300109
J	Christensen, NJ; Kepp, KP				Christensen, Niels J.; Kepp, Kasper P.			Stability Mechanisms of a Thermophilic Laccase Probed by Molecular Dynamics	PLOS ONE			English	Article							ENTHALPY-ENTROPY COMPENSATION; TRAMETES-VERSICOLOR; THERMAL-STABILITY; PROTEIN STABILITY; ERYTHRINA-CORALLODENDRON; DIHYDROFOLATE-REDUCTASE; STRUCTURAL FEATURES; POTENTIAL FUNCTIONS; CRYSTAL-STRUCTURE; ION-PAIRS	Laccases are highly stable, industrially important enzymes capable of oxidizing a large range of substrates. Causes for their stability are, as for other proteins, poorly understood. In this work, multiple-seed molecular dynamics (MD) was applied to a Trametes versicolor laccase in response to variable ionic strengths, temperatures, and glycosylation status. Near-physiological conditions provided excellent agreement with the crystal structure (average RMSD similar to 0.92 angstrom) and residual agreement with experimental B-factors. The persistence of backbone hydrogen bonds was identified as a key descriptor of structural response to environment, whereas solvent-accessibility, radius of gyration, and fluctuations were only locally relevant. Backbone hydrogen bonds decreased systematically with temperature in all simulations (similar to 9 per 50 K), probing structural changes associated with enthalpy-entropy compensation. Approaching T-opt (similar to 350 K) from 300 K, this change correlated with a beginning "unzipping" of critical beta-sheets. 0 M ionic strength triggered partial denucleation of the C-terminal (known experimentally to be sensitive) at 400 K, suggesting a general salt stabilization effect. In contrast, F- (but not Cl-) specifically impaired secondary structure by formation of strong hydrogen bonds with backbone NH, providing a mechanism for experimentally observed small anion destabilization, potentially remedied by site-directed mutagenesis at critical intrusion sites. N-glycosylation was found to support structural integrity by increasing persistent backbone hydrogen bonds by similar to 4 across simulations, mainly via prevention of F- intrusion. Hydrogen-bond loss in distinct loop regions and ends of critical beta-sheets suggest potential strategies for laboratory optimization of these industrially important enzymes.	[Christensen, Niels J.; Kepp, Kasper P.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark	Technical University of Denmark	Kepp, KP (corresponding author), Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark.	kpj@kemi.dtu.dk	Kepp, Kasper Planeta/G-1748-2013; Christensen, Niels Johan/J-3820-2014; Kepp, Kasper P./AAA-4626-2021	Kepp, Kasper Planeta/0000-0002-6754-7348; Christensen, Niels Johan/0000-0001-9588-2656; Kepp, Kasper P./0000-0002-6754-7348	Danish Agency for Science, Technology, and Innovation; Technical Science Council (FTP) [10-082488]	Danish Agency for Science, Technology, and Innovation; Technical Science Council (FTP)	The authors acknowledge support from the Danish Agency for Science, Technology, and Innovation, the Technical Science Council (FTP), grant no. 10-082488 (http://en.fi.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MAESTRO DESMOND INTE; [Anonymous], 2011, MAESTRO 9 2; [Anonymous], 2011, DESM MOL DYN SYST 3; Autore F, 2009, ENZYME MICROB TECH, V45, P507, DOI 10.1016/j.enzmictec.2009.08.004; Bae E, 2005, J BIOL CHEM, V280, P30943, DOI 10.1074/jbc.M504216200; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Chen JM, 2001, BIOCHEMISTRY-US, V40, P15280, DOI 10.1021/bi011776v; Colombo G, 1999, J AM CHEM SOC, V121, P6895, DOI 10.1021/ja990420s; Damm W, 1997, J COMPUT CHEM, V18, P1955, DOI 10.1002/(SICI)1096-987X(199712)18:16<1955::AID-JCC1>3.0.CO;2-L; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Drabik P, 2001, PROTEIN ENG, V14, P747, DOI 10.1093/protein/14.10.747; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Festa G, 2008, PROTEINS, V72, P25, DOI 10.1002/prot.21889; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fu HL, 2009, PROTEINS, V77, P491, DOI 10.1002/prot.22509; Gelo-Pujic M, 1999, APPL ENVIRON MICROB, V65, P5515; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Glykos NM, 2007, ACTA CRYSTALLOGR D, V63, P705, DOI 10.1107/S0907444907014928; Gruia AD, 2003, PROTEINS, V50, P507, DOI 10.1002/prot.10312; GRUNWALD E, 1995, J AM CHEM SOC, V117, P5687, DOI 10.1021/ja00126a009; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hilden K, 2009, BIOTECHNOL LETT, V31, P1117, DOI 10.1007/s10529-009-9998-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Ibragimova GT, 1999, BIOPHYS J, V77, P2191, DOI 10.1016/S0006-3495(99)77059-1; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jensen KP, 2006, J CHEM THEORY COMPUT, V2, P1499, DOI 10.1021/ct600252r; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kallio JP, 2011, FEBS J, V278, P2283, DOI 10.1111/j.1742-4658.2011.08146.x; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kaushik S, 2012, J BIOMOL STRUCT DYN, V29, P905, DOI 10.1080/073911012010525026; Kaushik S, 2011, PROTEIN SCI, V20, P465, DOI 10.1002/pro.578; Koschorreck K, 2008, ARCH BIOCHEM BIOPHYS, V474, P213, DOI 10.1016/j.abb.2008.03.009; KRUG RR, 1976, J PHYS CHEM-US, V80, P2341, DOI 10.1021/j100562a007; KRUG RR, 1976, J PHYS CHEM-US, V80, P2335, DOI 10.1021/j100562a006; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; LEE B, 1994, BIOPHYS CHEM, V51, P271, DOI 10.1016/0301-4622(94)00048-4; Li WF, 2005, BIOTECHNOL ADV, V23, P271, DOI 10.1016/j.biotechadv.2005.01.002; Liu J, 2008, J MOL GRAPH MODEL, V27, P529, DOI 10.1016/j.jmgm.2008.09.004; Lumry R, 2003, BIOPHYS CHEM, V105, P545, DOI 10.1016/S0301-4622(03)00065-6; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Matsui I, 2007, FEBS J, V274, P4012, DOI 10.1111/j.1742-4658.2007.05956.x; Missimer JH, 2007, PROTEIN SCI, V16, P1349, DOI 10.1110/ps.062542907; Mitra N, 2003, BIOCHEMISTRY-US, V42, P12208, DOI 10.1021/bi035169e; Naidoo KJ, 1997, PROTEIN ENG, V10, P1249, DOI 10.1093/protein/10.11.1249; Necochea R, 2005, FEMS MICROBIOL LETT, V244, P235, DOI 10.1016/j.femsle.2005.01.054; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PETSKO GA, 1984, ANNU REV BIOPHYS BIO, V13, P331; Pikkemaat MG, 2002, PROTEIN ENG, V15, P185, DOI 10.1093/protein/15.3.185; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Piscitelli Alessandra, 2010, Bioeng Bugs, V1, P252, DOI 10.4161/bbug.1.4.11438; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Rulisek L, 2013, COORDIN CHEM REV, V257, P445, DOI 10.1016/j.ccr.2012.04.019; Ruvinsky AM, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3498743; Sedlak E, 2008, P NATL ACAD SCI USA, V105, P19258, DOI 10.1073/pnas.0806431105; Sola RJ, 2007, CELL MOL LIFE SCI, V64, P2133, DOI 10.1007/s00018-007-6551-y; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Swanwick RS, 2005, CHEMBIOCHEM, V6, P1338, DOI 10.1002/cbic.200500103; Tey LH, 2010, FEBS J, V277, P2171, DOI 10.1111/j.1742-4658.2010.07634.x; Tian JA, 2010, FEBS J, V277, P4901, DOI 10.1111/j.1742-4658.2010.07895.x; TIRADORIVES J, 1990, J AM CHEM SOC, V112, P2773, DOI 10.1021/ja00163a046; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1; YOSHITAKE A, 1993, J GEN MICROBIOL, V139, P179, DOI 10.1099/00221287-139-1-179; Zuegg J, 2000, GLYCOBIOLOGY, V10, P959, DOI 10.1093/glycob/10.10.959	78	39	40	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e61985	10.1371/journal.pone.0061985	http://dx.doi.org/10.1371/journal.pone.0061985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658618	Green Published, Green Submitted, gold			2022-12-27	WOS:000321662800018
J	Das, SK; Ahmed, S; Ferdous, F; Farzana, FD; Chisti, MJ; Leung, DT; Malek, MA; Talukder, KA; Bardhan, PK; Salam, MA; Faruque, AG; Raqib, R				Das, Sumon Kumar; Ahmed, Shahnawaz; Ferdous, Farzana; Farzana, Fahmida Dil; Chisti, Mohammod Jobayer; Leung, Daniel T.; Malek, Mohammad Abdul; Talukder, Kaisar Ali; Bardhan, Pradip Kumar; Salam, Mohammed Abdus; Faruque, Abu Syed Golam; Raqib, Rubhana			Changing Emergence of Shigella Sero-Groups in Bangladesh: Observation from Four Different Diarrheal Disease Hospitals	PLOS ONE			English	Article							PLESIOMONAS-SHIGELLOIDES; SURVEILLANCE; MULTICENTER; CHILDREN; BURDEN	Background: Shigellosis continues to be a public health challenge for developing countries, including Bangladesh. The aim of the study is to demonstrate recent changes in Shigella sero-groups and their geographical diversity. Methods: Data were extracted from data archive of four diarrheal disease surveillance systems. A 2% sub sample from urban Dhaka Hospital (2008-2011; n = 10,650), and 10% from urban Mirpur Treatment Centre (2009-2011; n = 3,585), were enrolled systematically; whereas, all patients coming from the Health and Demographic Surveillance System area in rural Matlab (2008-2011; n = 6,399) and rural Mirzapur (2010-2011; n = 2,812) were included irrespective of age, sex, and disease severity. A fresh stool specimen was collected for identification of Shigella spp. Of them, 315 (3%) were positive for Shigella in Dhaka, 490 (8%) from Matlab, 109 (3%) from Mirpur and 369 (13%) from Mirzapur and considered as analyzable sample size. Results: Among all Shigella isolates regardless of age, significant decreases in percentage of S. flexneri over time was observed in Mirpur (55 -> 29%; p value of chi(2)-for trend = 0.019) and Mirzapur (59 -> 47%; p = 0.025). A non-significant decrease was also seen in Dhaka (58 -> 48%), while in Matlab there was a non-significant increase (73 -> 81%). Similar patterns were observed among under-5 children at all sites. Emergence of S. sonnei was found in Dhaka (8 -> 25%; p<0.001) and Mirpur (10 -> 33%; p = 0.015), whereas it decreased in Mirzapur (32 -> 23%; p = 0.056). The emergence of S. boydii was seen in all ages in Mirzapur [(3 -> 28%; p<0.001); (3 -> 27%; p<0.001)]. On the other hand, we saw non-significant percent reductions in S. boydii in Dhaka [overall (25 -> 16%); under-5 (16 -> 9%)]. Decreasing rates of Shigella dysenteriae were observed in Matlab, Mirpur and Mirzapur; whereas, in Dhaka it remained unchanged. Conclusion and Significance: Emergence of S. sonnei and S. boydii as important infectious diarrhea etiologies and variations in geographical diversity underscore the need for monitoring, with possible implications for vaccine development.	[Das, Sumon Kumar; Ahmed, Shahnawaz; Ferdous, Farzana; Farzana, Fahmida Dil; Chisti, Mohammod Jobayer; Malek, Mohammad Abdul; Faruque, Abu Syed Golam] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, CNFS, Dhaka, Bangladesh; [Leung, Daniel T.; Raqib, Rubhana] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, CVS, Dhaka, Bangladesh; [Talukder, Kaisar Ali] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, CFWD, Dhaka, Bangladesh; [Chisti, Mohammod Jobayer; Bardhan, Pradip Kumar] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka Hosp, Dhaka, Bangladesh; [Salam, Mohammed Abdus] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, RAS, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Faruque, AG (corresponding author), Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, CNFS, Dhaka, Bangladesh.	gfaruque@icddrb.org	Das, Sumon Kumar/AAD-1551-2019; Das, Sumon Kumar/T-6384-2019; Chisti, Mohammod J/A-7216-2018	Raqib, Rubhana/0000-0002-8116-4511; FERDOUS, FARZANA/0000-0002-6373-3581; Ahmed, Shahnawaz/0000-0001-8339-4137; Leung, Daniel/0000-0001-8401-0801	Swedish International Development Cooperation Agency (Sida) [MD-0020, GR-00599]; icddr,b; Government of the People's Republic of Bangladesh through IHP-HNPRP; Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swiss Agency for Development and Cooperation (SDC); Department for International Development, UK (DFID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI100923] Funding Source: NIH RePORTER	Swedish International Development Cooperation Agency (Sida); icddr,b; Government of the People's Republic of Bangladesh through IHP-HNPRP; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swiss Agency for Development and Cooperation (SDC); Department for International Development, UK (DFID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research protocol was funded by Swedish International Development Cooperation Agency (Sida), grant number MD-0020 and GR-00599. icddr,b acknowledges with gratitude the commitment of Sida to its research efforts. Hospital surveillance was funded by icddr,b and the Government of the People's Republic of Bangladesh through IHP-HNPRP. icddr,b acknowledges with gratitude the commitment of the Government of the People's Republic of Bangladesh to the Centre's research efforts. icddr,b also gratefully acknowledges the following donors who provide unrestricted support to the Centre's research efforts: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), Swiss Agency for Development and Cooperation (SDC), and Department for International Development, UK (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chompook P, 2005, B WORLD HEALTH ORGAN, V83, P739; Christopher PRH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006784.pub4; Clemens J., 1999, GENERIC PROTOCOL EST; Feil EJ, 2012, NAT GENET, V44, P964, DOI 10.1038/ng.2389; Greenhill Claire, 2012, Nat Rev Gastroenterol Hepatol, V9, P487, DOI 10.1038/nrgastro.2012.160; Vinh H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001264; Ha V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-204; Hale TL., 1996, MED MICROBIOLOGY; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Kaminski RW, 2009, EXPERT REV VACCINES, V8, P1693, DOI 10.1586/ERV.09.127; Kelly-Hope LA, 2007, AM J TROP MED HYG, V76, P706, DOI 10.4269/ajtmh.2007.76.706; Khan AM, 2009, J TROP PEDIATRICS, V55, P122, DOI 10.1093/tropej/fmn090; Khan AM, 2004, J TROP PEDIATRICS, V50, P354, DOI 10.1093/tropej/50.6.354; Khatun F, 2011, EPIDEMIOL INFECT, V139, P446, DOI 10.1017/S0950268810001093; SACK DA, 1994, LANCET, V343, P1413, DOI 10.1016/S0140-6736(94)92531-3; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; WHO, 2009, IN VACC RES DIARRH D; World Health Organization, 1987, MAN LAB INV AC ENT I, P9	18	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62029	10.1371/journal.pone.0062029	http://dx.doi.org/10.1371/journal.pone.0062029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658619	Green Submitted, Green Published, gold			2022-12-27	WOS:000321662800020
J	Huang, TW; Chen, TL; Chen, YT; Lauderdale, TL; Liao, TL; Lee, YT; Chen, CP; Liu, YM; Lin, AC; Chang, YH; Wu, KM; Kirby, R; Lai, JF; Tan, MC; Siu, LK; Chang, CM; Fung, CP; Tsai, SF				Huang, Tzu-Wen; Chen, Te-Li; Chen, Ying-Tsong; Lauderdale, Tsai-Ling; Liao, Tsai-Lien; Lee, Yi-Tzu; Chen, Chien-Pei; Liu, Yen-Ming; Lin, Ann-Chi; Chang, Ya-Hui; Wu, Keh-Ming; Kirby, Ralph; Lai, Jui-Fen; Tan, Mei-Chen; Siu, Leung-Kei; Chang, Chung-Ming; Fung, Chang-Phone; Tsai, Shih-Feng			Copy Number Change of the NDM-1 Sequence in a Multidrug-Resistant Klebsiella pneumoniae Clinical Isolate	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAIN; BETA-LACTAM RESISTANCE; TETRACYCLINE RESISTANCE; STREPTOCOCCUS-FAECALIS; GENE AMPLIFICATION; ACINETOBACTER-BAUMANNII; ANTIBIOTIC-RESISTANCE; CARRYING BLA(NDM-1); PLASMID; CARBAPENEMASE	The genetic features of the antimicrobial resistance of a multidrug resistant Klebsiella pneumoniae strain harboring bla(NDM-1) were investigated to increase our understanding of the evolution of NDM-1. The strain, KPX, came from a Taiwanese patient with a hospitalization history in New Delhi. Complete DNA sequencing was performed; and the genes responsible for antimicrobial resistance were systematically examined and isolated by library screening. KPX harbored two resistance plasmids, pKPX-1 and pKPX-2, which are 250-kb and 141-kb in size, respectively, with bla(NDM-1) present on pKPX-1. The plasmid pKPX-1 contained genes associated with the IncR and IncF groups, while pKPX-2 belonged to the IncF family. Each plasmid carried multiple antimicrobial resistance genetic determinants. The gene responsible for resistance to carbapenems was found on pKPX-1 and that for resistance to aztreonam was found on pKPX-2. To our surprise, we discovered that bla(NDM-1) exists on pKPX-1 as multiple copies in the form of tandem repeats. Amplification of bla(NDM-1) was found to occur by duplication of an 8.6-kb unit, with the copy number of the repeat varying from colony to colony. This repeat sequence is identical to that of the pNDM-MAR except for two base substitutions. The copy number of bla(NDM-1) of colonies under different conditions was assessed by Southern blotting and quantitative PCR. The bla(NDM-1) sequence was maintained in the presence of the antimicrobial selection; however, removal of antimicrobial selection led to the emergence of susceptible bacterial populations with a reduced copy number or even the complete loss of the bla(NDM-1) sequence. The dynamic nature of the NDM-1 sequence provides a strong argument for judicious use of the broad-spectrum antimicrobials in order to reduce the development and spread of antimicrobial resistance among pathogens.	[Huang, Tzu-Wen; Chen, Ying-Tsong; Liao, Tsai-Lien; Liu, Yen-Ming; Lin, Ann-Chi; Chang, Ya-Hui; Chang, Chung-Ming; Tsai, Shih-Feng] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Lauderdale, Tsai-Ling; Lai, Jui-Fen; Tan, Mei-Chen; Siu, Leung-Kei] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Chen, Te-Li; Chen, Chien-Pei] Taipei Vet Gen Hosp, Div Infect Dis, Taipei, Taiwan; [Chen, Te-Li; Fung, Chang-Phone] Taipei Vet Gen Hosp, Immunol Res Ctr, Taipei, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Chen, Te-Li; Lee, Yi-Tzu; Fung, Chang-Phone] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wu, Keh-Ming; Tsai, Shih-Feng] Natl Yang Ming Univ, Genome Res Ctr, Taipei 112, Taiwan; [Kirby, Ralph; Tsai, Shih-Feng] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Kirby, Ralph; Tsai, Shih-Feng] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Lee, Yi-Tzu] Chutung Vet Hosp, Dept Med, Chutung, Hsinchu County, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Tsai, SF (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan.	petsai@nhri.org.tw	Chang, Chung-Ming/E-3945-2010; Lauderdale, Tsai-Ling/B-2660-2010; Tsai, Shih-Feng/E-3997-2010; Siu, Leung-Kei/C-1368-2010	Chen, Ying-Tsong/0000-0003-1337-4127	National Science Council [NSC 98-2314-B-010-010-MY3]; SFT [NSC 99-2320-B-400 -013-MY3]; YTC [NSC 100-2311-B-005-001]; National Health Research Institutes; Immunology Research Center at Taipei Veterans General Hospital [V100E4-005]	National Science Council(Ministry of Science and Technology, Taiwan); SFT; YTC; National Health Research Institutes(National Health Research Institutes, Japan); Immunology Research Center at Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work is supported in part by National Science Council grants to TLC (NSC 98-2314-B-010-010-MY3), SFT (NSC 99-2320-B-400 -013-MY3) and YTC (NSC 100-2311-B-005-001). SFT, TLL, CMC have received long-term support from the National Health Research Institutes. TLC is supported by Immunology Research Center at Taipei Veterans General Hospital (V100E4-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertini A, 2007, ANTIMICROB AGENTS CH, V51, P2324, DOI 10.1128/AAC.01502-06; Bonnin RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034752; Carattoli A, 2012, ANTIMICROB AGENTS CH, V56, P783, DOI 10.1128/AAC.05116-11; Carvalhaes CG, 2010, J ANTIMICROB CHEMOTH, V65, P249, DOI 10.1093/jac/dkp431; Chen TL, 2008, J CLIN MICROBIOL, V46, P2938, DOI 10.1128/JCM.00232-08; Chen TL, 2011, J CHIN MED ASSOC, V74, P104, DOI 10.1016/j.jcma.2011.01.022; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; CLEWELL DB, 1975, P NATL ACAD SCI USA, V72, P1720, DOI 10.1073/pnas.72.5.1720; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Dolejska M, 2012, J ANTIMICROB CHEMOTH, V68, P34; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fraser CM, 1997, ELECTROPHORESIS, V18, P1207, DOI 10.1002/elps.1150180803; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hammond DS, 2005, ANTIMICROB AGENTS CH, V49, P256, DOI 10.1128/AAC.49.1.256-263.2005; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Hu HY, 2012, ANTIMICROB AGENTS CH, V56, P1698, DOI 10.1128/AAC.06199-11; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Karthikeyan K, 2010, J ANTIMICROB CHEMOTH, V65, P2253, DOI 10.1093/jac/dkq273; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Livermore DM, 2011, INT J ANTIMICROB AG, V37, P415, DOI 10.1016/j.ijantimicag.2011.01.012; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mc Gann P, 2012, ANTIMICROB AGENTS CH, V56, P1673, DOI 10.1128/AAC.05604-11; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; NOGUCHI N, 1995, ANTIMICROB AGENTS CH, V39, P2359, DOI 10.1128/AAC.39.10.2359; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Nordmann P, 2011, J ANTIMICROB CHEMOTH, V66, P689, DOI 10.1093/jac/dkq520; Pillai DR, 2011, CAN MED ASSOC J, V183, P59, DOI 10.1503/cmaj.101487; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Potron A, 2011, FEMS MICROBIOL LETT, V324, P111, DOI 10.1111/j.1574-6968.2011.02392.x; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sekizuka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025334; Sole M, 2011, ANTIMICROB AGENTS CH, V55, P4402, DOI 10.1128/AAC.00642-11; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Sun S, 2009, GENETICS, V182, P1183, DOI 10.1534/genetics.109.103028; Szczepanowski R, 2004, ARCH MICROBIOL, V182, P429, DOI 10.1007/s00203-004-0726-9; Turton JF, 2008, FEMS MICROBIOL LETT, V284, P247, DOI 10.1111/j.1574-6968.2008.01208.x; Villa L, 2012, J ANTIMICROB CHEMOTH, V67, P1645, DOI 10.1093/jac/dks114; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wu HS, 2010, J CHIN MED ASSOC, V73, P596, DOI 10.1016/S1726-4901(10)70129-5; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; YAGI Y, 1980, J BACTERIOL, V143, P1070, DOI 10.1128/JB.143.2.1070-1072.1980; YAGI Y, 1976, J MOL BIOL, V102, P583, DOI 10.1016/0022-2836(76)90336-3; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	46	58	60	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62774	10.1371/journal.pone.0062774	http://dx.doi.org/10.1371/journal.pone.0062774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658651	gold, Green Published, Green Submitted			2022-12-27	WOS:000321662800061
J	Varadi, E; Vegi, B; Liptoi, K; Barna, J				Varadi, Eva; Vegi, Barbara; Liptoi, Krisztina; Barna, Judit			Methods for Cryopreservation of Guinea Fowl Sperm	PLOS ONE			English	Article							SEMEN CRYOPRESERVATION; GENETIC-RESOURCES; DNA-DAMAGE; SPERMATOZOA; FERTILITY; CHALLENGES; DIVERSITY; CRYOBANK; CREATION; BREEDS	Conservation of indigenous poultry species is an important part of the new Hungarian agricultural strategy. Semen cryopreservation is the most practical method for the long term storage of poultry genetic material. The objective was to compare four protocols for cryopreservation of guinea fowl sperm (slow and fast programmable, freezing in nitrogen vapor, and pellet) and three cryoprotectants (10% ethylene glycol, 6% dimethyl-formamide and 6% dimethyl-acetamide). The efficiency of the methods was examined by in vitro tests (subjective motility scoring, sperm concentration, morphological and live/dead sperm analysis with eosin-aniline staining). Thereafter, the two most promising methods were tested by artificial insemination of frozen-thawed semen (3 times a week for 3 weeks using 300 million spermatozoa/hen), followed by candling of incubated eggs, assessment of fertilization, embryonic death, and hatching rate. The survival rate of live, intact spermatozoa was greatest (p <= 0.05) in pellet method and the slow programmable protocol (with 10% ethylene glycol) (28.6 and 23.5%). The two best protocols (based on in vitro assessment of post-thaw semen quality) were subsequently tested in vivo with artificial insemination. The pellet method yielded a 64% fertility rate compared to slow protocol with only 30% fertility. Regardless, both freezing protocols significantly increased embryonic deaths compared to the control group (16,7; 9,1 and 8,3%, respectively). During the 3-week in vivo trial, fertility increased and early embryonic death decreased over time. According to the results the guinea fowl sperm could tolerate the fast freezing in pellet better than the slower freezing rates and resulted acceptable fertility rate.	[Varadi, Eva] Inst Small Anim Res, Godollo, Hungary; Coordinat Ctr Gene Conservat, Godollo, Hungary		Varadi, E (corresponding author), Inst Small Anim Res, Godollo, Hungary.	varadievi@hotmail.com	Liptoi, Krisztina/S-5484-2018	Liptoi, Krisztina/0000-0002-9083-7570	National Innovation Office [TET_09_FR_ANR_BIO-CryoBird]	National Innovation Office	The research was supported by the National Innovation Office (TET_09_FR_ANR_BIO-CryoBird) (www.nih.gov.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barna J., 2010, WORLDS POULT SCI J, V66, P508; Baumber J, 2003, J ANDROL, V24, P621; Blackburn HD, 2006, POULTRY SCI, V85, P210, DOI 10.1093/ps/85.2.210; Blesbois E, 2007, POULTRY SCI, V86, P555, DOI 10.1093/ps/86.3.555; Blesbois E, 2005, REPRODUCTION, V129, P371, DOI 10.1530/rep.1.00454; BLESBOIS E, 2006, ACTES BRG, V6, P415; Boa-Amponsem K, 2004, WORLD POULTR C JUN 8; Bramwell RK, 2002, AVIAN ADVICE, V4, P1; BURROWS W. H., 1937, POULTRY SCI, V16, P19, DOI 10.3382/ps.0160019; Gee G.F., 1995, P 1 INT S ART INS PO, P262; Hoffmann I, 2005, WORLD POULTRY SCI J, V61, P57, DOI 10.1079/WPS200449; Horvath A, 2003, AQUAT LIVING RESOUR, V16, P457, DOI 10.1016/S0990-7440(03)00084-6; Iaffaldano N, 2011, THERIOGENOLOGY, V76, P794, DOI 10.1016/j.theriogenology.2011.04.012; LAKE PE, 1986, POULTRY SCI, V65, P1, DOI 10.3382/ps.0650001; Linfor JJ, 2002, J ANDROL, V23, P107, DOI 10.1002/j.1939-4640.2002.tb02603.x; Liptoi K, 2004, ACTA VET HUNG, V52, P227, DOI 10.1556/AVet.52.2004.2.11; Lukaszewicz E, 2002, THERIOGENOLOGY, V58, P19, DOI 10.1016/S0093-691X(01)00690-2; Morris ID, 2002, HUM REPROD, V17, P990, DOI 10.1093/humrep/17.4.990; Reedy S.E., 1995, P 1 S ART INS POULTR, P229; Saint Jalme M, 2003, THERIOGENOLOGY, V59, P875, DOI 10.1016/S0093-691X(02)01153-6; Santiago-Moreno J, 2011, POULTRY SCI, V90, P2047, DOI 10.3382/ps.2011-01355; SCHRAMM GP, 1989, ARCH TIERZUCHT, V32, P51; Seigneurin F, 2005, P FRENCH POULTRY RES, P23; Sood S, 2011, ANIM REPROD SCI, V129, P89, DOI 10.1016/j.anireprosci.2011.10.010; Tisdell C, 2003, ECOL ECON, V45, P365, DOI 10.1016/S0921-8009(03)00091-0; TSELUTIN K, 1995, BRIT POULTRY SCI, V36, P805, DOI 10.1080/00071669508417825; Tselutin K, 1999, POULTRY SCI, V78, P586, DOI 10.1093/ps/78.4.586; VANKREY HP, 1966, J REPROD FERTIL, V11, P257, DOI 10.1530/jrf.0.0110257; Vegi B., 2005, P 2 COMB WORKSH FUND, P55; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; Woelders H, 2006, POULTRY SCI, V85, P216, DOI 10.1093/ps/85.2.216	31	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62759	10.1371/journal.pone.0062759	http://dx.doi.org/10.1371/journal.pone.0062759			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658648	gold, Green Published, Green Submitted			2022-12-27	WOS:000321662800060
J	Sun, YR; Song, HG; Li, J; Li, Y; Jiang, M; Zhou, JH; Guo, ZH				Sun, Yueru; Song, Haigang; Li, Jie; Li, Yan; Jiang, Ming; Zhou, Jiahai; Guo, Zhihong			Structural Basis of the Induced-Fit Mechanism of 1,4-Dihydroxy-2-Naphthoyl Coenzyme A Synthase from the Crotonase Fold Superfamily	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; CENTER-DOT-PI; MENAQUINONE BIOSYNTHESIS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; PROTEIN STRUCTURES; BICARBONATE ION; COA SYNTHETASE; INHIBITORS	1,4-Dihydroxy-2-naphthoyl coenzyme A (DHNA-CoA) synthase is a typical crotonase fold enzyme with an implicated role of conformational changes in catalysis. We have identified these conformational changes by determining the structures of its Escherichia coli and Synechocystis sp. PCC6803 orthologues in complex with a product analog. The structural changes include the folding of an active-site loop into a beta-hairpin and significant reorientation of a helix at the carboxy terminus. Interestingly, a new interface is formed between the ordered loop and the reoriented helix, both of which also form additional interactions with the coenzyme A moiety of the ligand. Site-directed mutation of the amino acid residues involved in these ligand-induced interactions significantly diminishes the enzyme activity. These results suggest a catalytically essential induced-fit that is likely initiated by the enzyme-ligand interactions at the active site.	[Sun, Yueru; Song, Haigang; Jiang, Ming; Guo, Zhihong] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Sun, Yueru; Song, Haigang; Jiang, Ming; Guo, Zhihong] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Li, Jie; Li, Yan; Zhou, Jiahai] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Zhou, JH (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Lu, Shanghai 200032, Peoples R China.	jiahai@mail.sioc.ac.cn; chguo@ust.hk		Guo, Zhihong/0000-0003-0374-8412	Research Grants Council of the HKSAR government [GRF601209, RPC11SC16]; National Program on Key Basic Research of China [2009CB918600]	Research Grants Council of the HKSAR government(Hong Kong Research Grants Council); National Program on Key Basic Research of China	This work was supported in part by GRF601209 and RPC11SC16 from the Research Grants Council of the HKSAR government (to Z.G.) and 2009CB918600 from the National Program on Key Basic Research of China (to J.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Chen MJ, 2011, BIOCHEMISTRY-US, V50, P5893, DOI 10.1021/bi200376x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Courtois F, 2005, BIOCHEMISTRY-US, V44, P13583, DOI 10.1021/bi051159x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Egli M, 2007, ACCOUNTS CHEM RES, V40, P197, DOI 10.1021/ar068174u; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Fang MH, 2010, BIOCHEMISTRY-US, V49, P2672, DOI 10.1021/bi901432d; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; Gross J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-117; Guo ZF, 2008, ORG LETT, V10, P649, DOI 10.1021/ol7030153; Guo ZF, 2010, BIOORG MED CHEM LETT, V20, P3855, DOI 10.1016/j.bmcl.2010.05.051; Guo ZF, 2009, BIOCHEMISTRY-US, V48, P1712, DOI 10.1021/bi802165x; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; Hernandez-Guillamon M, 2007, J BIOCHEM, V142, P571, DOI 10.1093/jb/mvm165; Iwig DF, 2005, J AM CHEM SOC, V127, P11612, DOI 10.1021/ja053899z; Jain A, 2007, J PHYS CHEM B, V111, P8680, DOI [10.1021/jp072742l, 10.1021/jp0727421]; Jain A, 2009, PROTEIN SCI, V18, P595, DOI 10.1002/pro.67; Jiang M, 2008, BIOCHEMISTRY-US, V47, P3426, DOI 10.1021/bi7023755; Jiang M, 2007, ORG LETT, V9, P4765, DOI 10.1021/ol702126m; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jiang M, 2010, J BIOL CHEM, V285, P30159, DOI 10.1074/jbc.M110.147702; Jiang M, 2009, BIOCHEMISTRY-US, V48, P6921, DOI 10.1021/bi900897h; Johnston JM, 2005, ACTA CRYSTALLOGR D, V61, P1199, DOI [10.1107/s0907444905017531, 10.1107/S0904777905017531]; Kanaujia SP, 2007, ACTA CRYSTALLOGR F, V63, P103, DOI 10.1107/S1744309106056521; Kasaragod P, 2010, J BIOL CHEM, V285, P24089, DOI 10.1074/jbc.M110.117606; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kurosu M, 2007, J MED CHEM, V50, P3973, DOI 10.1021/jm070638m; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li HJ, 2011, BIOCHEMISTRY-US, V50, P9532, DOI 10.1021/bi200877x; Li XK, 2011, ACS MED CHEM LETT, V2, P818, DOI 10.1021/ml200141e; Li XK, 2010, BIOORG MED CHEM LETT, V20, P6306, DOI 10.1016/j.bmcl.2010.08.076; Lu XQ, 2008, BIOORG MED CHEM LETT, V18, P5963, DOI 10.1016/j.bmcl.2008.07.130; Lu XQ, 2012, CHEMBIOCHEM, V13, P129, DOI 10.1002/cbic.201100585; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meganathan R, 2001, VITAM HORM, V61, P173; Minasov G, 2009, CENT STRUCT GENOMICS, DOI [10.2210/pdb3h02/pdb, DOI 10.2210/PDB3H02/PDB]; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Shevela D, 2007, PHOTOSYNTH RES, V94, P247, DOI 10.1007/s11120-007-9200-2; Song HG, 2012, SCI CHINA CHEM, V55, P98, DOI 10.1007/s11426-011-4448-y; Strater N, 1999, P NATL ACAD SCI USA, V96, P11151, DOI 10.1073/pnas.96.20.11151; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; Sun YR, 2012, BIOCHEMISTRY-US, V51, P4580, DOI 10.1021/bi300486j; Truglio JJ, 2003, J BIOL CHEM, V278, P42352, DOI 10.1074/jbc.M307399200; Ulaganathan V, 2007, ACTA CRYSTALLOGR F, V63, P908, DOI 10.1107/S1744309107047720; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510	55	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e63095	10.1371/journal.pone.0063095	http://dx.doi.org/10.1371/journal.pone.0063095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658663	Green Published, gold, Green Submitted			2022-12-27	WOS:000318343700091
J	Sanabani, SS; Pessoa, R; de Oliveira, ACS; Martinez, VP; Giret, MTM; Succi, RCD; Carvalho, K; Tomiyama, CS; Nixon, DF; Sabino, EC; Kallas, EG				Sanabani, Sabri Saeed; Pessoa, Rodrigo; Soares de Oliveira, Ana Carolina; Martinez, Vanessa Pouza; Giret, Maria Teresa Maidana; de Menezes Succi, Regina Celia; Carvalho, Karina; Tomiyama, Claudia Satiko; Nixon, Douglas F.; Sabino, Ester Cerdeira; Kallas, Esper Georges			Variability of HIV-1 Genomes among Children and Adolescents from Sao Paulo, Brazil	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CIRCULATING RECOMBINANT FORM; SUBTYPE-C; VERTICAL TRANSMISSION; MOLECULAR EPIDEMIOLOGY; GENOTYPIC RESISTANCE; DRUG-RESISTANCE; DUAL INFECTION; VIRAL LOAD; CLADE-B	Background: Genetic variability is a major feature of the human immunodeficiency virus type 1 (HIV-1) and considered the key factor to frustrating efforts to halt the virus epidemic. In this study, we aimed to investigate the genetic variability of HIV-1 strains among children and adolescents born from 1992 to 2009 in the state of Sao Paulo, Brazil. Methodology: Plasma and peripheral blood mononuclear cells (PBMC) were collected from 51 HIV-1-positive children and adolescents on ART followed between September 1992 and July 2009. After extraction, the genetic materials were used in a polymerase chain reaction (PCR) to amplify the viral near full length genomes (NFLGs) from 5 overlapped fragments. NFLGs and partial amplicons were directly sequenced and data were phylogenetically inferred. Results: Of the 51 samples studied, the NFLGs and partial fragments of HIV-1 from 42 PBMCs and 25 plasma were successfully subtyped. Results based on proviral DNA revealed that 22 (52.4%) patients were infected with subtype B, 16 (38.1%) were infected with BF1 mosaic variants and 4 (9.5%) were infected with sub-subtype F1. All the BF1 recombinants were unique and distinct from any previously identified unique or circulating recombinant forms in South America. Evidence of dual infections was detected in 3 patients coinfected with the same or distinct HIV-1 subtypes. Ten of the 31 (32.2%) and 12 of the 21 (57.1%) subjects with recovered proviral and plasma, respectively, protease sequences were infected with major mutants resistant to protease inhibitors. The V3 sequences of 14 patients with available sequences from PBMC/or plasma were predicted to be R5-tropic virus except for two patients who harbored an X4 strain. Conclusions: The high proportion of HIV-1 BF1 recombinant, coinfection rate and vertical transmission in Brazil merits urgent attention and effective measures to reduce the transmission of HIV among spouses and sex partners.	[Sanabani, Sabri Saeed] Univ Sao Paulo, Sch Med, Clin & Res Lab LIM 03, Sao Paulo, Brazil; [Sanabani, Sabri Saeed; Pessoa, Rodrigo; Soares de Oliveira, Ana Carolina; Martinez, Vanessa Pouza; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Trop Med, Virol Lab LIM HCFMUSP 52, Sao Paulo, Brazil; [Giret, Maria Teresa Maidana] Univ Florida, Miller Sch Med, Story Lab 2, Miami, FL USA; [de Menezes Succi, Regina Celia] Univ Fed Sao Paulo, Paulista Sch Med, Dept Pediat, Sao Paulo, Brazil; [Carvalho, Karina; Tomiyama, Claudia Satiko; Kallas, Esper Georges] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; State University System of Florida; University of Florida; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; University of California System; University of California San Francisco	Sanabani, SS (corresponding author), Univ Sao Paulo, Sch Med, Clin & Res Lab LIM 03, Sao Paulo, Brazil.	sabyem_63@yahoo.com	Carvalho, Karina IL/J-6789-2012; Sanabani, Sabri Saeed/F-5600-2012; Sabino, Ester C/F-7750-2010; Pessôa, Rodrigo/B-7206-2018; Nixon, Douglas/AAU-5734-2020	Carvalho, Karina IL/0000-0002-7763-8139; Sanabani, Sabri Saeed/0000-0002-8876-8262; Sabino, Ester C/0000-0003-2623-5126; Nixon, Douglas/0000-0002-2801-1786; Kallas, Esper/0000-0003-2026-6925	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/09983-1, 2009/540055-5, 2009/52381-2, 2010/05845-0 2004/15856-9, 2006/50096-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [2571/2009]; National Institutes of Health [R01 AI060379]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060379] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by grants 2011/09983-1, 2009/540055-5, 2009/52381-2 and 2010/05845-0 2004/15856-9 and 2006/50096-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The study was also partially supported by grant 2571/2009 from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Additional support was provided by grant R01 AI060379 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara KC, 2012, J CLIN VIROL, V54, P15, DOI 10.1016/j.jcv.2012.01.011; Almeida FJ, 2009, J PEDIAT, V85, P104, DOI [10.2223/JPED.1877, 10.1590/S0021-75572009000200004]; Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; Aulicino PC, 2011, INFECT GENET EVOL, V11, P349, DOI 10.1016/j.meegid.2010.11.008; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bitnun A, 2002, CAN MED ASSOC J, V166, P904; Passaes CPB, 2009, AIDS RES HUM RETROV, V25, P1339, DOI 10.1089/aid.2009.0167; Brindeiro PA, 2002, J CLIN MICROBIOL, V40, P4512, DOI 10.1128/JCM.40.12.4512-4519.2002; Bushman FD, 2008, AIDS, V22, P1411, DOI 10.1097/QAD.0b013e3282fc972e; Chueca N, 2009, J MED VIROL, V81, P763, DOI 10.1002/jmv.21425; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; da Silveira AA, 2012, AIDS RES HUM RETROV, V28, P304, DOI 10.1089/aid.2011.0128; de Oliveira CM, 2008, ARCH VIROL, V153, P1799, DOI 10.1007/s00705-008-0178-7; DIAZ RS, 1995, J VIROL, V69, P3273, DOI 10.1128/JVI.69.6.3273-3281.1995; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Janini LM, 1998, J INFECT DIS, V177, P227, DOI 10.1086/517360; Koelsch KK, 2003, AIDS, V17, pF11, DOI 10.1097/00002030-200305020-00001; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Machado ES, 2004, J CLIN VIROL, V30, P24, DOI 10.1016/j.jcv.2003.08.001; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; McBurney SP, 2008, EXPERT REV VACCINES, V7, P1405, DOI 10.1586/14760584.7.9.1405; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Peeters M, 2003, AIDS, V17, P2547, DOI 10.1097/00002030-200312050-00002; Peters V, 2003, PEDIATRICS, V111, P1186; Pitt J, 1997, J INFECT DIS, V175, P567, DOI 10.1093/infdis/175.3.567; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Russell ES, 2011, J VIROL, V85, P8253, DOI 10.1128/JVI.00197-11; SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Samleerat T, 2008, J INFECT DIS, V198, P868, DOI 10.1086/591251; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Sanabani SS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-78; Santos AF, 2006, AIDS, V20, P2011; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; de Oliveira ACS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-223; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Templeton AR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-54; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson MM, 2005, AIDS REV, V7, P210; Verhofstede C, 2003, J VIROL, V77, P3050, DOI 10.1128/JVI.77.5.3050-3057.2003; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wiktor S Z, 1997, AIDS, V11 Suppl B, pS79; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316	55	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62552	10.1371/journal.pone.0062552	http://dx.doi.org/10.1371/journal.pone.0062552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667488	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700046
J	Shepheard, MA; Fleming, VM; Connor, TR; Corander, J; Feil, EJ; Fraser, C; Hanage, WP				Shepheard, Marcus A.; Fleming, Vicki M.; Connor, Thomas R.; Corander, Jukka; Feil, Edward J.; Fraser, Christophe; Hanage, William P.			Historical Zoonoses and Other Changes in Host Tropism of Staphylococcus aureus, Identified by Phylogenetic Analysis of a Population Dataset	PLOS ONE			English	Article							METHICILLIN-RESISTANT; HOMOLOGOUS RECOMBINATION; ADAPTATION; REVEALS; SPREAD; MICROARRAY; DIVERSITY; VIRULENCE; GENOMICS; RUMINANT	Background: Staphylococcus aureus exhibits tropisms to many distinct animal hosts. While spillover events can occur wherever there is an interface between host species, changes in host tropism only occur with the establishment of sustained transmission in the new host species, leading to clonal expansion. Although the genomic variation underpinning adaptation in S. aureus genotypes infecting bovids and poultry has been well characterized the frequency of switches from one host to another remains obscure. We sought to identify sustained switches in host tropism in the S. aureus population, both anthroponotic and zoonotic, and their distribution over the species phylogeny. Methodologies/Results: We have used a sample of 3042 isolates, representing 696 distinct MLST genotypes, from a well-established database (www.mlst.net). Using an empirical parsimony approach (AdaptML) we have investigated the distribution of switches in host association between both human and non-human (henceforth referred to as animal) hosts. We reconstructed a credible description of past events in the form of a phylogenetic tree; the nodes and leaves of which are statistically associated with either human or animal habitats, estimated from extant host-association and the degree of sequence divergence between genotypes. We identified 15 likely historical switching events; 13 anthroponoses and two zoonoses. Importantly, we identified two human-associated clade candidates (CC25 and CC59) that have arisen from animal-associated ancestors; this demonstrates that a human-specific lineage can emerge from an animal host. We also highlight novel rabbit-associated genotypes arising from a human ancestor. Conclusions: S. aureus is an organism with the capacity to switch into and adapt to novel hosts, even after long periods of isolation in a single host species. Based on this evidence, animal-adapted S. aureus lineages exhibiting resistance to antibiotics must be considered a major threat to public health, as they can adapt to the human population.	[Shepheard, Marcus A.; Fraser, Christophe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Fleming, Vicki M.; Feil, Edward J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Connor, Thomas R.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Hanage, William P.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Cambridge, MA 02138 USA	Imperial College London; University of Bath; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health	Shepheard, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England.	mas03@ic.ac.uk	Connor, Thomas/ABE-5989-2020; Hanage, Bill/CAF-1813-2022; Fraser, Christophe/A-8109-2008; Fleming, Vicki M/CAF-2082-2022; Connor, Thomas/ABD-6533-2021	Connor, Thomas/0000-0003-2394-6504; Fraser, Christophe/0000-0003-2399-9657; Fleming, Vicki/0000-0002-0460-3533	Wellcome Trust; The Royal Society; National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) MIDAS initiative; European Research Council (ERC); Academy of Finland; Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council; EU (FP7 [HEALTH] TROCAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; Medical Research Council [G0800596, MR/K010174/1, G0600719, MR/K010174/1B, G0600719B] Funding Source: researchfish; MRC [MR/K010174/1, G0600719, G0800596] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); The Royal Society(Royal Society of London); National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) MIDAS initiative; European Research Council (ERC)(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU (FP7 [HEALTH] TROCAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors wish to thank the Wellcome Trust, The Royal Society, the National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) MIDAS initiative, the European Research Council (ERC), the Academy of Finland, the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council and the EU (FP7 [HEALTH] TROCAR) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; Didelot X, 2010, GENETICS, V186, P1435, DOI 10.1534/genetics.110.120121; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006216; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Furia JP, 2010, J BONE JOINT SURG AM, V92A, P846, DOI 10.2106/JBJS.I.00653; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Grave K, 2010, J ANTIMICROB CHEMOTH, V65, P2037, DOI 10.1093/jac/dkq247; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holt DC, 2011, GENOME BIOL EVOL; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; King LJ, 2008, JAVMA-J AM VET MED A, V233, P259, DOI 10.2460/javma.233.2.259; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rabello RF, 2007, J MED MICROBIOL, V56, P1505, DOI 10.1099/jmm.0.47357-0; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Sakwinska O, 2011, APPL ENVIRON MICROB, V77, P5908, DOI 10.1128/AEM.00238-11; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Stegger M, 2010, CLIN MICROBIOL INFEC, V16, P1018, DOI 10.1111/j.1469-0691.2009.03003.x; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Sung JML, 2007, ANTIMICROB AGENTS CH, V51, P2189, DOI 10.1128/AAC.01442-06; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Weinert LA, 2012, BIOL LETTERS, V8, P829, DOI 10.1098/rsbl.2012.0290; Wiles S, 2006, NAT REV MICROBIOL, V4, P307, DOI 10.1038/nrmicro1386; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	48	37	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62369	10.1371/journal.pone.0062369	http://dx.doi.org/10.1371/journal.pone.0062369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667472	Green Published, gold, Green Accepted			2022-12-27	WOS:000319654700033
J	Xue, L; Cohnstaedt, LW; Scott, HM; Scoglio, C				Xue, Ling; Cohnstaedt, Lee W.; Scott, H. Morgan; Scoglio, Caterina			A Hierarchical Network Approach for Modeling Rift Valley Fever Epidemics with Applications in North America	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; MOSQUITOS DIPTERA; CULICIDAE; TRANSMISSION; DISEASE; VIRUS; SURVIVAL; CLIMATE; AFRICA; SPREAD	Rift Valley fever is a vector-borne zoonotic disease which causes high morbidity and mortality in livestock. In the event Rift Valley fever virus is introduced to the United States or other non-endemic areas, understanding the potential patterns of spread and the areas at risk based on disease vectors and hosts will be vital for developing mitigation strategies. Presented here is a general network-based mathematical model of Rift Valley fever. Given a lack of empirical data on disease vector species and their vector competence, this discrete time epidemic model uses stochastic parameters following several PERT distributions to model the dynamic interactions between hosts and likely North American mosquito vectors in dispersed geographic areas. Spatial effects and climate factors are also addressed in the model. The model is applied to a large directed asymmetric network of 3,621 nodes based on actual farms to examine a hypothetical introduction to some counties of Texas, an important ranching area in the United States of America. The nodes of the networks represent livestock farms, livestock markets, and feedlots, and the links represent cattle movements and mosquito diffusion between different nodes. Cattle and mosquito (Aedes and Culex) populations are treated with different contact networks to assess virus propagation. Rift Valley fever virus spread is assessed under various initial infection conditions (infected mosquito eggs, adults or cattle). A surprising trend is fewer initial infectious organisms result in a longer delay before a larger and more prolonged outbreak. The delay is likely caused by a lack of herd immunity while the infection expands geographically before becoming an epidemic involving many dispersed farms and animals almost simultaneously. Cattle movement between farms is a large driver of virus expansion, thus quarantines can be efficient mitigation strategy to prevent further geographic spread.	[Xue, Ling; Scoglio, Caterina] Kansas State Univ, Dept Elect & Comp Engn, Kansas State Epictr, Manhattan, KS 66506 USA; [Cohnstaedt, Lee W.] USDA, Ctr Grain & Anim Hlth Res, Manhattan, KS USA; [Scott, H. Morgan] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; United States Department of Agriculture (USDA); Kansas State University	Cohnstaedt, LW (corresponding author), USDA, Ctr Grain & Anim Hlth Res, Manhattan, KS USA.	lee.cohnstaedt@ars.usda.gov		Scoglio, Caterina/0000-0003-4486-9229; Scott, Harvey/0000-0002-0538-5961	U.S. Department of Homeland Security [2010-ST061-AG0001]; Kansas Biosciences Authority	U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Kansas Biosciences Authority	This material is based upon work supported by the U.S. Department of Homeland Security under Grant Award Number 2010-ST061-AG0001 and a grant through the Kansas Biosciences Authority. The views and conclusions contained in this publication are those of the authors and should not be interpreted as necessarily representing the official policies, either explicit or implicit, of the U.S. Department of Homeland Security and Kansas Biosciences Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo-Salem S, 2011, TROP ANIM HEALTH PRO, V43, P471, DOI 10.1007/s11250-010-9719-7; Arino J, 2007, MATH BIOSCI, V206, P46, DOI 10.1016/j.mbs.2005.09.002; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; Bates M., 1949, NATURAL HIST MOSQUIT; Brauer F, 2010, MATH BIOSCI ENG, V7, P1, DOI 10.3934/mbe.2010.7.1; Canyon DV, 1999, B ENTOMOL RES, V89, P35, DOI 10.1017/S000748539900005X; Chevalier V, 2010, EUROSURVEILLANCE, V15, P18; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Davies FG, 2006, REV SCI TECH OIE, V25, P137, DOI 10.20506/rst.25.1.1648; Dominguez BJ, 2007, THESIS TEXAS A M U U; *EFSA, 2005, OP SCI PAN AN HLTH W; Erasmus B. J., 1981, Rift Valley fever. Proceedings of a workshop, Herzlia, Israel, 18th-21st March 1980., P77; Favier C, 2006, TROP MED INT HEALTH, V11, P1878, DOI 10.1111/j.1365-3156.2006.01746.x; FREIER JE, 1987, AM J TROP MED HYG, V37, P640, DOI 10.4269/ajtmh.1987.37.640; Gaff H, 2007, ELECTRON J DIFFER EQ, V115, P1, DOI DOI 10.1155/2012/138757; Gao DZ, 2013, B MATH BIOL, V75, P523, DOI 10.1007/s11538-013-9818-5; Gong HF, 2011, INT J BIOMETEOROL, V55, P435, DOI 10.1007/s00484-010-0354-9; HAYES RO, 1973, AM J TROP MED HYG, V22, P270, DOI 10.4269/ajtmh.1973.22.270; JONES CJ, 1985, J AM MOSQUITO CONTR, V1, P530; JOUAN A, 1988, ANN INST PASTEUR VIR, V139, P307, DOI 10.1016/S0769-2617(88)80046-7; Katriel G, 2013, INT J BIOMATH, V6, DOI 10.1142/S1793524512500660; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; LONGINI IM, 1986, MATH BIOSCI, V82, P19, DOI 10.1016/0025-5564(86)90003-9; Luz PM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000761; Ma S., 2009, MATH UNDERSTANDING I; MAGNARELLI LA, 1977, AM J TROP MED HYG, V26, P547, DOI 10.4269/ajtmh.1977.26.547; Manore C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-55; Martin V, 2008, REV SCI TECH OIE, V27, P413, DOI 10.20506/rst.27.2.1802; Metras R, 2011, VECTOR-BORNE ZOONOT, V11, P761, DOI 10.1089/vbz.2010.0200; Moore C. G., 1993, GUIDELINES ARBOVIRUS; Mpeshe SC, 2011, ACTA BIOTHEOR, V59, P231, DOI 10.1007/s10441-011-9132-2; National Climatic Center, NOAA SAT INF SERV; National Institute for Communicable Diseases, 2012, INT REP RIFT VALL FE; Niu TC, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/138757; Otero M, 2010, MATH BIOSCI, V223, P32, DOI 10.1016/j.mbs.2009.10.005; Peters C. J., 1994, HDB ZOONOSES B, P125; Pratt H.D., 1993, VECTOR BORNE DIS CON; Radostits OM, 2001, HERD HLTH FOOD ANIMA; Riley S, 2010, P NATL ACAD SCI USA, V107, P957, DOI 10.1073/pnas.0913286107; Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; SELLERS RF, 1982, VET REC, V110, P73, DOI 10.1136/vr.110.4.73; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; Turell MJ, 2010, J MED ENTOMOL, V47, P884, DOI 10.1603/ME10007; TURELL MJ, 1988, J MED ENTOMOL, V25, P262, DOI 10.1093/jmedent/25.4.262; Turell MJ, 1998, J MED ENTOMOL, V35, P132, DOI 10.1093/jmedent/35.2.132; TURELL MJ, 1987, J MED ENTOMOL, V24, P11, DOI 10.1093/jmedent/24.1.11; United States Department of Agriculture, 2007, 2007 CENS PUBL; Wekesa JW, 1997, J MED ENTOMOL, V34, P219, DOI 10.1093/jmedent/34.2.219; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x; World Health Organization, RIFT VALL FEV SUD UP; Xue L, 2012, J THEOR BIOL, V306, P129, DOI 10.1016/j.jtbi.2012.04.029; Zeller HG, 1997, AM J TROP MED HYG, V56, P265, DOI 10.4269/ajtmh.1997.56.265	57	14	14	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62049	10.1371/journal.pone.0062049	http://dx.doi.org/10.1371/journal.pone.0062049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667453	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700022
J	Kawashima, S; Ueki, Y; Mima, T; Fukuyama, H; Ojika, K; Matsukawa, N				Kawashima, Shoji; Ueki, Yoshino; Mima, Tatsuya; Fukuyama, Hidenao; Ojika, Kosei; Matsukawa, Noriyuki			Differences in Dopaminergic Modulation to Motor Cortical Plasticity between Parkinson's Disease and Multiple System Atrophy	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; OLIVOPONTOCEREBELLAR ATROPHY; DEPENDENT PLASTICITY; EXCITABILITY; RECEPTORS; POTENTIATION; STIMULATION; DIAGNOSIS; CRITERIA	Dopamine modulates the synaptic plasticity in the primary motor cortex (M1). To evaluate whether the functioning of the cortico-striatal circuit is necessary for this modulation, we applied a paired associative stimulation (PAS) protocol that comprised an electric stimulus to the right median nerve at the wrist and subsequent transcranial magnetic stimulation of the left M1, to 10 patients with Parkinson's disease (PD) and 10 with multiple system atrophy of the parkinsonian type (MSA-P) with and without dopamine replacement therapy (-on/off). To investigate the M1 function, motor-evoked potentials (MEPs) were measured before and after the PAS. In both patient groups without medication, the PAS protocol failed to increase the averaged amplitude of MEPs. The dopamine replacement therapy in PD, but not in MSA-P effectively restored the PAS-induced MEP increase. This suggests that not the existence of dopamine itself but the activation of cortico-striatal circuit might play an important role for cortical plasticity in the human M1.	[Kawashima, Shoji; Ueki, Yoshino; Ojika, Kosei; Matsukawa, Noriyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Neurol & Neurosci, Nagoya, Aichi, Japan; [Mima, Tatsuya; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan	Nagoya City University; Kyoto University	Ueki, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Neurol & Neurosci, Nagoya, Aichi, Japan.	yueki@med.nagoya-cu.ac.jp	Fukuyama, Hidenao/AAI-7118-2020	Mima, Tatsuya/0000-0001-7787-4855	Takeda Pharmaceutical Company; Ministry of Education, Culture, Sports, Science and Technology	Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Takeda Pharmaceutical Company and the Ministry of Education, Culture, Sports, Science and Technology to Y.U. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 1997, MOVEMENT DISORD, V12, P315, DOI 10.1002/mds.870120309; Brooks DJ, 2009, MOVEMENT DISORD, V24, P949, DOI 10.1002/mds.22413; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Brown P, 1998, LANCET, V351, P1801, DOI 10.1016/S0140-6736(97)11225-9; Cantello R, 2007, NEUROSCIENCE, V150, P64, DOI 10.1016/j.neuroscience.2007.08.033; Centonze D, 2003, J NEUROSCI, V23, P8506, DOI 10.1523/jneurosci.23-24-08506.2003; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; CHERUBINI E, 1988, J PHYSIOL-LONDON, V400, P677, DOI 10.1113/jphysiol.1988.sp017143; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Eusebio A, 2007, CLIN NEUROPHYSIOL, V118, P815, DOI 10.1016/j.clinph.2007.01.004; FRITH CD, 1986, J NEUROL NEUROSUR PS, V49, P661, DOI 10.1136/jnnp.49.6.661; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Gilman S, 1999, ANN NEUROL, V45, P769, DOI 10.1002/1531-8249(199906)45:6<769::AID-ANA11>3.0.CO;2-G; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; HERRLING PL, 1985, NEUROSCIENCE, V14, P417, DOI 10.1016/0306-4522(85)90301-X; Huang YZ, 2011, BRAIN, V134, P2312, DOI 10.1093/brain/awr158; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Ito S, 2009, AM J NEURORADIOL, V30, P689, DOI 10.3174/ajnr.A1443; Kawashima S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031728; Kita H, 1996, NEUROSCIENCE, V70, P925, DOI 10.1016/0306-4522(95)00410-6; Kolomiets B, 2009, CEREB CORTEX, V19, P2708, DOI 10.1093/cercor/bhp047; Kuhn AA, 2004, CLIN NEUROPHYSIOL, V115, P1786, DOI 10.1016/j.clinph.2004.03.020; Lefaucheur JP, 2005, CLIN NEUROPHYSIOL, V116, P244, DOI 10.1016/j.clinph.2004.11.017; Marchese R, 2000, MOVEMENT DISORD, V15, P1210, DOI 10.1002/1531-8257(200011)15:6<1210::AID-MDS1022>3.0.CO;2-R; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; Miyatake S, 2010, J NEUROL, V257, P419, DOI 10.1007/s00415-009-5338-5; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Monte-Silva K, 2010, J PHYSIOL-LONDON, V588, P3415, DOI 10.1113/jphysiol.2010.190181; Morgante F, 2006, BRAIN, V129, P1059, DOI 10.1093/brain/awl031; Nitsche MA, 2010, REV NEUROSCIENCE, V21, P289; Nitsche MA, 2009, J NEUROSCI, V29, P2648, DOI 10.1523/JNEUROSCI.5366-08.2009; OPPENHEIMER DR, 1992, GREENFIELDS NEUROPAT, P988; Osaki Y, 2002, NEUROLOGY, V59, P1486, DOI 10.1212/01.WNL.0000028690.15001.00; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; RINNE JO, 1995, J NEUROL SCI, V132, P156, DOI 10.1016/0022-510X(95)00137-Q; Rolland Y, 2011, J NEUROL NEUROSUR PS, V82, P1025, DOI 10.1136/jnnp.2010.214890; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell J, 2007, PARKINSONISM RELAT D, V13, pS417, DOI 10.1016/S1353-8020(08)70040-3; Sakurai K, 2010, NEURORADIOLOGY, V52, P809, DOI 10.1007/s00234-009-0621-9; SCHNIDER A, 1995, BRAIN, V118, P485, DOI 10.1093/brain/118.2.485; Smiley-Oyen AL, 2003, EXP BRAIN RES, V152, P453, DOI 10.1007/s00221-003-1570-x; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Ueki Y, 2006, ANN NEUROL, V59, P60, DOI 10.1002/ana.20692; Van Laere K, 2010, J NUCL MED, V51, P588, DOI 10.2967/jnumed.109.070144; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Wu AD, 2007, MOVEMENT DISORD, V22, P1587, DOI 10.1002/mds.21565; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	52	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62515	10.1371/journal.pone.0062515	http://dx.doi.org/10.1371/journal.pone.0062515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658735	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100012
J	Paldanius, PM; Ivaska, KK; Hovi, P; Andersson, S; Eriksson, JG; Vaananen, K; Kajantie, E; Makitie, O				Paldanius, Paivi M.; Ivaska, Kaisa K.; Hovi, Petteri; Andersson, Sture; Eriksson, Johan G.; Vaananen, Kalervo; Kajantie, Eero; Makitie, Outi			Total and Carboxylated Osteocalcin Associate with Insulin Levels in Young Adults Born with Normal or Very Low Birth Weight	PLOS ONE			English	Article							BETA-CELL FUNCTION; SERUM OSTEOCALCIN; GLUCOSE-TOLERANCE; PLASMA-GLUCOSE; BONE TURNOVER; RESISTANCE; METABOLISM; MARKERS; ASSAYS; MASS	Objective: Osteocalcin (OC), a bone-derived protein, has been implicated in the regulation of glucose and energy metabolism. Young adults born with very low birth weight (VLBW) have altered glucose regulation and lower bone mineral density (BMD) compared with those born at term. The aim of this study was to explore the association between bone and glucose metabolism in healthy young adults born prematurely or at term. Methods: The cohort of this cross-sectional study comprised 332 non-diabetic young adults (age 18 to 27 years) born either preterm with VLBW (n = 163) or at term (n = 169). OC, carboxylated osteocalcin (cOC) and markers of glucose metabolism were measured at fasting and after a 75-g oral glucose tolerance test (OGTT). Results: VLBW adults were shorter, had lower BMD (p < 0.001) and higher fasting OC (p = 0.027) and cOC (p = 0.005) than term-born subjects. They also had higher 2-hour insulin (p = 0.001) and glucose (p = 0.037) concentrations. OGTT induced a significant reduction in OC (p < 0.001), similar in both groups. OC reduction was not associated with OGTT-induced increases in insulin (p = 0.54). However, fasting total OC and cOC correlated negatively with fasting insulin after adjustment for age, gender, BMD and VLBW status (r = -0.182, p = 0.009 and r = -0.283, p < 0.001, respectively). Conclusion: Adults born with VLBW have higher OC and cOC than their peers born at term. This may in part reflect the mechanisms that underlie their lower BMD and decreased insulin sensitivity. Serum OC appears to be negatively associated with long-term glucose regulation whereas acute changes during OGTT may be mediated via other mechanisms.	[Paldanius, Paivi M.; Hovi, Petteri; Andersson, Sture; Kajantie, Eero; Makitie, Outi] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Paldanius, Paivi M.; Hovi, Petteri; Andersson, Sture; Kajantie, Eero; Makitie, Outi] Univ Helsinki, Inst Clin Med, Helsinki, Finland; [Paldanius, Paivi M.] Novartis Pharma AG, Basel, Switzerland; [Ivaska, Kaisa K.; Vaananen, Kalervo] Univ Turku, Inst Biomed, Dept Cell Biol & Anat, Turku, Finland; [Hovi, Petteri; Eriksson, Johan G.; Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.; Makitie, Outi] Folkhalsan Res Ctr, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Novartis; University of Turku; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center	Paldanius, PM (corresponding author), Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland.	ppaldanius@gmail.com	Ivaska, Kaisa/G-1406-2012; Paldanius, Päivi/AAR-6793-2020	Ivaska, Kaisa/0000-0001-7482-7623; Paldanius, Paivi Maria/0000-0001-5997-4879; Makitie, Outi/0000-0002-4547-001X; Eriksson, Johan/0000-0002-2516-2060	Academy of Finland; Foundation for Pediatric Research; Sigrid Juselius Foundation; Orion-Farmos Research Foundation; Clinical Chemistry Research Foundation; Folkhalsan Research Foundation; Helsinki University Hospital Research Funds; Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish	Academy of Finland(Academy of Finland); Foundation for Pediatric Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Orion-Farmos Research Foundation; Clinical Chemistry Research Foundation; Folkhalsan Research Foundation; Helsinki University Hospital Research Funds; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was financially supported by grants from the Academy of Finland, the Foundation for Pediatric Research, the Sigrid Juselius Foundation, the Orion-Farmos Research Foundation, the Clinical Chemistry Research Foundation, the Folkhalsan Research Foundation and the Helsinki University Hospital Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff S.L, 2004, DIABETES SPECTR, V17, P183, DOI [DOI 10.2337/DIASPECT.17.3.183, 10.2337/diaspect.17.3.183]; Basu R, 2011, J CLIN ENDOCR METAB, V96, P1450, DOI 10.1210/jc.2010-2877; Booth SL, 2013, NAT REV ENDOCRINOL, V9, P43, DOI 10.1038/nrendo.2012.201; Brennan-Speranza TC, 2012, J CLIN INVEST, V122, P4172, DOI 10.1172/JCI63377; Bullo M, 2012, AM J CLIN NUTR, V95, P249, DOI 10.3945/ajcn.111.016642; CARTER DR, 1992, J BONE MINER RES, V7, P137; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Clowes JA, 2002, J CLIN ENDOCR METAB, V87, P3324, DOI 10.1210/jc.87.7.3324; Cryer PE., 1992, WILLIAMS TXB ENDOCRI, P1223; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gravenstein KS, 2011, J CLIN ENDOCR METAB, V96, pE884, DOI 10.1210/jc.2010-2589; Gundberg CM, 2012, ADV NUTR, V3, P149, DOI 10.3945/an.112.001834; Hack M, 2005, PEDIATR RES, V58, P677, DOI 10.1203/01.PDR.0000180551.93470.56; Hellman J, 1996, J BONE MINER RES, V11, P1165; Henriksen DB, 2003, J BONE MINER RES, V18, P2180, DOI 10.1359/jbmr.2003.18.12.2180; Henriksen DB, 2007, BONE, V40, P723, DOI 10.1016/j.bone.2006.09.025; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Iglesias P, 2011, CLIN ENDOCRINOL, V75, P184, DOI 10.1111/j.1365-2265.2011.04035.x; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Kakonen SM, 2000, CLIN CHEM, V46, P332; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]; Kovacs CS, 2006, PRIMER METABOLIC BON, P63; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leger J, 1997, BRIT MED J, V315, P341; Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P237, DOI 10.1210/jc.2008-0270; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Motyl KJ, 2010, ARCH BIOCHEM BIOPHYS, V503, P2, DOI 10.1016/j.abb.2010.07.030; Paldanius PM, 2012, CALCIFIED TISSUE INT, V90, P90, DOI 10.1007/s00223-011-9551-8; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Sayer AA, 2005, EARLY HUM DEV, V81, P735, DOI 10.1016/j.earlhumdev.2005.07.003; Schwetz V, 2012, EUR J ENDOCRINOL, V166, P959, DOI 10.1530/EJE-12-0030; Shea MK, 2009, AM J CLIN NUTR, V90, P1230, DOI 10.3945/ajcn.2009.28151; Smith CM, 2011, CLIN ENDOCRINOL, V75, P443, DOI 10.1111/j.1365-2265.2011.04118.x; Szathmari M, 2000, CALCIFIED TISSUE INT, V67, P429, DOI 10.1007/s002230001193; Vaccaro O, 1999, DIABETES CARE, V22, P1490, DOI 10.2337/diacare.22.9.1490; Wallum BJ, 1992, INT TXB DIABETES MEL, P285; Xie D, 2007, BONE, V40, P1352, DOI 10.1016/j.bone.2007.01.007	44	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63036	10.1371/journal.pone.0063036	http://dx.doi.org/10.1371/journal.pone.0063036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658795	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100050
J	Bubl, E; Dorr, M; Philipsen, A; Ebert, D; Bach, M; van Elst, LT				Bubl, Emanuel; Doerr, Michael; Philipsen, Alexandra; Ebert, Dieter; Bach, Michael; van Elst, Ludger Tebartz			Retinal Contrast Transfer Functions in Adults with and without ADHD	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; VISUALLY EVOKED-POTENTIALS; STEADY-STATE RESPONSES; PARKINSONS-DISEASE; SELECTIVE ATTENTION; DEPRESSIVE DISORDER; RATING-SCALE; CHILDREN; DOPAMINE	In previous studies, we found a strong reduction in contrast perception and retinal contrast gain in patients with major depression, which normalized after remission of depression. We also identified a possible role of the dopaminergic system in this effect, because visual contrast perception depends on dopaminergic neurotransmission. Dopamine is also known to play an important role in the pathogenesis of attention deficit hyperactivity disorder (ADHD). Therefore, in order to explore the specificity of retinal contrast gain as a marker of depression in comparison with other psychiatric diseases, we recorded the pattern electroretinogram (PERG) in patients with ADHD. Twenty patients diagnosed with ADHD and 20 matched healthy subjects were studied. Visual pattern electroretinograms were recorded from both eyes. The contrast gain of the patients with attention deficit disorder (ADD) did not differ from the control group, nor did the contrast gain of any ADHD subgroup (predominantly inattentive or combined patients). In the healthy subjects, a significant correlation between depression score and contrast gain was found. As the contrast gain in an earlier study clearly separated the patients with depression from the controls, we assume that retinal contrast gain might be a specific marker in depression.	[Bubl, Emanuel; Doerr, Michael; Philipsen, Alexandra; Ebert, Dieter; van Elst, Ludger Tebartz] Univ Freiburg, Dept Psychiat & Psychotherapy, D-79106 Freiburg, Germany; [Bach, Michael] Univ Freiburg, Univ Eye Hosp, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	van Elst, LT (corresponding author), Univ Freiburg, Dept Psychiat & Psychotherapy, Hugstetter Str 55, D-79106 Freiburg, Germany.	tebartzvanelst@uniklinik-freiburg.de	Bach, Michael/A-6637-2010; Philipsen, Alexandra/E-4505-2017	Bach, Michael/0000-0003-2028-535X; Philipsen, Alexandra/0000-0001-6876-518X; Bubl, Emanuel/0000-0003-4951-8970				Ahrendts J, 2011, WORLD J BIOL PSYCHIA, V12, P260, DOI 10.3109/15622975.2010.518624; Bach M, 1997, SPATIAL VISION, V10, P403, DOI 10.1163/156856897X00311; Bach M, 1999, DOC OPHTHALMOL, V99, P69, DOI 10.1023/A:1002648202420; Bach M., 2006, PRINCIPLES PRACTICE, P185; Bach M., 2000, FREIBURG EVOKED POTE; Bach M., 2007, PREPARATION MONTAGE; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Bartgis J, 2009, DEV NEUROPSYCHOL, V34, P663, DOI 10.1080/87565640902964474; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bellgrove MA, 2009, ARCH GEN PSYCHIAT, V66, P1135, DOI 10.1001/archgenpsychiatry.2009.120; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Biederman J, 2010, AM J PSYCHIAT, V167, P409, DOI 10.1176/appi.ajp.2009.09050736; Bodis-Wollner I, 1998, VISION RES, V38, P1479, DOI 10.1016/S0042-6989(98)00028-5; Bodis-Wollner I, 2006, PRINCIPLES PRACTICE, P867; Brennan AR, 2008, ANN NY ACAD SCI, V1129, P236, DOI 10.1196/annals.1417.007; Bubl E, 2012, BRIT J PSYCHIAT, V201, P151, DOI 10.1192/bjp.bp.111.100560; Bubl E, 2010, BIOL PSYCHIAT, V68, P205, DOI 10.1016/j.biopsych.2010.02.009; Bubl E, 2009, WORLD J BIOL PSYCHIA, V10, P377, DOI 10.1080/15622970701513756; Bundesarztekammer B, 2007, ADHS ERWACHSENENALTE; Djamgoz MBA, 1997, VISION RES, V37, P3509, DOI 10.1016/S0042-6989(97)00129-6; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Faraone SV, 1998, BIOL PSYCHIAT, V44, P951, DOI 10.1016/S0006-3223(98)00240-6; Jonkman LM, 2004, CLIN NEUROPHYSIOL, V115, P1537, DOI 10.1016/j.clinph.2004.01.022; KUPERSMITH MJ, 1982, ARCH NEUROL-CHICAGO, V39, P284, DOI 10.1001/archneur.1982.00510170026007; Langheinrich T, 2000, CLIN NEUROPHYSIOL, V111, P66, DOI 10.1016/S1388-2457(99)00223-0; Lavoie MP, 2009, BIOL PSYCHIAT, V66, P253, DOI 10.1016/j.biopsych.2008.11.020; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; Martin L, 2008, ACTA OPHTHALMOL, V86, P259, DOI 10.1111/j.1755-3768.2008.01189.x; MASSON G, 1993, FUND CLIN PHARMACOL, V7, P449, DOI 10.1111/j.1472-8206.1993.tb01041.x; Meigen T, 1999, DOC OPHTHALMOL, V98, P207, DOI 10.1023/A:1002097208337; Normann C, 2007, BIOL PSYCHIAT, V62, P373, DOI 10.1016/j.biopsych.2006.10.006; Retz-Junginger P, 2002, NERVENARZT, V73, P830, DOI 10.1007/s00115-001-1215-x; Roessner V, 2008, J NEURAL TRANSM, V115, P235, DOI 10.1007/s00702-007-0817-2; Rosler M, 2004, NERVENARZT, V75, P888, DOI 10.1007/s00115-003-1622-2; SPECK LB, 1966, ARCH GEN PSYCHIAT, V15, P59; Steer RA, 2003, J PERS ASSESS, V80, P58, DOI 10.1207/S15327752JPA8001_14; van der Stelt O, 2001, COGNITIVE BRAIN RES, V12, P245, DOI 10.1016/S0926-6410(01)00055-6; van Elst LT, 1997, BRAIN, V120, P2219, DOI 10.1093/brain/120.12.2219; VICTOR JD, 1993, VISUAL NEUROSCI, V10, P939, DOI 10.1017/S0952523800006155; WARD MF, 1993, AM J PSYCHIAT, V150, P885	41	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61728	10.1371/journal.pone.0061728	http://dx.doi.org/10.1371/journal.pone.0061728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658697	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500010
J	Balbas-Martinez, C; Rodriguez-Pinilla, M; Casanova, A; Dominguez, O; Pisano, DG; Gomez, G; Lloreta, J; Lorente, JA; Malats, N; Real, FX				Balbas-Martinez, Cristina; Rodriguez-Pinilla, Maria; Casanova, Ariel; Dominguez, Orlando; Pisano, David G.; Gomez, Gonzalo; Lloreta, Josep; Lorente, Jose A.; Malats, Nuria; Real, Francisco X.			ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors	PLOS ONE			English	Article							TRANSITIONAL-CELL-CARCINOMA; REMODELING GENE ARID1A; PROTEIN EXPRESSION; PIK3CA MUTATIONS; HEPATOCELLULAR-CARCINOMA; FREQUENT MUTATIONS; SOMATIC MUTATIONS; CANCER; LINES; RISK	Urothelial bladder cancer (UBC) is heterogeneous at the clinical, pathological, genetic, and epigenetic levels. Exome sequencing has identified ARID1A as a novel tumor suppressor gene coding for a chromatin remodeling protein that is mutated in UBC. Here, we assess ARID1A alterations in two series of patients with UBC. In the first tumor series, we analyze exons 2-20 in 52 primary UBC and find that all mutant tumors belong to the aggressive UBC phenotype (high grade non-muscle invasive and muscle invasive tumors) (P = 0.05). In a second series (n = 84), we assess ARID1A expression using immunohistochemistry, a surrogate for mutation analysis, and find that loss of expression increases with higher stage/grade, it is inversely associated with FGFR3 overexpression (P = 0.03) but it is not correlated with p53 overexpression (P = 0.30). We also analyzed the expression of cytokeratins in the same set of tumor and find, using unsupervised clustering, that tumors with ARID1A loss of expression are generally KRT5/6-low. In this patient series, loss of ARID1A expression is also associated with worse prognosis, likely reflecting the higher prevalence of losses found in tumors of higher stage and grade. The independent findings in these two sets of patients strongly support the notion that ARID1A inactivation is a key player in bladder carcinogenesis occurring predominantly in FGFR3 wild type tumors.	[Balbas-Martinez, Cristina; Casanova, Ariel; Real, Francisco X.] Spanish Natl Canc Res Ctr, Mol Pathol Programme, Epithelial Carcinogenesis Grp, Madrid, Spain; [Rodriguez-Pinilla, Maria] Spanish Natl Canc Res Ctr, Mol Pathol Programme, Lymphoma Grp, Madrid, Spain; [Dominguez, Orlando] Spanish Natl Canc Res Ctr, Biotechnol Programme, Genom Unit, Madrid, Spain; [Pisano, David G.; Gomez, Gonzalo] Spanish Natl Canc Res Ctr, Struct & Computat Biol Programme, Bioinformat Unit, Madrid, Spain; [Lloreta, Josep] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Lloreta, Josep; Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencias Expt & Salut, Barcelona, Spain; [Lorente, Jose A.] Hosp del Mar, Urol Serv, Barcelona, Spain; [Malats, Nuria] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Genet & Mol Epidemiol Grp, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Centro Nacional de Investigaciones Oncologicas (CNIO)	Real, FX (corresponding author), Spanish Natl Canc Res Ctr, Mol Pathol Programme, Epithelial Carcinogenesis Grp, Madrid, Spain.	freal@cnio.es	Malats, Nuria/H-7041-2015; Lloreta-Trull, Josep/GRR-9682-2022; Dominguez, Orlando/M-7515-2018; Pisano, David/N-5817-2014; Lloreta, J/I-2112-2014; Lloreta-Trull, Josep/AAZ-1229-2020; Arribas, Francisco X Real/H-5275-2015; Gomez-Lopez, Gonzalo/D-9123-2016	Malats, Nuria/0000-0003-2538-3784; Pisano, David/0000-0002-4895-4124; Lloreta, J/0000-0003-1644-9470; Arribas, Francisco X Real/0000-0001-9501-498X; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Balbas Martinez, Cristina/0000-0002-2565-7733	Consolider ONCOBIO from Ministerio de Economia y Competitividad, Spain [00/0745, PI051436, PI061614, G03/174]; Red Tematica de Investigacion Cooperativa en Cancer from Instituto de Salud Carlos III [D06/0020-RTICC]; Asociacion Espanola Contra el Cancer; EU [201663, 201333]; La Caixa International PhD Fellowship	Consolider ONCOBIO from Ministerio de Economia y Competitividad, Spain; Red Tematica de Investigacion Cooperativa en Cancer from Instituto de Salud Carlos III(Instituto de Salud Carlos III); Asociacion Espanola Contra el Cancer; EU(European Commission); La Caixa International PhD Fellowship(La Caixa Foundation)	This work was supported in part by grant Consolider ONCOBIO from Ministerio de Economia y Competitividad, Spain; grants 00/0745, PI051436, PI061614, G03/174 and Red Tematica de Investigacion Cooperativa en Cancer (grant RD06/0020-RTICC) from Instituto de Salud Carlos III; Asociacion Espanola Contra el Cancer; and EU FP7 grant agreement numbers 201663 (UROMOL) and 201333 (DECANBIO). CBM is recipient of a La Caixa International PhD Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AFS, 2012, JNCI-J NATL CANCER I, V104, P1897, DOI 10.1093/jnci/djs444; Bakkar AA, 2003, CANCER RES, V63, P8108; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Deem AK, 2012, CHROMOSOMA, V121, P131, DOI 10.1007/s00412-011-0358-1; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Guey LT, 2010, EUR UROL, V57, P283, DOI 10.1016/j.eururo.2009.08.001; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hafner C, 2006, J CLIN INVEST, V116, P2201, DOI 10.1172/JCI28163; Hernandez S, 2005, CLIN CANCER RES, V11, P5444, DOI 10.1158/1078-0432.CCR-05-0122; Hernandez S, 2006, J CLIN ONCOL, V24, P3664, DOI 10.1200/JCO.2005.05.1771; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LIN CW, 1985, CANCER RES, V45, P5070; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; Lopez-Knowles E, 2006, CLIN CANCER RES, V12, P6029, DOI 10.1158/1078-0432.CCR-06-0206; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Luis NM, 2007, CLIN TRANSL ONCOL, V9, P5, DOI 10.1007/s12094-007-0003-x; Malats W, 2005, LANCET ONCOL, V6, P678; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; MASTERS JRW, 1986, CANCER RES, V46, P3630; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Real FX, 2007, J CLIN ONCOL, V25, P5341, DOI 10.1200/JCO.2007.13.1904; RIEGER KM, 1995, BRIT J CANCER, V72, P683, DOI 10.1038/bjc.1995.394; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Sabichi A, 2006, J UROLOGY, V175, P1133, DOI 10.1016/S0022-5347(05)00323-X; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Thomas F, 2012, CANCER, DOI [10.1002/cncr.27587, DOI 10.1002/CNCR.27587.[]; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Vallot C, 2011, JNCI-J NATL CANCER I, V103, P47, DOI 10.1093/jnci/djq470; van Rhijn BWG, 2012, J UROLOGY, V187, P310, DOI 10.1016/j.juro.2011.09.008; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yamamoto S, 2012, MODERN PATHOL, V25, P615, DOI 10.1038/modpathol.2011.189; Yamamoto S, 2012, VIRCHOWS ARCH, V460, P77, DOI 10.1007/s00428-011-1169-8; ZHANG JL, 2011, DATABASE-OXFORD, V20, DOI DOI 10.1088/1674-1056/20/2/026401; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]	55	44	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62483	10.1371/journal.pone.0062483	http://dx.doi.org/10.1371/journal.pone.0062483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650517	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000052
J	Cardoso, P; Rigal, F; Fattorini, S; Terzopoulou, S; Borges, PAV				Cardoso, Pedro; Rigal, Francois; Fattorini, Simone; Terzopoulou, Sofia; Borges, Paulo A. V.			Integrating Landscape Disturbance and Indicator Species in Conservation Studies	PLOS ONE			English	Article							ECOLOGICAL THRESHOLDS; ARTHROPOD COMMUNITIES; HABITAT FRAGMENTATION; OCEANIC ISLANDS; TROPICAL FOREST; BIODIVERSITY; AZORES; MANAGEMENT; DIVERSITY; RESPONSES	Successful conservation plans are conditioned by our ability to detect anthropogenic change in space and time and various statistical analyses have been developed to handle this critical issue. The main objective of this paper is to illustrate a new approach for spatial analysis in conservation biology. Here, we propose a two-step protocol. First, we introduce a new disturbance metric which provides a continuous measure of disturbance for any focal communities on the basis of the surrounding landscape matrix. Second, we use this new gradient to estimate species and community disturbance thresholds by implementing a recently developed method called Threshold Indicator Taxa ANalysis (TITAN). TITAN detects changes in species distributions along environmental gradients using indicators species analysis and assesses synchrony among species change points as evidence for community thresholds. We demonstrate our method with soil arthropod assemblages along a disturbance gradient in Terceira Island (Azores, Portugal). We show that our new disturbance metric realistically reflects disturbance patterns, especially in buffer zones (ecotones) between land use categories. By estimating species disturbance thresholds with TITAN along the disturbance gradient in Terceira, we show that species significantly associated with low disturbance differ from those associated with high disturbance in their biogeographical origin (endemics, non-endemic natives and exotics) and taxonomy (order). Finally, we suggest that mapping the disturbance community thresholds may reveal areas of primary interest for conservation, since these may host indigenous species sensitive to high disturbance levels. This new framework may be useful when: (1) both local and regional processes are to be reflected on single disturbance measures; (2) these are better quantified in a continuous gradient; (3) mapping disturbance of large regions using fine scales is necessary; (4) indicator species for disturbance are searched for and; (5) community thresholds are useful to understand the global dynamics of habitats.	[Cardoso, Pedro] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Cardoso, Pedro; Rigal, Francois; Fattorini, Simone; Terzopoulou, Sofia; Borges, Paulo A. V.] Univ Azores, Portuguese Platform Enhancing Ecol Res & Sustaina, Angra Do Heroismo, Azores, Portugal; [Cardoso, Pedro; Rigal, Francois; Fattorini, Simone; Terzopoulou, Sofia; Borges, Paulo A. V.] Univ Azores, Azorean Biodivers Grp GBA, CITA A, Angra Do Heroismo, Azores, Portugal; [Fattorini, Simone] Univ Milan, Dept Biotechnol & Biosci, Water Ecol Team, Milan, Italy; [Terzopoulou, Sofia] Univ Athens, Fac Biol, Dept Ecol & Taxon, Athens 11528, Greece	University of Helsinki; Universidade dos Acores; Universidade dos Acores; University of Milan; University of Milano-Bicocca; National & Kapodistrian University of Athens	Cardoso, P (corresponding author), Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland.	pedro.cardoso@helsinki.fi	Borges, Paulo/H-5153-2019; Fattorini, Simone/AAR-8028-2020; Cardoso, Pedro/AAY-9650-2020; Fattorini, Simone/E-7075-2012; Cardoso, Pedro/A-8820-2008; Borges, Paulo/B-2780-2008	Borges, Paulo/0000-0002-8448-7623; Fattorini, Simone/0000-0002-4517-2135; Cardoso, Pedro/0000-0001-8119-9960; Fattorini, Simone/0000-0002-4517-2135; Cardoso, Pedro/0000-0001-8119-9960; Borges, Paulo/0000-0002-8448-7623; Rigal, Francois/0000-0001-6882-1591	Direccao Regional dos Recursos Florestais [17.01-080203]; Direccao Regional da Ciencia e Tecnologia [M.2.1.2/I/003/2008]; Fundacao Ciencia e Tecnologia [SFRH/BPD/40688/2007, PTDC/BIA-BEC/100182/2008]; Azorean Biodiversity Group (CITA-A)	Direccao Regional dos Recursos Florestais; Direccao Regional da Ciencia e Tecnologia; Fundacao Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Azorean Biodiversity Group (CITA-A)	Data used in this manuscript were obtained in the projects funded by Direccao Regional dos Recursos Florestais (Project: 17.01-080203, 1999-2004) and Direccao Regional da Ciencia e Tecnologia (Project: "Consequences of land-use change on Azorean fauna and flora - the 2010 Target'', M.2.1.2/I/003/2008). Grants and fellowships to the authors were provided by Fundacao Ciencia e Tecnologia (SFRH/BPD/40688/2007 and PTDC/BIA-BEC/100182/2008 for PC and FR, respectively) and Azorean Biodiversity Group (CITA-A) (Summer 2010, 2011 and 2012 grants to SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Basset Y, 2008, INSECT CONSERV DIVER, V1, P55, DOI 10.1111/j.1752-4598.2007.00011.x; Bonte D, 2008, BASIC APPL ECOL, V9, P726, DOI 10.1016/j.baae.2007.09.008; Borges P. A. V., 2008, INSECT ECOLOGY CONSE, P47; Borges P.A.V., 2010, LIST TERRESTRIAL MAR, P9; Borges PAV, 2006, J BIOGEOGR, V33, P169, DOI 10.1111/j.1365-2699.2005.01324.x; Borges PAV, 2004, B ENTOMOL RES, V94, P111, DOI 10.1079/BER2004289; Borges PAV, 2011, CELEBRATING DARWIN, P93; Brenden TO, 2008, ENVIRON MANAGE, V42, P821, DOI 10.1007/s00267-008-9150-2; Cardoso P, 2007, BIODIVERS CONSERV, V16, P2883, DOI 10.1007/s10531-006-9078-x; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Cardoso P, 2010, J BIOGEOGR, V37, P1034, DOI 10.1111/j.1365-2699.2009.02264.x; Cardoso P, 2009, ACTA OECOL, V35, P590, DOI 10.1016/j.actao.2009.05.005; Carvalho JC, 2013, OIKOS IN PRESS; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Comor V, 2008, BIODIVERS CONSERV, V17, P1837, DOI 10.1007/s10531-007-9290-3; Connor SE, 2012, J BIOGEOGR, V39, P1007, DOI 10.1111/j.1365-2699.2011.02671.x; Cuffney TF, 2011, ECOL APPL, V21, P2840, DOI 10.1890/10-2075.1; Cuffney TF, 2010, ECOL APPL, V20, P1384, DOI 10.1890/08-1311.1; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Donaldson J, 2002, CONSERV BIOL, V16, P1267, DOI 10.1046/j.1523-1739.2002.99515.x; Drake DR, 2009, BIOL INVASIONS, V11, P1483, DOI 10.1007/s10530-008-9392-1; DROTRH. DireccAo Regional do Ordenamento do Territorio e Recursos Hidricos, 2008, CART OC SOL REG AUT; DUELLI P, 1990, BIOL CONSERV, V54, P193, DOI 10.1016/0006-3207(90)90051-P; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Fattorini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033995; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Gaspar C, 2011, J INSECT CONSERV, V15, P671, DOI 10.1007/s10841-010-9365-4; Gaston KJ, 2006, J ANIM ECOL, V75, P646, DOI 10.1111/j.1365-2656.2006.01085.x; Groffman P, 2006, ECOSYSTEMS, V9, P1, DOI 10.1007/s10021-003-0142-z; Huggett AJ, 2005, BIOL CONSERV, V124, P301, DOI 10.1016/j.biocon.2005.01.037; Jager H, 2007, BIOL CONSERV, V140, P297, DOI 10.1016/j.biocon.2007.08.014; Jardim R, 2008, FUNCHAL ANGRA HEROIS, P157; Kallimanis AS, 2005, CONSERV BIOL, V19, P534, DOI 10.1111/j.1523-1739.2005.00418.x; King RS, 2011, ECOL APPL, V21, P2833, DOI 10.1890/10-0882.1; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Malanson George P., 1999, Diversity and Distributions, V5, P27, DOI 10.1046/j.1472-4642.1999.00035.x; Martorell C, 2009, CONSERV BIOL, V23, P377, DOI 10.1111/j.1523-1739.2008.01134.x; Meijer SS, 2011, J INSECT CONSERV, V15, P505, DOI 10.1007/s10841-010-9330-2; MORAN VC, 1982, J ANIM ECOL, V51, P289, DOI 10.2307/4325; PAULAY G, 1994, AM ZOOL, V34, P134; Pe'er G, 2011, DIVERS DISTRIB, V17, P1186, DOI 10.1111/j.1472-4642.2011.00795.x; Pryke JS, 2012, LANDSCAPE ECOL, V27, P73, DOI 10.1007/s10980-011-9668-1; R Core Team, 2020, R LANG ENV STAT COMP; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Sonderegger DL, 2009, FRONT ECOL ENVIRON, V7, P190, DOI 10.1890/070179; Starzomski BM, 2007, OIKOS, V116, P690, DOI 10.1111/j.2007.0030-1299.15547.x; Steadman DW, 2006, EXTINCTION BIOGEOGRA; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Triantis KA, 2010, ECOGRAPHY, V33, P285, DOI 10.1111/j.1600-0587.2010.06203.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY	59	44	48	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63294	10.1371/journal.pone.0063294	http://dx.doi.org/10.1371/journal.pone.0063294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650560	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000105
J	Ehlen, JC; Hesse, S; Pinckney, L; Paul, KN				Ehlen, J. Christopher; Hesse, September; Pinckney, Lennisha; Paul, Ketema N.			Sex Chromosomes Regulate Nighttime Sleep Propensity during Recovery from Sleep Loss in Mice	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; WHITEHALL-II; FEMALE RATS; DURATION; SIESTA; WAKEFULNESS; OVARIECTOMY; PATTERNS; ESTROGEN; PERIOD	Sex differences in spontaneous sleep amount are largely dependent on reproductive hormones; however, in mice some sex differences in sleep amount during the active phase are preserved after gonadectomy and may be driven by non-hormonal factors. In this study, we sought to determine whether or not these sex differences are driven by sex chromosome complement. Mice from the four core genotype (FCG) mouse model, whose sex chromosome complement (XY, XX) is independent of phenotype (male or female), were implanted with electroencephalographic (EEG) and electromyographic (EMG) electrodes for the recording of sleep-wake states and underwent a 24-hr baseline recording followed by six hours of forced wakefulness. During baseline conditions in mice whose gonads remained intact, males had more total sleep and non-rapid eye movement sleep than females during the active phase. Gonadectomized FCG mice exhibited no sex differences in rest-phase sleep amount; however, during the mid-active-phase (nighttime), XX males had more spontaneous non-rapid eye movement (NREM) sleep than XX females. The XY mice did not exhibit sex differences in sleep amount. Following forced wakefulness there was a change in the factors regulating sleep. XY females slept more during their mid-active phase siestas than XX females and had higher NREM slow wave activity, a measure of sleep propensity. These findings suggest that the process that regulates sleep propensity is sex-linked, and that sleep amount and sleep propensity are regulated differently in males and females following sleep loss.	[Ehlen, J. Christopher; Hesse, September; Pinckney, Lennisha; Paul, Ketema N.] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA	Morehouse School of Medicine	Paul, KN (corresponding author), Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA.	kpaul@msm.edu	Ehlen, Christopher/GXV-9278-2022	Ehlen, J. Christopher/0000-0003-3223-9262	National Institute of Neurological Disorders and Stroke [NS078410, NS060659]; National Institute of General Medical Sciences [GM058268]; Science and Technology Centers Program of the National Science Foundation [IBN-9876754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS060659, R01NS078410] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Science and Technology Centers Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke awards NS078410, NS060659, National Institute of General Medical Sciences award GM058268, and by the Science and Technology Centers Program of the National Science Foundation under Agreement No. IBN-9876754. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage R, 2007, ACTA PSYCHIAT SCAND, V115, P104, DOI 10.1111/j.1600-0447.2007.00968.x; Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; Barker JM, 2010, J NEUROSCI, V30, P9140, DOI 10.1523/JNEUROSCI.0548-10.2010; BRANCHEY M, 1971, PHYSIOL BEHAV, V6, P743, DOI 10.1016/0031-9384(71)90267-8; Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Carruth LL, 2002, NAT NEUROSCI, V5, P933, DOI 10.1038/nn922; COLVIN GB, 1969, EXP NEUROL, V25, P616, DOI 10.1016/0014-4886(69)90104-6; De Vries GJ, 2002, J NEUROSCI, V22, P9005; Fang JD, 1996, BRAIN RES, V734, P275, DOI 10.1016/0006-8993(96)00652-X; Gangwisch JE, 2010, SLEEP, V33, P956, DOI 10.1093/sleep/33.7.956; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Li H, 1996, AM J PHYSIOL, V269, pR208; Lyytikainen Peppi, 2011, J Sleep Res, V20, P298, DOI 10.1111/j.1365-2869.2010.00903.x; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; McPhie-Lalmansingh AA, 2008, HORM BEHAV, V54, P565, DOI 10.1016/j.yhbeh.2008.05.016; Miller MA, 2009, SLEEP, V32, P857; Monk TH, 2001, SLEEP, V24, P680, DOI 10.1093/sleep/24.6.680; Naska A, 2007, ARCH INTERN MED, V167, P296, DOI 10.1001/archinte.167.3.296; Paul KN, 2006, SLEEP, V29, P1211, DOI 10.1093/sleep/29.9.1211; Pawlyk AC, 2008, HORM BEHAV, V53, P217, DOI 10.1016/j.yhbeh.2007.09.018; Reimao R, 2000, ARQ NEURO-PSIQUIAT, V58, P39, DOI 10.1590/S0004-282X2000000100006; Schwartz MD, 2011, PHYSIOL BEHAV, V104, P962, DOI 10.1016/j.physbeh.2011.06.016; Wijnen H, 2008, NEURON, V60, P943, DOI 10.1016/j.neuron.2008.12.009; Yamoaka S, 1980, BRAIN RES, V185, P385; Zaregarizi M, 2007, J APPL PHYSIOL, V103, P1332, DOI 10.1152/japplphysiol.00474.2007	25	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62205	10.1371/journal.pone.0062205	http://dx.doi.org/10.1371/journal.pone.0062205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658713	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000034
J	Murray, DR; Schaller, M; Suedfeld, P				Murray, Damian R.; Schaller, Mark; Suedfeld, Peter			Pathogens and Politics: Further Evidence That Parasite Prevalence Predicts Authoritarianism	PLOS ONE			English	Article							RIGHT-WING AUTHORITARIANISM; INFECTIOUS-DISEASE; ASSORTATIVE SOCIALITY; DISGUST SENSITIVITY; PERCEIVED THREAT; ATTITUDES; CONFORMITY; AVOIDANCE; PREJUDICE; ORIGINS	According to a "parasite stress" hypothesis, authoritarian governments are more likely to emerge in regions characterized by a high prevalence of disease-causing pathogens. Recent cross-national evidence is consistent with this hypothesis, but there are inferential limitations associated with that evidence. We report two studies that address some of these limitations, and provide further tests of the hypothesis. Study 1 revealed that parasite prevalence strongly predicted cross-national differences on measures assessing individuals' authoritarian personalities, and this effect statistically mediated the relationship between parasite prevalence and authoritarian governance. The mediation result is inconsistent with an alternative explanation for previous findings. To address further limitations associated with cross-national comparisons, Study 2 tested the parasite stress hypothesis on a sample of traditional small-scale societies (the Standard Cross-Cultural Sample). Results revealed that parasite prevalence predicted measures of authoritarian governance, and did so even when statistically controlling for other threats to human welfare. (One additional threat-famine-also uniquely predicted authoritarianism.) Together, these results further substantiate the parasite stress hypothesis of authoritarianism, and suggest that societal differences in authoritarian governance result, in part, from cultural differences in individuals' authoritarian personalities.	[Murray, Damian R.; Schaller, Mark; Suedfeld, Peter] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Murray, DR (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	dmurray@psych.ubc.ca			Canada Graduate Scholarship	Canada Graduate Scholarship	This work was supported by a Canada Graduate Scholarship (awarded to DRM; http://www.sshrc-crsh.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2001, AM ECON REV, V91, P1369, DOI 10.1257/aer.91.5.1369; Adorno Theodor W, 1950, AUTHORITARIAN PERSON; Altemeyer, 1996, AUTHORITARIAN SPECTE; Altemeyer B., 1988, ENEMIES FREEDOM UNDE; Cashdan E, HUM NATURE IN PRESS; Cohrs JC, 2009, BASIC APPL SOC PSYCH, V31, P81, DOI 10.1080/01973530802659638; Cohrs J.Christopher., 2005, ANAL SOC ISS PUB POL, V5, P263, DOI DOI 10.1111/J.1530-2415.2005.00071.X; Currie TE, 2012, BEHAV BRAIN SCI, V35, P83, DOI 10.1017/S0140525X11000963; Dirks Robert, 1993, CROSS-CULT RES, V27, P28, DOI DOI 10.1177/106939719302700103; DOTY RM, 1991, J PERS SOC PSYCHOL, V61, P629, DOI 10.1037/0022-3514.61.4.629; Easterly W, 2003, J MONETARY ECON, V50, P3, DOI 10.1016/S0304-3932(02)00200-3; Fabrega H, 1997, MED ANTHROPOL Q, V11, P26, DOI 10.1525/maq.1997.11.1.26; Faulkner J, 2004, GROUP PROCESS INTERG, V7, P333, DOI 10.1177/1368430204046142; Feldman S, 1997, POLIT PSYCHOL, V18, P741, DOI 10.1111/0162-895X.00077; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P2587, DOI 10.1098/rspb.2008.0688; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P1279, DOI 10.1098/rspb.2008.0094; Fincher CL, 2012, BEHAV BRAIN SCI, V35, P61, DOI 10.1017/S0140525X11000021; Gaddis John Lewis, 1997, WE NOW KNOW RETHINKI; Haber S, 2011, AM POLIT SCI REV, V105, P1, DOI 10.1017/S0003055410000584; Hackman J, EVOL HUM BE IN PRESS; Helzer EG, 2011, PSYCHOL SCI, V22, P517, DOI 10.1177/0956797611402514; Henriksen T.H., 2001, J INT AFF, V54, P349; Hetherington M.J., 2009, AUTHORITARIANISM POL; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Jones A, 2008, EMOTION, V8, P613, DOI 10.1037/a0013435; Jugert P, 2009, POLIT PSYCHOL, V30, P693, DOI 10.1111/j.1467-9221.2009.00722.x; Kool VK, 1983, AUTHORITARIANISM CUL; Lavine H, 2005, POLIT PSYCHOL, V26, P219, DOI 10.1111/j.1467-9221.2005.00416.x; Letendre K, 2010, BIOL REV, V85, P669, DOI 10.1111/j.1469-185X.2010.00133.x; Little AC, 2011, P ROY SOC B-BIOL SCI, V278, P2032, DOI 10.1098/rspb.2010.1925; Low B. S., 1988, HUMAN REPRODUCTIVE B, P115; MATHEWS JT, 1989, FOREIGN AFF, V68, P162, DOI 10.2307/20043906; Meloen J., 1996, DEMOCRACY SOCIALIZAT, P20; MURDOCK GP, 1969, ETHNOLOGY, V8, P329, DOI 10.2307/3772907; Murdock GPM, 1949, SOCIAL STRUCTURE; Murray DR, 2012, EUR J SOC PSYCHOL, V42, P180, DOI 10.1002/ejsp.863; Murray DR, 2011, PERS SOC PSYCHOL B, V37, P318, DOI 10.1177/0146167210394451; Murray DR, 2010, J CROSS CULT PSYCHOL, V41, P99, DOI 10.1177/0022022109349510; Navarrete CD, 2007, EVOL HUM BEHAV, V28, P60, DOI 10.1016/j.evolhumbehav.2006.06.002; Navarrete CD, 2006, EVOL HUM BEHAV, V27, P270, DOI 10.1016/j.evolhumbehav.2005.12.001; Nettle D, 2009, TRENDS ECOL EVOL, V24, P618, DOI 10.1016/j.tree.2009.05.013; Neuberg SL, 2011, NEUROSCI BIOBEHAV R, V35, P1042, DOI 10.1016/j.neubiorev.2010.08.011; PERRY RL, 2002, COMP ANAL NATIONS QU; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Robinson J., 2005, EC ORIGINS DICTATORS; ROSS MH, 1983, ETHNOLOGY, V22, P169, DOI 10.2307/3773578; SALES SM, 1973, J PERS SOC PSYCHOL, V28, P44, DOI 10.1037/h0035588; SCHALLER M, 2011, ADV CULTURE PSYCHOL, V1, P99; Schaller M, 2008, J PERS SOC PSYCHOL, V95, P212, DOI 10.1037/0022-3514.95.1.212; Schaller M, 2012, BEHAV BRAIN SCI, V35, P91, DOI 10.1017/S0140525X11001038; Schaller M, 2011, PHILOS T R SOC B, V366, P3418, DOI 10.1098/rstb.2011.0029; Thorisdottir H, 2011, POLIT PSYCHOL, V32, P785, DOI 10.1111/j.1467-9221.2011.00840.x; Thornhill R, 2010, EVOL PSYCHOL-US, V8, P151; Thornhill R, 2009, BIOL REV, V84, P113, DOI 10.1111/j.1469-185X.2008.00062.x; van Leeuwen F, 2012, EVOL HUM BEHAV, V33, P429, DOI 10.1016/j.evolhumbehav.2011.12.005; Vanhanen T., 2003, DEMOCRATIZATION COMP; Vestal T.M., 1999, ETHIOPIA POST COLD W; Whitley BE, 1999, J PERS SOC PSYCHOL, V77, P126, DOI 10.1037/0022-3514.77.1.126; WILSON GM, 1968, COMP STUD SOC HIST, V10, P401, DOI 10.1017/S0010417500005016; Wu BP, 2012, PERS INDIV DIFFER, V53, P50, DOI 10.1016/j.paid.2012.02.023; WYLIE L, 1992, PSYCHOL REP, V71, P1291, DOI 10.2466/PR0.71.8.1291-1298	61	86	88	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62275	10.1371/journal.pone.0062275	http://dx.doi.org/10.1371/journal.pone.0062275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23658718	Green Published, gold			2022-12-27	WOS:000319167000037
J	Filgueiras, MD; Morrot, A; Soares, PMG; Costa, ML; Mermelstein, C				Filgueiras, Marcelo de Carvalho; Morrot, Alexandre; Gomes Soares, Pedro Marcos; Costa, Manoel Luis; Mermelstein, Claudia			Effects of 5-Fluorouracil in Nuclear and Cellular Morphology, Proliferation, Cell Cycle, Apoptosis, Cytoskeletal and Caveolar Distribution in Primary Cultures of Smooth Muscle Cells	PLOS ONE			English	Article							DIFFERENTIATION; CHEMOTHERAPY; FIBROBLASTS; MEMBRANE; SKELETAL; PROTEIN; CANCER; DESMIN	Colon cancer is one of the most prevalent types of cancer in the world and is one of the leading causes of cancer death. The anti-metabolite 5-fluorouracil (5-FU) is widely used in the treatment of patients with colon cancer and other cancer types. 5-FU-based chemotherapy has been shown to be very efficient in the improvement of overall survival of the patients and for the eradication of the disease. Unfortunately, common side effects of 5-FU include severe alterations in the motility of the gastrointestinal tissues. Nevertheless, the molecular and cellular effects of 5-FU in smooth muscle cells are poorly understood. Primary smooth muscle cell cultures are an important tool for studies of the biological consequences of 5-FU at the cellular level. The avian gizzard is one of the most robust organs of smooth muscle cells. Here we studied the molecular and cellular effects of the chemotherapic drug 5-FU in a primary culture of chick gizzard smooth muscle cells. We found that treatment of smooth muscle cells with 5-FU inhibits cell proliferation by the arrest of cells in the G1 phase of cell cycle and induce apoptosis. 5-FU induced a decrease in the percentage of histone H3-positive cells. Treatment of cells with 5-FU induced changes in cellular and nuclear morphology, a decrease in the number of stress fibers and a major decrease in the number of caveolin-3 positive cells. Our results suggest that the disorganization of the actin cytoskeleton and the reduction of caveolin-3 expression could explain the alterations in contractility observed in patients treated with 5-FU. These findings might have an impact in the understanding of the cellular effects of 5-FU in smooth muscle tissues and might help the improvement of new therapeutic protocols for the treatment of colon cancer.	[Filgueiras, Marcelo de Carvalho; Costa, Manoel Luis; Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Diferenciacao Muscular & Citoesqueleto, Rio De Janeiro, Brazil; [Filgueiras, Marcelo de Carvalho; Gomes Soares, Pedro Marcos] Univ Fed Ceara, Dept Morfol, Fortaleza, Ceara, Brazil; [Filgueiras, Marcelo de Carvalho] Univ Fed Piaui, Teresina, Piaui, Brazil; [Morrot, Alexandre] Univ Fed Rio de Janeiro, Lab Imunol, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Ceara; Universidade Federal do Piaui; Universidade Federal do Rio de Janeiro	Mermelstein, C (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Diferenciacao Muscular & Citoesqueleto, Rio De Janeiro, Brazil.	mermelstein@ufrj.br	Costa, Manoel/B-5009-2010; mermelstein, Claudia S/C-1464-2010; SOARES, PEDRO/V-7562-2019	Costa, Manoel/0000-0002-9037-0085; mermelstein, Claudia S/0000-0002-8897-8526; SOARES, PEDRO/0000-0003-0606-2539	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programas de Apoio aos Nucleos de Excelencia (Pronex)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programas de Apoio aos Nucleos de Excelencia (Pronex)	This work was supported by Brazilian grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and the Programas de Apoio aos Nucleos de Excelencia (Pronex). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMPBELL GR, 1971, J CELL BIOL, V49, P21, DOI 10.1083/jcb.49.1.21; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; Cragg AH, 1992, VASC INTERV RADIOL, V3, P273; Draeger A, 2003, DEV BIOL, V262, P324, DOI 10.1016/S0012-1606(03)00398-1; DRAEGER A, 1990, J CELL BIOL, V111, P2463, DOI 10.1083/jcb.111.6.2463; GABELLA G, 1989, ANAT EMBRYOL, V180, P213, DOI 10.1007/BF00315880; Gordon SR, 2005, CELL MOTIL CYTOSKEL, V62, P244, DOI 10.1002/cm.20099; Huang L, 2010, BRIT J DERMATOL, V163, P1181, DOI 10.1111/j.1365-2133.2010.09939.x; Keefe DMK, 1997, CLIN SCI, V92, P385, DOI 10.1042/cs0920385; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Matuo R, 2009, J APPL TOXICOL, V29, P308, DOI 10.1002/jat.1411; Mermelstein CS, 2007, CELL TISSUE RES, V327, P343, DOI 10.1007/s00441-006-0296-z; Nelson K, 2002, SUPPORT CARE CANCER, V10, P455, DOI 10.1007/s00520-002-0340-9; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Soares PMG, 2008, CANCER CHEMOTH PHARM, V63, P91, DOI 10.1007/s00280-008-0715-9; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Taggart MJ, 2001, NEWS PHYSIOL SCI, V16, P61; Yang B, 1996, CLIN CANCER RES, V2, P1649	20	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63177	10.1371/journal.pone.0063177	http://dx.doi.org/10.1371/journal.pone.0063177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646193	Green Submitted, Green Published, gold			2022-12-27	WOS:000319077300148
J	Zemanick, ET; Harris, JK; Wagner, BD; Robertson, CE; Sagel, SD; Stevens, MJ; Accurso, FJ; Laguna, TA				Zemanick, Edith T.; Harris, J. Kirk; Wagner, Brandie D.; Robertson, Charles E.; Sagel, Scott D.; Stevens, Mark J.; Accurso, Frank J.; Laguna, Theresa A.			Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; BARCODED PRIMERS; FEV1 DECLINE; SPUTUM; INFECTIONS; IDENTIFICATION; ANTIBIOTICS; DESMOSINE; CHILDREN; SAMPLES	Background: Pulmonary exacerbations (PEx), frequently associated with airway infection and inflammation, are the leading cause of morbidity in cystic fibrosis (CF). Molecular microbiologic approaches detect complex microbiota from CF airway samples taken during PEx. The relationship between airway microbiota, inflammation, and lung function during CF PEx is not well understood. Objective: To determine the relationships between airway microbiota, inflammation, and lung function in CF subjects treated for PEx. Methods: Expectorated sputum and blood were collected and lung function testing performed in CF subjects during early (0-3d.) and late treatment (>7d.) for PEx. Sputum was analyzed by culture, pyrosequencing of 16S rRNA amplicons, and quantitative PCR for total and specific bacteria. Sputum IL-8 and neutrophil elastase (NE); and circulating C-reactive protein (CRP) were measured. Results: Thirty-seven sputum samples were collected from 21 CF subjects. At early treatment, lower diversity was associated with high relative abundance (RA) of Pseudomonas (r = -0.67, p<0.001), decreased FEV1% predicted (r = 0.49, p = 0.03) and increased CRP (r = -0.58, p = 0.01). In contrast to Pseudomonas, obligate and facultative anaerobic genera were associated with less inflammation and higher FEV1. With treatment, Pseudomonas RA and P. aeruginosa by qPCR decreased while anaerobic genera showed marked variability in response. Change in RA of Prevotella was associated with more variability in FEV1 response to treatment than Pseudomonas or Staphylococcus. Conclusions: Anaerobes identified from sputum by sequencing are associated with less inflammation and higher lung function compared to Pseudomonas at early exacerbation. CF PEx treatment results in variable changes of anaerobic genera suggesting the need for larger studies particularly of patients without traditional CF pathogens.	[Zemanick, Edith T.; Harris, J. Kirk; Sagel, Scott D.; Stevens, Mark J.; Accurso, Frank J.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Wagner, Brandie D.] Univ Colorado, Sch Med, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Laguna, Theresa A.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Laguna, Theresa A.] Univ Minnesota, Amplatz Childrens Hosp, Minneapolis, MN 55455 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zemanick, ET (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.	edith.zemanick@childrenscolorado.org	Zemanick, Edith T/ABF-9455-2020; Zemanick, Edith/D-5260-2017	Zemanick, Edith T/0000-0002-7507-9337; Zemanick, Edith/0000-0002-7507-9337; ROBERTSON, CHARLES/0000-0002-4136-4121; Harris, Jonathan/0000-0002-2378-4202; Wagner, brandie/0000-0002-2745-0103; Laguna, Theresa/0000-0003-4255-0310	Cystic Fibrosis Foundation [LAGUNA06A, ZEMANI08A0, SAGEL07B0]; National Institutes of Health (NIH/NCRR) [1 UL 1RR025780-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068322] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Cystic Fibrosis Foundation (LAGUNA06A, ZEMANI08A0 and SAGEL07B0) and the National Institutes of Health (NIH/NCRR 1 UL 1RR025780-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amadori A, 2009, RESP MED, V103, P407, DOI 10.1016/j.rmed.2008.09.024; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cohen J., 2003, APPL MULTIPLE REGRES; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collaco JM, 2010, AM J RESP CRIT CARE, V182, P1137, DOI 10.1164/rccm.201001-0057OC; Colombo C, 2005, PEDIATR PULM, V40, P15, DOI 10.1002/ppul.20237; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Daniels TWV, 2013, J CYST FIBROS, V12, P22, DOI 10.1016/j.jcf.2012.05.008; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Eribe ERK, 2008, ANAEROBE, V14, P131, DOI 10.1016/j.anaerobe.2008.04.004; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Harris JK, 2010, APPL ENVIRON MICROB, V76, P3863, DOI 10.1128/AEM.02585-09; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Laguna TA, 2012, PEDIATR PULM, V47, P856, DOI 10.1002/ppul.22525; Laguna TA, 2009, CHEST, V136, P1561, DOI 10.1378/chest.09-0217; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nadkarni MA, 2004, J CLIN MICROBIOL, V42, P5238, DOI 10.1128/JCM.42.11.5238-5244.2004; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ordonez CL, 2003, AM J RESP CRIT CARE, V168, P1471, DOI 10.1164/rccm.200306-731OC; Parkins MD, 2008, PEDIATR PULM, V43, P490, DOI 10.1002/ppul.20809; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2010, CLIN MICROBIOL INFEC, V16, P1656, DOI 10.1111/j.1469-0691.2010.03189.x; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Sanders DB, 2011, PEDIATR PULM, V46, P393, DOI 10.1002/ppul.21374; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Ulrich M, 2010, THORAX, V65, P978, DOI 10.1136/thx.2010.137745; VanDevanter DR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-137; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Worlitzsch D, 2009, CLIN MICROBIOL INFEC, V15, P454, DOI 10.1111/j.1469-0691.2008.02659.x; Zemanick ET, 2011, PEDIATR PULM, P306; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101; Zemanick ET, 2010, PEDIATR PULM, V45, P569, DOI 10.1002/ppul.21221; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	55	130	134	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62917	10.1371/journal.pone.0062917	http://dx.doi.org/10.1371/journal.pone.0062917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646159	Green Submitted, Green Published, gold			2022-12-27	WOS:000319077300113
J	Safaee, M; Clark, AJ; Oh, MC; Ivan, ME; Bloch, O; Kaur, G; Sun, MZ; Kim, JM; Oh, T; Berger, MS; Parsa, AT				Safaee, Michael; Clark, Aaron J.; Oh, Michael C.; Ivan, Michael E.; Bloch, Orin; Kaur, Gurvinder; Sun, Matthew Z.; Kim, Joseph M.; Oh, Taemin; Berger, Mitchel S.; Parsa, Andrew T.			Overexpression of CD97 Confers an Invasive Phenotype in Glioblastoma Cells and Is Associated with Decreased Survival of Glioblastoma Patients	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITOR; TRANSMEMBRANE RECEPTOR CD97; PHASE-II TRIAL; IN-VITRO; ENDOTHELIAL-CELLS; MALIGNANT GLIOMA; CELLULAR LIGAND; EGF-TM7 FAMILY; CANCER CELLS; TUMOR-GROWTH	Mechanisms of invasion in glioblastoma (GBM) relate to differential expression of proteins conferring increased motility and penetration of the extracellular matrix. CD97 is a member of the epidermal growth factor seven-span transmembrane family of adhesion G-protein coupled receptors. These proteins facilitate mobility of leukocytes into tissue. In this study we show that CD97 is expressed in glioma, has functional effects on invasion, and is associated with poor overall survival. Glioma cell lines and low passage primary cultures were analyzed. Functional significance was assessed by transient knockdown using siRNA targeting CD97 or a non-target control sequence. Invasion was assessed 48 hours after siRNA-mediated knockdown using a Matrigel-coated invasion chamber. Migration was quantified using a scratch assay over 12 hours. Proliferation was measured 24 and 48 hours after confirmed protein knockdown. GBM cell lines and primary cultures were found to express CD97. Knockdown of CD97 decreased invasion and migration in GBM cell lines, with no difference in proliferation. Gene-expression based Kaplan-Meier analysis was performed using The Cancer Genome Atlas, demonstrating an inverse relationship between CD97 expression and survival. GBMs expressing high levels of CD97 were associated with decreased survival compared to those with low CD97 (p = 0.007). CD97 promotes invasion and migration in GBM, but has no effect on tumor proliferation. This phenotype may explain the discrepancy in survival between high and low CD97-expressing tumors. This data provides impetus for further studies to determine its viability as a therapeutic target in the treatment of GBM.	[Safaee, Michael; Clark, Aaron J.; Oh, Michael C.; Ivan, Michael E.; Bloch, Orin; Kaur, Gurvinder; Sun, Matthew Z.; Kim, Joseph M.; Oh, Taemin; Berger, Mitchel S.; Parsa, Andrew T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Parsa, AT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	ParsaA@Neurosurg.ucsf.edu		Bloch, Orin/0000-0001-9810-6011; Kim, Joseph/0000-0002-1108-2625; Ivan, Michael/0000-0002-4798-4989	Doris Duke Charitable Foundation; Reza and Georgianna Khatib Endowed Chair in Skull Base Tumor Surgery	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Reza and Georgianna Khatib Endowed Chair in Skull Base Tumor Surgery	Mr. Safaee was supported by a grant from the Doris Duke Charitable Foundation. Dr. Parsa was partially funded by the Reza and Georgianna Khatib Endowed Chair in Skull Base Tumor Surgery. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand M, 2011, J NEURO-ONCOL, V104, P679, DOI 10.1007/s11060-011-0549-x; Aust G, 1997, CANCER RES, V57, P1798; Aust G, 2002, AM J CLIN PATHOL, V118, P699; Becker S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008507; Caminschi I, 2001, J IMMUNOL, V167, P3570, DOI 10.4049/jimmunol.167.7.3570; Chidambaram A, 2012, J NEUROSURG, V116, P843, DOI 10.3171/2011.11.JNS111455; Eichler W, 1997, TISSUE ANTIGENS, V50, P429, DOI 10.1111/j.1399-0039.1997.tb02897.x; Friedlander DR, 1996, CANCER RES, V56, P1939; Galle J, 2006, AM J PATHOL, V169, P1802, DOI 10.2353/ajpath.2006.060006; Gilbert MR, 2012, J NEURO-ONCOL, V106, P147, DOI 10.1007/s11060-011-0650-1; Gray JX, 1996, J IMMUNOL, V157, P5438; Groves MD, 2002, J CLIN ONCOL, V20, P1383, DOI 10.1200/JCO.20.5.1383; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hoang-Vu C, 1999, J CLIN ENDOCR METAB, V84, P1104, DOI 10.1210/jc.84.3.1104; HOLTING T, 1995, EUR J ENDOCRINOL, V132, P229, DOI 10.1530/eje.0.1320229; Kane AJ, 2010, NEUROREPORT, V21, P1018, DOI 10.1097/WNR.0b013e32833f19f2; Kop EN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2049; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; Levin VA, 2006, J NEURO-ONCOL, V78, P295, DOI 10.1007/s11060-005-9098-5; Lin HH, 2000, GENOMICS, V67, P188, DOI 10.1006/geno.2000.6238; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Mahesparan R, 1999, ACTA NEUROPATHOL, V97, P231, DOI 10.1007/s004010050979; Martinkova E, 2010, INT J CANCER, V127, P1240, DOI 10.1002/ijc.25187; MATSUKADO Y, 1961, J NEUROSURG, V18, P636, DOI 10.3171/jns.1961.18.5.0636; Mustafa T, 2005, CANCER EPIDEM BIOMAR, V14, P108; Nechiporuk T, 2001, J BIOL CHEM, V276, P4150, DOI 10.1074/jbc.M004814200; Park JW, 2005, THYROID, V15, P222, DOI 10.1089/thy.2005.15.222; Parsa AT, 2005, J NEUROSURG, V102, P622, DOI 10.3171/jns.2005.102.4.0622; Price A, 1999, CLIN CANCER RES, V5, P845; Qian YM, 1999, IMMUNOLOGY, V98, P303; Rooprai HK, 1999, INT J DEV NEUROSCI, V17, P613, DOI 10.1016/S0736-5748(99)00051-9; Rutkowski MJ, 2011, J NEURO-ONCOL, V105, P165, DOI 10.1007/s11060-011-0576-7; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Stacey M, 2002, J BIOL CHEM, V277, P29283, DOI 10.1074/jbc.M204306200; Stacey M, 2001, J BIOL CHEM, V276, P18863, DOI 10.1074/jbc.M101147200; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tchaicha JH, 2011, CANCER RES, V71, P6371, DOI 10.1158/0008-5472.CAN-11-0991; Tonn JC, 1998, ANTICANCER RES, V18, P2599; Tonn JC, 2003, ACT NEUR S, V88, P163; Voris HC, 1934, P MAYO CLIN, V9, P396; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	48	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e62765	10.1371/journal.pone.0062765	http://dx.doi.org/10.1371/journal.pone.0062765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658650	Green Published, gold, Green Submitted			2022-12-27	WOS:000318343700073
J	Nanni, S; Aiello, A; Re, A; Guffanti, A; Benvenuti, V; Colussi, C; Castro-Vega, LJ; Felsani, A; Londono-Vallejo, A; Capogrossi, MC; Bacchetti, S; Gaetano, C; Pontecorvi, A; Farsetti, A				Nanni, Simona; Aiello, Aurora; Re, Agnese; Guffanti, Alessandro; Benvenuti, Valentina; Colussi, Claudia; Castro-Vega, Luis Jaime; Felsani, Armando; Londono-Vallejo, Arturo; Capogrossi, Maurizio C.; Bacchetti, Silvia; Gaetano, Carlo; Pontecorvi, Alfredo; Farsetti, Antonella			Estrogen-Dependent Dynamic Profile of eNOS-DNA Associations in Prostate Cancer	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DIFFERENTIAL EXPRESSION ANALYSIS; RECEPTOR-BETA; BIOCONDUCTOR PACKAGE; TELOMERASE ACTIVITY; ANDROGEN RECEPTOR; CHIP-SEQ; BINDING; GENE; SIRT1	In previous work we have documented the nuclear translocation of endothelial NOS (eNOS) and its participation in combinatorial complexes with Estrogen Receptor Beta (ER beta) and Hypoxia Inducible Factors (HIFs) that determine localized chromatin remodeling in response to estrogen (E2) and hypoxia stimuli, resulting in transcriptional regulation of genes associated with adverse prognosis in prostate cancer (PCa). To explore the role of nuclear eNOS in the acquisition of aggressive phenotype in PCa, we performed ChIP-Sequencing on chromatin-associated eNOS from cells from a primary tumor with poor outcome and from metastatic LNCaP cells. We found that: 1. the eNOS-bound regions (peaks) are widely distributed across the genome encompassing multiple transcription factors binding sites, including Estrogen Response Elements. 2. E2 increased the number of peaks, indicating hormone-dependent eNOS re-localization. 3. Peak distribution was similar with/without E2 with approximate to 55% of them in extragenic DNA regions and an intriguing involvement of the 59 domain of several miRs deregulated in PCa. Numerous potentially novel eNOS-targeted genes have been identified suggesting that eNOS participates in the regulation of large gene sets. The parallel finding of downregulation of a cluster of miRs, including miR-34a, in PCa cells associated with poor outcome led us to unveil a molecular link between eNOS and SIRT1, an epigenetic regulator of aging and tumorigenicity, negatively regulated by miR-34a and in turn activating eNOS. E2 potentiates miR-34a downregulation thus enhancing SIRT1 expression, depicting a novel eNOS/SIRT1 interplay fine-tuned by E2-activated ER signaling, and suggesting that eNOS may play an important role in aggressive PCa.	[Nanni, Simona; Bacchetti, Silvia; Farsetti, Antonella] Natl Canc Inst Regina Elena, Dept Expt Oncol, Rome, Italy; [Nanni, Simona; Aiello, Aurora; Re, Agnese; Colussi, Claudia; Pontecorvi, Alfredo] Univ Cattolica Sacro Cuore, Med Pathol Inst, Rome, Italy; [Aiello, Aurora; Benvenuti, Valentina; Colussi, Claudia; Felsani, Armando; Farsetti, Antonella] Natl Res Council CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Re, Agnese] Univ Messina, Messina, Italy; [Guffanti, Alessandro; Felsani, Armando] Genomnia Srl, Milan, Italy; [Castro-Vega, Luis Jaime; Londono-Vallejo, Arturo] Inst Curie, Paris, France; [Capogrossi, Maurizio C.] Ist Dermopat Immacolata, Rome, Italy; [Gaetano, Carlo] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Messina; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Goethe University Frankfurt	Gaetano, C (corresponding author), Goethe Univ Frankfurt, D-60054 Frankfurt, Germany.	Gaetano@em.uni-frankfurt.de; afarsetti@gmail.com	Re, Agnese/O-4647-2019; Gaetano, Carlo/P-9997-2019; Castro-Vega, Luis Jaime/L-5587-2019; Colussi, Claudia/H-8609-2019; Felsani, Armando/D-1784-2010; Farsetti, Antonella/I-8710-2018; Castro-Vega, Luis Jaime/AAO-9988-2021; Londono-Vallejo, Arturo/ABH-5555-2020; Re, Agnese/E-3673-2016	Gaetano, Carlo/0000-0002-5238-1832; Felsani, Armando/0000-0001-8851-6295; Farsetti, Antonella/0000-0002-8603-7925; Castro-Vega, Luis Jaime/0000-0002-7232-9871; Londono-Vallejo, Arturo/0000-0003-3535-7563; Re, Agnese/0000-0003-0929-6568; Colussi, Claudia/0000-0002-7727-8911; Aiello, Aurora/0000-0002-8303-1528	Associazione Italiana Ricerca sul Cancro; Italian Ministry of Education, University, and Research [PRIN 2008NY72SJ, FIRB RBFR087JMZ, FIRB RBFR10URHP]; FIRC (Federazione Italiana Ricerca sul Cancro) Fellowship; Susan G. Komen for the Cure Foundation; LOEWE Center for Cell and Gene Therapy, Goethe University, Frankfurt (DE)	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); FIRC (Federazione Italiana Ricerca sul Cancro) Fellowship(Fondazione AIRC per la ricerca sul cancro); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); LOEWE Center for Cell and Gene Therapy, Goethe University, Frankfurt (DE)	This work was supported by the Associazione Italiana Ricerca sul Cancro to AFa; Italian Ministry of Education, University, and Research Grants: PRIN 2008NY72SJ and FIRB RBFR087JMZ to AFa and FIRB RBFR10URHP to S.N. V.B. is recipient of a FIRC (Federazione Italiana Ricerca sul Cancro) Fellowship. A.A. is supported by funding from Susan G. Komen for the Cure Foundation. C.G. research is supported by the LOEWE Center for Cell and Gene Therapy, Goethe University, Frankfurt (DE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chen Y, 2012, NAT METHODS; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Giovannelli P, 2011, FRONT BIOSCI-LANDMRK, V16, P2224, DOI 10.2741/3849; Grasselli A, 2008, CIRC RES, V103, P34, DOI 10.1161/CIRCRESAHA.107.169037; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kyo S, 1999, CANCER RES, V59, P5917; Lampson BL, 2012, CANCER; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Nanni S, 2002, J CLIN INVEST, V110, P219, DOI 10.1172/JCI200215552; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Prehn RT, 1999, CANCER RES, V59, P4161; Re A, 2011, MOL ENDOCRINOL, V25, P2003, DOI 10.1210/me.2011-1024; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Wu Q, 2011, J BIOL CHEM, V286, P14737, DOI 10.1074/jbc.R110.191791; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00068; Ying L, 2007, CANCER RES, V67, P1407, DOI 10.1158/0008-5472.CAN-06-2149; Zaman MS, 2010, BRIT J CANCER, V103, P256, DOI 10.1038/sj.bjc.6605742; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zeng L, 2008, CIRC RES, V103, P10, DOI 10.1161/CIRCRESAHA.108.179986; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	54	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62522	10.1371/journal.pone.0062522	http://dx.doi.org/10.1371/journal.pone.0062522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658738	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100013
J	Okahashi, N; Nakata, M; Sumitomo, T; Terao, Y; Kawabata, S				Okahashi, Nobuo; Nakata, Masanobu; Sumitomo, Tomoko; Terao, Yutaka; Kawabata, Shigetada			Hydrogen Peroxide Produced by Oral Streptococci Induces Macrophage Cell Death	PLOS ONE			English	Article							IDENTIFICATION; SANGUINIS; ENDOCARDITIS; VIRULENCE; PILI	Hydrogen peroxide (H2O2) produced by members of the mitis group of oral streptococci plays important roles in microbial communities such as oral biofilms. Although the cytotoxicity of H2O2 has been widely recognized, the effects of H2O2 produced by oral streptococci on host defense systems remain unknown. In the present study, we investigated the effect of H2O2 produced by Streptococcus oralis on human macrophage cell death. Infection by S. oralis was found to stimulate cell death of a THP-1 human macrophage cell line at multiplicities of infection greater than 100. Catalase, an enzyme that catalyzes the decomposition of H2O2, inhibited the cytotoxic effect of S. oralis. S. oralis deletion mutants lacking the spxB gene, which encodes pyruvate oxidase, and are therefore deficient in H2O2 production, showed reduced cytotoxicity toward THP-1 macrophages. Furthermore, H2O2 alone was capable of inducing cell death. The cytotoxic effect seemed to be independent of inflammatory responses, because H2O2 was not a potent stimulator of tumor necrosis factor-a production in macrophages. These results indicate that streptococcal H2O2 plays a role as a cytotoxin, and is implicated in the cell death of infected human macrophages.	[Okahashi, Nobuo] Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Suita, Osaka, Japan; [Nakata, Masanobu; Sumitomo, Tomoko; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka, Japan; [Terao, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Niigata, Japan	Osaka University; Osaka University; Niigata University	Okahashi, N (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Suita, Osaka, Japan.	okahashi@dent.osaka-u.ac.jp	okahashi, nobuo/A-4032-2010	okahashi, nobuo/0000-0002-8045-7021; Terao, Yutaka/0000-0002-4450-5583; Nakata, Masanobu/0000-0003-1686-5415	Japan Society for the Promotion of Science [24390410, 23593027, 24659812]; Grants-in-Aid for Scientific Research [23593027, 23592700, 24659812] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) (#24390410) and (C) (#23593027), and Grants-in Aid for Challenging Exploratory Research (#24659812) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Braun JS, 2002, J CLIN INVEST, V109, P19; BRIDGE PD, 1982, INT J SYST BACTERIOL, V32, P410, DOI 10.1099/00207713-32-4-410; Chen L, 2011, MICROBIOL-SGM, V157, P13, DOI 10.1099/mic.0.039669-0; Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2; COYKENDALL AL, 1989, CLIN MICROBIOL REV, V2, P315, DOI 10.1128/CMR.2.3.315-328.1989; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; Dyson C, 1999, J INFECTION, V38, P87, DOI 10.1016/S0163-4453(99)90074-9; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Health Protection Agency, 2012, HLTH PROT REP; Hoshino T, 2004, DIAGN MICR INFEC DIS, V48, P195, DOI 10.1016/j.diagmicrobio.2003.10.002; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Nakano K, 2006, J CLIN MICROBIOL, V44, P3313, DOI 10.1128/JCM.00377-06; Nakata M, 2011, J BIOL CHEM, V286, P37566, DOI 10.1074/jbc.M111.239780; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Okahashi N, 2011, FEMS MICROBIOL LETT, V323, P164, DOI 10.1111/j.1574-6968.2011.02375.x; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; Stinson MW, 2003, INFECT IMMUN, V71, P2365, DOI 10.1128/IAI.71.5.2365-2372.2003; Sumitomo T, 2011, J BIOL CHEM, V286, P2750, DOI 10.1074/jbc.M110.171504; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; VANDERMEER JTM, 1991, EUR J CLIN MICROBIOL, V10, P728; Watt Barbara E, 2004, Toxicol Rev, V23, P51, DOI 10.2165/00139709-200423010-00006; Zhu L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/717843	33	30	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62563	10.1371/journal.pone.0062563	http://dx.doi.org/10.1371/journal.pone.0062563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658745	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100018
J	Zhang, HX; Jiang, WQ; Lin, ZG; Du, YS; Vance, A				Zhang, Hong-Xia; Jiang, Wen-Qing; Lin, Zhi-Guang; Du, Ya-Song; Vance, Alasdair			Comparison of Psychological Symptoms and Serum Levels of Neurotransmitters in Shanghai Adolescents with and without Internet Addiction Disorder: A Case-Control Study	PLOS ONE			English	Article							PSYCHIATRIC-SYMPTOMS; DEPRESSION; SEROTONIN; DOPAMINE; ANXIETY	Background: Internet addiction disorder (IAD) is now recognized internationally and is known to be linked with academic and social impairment. To date, we know little about its associated main biological factors. This study aimed to collect a carefully defined group of adolescents with IAD and an age- and gender-matched typically developing comparison group. We hypothesized that the young people with IAD would have higher rates of self-reported anxiety and depressive symptoms, have altered levels of peripheral blood dopamine, norepinephrine and serotonin. In addition, we hypothesized the hours spent online are correlated with the severity of depression and anxiety among these young people with IAD. Methodology/Principal Finding: A cross-sectional study of 20 adolescents who met Beard's criteria for IAD and 15 typically developing adolescents (comparison group) was conducted. All the participants completed the Self Rating Depression Scale (SDS), Self Rating Anxiety Scale (SAS), and the Screen for Child Anxiety Related Emotional Disorders (SCARED). Peripheral blood dopamine, serotonin and norepinephrine were assayed. The mean level of norepinephrine was lower in the IAD group than that in the typically developing participants, while dopamine and serotonin levels did not differ. The SDS, SAS and SCARED symptom scores were increased in the adolescents with IAD. A logistic regression analysis revealed that a higher SAS score and lower level of norepinephrine independently predicted IAD group membership. There was no significant correlation between hours spent online and scores of SAS/SDS in IAD group. Conclusions/Significance: Increased self-reported anxiety and lower peripheral blood norepinephrine are independently associated with IAD.	[Zhang, Hong-Xia] Fudan Univ, Zhongshan Hosp, Dept Psychol Med, Shanghai 200433, Peoples R China; [Jiang, Wen-Qing; Du, Ya-Song] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Child & Adolescent Psychiat, Shanghai 200030, Peoples R China; [Lin, Zhi-Guang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Biol Psychiat, Shanghai 200030, Peoples R China; [Vance, Alasdair] Univ Melbourne, Royal Childrens Hosp, Acad Child Psychiat Unit, Melbourne, Vic, Australia	Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Royal Children's Hospital Melbourne; University of Melbourne	Du, YS (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Child & Adolescent Psychiat, Shanghai 200030, Peoples R China.	yasongdu@yahoo.com.cn; avance@unimelb.edu.au		Vance, Alasdair/0000-0002-7471-9769	Country's "11th five-year plan" supporting science and technology projects in China [2007BAI17B03]	Country's "11th five-year plan" supporting science and technology projects in China	This work was supported by grants from the Country's "11th five-year plan" supporting science and technology projects in China, component (2007BAI17B03). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The website of the Ministry of Science and Technology of the People's Republic of China is as follows: http://www.most.gov.cn/.	Akimova E, 2009, BIOL PSYCHIAT, V66, P627, DOI 10.1016/j.biopsych.2009.03.012; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Bernardi S, 2009, COMPR PSYCHIAT, V50, P510, DOI 10.1016/j.comppsych.2008.11.011; Cashman JR, 2009, BIOORGAN MED CHEM, V17, P6890, DOI 10.1016/j.bmc.2009.08.025; Cho SM, 2012, CHILD PSYCHIATRY HUM; Christakis DA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-61; D'Aquila PS, 2000, EUR J PHARMACOL, V405, P365, DOI 10.1016/S0014-2999(00)00566-5; Du YS, 2010, AUST NZ J PSYCHIAT, V44, P129, DOI 10.3109/00048670903282725; Fajardo O, 2003, INT IMMUNOPHARMACOL, V3, P1345, DOI 10.1016/S1567-5769(03)00116-4; Fan J, 2007, SHANGHAI ARCHIVES OF, V19, P71; Flisher C, 2010, J PAEDIATR CHILD H, V46, P557, DOI 10.1111/j.1440-1754.2010.01879.x; Fu KW, 2010, BRIT J PSYCHIAT, V196, P486, DOI 10.1192/bjp.bp.109.075002; Ha JH, 2007, PSYCHOPATHOLOGY, V40, P424, DOI 10.1159/000107426; Harley CW, 2003, EXP NEUROL, V184, P24, DOI 10.1016/S0014-4886(03)00317-0; Jang KS, 2008, J SCHOOL HEALTH, V78, P165, DOI 10.1111/j.1746-1561.2007.00279.x; JIAO M, 2005, SHANGHAI ARCH PSYCHI, V17, P72; Kent JM, 1998, BIOL PSYCHIAT, V44, P812, DOI 10.1016/S0006-3223(98)00210-8; Kim HK, 2009, COMPUT HUM BEHAV, V25, P490, DOI 10.1016/j.chb.2008.11.001; Kim K, 2006, INT J NURS STUD, V43, P185, DOI 10.1016/j.ijnurstu.2005.02.005; Lee YS, 2008, J AFFECT DISORDERS, V109, P165, DOI 10.1016/j.jad.2007.10.020; Morrison CM, 2010, PSYCHOPATHOLOGY, V43, P121, DOI 10.1159/000277001; Soule LC, 2003, J COMPUT INFORM SYST, V44, P64; Thorens G, 2009, PSYCHIAT QUART, V80, P117, DOI 10.1007/s11126-009-9098-2; Tonioni F, 2012, GEN HOSP PSYCHIAT, V34, P80, DOI 10.1016/j.genhosppsych.2011.09.013; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; [王凯 Wang Kai], 2002, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V10, P270; Yang SC, 2007, COMPUT HUM BEHAV, V23, P79, DOI 10.1016/j.chb.2004.03.037; Yen JY, 2007, J ADOLESCENT HEALTH, V41, P93, DOI 10.1016/j.jadohealth.2007.02.002; Zhu Tian-Min, 2008, Zhongguo Zhen Jiu, V28, P561; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	31	13	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63089	10.1371/journal.pone.0063089	http://dx.doi.org/10.1371/journal.pone.0063089			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AS	23658801	Green Published, gold			2022-12-27	WOS:000321202100052
J	Donini, LM; Poggiogalle, E; Piredda, M; Pinto, A; Barbagallo, M; Cucinotta, D; Sergi, G				Donini, Lorenzo Maria; Poggiogalle, Eleonora; Piredda, Maria; Pinto, Alessandro; Barbagallo, Mario; Cucinotta, Domenico; Sergi, Giuseppe			Anorexia and Eating Patterns in the Elderly	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; DIETARY-PROTEIN INTAKE; FOOD-INTAKE; CEREBROSPINAL-FLUID; NUTRITIONAL-STATUS; VEGETABLE INTAKE; OLDER; PLASMA; APPETITE; ADULTS	Objectives: To evaluate the change in eating habits occurring in community- dwelling and institutionalized elderly subjects with senile anorexia. Design: Cross- sectional, observational. Setting: Community, nursing homes and rehabilitation or acute care facilities in four Italian regions. Participants: A random sample of 526 subjects, aged 65 years and older (217 free living individuals, 213 residents in nursing homes, and 93 patients in rehabilitation and acute wards). Measurements: All subjects underwent a multidimensional geriatric evaluation of: nutritional status, anthropometric parameters, health and cognitive status, depression, taste, chewing and swallowing function, and some hormones related to appetite. Diet variety was assessed, considering the frequency of consumption of different food groups (milk and dairy products; meat, fish, and eggs; cereals and derivatives; fruit and vegetables). Results: In anorexic elderly subjects the global food intake was reduced, and the eating pattern was characterized by the reduced consumption of certain food groups ("meat, eggs and fish" and "fruit and vegetables") whereas the frequency of consumption of milk and cereals remained almost unchanged. Nutritional parameters were significantly better in normal eating subjects and correlated with diet variety. Conclusion: Because of the high prevalence of senile anorexia in the geriatric population and its impact on the nutritional status, further research should be prompted to establish an intervention. protocol allowing the early diagnosis of anorexia of aging, aimed at identifying its causes and at optimizing treatment of anorexic patients.	[Donini, Lorenzo Maria; Poggiogalle, Eleonora; Piredda, Maria; Pinto, Alessandro] Univ Roma La Sapienza, Med Physiopathol Food Sci & Endocrinol Sect, Dept Expt Med, Rome, Italy; [Barbagallo, Mario] Univ Palermo, Dept Clin Med & Emerging Pathol, Geriatr Unit, I-90133 Palermo, Italy; [Cucinotta, Domenico] St Orsola Marcello Malpighi Hosp, Dept Clin Med & Aging, Bologna, Italy; [Sergi, Giuseppe] Univ Padua, Dept Med & Surg Sci, Geriatr Sect, I-35100 Padua, Italy	Sapienza University Rome; University of Palermo; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Padua	Donini, LM (corresponding author), Univ Roma La Sapienza, Med Physiopathol Food Sci & Endocrinol Sect, Dept Expt Med, Rome, Italy.	lorenzomaria.donini@uniroma1.it	SERGI, GIUSEPPE/J-9396-2018; Donini, Lorenzo/AAS-3873-2020; Poggiogalle, Eleonora/AAB-9338-2019; BARBAGALLO, MARIO/K-4794-2017	SERGI, GIUSEPPE/0000-0001-9757-856X; Donini, Lorenzo/0000-0003-4692-4754; BARBAGALLO, MARIO/0000-0002-1349-6530; Pinto, Antonio/0000-0002-8083-3699; Pinto, Alessandro/0000-0002-4864-2294; Poggiogalle, Eleonora/0000-0003-0862-5892; CUCINOTTA, Domenico Maria/0000-0002-8159-5709	Italian Ministry of Instruction, University and Research [2005-067913]	Italian Ministry of Instruction, University and Research(Ministry of Education, Universities and Research (MIUR))	The study was funded as a Research Project of National Interest (PRIN n. 2005-067913) titled "Causes and prevalence of senile anorexia" from the Italian Ministry of Instruction, University and Research. The authors have no financial or any other kind of personal conflicts with this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS GS, 1988, J AM GERIATR SOC, V36, P230, DOI 10.1111/j.1532-5415.1988.tb01806.x; [Anonymous], 2012, LIV ASS RACC EN NUTR; Bermejo LM, 2007, PUBLIC HEALTH NUTR, V10, P266, DOI 10.1017/S1368980007246580; Bernstein MA, 2002, J AM DIET ASSOC, V102, P1096, DOI 10.1016/S0002-8223(02)90246-4; Chapman IM, 2004, BEST PRACT RES CL EN, V18, P437, DOI 10.1016/j.beem.2004.02.004; Donini LM, 2008, J NUTR HEALTH AGING, V12, P511, DOI 10.1007/BF02983203; Donini LM, 2009, WOODHEAD PUBL FOOD S, P43, DOI 10.1533/9781845695484.1.43; Donini LM, 2010, J NUTR HEALTH AGING, V14, P494; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hamidi M, 2011, OSTEOPOROSIS INT, V22, P1681, DOI 10.1007/s00198-010-1510-0; Hayakawa I, 1998, INT J PROSTHODONT, V11, P173; Houston DK, 2008, AM J CLIN NUTR, V87, P150, DOI 10.1093/ajcn/87.1.150; Houston DK, 2005, AM J CLIN NUTR, V81, P515; Huth PJ, 2006, J DAIRY SCI, V89, P1207, DOI 10.3168/jds.S0022-0302(06)72190-7; INRAN, 2003, LIN GUID SAN AL IT 2; Kane RA, 1997, J AM GERIATR SOC, V45, P1086, DOI 10.1111/j.1532-5415.1997.tb05971.x; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; LIPSCHITZ DA, 1991, SEMIN DERMATOL, V10, P273; Lohman T. G., 1992, MANUALE RIFERIMENTO; MacIntosh CG, 2001, J CLIN ENDOCR METAB, V86, P5830, DOI 10.1210/jc.86.12.5830; MacIntosh CG, 2001, AM J GASTROENTEROL, V96, P997, DOI 10.1111/j.1572-0241.2001.03684.x; Marcus EL, 1998, NUTR REV, V56, P163, DOI 10.1111/j.1753-4887.1998.tb06130.x; Martin A, 2002, J Nutr Health Aging, V6, P392; MARTINEZ M, 1993, REGUL PEPTIDES, V49, P109, DOI 10.1016/0167-0115(93)90432-8; MARTINEZ M, 1993, MECH AGEING DEV, V72, P145, DOI 10.1016/0047-6374(93)90096-A; McHorney CA, 2000, DYSPHAGIA, V15, P115, DOI 10.1007/s004550010012; MORLEY JE, 1994, J AM GERIATR SOC, V42, P583, DOI 10.1111/j.1532-5415.1994.tb06853.x; Morley JE, 2001, J GERONTOL A-BIOL, V56, P81, DOI 10.1093/gerona/56.suppl_2.81; Morley JE, 1997, AM J CLIN NUTR, V66, P760, DOI 10.1093/ajcn/66.4.760; Moss C, 2012, J HUM NUTR DIET, V25, P3, DOI 10.1111/j.1365-277X.2011.01211.x; Mulligan C, 2002, GERONTOLOGY, V48, P39, DOI 10.1159/000048923; Nieuwenhuizen WF, 2010, CLIN NUTR, V29, P160, DOI 10.1016/j.clnu.2009.09.003; Nieves JW, 2008, OSTEOPOROSIS INT, V19, P673, DOI 10.1007/s00198-007-0501-2; Parker BA, 2004, MECH AGEING DEV, V125, P859, DOI 10.1016/j.mad.2004.05.006; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Payette H, 2005, CAN J PUBLIC HEALTH, V96, pS27, DOI 10.1007/BF03405198; Rassool G Hussein, 2003, J Adv Nurs, V43, P544, DOI 10.1046/j.1365-2648.2003.02792.x; Raynaud-Simon A, 2012, CURR OPIN CLIN NUTR, V15, P42, DOI 10.1097/MCO.0b013e32834dfeab; Reynish W, 2001, J GERONTOL A-BIOL, V56, pM675, DOI 10.1093/gerona/56.11.M675; ROSENBLOOM CA, 1993, J GERONTOL, V48, pS223, DOI 10.1093/geronj/48.4.S223; Schiffman SS, 2000, EUR J CLIN NUTR, V54, pS54, DOI 10.1038/sj.ejcn.1601026; Sullivan DH, 2011, J NUTR HEALTH AGING, V15, P311, DOI 10.1007/s12603-010-0297-1; VanStaveren WA, 1995, P NUTR SOC, V54, P617, DOI 10.1079/PNS19950062; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Vikstedt T, 2011, J AM MED DIR ASSOC, V12, P302, DOI 10.1016/j.jamda.2010.12.098; Volkert D, 2011, INT J VITAM NUTR RES, V81, P109, DOI 10.1024/0300-9831/a000061; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Young KWH, 2001, J GERONTOL A-BIOL, V56, pM700, DOI 10.1093/gerona/56.11.M700; Zoltick ES, 2011, J NUTR HEALTH AGING, V15, P147, DOI 10.1007/s12603-011-0028-2	50	64	69	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63539	10.1371/journal.pone.0063539	http://dx.doi.org/10.1371/journal.pone.0063539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658838	Green Published, gold			2022-12-27	WOS:000321200500075
J	Ghali, B; Anantha, NT; Chan, J; Chau, T				Ghali, Bassma; Anantha, Nayanashri Thalanki; Chan, Jennifer; Chau, Tom			Variability of Grip Kinetics during Adult Signature Writing	PLOS ONE			English	Article							PENCIL GRASP; FORCE; VERIFICATION; LEGIBILITY; KINEMATICS; TASK	Grip kinetics and their variation are emerging as important considerations in the clinical assessment of handwriting pathologies, fine motor rehabilitation, biometrics, forensics and ergonomic pen design. This study evaluated the intra- and inter-participant variability of grip shape kinetics in adults during signature writing. Twenty (20) adult participants wrote on a digitizing tablet using an instrumented pen that measured the forces exerted on its barrel. Signature samples were collected over 10 days, 3 times a day, to capture temporal variations in grip shape kinetics. A kinetic topography (i.e., grip shape image) was derived per signature by time-averaging the measured force at each of 32 locations around the pen barrel. The normalized cross correlations (NCC) of grip shape images were calculated within- and between-participants. Several classification algorithms were implemented to gauge the error rate of participant discrimination based on grip shape kinetics. Four different grip shapes emerged and several participants made grip adjustments (change in grip shape or grip height) or rotated the pen during writing. Nonetheless, intra-participant variation in grip kinetics was generally much smaller than inter-participant force variations. Using the entire grip shape images as a 32-dimensional input feature vector, a K-nearest neighbor classifier achieved an error rate of 1.2 +/- 0.4% in discriminating among participants. These results indicate that writers had unique grip shape kinetics that were repeatable over time but distinct from those of other participants. The topographic analysis of grip kinetics may inform the development of personalized interventions or customizable grips in clinical and industrial applications, respectively.	[Ghali, Bassma; Anantha, Nayanashri Thalanki; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Ghali, Bassma; Anantha, Nayanashri Thalanki; Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Chan, Jennifer] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; University of Toronto; University of Toronto	Chau, T (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.	tom.chau@utoronto.ca	Chau, Tom TK/C-8426-2009	Chau, Tom TK/0000-0002-7486-0316	Natural Sciences and Engineering Research Council of Canada [CRDPJ 391549]; Syngrafii Inc.; Canada Research Chairs program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Syngrafii Inc.; Canada Research Chairs program(Canada Research Chairs)	This work was financially supported by the Natural Sciences and Engineering Research Council of Canada (Grant number: CRDPJ 391549) (http://www.nserc-crsng.gc.ca/Index_eng.asp), Syngrafii Inc., and the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo R. S. A., 2006, 10 INT WORKSH FRONT; Baur B, 2009, ARCH PHYS MED REHAB, V90, P867, DOI 10.1016/j.apmr.2008.10.015; Baur B, 2009, J HAND THER, V22, P163, DOI 10.1016/j.jht.2008.11.001; BERGMANN KP, 1990, AM J OCCUP THER, V44, P736, DOI 10.5014/ajot.44.8.736; Bulacu M, 2007, THESIS U GRONINGEN N; Burton AW, 2000, AM J OCCUP THER, V54, P9, DOI 10.5014/ajot.54.1.9; Chau T, 2006, ARCH PHYS MED REHAB, V87, P1542, DOI 10.1016/j.apmr.2006.08.328; Dennis JL, 2001, AM J OCCUP THER, V55, P175, DOI 10.5014/ajot.55.2.175; Duda R.O., 2006, PATTERN CLASSIFICATI; Falk TH, 2011, COMPUT METH PROG BIO, V104, pE102, DOI 10.1016/j.cmpb.2010.12.010; Falk TH, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002611; Fernandes DN, 2008, J BIOMECH, V41, P40, DOI 10.1016/j.jbiomech.2007.07.017; Franke K, 2009, LECT NOTES COMPUT SC, V5718, P150, DOI 10.1007/978-3-642-03521-0_14; Furukawa T, 2011, LECT NOTES COMPUT SC, V6540, P114, DOI 10.1007/978-3-642-19376-7_10; Greer T, 1998, CHILD DEV, V69, P888; Hepp-Reymond MC, 2009, BRAIN RES BULL, V79, P365, DOI 10.1016/j.brainresbull.2009.05.013; HERBST NM, 1977, IBM J RES DEV, V21, P245, DOI 10.1147/rd.213.0245; Hermsdorfer J, 2011, HUM MOVEMENT SCI, V30, P807, DOI 10.1016/j.humov.2010.04.004; HERRICK VE, 1961, J EXP EDUC, V30, P215, DOI 10.1080/00220973.1961.11010709; Hooke AW, 2008, J BIOMECH, V41, P2060, DOI 10.1016/j.jbiomech.2008.03.036; Impedovo D, 2008, IEEE T SYST MAN CY C, V38, P609, DOI 10.1109/TSMCC.2008.923866; Johnston JA, 2010, NEUROSCI LETT, V474, P104, DOI 10.1016/j.neulet.2010.03.017; Komi ER, 2007, P I MECH ENG C-J MEC, V221, P1687, DOI 10.1243/09544062JMES700; Komi ER, 2008, P I MECH ENG P-J SPO, V222, P23, DOI 10.1243/17543371JSET9; Kushki A, 2011, RES DEV DISABIL, V32, P1058, DOI 10.1016/j.ridd.2011.01.026; Latash ML, 2003, HUM MOVEMENT SCI, V22, P153, DOI 10.1016/S0167-9457(02)00157-4; Lee SJ, 2009, ERGONOMICS, V52, P601, DOI 10.1080/00140130802422481; Lei HS, 2005, PATTERN RECOGN LETT, V26, P2483, DOI 10.1016/j.patrec.2005.05.005; Poston B, 2010, J NEUROPHYSIOL, V104, P1141, DOI 10.1152/jn.00185.2010; Ramsay JO, 2000, J AM STAT ASSOC, V95, P9; Schmidt E., 2006, ENG SPORT, V6, P57; Schmidt RA, 2011, HUMAN KINETICS, V5th; Schneider AS, 2010, CLIN NEUROPHYSIOL, V121, P1898, DOI 10.1016/j.clinph.2010.04.023; Schwellnus H, 2012, AM J OCCUP THER, V66, P718, DOI 10.5014/ajot.2012.004515; Selin A, 2003, THESIS; Shang X., 2008, MILCOM 2008 IEEE MIL, P1, DOI [10.1109/MILCOM.2008.4753283, DOI 10.1109/MILCOM.2008.4753283]; Shang XX, 2008, LECT NOTES COMPUT SC, V5099, P289, DOI 10.1007/978-3-540-69905-7_33; Shang X, 2008, J ELECTRON IMAGING, V17, DOI 10.1117/1.2892675; Shim JK, 2010, J BIOMECH, V43, P2249, DOI 10.1016/j.jbiomech.2010.04.033; STELMACH GE, 1983, ACTA PSYCHOL, V54, P51, DOI 10.1016/0001-6918(83)90022-7; Stevens A, 2009, THESIS TEXAS WOMANS; Summers J., 2003, AUSTR OCCUPATIONAL T, V50, P148, DOI DOI 10.1046/J.1440-1630.2003.00310.X; Szabo F, 2000, LINEAR ALGEBRA INTRO; TEASDALE N, 1993, ACTA PSYCHOL, V82, P179, DOI 10.1016/0001-6918(93)90011-F; Tseng MH, 1998, OCCUP THER J RES, V18, P207, DOI 10.1177/153944929801800406; Udo H, 2000, IND HEALTH, V38, P47, DOI 10.2486/indhealth.38.47; van Drempt N, 2011, AUST OCCUP THER J, V58, P321, DOI 10.1111/j.1440-1630.2011.00960.x; Wu Z, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P4239, DOI 10.1109/IROS.2006.281951; Yanushkevich S.N., 2018, BIOMETRIC INVERSE PR	49	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63216	10.1371/journal.pone.0063216	http://dx.doi.org/10.1371/journal.pone.0063216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AF	23658812	Green Submitted, gold, Green Published			2022-12-27	WOS:000321200500062
J	Johnson, LR; Robinson, JD; Lester, KN; Pitcher, JA				Johnson, Laura R.; Robinson, James D.; Lester, Katrina N.; Pitcher, Julie A.			Distinct Structural Features of G Protein-Coupled Receptor Kinase 5 (GRK5) Regulate Its Nuclear Localization and DNA-Binding Ability	PLOS ONE			English	Article							EXPORT SIGNALS; DOMAIN; IDENTIFICATION; EXPRESSION; MEMBRANE; VARIANTS; SEQUENCE; ALPHA	G protein-coupled receptor kinases (GRKs) act to desensitize G protein-coupled receptors (GPCRs). In addition to this role at the plasma membrane, a nuclear function for GRK5, a member of the GRK4 subfamily of GRKs, has been reported. GRK5 phosphorylates and promotes the nuclear export of the histone deacetylase, HDAC5. Here we demonstrate that the possession of a nuclear localization sequence (NLS) is a common feature of GRK4 subfamily members (GRKs 4, 5 and 6). However, the location of the NLS and the ability of these GRKs to bind DNA in vitro are different. The NLSs of GRK5 and 6 bind DNA in vitro, whilst the NLS of GRK4 does not. Using mutants of GRK5 we identify the regions of GRK5 required for DNA-binding in vitro and nuclear localization in cells. The DNA-binding ability of GRK5 requires both the NLS and an N-terminal calmodulin (CaM)-binding site. A functional nuclear export sequence (NES), required for CaM-dependent nuclear export of the kinase, is also identified. Based on our observations we propose a model to explain how nuclear localization of GRK5 may be regulated. Notably, the nuclear localization of GRK5 and 6 is differentially regulated. These results suggest subfamily specific nuclear functions for the GRK4 subfamily members. Identification of GRK specific small molecule inhibitors of nuclear localization and/or function for the GRK4 subfamily may thus be an achievable goal.	[Pitcher, Julie A.] UCL, MRC, Mol Cell Biol Lab, London, England; UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London	Pitcher, JA (corresponding author), UCL, MRC, Mol Cell Biol Lab, London, England.	julie.pitcher@ucl.ac.uk	Pitcher, Julie/ABH-2078-2020		Wellcome Trust; MRC	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work was supported by The Wellcome Trust (JAP) and the MRC (LRJ, JDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Dorn GW, 2009, J MOL MED, V87, P455, DOI 10.1007/s00109-009-0450-7; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Greschik H, 1999, MOL CELL BIOL, V19, P690; Jiang XS, 2007, MOL BIOL CELL, V18, P2960, DOI 10.1091/mbc.E07-01-0013; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; KUNAPULI P, 1994, J BIOL CHEM, V269, P10209; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; LEE JW, 1992, MOL ENDOCRINOL, V6, P1867, DOI 10.1210/me.6.11.1867; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Moepps B, 1999, GENOMICS, V60, P199, DOI 10.1006/geno.1999.5901; Patial S, 2010, BIOCHEM J, V425, P169, DOI 10.1042/BJ20090908; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Perander M, 2001, J BIOL CHEM, V276, P13015, DOI 10.1074/jbc.M010356200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; Premont RT, 1996, J BIOL CHEM, V271, P6403, DOI 10.1074/jbc.271.11.6403; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sorriento D, 2010, HYPERTENSION, V56, P696, DOI 10.1161/HYPERTENSIONAHA.110.155960; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; Stedman DR, 2004, FEBS LETT, V566, P275, DOI 10.1016/j.febslet.2004.04.042	28	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62508	10.1371/journal.pone.0062508	http://dx.doi.org/10.1371/journal.pone.0062508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658733	Green Submitted, gold, Green Published			2022-12-27	WOS:000321200500026
J	Celay, J; Blanco, I; Lazcoz, P; Rotinen, M; Castresana, JS; Encio, I				Celay, Jon; Blanco, Idoia; Lazcoz, Paula; Rotinen, Mirja; Castresana, Javier S.; Enci, Ignacio			Changes in Gene Expression Profiling of Apoptotic Genes in Neuroblastoma Cell Lines upon Retinoic Acid Treatment	PLOS ONE			English	Article							NF-KAPPA-B; CHILDRENS ONCOLOGY GROUP; INDUCED DIFFERENTIATION; MYELOABLATIVE THERAPY; 13-CIS-RETINOIC ACID; NUCLEAR-FACTOR; ACTIVATION; PROTEIN; 9-CIS; INHIBITOR	To determine the effect of retinoic acid (RA) in neuroblastoma we treated RA sensitive neuroblastoma cell lines with 9-cis RA or ATRA for 9 days, or for 5 days followed by absence of RA for another 4 days. Both isomers induced apoptosis and reduced cell density as a result of cell differentiation and/or apoptosis. Flow cytometry revealed that 9-cis RA induced apoptosis more effectively than ATRA. The expression profile of apoptosis and survival pathways was cell line specific and depended on the isomer used.	[Celay, Jon; Blanco, Idoia; Lazcoz, Paula; Rotinen, Mirja; Enci, Ignacio] Univ Publ Navarra, Dept Hlth Sci, Pamplona, Spain; [Castresana, Javier S.] Univ Navarra, Brain Tumor Biol Unit, Sch Sci, E-31080 Pamplona, Spain	Universidad Publica de Navarra; University of Navarra	Encio, I (corresponding author), Univ Publ Navarra, Dept Hlth Sci, Pamplona, Spain.	ignacio.encio@unavarra.es	Celay, Jon/A-7296-2017; Castresana, Javier S/AFT-2167-2022	Celay, Jon/0000-0002-2017-4206; ROTINEN, MIRJA/0000-0002-0755-8360; Castresana, Javier S./0000-0002-2373-482X; Encio, Ignacio/0000-0003-1732-1989	Departmento de Salud, Gobierno de Navarra, Pamplona; Fondo de Investigacion Sanitaria, Madrid, Spain [PI08/1849]	Departmento de Salud, Gobierno de Navarra, Pamplona; Fondo de Investigacion Sanitaria, Madrid, Spain(Instituto de Salud Carlos III)	This work was supported by grants from the Departmento de Salud, Gobierno de Navarra, Pamplona, and from the Fondo de Investigacion Sanitaria (PI08/1849), Madrid, Spain. J.C. and M.R. were fellows from the Departamento de Educacion, and I.B. was a fellow from the Departamento de Industria, Gobierno de Navarra, Pamplona, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano T, 2011, NUCLEIC ACIDS RES, V39, P1993, DOI 10.1093/nar/gkq864; Begaud-Grimaud G, 2007, INT J ONCOL, V31, P883; Borriello A, 2002, HAEMATOLOGICA, V87, P196; Borysenko CW, 2006, J CELL PHYSIOL, V209, P1021, DOI 10.1002/jcp.20812; Brown KD, 2002, J BIOL CHEM, V277, P19433, DOI 10.1074/jbc.M111522200; BUNONE G, 1995, EXP CELL RES, V217, P92, DOI 10.1006/excr.1995.1067; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Dufner A, 2006, P NATL ACAD SCI USA, V103, P988, DOI 10.1073/pnas.0510380103; Fang YF, 2011, MOL CARCINOGEN, V50, P24, DOI 10.1002/mc.20687; Furusu A, 2007, J CELL PHYSIOL, V210, P703, DOI 10.1002/jcp.20881; Futami H, 2010, CANCER LETT, V297, P220, DOI 10.1016/j.canlet.2010.05.014; GAETANO C, 1991, PROG CLIN BIOL RES, V366, P165; Irving H, 1998, EUR J CANCER, V34, P111, DOI 10.1016/S0959-8049(97)10027-2; Kim GM, 2001, J NEUROSCI, V21, P6617, DOI 10.1523/JNEUROSCI.21-17-06617.2001; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lazcoz P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-254; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovat PE, 1997, EUR J CANCER, V33, P2075, DOI 10.1016/S0959-8049(97)00242-6; Lovat PE, 1997, J NEURO-ONCOL, V31, P85, DOI 10.1023/A:1005785431343; Lovat PE, 1997, JNCI-J NATL CANCER I, V89, P446, DOI 10.1093/jnci/89.6.446; MATSUMOTO M, 1989, ACTA NEUROPATHOL, V79, P217, DOI 10.1007/BF00294382; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Mercader J, 2007, CELL PHYSIOL BIOCHEM, V20, P1061, DOI 10.1159/000110717; Morriss-Kay GM, 1997, RETINOIDS THEIR PHYS, P79; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Oppenheimer O, 2007, MOL CANCER THER, V6, P1300, DOI 10.1158/1535-7163.MCT-06-0587; Park JR, 2009, PEDIATR BLOOD CANCER, V52, P44, DOI 10.1002/pbc.21784; PONZONI M, 1995, CANCER RES, V55, P853; REDFERN CPF, 1995, EUR J CANCER, V31A, P486, DOI 10.1016/0959-8049(95)00066-R; REDFERN CPF, 1997, RETINOIDS THEIR PHYS, P35; Ronca F, 1999, J BIOL CHEM, V274, P18128, DOI 10.1074/jbc.274.25.18128; Sarkanen JR, 2007, J NEUROCHEM, V102, P1941, DOI 10.1111/j.1471-4159.2007.04676.x; Stehlik C, 2003, J BIOL CHEM, V278, P31941, DOI 10.1074/jbc.M300009200; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042; Voigt A, 2003, MED PEDIATR ONCOL, V40, P205, DOI 10.1002/mpo.10250; Wajant H, 2002, APOPTOSIS, V7, P449, DOI 10.1023/A:1020039225764; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wen L, 2003, J BIOL CHEM, V278, P39251, DOI 10.1074/jbc.M305833200; Westermark UK, 2011, SEMIN CANCER BIOL, V21, P256, DOI 10.1016/j.semcancer.2011.08.001; Yeh PY, 2006, J BIOL CHEM, V281, P167, DOI 10.1074/jbc.M511014200	43	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62771	10.1371/journal.pone.0062771	http://dx.doi.org/10.1371/journal.pone.0062771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650528	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000073
J	He, BF; Wang, JC; Qian, GS; Hu, MD; Qu, XM; Wei, ZH; Li, J; Chen, Y; Chen, HP; Zhou, QQ; Wang, GS				He, Binfeng; Wang, Jianchun; Qian, Guisheng; Hu, Mingdong; Qu, Xinming; Wei, Zhenghua; Li, Jin; Chen, Yan; Chen, Huaping; Zhou, Qiquan; Wang, Guansong			Analysis of High-Altitude De-Acclimatization Syndrome after Exposure to High Altitudes: A Cluster-Randomized Controlled Trial	PLOS ONE			English	Article							INTERMITTENT HYPOXIA; SEA-LEVEL; HYPOBARIC HYPOXIA; PRE-ADAPTATION; HUMANS; INJURY; MECHANISM; BLOOD; ERYTHROPOIETIN; REPERFUSION	The syndrome of high-altitude de-acclimatization commonly takes place after long-term exposure to high altitudes upon return to low altitudes. The syndrome severely affects the returnee's quality of life. However, little attention has been paid to careful characterization of the syndrome and their underlying mechanisms. Male subjects from Chongqing (n = 67, 180 m) and Kunming (n = 70, 1800 m) visited a high-altitude area (3650 m) about 6 months and then returned to low-altitude. After they came back, all subjects were evaluated for high-altitude de-acclimatization syndrome on the 3rd, 50th, and 100th. Symptom scores, routine blood and blood gas tests, and myocardial zymograms assay were used for observation their syndrome. The results showed that the incidence and severity of symptoms had decreased markedly on the 50th and 100th days, compared with the 3rd day. The symptom scores and incidence of different symptoms were lower among subjects returning to Kunming than among those returning to Chongqing. On the 3rd day, RBC, Hb, Hct, CK, CK-MB, and LDH values were significantly lower than values recorded at high altitudes, but they were higher than baseline values. On the 50th day, these values were not different from baseline values, but LDH levels did not return to baseline until the 100th day. These data show that, subjects who suffered high-altitude de-acclimatization syndrome, the recovery fully processes takes a long time (>= 100th days). The appearance of the syndrome is found to be related to the changes in RBC, Hb, Hct, CK, CK-MB, and LDH levels, which should be caused by reoxygenation after hypoxia.	[He, Binfeng; Wang, Jianchun; Qian, Guisheng; Hu, Mingdong; Qu, Xinming; Wei, Zhenghua; Li, Jin; Chen, Yan; Chen, Huaping; Wang, Guansong] Third Mil Med Univ, Inst Resp Dis, Affiliated Hosp 2, Chongqing, Peoples R China; [Zhou, Qiquan] Third Mil Med Univ, Dept High Altitude Dis, Coll High Altitude Mil Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Wang, GS (corresponding author), Third Mil Med Univ, Inst Resp Dis, Affiliated Hosp 2, Chongqing, Peoples R China.	wanggs2003@hotmail.com	He, Binfeng/AAM-9190-2021	He, Binfeng/0000-0002-7243-1972	Ministry of Science and Technology of China [2009BAI85B03]; National Science Foundation of China (NSFC) [30971309, 81170066, 80070067]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China 2009BAI85B03 (to QZ and GW) and grants 30971309 and 81170066 from National Science Foundation of China (NSFC) (to GW) and 80070067 from NSFC (to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041584; Bao M, 2012, P NATL ACAD SCI USA, V109, P5898, DOI 10.1073/pnas.1113503109; Boning D, 1997, INT J SPORTS MED, V18, P179, DOI 10.1055/s-2007-972616; BUDERER MC, 1972, AM J PHYSIOL, V223, P346, DOI 10.1152/ajplegacy.1972.223.2.346; CAVALETTI G, 1993, ACTA NEUROL SCAND, V87, P103; Cui S. Z., 1998, MED J NATL DEFENDING, V8; DILL DB, 1969, J APPL PHYSIOL, V27, P514, DOI 10.1152/jappl.1969.27.4.514; Gao Y. Q., 2005, HIGH ALTITUDE MILITA, P237; Gunga HC, 1996, J APPL PHYSIOL, V81, P846, DOI 10.1152/jappl.1996.81.2.846; Hansen J, 2003, J PHYSIOL-LONDON, V546, P921, DOI 10.1113/jphysiol.2002.031765; Heinicke K, 2003, EUR J APPL PHYSIOL, V88, P535, DOI 10.1007/s00421-002-0732-z; Hornbein TF, 2001, J EXP BIOL, V204, P3129; Joanny P, 2001, RESUSCITATION, V49, P307, DOI 10.1016/S0300-9572(00)00373-7; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Katayama K, 2004, EUR J APPL PHYSIOL, V92, P75, DOI 10.1007/s00421-004-1054-0; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Neubauer JA, 2001, J APPL PHYSIOL, V90, P1593, DOI 10.1152/jappl.2001.90.4.1593; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; PACE N, 1956, J APPL PHYSIOL, V9, P141, DOI 10.1152/jappl.1956.9.2.141; Richalet JP, 2002, HIGH ALT MED BIOL, V3, P159, DOI 10.1089/15270290260131894; Risso A, 2007, BLOOD CELL MOL DIS, V38, P83, DOI 10.1016/j.bcmd.2006.10.161; Savourey G, 1996, EUR J APPL PHYSIOL, V73, P529, DOI 10.1007/BF00357675; Savourey G, 1998, EUR J APPL PHYSIOL O, V77, P37; SHI Y, 1991, CHINESE J APPL PHYSL, V7, P4; Shi Z., 2011, J PREVENTIVE MED CHI, V29, P114; Shi Zi-fu, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P395, DOI 10.3736/jcim20110408; SONG RF, 1994, J NANJING RAILWAY ME, V13, P207; Stice JP, 2011, ENDOCRINOLOGY, V152, P1589, DOI 10.1210/en.2010-0627; Svedenhag J, 1997, ACTA PHYSIOL SCAND, V161, P63, DOI 10.1046/j.1365-201X.1997.00204.x; Tagami M, 1998, LAB INVEST, V78, P1415; Terada LS, 1996, AM J PHYSIOL-HEART C, V270, pH945, DOI 10.1152/ajpheart.1996.270.3.H945; University of British Columbia, 2011, ACC DEACC REACC HYP, P16; Ward RO, 1908, J PHYSIOL-LONDON, V37, P378; ZHANG XZ, 1994, CHINESE J INTERNAL M, V33, P1; Zhang Y. B., 1996, PEOPLE HIGH ALTITUDE, P297; [周其全 Zhou Qiquan], 2012, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V37, P146; Zubieta-Calleja G, 2010, HUMAN ADAPTATION HIG, P38; 张华耀, 2012, [中国应用生理学杂志, Chinese Journal of Applied Physiology], V28, P94	39	10	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62072	10.1371/journal.pone.0062072	http://dx.doi.org/10.1371/journal.pone.0062072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650508	Green Submitted, gold, Green Published			2022-12-27	WOS:000319167000027
J	Zhou, JH; Manor, B; Liu, DD; Hu, K; Zhang, J; Fang, J				Zhou, Junhong; Manor, Brad; Liu, Dongdong; Hu, Kun; Zhang, Jue; Fang, Jing			The Complexity of Standing Postural Control in Older Adults: A Modified Detrended Fluctuation Analysis Based upon the Empirical Mode Decomposition Algorithm	PLOS ONE			English	Article							NONSTATIONARY TIME-SERIES; PHYSIOLOGICAL COMPLEXITY; CIRCADIAN-RHYTHM; DUAL-TASK; OPEN-LOOP; DYNAMICS; STABILITY; MAGNITUDE; BALANCE; SYSTEM	Human aging into senescence diminishes the capacity of the postural control system to adapt to the stressors of everyday life. Diminished adaptive capacity may be reflected by a loss of the fractal-like, multiscale complexity within the dynamics of standing postural sway (i.e., center-of-pressure, COP). We therefore studied the relationship between COP complexity and adaptive capacity in 22 older and 22 younger healthy adults. COP magnitude dynamics were assessed from raw data during quiet standing with eyes open and closed, and complexity was quantified with a new technique termed empirical mode decomposition embedded detrended fluctuation analysis (EMD-DFA). Adaptive capacity of the postural control system was assessed with the sharpened Romberg test. As compared to traditional DFA, EMD-DFA more accurately identified trends in COP data with intrinsic scales and produced short and long-term scaling exponents (i. e., alpha(Short), alpha(Long)) with greater reliability. The fractal-like properties of COP fluctuations were time-scale dependent and highly complex (i.e., alpha(Short) values were close to one) over relatively short time scales. As compared to younger adults, older adults demonstrated lower short-term COP complexity (i.e., greater alpha(Short) values) in both visual conditions (p>0.001). Closing the eyes decreased short-term COP complexity, yet this decrease was greater in older compared to younger adults (p<0.001). In older adults, those with higher short-term COP complexity exhibited better adaptive capacity as quantified by Romberg test performance (r(2) = 0.38, p<0.001). These results indicate that an age-related loss of COP complexity of magnitude series may reflect a clinically important reduction in postural control system functionality as a new biomarker.	[Zhou, Junhong; Manor, Brad; Zhang, Jue; Fang, Jing] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Manor, Brad] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA USA; [Liu, Dongdong; Zhang, Jue; Fang, Jing] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Hu, Kun] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep Med,Med Biodynam Program, Boston, MA 02115 USA; [Hu, Kun] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan	Peking University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Peking University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Central University	Zhang, J (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.	zhangjue@pku.edu.cn	Hu, Kun/AAJ-1897-2020; Hu, Kun/GVS-8580-2022; Zhang, Jue/N-7594-2013	Zhou, Junhong/0000-0002-7931-7646; Hu, Kun/0000-0003-0350-3132	National Institutes of Health [K99HL102241, R00HL102241]; National Science Council in Taiwan (ROC) [NSC 101-2911-I-008-001]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL102241, K99HL102241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council in Taiwan (ROC)(Ministry of Science and Technology, Taiwan); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Kun Hu (KH), one of the co-authors, is supported by National Institutes of Health Grants K99HL102241 and R00HL102241, and the grant from National Science Council in Taiwan (ROC) NSC 101-2911-I-008-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoud H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-12; APPLEGATE C, 1988, EXP BRAIN RES, V71, P183; Ashkenazy Y, 2003, PHYSICA A, V323, P19, DOI 10.1016/S0378-4371(03)00008-6; Ashkenazy Y, 2002, PHYSICA A, V316, P662, DOI 10.1016/S0378-4371(02)01453-X; Ashkenazy Y, 2001, PHYS REV LETT, V86, P1900, DOI 10.1103/PhysRevLett.86.1900; Blaszczyk JW, 2001, ACTA NEUROBIOL EXP, V61, P105; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Chen Z, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011104; COLLINS JJ, 1995, EXP BRAIN RES, V104, P480, DOI 10.1007/BF00231982; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; David E, 2002, NEUROBIOL AGING, V23, P1; Delignieres D, 2003, J MOTOR BEHAV, V35, P86, DOI 10.1080/00222890309602124; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Duarte M, 2008, EXP BRAIN RES, V191, P265, DOI 10.1007/s00221-008-1521-7; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; HAMALAINEN H, 1992, HUM MOVEMENT SCI, V11, P549, DOI 10.1016/0167-9457(92)90015-4; Hausdorff JM, 2001, PHYSICA A, V302, P138, DOI 10.1016/S0378-4371(01)00460-5; HAVLIN S, 1988, PHYS REV LETT, V61, P1438, DOI 10.1103/PhysRevLett.61.1438; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Horvatic D, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18007; Hu K, 2007, NEUROSCIENCE, V149, P508, DOI 10.1016/j.neuroscience.2007.03.058; Hu K, 2004, PHYSICA A, V337, P307, DOI 10.1016/j.physa.2004.01.042; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Hu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048927; Hu K, 2009, P NATL ACAD SCI USA, V106, P2490, DOI 10.1073/pnas.0806087106; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Ivanov PC, 1998, EUROPHYS LETT, V43, P363, DOI 10.1209/epl/i1998-00366-3; Ivanov PC, 2007, P NATL ACAD SCI USA, V104, P20702, DOI 10.1073/pnas.0709957104; Ivanov PC, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041920; Kang HG, 2010, J NEUROPHYSIOL, V104, P3510, DOI 10.1152/jn.00820.2009; Kang HG, 2009, J GERONTOL A-BIOL, V64, P1304, DOI 10.1093/gerona/glp113; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Lipsitz LA, 2004, SCI AGING KNOWLEDGE, V16, P16, DOI DOI 10.1126/SAGEKE.2004; Manor B, 2012, PROG NEUROPSYCHOPH; Manor B, 2013, PROG NEURO-PSYCHOPH, V45, P287, DOI 10.1016/j.pnpbp.2012.08.020; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; McChesney JW, 2000, J GERONTOL A-BIOL, V55, pM658, DOI 10.1093/gerona/55.11.M658; Mergner T, 2003, PROG BRAIN RES, V142, P189; Michikawa T, 2009, J ORTHOP SCI, V14, P675, DOI 10.1007/s00776-009-1371-6; Nelson-Wong E, 2012, EUR J APPL PHYSIOL, V112, P1379, DOI 10.1007/s00421-011-2094-x; Norris V, 2005, INT J PHARM MED, V19, P233, DOI 10.2165/00124363-200519040-00005; Peng CK, 2009, ADV DATA SCI ADAPT, V1, P61, DOI 10.1142/S1793536909000035; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Pittman-Polletta B, 2013, BIOL REV IN PRESS; Schmitt DT, 2007, AM J PHYSIOL-REG I, V293, pR1923, DOI 10.1152/ajpregu.00372.2007; Schmitt DT, 2009, IEEE T BIO-MED ENG, V56, P1564, DOI 10.1109/TBME.2009.2014819; SKINNER HB, 1984, CLIN ORTHOP RELAT R, P208; Thurner S, 2002, AUDIOL NEURO-OTOL, V7, P240, DOI 10.1159/000063740; Yeh JR, 2009, MED ENG PHYS, V31, P92, DOI 10.1016/j.medengphy.2008.04.011	54	25	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62585	10.1371/journal.pone.0062585	http://dx.doi.org/10.1371/journal.pone.0062585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650518	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000059
J	Mlisana, K; Sobieszczyk, M; Werner, L; Feinstein, A; van Loggerenberg, F; Naicker, N; Williamson, C; Garrett, N				Mlisana, Koleka; Sobieszczyk, Magdalena; Werner, Lise; Feinstein, Addi; van Loggerenberg, Francois; Naicker, Nivashnee; Williamson, Carolyn; Garrett, Nigel			Challenges of Diagnosing Acute HIV-1 Subtype C Infection in African Women: Performance of a Clinical Algorithm and the Need for Point-of-Care Nucleic-Acid Based Testing	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; COITAL-ACT; HIGH PREVALENCE; SOUTH-AFRICA; VIRAL LOAD; SET-POINT; FOLLOW-UP; HIGH-RISK; TRANSMISSION	Background: Prompt diagnosis of acute HIV infection (AHI) benefits the individual and provides opportunities for public health The aim of this study was to describe most common signs and symptoms of AHI, correlate these with early disease progression and develop a clinical algorithm to identify acute HIV cases in resource limited setting. Methods: 245 South African women at high-risk of HIV-1 were assessed for AHI and received monthly HIV-1 antibody and RNA testing. Signs and symptoms at first HIV-positive visit were compared to HIV-negative visits. Logistic regression identified clinical predictors of AHI. A model-based score was assigned to each predictor to create a risk score for every woman. Results: Twenty-eight women seroconverted after a total of 390 person-years of follow-up with an HIV incidence of 7.2/100 person-years (95%CI 4.5-9.8). Fifty-seven percent reported >= 1 sign or symptom at the AHI visit. Factors predictive of AHI included age <25 years (OR = 3.2; 1.4-7.1), rash (OR = 6.1; 2.4-15.4), sore throat (OR = 2.7; 1.0-7.6), weight loss (OR = 4.4; 1.5-13.4), genital ulcers (OR = 8.0; 1.6-39.5) and vaginal discharge (OR = 5.4; 1.6-18.4). A risk score of 2 correctly predicted AHI in 50.0% of cases. The number of signs and symptoms correlated with higher HIV-1 RNA at diagnosis (r = 0.63; p<0.001). Conclusions: Accurate recognition of signs and symptoms of AHI is critical for early diagnosis of HIV infection. Our algorithm may assist in risk-stratifying individuals for AHI, especially in resource-limited settings where there is no routine testing for AHI. Independent validation of the algorithm on another cohort is needed to assess its utility further. Point-of-care antigen or viral load technology is required, however, to detect asymptomatic, antibody negative cases enabling early interventions and prevention of transmission.	[Mlisana, Koleka; Werner, Lise; van Loggerenberg, Francois; Naicker, Nivashnee; Williamson, Carolyn; Garrett, Nigel] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Mlisana, Koleka] Univ KwaZulu Natal, Dept Med Microbiol, Durban, South Africa; [Mlisana, Koleka] Natl Hlth Lab Serv, Durban, South Africa; [Sobieszczyk, Magdalena; Feinstein, Addi] Columbia Univ, New York, NY USA; [Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Williamson, Carolyn] Univ Cape Town, Div Med Virol, ZA-7925 Cape Town, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; Columbia University; University of Cape Town; University of Cape Town	Mlisana, K (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.	mlisanak@ukzn.ac.za	; Mlisana, Koleka/N-6204-2013	van Loggerenberg, Francois/0000-0001-5317-7983; , Carolyn/0000-0003-0125-1226; Mlisana, Koleka/0000-0002-8436-3268	National Institute of Allergy and Infectious Disease (NIAID); National Institutes of Health (NIH); US Department of Health and Human Services (DHHS) [AI51794]; National Research Foundation, South Africa [67385]; FOGARTY INTERNATIONAL CENTER [R24TW008863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services (DHHS); National Research Foundation, South Africa(National Research Foundation - South Africa); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CAPRISA is part of the Comprehensive International Program of Research on AIDS (CIPRA), which is funded by the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) and the US Department of Health and Human Services (DHHS) Grant #AI51794 and the National Research Foundation, South Africa, Grant # 67385. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, REP GLOB HIV AIDS EP; Bell SK, 2010, J INFECT DIS, V202, pS278, DOI 10.1086/655655; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Cohen T, 2011, LANCET, V378, P204, DOI 10.1016/S0140-6736(11)60896-9; FIDLER S., 2011, 6 INT AIDS SOC C HIV; Francois van Loggerenberg AAD, 2012, HIV PREVENTION HIGH; Ghosn J, 2010, J ANTIMICROB CHEMOTH, V65, P741, DOI 10.1093/jac/dkq035; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; HENRARD DR, 1995, J ACQ IMMUN DEF SYND, V9, P305; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Kaufmann GR, 1998, AIDS PATIENT CARE ST, V12, P759, DOI 10.1089/apc.1998.12.759; Kaufmann GR, 1999, J ACQ IMMUN DEF SYND, V22, P437; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Lavreys L, 2006, CLIN INFECT DIS, V42, P1333, DOI 10.1086/503258; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; Lavreys L, 2002, CLIN INFECT DIS, V35, P77, DOI 10.1086/340862; Lindback S, 2000, AIDS, V14, P2333, DOI 10.1097/00002030-200010200-00014; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Ndung'u T, 2006, VIROLOGY, V347, P247, DOI 10.1016/j.virol.2005.11.047; NIU MT, 1993, J INFECT DIS, V168, P1490, DOI 10.1093/infdis/168.6.1490; Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Serna-Bolea C, 2010, AIDS, V24, P603, DOI 10.1097/QAD.0b013e328335cda3; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; TINDALL B, 1988, ARCH INTERN MED, V148, P945, DOI 10.1001/archinte.148.4.945; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Vanhems P, 2000, J INFECT DIS, V182, P334, DOI 10.1086/315687; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2	43	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62928	10.1371/journal.pone.0062928	http://dx.doi.org/10.1371/journal.pone.0062928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646162	Green Published, gold			2022-12-27	WOS:000319077300116
J	Subhadra, S; Karthik, M; Raman, M				Subhadra, Subhra; Karthik, Mohanraj; Raman, Muthusamy			Development and Validation of Real-Time PCR for Rapid Detection of Mecistocirrus digitatus	PLOS ONE			English	Article							PARASITIC INFECTIONS; MULTIPLEX PCR; CATTLE; DIFFERENTIATION; NEMATODA; TRICHOSTRONGYLIDAE; PREVALENCE; ASSAY	Hematophagous activity of Mecistocirrus digitatus, which causes substantial blood and weight loss in large ruminants, is an emerging challenge due to the economic loss it brings to the livestock industry. Infected animals are treated with anthelmintic drugs, based on the identification of helminth species and the severity of infection; however, traditional methods such as microscopic identification and the counting of eggs for diagnosis and determination of level of infection are laborious, cumbersome and unreliable. To facilitate the detection of this parasite, a SYBR green-based real-time PCR was standardized and validated for the detection of M. digitatus infection in cattle and buffaloes. Oligonucleotides were designed to amplify partial Internal Transcribed Spacer (ITS)-1 sequence of M. digitatus. The specificity of the primers was confirmed by non-amplification of DNA extracted from other commonly occurring gastrointestinal nematodes in ruminants. Plasmids were ligated with partial ITS-1 sequence of M. digitatus, serially diluted (hundred fold) and used as standards in the real-time PCR assay. The quantification cycle (Cq) values were plotted against the standard DNA concentration to produce a standard curve. The assay was sensitive enough to detect one plasmid containing the M. digitatus DNA. Clinical application of this assay was validated by testing the DNA extracted from the faeces of naturally infected cattle (n = 40) and buffaloes (n = 25). The results were compared with our standard curve to calculate the quantity of M. digitatus in each faecal sample. The Cq value of the assay depicted a strong linear relationship with faecal DNA content, with a regression coefficient of 0.984 and efficiency of 99%. This assay has noteworthy advantages over the conventional methods of diagnosis because it is more specific, sensitive and reliable.	[Subhadra, Subhra; Karthik, Mohanraj; Raman, Muthusamy] Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Vet Parasitol, Madras, Tamil Nadu, India	Tamil Nadu Veterinary & Animal Sciences University	Raman, M (corresponding author), Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Vet Parasitol, Madras, Tamil Nadu, India.	raman@tanuvas.org.in	M., Raman/GPP-6589-2022; Muthusamy, Raman/GPS-8338-2022; Raman, Muthusamy/M-1002-2019	Muthusamy, Raman/0000-0002-6747-3799; Subhadra, Subhra/0000-0002-3388-9075; Mohanraj, Karthik/0000-0002-5817-0681	TANUVAS	TANUVAS	The work was supported by TANUVAS funding (http://www.tanuvas.tn.nic.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman M. S., 1991, Veterinary Medical Journal Giza, V39, P119; Bandyopadhyay S, 2010, TROP ANIM HEALTH PRO, V42, P1481, DOI 10.1007/s11250-010-9582-6; Baylis HA, 1923, REC INDIAN MUS, V25, P575; Bhalerao G. D., 1933, Agriculture and Live Stock in India, V3, P354; Bott NJ, 2009, INT J PARASITOL, V39, P1277, DOI 10.1016/j.ijpara.2009.03.002; Caldeira RL, 2003, MEM I OSWALDO CRUZ, V98, P1039, DOI 10.1590/S0074-02762003000800011; FERNANDO ST, 1965, J PARASITOL, V51, P149, DOI 10.2307/3276069; Gasser RB, 2000, INT J PARASITOL, V30, P509, DOI 10.1016/S0020-7519(00)00021-7; Gaur S. N. S., 1973, Philippine Journal of Veterinary Medicine, V12, P64; HOSTE H, 1993, INT J PARASITOL, V23, P1069, DOI 10.1016/0020-7519(93)90128-L; Ivashkin VM., 1947, DOKLADI AKAD NAUKSSR, V56, P1251; Jefferies R, 2009, VET PARASITOL, V166, P112, DOI 10.1016/j.vetpar.2009.07.042; Laha R, 2013, VET WORLD, V6, P109, DOI 10.5455/vetworld.2013.109-112; Learmount J, 2009, VET PARASITOL, V166, P268, DOI 10.1016/j.vetpar.2009.08.017; Marek M, 2005, HELMINTHOLOGIA, V42, P49; Mochizuki R, 2006, J VET MED SCI, V68, P345, DOI 10.1292/jvms.68.345; Raman M, 1996, INDIAN J ANIM SCI, V66, P1010; Roeber F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037327; Sambrook J., 2001, MOL CLONING LAB MANU; Soulsby EJL, 1986, HELMINTHS ARTHROPODS, V7; Sreedhar S, 2009, INDIAN J ANIM RES, V43, P230; STEVENSON LA, 1995, INT J PARASITOL, V25, P483, DOI 10.1016/0020-7519(94)00156-I; Van Aken D, 1998, VET PARASITOL, V74, P29, DOI 10.1016/S0304-4017(97)00142-8; VanAken D, 1997, VET PARASITOL, V69, P255, DOI 10.1016/S0304-4017(96)01132-6; von Samson-Himmestjerna G, 2002, INT J PARASITOL, V32, P1529, DOI 10.1016/S0020-7519(02)00163-7; Wadhwa A, 2011, VET WORLD, V4, P417, DOI 10.5455/vetworld.2011.417-419; WHITLOCK JH, 1960, DIAGNOSIS VET PARASI; Zarlenga DS, 1999, INT J PARASITOL, V29, P1859, DOI 10.1016/S0020-7519(99)00107-1; Zarlenga DS, 2001, VET PARASITOL, V97, P199, DOI 10.1016/S0304-4017(01)00410-1	29	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63019	10.1371/journal.pone.0063019	http://dx.doi.org/10.1371/journal.pone.0063019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646171	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300126
J	Zhang, Y; Wang, Y; Liu, Y; Wang, NP; Qi, YF; Du, J				Zhang, Yi; Wang, Ying; Liu, Yan; Wang, Nanping; Qi, Yongfen; Du, Jie			Kruppel-Like Factor 4 Transcriptionally Regulates TGF-beta 1 and Contributes to Cardiac Myofibroblast Differentiation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; GENE-EXPRESSION; FACTOR KLF4; ACTIVATION; FIBROSIS; HYPERTROPHY; FIBROBLASTS; KINASE; INFLAMMATION	Angiotensin II (Ang II) plays a major role in the pathogenesis of cardiac fibrosis in hypertension. It is known that Ang II induces TGF-beta 1 expression. How transcription mediates Ang II-induced TGF-beta 1 expression, as well as its contribution to cardiac fibrosis, is unknown. We studied the role of Kruppel-like family transcription factors in Ang II-induced myofibroblast formation. We found that among the Kruppel-like family members, Kruppel-like factor 4 (Klf4) was the highest expressed form in isolated cardiac fibroblasts after Ang II treatment. Klf4 increased expression of alpha-SMA and collagen, as well as increased myofibroblast formation. ChIP assays showed that Klf4 specifically bound to the TGF-b1 promoter. Deletion and mutagenesis analysis showed that the sites at -184 similar to-180 bp and -45 similar to-41 bp in the TGF-beta 1 promoter were responsible for Klf4 transactivation of the TGF-beta 1 promoter. Our studies demonstrate that Klf4 plays a pivotal role in Ang II-induced cardiac myofibroblast differentiation and collagen synthesis through transcriptional upregulation of TGF-beta 1.	[Zhang, Yi; Wang, Ying; Liu, Yan; Wang, Nanping; Qi, Yongfen; Du, Jie] Capital Med Univ, Beijing Anzhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ,Beijing Inst Heart Lung & Blood Vesse, Beijing, Peoples R China	Capital Medical University	Du, J (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ,Beijing Inst Heart Lung & Blood Vesse, Beijing, Peoples R China.	jdu@bcm.edu	Liu, Yan/S-6650-2017; Wang, Nanping/G-1818-2011; Liu, Yan/J-7597-2019	Liu, Yan/0000-0002-3961-9172; Liu, Yan/0000-0002-3961-9172; Wang, Ying/0000-0002-7852-386X; Wang, Nanping/0000-0002-8528-8132	Chinese Ministry of Science and Technology [2012CB945104, 2012CB517802]; National Natural Science Foundation of China [81230006, 31090363]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Chinese Ministry of Science and Technology (2012CB945104, 2012CB517802) and National Natural Science Foundation of China (81230006, 31090363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai WD, 2004, J BIOL CHEM, V279, P8684, DOI 10.1074/jbc.M308278200; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; CAULFIELD M, 1994, NEW ENGL J MED, V330, P1629, DOI 10.1056/NEJM199406093302301; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Feng WG, 2012, HYPERTENSION, V60, P1226, DOI 10.1161/HYPERTENSIONAHA.112.197871; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Force T, 1998, HYPERTENSION, V31, P152, DOI 10.1161/01.HYP.31.1.152; Haldar SM, 2007, J MOL CELL CARDIOL, V43, P1, DOI 10.1016/j.yjmcc.2007.04.005; Hamaguchi A, 1999, HYPERTENSION, V34, P126, DOI 10.1161/01.HYP.34.1.126; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; NAFTILAN AJ, 1990, MOL CELL BIOL, V10, P5536, DOI 10.1128/MCB.10.10.5536; NAFTILAN AJ, 1989, J CLIN INVEST, V83, P1419, DOI 10.1172/JCI114032; Qi GM, 2011, CARDIOVASC TOXICOL, V11, P157, DOI 10.1007/s12012-011-9109-z; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; TAUBMAN MB, 1989, J BIOL CHEM, V264, P526; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Wang NP, 2002, J BIOL CHEM, V277, P34176, DOI 10.1074/jbc.M203436200; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Yang M, 2012, ARTERIOSCL THROM VAS, V32, P1675, DOI 10.1161/ATVBAHA.112.248732; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Zhang LP, 2005, ARTERIOSCL THROM VAS, V25, P1148, DOI 10.1161/01.ATV.0000164624.00099.e7; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056	41	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63424	10.1371/journal.pone.0063424	http://dx.doi.org/10.1371/journal.pone.0063424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646205	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300164
J	Yoon, J; Kikuma, T; Maruyama, J; Kitamoto, K				Yoon, Jaewoo; Kikuma, Takashi; Maruyama, Jun-ichi; Kitamoto, Katsuhiko			Enhanced Production of Bovine Chymosin by Autophagy Deficiency in the Filamentous Fungus Aspergillus oryzae	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; HETEROLOGOUS PROTEINS; CALF CHYMOSIN; DISRUPTION; GENE; SECRETION; LEVEL; YEAST	Aspergillus oryzae has been utilized as a host for heterologous protein production because of its high protein secretory capacity and food-safety properties. However, A. oryzae often produces lower-than-expected yields of target heterologous proteins due to various underlying mechanisms, including degradation processes such as autophagy, which may be a significant bottleneck for protein production. In the present study, we examined the production of heterologous protein in several autophagy (Aoatg) gene disruptants of A. oryzae. We transformed A. oryzae gene disruptants of Aoatg1, Aoatg13, Aoatg4, Aoatg8, or Aoatg15, with a bovine chymosin (CHY) expression construct and found that the production levels of CHY increased up to three fold compared to the control strain. Notably, however, conidia formation by the Aoatg gene disruptants was significantly reduced. As large amounts of conidia are necessary for inoculating large-scale cultures, we also constructed Aoatg gene-conditional expression strains in which the promoter region of the Aoatg gene was replaced with the thiamine-controllable thiA promoter. Conidiation by the resultant transformants was clearly enhanced in the absence of thiamine, while autophagy remained repressed in the presence of thiamine. Moreover, these transformants displayed increased CHY productivity, which was comparable to that of the Aoatg gene disruptants. Consequently, we succeeded in the construction of A. oryzae strains capable of producing high levels of CHY due to defects in autophagy. Our finding suggests that the conditional regulation of autophagy is an effective method for increasing heterologous protein production in A. oryzae.	[Yoon, Jaewoo; Kikuma, Takashi; Maruyama, Jun-ichi; Kitamoto, Katsuhiko] Univ Tokyo, Dept Biotechnol, Tokyo, Japan	University of Tokyo	Kitamoto, K (corresponding author), Univ Tokyo, Dept Biotechnol, Tokyo, Japan.	akitamo@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Challenging Exploratory Research to K. Kitamoto from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; CHRISTENSEN T, 1988, BIO-TECHNOL, V6, P1419, DOI 10.1038/nbt1288-1419; Epple UD, 2001, J BACTERIOL, V183, P5942, DOI 10.1128/JB.183.20.5942-5955.2001; Epple UD, 2003, J BIOL CHEM, V278, P7810, DOI 10.1074/jbc.M209309200; Foltman B., 1970, METHOD ENZYMOL, V19, P421; Funakoshi T, 1997, GENE, V192, P207, DOI 10.1016/S0378-1119(97)00031-0; Higuchi Y, 2009, EUKARYOT CELL, V8, P37, DOI 10.1128/EC.00207-08; Idiris A, 2006, APPL MICROBIOL BIOT, V73, P404, DOI 10.1007/s00253-006-0489-0; Ito K, 2007, BIOCHEM BIOPH RES CO, V360, P407, DOI 10.1016/j.bbrc.2007.06.064; Jin FJ, 2007, APPL MICROBIOL BIOT, V76, P1059, DOI 10.1007/s00253-007-1088-4; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kario E, 2011, J BIOL CHEM, V286, P11479, DOI 10.1074/jbc.M110.177618; Kikuma T, 2006, EUKARYOT CELL, V5, P1328, DOI 10.1128/EC.00024-06; Kikuma T, 2011, FEMS MICROBIOL LETT, V316, P61, DOI 10.1111/j.1574-6968.2010.02192.x; Kimura S, 2011, BIOCHEM BIOPH RES CO, V406, P464, DOI 10.1016/j.bbrc.2011.02.075; Kimura S, 2010, FUNGAL GENET BIOL, V47, P1044, DOI 10.1016/j.fgb.2010.09.003; Kitamoto K, 2002, ADV APPL MICROBIOL, V51, P129, DOI 10.1016/S0065-2164(02)51004-2; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Maruyama JI, 2008, BIOTECHNOL LETT, V30, P1811, DOI 10.1007/s10529-008-9763-9; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Pollack JK, 2009, FUNGAL GENET BIOL, V46, P1, DOI 10.1016/j.fgb.2008.10.010; Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shoji JY, 2005, FEMS MICROBIOL LETT, V244, P41, DOI 10.1016/j.femsle.2005.01.014; Takahashi T, 2006, BIOSCI BIOTECH BIOCH, V70, P135, DOI 10.1271/bbb.70.135; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; TSUCHIYA K, 1994, BIOSCI BIOTECH BIOCH, V58, P895, DOI 10.1271/bbb.58.895; TSUCHIYA K, 1993, APPL MICROBIOL BIOT, V40, P327, DOI 10.1007/BF00170388; Tsuchiya K, 1992, APPL MICROBIOL BIOT, V39, P738; Yanagisawa S, 2013, FEMS MICROBIOL LETT, V338, P168, DOI 10.1111/1574-6968.12047; Yoon J, 2011, APPL MICROBIOL BIOT, V89, P747, DOI 10.1007/s00253-010-2937-0; Yoon J, 2010, APPL ENVIRON MICROB, V76, P5718, DOI 10.1128/AEM.03087-09; Yoon J, 2009, APPL MICROBIOL BIOT, V82, P691, DOI 10.1007/s00253-008-1815-5; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	37	25	28	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62512	10.1371/journal.pone.0062512	http://dx.doi.org/10.1371/journal.pone.0062512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658635	Green Published, gold, Green Submitted			2022-12-27	WOS:000321662800049
J	Bender, RJ; Mac Gabhann, F				Bender, R. Joseph; Mac Gabhann, Feilim			Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; RENAL-CELL CARCINOMA; PHASE-III TRIAL; NEOADJUVANT CHEMOTHERAPY; INDUCED ANGIOGENESIS; SIGNAL-TRANSDUCTION; TUMOR ANGIOGENESIS; RANDOMIZED-TRIAL; BEVACIZUMAB; LUNG	Triple negative breast cancers (TNBC) are difficult to treat due to a lack of targets and heterogeneity. Inhibition of angiogenesis is a promising therapeutic strategy, but has had limited effectiveness so far in breast cancer. To quantify heterogeneity in angiogenesis-related gene expression in breast cancer, we focused on two families - VEGFs and semaphorins - that compete for neuropilin co-receptors on endothelial cells. We compiled microarray data for over 2,600 patient tumor samples and analyzed the expression of VEGF-and semaphorin-related ligands and receptors. We used principal component analysis to identify patterns of gene expression, and clustering to group samples according to these patterns. We used available survival data to determine whether these clusters had prognostic as well as therapeutic relevance. TNBC was highly associated with dysregulation of VEGF- and semaphorin-related genes; in particular, it appeared that expression of both VEGF and semaphorin genes were altered in a pro-angiogenesis direction. A pattern of high VEGFA expression with low expression of secreted semaphorins was associated with 60% of triple-negative breast tumors. While all TNBC groups demonstrated poor prognosis, this signature also correlated with lower 5-year survival rates in non-TNBC samples. A second TNBC pattern, including high VEGFC expression, was also identified. These pro-angiogenesis signatures may identify cancers that are more susceptible to VEGF inhibition.	[Mac Gabhann, Feilim] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Mac Gabhann, F (corresponding author), Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21218 USA.	feilim@jhu.edu			Open Access Promotion Fund of the Johns Hopkins University Libraries	Open Access Promotion Fund of the Johns Hopkins University Libraries	Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Bertucci F, 2012, CURR MOL MED, V12, P96, DOI 10.2174/156652412798376134; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Catalano A, 2009, CANCER RES, V69, P1485, DOI 10.1158/0008-5472.CAN-08-3659; Creighton CJ, 2012, BREAST CANCER RES TR, V132, P993, DOI 10.1007/s10549-011-1595-y; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dhanabal M, 2005, CANCER BIOL THER, V4, P659, DOI 10.4161/cbt.4.6.1733; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Esselens C, 2010, J BIOL CHEM, V285, P2463, DOI 10.1074/jbc.M109.055129; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Finley SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-193; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gabrovska PN, 2011, GENE, V489, P63, DOI 10.1016/j.gene.2011.08.024; Gaur P, 2009, CLIN CANCER RES, V15, P6763, DOI 10.1158/1078-0432.CCR-09-1810; Ghanem RC, 2011, CURR EYE RES, V36, P989, DOI 10.3109/02713683.2011.593730; Gonzalez-Angulo AM, 2012, CLIN CANCER RES, V18, P1109, DOI 10.1158/1078-0432.CCR-11-2762; Graham K, 2010, BRIT J CANCER, V102, P1284, DOI 10.1038/sj.bjc.6605576; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iwamoto T, 2011, J NATL CANCER I, V103, P264, DOI 10.1093/jnci/djq524; Iwamoto T, 2011, BREAST CANCER RES TR, V125, P785, DOI 10.1007/s10549-010-1280-6; Jubb AM, 2012, J PATHOL, V226, P50, DOI 10.1002/path.2989; Jubb AM, 2011, CLIN CANCER RES, V17, P372, DOI 10.1158/1078-0432.CCR-10-1791; Jubb AM, 2012, HISTOPATHOLOGY; Karn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028403; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kigel B, 2011, BLOOD, V118, P4285, DOI 10.1182/blood-2011-03-341388; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kutschera S, 2011, ARTERIOSCL THROM VAS, V31, P151, DOI 10.1161/ATVBAHA.110.215871; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Linderholm BK, 2009, ANN ONCOL, V20, P1639, DOI 10.1093/annonc/mdp062; Liu HT, 2009, INT J SURG PATHOL, V17, P426, DOI 10.1177/1066896909337505; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mac Gabhann F, 2006, PLOS COMPUT BIOL, V2, P1649, DOI 10.1371/journal.pcbi.0020180; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Mohammed RAA, 2011, MODERN PATHOL, V24, P774, DOI 10.1038/modpathol.2011.4; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Neufeld G, 2011, COLD SPRING HARB PER; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Palaskas N, 2011, CANCER RES, V71, P5164, DOI 10.1158/0008-5472.CAN-10-4633; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Parker MW, 2010, BIOCHEMISTRY-US, V49, P4068, DOI 10.1021/bi100327r; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Rody A, 2007, CLIN CANCER RES, V13, P1115, DOI 10.1158/1078-0432.CCR-06-2433; Ryden L, 2010, BREAST CANCER RES TR, V120, P491, DOI 10.1007/s10549-010-0758-6; Sadanandam A, 2010, MICROVASC RES, V79, P1, DOI 10.1016/j.mvr.2009.10.005; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Staton CA, 2011, HISTOPATHOLOGY, V59, P274, DOI 10.1111/j.1365-2559.2011.03922.x; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Vredenburgh JJ, 2011, CLIN CANCER RES, V17, P4119, DOI 10.1158/1078-0432.CCR-11-0120; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	84	55	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61788	10.1371/journal.pone.0061788	http://dx.doi.org/10.1371/journal.pone.0061788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667446	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600015
J	Balderston, NL; Schultz, DH; Helmstetter, FJ				Balderston, Nicholas L.; Schultz, Doug H.; Helmstetter, Fred J.			The Effect of Threat on Novelty Evoked Amygdala Responses	PLOS ONE			English	Article							FEAR-RELEVANT STIMULI; FUNCTIONAL MRI; MASKED STIMULI; ELECTRODERMAL RESPONSES; PHOBIC INDIVIDUALS; NEURAL MECHANISMS; EMOTIONAL STIMULI; HUMAN HIPPOCAMPAL; BRAIN ACTIVATION; RHESUS-MONKEYS	A number of recent papers have suggested that the amygdala plays a role in the brain's novelty detection circuit. In a recent study, we showed that this role may be specific to certain classes of biologically-relevant stimuli, such as human faces. The purpose of the present experiment was to determine whether other biologically-relevant stimuli also evoke novelty specific amygdala responses. To test this idea, we presented novel and repeated images of snakes and flowers while measuring BOLD. Surprisingly, we found that novel images of snakes and flowers evoke more amygdala activity than repeated images of snakes and flowers. Our results further confirm the robustness of the novelty evoked amygdala responses, even when compared with effects more traditionally associated with the amygdala. In addition, our results suggest that threatening stimuli may prime the amygdala to respond to other types of stimuli as well.	[Balderston, Nicholas L.; Schultz, Doug H.; Helmstetter, Fred J.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Helmstetter, Fred J.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Milwaukee; Medical College of Wisconsin	Helmstetter, FJ (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	fjh@uwm.edu	Schultz, Douglas/AAB-2365-2020; Balderston, Nicholas/U-9126-2019	Schultz, Douglas/0000-0003-0809-9036; Balderston, Nicholas/0000-0002-8565-1544; Helmstetter, Fred/0000-0003-3413-2418	National Institute of Mental Health [MH060668, MH069558]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069558, R01MH060668] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institute of Mental Health, grants MH060668 and MH069558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderston NL, 2011, NEUROIMAGE, V55, P1889, DOI 10.1016/j.neuroimage.2011.01.034; Balderston NL, 2010, BEHAV NEUROSCI, V124, P478, DOI 10.1037/a0019927; Blackford JU, 2010, NEUROIMAGE, V50, P1188, DOI 10.1016/j.neuroimage.2009.12.083; Carlsson K, 2004, EMOTION, V4, P340, DOI 10.1037/1528-3542.4.4.340; Cheng DT, 2007, LEARN MEMORY, V14, P485, DOI 10.1101/lm.632007; Cheng DT, 2006, BEHAV NEUROSCI, V120, P1187, DOI 10.1037/0735-7044.120.5.1187; Cheng DT, 2003, BEHAV NEUROSCI, V117, P3, DOI 10.1037/0735-7044.117.1.3; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21773, DOI 10.1073/pnas.1010079108; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Demos KE, 2008, CEREB CORTEX, V18, P2729, DOI 10.1093/cercor/bhn034; Dilger S, 2003, NEUROSCI LETT, V348, P29, DOI 10.1016/S0304-3940(03)00647-5; Fanselow M.S., 1988, P185; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FREDRIKSON M, 1976, BIOL PSYCHOL, V4, P305, DOI 10.1016/0301-0511(76)90021-1; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Glascher J, 2007, J NEUROSCI, V27, P4366, DOI 10.1523/JNEUROSCI.3310-06.2007; Grunwald T, 1998, P NATL ACAD SCI USA, V95, P3193, DOI 10.1073/pnas.95.6.3193; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; HUGDAHL K, 1977, J EXP PSYCHOL-HUM L, V3, P608, DOI 10.1037/0278-7393.3.5.608; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; Jeneson A, 2010, LEARN MEMORY, V17, P852, DOI 10.1101/lm.1546110; Kalin NH, 2001, J NEUROSCI, V21, P2067, DOI 10.1523/JNEUROSCI.21-06-02067.2001; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kirwan CB, 2008, J NEUROSCI, V28, P10541, DOI 10.1523/JNEUROSCI.3456-08.2008; Knight DC, 2004, COGN AFFECT BEHAV NE, V4, P317, DOI 10.3758/CABN.4.3.317; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; Knight DC, 1999, NEUROREPORT, V10, P3665, DOI 10.1097/00001756-199911260-00037; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Lang P. J., 2005, INT AFFECTIVE PICTUR; Larson CL, 2006, BIOL PSYCHIAT, V60, P410, DOI 10.1016/j.biopsych.2006.03.079; Lever C, 2010, HIPPOCAMPUS, V20, P229, DOI 10.1002/hipo.20671; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Menon V, 2000, HUM BRAIN MAPP, V11, P117, DOI 10.1002/1097-0193(200010)11:2<117::AID-HBM50>3.0.CO;2-M; Michalowski JM, 2009, EMOTION, V9, P306, DOI 10.1037/a0015550; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Nyberg L, 2005, CURR OPIN NEUROL, V18, P424, DOI 10.1097/01.wco.0000168080.99730.1c; Ohman A, 1998, J EXP PSYCHOL GEN, V127, P69, DOI 10.1037/0096-3445.127.1.69; OHMAN A, 1993, J ABNORM PSYCHOL, V102, P121; OHMAN A, 1994, J ABNORM PSYCHOL, V103, P231, DOI 10.1037/0021-843X.103.2.231; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Poppenk J, 2010, J NEUROSCI, V30, P4707, DOI 10.1523/JNEUROSCI.5466-09.2010; Rutishauser U, 2006, NEURON, V49, P805, DOI 10.1016/j.neuron.2006.02.015; Rutishauser U, 2008, P NATL ACAD SCI USA, V105, P329, DOI 10.1073/pnas.0706015105; Sabatinelli D, 2009, J NEUROSCI, V29, P14864, DOI 10.1523/JNEUROSCI.3278-09.2009; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schultz DH, 2010, J EXP PSYCHOL-ANIM B, V36, P495, DOI 10.1037/a0020263; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Soares SC, 2009, BEHAV RES THER, V47, P1032, DOI 10.1016/j.brat.2009.07.022; Strange BA, 2001, HIPPOCAMPUS, V11, P690, DOI 10.1002/hipo.1084; Straube T, 2007, NEUROIMAGE, V37, P1427, DOI 10.1016/j.neuroimage.2007.06.023; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Ward R, 2005, CURR BIOL, V15, P571, DOI 10.1016/j.cub.2005.01.056; Weierich MR, 2010, NEUROIMAGE, V49, P2871, DOI 10.1016/j.neuroimage.2009.09.047; Whalen PJ, 1998, J NEUROSCI, V18, P411; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Wright CI, 2006, NEUROBIOL AGING, V27, P361, DOI 10.1016/j.neurobiolaging.2005.01.014; Wright CI, 2003, NEUROIMAGE, V18, P660, DOI 10.1016/S1053-8119(02)00037-X; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004	68	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63220	10.1371/journal.pone.0063220	http://dx.doi.org/10.1371/journal.pone.0063220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658813	Green Published, gold			2022-12-27	WOS:000321202100057
J	Huen, K; Harley, K; Beckman, K; Eskenazi, B; Holland, N				Huen, Karen; Harley, Kim; Beckman, Kenneth; Eskenazi, Brenda; Holland, Nina			Associations of PON1 and Genetic Ancestry with Obesity in Early Childhood	PLOS ONE			English	Article							SYSTEMIC OXIDATIVE STRESS; BODY-MASS INDEX; POPULATION-STRUCTURE; PARAOXONASE-1 GENE; ENZYME-ACTIVITY; STATUS REQUIRES; BREAST-CANCER; US CHILDREN; RISK-FACTOR; POLYMORPHISMS	Obesity in children has become an epidemic in the U. S. and is particularly prominent in minority populations such as Mexican-Americans. In addition to physical activity and diet, genetics also plays a role in obesity etiology. A few studies in adults and adolescents suggest a link between obesity and paraoxonase 1 (PON1), a multifunctional enzyme that can metabolize organophosphate pesticides and also has antioxidant properties. We determined PON1(192) genotype and arylesterase levels (ARYase, measure of PON1 enzyme quantity), to characterize the relationship between PON1 and obesity in young Mexican-American children (n = 373) living in an agricultural community in California. Since PON1 polymorphisms and obesity both vary between ethnic groups, we estimated proportional genetic ancestry using 106 ancestral informative markers (AIMs). Among children, PON1(192) allele frequencies were 0.5 for both alleles, and the prevalence of obesity was high (15% and 33% at ages two and five, respectively). The average proportion of European, African, and Native American ancestry was 0.40, 0.09, and 0.51, yet there was wide inter-individual variation. We found a significantly higher odds of obesity (9.3 and 2.5-fold) in PON1(192QQ) children compared to PON1(192RR) children at ages two and five, respectively. Similar relationships were seen with BMI Z-scores at age two and waist circumference at age five. After adjusting for genetic ancestry in models of PON1 and BMI Z-score, effect estimates for PON1(192) genotype changed 15% and 9% among two and five year old children, respectively, providing evidence of genetic confounding by population stratification. However even after adjustment for genetic ancestry, the trend of increased BMI Z-scores with increased number of PON1(192) Q alleles remained. Our findings suggest that PON1 may play a role in obesity independent of genetic ancestry and that studies of PON1 and health outcomes, especially in admixed populations, should account for differences due to population stratification.	[Huen, Karen; Harley, Kim; Eskenazi, Brenda; Holland, Nina] Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth, Berkeley, CA 94720 USA; [Beckman, Kenneth] Univ Minnesota, Inst Hlth Informat, Biomed Genom Ctr, Minneapolis, MN USA	University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities	Huen, K (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth, Berkeley, CA 94720 USA.	khuen@berkeley.edu		Huen, Karen/0000-0003-3604-2096	U.S. Environmental Protection Agency (EPA) [R826886, R82670901]; National Institute of Environmental Health Science (NIEHS) [R01ESO12503-03, PO1 ES009605]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009605] Funding Source: NIH RePORTER	U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible by grant numbers R826886 and R82670901 from the U.S. Environmental Protection Agency (EPA) and R01ESO12503-03 and PO1 ES009605 from the National Institute of Environmental Health Science (NIEHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036830; Aviram M, 2005, HANDB EXP PHARM, V170, P263; Bajnok L, 2008, ATHEROSCLEROSIS, V197, P363, DOI 10.1016/j.atherosclerosis.2007.06.001; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Bouchard C, 2009, AM J CLIN NUTR, V89, pS1494, DOI 10.3945/ajcn.2009.27113C; Brophy VH, 2000, PHARMACOGENETICS, V10, P453, DOI 10.1097/00008571-200007000-00008; Bueno AC, 2010, EUR J ENDOCRINOL, V162, P53, DOI 10.1530/EJE-09-0697; Chen J, 2003, ENVIRON HEALTH PERSP, V111, P1403, DOI 10.1289/ehp.6105; Choudhry S, 2008, HUM GENET, V123, P455, DOI 10.1007/s00439-008-0495-7; Connelly PW, 2008, J LIPID RES, V49, P245, DOI 10.1194/jlr.D700022-JLR200; Cossrow N, 2004, J CLIN ENDOCR METAB, V89, P2590, DOI 10.1210/jc.2004-0339; Eskenazi B., 2003, J CHILD HLTH, V1, P3, DOI [DOI 10.3109/713610244, 10.3109/713610244]; Falush D, 2003, GENETICS, V164, P1567; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Fejerman L, 2010, CANCER EPIDEM BIOMAR, V19, P1074, DOI 10.1158/1055-9965.EPI-09-1193; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Ferretti G, 2005, J CLIN ENDOCR METAB, V90, P1728, DOI 10.1210/jc.2004-0486; Ferretti G, 2009, OBESITY SILVER SPRIN; Harley KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023923; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Holland N, 2006, ENVIRON HEALTH PERSP, V114, P985, DOI 10.1289/ehp.8540; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huen K, 2011, ENVIRON MOL MUTAGEN, V52, P105, DOI 10.1002/em.20567; Huen K, 2010, TOXICOL APPL PHARM, V244, P181, DOI 10.1016/j.taap.2009.12.031; Huen K, 2009, ENVIRON HEALTH PERSP, V117, P1632, DOI 10.1289/ehp.0900870; Huen K, 2009, CLIN CHIM ACTA, V402, P67, DOI 10.1016/j.cca.2008.12.019; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Kimm SYS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e54; Koncsos P, 2010, PEDIATR RES, V67, P309, DOI 10.1203/PDR.0b013e3181c9fb66; Kujiraoka T, 2000, J LIPID RES, V41, P1358; Lai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7; Lee YL, 2010, J GENET, V89, P417, DOI 10.1007/s12041-010-0060-8; Li HL, 2003, J MOL MED, V81, P766, DOI 10.1007/s00109-003-0481-4; Lighthall D, 2001, WESTERN J MED, V175, P223, DOI 10.1136/ewjm.175.4.223; Loos RJF, 2009, BRIT J CLIN PHARMACO, V68, P811, DOI 10.1111/j.1365-2125.2009.03523.x; Mackness MI, 2000, CURR OPIN LIPIDOL, V11, P383, DOI 10.1097/00041433-200008000-00007; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martinez-Salazar MF, 2011, GENES NUTR, V6, P361, DOI 10.1007/s12263-011-0215-0; National Center for Health Statistics, 2005, CDC GROWTH CHARTS; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Ogden Cynthia L, 2010, Natl Health Stat Report, P1; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Paragh G, 2009, NEPHRON CLIN PRACT, V113, pC46, DOI 10.1159/000228075; Pritchard JK, 2000, GENETICS, V155, P945; Rankinen T, 2006, MED SCI SPORT EXER, V38, P1863, DOI 10.1249/01.mss.0000233789.01164.4f; Rankinen T, 2010, OBESITY, V18, P322, DOI 10.1038/oby.2009.205; Richter RJ, 2010, ADV EXP MED BIOL, V660, P29, DOI 10.1007/978-1-60761-350-3_4; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/01213011-199912000-00009; Rojas-Garcia AE, 2005, TOXICOL APPL PHARM, V205, P282, DOI 10.1016/j.taap.2004.10.015; Rosas LG, 2011, J IMMIGR MINOR HEALT, V13, P169, DOI 10.1007/s10903-010-9332-x; Rosas LG, 2010, MATERN CHILD HLTH J, V14, P886, DOI 10.1007/s10995-009-0534-6; Rothman K., 1998, MODERN EPIDEMIOLOGY; Seres I, 2010, ADV EXP MED BIOL, V660, P129, DOI 10.1007/978-1-60761-350-3_12; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; Sisson SB, 2009, INT J PEDIATR OBES, V4, P353, DOI 10.3109/17477160902934777; Tang H, 2006, HUM GENET, V119, P624, DOI 10.1007/s00439-006-0175-4; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; Vaught J, 2012, BIOPRESERV BIOBANK, V10, P76, DOI [10.1089/bio.2012.1024, 10.1089/bio.2012.1025]; Veiga L, 2011, EUR J ENDOCRINOL, V164, P213, DOI 10.1530/EJE-10-0825; Warner ML, 2006, OBESITY, V14, P1966, DOI 10.1038/oby.2006.230; Zhao JH, 2011, J OBES, V2011, DOI 10.1155/2011/845148; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758	65	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62565	10.1371/journal.pone.0062565	http://dx.doi.org/10.1371/journal.pone.0062565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658746	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100019
J	Maestrale, C; Di Guardo, G; Cancedda, MG; Marruchella, G; Masia, M; Sechi, S; Macciocu, S; Santucciu, C; Petruzzi, M; Ligios, C				Maestrale, Caterina; Di Guardo, Giovanni; Cancedda, Maria Giovanna; Marruchella, Giuseppe; Masia, Mariangela; Sechi, Stefania; Macciocu, Simonetta; Santucciu, Cinzia; Petruzzi, Mara; Ligios, Ciriaco			A Lympho-Follicular Microenvironment Is Required for Pathological Prion Protein Deposition in Chronically Inflamed Tissues from Scrapie-Affected Sheep	PLOS ONE			English	Article							PRPSC ACCUMULATION; CELL RECRUITMENT; EXPRESSION; ARTHRITIS; REPLICATION; FOLLICLES; GLANDS; BETA	In sheep scrapie, pathological prion protein (PrPSc) deposition occurs in the lymphoreticular and central nervous systems. We investigated PrPSc distribution in scrapie-affected sheep showing simultaneous evidence of chronic lymphofollicular, lymphoproliferative/non-lymphofollicular, and/or granulomatous inflammations in their mammary gland, lung, and ileum. To do this, PrPSc detection was carried out via immunohistochemistry and Western Blotting techniques, as well as through inflammatory cell immunophenotyping. Expression studies of gene coding for biological factors modulating the host's inflammatory response were also carried out. We demonstrated that ectopic PrPSc deposition occurs exclusively in the context of lymphofollicular inflammatory sites, inside newly formed and well-organized lymphoid follicles harboring follicular dendritic cells. On the contrary, no PrPSc deposition was detected in granulomas, even when they were closely located to newly formed lymphoid follicles. A significantly more consistent expression of lymphotoxin alpha and beta mRNA was detected in lymphofollicular inflammation compared to the other two types, with lymphotoxin alpha and beta signaling new lymphoid follicles' formation and, likely, the occurrence of ectopic PrPSc deposition inside them. Our findings suggest that, in sheep co-affected by scrapie and chronic inflammatory conditions, only newly formed lymphoid follicles provide a suitable micro-environment that supports the scrapie agent's replication in inflammatory sites, with an increased risk of prion shedding through body secretions/excretions.	[Maestrale, Caterina; Cancedda, Maria Giovanna; Masia, Mariangela; Macciocu, Simonetta; Santucciu, Cinzia; Petruzzi, Mara; Ligios, Ciriaco] Ist Zooprofilatt Sperimentale Sardegna, Dipartimento Sanita Anim, Sassari, Italy; [Di Guardo, Giovanni; Marruchella, Giuseppe] Univ Teramo, Fac Med Vet, Dipartimento Sci Biomediche Comparate, Teramo, Italy; [Sechi, Stefania] AGRIS, DIRPA, Res Unit Genet & Biotechnol, Olmedo, Italy	IZS Della Sardegna; University of Teramo	Ligios, C (corresponding author), Ist Zooprofilatt Sperimentale Sardegna, Dipartimento Sanita Anim, Sassari, Italy.	ciriaco.ligios@izs-sardegna.it	Santucciu, Cinzia/D-1229-2012	Santucciu, Cinzia/0000-0001-9699-3745	Italian Ministry of Health [IZS SA 04/09, IZS SA 05/09]; EMIDA ERA-NET Research Project	Italian Ministry of Health(Ministry of Health, Italy); EMIDA ERA-NET Research Project	This work was supported by IZS SA 04/09 and IZS SA 05/09 RC grants from the Italian Ministry of Health, as well as by an EMIDA ERA-NET 2011 Research Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Andreoletti O, 2002, J GEN VIROL, V83, P2607, DOI 10.1099/0022-1317-83-10-2607; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Armengol MP, 2003, J IMMUNOL, V170, P6320, DOI 10.4049/jimmunol.170.12.6320; Blacklaws BA, 2012, COMP IMMUNOL MICROB, V35, P259, DOI 10.1016/j.cimid.2011.12.003; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Cheville NF, 2006, INTRO VET PATHOLOGY, P61; Ghosh S, 2005, J IMMUNOL, V174, P2860, DOI 10.4049/jimmunol.174.5.2860; Gonzalez L, 2003, J GEN VIROL, V84, P1339, DOI 10.1099/vir.0.18800-0; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Hamir AN, 2006, VET PATHOL, V43, P367, DOI 10.1354/vp.43-3-367; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Heikenwalder M, 2008, IMMUNITY, V29, P998, DOI 10.1016/j.immuni.2008.10.014; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; Lacroux C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000238; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; Ligios C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000859; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; McCulloch L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002402; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Murakami J, 1999, HEPATOLOGY, V30, P143, DOI 10.1002/hep.510300107; O'Rourke KP, 2008, RHEUMATOL INT, V28, P979, DOI 10.1007/s00296-008-0574-z; Pammer J, 1998, AM J PATHOL, V153, P1353, DOI 10.1016/S0002-9440(10)65720-3; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Sorby R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006885; Thomzig A, 2007, PLOS PATHOG, V3, P659, DOI 10.1371/journal.ppat.0030066; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638	40	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62830	10.1371/journal.pone.0062830	http://dx.doi.org/10.1371/journal.pone.0062830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658779	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100043
J	Carlin, J; George, R; Reyes, TM				Carlin, JesseLea; George, Robert; Reyes, Teresa M.			Methyl Donor Supplementation Blocks the Adverse Effects of Maternal High Fat Diet on Offspring Physiology	PLOS ONE			English	Article							BODY-MASS INDEX; GESTATIONAL WEIGHT-GAIN; DNA HYPOMETHYLATION; CHILDBEARING AGE; GENE-EXPRESSION; JUNK-FOOD; PREGNANCY; RAT; OBESITY; DOPAMINE	Maternal consumption of a high fat diet during pregnancy increases the offspring risk for obesity. Using a mouse model, we have previously shown that maternal consumption of a high fat (60%) diet leads to global and gene specific decreases in DNA methylation in the brain of the offspring. The present experiments were designed to attempt to reverse this DNA hypomethylation through supplementation of the maternal diet with methyl donors, and to determine whether methyl donor supplementation could block or attenuate phenotypes associated with maternal consumption of a HF diet. Metabolic and behavioral (fat preference) outcomes were assessed in male and female adult offspring. Expression of the mu-opioid receptor and dopamine transporter mRNA, as well as global DNA methylation were measured in the brain. Supplementation of the maternal diet with methyl donors attenuated the development of some of the adverse effects seen in offspring from dams fed a high fat diet; including weight gain, increased fat preference (males), changes in CNS gene expression and global hypomethylation in the prefrontal cortex. Notable sex differences were observed. These findings identify the importance of balanced methylation status during pregnancy, particularly in the context of a maternal high fat diet, for optimal offspring outcome.	[Carlin, JesseLea; George, Robert; Reyes, Teresa M.] Univ Penn, Sch Med, Dept Pharmacol, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Reyes, TM (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	reyestm@mail.med.upenn.edu	Reyes, Teresa/GYI-8942-2022	Reyes, Teresa/0000-0003-3009-3749	National Institutes for Health [MH087978, MH091372]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087978, R21MH091372] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research supported by National Institutes for Health grants MH087978 (Reyes) and MH091372 (Reyes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Berrendero F, 2010, NEUROSCI BIOBEHAV RE; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Brawarsky P, 2005, INT J GYNECOL OBSTET, V91, P125, DOI 10.1016/j.ijgo.2005.08.008; Caudill MA, 2001, J AM COLL NUTR, V20, P129, DOI 10.1080/07315724.2001.10719024; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Chefer VI, 2009, EUR J NEUROSCI, V30, P272, DOI 10.1111/j.1460-9568.2009.06827.x; Chen XL, 2010, BIRTH DEFECTS RES A, V88, P575, DOI 10.1002/bdra.20670; Cropley JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009055; Davison JM, 2009, J BIOL CHEM, V284, P1982, DOI 10.1074/jbc.M807651200; Day CJ, 2012, APPETITE, V58, P679, DOI 10.1016/j.appet.2011.12.013; Engeham SF, 2010, BRIT J NUTR, V103, P996, DOI 10.1017/S0007114509992662; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Gago B, 2007, J COMP NEUROL, V502, P358, DOI 10.1002/cne.21327; Golshani Peyman, 2005, Thalamus & Related Systems, V3, P227, DOI 10.1017/S1472928807000222; Hoyo C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-46; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Ignar DM, 2011, J PHARMACOL EXP THER, V339, P24, DOI 10.1124/jpet.111.180943; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Klein G, 2009, NEUROSCI LETT, V457, P115, DOI 10.1016/j.neulet.2009.04.012; Lanfer A, 2011, INT J OBES LOND; Langsdorf EF, 2011, SYNAPSE, V65, P858, DOI 10.1002/syn.20913; Laraia BA, 2007, PUBLIC HEALTH NUTR, V10, P920, DOI 10.1017/S1368980007657991; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Leibowitz SF, 1998, ENDOCRINOLOGY, V139, P1771, DOI 10.1210/en.139.4.1771; Livy DJ, 2003, NEUROTOXICOL TERATOL, V25, P447, DOI 10.1016/S0892-0362(03)00030-8; Mena JD, 2011, J NEUROSCI, V31, P3249, DOI 10.1523/JNEUROSCI.2050-10.2011; Naef L, 2011, NEUROSCIENCE, V176, P225, DOI 10.1016/j.neuroscience.2010.12.037; Nathan PJ, 2011, J CLIN PHARM; Novikova SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001919; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Papaleo F, 2007, EUR J NEUROSCI, V25, P3398, DOI 10.1111/j.1460-9568.2007.05595.x; Rifas-Shiman SL, 2009, J AM DIET ASSOC, V109, P1004, DOI 10.1016/j.jada.2009.03.001; Rother E, 2012, ENDOCRINOLOGY, V153, P770, DOI 10.1210/en.2011-1589; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Stuebe AM, 2009, INT J OBESITY, V33, P743, DOI 10.1038/ijo.2009.101; Sullivan EL, 2011, NEUROENDOCRINOLOGY, V93, P1, DOI 10.1159/000322038; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Teegarden SL, 2009, NEUROSCIENCE, V162, P924, DOI 10.1016/j.neuroscience.2009.05.029; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wolff GL, 1988, FASEB J, V12; Yang QH, 2007, AM J CLIN NUTR, V85, P1409, DOI 10.1093/ajcn/85.5.1409; Zhang M, 2000, NEUROSCIENCE, V99, P267, DOI 10.1016/S0306-4522(00)00198-6	50	78	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63549	10.1371/journal.pone.0063549	http://dx.doi.org/10.1371/journal.pone.0063549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658839	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500076
J	Hellen, EH; Dana, SK; Zhurov, B; Volkov, E				Hellen, Edward H.; Dana, Syamal K.; Zhurov, Boris; Volkov, Evgeny			Electronic Implementation of a Repressilator with Quorum Sensing Feedback	PLOS ONE			English	Article							MODEL	We investigate the dynamics of a synthetic genetic repressilator with quorum sensing feedback. In a basic genetic ring oscillator network in which three genes inhibit each other in unidirectional manner, an additional quorum sensing feedback loop stimulates the activity of a chosen gene providing competition between inhibitory and stimulatory activities localized in that gene. Numerical simulations show several interesting dynamics, multi-stability of limit cycle with stable steady-state, multi-stability of different stable steady-states, limit cycle with period-doubling and reverse period-doubling, and infinite period bifurcation transitions for both increasing and decreasing strength of quorum sensing feedback. We design an electronic analog of the repressilator with quorum sensing feedback and reproduce, in experiment, the numerically predicted dynamical features of the system. Noise amplification near infinite period bifurcation is also observed. An important feature of the electronic design is the accessibility and control of the important system parameters.	[Hellen, Edward H.] Univ North Carolina Greensboro, Dept Phys & Astron, Greensboro, NC USA; [Dana, Syamal K.] CSIR Indian Inst Chem Biol, Kolkata, India; [Zhurov, Boris; Volkov, Evgeny] Lebedev Phys Inst, Dept Theoret Phys, Moscow, Russia	University of North Carolina; University of North Carolina Greensboro; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute	Hellen, EH (corresponding author), Univ North Carolina Greensboro, Dept Phys & Astron, Greensboro, NC USA.	ehhellen@uncg.edu	Zhurov, Boris/M-6965-2015; Hellen, Edward/AAN-7714-2021; Volkov, Evgeny I/K-9176-2015	Hellen, Edward/0000-0001-5060-7220; 	RFBR [12-02-00529]; CSIR Network project GENESIS	RFBR(Russian Foundation for Basic Research (RFBR)); CSIR Network project GENESIS	E.V. and B.Z. thank RFBR 12-02-00529 for partial support. S.K.D. acknowledges support by the CSIR Network project GENESIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alon U., 2006, INTRO SYSTEMS BIOL D; Bennett MR, 2007, BIOPHYS J, V92, P3501, DOI 10.1529/biophysj.106.095638; Buse O, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066206; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Goryachev AB, 2011, CHEM REV, V111, P238, DOI 10.1021/cr100286z; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hellen EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023286; Hellen EH, 2012, ARXIV12124470; Kobayashi Y, 2010, EUR PHYS J B, V76, P167, DOI 10.1140/epjb/e2010-00200-9; Kobayashi Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.060901; Koseska A, 2010, J THEOR BIOL, V263, P189, DOI 10.1016/j.jtbi.2009.11.007; Kuznetsov A, 2005, SIAM J APPL MATH, V65, P392, DOI 10.1137/S0036139903436029; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Liu CL, 2011, SCIENCE, V334, P238, DOI 10.1126/science.1209042; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Muller S, 2006, J MATH BIOL, V53, P905, DOI 10.1007/s00285-006-0035-9; Potapov I, 2012, CHAOS, V22, DOI 10.1063/1.4705085; Potapov I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031901; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; SMITH H, 1987, J MATH BIOL, V25, P169, DOI 10.1007/BF00276388; Strelkowa N, 2010, J R SOC INTERFACE, V7, P1071, DOI 10.1098/rsif.2009.0487; Tuttle LM, 2005, BIOPHYS J, V89, P3873, DOI 10.1529/biophysj.105.064204; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Ullner E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148103; Wagemakers A, 2006, CHAOS, V16, DOI 10.1063/1.2173048; WIESENFELD K, 1986, PHYS REV A, V33, P629, DOI 10.1103/PhysRevA.33.629; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	31	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62997	10.1371/journal.pone.0062997	http://dx.doi.org/10.1371/journal.pone.0062997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658793	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500050
J	Illingworth, CJR; Parts, L; Bergstrom, A; Liti, G; Mustonen, V				Illingworth, Christopher J. R.; Parts, Leopold; Bergstroem, Anders; Liti, Gianni; Mustonen, Ville			Inferring Genome-Wide Recombination Landscapes from Advanced Intercross Lines: Application to Yeast Crosses	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; SACCHAROMYCES-CEREVISIAE; COLLABORATIVE CROSS; GENETIC-ANALYSIS; POPULATION; HOTSPOTS; RATES; DISTRIBUTIONS; FREQUENCY; INFERENCE	Accurate estimates of recombination rates are of great importance for understanding evolution. In an experimental genetic cross, recombination breaks apart and rejoins genetic material, such that the genomes of the resulting isolates are comprised of distinct blocks of differing parental origin. We here describe a method exploiting this fact to infer genome-wide recombination profiles from sequenced isolates from an advanced intercross line (AIL). We verified the accuracy of the method against simulated data. Next, we sequenced 192 isolates from a twelve-generation cross between West African and North American yeast Saccharomyces cerevisiae strains and inferred the underlying recombination landscape at a fine genomic resolution (mean segregating site distance 0.22 kb). Comparison was made with landscapes inferred for a similar cross between four yeast strains, and with a previous single-generation, intra-strain cross (Mancera et al., Nature 2008). Moderate congruence was identified between landscapes (correlation 0.58-0.77 at 5 kb resolution), albeit with variance between mean genome-wide recombination rates. The multiple generations of mating undergone in the AILs gave more precise inference of recombination rates than could be achieved from a single-generation cross, in particular in identifying recombination cold-spots. The recombination landscapes we describe have particular utility; both AILs are part of a resource to study complex yeast traits (see e. g. Parts et al., Genome Res 2011). Our results will enable future applications of this resource to take better account of local linkage structure heterogeneities. Our method has general applicability to other crossing experiments, including a variety of experimental designs.	[Illingworth, Christopher J. R.; Parts, Leopold; Mustonen, Ville] Wellcome Trust Sanger Inst, Cambridge, England; [Parts, Leopold] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Bergstroem, Anders; Liti, Gianni] Univ Nice Sophia Antipolis, Inst Res Canc & Ageing Nice, F-06189 Nice, France	Wellcome Trust Sanger Institute; University of Toronto; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur	Mustonen, V (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	vm5@sanger.ac.uk	Mustonen, Ville/X-1599-2019; Liti, Gianni/I-9929-2014; Illingworth, Christopher/F-1715-2010; Mustonen, Ville/J-1155-2018	Mustonen, Ville/0000-0002-7270-1792; Mustonen, Ville/0000-0002-7270-1792; Bergstrom, Anders/0000-0002-4096-9268; Illingworth, Chris/0000-0002-0030-2784; Parts, Leopold/0000-0002-2618-670X; Liti, Gianni/0000-0002-2318-0775	Wellcome Trust [098051]; Canadian Institute for Advanced Research	Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	The authors would like to acknowledge the Wellcome Trust for support under grant reference 098051. LP was supported by a fellowship from the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA A, 1989, GENETICS, V123, P683; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Baake E, 2008, B MATH BIOL, V70, P603, DOI 10.1007/s11538-007-9270-5; Broman KW, 2012, G3-GENES GENOM GENET, V2, P199, DOI 10.1534/g3.111.001818; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Clark AG, 2003, AM J HUM GENET, V73, P285, DOI 10.1086/377138; Clark AG, 2010, ANNU REV GENOM HUM G, V11, P45, DOI 10.1146/annurev-genom-082908-150031; Comeron JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002905; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; DARVASI A, 1995, GENETICS, V141, P1199; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; HUBERT R, 1994, NAT GENET, V7, P420, DOI 10.1038/ng0794-420; Hudson RR, 2001, GENETICS, V159, P1805; Illingworth CJR, 2012, MOL BIOL EVOL, V29, P1187, DOI 10.1093/molbev/msr289; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulathinal RJ, 2008, P NATL ACAD SCI USA, V105, P10051, DOI 10.1073/pnas.0801848105; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Liu EY, 2010, BIOINFORMATICS, V26, pi199, DOI 10.1093/bioinformatics/btq187; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; McVean G, 2002, GENETICS, V160, P1231; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Philip VM, 2011, GENOME RES, V21, P1223, DOI 10.1101/gr.113886.110; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Smukowski CS, 2011, HEREDITY, V107, P496, DOI 10.1038/hdy.2011.44; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; Tsai IJ, 2010, P NATL ACAD SCI USA, V107, P7847, DOI 10.1073/pnas.0908774107; Wakeley J, 2005, COALESCENT THEORY IN; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; WU TC, 1995, GENETICS, V140, P55	38	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62266	10.1371/journal.pone.0062266	http://dx.doi.org/10.1371/journal.pone.0062266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658715	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000321200500020
J	Li, JJ; Zheng, YM; Yan, JX; Li, HJ; Wang, X; He, JZ; Ding, GW				Li, Junjian; Zheng, Yuanming; Yan, Junxia; Li, Hongjian; Wang, Xiang; He, Jizheng; Ding, Guangwei			Effects of Different Regeneration Scenarios and Fertilizer Treatments on Soil Microbial Ecology in Reclaimed Opencast Mining Areas on the Loess Plateau, China	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; ARBUSCULAR MYCORRHIZAL FUNGUS; SURFACE MINE RECLAMATION; ORGANIC-MATTER; SUCCESSION; FOREST; BIOMASS; CARBON; RHIZOSPHERE; POPULATIONS	The soil microbial community in reclaimed mining areas is fundamental to vegetative establishment. However, how this community responds to different regeneration scenarios and fertilizer treatments is poorly understood. This research evaluated plant and soil microbial communities from different regeneration scenarios and different fertilizer treatments. Regeneration scenarios significantly influenced soil bacterial, archaeal, and fungal rDNA abundance. The ratios of fungi to bacteria or archaea were increased with fertilizer application. The diversity of both plants and microbes was lowest in Lotus corniculatus grasslands. Regeneration scenario, fertilizer treatment, and their interaction influenced soil microbial richness, diversity and evenness indices. Labile carbon pool 2 was a significant factor affected plant and microbe communities in July, suggesting that plants and microbes may be competing for nutrients. The higher ratios of positive to negative association were found in soil bacteria and total microbe than in archaea and fungi. Stronger clustering of microbial communities from the same regeneration scenario indicated that the vegetative composition of regeneration site may have a greater influence on soil microbial communities than fertilizer treatment.	[Li, Junjian; Yan, Junxia; Li, Hongjian] Shanxi Univ, Inst Loess Plateau, Taiyuan, Shanxi, Peoples R China; [Li, Junjian; Zheng, Yuanming; He, Jizheng] Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Wang, Xiang] Biol Inst Shanxi, Taiyuan, Shanxi, Peoples R China; [Ding, Guangwei] Northern State Univ, Dept Chem, Aberdeen, SD USA	Shanxi University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Northern State University	He, JZ (corresponding author), Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.	jzhe@rcees.ac.cn	LI, junjian/HHC-3968-2022; He, Ji-Zheng/A-4488-2009	He, Ji-Zheng/0000-0002-9169-8058	Natural Science Foundation of China [41271530]; National Science and Technology Program [2012BAC10B04, 2008BAD95B04]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Program	This work was financially supported by the Natural Science Foundation of China (41271530) and the National Science and Technology Program (2012BAC10B04 and 2008BAD95B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashagrie Y, 2005, AGR ECOSYST ENVIRON, V106, P89, DOI 10.1016/j.agee.2004.07.015; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Baldrian P, 2008, SOIL BIOL BIOCHEM, V40, P2107, DOI 10.1016/j.soilbio.2008.02.019; Behera N, 2003, FOREST ECOL MANAG, V174, P1, DOI 10.1016/S0378-1127(02)00057-9; Bennett LT, 2008, SOIL BIOL BIOCHEM, V40, P1601, DOI 10.1016/j.soilbio.2008.01.008; [蔡晓布 Cai Xiaobu], 2002, [水土保持学报, Journal of soil and water conservation], V16, P12; Chen BD, 2007, ENVIRON POLLUT, V147, P374, DOI 10.1016/j.envpol.2006.04.027; Chen BD, 2008, J ENVIRON RADIOACTIV, V99, P801, DOI 10.1016/j.jenvrad.2007.10.007; Dimitriu PA, 2010, SOIL BIOL BIOCHEM, V42, P2289, DOI 10.1016/j.soilbio.2010.09.001; Edwards IP, 2006, MICROB ECOL, V52, P679, DOI 10.1007/s00248-006-9097-x; Eskelinen A, 2009, OECOLOGIA, V161, P113, DOI 10.1007/s00442-009-1362-5; Fang M, 2007, APPL SOIL ECOL, V37, P150, DOI 10.1016/j.apsoil.2007.06.001; Frey B, 2006, SOIL BIOL BIOCHEM, V38, P1745, DOI 10.1016/j.soilbio.2005.11.032; Ge Y, 2008, ISME J, V2, P254, DOI 10.1038/ismej.2008.2; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hu SJ, 1999, APPL SOIL ECOL, V13, P21, DOI 10.1016/S0929-1393(99)00015-3; Johnson MJ, 2003, GEODERMA, V114, P279, DOI 10.1016/S0016-7061(03)00045-4; Knelman JE, 2012, SOIL BIOL BIOCHEM, V46, P172, DOI 10.1016/j.soilbio.2011.12.001; Koide RT, 2002, PLANT SOIL, V244, P307, DOI 10.1023/A:1020204004844; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leybo AI, 2006, MICROBIOLOGY+, V75, P683, DOI 10.1134/S0026261706060105; [李凤民 Li Fengmin], 2003, [生态学报, Acta Ecologica Sinica], V23, P1901; Li Juan, 2008, Agricultural Sciences in China, V7, P336, DOI 10.1016/S1671-2927(08)60074-7; Li Juan, 2008, Zhiwu Shengtai Xuebao, V32, P891, DOI 10.3773/j.issn.1005-264x.2008.04.018; Li JJ, 2011, SOIL SCI, V176, P313, DOI 10.1097/SS.0b013e31821d6e7c; Liang B, 2011, BIOL FERT SOILS, V47, P121, DOI 10.1007/s00374-010-0511-7; Lipson DA, 1998, OECOLOGIA, V113, P406, DOI 10.1007/s004420050393; [龙健 Long Jian], 2003, [生态学报, Acta Ecologica Sinica], V23, P496; Lu R.K, 2000, METHODS SOIL AGROCHE, P127; Lukow T, 2000, FEMS MICROBIOL ECOL, V32, P241, DOI 10.1111/j.1574-6941.2000.tb00717.x; Machulla G, 2005, SOIL SCI SOC AM J, V69, P1069, DOI 10.2136/sssaj2004.0271; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; May LA, 2001, CAN J MICROBIOL, V47, P829, DOI 10.1139/cjm-47-9-829; McCrackin ML, 2008, BIOGEOCHEMISTRY, V87, P143, DOI 10.1007/s10533-007-9173-4; McMahon SK, 2011, SOIL BIOL BIOCHEM, V43, P287, DOI 10.1016/j.soilbio.2010.10.013; Menyailo OV, 2002, PLANT SOIL, V242, P183, DOI 10.1023/A:1016245619357; Mummey DL, 2002, SOIL BIOL BIOCHEM, V34, P1717, DOI 10.1016/S0038-0717(02)00158-X; Mummey DL, 2002, APPL SOIL ECOL, V21, P251, DOI 10.1016/S0929-1393(02)00090-2; Nemergut DR, 2007, MICROB ECOL, V53, P110, DOI 10.1007/s00248-006-9144-7; Rillig MC, 2002, SOIL BIOL BIOCHEM, V34, P1371, DOI 10.1016/S0038-0717(02)00060-3; Rovira P, 2002, GEODERMA, V107, P109, DOI 10.1016/S0016-7061(01)00143-4; Rumpel C, 2004, SOIL BIOL BIOCHEM, V36, P67, DOI 10.1016/j.soilbio.2003.08.020; Schellenberger S, 2010, ENVIRON MICROBIOL, V12, P845, DOI 10.1111/j.1462-2920.2009.02128.x; Shi FC, 2008, ACTA AGR SCAND B-S P, V58, P1, DOI 10.1080/09064710601065970; Singh BK, 2007, APPL SOIL ECOL, V36, P147, DOI 10.1016/j.apsoil.2007.01.004; Sourkova M, 2005, GEODERMA, V129, P73, DOI 10.1016/j.geoderma.2004.12.032; Susyan EA, 2011, EUR J SOIL BIOL, V47, P169, DOI 10.1016/j.ejsobi.2011.04.002; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tscherko D, 2005, BASIC APPL ECOL, V6, P367, DOI 10.1016/j.baae.2005.02.004; Wang B.S., 2000, CHIN J PLANT ECOL, V24, P332; Wang L, 2009, MINING SCI TECHNOLOG, V19, P479, DOI DOI 10.1016/S1674-5264(09)60089-2; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Xiu-ling Zhang, 2008, Journal of Ecology and Rural Environment, V24, P32; Zhang JT, 2010, ECOL ENG, V36, P345, DOI 10.1016/j.ecoleng.2009.04.001; Zhang JT, 2005, J ARID ENVIRON, V63, P458, DOI 10.1016/j.jaridenv.2005.03.027; Zhang QC, 2007, J ENVIRON SCI, V19, P55, DOI 10.1016/S1001-0742(07)60009-6	58	22	27	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63275	10.1371/journal.pone.0063275	http://dx.doi.org/10.1371/journal.pone.0063275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658819	gold, Green Published			2022-12-27	WOS:000321200500066
J	Fognani, E; Giannini, C; Piluso, A; Gragnani, L; Monti, M; Caini, P; Ranieri, J; Urraro, T; Triboli, E; Laffi, G; Zignego, AL				Fognani, Elisa; Giannini, Carlo; Piluso, Alessia; Gragnani, Laura; Monti, Monica; Caini, Patrizio; Ranieri, Jessica; Urraro, Teresa; Triboli, Elisa; Laffi, Giacomo; Zignego, Anna Linda			Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; HCV INFECTION; B-CELLS; EXPRESSION; LYMPHOMA; IDENTIFICATION; PATHOGENESIS; INTERFERON; MANAGEMENT; DIAGNOSIS	Hepatitis C virus infection is closely related to lymphoproliferative disorders (LPDs), including mixed cryoglobulinemia (MC) and some lymphomas. Modification of the expression of specific microRNAs (miRNAs) has been associated with different autoimmune diseases and/or LPDs. No data exist about the modifications in miRNA expression in HCV-associated LPDs. The aim of this study was to analyze the expression levels of a panel of miRNAs previously associated with autoimmune/LPDs in a large population of HCV patients with and without MC or non-Hodgkin's lymphoma (NHL), to identify potential markers of evolution of HCV infection. PBMC expression of miR-Let-7d, miR-16, miR-21, miR-26b, miR-146a and miR-155 was evaluated by real-time PCR in 167 HCV patients (75 with MC [MC-HCV], 11 with HCV-associated NHL [NHL-HCV], 81 without LPD [HCV]) and in 35 healthy subjects (HS). A significant increase in miR-21 (p<0.001), miR-16 (p<0.01) and miR-155 (p<0.01) expression was detected in PBMCs from only NHL patients whereas a significant decrease in miR-26b was detected in both MC and NHL subjects (p<0.01) when compared to HS and HCV groups. A restoration of miR-26b levels was observed in the post-treatment PBMCs of 35 HCV-MC patients experiencing complete virological and clinical response following antiviral therapy. This study, for the first time, shows that specific microRNAs in PBMC from HCV patients who developed MC and/or NHL are modulated differently. The specific, reversible downregulation of miR-26b strongly suggests the key role it plays in the pathogenesis of HCV-related LPDs and its usefulness as a biomarker of the evolution of HCV infection to these disorders.	[Fognani, Elisa; Giannini, Carlo; Piluso, Alessia; Gragnani, Laura; Monti, Monica; Caini, Patrizio; Ranieri, Jessica; Urraro, Teresa; Triboli, Elisa; Laffi, Giacomo; Zignego, Anna Linda] Univ Florence, Dept Expt & Clin Med, Ctr Syst Manifestat Hepatitis Viruses MASVE, Florence, Italy	University of Florence	Zignego, AL (corresponding author), Univ Florence, Dept Expt & Clin Med, Ctr Syst Manifestat Hepatitis Viruses MASVE, Florence, Italy.	a.zignego@dmi.unifi.it	Gragnani, Laura/H-7755-2019; GRAGNANI, LAURA/K-7751-2013; Zignego, Anna Linda/AAL-8205-2021	Gragnani, Laura/0000-0001-6800-9149; GRAGNANI, LAURA/0000-0001-6800-9149; Laffi, Giacomo/0000-0001-6916-1134	Associazione Italiana per la Ricerca sul Cancro (AIRC) Investigator Grant [1461]; Istituto Toscano Tumori (ITT); Fondazione Istituto di Ricerche Virologiche Oretta Bartolomei Corsi; Fondazione Cassa di Risparmio di Pistoia e Pescia; Ente Cassa di Risparmio di Firenze	Associazione Italiana per la Ricerca sul Cancro (AIRC) Investigator Grant(Fondazione AIRC per la ricerca sul cancro); Istituto Toscano Tumori (ITT); Fondazione Istituto di Ricerche Virologiche Oretta Bartolomei Corsi; Fondazione Cassa di Risparmio di Pistoia e Pescia; Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This work was supported by grants from the "Associazione Italiana per la Ricerca sul Cancro'' (AIRC) Investigator Grant # 1461, "Istituto Toscano Tumori'' (ITT), "Fondazione Istituto di Ricerche Virologiche Oretta Bartolomei Corsi'', "Fondazione Cassa di Risparmio di Pistoia e Pescia'' and "Ente Cassa di Risparmio di Firenze''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizos I, 2011, ARTHRITIS RHEUM-US, V63, P535, DOI 10.1002/art.30131; Andreone P, 1998, ANN INTERN MED, V129, P294, DOI 10.7326/0003-4819-129-4-199808150-00005; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bianchettin G, 2007, J VIROL, V81, P4564, DOI 10.1128/JVI.02104-06; Bouteloup M, 2012, BRIT J HAEMATOL, V156, P279, DOI 10.1111/j.1365-2141.2011.08848.x; Cheng CJ, 2012, CANCER J, V18, P232, DOI 10.1097/PPO.0b013e318258b75b; Craxi A, 2008, MOL ASPECTS MED, V29, P85, DOI 10.1016/j.mam.2007.09.017; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Cubedo E, 2012, BLOOD, V119, P5478, DOI 10.1182/blood-2012-01-403154; de Re V, 2007, ANN NY ACAD SCI, V1107, P308, DOI 10.1196/annals.1381.033; Di Lisio L, 2012, BLOOD, V120, P1782, DOI 10.1182/blood-2012-05-402784; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferri C, 1995, CLIN EXP RHEUMATOL, V13, pS135; FERRI C, 1994, J INTERN MED, V236, P31, DOI 10.1111/j.1365-2796.1994.tb01116.x; FERRI C, 1993, BLOOD, V82, P3701; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gragnani L, 2011, ARTHRITIS RHEUM-US, V63, P1446, DOI 10.1002/art.30274; Gramantieri L, 2008, J CELL MOL MED, V12, P2189, DOI 10.1111/j.1582-4934.2008.00533.x; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; HARRIS NL, 1994, BLOOD, V84, P1361; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; Hughes T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3484; Ito M, 2010, CLIN IMMUNOL, V135, P459, DOI 10.1016/j.clim.2010.02.002; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kawamura Y, 2007, AM J MED, V120, P1034, DOI 10.1016/j.amjmed.2007.06.022; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Knight GB, 2010, ARTHRITIS RHEUM-US, V62, P2152, DOI 10.1002/art.27490; Kotani A, 2010, INT J HEMATOL, V92, P255, DOI 10.1007/s12185-010-0633-6; Kumar A, 2011, BBA-GENE REGUL MECH, V1809, P694, DOI 10.1016/j.bbagrm.2011.07.010; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; Li S, 2012, MOL CELL BIOCHEM, V360, P147, DOI 10.1007/s11010-011-1052-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Nassirpour R, 2010, MOL CANCER RES, V8, P717, DOI 10.1158/1541-7786.MCR-09-0291; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Petrarca A, 2010, BLOOD, V116, P335, DOI 10.1182/blood-2009-11-253948; Peveling-Oberhag J, 2012, LEUKEMIA, V26, P1654, DOI 10.1038/leu.2012.29; Pietrogrande M, 2011, AUTOIMMUN REV, V10, P444, DOI 10.1016/j.autrev.2011.01.008; Piluso A, 2013, J VIRAL HEPATITIS, V20, pe107, DOI 10.1111/jvh.12017; Qi RQ, 2012, HEPATOLOGY, V55, P1640, DOI 10.1002/hep.25558; Sansonno D, 1998, J IMMUNOL, V160, P3594; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008; Zignego AL, 1996, ANN INTERN MED, V124, P31, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00006; Zignego AL, 1995, CLIN EXP RHEUMATOL, V13, pS33; ZIGNEGO AL, 1992, J HEPATOL, V15, P382, DOI 10.1016/0168-8278(92)90073-X; Zignego AL, 2000, HEPATOLOGY, V31, P474, DOI 10.1002/hep.510310230; Zignego AL, 2007, WORLD J GASTROENTERO, V13, P2467, DOI 10.3748/wjg.v13.i17.2467; Zignego AL, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980942	59	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62965	10.1371/journal.pone.0062965	http://dx.doi.org/10.1371/journal.pone.0062965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650540	gold, Green Published, Green Submitted			2022-12-27	WOS:000319167000085
J	Rohatgi, N; Aly, H; Marshall, CA; McDonald, WG; Kletzien, RF; Colca, JR; McDaniel, ML				Rohatgi, Nidhi; Aly, Haytham; Marshall, Connie A.; McDonald, William G.; Kletzien, Rolf F.; Colca, Jerry R.; McDaniel, Michael L.			Novel Insulin Sensitizer Modulates Nutrient Sensing Pathways and Maintains beta-Cell Phenotype in Human Islets	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL PYRUVATE CARRIER; TYPE-2 DIABETIC SUBJECTS; MAMMALIAN TARGET; IN-VITRO; RECEPTOR SUBSTRATE-2; SIGNALING PATHWAY; CYCLE PROGRESSION; DNA-SYNTHESIS; PPAR-GAMMA	Major bottlenecks in the expansion of human beta-cell mass are limited proliferation, loss of beta-cell phenotype, and increased apoptosis. In our previous studies, activation of Wnt and mTOR signaling significantly enhanced human beta-cell proliferation. However, isolated human islets displayed insulin signaling pathway resistance, due in part to chronic activation of mTOR/S6K1 signaling that results in negative feedback of the insulin signaling pathway and a loss of Akt phosphorylation and insulin content. We evaluated the effects of a new generation insulin sensitizer, MSDC-0160, on restoring insulin/IGF-1 sensitivity and insulin content in human beta-cells. This novel TZD has low affinity for binding and activation of PPARc and has insulin-sensitizing effects in mouse models of diabetes and ability to lower glucose in Phase 2 clinical trials. MSDC-0160 treatment of human islets increased AMPK activity and reduced mTOR activity. This was associated with the restoration of IGF-1-induced phosphorylation of Akt, GSK-3, and increased protein expression of Pdx1. Furthermore, MSDC-0160 in combination with IGF-1 and 8 mM glucose increased b-cell specific gene expression of insulin, pdx1, nkx6.1, and nkx2.2, and maintained insulin content without altering glucose-stimulated insulin secretion. Human islets were unable to simultaneously promote DNA synthesis and maintain the beta-cell phenotype. Lithium-induced GSK-3 inhibition that promotes DNA synthesis blocked the ability of MSDC-0160 to maintain the beta-cell phenotype. Conversely, MSDC-0160 prevented an increase in DNA synthesis by blocking beta-catenin nuclear translocation. Due to the counteracting pathways involved in these processes, we employed a sequential ex vivo strategy to first induce human islet DNA synthesis, followed by MSDC-0160 to promote the beta-cell phenotype and insulin content. This new generation PPARc sparing insulin sensitizer may provide an initial tool for relieving inherent human islet insulin signaling pathway resistance that is necessary to preserve the beta-cell phenotype during b-cell expansion for the treatment of diabetes.	[Rohatgi, Nidhi; Aly, Haytham; Marshall, Connie A.; McDaniel, Michael L.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA; [McDonald, William G.; Kletzien, Rolf F.; Colca, Jerry R.] Metab Solut Dev Co, Kalamazoo, MI USA	Washington University (WUSTL)	McDaniel, ML (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mmcdaniel@wustl.edu	Rohatgi, Nidhi/GWR-1096-2022		National Institutes of Health (NIH) [DK006181, NIH DK00618146S1, DK07296]; NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core [DK20579]; American Diabetes Association Grant [7-04-MN-32]; BarnesJewish Hospital Foundation [7401-00]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile Diabetes Research Foundation International (JDRFI) [JDRF-31-2008-382]; MSDC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK006181, P60DK020579, P30DK020579, R56DK006181, T32DK007296] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core; American Diabetes Association Grant(American Diabetes Association); BarnesJewish Hospital Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation International (JDRFI)(Juvenile Diabetes Research Foundation); MSDC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grants DK006181 (MLM), NIH DK00618146S1 (MLM), DK07296 (MLM), NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core DK20579 (MLM), American Diabetes Association Grant 7-04-MN-32 (MLM), BarnesJewish Hospital Foundation Grant 7401-00 (MLM). Human islets were obtained from the Integrated Islet Distribution Program (IIDP) sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Juvenile Diabetes Research Foundation International (JDRFI) and the JDRFI Sponsored Islets for Research Program at Washington University (JDRF-31-2008-382). The Washington University Human Studies Committee approved all studies involving the use of isolated cadaver-derived human islets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JRC, WGM and RFK are employees of Metabolic Solutions Development Company (MSDC). MSDC provided limited research funds to the Barnes-Jewish Hospital Foundation for the purchase of human islets. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Bolten CW, 2007, GENE REGUL SYST BIO, V1, P73; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Campbell IW, 2007, DIABETES RES CLIN PR, V76, P163, DOI 10.1016/j.diabres.2006.08.015; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Ciaraldi TP, 2002, DIABETES, V51, P30, DOI 10.2337/diabetes.51.1.30; Colca JR, 2013, CLIN PHARMACOL THER, V93, P352, DOI 10.1038/clpt.2013.10; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Colca JR, 2013, PLOS ONE IN PRESS; Desouza CV, 2009, VASC PHARMACOL, V51, P162, DOI 10.1016/j.vph.2009.05.001; Divakaruni AS, 2012, SCIENCE, V337, P41, DOI 10.1126/science.1225601; Efrat Shimon, 2008, Rev Diabet Stud, V5, P116, DOI 10.1900/RDS.2008.5.116; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Hanley SC, 2008, LAB INVEST, V88, P761, DOI 10.1038/labinvest.2008.41; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Kim YB, 2002, DIABETES, V51, P443, DOI 10.2337/diabetes.51.2.443; Kwon G, 2006, J BIOL CHEM, V281, P3261, DOI 10.1074/jbc.M508821200; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Leahy JL, 2009, CURR DIABETES REP, V9, P215, DOI 10.1007/s11892-009-0035-4; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Lechner A, 2005, BIOCHEM BIOPH RES CO, V327, P581, DOI 10.1016/j.bbrc.2004.12.043; Leonardini A, 2009, PPAR RES, V2009, DOI 10.1155/2009/818945; Liu H, 2009, DIABETES, V58, P663, DOI 10.2337/db07-1208; Liu YM, 2009, DIABETES OBES METAB, V11, P54, DOI 10.1111/j.1463-1326.2009.01107.x; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Mcdonald WG, 2012, DIABETES, V61, pA283; Negi S, 2012, CELL TRANSPLANT, V21, P889, DOI 10.3727/096368911X603639; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Patel P, 2010, KIDNEY INT, V77, P319, DOI 10.1038/ki.2009.436; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; ROHATGI N, 2010, OPEN ENDOCRINOL J, V4, P40; Segrelles C, 2006, ONCOGENE, V25, P1174, DOI 10.1038/sj.onc.1209155; Semenkovich CF, 2005, NAT MED, V11, P822, DOI 10.1038/nm0805-822; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Szabat M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.119; Szabat M, 2009, ENDOCRINOLOGY, V150, P1627, DOI 10.1210/en.2008-1224; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Watson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025975; Wicksteed B, 2003, J BIOL CHEM, V278, P42080, DOI 10.1074/jbc.M303509200; Wu H, 1999, BIOCHEM J, V344, P813, DOI 10.1042/0264-6021:3440813	55	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62012	10.1371/journal.pone.0062012	http://dx.doi.org/10.1371/journal.pone.0062012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650507	Green Published, gold			2022-12-27	WOS:000319167000026
J	Shah, M; Lee, G; Lefebvre, DR; Kronberg, B; Loomis, S; Brauner, SC; Turalba, A; Rhee, DJ; Freitag, SK; Pasquale, LR				Shah, Mamta; Lee, Grace; Lefebvre, Daniel R.; Kronberg, Benjamin; Loomis, Stephanie; Brauner, Stacey C.; Turalba, Angela; Rhee, Douglas J.; Freitag, Suzanne K.; Pasquale, Louis R.			A Cross-Sectional Survey of the Association between Bilateral Topical Prostaglandin Analogue Use and Ocular Adnexal Features	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ORBITAL FAT; MATRIX METALLOPROTEINASES; BIMATOPROST THERAPY; LID SULCUS; LATANOPROST; INVOLVEMENT; TRAVOPROST	We studied the relation between prostaglandin analogue use and ocular adnexal features. We used a prospective, cross-sectional study involving 157 current, 15 past, and 171 never users of prostaglandin analogues. Patients 50 years of age or older and without conditions affecting ocular adnexal anatomy underwent glaucoma medication use history, external digital photography and systematic external adnexal exam. Two masked readers assessed the digital photos for upper lid dermatochalasis and lower lid steatoblepharon using a validated grading scheme. Another masked clinical examiner also assessed upper lid ptosis, levator muscle function, and inferior scleral show. We performed ordinal logistic regression analysis accounting for multiple covariates to assess the relation between prostaglandin analogue use and adnexal features. Multivariable analyses indicated there was a 230-fold increased risk of incremental involution of dermatochalasis (odds ratio (OR) = 2.30; 95% confidence interval (CI) 1.43-3.69; p = 5.44E-04) and a 249-fold increased risk of incremental loss of lower lid steatoblepharon (OR = 2.49; 95% CI, 1.54-4.03; p = 1.98E-04) associated with current prostaglandin analogue use (bimatoprost 0.03%, travoprost 0.005%, or latanoprost 0.004%) versus prostaglandin analogue never or past users. Upper lid ptosis (OR = 4.04; 95% CI, 2.43-6.72; p = 7.37E-08), levator dysfunction (OR = 7.51; 95% CI, 3.39-16.65; p = 6.74E-07) and lower lid retraction (OR = 2.60; 95% CI, 1.58-4.28; p = 1.72E-04) were highly associated with current prostaglandin analogue use versus prostaglandin analogue never or past users. The associations between prostaglandin analogue use and deepening of the upper lid sulci and between prostaglandin analogue use and loss of inferior periorbital fat are confirmed in this multivariable analysis. The associations between prostaglandin analogue use and levator muscle dysfunction and between prostaglandin analogue use and upper lid ptosis represent significant side effects that could impact visual function in glaucoma patients.	[Shah, Mamta] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Lee, Grace; Lefebvre, Daniel R.; Kronberg, Benjamin; Loomis, Stephanie; Brauner, Stacey C.; Turalba, Angela; Rhee, Douglas J.; Freitag, Suzanne K.; Pasquale, Louis R.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA	Boston University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Shah, M (corresponding author), Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.	mshah@bu.edu	Lee, Nahyoung/O-1004-2018	Lee, Nahyoung/0000-0001-7892-2871; Lefebvre, Daniel/0000-0001-8225-4343	Research to Prevent Blindness (RPB) Medical Student Fellowship; Harvard Glaucoma Center of Excellence and a Distinguished Ophthalmology Scholar award	Research to Prevent Blindness (RPB) Medical Student Fellowship; Harvard Glaucoma Center of Excellence and a Distinguished Ophthalmology Scholar award	The study is supported by the Research to Prevent Blindness (RPB) Medical Student Fellowship 2011-2012. The Harvard Glaucoma Center of Excellence and a Distinguished Ophthalmology Scholar award support Dr. LRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2011, JPN J OPHTHALMOL, V55, P600, DOI 10.1007/s10384-011-0075-6; Alm A, 2008, SURV OPHTHALMOL, V53, pS93, DOI 10.1016/j.survophthal.2008.08.004; [Anonymous], TRAV FULL PROD INF; [Anonymous], LUM FULL PROD INF; [Anonymous], XAL FULL PROD INF; Aydin S, 2010, CUTAN OCUL TOXICOL, V29, P212, DOI 10.3109/15569521003796860; Boboridis K, 2001, BRIT J OPHTHALMOL, V85, P99, DOI 10.1136/bjo.85.1.99; Edwards DT, 2004, OPHTHALMOLOGY, V111, P1029, DOI 10.1016/j.ophtha.2003.08.027; Filippopoulos T, 2008, OPHTHAL PLAST RECONS, V24, P302, DOI 10.1097/IOP.0b013e31817d81df; Garg P, 2012, NEPAL J OPHTHALMOL, V4, P150, DOI 10.3126/nepjoph.v4i1.5867; Inoue K, 2012, J GLAUCOMA; Jayaprakasam A, 2010, ORBIT, V29, P357, DOI 10.3109/01676830.2010.527028; Nakakura S, 2011, OPTOMETRY VISION SCI, V88, P1140, DOI 10.1097/OPX.0b013e3182231202; Ooi YH, 2009, INVEST OPHTH VIS SCI, V50, P5259, DOI 10.1167/iovs.08-3356; Orme M, 2010, CURR MED RES OPIN, V26, P511, DOI 10.1185/03007990903498786; Park J, 2011, JPN J OPHTHALMOL, V55, P22, DOI 10.1007/s10384-010-0904-z; Peplinski LS, 2004, OPTOMETRY VISION SCI, V81, P574, DOI 10.1097/01.opx.0000141791.16683.4a; Pfennigsdorf S, 2012, CLIN OPHTHALMOL, V6, P739, DOI 10.2147/OPTH.S31330; RENFRO L, 1992, DERMATOL CLIN, V10, P505; Romano MR, 2007, INVEST OPHTH VIS SCI, V48, P3677, DOI 10.1167/iovs.06-0896; Schlotzer-Schrehardt U, 2005, OPHTHALMOLOGY, V112, P694, DOI 10.1016/j.ophtha.2004.11.031; Tappeiner C, 2008, KLIN MONATSBL AUGENH, V225, P443, DOI 10.1055/s-2008-1027362; Toris CB, 2008, SURV OPHTHALMOL, V53, pS107, DOI 10.1016/j.survophthal.2008.08.010; Tung JD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001106; Ung T, 2012, OPHTHAL PLAST RECONS, V28, pE42, DOI 10.1097/IOP.0b013e31821d86a5; Weinreb RN, 1997, INVEST OPHTH VIS SCI, V38, P2772	26	46	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61638	10.1371/journal.pone.0061638	http://dx.doi.org/10.1371/journal.pone.0061638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650502	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000019
J	Song, K; Shankar, E; Yang, JY; Bane, KL; Wahdan-Alaswad, R; Danielpour, D				Song, Kyung; Shankar, Eswar; Yang, Jiayi; Bane, Kara L.; Wahdan-Alaswad, Reema; Danielpour, David			Critical Role of a Survivin/TGF-beta/mTORC1 Axis in IGF-I-Mediated Growth of Prostate Epithelial Cells	PLOS ONE			English	Article							BETA-INDUCED APOPTOSIS; RECEPTOR-TYPE-II; CANCER CELLS; MALIGNANT-TRANSFORMATION; TRANSCRIPTION FACTORS; SURVIVIN EXPRESSION; TUMOR SUPPRESSION; IAP PROTEINS; INSULIN; SMAD3	Survivin is a unique member of the inhibitor of apoptosis (IAP) proteins that is overexpressed in numerous cancers through poorly defined mechanisms. One such mechanism may be through constitutive activation of the insulin-like growth factor-I (IGF-I) signaling pathway, implicated in the development and progression of prostate cancer. Using the pre-neoplastic NRP152 rat prostate cell line as a model, we showed that IGF-I induces Survivin expression, and that silencing Survivin by lentiviral-mediated small hairpin RNA (shRNA) represses IGF-I-stimulated cell growth, implicating Survivin as a mediator of this growth response. Moreover, our data support that the induction of Survivin by IGF-I occurs through a transcriptional mechanism that is mediated in part by the PI3K/Akt/mTORC1 pathway. Use of various Survivin promoter-luciferase constructs revealed that the CDE and CHR response elements in the proximal region of the Survivin promoter are involved in this IGF-I response. Transforming growth factor (TGF-beta) signaling antagonists similarly activated the Surivin promoter and rendered cells refractory to further promoter activation by IGF-I. IGF-I suppressed levels of phospho-Smads 2 and 3 with kinetics similar to that of Survivin induction. Suppression of TGF-beta signaling, either by TGF-beta receptor kinase inhibitors or by silencing Smads 2 and 3, induced Survivin expression and promoted cell growth similar to that induced by IGF-I. TGF-beta receptor antagonists also rescued cells from down-regulation of Survivin expression and growth suppression by pharmacological inhibitors of PI3K, Akt, MEK and mTOR. Sh-RNA gene silencing studies suggest that mTORC1 induces while mTORC2 represses the expression of Survivin by IGF-I. Taken together, these results suggest that IGF-I signaling through a PI3K/Akt/mTORC1 mechanism elevates expression of Survivin and promotes growth of prostate epithelial cells by suppressing Smad-dependent autocrine TGF-beta signaling.	[Song, Kyung; Shankar, Eswar; Bane, Kara L.; Danielpour, David] Case Western Reserve Univ, Case Comprehens Canc Ctr Res Labs, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Wahdan-Alaswad, Reema; Danielpour, David] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Yang, Jiayi] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Danielpour, D (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr Res Labs, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA.	dxd49@case.edu	Wahdan-alaswad, Reema/AAA-5604-2021; Shankar, Eswar/E-5139-2015	Shankar, Eswar/0000-0001-8968-838X	National Cancer Institute [R01CA134878]; Case Comprehensive Cancer Center [P30 CA43703]; NATIONAL CANCER INSTITUTE [R01CA134878, P30CA043703] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute grant R01CA134878 (to D. Danielpour) and the Case Comprehensive Cancer Center P30 CA43703 (for use of the Cytometry Core Facility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Altieri DC, 2012, CANC LETT; Baserga R, 1997, ENDOCRINE, V7, P99, DOI 10.1007/BF02778073; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bonham MJ, 1996, BIOTECHNIQUES, V21, P57; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chan JM, 2000, GROWTH HORM IGF RES, V10, pS32, DOI 10.1016/S1096-6374(00)90015-7; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; DANIELPOUR D, 1994, CANCER RES, V54, P3413; Danielpour D, 2006, CYTOKINE GROWTH F R, V17, P59, DOI 10.1016/j.cytogfr.2005.09.007; Danielpour D, 1999, J CELL SCI, V112, P169; Davies MA, 1999, CANCER RES, V59, P2551; DiGiovanni J, 2000, P NATL ACAD SCI USA, V97, P3455, DOI 10.1073/pnas.97.7.3455; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Gellibert FO, 2004, J MED CHEM, V47, P4494, DOI 10.1021/jm0400247; Guha M, 2009, CANCER RES, V69, P4954, DOI 10.1158/0008-5472.CAN-09-0584; Hayward SW, 1999, PROSTATE, V39, P205; Hsing AY, 1996, CANCER RES, V56, P5146; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Khan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046737; Kurimchak A, 2012, GENE, V499, P1, DOI 10.1016/j.gene.2012.02.015; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Lucibello FC, 1997, NUCLEIC ACIDS RES, V25, P4921, DOI 10.1093/nar/25.24.4921; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McMenamin ME, 1999, CANCER RES, V59, P4291; MEGYESI K, 1975, J BIOL CHEM, V250, P8990; Nastiuk KL, 2008, MOL CANCER RES, V6, P231, DOI 10.1158/1541-7786.MCR-07-0386; Nickerson T, 2001, CANCER RES, V61, P6276; Plymate SR, 2007, CLIN CANCER RES, V13, P6429, DOI 10.1158/1078-0432.CCR-07-0648; Pollak M, 2008, CURR OPIN PHARMACOL, V8, P384, DOI 10.1016/j.coph.2008.07.004; Pu H, 2009, CANCER RES, V69, P7366, DOI 10.1158/0008-5472.CAN-09-0758; Riolo MT, 2012, J BIOL CHEM; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Rosa J, 2006, MOL BIOL CELL, V17, P1483, DOI 10.1091/mbc.e05-08-0723; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shariat SF, 2004, CANCER, V100, P751, DOI 10.1002/cncr.20039; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sohn DM, 2006, BIOMED PHARMACOTHER, V60, P289, DOI 10.1016/j.biopha.2006.06.008; Song K, 2006, J BIOL CHEM, V281, P7765, DOI 10.1074/jbc.M511781200; Song K, 2003, J BIOL CHEM, V278, P38342, DOI 10.1074/jbc.M304583200; Song K, 2003, CANCER RES, V63, P4358; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Song K, 2008, CANCER RES, V68, P8173, DOI 10.1158/0008-5472.CAN-08-2290; Song K, 2010, MOL ENDOCRINOL, V24, P2019, DOI 10.1210/me.2010-0165; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Stewart LMV, 2003, EXP CELL RES, V284, P303, DOI 10.1016/S0014(02)00037-X; Tang BW, 1999, CANCER RES, V59, P4834; Tang L, 2012, BIOCHEM BIOPH RES CO, V421, P249, DOI 10.1016/j.bbrc.2012.03.147; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Vaira V, 2007, ONCOGENE, V26, P2678, DOI 10.1038/sj.onc.1210094; Vischioni B, 2004, ANN ONCOL, V15, P1654, DOI 10.1093/annonc/mdh436; Wahdan-Alaswad RS, 2012, MOL CANCER RES, V10, P821, DOI 10.1158/1541-7786.MCR-11-0615; Wahdan-Alaswad RS, 2010, CANCER RES, V70, P9106, DOI 10.1158/0008-5472.CAN-10-1119; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Yang J, 2008, ONCOGENE, V27, P5326, DOI 10.1038/onc.2008.165; Yang JY, 2009, CANCER RES, V69, P2185, DOI 10.1158/0008-5472.CAN-08-3961	64	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61896	10.1371/journal.pone.0061896	http://dx.doi.org/10.1371/journal.pone.0061896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658701	gold, Green Submitted, Green Published			2022-12-27	WOS:000319167000023
J	Steven, R; Castley, JG; Buckley, R				Steven, Rochelle; Castley, J. Guy; Buckley, Ralf			Tourism Revenue as a Conservation Tool for Threatened Birds in Protected Areas	PLOS ONE			English	Article							OKAVANGO DELTA; IMPACTS; SEYCHELLES; RECREATION; ATTITUDES	Many bird populations worldwide are at risk of extinction, and rely heavily on protected area networks for their continued conservation. Tourism to these areas contributes to conservation by generating revenue for management. Here we quantify the contribution of tourism revenue for bird species in the IUCN Red List, using a simple accounting method. Relevant data are available for 90 (16%) of the 562 critically endangered and endangered species. Contributions of tourism to bird conservation are highest, 10-64%, in South America, Africa, and their neighbouring islands. Critically endangered bird species rely on tourism more heavily than endangered species (p < 0.02). Many protected areas could also enhance their management budgets by promoting birdwatching tourism specifically.	[Steven, Rochelle; Castley, J. Guy; Buckley, Ralf] Griffith Univ, Int Ctr Ecotourism Res, Gold Coast, Qld, Australia	Griffith University	Steven, R (corresponding author), Griffith Univ, Int Ctr Ecotourism Res, Gold Coast, Qld, Australia.	r.steven@griffith.edu.au	Castley, James Guy/A-7056-2010; Steven, Rochelle/AAD-5898-2020; Buckley, Ralf/G-7032-2014	Castley, James Guy/0000-0002-8418-5828; Steven, Rochelle/0000-0002-3474-6818; Buckley, Ralf/0000-0003-0442-5818	Griffith Scool of Environment, Griffith University	Griffith Scool of Environment, Griffith University(Griffith University)	This project was supported by funding from the Griffith Scool of Environment, Griffith University (www.griffith.edu.au).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SUSTAINABLE FINANCIN; [Anonymous], 2010, CONSERVATION TOURISM; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Benitez SP, 2001, ECOTOURISM PROGRAM T, V3; Beresford AE, 2011, ANIM CONSERV, V14, P99, DOI 10.1111/j.1469-1795.2010.00398.x; Biggs D., 2011, Conservation and Society, V9, P80, DOI 10.4103/0972-4923.79198; Birdlife International, 2011, IUCN RED LIST BIRDS; Bookbinder MP, 1998, CONSERV BIOL, V12, P1399, DOI 10.1046/j.1523-1739.1998.97229.x; Booth JE, 2011, BIOL CONSERV, V144, P2728, DOI 10.1016/j.biocon.2011.02.018; Bovarnick A, 2010, FINANCIAL SUSTAINABI; Buckley R., 2003, Journal of Sustainable Tourism, V11, P56, DOI 10.1080/09669580308667193; Buckley R., 2004, Environmental impacts of ecotourism, DOI 10.1079/9780851998107.0000; Buckley R, 2012, ANN TOURISM RES, V39, P528, DOI 10.1016/j.annals.2012.02.003; Buckley R, 2011, ANNU REV ENV RESOUR, V36, P397, DOI 10.1146/annurev-environ-041210-132637; Buckley R, 2010, NATURE, V467, P1047, DOI 10.1038/4671047d; Buckley R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000143; Buckley RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044134; Buckley RC, 2012, NATURE, V489, P33, DOI 10.1038/489033b; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; Castley G, 2009, EVOLUTION INNOVATION, P307; Castley G, 2010, CONSERVATION TOURISM, P145, DOI 10.1079/9781845936655.0145; Connell J, 2009, AUST GEOGR, V40, P203, DOI 10.1080/00049180902964942; Cousins JA, 2008, ECOL SOC, V13; Department of Conservation New Zealand (DOC), 2011, KAK; Department of Conservation New Zealand (DOC), 2011, OFFSH ISL CONS MAN I; Department of Conservation New Zealand (DOC), 2011, BLACK ROB; Eagles P. F., 2002, SUSTAINABLE TOURISM; Hilton-Taylor C, 2009, WILDLIFE CHANGING WO, P15, DOI DOI 10.2305/IUCN.CH.2009.17.EN; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hvenegaard Glen T., 2002, Human Dimensions of Wildlife, V7, P21, DOI 10.1080/108712002753574765; Langholz Jeffrey A., 2004, Journal of International Wildlife Law and Policy, V7, P9, DOI 10.1080/13880290490480112; Lockwood M, 2010, J ENVIRON MANAGE, V91, P754, DOI 10.1016/j.jenvman.2009.10.005; Mansourian S., 2008, PUBLIC FUNDS PROTECT; Mbaiwa JE, 2003, J ARID ENVIRON, V54, P447, DOI 10.1006/jare.2002.1101; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Mmopelwa G, 2006, S AFR J ECON MANAG S, V9, P113; Morrison C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043757; Puhakka L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026786; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rocamora G., 2001, IMPORTANT BIRD AREAS, P751; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Sekhar NU, 2003, J ENVIRON MANAGE, V69, P339, DOI 10.1016/j.jenvman.2003.09.002; Shah NJ, 2001, BIODIVERS CONSERV, V10, P1219, DOI 10.1023/A:1016764124890; Shareef R, 2008, MATH COMPUT SIMULAT, V78, P459, DOI 10.1016/j.matcom.2008.01.025; Smeral E, 2010, J TRAVEL RES, V49, P31, DOI 10.1177/0047287509353192; Steven R, 2011, J ENVIRON MANAGE, V92, P2287, DOI 10.1016/j.jenvman.2011.05.005; Tisdell C, 2012, NATURE-BASED TOURISM AND CONSERVATION: NEW ECONOMIC INSIGHTS AND CASE STUDIES, P1; Verissimo D, 2009, ANIM CONSERV, V12, P549, DOI 10.1111/j.1469-1795.2009.00282.x; Walpole MJ, 2001, ENVIRON CONSERV, V28, P160, DOI 10.1017/S0376892901000169; WHITTAKER RJ, 1995, TRENDS ECOL EVOL, V10, P421, DOI 10.1016/S0169-5347(00)89164-8	52	53	53	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62598	10.1371/journal.pone.0062598	http://dx.doi.org/10.1371/journal.pone.0062598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667498	gold, Green Published			2022-12-27	WOS:000319055600033
J	Ito, M; Ohba, S; Gaensler, K; Ronen, SM; Mukherjee, J; Pieper, RO				Ito, Motokazu; Ohba, Shigeo; Gaensler, Karin; Ronen, Sabrina M.; Mukherjee, Joydeep; Pieper, Russell O.			Early Chk1 Phosphorylation Is Driven by Temozolomide-Induced, DNA Double Strand Break- and Mismatch Repair-Independent DNA Damage	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN GLIOBLASTOMA CELLS; METHYLATING AGENTS; G(2) CHECKPOINT; GLIOMA-CELLS; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; ESCHERICHIA-COLI; O-6-METHYLGUANINE; APOPTOSIS; SYSTEM	Temozolomide (TMZ) is a DNA methylating agent used to treat brain cancer. TMZ-induced O6-methylguanine adducts, in the absence of repair by O6-methylguanine DNA methyltransferase (MGMT), mispair during DNA replication and trigger cycles of futile mismatch repair (MMR). Futile MMR in turn leads to the formation of DNA single and double strand breaks, Chk1 and Chk2 phosphorylation/activation, cell cycle arrest, and ultimately cell death. Although both pChk1 and pChk2 are considered to be biomarkers of TMZ-induced DNA damage, cell-cycle arrest, and TMZ induced cytotoxicity, we found that levels of pChk1 (ser345), its downstream target pCdc25C (ser216), and the activity of its upstream activator ATR, were elevated within 3 hours of TMZ exposure, long before the onset of TMZ-induced DNA double strand breaks, Chk2 phosphorylation/activation, and cell cycle arrest. Furthermore, TMZ-induced early phosphorylation of Chk1 was noted in glioma cells regardless of whether they were MGMT-proficient or MGMT-deficient, and regardless of their MMR status. Early Chk1 phosphorylation was not associated with TMZ-induced reactive oxygen species, but was temporally associated with TMZ-induced alkalai-labile DNA damage produced by the non-O6-methylguanine DNA adducts and which, like Chk1 phosphorylation, was transient in MGMT-proficient cells but persistent in MGMT-deficient cells. These results re-define the TMZ-induced DNA damage response, and show that Chk1 phosphorylation is driven by TMZ-induced mismatch repair-independent DNA damage independently of DNA double strand breaks, Chk2 activation, and cell cycle arrest, and as such is a suboptimal biomarker of TMZ-induced drug action.	[Ito, Motokazu; Ohba, Shigeo; Mukherjee, Joydeep; Pieper, Russell O.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Gaensler, Karin] Univ Calif San Francisco, Dept Hematol Oncol, San Francisco, CA 94143 USA; [Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Ito, Motokazu; Ohba, Shigeo; Ronen, Sabrina M.; Mukherjee, Joydeep; Pieper, Russell O.] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pieper, RO (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	rpieper@cc.ucsf.edu			United States National Institutes of Health [CA136774, CA097257, CA154915]; NATIONAL CANCER INSTITUTE [P50CA097257, R01CA154915, R01CA136774] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by United States National Institutes of Health Grants CA136774 and CA097257 (SPORE) to ROP and CA154915 to SMR, http://www.cancer.gov/researchandfunding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbotts R, 2010, CANCER TREAT REV, V36, P425, DOI 10.1016/j.ctrv.2009.12.006; Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Adamson AW, 2002, J BIOL CHEM, V277, P38222, DOI 10.1074/jbc.M204409200; AU KG, 1992, J BIOL CHEM, V267, P12142; Boysen G, 2009, MUTAT RES-GEN TOX EN, V678, P76, DOI 10.1016/j.mrgentox.2009.05.006; Caporali S, 2004, MOL PHARMACOL, V66, P478; Chen CC, 2009, CNS CANC CANC DRUG D, P680; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Friedman HS, 1997, CANCER RES, V57, P2933; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Hirose Y, 2001, CANCER RES, V61, P5843; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Hirose Y, 2001, CANCER RES, V61, P1957; Hirose Y, 2005, CANCER RES, V65, P4587; Huang XJ, 2008, PHARMACOLOGY, V82, P1, DOI 10.1159/000125673; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; KARRAN P, 1982, NATURE, V296, P868, DOI 10.1038/296868a0; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Margison GP, 2002, MUTAGENESIS, V17, P483, DOI 10.1093/mutage/17.6.483; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Mirzoeva OK, 2006, MOL CANCER THER, V5, P2757, DOI 10.1158/1535-7163.MCT-06-0183; Naidu MD, 2010, J RADIAT RES, V51, P393, DOI 10.1269/jrr.09077; Neidle S, 2005, NAT REV CANCER, V5, P285, DOI 10.1038/nrc1587; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Osoba D, 2000, J CLIN ONCOL, V18, P1481, DOI 10.1200/JCO.2000.18.7.1481; Park I, 2011, J MAGN RESON IMAGING, V33, P1284, DOI 10.1002/jmri.22563; PEGG AE, 1990, CANCER RES, V50, P6119; PEGG AE, 1983, J BIOL CHEM, V258, P2327; Plummer ER, 2005, CLIN CANCER RES, V11, P3402, DOI 10.1158/1078-0432.CCR-04-2353; Quiros S, 2010, CELL CYCLE, V9, P168, DOI 10.4161/cc.9.1.10363; RIAZUDDIN S, 1978, BIOCHEMISTRY-US, V17, P2110, DOI 10.1021/bi00604a014; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; SINGER B, 1981, P NATL ACAD SCI-BIOL, V78, P856, DOI 10.1073/pnas.78.2.856; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Stojic L, 2005, CELL CYCLE, V4, P473, DOI 10.4161/cc.4.3.1528; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Wang XZ, 2011, AM J CANCER RES, V1, P301; WESTPHAL M, 1994, ACTA NEUROCHIR, V126, P17, DOI 10.1007/BF01476489; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Xu-Welliver M, 1998, CANCER RES, V58, P1936; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	44	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62351	10.1371/journal.pone.0062351	http://dx.doi.org/10.1371/journal.pone.0062351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667469	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700031
J	Porta, M; Vandenbroucke, JP; Ioannidis, JPA; Sanz, S; Fernandez, E; Bhopal, R; Morabia, A; Victora, C; Lopez, T				Porta, Miquel; Vandenbroucke, Jan P.; Ioannidis, John P. A.; Sanz, Sergio; Fernandez, Esteve; Bhopal, Raj; Morabia, Alfredo; Victora, Cesar; Lopez, Tomas			Trends in Citations to Books on Epidemiological and Statistical Methods in the Biomedical Literature	PLOS ONE			English	Article							BIBLIOGRAPHIC IMPACT FACTOR; SCIENCE; JOURNALS; ASSOCIATION; FREQUENCY; MORTALITY; TEXTBOOKS; SOCIOLOGY; THINKING; CANCER	Background: There are no analyses of citations to books on epidemiological and statistical methods in the biomedical literature. Such analyses may shed light on how concepts and methods changed while biomedical research evolved. Our aim was to analyze the number and time trends of citations received from biomedical articles by books on epidemiological and statistical methods, and related disciplines. Methods and Findings: The data source was the Web of Science. The study books were published between 1957 and 2010. The first year of publication of the citing articles was 1945. We identified 125 books that received at least 25 citations. Books first published in 1980-1989 had the highest total and median number of citations per year. Nine of the 10 most cited texts focused on statistical methods. Hosmer & Lemeshow's Applied logistic regression received the highest number of citations and highest average annual rate. It was followed by books by Fleiss, Armitage, et al., Rothman, et al., and Kalbfleisch and Prentice. Fifth in citations per year was Sackett, et al., Evidence-based medicine. The rise of multivariate methods, clinical epidemiology, or nutritional epidemiology was reflected in the citation trends. Educational textbooks, practice-oriented books, books on epidemiological substantive knowledge, and on theory and health policies were much less cited. None of the 25 top-cited books had the theoretical or sociopolitical scope of works by Cochrane, McKeown, Rose, or Morris. Conclusions: Books were mainly cited to reference methods. Books first published in the 1980s continue to be most influential. Older books on theory and policies were rooted in societal and general medical concerns, while the most modern books are almost purely on methods.	[Porta, Miquel; Sanz, Sergio; Lopez, Tomas] Univ Autonoma Barcelona, Hosp del Mar, Inst Med Res IMIM, CIBER Epidemiol & Salud Publ CIBERESP, Catalonia, Spain; [Porta, Miquel; Sanz, Sergio; Lopez, Tomas] Univ Autonoma Barcelona, Sch Med, Catalonia, Spain; [Porta, Miquel] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Vandenbroucke, Jan P.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA; [Fernandez, Esteve] Univ Barcelona, Inst Catala Oncol ICO IDIBELL, Canc Prevent & Control Programme, Barcelona, Spain; [Fernandez, Esteve] Univ Barcelona, Sch Med, Barcelona, Spain; [Bhopal, Raj] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Morabia, Alfredo] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Morabia, Alfredo] CUNY Queens Coll, Sch Earth & Environm Sci, Flushing, NY 11367 USA; [Morabia, Alfredo] CUNY Queens Coll, Ctr Biol Nat Syst, Flushing, NY 11367 USA; [Victora, Cesar] Univ Fed Pelotas, Pelotas, Brazil	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; University of North Carolina; University of North Carolina Chapel Hill; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Ioannina; Stanford University; Stanford University; Stanford University; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; University of Edinburgh; Columbia University; City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; Queens College NY (CUNY); Universidade Federal de Pelotas	Porta, M (corresponding author), Univ Autonoma Barcelona, Hosp del Mar, Inst Med Res IMIM, CIBER Epidemiol & Salud Publ CIBERESP, Catalonia, Spain.	mporta@imim.es	Victora, Cesar Gomes/Y-2455-2019; Fernandez, Esteve/A-9750-2008; Porta, Miquel/B-5787-2008; Victora, Cesar G/D-4476-2013; Porta, Miquel/AAD-5371-2020; Vandenbroucke, Jan/AAM-3928-2020; Ioannidis, John P. A./G-9836-2011	Victora, Cesar Gomes/0000-0002-2465-2180; Fernandez, Esteve/0000-0003-4239-723X; Porta, Miquel/0000-0003-1684-7428; Victora, Cesar G/0000-0002-2465-2180; Porta, Miquel/0000-0003-1684-7428; Vandenbroucke, Jan/0000-0001-5668-6716; Lopez-Jimenez, Tomas/0000-0001-8255-4936; Sanz, Sergio/0000-0002-5787-0096	Government of Catalonia [2009 SGR 1350, 2009 SGR 192]; CIBER de Epidemiologia y Salud Publica (CIBERESP); RTIC Cancer, Instituto de Salud Carlos III, Government of Spain [RD06/0020/0089]	Government of Catalonia(Generalitat de Catalunya); CIBER de Epidemiologia y Salud Publica (CIBERESP); RTIC Cancer, Instituto de Salud Carlos III, Government of Spain	This work was supported in part by research grants from the Government of Catalonia (2009 SGR 1350 and 2009 SGR 192); CIBER de Epidemiologia y Salud Publica (CIBERESP); and RTIC Cancer (RD06/0020/0089), Instituto de Salud Carlos III, Government of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J., 2001, MAKING SENSE DATA SE, DOI 10.1093/acprof:oso/9780195145250.001.0001/acprof-9780195145250; Abramson J.H., 2008, RES METHODS COMMUNIT, V6; Abramson JH, 1984, SURVEY METHODS COMMU; Abramson JH, 1988, MAKING SENSE DATA SE; Abramson JH, 1979, SURVEY METHODS COMMU; Abramson JH., 1974, SURVEY METHODS COMMU; ABRAMSON JH, 1990, SURVEY METHODS COMMU; Abramson JH, 1994, MAKING SENSE DATA SE; Abramson JH, 1999, SURVEY METHODS COMMU, V5th; Adami HO, 2002, TXB CANC EPIDEMIOLOG; Adams J, 2011, PRO INT CONF SCI INF, P13; AHLBOM A, 1984, INTRO MODERN EPIDEMI; Ahlbom A, 1990, INTRO MODERN EPIDEMI; ALVAREZDARDET C, 1993, BMJ-BRIT MED J, V306, P1252, DOI 10.1136/bmj.306.6887.1252; Amsterdamska O, 2005, SCI TECHNOL HUM VAL, V30, P17, DOI 10.1177/0162243904270719; [Anonymous], PRINCIPLES PRACTICE; [Anonymous], FIELD EPIDEMIOLOGY; [Anonymous], 1993, HIST PUBLIC HLTH; [Anonymous], 2007, INFECT DIS EPIDEMIOL; [Anonymous], 1985, THEORETICAL EPIDEMIO; [Anonymous], OCCUPATIONAL EPIDEMI; [Anonymous], 1987, EPIDEMIOLOGY HLTH SO; Armenian HK, 1998, EPIDEMIOLOGY HLTH SE; Armitage P., 1971, STAT METHODS MED RES, V1; Armitage P., 2002, STAT METHODS MED RES; Armitage P., 2001, STAT METHODS MED RES; Armitage P., 1987, STAT METHODS MED RES; Aschengrau A., 2020, ESSENTIALS EPIDEMIOL; Aschengrau A, 2008, ESSENTIALS EPIDEMIOL; Ashton J., 1994, EPIDEMIOLOGICAL IMAG; Astrom F, 2011, PRO INT CONF SCI INF, P89; Bailar III JC, 1986, MED USES STAT; Bailar JC., 1992, MED USES STAT; Bailar JC, 2009, MED USES STAT; Barker DJP, 1990, EPIDEMIOLOGY MED PRA; Barker DJP., 1976, EPIDEMIOLOGY MED PRA, V2nd edn; BARKER DJP, 1998, EPIDEMIOLOGY MED PRA; Barker DJP, 1984, EPIDEMIOLOGY MED PRA; Barker DJP, 1979, EPIDEMIOLOGY MED PRA; Beaglehole R, 1993, BASIC EPIDEMIOLOGY, V1st; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Bhopal R, 1997, J EPIDEMIOL COMMUN H, V51, P612, DOI 10.1136/jech.51.6.612; Bhopal R, 1999, AM J PUBLIC HEALTH, V89, P1162, DOI 10.2105/AJPH.89.8.1162; Bhopal R., 2008, CONCEPTS EPIDEMIOLOG; Bhopal R.S., 2002, CONCEPTS EPIDEMIOLOG; Black Nick, 2006, J Health Serv Res Policy, V11, P180, DOI 10.1258/135581906777641695; Blalock H.M., 1964, CAUSAL INFERENCE NON; Blalock Jr. HM, 1971, CAUSAL MODELS SOCIAL; Blalock Jr HM, 1985, CAUSAL MODELS SOCIAL; Blalock Jr HM, 1985, CAUSAL MODELS PANEL; BLAND M, 1995, INTRO MED STAT; Bland M, 1987, INTRO MED STAT; Bland M., 2000, INTRO MED STAT, V3rd; Bolumar F, 2004, EUR J EPIDEMIOL, V19, P733; Bradburn NM., 2004, ASKING QUESTIONS DEF, VRev. edn; Bradford Hill A., 1937, PRINCIPLES MED STAT; Breslow N E, 1987, IARC Sci Publ, P1; Breslow N E, 1980, IARC Sci Publ, P5; Brownson RC, 2002, EVIDENCE BASED PUBLI; Buck C, 1988, CHALLENGE EPIDEMIOLO; Butler L, 2006, SCIENTOMETRICS, V66, P327, DOI 10.1007/s11192-006-0024-1; Carrington M, 2001, MOL EPIDEMIOLOGY; Checkoway H., 1989, RES METHODS OCCUPATI; Checkoway H., 2004, Research methods in occupational epidemiology, V2nd; CHIN J, 2000, CONTROL COMMUNICABLE; Clayton D., 1992, GEOGRAPHICAL ENV EPI; Cochrane AL., 1999, EFFECTIVENESS EFFICI; Cochrane AL, 1999, BRIT MED J; Coggon D, 1993, EPIDEMIOLOGY UNINITI; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; Detels R., 2009, OXFORD TXB PUBLIC HL; DETELS R, 2002, OXFORD TXB PUBLIC HL; Detels R, 1997, OXFORD TXB PUBLIC HL; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Doll R, 2008, PREVENTION CANC POIN; Doll R, 1967, PREVENTION CANC POIN; Doll R, 1981, CAUSES CANC QUANTITA; Elston RC, 1987, ESSENTIALS BIOSTATIS; Elston RC, 1994, ESSENTIALS BIOSTATIS; Elston RC, 2002, BIOSTATISTICAL GENET; Elwood M., 2007, CRITICAL APPRAISAL E, V3rd; Elwood M, 1988, CAUSAL RELATIONSHIPS; Elwood M, 1998, CRITICAL APPRAISAL E; ELWOOD PC, 1974, BRIT MED J, V1, P436, DOI 10.1136/bmj.1.5905.436; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; Farmer R, 1977, LECT NOTES COMMUNITY; Farmer R, 1991, LECT NOTES EPIDEMIOL; Farmer R, 1996, LECT NOTES EPIDEMIOL; Farmer R, 1983, LECT NOTES EPIDEMIOL; Feinstein AR, 1987, CLINIMETRICS; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; Fleiss J, 1973, STAT METHODS RATES P; Fleiss J.L., 2013, STAT METHODS RATES P; Fleiss JL., 2003, STAT METHODS RATES P; Fletcher R., 1982, CLIN EPIDEMIOLOGY ES; Fletcher RH, 1988, CLIN EPIDEMIOLOGY ES; Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, V5; Fletcher RH, 1988, CLIN EPIDEMIOLOGY ES, V2nd; Fox JP, 1970, EPIDEMIOLOGY MAN DIS; Friedman G, 1974, PRIMER EPIDEMIOLOGY; Friedman G, 1980, PRIMER EPIDEMIOLOGY; Friedman G, 1994, PRIMER EPIDEMIOLOGY; Friedman G, 1987, PRIMER EPIDEMIOLOGY; Friedman G. D., 2004, PRIMER EPIDEMIOLOGY; Friedman LM., 1981, FUNDAMENTALS CLIN TR; FRIEDMAN LM, 1996, FUNDAMENTALS CLIN TR; Friedman LM, 1985, FUNDAMENTALS CLIN TR; Friedmen LM, 2010, FUNDAMENTALS OF CLINICAL TRIALS, FOURTH EDITION, P1; Friis RH, 1999, EPIDEMIOLOGY PUBLIC; Friis RH, 2009, EPIDEMIOLOGY PUBLIC; Friis RH, 2004, EPIDEMIOLOGY PUBLIC; Friis RH, 1996, EPIDEMIOLOGY PUBLIC; Fuchs Victor R., 1998, WHO SHALL LIVE HLTH; GARFIELD E, 1985, CURR CONTENTS, V12, P3; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; GARFIELD E, 1987, CURR CONTENTS, P3; Glaser J, 2004, J SOCIOL, V40, P261, DOI 10.1177/1440783304046370; Gordis L, 1996, EPIDEMIOLOGY; Gordis L., 2000, EPIDEMIOLOGY, V2; Gordis L., 2004, EPIDEMIOLOGY; Gore S.M, 1982, STAT PRACTICE; Gray JAM, 1984, ESSENTIALS PREVENTIV; Greenberg R, 1996, MED EPIDEMIOLOGY; Greenberg R.S.D.S., 2005, MED EPIDEMIOLOGY, Vfourth; Greenberg RS, 2001, MED EPIDEMIOLOGY; Greenberg RS., 1993, EPIDEMIOLOGIA CLN; Greenland S., 1987, EVOLUTION EPIDEMIOLO; Greenwood M., 1935, EPIDEMICS CROWD DIS; Gregg M, 2008, FIELD EPIDEMIOLOGY, V3rd; Gregg MB, 2002, FIELD EPIDEMIOLOGY; Harkness GA, 1995, EPIDEMIOLOGY NURSING; Hartzema A. G., 1998, PHARMACOEPIDEMIOLOGY; Hartzema A.G., 2008, PHARMACOEPIDEMIOLOGY; Hartzema AG, 1988, PHARMACOEPIDEMIOLOGY; Hartzema AG, 1991, PHARMACOEPIDEMIOLOGY; Haynes RB, 2005, CLIN EPIDEMIOLOGY DO; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Heymann DL, 2008, CONTROL COMMUNICABLE; Hill A. B., 1977, SHORT TXB MED STAT; Hill A. B, 1962, STAT METHODS CLIN PR; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HILL AB, 1991, B HILLS PRINCIPLES M; Hills, 1993, STAT MODELS EPIDEMIO; Holford TR, 2002, MULTIVARIATE METHODS; Holland WW, 1990, SCREENING HLTH CARE; Holland WW, 1984, OXFORD TXB PUBLIC HL; Holland WW, 1991, OXFORD TXB PUBLIC HL; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hudson TW, 1988, CLIN PREVENTIVE MED; Hulka BS., 1990, BIOL MARKERS EPIDEMI, P3; Hulley S., 2007, DESIGNING CLIN RES E; Hulley SB, 2007, DESIGNING CLIN RES; Hulley SB., 2001, DESIGNING CLIN RES; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Jacso P, 2008, LIBR TRENDS, V56, P784; Jekel J. F., 1996, EPIDEMIOLOGY BIOSTAT; Jekel JF, 2007, EPIDEMIOLOGY BIOSTAT; Jekel JF, 2001, EPIDEMIOLOGY BIOSTAT; Jenicek M., 1995, EPIDEMIOLOGY LOGIC M; Jensen OM, 1991, IARC SCI PUBLICATION, V95; Kahn HA, 1989, STAT METHODS EPIDEMI; KAHN HA, 1983, INTRO EPIDEMIOLOGIC; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kaufman JS, 2000, ANNU REV PUBL HEALTH, V21, P101, DOI 10.1146/annurev.publhealth.21.1.101; KELSEY JL, 1986, METHODS OBSERVATIONA; Kelsey JL., 1996, METHODS OBSERVATIONA; Khoury M, 1993, FUNDAMENTALS GENETIC; Khoury M. J., 2004, HUMAN GENOME EPIDEMI; Khoury M. J., 2000, GENETICS PUBLIC HLTH; Khoury MJ, 2010, HUMAN GENOME EPIDEMI; Kleinbaum D, 1988, APPL REGRESSION ANAL; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Kleinbaum D. G., 2002, LOGISTIC REGRESSION; KLEINBAUM DG, 2007, APPL REGRESSION ANAL; Kleinbaum DG, 1978, APPL REGRESSION ANAL; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Kleinbaum DG, 1994, LOGISTIC REGRESSION; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; Kleinman A., 1988, ILLNESS NARRATIVES; Knowles JH., 1977, DOING BETTER FEELING; Kousha K, 2011, J AM SOC INF SCI TEC, V62, P2147, DOI 10.1002/asi.21608; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Krieger N, 2007, INT J EPIDEMIOL, V36, P1173, DOI 10.1093/ije/dym228; Lariviere V, 2009, J AM SOC INF SCI TEC, V60, P858, DOI 10.1002/asi.21011; Last J., 1988, DICT EPIDEMIOLOGY; Last JM, 1983, DICT EPIDEMIOLOGY; LAST JM, 1995, DICT EPIDEMIOLOGY; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Last JM, 1992, MAXCY ROSENAU LAST P, V13th; Last JM, 1980, MAXCY ROSENAU PUBLIC; LEYDESDORFF L, 1990, SCI TECHNOL HUM VAL, V15, P305, DOI 10.1177/016224399001500303; Lilienfeld AM, 1980, FDN EPIDEMIOLOGY; Lilienfeld AM, 1976, FDN EPIDEMIOLOGY; LILIENFELD DE, 1994, FDN EPIDEMIOLOGY; Linet MS, 1985, LEUKEMIAS EPIDEMIOLO; Luepker R. V., 2004, Cardiovascular survey methods; MacMahon B., 1996, EPIDEMIOLOGY PRINCIP, V2nd; MacMahon B, 1960, EPIDEMIOLOGY PRINCIP; MANTEL N, 1959, J NATL CANCER I, V22, P719; Margetts BM, 1991, DESIGN CONCEPTS NUTR; Marmot M, 2006, SOCIAL DETERMINANTS; MARMOT M, 2005, CORONARY HEART DIS E; Marmot M, 1992, CORONARY HEART DIS E; Marmot MG., 2006, SOCIAL DETERMINANTS; Mausner J, 1985, EPIDEMIOLOGY INTRO T; Mausner JS., 1974, EPIDEMIOLOGY INTRO T; Maxcy K. F., 1951, ROSENAU PREVENTIVE M, VSeventh; McDowell I., 1996, MEASURING HLTH GUIDE; McDowell I., 2006, MEASURING HLTH GUIDE; McDowell I, 1987, MEASURING HLTH GUIDE; McKeown T., 1976, ROLE MED DREAM MIRAG; Meinert CL, 1986, CLIN TRIALS DESIGN C; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Monson R., 1990, OCCUPATIONAL EPIDEMI, V2; Morabia A, 2004, HIST EPIDEMIOLOGIC M; Morrell D, 1988, EPIDEMIOLOGY GEN PRA; Morris JN, 1964, USES OF EPIDEMIOLOGY; Morris JN, 1975, USES OF EPIDEMIOLOGY; Morris JN, 1957, USES OF EPIDEMIOLOGY; Morrison AS., 1985, SCREENING CHRONIC DI; Morrison AS, 1992, SCREENING CHRONIC DI; MORTON RF, 2001, STUDY GUIDE EPIDEMIO; Morton RF, 1984, STUDY GUIDE EPIDEMIO; Morton RF, 1979, STUDY GUIDE EPIDEMIO; MORTON RF, 1996, STUDY GUIDE EPIDEMIO; Morton RF, 1990, STUDY GUIDE EPIDEMIO; Morton RF, 2005, STUDY GUIDE EPIDEMIO; Murphy E.A., 1976, LOGIC MED; Murphy EA, 1997, LOGIC MED; Nederhof AJ, 2010, SCIENTOMETRICS, V83, P363, DOI 10.1007/s11192-009-0086-y; Nelson KE, 2001, INFECT DIS EPIDEMIOL; Nelson M, 1997, DESIGN CONCEPTS NUTR; NORELL SE, 1995, WORKBOOK EPIDEMIOLOG; OLSEN J, 1992, TEACHING EPIDEMIOLOG; Olsen J, 2001, TEACHING EPIDEMIOLOG; Olsen J., 2010, TEACHING EPIDEMIOLOG; PAGE RM, 1995, BASIC EPIDEMIOLOGICA; Patrick D. L., 1993, HLTH STATUS HLTH POL; Patrick D.L., 1989, DISABLEMENT COMMUNIT; Petitti D, 1994, METAANALYSIS DECISIO; PETITTI DB, 2000, METAANALYSIS DECISIO; Pocock S.J., 2013, CLIN TRIALS PRACTICA; Pocock S. J., 2002, CLIN TRIALS PRACTICA; Polgar S, 1988, INTRO RES HLTH SCI; Porta M, 1996, J EPIDEMIOL COMMUN H, V50, P606, DOI 10.1136/jech.50.6.606; Porta M, 1998, J EPIDEMIOL COMMUN H, V52, P605, DOI 10.1136/jech.52.10.605; Porta M, 2008, DICT EPIDEMIOLOGY; Porta M, 2006, INT J EPIDEMIOL, V35, P1130, DOI 10.1093/ije/dyl196; Porta M, 2006, REV SAUDE PUBL, V40, P50, DOI 10.1590/S0034-89102006000400008; Porta M, 2006, J EPIDEMIOL COMMUN H, V60, P559, DOI 10.1136/jech.2005.043661; Prince M., 2003, PRACTICAL PSYCHIAT E; Rebbeck TR, 2008, MOL EPIDEMIOLOGY APP; Reuters Thomson, BOOK CIT IND; Roberts CJ, 1977, EPIDEMIOLOGY CLIN; Robertson L, 2007, INJURY EPIDEMIOLOGY; Robertson L, 1998, INJURY EPIDEMIOLOGY; Robertson L. S., 1992, INJURY EPIDEMIOLOGY; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Rose G, 1982, CARDIOVASCULAR SURVE; Rose G., 1992, STRATEGY PREVENTIVE; Rose GA, 1968, WHO MONOGRAPH SERIES; Rosen George, 1958, HIST PUBLIC HLTH; Rosenau MJ, PREVENTIVE MED HYGIE; Rosner B., 2011, FUNDAMENTALS BIOSTAT; Rosner B., 2010, FUNDAMENTALS BIOSTAT; Rosner B., 1986, FUNDAMENTALS BIOSTAT, V2nd, P442; Rosner B, 1982, FUNDAMENTALS BIOSTAT; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Rothman K, 1986, MODERN EPIDEMIOLOGY; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Rothman KJ, 1988, CAUSAL INFERENCE; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Sackett D.L., 1985, CLIN EPIDEMIOLOGY BA; Sackett D. L., 1997, EVIDENCE BASED MED P; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Sartwell PE, 1973, MAXCY ROSENAU PREVEN; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; Schottenfeld D, 1982, CANC EPIDEMIOLOGY PR; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; Schottenfeld D, 1975, CANC EPIDEMIOLOGY PR; Schulte PA., 1993, MOL EPIDEMIOLOGY PRI; Schuman SH, 1986, PRACTICE BASED EPIDE; SEGLEN PO, 1992, RES EVALUAT, V2, P143, DOI DOI 10.1093/REV/2.3.143; Silman A., 1995, EPIDEMIOLOGICAL STUD; Silman A. J., 2002, EPIDEMIOLOGICAL STUD; Starfield B, 1985, EFFECTIVENESS MED CA; Steenland K, 1993, CASE STUDIES OCCUPAT; STLEGER AS, 1979, LANCET, V1, P1017, DOI 10.1016/S0140-6736(79)92765-X; Stolley P, 1995, INVESTIGATING DIS PA; Straus SE, 2005, EVIDENCE BASED MED P; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Streiner DL, 2008, HLTH MEASUREMENT SCA, V4th; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; Streiner DL., 2001, HLTH MEASUREMENT SCA, V2nd; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P1; Strom BL, 1989, PHARMACOEPIDEMIOLOGY; Strom BL, 1994, PHARMACOEPIDEMIOLOGY; Strom BL, 2000, PHARMACOEPIDEMIOLOGY; Sudman Seymour, 1982, ASKING QUESTIONS PRA; Susser M., 1973, CAUSAL THINKING HLTH; Susser M., 2009, ERAS EPIDEMIOLOGY EV; Susser MW, 1985, SOCIOLOGY MED; Sydenstricker E., 1933, HLTH ENV, DOI [10.1097/00007611-193310000-00035, DOI 10.1097/00007611-193310000-00035]; Sydenstricker E, 1972, HLTH ENV; SZKLO M., 2014, EPIDEMIOLOGY BASICS, V3; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Teutsch S.M., 2000, PRINCIPLES PRACTICE; Timmreck T. C., 2002, INTRO EPIDEMIOLOGY; Timmreck TC, 1998, INTRO EPIDEMIOLOGY; TIMMRECK TC, 1994, INTRO EPIDEMIOLOGY; Toniolo P, 1997, IARC SCI PUBLICATION, V142; Townsend P., 1982, INEQUALITIES HLTH BL; Trichopoulos D., 2008, TXB CANC EPIDEMIOLOG; UNWIN N, 1997, INTRO STUDY GUIDE PU; Vandenbroucke JP, 1998, LANCET, V352, P12; Vandenbroucke JP, 1998, LANCET, V352, P2001, DOI 10.1016/S0140-6736(98)10208-8; VANDENBROUCKE JP, 1988, INT J EPIDEMIOL, V17, P708, DOI 10.1093/ije/17.4.708; Vineis P, 1999, IARC SCI PUBLICATION, V148; Wallace RB, 2008, MAXCY ROSENAU LAST P; Waning B, 2000, PHARMACOEPIDEMIOLOGY; Weiss NS, 1986, CLIN EPIDEMIOLOGY ST; WEISS NS, 1996, CLIN EPIDEMIOLOGY ST; White KL, 1976, EPIDEMIOLOGY FUNDAME; White KL, 1980, EPIDEMIOLOGY FUNDAME; Wild C, 2008, MOL EPIDEMIOLOGY CHR; Willett W., 1990, NUTR EPIDEMIOLOGY; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Winklestein Jr W, 1970, BASIC READINGS EPIDE; Zhang FF, 2004, SOZ PRAVENTIV MED, V49, P97, DOI 10.1007/S00038-004-3117-8	340	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61837	10.1371/journal.pone.0061837	http://dx.doi.org/10.1371/journal.pone.0061837			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667447	Green Published, gold			2022-12-27	WOS:000319654700016
J	Cottard, F; Asmane, I; Erdmann, E; Bergerat, JP; Kurtz, JE; Ceraline, J				Cottard, Felicie; Asmane, Irene; Erdmann, Eva; Bergerat, Jean-Pierre; Kurtz, Jean-Emmanuel; Ceraline, Jocelyn			Constitutively Active Androgen Receptor Variants Upregulate Expression of Mesenchymal Markers in Prostate Cancer Cells	PLOS ONE			English	Article							N-CADHERIN INCREASES; SPLICE VARIANTS; STEM-CELLS; PROGRESSION; METASTASIS; TRANSITION; RESISTANCE; ADHESION; GROWTH; SNAIL	Androgen receptor (AR) signaling pathway remains the foremost target of novel therapeutics for castration-resistant prostate cancer (CRPC). However, the expression of constitutively active AR variants lacking the carboxy-terminal region in CRPC may lead to therapy inefficacy. These AR variants are supposed to support PCa cell growth in an androgen-depleted environment, but their mode of action still remains unresolved. Moreover, recent studies indicate that constitutively active AR variants are expressed in primary prostate tumors and may contribute to tumor progression. The aim of this study was to investigate the impact of constitutively active AR variants on the expression of tumor progression markers. N-cadherin expression was analyzed in LNCaP cells overexpressing the wild type AR or a constitutively active AR variant by qRT-PCR, Western blot and immunofluorescence. We showed here for the first time that N-cadherin expression was increased in the presence of constitutively active AR variants. These results were confirmed in C4-2B cells overexpressing these AR variants. Although N-cadherin expression is often associated with a downregulation of E-cadherin, this phenomenon was not observed in our model. Nevertheless, in addition to the increased expression of N-cadherin, an upregulation of other mesenchymal markers expression such as VIMENTIN, SNAIL and ZEB1 was observed in the presence of constitutively active variants. In conclusion, our findings highlight novel consequences of constitutively active AR variants on the regulation of mesenchymal markers in prostate cancer.	[Cottard, Felicie; Asmane, Irene; Erdmann, Eva; Bergerat, Jean-Pierre; Kurtz, Jean-Emmanuel; Ceraline, Jocelyn] Univ Strasbourg, INSERM, U1113, Fedrat Med Translat Strasbourg, Strasbourg, France; [Asmane, Irene; Bergerat, Jean-Pierre; Kurtz, Jean-Emmanuel; Ceraline, Jocelyn] CHRU Strasbourg, Hematol & Oncol Unit, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ceraline, J (corresponding author), Univ Strasbourg, INSERM, U1113, Fedrat Med Translat Strasbourg, Strasbourg, France.	ceraline@unistra.fr	Kurtz, Jean-Emmanuel/R-3286-2016	CERALINE, Jocelyn/0000-0001-6476-8797	University of Strasbourg; Ligue Contre le Cancer; Alsace Contre le Cancer; Association pour la Recherche sur les Tumeurs Prostatiques (ARTP)	University of Strasbourg; Ligue Contre le Cancer(Ligue nationale contre le cancer); Alsace Contre le Cancer; Association pour la Recherche sur les Tumeurs Prostatiques (ARTP)	This work was supported by the University of Strasbourg; the Ligue Contre le Cancer, the Alsace Contre le Cancer; and the Association pour la Recherche sur les Tumeurs Prostatiques (ARTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Bergerat JP, 2009, HUM MUTAT, V30, P145, DOI 10.1002/humu.20848; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Ceraline J, 2004, INT J CANCER, V108, P152, DOI 10.1002/ijc.11404; Clarke NW, 2009, ASIAN J ANDROL, V11, P57, DOI 10.1038/aja.2008.29; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Gustavsson H, 2005, PROSTATE, V62, P364, DOI 10.1002/pros.20145; Guyader C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042252; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Jennbacken K, 2006, PROSTATE, V66, P1631, DOI 10.1002/pros.20469; Jennbacken K, 2010, ENDOCR-RELAT CANCER, V17, P469, DOI 10.1677/ERC-10-0015; Jin JK, 2011, INT J CANCER, V128, P2545, DOI 10.1002/ijc.26024; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Lapouge G, 2008, ADV EXP MED BIOL, V617, P529, DOI 10.1007/978-0-387-69080-3_53; Lapouge G, 2007, INT J CANCER, V121, P1238, DOI 10.1002/ijc.22830; Li G, 2001, CANCER RES, V61, P3819; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcias G, 2010, HUM MUTAT, V31, P74, DOI 10.1002/humu.21138; McKeithen D, 2010, PROSTATE, V70, P982, DOI 10.1002/pros.21132; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Nalla AK, 2011, EXP CELL RES, V317, P2512, DOI 10.1016/j.yexcr.2011.07.024; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Takayama K, 2007, ONCOGENE, V26, P4453, DOI 10.1038/sj.onc.1210229; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Tiwari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057329; Tomita K, 2000, CANCER RES, V60, P3650; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107	41	36	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63466	10.1371/journal.pone.0063466	http://dx.doi.org/10.1371/journal.pone.0063466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658830	gold, Green Published, Green Submitted			2022-12-27	WOS:000321200500072
J	Gao, N; Yang, N; Tang, JJ				Gao, Nan; Yang, Ning; Tang, Jijun			Ancestral Genome Inference Using a Genetic Algorithm Approach	PLOS ONE			English	Article							INVERSION	Recent advancement of technologies has now made it routine to obtain and compare gene orders within genomes. Rearrangements of gene orders by operations such as reversal and transposition are rare events that enable researchers to reconstruct deep evolutionary histories. An important application of genome rearrangement analysis is to infer gene orders of ancestral genomes, which is valuable for identifying patterns of evolution and for modeling the evolutionary processes. Among various available methods, parsimony-based methods (including GRAPPA and MGR) are the most widely used. Since the core algorithms of these methods are solvers for the so called median problem, providing efficient and accurate median solver has attracted lots of attention in this field. The "double-cut-and-join" (DCJ) model uses the single DCJ operation to account for all genome rearrangement events. Because mathematically it is much simpler than handling events directly, parsimony methods using DCJ median solvers has better speed and accuracy. However, the DCJ median problem is NP-hard and although several exact algorithms are available, they all have great difficulties when given genomes are distant. In this paper, we present a new algorithm that combines genetic algorithm (GA) with genomic sorting to produce a new method which can solve the DCJ median problem in limited time and space, especially in large and distant datasets. Our experimental results show that this new GA-based method can find optimal or near optimal results for problems ranging from easy to very difficult. Compared to existing parsimony methods which may severely underestimate the true number of evolutionary events, the sorting-based approach can infer ancestral genomes which are much closer to their true ancestors. The code is available at http://phylo.cse.sc.edu.	[Tang, Jijun] Tianjin Univ, Tianjin Key Lab Cognit Comp & Applicat, Tianjin 300072, Peoples R China; [Gao, Nan; Tang, Jijun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA; [Yang, Ning] Northwestern Polytech Univ, Sch Automat, Xian 710072, Shaanxi, Peoples R China	Tianjin University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Northwestern Polytechnical University	Tang, JJ (corresponding author), Tianjin Univ, Tianjin Key Lab Cognit Comp & Applicat, Tianjin 300072, Peoples R China.	jtang@cse.sc.edu	Tang, Jijun/ABH-6528-2020		National Science Foundation (NSF) [0904179]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by a National Science Foundation (NSF) grant (Number 0904179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron A, 2006, LECT NOTES COMPUT SC, V4175, P163; Bourque G, 2002, GENOME RES, V12, P26; Bulteau L, 2012, SIAM J DISCRETE MATH, V26, P1148, DOI 10.1137/110851390; Caprara A., 2001, Algorithms in Bioinformatics. First International Workshop, WABI 2001. Proceedings (Lecture Notes in Computer Science Vol.2149), P238; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Haghighi M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S5; Hannenhalli S., 1995, Proceedings of the Twenty-Seventh Annual ACM Symposium on the Theory of Computing, P178, DOI 10.1145/225058.225112; Hill T, 2005, BBA-GEN SUBJECTS, V1725, P19, DOI 10.1016/j.bbagen.2005.04.027; Holland, 1975, ADAPTATION NATURAL A; Mitra AP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-159; Moret B M, 2001, Pac Symp Biocomput, P583; Moret BME, 2002, LECT NOTES COMPUT SC, V2452, P521; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; RAUBESON LA, 1992, SCIENCE, V255, P1697, DOI 10.1126/science.255.5052.1697; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Sankoff D, 1998, J COMPUT BIOL, V5, P555, DOI 10.1089/cmb.1998.5.555; Tannier E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-120; Unger R, 1993, 5 INT C GEN ALG; Xu AW, 2008, 8 INT WORKSH ALG BIO, P25; Yancopoulos S, 2005, BIOINFORMATICS, V21, P3340, DOI 10.1093/bioinformatics/bti535	20	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62156	10.1371/journal.pone.0062156	http://dx.doi.org/10.1371/journal.pone.0062156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658708	gold, Green Published, Green Submitted			2022-12-27	WOS:000321200500016
J	Jongeneel-Grimen, B; Busschers, W; Droomers, M; van Oers, HAM; Stronks, K; Kunst, AE				Jongeneel-Grimen, Birthe; Busschers, Wim; Droomers, Mariel; van Oers, Hans A. M.; Stronks, Karien; Kunst, Anton E.			Change in Neighborhood Traffic Safety: Does It Matter in Terms of Physical Activity?	PLOS ONE			English	Article							BUILT-ENVIRONMENT; LOCAL NEIGHBORHOOD; WALKING ACTIVITY; ASSOCIATIONS; PERCEPTIONS; ADULTS; ATTRIBUTES; MULTILEVEL; SAMPLE	Background: There is limited evidence on the causality of previously observed associations between neighborhood traffic safety and physical activity (PA). This study aims to contribute to this evidence by assessing the extent to which changes over time in neighborhood traffic safety were associated with PA. Methods: Data were accessed from the national survey Netherlands Housing Research for 2006 and 2009. The two samples of in total 57,092 Dutch residents aged 18-84 years lived in 320 neighbourhoods. Using multi-level hurdle models, the authors assessed whether the odds of being physically active and the mean hours of PA among active people (in 2009) were related to the levels of neighborhood traffic safety (in 2006) and changes in the levels of neighborhood traffic safety (between 2006 and 2009). Next, we examined if these associations varied according to gender, age, and employment status. Results: Higher levels of neighborhood traffic safety were associated with higher odds of being active (OR 1.080 (1.025-1.139)). An increase in levels of neighborhood traffic safety was associated with increased odds of being active (OR 1.060 (1.006-1.119)). This association was stronger among women, people aged 35 to 59, and those who were gainfully employed. Neither levels of traffic safety nor changes in these levels were associated with the mean hours of PA among people who were physically active (OR 0.997 (0.975-1.020); OR 1.001 (0.978-1.025), respectively). Conclusion: Not only levels of neighborhood traffic safety, but also increases in neighborhood traffic safety were related to increased odds of being active. This relationship supports claims for a causal relationship between neighborhood traffic safety and PA.	[Jongeneel-Grimen, Birthe; Busschers, Wim; Droomers, Mariel; Stronks, Karien; Kunst, Anton E.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [van Oers, Hans A. M.] Natl Inst Publ Hlth & Environm, Ctr Publ Hlth Status & Forecasting, NL-3720 BA Bilthoven, Netherlands; [van Oers, Hans A. M.] Tilburg Univ, Acad Collaborat, Ctr Publ Hlth Brabant, Fac Social Sci, NL-5000 LE Tilburg, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment; Tilburg University	Jongeneel-Grimen, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.jongeneel@amc.uva.nl		Stronks, Karien/0000-0002-0921-2232; Kunst, Anton/0000-0002-3313-5273; van Oers, Hans/0000-0003-4063-2240	Netherlands Organization for Health Research and Development(ZonMW)	Netherlands Organization for Health Research and Development(ZonMW)(Netherlands Organization for Health Research and Development)	The present study is part of the URBAN40 study, which is supported by a grant of The Netherlands Organization for Health Research and Development(ZonMW) (http://www.zonmw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy CL, 2004, AM J PUBLIC HEALTH, V94, P440, DOI 10.2105/AJPH.94.3.440; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Boone-Heinonen J, 2011, PSYCHOL SPORT EXERC, V12, P54, DOI 10.1016/j.psychsport.2009.09.003; BUHMANN B, 1988, REV INCOME WEALTH, P115; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P143; Cochrane T, 2009, INT J ENV RES PUB HE, V6, P654, DOI 10.3390/ijerph6020654; De Bourdeaudhuij I, 2005, PUBLIC HEALTH NUTR, V8, P886, DOI 10.1079/PHN2005735; De Bourdeaudhuij I, 2003, AM J HEALTH PROMOT, V18, P83, DOI 10.4278/0890-1171-18.1.83; De Greef K, 2011, HEALTH SOC CARE COMM, V19, P178, DOI 10.1111/j.1365-2524.2010.00958.x; de Vries SI, 2007, AM J HEALTH PROMOT, V21, P312, DOI 10.4278/0890-1171-21.4s.312; Duncan M, 2005, INT J BEHAV NUTR PHY, V2, pe11; Foster C, 2004, J EPIDEMIOL COMMUN H, V58, P924, DOI 10.1136/jech.2003.014068; Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115; Giles-Corti B, 2006, PREV MED, V42, P455, DOI 10.1016/j.ypmed.2006.01.019; Hall KS, 2010, HEALTH EDUC RES, V25, P478, DOI 10.1093/her/cyq019; Hoehner CM, 2005, AM J PREV MED, V28, P105, DOI 10.1016/j.amepre.2004.10.023; Hooker Steven P, 2005, Prev Chronic Dis, V2, pA11; Humpel N, 2004, ANN BEHAV MED, V27, P60, DOI 10.1207/s15324796abm2701_8; Inoue S, 2010, J EPIDEMIOL, V20, P277, DOI 10.2188/jea.JE20090120; Ishii K, 2010, JPN J PHYS FIT SPORT, V59, P215, DOI 10.7600/jspfsm.59.215; Lee C, 2008, BUILD RES INF, V36, P395, DOI 10.1080/09613210802045547; Leslie E, 2005, HEALTH PLACE, V11, P227, DOI 10.1016/j.healthplace.2004.05.005; Li FZ, 2005, J EPIDEMIOL COMMUN H, V59, P558, DOI 10.1136/jech.2004.028399; Matthews C.E., 2002, PHYS ACTIVITY ASSESS, P107; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; McGinn AP, 2007, J URBAN HEALTH, V84, P162, DOI 10.1007/s11524-006-9136-4; Nagel CL, 2008, AM J EPIDEMIOL, V168, P461, DOI 10.1093/aje/kwn158; Oxley J, 1997, ACCIDENT ANAL PREV, V29, P839, DOI 10.1016/S0001-4575(97)00053-5; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Schwanen T, 2004, URBAN STUD, V41, P579, DOI 10.1080/0042098042000178690; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Sugiyama T, 2009, HEALTH PLACE, V15, P1058, DOI 10.1016/j.healthplace.2009.05.001; Taylor LM, 2008, ANN BEHAV MED, V35, P170, DOI 10.1007/s12160-008-9021-3; Timperio A, 2004, PREV MED, V38, P39, DOI 10.1016/j.ypmed.2003.09.026; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troped PJ, 2003, PREV MED, V37, P304, DOI 10.1016/S0091-7435(03)00137-3; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Vlakveld W.P., 2008, BELEVING VERKEERSONV; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wen XJ, 2009, J ENVIRON HEALTH, V72, P40; Wilcox S, 2003, J GERONTOL B-PSYCHOL, V58, pP329, DOI 10.1093/geronb/58.6.P329	43	23	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62525	10.1371/journal.pone.0062525	http://dx.doi.org/10.1371/journal.pone.0062525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AF	23658741	gold, Green Published, Green Submitted			2022-12-27	WOS:000321200500028
J	Delnooz, CCS; Pasman, JW; Beckmann, CF; van de Warrenburg, BPC				Delnooz, Catherine C. S. y; Pasman, Jaco W.; Beckmann, Christian F.; van de Warrenburg, Bart P. C.			Task-Free Functional MRI in Cervical Dystonia Reveals Multi-Network Changes That Partially Normalize with Botulinum Toxin	PLOS ONE			English	Article							FOCAL HAND DYSTONIA; IDIOPATHIC TORSION DYSTONIA; VOXEL-BASED MORPHOMETRY; STATE BRAIN NETWORKS; GRAY-MATTER CHANGES; WRITERS CRAMP; BASAL-GANGLIA; SENSORIMOTOR INTEGRATION; SPASMODIC TORTICOLLIS; MOTOR	Cervical dystonia is characterized by involuntary, abnormal movements and postures of the head and neck. Current views on its pathophysiology, such as faulty sensorimotor integration and impaired motor planning, are largely based on studies of focal hand dystonia. Using resting state fMRI, we explored whether cervical dystonia patients have altered functional brain connectivity compared to healthy controls, by investigating 10 resting state networks. Scans were repeated immediately before and some weeks after botulinum toxin injections to see whether connectivity abnormalities were restored. We here show that cervical dystonia patients have reduced connectivity in selected regions of the prefrontal cortex, premotor cortex and superior parietal lobule within a distributed network that comprises the premotor cortex, supplementary motor area, primary sensorimotor cortex, and secondary somatosensory cortex ( sensorimotor network). With regard to a network originating from the occipital cortex ( primary visual network), selected regions in the prefrontal and premotor cortex, superior parietal lobule, and middle temporal gyrus areas have reduced connectivity. In selected regions of the prefrontal, premotor, primary motor and early visual cortex increased connectivity was found within a network that comprises the prefrontal cortex including the anterior cingulate cortex and parietal cortex ( executive control network). Botulinum toxin treatment resulted in a partial restoration of connectivity abnormalities in the sensorimotor and primary visual network. These findings demonstrate the involvement of multiple neural networks in cervical dystonia. The reduced connectivity within the sensorimotor and primary visual networks may provide the neural substrate to expect defective motor planning and disturbed spatial cognition. Increased connectivity within the executive control network suggests excessive attentional control and while this may be a primary trait, perhaps contributing to abnormal motor control, this may alternatively serve a compensatory function in order to reduce the consequences of the motor planning defect inflicted by the other network abnormalities.	[Delnooz, Catherine C. S. y; Pasman, Jaco W.; van de Warrenburg, Bart P. C.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Beckmann, Christian F.] Univ Twente, MIRA Inst, NL-7500 AE Enschede, Netherlands; [Beckmann, Christian F.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Twente; Radboud University Nijmegen	van de Warrenburg, BPC (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	B.vandewarrenburg@neuro.umcn.nl	Beckmann, Christian F./E-6374-2012	Beckmann, Christian F./0000-0002-3373-3193	Netherlands Brain Foundation; Prinses Beatrix Fonds; Gossweiler Foundation; Royal Dutch Society for Physical therapy	Netherlands Brain Foundation; Prinses Beatrix Fonds; Gossweiler Foundation; Royal Dutch Society for Physical therapy	BvdW receives research support from the Netherlands Brain Foundation, the Prinses Beatrix Fonds, the Gossweiler Foundation, and the Royal Dutch Society for Physical therapy. The other authors have nothing to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blood AJ, 2004, ANN NEUROL, V55, P744, DOI 10.1002/ana.20108; Bradley D, 2009, BRAIN, V132, P2327, DOI 10.1093/brain/awp156; Byrnes ML, 1998, BRAIN, V121, P977, DOI 10.1093/brain/121.5.977; Cakmur Raif, 2004, Adv Neurol, V94, P37; Castrop F., 2012, MOV DISORD; CeballosBaumann AO, 1997, BRAIN, V120, P571, DOI 10.1093/brain/120.4.571; Consky E, 1990, NEUROLOGY, V40; Curra A, 2004, MOVEMENT DISORD, V19, pS60, DOI 10.1002/mds.20011; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Vries PM, 2008, CLIN NEUROL NEUROSUR, V110, P120, DOI 10.1016/j.clineuro.2007.09.020; de Vries PM, 2012, CLIN NEUROL NEUROSUR, V114, P914, DOI 10.1016/j.clineuro.2012.02.006; de Vries PM, 2009, BRAIN RES, V1285, P58, DOI 10.1016/j.brainres.2009.06.006; Deco G, 2004, EUR J NEUROSCI, V20, P1089, DOI 10.1111/j.1460-9568.2004.03528.x; Defazio G, 2004, LANCET NEUROL, V3, P673, DOI 10.1016/S1474-4422(04)00907-X; Delmaire C, 2005, NEUROLOGY, V64, P1391, DOI 10.1212/01.WNL.0000158424.01299.76; Delnooz CC, 2012, MOV DISORD; Draganski B, 2003, NEUROLOGY, V61, P1228, DOI 10.1212/01.WNL.0000094240.93745.83; Edwards MJ, 2011, MOVEMENT DISORD, V26, P1969, DOI 10.1002/mds.23920; Egger K, 2007, MOVEMENT DISORD, V22, P1538, DOI 10.1002/mds.21619; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fiorio M, 2007, NEUROPSYCHOLOGIA, V45, P2346, DOI 10.1016/j.neuropsychologia.2007.02.005; Forss N, 1998, BRAIN RES, V781, P259, DOI 10.1016/S0006-8993(97)01240-7; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Galati G, 2010, EXP BRAIN RES, V206, P109, DOI 10.1007/s00221-010-2168-8; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hallett M, 2011, NEUROBIOL DIS, V42, P177, DOI 10.1016/j.nbd.2010.08.025; Hanajima R, 1998, ELECTROMYOGR MOTOR C, V109, P391, DOI 10.1016/S0924-980X(98)00036-8; Hanakawa T, 2011, NEUROSCI RES, V70, P144, DOI 10.1016/j.neures.2011.02.010; Hinse P, 1996, J NEUROL, V243, P29; KAJI R, 1995, BRAIN, V118, P511, DOI 10.1093/brain/118.2.511; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Mohammadi B, 2012, HUM BRAIN MAPP, V33, P840, DOI 10.1002/hbm.21250; Moore RD, 2012, NEUROIMAGE, V61, P823, DOI 10.1016/j.neuroimage.2012.03.066; Muller SV, 2005, MOVEMENT DISORD, V20, P58, DOI 10.1002/mds.20293; Munneke J, 2010, BRAIN COGNITION, V72, P368, DOI 10.1016/j.bandc.2009.11.001; Naumann M, 2000, ANN NEUROL, V47, P322, DOI 10.1002/1531-8249(200003)47:3<322::AID-ANA7>3.0.CO;2-E; Nelson RJ, 1996, CURR OPIN NEUROBIOL, V6, P801, DOI 10.1016/S0959-4388(96)80031-6; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Obermann M, 2008, EUR J NEUROL, V15, P831, DOI 10.1111/j.1468-1331.2008.02196.x; Obermann M, 2010, MOVEMENT DISORD, V25, P2627, DOI 10.1002/mds.23321; Opavsky R, 2012, INT J NEUROSCI, V122, P45, DOI 10.3109/00207454.2011.623807; Pantano P, 2011, AM J NEURORADIOL, V32, P81, DOI 10.3174/ajnr.A2242; Peller M, 2006, BRAIN, V129, P2697, DOI 10.1093/brain/awl181; Playford ED, 1998, MOVEMENT DISORD, V13, P309; Ploner CJ, 2005, NEUROLOGY, V64, P1733, DOI 10.1212/01.WNL.0000161869.83783.05; Poser BA, 2006, MAGN RESON MED, V55, P1227, DOI 10.1002/mrm.20900; Possin KL, 2010, NEUROCASE, V16, P466, DOI 10.1080/13554791003730600; Quartarone A, 2008, J NEUROL NEUROSUR PS, V79, P985, DOI 10.1136/jnnp.2007.121632; Quartarone A, 2005, MOVEMENT DISORD, V20, P1488, DOI 10.1002/mds.20626; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Scontrini A, 2011, MOVEMENT DISORD, V26, P742, DOI 10.1002/mds.23447; Shamim EA, 2011, MOVEMENT DISORD, V26, P2107, DOI 10.1002/mds.23827; Siggelkow S, 2002, J CLIN NEUROPHYSIOL, V19, P232, DOI 10.1097/00004691-200206000-00006; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SB, 2009, BEHAV BRAIN RES, V196, P180, DOI 10.1016/j.bbr.2008.09.034; Stamelou M, 2012, BRAIN, V135, P1668, DOI 10.1093/brain/awr224; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Thickbroom GW, 2003, MOVEMENT DISORD, V18, P395, DOI 10.1002/mds.10383; Thomson RHS, 2008, CLIN NEUROPHYSIOL, V119, P52, DOI 10.1016/j.clinph.2007.09.060; Trompetto C, 2006, MOVEMENT DISORD, V21, P777, DOI 10.1002/mds.20801; VANDERKAMP W, 1995, MOVEMENT DISORD, V10, P630, DOI 10.1002/mds.870100516; Walsh RA, 2009, J NEUROL, V256, P1307, DOI 10.1007/s00415-009-5119-1; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558	72	80	81	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62877	10.1371/journal.pone.0062877	http://dx.doi.org/10.1371/journal.pone.0062877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650536	Green Published, gold			2022-12-27	WOS:000319167000081
J	Ghazvini, M; Movahedinia, N; Jamshidi, K				Ghazvini, Mahdieh; Movahedinia, Naser; Jamshidi, Kamal			GTXOP: A Game Theoretic Approach for QoS Provisioning Using Transmission Opportunity Tuning	PLOS ONE			English	Article							TXOP; ALLOCATION; NETWORKS; FAIRNESS; SCHEME; ACCESS; MAC	In unsupervised contention-based networks such as EDCA mode of IEEE 802.11(e)(s), upon winning the channel, each node gets a transmission opportunity (TXOP) in which the node can transmit multiple frames consequently without releasing the channel. Adjusting TXOP can lead to better bandwidth utilization and QoS provisioning. To improve WLAN throughput performance, EDCA packet bursting can be used in 802.11e, meaning that once a station has gained an EDCA-TXOP, it can be allowed to transmit more than one frame without re-contending for the channel. Following the access to the channel, the station can send multiple frames as long as the total access time does not exceed the TXOP Limit. This mechanism can reduce the network overhead and increase the channel utilization instead. However, packet bursting may cause unfairness in addition to increasing jitter, delay and loss. To the best of the authors' knowledge, although TXOP tuning has been investigated through different methods, it has not been considered within a game theory framework. In this study, based on the analytical models of EDCA, a game theoretic approach called GTXOP is proposed to determine TXOP dynamically (i.e. according to the dynamisms of WLAN networks and the number of nodes in the network). Using GTXOP, each node can choose its TXOP autonomously, such that in addition to QoS improvement, the overall network performance is also improved.	[Ghazvini, Mahdieh; Movahedinia, Naser; Jamshidi, Kamal] Univ Isfahan, Fac Engn, Dept Comp Engn, Esfahan, Iran	University of Isfahan	Ghazvini, M (corresponding author), Univ Isfahan, Fac Engn, Dept Comp Engn, Esfahan, Iran.	ghazvini@eng.ui.ac.ir	Ghazvini, Mahdieh/AAC-1630-2022	Ghazvini, Mahdieh/0000-0002-3647-2101	Iran Telecommunication Research Centre (ITRC) [18507/500/T]	Iran Telecommunication Research Centre (ITRC)	This work was partially supported by the Iran Telecommunication Research Centre (ITRC No. 18507/500/T). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YW, 2011, IEEE SYST J, V5, P486, DOI 10.1109/JSYST.2011.2165598; Akkarajitsakul K, 2011, IEEE COMMUN MAG, V49, P120, DOI 10.1109/MCOM.2011.5978425; Andreadis A, 2012, INT J WIREL INF NETW, V19, P49, DOI 10.1007/s10776-011-0162-0; Banchs A, 2011, IEEE ACM T IN PRESS; Bianchi G, 2000, IEEE J SEL AREA COMM, V18, P535, DOI 10.1109/49.840210; Cagalj M, 2005, IEEE INFOCOM SER, P2513; Charilas Dimitris E., 2010, COMPUTER NETWORKS; Chen LJ, 2010, IEEE ACM T NETWORK, V18, P1303, DOI 10.1109/TNET.2010.2041066; Datta BN, 2010, NUMERICAL LINEAR ALG; Felegyhazi M, 2006, DISTR COMP SYST WORK, P36; Felegyhazi M., 2006, LCAREPORT2006002 EPF; Felegyhazi M, 2007, IEEE INFOCOM SER, P1442, DOI 10.1109/INFCOM.2007.170; Felegyhazi M, 2009, IEEE T WIREL COMMUN, V8, P1984, DOI 10.1109/TWC.2009.080284; Georgiev V, 2008, USING GAME THEORY AN; Ghasemi A, 2010, COMPUT COMMUN, V33, P1440, DOI 10.1016/j.comcom.2010.03.022; Ghazvini M, 2012, IEEE COMMUN IN PRESS; Hu J, 2012, INFORM SCIENCES, V214, P20, DOI 10.1016/j.ins.2012.05.013; Hu J, 2011, COMPUT COMMUN, V34, P1593, DOI 10.1016/j.comcom.2010.08.004; Huang JJ, 2008, 5 IFIP INT C WIR OPT; Huang ML, 2007, ELE COM ENG, P13; IEEE 802.11 Working Group, 2007, 80211 IEEE; Kim EK, 2005, 60 VEH TECHN C 2004, P2678; Kim E, 2007, IEEE ICC, P4523, DOI 10.1109/ICC.2007.747; Kwangsung Ju, 2012, Proceedings of the 2012 8th International Conference on Computing Technology and Information Management (NCM and ICNIT), P721; Lee D, 2012, INT J COMPUT SCI NET, V12, P33; Lee JY, 2011, 2011 IEEE 22ND INTERNATIONAL SYMPOSIUM ON PERSONAL INDOOR AND MOBILE RADIO COMMUNICATIONS (PIMRC), P935, DOI 10.1109/PIMRC.2011.6140106; Manshaei M., 2007, SPECTRUM SHARING GAM; Mehta S., 2010, CONVERGENCE HYBRID I; Min GY, 2008, IEEE ICC, P2632, DOI 10.1109/ICC.2008.498; Min GY, 2011, COMPUT NETW, V55, P2545, DOI 10.1016/j.comnet.2011.04.015; Rashwand S, 2012, AD HOC NETW, V10, P162, DOI 10.1016/j.adhoc.2010.07.010; Rashwand S, 2011, IEEE T VEH TECHNOL, V60, P1099, DOI 10.1109/TVT.2011.2107928; Romdhani L, 2007, 3 IEEE INT C WIR MOB, P68; Saad W, 2012, ARXIV12020452; Serrano P, 2010, IEEE COMMUN LETT, V14, P142, DOI 10.1109/LCOMM.2010.02.092026; Srivastava V, 2005, IEEE COMMUN SURV TUT, V7, P46, DOI 10.1109/COMST.2005.1593279; Taher NC, 2011, J COMPUT NETW COMMUN, V2011, DOI 10.1155/2011/136585; Tao ZF, 2004, WRKS LOC METRO AREA, P39, DOI 10.1109/LANMAN.2004.1338397; Tinnirello I, 2005, I S WORLD WIREL MOBI, P220, DOI 10.1109/WOWMOM.2005.101	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62925	10.1371/journal.pone.0062925	http://dx.doi.org/10.1371/journal.pone.0062925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650539	gold, Green Published			2022-12-27	WOS:000319167000084
J	Needham, SR; Hirsch, M; Rolfe, DJ; Clarke, DT; Zanetti-Domingues, LC; Wareham, R; Martin-Fernandez, ML				Needham, Sarah R.; Hirsch, Michael; Rolfe, Daniel J.; Clarke, David T.; Zanetti-Domingues, Laura C.; Wareham, Richard; Martin-Fernandez, Marisa L.			Measuring EGFR Separations on Cells with similar to 10 nm Resolution via Fluorophore Localization Imaging with Photobleaching	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MOLECULE FLUORESCENCE MICROSCOPY; RECEPTOR TYROSINE KINASES; PLASMA-MEMBRANE; A431 CELLS; DOMAIN ORGANIZATION; CRYSTAL-STRUCTURE; ACTIVATION; DIMERIZATION; BINDING	Detecting receptor dimerisation and other forms of clustering on the cell surface depends on methods capable of determining protein-protein separations with high resolution in the similar to 10-50 nm range. However, this distance range poses a significant challenge because it is too large for fluorescence resonance energy transfer and contains distances too small for all other techniques capable of high-resolution in cells. Here we have adapted the technique of fluorophore localisation imaging with photobleaching to measure inter-receptor separations in the cellular environment. Using the epidermal growth factor receptor, a key cancer target molecule, we demonstrate,10 nm resolution while continuously covering the range of similar to 10-80 nm. By labelling the receptor on cells expressing low receptor numbers with a fluorescent antagonist we have found inter-receptor separations all the way up from 8 nm to 59 nm. Our data are consistent with epidermal growth factor receptors being able to form homo-polymers of at least 10 receptors in the absence of activating ligands.	[Needham, Sarah R.; Hirsch, Michael; Rolfe, Daniel J.; Clarke, David T.; Zanetti-Domingues, Laura C.; Martin-Fernandez, Marisa L.] Harwell Oxford, STFC Rutherford Appleton Lab, Cent Laser Facil, Res Complex Harwell, Didcot, Oxon, England; [Wareham, Richard] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Cambridge	Martin-Fernandez, ML (corresponding author), Harwell Oxford, STFC Rutherford Appleton Lab, Cent Laser Facil, Res Complex Harwell, Didcot, Oxon, England.	marisa.martin-fernandez@stfc.ac.uk	Zanetti-Domingues, Laura Carolina/GWB-9443-2022; Zanetti-Domingues, Laura Carolina/AAJ-1387-2021	Zanetti-Domingues, Laura Carolina/0000-0003-0514-3185; Zanetti-Domingues, Laura Carolina/0000-0003-0514-3185; Needham, Sarah/0000-0002-3311-1036; Hirsch, Michael/0000-0001-6183-6256; Clarke, David/0000-0002-8776-1341; Rolfe, Daniel/0000-0002-8394-8395; martin-fernandez, marisa/0000-0001-5496-6300	Biotechnology and Biological Sciences Research Council [BB/G006911/1]; BBSRC [BB/G007160/1, BB/G006911/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G007160/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council BB/G006911/1. http://www.bbsrc.ac.uk/home/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A, 2010, J BIOL CHEM, V285, P3145, DOI 10.1074/jbc.M109.073338; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Barrera NP, 2011, ANNU REV BIOCHEM, V80, P247, DOI 10.1146/annurev-biochem-062309-093307; BEERLI RR, 1995, MOL CELL BIOL, V15, P6496; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Churchman LS, 2006, BIOPHYS J, V90, P668, DOI 10.1529/biophysj.105.065599; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clayton AHA, 2007, BIOCHEMISTRY-US, V46, P4589, DOI 10.1021/bi700002b; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; DURIG U, 1986, J APPL PHYS, V59, P3318, DOI 10.1063/1.336848; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; HENEGOUWEN PMP, 1992, EXP CELL RES, V199, P90; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; MCCUNE BK, 1989, J BIOL CHEM, V264, P15501; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; NELSON TJ, 1991, J CHROMATOGR, V587, P129, DOI 10.1016/0021-9673(91)85149-A; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Press W. H., 1996, NUMERICAL RECIPES C; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; REES AR, 1984, EMBO J, V3, P1843, DOI 10.1002/j.1460-2075.1984.tb02057.x; Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Schierle GSK, 2011, J AM CHEM SOC, V133, P12902, DOI 10.1021/ja201651w; SONG WX, 1993, BIOCHEMISTRY-US, V32, P8602, DOI 10.1021/bi00084a030; Sorkin A, 2001, BIOCHEM SOC T, V29, P480, DOI 10.1042/BST0290480; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; VANBELZEN N, 1988, J CELL PHYSIOL, V134, P413, DOI 10.1002/jcp.1041340312; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yu CX, 2009, BIOCHEM BIOPH RES CO, V378, P376, DOI 10.1016/j.bbrc.2008.11.018; Zanetti-Domingues LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045655; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	49	29	30	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62331	10.1371/journal.pone.0062331	http://dx.doi.org/10.1371/journal.pone.0062331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650512	gold, Green Published, Green Submitted			2022-12-27	WOS:000319167000042
J	Sauer, J; Oldeland, J; Hausdorf, B				Sauer, Jan; Oldeland, Jens; Hausdorf, Bernhard			Continuing Fragmentation of a Widespread Species by Geographical Barriers as Initial Step in a Land Snail Radiation on Crete	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; GENE FLOW; PHYLOGEOGRAPHIC BREAKS; EVOLUTIONARY HISTORY; Y-CHROMOSOME; SHELL SHAPE; PATTERNS; PULMONATA; SELECTION	The phylogeographic structure of the land snail Xerocrassa mesostena on Crete inferred from AFLP markers and mitochondrial cox1 sequences can be explained by three mechanisms: gene flow restriction, population expansion and leptokurtic dispersal. Gene flow restriction by geographic barriers caused subdivision of the gene pool into distinct clusters. Population expansion was probably facilitated by deforestation of Crete in the postglacial. Newly available areas were colonized by leptokurtic dispersal, i.e. slow active expansion resulting in isolation by distance within the clusters and occasional long distance dispersal events that resulted in departures from the isolation by distance model. Less than one percent of the AFLP markers show correlations with environmental variables. Random phylogeographic breaks in the distribution of the mitochondrial haplotype groups indicate that single locus markers, especially mitochondrial DNA, might result in a misleading picture of the phylogeographic structure of a species. Restriction of gene flow between metapopulations caused by geographical barriers can interact with sexual selection resulting in the differentiation of these metapopulations into separate species without noticeable ecological differentiation. Evidence for gene flow between parapatrically distributed evolutionary units representing different stages of the speciation process suggests that the ongoing process of fragmentation of the X. mesostena complex might be an example for parapatric speciation. The lack of ecological differentiation between these units confirms theoretical predictions that divergent selection for local adaptation is not required for rapid speciation.	[Sauer, Jan] Univ Bielefeld, Dept Chem Ecol, D-33615 Bielefeld, Germany; [Sauer, Jan; Hausdorf, Bernhard] Univ Hamburg, Zool Museum, Hamburg, Germany; [Oldeland, Jens] Univ Hamburg, Biozentrum Klein Flottbek, Hamburg, Germany	University of Bielefeld; University of Hamburg; University of Hamburg	Hausdorf, B (corresponding author), Univ Hamburg, Zool Museum, Hamburg, Germany.	hausdorf@zoologie.uni-hamburg.de	Hausdorf, Bernhard/E-9829-2016	Hausdorf, Bernhard/0000-0002-1604-1689; Oldeland, Jens/0000-0002-7833-4903	Deutsche Forschungsgemeinschaft [HA 2763/3-1,2]; Open Access Publication Funds of Bielefeld University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University	This study was partially funded by the priority program "Radiations - Origins of Biological Diversity'' of the Deutsche Forschungsgemeinschaft (HA 2763/3-1,2). In addition we acknowledge the support for the publication fee by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2004, DISTML V 5 FORTRAN C; ARTER HE, 1990, EVOLUTION, V44, P966, DOI 10.1111/j.1558-5646.1990.tb03818.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Balloux F, 2010, HEREDITY, V104, P419, DOI 10.1038/hdy.2009.122; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Bensch S, 2006, MOL ECOL, V15, P161, DOI 10.1111/j.1365-294X.2005.02766.x; Boissinot S, 1997, GENETICS, V146, P1019; BOTTEMA S, 1980, REV PALAEOBOT PALYNO, V31, P193, DOI 10.1016/0034-6667(80)90027-5; Braaker S, 2009, MOL ECOL, V18, P2518, DOI 10.1111/j.1365-294X.2009.04189.x; Buntjer J, 2001, PHYLTOOLS VERSION 1; Cimmery V, 2010, USER GUIDE SAGA VERS; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coyne J.A., 2004, SPECIATION; CRONIN MA, 1993, WILDLIFE SOC B, V21, P339; Davison A, 2000, P ROY SOC B-BIOL SCI, V267, P1399, DOI 10.1098/rspb.2000.1156; Davison A, 2002, POPUL ECOL, V44, P129, DOI 10.1007/s101440200016; Dorge N., 1999, Zeitschrift fur Okologie und Naturschutz, V8, P1; Douris V, 1998, EVOLUTION, V52, P116, DOI 10.1111/j.1558-5646.1998.tb05144.x; ESRI, 2008, ARCGIS REL 9 3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fraley C, 1999, J CLASSIF, V16, P297, DOI 10.1007/s003579900058; Frenzel B, 1992, ATLAS PALEOCLIMATES; Fu YX, 1997, GENETICS, V147, P915; Gavrilets S, 2000, EVOLUTION, V54, P1126; Gittenberger E., 2004, Basteria, V68, P93; Godinho R, 2008, MOL ECOL, V17, P4670, DOI 10.1111/j.1365-294X.2008.03929.x; Gompert Z, 2008, MOL ECOL, V17, P5231, DOI 10.1111/j.1365-294X.2008.03988.x; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Goodacre SL, 2006, BIOL J LINN SOC, V87, P167, DOI 10.1111/j.1095-8312.2006.00565.x; Goodacre SL, 2001, P ROY SOC B-BIOL SCI, V268, P121, DOI 10.1098/rspb.2000.1339; Greve C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034339; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hausdorf B, 2011, MOL PHYLOGENET EVOL, V60, P89, DOI 10.1016/j.ympev.2011.03.009; Hausdorf B, 2009, ZOOL J LINN SOC-LOND, V157, P373, DOI 10.1111/j.1096-3642.2008.00504.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hennig C, 2008, PRABCLUS PACKAGE VER; Hoekstra P, 2011, J ZOOL SYST EVOL RES, V49, P266, DOI 10.1111/j.1439-0469.2011.00623.x; Hoelzer G, 2001, SELF ORG POPULATION, P71; Hoelzer GA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000126; Hoso M, 2008, AM NAT, V172, P726, DOI 10.1086/591681; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Irwin DE, 2009, BIOL J LINN SOC, V98, P422, DOI 10.1111/j.1095-8312.2009.01282.x; Irwin DE, 2005, SCIENCE, V307, P414, DOI 10.1126/science.1105201; Irwin DE, 2002, EVOLUTION, V56, P2383; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jobb G, 2007, TREEFINDER VERSION N; Johannesson K, 2001, TRENDS ECOL EVOL, V16, P148, DOI 10.1016/S0169-5347(00)02078-4; Johannesson K, 2010, PHILOS T R SOC B, V365, P1735, DOI 10.1098/rstb.2009.0256; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kuo CH, 2005, GENETICA, V124, P179, DOI 10.1007/s10709-005-2095-y; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Maassen W. J. M., 1995, Basteria, V59, P31; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nordsieck Hartmut, 2004, Basteria, V68, P51; Parmakelis A, 2005, EVOLUTION, V59, P991; Pidancier N, 2006, MOL PHYLOGENET EVOL, V40, P739, DOI 10.1016/j.ympev.2006.04.002; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; QUADE J, 1994, PALAEOGEOGR PALAEOCL, V108, P41, DOI 10.1016/0031-0182(94)90021-3; R Core Team, 2021, R LANGUAGE ENV STAT; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Sauer J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-299; Sauer J, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P437, DOI 10.1007/978-3-642-12425-9_20; Sauer J, 2009, EVOLUTION, V63, P2535, DOI 10.1111/j.1558-5646.2009.00751.x; Scheel BM, 2012, MOL ECOL, V21, P3794, DOI 10.1111/j.1365-294X.2012.05649.x; SCHILTHUIZEN M, 1994, EVOLUTION, V48, P577, DOI 10.1111/j.1558-5646.1994.tb01345.x; Schilthuizen M, 2005, J ZOOL SYST EVOL RES, V43, P133, DOI 10.1111/j.1439-0469.2004.00289.x; Schilthuizen M, 2004, BIOL J LINN SOC, V83, P317, DOI 10.1111/j.1095-8312.2004.00391.x; Schilthuizen M, 2012, BIOL J LINN SOC LOND, V105; Schilthuizen M, 2006, EVOLUTION, V60, P1851, DOI 10.1554/06-114.1; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Smith MA, 2004, MOL ECOL, V13, P3723, DOI 10.1111/j.1365-294X.2004.02301.x; Sokolov EP, 2000, J MOLLUS STUD, V66, P573, DOI 10.1093/mollus/66.4.573; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wakeley J, 2000, EVOLUTION, V54, P1092, DOI 10.1111/j.0014-3820.2000.tb00545.x; Watanabe Y, 2001, MOL ECOL, V10, P2635, DOI 10.1046/j.0962-1083.2001.01388.x; Welter-Schultes FW, 2010, ARCH MOLLUSKENKD, V139, P143, DOI 10.1127/arch.moll/1869-0963/139/143-245; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x; Wright S, 1943, GENETICS, V28, P114; Yang DS, 2009, MOL ECOL, V18, P5115, DOI 10.1111/j.1365-294X.2009.04399.x	93	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62569	10.1371/journal.pone.0062569	http://dx.doi.org/10.1371/journal.pone.0062569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658748	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000057
J	Wolinsky, FD; Vander Weg, MW; Howren, MB; Jones, MP; Dotson, MM				Wolinsky, Fredric D.; Vander Weg, Mark W.; Howren, M. Bryant; Jones, Michael P.; Dotson, Megan M.			A Randomized Controlled Trial of Cognitive Training Using a Visual Speed of Processing Intervention in Middle Aged and Older Adults	PLOS ONE			English	Article							FIELD-OF-VIEW; NORMATIVE DATA; HEALTH; DECLINE; IMPACT	Background: Age-related cognitive decline is common and may lead to substantial difficulties and disabilities in everyday life. We hypothesized that 10 hours of visual speed of processing training would prevent age-related declines and potentially improve cognitive processing speed. Methods: Within two age bands (50-64 and >= 65) 681 patients were randomized to (a) three computerized visual speed of processing training arms (10 hours on-site, 14 hours on-site, or 10 hours at-home) or (b) an on-site attention control group using computerized crossword puzzles for 10 hours. The primary outcome was the Useful Field of View (UFOV) test, and the secondary outcomes were the Trail Making (Trails) A and B Tests, Symbol Digit Modalities Test (SDMT), Stroop Color and Word Tests, Controlled Oral Word Association Test (COWAT), and the Digit Vigilance Test (DVT), which were assessed at baseline and at one year. 620 participants (91%) completed the study and were included in the analyses. Linear mixed models were used with Blom rank transformations within age bands. Results: All intervention groups had (p<0.05) small to medium standardized effect size improvements on UFOV (Cohen's d = -0.322 to -0.579, depending on intervention arm), Trails A (d = -0.204 to -0.265), Trails B (d = -0.225 to -0.320), SDMT (d = 0.263 to 0.351), and Stroop Word (d = 0.240 to 0.271). Converted to years of protection against age-related cognitive declines, these effects reflect 3.0 to 4.1 years on UFOV, 2.2 to 3.5 years on Trails A, 1.5 to 2.0 years on Trails B, 5.4 to 6.6 years on SDMT, and 2.3 to 2.7 years on Stroop Word. Conclusion: Visual speed of processing training delivered on-site or at-home to middle-aged or older adults using standard home computers resulted in stabilization or improvement in several cognitive function tests. Widespread implementation of this intervention is feasible.	[Wolinsky, Fredric D.] Univ Iowa, Dept Hlth Management & Policy, Iowa City, IA 52242 USA; [Vander Weg, Mark W.; Howren, M. Bryant] Iowa City VA Hlth Care Syst, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City, IA USA; [Jones, Michael P.] Univ Iowa, Dept Biostat, Iowa City, IA USA; [Dotson, Megan M.] Univ Iowa, Coll Nursing, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa	Wolinsky, FD (corresponding author), Univ Iowa, Dept Hlth Management & Policy, Iowa City, IA 52242 USA.	fredric-wolinsky@uiowa.edu	Wolinsky, Fredric D/F-9231-2011	Vander Weg, Mark/0000-0003-3631-0812; Wolinsky, Fredric/0000-0002-0916-4955	National Institutes of Health (NIH) [RC1 AG-035546]; NATIONAL INSTITUTE ON AGING [RC1AG035546] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (NIH) grant RC1 AG-035546 to FDW. The visual speed of processing training video game used in IHAMS is commercially available from Posit Science Corporation (San Francisco, CA, USA). None of the members of the investigative team have any conflicts of interest or commitment involving Posit Science. Specifically, no one on the investigative team will financially profit in any way from the use of the visual speed of processing training. Posit Science acquired ownership in October 2007 of Ball and Roenker's original speed of processing intervention that was used in the multisite ACTIVE study on which FW was a co-investigator. In collaboration with Professors Ball and Roenker, Posit Science subsequently developed the current version of the VSP training video game used in IHAMS. From December 2007 to March 2009, FW had a part-time consulting arrangement (15 days total) with Posit Science to support additional analyses of the first five-years of the ACTIVE follow-up data that had not been identified in the original ACTIVE protocols nor funded by the various NIH grants supporting ACTIVE. That arrangement was approved in advance by the ACTIVE Executive Committee (which included the NIH project officers), and was approved by the Provost of the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; Ball K, 2010, J AM GERIATR SOC, V58, P2107, DOI 10.1111/j.1532-5415.2010.03138.x; Benton AL, 1994, MULTILINGUAL APHASIA; Birren J. E., 1980, AGING 1980S PSYCHOL, P293; Blom G., 1958, STAT ESTIMATES TRANS; Burdick DJ, 2005, J GERONTOL A-BIOL, V60, P258, DOI 10.1093/gerona/60.2.258; Cahn-Weiner DA, 2000, CLIN NEUROPSYCHOL, V14, P187, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT187; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Doidge N., 2007, BRAIN CHANGES ITSELF; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Edwards JD, 2006, ARCH CLIN NEUROPSYCH, V21, P275, DOI 10.1016/j.acn.2006.03.001; Golden C.J., 1978, STROOP COLOR WORD TE; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Institute of Medicine, 2012, LIV WELL CHRON ILLN; Jobe JB, 2001, CONTROL CLIN TRIALS, V22, P453, DOI 10.1016/S0197-2456(01)00139-8; JONES RN, 2012, J HLTH AGING, DOI DOI 10.1177/0898264312461938; Lewis RF, 1979, MANUAL REPEATABLE CO; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; MADDEN DJ, 1992, J GERONTOL, V47, pP59, DOI 10.1093/geronj/47.2.P59; *NAT AC SCI, 2006, WORKSH ID NEW INT EX; *NIH, 2011, PA 11 123 TRANSL RES; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Reitan RM, 1985, HALSTEAD REITAN NEUR; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; SALTHOUSE TA, 1994, DEV PSYCHOL, V30, P240, DOI 10.1037/0012-1649.30.2.240; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse T, 2012, ANNU REV PSYCHOL, V63, P201, DOI 10.1146/annurev-psych-120710-100328; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Salthouse TA, 2010, NEUROPSYCHOLOGY, V24, P563, DOI 10.1037/a0019026; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Smith A., 1982, SYMBOL DIGIT MODALIT; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; VOGEL A, 2012, NEUROPSYCHO IN PRESS, V28; Wadley VG, 2006, ARCH PHYS MED REHAB, V87, P757, DOI 10.1016/j.apmr.2006.02.027; Wahl HW, 2010, J AGING HEALTH, V22, P691, DOI 10.1177/0898264310372410; Wang HD, 2009, P NATL ACAD SCI USA, V106, P393, DOI 10.1073/pnas.0811809106; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wolinsky FD, 2006, J GERONTOL A-BIOL, V61, P1324, DOI 10.1093/gerona/61.12.1324; Wolinsky FD, 2006, J GERONTOL B-PSYCHOL, V61, pS281, DOI 10.1093/geronb/61.5.S281; Wolinsky FD, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-109; Wolinsky FD, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000218; Wolinsky FD, 2010, INT PSYCHOGERIATR, V22, P470, DOI 10.1017/S1041610209991281; Wolinsky FD, 2010, J GERONTOL A-BIOL, V65, P421, DOI 10.1093/gerona/glp188; Wolinsky FD, 2009, J GERONTOL A-BIOL, V64, P468, DOI 10.1093/gerona/gln044; Wolinsky FD, 2009, J GERONTOL B-PSYCHOL, V64, P577, DOI 10.1093/geronb/gbp061; Zimprich D, 2002, PSYCHOL AGING, V17, P690, DOI 10.1037/0882-7974.17.4.690	53	130	141	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e61624	10.1371/journal.pone.0061624	http://dx.doi.org/10.1371/journal.pone.0061624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23650501	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000018
J	Xu, Y; Xu, QH; Yang, L; Liu, F; Ye, X; Wu, F; Ni, SJ; Tan, C; Cai, GX; Meng, X; Cai, SJ; Du, X				Xu, Ye; Xu, Qinghua; Yang, Li; Liu, Fang; Ye, Xun; Wu, Fei; Ni, Shujuan; Tan, Cong; Cai, Guoxiang; Meng, Xia; Cai, Sanjun; Du, Xiang			Gene Expression Analysis of Peripheral Blood Cells Reveals Toll-Like Receptor Pathway Deregulation in Colorectal Cancer	PLOS ONE			English	Article							PROBE LEVEL; IMMUNITY; BIOCONDUCTOR; INFLAMMATION; FRAMEWORK; GENOMICS; RISK	Colorectal cancer is the leading cause of cancer-related deaths worldwide. The disease is curable when detected at an early stage. However, the compliance rate with current screening recommendations remains poor. An accurate, minimally invasive blood test that has the potential for greater patient compliance would be a welcome addition to the current methods. Recent data have shown that gene expression profile of peripheral blood cells can reflect disease states and thus have diagnostic value. In this study, genome-wide gene expression profiling of peripheral blood cells from 20 healthy controls and 20 colorectal cancer patients were performed using PAXgene (TM) technology and Affymetrix GeneChip (R) microarrays. We identified a list of 1,469 genes that were differentially expressed between the healthy controls and cancer patients. Gene annotation and functional enrichment analysis revealed that those genes are mainly related to immune functions. Particularly, a set of genes belonging to the Toll-Like Receptor pathways were up-regulated in the colorectal cancer patients. These findings provide a new understanding of blood gene expression profile in colorectal cancer. Our result may serve as the basis for further development of blood biomarkers for the diagnosis and treatment of colorectal cancer.	[Xu, Ye; Xu, Qinghua; Yang, Li; Ni, Shujuan; Tan, Cong; Cai, Guoxiang; Cai, Sanjun; Du, Xiang] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Xu, Ye; Yang, Li; Cai, Guoxiang; Cai, Sanjun] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200433, Peoples R China; [Ni, Shujuan; Tan, Cong; Du, Xiang] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Xu, Qinghua; Liu, Fang; Ye, Xun; Wu, Fei; Meng, Xia] Fudan Univ, Shanghai Canc Ctr, Inst Merieux Lab, Shanghai, Peoples R China; [Xu, Qinghua; Liu, Fang; Ye, Xun; Wu, Fei; Meng, Xia] BioMerieux Shanghai Co Ltd, Shanghai, Peoples R China; [Ni, Shujuan; Tan, Cong; Du, Xiang] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Ni, Shujuan; Tan, Cong; Du, Xiang] Fudan Univ, Inst Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Yang, L (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China.	10211230016@fudan.edu.cn; caisanjun@csco.org.cn; dx2008cn@163.com	XU, Qinghua/AAZ-9641-2021	XU, Qinghua/0000-0002-9380-5566	Chinese National Clinical Key Discipline; Shanghai Science and Technology Commission of Shanghai Municipality [10DJ1400500]; bioMerieux company	Chinese National Clinical Key Discipline; Shanghai Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); bioMerieux company	This work was supported by bioMerieux company. This study was also supported by grants from the Chinese National Clinical Key Discipline (2011-2012) and the Shanghai Science and Technology Commission of Shanghai Municipality (number 10DJ1400500). As QX, FW, FL, XY, BM and XM are the employees of bioMerieux company and have contributed to this work, hence, as one of the funders, bioMerieux company played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aaroe J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2472; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blake JA, 2008, CURR PROTOC BIOINFOR, P2; Burczynski ME, 2006, PHARMACOGENOMICS, V7, P187, DOI 10.2217/14622416.7.2.187; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Marshall KW, 2010, INT J CANCER, V126, P1177, DOI 10.1002/ijc.24910; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Qin LX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-23; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Rotunno M, 2011, CANCER PREV RES, V4, P1599, DOI 10.1158/1940-6207.CAPR-10-0170; Sato Y, 2009, CANCER MICROENVIRON, V2, pS205, DOI 10.1007/s12307-009-0022-y; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Stamova BS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-49; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tsai CA, 2003, BIOMETRICS, V59, P1071, DOI 10.1111/j.0006-341X.2003.00123.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1288, DOI 10.1001/jama.289.10.1288; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Xu Y, 2011, CANCER BIOL THER, V11, P188, DOI 10.4161/cbt.11.2.13670; Yang BL, 2010, CANCER BIOL THER, V10, P1235, DOI 10.4161/cbt.10.12.13437; Zander T, 2011, CLIN CANCER RES, V17, P3360, DOI 10.1158/1078-0432.CCR-10-0533; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	47	7	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62870	10.1371/journal.pone.0062870	http://dx.doi.org/10.1371/journal.pone.0062870			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650534	Green Submitted, Green Published, gold			2022-12-27	WOS:000319167000079
J	Zhou, S; Raj, SM; Ashok, S; Edwardraja, S; Lee, SG; Park, S				Zhou, Shengfang; Raj, Subramanian Mohan; Ashok, Somasundar; Edwardraja, Selvakumar; Lee, Sun-gu; Park, Sunghoon			Cloning, Expression and Characterization of 3-Hydroxyisobutyrate Dehydrogenase from Pseudomonas denitrificans ATCC 13867	PLOS ONE			English	Article							ESCHERICHIA-COLI; 3-HYDROXYPROPIONIC ACID; PURIFICATION; SEQUENCE; GENE	The gene encoding an NAD+-dependent, 3-hydroxyisobutyrate dehydrogenase (3HIBDH-IV) from Pseudomonas denitrificans ATCC 13867 was cloned and expressed in Escherichia coli BL 21 (DE3) and characterized to understand its physiological relevance in the degradation of 3-hydroxypropionic acid (3-HP). The deduced amino acid sequence showed high similarity to other 3-hydroxyisobutyrate dehydrogenase isozymes (3HIBDHs) of P. denitrificans ATCC 13867. A comparison of 3HIBDH-IV with its relevant enzymes along with molecular docking studies suggested that Lys171, Asn175 and Gly123 are important for its catalytic function on 3-hydroxyacids. The recombinant 3HIBDH-IV was purified to homogeneity utilizing a Ni-NTA-HP resin column in high yield. 3HIBDH-IV was very specific to (S)-3-hydroxyisobutyrate, but also catalyzed the oxidation of 3-HP to malonate semialdehyde. The specific activity and half-saturation constant (K-m) for 3-HP at 30 degrees C and pH 9.0 were determined to be 17 U/mg protein and 1.0 mM, respectively. Heavy metals, such as Ag+ and Hg2+, completely inhibited the 3HIBDH-IV activity, whereas dithiothreitol, 2-mercaptoethanol and ethylenediaminetetraacetic acid increased its activity 1.5-1.8-fold. This paper reports the characteristics of 3HIBDH-IV as well as its probable role in 3-HP degradation.	[Zhou, Shengfang; Raj, Subramanian Mohan; Ashok, Somasundar; Edwardraja, Selvakumar; Lee, Sun-gu; Park, Sunghoon] Pusan Natl Univ, Dept Chem & Biomol Engn, Pusan, South Korea; [Raj, Subramanian Mohan] PRIST Univ, Ctr Res & Dev, Thanjavur, India; [Edwardraja, Selvakumar] Tech Univ Munich, Lehrstuhl Biol Chem, Freising Weihenstephan, Germany	Pusan National University; PRIST (Deemed to be University); Technical University of Munich	Park, S (corresponding author), Pusan Natl Univ, Dept Chem & Biomol Engn, Pusan, South Korea.	parksh@pusan.ac.kr	Edwardraja, Selvakumar/E-3948-2010; Edwardraja, Selvakumar/X-6434-2019	Edwardraja, Selvakumar/0000-0002-4723-5152; Edwardraja, Selvakumar/0000-0002-4723-5152	Pusan National University; Brain Korea 21 program (Pusan National University)	Pusan National University(Pusan National University); Brain Korea 21 program (Pusan National University)	This work was supported by a 2-Year Research Grant of Pusan National University. The authors are grateful to the Brain Korea 21 program (Pusan National University) for their financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber BE, 2008, J BACTERIOL, V190, P1383, DOI 10.1128/JB.01593-07; BLANCHE F, 1992, J BACTERIOL, V174, P1050, DOI 10.1128/jb.174.3.1050-1052.1992; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chowdhury EK, 2003, BIOSCI BIOTECH BIOCH, V67, P438, DOI 10.1271/bbb.67.438; Chowdhury EK, 1996, BIOSCI BIOTECH BIOCH, V60, P2043, DOI 10.1271/bbb.60.2043; Hawes JW, 1996, FEBS LETT, V389, P263, DOI 10.1016/0014-5793(96)00597-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leal NA, 2003, ARCH MICROBIOL, V180, P353, DOI 10.1007/s00203-003-0601-0; Njau RK, 2001, CHEM-BIOL INTERACT, V130, P785, DOI 10.1016/S0009-2797(00)00234-9; Njau RK, 2000, J BIOL CHEM, V275, P38780, DOI 10.1074/jbc.M007432200; NURMIKKO V, 1972, SUOM KEMISTIL, V45, P193; PACKDIBAMRUNG K, 1993, J BIOCHEM, V114, P930, DOI 10.1093/oxfordjournals.jbchem.a124279; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Raj SM, 2008, PROCESS BIOCHEM, V43, P1440, DOI 10.1016/j.procbio.2008.04.027; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rathnasingh C, 2009, BIOTECHNOL BIOENG, V104, P729, DOI 10.1002/bit.22429; ROUGRAFF PM, 1988, J BIOL CHEM, V263, P327; Sambrook J., 2001, MOL CLONING LAB MANU; STRAUSS G, 1993, EUR J BIOCHEM, V215, P633, DOI 10.1111/j.1432-1033.1993.tb18074.x; Tchigvintsev A, 2012, J BIOL CHEM, V287, P1874, DOI 10.1074/jbc.M111.294561; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yao TR, 2010, APPL BIOCHEM BIOTECH, V160, P694, DOI 10.1007/s12010-009-8685-x; Yim SH, 2010, HUM MOL GENET, V19, P1001, DOI 10.1093/hmg/ddp564	24	12	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62666	10.1371/journal.pone.0062666	http://dx.doi.org/10.1371/journal.pone.0062666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23658760	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000069
J	Nashine, S; Bhootada, Y; Lewin, AS; Gorbatyuk, M				Nashine, Sonali; Bhootada, Yogesh; Lewin, Alfred S.; Gorbatyuk, Marina			Ablation of C/EBP Homologous Protein Does Not Protect T17M RHO Mice from Retinal Degeneration	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; RHODOPSIN; APOPTOSIS; NRL	Despite the proposed link between ablation of the CHOP protein and delay of the onset of ER stress-mediated disorders including diabetes, Alzheimer Disease, and cardiac hypertrophy, the role of CHOP protein in photoreceptor cell death associated with Autosomal Dominant Retinitis Pigmentosa (ADRP) has not been investigated. T17M RHO transgenic mice carry a mutated human rhodopsin transgene, the expression of which in retina leads to protein misfolding, activation of UPR and progressive retinal degeneration. The purpose of this study is to investigate the role of CHOP protein in T17M RHO retina. Wild-type, CHOP-/-, T17M RHO and T17M RHO CHOP-/-mice were used in the study. Evaluation of the impact of CHOP ablation was performed using electroretinography (ERG), spectral-domain optical coherence tomography (SD-OCT), quantitative Real-Time PCR (qRT-PCR) and western blot analysis. Dark-adapted ERG analysis demonstrated that by 1 month, the T17M RHO CHOP-/- mice had a 70% reduction of the a-wave amplitude compared to the T17M RHO mice. The loss of function in T17M RHO CHOP-/- photoreceptors was associated with a 22-24% decline in the thickness of the outer nuclear layer. These mice had significant reduction in the expression of transcription factors, Crx and Nrl, and also in mouse Rho, and human RHO. The reduction was associated with an 8-fold elevation of the UPR marker, p-eIf-alpha protein and 30% down-regulation of sXbp1 protein. In addition, the histone deacetylase 1 (Hdac1) protein was 2-fold elevated in the T17M RHO CHOP-/- retina. The ablation of CHOP led to a reduction in the expression of photoreceptor-specific transcriptional factors, and both endogenous and exogenous RHO mRNA. Thus, despite its role in promoting apoptosis, CHOP protects rod photoreceptors carrying an ADRP mutation.	[Nashine, Sonali] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA; [Bhootada, Yogesh; Gorbatyuk, Marina] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35294 USA; [Lewin, Alfred S.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	University of North Texas System; University of North Texas Health Science Center; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida	Gorbatyuk, M (corresponding author), Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35294 USA.	mgortk@uab.edu	NASHINE, SONALI/AAG-1474-2020; Bhootada, Yogesh/AAD-3539-2020	Bhootada, Yogesh/0000-0002-4656-7868; Gorbatyuk, Marina/0000-0001-9060-856X; Lewin, Alfred/0000-0002-4192-9727	National Institutes of Health (NIH) [R01EY020905]; Foundation Fighting Blindness [TA-GT-0409-0508-NTERI]; Hope for Vision and DOD [W81XH-10-2-0003]; Shaler Richardson Professorship endowment; NATIONAL EYE INSTITUTE [R01EY020905, P30EY021721] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Hope for Vision and DOD; Shaler Richardson Professorship endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (NIH) (R01EY020905), the Foundation Fighting Blindness (TA-GT-0409-0508-NTERI), Hope for Vision and DOD W81XH-10-2-0003, and the Shaler Richardson Professorship endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAGNAT F, 2012, CELL DEATH DIFFER; Behrman S, 2011, J CELL BIOL, V192, P919, DOI 10.1083/jcb.201010055; Chen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040801; Chiang WC, 2012, MOL BIOL CELL, V23, P758, DOI 10.1091/mbc.E11-08-0663; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; KUNTE MM, 2012, INVEST OPHTHALMOL VI; Lee ES, 2007, INVEST OPHTH VIS SCI, V48, P2868, DOI 10.1167/iovs.06-0035; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Ohoka N, 2007, J BIOL CHEM, V282, P35687, DOI 10.1074/jbc.M703735200; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Prasanthi RPJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026420; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Wang FM, 2011, EXP HEMATOL, V39, P999, DOI 10.1016/j.exphem.2011.06.007; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131	28	33	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63205	10.1371/journal.pone.0063205	http://dx.doi.org/10.1371/journal.pone.0063205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646198	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300155
J	Silva, JL; Souza, MC; Ferreira-DaSilva, CT; Silva, LS; Costa, MFS; Padua, TA; Henriques, MD; Morrot, A; Savino, W; Caruso-Neves, C; Pinheiro, AAS				Silva-Filho, Joao Luiz; Souza, Mariana Conceicao; Ferreira-DaSilva, Claudio Teixeira; Silva, Leandro Souza; Souza Costa, Maria Fernanda; Padua, Tatiana Almeida; Henriques, Maria das Gracas; Morrot, Alexandre; Savino, Wilson; Caruso-Neves, Celso; Sa Pinheiro, Ana Acacia			Angiotensin II Is a New Component Involved in Splenic T Lymphocyte Responses during Plasmodium berghei ANKA Infection	PLOS ONE			English	Article							EXPERIMENTAL CEREBRAL MALARIA; TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; CONVERTING-ENZYME; ADHESION MOLECULES; LYMPHOTOXIN-ALPHA; INTERFERON-GAMMA; CELL RESPONSES; UP-REGULATION; RABBIT MODEL	The contribution of T cells in severe malaria pathogenesis has been described. Here, we provide evidence for the potential role of angiotensin II (Ang II) in modulating splenic T cell responses in a rodent model of cerebral malaria. T cell activation induced by infection, determined by 3 to 4-fold enhancement in CD69 expression, was reduced to control levels when mice were treated with 20 mg/kg losartan (IC50 = 0.966 mg/kg/d), an AT(1) receptor antagonist, or captopril (IC50 = 1.940 mg/kg/d), an inhibitor of angiotensin-converting enzyme (ACE). Moreover, the production of interferon-gamma and interleukin-17 by CD4(+) T cells diminished 67% and 70%, respectively, by both treatments. Losartan reduced perforin expression in CD8(+) T cells by 33% while captopril completely blocked it. The upregulation in chemokine receptor expression (CCR2 and CCR5) observed during infection was abolished and CD11a expression was partially reduced when mice were treated with drugs. T cells activated by Plasmodium berghei ANKA antigens showed 6-fold enhance in AT(1) levels in comparison with naive cells. The upregulation of AT(1) expression was reduced by losartan (80%) but not by captopril. Our results suggest that the AT(1)/Ang II axis has a role in the establishment of an efficient T cell response in the spleen and therefore could participate in a misbalanced parasite-induced T cell immune response during P. berghei ANKA infection.	[Silva-Filho, Joao Luiz; Ferreira-DaSilva, Claudio Teixeira; Silva, Leandro Souza; Caruso-Neves, Celso; Sa Pinheiro, Ana Acacia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil; [Souza, Mariana Conceicao; Souza Costa, Maria Fernanda; Padua, Tatiana Almeida; Henriques, Maria das Gracas] Fundacao Oswaldo Cruz, Inst Tecnol Farmacos, Rio De Janeiro, RJ, Brazil; [Morrot, Alexandre] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, RJ, Brazil; [Savino, Wilson] Fundacao Oswaldo Cruz, Dept Imunol, Rio De Janeiro, RJ, Brazil; [Caruso-Neves, Celso] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Ciencia & Tecnol Biol & Bioimagem, Rio De Janeiro, RJ, Brazil; [Sa Pinheiro, Ana Acacia] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Pesquisa Translac Saude & Ambiente Regi, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Pinheiro, AAS (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil.	acacia@biof.ufrj.br	Caruso-Neves, Celso/C-4014-2013; Souza, Mariana/GQQ-6648-2022; Silva-Filho, João Luiz/I-5704-2016; Henriques, Maria das Graças M O/G-2998-2013; Sila, Leandro/B-1381-2018; Costa, Maria Fernanda Furtado de Lima e/ABE-3779-2021; Souza, Mariana/C-1677-2015	Caruso-Neves, Celso/0000-0002-2415-7753; Silva-Filho, João Luiz/0000-0003-4762-2205; Henriques, Maria das Graças M O/0000-0003-3065-0541; Sila, Leandro/0000-0001-8720-0088; Costa, Maria Fernanda Furtado de Lima e/0000-0002-3474-2980; de souza costa, Maria Fernanda/0000-0003-2300-5384; Pinheiro, Ana Acacia/0000-0002-3894-1645; Souza, Mariana/0000-0002-6933-9227	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [INCT-INPeTAm/CNPq/MCT, INCT-INBEB/CNPq/MCT]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [Pronex/FAPERJ E-26/110.562/2010, Pronex/FAPERJ E-26/110.551/2010, APQ1/FAPERJ E-26/110.792/2009, JCNE/FAPERJ E-26/101.450/2010, PRONEM/FAPERJ/CNPq E-26/111.182/2011]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT, INCT-INBEB/CNPq/MCT) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (Pronex/FAPERJ E-26/110.562/2010, Pronex/FAPERJ E-26/110.551/2010, APQ1/FAPERJ E-26/110.792/2009, JCNE/FAPERJ E-26/101.450/2010, PRONEM/FAPERJ/CNPq E-26/111.182/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Abu Nabah YN, 2004, CIRCULATION, V110, P3581, DOI 10.1161/01.CIR.0000148824.93600.F3; Andrade WN, 1998, BLOOD, V91, P1653, DOI 10.1182/blood.V91.5.1653.1653_1653_1661; Bannard O, 2009, EUR J IMMUNOL, V39, P2083, DOI 10.1002/eji.200939555; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2003, BLOOD, V101, P4253, DOI 10.1182/blood-2002-05-1493; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Belnoue E, 2003, INFECT IMMUN, V71, P3648, DOI 10.1128/IAI.71.6.3648-3651.2003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bueno LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009623; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; Chen XL, 1998, CIRC RES, V83, P952; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; COSTEROUSSE O, 1993, BIOCHEM J, V290, P33, DOI 10.1042/bj2900033; Crowley SD, 2008, AM J PHYSIOL-RENAL, V295, pF515, DOI 10.1152/ajprenal.00527.2007; Elias RM, 2005, J IMMUNOL, V174, P790, DOI 10.4049/jimmunol.174.2.790; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Ferraris FK, 2011, INT IMMUNOPHARMACOL, V11, P1, DOI 10.1016/j.intimp.2010.09.010; GRAU GE, 1986, J IMMUNOL, V137, P2348; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hansen DS, 2003, IMMUNITY, V18, P391, DOI 10.1016/S1074-7613(03)00052-9; Hernandez-Presa MA, 1998, AM J PATHOL, V153, P1825, DOI 10.1016/S0002-9440(10)65697-0; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Hoch NE, 2009, AM J PHYSIOL-REG I, V296, pR208, DOI 10.1152/ajpregu.90521.2008; Ishida H, 2010, BIOCHEM BIOPH RES CO, V402, P790, DOI 10.1016/j.bbrc.2010.10.114; Jurewicz M, 2007, J AM SOC NEPHROL, V18, P1093, DOI 10.1681/ASN.2006070707; Ma NL, 1996, AM J PATHOL, V149, P1745; Martins YC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-85; Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje; Nahmod K, 2010, J PHARMACOL EXP THER, V334, P854, DOI 10.1124/jpet.109.161760; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ohayon A, 2010, INFECT IMMUN, V78, P4195, DOI 10.1128/IAI.00465-10; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Pastore L, 1999, CIRCULATION, V100, P1646, DOI 10.1161/01.CIR.100.15.1646; Piqueras L, 2000, CIRCULATION, V102, P2118, DOI 10.1161/01.CIR.102.17.2118; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430; Ruiz-Ortega M, 2001, CURR OPIN NEPHROL HY, V10, P321, DOI 10.1097/00041552-200105000-00005; Saraiva VB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017174; Sarto BY, 2004, ANN TROP MED PARASIT, V98, P297, DOI 10.1179/000349804225003271; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schofield L, 2007, IMMUNOL CELL BIOL, V85, P130, DOI 10.1038/sj.icb.7100040; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Shao J, 2003, HYPERTENSION, V42, P31, DOI 10.1161/01.HYP.0000075082.06183.4E; Silva JL, 2011, MOL IMMUNOL, V48, P1835, DOI 10.1016/j.molimm.2011.05.008; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Suzuki Y, 2000, J NEPHROL, V13, pS101; Tummala PE, 1999, CIRCULATION, V100, P1223, DOI 10.1161/01.CIR.100.11.1223; Vigario AM, 2007, INT J PARASITOL, V37, P963, DOI 10.1016/j.ijpara.2007.01.004; Villegas-Mendez A, 2011, J IMMUNOL, V187, P2885, DOI 10.4049/jimmunol.1100241; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Weiser S, 2007, CYTOKINE, V37, P84, DOI 10.1016/j.cyto.2007.02.021; WILLIAMSON WA, 1978, LANCET, V1, P1328; WRIGHT DH, 1968, BRIT J EXP PATHOL, V49, P379; Yanez DM, 1996, J IMMUNOL, V157, P1620	64	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62999	10.1371/journal.pone.0062999	http://dx.doi.org/10.1371/journal.pone.0062999			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646169	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300124
J	Norbu, N; Wikelski, MC; Wilcove, DS; Partecke, J; Ugyen; Tenzin, U; Sherub; Tempa, T				Norbu, Nawang; Wikelski, Martin C.; Wilcove, David S.; Partecke, Jesko; Ugyen; Tenzin, Ugyen; Sherub; Tempa, Tshering			Partial Altitudinal Migration of a Himalayan Forest Pheasant	PLOS ONE			English	Article							PARTIAL BIRD MIGRATION; GRAND CHALLENGES; POPULATION; HYPOTHESES; MOVEMENTS; EVOLUTION; MIGRANTS; SYSTEMS; MODEL; SEX	Background: Altitudinal migration systems are poorly understood. Recent advances in animal telemetry which enables tracking of migrants across their annual cycles will help illustrate unknown migration patterns and test existing hypotheses. Using telemetry, we show the existence of a complex partial altitudinal migration system in the Himalayas and discuss our findings to help better understand partial and altitudinal migration. Methodology/Principal Findings: We used GPS/accelerometer tags to monitor the migration of Satyr tragopan (Tragopan satyra) in the Bhutan Himalayas. We tagged 38 birds from 2009 - 2011 and found that tragopans are partially migratory. Fall migration lasted from the 3rd week of September till the 3rd week of November with migrants traveling distances ranging from 1.25 km to 13.5 km over 1 to 32 days. Snowfall did not influence the onset of migration. Return migration started by the 1st week of March and lasted until the 1st week of April. Individuals returned within 4 to 10 days and displayed site fidelity. One bird switched from being a migrant to a non-migrant. Tragopans displayed three main migration patterns: 1) crossing multiple mountains; 2) descending/ascending longitudinally; 3) moving higher up in winter and lower down in summer. More females migrated than males; but, within males, body size was not a factor for predicting migrants. Conclusions/Significance: Our observations of migrants traversing over multiple mountain ridges and even of others climbing to higher elevations is novel. We support the need for existing hypotheses to consider how best to explain inter- as well as intra-sexual differences. Most importantly, having shown that the patterns of an altitudinal migration system are complex and not a simple up and down slope movement, we hope our findings will influence the way altitudinal migrations are perceived and thereby contribute to a better understanding of how species may respond to climate change.	[Norbu, Nawang; Ugyen; Tenzin, Ugyen; Sherub; Tempa, Tshering] Ugyen Wangchuck Inst Conservat & Environm, Lamai Gompa, Bumtang, Bhutan; [Norbu, Nawang; Wikelski, Martin C.; Partecke, Jesko] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Norbu, Nawang; Wikelski, Martin C.] Univ Konstanz, Int Max Planck Res Sch Organismal Biol, Constance, Germany; [Wilcove, David S.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Tempa, Tshering] Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA	Max Planck Society; Max Planck Society; University of Konstanz; Princeton University; University of Montana System; University of Montana	Norbu, N (corresponding author), Ugyen Wangchuck Inst Conservat & Environm, Lamai Gompa, Bumtang, Bhutan.	norbu.nawang@gmail.com		Wilcove, David S./0000-0002-1354-0503	International Max-Planck Research School for Organismal Biology; Max-Planck Institute for Ornithology	International Max-Planck Research School for Organismal Biology; Max-Planck Institute for Ornithology	The work was supported by the International Max-Planck Research School for Organismal Biology and the Max-Planck Institute for Ornithology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1705, DOI 10.1007/s00265-009-0783-9; [Anonymous], 2020, ECONOMIST 0326; Bell Christopher Paul, 2005, P41; Berthold P, 2001, AUK, V2nd; BirdLife International, 2012, SPEC FACTSH TRAG SAT; Blake JG, 1993, 4 NEOTROPICAL RAIN F, P161; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Boyle WA, 2010, CAN J ZOOL, V88, P204, DOI 10.1139/Z09-133; Boyle WA, 2008, J ANIM ECOL, V77, P1122, DOI 10.1111/j.1365-2656.2008.01451.x; Boyle WA, 2008, OECOLOGIA, V155, P397, DOI 10.1007/s00442-007-0897-6; Boyle WA, 2011, BIOL LETTERS, V7, P661, DOI 10.1098/rsbl.2011.0115; Boyle WA, 2011, EVOL ECOL, V25, P219, DOI 10.1007/s10682-010-9403-4; Boyle WA, 2010, P ROY SOC B-BIOL SCI, V277, P2511, DOI 10.1098/rspb.2010.0344; Brodersen J, 2012, BIOL LETTERS, V8, P21, DOI 10.1098/rsbl.2011.0634; CADE BS, 1993, AUK, V110, P70; Calder W.A. III., 1974, Publications Nuttall Orn Club, VNo. 15, P86; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chapman BB, 2011, OIKOS, V120, P1761, DOI 10.1111/j.1600-0706.2011.20070.x; Chaves-Campos J, 2003, BIRD CONSERV INT, V13, P45, DOI 10.1017/S0959270903003046; Cristol Daniel A., 1999, Current Ornithology, V15, P33; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; DIXON KEITH L., 1964, CONDOR, V66, P61, DOI 10.2307/1365238; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Gauthreaux S.A. Jr, 1978, Perspectives in Ethology, V3, P17; Grimmett R, 1999, BIRDS INDIA PAKISTAN; Hahn TP, 2004, AUK, V121, P1269, DOI 10.1642/0004-8038(2004)121[1269:FAMBMW]2.0.CO;2; HERZOG PW, 1980, CONDOR, V82, P366, DOI 10.2307/1367557; Hess SC, 2012, WILSON J ORNITHOL, V124, P478, DOI 10.1676/12-005.1; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; *IUCN, 2008, IUCN RED LIST; Jahn AE, 2010, J ANIM ECOL, V79, P983, DOI 10.1111/j.1365-2656.2010.01713.x; Ketterson E.D., 1983, Current Ornithology, V1, P357; KETTERSON ED, 1976, ECOLOGY, V57, P679, DOI 10.2307/1936182; Laymon SA, 2010, SIERRA, V91, P837; LOISELLE BA, 1991, ECOLOGY, V72, P180, DOI 10.2307/1938913; LUNDBERG P, 1987, J THEOR BIOL, V125, P351, DOI 10.1016/S0022-5193(87)80067-X; LUNDBERG P, 1988, TRENDS ECOL EVOL, V3, P172, DOI 10.1016/0169-5347(88)90035-3; LUNDBERG P, 1985, BEHAV ECOL SOCIOBIOL, V17, P185; Mackas RH, 2010, CAN J ZOOL, V88, P369, DOI 10.1139/Z10-013; Morbey YE, 2012, J ORNITHOL, V153, pS207, DOI 10.1007/s10336-012-0854-y; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Powell George V. N., 1994, Bird Conservation International, V4, P161; POWELL GVN, 1995, CONSERV BIOL, V9, P354, DOI 10.1046/j.1523-1739.1995.9020354.x; Pulido F, 2011, OIKOS, V120, P1776, DOI 10.1111/j.1600-0706.2011.19844.x; SCHROEDER MA, 1993, AUK, V110, P21; Schwenk K, 2009, INTEGR COMP BIOL, V49, P7, DOI 10.1093/icb/icp034; Shaw AK, 2011, OIKOS, V120, P1871, DOI 10.1111/j.1600-0706.2011.19443.x; Sibley CG, 1990, DISTRIBUTION TAXONOM; STILES F.G., 1988, TROPICAL RAINFORESTS, P243; Taylor CM, 2007, BIOLOGY LETT, V3, P280, DOI 10.1098/rsbl.2007.0053; Wilcove D.S., 2008, NO WAY HOME DECLINE; Wilcove DS, 2008, ISSUES SCI TECHNOL, V24, P71; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188	54	8	8	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e60979	10.1371/journal.pone.0060979	http://dx.doi.org/10.1371/journal.pone.0060979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658608	Green Published, Green Submitted, gold			2022-12-27	WOS:000318343700008
J	De Roover, K; Timmerman, ME; Mesquita, B; Ceulemans, E				De Roover, Kim; Timmerman, Marieke E.; Mesquita, Batja; Ceulemans, Eva			Common and Cluster-Specific Simultaneous Component Analysis	PLOS ONE			English	Article							MEASUREMENT INVARIANCE; PERSONALITY; NUMBER; CONGRUENCE; DIMENSIONS; FACTORIAL; MATRICES	In many fields of research, so-called 'multiblock' data are collected, i.e., data containing multivariate observations that are nested within higher-level research units (e.g., inhabitants of different countries). Each higher-level unit (e.g., country) then corresponds to a 'data block'. For such data, it may be interesting to investigate the extent to which the correlation structure of the variables differs between the data blocks. More specifically, when capturing the correlation structure by means of component analysis, one may want to explore which components are common across all data blocks and which components differ across the data blocks. This paper presents a common and cluster-specific simultaneous component method which clusters the data blocks according to their correlation structure and allows for common and cluster-specific components. Model estimation and model selection procedures are described and simulation results validate their performance. Also, the method is applied to data from cross-cultural values research to illustrate its empirical value.	[De Roover, Kim; Ceulemans, Eva] Katholieke Univ Leuven, Methodol Educ Sci Res Unit, Louvain, Belgium; [Timmerman, Marieke E.] Univ Groningen, Heymans Inst Psychol, Groningen, Netherlands; [Mesquita, Batja] Katholieke Univ Leuven, Social & Cultural Psychol Res Unit, Louvain, Belgium	KU Leuven; University of Groningen; KU Leuven	De Roover, K (corresponding author), Katholieke Univ Leuven, Methodol Educ Sci Res Unit, Louvain, Belgium.	Kim.DeRoover@ppw.kuleuven.be	Ceulemans, Eva/AAQ-6617-2020; De Roover, Kim/HGD-4120-2022	Ceulemans, Eva/0000-0002-7611-4683; De Roover, Kim/0000-0002-0299-0648; Mesquita, Batja/0000-0001-8065-1089	fund for Scientific Research-Flanders (Belgium) [G.0477.09]; Research Council of KU Leuven [GOA/2010/02]	fund for Scientific Research-Flanders (Belgium)(FWO); Research Council of KU Leuven(KU Leuven)	The research reported in this paper was partially supported by the fund for Scientific Research-Flanders (Belgium), Project No. G.0477.09 awarded to Eva Ceulemans, Marieke Timmerman and Patrick Onghena and by the Research Council of KU Leuven (GOA/2010/02). http://www.fwo.be/; https://admin.kuleuven.be/raden/en/research-council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Bai Z, 1992, IMA PREPRINT SERIES; Bond MH, 2004, J CROSS CULT PSYCHOL, V35, P548, DOI 10.1177/0022022104268388; Bro R, 2003, J CHEMOMETR, V17, P16, DOI 10.1002/cem.773; BROKKEN FB, 1985, PSYCHOMETRIKA, V50, P51, DOI 10.1007/BF02294147; Brusco MJ, 2005, J MATH PSYCHOL, V49, P142, DOI 10.1016/j.jmp.2004.11.004; Brusco MJ, 2001, PSYCHOMETRIKA, V66, P249, DOI 10.1007/BF02294838; Bulteel K, 2013, BEHAV RES METHODS, V45, P782, DOI 10.3758/s13428-012-0293-y; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Ceulemans E, 2011, CHEMOMETR INTELL LAB, V106, P12, DOI 10.1016/j.chemolab.2010.08.001; Ceulemans E, 2009, BRIT J MATH STAT PSY, V62, P601, DOI 10.1348/000711008X369474; De Raad B, 2010, J PERS SOC PSYCHOL, V98, P160, DOI 10.1037/a0017184; De Roover K, 2013, SWITCHING PRIN UNPUB; De Roover K, 2013, PSYCHOMETRIKA, V78, P648, DOI 10.1007/s11336-013-9318-4; De Roover K, 2013, BRIT J MATH STAT PSY, V66, P81, DOI 10.1111/j.2044-8317.2012.02040.x; De Roover K, 2012, PSYCHOL METHODS, V17, P100, DOI 10.1037/a0025385; De Roover K, 2012, BEHAV RES METHODS, V44, P41, DOI 10.3758/s13428-011-0129-1; Di Blas L, 1998, EUR J PERSONALITY, V12, P75, DOI 10.1002/(SICI)1099-0984(199803/04)12:2<75::AID-PER288>3.0.CO;2-H; Diaz-Loving R, 1998, J CROSS CULT PSYCHOL, V29, P104, DOI 10.1177/0022022198291006; Diener E., 2001, INT COLL SURVE UNPUB; Dolan CV, 2009, STRUCT EQU MODELING, V16, P295, DOI 10.1080/10705510902751416; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; HAVEN S, 1977, HEYMANS B, V290; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Inglehart R, 2000, AM SOCIOL REV, V65, P19, DOI 10.2307/2657288; Inglehart R., 2005, MODERNIZATION CULTUR; JORESKOG KG, 1971, PSYCHOMETRIKA, V36, P409, DOI 10.1007/BF02291366; Kiers HAL, 1996, PSYCHOMETRIKA, V61, P375, DOI 10.1007/BF02294345; Kuppens P, 2006, J CROSS CULT PSYCHOL, V37, P491, DOI 10.1177/0022022106290474; Lofstedt T, 2011, J CHEMOMETR, V25, P441, DOI 10.1002/cem.1388; Lorenzo-Seva U., 2006, METHODOLOGY, V2, P57, DOI [10.1027/1614-2241.2.2.57, DOI 10.1027/1614-2241.2.2.57]; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; MILLIGAN GW, 1983, IEEE T PATTERN ANAL, V5, P40, DOI 10.1109/TPAMI.1983.4767342; PAIGE CC, 1981, SIAM J NUMER ANAL, V18, P398, DOI 10.1137/0718026; Schouteden M, 2012, BEHAV RES M IN PRESS; Schouteden M, 2010, COMPSTAT 2010 22 27; Schouteden M, 2012, THESIS KU LEUVEN LEU; Smilde AK, 2012, BRIEF BIOINFORM, V13, P524, DOI 10.1093/bib/bbr071; SORBOM D, 1974, BRIT J MATH STAT PSY, V27, P229; Steinley D, 2004, PSYCHOL METHODS, V9, P386, DOI 10.1037/1082-989X.9.3.386; Steinley D, 2003, PSYCHOL METHODS, V8, P294, DOI 10.1037/1082-989X.8.3.294; Timmerman ME, 2006, BRIT J MATH STAT PSY, V59, P301, DOI 10.1348/000711005X67599; Timmerman ME, 2010, COMPUT STAT DATA AN, V54, P1858, DOI 10.1016/j.csda.2010.02.009; Timmerman ME, 2003, PSYCHOMETRIKA, V68, P105, DOI 10.1007/BF02296656; Tucker L R., 1951, PSYCHOMETRIKA; Van Deun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037840; VANLOAN CF, 1976, SIAM J NUMER ANAL, V13, P76, DOI 10.1137/0713009; Wilderjans TF, 2012, BEHAV RES METHODS, V44, P532, DOI 10.3758/s13428-011-0166-9; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	49	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62280	10.1371/journal.pone.0062280	http://dx.doi.org/10.1371/journal.pone.0062280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667463	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600019
J	Furusawa, C; Kaneko, K				Furusawa, Chikara; Kaneko, Kunihiko			Epigenetic Feedback Regulation Accelerates Adaptation and Evolution	PLOS ONE			English	Article							GENE-REGULATION; EXPRESSION	A simple cell model consisting of a gene regulatory network with epigenetic feedback regulation is studied to evaluate the effect of epigenetic dynamics on adaptation and evolution. We find that, the type of epigenetic dynamics considered enables a cell to adapt to unfamiliar environmental changes, for which no regulatory program has been prepared, through noise-driven selection of a cellular state with a high growth rate. Furthermore, we demonstrate that the inclusion of epigenetic regulation promotes evolutionary development of a regulatory network that can respond to environmental changes in a fast and precise manner. These results strongly suggest that epigenetic feedback regulation in gene expression dynamics provides a significant increase in fitness by engendering an increase in cellular plasticity during adaptation and evolution.	[Furusawa, Chikara] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Kaneko, Kunihiko] Univ Tokyo, Res Ctr Complex Syst Biol, Meguro Ku, Tokyo, Japan	RIKEN; University of Tokyo	Furusawa, C (corresponding author), RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan.	chikara.furusawa@riken.jp	Furusawa, Chikara/N-6103-2015; Furusawa, Chikara/ABB-6516-2021	Furusawa, Chikara/0000-0003-3554-4975; Furusawa, Chikara/0000-0003-3554-4975	Japan Society for the Promotion of Science [23680030]; Ministry of Education, Culture, Sports, Science & Technology, Japan [23128509, 21120004]; Grants-in-Aid for Scientific Research [23650152] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science & Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Young Scientists (A) to CF (No. 23680030) from the Japan Society for the Promotion of Science, and a Grant-in-Aid for Scientific Research on Innovative Areas to CF (No. 23128509) and to KK (No. 21120004) from the Ministry of Education, Culture, Sports, Science & Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bremer H, 1996, ESCHERICHIA COLI SAL; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Furusawa C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040003; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin DJ, 2012, FEMS MICROBIOL REV, V36, P269, DOI 10.1111/j.1574-6976.2011.00279.x; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rohlf T, 2012, EPIGENOMICS-UK, V4, P205, DOI [10.2217/epi.11.117, 10.2217/EPI.11.117]; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Satory D, 2011, CURR OPIN MICROBIOL, V14, P212, DOI 10.1016/j.mib.2010.12.004; Shinfuku Y, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-43; Sneppen K, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.21; Stolovicki E, 2006, GENETICS, V173, P75, DOI 10.1534/genetics.106.055442; Thon G, 1997, GENETICS, V145, P685	23	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61251	10.1371/journal.pone.0061251	http://dx.doi.org/10.1371/journal.pone.0061251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667436	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600010
J	Chow, WZ; Ong, LY; Razak, SH; Lee, YM; Ng, KT; Yong, YK; Azmel, A; Takebe, Y; Al-Darraji, HAA; Kamarulzaman, A; Tee, KK				Chow, Wei Zhen; Ong, Lai Yee; Razak, Siti Humaira; Lee, Yeat Mei; Ng, Kim Tien; Yong, Yean Kong; Azmel, Azureen; Takebe, Yutaka; Al-Darraji, Haider Abdulrazzaq Abed; Kamarulzaman, Adeeba; Tee, Kok Keng			Molecular Diversity of HIV-1 among People Who Inject Drugs in Kuala Lumpur, Malaysia: Massive Expansion of Circulating Recombinant Form (CRF) 33_01B and Emergence of Multiple Unique Recombinant Clusters	PLOS ONE			English	Article							CRF01-AE/B RECOMBINANT; RISK POPULATIONS; TYPE-1 SUBTYPES; IDENTIFICATION; EPIDEMIOLOGY; USERS; CRF33-01B; SEROCONVERTERS; RESISTANCE; CRF15-01B	Since the discovery of HIV-1 circulating recombinant form (CRF) 33_01B in Malaysia in the early 2000 s, continuous genetic diversification and active recombination involving CRF33_01B and other circulating genotypes in the region including CRF01_AE and subtype B' of Thai origin, have led to the emergence of novel CRFs and unique recombinant forms. The history and magnitude of CRF33_01B transmission among various risk groups including people who inject drugs (PWID) however have not been investigated despite the high epidemiological impact of CRF33_01B in the region. We update the most recent molecular epidemiology of HIV-1 among PWIDs recruited in Malaysia between 2010 and 2011 by population sequencing and phylogenetic analysis of 128 gag-pol sequences. HIV-1 CRF33_01B was circulating among 71% of PWIDs whilst a lower prevalence of other previously dominant HIV-1 genotypes [subtype B' (11%) and CRF01_AE (5%)] and CRF01_AE/B' unique recombinants (13%) were detected, indicating a significant shift in genotype replacement in this population. Three clusters of CRF01_AE/B' recombinants displaying divergent yet phylogenetically-related mosaic genomes to CRF33_01B were identified and characterized, suggestive of an abrupt emergence of multiple novel CRF clades. Using rigorous maximum likelihood approach and the Bayesian Markov chain Monte Carlo (MCMC) sampling of CRF33_01B(pol) sequences to elucidate the past population dynamics, we found that the founder lineages of CRF33_01B were likely to have first emerged among PWIDs in the early 1990 s before spreading exponentially to various high and low-risk populations (including children who acquired infections from their mothers) and later on became endemic around the early 2000 s. Taken together, our findings provide notable genetic evidence indicating the widespread expansion of CRF33_01B among PWIDs and into the general population. The emergence of numerous previously unknown recombinant clades highlights the escalating genetic complexity of HIV-1 in the Southeast Asian region.	[Chow, Wei Zhen; Ong, Lai Yee; Razak, Siti Humaira; Lee, Yeat Mei; Ng, Kim Tien; Yong, Yean Kong; Azmel, Azureen; Takebe, Yutaka; Al-Darraji, Haider Abdulrazzaq Abed; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan	Universiti Malaya; National Institute of Infectious Diseases (NIID)	Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Yong, Yean/B-9202-2017; KAMARULZAMAN, ADEEBA/B-5216-2010; Yong, Yean Kong/Q-5318-2016; Chow, Wei Zhen/L-8228-2013; Tee, Kok Keng/A-8148-2008; Al-Darraji, Haider Abdulrazzaq Abed/B-7978-2012; Ng, Kim Tien/K-7667-2013	Yong, Yean/0000-0002-8409-6251; Tee, Kok Keng/0000-0002-7923-5448; Al-Darraji, Haider Abdulrazzaq Abed/0000-0003-2576-3218; Ng, Kim Tien/0000-0002-4097-9984	Ministry of Higher Education, Malaysia: High Impact Research [E-000001-20001, H-500001-00-A000011-000001, H-500001-00-A000012-000001, J-50001-73596]	Ministry of Higher Education, Malaysia: High Impact Research	This work was supported by grants from the Ministry of Higher Education, Malaysia: High Impact Research E-000001-20001 to A.K., and High Impact Research H-500001-00-A000011-000001, H-500001-00-A000012-000001 and J-50001-73596 to K.K.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; [Anonymous], 2012, GLOB REP UNAIDS REP; Beyrer C, 1998, AIDS RES HUM RETROV, V14, P1687, DOI 10.1089/aid.1998.14.1687; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown TM, 1996, AIDS RES HUM RETROV, V12, P1655, DOI 10.1089/aid.1996.12.1655; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lau KA, 2008, CURR HIV RES, V6, P108, DOI 10.2174/157016208783885010; Lau KA, 2007, AIDS RES HUM RETROV, V23, P1139, DOI 10.1089/aid.2007.0056; Lee CC, 2009, HIV MED, V10, P370, DOI 10.1111/j.1468-1293.2009.00698.x; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Liu YL, 2012, J OCUL PHARMACOL TH, V28, P1, DOI 10.1089/jop.2011.0182; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Ministry of Health, 2012, GLOB AIDS RESP COUNT; Mohamad S, 2012, BRAZ J INFECT DIS, V16, P284, DOI 10.1590/S1413-86702012000300012; Ng OT, 2012, AIDS RES HUM RETROV, V28, P527, DOI [10.1089/aid.2011.0177, 10.1089/AID.2011.0177]; Ng OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015738; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; SahBandar IN, 2011, AIDS RES HUM RETROV, V27, P97, DOI 10.1089/aid.2010.0163; Sahbandar IN, 2009, AIDS RES HUM RETROV, V25, P637, DOI 10.1089/aid.2008.0266; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Saraswathy T. S., 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P283; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2005, AIDS RES HUM RETROV, V21, P1046, DOI 10.1089/aid.2005.21.1046; Tee KK, 2005, AIDS, V19, P119, DOI 10.1097/00002030-200501280-00003; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Tee KK, 2009, VIROLOGY, V387, P229, DOI 10.1016/j.virol.2009.02.020; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; Tovanabutra S, 2001, AIDS, V15, P1063, DOI 10.1097/00002030-200105250-00018; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Tovanabutra S, 2004, AIDS RES HUM RETROV, V20, P465, DOI 10.1089/088922204323087705; Tovanabutra S, 2007, AIDS RES HUM RETROV, V23, P829, DOI 10.1089/aid.2006.0300; Wang B, 2007, VIROLOGY, V367, P288, DOI 10.1016/j.virol.2007.05.033; WENIGER BG, 1994, AIDS, V8, pS13; Weniger BG, 1996, NEW ENGL J MED, V335, P343, DOI 10.1056/NEJM199608013350510; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	49	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62560	10.1371/journal.pone.0062560	http://dx.doi.org/10.1371/journal.pone.0062560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667490	gold, Green Submitted, Green Published			2022-12-27	WOS:000319654700048
J	Kuroiwa, Y; Takakusagi, Y; Kusayanagi, T; Kuramochi, K; Imai, T; Hirayama, T; Ito, I; Yoshida, M; Sakaguchi, K; Sugawara, F				Kuroiwa, Yuki; Takakusagi, Yoichi; Kusayanagi, Tomoe; Kuramochi, Kouji; Imai, Takahiko; Hirayama, Tomoko; Ito, Ichiaki; Yoshida, Michiteru; Sakaguchi, Kengo; Sugawara, Fumio			Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; AFFINITY PURIFICATION; BIOTIN DERIVATIVES; CYTOKINE ACTIVITY; BINDING PEPTIDE; RECEPTOR; ACTIVATION; AMPHOTERIN; RECOMMENDATIONS; MIGRATION	Background: Methotrexate (MTX) is an agent used in chemotherapy of tumors and autoimmune disease including rheumatoid arthritis (RA). In addition, MTX has some anti-inflammatory activity. Although dihydrofolate reductase (DHFR) is a well-known target for the anti-tumor effect of MTX, the mode of action for the anti-inflammatory activity of MTX is not fully understood. Methodology/Result: Here, we performed a screening of MTX-binding proteins using T7 phage display with a synthetic biotinylated MTX derivative. We then characterized the interactions using surface plasmon resonance (SPR) analysis and electrophoretic mobility shift assay (EMSA). Using a T7 phage display screen, we identified T7 phages that displayed part of high-mobility group box 1 (HMGB1) protein (K86-V175). Binding affinities as well as likely binding sites were characterized using genetically engineered truncated versions of HMGB1 protein (Al G1-K87, Bj: F88-K181), indicating that MTX binds to HMGB1 via two independent sites with a dissociation constants (K-D) of 0.50 +/- 0.03 mu M for Al and 0.24 +/- 0.01 mu M for Bj. Although MTX did not inhibit the binding of HMGB1 to DNA via these domains, HMGB1/RAGE association was impeded in the presence of MTX. These data suggested that binding of MTX to part of the RAGE-binding region (K149-V175) in HMGB1 might be significant for the anti-inflammatory effect of MTX. Indeed, in murine macrophage-like cells (RAW 264.7), TNF-alpha release and mitogenic activity elicited by specific RAGE stimulation with a truncated monomeric HMGB1 were inhibited in the presence of MTX. Conclusions/Significance: These data demonstrate that HMGB1 is a direct binding protein of MTX. Moreover, binding of MTX to RAGE-binding region in HMGB1 inhibited the HMGB1/RAGE interaction at the molecular and cellular levels. These data might explain the molecular basis underlying the mechanism of action for the anti-inflammatory effect of MTX.	[Kuroiwa, Yuki; Takakusagi, Yoichi; Kusayanagi, Tomoe; Kuramochi, Kouji; Imai, Takahiko; Hirayama, Tomoko; Sakaguchi, Kengo; Sugawara, Fumio] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Ito, Ichiaki; Yoshida, Michiteru] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 278, Japan; [Takakusagi, Yoichi] Natl Canc Inst, Natl Inst Hlth, Bethesda, MD USA	Tokyo University of Science; Tokyo University of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sugawara, F (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan.	sugawara@rs.noda.tus.ac.jp	Takakusagi, Yoichi/AAA-1998-2021	Takakusagi, Yoichi/0000-0002-6786-0748; Kuramochi, Kouji/0000-0003-0571-9703	The Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Society for the Promotion of Science; Tokyo University of Science	The Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo University of Science	This work was supported by a Grant-in-Aid for Scientific Research (The Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Society for the Promotion of Science), and research grant from Tokyo University of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Fan JG, 1997, METHOD ENZYMOL, V281, P97; FAN JG, 1991, J BIOL CHEM, V266, P14862; Gargaro AR, 1998, J MOL BIOL, V277, P119, DOI 10.1006/jmbi.1997.1560; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hreggvidsdottir HS, 2012, MOL MED, V18, P224, DOI 10.2119/molmed.2011.00327; Huttunen HJ, 2004, J INTERN MED, V255, P351, DOI 10.1111/j.1365-2796.2003.01301.x; Huttunen HJ, 2002, CANCER RES, V62, P4805; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Majumdar S, 2001, J IMMUNOL, V167, P2911, DOI 10.4049/jimmunol.167.5.2911; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Novagen, 2009, ORIENTEXPRESSTM CDNA; Novagen, 2009, T7 SEL SYST MAN; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Saito K, 1999, J BIOCHEM, V125, P399, DOI 10.1093/oxfordjournals.jbchem.a022300; Schierbeck H, 2010, MOL MED, V16, P343, DOI 10.2119/molmed.2010.00031; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Stott K, 2006, J MOL BIOL, V360, P90, DOI 10.1016/j.jmb.2006.04.059; Swierkot J, 2006, PHARMACOL REP, V58, P473; Takakusagi Y, 2008, BIOORGAN MED CHEM, V16, P7410, DOI 10.1016/j.bmc.2008.06.007; Takakusagi Y, 2011, MEDCHEMCOMM, V2, P1188, DOI 10.1039/c1md00180a; Takakusagi Y, 2010, EXPERT OPIN DRUG DIS, V5, P361, DOI 10.1517/17460441003653155; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Ueda T, 2010, BBA-GENE REGUL MECH, V1799, P114, DOI 10.1016/j.bbagrm.2009.11.005; Uga H, 2006, MOL PHARMACOL, V70, P1832, DOI 10.1124/mol.106.025866; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; WALLACE CA, 1989, ARTHRITIS RHEUM, V32, P677, DOI 10.1002/anr.1780320604; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; Yamamoto A, 1997, J BIOCHEM-TOKYO, V122, P586; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Youn JH, 2011, EUR J IMMUNOL, V41, P2753, DOI 10.1002/eji.201141391; ZIERLER K, 1989, TRENDS BIOCHEM SCI, V14, P314, DOI 10.1016/0968-0004(89)90157-6	40	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63073	10.1371/journal.pone.0063073	http://dx.doi.org/10.1371/journal.pone.0063073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658798	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100051
J	Sundstrom, LF; Kaspersson, R; Naslund, J; Johnsson, JI				Sundstrom, L. Fredrik; Kaspersson, Rasmus; Naslund, Joacim; Johnsson, Jorgen I.			Density-Dependent Compensatory Growth in Brown Trout (Salmo trutta) in Nature	PLOS ONE			English	Article							WILD SEA-TROUT; COHO SALMON; BODY-SIZE; RATES; TRAJECTORIES; TEMPERATURE; POPULATION; AGGRESSION; MORTALITY; MIGRATION	Density-dependence is a major ecological mechanism that is known to limit individual growth. To examine if compensatory growth (unusually rapid growth following a period of imposed slow growth) in nature is density-dependent, one-year-old brown trout (Salmo trutta L.) were first starved in the laboratory, and then released back into their natural stream, either at natural or at experimentally increased population density. The experimental trout were captured three times over a one-year period. We found no differences in growth, within the first month after release (May-June), between the starved fish and the control group (i.e. no evidence of compensation). During the summer however (July-September), the starved fish grew more than the control group (i.e. compensation), and the starved fish released into the stream at a higher density, grew less than those released at a natural density, both in terms of weight and length (i.e. density-dependent compensation). Over the winter (October-April), there were no effects of either starvation or density on weight and length growth. After the winter, starved fish released at either density had caught up with control fish in body size, but recapture rates (proxy for survival) did not indicate any costs of compensation. Our results suggest that compensatory growth in nature can be density-dependent. Thus, this is the first study to demonstrate the presence of ecological restrictions on the compensatory growth response in free-ranging animals.	[Sundstrom, L. Fredrik; Kaspersson, Rasmus; Naslund, Joacim; Johnsson, Jorgen I.] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Sundstrom, LF (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	fred.sundstrom@gmail.com	Näslund, Joacim/Q-1734-2015; Sundstrom, Fred/E-6736-2011	Näslund, Joacim/0000-0003-1091-2225; Sundstrom, Fred/0000-0002-3157-7289	Swedish Research Council Vetenskapsradet; European Community's Sixth Framework Programme [MOIF-CT-2005-8141]; Swedish Research Council for Agriculture Research and Spatial Planning	Swedish Research Council Vetenskapsradet(Swedish Research Council); European Community's Sixth Framework Programme; Swedish Research Council for Agriculture Research and Spatial Planning	LFS was funded by the Swedish Research Council Vetenskapsradet and as a Marie Curie Outgoing International Fellow under contract MOIF-CT-2005-8141 from the European Community's Sixth Framework Programme. The present work does not necessarily reflect the Community's views and in no way anticipates its future policy in this area. JIJ was funded by the Swedish Research Council for Agriculture Research and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; Alvarez D, 2005, P ROY SOC B-BIOL SCI, V272, P601, DOI 10.1098/rspb.2004.2991; Apanius V., 1998, AVIAN GROWTH DEV EVO; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Auer SK, 2010, ECOL LETT, V13, P998, DOI 10.1111/j.1461-0248.2010.01491.x; Ayllon D, 2010, ECOL FRESHW FISH, V19, P420, DOI 10.1111/j.1600-0633.2010.00426.x; Biro PA, 2007, ANIM BEHAV, V73, P891, DOI 10.1016/j.anbehav.2006.10.019; Bohlin T, 2002, J ANIM ECOL, V71, P683, DOI 10.1046/j.1365-2656.2002.00631.x; Bohlin T, 1996, J FISH BIOL, V49, P157; BOHLIN T, 1993, CAN J FISH AQUAT SCI, V50, P224, DOI 10.1139/f93-025; Carlson SM, 2004, EVOL ECOL RES, V6, P955; DELLEFORS C, 1988, J FISH BIOL, V33, P741, DOI 10.1111/j.1095-8649.1988.tb05519.x; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; HAWKINS CP, 1986, ECOLOGY, V67, P1384, DOI 10.2307/1938694; Hornick JL, 2000, DOMEST ANIM ENDOCRIN, V19, P121, DOI 10.1016/S0739-7240(00)00072-2; Houlihan D, 2001, FOOD INTAKE FISH; Johnsson JI, 2005, OIKOS, V111, P31, DOI 10.1111/j.0030-1299.2005.13972.x; Johnsson JI, 2006, P ROY SOC B-BIOL SCI, V273, P1281, DOI 10.1098/rspb.2005.3437; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Loman J, 2009, ACTA OECOL, V35, P824, DOI 10.1016/j.actao.2009.08.011; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Mobaek R, 2013, OIKOS, V122, P421, DOI 10.1111/j.1600-0706.2012.20888.x; Nephew BC, 2003, HORM BEHAV, V44, P222, DOI 10.1016/j.yhbeh.2003.06.002; Nicieza AG, 1999, FUNCT ECOL, V13, P793, DOI 10.1046/j.1365-2435.1999.00371.x; PETRANKA JW, 1986, ECOLOGY, V67, P729, DOI 10.2307/1937696; Quinn GP, 2003, EXPT DESIGN DATA ANA; SEBER GAF, 1967, J ANIM ECOL, V36, P631, DOI 10.2307/2818; Sundstrom LF, 2004, J FISH BIOL, V65, P1385, DOI 10.1111/j.0022-1112.2004.00537.x; Sundstrom LF, 2005, EVOLUTION, V59, P1560, DOI 10.1111/j.0014-3820.2005.tb01805.x; van Dijk PLM, 2002, OECOLOGIA, V130, P496, DOI 10.1007/s00442-001-0830-3; Vollestad LA, 2003, ANIM BEHAV, V66, P561, DOI 10.1006/anbe.2003.2237; WILSON PN, 1960, BIOL REV, V35, P324, DOI 10.1111/j.1469-185X.1960.tb01327.x; Xu CL, 2010, J FISH BIOL, V76, P2342, DOI 10.1111/j.1095-8649.2010.02619.x	34	14	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63287	10.1371/journal.pone.0063287	http://dx.doi.org/10.1371/journal.pone.0063287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658820	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100060
J	Szczepaniec, A; Raupp, MJ; Parker, RD; Kerns, D; Eubanks, MD				Szczepaniec, Adrianna; Raupp, Michael J.; Parker, Roy D.; Kerns, David; Eubanks, Micky D.			Neonicotinoid Insecticides Alter Induced Defenses and Increase Susceptibility to Spider Mites in Distantly Related Crop Plants	PLOS ONE			English	Article							INDUCED RESISTANCE; SALICYLIC-ACID; JASMONIC ACID; STATISTICAL-ANALYSIS; RESPONSES; TOMATO; TETRANYCHIDAE; SPECIFICITY; HERBIVORES; MUTATION	Background: Chemical suppression of arthropod herbivores is the most common approach to plant protection. Insecticides, however, can cause unintended, adverse consequences for non-target organisms. Previous studies focused on the effects of pesticides on target and non-target pests, predatory arthropods, and concomitant ecological disruptions. Little research, however, has focused on the direct effects of insecticides on plants. Here we demonstrate that applications of neonicotinoid insecticides, one of the most important insecticide classes worldwide, suppress expression of important plant defense genes, alter levels of phytohormones involved in plant defense, and decrease plant resistance to unsusceptible herbivores, spider mites Tetranychus urticae (Acari: Tetranychidae), in multiple, distantly related crop plants. Methodology/Principal Findings: Using cotton (Gossypium hirsutum), corn (Zea mays) and tomato (Solanum lycopersicum) plants, we show that transcription of phenylalanine amonia lyase, coenzyme A ligase, trypsin protease inhibitor and chitinase are suppressed and concentrations of the phytohormone OPDA and salicylic acid were altered by neonicotinoid insecticides. Consequently, the population growth of spider mites increased from 30% to over 100% on neonicotinoid-treated plants in the greenhouse and by nearly 200% in the field experiment. Conclusions/Significance: Our findings are important because applications of neonicotinoid insecticides have been associated with outbreaks of spider mites in several unrelated plant species. More importantly, this is the first study to document insecticide-mediated disruption of plant defenses and link it to increased population growth of a non-target herbivore. This study adds to growing evidence that bioactive agrochemicals can have unanticipated ecological effects and suggests that the direct effects of insecticides on plant defenses should be considered when the ecological costs of insecticides are evaluated.	[Szczepaniec, Adrianna; Eubanks, Micky D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Raupp, Michael J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Parker, Roy D.] Texas A&M Univ, Texas AgriLife Res & Extens Ctr, Corpus Christi, TX USA; [Kerns, David] Texas A&M Univ, Texas AgriLife Res & Extens Ctr, Lubbock, TX USA	Texas A&M University System; Texas A&M University College Station; University System of Maryland; University of Maryland College Park; Texas A&M University System; Texas A&M University System	Szczepaniec, A (corresponding author), S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA.	adrianna.szczepaniec@sdstate.edu		Szczepaniec, Adrianna/0000-0002-9603-4533	Texas AgriLife Research; USDA National Research Initiative (NRI) [2008-35302-04491]; USDA NRI [2012-67013-19346]; NRI USDA [2005-35303-16269]; Gahan Fellowship; Bamford Fellowship	Texas AgriLife Research; USDA National Research Initiative (NRI)(United States Department of Agriculture (USDA)); USDA NRI(United States Department of Agriculture (USDA)); NRI USDA(United States Department of Agriculture (USDA)); Gahan Fellowship; Bamford Fellowship	This work was supported by grants from Texas AgriLife Research and the USDA National Research Initiative (NRI) to M.D.E. (2008-35302-04491), USDA NRI grant to M.D.E. and A.S. (2012-67013-19346), NRI USDA grant to M.J.R. (2005-35303-16269), and the Gahan and Bamford Fellowships to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ament K, 2004, PLANT PHYSIOL, V135, P2025, DOI 10.1104/pp.104.048694; [Anonymous], USDA NASS AGR CHEM U; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Cipollini D, 2004, MOL ECOL, V13, P1643, DOI 10.1111/j.1365-294X.2004.02161.x; Croft BA, 1997, ENVIRON ENTOMOL, V26, P391, DOI 10.1093/ee/26.2.391; DAHLSTEN DL, 1969, CALIF AGR, V23, P4; DEBACH P, 1977, CALIF AGR, V31, P8; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; Dutcher J.D., 2007, GEN CONCEPTS INTEGRA, P27, DOI [10.1007/978-1-4020-6061-8_2, DOI 10.1007/978-1-4020-6061-8_2]; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; Gupta G, 2007, J ECON ENTOMOL, V100, P830, DOI 10.1603/0022-0493(2007)100[830:PACIFM]2.0.CO;2; Halim VA, 2009, PLANT J, V57, P230, DOI 10.1111/j.1365-313X.2008.03688.x; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Kant MR, 2004, PLANT PHYSIOL, V135, P483, DOI 10.1104/pp.103.038315; Karthikeyan Gandhi, 2009, Archives of Phytopathology and Plant Protection, V42, P1, DOI 10.1080/03235400600914314; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Li CY, 2002, PLANT PHYSIOL, V130, P494, DOI 10.1104/pp.005314; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matheny A. L., 2009, Outlooks on Pest Management, V20, P51, DOI 10.1564/20apr02; MULLINS JW, 1993, ACS SYM SER, V524, P183; Pratt P. D., 2000, Journal of Environmental Horticulture, V18, P218; PYKE DA, 1986, ECOLOGY, V67, P240, DOI 10.2307/1938523; R Core Team, 2018, R LANG ENV STAT COMP; Raupp Michael J., 2004, Journal of Arboriculture, V30, P108; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x; Relyea RA, 2009, OECOLOGIA, V159, P363, DOI [10.1007/s00442-008-1141-8, 10.1007/s00442-008-1213-9]; Roy M, 1999, ENVIRON ENTOMOL, V28, P735, DOI 10.1093/ee/28.4.735; *SAS I, 2008, SAS SYST WIND VERS 9; Sclar DC, 1998, J ECON ENTOMOL, V91, P250, DOI 10.1093/jee/91.1.250; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Smith JF, 2010, EARLY SEASON MANAGEM; Smith JL, 2009, PEST MANAG SCI, V65, P497, DOI 10.1002/ps.1714; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Stout MJ, 1998, OECOLOGIA, V113, P74, DOI 10.1007/s004420050355; Szczepaniec A, 2009, MECH UNDERLYING OUTB; Szczepaniec A, 2013, EXP APPL ACAROL, V59, P307, DOI 10.1007/s10493-012-9614-1; Szczepaniec A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020018; Thaler JS, 2002, J CHEM ECOL, V28, P1131, DOI 10.1023/A:1016225515936; Thielert W., 2006, Pflanzenschutz-Nachrichten Bayer, V59, P73; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Wu Y, 2004, ACTA GOSSYPII SINICA, V2, P1; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324	48	59	64	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62620	10.1371/journal.pone.0062620	http://dx.doi.org/10.1371/journal.pone.0062620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658754	Green Submitted, Green Published, gold			2022-12-27	WOS:000321202100022
J	Zehendner, CM; Luhmann, HJ; Yang, JW				Zehendner, Christoph M.; Luhmann, Heiko J.; Yang, Jenq-Wei			A Simple and Novel Method to Monitor Breathing and Heart Rate in Awake and Urethane-Anesthetized Newborn Rodents	PLOS ONE			English	Article							BRAIN BLOOD-FLOW; VENTILATORY RESPONSE; NEONATAL-RAT; IN-VIVO; MICE; ANESTHESIA; HYPOXIA; CORTEX; STIMULATION; HYPERCAPNIA	Rodents are most useful models to study physiological and pathophysiological processes in early development, because they are born in a relatively immature state. However, only few techniques are available to monitor non-invasively heart frequency and respiratory rate in neonatal rodents without restraining or hindering access to the animal. Here we describe experimental procedures that allow monitoring of heart frequency by electrocardiography (ECG) and breathing rate with a piezoelectric transducer (PZT) element without hindering access to the animal. These techniques can be easily installed and are used in the present study in unrestrained awake and anesthetized neonatal C57/Bl6 mice and Wistar rats between postnatal day 0 and 7. In line with previous reports from awake rodents we demonstrate that heart rate in rats and mice increases during the first postnatal week. Respiratory frequency did not differ between both species, but heart rate was significantly higher in mice than in rats. Further our data indicate that urethane, an agent that is widely used for anesthesia, induces a hypoventilation in neonates whilst heart rate remains unaffected at a dose of 1 g per kg body weight. Of note, hypoventilation induced by urethane was not detected in rats at postnatal 0/1. To verify the detected hypoventilation we performed blood gas analyses. We detected a respiratory acidosis reflected by a lower pH and elevated level in CO2 tension (pCO(2)) in both species upon urethane treatment. Furthermore we found that metabolism of urethane is different in P0/1 mice and rats and between P0/1 and P6/7 in both species. Our findings underline the usefulness of monitoring basic cardio-respiratory parameters in neonates during anesthesia. In addition our study gives information on developmental changes in heart and breathing frequency in newborn mice and rats and the effects of urethane in both species during the first postnatal week.	[Zehendner, Christoph M.; Luhmann, Heiko J.; Yang, Jenq-Wei] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz	Zehendner, CM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, Mainz, Germany.	Zehendner@uni-mainz.de; YangJ@uni-mainz.de	Luhmann, Heiko J./N-8797-2019	Luhmann, Heiko J./0000-0002-7934-8661	DFG; University Medical Center of the Johannes Gutenberg-University Mainz	DFG(German Research Foundation (DFG)); University Medical Center of the Johannes Gutenberg-University Mainz	This work was supported by DFG grants to HJL and a Stage 1 grant to CMZ by the University Medical Center of the Johannes Gutenberg-University Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SM, 2012, J NEUROSCI, V32, P9511, DOI 10.1523/JNEUROSCI.1212-12.2012; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Ayers P, 2008, NUTR CLIN PRACT, V23, P122, DOI 10.1177/0884533608314534; BARTELS H, 1979, RESP PHYSIOL, V36, P375, DOI 10.1016/0034-5687(79)90049-5; Bleich HL, 1980, NEW ENGL J MED, V303, P436, DOI [10.1056/ NEJM198008213030806, DOI 10.1056/NEJM198008213030806]; Brockmann MD, 2011, NEURON, V71, P332, DOI 10.1016/j.neuron.2011.05.041; Cabot RC, 2012, NEW ENGL J MED, V366, P2409, DOI [10.1056/ NEJMcpc1109276, DOI 10.1056/NEJMCPC1109276]; DEWILDT DJ, 1983, BRIT J PHARMACOL, V79, P461; DOWNING SE, 1977, AM J PHYSIOL, V233, pH451, DOI 10.1152/ajpheart.1977.233.4.H451; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; FIELD KJ, 1993, LAB ANIM, V27, P258, DOI 10.1258/002367793780745471; Franceschini MA, 2010, NEUROIMAGE, V51, P1367, DOI 10.1016/j.neuroimage.2010.03.060; Fritz KI, 2005, PEDIATR RES, V57, P299, DOI 10.1203/01.PDR.0000148718.47137.9B; GOOTMAN PM, 1986, AM J PHYSIOL, V251, pH748, DOI 10.1152/ajpheart.1986.251.4.H748; Hilaire G, 1997, NEUROSCI LETT, V224, P13, DOI 10.1016/S0304-3940(97)13458-9; Hoffler U, 2003, J PHARMACOL EXP THER, V305, P557, DOI 10.1124/jpet.102.049072; HOU PCL, 1989, RESP PHYSIOL, V78, P265, DOI 10.1016/0034-5687(89)90103-5; Lu H, 1998, ANESTH ANALG, V87, P854, DOI 10.1097/00000539-199810000-00020; MAGGI CA, 1986, EXPERIENTIA, V42, P292, DOI 10.1007/BF01942510; Masamoto K, 2012, J CEREBRAL BLOOD FLO; Matrot B, 2005, J APPL PHYSIOL, V98, P365, DOI 10.1152/japplphysiol.00803.2004; MORTOLA JP, 1989, RESP PHYSIOL, V78, P31, DOI 10.1016/0034-5687(89)90140-0; Pagliardini S, 2012, J NEUROSCI, V32, P11259, DOI 10.1523/JNEUROSCI.0948-12.2012; PATON JFR, 1995, PFLUG ARCH EUR J PHY, V430, P115, DOI 10.1007/BF00373846; Ramanantsoa N, 2007, AM J PHYSIOL-REG I, V293, pR2027, DOI 10.1152/ajpregu.00349.2007; Robinson DM, 2000, J APPL PHYSIOL, V88, P1907, DOI 10.1152/jappl.2000.88.5.1907; Salmon AG, 1991, RISKS CARCINOGENESIS; Sato S, 2008, AM J PHYSIOL-HEART C, V294, pH1708, DOI 10.1152/ajpheart.01122.2007; Sato S, 2006, MED BIOL ENG COMPUT, V44, P353, DOI 10.1007/s11517-006-0047-z; Schmidt RF, 2011, PHYSL MENSCHEN PATHO, DOI DOI 10.1007/978-3-642-01651-6.ACCESSED; Tankersley CG, 1997, J APPL PHYSIOL, V82, P874, DOI 10.1152/jappl.1997.82.3.874; Teppema LJ, 2010, PHYSIOL REV, V90, P675, DOI 10.1152/physrev.00012.2009; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009	36	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62628	10.1371/journal.pone.0062628	http://dx.doi.org/10.1371/journal.pone.0062628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658756	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100024
J	Fallis, BA; Dhalla, IA; Klemensberg, J; Bell, CM				Fallis, Brooks A.; Dhalla, Irfan A.; Klemensberg, Jason; Bell, Chaim M.			Primary Medication Non-Adherence after Discharge from a General Internal Medicine Service	PLOS ONE			English	Article							ADHERENCE; THERAPY; HOSPITALIZATION; DISCONTINUATION; MORTALITY; IMPACT; CARE	Background: Medication non-adherence frequently leads to suboptimal patient outcomes. Primary non-adherence, which occurs when a patient does not fill an initial prescription, is particularly important at the time of hospital discharge because new medications are often being prescribed to treat an illness rather than for prevention. Methods: We studied older adults consecutively discharged from a general internal medicine service at a large urban teaching hospital to determine the prevalence of primary non-adherence and identify characteristics associated with primary non-adherence. We reviewed electronic prescriptions, electronic discharge summaries and pharmacy dispensing data from April to August 2010 for drugs listed on the public formulary. Primary non-adherence was defined as failure to fill one or more new prescriptions after hospital discharge. In addition to descriptive analyses, we developed a logistical regression model to identify patient characteristics associated with primary non-adherence. Results: There were 493 patients eligible for inclusion in our study, 232 of whom were prescribed new medications. In total, 66 (28%) exhibited primary non-adherence at 7 days after discharge and 55 (24%) at 30 days after discharge. Examples of medications to which patients were non-adherent included antibiotics, drugs for the management of coronary artery disease (e. g. beta-blockers, statins), heart failure (e. g. beta-blockers, angiotensin converting enzyme inhibitors, furosemide), stroke (e. g. statins, clopidogrel), diabetes (e. g. insulin), and chronic obstructive pulmonary disease (e. g. long-acting bronchodilators, prednisone). Discharge to a nursing home was associated with an increased risk of primary non-adherence (OR 2.25, 95% CI 1.01-4.95). Conclusions: Primary non-adherence after medications are newly prescribed during a hospitalization is common, and was more likely to occur in patients discharged to a nursing home.	[Fallis, Brooks A.; Dhalla, Irfan A.; Bell, Chaim M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Dhalla, Irfan A.; Bell, Chaim M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Dhalla, Irfan A.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.; Klemensberg, Jason] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.; Bell, Chaim M.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bell, CM (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	cbell@mtsinai.on.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469	Canadian Institutes of Health Research; Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care	Dr. Bell is supported by a Canadian Institutes of Health Research and Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care. The funding agencies had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript. The corresponding author had full access to all of the data and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors report no conflicts of interest.	Baudendistel TE, 2011, J HOSP MED, V6, P487, DOI 10.1002/jhm.998; BEARDON PHG, 1993, BRIT MED J, V307, P846, DOI 10.1136/bmj.307.6908.846; Bell CM, 2011, JAMA-J AM MED ASSOC, V306, P840, DOI 10.1001/jama.2011.1206; Boockvar KS, 2007, J AM GERIATR SOC, V55, P1078, DOI 10.1111/j.1532-5415.2007.01235.x; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Fischer MA, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.05.028; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ho PM, 2006, ARCH INTERN MED, V166, P1842, DOI 10.1001/archinte.166.17.1842; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jackevicius CA, 2008, CIRCULATION, V117, P1028, DOI 10.1161/CIRCULATIONAHA.107.706820; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Maslove DM, 2009, J GEN INTERN MED, V24, P995, DOI 10.1007/s11606-009-1053-2; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Raebel MA, 2011, ANN PHARMACOTHER, V45, P1053, DOI 10.1345/aph.1Q146; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af	17	66	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e61735	10.1371/journal.pone.0061735	http://dx.doi.org/10.1371/journal.pone.0061735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658698	Green Published, Green Submitted, gold			2022-12-27	WOS:000321200500011
J	Hackel, D; Pflucke, D; Neumann, A; Viebahn, J; Mousa, S; Wischmeyer, E; Roewer, N; Brack, A; Rittner, HL				Hackel, Dagmar; Pfluecke, Diana; Neumann, Annick; Viebahn, Johannes; Mousa, Shaaban; Wischmeyer, Erhard; Roewer, Norbert; Brack, Alexander; Rittner, Heike Lydia			The Connection of Monocytes and Reactive Oxygen Species in Pain	PLOS ONE			English	Article							OPIOID-PEPTIDES; SENSORY NEURONS; NADPH OXIDASE; ARTHRITIS; RECRUITMENT; ACTIVATION; RECEPTOR; RELEASE; IDENTIFICATION; TOLERANCE	The interplay of specific leukocyte subpopulations, resident cells and proalgesic mediators results in pain in inflammation. Proalgesic mediators like reactive oxygen species (ROS) and downstream products elicit pain by stimulation of transient receptor potential (TRP) channels. The contribution of leukocyte subpopulations however is less clear. Local injection of neutrophilic chemokines elicits neutrophil recruitment but no hyperalgesia in rats. In meta-analyses the monocytic chemoattractant, CCL2 (monocyte chemoattractant protein-1; MCP-1), was identified as an important factor in the pathophysiology of human and animal pain. In this study, intraplantar injection of CCL2 elicited thermal and mechanical pain in Wistar but not in Dark Agouti (DA) rats, which lack p47(phox), a part of the NADPH oxidase complex. Inflammatory hyperalgesia after complete Freund's adjuvant (CFA) as well as capsaicin-induced hyperalgesia and capsaicin-induced current flow in dorsal root ganglion neurons in DA were comparable to Wistar rats. Macrophages from DA expressed lower levels of CCR2 and thereby migrated less towards CCL2 and formed limited amounts of ROS in vitro and 4-hydroxynonenal (4-HNE) in the tissue in response to CCL2 compared to Wistar rats. Local adoptive transfer of peritoneal macrophages from Wistar but not from DA rats reconstituted CCL2-triggered hyperalgesia in leukocyte-depleted DA and Wistar rats. A pharmacological stimulator of ROS production (phytol) restored CCL2-induced hyperalgesia in vivo in DA rats. In Wistar rats, CCL2-induced hyperalgesia was completely blocked by superoxide dismutase (SOD), catalase or tempol. Likewise, inhibition of NADPH oxidase by apocynin reduced CCL2-elicited hyperalgesia but not CFA-induced inflammatory hyperalgesia. In summary, we provide a link between CCL2, CCR2 expression on macrophages, NADPH oxidase, ROS and the development CCL2-triggered hyperalgesia, which is different from CFA-induced hyperalgesia. The study further supports the impact of CCL2 and ROS as potential targets in pain therapy.	[Hackel, Dagmar; Pfluecke, Diana; Neumann, Annick; Roewer, Norbert; Brack, Alexander; Rittner, Heike Lydia] Univ Klinikum, Klin & Poliklin Anaesthesiol, Wurzburg, Germany; [Hackel, Dagmar] Charite Univ Med Berlin, Klin Anesthaesiol MS Operat Intens Med, Berlin, Germany; [Viebahn, Johannes; Wischmeyer, Erhard] Univ Wurzburg, Inst Physiol, Wurzburg, Germany; [Mousa, Shaaban] Charite Univ Med Berlin, Klin Anaesthesiol, Berlin, Germany	University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rittner, HL (corresponding author), Univ Klinikum, Klin & Poliklin Anaesthesiol, Wurzburg, Germany.	rittner_h@klinik.uni-wuerzburg.de	RIttner, Heike/AAC-6523-2019	RIttner, Heike/0000-0003-4867-0188	Interdisciplinary Center of Clinical Studies University of Wuerzburg [N-113]; German Research Foundation (DFG); University of Wuerzburg	Interdisciplinary Center of Clinical Studies University of Wuerzburg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was supported by the Interdisciplinary Center of Clinical Studies University of Wuerzburg N-113. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Aukrust P, 2001, J AM COLL CARDIOL, V37, P485, DOI 10.1016/S0735-1097(00)01110-4; Azuma EK, 1996, EXP HEMATOL, V24, P169; Brack A, 2004, ANESTHESIOLOGY, V100, P149, DOI 10.1097/00000542-200401000-00024; Cao L, 2012, J IMMUNOL, V189, P3724, DOI 10.4049/jimmunol.1201313; Cathcart MK, 2004, ARTERIOSCL THROM VAS, V24, P23, DOI 10.1161/01.ATV.0000097769.47306.12; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Dimitrijevic M, 2001, BRAIN BEHAV IMMUN, V15, P255, DOI 10.1006/brbi.2000.0599; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Doyle T, 2011, PAIN, V152, P643, DOI 10.1016/j.pain.2010.12.011; Endres-Becker J, 2007, MOL PHARMACOL, V71, P12, DOI 10.1124/mol.106.026740; Fidanboylu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025212; Hackel D, 2011, J NEUROIMMUNOL, V230, P65, DOI 10.1016/j.jneuroim.2010.08.027; Heo SK, 2008, BIOCHEM BIOPH RES CO, V371, P834, DOI 10.1016/j.bbrc.2008.04.184; Hultqvist M, 2007, J IMMUNOL, V179, P1431, DOI 10.4049/jimmunol.179.3.1431; Hultqvist M, 2006, PLOS MED, V3, P1625, DOI 10.1371/journal.pmed.0030348; Ibi M, 2008, J NEUROSCI, V28, P9486, DOI 10.1523/JNEUROSCI.1857-08.2008; Juniantito V, 2010, HISTOL HISTOPATHOL, V25, P985, DOI 10.14670/HH-25.985; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kuiper JWP, 2011, BLOOD, V118, P6164, DOI 10.1182/blood-2010-09-310383; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; Miletic T, 2007, IMMUNOBIOLOGY, V212, P95, DOI 10.1016/j.imbio.2006.11.012; Mousa SA, 2010, BRAIN BEHAV IMMUN, V24, P1310, DOI 10.1016/j.bbi.2010.06.008; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Qin XM, 2005, J NEUROSCI RES, V82, P51, DOI 10.1002/jnr.20612; Quick ML, 2012, AM J PHYSIOL-REG I, V303, pR580, DOI 10.1152/ajpregu.00240.2012; Rattan V, 1997, AM J PHYSIOL-ENDOC M, V273, pE369, DOI 10.1152/ajpendo.1997.273.2.E369; Rittner HL, 2008, BRIT J ANAESTH, V101, P40, DOI 10.1093/bja/aen078; Rittner HL, 2007, BRAIN BEHAV IMMUN, V21, P1021, DOI 10.1016/j.bbi.2007.05.002; Rittner HL, 2006, FASEB J, V20, P2627, DOI 10.1096/fj.06-6077fje; Rittner HL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000362; Rittner HL, 2006, J LEUKOCYTE BIOL, V79, P1022, DOI 10.1189/jlb.0805452; Rittner HL, 2006, J LEUKOCYTE BIOL, V80, P729, DOI 10.1189/jlb.0506337; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; ROLLINS BJ, 1991, BLOOD, V78, P1112; Schwartz ES, 2009, J NEUROSCI, V29, P159, DOI 10.1523/JNEUROSCI.3792-08.2009; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Xu XJ, 2001, PAIN, V89, P135, DOI 10.1016/S0304-3959(00)00356-0; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zollner C, 2008, J CLIN INVEST, V118, P1065, DOI 10.1172/JCI25911	44	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63564	10.1371/journal.pone.0063564	http://dx.doi.org/10.1371/journal.pone.0063564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658840	Green Published, gold			2022-12-27	WOS:000321200500077
J	Huveneers, C; Rogers, PJ; Semmens, JM; Beckmann, C; Kock, AA; Page, B; Goldsworthy, SD				Huveneers, Charlie; Rogers, Paul J.; Semmens, Jayson M.; Beckmann, Crystal; Kock, Alison A.; Page, Brad; Goldsworthy, Simon D.			Effects of an Electric Field on White Sharks: In Situ Testing of an Electric Deterrent	PLOS ONE			English	Article							LATERAL-LINE ORGANS; CARCHARODON-CARCHARIAS; BEHAVIORAL-RESPONSES; ELECTRORECEPTION; INNERVATION; SYSTEM; ISLAND; SENSE	Elasmobranchs can detect minute electromagnetic fields, <1 nVcm(-1), using their ampullae of Lorenzini. Behavioural responses to electric fields have been investigated in various species, sometimes with the aim to develop shark deterrents to improve human safety. The present study tested the effects of the Shark Shield Freedom7 (TM) electric deterrent on (1) the behaviour of 18 white sharks (Carcharodon carcharias) near a static bait, and (2) the rates of attacks on a towed seal decoy. In the first experiment, 116 trials using a static bait were performed at the Neptune Islands, South Australia. The proportion of baits taken during static bait trials was not affected by the electric field. The electric field, however, increased the time it took them to consume the bait, the number of interactions per approach, and decreased the proportion of interactions within two metres of the field source. The effect of the electric field was not uniform across all sharks. In the second experiment, 189 tows using a seal decoy were conducted near Seal Island, South Africa. No breaches and only two surface interactions were observed during the tows when the electric field was activated, compared with 16 breaches and 27 surface interactions without the electric field. The present study suggests that the behavioural response of white sharks and the level of risk reduction resulting from the electric field is contextually specific, and depends on the motivational state of sharks.	[Huveneers, Charlie; Rogers, Paul J.; Page, Brad; Goldsworthy, Simon D.] South Australian Res & Dev Inst Aquat Sci, Threatened Endangered & Protected Species Sub Pro, Adelaide, SA, Australia; [Huveneers, Charlie; Beckmann, Crystal] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Semmens, Jayson M.] Univ Tasmania, Fisheries Aquaculture & Coasts Ctr, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Kock, Alison A.] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, Western Cape, South Africa; [Kock, Alison A.] Shark Spotters, Cape Town, Western Cape, South Africa	Flinders University South Australia; University of Tasmania; University of Cape Town	Huveneers, C (corresponding author), South Australian Res & Dev Inst Aquat Sci, Threatened Endangered & Protected Species Sub Pro, Adelaide, SA, Australia.	charlie.huveneers@sa.gov.au		Goldsworthy, Simon/0000-0003-4988-9085; Beckmann, Crystal/0000-0002-1704-9578; Huveneers, Charlie/0000-0001-8937-1358; Semmens, Jayson/0000-0003-1742-6692; Kock, Alison/0000-0001-9981-1652	SafeWork SA; Winifred Violet Scott Charitable Trust; Neiser Foundation; University of Adelaide; Flinders University; Wildlife Conservation Fund; Nature Foundation of South Australia; Solar Online; Australian Research Council's Discovery Projects funding scheme [DP0988554]; umbrella of a Save Our Seas Foundation	SafeWork SA; Winifred Violet Scott Charitable Trust; Neiser Foundation; University of Adelaide; Flinders University; Wildlife Conservation Fund; Nature Foundation of South Australia; Solar Online; Australian Research Council's Discovery Projects funding scheme(Australian Research Council); umbrella of a Save Our Seas Foundation	This project was funded by SafeWork SA, Winifred Violet Scott Charitable Trust, Neiser Foundation, University of Adelaide, Flinders University, Wildlife Conservation Fund, Nature Foundation of South Australia, and Solar Online. This research was also partly supported under Australian Research Council's Discovery Projects funding scheme (project number DP0988554; www.arc.gov.au). Fieldwork in South Africa was funded under the umbrella of a Save Our Seas Foundation grant provided to AAK as part of a white shark monitoring project. The authors thank Andrew Fox, Jennifer Taylor, and Rachel Robbins from the Rodney Fox Shark Expeditions for the logistic support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SD, 2011, MAR BIOL, V158, P1233, DOI 10.1007/s00227-011-1643-5; BLONDER BI, 1988, COPEIA, P33, DOI 10.2307/1445919; BRATTON BO, 1987, ENVIRON BIOL FISH, V20, P241; Brill R, 2009, FISH B-NOAA, V107, P298; Broad A, 2010, MAR ECOL PROG SER, V408, P295, DOI 10.3354/meps08591; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce BD., 2011, EFFECTS BERLEYING DI; Burgess GH, 2010, CRC MAR BIOL SER, P541; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chapple TK, 2011, BIOL LETTERS, V7, P581, DOI 10.1098/rsbl.2011.0124; Curtis T.H., 2012, GLOBAL PERSPECTIVES; Czech-Damal NU, 2012, P ROY SOC B-BIOL SCI, V279, P663, DOI 10.1098/rspb.2011.1127; De Vos A, 2010, BIOL LETTERS, V6, P48, DOI 10.1098/rsbl.2009.0628; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Fay MP, 2010, R J, V2, P53; Gilbert P.W., 1973, Underwater J Inf Bull, V5, P69; Gubili C, 2012, GLOBAL PERSPECTIVES; Haine OS, 2001, MAR FRESHWATER RES, V52, P291, DOI 10.1071/MF00036; Huveneers C., 2012, SARDI RES REPORT SER; Jordan LK, 2011, J EXP MAR BIOL ECOL, V409, P345, DOI 10.1016/j.jembe.2011.09.016; JORGENSEN JM, 1972, Z ZELLFORSCH MIK ANA, V130, P362; Kajiura SM, 2002, J EXP BIOL, V205, P3609; Kalmijn A.J., 1978, P507; Kalmijn A.J., 1974, P147; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KALMIJN AJ, 1966, NATURE, V212, P1232, DOI 10.1038/2121232b0; Laroche RK, 2008, ANIM BEHAV, V76, P1901, DOI 10.1016/j.anbehav.2008.06.025; LOWE CG, 1994, MAR BIOL, V120, P161; Malcolm H., 2001, REV BIOL STATUS WHIT; Marcotte MM, 2008, MAR TECHNOL SOC J, V42, P53, DOI 10.4031/002533208786829133; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; New JG, 1997, BRAIN BEHAV EVOLUT, V50, P244, DOI 10.1159/000113338; Northcutt R.G., 1986, P257; NORTHCUTT RG, 1992, J COMP NEUROL, V325, P95, DOI 10.1002/cne.903250109; Northcutt RG, 2000, J COMP NEUROL, V421, P570; PAULIN MG, 1995, J THEOR BIOL, V174, P325, DOI 10.1006/jtbi.1995.0102; PETERS RC, 1985, J EXP BIOL, V118, P99; Rigg DP, 2009, MAR FRESHWATER RES, V60, P942, DOI 10.1071/MF08180; Robbins WD, 2011, FISH RES, V109, P100, DOI 10.1016/j.fishres.2011.01.023; SCHEICH H, 1986, NATURE, V319, P401, DOI 10.1038/319401a0; Sepulveda CA, 2007, MAR BIOL, V152, P1087, DOI 10.1007/s00227-007-0757-2; Sisneros JA, 1998, J COMP PHYSIOL A, V183, P87, DOI 10.1007/s003590050237; Smit C.F., 2003, S AFRICAN J STAT, V37, P59; Smith E. D., 1974, Transactions of the South African Institute of Electrical Engineers, V65, P166; Smith E.D., 1990, S AFRICAN SHIPPING N, P40; Smith E.D., 1973, CIVIL ENG PUBLIC WOR, V68, P174; Smith ED, 1966, GEO MAR TECH, V2, P10; Tricas TC, 1995, NEUROSCI LETT, V202, P129, DOI 10.1016/0304-3940(95)12230-3; West JG, 2011, MAR FRESHWATER RES, V62, P744, DOI 10.1071/MF10181; Wueringer BE, 2012, BRAIN BEHAV EVOLUT, V80, P97, DOI 10.1159/000339873	51	27	27	5	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62730	10.1371/journal.pone.0062730	http://dx.doi.org/10.1371/journal.pone.0062730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658766	Green Published, gold			2022-12-27	WOS:000321200500034
J	Magalhaes, V; Andrade, EB; Alves, J; Ribeiro, A; Kim, KS; Lima, M; Trieu-Cuot, P; Ferreira, P				Magalhaes, Vanessa; Andrade, Elva Bonifacio; Alves, Joana; Ribeiro, Adilia; Kim, Kwang Sik; Lima, Margarida; Trieu-Cuot, Patrick; Ferreira, Paula			Group B Streptococcus Hijacks the Host Plasminogen System to Promote Brain Endothelial Cell Invasion	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; EXTRACELLULAR-MATRIX; NEONATAL MENINGITIS; BACTERIAL INVASION; BARRIER; SURFACE; PENETRATION; INFECTION; BINDING; ACTIVATION	Group B Streptococcus (GBS) is the leading cause of meningitis in neonates. We have previously shown that plasminogen, once recruited to the GBS cell surface and converted into plasmin by host-derived activators, leads to an enhancement of bacterial virulence. Here, we investigated whether plasmin(ogen) bound at the GBS surface contributes to blood-brain barrier penetration and invasion of the central nervous system. For that purpose, GBS strain NEM316 preincubated with or without plasminogen plus tissue type plasminogen activator was analyzed for the capacity to adhere to, invade and transmigrate the human brain microvascular endothelial cell (hBMEC) monolayer, and to penetrate the central nervous system using a neonatal mouse model. At earlier times of infection, plasmin(ogen)-treated GBS exhibited a significant increase in adherence to and invasion of hBMECs. Later, injury of hBMECs were observed with plasmin(ogen)-treated GBS that displayed a plasmin-like activity. The same results were obtained when hBMECs were incubated with whole human plasma and infected with untreated GBS. To confirm that the observed effects were due to the recruitment and activation of plasminogen on GBS surface, the bacteria were first incubated with epsilon-aminocaproic acid (epsilon ACA), an inhibitor of plasminogen binding, and thereafter with plasmin(ogen). A significant decrease in the hBMECs injury that was correlated with a decrease of the GBS surface proteolytic activity was observed. Furthermore, plasmin(ogen)-treated GBS infected more efficiently the brain of neonatal mice than the untreated bacteria, indicating that plasmin(ogen) bound to GBS surface may facilitate the traversal of the blood-brain barrier. A higher survival rate was observed in offspring born from epsilon ACA-treated mothers, compared to untreated mice, and no brain infection was detected in these neonates. Our findings suggest that capture of the host plasmin(ogen) by the GBS surface promotes the crossing of the blood-brain barrier and contributes to the establishment of meningitis.	[Magalhaes, Vanessa; Andrade, Elva Bonifacio; Alves, Joana; Ribeiro, Adilia; Ferreira, Paula] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [Magalhaes, Vanessa; Andrade, Elva Bonifacio; Alves, Joana; Ribeiro, Adilia; Ferreira, Paula] IBMC, Oporto, Portugal; [Magalhaes, Vanessa] UFP, Fac Ciencias Saude, Oporto, Portugal; [Kim, Kwang Sik] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Lima, Margarida] CHP, HSA, Dept Hematol, Oporto, Portugal; [Trieu-Cuot, Patrick] CNRS, Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, ERL3526, Paris, France	Universidade do Porto; Universidade do Porto; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ferreira, P (corresponding author), Univ Porto, ICBAS, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	pauferr@icbas.up.pt	Alves, Joana EV/J-6866-2013; Magalhães, Vanessa/GPS-9333-2022; Lima, Margarida/S-7466-2016; Andrade, Elva Bonifácio/K-3096-2013; Magalhães, Vanessa/M-3095-2013; Ferreira, Paula/J-6149-2013	Alves, Joana EV/0000-0003-3131-9834; Lima, Margarida/0000-0001-9702-5260; Andrade, Elva Bonifácio/0000-0002-1941-580X; Magalhães, Vanessa/0000-0001-6081-117X; Ferreira, Paula/0000-0001-8639-9224; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Ribeiro, Adilia/0000-0002-0142-3182	Fundacao para a Ciencia e Tecnologia (FCT); Fundo Europeu de Desenvolvimento Regional (FEDER); Programa Operacional Fatores de Competitividade (COMPETE) [PTDC/SAU-MIC/111387/2009]; PhD FCT fellowship [SFRH/BD/38380/2007, SRFH/BD/77232/2011]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); Programa Operacional Fatores de Competitividade (COMPETE); PhD FCT fellowship	This work was supported by research funding from Fundacao para a Ciencia e Tecnologia (FCT), Fundo Europeu de Desenvolvimento Regional (FEDER) and Programa Operacional Fatores de Competitividade (COMPETE) through the grant no PTDC/SAU-MIC/111387/2009. Elva Bonifacio Andrade and Joana Alves were supported by a PhD FCT fellowship SFRH/BD/38380/2007 and SRFH/BD/77232/2011, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Berardi A, 2010, Minerva Pediatr, V62, P51; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; Chang YC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002082; Coleman JL, 2000, METHODS, V21, P133, DOI 10.1006/meth.2000.0984; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1999, INFECT IMMUN, V67, P3929, DOI 10.1128/IAI.67.8.3929-3936.1999; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Collen D, 2001, Hematology Am Soc Hematol Educ Program, P1; COLLEN D, 1975, THROMB DIATH HAEMOST, V34, P403, DOI 10.1055/s-0038-1651399; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; EDWARDS MS, 1985, J PEDIATR-US, V106, P717, DOI 10.1016/S0022-3476(85)80342-5; Gebbia JA, 1999, J CLIN INVEST, V103, P81, DOI 10.1172/JCI5171; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; Join-Lambert O, 2010, PROG NEUROBIOL, V91, P130, DOI 10.1016/j.pneurobio.2009.12.004; Kim KJ, 2003, CELL MICROBIOL, V5, P245, DOI 10.1046/j.1462-5822.2003.t01-1-00271.x; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Kim KS, 2006, INT J PARASITOL, V36, P607, DOI 10.1016/j.ijpara.2006.01.013; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Kinnby B, 2008, MICROBIOL-SGM, V154, P924, DOI 10.1099/mic.0.2007/013235-0; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Li ZQ, 1999, J INFECT DIS, V179, P907, DOI 10.1086/314654; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Nilsson I M, 1980, J Clin Pathol Suppl (R Coll Pathol), V14, P41; Nitsche-Schmitz DP, 2007, THROMB HAEMOSTASIS, V98, P488, DOI 10.1160/TH07-03-0179; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Nordstrand A, 2001, INFECT IMMUN, V69, P5832, DOI 10.1128/IAI.69.9.5832-5839.2001; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Sanderson-Smith ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/272148; Stevens JP, 2003, ARCH DIS CHILD-FETAL, V88, P179; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; Tazi A, 2011, CURR OPIN MICROBIOL; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; WONG AP, 1992, AM J PHYSIOL, V263, pF1112, DOI 10.1152/ajprenal.1992.263.6.F1112	49	21	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63244	10.1371/journal.pone.0063244	http://dx.doi.org/10.1371/journal.pone.0063244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658816	Green Submitted, Green Published, gold			2022-12-27	WOS:000321200500064
J	Bohmer, SA; Weibrecht, I; Soderberg, O; Bohmer, FD				Bohmer, Sylvia-Annette; Weibrecht, Irene; Soderberg, Ola; Bohmer, Frank-D.			Association of the Protein-Tyrosine Phosphatase DEP-1 with Its Substrate FLT3 Visualized by In Situ Proximity Ligation Assay	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FLUORESCENCE MICROSCOPY; ENDOPLASMIC-RETICULUM; CELL; 1B; DEPHOSPHORYLATION; INACTIVATION; MECHANISM; REVEALS; PTP1B	Protein-tyrosine phosphatases (PTPs) are important regulators of signal transduction processes. Essential for the functional characterization of PTPs is the identification of their physiological substrates, and an important step towards this goal is the demonstration of a physical interaction. The association of PTPs with their cellular substrates is, however, often transient and difficult to detect with unmodified proteins at endogenous levels. Density-enhanced phosphatase-1 (DEP-1/PTPRJ) is a regulator of hematopoietic cell functions, and a candidate tumor suppressor. However, association of DEP-1 with any of its proposed substrates at endogenous levels has not yet been shown. We have previously obtained functional and biochemical evidence for a direct interaction of DEP-1 with the hematopoietic receptor-tyrosine kinase Fms-like tyrosine kinase-3 (FLT3). In the current study we have used the method of in situ proximity ligation assay (in situ PLA) to validate this interaction at endogenous levels, and to further characterize it. In situ PLA readily detected association of endogenous DEP1 and FLT3 in the human acute monocytic leukemia cell line THP-1, which was enhanced by FLT3 ligand (FL) stimulation in a time-dependent manner. Association peaked between 10 and 20 min of stimulation and returned to basal levels at 30 min. This time course was similar to the time course of FLT3 autophosphorylation. FLT3 kinase inhibition and DEP-1 oxidation abrogated association. Consistent with a functional role of DEP-1-FLT3 interaction, stable knockdown of DEP-1 in THP-1 cells enhanced FL-induced ERK1/2 activation. These findings support that FLT3 is a bona fide substrate of DEP-1 and that interaction occurs mainly via an enzyme-substrate complex formation triggered by FLT3 ligand stimulation.	[Bohmer, Sylvia-Annette; Bohmer, Frank-D.] Jena Univ Hosp, Inst Mol Cell Biol, Ctr Mol Biomed, Jena, Germany; [Weibrecht, Irene; Soderberg, Ola] Uppsala Univ, Rudbeck Lab, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden	Friedrich Schiller University of Jena; Uppsala University	Bohmer, FD (corresponding author), Jena Univ Hosp, Inst Mol Cell Biol, Ctr Mol Biomed, Jena, Germany.	boehmer@med.uni-jena.de	Söderberg, Ola/O-5130-2017	Söderberg, Ola/0000-0003-2883-1925	Deutsche Krebshilfe [108401, TP2]; Swedish Foundation for Strategic Research	Deutsche Krebshilfe(Deutsche Krebshilfe); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	Deutsche Krebshilfe (Collaborative grant 108401, TP2 to F.D.B.), and to the Swedish Foundation for Strategic Research (to I.W. and O.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Arora D, 2011, J BIOL CHEM, V286, P10918, DOI 10.1074/jbc.M110.205021; Biskup C, 2004, J CELL SCI, V117, P5165, DOI 10.1242/jcs.01397; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Gavrilovic M, 2011, CYTOM PART A, V79A, P518, DOI 10.1002/cyto.a.21087; Godfrey R, 2012, BLOOD, V119, P4499, DOI 10.1182/blood-2011-02-336446; Gross S, 1999, J BIOL CHEM, V274, P26378, DOI 10.1074/jbc.274.37.26378; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Iervolino A, 2006, CANCER RES, V66, P6280, DOI 10.1158/0008-5472.CAN-06-0228; Jandt E, 2003, ONCOGENE, V22, P4175, DOI 10.1038/sj.onc.1206652; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Kappert K, 2007, FASEB J, V21, P523, DOI 10.1096/fj.06-6219com; Karagyozov L, 2008, NUCLEIC ACIDS RES, V36, P4443, DOI 10.1093/nar/gkn391; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Machide M, 2006, J BIOL CHEM, V281, P8765, DOI 10.1074/jbc.M512298200; Mahboobi S, 2006, J MED CHEM, V49, P3101, DOI 10.1021/jm058033i; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Petermann A, 2011, BRAIN PATHOL, V21, P405, DOI 10.1111/j.1750-3639.2010.00464.x; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Senis YA, 2009, BLOOD, V113, P4942, DOI 10.1182/blood-2008-08-174318; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Yang T, 2006, J NEUROBIOL, V66, P1420, DOI 10.1002/neu.20291; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	31	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62871	10.1371/journal.pone.0062871	http://dx.doi.org/10.1371/journal.pone.0062871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650535	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000080
J	Yang, J; Swenson, NG; Cao, M; Chuyong, GB; Ewango, CEN; Howe, R; Kenfack, D; Thomas, D; Wolf, A; Lin, LX				Yang, Jie; Swenson, Nathan G.; Cao, Min; Chuyong, George B.; Ewango, Corneille E. N.; Howe, Robert; Kenfack, David; Thomas, Duncan; Wolf, Amy; Lin, Luxiang			A Phylogenetic Perspective on the Individual Species-Area Relationship in Temperate and Tropical Tree Communities	PLOS ONE			English	Article							NEUTRAL THEORY; NULL MODELS; RAIN-FOREST; DIVERSITY; ECOLOGY; SCALE; TRAIT	Ecologists have historically used species-area relationships (SARs) as a tool to understand the spatial distribution of species. Recent work has extended SARs to focus on individual-level distributions to generate individual species area relationships (ISARs). The ISAR approach quantifies whether individuals of a species tend have more or less species richness surrounding them than expected by chance. By identifying richness 'accumulators' and 'repellers', respectively, the ISAR approach has been used to infer the relative importance of abiotic and biotic interactions and neutrality. A clear limitation of the SAR and ISAR approaches is that all species are treated as evolutionarily independent and that a large amount of work has now shown that local tree neighborhoods exhibit non-random phylogenetic structure given the species richness. Here, we use nine tropical and temperate forest dynamics plots to ask: (i) do ISARs change predictably across latitude?; (ii) is the phylogenetic diversity in the neighborhood of species accumulators and repellers higher or lower than that expected given the observed species richness?; and (iii) do species accumulators, repellers distributed non-randomly on the community phylogenetic tree? The results indicate no clear trend in ISARs from the temperate zone to the tropics and that the phylogenetic diversity surrounding the individuals of species is generally only non-random on very local scales. Interestingly the distribution of species accumulators and repellers was non-random on the community phylogenies suggesting the presence of phylogenetic signal in the ISAR across latitude.	[Yang, Jie; Cao, Min; Lin, Luxiang] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Yang, Jie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Chuyong, George B.] Univ Buea, Dept Bot & Plant Physiol, Buea, Cameroon; [Ewango, Corneille E. N.] Ctr Format & Rech Conservat Forestiere CEFRECOF E, Reserve De Faune A Okapi, DEM REP CONGO; [Howe, Robert; Wolf, Amy] Univ Wisconsin, Dept Nat & Appl Sci, Green Bay, WI 54302 USA; [Kenfack, David] Smithsonian Inst, Smithsonian Global Earth Observ Network, Washington, DC USA; [Thomas, Duncan] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Michigan State University; University of Wisconsin System; Smithsonian Institution; Smithsonian Tropical Research Institute; Oregon State University	Lin, LX (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.	linluxa@xtbg.ac.cn		Kenfack, David/0000-0001-8208-3388	United States National Science Foundation [DEB - 1046113]; National Science Foundation of China [31061160188, 31000201]; Queensland-Chinese Academy of Science Joint Biotechnology Projects [GJHZ1130]; Direct For Biological Sciences [1046113] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Queensland-Chinese Academy of Science Joint Biotechnology Projects; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was conducted as a part of a Dimensions of Biodiversity IRCN workshop in Changbaishan, China, funded by the United States National Science Foundation (DEB - 1046113). This study was supported by the National Science Foundation of China (31061160188 and 31000201) and the Queensland-Chinese Academy of Science Joint Biotechnology Projects (GJHZ1130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lan GY, 2011, FOREST ECOL MANAG, V262, P1507, DOI 10.1016/j.foreco.2011.06.052; Losos EC, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P3; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mi XC, 2012, AM NAT, V180, pE17, DOI 10.1086/665999; Orme D, 2012, CAPER COMPARATIVE AN; R Development Core Team, 2012, R LANG ENV STAT COMP; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Swenson NG, 2011, AM J BOT, V98, P472, DOI 10.3732/ajb.1000289; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Tilman D., 1982, Monographs in Population Biology, pi; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wiegand T, 2007, P NATL ACAD SCI USA, V104, P19029, DOI 10.1073/pnas.0705621104; Wiegand T, 2012, P ROY SOC B-BIOL SCI, V279, P3312, DOI 10.1098/rspb.2012.0376; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	40	12	18	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63192	10.1371/journal.pone.0063192	http://dx.doi.org/10.1371/journal.pone.0063192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650553	gold, Green Published, Green Submitted			2022-12-27	WOS:000319167000098
J	Mabalirajan, U; Ahmad, T; Rehman, R; Leishangthem, GD; Dinda, AK; Agrawal, A; Ghosh, B; Sharma, SK				Mabalirajan, Ulaganathan; Ahmad, Tanveer; Rehman, Rakhshinda; Leishangthem, Geeta Devi; Dinda, Amit Kumar; Agrawal, Anurag; Ghosh, Balaram; Sharma, Surendra Kumar			Baicalein Reduces Airway Injury in Allergen and IL-13 Induced Airway Inflammation	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; INDUCED APOPTOSIS; PROTECTS; CELLS; 12/15-LIPOXYGENASE; EXPRESSION; ASTHMA; LIPOXYGENASE; PATHWAY; STRESS	Background: Baicalein, a bioflavone present in the dry roots of Scutellaria baicalensis Georgi, is known to reduce eotaxin production in human fibroblasts. However, there are no reports of its anti-asthma activity or its effect on airway injury. Methodology/Principal Findings: In a standard experimental asthma model, male Balb/c mice that were sensitized with ovalbumin (OVA), treated with baicalein (10 mg/kg, ip) or a vehicle control, either during (preventive use) or after OVA challenge (therapeutic use). In an alternate model, baicalein was administered to male Balb/c mice which were given either IL-4 or IL-13 intranasally. Features of asthma were determined by estimating airway hyperresponsiveness (AHR), histopathological changes and biochemical assays of key inflammatory molecules. Airway injury was determined with apoptotic assays, transmission electron microscopy and assessing key mitochondrial functions. Baicalein treatment reduced AHR and inflammation in both experimental models. TGF-beta(1), sub-epithelial fibrosis and goblet cell metaplasia, were also reduced. Furthermore, baicalein treatment significantly reduced 12/15-LOX activity, features of mitochondrial dysfunctions, and apoptosis of bronchial epithelia. Conclusion/Significance: Our findings demonstrate that baicalein can attenuate important features of asthma, possibly through the reduction of airway injury and restoration of mitochondrial function.	[Mabalirajan, Ulaganathan; Ahmad, Tanveer; Rehman, Rakhshinda; Agrawal, Anurag; Ghosh, Balaram] CSIR Inst Genom & Integrat Biol, Immunogenet Mol Lab, Delhi, India; [Mabalirajan, Ulaganathan; Ahmad, Tanveer; Rehman, Rakhshinda; Agrawal, Anurag; Ghosh, Balaram] CSIR Inst Genom & Integrat Biol, Ctr Excellence Translat Res Asthma & Lung Dis, Delhi, India; [Leishangthem, Geeta Devi; Dinda, Amit Kumar] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Sharma, Surendra Kumar] All India Inst Med Sci, Dept Med, Div Pulm Crit Care & Sleep Med, New Delhi 110029, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Mabalirajan, U (corresponding author), CSIR Inst Genom & Integrat Biol, Immunogenet Mol Lab, Mall Rd, Delhi, India.	um.rajan@igib.res.in	Agrawal, Anurag/GZL-5821-2022; Leishangthem, Geeta Devi/AAE-6153-2022; Rehman, Rakhshinda/AAC-4141-2022	Rehman, Rakhshinda/0000-0002-1755-3416; Agrawal, Anurag/0000-0002-0340-5252; Ahmad, Tanveer/0000-0002-8384-5273	Council of Scientific and Industrial Research, Government of India [BSC 0116, MLP 5502]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants BSC 0116 and MLP 5502 from the Council of Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; Borish L, 2011, CURR ALLERGY ASTHM R, V11, P7, DOI 10.1007/s11882-010-0153-8; Chang WT, 2011, J CELL BIOCHEM, V112, P2873, DOI 10.1002/jcb.23201; Chilvers MA, 2001, EUR RESPIR J, V18, P965, DOI 10.1183/09031936.01.00093001; Choi JH, 2010, EXP MOL MED, V42, P811, DOI 10.3858/emm.2010.42.12.084; Donald G, 2012, CURR DRUG TARGETS, V13, P1772, DOI 10.2174/138945012804545470; Gao JB, 2011, MOL CANCER THER, V10, P1774, DOI 10.1158/1535-7163.MCT-11-0304; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x; He XL, 2009, BRAIN RES, V1249, P212, DOI 10.1016/j.brainres.2008.10.005; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Hu Q, 2009, NEPHROL DIAL TRANSPL, V24, P3033, DOI 10.1093/ndt/gfp245; Huang Yu, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P177, DOI 10.2174/1568006043586206; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kim SJ, 2012, MOL MED REP, V6, P1443, DOI 10.3892/mmr.2012.1085; Kimura Y, 1997, J ETHNOPHARMACOL, V57, P63, DOI 10.1016/S0378-8741(97)00045-7; KUHN H, 1990, J BIOL CHEM, V265, P1454; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lapchak PA, 2007, NEUROSCIENCE, V150, P585, DOI 10.1016/j.neuroscience.2007.09.033; Li HY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/267890; Li QX, 2004, J BIOL CHEM, V279, P11570, DOI 10.1074/jbc.M311773200; Li ZF, 2009, HEPATOB PANCREAT DIS, V8, P201; Mabalirajan U, 2008, J IMMUNOL, V181, P3540, DOI 10.4049/jimmunol.181.5.3540; Mabalirajan U, 2013, SCI REP-UK, V3, DOI 10.1038/srep01540; Mabalirajan U, 2013, SCI REP-UK, V3, DOI 10.1038/srep01349; Mabalirajan U, 2010, INT IMMUNOPHARMACOL, V10, P1514, DOI 10.1016/j.intimp.2010.08.025; Mabalirajan U, 2010, J ALLERGY CLIN IMMUN, V125, P626, DOI 10.1016/j.jaci.2009.10.065; Mabalirajan U, 2009, J IMMUNOL, V183, P2059, DOI 10.4049/jimmunol.0900342; Mabalirajan U, 2009, AM J PHYSIOL-LUNG C, V297, pL411, DOI 10.1152/ajplung.00138.2009; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Mu X, 2009, PHARMACOL BIOCHEM BE, V92, P642, DOI 10.1016/j.pbb.2009.03.008; Nakajima T, 2001, PLANTA MED, V67, P132, DOI 10.1055/s-2001-11532; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; Schewe T, 2002, BIOL CHEM, V383, P365, DOI 10.1515/BC.2002.041; Song JX, 2012, CHIN MED-UK, V7, DOI 10.1186/1749-8546-7-1; Suzukawa M, 2012, J IMMUNOL, V189, P3641, DOI 10.4049/jimmunol.1200461; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; TANNO Y, 1989, AM J CHINESE MED, V17, P45, DOI 10.1142/S0192415X89000085; Thomas B, 2010, J ALLERGY CLIN IMMUN, V126, P722, DOI 10.1016/j.jaci.2010.05.046; van Leyen K, 2006, STROKE, V37, P3014, DOI 10.1161/01.STR.0000249004.25444.a5; Wood LG, 2003, EUR RESPIR J, V21, P177, DOI 10.1183/09031936.03.00017003a; Yang LP, 2009, INVEST OPHTH VIS SCI, V50, P2319, DOI 10.1167/iovs.08-2642; You KR, 2002, J BIOL CHEM, V277, P3870, DOI 10.1074/jbc.M109284200; Zhang Y, 2013, FOOD CHEM TOXICOL, V53, P325, DOI 10.1016/j.fct.2012.12.019; Zhao JM, 2011, P NATL ACAD SCI USA, V108, P14246, DOI 10.1073/pnas.1018075108; Zhao JM, 2009, AM J RESP CRIT CARE, V179, P782, DOI 10.1164/rccm.200811-1744OC	47	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62916	10.1371/journal.pone.0062916	http://dx.doi.org/10.1371/journal.pone.0062916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646158	Green Published, gold, Green Submitted			2022-12-27	WOS:000319077300112
J	Matsuoka, RL; Sun, LO; Katayama, K; Yoshida, Y; Kolodkin, AL				Matsuoka, Ryota L.; Sun, Lu O.; Katayama, Kei-ichi; Yoshida, Yutaka; Kolodkin, Alex L.			Sema6B, Sema6C, and Sema6D Expression and Function during Mammalian Retinal Development	PLOS ONE			English	Article							LAMINA-RESTRICTED PROJECTION; HIPPOCAMPAL MOSSY FIBERS; MOUSE RETINA; TRANSMEMBRANE SEMAPHORINS; SYNAPSE FORMATION; SPINAL-CORD; CELL-TYPES; ROLES; DSCAM; CONE	In the vertebrate retina, the formation of neural circuits within discrete laminae is critical for the establishment of retinal visual function. Precise formation of retinal circuits requires the coordinated actions of adhesive and repulsive molecules, including repulsive transmembrane semaphorins (Sema6A, Sema5A, and Sema5B). These semaphorins signal through different Plexin A (PlexA) receptors, thereby regulating distinct aspects of retinal circuit assembly. Here, we investigate the physiological roles of three Class 6 transmembrane semaphorins (Sema6B, Sema6C, and Sema6D), previously identified as PlexA receptor ligands in non-retinal tissues, in mammalian retinal development. We performed expression analysis and also phenotypic analyses of mice that carry null mutations in each of genes encoding these proteins using abroad range of inner and outer retinal markers. We find that these Class 6 semaphorins are uniquely expressed throughout postnatal retinal development in specific domains and cell types of the developing retina. However, we do not observe defectsin stereotypical lamina-specific neurite stratification of retinal neuron subtypes in Sema6B(-/-) or Sema6C(-/-); Sema6D(-/-) retinas. These findings indicate these Class 6 transmembrane semaphorins are unlikely to serve as major PlexA receptor ligands for the assembly of murine retinal circuit laminar organization.	[Matsuoka, Ryota L.; Sun, Lu O.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Katayama, Kei-ichi; Yoshida, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA	Howard Hughes Medical Institute; Johns Hopkins University; Cincinnati Children's Hospital Medical Center	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu	Matsuoka, Ryota L./K-5439-2019; Sun, Lu O/P-9339-2015; Katayama, Kei-ichi/J-4699-2013	Matsuoka, Ryota L./0000-0001-6214-2889; Sun, Lu O/0000-0002-9293-7241; Katayama, Kei-ichi/0000-0003-0527-4644	National Institutes of Health (NIH) [R01 NS35165, R01 NS065048]; Howard Hughes Medical Institute; Nakajima Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065048, R01NS035165] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Nakajima Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) R01 NS35165 and NIH R01 NS065048 (http://www.nih.gov/), the Howard Hughes Medical Institute (http://www.hhmi.org/), and The Nakajima Foundation (http://www.nakajimafound.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Fuerst PG, 2010, GENESIS, V48, P578, DOI 10.1002/dvg.20662; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Leslie JR, 2011, DEVELOPMENT, V138, P4085, DOI 10.1242/dev.066076; Matsuoka RL, 2012, J NEUROSCI, V32, P6859, DOI 10.1523/JNEUROSCI.0267-12.2012; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Tawarayama H, 2010, J NEUROSCI, V30, P7049, DOI 10.1523/JNEUROSCI.0073-10.2010; Timofeev K, 2012, NEURON, V75, P80, DOI 10.1016/j.neuron.2012.04.037; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Xiao T, 2011, CELL, V146, P164, DOI 10.1016/j.cell.2011.06.016; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Zhu XM, 2002, MOL VIS, V8, P462	25	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63207	10.1371/journal.pone.0063207	http://dx.doi.org/10.1371/journal.pone.0063207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646199	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300156
J	McKenzie, F; Ellison-Loschmann, L; Jeffreys, M; Firestone, R; Pearce, N; Romieu, I				McKenzie, Fiona; Ellison-Loschmann, Lis; Jeffreys, Mona; Firestone, Ridvan; Pearce, Neil; Romieu, Isabelle			Cigarette Smoking and Risk of Breast Cancer in a New Zealand Multi-Ethnic Case-Control Study	PLOS ONE			English	Article							PASSIVE SMOKING; ACTIVE SMOKING; WOMEN; TOBACCO	Background: The association between breast cancer and tobacco smoke is currently unclear. The aim of this study was to assess the effect of smoking behaviours on the risk of breast cancer among three ethnic groups of New Zealand women. Methods: A population-based case-control study was conducted including breast cancer cases registered on the New Zealand Cancer Registry between 2005 and 2007. Controls were matched by ethnicity and 5-year age-group. Logistic regression was used to estimate the association between breast cancer and smoking at different time points across the lifecourse, for each ethnic group. Estimated odds ratios (OR) were adjusted for established risk factors. Results: The study comprised 1,799 cases (302 Maori, 70 Pacific, 1,427 non-Maori/non-Pacific) and 2,540 controls (746 Maori, 191 Pacific, 1,603 non-Maori/non-Pacific). There was no clear association between smoking and breast cancer for non-Maori/non-Pacific women, although non-Maori/non-Pacific ex-smokers had statistically significant increased risk of breast cancer when smoking duration was 20 years or more, and this remained significant in the fully adjusted model (OR 1.31, 95% CI 1.03 to 1.66). Maori showed more consistent increased risk of breast cancer with increasing duration among current smokers (<20 years OR 1.61, 95% CI 0.55 to 4.74; 20+ years OR 2.03, 95% CI 1.29 to 3.22). There was a clear pattern of shorter duration since smoking cessation being associated with increased likelihood of breast cancer, and this was apparent for all ethnic groups. Conclusion: There was no clear pattern for cigarette smoking and breast cancer incidence in non-Maori/non-Pacific women, but increased risks were observed for Maori and Pacific women. These findings suggest that lowering the prevalence of smoking, especially among Maori and Pacific women, could be important for reducing breast cancer incidence.	[McKenzie, Fiona; Romieu, Isabelle] Int Agcy Res Canc, F-69372 Lyon, France; [McKenzie, Fiona; Ellison-Loschmann, Lis; Firestone, Ridvan; Pearce, Neil] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Jeffreys, Mona] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Pearce, Neil] London Sch Hyg & Trop Med, London WC1, England	World Health Organization; International Agency for Research on Cancer (IARC); Massey University; University of Bristol; University of London; London School of Hygiene & Tropical Medicine	McKenzie, F (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	mckenzief@fellows.iarc.fr	Jeffreys, Mona/W-3425-2019; Firestone, Riz/AAU-2414-2021	Firestone, Riz/0000-0003-2834-8044; Pearce, Neil/0000-0002-9938-7852; Jeffreys, Mona/0000-0002-2617-0361	Cancer Society of New Zealand; Massey University Research Fund; Genesis Oncology Trust Postdoctoral Fellowship; Programme Grant from the Health Research Council of New Zealand	Cancer Society of New Zealand; Massey University Research Fund; Genesis Oncology Trust Postdoctoral Fellowship; Programme Grant from the Health Research Council of New Zealand	The New Zealand Breast Cancer Study was supported by the Cancer Society of New Zealand and the Massey University Research Fund. FM is currently funded through a Genesis Oncology Trust Postdoctoral Fellowship. The Centre for Public Health Research, Massey University Wellington is supported by a Programme Grant from the Health Research Council of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TP, 2009, CANCER CAUSE CONTROL, V20, P1837, DOI 10.1007/s10552-009-9376-1; Al-Delaimy WK, 2004, CANCER EPIDEM BIOMAR, V13, P398; Ambrosone CB, 2008, CANCER EPIDEM BIOMAR, V17, P15, DOI 10.1158/1055-9965.EPI-07-0598; Band PR, 2002, LANCET, V360, P1044, DOI 10.1016/S0140-6736(02)11140-8; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Chen CZ, 2005, ENVIRON HEALTH PERSP, V113, P412, DOI 10.1289/ehp.7436; Conway K, 2002, CANCER RES, V62, P1987; Cui Y, 2006, BREAST CANCER RES TR, V100, P293, DOI 10.1007/s10549-006-9255-3; Deroo LA, 2011, AM J EPIDEMIOL, V174, P390, DOI 10.1093/aje/kwr090; Egan KM, 2002, EPIDEMIOLOGY, V13, P138, DOI 10.1097/00001648-200203000-00007; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Godin G, 1997, MED SCI SPORTS EXERC, pS36, DOI [10.2466/03.27.PMS.120v19x7, DOI 10.2466/03.27.PMS.120V19X7]; Gram IT, 2005, CANCER EPIDEM BIOMAR, V14, P61; Ha M, 2007, AM J EPIDEMIOL, V166, P55, DOI 10.1093/aje/kwm045; Hanaoka T, 2005, INT J CANCER, V114, P317, DOI 10.1002/ijc.20709; Hecht SS, 2002, ENVIRON MOL MUTAGEN, V39, P119, DOI 10.1002/em.10071; International Agency for Research on Cancer, 2012, REV HUM CARC PERS HA, V100; International Agency for Research on Cancer, 2004, TOB SMOK INV SMOK, V83; JEFFREYS M, 2012, CANCER CAUSE CONTROL, P21; Johnson KC, 2000, CANCER CAUSE CONTROL, V11, P211, DOI 10.1023/A:1008906105790; Johnson KC, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.035931; Lawlor DA, 2004, BRIT J CANCER, V91, P512, DOI 10.1038/sj.bjc.6601916; Lawton BA, 2008, CLIMACTERIC, V11, P467, DOI 10.1080/13697130802351094; Li CI, 2005, CANCER CAUSE CONTROL, V16, P975, DOI 10.1007/s10552-005-2906-6; Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; MACMAHON B, 1982, NEW ENGL J MED, V307, P1062, DOI 10.1056/NEJM198210213071707; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; *MIN SOC DEV, 2007, SOC REP; Ministry of Health, 2011, MAOR SMOK TOB US 201; Ministry of Health, 2012, CANC NEW REG DEATHS; Olson JE, 2005, MAYO CLIN PROC, V80, P1423, DOI 10.4065/80.11.1423; PALMER JR, 1993, EPIDEMIOL REV, V15, P145, DOI 10.1093/oxfordjournals.epirev.a036098; Pokoradi AJ, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.059; Reynolds P, 2004, JNCI-J NATL CANCER I, V96, P29, DOI 10.1093/jnci/djh002; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; Russo J, 1993, Eur J Cancer Prev, V2 Suppl 3, P85; Salmond C., 2007, NZDEP2006 INDEX DEPR; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Terry PD, 2002, INT J CANCER, V100, P723, DOI 10.1002/ijc.10536; Terry PD, 2002, CANCER EPIDEM BIOMAR, V11, P953; Xue F, 2011, ARCH INTERN MED, V171, P125, DOI 10.1001/archinternmed.2010.503	42	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e63132	10.1371/journal.pone.0063132	http://dx.doi.org/10.1371/journal.pone.0063132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646186	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000319077300141
J	Chapman, SK; Newman, GS; Hart, SC; Schweitzer, JA; Koch, GW				Chapman, Samantha K.; Newman, Gregory S.; Hart, Stephen C.; Schweitzer, Jennifer A.; Koch, George W.			Leaf Litter Mixtures Alter Microbial Community Development: Mechanisms for Non-Additive Effects in Litter Decomposition	PLOS ONE			English	Article							FATTY-ACID ANALYSIS; ECOSYSTEM FUNCTION; SPECIES-DIVERSITY; FOREST SOILS; DYNAMICS; BIOMASS; CHEMISTRY; RATES; SUCCESSION; CARBON	To what extent microbial community composition can explain variability in ecosystem processes remains an open question in ecology. Microbial decomposer communities can change during litter decomposition due to biotic interactions and shifting substrate availability. Though relative abundance of decomposers may change due to mixing leaf litter, linking these shifts to the non-additive patterns often recorded in mixed species litter decomposition rates has been elusive, and links community composition to ecosystem function. We extracted phospholipid fatty acids (PLFAs) from single species and mixed species leaf litterbags after 10 and 27 months of decomposition in a mixed conifer forest. Total PLFA concentrations were 70% higher on litter mixtures than single litter types after 10 months, but were only 20% higher after 27 months. Similarly, fungal-to-bacterial ratios differed between mixed and single litter types after 10 months of decomposition, but equalized over time. Microbial community composition, as indicated by principal components analyses, differed due to both litter mixing and stage of litter decomposition. PLFA biomarkers a15:0 and cy17:0, which indicate gram-positive and gram-negative bacteria respectively, in particular drove these shifts. Total PLFA correlated significantly with single litter mass loss early in decomposition but not at later stages. We conclude that litter mixing alters microbial community development, which can contribute to synergisms in litter decomposition. These findings advance our understanding of how changing forest biodiversity can alter microbial communities and the ecosystem processes they mediate.	[Chapman, Samantha K.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Newman, Gregory S.; Schweitzer, Jennifer A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Hart, Stephen C.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Koch, George W.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Villanova University; University of Tennessee System; University of Tennessee Knoxville; University of California System; University of California Merced; Northern Arizona University	Chapman, SK (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.	samantha.chapman@villanova.edu	Newman, Greg/B-9456-2015; Newman, Greg/AAW-9419-2020	Newman, Greg/0000-0001-8932-0809; Newman, Greg/0000-0001-8932-0809				Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Aneja MK, 2006, MICROB ECOL, V52, P127, DOI 10.1007/s00248-006-9006-3; Aneja MK, 2004, J MICROBIOL METH, V59, P223, DOI 10.1016/j.mimet.2004.07.005; [Anonymous], 1996, SOIL MICROBIOLOGY BI; Ball BA, 2009, SOIL BIOL BIOCHEM, V41, P1155, DOI 10.1016/j.soilbio.2009.02.025; Bardgett RD, 2004, SOIL BIOL BIOCHEM, V36, P555, DOI 10.1016/j.soilbio.2003.11.002; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P317, DOI 10.1016/S0038-0717(98)00121-7; Baumann K, 2009, SOIL BIOL BIOCHEM, V41, P1966, DOI 10.1016/j.soilbio.2009.06.022; BLACK RLB, 1977, T BRIT MYCOL SOC, V68, P284, DOI 10.1016/S0007-1536(77)80020-X; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bray SR, 2012, SOIL BIOL BIOCHEM, V49, P30, DOI 10.1016/j.soilbio.2012.02.009; Chapman SK, 2007, PLANT SOIL, V299, P153, DOI 10.1007/s11104-007-9372-8; Chapman SK, 2010, OECOLOGIA, V162, P763, DOI 10.1007/s00442-009-1498-3; Cotrufo MF, 2010, PLANT SOIL, V334, P365, DOI 10.1007/s11104-010-0388-0; De Marco A, 2011, PLANT SOIL, V344, P305, DOI 10.1007/s11104-011-0748-4; Frankland JC, 1998, MYCOL RES, V102, P1, DOI 10.1017/S0953756297005364; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Hansen RA, 1998, APPL SOIL ECOL, V9, P17, DOI 10.1016/S0929-1393(98)00048-1; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hattenschwiler S, 2005, P NATL ACAD SCI USA, V102, P1519, DOI 10.1073/pnas.0404977102; Hernandez DL, 2010, PLANT SOIL, V335, P397, DOI 10.1007/s11104-010-0428-9; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; HU S, 1995, SOIL BIOL BIOCHEM, V27, P1127, DOI 10.1016/0038-0717(95)00041-C; Kaneko N, 1999, ECOL RES, V14, P131, DOI 10.1046/j.1440-1703.1999.00292.x; Koide Kanade, 2005, Mycoscience, V46, P280, DOI 10.1007/s10267-005-0247-7; Kominoski JS, 2007, ECOLOGY, V88, P1167, DOI 10.1890/06-0674; Leary WMO, 1988, MICROBIAL LIPIDS, P117; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; Leckie SE, 2005, FOREST ECOL MANAG, V220, P88, DOI 10.1016/j.foreco.2005.08.007; Lundquist EJ, 1999, SOIL BIOL BIOCHEM, V31, P221, DOI 10.1016/S0038-0717(98)00093-5; McMahon SK, 2005, SOIL SCI SOC AM J, V69, P1238, DOI 10.2136/sssaj2004.0289; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; Meier CL, 2010, SOIL BIOL BIOCHEM, V42, P1447, DOI 10.1016/j.soilbio.2010.05.005; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; Mitchell RJ, 2012, PLANT SOIL, V351, P355, DOI 10.1007/s11104-011-0968-7; Nakamura A, 2003, BIOL FERT SOILS, V38, P288, DOI 10.1007/s00374-003-0658-6; Osono T, 2006, SOIL BIOL BIOCHEM, V38, P2743, DOI 10.1016/j.soilbio.2006.04.028; Poll C, 2008, SOIL BIOL BIOCHEM, V40, P1306, DOI 10.1016/j.soilbio.2007.04.002; Poll C, 2010, MICROB ECOL, V59, P130, DOI 10.1007/s00248-009-9541-9; Purahong W, 2011, FUNGAL DIVERS, V47, P1, DOI 10.1007/s13225-010-0083-8; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramsey PW, 2006, PEDOBIOLOGIA, V50, P275, DOI 10.1016/j.pedobi.2006.03.003; Schimel JP, 2007, SOIL BIOL BIOCHEM, V39, P1428, DOI 10.1016/j.soilbio.2006.12.037; Schweitzer JA, 2005, ECOLOGY, V86, P2834, DOI 10.1890/04-1955; Schweitzer JA, 2008, ECOLOGY, V89, P773, DOI 10.1890/07-0337.1; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; SUBERKROPP K, 1976, ECOLOGY, V57, P707, DOI 10.2307/1936184; Swan CM, 2006, OECOLOGIA, V149, P107, DOI 10.1007/s00442-006-0436-x; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Torres PA, 2005, SOIL BIOL BIOCHEM, V37, P49, DOI 10.1016/j.soilbio.2004.04.042; Vos VCA, 2011, OIKOS, V120, P1092, DOI 10.1111/j.1600-0706.2010.18650.x; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Wilkinson SC, 2002, SOIL BIOL BIOCHEM, V34, P189, DOI 10.1016/S0038-0717(01)00168-7; Wilkinson SJ, 1989, MICROBIAL LIPIDS; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	60	101	106	7	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62671	10.1371/journal.pone.0062671	http://dx.doi.org/10.1371/journal.pone.0062671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658639	Green Published, gold			2022-12-27	WOS:000321662800053
J	Orellana, MV; Pang, WL; Durand, PM; Whitehead, K; Baliga, NS				Orellana, Monica V.; Pang, Wyming L.; Durand, Pierre M.; Whitehead, Kenia; Baliga, Nitin S.			A Role for Programmed Cell Death in the Microbial Loop	PLOS ONE			English	Article							CO2 CONCENTRATING MECHANISMS; MAJOR BACTERIAL CONTRIBUTION; GREAT SALT LAKE; MARINE-PHYTOPLANKTON; ORGANIC-CARBON; DUNALIELLA; STRESS; IDENTIFICATION; POPULATIONS; EXOCYTOSIS	The microbial loop is the conventional model by which nutrients and minerals are recycled in aquatic eco-systems. Biochemical pathways in different organisms become metabolically inter-connected such that nutrients are utilized, processed, released and re-utilized by others. The result is that unrelated individuals end up impacting each others' fitness directly through their metabolic activities. This study focused on the impact of programmed cell death (PCD) on a population's growth as well as its role in the exchange of carbon between two naturally co-occurring halophilic organisms. Flow cytometric, biochemical, C-14 radioisotope tracing assays, and global transcriptomic analyses show that organic algal photosynthate released by Dunalliela salina cells undergoing PCD complements the nutritional needs of other non-PCD D. salina cells. This occurs in vitro in a carbon limited environment and enhances the growth of the population. In addition, a co-occurring heterotroph Halobacterium salinarum re-mineralizes the carbon providing elemental nutrients for the mixoheterotrophic chlorophyte. The significance of this is uncertain and the archaeon can also subsist entirely on the lysate of apoptotic algae. PCD is now well established in unicellular organisms; however its ecological relevance has been difficult to decipher. In this study we found that PCD in D. salina causes the release of organic nutrients such as glycerol, which can be used by others in the population as well as a co-occurring halophilic archaeon. H. salinarum also re-mineralizes the dissolved material promoting algal growth. PCD in D. salina was the mechanism for the flow of dissolved photosynthate between unrelated organisms. Ironically, programmed death plays a central role in an organism's own population growth and in the exchange of nutrients in the microbial loop.	[Orellana, Monica V.; Pang, Wyming L.; Whitehead, Kenia; Baliga, Nitin S.] Inst Syst Biol, Seattle, WA USA; [Orellana, Monica V.] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [Pang, Wyming L.] Genomatica Inc, San Diego, CA USA; [Durand, Pierre M.] Univ Witwatersrand, Dept Mol Med, Parktown, South Africa; [Durand, Pierre M.] Natl Hlth Lab Serv, Parktown, South Africa; [Durand, Pierre M.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Whitehead, Kenia] Integral Consulting Inc, Seattle, WA USA; [Baliga, Nitin S.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Witwatersrand; University of Arizona; University of Washington; University of Washington Seattle	Baliga, NS (corresponding author), Inst Syst Biol, Seattle, WA USA.	Nitin.Baliga@systemsbiology.org		Durand, Pierre M./0000-0002-9614-1371; , ENIGMA/0000-0002-0894-2831; baliga, nitin/0000-0001-9157-5974; Orellana, Monica/0000-0001-5990-9380	National Institutes of Health (NIH) [P50GM076547, 1R01GM077398-01A2]; U.S. Department of Energy (DOE) (ENIGMA) [DE-FG02-07ER64327]; National Science Foundation (NSF) [EF-0313754, EIA-0220153, MCB-0425825, DBI-0640950, OCE-0452563, OCE-0434087, ARC-0707555]; NIH Ruth L. Kirchstein NSRA [1F32GM086077-01A1]; National Health Laboratory Service, University of the Witwatersrand and Medical Research Council, South Africa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM077398, F32GM086077] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (DOE) (ENIGMA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH Ruth L. Kirchstein NSRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Laboratory Service, University of the Witwatersrand and Medical Research Council, South Africa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from National Institutes of Health (NIH) (P50GM076547 and 1R01GM077398-01A2), U.S. Department of Energy (DOE) (ENIGMA: DE-FG02-07ER64327 and DE-FG02-07ER64327), and National Science Foundation (NSF) (EF-0313754, EIA-0220153, MCB-0425825, DBI-0640950) to NB; NSF OCE-0452563, OCE-0434087, and ARC-0707555 to MVO; and NIH Ruth L. Kirchstein NSRA 1F32GM086077-01A1 to WLP. Grants from the National Health Laboratory Service, University of the Witwatersrand and Medical Research Council, South Africa, to PMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluwihare LI, 2005, SCIENCE, V308, P1007, DOI 10.1126/science.1108925; Aluwihare LI, 1997, NATURE, V387, P166, DOI 10.1038/387166a0; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504; Bardavid RE, 2008, EXTREMOPHILES, V12, P5, DOI 10.1007/s00792-006-0053-y; BENAMOTZ A, 1973, PLANT PHYSIOL, V51, P875, DOI 10.1104/pp.51.5.875; BenAmotz A., 2009, ALGA DUNALIELLA BIOD; Berges JA, 1998, LIMNOL OCEANOGR, V43, P129, DOI 10.4319/lo.1998.43.1.0129; Berman-Frank I, 2004, LIMNOL OCEANOGR, V49, P997, DOI 10.4319/lo.2004.49.4.0997; Bidle KD, 2008, EUKARYOT CELL, V7, P223, DOI 10.1128/EC.00296-07; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; BOGOMOLNI RA, 1982, P NATL ACAD SCI-BIOL, V79, P6250, DOI 10.1073/pnas.79.20.6250; Bonneau R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r52; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; Brooun A, 1998, J BACTERIOL, V180, P1642, DOI 10.1128/JB.180.7.1642-1646.1998; Chanley MH, 1975, CULT MAR INV AN P 1; Chin WC, 2004, PLANT CELL PHYSIOL, V45, P535, DOI 10.1093/pcp/pch062; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; DASSARMA S, 1994, J BACTERIOL, V176, P7646, DOI 10.1128/JB.176.24.7646-7652.1994; DasSarma S, 1995, ARCHAEA LAB MANUAL H; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Droop MR, 2007, J PLANKTON RES, V29, P107, DOI 10.1093/plankt/fbm009; DROOP MR, 1973, J PHYCOL, V9, P264; Durand PM, 2011, AM NAT, V177, P224, DOI 10.1086/657686; Engelbrecht D, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/646534; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; FERNANDEZ JM, 1991, BIOPHYS J, V59, P1022, DOI 10.1016/S0006-3495(91)82317-7; Franklin DJ, 2006, EUR J PHYCOL, V41, P1, DOI 10.1080/09670260500505433; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gonzalez MA, 2001, J PHYCOL, V37, P604, DOI 10.1046/j.1529-8817.2001.037004604.x; HALLADAY JT, 1993, J BACTERIOL, V175, P684, DOI 10.1128/JB.175.3.684-692.1993; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; IVERSON RL, 1976, LIMNOL OCEANOGR, V21, P756, DOI 10.4319/lo.1976.21.5.0756; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Jimenez C, 2009, J EXP BOT, V60, P815, DOI 10.1093/jxb/ern330; Kaiser K, 2008, LIMNOL OCEANOGR, V53, P99, DOI 10.4319/lo.2008.53.1.0099; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Kaur A, 2006, GENOME RES, V16, P841, DOI 10.1101/gr.5189606; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Kirchman DL, 2005, DEEP-SEA RES PT II, V52, P3386, DOI 10.1016/j.dsr2.2005.09.005; Kokoeva MV, 2000, MOL MICROBIOL, V35, P647, DOI 10.1046/j.1365-2958.2000.01735.x; Kottemann M, 2005, EXTREMOPHILES, V9, P219, DOI 10.1007/s00792-005-0437-4; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lau WWY, 2007, APPL ENVIRON MICROB, V73, P2440, DOI 10.1128/AEM.01965-06; Leigh EG, 2010, J EVOLUTION BIOL, V23, P2507, DOI 10.1111/j.1420-9101.2010.02114.x; Lewis J, 2001, PHYCOLOGIA, V40, P280, DOI 10.2216/i0031-8884-40-3-280.1; Liow LH, 2011, TRENDS ECOL EVOL, V26, P349, DOI 10.1016/j.tree.2011.03.016; Liska AJ, 2004, PLANT PHYSIOL, V136, P2806, DOI 10.1104/pp.104.039438; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Mary I, 2008, ENVIRON MICROBIOL, V10, P2124, DOI 10.1111/j.1462-2920.2008.01633.x; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; Moharikar S, 2006, J PHYCOL, V42, P423, DOI 10.1111/j.1529-8817.2006.00207.x; Muller JA, 2005, J BACTERIOL, V187, P1659, DOI 10.1128/JB.187.5.1659-1667.2005; Nagata T, 1997, ADV MICROB ECOL, V15, P81; Nedelcu AM, 2011, EVOLUTION, V65, P3, DOI 10.1111/j.1558-5646.2010.01103.x; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Orellana MV, 2011, J PHYCOL, V47, P112, DOI 10.1111/j.1529-8817.2010.00936.x; OREN A, 1993, FEMS MICROBIOL ECOL, V12, P15, DOI 10.1016/0168-6496(93)90020-8; Pace ML, 1996, LIMNOL OCEANOGR, V41, P1448, DOI 10.4319/lo.1996.41.7.1448; PAYNE JW, 1980, MICROORGANISMS NITRO, P212; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; POST FJ, 1981, HYDROBIOLOGIA, V81-2, P59, DOI 10.1007/BF00048706; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Rao SDV, 2009, CULTIVATION GROWTH M; RIEBESELL U, 1993, NATURE, V361, P249, DOI 10.1038/361249a0; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; ROSENZWEIG ML, 1977, Q REV BIOL, V52, P371, DOI 10.1086/410124; SCHIDLOWSKI M, 1984, NATURWISSENSCHAFTEN, V71, P303, DOI 10.1007/BF00396613; Segovia M, 2003, PLANT PHYSIOL, V132, P99, DOI 10.1104/pp.102.017129; SPUDICH EN, 1989, P NATL ACAD SCI USA, V86, P7746, DOI 10.1073/pnas.86.20.7746; SPUDICH JL, 1993, J BACTERIOL, V175, P7755, DOI 10.1128/JB.175.24.7755-7761.1993; STEPHENS DW, 1976, LIMNOL OCEANOGR, V21, P74, DOI 10.4319/lo.1976.21.1.0074; Storch KF, 1999, EMBO J, V18, P1146, DOI 10.1093/emboj/18.5.1146; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Strom SL, 1997, LIMNOL OCEANOGR, V42, P1364, DOI 10.4319/lo.1997.42.6.1364; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Sverdrup Hu, 1957, OCEANS; Tafreshi AH, 2006, WORLD J MICROB BIOT, V22, P1003, DOI 10.1007/s11274-006-9145-1; Van PT, 2008, J PROTEOME RES, V7, P3755, DOI 10.1021/pr800031f; Vardi A, 2007, ENVIRON MICROBIOL, V9, P360, DOI 10.1111/j.1462-2920.2006.01146.x; Vardi A, 2012, P NATL ACAD SCI USA, V109, P19327, DOI 10.1073/pnas.1208895109; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; Verdugo P, 2012, ANNU REV MAR SCI, V4, P375, DOI 10.1146/annurev-marine-120709-142759; Whitehead K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005485; Wilkerson CR, 1987, SCIENCE, V236; Williams G. C., 1966, P307; Zhang HN, 1996, MAR CHEM, V52, P17, DOI 10.1016/0304-4203(95)00076-3	98	41	43	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62595	10.1371/journal.pone.0062595	http://dx.doi.org/10.1371/journal.pone.0062595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667496	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600031
J	Tesei, A; Leonetti, C; Di Donato, M; Gabucci, E; Porru, M; Varchi, G; Guerrini, A; Amadori, D; Arienti, C; Pignatta, S; Paganelli, G; Caraglia, M; Castoria, G; Zoli, W				Tesei, Anna; Leonetti, Carlo; Di Donato, Marzia; Gabucci, Elisa; Porru, Manuela; Varchi, Greta; Guerrini, Andrea; Amadori, Dino; Arienti, Chiara; Pignatta, Sara; Paganelli, Giulia; Caraglia, Michele; Castoria, Gabriella; Zoli, Wainer			Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models	PLOS ONE			English	Article							DEPENDENT NUCLEAR EXPORT; ESTRADIOL-RECEPTOR; BICALUTAMIDE MONOTHERAPY; DNA-SYNTHESIS; CASTRATION; CELLS; GENE; AMPLIFICATION; PROGRESSION; MUTATION	The management of hormone-refractory prostate cancer represents a major challenge in the therapy of this tumor, and identification of novel androgen receptor antagonists is needed to render treatment more effective. We analyzed the activity of two novel androgen receptor antagonists, (S)-11 and (R)-9, in in vitro and in vivo experimental models of hormone-sensitive or castration-resistant prostate cancer (CRPC). In vitro experiments were performed on LNCaP, LNCaP-AR, LNCaP-Rbic and VCaP human prostate cancer cells. Cytotoxic activity was assessed by SRB and BrdU uptake, AR transactivation by luciferase reporter assay and PSA levels by Real Time RT-PCR and ELISA assays. Cell cycle progression-related markers were evaluated by western blot. In vivo experiments were performed on SCID mice xenografted with cells with different sensitivity to hormonal treatment. In hormone-sensitive LNCaP and LNCaP-AR cells, the latter expressing high androgen receptor levels, (R)-9 and (S)-11 exhibited a higher cytotoxic effect compared to that of the reference compound ((R)-bicalutamide), also in the presence of the synthetic androgen R1881. Furthermore, the cytotoxic effect produced by (R)9 was higher than that of (S)-11 in the two hormone-resistant LNCaP-AR and VCaP cells. A significant reduction in PSA levels was observed after exposure to both molecules. Moreover, (S)-11 and (R)-9 inhibited DNA synthesis by blocking the androgen-induced increase in cyclin D1 protein levels. In vivo studies on the toxicological profile of (R)-9 did not reveal the presence of adverse events. Furthermore, (R)-9 inhibited tumor growth in various in vivo models, especially LNCaP-Rbic xenografts, representative of recurrent disease. Our in vitro results highlight the antitumor activity of the two novel molecules (R)-9 and (S)-11, making them a potentially attractive option for the treatment of CRPC.	[Tesei, Anna; Gabucci, Elisa; Arienti, Chiara; Pignatta, Sara; Paganelli, Giulia; Zoli, Wainer] IRCCS Ist Sci Romagnolo Studio & Cura Tumori IRST, Biosci Lab, Meldola, Italy; [Leonetti, Carlo; Porru, Manuela] Natl Canc Inst Regina Elena, Lab Expt Preclin Chemotherapy, Dept Expt Oncol, Rome, Italy; [Di Donato, Marzia; Castoria, Gabriella] Univ Naples 2, Dept Gen Pathol, Naples, Italy; [Varchi, Greta; Guerrini, Andrea] Italian Natl Res Council, Inst Organ Chem & Photoreact, Bologna, Italy; [Amadori, Dino] IRCCS Ist Sci Romagnolo Studio & Cura Tumori IRST, Dept Med Oncol, Meldola, Italy; [Caraglia, Michele] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy	IRCCS Meldola (IRST); Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); IRCCS Meldola (IRST); Universita della Campania Vanvitelli	Tesei, A (corresponding author), IRCCS Ist Sci Romagnolo Studio & Cura Tumori IRST, Biosci Lab, Meldola, Italy.	anna.tesei@irst.emr.it; leonetti@ifo.it	Varchi, Greta/CAG-3391-2022; Castoria, Gabriella/I-3349-2019; Tesei, Anna/C-7748-2016; Caraglia, Michele/AFY-9729-2022; Porru, Manuela/AAA-5510-2021; Leonetti, Carlo/B-2860-2018; PORRU, MANUELA/K-4809-2018; Caraglia, Michele/AAK-4569-2020; Caraglia, Michele/N-5670-2015; Arienti, Chiara/K-4443-2016; arienti, chiara/AAA-9493-2021; Varchi, Greta/J-9722-2018; Pignatta, Sara/X-1508-2018; Di Donato, Marzia/M-3114-2018	Varchi, Greta/0000-0002-8358-3437; Castoria, Gabriella/0000-0002-0576-4494; Tesei, Anna/0000-0002-8351-5952; Caraglia, Michele/0000-0003-2408-6091; Porru, Manuela/0000-0002-6614-9110; Leonetti, Carlo/0000-0002-3526-7827; PORRU, MANUELA/0000-0002-6614-9110; Caraglia, Michele/0000-0003-2408-6091; Caraglia, Michele/0000-0003-2408-6091; arienti, chiara/0000-0002-2265-828X; Varchi, Greta/0000-0002-8358-3437; Pignatta, Sara/0000-0001-5464-0052; Di Donato, Marzia/0000-0001-7207-826X	Associazione Italiana per la Ricerca sul Cancro [A.I.R.C.-IG11520]; Ministero Italiano per la Ricerca Scientifica [PRIN 2010NFEB9L_002]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano per la Ricerca Scientifica	Gabriella Castoria and Marzia Di Donato received funds from the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.-IG11520) and Ministero Italiano per la Ricerca Scientifica (PRIN 2010NFEB9L_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2007, MOL CELL ENDOCRINOL, V270, P50, DOI 10.1016/j.mce.2007.02.006; AIRT Working Group, 2006, Epidemiol Prev, V30, P8; Bai VU, 2005, J CELL PHYSIOL, V204, P381, DOI 10.1002/jcp.20422; Boccardo F, 1999, J CLIN ONCOL, V17, P2027, DOI 10.1200/JCO.1999.17.7.2027; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Castoria G, 2012, ONCOGENE, V31, P4868, DOI 10.1038/onc.2011.642; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218; CHANG CS, 1987, J STEROID BIOCHEM, V27, P123, DOI 10.1016/0022-4731(87)90303-7; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Comstock CES, 2011, J BIOL CHEM, V286, P8117, DOI 10.1074/jbc.M110.170720; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; DEVOOGT HJ, 1992, PROSTATE, P91; Edwards J, 2005, BJU INT, V95, P1327, DOI 10.1111/j.1464-410X.2005.05527.x; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Feau C, 2011, METHODS MOL BIOL, V776, P59, DOI 10.1007/978-1-61779-243-4_4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FURR BJA, 1995, ANN NY ACAD SCI, V761, P79, DOI 10.1111/j.1749-6632.1995.tb31371.x; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102; Hedlund PO, 2000, PROSTATE, P32; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Iversen P, 2000, J UROLOGY, V164, P1579, DOI 10.1016/S0022-5347(05)67032-2; Jordan VC, 2004, CANCER CELL, V5, P207, DOI 10.1016/S1535-6108(04)00059-5; Joyce R, 1998, J UROLOGY, V159, P149, DOI 10.1016/S0022-5347(01)64039-4; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Linja MJ, 2001, CANCER RES, V61, P3550; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Pienta KJ, 2005, CA-CANCER J CLIN, V55, P300, DOI 10.3322/canjclin.55.5.300; Sasaki M, 2002, J NATL CANCER I, V94, P384; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Schweizer L, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-4; See WA, 2002, J UROLOGY, V168, P429, DOI 10.1016/S0022-5347(05)64652-6; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Small EJ, 2004, J CLIN ONCOL, V22, P1025, DOI 10.1200/JCO.2004.06.037; SONNENSCHEIN C, 1989, CANCER RES, V49, P3474; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Varchi Greta, 2010, Patent No. [WO/2010/092546, 2010092546]; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Verrijdt G, 2000, J BIOL CHEM, V275, P12298, DOI 10.1074/jbc.275.16.12298; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wu Y, 2007, ENDOCRINOLOGY, V148, P2984, DOI 10.1210/en.2006-1653; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zhang YX, 2008, MOL CANCER THER, V7, P3176, DOI 10.1158/1535-7163.MCT-08-0526	52	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62657	10.1371/journal.pone.0062657	http://dx.doi.org/10.1371/journal.pone.0062657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667504	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600038
J	Zhu, F; Wu, BY; Li, P; Wang, JB; Tang, HY; Liu, Y; Zuo, XB; Cheng, H; Ding, YT; Wang, W; Zhai, YJ; Qian, FF; Wang, WJ; Yuan, XF; Wang, J; Ha, WW; Hou, JS; Zhou, FS; Wang, Y; Gao, JP; Sheng, YJ; Sun, LD; Liu, JJ; Yang, S; Zhang, XJ				Zhu, Fei; Wu, Baoyu; Li, Ping; Wang, Jianbo; Tang, Huayang; Liu, Ye; Zuo, Xianbo; Cheng, Hui; Ding, Yantao; Wang, Wen; Zhai, Yujuan; Qian, Fangfang; Wang, Wenju; Yuan, Xiangfeng; Wang, Jing; Ha, Weiwei; Hou, Junsheng; Zhou, Fusheng; Wang, Yin; Gao, Jinping; Sheng, Yujun; Sun, Liangdan; Liu, Jianjun; Yang, Sen; Zhang, Xuejun			Association Study Confirmed Susceptibility Loci with Keloid in the Chinese Han Population	PLOS ONE			English	Article							GENETIC SUSCEPTIBILITY; TGF-BETA; FIBROBLAST PROLIFERATION; DISEASE; POLYMORPHISMS; DEGRADATION; EXPRESSION; RECEPTOR; LIGASE; NEDD4	Keloid is benign fibroproliferative dermal tumors with unknown etiology. Recently, a genome-wide association study (GWAS) in Japanese population has identified 3 susceptibility loci (rs873549 at 1q41, rs940187 and rs1511412 at 3q22.3, rs8032158 at 15p21.3) for keloid. In order to examine whether these susceptibility loci are associated with keloid in the Chinese Han population, twelve previously reported SNPs were selected for replication in 714 cases and 2,944 controls by using Sequenom MassArray system. We found three SNPs in two regions showed significant association with keloid in the Chinese Han population: 1q41 (rs873549, P = 3.03 x 10(-33), OR = 2.05, 95% CI: 1.82-2.31 and rs1442440, P = 9.85 x 10(-18), OR = 0.56, 95% CI: 0.49-0.64, respectively) and 15q21.3 (rs2271289 located in NEDD4, P = 1.02 x 10(-11), OR = 0.66, 95% CI: 0.58-0.74). We also detected one risk haplotype AG (P = 1.36 x 10(-31), OR = 2.02) and two protective haplotypes of GA and AA (GA, P = 1.94 x 10(-19), OR = 0.53, AA, P = 0.00043, OR = 0.78, respectively) from the two SNPs (rs873549 and rs1442440). Our study confirmed two previously reported loci 1q41 and 15q21.3 for keloid in the Chinese Han population, which suggested the common genetic factor predisposing to the development of keloid shared by the Chinese Han and Japanese populations.	[Zhu, Fei; Wu, Baoyu; Li, Ping; Wang, Jianbo; Tang, Huayang; Cheng, Hui; Ding, Yantao; Wang, Wen; Zhai, Yujuan; Qian, Fangfang; Wang, Wenju; Yuan, Xiangfeng; Wang, Jing; Ha, Weiwei; Hou, Junsheng; Gao, Jinping; Sheng, Yujun; Sun, Liangdan; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Zhu, Fei; Wu, Baoyu; Li, Ping; Wang, Jianbo; Tang, Huayang; Cheng, Hui; Ding, Yantao; Wang, Wen; Zhai, Yujuan; Qian, Fangfang; Wang, Wenju; Yuan, Xiangfeng; Wang, Jing; Ha, Weiwei; Hou, Junsheng; Gao, Jinping; Sheng, Yujun; Sun, Liangdan; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Zhu, Fei; Wu, Baoyu; Li, Ping; Wang, Jianbo; Tang, Huayang; Zuo, Xianbo; Cheng, Hui; Ding, Yantao; Wang, Wen; Zhai, Yujuan; Qian, Fangfang; Wang, Wenju; Yuan, Xiangfeng; Wang, Jing; Ha, Weiwei; Hou, Junsheng; Zhou, Fusheng; Gao, Jinping; Sheng, Yujun; Sun, Liangdan; Liu, Jianjun; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Zhu, Fei; Wu, Baoyu; Li, Ping; Wang, Jianbo; Tang, Huayang; Zuo, Xianbo; Cheng, Hui; Ding, Yantao; Wang, Wen; Zhai, Yujuan; Qian, Fangfang; Wang, Wenju; Yuan, Xiangfeng; Wang, Jing; Ha, Weiwei; Hou, Junsheng; Zhou, Fusheng; Gao, Jinping; Sheng, Yujun; Sun, Liangdan; Liu, Jianjun; Yang, Sen] Anhui Med Univ, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China; [Zhu, Fei; Liu, Ye; Wang, Yin] Anhui Med Univ, Hosp 1, Dept Plast Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Liu, JJ (corresponding author), Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China.	liuj3@gis.a-star.edu.sg; ayzxj@vip.sina.com	Chen, Gang/G-2722-2010; Liu, Jianjun/AAK-4989-2020; SHENG, Yu/GXZ-8269-2022	Liu, Jianjun/0000-0002-3255-3019; Wang, Wen/0000-0001-6620-1049; zhu, fei/0000-0002-9122-1161	General Program of National Natural Science Foundation of China [30973124]	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by General Program of National Natural Science Foundation of China (30973124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bayat A, 2005, BRIT J PLAST SURG, V58, P28, DOI 10.1016/j.bjps.2004.04.024; Bayat A, 2004, EXP DERMATOL, V13, P120, DOI 10.1111/j.0906-6705.2004.00165.x; Bayat A, 2003, PLAST RECONSTR SURG, V111, P535, DOI 10.1097/01.PRS.0000041536.02524.A3; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Bettinger DA, 1996, PLAST RECONSTR SURG, V98, P827, DOI 10.1097/00006534-199610000-00012; Brown BC, 2008, J PLAST RECONSTR AES, V61, P1049, DOI 10.1016/j.bjps.2008.03.020; Brown JJ, 2009, BRIT J DERMATOL, V161, P8, DOI 10.1111/j.1365-2133.2009.09258.x; Brown JJ, 2008, EXP DERMATOL, V17, P610, DOI 10.1111/j.1600-0625.2007.00654.x; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Kelly A Paul, 2004, Dermatol Ther, V17, P212, DOI 10.1111/j.1396-0296.2004.04022.x; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Lua WS, 2011, BURNS, V37, P794, DOI 10.1016/j.burns.2011.01.003; Marneros AG, 2004, J INVEST DERMATOL, V122, P1126, DOI 10.1111/j.0022-202X.2004.22327.x; Marneros Alexander G, 2004, J Dtsch Dermatol Ges, V2, P905, DOI 10.1046/j.1439-0353.2004.04077.x; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Nakashima M, 2010, NAT GENET, V42, P768, DOI 10.1038/ng.645; Phan TT, 2003, AM J PHYSIOL-CELL PH, V284, pC860, DOI 10.1152/ajpcell.00350.2002; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shih B, 2010, ARCH DERMATOL RES, V302, P319, DOI 10.1007/s00403-009-1014-y; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039	26	29	31	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62377	10.1371/journal.pone.0062377	http://dx.doi.org/10.1371/journal.pone.0062377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667473	gold, Green Published			2022-12-27	WOS:000319654700034
J	Fang, Y; Wei, JH; Cao, JZ; Zhao, HW; Liao, B; Qiu, SP; Wang, DH; Luo, JH; Chen, W				Fang, Yong; Wei, Jinhuan; Cao, Jiazheng; Zhao, Hongwei; Liao, Bing; Qiu, Shaopeng; Wang, Daohu; Luo, Junhang; Chen, Wei			Protein Expression of ZEB2 in Renal Cell Carcinoma and Its Prognostic Significance in Patient Survival	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SMAD-INTERACTING PROTEIN-1; E-CADHERIN REPRESSORS; REGULATES E-CADHERIN; TRANSCRIPTION FACTORS; TUMOR PROGRESSION; OVARIAN-CARCINOMA; MIR-200 FAMILY; SIP1; CANCER	Background: ZEB2 has been reportedly shown to mediate the epithelial-to-mesenchymal transition (EMT) and disease aggressiveness in human tumors. However, the expression status of ZEB2 in renal cell carcinoma (RCC) and ZEB2's clinicopathologic/prognostic significance are poorly understood. Methodology/Principal Findings: In this study, tissue microarray, immunohistochemistry (IHC) and western blot analyses were utilized to investigate the ZEB2 expression status in RCC and adjacent renal tissue samples. In our study, samples from 116 RCC patients treated with radical nephrectomy were used as a training set to generate a ZEB2 optimal cut-point for patient outcome by receiver operating characteristic (ROC) analysis. For validation, the correlation of ZEB2 expression with the clinical characteristics and patient outcomes in another set (including 113 patients) was analyzed to validate the obtained cut-point. In the training and validation sets, high expression of ZEB2, defined by ROC analysis, predicted a poorer overall survival and progression-free survival, as evidenced by the univariate and multivariate analyses. In different subsets of overall patients, ZEB2 expression was also a prognostic indicator in patients with stage I/II, stage III/IV, grade 1/2 and grade 3/4 disease (P<0.05). Downregulation of ZEB2 by shRNA decreased the migration and invasion ability of 769-P cells in vitro. Furthermore, high ZEB2 expression was positively correlated with vimentin expression and inversely linked to E-cadherin expression in RCC. Conclusions/Significance: Our findings provide a basis for the concept that high ZEB2 expression in RCC may be important in the acquisition of an aggressive phenotype. This evidence suggests that ZEB2 overexpression (examined by IHC) is an independent biomarker for the poor prognosis of patients with RCC.	[Fang, Yong; Wei, Jinhuan; Qiu, Shaopeng; Wang, Daohu; Luo, Junhang; Chen, Wei] Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Jiazheng] Sun Yat Sen Univ, Affiliated Jiangmen Hosp, Dept Urol, Jiangmen, Peoples R China; [Zhao, Hongwei] Qingdao Univ, Coll Med, Affiliated Yantai Yuhuangding Hosp, Dept Urol, Yantai, Peoples R China; [Liao, Bing] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Qingdao University; Sun Yat Sen University	Luo, JH (corresponding author), Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	unhangluo@126.com; chenw3@mail.sysu.edu.cn						[Anonymous], 2008, CANC INCIDENCE 5 CON, VIX, P1; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Bettendorf U, 2009, PATHOLOGE, V30, P20, DOI [10.1007/s00292-008-1121-0, 10.1007/s00292-009-1179-3]; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Cai MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032838; Cai MY, 2011, GUT, V60, P967, DOI 10.1136/gut.2010.231993; Cai MY, 2011, MOL MED, V17, P12, DOI 10.2119/molmed.2010.00103; Cai MY, 2010, CANCER SCI, V101, P1543, DOI 10.1111/j.1349-7006.2010.01560.x; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harada K, 2012, BJU INT, V110, pE1131, DOI 10.1111/j.1464-410X.2012.11297.x; Imamichi Y, 2007, ONCOGENE, V26, P2381, DOI 10.1038/sj.onc.1210012; Kim SP, 2011, J UROLOGY, V185, P2035, DOI 10.1016/j.juro.2011.02.059; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Lam JS, 2006, J CLIN ONCOL, V24, P5565, DOI 10.1200/JCO.2006.08.1794; Maeda G, 2005, INT J ONCOL, V27, P1535; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Oztas E, 2010, EXP MOL PATHOL, V89, P182, DOI 10.1016/j.yexmp.2010.05.010; Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Sakamoto K, 2012, ANN SURG ONCOL, V19, P612, DOI 10.1245/s10434-011-2052-1; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Grunsven LA, 2003, J BIOL CHEM, V278, P26135, DOI 10.1074/jbc.M300597200; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoshida J, 2009, MED MOL MORPHOL, V42, P82, DOI 10.1007/s00795-008-0436-5	36	58	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e62558	10.1371/journal.pone.0062558	http://dx.doi.org/10.1371/journal.pone.0062558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658743	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500029
J	Shah, SN; Cope, L; Poh, W; Belton, A; Roy, S; Talbot, CC; Sukumar, S; Huso, DL; Resar, LMS				Shah, Sandeep N.; Cope, Leslie; Poh, Weijie; Belton, Amy; Roy, Sujayita; Talbot, C. Conover, Jr.; Sukumar, Saraswati; Huso, David L.; Resar, Linda M. S.			HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELL; MESENCHYMAL TRANSITION; UTERINE TUMORIGENESIS; EPITHELIAL-CELLS; TRANSGENIC MICE; TARGET GENE; C-MYC; TRANSFORMATION; TRANSCRIPTION	Emerging evidence suggests that tumor cells metastasize by co-opting stem cell transcriptional networks, although the molecular underpinnings of this process are poorly understood. Here, we show for the first time that the high mobility group A1 (HMGA1) gene drives metastatic progression in triple negative breast cancer cells (MDA-MB-231, Hs578T) by reprogramming cancer cells to a stem-like state. Silencing HMGA1 expression in invasive, aggressive breast cancer cells dramatically halts cell growth and results in striking morphologic changes from mesenchymal-like, spindle-shaped cells to cuboidal, epithelial-like cells. Mesenchymal genes (Vimentin, Snail) are repressed, while E-cadherin is induced in the knock-down cells. Silencing HMGA1 also blocks oncogenic properties, including proliferation, migration, invasion, and orthotopic tumorigenesis. Metastatic progression following mammary implantation is almost completely abrogated in the HMGA1 knock-down cells. Moreover, silencing HMGA1 inhibits the stem cell property of three-dimensional mammosphere formation, including primary, secondary, and tertiary spheres. In addition, knock-down of HMGA1 depletes cancer initiator/cancer stem cells and prevents tumorigenesis at limiting dilutions. We also discovered an HMGA1 signature in triple negative breast cancer cells that is highly enriched in embryonic stem cells. Together, these findings indicate that HMGA1 is a master regulator of tumor progression in breast cancer by reprogramming cancer cells through stem cell transcriptional networks. Future studies are needed to determine how to target HMGA1 in therapy.	[Shah, Sandeep N.; Belton, Amy; Roy, Sujayita; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Cope, Leslie; Sukumar, Saraswati; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Cope, Leslie] Johns Hopkins Univ, Sch Med, Dept Biostat, Baltimore, MD USA; [Poh, Weijie; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Pathobiol Grad Program, Baltimore, MD USA; [Talbot, C. Conover, Jr.] Johns Hopkins Univ, Sch Med, Inst Basic Biomed Sci, Baltimore, MD USA; [Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Comparat Mol & Pathobiol, Baltimore, MD USA; [Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Inst Cellular Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Resar, LMS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA.	lresar@jhmi.edu			NIH [R21 CA2149550-0131, RO1 CA092339]; Safeway Breast Cancer Fund; Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Initiative Exploratory Award [2009-MSCRFE-0105-00]; Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Research Fund [2011-MSCRFE-0135-00]; TEDCO State of Maryland Stem Cell Initiative Exploratory Award [2011-MSCRFE-0102-00]; NATIONAL CANCER INSTITUTE [R01CA092339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Safeway Breast Cancer Fund; Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Initiative Exploratory Award; Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Research Fund; TEDCO State of Maryland Stem Cell Initiative Exploratory Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by the following: LMSR: NIH R21 CA2149550-0131, NIH RO1 CA092339, Safeway Breast Cancer Fund, Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Initiative Exploratory Award 2009-MSCRFE-0105-00. SNS: Maryland Technology Development Corporation (TEDCO) State of Maryland Stem Cell Research Fund 2011-MSCRFE-0135-00. AB: TEDCO State of Maryland Stem Cell Initiative Exploratory Award 2011-MSCRFE-0102-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Belton A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030034; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Dang CV, 2012, CANCER DISCOV, V2, P304, DOI 10.1158/2159-8290.CD-12-0069; Dhar A, 2004, ONCOGENE, V23, P4466, DOI 10.1038/sj.onc.1207581; Di Cello F, 2013, LEUK LYMPHOMA; Di Cello F, 2008, MOL CANCER THER, V7, P2090, DOI 10.1158/1535-7163.MCT-07-2282; Dolde CE, 2002, BREAST CANCER RES TR, V71, P181, DOI 10.1023/A:1014444114804; Flohr AM, 2003, HISTOL HISTOPATHOL, V18, P999, DOI 10.14670/HH-18.999; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hillion J, 2009, MOL CANCER RES, V7, P1803, DOI 10.1158/1541-7786.MCR-08-0336; Hillion J, 2008, CANCER RES, V68, P10121, DOI 10.1158/0008-5472.CAN-08-2121; Hommura F, 2004, MOL CANCER RES, V2, P305; Hristov AC, 2010, MODERN PATHOL, V23, P98, DOI 10.1038/modpathol.2009.139; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karp JE, 2011, BLOOD, V117, P3302, DOI 10.1182/blood-2010-09-310862; Lee JS, 2010, CANCER BIOL THER, V9, P1017, DOI 10.4161/cbt.9.12.11804; Liau SS, 2006, CANCER RES, V66, P11613, DOI 10.1158/0008-5472.CAN-06-1460; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Muromoto R, 2008, INT IMMUNOL, V20, P395, DOI 10.1093/intimm/dxm154; Nelson DM, 2011, LEUKEMIA LYMPHOMA, V52, P1999, DOI 10.3109/10428194.2011.591012; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pedulla ML, 2001, GENE, V271, P51, DOI 10.1016/S0378-1119(01)00500-5; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Resar LMS, 2010, CANCER RES, V70, P436, DOI 10.1158/0008-5472.CAN-09-1212; Schuldenfrei A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-549; Semenza GL, 2012, ONCOGENE IN PRESS; Shah SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048533; Shah SN, 2012, HISTOL HISTOPATHOL, V27, P567, DOI 10.14670/HH-27.567; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Takaha N, 2004, PROSTATE, V60, P160, DOI 10.1002/pros.20049; Tesfaye A, 2007, CANCER RES, V67, P3998, DOI 10.1158/0008-5472.CAN-05-1684; Thibodeaux CA, 2009, BREAST CANCER RES TR, V116, P281, DOI 10.1007/s10549-008-0127-x; Tront JS, 2010, CANCER RES, V70, P9671, DOI 10.1158/0008-5472.CAN-10-2177; WILLIAMS MD, 2013, ANAL BIOANAL CHEM; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Xu Y, 2004, CANCER RES, V64, P3371, DOI 10.1158/0008-5472.CAN-04-0044; Zhou GL, 2001, P NATL ACAD SCI USA, V98, P13966, DOI 10.1073/pnas.241526198	48	101	105	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63419	10.1371/journal.pone.0063419	http://dx.doi.org/10.1371/journal.pone.0063419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658826	gold, Green Published, Green Submitted			2022-12-27	WOS:000321200500068
J	Chakraborty, D; Conley, SM; Naash, MI				Chakraborty, Dibyendu; Conley, Shannon M.; Naash, Muna I.			Overexpression of Retinal Degeneration Slow (RDS) Protein Adversely Affects Rods in the rd7 Model of Enhanced S-Cone Syndrome	PLOS ONE			English	Article							NUCLEAR RECEPTOR NR2E3; OF-FUNCTION PHENOTYPE; PERIPHERIN/RDS CAUSES; MUTATION; GENE; EXPRESSION; OLIGOMERIZATION; MORPHOGENESIS; NRL; TRANSCRIPTION	The nuclear receptor NR2E3 promotes expression of rod photoreceptor genes while repressing cone genes. Mice lacking NR2E3 (Nr2e3(rd7/rd7) referred to here as rd7) are a model for enhanced S-cone syndrome, a disease associated with increased sensitivity to blue light and night blindness. Rd7 retinas have reduced levels of the outer segment (OS) structural protein retinal degeneration slow (RDS). We test the hypothesis that increasing RDS levels would improve the Rd7 phenotype. Transgenic mice over-expressing normal mouse peripherin/RDS (NMP) in rods and cones were crossed onto the rd7 background. Disease phenotypes were assessed in NMP/rd7 eyes and compared to wild-type (WT) and rd7 eyes at postnatal day 30. NMP/rd7 retinas expressed total RDS (transgenic and endogenous) message at WT levels, and NMP protein was correctly localized to the OS. NMP/rd7 retinas have shorter OSs compared to rd7 and WT and significantly reduced number of rosettes. NMP/rd7 mice also exhibited significant deficits in scotopic ERG amplitudes compared to rd7 while photopic amplitudes remained unaffected. Protein levels of rhodopsin, RDS, and the RDS homologue ROM-1 were significantly reduced in the NMP/rd7 retinas compared to rd7. We show that correcting the levels of RDS gene expression does not improve the phenotype of the rd7 suggesting that RDS deficiency is not responsible for the defect in this model. We suggest that the specific rod defect in the NMP/rd7 is likely associated with ongoing problems in the rd7 that are related to the expression of cone genes in rod cells, a characteristic of the model.	[Chakraborty, Dibyendu; Conley, Shannon M.; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA.	muna-naash@ouhsc.edu			NIH [EY10609-MIN, EY018512-SMC]; Foundation Fighting Blindness; Oklahoma Center for the Advancement of Science and Technology; NATIONAL EYE INSTITUTE [R56EY010609, F32EY018512, R01EY010609, R55EY010609] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Oklahoma Center for the Advancement of Science and Technology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by funding from the NIH (EY10609-MIN, EY018512-SMC), The Foundation Fighting Blindness (MIN), and the Oklahoma Center for the Advancement of Science and Technology (MIN, SMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Chavala SH, 2005, BRIT J OPHTHALMOL, V89, P1065, DOI 10.1136/bjo.2005.068130; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Cheng H, 2011, HUM MOL GENET, V20, P4102, DOI 10.1093/hmg/ddr334; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Conley SM, 2012, ADV EXP MED BIOL, V723, P657, DOI 10.1007/978-1-4614-0631-0_83; Conley SM, 2010, BIOCHEMISTRY-US, V49, P905, DOI 10.1021/bi901622w; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Ding XQ, 2005, BIOCHEMISTRY-US, V44, P4897, DOI 10.1021/bi048414i; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjo R, 2007, J COMP NEUROL, V504, P619, DOI 10.1002/cne.21476; FISHMAN GA, 1976, BRIT J OPHTHALMOL, V60, P345, DOI 10.1136/bjo.60.5.345; Gire AI, 2007, MOL VIS, V13, P1970; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Han ZC, 2012, J CLIN INVEST, V122, P3221, DOI 10.1172/JCI64833; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Hayashi T, 2005, OPHTHALMOLOGY, V112, P2115, DOI 10.1016/j.ophtha.2005.07.002; JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827; JACOBSON SG, 1991, AM J OPHTHALMOL, V111, P446, DOI 10.1016/S0002-9394(14)72379-7; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Lam BL, 2007, AM J OPHTHALMOL, V144, P157, DOI 10.1016/j.ajo.2007.03.012; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; Nour M, 2008, ADV EXP MED BIOL, V613, P129, DOI 10.1007/978-0-387-74904-4_14; Nystuen AM, 2008, MAMM GENOME, V19, P623, DOI 10.1007/s00335-008-9138-5; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016	42	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63321	10.1371/journal.pone.0063321	http://dx.doi.org/10.1371/journal.pone.0063321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650562	Green Published, Green Submitted, gold			2022-12-27	WOS:000319167000107
J	Yang, YX; Liao, QJ; Wei, F; Li, XL; Zhang, WL; Fan, SQ; Shi, L; Li, XY; Gong, ZJ; Ma, J; Zhou, M; Xiang, JJ; Peng, SP; Xiang, B; Deng, H; Yang, YB; Li, Y; Xiong, W; Zeng, ZY; Li, GY				Yang, Yixin; Liao, Qianjin; Wei, Fang; Li, Xiaoling; Zhang, Wenling; Fan, Songqing; Shi, Lei; Li, Xiayu; Gong, Zhaojian; Ma, Jian; Zhou, Ming; Xiang, Juanjuan; Peng, Shuping; Xiang, Bo; Deng, Hao; Yang, Yunbo; Li, Yong; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan			LPLUNC1 Inhibits Nasopharyngeal Carcinoma Cell Growth via Down-Regulation of the MAP Kinase and Cyclin D1/E2F Pathways	PLOS ONE			English	Article							SUPPRESSION SUBTRACTIVE HYBRIDIZATION; CANDIDATE MOLECULAR MARKERS; EPSTEIN-BARR-VIRUS; CDNA MICROARRAY; SUSCEPTIBILITY LOCUS; INCREASING PROTEIN; SIGNALING PATHWAY; SPLUNC1 PROTEIN; CHROMOSOME 3P21; EXPRESSION	Long-palate, lung and nasal epithelium clone 1 (LPLUNC1) gene expression is relatively tissue specific. It is highly expressed in nontumor nasopharyngeal epithelial tissues, but its expression is reduced in nasopharyngeal carcinoma (NPC), indicating that LPLUNC1 may be associated with the tumorigenesis of NPC. To study the effects of LPLUNC1 on NPC tumorigenesis, a full-length LPLUNC1 expression plasmid was stably transfected into the NPC cell line, 5-8F. Our data indicated that LPLUNC1 inhibited NPC cell proliferation in vitro and tumor formation in vivo. LPLUNC1 also delayed cell cycle progression from G1 to S phase and inhibited the expression of cyclin D1, cyclin-dependent kinase 4 (CDK4) and phosphorylated Rb. To further investigate the molecular mechanisms underlying the suppressive effects of LPLUNC1 on NPC tumorigenesis, cDNA microarray was performed. These studies revealed that LPLUNC1 inhibited the expression of certain mitogen-activated protein (MAP) kinases (MAPK) kinases and cell cycle-related molecules. Western blotting confirmed that the expression of MEK1, phosphorylated ERK1/2, phosphorylated JNK1/2, c-Myc and c-Jun were inhibited by LPLUNC1. Furthermore, the transcriptional activity of AP-1 was down-regulated by LPLUNC1, suggesting that the MAPK signaling pathway is regulated by LPLUNC1. Taken together, the present study indicates that LPLUNC1 delays NPC cell growth by inhibiting the MAPK and cyclin D1/E2F pathways and suggests that LPLUNC1 may represent a promising candidate tumor suppressor gene associated with NPC.	[Yang, Yixin; Li, Xiaoling; Li, Xiayu; Deng, Hao; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan] Cent S Univ, Xiangya Hosp 3, Hunan Key Lab Nonresolving Inflammat & Canc, Dis Genome Res Ctr, Changsha 410083, Hunan, Peoples R China; [Yang, Yixin; Liao, Qianjin; Wei, Fang; Li, Xiaoling; Zhang, Wenling; Gong, Zhaojian; Ma, Jian; Zhou, Ming; Xiang, Juanjuan; Peng, Shuping; Xiang, Bo; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan] Cent S Univ, Minist Hlth, Key Lab Carcinogenesis, Canc Res Inst, Changsha 410083, Hunan, Peoples R China; [Yang, Yixin; Liao, Qianjin; Wei, Fang; Li, Xiaoling; Zhang, Wenling; Gong, Zhaojian; Ma, Jian; Zhou, Ming; Xiang, Juanjuan; Peng, Shuping; Xiang, Bo; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan] Cent S Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Canc Res Inst, Changsha 410083, Hunan, Peoples R China; [Li, Xiaoling; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan] Cent S Univ, Hunan Prov Tumor Hosp, Xiangya Sch Med, Changsha 410083, Hunan, Peoples R China; [Li, Xiaoling; Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan] Cent S Univ, Affiliated Tumor Hosp, Xiangya Sch Med, Changsha 410083, Hunan, Peoples R China; [Fan, Songqing; Shi, Lei; Gong, Zhaojian; Yang, Yunbo] Cent S Univ, Xiangya Hosp 2, Changsha 410083, Hunan, Peoples R China; [Li, Yong] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; University of Louisville	Zeng, ZY (corresponding author), Cent S Univ, Xiangya Hosp 3, Hunan Key Lab Nonresolving Inflammat & Canc, Dis Genome Res Ctr, Changsha 410083, Hunan, Peoples R China.	zengzhaoyang@xysm.net; ligy@xysm.net	li, xia/HHZ-7468-2022; Deng, Hao/O-6340-2017	Deng, Hao/0000-0003-3240-4352	National High Technology Research and Development Program of China [2012AA02A206]; National Natural Science Foundation of China [91229122, 81071644, 81172189, 81101509, 81171930, 81272254, 81272298]; 111 Project [111-2-12]; Hunan Province Natural Sciences Foundation of China [10JJ7003]; Fundamental Research Funds for the Central Universities [2011JQ020]; National Science Foundation for Post-doctoral Scientists of China [20110491758]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Hunan Province Natural Sciences Foundation of China(Natural Science Foundation of Hunan Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC))	This study was supported by grants from the National High Technology Research and Development Program of China (2012AA02A206), the National Natural Science Foundation of China (91229122, 81071644, 81172189, 81101509, 81171930, 81272254 and 81272298), the 111 Project (111-2-12), the Hunan Province Natural Sciences Foundation of China (10JJ7003), the Fundamental Research Funds for the Central Universities (2011JQ020) and the National Science Foundation for Post-doctoral Scientists of China (20110491758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JA, 2008, J LEUKOCYTE BIOL, V83, P1201, DOI 10.1189/jlb.0507302; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Deng LW, 1998, GENE CHROMOSOME CANC, V23, P21, DOI 10.1002/(SICI)1098-2264(199809)23:1<21::AID-GCC4>3.0.CO;2-8; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Feng BJ, 2002, NAT GENET, V31, P395, DOI 10.1038/ng932; Finzi L, 2009, J IMMUNOL, V182, P2269, DOI 10.4049/jimmunol.0801768; Freeman SM, 2004, DRUG NEWS PERSPECT, V17, P237, DOI 10.1358/dnp.2004.17.4.829050; GAZZANOSANTORO H, 1994, INFECT IMMUN, V62, P1185, DOI 10.1128/IAI.62.4.1185-1191.1994; He Y, 2005, J MED GENET, V42, P172, DOI 10.1136/jmg.2004.022616; HILDESHEIM A, 1993, EPIDEMIOL REV, V15, P466, DOI 10.1093/oxfordjournals.epirev.a036130; Peng C, 2007, MOL CELL BIOCHEM, V303, P141, DOI 10.1007/s11010-007-9466-x; Peng SP, 2006, ONCOLOGY-BASEL, V71, P273, DOI 10.1159/000106073; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Yang YX, 2007, MOL IMMUNOL, V44, P984, DOI 10.1016/j.molimm.2006.03.013; Zeng ZY, 2007, HUM PATHOL, V38, P120, DOI 10.1016/j.humpath.2006.06.023; Zeng ZY, 2007, J CANCER RES CLIN, V133, P71, DOI 10.1007/s00432-006-0136-2; Zeng ZY, 2011, SCI CHINA LIFE SCI, V54, P966, DOI 10.1007/s11427-011-4223-5; Zeng ZY, 2006, GENET MED, V8, P156, DOI 10.1097/01.gim.0000196821.87655.d0; Zhang BC, 2003, GENE CHROMOSOME CANC, V38, P80, DOI 10.1002/gcc.10247; Zhang WL, 2012, J MOL HISTOL, V43, P297, DOI 10.1007/s10735-012-9392-4; Zhang WL, 2009, ACTA BIOCH BIOPH SIN, V41, P414, DOI 10.1093/abbs/gmp025; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou HD, 2008, MOL CELL BIOCHEM, V309, P191, DOI 10.1007/s11010-007-9659-3; Zhou YH, 2008, EUR J CANCER PREV, V17, P561, DOI 10.1097/CEJ.0b013e328305a0e8; Zhou YH, 2008, INT J CANCER, V123, P2065, DOI 10.1002/ijc.23727	26	36	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62869	10.1371/journal.pone.0062869	http://dx.doi.org/10.1371/journal.pone.0062869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23650533	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000078
J	Kechkar, A; Nair, D; Heilemann, M; Choquet, D; Sibarita, JB				Kechkar, Adel; Nair, Deepak; Heilemann, Mike; Choquet, Daniel; Sibarita, Jean-Baptiste			Real-Time Analysis and Visualization for Single-Molecule Based Super-Resolution Microscopy	PLOS ONE			English	Article							PHOTOACTIVATION LOCALIZATION MICROSCOPY; OPTICAL RECONSTRUCTION MICROSCOPY; ACCURATE; SOFTWARE; TRACKING	Accurate multidimensional localization of isolated fluorescent emitters is a time consuming process in single-molecule based super-resolution microscopy. We demonstrate a functional method for real-time reconstruction with automatic feedback control, without compromising the localization accuracy. Compatible with high frame rates of EM-CCD cameras, it relies on a wavelet segmentation algorithm, together with a mix of CPU/GPU implementation. A combination with Gaussian fitting allows direct access to 3D localization. Automatic feedback control ensures optimal molecule density throughout the acquisition process. With this method, we significantly improve the efficiency and feasibility of localization-based super-resolution microscopy.	[Kechkar, Adel; Nair, Deepak; Choquet, Daniel; Sibarita, Jean-Baptiste] Univ Bordeaux, Interdisciplinary Inst Neurosci, Bordeaux, France; [Kechkar, Adel; Nair, Deepak; Choquet, Daniel; Sibarita, Jean-Baptiste] CNRS, UMR 5297, Bordeaux, France; [Heilemann, Mike] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, Frankfurt, Germany	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Goethe University Frankfurt	Sibarita, JB (corresponding author), Univ Bordeaux, Interdisciplinary Inst Neurosci, Bordeaux, France.	jean-baptiste.sibarita@u-bordeaux2.fr	Choquet, Daniel/K-7893-2018; Choquet, Daniel/GOJ-8825-2022	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Heilemann, Mike/0000-0002-9821-3578; Sibarita, Jean-Baptiste/0000-0002-9920-7700; Nair, Deepak/0000-0002-2103-1653	CNRS; ANR; Regional Council of Aquitaine; Fondation pour la Recherche Medicale; European Union's seventh framework program; ERC; ERA-NET; German Ministry of Research and Education	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); Regional Council of Aquitaine; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union's seventh framework program(European Commission); ERC(European Research Council (ERC)European Commission); ERA-NET; German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF))	This study was supported by CNRS; ANR; Regional Council of Aquitaine; Fondation pour la Recherche Medicale; European Union's seventh framework program for research and development for the Marie-Curie-Intra European Fellowship; ERC; ERA-NET; German Ministry of Research and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AV, 2009, OPT EXPRESS, V17, P23352, DOI 10.1364/OE.17.023352; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Hedde PN, 2009, NAT METHODS, V6, P689, DOI 10.1038/nmeth1009-689; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Henriques R, 2010, NAT METHODS, V7, P339, DOI 10.1038/nmeth0510-339; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Holtzer L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437066; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Izeddin I, 2012, OPT EXPRESS, V20, P2081, DOI 10.1364/OE.20.002081; Parthasarathy R, 2012, NAT METHODS, V9, P724, DOI [10.1038/NMETH.2071, 10.1038/nmeth.2071]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Small AR, 2009, BIOPHYS J, V96, pL16, DOI 10.1016/j.bpj.2008.11.001; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Wang Y, 2012, OPT EXPRESS, V20, P16039, DOI 10.1364/OE.20.016039; Wolter S, 2010, J MICROSC-OXFORD, V237, P12, DOI 10.1111/j.1365-2818.2009.03287.x; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224	17	85	86	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62918	10.1371/journal.pone.0062918	http://dx.doi.org/10.1371/journal.pone.0062918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23646160	Green Published, Green Submitted, gold			2022-12-27	WOS:000319077300114
J	Pilakka-Kanthikeel, S; Atluri, VSR; Sagar, V; Saxena, SK; Nair, M				Pilakka-Kanthikeel, Sudheesh; Atluri, Venkata Subba Rao; Sagar, Vidya; Saxena, Shailendra K.; Nair, Madhavan			Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; HIV-ASSOCIATED DEMENTIA; CENTRAL-NERVOUS-SYSTEM; LONG-TERM-MEMORY; FACTOR PREVENTS; SUBSTANTIA-NIGRA; EXPOSURE ALTERS; RAT HIPPOCAMPUS; SPINE DENSITY; CELL-DEATH	Parenteral use of drugs; such as opiates exert immunomodulatory effects and serve as a cofactor in the progression of HIV-1 infection, thereby potentiating HIV related neurotoxicity ultimately leading to progression of NeuroAIDS. Morphine exposure is known to induce apoptosis, down regulate cAMP response element-binding (CREB) expression and decrease in dendritic branching and spine density in cultured cells. Use of neuroprotective agent; brain derived neurotropic factor (BDNF), which protects neurons against these effects, could be of therapeutic benefit in the treatment of opiate addiction. Previous studies have shown that BDNF was not transported through the blood brain barrier (BBB) in-vivo.; and hence it is not effective in-vivo. Therefore development of a drug delivery system that can cross BBB may have significant therapeutic advantage. In the present study, we hypothesized that magnetically guided nanocarrier may provide a viable approach for targeting BDNF across the BBB. We developed a magnetic nanoparticle (MNP) based carrier bound to BDNF and evaluated its efficacy and ability to transmigrate across the BBB using an in-vitro BBB model. The end point determinations of BDNF that crossed BBB were apoptosis, CREB expression and dendritic spine density measurement. We found that transmigrated BDNF was effective in suppressing the morphine induced apoptosis, inducing CREB expression and restoring the spine density. Our results suggest that the developed nanocarrier will provide a potential therapeutic approach to treat opiate addiction, protect neurotoxicity and synaptic density degeneration.	[Pilakka-Kanthikeel, Sudheesh; Atluri, Venkata Subba Rao; Sagar, Vidya; Nair, Madhavan] Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Miami, FL 33199 USA; [Saxena, Shailendra K.] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	State University System of Florida; Florida International University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nair, M (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Miami, FL 33199 USA.	nairm@fiu.edu	Saxena, Shailendra K/ABK-6489-2022; Saxena, Shailendra K/X-4252-2019; Atluri, Venkata/G-3277-2014	Saxena, Shailendra K/0000-0003-2856-4185; Saxena, Shailendra K/0000-0003-2856-4185; Atluri, Venkata/0000-0002-8070-6745	National Institute of Drug abuse [1R01-DA027049]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027049] Funding Source: NIH RePORTER	National Institute of Drug abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant from National Institute of Drug abuse (1R01-DA027049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala-Barraza SR, 2010, J DRUG TARGET, V18, P179, DOI 10.3109/10611860903318134; Alexiou C, 2006, EUR BIOPHYS J BIOPHY, V35, P446, DOI 10.1007/s00249-006-0042-1; Alonso M, 2005, LEARN MEMORY, V12, P504, DOI 10.1101/lm.27305; ALTAR CA, 1992, P NATL ACAD SCI USA, V89, P11347, DOI 10.1073/pnas.89.23.11347; AYRE SG, 1989, MED HYPOTHESES, V29, P283, DOI 10.1016/0306-9877(89)90113-8; Bachis A, 2003, J NEUROSCI, V23, P5715; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; BETZ AL, 1980, BRAIN RES, V192, P17, DOI 10.1016/0006-8993(80)91004-5; BETZ AL, 1986, ANNU REV PHYSIOL, V48, P241; BETZ AL, 1978, SCIENCE, V202, P225, DOI 10.1126/science.211586; Blitts B, 2003, NEUROSCIENCE, V118, P271, DOI 10.1016/S0306-4522(02)00970-3; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Boyum A, 1968, SCAND J CLIN LAB INV, P77; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Cammarota M, 2000, MOL BRAIN RES, V76, P36, DOI 10.1016/S0169-328X(99)00329-0; Chapleau CA, 2008, J NEUROSCI METH, V169, P182, DOI 10.1016/j.jneumeth.2007.12.006; Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050; Frankfurt M, 2011, SYNAPSE, V65, P955, DOI 10.1002/syn.20918; FREIER DO, 1993, J PHARMACOL EXP THER, V265, P81; FUCHS BA, 1993, J PHARMACOL EXP THER, V266, P417; Gandhi N, 2010, J NEUROVIROL, V16, P294, DOI 10.3109/13550284.2010.499891; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Goswami R, 1998, J NEUROCHEM, V70, P1376; Guo CJ, 2002, J INVEST MED, V50, P435, DOI 10.1136/jim-50-06-03; Han B, 2009, ADDICTION, V104, P88, DOI 10.1111/j.1360-0443.2008.02411.x; Han BH, 2000, NEUROBIOL DIS, V7, P38; HURWITZ AA, 1994, ADV NEUROIMMUNOL, V4, P249, DOI 10.1016/S0960-5428(06)80263-9; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Ito A, 2005, J BIOSCI BIOENG, V100, P1, DOI 10.1263/jbb.100.1; Itoh K, 2000, ACTA NEUROPATHOL, V99, P376, DOI 10.1007/s004010051139; James HJ, 1999, NEUROPATH APPL NEURO, V25, P380, DOI 10.1046/j.1365-2990.1999.00195.x; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kwon M, 2011, J NEUROSCI, V31, P9735, DOI 10.1523/JNEUROSCI.6785-10.2011; Kwon SG, 2007, J AM CHEM SOC, V129, P12571, DOI 10.1021/ja074633q; Li YF, 2007, NEUROSCI LETT, V418, P227, DOI 10.1016/j.neulet.2007.03.023; Lubbe AS, 1996, CANCER RES, V56, P4694; Mahajan SD, 2005, CLIN IMMUNOL, V115, P323, DOI 10.1016/j.clim.2005.02.004; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Mandel RJ, 1999, EXP NEUROL, V155, P59, DOI 10.1006/exnr.1998.6961; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Mocchetti I, 2007, ANN NY ACAD SCI, V1122, P144, DOI 10.1196/annals.1403.010; Nair MPN, 1997, CLIN DIAGN LAB IMMUN, V4, P127, DOI 10.1128/CDLI.4.2.127-132.1997; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nosheny RL, 2007, EUR J NEUROSCI, V25, P2275, DOI 10.1111/j.1460-9568.2007.05506.x; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge WM, 1998, PHARMACEUT RES, V15, P576, DOI 10.1023/A:1011981927620; Persidsky Y, 1997, J IMMUNOL, V158, P3499; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Purohit V, 2011, MOL NEUROBIOL, V44, P102, DOI 10.1007/s12035-011-8195-z; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Roy S, 1996, NEUROCHEM RES, V21, P1375, DOI 10.1007/BF02532379; Saiyed ZM, 2007, J BIOTECHNOL, V131, P240, DOI 10.1016/j.jbiotec.2007.06.017; Saiyed ZM, 2007, ANAL BIOCHEM, V363, P288, DOI 10.1016/j.ab.2007.01.008; Saiyed ZM, 2010, INT J NANOMED, V5, P157; Saiyed ZM, 2009, J NEUROVIROL, V15, P343, DOI 10.1080/13550280903062813; Sarti F, 2007, EUR J NEUROSCI, V26, P749, DOI 10.1111/j.1460-9568.2007.05689.x; Silva GA, 2007, SURG NEUROL, V67, P113, DOI 10.1016/j.surneu.2006.08.033; Singhal PC, 1998, J IMMUNOL, V160, P1886; Singhal PG, 1999, J LEUKOCYTE BIOL, V66, P650, DOI 10.1002/jlb.66.4.650; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Stefano GB, 1996, CRIT REV IMMUNOL, V16, P109, DOI 10.1615/CritRevImmunol.v16.i2.10; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Suri Sarabjeet Singh, 2007, J Occup Med Toxicol, V2, P16, DOI 10.1186/1745-6673-2-16; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Viola HE, 2000, J NEUROSCI, V20; Wallace DR, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/65741; Wang GJ, 2004, BRAIN, V127, P2452, DOI 10.1093/brain/awh269; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; Xia Y, 2010, NEUROPHARMACOLOGY, V58, P330, DOI 10.1016/j.neuropharm.2009.10.009; Yin DL, 1999, NATURE, V397, P218, DOI 10.1038/16612	72	68	71	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e62241	10.1371/journal.pone.0062241	http://dx.doi.org/10.1371/journal.pone.0062241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23653680	gold, Green Published			2022-12-27	WOS:000319077300033
J	Camus, SMJ; Blois-Heulin, C; Li, Q; Hausberger, M; Bezard, E				Camus, Sandrine M. J.; Blois-Heulin, Catherine; Li, Qin; Hausberger, Martine; Bezard, Erwan			Behavioural Profiles in Captive-Bred Cynomolgus Macaques: Towards Monkey Models of Mental Disorders?	PLOS ONE			English	Article							CEREBROSPINAL-FLUID CONCENTRATIONS; CORTICOTROPIN-RELEASING-FACTOR; NONHUMAN-PRIMATES; SOCIAL-BEHAVIOR; ANIMAL-MODELS; INDIVIDUAL-DIFFERENCES; RHESUS-MONKEYS; MACACA-FASCICULARIS; PERSONALITY-TRAITS; COPING HYPOTHESIS	Background: To date, experimental and preclinical studies on neuropsychiatric conditions have almost exclusively been performed in experimentally-induced animal models and have only rarely relied upon an ethological approach where animals have been observed in more naturalistic settings. The laboratory species of choice has been the rodent while the potential of more closely-related non-human primates have remained largely underexplored. Methods: The present study, therefore, aimed at investigating the possible existence of spontaneous atypical/abnormal behaviours displayed by 40 cynomolgus macaques in captive conditions using an unbiased ethological scan-sampling analysis followed by multifactorial correspondence analysis and a hierarchical clustering. Results: The study identified five distinct profiles (groups A to E) that significantly differed on several behaviours, body postures, body orientations, gaze directions and locations in the cage environment. We suggest that animals from the low n groups (D and E) present depressive-like and anxious-like symptoms, reminiscent of depressive and generalized anxiety disorders. Inter-individual differences were highlighted through unbiased ethological observations of spontaneous behaviours and associated parameters, although these were not associated with differences in plasma or cerebrospinal fluid levels of either stress-related hormones or monoamines, i.e. in accordance with the human situation. Conclusions: No interventional behavioural testing was required to discriminate between 3 typical and 2 atypical ethologically-defined behavioural profiles, reminiscent of certain depressive-like and anxiety-like symptoms. The use of unbiased behavioural observations might, thus, allow the identification of animal models of human mental/behavioural disorders and their most appropriate control groups.	[Camus, Sandrine M. J.; Bezard, Erwan] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Blois-Heulin, Catherine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Paimpont, France; [Li, Qin] China Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Li, Qin; Bezard, Erwan] Motac Neurosci Ltd, Manchester, Lancs, England; [Hausberger, Martine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Bezard, Erwan] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bezard, E (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France.	erwan.bezard@u-bordeaux2.fr	Bezard, Erwan/ABD-5153-2021	Bezard, Erwan/0000-0002-0410-4638	Agence Nationale de la Recherche grants [ANR-08-MNP-018 MCHPRIMAPARK]; Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department; Motac Neuroscience Ltd. (UK)	Agence Nationale de la Recherche grants(French National Research Agency (ANR)); Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department; Motac Neuroscience Ltd. (UK)	This work was supported by ANR-08-MNP-018 MCHPRIMAPARK Agence Nationale de la Recherche grants (EB), Biotheque Primate - Centre National de la Recherche Scientifique Life Sciences Department (EB), and an unrestricted grant from Motac Neuroscience Ltd. (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; Albelda N, 2012, NEUROSCI BIOBEHAV R, V36, P47, DOI 10.1016/j.neubiorev.2011.04.006; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; Berton O, 2012, SCIENCE, V338, P75, DOI 10.1126/science.1222940; Bertrand M., 1969, BEHAV REPERTOIRE STU; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Bezard E, 2011, MOVEMENT DISORD, V26, P993, DOI 10.1002/mds.23696; BOLIG R, 1992, INT J PRIMATOL, V13, P287, DOI 10.1007/BF02547817; Brent L, 2002, INT J PRIMATOL, V23, P147, DOI 10.1023/A:1013206125884; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P1246, DOI 10.1016/j.neubiorev.2006.09.002; BUIRSKI P, 1973, Primates, V14, P67, DOI 10.1007/BF01730516; Camus SM, 2013, PLOS ONE IN PRESS; CHENEY DL, 1990, COGNITION, V37, P167, DOI 10.1016/0010-0277(90)90022-C; Claessens SEF, 2011, PSYCHOPHARMACOLOGY, V214, P141, DOI 10.1007/s00213-010-2118-y; CLARKE AS, 1988, INT J PRIMATOL, V9, P347, DOI 10.1007/BF02737382; Clarke AS, 1996, BIOL PSYCHIAT, V40, P338, DOI 10.1016/0006-3223(95)00663-X; Clubb R, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P58, DOI 10.1079/9780851990040.0058; COOPER JJ, 1993, ANIM BEHAV, V45, P616, DOI 10.1006/anbe.1993.1072; Coplan JD, 1998, ARCH GEN PSYCHIAT, V55, P473, DOI 10.1001/archpsyc.55.5.473; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; CROCKETT CM, 1995, J COMP PSYCHOL, V109, P368, DOI 10.1037/0735-7036.109.4.368; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Waal F.B.M., 1990, PEACEMAKING PRIMATES; De Waal Frans, 2009, QUESTION ANIMAL CULT, P19; Desbiolles C, 2007, BEHAV TRAITS VERVET; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Ellenbroek BA, 2002, BEHAV GENET, V32, P349, DOI 10.1023/A:1020214322065; Fairbanks LA, 2001, J COMP PSYCHOL, V115, P22, DOI 10.1037/0735-7036.115.1.22; FORDHAM DP, 1991, ANIM PROD, V52, P287, DOI 10.1017/S0003356100012794; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Fureix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039280; Geracioti T D Jr, 1997, Depress Anxiety, V6, P89, DOI 10.1002/(SICI)1520-6394(1997)6:3<89::AID-DA1>3.0.CO;2-0; Gilmer WS, 2003, J AFFECT DISORDERS, V75, P97, DOI 10.1016/S0165-0327(03)00046-6; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; HARLOW HF, 1974, BEHAV BIOL, V12, P273, DOI 10.1016/S0091-6773(74)91475-8; Henry DB, 2005, J FAM PSYCHOL, V19, P121, DOI 10.1037/0893-3200.19.1.121; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; Jensen KH, 1996, PHYSIOL BEHAV, V59, P741, DOI 10.1016/0031-9384(95)02159-0; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; KALIN NH, 1989, SCIENCE, V243, P1718, DOI 10.1126/science.2564702; LAWRENCE AB, 1991, APPL ANIM BEHAV SCI, V30, P73, DOI 10.1016/0168-1591(91)90086-D; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075; Maalouf FT, 2011, DEPRESS ANXIETY, V28, P946, DOI 10.1002/da.20884; MAESTRIPIERI D, 1991, DEV PSYCHOBIOL, V24, P571, DOI 10.1002/dev.420240805; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Mason GJ, 2006, STEROTYPIC ANIMAL BE; Mathew SJ, 2002, STRESS, V5, P185, DOI 10.1080/1025389021000010521; Meissner W, 2006, NEUROBIOL DIS, V22, P586, DOI 10.1016/j.nbd.2006.01.009; Miller G, 2010, SCIENCE, V327, P770, DOI 10.1126/science.327.5967.770-a; Montaudouin S, 2004, BEHAV PROCESS, V67, P235, DOI 10.1016/j.beproc.2004.02.008; NAKAMICHI M, 1990, PRIMATES, V31, P213, DOI 10.1007/BF02380943; Nelson EE, 2009, NEUROPSYCHOPHARMACOL, V34, P90, DOI 10.1038/npp.2008.150; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Prins J, 2011, EXPERT OPIN INV DRUG, V20, P1107, DOI 10.1517/13543784.2011.594039; Rao Uma, 2009, Dialogues Clin Neurosci, V11, P45; Rascol O, 2012, ANTIDYSKINETIC EFFEC; Roonwal M. L., 1977, PRIMATES S ASIA ECOL; ROSE RM, 1978, PSYCHOSOM MED, V40, P60, DOI 10.1097/00006842-197802000-00007; ROSENBLUM LA, 1984, CHILD DEV, V55, P305, DOI 10.1111/j.1467-8624.1984.tb00293.x; Rouff JH, 2005, AM J PRIMATOL, V67, P177, DOI 10.1002/ajp.20176; RUSHEN J, 1993, ANIM BEHAV, V45, P613, DOI 10.1006/anbe.1993.1071; Rygula R, 2008, BEHAV PHARMACOL, V19, P183, DOI 10.1097/FBP.0b013e3282fe8871; Rylander D, 2010, NEUROBIOL DIS, V39, P352, DOI 10.1016/j.nbd.2010.05.001; Schino G, 1996, ANXIETY, V2, P186; Shannon C, 2005, AM J PSYCHIAT, V162, P1658, DOI 10.1176/appi.ajp.162.9.1658; Shivel CA, 2012, EXP NEUROL, V233, P87, DOI 10.1016/j.expneurol.2011.09.026; Shively CA, 1997, BIOL PSYCHIAT, V41, P871, DOI 10.1016/S0006-3223(96)00185-0; Shively CA, 2005, BIOL PSYCHOL, V69, P67, DOI 10.1016/j.biopsycho.2004.11.006; SOUTHWICK CH, 1967, BEHAVIOUR, V28, P182, DOI 10.1163/156853967X00235; STEVENSON-HINDE J, 1980, Primates, V21, P498, DOI 10.1007/BF02373838; SUOMI SJ, 1975, J ABNORM PSYCHOL, V84, P576, DOI 10.1037/h0077066; Suomi SJ, 1997, BRIT MED BULL, V53, P170; SUOMI SJ, 1983, DEV PSYCHOL, V19, P770; Suomi SJ, 1991, NEUROBIOLOGY LEARNIN, P195; Taylor WJ, 1998, CONTEMP TOP LAB ANIM, V37, P47; Thierry B., 2000, Primate Research, V16, P203; Thierry B, 2000, ETHOLOGY, V106, P713, DOI 10.1046/j.1439-0310.2000.00583.x; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; van der Staay FJ, 2006, BRAIN RES REV, V52, P131, DOI 10.1016/j.brainresrev.2006.01.006; Vandeleest JJ, 2011, APPL ANIM BEHAV SCI, V132, P81, DOI 10.1016/j.applanim.2011.02.010; Veen G, 2011, PSYCHIAT RES, V185, P121, DOI 10.1016/j.psychres.2009.07.013; Weatherall D., 2006, USE NONHUMAN PRIMATE; Williamson DE, 2003, BIOL PSYCHIAT, V53, P284, DOI 10.1016/S0006-3223(02)01601-3; Wurbel H, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P86, DOI 10.1079/9780851990040.0086	89	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62141	10.1371/journal.pone.0062141	http://dx.doi.org/10.1371/journal.pone.0062141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23658620	Green Published, gold, Green Submitted			2022-12-27	WOS:000321662800029
J	Tesniere, C; Delobel, P; Pradal, M; Blondin, B				Tesniere, Catherine; Delobel, Pierre; Pradal, Martine; Blondin, Bruno			Impact of Nutrient Imbalance on Wine Alcoholic Fermentations: Nitrogen Excess Enhances Yeast Cell Death in Lipid-Limited Must	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PLASMA-MEMBRANE; SCH9; DESICCATION; TOLERANCE; TREHALOSE; VIABILITY; REVEALS	We evaluated the consequences of nutritional imbalances, particularly lipid/nitrogen imbalances, on wine yeast survival during alcoholic fermentation. We report that lipid limitation (ergosterol limitation in our model) led to a rapid loss of viability during the stationary phase of fermentation and that the cell death rate is strongly modulated by nitrogen availability and nature. Yeast survival was reduced in the presence of excess nitrogen in lipid-limited fermentations. The rapidly dying yeast cells in fermentations in high nitrogen and lipid-limited conditions displayed a lower storage of the carbohydrates trehalose and glycogen than observed in nitrogen-limited cells. We studied the cell stress response using HSP12 promoter-driven GFP expression as a marker, and found that lipid limitation triggered a weaker stress response than nitrogen limitation. We used a SCH9-deleted strain to assess the involvement of nitrogen signalling pathways in the triggering of cell death. Deletion of SCH9 increased yeast viability in the presence of excess nitrogen, indicating that a signalling pathway acting through Sch9p is involved in this nitrogen-triggered cell death. We also show that various nitrogen sources, but not histidine or proline, provoked cell death. Our various findings indicate that lipid limitation does not elicit a transcriptional programme that leads to a stress response protecting yeast cells and that nitrogen excess triggers cell death by modulating this stress response, but not through HSP12. These results reveal a possibly negative role of nitrogen in fermentation, with reported effects referring to ergosterol limitation conditions. These effects should be taken into account in the management of alcoholic fermentations.	[Tesniere, Catherine; Delobel, Pierre; Pradal, Martine; Blondin, Bruno] INRA, UMR1083, F-34060 Montpellier, France; [Tesniere, Catherine; Delobel, Pierre; Pradal, Martine; Blondin, Bruno] SupAgro, UMR1083, Montpellier, France; [Tesniere, Catherine; Delobel, Pierre; Pradal, Martine; Blondin, Bruno] Univ Montpellier I, UMR1083, Montpellier, France	INRAE; Universite de Montpellier; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Universite de Montpellier	Tesniere, C (corresponding author), INRA, UMR1083, F-34060 Montpellier, France.	tesniere@supagro.inra.fr	Tesnière, Catherine/L-8771-2018	Tesnière, Catherine/0000-0003-4865-9229; Delobel, pierre/0000-0002-8770-3192	INRA	INRA	Grants have been obtained from INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Agenbach W. A., 1977, P S AFR SOC EN VIT 2, P66; Alexandre H., 1994, BLOOD CELLS, V146, P11; Ambroset C, 2012, G3, V1, P263; BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4; BELY M, 1990, AM J ENOL VITICULT, V41, P319; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cramer AC, 2002, BIOTECHNOL BIOENG, V77, P49, DOI 10.1002/bit.10133; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Delobel P, 2012, LETT APPL MICROBIOL, V55, P338, DOI 10.1111/j.1472-765X.2012.03301.x; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fornairon-Bonnefond C, 2002, J BIOSCI BIOENG, V93, P176, DOI 10.1263/jbb.93.176; Ge HY, 2010, NUCLEIC ACIDS RES, V38, P143, DOI 10.1093/nar/gkp849; GROAT M, 1978, AM J ENOL VITICULT, V29, P112; Houtman AC, 1986, S AFR J ENOL VITIC, V1, P39; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Lavoie H, 2008, EUKARYOT CELL, V7, P1127, DOI 10.1128/EC.00330-07; Loewith R, 2010, ENZYMES, V27, P147, DOI 10.1016/S1874-6047(10)27009-9; Luparia V, 2004, APPL MICROBIOL BIOT, V65, P25, DOI 10.1007/s00253-003-1549-3; Matecic M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000921; Orozco H, 2012, MECH AGEING DEV, V133, P348, DOI 10.1016/j.mad.2012.03.013; Pacheco A, 2009, MICROBIOL-SGM, V155, P2021, DOI 10.1099/mic.0.025981-0; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rohde JR, 2008, CURR OPIN MICROBIOL, V11, P153, DOI 10.1016/j.mib.2008.02.013; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Rossignol T, 2004, ANAL EXPRESSION GENO; Roustan JL, 2002, BIOTECHNOL LETT, V24, P1059, DOI 10.1023/A:1016078429200; Sablayrolles JM, 2009, FOOD RES INT, V42, P418, DOI 10.1016/j.foodres.2008.12.016; SABLAYROLLES J M, 1987, Biotechnology Techniques, V1, P181; Sales K, 2000, BBA-BIOMEMBRANES, V1463, P267, DOI 10.1016/S0005-2736(99)00215-1; Santos J, 2008, MICROBIOL-SGM, V154, P422, DOI 10.1099/mic.0.2007/011445-0; Santos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037090; Shamrock VJ, 2008, CAN J MICROBIOL, V54, P559, DOI [10.1139/W08-044, 10.1139/w08-044]; Shin CS, 2009, J CELL SCI, V122, P2089, DOI 10.1242/jcs.047191; Smets B, 2008, FEMS YEAST RES, V8, P1276, DOI 10.1111/j.1567-1364.2008.00432.x; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zara G, 2009, FEMS YEAST RES, V9, P217, DOI 10.1111/j.1567-1364.2008.00472.x	50	36	37	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e61645	10.1371/journal.pone.0061645	http://dx.doi.org/10.1371/journal.pone.0061645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658613	Green Published, gold			2022-12-27	WOS:000318343700018
J	Chen, SF; Lin, YS; Jao, SW; Chang, YC; Liu, CL; Lin, YJ; Nieh, S				Chen, Su-Feng; Lin, Yaoh-Shiang; Jao, Shu-Wen; Chang, Yun-Ching; Liu, Chia-Lin; Lin, Yu-Ju; Nieh, Shin			Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROGNOSTIC IMPACT; DRUG-RESISTANCE; BREAST-CANCER; TUMOR-GROWTH; E-CADHERIN; EXPRESSION; CD133; SURVIVAL; OPINION	Background: Metastasis occurs in a series of discrete steps involving invasion, angiogenesis, lymphovascular space permeation, and establishment of secondary tumors. Malignant pleural effusion (MPE), a type of tumor metastasis, is usually a poor prognostic sign for patients with pulmonary adenocarcinoma, although its underlying mechanism has received less attention than other types of metastases have. The objective of the current study was to confirm whether cancer stem cells (CSCs) in MPE contribute to the "metastatic cascade'' through the epithelial - mesenchymal transition (EMT), anoikis, and adaptation in the microenvironment. Methods: Pulmonary tissue and corresponding cell blocks of MPE samples from 20 patients with primary adenocarcinoma were analyzed by immunohistochemical staining with CSC-representative markers (CD133, Nanog, and OCT-4) and EMT-associated markers (E-cadherin and vimentin). Correlations between these variables and clinico-pathological parameters were analyzed. Primary cultures from eight cases of MPE were investigated to characterize the CSC properties, including marker expression, sphere formation, and differentiation. Results: Expressions of CSC-representative markers for 20 cases of MPE cell blocks were quite diverse and variable ranging from 15% to 90%. Stronger expression of CSC-representative markers and alteration of EMT-associated markers were found at the invasive fronts and in MPEs compared with the expression in primary pulmonary tumor tissues. The expression of OCT-4 in MPEs significantly related to distant metastasis and stage, as well as inversely correlated with patient survival. Primary cultures confirmed the CSC properties in MPE. Five of eight cases of MPE yielded adequate cell clusters, which also showed variable expressions of CSC markers in addition to sphere formation and the ability for differentiation and metastasis. Conclusion: This pilot study offers a better understanding of the metastatic cascade. Establishing a model of MPE will provide further insight into the role of CSCs in metastasis and may explain the high therapeutic failure rates for patients with MPE.	[Chen, Su-Feng] China Med Univ, Dept Dent Hyg, Taichung, Taiwan; [Lin, Yaoh-Shiang] Kaohsiung Vet Gen Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Jao, Shu-Wen] Natl Def Med Ctr, Div Colon & Rectal Surg, Taipei, Taiwan; [Jao, Shu-Wen; Chang, Yun-Ching; Liu, Chia-Lin; Lin, Yu-Ju; Nieh, Shin] Triserv Gen Hosp, Taipei, Taiwan; [Chang, Yun-Ching; Liu, Chia-Lin] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Yu-Ju; Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan	China Medical University Taiwan; Kaohsiung Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Nieh, S (corresponding author), Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan.	niehshin1014@yahoo.com.tw	Yang, Xiaohan/AAM-2449-2020; Yang, Xiaohan/A-6975-2011	Yang, Xiaohan/0000-0001-5207-4210; Yang, Xiaohan/0000-0001-5207-4210	National Science Council, Republic of China [NSC100-2320-B-016-009]; Tri-Service General Hospital [TSGH-C101-076]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	This study was partly supported by the National Science Council, Republic of China, Grant Nos. NSC100-2320-B-016-009 and by the Tri-Service General Hospital, Grant No. TSGH-C101-076. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antic T, 2012, DIAGN CYTOPATHOL, V40, P311, DOI 10.1002/dc.21563; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Basak SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005884; Bertrand K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/534139; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen KL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-72; Chen SF, 2007, HISTOPATHOLOGY, V51, P173, DOI 10.1111/j.1365-2559.2007.02755.x; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031864; Cheng DS, 2000, CHEST, V118, P1747, DOI 10.1378/chest.118.6.1747; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Elloul S, 2010, CLIN EXP METASTAS, V27, P161, DOI 10.1007/s10585-010-9315-2; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Guo HS, 2012, ONCOL REP, V27, P880, DOI 10.3892/or.2011.1559; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hackbarth JS, 2010, CLIN BIOCHEM, V43, P1051, DOI 10.1016/j.clinbiochem.2010.05.016; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Hsu IL, 2009, LUNG CANCER, V65, P371, DOI 10.1016/j.lungcan.2008.12.007; Ishigami S, 2010, ANTICANCER RES, V30, P2453; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Mancini R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021320; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; NAGASAWA T, 1983, ACTA CYTOL, V27, P119; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Perona R, 2011, CLIN TRANSL ONCOL, V13, P289, DOI 10.1007/s12094-011-0656-3; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rapp UR, 2008, CELL CYCLE, V7, P45, DOI 10.4161/cc.7.1.5203; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sikora JJ, 2004, CANCER DETECT PREV, V28, P325, DOI 10.1016/j.cdp.2004.04.003; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Thelmo MC, 2010, FETAL PEDIATR PATHOL, V29, P45, DOI 10.3109/15513810903266625; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Wei L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3042; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	53	79	85	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e54659	10.1371/journal.pone.0054659	http://dx.doi.org/10.1371/journal.pone.0054659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	23861841	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000001
J	Oliver, RE; Tinker, NA; Lazo, GR; Chao, SM; Jellen, EN; Carson, ML; Rines, HW; Obert, DE; Lutz, JD; Shackelford, I; Korol, AB; Wight, CP; Gardner, KM; Hattori, J; Beattie, AD; Bjornstad, A; Bonman, JM; Jannink, JL; Sorrells, ME; Brown-Guedira, GL; Fetch, JWM; Harrison, SA; Howarth, CJ; Ibrahim, A; Kolb, FL; McMullen, MS; Murphy, JP; Ohm, HW; Rossnagel, BG; Yan, WK; Miclaus, KJ; Hiller, J; Maughan, PJ; Hulse, RRR; Anderson, JM; Islamovic, E; Jackson, EW				Oliver, Rebekah E.; Tinker, Nicholas A.; Lazo, Gerard R.; Chao, Shiaoman; Jellen, Eric N.; Carson, Martin L.; Rines, Howard W.; Obert, Donald E.; Lutz, Joseph D.; Shackelford, Irene; Korol, Abraham B.; Wight, Charlene P.; Gardner, Kyle M.; Hattori, Jiro; Beattie, Aaron D.; Bjornstad, Asmund; Bonman, J. Michael; Jannink, Jean-Luc; Sorrells, Mark E.; Brown-Guedira, Gina L.; Fetch, Jennifer W. Mitchell; Harrison, Stephen A.; Howarth, Catherine J.; Ibrahim, Amir; Kolb, Frederic L.; McMullen, Michael S.; Murphy, J. Paul; Ohm, Herbert W.; Rossnagel, Brian G.; Yan, Weikai; Miclaus, Kelci J.; Hiller, Jordan; Maughan, Peter J.; Hulse, Rachel R. Redman; Anderson, Joseph M.; Islamovic, Emir; Jackson, Eric W.			SNP Discovery and Chromosome Anchoring Provide the First Physically-Anchored Hexaploid Oat Map and Reveal Synteny with Model Species	PLOS ONE			English	Article							LINKAGE MAP; C-GENOME; MARKERS; IDENTIFICATION; MONOSOMICS; ASSIGNMENT; BARLEY	A physically anchored consensus map is foundational to modern genomics research; however, construction of such a map in oat (Avena sativa L., 2n = 6x = 42) has been hindered by the size and complexity of the genome, the scarcity of robust molecular markers, and the lack of aneuploid stocks. Resources developed in this study include a modified SNP discovery method for complex genomes, a diverse set of oat SNP markers, and a novel chromosome-deficient SNP anchoring strategy. These resources were applied to build the first complete, physically-anchored consensus map of hexaploid oat. Approximately 11,000 high-confidence in silico SNPs were discovered based on nine million inter-varietal sequence reads of genomic and cDNA origin. GoldenGate genotyping of 3,072 SNP assays yielded 1,311 robust markers, of which 985 were mapped in 390 recombinant-inbred lines from six bi-parental mapping populations ranging in size from 49 to 97 progeny. The consensus map included 985 SNPs and 68 previously-published markers, resolving 21 linkage groups with a total map distance of 1,838.8 cM. Consensus linkage groups were assigned to 21 chromosomes using SNP deletion analysis of chromosome-deficient monosomic hybrid stocks. Alignments with sequenced genomes of rice and Brachypodium provide evidence for extensive conservation of genomic regions, and renewed encouragement for orthology-based genomic discovery in this important hexaploid species. These results also provide a framework for high-resolution genetic analysis in oat, and a model for marker development and map construction in other species with complex genomes and limited resources.	[Oliver, Rebekah E.; Lutz, Joseph D.; Jackson, Eric W.] Gen Mills Crop Biosci, Kannapolis, NC USA; [Tinker, Nicholas A.; Wight, Charlene P.; Gardner, Kyle M.; Hattori, Jiro; Yan, Weikai] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada; [Lazo, Gerard R.] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Chao, Shiaoman] USDA ARS, Biosci Res Lab, Fargo, ND 58105 USA; [Jellen, Eric N.; Maughan, Peter J.; Hulse, Rachel R. Redman] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Carson, Martin L.] USDA ARS, Cereal Dis Lab, St Paul, MN USA; [Rines, Howard W.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Obert, Donald E.] Limagrain Cereal Seeds, Lafayette, IN USA; [Shackelford, Irene; Bonman, J. Michael] USDA ARS, Small Grains & Potato Germplasm Res Unit, Aberdeen, ID USA; [Korol, Abraham B.] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Korol, Abraham B.] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Beattie, Aaron D.; Rossnagel, Brian G.] Univ Saskatchewan, Ctr Crop Dev, Dept Plant Sci, Saskatoon, SK S7N 0W0, Canada; [Bjornstad, Asmund; Islamovic, Emir] Norwegian Univ Life Sci, Dept Plant & Environm Sci, As, Norway; [Jannink, Jean-Luc] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Sorrells, Mark E.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Brown-Guedira, Gina L.] N Carolina State Univ, USDA ARS, Eastern Reg Small Grains Genotyping Lab, Raleigh, NC 27695 USA; [Fetch, Jennifer W. Mitchell] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Harrison, Stephen A.] Louisiana State Univ, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA; [Howarth, Catherine J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales; [Ibrahim, Amir] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Kolb, Frederic L.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [McMullen, Michael S.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Murphy, J. Paul] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Ohm, Herbert W.; Anderson, Joseph M.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Miclaus, Kelci J.; Hiller, Jordan] SAS Inst Inc, JMP, Cary, NC USA	Agriculture & Agri Food Canada; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Brigham Young University; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); University of Haifa; University of Haifa; University of Saskatchewan; Norwegian University of Life Sciences; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Agriculture & Agri Food Canada; Louisiana State University System; Louisiana State University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Urbana-Champaign; North Dakota State University Fargo; University of North Carolina; North Carolina State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; SAS Institute Inc	Tinker, NA (corresponding author), Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada.	Nick.Tinker@agr.gc.ca	Lazo, Gerard/A-8900-2009; Jellen, Eric/S-1166-2019; Jellen, Eric/K-4443-2019; Maughan, Peter/G-1600-2013; Columbus, Linda/F-5877-2010	Lazo, Gerard/0000-0002-9160-2052; Jellen, Eric/0000-0002-7906-4845; Jannink, Jean-Luc/0000-0003-4849-628X; Tinker, Nicholas/0000-0002-2452-4779; Brown-Guedira, Gina/0000-0002-1958-2827; Oliver, Ryan/0000-0003-4489-0861; Yan, Weikai/0000-0003-2399-1452; Howarth, Catherine/0000-0001-9364-0880; Bonman, John/0000-0002-7414-044X; Lipfert, Jan/0000-0003-3613-7896; Columbus, Linda/0000-0002-2574-0561	United States Department of Agriculture National Food Research Initiative; North American Millers' Association; Prairie Oat Growers Association, General Mills Inc.; United States Department of Agriculture - Agricultural Research Service CRIS project [301]; Agriculture and Agri-Food Canada; General Mills; Biotechnology and Biological Sciences Research Council [BBS/E/W/10962A01C, BBS/E/W/10962A01D, BBS/E/G/00003012, BB/H009582/1] Funding Source: researchfish; BBSRC [BBS/E/W/10962A01D, BB/H009582/1, BBS/E/W/10962A01C] Funding Source: UKRI	United States Department of Agriculture National Food Research Initiative; North American Millers' Association; Prairie Oat Growers Association, General Mills Inc.; United States Department of Agriculture - Agricultural Research Service CRIS project; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); General Mills; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants from the United States Department of Agriculture National Food Research Initiative, the North American Millers' Association, the Prairie Oat Growers Association, General Mills Inc., the United States Department of Agriculture - Agricultural Research Service CRIS project 301, and by Agriculture and Agri-Food Canada. Scientists REO and EWJ contributed to data collection, decision to publish, and preparation of the manuscript prior to employment at General Mills Inc., and these authors declare that the work presented was not in any way influenced by their current relationship with their employer. Staff scientist JDL from General Mills Inc. engaged in discussions leading to experimental design, and participated in manuscript preparation, but this was entirely limited to scientific input. Author DEO is currently employed at Limagrain Cereal Seeds, but contributed all work except for manuscript revision prior to this employment. Staff Scientists KJM and JH from SAS Institute Inc. contributed scientific input and data analysis. In no other way did the funders play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding from General Mills and the contributions of employees from General Mills, Limagrain and SAS does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; Scientists REO and EWJ contributed to data collection, decision to publish, and preparation of the manuscript prior to employment at General Mills Inc., and these authors declare that the work presented was not in any way influenced by their current relationship with their employer. Staff scientist JDL from General Mills Inc. engaged in discussions leading to experimental design, and participated in manuscript preparation, but this was entirely limited to scientific input. Author DEO is currently employed at Limagrain Cereal Seeds, but contributed all work except for manuscript revision prior to this employment. The funding from General Mills and the contributions of employees from General Mills and Limagrain does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andon MB, 2008, AM J LIFESTYLE MED, V2, P51, DOI [10.1177/1559827607309130., 10.1177/1559827607309130]; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Fox SL, 2001, THEOR APPL GENET, V102, P320, DOI 10.1007/s001220051648; Gutierrez-Gonzalez JJ, 2011, PLANT GENOME-US, V4, P178, DOI 10.3835/plantgenome2011.01.0004; HELENTJARIS T, 1986, P NATL ACAD SCI USA, V83, P6035, DOI 10.1073/pnas.83.16.6035; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Jannink JL, 2005, CROP SCI, V45, P2383, DOI 10.2135/cropsci2005.0285; JELLEN EN, 1993, GENOME, V36, P962, DOI 10.1139/g93-126; JELLEN EN, 1994, GENOME, V37, P613, DOI 10.1139/g94-087; JELLEN EN, 1993, GENOME, V36, P1129, DOI 10.1139/g93-151; Jellen EN, 1997, THEOR APPL GENET, V95, P1190, DOI 10.1007/s001220050680; Jellen EN, 2000, CROP SCI, V40, P256, DOI 10.2135/cropsci2000.401256x; Kianian SF, 1997, GENOME, V40, P386, DOI 10.1139/g97-052; Korol A, 2009, PLANT GENET GENOMICS, V7, P163, DOI 10.1007/978-0-387-77489-3_6; LADIZINSKY G, 1970, HEREDITY, V25, P457, DOI 10.1038/hdy.1970.46; LEGGETT JM, 1995, GENOME, V38, P747, DOI 10.1139/g95-094; Mester DI, 2003, THEOR APPL GENET, V107, P1102, DOI 10.1007/s00122-003-1305-1; Mochida K., 2003, MGG Molecular Genetics and Genomics, V270, P371, DOI 10.1007/s00438-003-0939-7; MORIKAWA T, 1985, THEOR APPL GENET, V70, P271, DOI 10.1007/BF00304911; ODONOUGHUE LS, 1995, GENOME, V38, P368, DOI 10.1139/g95-048; Oliver RE, 2010, GENOME, V53, P458, DOI [10.1139/G10-021, 10.1139/g10-021]; Oliver RE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-77; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Portyanko VA, 2001, GENOME, V44, P249, DOI 10.1139/gen-44-2-249; Rajhathy T., 1974, MISC PUBL GENET SOC, V2, P1; Rickert AM, 2002, BIOTECHNIQUES, V32, P592, DOI 10.2144/02323rr01; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Sanz MJ, 2010, THEOR APPL GENET, V121, P1541, DOI 10.1007/s00122-010-1409-3; SEARS ER, 1969, ANNU REV GENET, V3, P451, DOI 10.1146/annurev.ge.03.120169.002315; Tinker NA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-39; Van Ooijen JW., 2006, JOINMAP 4 SOFTWARE C, V4; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; WERNER JE, 1992, P NATL ACAD SCI USA, V89, P11307, DOI 10.1073/pnas.89.23.11307; Wight CP, 2003, GENOME, V46, P28, DOI [10.1139/g02-099, 10.1139/G02-099]; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yu JK, 2004, GENOME, V47, P805, DOI [10.1139/g04-057, 10.1139/G04-057]	41	99	104	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58068	10.1371/journal.pone.0058068	http://dx.doi.org/10.1371/journal.pone.0058068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533580	Green Submitted, Green Published, gold			2022-12-27	WOS:000316549400017
J	Lu, J; Xin, SC; Meng, H; Veldman, M; Schoenfeld, D; Che, C; Yan, RB; Zhong, HB; Li, S; Lin, S				Lu, Jing; Xin, Shengchang; Meng, Huan; Veldman, Matt; Schoenfeld, David; Che, Chao; Yan, Ruibin; Zhong, Hanbing; Li, Song; Lin, Shuo			A Novel Anti-Tumor Inhibitor Identified by Virtual Screen with PLK1 Structure and Zebrafish Assay	PLOS ONE			English	Article							POLO-LIKE-KINASE; CANCER-CELLS; PROGNOSTIC-SIGNIFICANCE; CENTRIOLE DUPLICATION; EMBRYONIC-DEVELOPMENT; DOWN-REGULATION; DNA-DAMAGE; PROTEIN; EXPRESSION; DROSOPHILA	Polo-like kinase 1 (PLK1), one of the key regulators of mitosis, is a target for cancer therapy due to its abnormally high activity in several tumors. Plk1 is highly conserved and shares a nearly identical 3-D structure between zebrafish and humans. The initial 10 mitoses of zebrafish embryonic cleavages occur every similar to 30 minutes, and therefore provide a rapid assay to evaluate mitosis inhibitors including those targeting Plk1. To increase efficiency and specificity, we first performed a computational virtual screen of similar to 60000 compounds against the human Plk1 3-D structure docked to both its kinase and Polo box domain. 370 candidates with the top free-energy scores were subjected to zebrafish assay and 3 were shown to inhibit cell division. Compared to general screen for compounds inhibiting zebrafish embryonic cleavage, computation increased the efficiency by 11 folds. One of the 3 compounds, named I2, was further demonstrated to effectively inhibit multiple tumor cell proliferation in vitro and PC3 prostate cancer growth in Xenograft mouse model in vivo. Furthermore, I2 inhibited Plk1 enzyme activity in a dose dependent manner. The IC50 values of I2 in these assays are compatible to those of ON-01910, a Plk1 inhibitor currently in Phase III clinic trials. Our studies demonstrate that zebrafish assays coupled with computational screening significantly improves the efficiency of identifying specific regulators of biological targets. The PLK1 inhibitor I2, and its analogs, may have potential in cancer therapeutics.	[Lu, Jing; Xin, Shengchang; Che, Chao; Yan, Ruibin; Zhong, Hanbing; Li, Song; Lin, Shuo] Peking Univ, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Lu, Jing; Meng, Huan; Veldman, Matt; Schoenfeld, David; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Peking University; University Town of Shenzhen; University of California System; University of California Los Angeles	Lin, S (corresponding author), Peking Univ, Shenzhen Grad Sch, Shenzhen, Peoples R China.	shuolin@ucla.edu	WANG, Jiangxin/AFE-8446-2022; Meng, Huan/AAM-1072-2020; Meng, Huan/T-7954-2017; lu, shuhuan/AAV-6927-2020	WANG, Jiangxin/0000-0002-9917-067X; Meng, Huan/0000-0001-8844-3938; Meng, Huan/0000-0001-8844-3938; Che, Chao/0000-0001-7773-0907	National Institutes of Health [DK54508, HL097561, 973-2009CB941203, 973-ZYC201006170364A, JC201005270280A]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was in part supported by research grants from the National Institutes of Health to SL (DK54508 and HL097561) and to ZH/SL (973-2009CB941203, 973-ZYC201006170364A, and JC201005270280A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Andrysik Z, 2010, NUCLEIC ACIDS RES, V38, P2931, DOI 10.1093/nar/gkq011; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Cogswell JP, 2000, CELL GROWTH DIFFER, V11, P615; Eckerdt F, 2006, CANCER RES, V66, P6895, DOI 10.1158/0008-5472.CAN-06-0358; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; HOLTRICH U, 1994, P NATL ACAD SCI USA, V91, P1736, DOI 10.1073/pnas.91.5.1736; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Jeong K, 2010, DEV BIOL, V345, P34, DOI 10.1016/j.ydbio.2010.06.004; Knecht R, 1999, CANCER RES, V59, P2794; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; McInnes C, 2005, CURR TOP MED CHEM, V5, P181, DOI 10.2174/1568026053507660; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; SUNKEL CE, 1988, J CELL SCI, V89, P25; Tan JL, 2011, METHOD CELL BIOL, V105, P493, DOI 10.1016/B978-0-12-381320-6.00021-7; van de Weerdt BCM, 2008, BBA-MOL CELL RES, V1783, P1015, DOI 10.1016/j.bbamcr.2008.02.019; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Wolf G, 1997, ONCOGENE, V14, P543, DOI 10.1038/sj.onc.1200862; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Zhong H, MOL BIOSYST, V6, P1463; Zhong HB, 2010, MOL BIOSYST, V6, P1463, DOI 10.1039/b919743e; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104	39	31	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2013	8	4							e53317	10.1371/journal.pone.0053317	http://dx.doi.org/10.1371/journal.pone.0053317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EF	23658603	Green Published, Green Submitted, gold			2022-12-27	WOS:000318343700001
J	Chen, SY; Huang, X; Yan, XQ; Liang, Y; Wang, YZ; Li, XF; Peng, XJ; Ma, XY; Zhang, LX; Cai, YY; Ma, T; Cheng, LQ; Qi, DM; Zheng, HJ; Yang, XH; Li, XX; Liu, GS				Chen, Shuangyan; Huang, Xin; Yan, Xueqing; Liang, Ye; Wang, Yuezhu; Li, Xiaofeng; Peng, Xianjun; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Ma, Tian; Cheng, Liqin; Qi, Dongmei; Zheng, Huajun; Yang, Xiaohan; Li, Xiaoxia; Liu, Gongshe			Transcriptome Analysis in Sheepgrass (Leymus chinensis): A Dominant Perennial Grass of the Eurasian Steppe	PLOS ONE			English	Article							FREEZING TOLERANCE; SSR-MARKERS; ARABIDOPSIS-THALIANA; COLD-ACCLIMATION; MICROSATELLITE MARKERS; PHYLOGENETIC ANALYSIS; GENOME ANNOTATION; GENE DISCOVERY; SALT TOLERANCE; TRITICEAE	Background: Sheepgrass [Leymus chinensis (Trin.) Tzvel.] is an important perennial forage grass across the Eurasian Steppe and is known for its adaptability to various environmental conditions. However, insufficient data resources in public databases for sheepgrass limited our understanding of the mechanism of environmental adaptations, gene discovery and molecular marker development. Results: The transcriptome of sheepgrass was sequenced using Roche 454 pyrosequencing technology. We assembled 952,328 high-quality reads into 87,214 unigenes, including 32,416 contigs and 54,798 singletons. There were 15,450 contigs over 500 bp in length. BLAST searches of our database against Swiss-Prot and NCBI non-redundant protein sequences (nr) databases resulted in the annotation of 54,584 (62.6%) of the unigenes. Gene Ontology (GO) analysis assigned 89,129 GO term annotations for 17,463 unigenes. We identified 11,675 core Poaceae-specific and 12,811 putative sheepgrass-specific unigenes by BLAST searches against all plant genome and transcriptome databases. A total of 2,979 specific freezing-responsive unigenes were found from this RNAseq dataset. We identified 3,818 EST-SSRs in 3,597 unigenes, and some SSRs contained unigenes that were also candidates for freezing-response genes. Characterizations of nucleotide repeats and dominant motifs of SSRs in sheepgrass were also performed. Similarity and phylogenetic analysis indicated that sheepgrass is closely related to barley and wheat. Conclusions: This research has greatly enriched sheepgrass transcriptome resources. The identified stress-related genes will help us to decipher the genetic basis of the environmental and ecological adaptations of this species and will be used to improve wheat and barley crops through hybridization or genetic transformation. The EST-SSRs reported here will be a valuable resource for future gene-phenotype studies and for the molecular breeding of sheepgrass and other Poaceae species.	[Chen, Shuangyan; Huang, Xin; Yan, Xueqing; Liang, Ye; Li, Xiaofeng; Peng, Xianjun; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Ma, Tian; Cheng, Liqin; Qi, Dongmei; Li, Xiaoxia; Liu, Gongshe] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Huang, Xin; Yan, Xueqing; Liang, Ye; Ma, Xingyong; Zhang, Lexin; Cai, Yueyue; Li, Xiaoxia] Chinese Acad Sci, Grad Schoo1, Beijing, Peoples R China; [Wang, Yuezhu; Zheng, Huajun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Yang, Xiaohan] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; United States Department of Energy (DOE); Oak Ridge National Laboratory	Chen, SY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	sychen@ibcas.ac.cn; lixx258258@163.com; liugs@ibcas.ac.cn	Yang, Xiaohan/AAM-2449-2020; Yang, Xiaohan/A-6975-2011	Yang, Xiaohan/0000-0001-5207-4210; Yang, Xiaohan/0000-0001-5207-4210	National High Technology Research and Development Program of China ("863") [2011AA100209]; National Natural Science Foundation of China [30970291, 31170316]; Key Project of the Chinese Academy of Sciences [KSCX2-EW-J-1]; Project of Ningxia Agricultural Comprehensive Development Office [NNTK-11-04, NTKJ-2012-03]	National High Technology Research and Development Program of China ("863")(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); Project of Ningxia Agricultural Comprehensive Development Office	This work was supported by the National High Technology Research and Development Program of China ("863", 2011AA100209), the National Natural Science Foundation of China (30970291; 31170316), the Key Project of the Chinese Academy of Sciences (KSCX2-EW-J-1), and the Project of Ningxia Agricultural Comprehensive Development Office (NNTK-11-04; NTKJ-2012-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Bai WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012125; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Bushman BS, 2008, GENOME, V51, P779, DOI 10.1139/G08-062; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chen PD, 2005, THEOR APPL GENET, V111, P941, DOI 10.1007/s00122-005-0026-z; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; da Maia LC, 2009, GENET MOL BIOL, V32, P822, DOI 10.1590/S1415-47572009005000091; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Deschamps S, 2010, PLANT GENOME-US, V3, P53, DOI 10.3835/plantgenome2009.09.0026; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Fan X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-247; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; He RF, 2012, AM J BOT, V99, P232, DOI 10.3732/ajb.1100429; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; [马红媛 Hongyuan Ma], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P181; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Jin H, 2006, PLANT SCI, V170, P1081, DOI 10.1016/j.plantsci.2006.01.002; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liu X, 2001, ACTA BOT SIN, V43, P948; Liu ZP, 2008, MOL PHYLOGENET EVOL, V46, P278, DOI 10.1016/j.ympev.2007.10.009; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Ma PD, 2012, APPL BIOCHEM BIOTECH, V166, P479, DOI 10.1007/s12010-011-9443-4; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Niu SL, 2008, J EXP BOT, V59, P1431, DOI 10.1093/jxb/ern051; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Palmer NA, 2012, BIOENERG RES, V5, P649, DOI 10.1007/s12155-011-9171-1; Peng XJ, 2011, PLANT CELL REP, V30, P1493, DOI 10.1007/s00299-011-1058-2; Qi LL, 2008, THEOR APPL GENET, V117, P1155, DOI 10.1007/s00122-008-0853-9; Reyes JC, 2006, CURR OPIN PLANT BIOL, V9, P21, DOI 10.1016/j.pbi.2005.11.010; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sha LN, 2008, BIOCHEM GENET, V46, P605, DOI 10.1007/s10528-008-9175-5; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Subbarao GV, 2007, PLANT SOIL, V299, P55, DOI 10.1007/s11104-007-9360-z; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang LJ, 2009, BIOTECHNOL LETT, V31, P313, DOI 10.1007/s10529-008-9864-5; Wang RZ, 2008, J PLANT GROWTH REGUL, V27, P39, DOI 10.1007/s00344-007-9029-0; WANG RRC, 1994, GENOME, V37, P231, DOI 10.1139/g94-032; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Wang YH, 2007, CLIMATIC CHANGE, V82, P437, DOI 10.1007/s10584-006-9145-z; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Xiong LM, 2002, P NATL ACAD SCI USA, V99, P10899, DOI 10.1073/pnas.162111599; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Xu ZZ, 2009, J EXP BOT, V60, P3737, DOI 10.1093/jxb/erp216; Young ET, 2000, GENETICS, V154, P1053; ZHANG HB, 1991, AM J BOT, V78, P871, DOI 10.2307/2445166; Zhang L, 2010, J ENVIRON QUAL, V39, P251, DOI 10.2134/jeq2009.0109; Zhang WD, 2004, GRASS FORAGE SCI, V59, P180, DOI 10.1111/j.1365-2494.2004.00419.x; Zhou Q, 2008, J GENET GENOMICS, V35, P639, DOI 10.1016/S1673-8527(08)60085-5; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105	88	79	85	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e67974	10.1371/journal.pone.0067974	http://dx.doi.org/10.1371/journal.pone.0067974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861841	gold, Green Published, Green Submitted			2022-12-27	WOS:000323350700067
J	Wang, YL; Wang, YJ; Luan, JB; Yan, GH; Liu, SS; Wang, XW				Wang, Yong-Liang; Wang, Yu-Jun; Luan, Jun-Bo; Yan, Gen-Hong; Liu, Shu-Sheng; Wang, Xiao-Wei			Analysis of the Transcriptional Differences between Indigenous and Invasive Whiteflies Reveals Possible Mechanisms of Whitefly Invasion	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; SUPEROXIDE-DISMUTASE GENE; INSECTICIDE RESISTANCE; ALEYRODIDAE BIOTYPES; B-BIOTYPE; EXPRESSION; DIVERGENCE; ADAPTATION; GENNADIUS; CATALASE	Background: The whitefly Bemisa tabaci is a species complex of more than 31 cryptic species which include some of the most destructive invasive pests of crops worldwide. Among them, Middle East-Asia Minor 1 (MEAM1) and Mediterranean have invaded many countries and displaced the native whitefly species. The successful invasion of the two species is largely due to their wide range of host plants, high resistance to insecticides and remarkable tolerance to environmental stresses. However, the molecular differences between invasive and indigenous whiteflies remain largely unknown. Methodology/Principal Findings: Here the global transcriptional difference between the two invasive whitefly species (MEAM1, MED) and one indigenous whitefly species (Asia II 3) were analyzed using the Illumina sequencing. Our analysis indicated that 2,422 genes between MEAM1 and MED; 3,073 genes between MEAM1 and Asia II 3; and 3,644 genes between MED and Asia II 3 were differentially expressed. Gene Ontology enrichment analysis revealed that the differently expressed genes between the invasive and indigenous whiteflies were significantly enriched in the term of 'oxidoreductase activity'. Pathway enrichment analysis showed that carbohydrate, amino acid and glycerolipid metabolisms were more active in MEAM1 and MED than in Asia II 3, which may contribute to their differences in biological characteristics. Our analysis also illustrated that the majority of genes involved in 'drug metabolic pathway' were expressed at a higher level in MEAM1 and MED than in Asia II 3. Taken together, these results revealed that the genes related to basic metabolism and detoxification were expressed at an elevated level in the invasive whiteflies, which might be responsible for their higher resistance to insecticides and environmental stresses. Conclusions/Significance: The extensive comparison of MEAM1, MED and Asia II 3 gene expression may serve as an invaluable resource for revealing the molecular mechanisms underlying their biological differences and the whitefly invasion.	[Wang, Yong-Liang; Wang, Yu-Jun; Luan, Jun-Bo; Yan, Gen-Hong; Liu, Shu-Sheng; Wang, Xiao-Wei] Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University	Liu, SS (corresponding author), Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China.	shshliu@zju.edu.cn; xwwang@zju.edu.cn	Chen, kewei/P-6304-2015	Chen, kewei/0000-0001-8497-3069	National Natural Science Foundation of China [31272104, 31171848]; National Basic Research Program of China [2009CB119203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	Financial support for this study was provided by the National Natural Science Foundation of China (Project 31272104, 31171848) and the National Basic Research Program of China (Project 2009CB119203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2011, ARCH INSECT BIOCHEM, V78, P104, DOI 10.1002/arch.20444; Alemandri V, 2012, J ECON ENTOMOL, V105, P48, DOI 10.1603/EC11161; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barro P, 2007, AUST J ENTOMOL, V36, P149; BEENAKKE.AM, 1969, J INSECT PHYSIOL, V15, P353, DOI 10.1016/0022-1910(69)90281-9; BOLTER CJ, 1990, PESTIC BIOCHEM PHYS, V36, P52, DOI 10.1016/0048-3575(90)90020-3; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Byrne FJ, 2003, PEST MANAG SCI, V59, P347, DOI 10.1002/ps.649; Carabali A, 2005, CROP PROT, V24, P643, DOI 10.1016/j.cropro.2004.11.008; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Crowder DW, 2011, BASIC APPL ECOL, V12, P685, DOI 10.1016/j.baae.2011.09.007; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Crowder DW, 2010, ANIM BEHAV, V79, P579, DOI 10.1016/j.anbehav.2009.11.025; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; FELTON GW, 1991, J CHEM ECOL, V17, P1715, DOI 10.1007/BF00993724; Fernandez E, 2009, PEST MANAG SCI, V65, P885, DOI 10.1002/ps.1769; Gao XL, 2013, INT J MOL SCI, V14, P871, DOI 10.3390/ijms14010871; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Horowitz AR, 2003, PHYTOPARASITICA, V31, P94, DOI 10.1007/BF02979772; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; LARDY HA, 1969, ANNU REV BIOCHEM, V38, P991, DOI 10.1146/annurev.bi.38.070169.005015; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li JM, 2011, ARCH INSECT BIOCHEM, V77, P118, DOI 10.1002/arch.20428; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Marchioro CA, 2012, AGR FOREST ENTOMOL, V14, P29, DOI 10.1111/j.1461-9563.2011.00548.x; McKenzie CL, 2009, J ECON ENTOMOL, V102, P670, DOI 10.1603/029.102.0227; McKenzie CL, 2012, J ECON ENTOMOL, V105, P753, DOI 10.1603/EC11337; Naranjo Steven E., 2010, P185; Neves CA, 2000, DIS AQUAT ORGAN, V39, P155, DOI 10.3354/dao039155; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Parker JD, 2004, INSECT MOL BIOL, V13, P587, DOI 10.1111/j.0962-1075.2004.00515.x; Parrella G, 2012, J PEST SCI, V85, P227, DOI 10.1007/s10340-012-0417-2; Pavey SA, 2010, ANN NY ACAD SCI, V1206, P110, DOI 10.1111/j.1749-6632.2010.05765.x; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Qiu Bao-Li, 2003, Acta Entomologica Sinica, V46, P605; Rao Q, 2011, B ENTOMOL RES, V101, P81, DOI 10.1017/S0007485310000428; Rao Q, 2012, J INTEGR AGR, V11, P321, DOI 10.1016/S2095-3119(12)60016-1; Shin S, 2012, J EXP BOT, V63, P4731, DOI 10.1093/jxb/ers141; Sun DB, 2013, B ENTOMOL RES, V103, P344, DOI 10.1017/S0007485312000788; Sun W, 2012, INSECT BIOCHEM MOLEC, V42, P935, DOI 10.1016/j.ibmb.2012.09.006; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Wan FH, 2008, J INSECT SCI, V8, P49; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wu XX, 2003, PROG NAT SCI-MATER, V13, P276, DOI 10.1360/03jz9049; Yoo HY, 1999, MOL GEN GENET, V262, P310, DOI 10.1007/s004380051088; Yoshinaga N, 2010, J CHEM ECOL, V36, P319, DOI 10.1007/s10886-010-9764-8; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x; Zang LianSheng, 2005, Biodiversity Science, V13, P181, DOI 10.1360/biodiv.040202	72	13	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62176	10.1371/journal.pone.0062176	http://dx.doi.org/10.1371/journal.pone.0062176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	24015315	gold, Green Submitted, Green Published			2022-12-27	WOS:000319055600017
J	Liu, KC; Ge, W				Liu, Ka-Cheuk; Ge, Wei			Evidence for Gating Roles of Protein Kinase A and Protein Kinase C in Estradiol-Induced Luteinizing Hormone Receptor (lhcgr) Expression in Zebrafish Ovarian Follicle Cells	PLOS ONE			English	Article							MEMBRANE ESTROGEN-RECEPTOR; BRAIN TYROSINE-HYDROXYLASE; NITRIC-OXIDE SYNTHASE; GONADOTROPIN RECEPTORS; GENE-EXPRESSION; MESSENGER-RNA; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL REGULATION; DOWN-REGULATION; UP-REGULATION	Estradiol (E2) stimulates luteinizing hormone receptor (lhcgr) expression in zebrafish follicle cells via nuclear estrogen receptors (nERs) that are likely expressed on the membrane, and lhcgr responds to E2 in a biphasic manner during 24-h treatment. These observations raise an interesting question on the signaling mechanism underlying E2 regulation, in particular the biphasic response of lhcgr expression. In the present study, we demonstrated that E2 regulation of lhcgr was significantly influenced by the activity of cAMP-PKA pathway. Activation of cAMP-PKA pathway by forskolin or db-cAMP suppressed E2-stimulated lhcgr expression in short-term (3 h) but enhanced its effect in long-term (24 h), suggesting differential roles of PKA at these two phases of lhcgr response. PKA inhibitor H89 showed reversed effects. In contrast, PKC pathway had consistent permissive effect on E2-induced lhcgr expression as evidenced by strong inhibition of E2 effect by PKC inhibitors GF109203X and Ro-31-8220 at both 3 and 24 h. One of the mechanisms by which PKA and PKC gated E2 effect might be through regulating nERs, particularly esr2a. Despite the strong influence of PKA and PKC, our data did not suggest direct mediating roles for these two pathways in E2 stimulation of lhcgr expression; yet they likely play critical gating roles in E2 signal transduction. As a follow-up study to our previous report on E2 regulation of gonadotropin receptors in the zebrafish ovary, the present study provides further evidence for the involvement of classical intracellular signal transduction pathways in E2 stimulation of lhcgr expression in the follicle cells.	[Ge, Wei] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Ctr Cell & Dev Biol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Ge, W (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	weige@cuhk.edu.hk	Ma, Miaojun/E-1320-2012	Ma, Miaojun/0000-0001-7046-9574; Liu, Kun/0000-0001-9127-053X; Liu, Ka Cheuk/0000-0001-6082-8801	Research Grants Council [CUHK464707, 464308, 464409]; Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	Research Grants Council(Hong Kong Research Grants Council); Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	The work was substantially supported by grants from the Research Grants Council (CUHK464707, 464308 and 464409) and the Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region to W.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's website: http://www.ugc.edu.hk/eng/rgc/grf/grf.htm	Amsterdam A, 2002, MOL CELL ENDOCRINOL, V187, P69, DOI 10.1016/S0303-7207(01)00701-8; Burns KH, 2002, ENDOCRINOLOGY, V143, P2823, DOI 10.1210/en.143.8.2823; Byers M, 1997, MOL ENDOCRINOL, V11, P172, DOI 10.1210/me.11.2.172; Caiazza F, 2007, BIOCHEM BIOPH RES CO, V359, P102, DOI 10.1016/j.bbrc.2007.05.059; CATT KJ, 1991, J BIOENERG BIOMEMBR, V23, P7; Chaube R, 2005, J NEUROENDOCRINOL, V17, P91, DOI 10.1111/j.1365-2826.2005.01282.x; Chaube R, 2005, GEN COMP ENDOCR, V141, P116, DOI 10.1016/j.ygcen.2004.12.010; Chen DB, 2004, ENDOCRINOLOGY, V145, P113, DOI 10.1210/en.2003-0547; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; Chen LH, 2011, CELL SIGNAL, V23, P497, DOI 10.1016/j.cellsig.2010.11.005; Chiang CH, 2000, J CLIN ENDOCR METAB, V85, P3828, DOI 10.1210/jc.85.10.3828; De Marinis YZ, 2010, DIABETOLOGIA, V53, P717, DOI 10.1007/s00125-009-1635-x; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; De Servi B, 2005, ONCOGENE, V24, P4946, DOI 10.1038/sj.onc.1208676; Dewing P, 2008, ENDOCRINOLOGY, V149, P5934, DOI 10.1210/en.2008-0847; Hatae J, 2009, J PHYSIOL SCI, V59, P181, DOI 10.1007/s12576-009-0023-0; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Jaubert AM, 2007, ENDOCRINOLOGY, V148, P2444, DOI 10.1210/en.2006-1329; Jeng SR, 2007, GEN COMP ENDOCR, V154, P161, DOI 10.1016/j.ygcen.2007.05.026; Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117; Kobayashi T, 2008, GEN COMP ENDOCR, V156, P595, DOI 10.1016/j.ygcen.2008.02.010; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; Le HH, 2010, ENDOCRINOLOGY, V151, P5689, DOI 10.1210/en.2010-0710; Lee MY, 2008, CELL RES, V18, P491, DOI 10.1038/cr.2008.42; LEUNG PCK, 1992, ENDOCR REV, V13, P476, DOI 10.1210/er.13.3.476; Levin ER, 2011, MOL ENDOCRINOL, V25, P377, DOI 10.1210/me.2010-0284; Li CW, 2012, GEN COMP ENDOCR, V176, P420, DOI 10.1016/j.ygcen.2011.12.032; Liu KC, 2013, GEN COMP ENDOCR, V181, P288, DOI 10.1016/j.ygcen.2012.07.032; Liu KC, 2011, ENDOCRINOLOGY, V152, P4418, DOI 10.1210/en.2011-1065; Liu XC, 2009, BIOL REPROD, V80, P1253, DOI 10.1095/biolreprod.108.070250; Longo M, 2006, J MOL ENDOCRINOL, V37, P489, DOI 10.1677/jme.1.02055; Lucas TF, 2008, BIOL REPROD, V78, P101; Luckenbach JA, 2011, GEN COMP ENDOCR, V171, P52, DOI 10.1016/j.ygcen.2010.12.016; Maharjan S, 2010, J NEUROCHEM, V112, P42, DOI 10.1111/j.1471-4159.2009.06430.x; Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013; Menon B, 2011, MOL ENDOCRINOL, V25, P282, DOI 10.1210/me.2010-0366; Menuet A, 2004, J MOL ENDOCRINOL, V32, P975, DOI 10.1677/jme.0.0320975; Mhyre AJ, 2006, ENDOCRINOLOGY, V147, P1796, DOI 10.1210/en.2005-1316; MIGLIACCIO S, 1993, MOL ENDOCRINOL, V7, P1133, DOI 10.1210/me.7.9.1133; Migliaccio S, 1998, STEROIDS, V63, P352, DOI 10.1016/S0039-128X(98)00040-3; Migliaccio S, 1998, ENDOCRINOLOGY, V139, P4598, DOI 10.1210/en.139.11.4598; Mize AL, 2002, NEUROENDOCRINOLOGY, V76, P339, DOI 10.1159/000067583; Nelson ER, 2007, MOL REPROD DEV, V74, P1105, DOI 10.1002/mrd.20634; Nelson ER, 2010, ENDOCRINOLOGY, V151, P1668, DOI 10.1210/en.2009-1447; Oba Y, 1999, BIOCHEM BIOPH RES CO, V263, P584, DOI 10.1006/bbrc.1999.1346; Oba Y, 1999, BIOCHEM BIOPH RES CO, V265, P366, DOI 10.1006/bbrc.1999.1700; Pang Y, 2008, ENDOCRINOLOGY, V149, P3410, DOI 10.1210/en.2007-1663; Pang YF, 2010, DEV BIOL, V342, P194, DOI 10.1016/j.ydbio.2010.03.027; Pang YF, 2009, GEN COMP ENDOCR, V161, P58, DOI 10.1016/j.ygcen.2008.10.003; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pinzone JJ, 2004, MOL CELL BIOL, V24, P4605, DOI 10.1128/MCB.24.11.4605-4612.2004; Qiu J, 2003, J NEUROSCI, V23, P9529; Radice S, 2004, CHEM-BIOL INTERACT, V147, P185, DOI 10.1016/j.cbi.2003.12.006; REE AH, 1992, ENDOCRINOLOGY, V131, P1810, DOI 10.1210/en.131.4.1810; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; SACEDA M, 1991, J BIOL CHEM, V266, P17809; Sheldahl LC, 2008, NEUROSCIENCE, V153, P751, DOI 10.1016/j.neuroscience.2008.02.035; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Soverchia L, 2005, TOXICOL APPL PHARM, V209, P236, DOI 10.1016/j.taap.2005.04.013; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Tischkau SA, 2000, J NEUROSCI, V20, P7830; Tonetti DA, 2000, BRIT J CANCER, V83, P782, DOI 10.1054/bjoc.2000.1326; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Zhang CG, 2010, ENDOCRINOLOGY, V151, P4477, DOI 10.1210/en.2010-0177; Zhang HH, 2010, ENDOCRINOLOGY, V151, P3874, DOI 10.1210/en.2009-1356; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031; Zhang ZG, 2002, BIOCHEM BIOPH RES CO, V294, P926, DOI 10.1016/S0006-291X(02)00348-0; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Zhou R, 2011, BIOL REPROD, V85, P615, DOI 10.1095/biolreprod.111.091884	75	26	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62524	10.1371/journal.pone.0062524	http://dx.doi.org/10.1371/journal.pone.0062524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658740	gold, Green Submitted, Green Published			2022-12-27	WOS:000321202100014
J	He, ZY; Xiong, LP; Han, S; Chen, AX; Qiu, JW; Fu, XS				He Zhongyi; Xiong Liping; Han Sheng; Chen Aixi; Qiu Jianwei; Fu Xisheng			Tribological and Antioxidation Synergistic Effect Study of Sulfonate-Modified Nano Calcium Carbonate	PLOS ONE			English	Article							CACO3 NANOPARTICLES	A middle base number sulphonate-modified nano calcium carbonate (SMC) with an average size of 35 nm was synthesized, and its tribological and antioxidation synergistic behaviors with ashless antioxidant N-phenyl-alpha-naphthylamine (T531) in hydrogenated oil (5Cst) were evaluated. The results demonstrate that adding this synethesized additive even at a low amount (<2.0 wt.%) can evidently improve its load-carrying capacity by 1.5 times and enhance its antiwear performance; in addition, the friction-reducing effect of additive in the high load was better than that in low load. The SMC have a good synergistic antioxidation effect with T531, which verifies the nano calcium carbonate compound was a kind of multifunctional and high-performance additive. The chemical composition of the rubbing surface which formed on the boundary film was analyzed by using scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS). The results indicating that the excellent antiwear and load-carrying performance could be attributed to the forming of boundary lubrication film which composed of calcium carbonate, oxides, ferrites, sulphide and FeSO4, and so on. Its ability to increase oxidation free energy of base oil is the main reason for increasing its antioxidant collaboration property with ashless antioxidant T531.	[He Zhongyi; Xiong Liping; Chen Aixi] East China Jiaotong Univ, Sch Basic Sci, Nanchang, Peoples R China; [He Zhongyi; Han Sheng] Shanghai Inst Technol, Shanghai, Peoples R China; [Qiu Jianwei; Fu Xisheng] PetroChina Lanzhou Lubricating Oil R&D Inst, Lanzhou, Peoples R China	East China Jiaotong University; Shanghai Institute of Technology; China National Petroleum Corporation	He, ZY (corresponding author), East China Jiaotong Univ, Sch Basic Sci, Nanchang, Peoples R China.	zhongyihe@yahoo.com.cn		Thomas, Stacey/0000-0002-5666-4311	Chinese Natural Science Foundation [21163006]; Jiangxi Provincial Natural Science Foundation [20122BAB203011]	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Natural Science Foundation	The work reported here was sponsored by Chinese Natural Science Foundation (No: 21163006); Jiangxi Provincial Natural Science Foundation (No: 20122BAB203011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakunin VN, 2004, J NANOPART RES, V6, P273, DOI 10.1023/B:NANO.0000034720.79452.e3; Battez AH, 2008, WEAR, V265, P422, DOI 10.1016/j.wear.2007.11.013; Chen H, 2008, WEAR, V265, P1504, DOI 10.1016/j.wear.2008.02.034; FIERRO G, 1989, CORROSION, V45, P814, DOI 10.5006/1.3584988; Fu X, 1996, LUBR SCI, V8, P269; GIASSON S, 1994, THIN SOLID FILMS, V252, P111, DOI 10.1016/0040-6090(94)90782-X; He ZY, 2011, MATER SCI FORUM, V694, P98, DOI 10.4028/www.scientific.net/MSF.694.98; Hu HQ, 2008, TRIBOL INT, V41, P549, DOI 10.1016/j.triboint.2007.11.020; Ji XB, 2011, TRIBOL LETT, V41, P113, DOI 10.1007/s11249-010-9688-z; Jin DL, 2008, MATER LETT, V62, P1565, DOI 10.1016/j.matlet.2007.09.023; [李久盛 LI Jiusheng], 2008, [分析科学学报, Journal of Analytical Science], V24, P189; Li T, 2010, LUBES FUELS, V20, P30; Michael TC, 2006, TRIBOL T, V592, P49; Wager C. D., 1979, HDB XRAY PHOTOELECTR; Wang LB, 2007, TRIBOL INT, V40, P1179, DOI 10.1016/j.triboint.2006.12.003; Xiangdong S, 2004, LUBR ENG, V164, P92; Xiong LP, 2011, LUBR SCI, V23, P33, DOI 10.1002/ls.139; Yao JB, 1996, TRIBOL T, V39, P498, DOI 10.1080/10402009608983559; Yao W, 2007, LUBRICATING OIL, V22, P1; Yu HL, 2008, SURF COAT TECH, V203, P28, DOI 10.1016/j.surfcoat.2008.07.032; Zhang M, 2009, TRIBOL INT, V42, P1029, DOI 10.1016/j.triboint.2009.02.012	21	16	18	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62050	10.1371/journal.pone.0062050	http://dx.doi.org/10.1371/journal.pone.0062050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658705	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100005
J	Lu, SH; Wang, JX; Ma, Q; Yang, J; Li, X; Yuan, YJ				Lu, Shuhuan; Wang, Jiangxin; Ma, Qian; Yang, Jie; Li, Xia; Yuan, Ying-Jin			Phospholipid Metabolism in an Industry Microalga Chlorella sorokiniana: The Impact of Inoculum Sizes	PLOS ONE			English	Article							LIPID CLASS COMPOSITION; BIODIESEL PRODUCTION; FATTY-ACID; CHAIN UNSATURATION; ENDOTHELIAL-CELLS; PHOTOSYSTEM-II; PHOSPHATIDYLGLYCEROL; CHLAMYDOMONAS; ACCUMULATION; PATHWAYS	Chlorella sorokiniana is an important industry microalga potential for biofuel production. Inoculum size is one of the important factors in algal large-scale culture, and has great effects on the growth, lipid accumulation and metabolism of microalgae. As the first barrier of cell contents, membrane plays a vital role in algal inoculum-related metabolism. The knowledge of phospholipids, the main membrane component and high accumulation of phospholipids as the major content of total lipids mass in some microalgae, is necessary to understand the role of membrane in cell growth and metabolism under different inoculum density. Profiling of C. sorokiniana phospholipids with LC-MS led to the identification of 119 phospholipid species. To discover the phospholipid molecules most related to change of inoculum sizes, Partial Least Squares Discriminant Analysis (PLS-DA) was employed and the results revealed that inoculum sizes significantly affected phospholipid profiling. Phosphatidylglycerol (PG), phosphatidyl-ethanolamine (PE) and several phosphatidylcholine (PC) species might play an important role under our experimental conditions. Further analysis of these biomarkers indicated that cell membrane status of C. sorokiniana might play an important role in the adaption to the inoculum sizes. And the culture with inoculum size of 1x10(6) cells mL(-1) presented the best membrane status with the highest content of PC and PG, and the lowest content of PE. We discovered that the inoculum size of 1x10(6) cells mL(-1) might provide the best growth condition for C. sorokiniana. Also we proposed that PG, PE and several PC may play an important role in inoculum-related metabolism in C. sorokiniana, which may work through thylakoid membrane and photosynthetic pathway. Thus this study would provide more potential targets for metabolic engineering to improve biofuel production and productivity in microalgae.	[Lu, Shuhuan; Wang, Jiangxin; Ma, Qian; Yang, Jie; Li, Xia; Yuan, Ying-Jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Lu, Shuhuan; Wang, Jiangxin; Ma, Qian; Yang, Jie; Li, Xia; Yuan, Ying-Jin] Tianjin Univ, Sch Chem Engn & Technol, Dept Pharmaceut Engn, Tianjin 300072, Peoples R China; [Lu, Shuhuan] CABIO Bioengn Wuhan Co Ltd, Wuhan, Hubei, Peoples R China	Tianjin University; Tianjin University	Yuan, YJ (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	WANG, Jiangxin/AFE-8446-2022; Meng, Huan/AAM-1072-2020; Meng, Huan/T-7954-2017; lu, shuhuan/AAV-6927-2020	WANG, Jiangxin/0000-0002-9917-067X; Meng, Huan/0000-0001-8844-3938; Meng, Huan/0000-0001-8844-3938; Che, Chao/0000-0001-7773-0907	National Basic Research Program of China ("973" Program) [2013CB733601]; National High Technology Research and Development Program of China ("863" Program) [2012AA02A701]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097561] Funding Source: NIH RePORTER	National Basic Research Program of China ("973" Program)(National Basic Research Program of China); National High Technology Research and Development Program of China ("863" Program)(National High Technology Research and Development Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful for the financial support from the National Basic Research Program of China ("973" Program: 2013CB733601), and the National High Technology Research and Development Program of China ("863" Program: 2012AA02A701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisz SA, 2011, J LIPID RES, V52, P2012, DOI 10.1194/jlr.M016873; Ballottari M, 2011, BIOCHIM BIOPHYS ACTA, V1817, P143; Beal CM, 2013, RENEW ENERG, V50, P86, DOI 10.1016/j.renene.2012.06.027; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; Bumbak F, 2011, APPL MICROBIOL BIOT, V91, P31, DOI 10.1007/s00253-011-3311-6; Carswell H, 2012, BRIT J PHARMACOL, V90, P175; Cengiz EI, 2012, TURK J FISH AQUAT SC, V12, P31, DOI 10.4194/1303-2712-v12_1_05; Chen GQ, 2008, FOOD CHEM, V109, P88, DOI 10.1016/j.foodchem.2007.12.022; Chen GQ, 2007, FOOD CHEM, V104, P1580, DOI 10.1016/j.foodchem.2007.03.008; Chen L, 2012, BIORESOURCE TECHNOL, V111, P208, DOI 10.1016/j.biortech.2012.02.033; Chiou SY, 2001, J BIOTECHNOL, V85, P247, DOI 10.1016/S0168-1656(00)00346-1; Cuaresma M, 2009, BIOTECHNOL BIOENG, V104, P352, DOI 10.1002/bit.22394; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; Deng XD, 2009, AFR J MICROBIOL RES, V3, P1008; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Goncharova SN, 2004, RUSS J PLANT PHYSL+, V51, P169, DOI 10.1023/B:RUPP.0000019209.10747.9d; Guschina IA, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2_1; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; He H, 2011, ENERG FUEL, V25, P4770, DOI 10.1021/ef201061J; Ivanov AG, 2012, BBA-BIOENERGETICS, V1817, P1374, DOI 10.1016/j.bbabio.2012.03.010; Johnson MB, 2010, APPL MICROBIOL BIOT, V85, P525, DOI 10.1007/s00253-009-2133-2; Johnson MB, 2009, ENERG FUEL, V23, P5179, DOI 10.1021/ef900704h; Joyard J, 2010, PROG LIPID RES, V49, P128, DOI 10.1016/j.plipres.2009.10.003; Kacka A, 2008, BIORESOURCE TECHNOL, V99, P8348, DOI 10.1016/j.biortech.2008.02.042; Khandelia H, 2009, BIOPHYS J, V96, P2734, DOI 10.1016/j.bpj.2009.01.007; Kubota H, 2010, BBA-BIOENERGETICS, V1797, P98, DOI 10.1016/j.bbabio.2009.09.001; Lei AP, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-18; Li XF, 2007, BIOTECHNOL BIOENG, V98, P764, DOI 10.1002/bit.21489; Li Y, 2011, ALGAE BIOFUELS; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; Li YC, 2012, BIOTECHNOL BIOENG, V109, P2222, DOI 10.1002/bit.24491; Lin S, 2011, GENE, V473, P139, DOI 10.1016/j.gene.2010.11.011; Lin WC, 2007, BIOPHYS J, V92, P2831, DOI 10.1529/biophysj.106.095422; Liu J, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-68; Lu N, 2012, EUR J LIPID SCI TECH, V114, P253, DOI 10.1002/ejlt.201100248; Lu SH, 2012, BIOTECHNOL BIOENG, V109, P1651, DOI 10.1002/bit.24447; Ma Q, 2013, BIOTECHNOL BIOENG, V110, P773, DOI 10.1002/bit.24762; Mock T, 2002, PHYTOCHEMISTRY, V61, P53, DOI 10.1016/S0031-9422(02)00215-7; Morita M, 2002, BIOTECHNOL BIOENG, V77, P155, DOI 10.1002/bit.10119; Muradyan EA, 2004, RUSS J PLANT PHYSL+, V51, P53, DOI 10.1023/B:RUPP.0000011303.11957.48; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; Pienkos PT, 2009, BIOFUEL BIOPROD BIOR, V3, P431, DOI 10.1002/bbb.159; Pineau B, 2004, EUR J BIOCHEM, V271, P329, DOI 10.1046/j.1432-1033.2003.03931.x; Prinetti A, 2009, BBA-BIOMEMBRANES, V1788, P184, DOI 10.1016/j.bbamem.2008.09.001; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Sakamoto A, 2004, PLANT CELL ENVIRON, V27, P99, DOI 10.1046/j.0016-8025.2003.01131.x; Salvador GA, 2002, J NEUROSCI RES, V70, P283, DOI 10.1002/jnr.10385; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Singh NK, 2011, AGRON SUSTAIN DEV, V31, P605, DOI 10.1007/s13593-011-0018-0; Soh L, 2011, GREEN CHEM, V13, P1422, DOI 10.1039/c1gc15068e; Stephenson AL, 2010, BIOFUELS-UK, V1, P47, DOI 10.4155/BFS.09.1; Sun XL, 2011, PLANT CELL REP, V30, P1939, DOI 10.1007/s00299-011-1102-2; Tian HC, 2010, APPL MICROBIOL BIOT, V87, P1507, DOI 10.1007/s00253-010-2615-2; Van Gerpen J, 2005, FUEL PROCESS TECHNOL, V86, P1097, DOI 10.1016/j.fuproc.2004.11.005; Wada H, 2010, LIPIDS PHOTOSYNTHESI, P243; Wang JX, 2009, PLANTA, V230, P191, DOI 10.1007/s00425-009-0932-4; Wang L, 2010, BIORESOURCE TECHNOL, V101, P2623, DOI 10.1016/j.biortech.2009.10.062; Wu ZC, 2012, BIORESOURCE TECHNOL, V110, P496, DOI 10.1016/j.biortech.2012.01.101; Wyatt NB, 2012, BIOTECHNOL BIOENG, V109, P493, DOI 10.1002/bit.23319; Yang FX, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-13; Yang J, 2012, OMICS, V16, P374, DOI 10.1089/omi.2011.0127; Yang J, 2012, MOL BIOSYST, V8, P1789, DOI 10.1039/c2mb05510d; Yang J, 2011, MOL BIOSYST, V7, P2428, DOI 10.1039/c1mb00002k; Yang S, 2008, BBA-MOL CELL BIOL L, V1781, P123, DOI 10.1016/j.bbalip.2007.11.005; Yang S, 2007, BBA-MOL CELL BIOL L, V1771, P600, DOI 10.1016/j.bbalip.2007.02.011; Yang S, 2009, CHEM PHYS LIPIDS, V159, P13, DOI 10.1016/j.chemphyslip.2009.02.004; Yoshioka M, 2012, AQUACULTURE, V338, P111, DOI 10.1016/j.aquaculture.2012.01.005; Yu B, 2003, PLANT J, V36, P762, DOI 10.1046/j.1365-313X.2003.01918.x; Zhang CF, 2010, FOOD CHEM, V120, P864, DOI 10.1016/j.foodchem.2009.11.029; Zhao LY, 2004, J COLLOID INTERF SCI, V274, P55, DOI 10.1016/j.jcis.2003.12.009; Zhu L, 2012, BIOCHEM CELL BIOL, V90, P188, DOI [10.1139/O11-081, 10.1139/o11-081]	75	31	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e70827	10.1371/journal.pone.0070827	http://dx.doi.org/10.1371/journal.pone.0070827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23658603	Green Submitted, Green Published, gold			2022-12-27	WOS:000324465000140
J	Chang, CL; Mills, GD; Karalus, NC; Jennings, LC; Laing, R; Murdoch, DR; Chambers, ST; Vettise, D; Tuffery, CM; Hancox, RJ				Chang, Catherina L.; Mills, Graham D.; Karalus, Noel C.; Jennings, Lance C.; Laing, Richard; Murdoch, David R.; Chambers, Stephen T.; Vettise, Dominic; Tuffery, Christine M.; Hancox, Robert J.			Biomarkers of Cardiac Dysfunction and Mortality from Community-Acquired Pneumonia in Adults	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; ACUTE PULMONARY-EMBOLISM; HOSPITALIZED-PATIENTS; RISK STRATIFICATION; PROGNOSTIC VALUE; PREDICTION RULE; TERM MORTALITY; DISEASE; MARKER; COMPLICATIONS	Background: Cardiac dysfunction is common in acute respiratory diseases and may influence prognosis. We hypothesised that blood levels of N-terminal B-type natriuretic peptide (NT-proBNP) and high-sensitivity Troponin T would predict mortality in adults with community-acquired pneumonia. Methods and Findings: A prospective cohort of 474 consecutive patients admitted with community-acquired pneumonia to two New Zealand hospitals over one year. Blood taken on admission was available for 453 patients and was analysed for NT-proBNP and Troponin T. Elevated levels of NT-proBNP (>220 pmol/L) were present in 148 (33%) and 86 (19%) of these patients respectively. Among the 26 patients who died within 30 days of admission, 23 (89%) had a raised NT-proBNP and 14 (53%) had a raised Troponin T level on admission compared to 125 (29%) and 72 (17%) of the 427 who survived (p values<0.001). Both NT-proBNP and Troponin T predicted 30-day mortality in age-adjusted analysis but after mutual adjustment for the other cardiac biomarker and the Pneumonia Severity Index, a raised N-terminal pro-brain natriuretic peptide remained a predictor of 30-day mortality (OR = 5.3, 95% CI 1.4-19.8, p = 0.013) but Troponin T did not (OR = 1.3, 95% CI 0.5-3.2, p = 0.630). The areas under the receiver-operating curves to predict 30-day mortality were similar for NT-proBNP (0.88) and the Pneumonia Severity Index (0.87). Conclusions: Elevated N-terminal B-type natriuretic peptide is a strong predictor of mortality from community-acquired pneumonia independent of clinical prognostic indicators. The pathophysiological basis for this is unknown but suggests that cardiac involvement may be an under-recognised determinant of outcome in pneumonia and may require a different approach to treatment. In the meantime, measurement of B-type natriuretic peptides may help to assess prognosis.	[Chang, Catherina L.; Mills, Graham D.; Karalus, Noel C.; Vettise, Dominic; Tuffery, Christine M.; Hancox, Robert J.] Waikato Hosp, Dept Resp Med, Hamilton, New Zealand; [Mills, Graham D.] Waikato Hosp, Dept Gen Med, Hamilton, New Zealand; [Jennings, Lance C.; Murdoch, David R.] Canterbury Hlth Labs, Christchurch, New Zealand; [Jennings, Lance C.; Murdoch, David R.; Chambers, Stephen T.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Laing, Richard] Canterbury Dist Hlth Board, Canterbury Resp Serv, Christchurch, New Zealand; [Hancox, Robert J.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	Waikato Hospital; Waikato Hospital; Canterbury Health Laboratories; University of Otago; University of Otago	Hancox, RJ (corresponding author), Waikato Hosp, Dept Resp Med, Hamilton, New Zealand.	bob.hancox@otago.ac.nz	Murdoch, David/A-2012-2009	Lee, Gon-Ann/0000-0001-8433-8268; Chambers, Stephen/0000-0002-0698-3285	Health Research Council of New Zealand [00/349]; Waikato Respiratory Research Fund; NZ Heart Foundation summer studentship via the Waikato Clinical School, University of Auckland	Health Research Council of New Zealand(Health Research Council of New Zealand); Waikato Respiratory Research Fund; NZ Heart Foundation summer studentship via the Waikato Clinical School, University of Auckland	The pneumonia cohort was funded by the Health Research Council of New Zealand, grant 00/349 (http://www.hrc.govt.nz/). Analysis of the cardiac biomarkers for this report was funded internally by the Waikato Respiratory Research Fund. Dominic Vettise was supported by a NZ Heart Foundation summer studentship via the Waikato Clinical School, University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Chang CL, 2011, THORAX, V66, P764, DOI 10.1136/thx.2010.155333; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Christ-Crain M, 2008, J INTERN MED, V264, P166, DOI 10.1111/j.1365-2796.2008.01934.x; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Corrales-Medina VF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001048; Espana PP, 2006, AM J RESP CRIT CARE, V174, P1249, DOI 10.1164/rccm.200602-177OC; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Goritsas C, 2010, EUR J EMERG MED, V17, P293, DOI 10.1097/MEJ.0b013e328332354b; Ilva TJ, 2010, J EMERG MED, V38, P1, DOI 10.1016/j.jemermed.2007.09.060; Ishii J, 2000, CLIN CHIM ACTA, V301, P19, DOI 10.1016/S0009-8981(00)00312-0; Jeong KY, 2011, EMERG MED J, V28, P122, DOI 10.1136/emj.2009.089383; Jimenez D, 2009, CHEST, V136, P974, DOI 10.1378/chest.09-0608; Kucher N, 2003, CIRCULATION, V107, P2545, DOI 10.1161/01.CIR.0000074039.45523.BE; Laing R, 2001, NEW ZEAL MED J, V114, P488; Leuchte HH, 2006, AM J RESP CRIT CARE, V173, P744, DOI 10.1164/rccm.200510-1545OC; Leuchte HH, 2004, J AM COLL CARDIOL, V43, P764, DOI 10.1016/j.jacc.2003.09.051; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Maeder M, 2006, CHEST, V129, P1349, DOI 10.1378/chest.129.5.1349; Mandal P, 2011, QJM-INT J MED, V104, P489, DOI 10.1093/qjmed/hcq247; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Moammar MQ, 2010, HEART LUNG CIRC, V19, P90, DOI 10.1016/j.hlc.2009.08.009; Nagaya N, 2000, CIRCULATION, V102, P865; Nowak A, 2012, CHEST, V141, P974, DOI 10.1378/chest.11-0824; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Singanayagam A, 2012, EUR RESPIR J, V39, P187, DOI 10.1183/09031936.00049111; Tulevski II, 2001, THROMB HAEMOSTASIS, V86, P1193, DOI 10.1055/s-0037-1616050; Viasus D, 2013, J INFECTION, V66, P27, DOI 10.1016/j.jinf.2012.09.003; WOODHEAD MA, 1987, LANCET, V1, P671	30	55	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62612	10.1371/journal.pone.0062612	http://dx.doi.org/10.1371/journal.pone.0062612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667500	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700051
J	Yang, DY; Baumgartner, RN; Slattery, ML; Wang, CX; Giuliano, AR; Murtaugh, MA; Risendal, BC; Byers, T; Baumgartner, KB				Yang, Dongyan; Baumgartner, Richard N.; Slattery, Martha L.; Wang, Chenxi; Giuliano, Anna R.; Murtaugh, Maureen A.; Risendal, Betsy C.; Byers, Tim; Baumgartner, Kathy B.			Dietary Intake of Folate, B-Vitamins and Methionine and Breast Cancer Risk among Hispanic and Non-Hispanic White Women	PLOS ONE			English	Article							ONE-CARBON METABOLISM; SOUTHWESTERN UNITED-STATES; ESTROGEN-RECEPTOR STATUS; MTHFR POLYMORPHISMS; BODY-SIZE; POSTMENOPAUSAL WOMEN; GENE POLYMORPHISMS; COLON-CANCER; ALCOHOL; NUTRIENTS	Background: Low dietary folate intake is associated with several neoplasias, but reports are inconsistent for breast cancer. Additionally, the association of folate with breast cancer estrogen receptor (ER) status is not well established. Objective: To determine if dietary intakes of folate, B-vitamins (B-2, B-6, B-12) and methionine are associated with breast cancer risk and ER status in Hispanic, and non-Hispanic White women in the southwestern US. Materials and Methods: Primary breast cancer cases (n = 2,325) in the 4-Corners region (Arizona, Colorado, New Mexico and Utah), diagnosed between October 1999 and May 2004, were identified through state cancer registries. Controls (n = 2,525) were frequency-matched by ethnicity and age (+/- 5 years). Dietary intake, physical activity and other exposures were assessed using in-person interviews. Risk was assessed through multivariable and multinomial logistic regression with adjustment for relevant covariates. Result: While there was no overall association with breast cancer, the highest quartile of folate intake was marginally inversely associated with ER- breast cancer (Odds Ratio (OR) = 0.50, 95% CI 0.25-1.00, p for trend = 0.07). Vitamin B-12 intake was inversely associated with breast cancer also (OR = 0.73, 95% CI 0.53-1.00, p for trend = 0.06), particularly for the highest quartile of ER+ breast cancer (OR = 0.67, 95% CI 0.46-0.99, p for trend = 0.06), among NHW women (OR = 0.49, 95% CI 0.29-0.81, p for trend = 0.01) and invasive breast cancer (OR = 0.63; 95% CI: 0.42, 0.93, P-trend = 0.01). Methionine intake was also inversely associated with ER+ breast cancer (OR for 4th quartile = 0.83, 95% CI 0.66-1.03, p for trend = 0.04), primarily among Hispanic women (OR = 0.71, 95% CI 0.47-1.06, and P for trend = 0.02). Conclusion: Higher intake of folate is marginally associated with a lower risk for ER- breast cancer, and higher intakes of vitamin B-12 and methionine are marginally associated with a lower risk of ER+ breast cancer.	[Yang, Dongyan; Baumgartner, Richard N.; Wang, Chenxi; Baumgartner, Kathy B.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA; [Slattery, Martha L.; Murtaugh, Maureen A.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Giuliano, Anna R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Risendal, Betsy C.; Byers, Tim] Univ Colorado, Sch Publ Hlth, Denver, CO 80202 USA	University of Louisville; Utah System of Higher Education; University of Utah; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Colorado School of Public Health; University of Colorado System; University of Colorado Denver	Yang, DY (corresponding author), Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA.	d0yang01@louisville.edu	Lv, Yuanjie/AER-0767-2022; Murtaugh, Maureen/AAN-6225-2020; Wang, Wei Eric/AAE-9504-2022; peng, yu/GXW-2071-2022; Wang, Wei Eric/AFE-0795-2022	Murtaugh, Maureen/0000-0001-5281-0302; 	National Cancer Institute [CA 078682, CA 078762, CA078552, CA078802, N01-PC-67000]; Utah Cancer Registry; State of Utah Department of Health	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Utah Cancer Registry; State of Utah Department of Health	This research was supported by the grants from the National Cancer Institute (CA 078682, CA 078762, CA078552, and CA078802). This research also was supported by the Utah Cancer Registry, which is funded by Contract #N01-PC-67000 from the National Cancer Institute, and with additional support from the State of Utah Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Baumgartner Kathy B., 2002, Ethnicity & Disease, V12, P460; Buechley RW, 1976, GEN USEFUL ETHNIC SE; Chen J, 2005, CANCER RES, V65, P1606, DOI 10.1158/0008-5472.CAN-04-2630; Cho EY, 2007, CANCER EPIDEM BIOMAR, V16, P2787, DOI 10.1158/1055-9965.EPI-07-0683; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Curtin K, 2007, CARCINOGENESIS, V28, P1672, DOI 10.1093/carcin/bgm089; DuBose Katrina D, 2007, J Phys Act Health, V4, P343; Durnitrescu RG, 2005, ALCOHOL, V35, P213, DOI 10.1016/j.alcohol.2005.04.005; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; Ericson U, 2007, AM J CLIN NUTR, V86, P434, DOI 10.1093/ajcn/86.2.434; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; Hines LM, 2008, CANCER EPIDEM BIOMAR, V17, P2700, DOI 10.1158/1055-9965.EPI-08-0504; HOWARD CA, 1983, AM J EPIDEMIOL, V117, P27, DOI 10.1093/oxfordjournals.aje.a113512; Institute of Medicine, 1998, DIET REF INT THIAM R, P1; Jatoi I, 2007, J CLIN ONCOL, V25, P1683, DOI 10.1200/JCO.2006.09.2106; JEWELL N. P., 2004, STAT EPIDEMIOLOGY; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; Kim YI, 2006, NUTR REV, V64, P468, DOI 10.1301/nr.2006.oct.468-475; Koutros S, 2008, AM J EPIDEMIOL, V167, P287, DOI 10.1093/aje/kwm307; Lajous M, 2006, CANCER EPIDEM BIOMAR, V15, P443, DOI 10.1158/1055-9965.EPI-05-0532; Lajous M, 2006, CANCER CAUSE CONTROL, V17, P1209, DOI 10.1007/s10552-006-0053-3; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Levi F, 2001, INT J CANCER, V91, P260, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1041&gt;3.3.CO;2-R; Lewis SJ, 2006, JNCI-J NATL CANCER I, V98, P1607, DOI 10.1093/jnci/djj440; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Maruti SS, 2009, AM J CLIN NUTR, V89, P624, DOI 10.3945/ajcn.2008.26568; Mason JB, 2005, ALCOHOL, V35, P235, DOI 10.1016/j.alcohol.2005.03.012; Moore CE, 2005, J NUTR, V135, P2478, DOI 10.1093/jn/135.10.2478; Murtaugh MA, 2008, AM J CLIN NUTR, V87, P978, DOI 10.1093/ajcn/87.4.978; Murtaugh MA, 2007, J AM DIET ASSOC, V107, P1311, DOI 10.1016/j.jada.2007.05.008; Murtaugh MA, 2007, CANCER CAUSE CONTROL, V18, P153, DOI 10.1007/s10552-006-0099-2; Negri E, 2000, J NATL CANCER I, V92, P1270, DOI 10.1093/jnci/92.15.1270-a; Osborne CK, 1991, BREAST DIS, P301; Prinz-Langenohl R, 2001, EUR J NUTR, V40, P98, DOI 10.1007/PL00007387; Risendal B, 2008, CANC CAUSES CONTROL; Rogers A, 2004, AM J EPIDEMIOL, V160, P85, DOI 10.1093/aje/kwh176; Rohan TE, 2000, J NATL CANCER I, V92, P266, DOI 10.1093/jnci/92.3.266; Rollison DE, 2008, AM J EPIDEMIOL, V167, P447, DOI 10.1093/aje/kwm322; Satia-Abouta J, 2003, CANCER EPIDEM BIOMAR, V12, P747; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Sellers TA, 2002, CANCER EPIDEM BIOMAR, V11, P1104; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Shrubsole MJ, 2011, AM J EPIDEMIOL, V173, P1171, DOI 10.1093/aje/kwq491; Shrubsole MJ, 2004, CANCER EPIDEM BIOMAR, V13, P190, DOI 10.1158/1055-9965.EPI-03-0273; Shrubsole MJ, 2001, CANCER RES, V61, P7136; Slattery ML, 2007, BREAST CANCER RES TR, V104, P197, DOI 10.1007/s10549-006-9403-9; Slattery ML, 2008, BREAST CANCER RES TR, V109, P101, DOI 10.1007/s10549-007-9629-1; Slattery ML, 2008, OBESITY, V16, P339, DOI 10.1038/oby.2007.44; Slattery ML, 2007, BREAST CANCER RES TR, V105, P327, DOI 10.1007/s10549-006-9453-z; Slattery ML, 2007, ANN EPIDEMIOL, V17, P342, DOI 10.1016/j.annepidem.2006.10.017; Slattery ML, 2007, CANCER EPIDEM BIOMAR, V16, P747, DOI 10.1158/1055-9965.EPI-06-0667; Slattery ML, 2007, BREAST CANCER RES TR, V102, P85, DOI 10.1007/s10549-006-9292-y; SLATTERY ML, 1994, J AM DIET ASSOC, V94, P761, DOI 10.1016/0002-8223(94)91944-5; Slattery ML, 2005, CANCER CAUSE CONTROL, V16, P1147, DOI 10.1007/s10552-005-0318-2; STANFORD JL, 1989, AM J PUBLIC HEALTH, V79, P71, DOI 10.2105/AJPH.79.1.71; Steffen AD, 2008, CANCER EPIDEM BIOMAR, V17, P447, DOI 10.1158/1055-9965.EPI-07-2576; Stevens VL, 2010, AM J CLIN NUTR, V91, P1708, DOI 10.3945/ajcn.2009.28553; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Suitor CW, 2000, J AM DIET ASSOC, V100, P88, DOI 10.1016/S0002-8223(00)00027-4; Suzuki T, 2008, CARCINOGENESIS, V29, P356, DOI 10.1093/carcin/bgm295; Sweeney C, 2008, CANCER CAUSE CONTROL, V19, P391, DOI 10.1007/s10552-007-9098-1; Sweeney C, 2007, AM J EPIDEMIOL, V166, P1210, DOI 10.1093/aje/kwm192; Sweeney C, 2007, CANCER EPIDEM BIOMAR, V16, P142, DOI 10.1158/1055-9965.EPI-06-0706; Ulrich CM, 2006, NUTRIENT-GENE INTERACTIONS IN CANCER, P75, DOI 10.1201/9781420004847.ch5; Ulrich CM, 2007, AM J CLIN NUTR, V86, P271, DOI 10.1093/ajcn/86.2.271; Wang C, 2008, BREAST CANC RES TREA; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett W., 2012, NUTR EPIDEMIOLOGY; Word DL, 1996, 13 US BUR CENS POP D, P1; Zhang SM, 2005, CANCER EPIDEM BIOMAR, V14, P2004, DOI 10.1158/1055-9965.EPI-05-0083; Zhang SM, 1999, JAMA-J AM MED ASSOC, V281, P1632, DOI 10.1001/jama.281.17.1632; Zhu KM, 1998, CANCER CAUSE CONTROL, V9, P615, DOI 10.1023/A:1008819210777	78	222	229	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54495	10.1371/journal.pone.0054495	http://dx.doi.org/10.1371/journal.pone.0054495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23667467	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000006
J	Yang, DZ; Wang, W; Li, LP; Peng, YL; Chen, P; Huang, HY; Guo, YL; Xia, XW; Wang, YY; Wang, HY; Wang, WE; Zeng, CY				Yang, Dezhong; Wang, Wei; Li, Liangpeng; Peng, Yulan; Chen, Peng; Huang, Haiyun; Guo, Yanli; Xia, Xuewei; Wang, Yuanyuan; Wang, Hongyong; Wang, Wei Eric; Zeng, Chunyu			The Relative Contribution of Paracine Effect versus Direct Differentiation on Adipose-Derived Stem Cell Transplantation Mediated Cardiac Repair	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FUNCTIONAL IMPROVEMENT; REGENERATIVE MEDICINE; PARACRINE MECHANISMS; CONDITIONED MEDIUM; STROMAL CELLS; IN-VITRO; HEART; THERAPY; DISEASE	Background: Recent studies have demonstrated that transplantation of adipose-derived stem cell (ADSC) can improve cardiac function in animal models of myocardial infarction (MI). However, the mechanisms underlying the beneficial effect are not fully understood. In this study, we characterized the paracrine effect of transplanted ADSC and investigated its relative importance versus direct differentiation in ADSC transplantation mediated cardiac repair. Methodology/Principal Findings: MI was experimentally induced in mice by ligation of the left anterior descending coronary artery. Either human ADSC, conditioned medium (CM) collected from the same amount of ADSC or control medium was injected into the peri-infarct region immediately after MI. Compared with the control group, both ADSC and ADSC-CM significantly reduced myocardial infarct size and improved cardiac function. The therapeutic efficacy of ADSC was moderately superior to ADSC-CM. ADSC-CM significantly reduced cardiomyocyte apoptosis in the infarct border zone, to a similar degree with ADSC treatment. ADSC enhanced angiogenesis in the infarct border zone, but to a stronger degree than that seen in the ADSC-CM treatment. ADSC was able to differentiate to endothelial cell and smooth muscle cell in post-MI heart; these ADSC-derived vascular cells amount to about 9% of the enhanced angiogenesis. No cardiomyocyte differentiated from ADSC was found. Conclusions: ADSC-CM is sufficient to improve cardiac function of infarcted hearts. The therapeutic function of ADSC transplantation is mainly induced by paracrine-mediated cardioprotection and angiogenesis, while ADSC differentiation contributes a minor benefit by being involved in angiogenesis. Highlights 1 ADSC-CM is sufficient to exert a therapeutic potential. 2. ADSC was able to differentiate to vascular cells but not cardiomyocyte. 3. ADSC derived vascular cells amount to about 9% of the enhanced angiogenesis. 4. Paracrine effect is the major mechanism of ADSC therapeutic function for MI.	[Yang, Dezhong; Wang, Wei; Li, Liangpeng; Peng, Yulan; Chen, Peng; Xia, Xuewei; Wang, Hongyong; Wang, Wei Eric; Zeng, Chunyu] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Huang, Haiyun; Guo, Yanli] Third Mil Med Univ, Southwest Hosp, Dept Ultrasonog, Chongqing, Peoples R China; [Wang, Yuanyuan] Third Mil Med Univ, Daping Hosp, Dept Plast Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Wang, WE (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	wangw28@gmail.com; cyzeng1@hotmail.com	Lv, Yuanjie/AER-0767-2022; Murtaugh, Maureen/AAN-6225-2020; Wang, Wei Eric/AAE-9504-2022; peng, yu/GXW-2071-2022; Wang, Wei Eric/AFE-0795-2022	Murtaugh, Maureen/0000-0001-5281-0302; 	National Natural Science Foundation of China [31130029, 81100111, 30925018]; Natural Science Foundation Project of CQ CSTC (CSTC) [2009BA5044]; National Basic Research Program of China (973 Program) [2008CB517308, 2012CB517801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC (CSTC)(Natural Science Foundation Project of CQ CSTC); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by the grants from the National Natural Science Foundation of China (31130029, 81100111, 30925018), Natural Science Foundation Project of CQ CSTC (CSTC, 2009BA5044), and National Basic Research Program of China (973 Program, 2008CB517308, 2012CB517801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XW, 2010, EUR HEART J, V31, P489, DOI 10.1093/eurheartj/ehp568; Bayes-Genis A, 2010, J MOL CELL CARDIOL, V49, P771, DOI 10.1016/j.yjmcc.2010.08.010; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063; Christoffels V, 2011, NATURE, V474, P585, DOI 10.1038/474585a; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Deveza L, 2013, STEM CELLS DEV, V22, P483, DOI 10.1089/scd.2012.0201; Egashira Y, 2012, BRAIN RES, V1461, P87, DOI 10.1016/j.brainres.2012.04.033; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li XH, 2007, J MOL CELL CARDIOL, V42, P295, DOI 10.1016/j.yjmcc.2006.07.002; Li YX, 2011, CIRCULATION, V123, P866, DOI 10.1161/CIRCULATIONAHA.110.947531; Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Ramkisoensing AA, 2012, STEM CELLS, V30, P1236, DOI 10.1002/stem.1086; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Sanchez PL, 2010, EUR HEART J, V31, P394, DOI 10.1093/eurheartj/ehp403; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Wang XH, 2009, CIRCULATION, V120, pS238, DOI 10.1161/CIRCULATIONAHA.109.885236; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xiong DZ, 2010, J MOL CELL CARDIOL, V48, P211, DOI 10.1016/j.yjmcc.2009.07.003; Yang JJ, 2012, TOHOKU J EXP MED, V226, P231, DOI 10.1620/tjem.226.231; Zhang HY, 2010, CIRC RES, V107, P800, DOI 10.1161/CIRCRESAHA.110.219220	40	222	229	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59020	10.1371/journal.pone.0059020	http://dx.doi.org/10.1371/journal.pone.0059020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23667467	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100066
J	Wang, H; Chen, K; Pan, YF; Jing, FY; Liu, H				Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He			Associations and Impact Factors between Living Arrangements and Functional Disability among Older Chinese Adults	PLOS ONE			English	Article							SOCIAL SUPPORT; MARITAL-STATUS; DEPRESSIVE SYMPTOMS; HEALTH-STATUS; MORTALITY; GENDER; INTEGRATION; PREDICTORS; CANCER; STAGE	Objectives: To examine the association of living arrangements with functional disability among older persons and explore the mediation of impact factors on the relationship. Design: Cross-sectional analysis using data from Healthy Aging study in Zhejiang Province. Participants: Analyzed sample was drawn from a representative rural population of older persons in Wuyi County, Zhejiang Province, including 1542 participants aged 60 and over in the second wave of the study. Measurements: Living arrangements, background, functional disability, self-rated health, number of diseases, along with contemporaneous circumstances including income, social support (physical assistance and emotional support). Instrument was Activities of Daily Living (ADL) scale, including Basic Activities Daily Living (BADL) and Instrumental Activities of Daily Living (IADL). Results: Living arrangements were significantly associated with BADL, IADL and ADL disability. Married persons living with or without children were more advantaged on all three dimensions of functional disability. Unmarried older adults living with children only had the worst functional status, even after controlling for background, social support, income and health status variables (compared with the unmarried living alone, beta for BADL: -1.262, beta for IADL: -2.112, beta for ADL: -3.388; compared with the married living with children only, beta for BADL: -1.166, beta for IADL: -2.723, beta for ADL: -3.902). In addition, older adults without difficulty in receiving emotional support, in excellent health and with advanced age had significantly better BADL, IADL and ADL function. However, a statistically significant association between physical assistance and functional disability was not found. Conclusion: Functional disabilities vary by living arrangements with different patterns and other factors. Our results highlight the association of unmarried elders living with children only and functioning decline comparing with other types. Our study implies policy makers should pay closer attention to unmarried elders living with children in community. Community service especially emotional support such as psychological counseling is important social support and should be improved.	[Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He] Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention	Chen, K (corresponding author), Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	ck@zju.edu.cn	wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022	YANG, CHIEN-MING/0000-0001-8144-8496; wang, huaizhou/0000-0002-4126-100X	Zhejiang Research Center on Aging	Zhejiang Research Center on Aging	The source of funding that has supported our research is from Zhejiang Research Center on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWIN DF, 1985, J MARRIAGE FAM, V47, P319, DOI 10.2307/352132; AUSLANDER GK, 1991, J AGING HEALTH, V3, P493, DOI [DOI 10.1177/089826439100300404, DOI 10.1177/089826439100.300404]; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Beydoun MA, 2005, SOC SCI MED, V60, P2045, DOI 10.1016/j.socscimed.2004.08.063; BLAZER DG, 1982, AM J EPIDEMIOL, V115, P684, DOI 10.1093/oxfordjournals.aje.a113351; BROADHEAD WE, 1983, AM J EPIDEMIOL, V117, P521, DOI 10.1093/oxfordjournals.aje.a113575; Chen FN, 2008, J FAM ISSUES, V29, P1379, DOI 10.1177/0192513X07313602; Cheng Ching-Yu, 2006, J Gerontol Nurs, V32, P16, DOI 10.3928/00989134-20060901-05; Cheng CY, 2006, J GERONTOLOGICAL NUR, V9, P24; Chou KL, 2006, AGING MENT HEALTH, V10, P583, DOI 10.1080/13607860600641150; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Davis MA, 1997, AM J PUBLIC HEALTH, V87, P371, DOI 10.2105/AJPH.87.3.371; Denton M, 1999, SOC SCI MED, V48, P1221, DOI 10.1016/S0277-9536(98)00421-3; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; GRIMBY G, 1988, SCAND J REHABIL MED, V20, P93; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; House JS, 1981, WORK STRESS SOCIAL S; HUGHES M, 1981, AM J SOCIOL, V87, P48, DOI 10.1086/227419; Hughes ME, 2002, J SOCIOL, V87, P48; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Hupcey JE, 1998, J ADV NURS, V27, P1231, DOI 10.1046/j.1365-2648.1998.01231.x; Jefferson AL, 2008, AM J GERIAT PSYCHIAT, V16, P375, DOI 10.1097/JGP.0b013e318162f197; JOUNG IMA, 1994, INT J EPIDEMIOL, V23, P91, DOI 10.1093/ije/23.1.91; Kharicha K, 2007, BRIT J GEN PRACT, V57, P271; Knodel J, 2002, PATTERNS DETERMINANT, P143; Koskinen S, 2007, INT J EPIDEMIOL, V36, P1255, DOI 10.1093/ije/dym212; LAWTON MP, 1984, RES AGING, V6, P323, DOI 10.1177/0164027584006003002; Lawton MP, 1976, HDB PSYCHOL AGING; Lennartsson C, 1999, RES AGING, V21, P657, DOI 10.1177/0164027599215002; Li LW, 2009, SOC SCI MED, V68, P220, DOI 10.1016/j.socscimed.2008.10.013; Litwin H, 2012, J AGING HEALTH, V24, P846, DOI 10.1177/0898264312436714; Lund R, 2002, SOC SCI MED, V55, P673, DOI 10.1016/S0277-9536(01)00219-2; Macran S, 1996, SOC SCI MED, V42, P1203, DOI 10.1016/0277-9536(95)00432-7; MOEN P, 1989, AM SOCIOL REV, V54, P635, DOI 10.2307/2095884; Mor-Barak M E, 1991, J Appl Gerontol, V10, P293, DOI 10.1177/073346489101000305; MORITZ DJ, 1993, J CLIN EPIDEMIOL, V46, P443, DOI 10.1016/0895-4356(93)90021-R; Russell D, 2009, J GERONTOL B-PSYCHOL, V64, P95, DOI 10.1093/geronb/gbn002; Sarwari AR, 1998, AM J EPIDEMIOL, V147, P370; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; Shin JK, 2008, PSYCHIAT INVEST, V5, P155, DOI 10.4306/pi.2008.5.3.155; Taylor MG, 2004, J GERONTOL B-PSYCHOL, V59, pS238, DOI 10.1093/geronb/59.4.S238; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Vanderhorst RK, 2005, AGING MENT HEALTH, V9, P517, DOI 10.1080/13607860500193062; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Waite LJ, 1999, J GERONTOL B-PSYCHOL, V54, pS136, DOI 10.1093/geronb/54B.3.S136; Wang JJ, 2001, INT J NURS STUD, V38, P339, DOI 10.1016/S0020-7489(00)00072-9; Wong YS, 2009, J CROSS-CULT GERONTO, V24, P209, DOI 10.1007/s10823-008-9081-7; Wu Z, 2008, SPRINGER SERIES DEMO, V20, P197; Yeh SCJ, 2004, SOC BEHAV PERSONAL, V32, P129, DOI 10.2224/sbp.2004.32.2.129; You KS, 2009, ARCH PSYCHIAT NURS, V23, P309, DOI 10.1016/j.apnu.2008.07.003; Zhang H, 2004, FILIAL PIETY PRACTIC, P63; Zunzunegui MV, 2001, INT J EPIDEMIOL, V30, P1090, DOI 10.1093/ije/30.5.1090; Zyzanski S J, 1989, Fam Med, V21, P199	54	90	99	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53879	10.1371/journal.pone.0053879	http://dx.doi.org/10.1371/journal.pone.0053879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23843989	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400094
J	Zhang, GL; Huang, SQ; Duan, QH; Shu, W; Hou, YC; Zhu, SY; Miao, XP; Nie, SF; Wei, S; Guo, N; Shan, H; Xu, YH				Zhang, Guoliang; Huang, Shuqiong; Duan, Qionghong; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Guo, Nan; Shan, Hua; Xu, Yihua			Application of a Hybrid Model for Predicting the Incidence of Tuberculosis in Hubei, China	PLOS ONE			English	Article							TIME-SERIES; HEALTH SYSTEM; SEASONALITY; TRANSMISSION	Background: A prediction model for tuberculosis incidence is needed in China which may be used as a decision-supportive tool for planning health interventions and allocating health resources. Methods: The autoregressive integrated moving average (ARIMA) model was first constructed with the data of tuberculosis report rate in Hubei Province from Jan 2004 to Dec 2011. The data from Jan 2012 to Jun 2012 were used to validate the model. Then the generalized regression neural network (GRNN)-ARIMA combination model was established based on the constructed ARIMA model. Finally, the fitting and prediction accuracy of the two models was evaluated. Results: A total of 465,960 cases were reported between Jan 2004 and Dec 2011 in Hubei Province. The report rate of tuberculosis was highest in 2005 (119.932 per 100,000 population) and lowest in 2010 (84.724 per 100,000 population). The time series of tuberculosis report rate show a gradual secular decline and a striking seasonal variation. The ARIMA (2, 1, 0) x (0, 1, 1) 12 model was selected from several plausible ARIMA models. The residual mean square error of the GRNN-ARIMA model and ARIMA model were 0.4467 and 0.6521 in training part, and 0.0958 and 0.1133 in validation part, respectively. The mean absolute error and mean absolute percentage error of the hybrid model were also less than the ARIMA model. Discussion and Conclusions: The gradual decline in tuberculosis report rate may be attributed to the effect of intensive measures on tuberculosis. The striking seasonal variation may have resulted from several factors. We suppose that a delay in the surveillance system may also have contributed to the variation. According to the fitting and prediction accuracy, the hybrid model outperforms the traditional ARIMA model, which may facilitate the allocation of health resources in China.	[Zhang, Guoliang; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Xu, Yihua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Huang, Shuqiong] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Duan, Qionghong] TB Inst TB Control & Prevent Wuhan City, Wuhan, Peoples R China; [Guo, Nan] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shan, Hua] Johns Hopkins Med Inst, Dept Pathol, Div Blood Transfus, Baltimore, MD 21205 USA	Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Xu, YH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	xuyihua_6@hotmail.com	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BuHamra S, 2003, APPL MATH MODEL, V27, P805, DOI 10.1016/S0307-904X(03)00079-9; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; Chen XY, 2004, LANCET, V364, P417; Cheng G, 2005, T ROY SOC TROP MED H, V99, P355, DOI 10.1016/j.trstmh.2004.07.005; Debanne SM, 2000, EMERG INFECT DIS, V6, P148, DOI 10.3201/eid0602.000207; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Hu WB, 2004, AM J TROP MED HYG, V71, P129, DOI 10.4269/ajtmh.2004.71.129; Jain A, 2007, APPL SOFT COMPUT, V7, P585, DOI 10.1016/j.asoc.2006.03.002; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057752; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Leung MT, 2000, COMPUT OPER RES, V27, P1093, DOI 10.1016/S0305-0548(99)00144-6; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Li WM, 2008, NEURAL COMPUT APPL, V17, P441, DOI 10.1007/s00521-007-0131-9; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; Medeiros MC, 2000, IEEE T NEURAL NETWOR, V11, P1402, DOI 10.1109/72.883463; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; Ozyildirim BM, 2013, NEURAL NETWORKS, V39, P18, DOI 10.1016/j.neunet.2012.12.001; Parrinello CM, 2012, INT J TUBERC LUNG D, V16, P32, DOI 10.5588/ijtld.11.0145; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076	31	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80969	10.1371/journal.pone.0080969	http://dx.doi.org/10.1371/journal.pone.0080969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223232	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200125
J	Zhang, A; Qi, QW; Jiang, LL; Zhou, F; Wang, JF				Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng			Population Exposure to PM2.5 in the Urban Area of Beijing	PLOS ONE			English	Article							COARSE PARTICLES; FINE PARTICLES; AIR-QUALITY	The air quality in Beijing, especially its PM2.5 level, has become of increasing public concern because of its importance and sensitivity related to health risks. A set of monitored PM2.5 data from 31 stations, released for the first time by the Beijing Environmental Protection Bureau, covering 37 days during autumn 2012, was processed using spatial interpolation and overlay analysis. Following analyses of these data, a distribution map of cumulative exceedance days of PM2.5 and a temporal variation map of PM2.5 for Beijing have been drawn. Computational and analytical results show periodic and directional trends of PM2.5 spreading and congregating in space, which reveals the regulation of PM2.5 overexposure on a discontinuous medium-term scale. With regard to the cumulative effect of PM2.5 on the human body, the harm from lower intensity overexposure in the medium term, and higher overexposure in the short term, are both obvious. Therefore, data of population distribution were integrated into the aforementioned PM2.5 spatial spectrum map. A spatial statistical analysis revealed the patterns of PM2.5 gross exposure and exposure probability of residents in the Beijing urban area. The methods and conclusions of this research reveal relationships between long-term overexposure to PM2.5 and people living in high-exposure areas of Beijing, during the autumn of 2012.	[Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Qi, QW (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	qiqw@igsnrr.ac.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	National Natural Science Foundation of China [41201412]; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Natural Science Foundation of China (41201412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktar H, 2005, STOCH ENV RES RISK A, V19, P301, DOI 10.1007/s00477-005-0234-8; Bureau BCA Mapping BIoSa, 2005, BEIJ ADM DISTR ATL; Bureau BCA Mapping BIoSa, 2007, BEIJ ADM DISTR TUZH; China's Ministry of Environmental Protection, 2012, AMB AIR QUAL STAND; Du XA, 2010, J ENVIRON SCI-CHINA, V22, P1757, DOI 10.1016/S1001-0742(09)60316-8; Fann N, 2011, RISK ANAL, DOI DOI 10.1111/J.1539-6924.2011.01630.X; Gavett SH, 2001, INT ARCH ALLERGY IMM, V124, P109, DOI 10.1159/000053685; Haley VB, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-42; Hao YP, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-3; Jorgensen NW, 2012, J AM COLL CARDIOL, V60; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kunii O, 2002, ARCH ENVIRON HEALTH, V57, P16, DOI 10.1080/00039890209602912; Li P, 2012, PLOS ONE; Lippmann M, 1998, ISSUES ENV SCI TECHN, V10, P75; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; Municipality OftSPCoB Statistics BMBo Beijing SOotNBoSi, 2012, TAB 2010 POP CENS BE; Pang W, 2010, ENVIRONMETRICS, V21, P305, DOI 10.1002/env.1007; Qiu F, 2012, GISCI REMOTE SENS, V49, P644, DOI 10.2747/1548-1603.49.5.644; Schwartz J, 2000, EPIDEMIOLOGY, V11, P6, DOI 10.1097/00001648-200001000-00004; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Urbat M, 2004, ATMOS ENVIRON, V38, P3781, DOI 10.1016/j.atmosenv.2004.03.061; Vallejo M, 2006, J EXPO SCI ENV EPID, V16, P125, DOI 10.1038/sj.jea.7500447; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; [袁杨森 YUAN Yangsen], 2007, [生态环境, Ecology and Environment], V16, P18; Zhao W, 2012, GEOGRAPHICAL RES, V417-428	25	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63486	10.1371/journal.pone.0063486	http://dx.doi.org/10.1371/journal.pone.0063486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	24223232	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500073
J	Zhang, YB; Wei, C; Jiang, WD; Wang, L; Li, CR; Wang, YY; Dow, JM; Sun, WX				Zhang, Yuanbao; Wei, Chao; Jiang, Wendi; Wang, Lei; Li, Churui; Wang, Yunyue; Dow, John Maxwell; Sun, Wenxian			The HD-GYP Domain Protein RpfG of Xanthomonas oryzae pv. oryzicola Regulates Synthesis of Extracellular Polysaccharides that Contribute to Biofilm Formation and Virulence on Rice	PLOS ONE			English	Article							DIFFUSIBLE SIGNAL FACTOR; 2-COMPONENT SYSTEM; GENE-EXPRESSION; CAMPESTRIS; VESICATORIA; PHOSPHODIESTERASE; SEQUENCES; ACTIVATOR; BACTERIA; CLUSTER	Bacterial leaf streak caused by Xanthomonas oryzae pv. oryzicola (Xoc) is one of the most important diseases in rice. However, little is known about the pathogenicity mechanisms of Xoc. Here we have investigated the function of three HD-GYP domain regulatory proteins in biofilm formation, the synthesis of virulence factors and virulence of Xoc. Deletion of rpfG resulted in altered production of extracellular polysaccharides (EPS), abolished virulence on rice and enhanced biofilm formation, but had little effect on the secretion of proteases and motility. In contrast, mutational analysis showed that the other two HD-GYP domain proteins had no effect on virulence factor synthesis and tested phenotypes. Mutation of rpfG led to up-regulation of the type III secretion system and altered expression of three putative glycosyltransferase genes gumD, pgaC and xagB, which are part of operons directing the synthesis of different extracellular polysaccharides. The pgaABCD and xagABCD operons were greatly up-regulated in the Xoc Delta rpfG mutant, whereas the expression of the gum genes was unaltered or slightly enhanced. The elevated biofilm formation of the Xoc Delta rpfG mutant was dramatically reduced upon deletion of gumD, xagA and xagB, but not when pgaA and pgaC were deleted. Interestingly, only the Delta gumD mutant, among these single gene mutants, exhibits multiple phenotype alterations including reduced biofilm and EPS production and attenuated virulence on rice. These data indicate that RpfG is a global regulator that controls biofilm formation, EPS production and bacterial virulence in Xoc and that both gumD- and xagB-dependent EPS contribute to biofilm formation under different conditions.	[Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China; [Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China; [Wei, Chao; Wang, Yunyue] Yunnan Agr Univ, Minist Educ, Key Lab Agr Biodivers & Plant Dis Management, Kunming, Peoples R China; [Dow, John Maxwell] Univ Coll Cork, Biosci Inst, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Yunnan Agricultural University; University College Cork	Zhang, YB (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China.	wxs@cau.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	973 program [2011CB100700]; National Natural Science Foundation of China (NSFC) [31272007]; PCSIRT Program [IRT1042, NCET-09-0736]; Ph.D. Programs Foundation of Ministry of Education of China; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	973 program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); PCSIRT Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the 973 program 2011CB100700, National Natural Science Foundation of China (NSFC) grant 31272007, PCSIRT Program IRT1042, NCET-09-0736 and Ph.D. Programs Foundation of Ministry of Education of China to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P911, DOI 10.1094/MPMI.2000.13.9.911; AWODERU VA, 1991, TROP PEST MANAGE, V37, P356, DOI 10.1080/09670879109371614; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; BOYER MH, 1984, J BIOTECHNOL, V1, P241, DOI 10.1016/0168-1656(84)90009-9; CANNON FC, 1979, MOL GEN GENET, V174, P59, DOI 10.1007/BF00433306; Castaneda A, 2005, MOL PLANT MICROBE IN, V18, P1306, DOI 10.1094/MPMI-18-1306; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; DiLuzio WR, 2005, NATURE, V435, P1271, DOI 10.1038/nature03660; Dow J M, 1994, Curr Top Microbiol Immunol, V192, P29; Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dow M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe23; Feng JX, 2009, MICROBIOL-SGM, V155, P3033, DOI 10.1099/mic.0.028910-0; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Guo YP, 2012, MOL PLANT MICROBE IN, V25, P165, DOI 10.1094/MPMI-07-11-0184; Han SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029192; HARDING NE, 1987, J BACTERIOL, V169, P2854, DOI 10.1128/jb.169.6.2854-2861.1987; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Huang DL, 2008, NUCLEIC ACIDS RES, V36, P4295, DOI 10.1093/nar/gkn328; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JIANG J, 2009, ACTA MICROBIOL SIN, V49, P1018; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Lee SW, 2008, J BACTERIOL, V190, P2183, DOI 10.1128/JB.01406-07; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Meng FH, 2011, J BACTERIOL, V193, P2477, DOI 10.1128/JB.01360-10; MOFFETT ML, 1983, PLANT BACTERIAL DIS, P393; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; OU SH, 1985, ROCE DIS; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Rai R, 2012, MOL PLANT MICROBE IN, V25, P789, DOI 10.1094/MPMI-11-11-0285-R; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Souza LCA, 2006, FEMS MICROBIOL LETT, V257, P236, DOI 10.1111/j.1574-6968.2006.00176.x; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Sultan SZ, 2010, FEMS MICROBIOL LETT, V302, P22, DOI 10.1111/j.1574-6968.2009.01837.x; Sun WX, 2011, MOL PLANT PATHOL, V12, P731, DOI [10.1111/j.1364-3703.2011.00707.x, 10.1111/J.1364-3703.2011.00707.X]; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Swift S, 1999, INFECT IMMUN, V67, P5192, DOI 10.1128/IAI.67.10.5192-5199.1999; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Yang FH, 2012, MOL PLANT MICROBE IN, V25, P1361, DOI 10.1094/MPMI-01-12-0014-R; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Zou HS, 2011, CURR MICROBIOL, V62, P908, DOI 10.1007/s00284-010-9804-1	73	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59428	10.1371/journal.pone.0059428	http://dx.doi.org/10.1371/journal.pone.0059428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	24223232	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700121
